PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ghrear, S; Baimel, A; Haddock, T; Birch, SAJ				Ghrear, Siba; Baimel, Adam; Haddock, Taeh; Birch, Susan A. J.			Are the classic false belief tasks cursed? Young children are just as likely as older children to pass a false belief task when they are not required to overcome the curse of knowledge	PLOS ONE			English	Article							EXECUTIVE FUNCTION; MIND DEVELOPMENT; METAANALYSIS; HINDSIGHT; COGNITION; CHILDHOOD; FLUENCY; ADULTS; PERSPECTIVE; DECEPTION	The question of when children understand that others have minds that can represent or misrepresent reality (i.e., possess a 'Theory of Mind') is hotly debated. This understanding plays a fundamental role in social interaction (e.g., interpreting human behavior, communicating, empathizing). Most research on this topic has relied on false belief tasks such as the 'Sally-Anne Task', because researchers have argued that it is the strongest litmus test examining one's understanding that the mind can misrepresent reality. Unfortunately, in addition to a variety of other cognitive demands this widely used measure also unnecessarily involves overcoming a bias that is especially pronounced in young children-the 'curse of knowledge' (the tendency to be biased by one's knowledge when considering less-informed perspectives). Three- to 6-year-old's (n = 230) false belief reasoning was examined across tasks that either did, or did not, require overcoming the curse of knowledge, revealing that when the curse of knowledge was removed three-year-olds were significantly better at inferring false beliefs, and as accurate as five- and six-year-olds. These findings reveal that the classic task is not specifically measuring false belief understanding. Instead, previously observed developmental changes in children's performance could be attributed to the ability to overcome the curse of knowledge. Similarly, previously observed relationships between individual differences in false belief reasoning and a variety of social outcomes could instead be the result of individual differences in the ability to overcome the curse of knowledge, highlighting the need to re-evaluate how best to interpret large bodies of research on false belief reasoning and social-emotional functioning.	[Ghrear, Siba; Haddock, Taeh; Birch, Susan A. J.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Baimel, Adam] Oxford Brookes Univ, Dept Psychol Hlth & Profess Dev, Oxford, England	University of British Columbia; Oxford Brookes University	Ghrear, S (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	siba.ghrear@psych.ubc.ca		Baimel, Adam/0000-0002-2629-7952	Natural Sciences and Engineering Research Council [2017-04067]; Social Sciences and Humanities Research Council [752-2017-2358]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was supported by The Natural Sciences and Engineering Research Council grant (2017-04067), as well as the Social Sciences and Humanities Research Council grant (752-2017-2358).	Ackerman R., 2016, LOOKING BACKWARD FOR; Apperly IA, 2009, PSYCHOL REV, V116, P953, DOI 10.1037/a0016923; Baillargeon R, 2010, TRENDS COGN SCI, V14, P110, DOI 10.1016/j.tics.2009.12.006; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Beaudoin C, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02905; Benson JE, 2013, DEV PSYCHOL, V49, P1615, DOI 10.1037/a0031056; Bernstein DM, 2007, CHILD DEV, V78, P1374, DOI 10.1111/j.1467-8624.2007.01071.x; Bernstein DM, 2018, MEM COGNITION, V46, P1331, DOI 10.3758/s13421-018-0840-6; Bernstein DM, 2011, J EXP PSYCHOL LEARN, V37, P378, DOI 10.1037/a0021971; Birch SAJ, 2017, ADV CHILD DEV BEHAV, V52, P185, DOI 10.1016/bs.acdb.2016.10.005; Birch SAJ, 2005, CURR DIR PSYCHOL SCI, V14, P25, DOI 10.1111/j.0963-7214.2005.00328.x; Birch SAJ, 2003, PSYCHOL SCI, V14, P283, DOI 10.1111/1467-9280.03436; Birch SAJ, 2007, PSYCHOL SCI, V18, P382, DOI 10.1111/j.1467-9280.2007.01909.x; Birch SAJ, 2017, COGNITION, V166, P447, DOI 10.1016/j.cognition.2017.04.015; Bloom P, 2000, COGNITION, V77, pB25, DOI 10.1016/S0010-0277(00)00096-2; Bzdok D, 2012, BRAIN STRUCT FUNCT, V217, P783, DOI 10.1007/s00429-012-0380-y; Call J, 1999, CHILD DEV, V70, P381, DOI 10.1111/1467-8624.00028; Capage L., 2001, EARLY EDUC DEV, V12, P613, DOI [DOI 10.1207/S15566935EED1204_7, 10.1207=s15566935eed1204_7]; Caputi M, 2012, DEV PSYCHOL, V48, P257, DOI 10.1037/a0025402; CHANDLER M, 1989, CHILD DEV, V60, P1263, DOI 10.2307/1130919; Charman T, 2002, SOC DEV, V11, P1, DOI 10.1111/1467-9507.00183; Coolin A, 2015, PSYCHON B REV, V22, P328, DOI 10.3758/s13423-014-0691-5; de Rosnay M, 2014, J CHILD LANG, V41, P1179, DOI 10.1017/S0305000913000433; de Villiers PA, 2012, BRIT J DEV PSYCHOL, V30, P188, DOI 10.1111/j.2044-835X.2011.02072.x; DENNETT DC, 1978, BEHAV BRAIN SCI, V1, P568, DOI 10.1017/S0140525X00076664; Devine RT, 2018, CHILD DEV, V89, P971, DOI 10.1111/cdev.12682; Devine RT, 2016, J EXP CHILD PSYCHOL, V149, P23, DOI 10.1016/j.jecp.2015.07.011; Devine RT, 2014, CHILD DEV, V85, P1777, DOI 10.1111/cdev.12237; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Durrleman S, 2016, RES AUTISM SPECT DIS, V21, P109, DOI 10.1016/j.rasd.2015.10.003; Etel E, 2019, J APPL DEV PSYCHOL, V60, P87, DOI 10.1016/j.appdev.2018.11.004; Fabricius WV, 2003, J COGN DEV, V4, P239, DOI 10.1207/S15327647JCD0403_01; Fabricius WV, 2010, DEV PSYCHOL, V46, P1402, DOI 10.1037/a0017648; Farhadian Mokhtar, 2010, Journal of Human Ecology, V29, P121; Farrar BG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198616; FISCHHOFF B, 1975, J EXP PSYCHOL HUMAN, V1, P288, DOI 10.1037/0096-1523.1.3.288; Fizke E, 2014, COGNITION, V130, P315, DOI 10.1016/j.cognition.2013.11.017; FODOR JA, 1992, COGNITION, V44, P283, DOI 10.1016/0010-0277(92)90004-2; Frith C, 2005, CURR BIOL, V15, pR644, DOI 10.1016/j.cub.2005.08.041; Geurten M, 2017, CHILD DEV, V88, P514, DOI 10.1111/cdev.12614; Ghrear S, 2021, CHILD DEV, V92, P54, DOI 10.1111/cdev.13437; Ghrear SE, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00118; GOPNIK A, 1993, BEHAV BRAIN SCI, V16, P90, DOI 10.1017/S0140525X00029253; GOPNIK A, 1988, CHILD DEV, V59, P26, DOI 10.2307/1130386; Grosso SS, 2019, INFANT BEHAV DEV, V54, P151, DOI 10.1016/j.infbeh.2018.09.012; Guilbault RL, 2004, BASIC APPL SOC PSYCH, V26, P103, DOI 10.1207/s15324834basp2602&3_1; Hala S, 1996, CHILD DEV, V67, P2948, DOI 10.2307/1131761; Happ6 FGE, 1994, J AUTISM DEV DISORD, V24; Harley EM, 2004, J EXP PSYCHOL LEARN, V30, P960, DOI 10.1037/0278-7393.30.5.960; He ZJ, 2012, BRIT J DEV PSYCHOL, V30, P14, DOI 10.1111/j.2044-835X.2011.02070.x; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Hughes C, 2005, CHILD DEV, V76, P356, DOI 10.1111/j.1467-8624.2005.00850_a.x; Imuta K, 2016, DEV PSYCHOL, V52, P1192, DOI 10.1037/dev0000140; JACOBY LL, 1989, J EXP PSYCHOL GEN, V118, P126, DOI 10.1037/0096-3445.118.2.126; Joseph RM, 2004, DEV PSYCHOPATHOL, V16, P137, DOI 10.1017/S095457940404444X; Koos O., 1997, WHY EATING SMARTIES; Kulke L, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190068; Lagattuta KH, 2014, CHILD DEV, V85, P659, DOI 10.1111/cdev.12154; Lagattuta KH, 2010, DEV PSYCHOL, V46, P1417, DOI 10.1037/a0021062; Lecce S, 2014, EUR J DEV PSYCHOL, V11, P305, DOI 10.1080/17405629.2013.821944; Lecce S, 2011, J EXP CHILD PSYCHOL, V110, P313, DOI 10.1016/j.jecp.2011.04.011; Legg EW, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170284; Leslie AM, 2004, TRENDS COGN SCI, V8, P528, DOI 10.1016/j.tics.2004.10.001; Liu D, 2008, DEV PSYCHOL, V44, P523, DOI 10.1037/0012-1649.44.2.523; Luo YY, 2011, COGNITION, V121, P289, DOI 10.1016/j.cognition.2011.07.011; McAlister A, 2007, COGNITIVE DEV, V22, P258, DOI 10.1016/j.cogdev.2006.10.009; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; Mitchell P, 1999, COGNITION, V70, P167, DOI 10.1016/S0010-0277(99)00011-6; Nilsen ES, 2009, COGNITIVE PSYCHOL, V58, P220, DOI 10.1016/j.cogpsych.2008.07.002; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; PERNER J, 1987, BRIT J DEV PSYCHOL, V5, P125, DOI 10.1111/j.2044-835X.1987.tb01048.x; Perner J, 1999, TRENDS COGN SCI, V3, P337, DOI 10.1016/S1364-6613(99)01362-5; Perner J, 1991, UNDERSTANDING REPRES; Peterson C, 2016, DEV PSYCHOL, V52, P46, DOI 10.1037/a0039833; Pineda-Alhucema W, 2018, NEUROPSYCHOL REV, V28, P341, DOI 10.1007/s11065-018-9381-9; Poulin-Dubois D, 2018, COGNITIVE DEV, V48, P302, DOI 10.1016/j.cogdev.2018.09.005; Powell LJ, 2018, COGNITIVE DEV, V46, P40, DOI 10.1016/j.cogdev.2017.10.004; Razza RA, 2009, J APPL DEV PSYCHOL, V30, P332, DOI 10.1016/j.appdev.2008.12.020; Repacholi BM, 1997, DEV PSYCHOL, V33, P12, DOI 10.1037/0012-1649.33.1.12; Ritblatt SN, 2000, J GENET PSYCHOL, V161, P53, DOI 10.1080/00221320009596694; Rothmayr C, 2011, NEUROIMAGE, V56, P1705, DOI 10.1016/j.neuroimage.2010.12.052; Rubio-Fernandez P, 2016, REV PHILOS PSYCHOL, V7, P835, DOI 10.1007/s13164-015-0290-z; Ruffman T, 2014, DEV REV, V34, P265, DOI 10.1016/j.dr.2014.04.001; Ryskin RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092406; Sabbagh MA, 2006, PSYCHOL SCI, V17, P74, DOI 10.1111/j.1467-9280.2005.01667.x; Schuwerk T, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.172273; Scott RM, 2017, TRENDS COGN SCI, V21, P237, DOI 10.1016/j.tics.2017.01.012; Setoh P, 2016, P NATL ACAD SCI USA, V113, P13360, DOI 10.1073/pnas.1609203113; Shih M, 2009, GROUP PROCESS INTERG, V12, P565, DOI 10.1177/1368430209337463; SIEGAL M, 1991, COGNITION, V38, P1, DOI 10.1016/0010-0277(91)90020-5; Sommer M, 2007, NEUROIMAGE, V35, P1378, DOI 10.1016/j.neuroimage.2007.01.042; SULLIVAN K, 1993, J EXP CHILD PSYCHOL, V56, P135, DOI 10.1006/jecp.1993.1029; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; Symons DK, 2005, BRIT J DEV PSYCHOL, V23, P81, DOI 10.1348/026151004x21080; Trauble B, 2010, INFANCY, V15, P434, DOI 10.1111/j.1532-7078.2009.00025.x; Walker S, 2005, J GENET PSYCHOL, V166, P297, DOI 10.3200/GNTP.166.3.297-312; Wang L, 2016, MIND LANG, V31, P147, DOI 10.1111/mila.12099; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wellman HM, 2004, CHILD DEV, V75, P523, DOI 10.1111/j.1467-8624.2004.00691.x; WHITTLESEA BWA, 1993, J EXP PSYCHOL LEARN, V19, P1235, DOI 10.1037/0278-7393.19.6.1235; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; WOOD G, 1978, J EXP PSYCHOL HUMAN, V4, P345, DOI 10.1037/0096-1523.4.2.345; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4	105	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0244141	10.1371/journal.pone.0244141	http://dx.doi.org/10.1371/journal.pone.0244141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606742	Green Published, gold			2022-12-26	WOS:000620629200161
J	Juliana, AE; Tang, MJ; Kemps, L; Noort, AC; Hermelijn, S; Plotz, FB; Zonneveld, R; Wilschut, JC				Juliana, Amadu E.; Tang, Ming-Jan; Kemps, Lex; Noort, Albert C.; Hermelijn, Sandra; Plotz, Frans B.; Zonneveld, Rens; Wilschut, Jan C.			Viral causes of severe acute respiratory infection in hospitalized children and association with outcomes: A two-year prospective surveillance study in Suriname	PLOS ONE			English	Article							INCREASED DISEASE SEVERITY; SYNCYTIAL VIRUS-DISEASE; YOUNG-CHILDREN; COINFECTIONS; MANAGEMENT; INFANTS; BURDEN; PANEL	Background Viruses are the most frequent cause of severe acute respiratory infection (SARI) in children. It is currently unknown whether presence of a virus, the number of viruses, or type of virus, are associated with clinical outcomes of pediatric SARI in developing countries. Methods Between 2012 and 2014 nasopharyngeal swabs and demographic and clinical variables were prospectively collected for surveillance of viral causes of SARI in Surinamese children within 48 hours after hospitalization. These swabs were tested for 18 respiratory viruses using a multiplex polymerase chain reaction (PCR) panel to identify the specific viral causes of SARI, unknown to the treating physicians. In post hoc analyses we evaluated if the PCR results, and demographic and clinical characteristics, were associated with course of disease, duration of respiratory support, and length of stay (LOS). Results Of a total of 316 analyzed children, 290 (92%) had one or more viruses. Rhinovirus/enterovirus (43%) and respiratory syncytial virus (34%) were most prevalent. Course of disease was mild in 234 (74%), moderate in 68 (22%), and severe in 14 (4%) children. Neither presence of a single virus, multiple viruses, or the type of virus, were different between groups. Prematurity and lower weight-for-age-z-score were independent predictors of a severe course of disease, longer duration of respiratory support, and longer LOS. Conclusions Viruses are common causes of pediatric SARI in Suriname, yet not necessarily associated with clinical outcomes. In developing countries, demographic and clinical variables can help to identify children at-risk for worse outcome, while PCR testing may be reserved to identify specific viruses, such as influenza, in specific patient groups or during outbreaks.	[Juliana, Amadu E.; Tang, Ming-Jan; Kemps, Lex; Zonneveld, Rens] Acad Hosp Paramaribo, Acad Pediat Ctr Suriname, Dept Pediat, Paramaribo, Suriname; [Noort, Albert C.] Univ Groningen, Fac Econ & Business, Groningen, Netherlands; [Hermelijn, Sandra] Acad Hosp Paramaribo, Dept Med Microbiol, Paramaribo, Suriname; [Plotz, Frans B.] Tergooi Hosp, Dept Pediat, Blaricum, Netherlands; [Plotz, Frans B.] Amsterdam UMC, Dept Pediat, Amsterdam, Netherlands; [Wilschut, Jan C.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands	Anton de Kom Universiteit van Suriname; Academisch Ziekenhuis Paramaribo; University of Groningen; Anton de Kom Universiteit van Suriname; Academisch Ziekenhuis Paramaribo; Tergooi Blaricum; University of Amsterdam; University of Groningen	Juliana, AE (corresponding author), Acad Hosp Paramaribo, Acad Pediat Ctr Suriname, Dept Pediat, Paramaribo, Suriname.	amadujuliana@gmail.com		Noort, A.C./0000-0003-2864-6498	AHP; University Medical Center Groningen; Twinning organization Suriname-Netherlands (Uitvoeringsorganisatie Twinningfaciliteit Suriname-Nederland: UTSN); Dutch Ministry of Foreign Affairs	AHP; University Medical Center Groningen; Twinning organization Suriname-Netherlands (Uitvoeringsorganisatie Twinningfaciliteit Suriname-Nederland: UTSN); Dutch Ministry of Foreign Affairs	Funding of the study originated from a collaborative project between the AHP and the University Medical Center Groningen, which was supported by the Twinning organization Suriname-Netherlands (Uitvoeringsorganisatie Twinningfaciliteit Suriname-Nederland: UTSN) and financed by the Dutch Ministry of Foreign Affairs. Funds were solely used for the purchasing of the multiplex PCR kits. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhin MR, 2013, INFLUENZA OTHER RESP, V7, P629, DOI 10.1111/irv.12037; Rodriguez DA, 2014, PEDIATR PULM, V49, P269, DOI 10.1002/ppul.22781; Anh HLD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018176; [Anonymous], WHO SURVEILLANCE CAS; [Anonymous], WHO WHO ANTHR SURV A; [Anonymous], WHO VACCINE PREVENTA; [Anonymous], WHO CHILD GROWTH STA; [Anonymous], SURINAME WHO STAT PR; Asner SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099392; Bicer S, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-22; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Brand HK, 2012, PEDIATR PULM, V47, P393, DOI 10.1002/ppul.21552; Cebey-Lopez M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136526; De Paulis M, 2011, J PEDIAT-BRAZIL, V87, P307, DOI [10.2223/JPED.2100, 10.1590/S0021-75572011000400006]; Dembele BPP, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026895; El-Radhi AS, 1999, ARCH DIS CHILD, V81, P231, DOI 10.1136/adc.81.3.231; Espinola EE, 2013, J INFECTION, V66, P196, DOI 10.1016/j.jinf.2012.10.014; Esposito S, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00196; Gamba-Sanchez N, 2016, EPIDEMIOL INFECT, V144, P2057, DOI 10.1017/S0950268816000273; Jin Y, 2012, CLIN MICROBIOL INFEC, V18, P74, DOI 10.1111/j.1469-0691.2011.03541.x; Jonnalagadda S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171687; Karron RA, 2017, LANCET, V390, P917, DOI 10.1016/S0140-6736(17)31476-9; Liu T, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0388-z; McGrath EJ, 2013, AM J INFECT CONTROL, V41, P868, DOI 10.1016/j.ajic.2013.01.010; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nascimento MS, 2010, CLINICS, V65, P1133, DOI 10.1590/S1807-59322010001100014; Omer SB, 2008, EPIDEMIOL INFECT, V136, P1319, DOI 10.1017/S0950268807000015; Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC; Parshuram CS, 2011, CRIT CARE, V15, DOI 10.1186/cc10337; Pourakbari B, 2014, TURKISH J PEDIATR, V56, P354; Schulert GS, 2013, PEDIATR INFECT DIS J, V32, P467, DOI 10.1097/INF.0b013e318284b146; Tiewsoh K, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-15; Umuhoza T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237857; Vieira Sandra E., 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P125, DOI 10.1590/S0036-46652001000300002; Wei L, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000742; Wishaupt JO, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2118-6; Wishaupt JO, 2011, PEDIATRICS, V128, pE1113, DOI 10.1542/peds.2010-2779	38	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247000	10.1371/journal.pone.0247000	http://dx.doi.org/10.1371/journal.pone.0247000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606795	Green Published, gold			2022-12-26	WOS:000620629200144
J	Cavalcanti, JC; Eriksson, A; Barbosa, PA				Cavalcanti, Julio Cesar; Eriksson, Anders; Barbosa, Plinio A.			Acoustic analysis of vowel formant frequencies in genetically-related and non-genetically related speakers with implications for forensic speaker comparison	PLOS ONE			English	Article								The purpose of this study was to explore the speaker-discriminatory potential of vowel formant mean frequencies in comparisons of identical twin pairs and non-genetically related speakers. The influences of lexical stress and the vowels' acoustic distances on the discriminatory patterns of formant frequencies were also assessed. Acoustic extraction and analysis of the first four speech formants F1-F4 were carried out using spontaneous speech materials. The recordings comprise telephone conversations between identical twin pairs while being directly recorded through high-quality microphones. The subjects were 20 male adult speakers of Brazilian Portuguese (BP), aged between 19 and 35. As for comparisons, stressed and unstressed oral vowels of BP were segmented and transcribed manually in the Praat software. F1-F4 formant estimates were automatically extracted from the middle points of each labeled vowel. Formant values were represented in both Hertz and Bark. Comparisons within identical twin pairs using the Bark scale were performed to verify whether the measured differences would be potentially significant when following a psychoacoustic criterion. The results revealed consistent patterns regarding the comparison of low-frequency and high-frequency formants in twin pairs and non-genetically related speakers, with high-frequency formants displaying a greater speaker-discriminatory power compared to low-frequency formants. Among all formants, F4 seemed to display the highest discriminatory potential within identical twin pairs, followed by F3. As for non-genetically related speakers, both F3 and F4 displayed a similar high discriminatory potential. Regarding vowel quality, the central vowel /a/ was found to be the most speaker-discriminatory segment, followed by front vowels. Moreover, stressed vowels displayed a higher inter-speaker discrimination than unstressed vowels in both groups; however, the combination of stressed and unstressed vowels was found even more explanatory in terms of the observed differences. Although identical twins displayed a higher phonetic similarity, they were not found phonetically identical.	[Cavalcanti, Julio Cesar; Eriksson, Anders] Stockholm Univ, Dept Linguist, Stockholm, Sweden; [Cavalcanti, Julio Cesar; Barbosa, Plinio A.] Univ Estadual Campinas, Inst Language Studies, Campinas, Brazil	Stockholm University; Universidade Estadual de Campinas	Cavalcanti, JC; Eriksson, A (corresponding author), Stockholm Univ, Dept Linguist, Stockholm, Sweden.; Cavalcanti, JC; Barbosa, PA (corresponding author), Univ Estadual Campinas, Inst Language Studies, Campinas, Brazil.	juliocesarcavalcanti@ling.su.se; anders.eriksson@ling.su.se; pbarbosa@unicamp.br	Barbosa, Plinio/AAP-5655-2021; Cavalcanti, Julio Cesar/AAJ-2475-2021	Barbosa, Plinio/0000-0001-6317-3548; Cavalcanti, Julio Cesar/0000-0002-4465-6242; Eriksson, Anders/0000-0002-6844-4834	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES); Swedish Foundation for International Cooperation in Research and Higher Education -Sweden (STINT) [88887.308270/2018-00]; National Council for Scientific and Technological Development - Brasil (CNPq) [140364/2017-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Swedish Foundation for International Cooperation in Research and Higher Education -Sweden (STINT); National Council for Scientific and Technological Development - Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) in cooperation with The Swedish Foundation for International Cooperation in Research and Higher Education -Sweden (STINT), Finance Code 88887.308270/2018-00, and in part by the National Council for Scientific and Technological Development - Brasil (CNPq), Finance code 140364/2017-0.	Barbosa P., 2012, Revista Diadorim, V12, P91; Barbosa PA, 2013, P NORDIC PROSODY, P97; Beck JM, 1997, HDB PHONETIC SCI, P256; Behlau M., 1988, ACTA AWHO, V7, P74; Berben L, 2012, INT J NURS STUD, V49, P1039, DOI 10.1016/j.ijnurstu.2012.01.015; Boersma P., 2010, PRAAT DOING PHONETIC, DOI DOI 10.1007/s10072-018-3598-5; Burzio L, 2007, LANG SCI, V29, P154, DOI 10.1016/j.langsci.2006.12.019; Cao H., 2019, P 19 INT C PHONETIC, P617, DOI [10.5167/uzh-177494, DOI 10.5167/UZH-177494]; Dilley LC, 2007, J PHONETICS, V35, P523, DOI 10.1016/j.wocn.2007.01.003; Escudero P, 2009, J ACOUST SOC AM, V126, P1379, DOI 10.1121/1.3180321; Fernandez ESS, 2012, INT ASS FOR PHON AC; Figueiredo RMd, 1994, IDENTIFICACAO FALANT; FOURAKIS M, 1991, J ACOUST SOC AM, V90, P1816, DOI 10.1121/1.401662; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; GARVIN PL, 1963, PHONETICA, V9, P193, DOI 10.1159/000258404; Gold E, 2011, INT J SPEECH LANG LA, V18, P293, DOI 10.1558/ijsll.v18i2.293; Gordon M, 2017, LINGUIST VANGUARD, V3, DOI 10.1515/lingvan-2017-0007; Harmegnies B., 1994, J PHYS 4, V4, pC5, DOI [10.1051/jp4:19945108, DOI 10.1051/JP4:19945108]; Kent RD, 2018, J COMMUN DISORD, V74, P74, DOI 10.1016/j.jcomdis.2018.05.004; Kunzel HJ, 2002, FORENSIC LINGUIST, V9, P83; LADEFOGED P, 1957, J ACOUST SOC AM, V29, P98, DOI 10.1121/1.1908694; Ladefoged P., 1996, ELEMENTS ACOUSTIC PH; LINDBLOM B, 1990, NATO ADV SCI I D-BEH, V55, P403; Lindblom B., 1990, PHONETIC EXPT RES, V11, P65; Loakes D, 2008, INT J SPEECH LANG LA, V15, P97, DOI [10.1558/ijsll.v15i1.97, DOI 10.1558/IJSLL.V15I1.97]; Loakes D, 2003, 15 INT C PHON SCI IC, V15, P691; Loakes D, 2004, P 10 AUSTR INT C SPE, P289; Loakes D, 2010, AUST J LINGUIST, V30, P155, DOI 10.1080/07268601003678601; Nolan F, 1983, PHONETIC BASES SPEAK; Nolan F., 2013, FORENSIC LINGUIST, V3, P39, DOI [10.1558/ijsll.v3i1.39, DOI 10.1558/IJSLL.V3I1.39]; Passetti RR, 2015, EFEITO TELEFONE CELU; Recasens D, 2006, SPEECH COMMUN, V48, P645, DOI 10.1016/j.specom.2005.09.011; Rose P, 2002, FORENSIC SPEAKER IDE, V3; San Segundo E, 2014, FORENSIC SPEAKER COM; San Segundo E., 2013, 7 JORN REC BIOM PERS, P10; San Segundo E, 2017, FORENSIC SCI INT, V270, P25, DOI 10.1016/j.forsciint.2016.11.020; Santiago F, 2018, P 9 INT C SPEECH PRO, P453; Schwartz JL, 1997, J PHONETICS, V25, P255, DOI 10.1006/jpho.1997.0043; Schwartz JL, 1997, J PHONETICS, V25, P233, DOI 10.1006/jpho.1997.0044; Segundo ES, 2019, J PHONETICS, V75, P1, DOI 10.1016/j.wocn.2019.04.001; Silber-Varod V, 2019, 19 INT C PHON SCI, P3538; STEVENS KN, 1955, J ACOUST SOC AM, V27, P484, DOI 10.1121/1.1907943; Sundberg J., 2015, CIENCIA VOZ FATOS VO; SUSSMAN HM, 1990, J ACOUST SOC AM, V88, P87, DOI 10.1121/1.399848; Takemoto H, 2006, J ACOUST SOC AM, V120, P2228, DOI 10.1121/1.2261270; Takemoto H, 2010, J ACOUST SOC AM, V128, P3724, DOI 10.1121/1.3502470; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Tomczak M., 2014, TRENDS SPORT SCI, V1, P19, DOI DOI 10.7326/0003-4819-159-3-201308060-00005; TRAUNMULLER H, 1990, J ACOUST SOC AM, V88, P97, DOI 10.1121/1.399849; TRAUNMULLER H, 1984, SPEECH COMMUN, V3, P49, DOI 10.1016/0167-6393(84)90008-6; Tsao YC, 2006, J ACOUST SOC AM, V119, P1074, DOI 10.1121/1.2149774; Vogel F., 1986, HUMAN GENETICS PROBL, P20; Weirich M., 2010, LINGUIST, V52, P19; Weirich M., 2012, INT J SPEECH LANGUAG, V19, P119, DOI [10.1558/ijsll.v19i1.119, DOI 10.1558/IJSLL.V19I1.119]; Weirich M, 2014, J PHONETICS, V43, P1, DOI 10.1016/j.wocn.2014.01.001; Weirich M, 2013, J ACOUST SOC AM, V134, P3766, DOI 10.1121/1.4822480; Whiteside SP, 2003, PHONETICA, V60, P273, DOI 10.1159/000076377; Zuo DH, 2015, J PHONETICS, V52, P1, DOI 10.1016/j.wocn.2015.03.003; ZWICKER E, 1961, J ACOUST SOC AM, V33, P248, DOI 10.1121/1.1908630; Zwicker E., 2013, FH PSYCHOACOUSTICS F	60	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0246645	10.1371/journal.pone.0246645	http://dx.doi.org/10.1371/journal.pone.0246645			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8JB	33600430	Green Published, gold			2022-12-26	WOS:000620625100045
J	Shiozaki, T; Itoh, F; Hirose, Y; Onodera, J; Kuwata, A; Harada, N				Shiozaki, Takuhei; Itoh, Fumihiro; Hirose, Yuu; Onodera, Jonaotaro; Kuwata, Akira; Harada, Naomi			A DNA metabarcoding approach for recovering plankton communities from archived samples fixed in formalin	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUES; PCR AMPLIFICATION; EXTRACTION; DIVERSITY; RETRIEVAL; PACIFIC	Plankton samples have been routinely collected and preserved in formalin in many laboratories and museums for more than 100 years. Recently, attention has turned to use DNA information from formalin-fixed samples to examine changes in plankton diversity over time. However, no molecular ecological studies have evaluated the impact of formalin fixation on the genetic composition of the plankton community structure. Here, we developed a method for extracting DNA from archived formalin-preserved plankton samples to determine their community structure by a DNA metabarcoding approach. We found that a lysis solution consisting of borate-NaOH buffer (pH 11) with SDS and proteinase K effectively cleaved the cross-link formed by formalin fixation. DNA was extracted from samples preserved for decades in formalin, and the diatom community of the extracted DNA was in good agreement with the microscopy analysis. Furthermore, we stored a plankton sample for 1.5 years and demonstrated that 18S rRNA gene community structures did not change significantly from non-formalin-fixed, time-zero samples. These results indicate that our method can be used to describe the original community structure of plankton archived in formalin for years. Our approach will be useful for examining the long-term variation of plankton diversity by metabarcoding analysis of 18S rRNA gene community structure.	[Shiozaki, Takuhei] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Shiozaki, Takuhei; Itoh, Fumihiro; Onodera, Jonaotaro; Harada, Naomi] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokosuka, Kanagawa, Japan; [Hirose, Yuu] Toyohashi Univ Technol, Dept Appl Chem & Life Sci, Toyohashi, Aichi, Japan; [Kuwata, Akira] Japan Fisheries Res & Educ Agcy, Fisheries Resources Inst, Shiogama Field Stn, Shiogama, Japan; [Itoh, Fumihiro] Phytopetrum Inc, Uruma, Japan	University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Toyohashi University of Technology; Japan Fisheries Research & Education Agency (FRA)	Shiozaki, T (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan.; Shiozaki, T (corresponding author), Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokosuka, Kanagawa, Japan.	shiozaki@g.ecu.u-tokyo.ac.jp		Shiozaki, Takuhei/0000-0002-5160-3472; Harada, Naomi/0000-0002-2725-7346	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP15H05712, JP19H05667, JP16H01599]; Arctic Challenge for Sustainability (ArCS) Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT); ArCS II Project of the MEXT	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Arctic Challenge for Sustainability (ArCS) Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT); ArCS II Project of the MEXT	This research was supported financially by the Japan Society for the Promotion of Science (JSPS; https://www.jsps.go.jp/english/) KAKENHI Grant JP15H05712 and JP19H05667 to N.H. and JP16H01599 to A.K., Arctic Challenge for Sustainability (ArCS) Project (https://www.nipr.ac.jp/arcs/e/) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to N.H., and ArCS II Project (https://www.nipr.ac.jp/arcs2/e/) of the MEXT to T.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAJORATH J, 1988, EUR J BIOCHEM, V176, P441, DOI 10.1111/j.1432-1033.1988.tb14301.x; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bucklin A, 2004, MOL PHYLOGENET EVOL, V30, P879, DOI 10.1016/j.ympev.2003.11.002; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cavicchioli R, 2019, NAT REV MICROBIOL, V17, P569, DOI 10.1038/s41579-019-0222-5; CRISAN D, 1993, DNA CELL BIOL, V12, P455, DOI 10.1089/dna.1993.12.455; Dabney J., 2013, CSH PERSPECT BIOL, V5, P1, DOI [10.1101/cshperspect.a012567, DOI 10.1101/cshperspect.a012567]; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Duval K, 2010, FORENSIC SCI INT-GEN, V4, P80, DOI 10.1016/j.fsigen.2009.06.003; El-Swais H, 2015, ENVIRON MICROBIOL, V17, P3642, DOI 10.1111/1462-2920.12629; Fordham DA, 2020, SCIENCE, V369, P1072, DOI 10.1126/science.abc5654; Fuhrman JA, 2015, NAT REV MICROBIOL, V13, P133, DOI 10.1038/nrmicro3417; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Honda MC, 2002, DEEP-SEA RES PT II, V49, P5595, DOI 10.1016/S0967-0645(02)00201-1; Hutchins DA, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.58; Ibarbalz FM, 2019, CELL, V179, P1084, DOI 10.1016/j.cell.2019.10.008; Karl DM, 2014, NAT REV MICROBIOL, V12, P699, DOI 10.1038/nrmicro3333; LEE C, 1992, LIMNOL OCEANOGR, V37, P117, DOI 10.4319/lo.1992.37.1.0117; Liu YX, 2018, INT J LEGAL MED, V132, P675, DOI 10.1007/s00414-017-1666-7; Malviya S, 2016, P NATL ACAD SCI USA, V113, pE1516, DOI 10.1073/pnas.1509523113; Mills EL., 2012, BIOL OCEANOGRAPHY EA; Motoda S., 1971, B FAC FISH HOKKAIDO, V22, P101; Paireder S, 2013, ANAL BIOCHEM, V439, P152, DOI 10.1016/j.ab.2013.04.006; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; Ripley SJ, 2008, J MICROBIOL METH, V73, P118, DOI 10.1016/j.mimet.2008.02.001; Ruane S, 2017, MOL ECOL RESOUR, V17, P1003, DOI 10.1111/1755-0998.12655; Schander C, 2003, ORG DIVERS EVOL, V3, P195, DOI 10.1078/1439-6092-00071; Shedlock AM, 1997, BIOTECHNIQUES, V22, P394, DOI 10.2144/97223bm03; Shi SR, 2004, HISTOCHEM CELL BIOL, V122, P211, DOI 10.1007/s00418-004-0693-x; Shi SR, 2002, J HISTOCHEM CYTOCHEM, V50, P1005, DOI 10.1177/002215540205000802; Shiozaki T, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02722; Skage M, 2007, MAR BIOL RES, V3, P289, DOI 10.1080/17451000701473942; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Steedman H.F., 1976, Monographs oceanogr Method, VNo. 4, P103; Taga M, 2013, INT J CLIN EXP PATHO, V6, P76; UNESCO, 1994, PROTOCOLS JOINT GLOB; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; Vezzulli L, 2012, ISME J, V6, P21, DOI 10.1038/ismej.2011.89	43	5	5	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0245936	10.1371/journal.pone.0245936	http://dx.doi.org/10.1371/journal.pone.0245936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596231	gold, Green Published			2022-12-26	WOS:000620633200014
J	Taylor, S; Asmundson, GJG				Taylor, Steven; Asmundson, Gordon J. G.			Negative attitudes about facemasks during the COVID-19 pandemic: The dual importance of perceived ineffectiveness and psychological reactance	PLOS ONE			English	Article								This study reports a comprehensive empirical investigation of the nature and correlates of anti-mask attitudes during the COVID-19 pandemic. Accumulating evidence underscores the importance of facemasks, as worn by the general public, in limiting the spread of infection. Accordingly, mask wearing has become increasingly mandatory in public places such as stores and on public transit. Although the public has been generally adherent to mask wearing, a small but vocal group of individuals refuse to wear masks. Anti-mask protest rallies have occurred in many places throughout the world, sometimes erupting violently. Few empirical studies have examined the relationship between anti-mask attitudes and mask non-adherence and little is known about how such attitudes relate to one another or other factors (e.g., non-adherence to social distancing, anti-vaccination attitudes). To investigate these issues, the present study surveyed 2,078 adults from the US and Canada. Consistent with other surveys, we found that most (84%) people wore masks because of COVID-19. The 16% who did not wear masks scored higher on most measures of negative attitudes towards masks. Network analyses indicated that negative attitudes about masks formed an intercorrelated network, with the central nodes in the network being (a) beliefs that masks are ineffective in preventing COVID-19, and (b) psychological reactance (PR; i.e., an aversion to being forced to wear masks). These central nodes served as links, connecting the network of anti-masks attitudes to negative attitudes toward SARSCoV2 vaccination, beliefs that the threat of COVID-19 has been exaggerated, disregard for social distancing, and political conservatism. Findings regarding PR are important because, theoretically, PR is likely to strengthen other anti-masks attitudes (e.g., beliefs that masks are ineffective) because people with strong PR react with anger and counter-arguments when their beliefs are challenged, thereby leading to a strengthening of their anti-mask beliefs. Implications for improving mask adherence are discussed.	[Taylor, Steven] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Asmundson, Gordon J. G.] Univ Regina, Dept Psychol, Regina, SK, Canada	University of British Columbia; University of Regina	Taylor, S (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	steven.taylor@ubc.ca			Canadian Institutes of Health Research [439751]; University of Regina	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Regina	This research was funded to G.J.G.A. and S.T. by the Canadian Institutes of Health Research (#439751) (https://cihr-irsc.gc.ca/e/193.html) and to G.J.G.A. from the University of Regina (https://www.uregina.ca/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S., 2020, LINCOLN J STAR; Angus Reid Institute, 2020, VAC VACC FEW HALF CA; Angus Reid Institute, 2020, COVID 19 CAN FALL IL; [Anonymous], 2020, ITV 1012; [Anonymous], 2020, MORNING CONSULT 0730; Armus T., 2020, WASH POST; Barcelo H., APPL COGNITIVE PSYCH; Barrow T., 2020, CTV NEWS; Battagello D, 2020, WINDSOR STAR 1026; Beer T., 2020, FORBES; Bennett I., 2020, SKY NEWS; Bilinski A, 2020, JAMA-J AM MED ASSOC, V324, P2100, DOI 10.1001/jama.2020.20717; Brehm J.W., 1966, THEORY PSYCHOL REACT; Brehm S.S., 1981, PSYCHOL REACTANCE, DOI DOI 10.1016/B978-0-12-129840-1.50005-3; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; CDC, 2020, CONS WEAR MASKS; Centers for Disease Control and Prevention (CDC), 2020, LIM WORKPL VIOL ASS; Chen YJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16924; Christodoulou H., 2020, SUN, DOI [12953943/anti-mask-protest-london-tier-2-lockdown/, DOI 12953943/ANTI-MASK-PROTEST-LONDON-TIER-2-LOCKDOWN]; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Cohn Jr. S. K., 2018, EPIDEMICS HATE COMPA; Crawford JT, 2017, J PERS SOC PSYCHOL, V112, P383, DOI 10.1037/pspa0000074; Curtis LD, 2020, KUTV 0407; Dolan B., 2020, PERSPECT MED HUM UC, V5, DOI [10.34947/M7QP4M, DOI 10.34947/M7QP4M]; Epskamp S., 2016, WILEY HDB PSYCHOMETR, V2, P953, DOI [10.1002/9781118489772.ch30, DOI 10.1002/9781118489772.CH30]; Epskamp S, 2018, BEHAV RES METHODS, V50, P195, DOI 10.3758/s13428-017-0862-1; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X; Frank SJ, 1998, J CLIN PSYCHOL, V54, P361, DOI 10.1002/(SICI)1097-4679(199804)54:3<361::AID-JCLP6>3.0.CO;2-S; Hapuhennedige S, 2020, CAN MED ASSOC J, V192, pE1274, DOI 10.1503/cmaj.1095901; Henley J, 2020, GUARDIAN 1018; Howard MC, 2020, BRIT J HEALTH PSYCH, V25, P912, DOI 10.1111/bjhp.12453; Ipsos, 2020, MOR PEOPL SAY THEYR; Ipsos, 2020, US COVID 19 AGGR TOP; Irmak C, 2020, J MARKETING RES, V57, P966, DOI 10.1177/0022243720919709; Kestler-D'Amours J, 2020, CTV NEWS; Lasseter B, 2020, SANPETE MESSENG 0901; Lewing CA, 2019, PERS INDIV DIFFER, V139, P355, DOI 10.1016/j.paid.2018.12.007; Little S, 2020, GLOBAL NEWS 0913; Ma YN, 2019, ENVIRON COMMUN, V13, P71, DOI 10.1080/17524032.2018.1548369; Mantzari E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2913; Martin LR, 2017, ANN BEHAV MED, V51, P652, DOI 10.1007/s12160-017-9888-y; McKay H., 2020, FOX NEWS; Mulraney F., 2020, DAILY MAIL; O'Brien S, 2020, IRISH CENTRAL 1011; Pew Research Center, 2020, MOST AM SAY THEY REG; Pew Research Center, 2020, MOR AM SAY THEY AR R; Philipose, 2020, COVID 19 LOOK ANTIMA; Rains SA, 2013, HUM COMMUN RES, V39, P47, DOI 10.1111/j.1468-2958.2012.01443.x; Raymond T, 2020, CTV NEWS; Richardson V, 2020, WASHINGTON TIME 0720; Roa R, 2020, LOS ANGELES TIMES; Rosenberg B.D., 2018, MOTIV SCI, V4, P281, DOI [10.1037/mot0000091, DOI 10.1037/MOT0000091]; Seligman M. E., 1975, HELPLESSNESS DEPRESS; Staunton TV, 2022, CURR PSYCHOL, V41, P611, DOI 10.1007/s12144-019-00588-0; Steindl C, 2015, Z PSYCHOL, V223, P205, DOI 10.1027/2151-2604/a000222; Szekeres J, 2020, NEWS, V1130; Tao ZY, 2020, TRANSBOUND EMERG DIS, V67, P3038, DOI 10.1111/tbed.13698; TAYLOR S, 2020, J ANXIETY DISORD, V72, DOI [DOI 10.1016/J.JANXDIS.2020.102232, 10.1016/j.janxdis.2020.102232(, 10.1016/j.janxdis.2020.102232]; Taylor S, 2020, FEM PSYCHOL, V30, P63, DOI 10.1177/0959353519864390; Taylor S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.575950; Taylor S, 2020, J ANXIETY DISORD, V76, DOI 10.1016/j.janxdis.2020.102327; Taylor S, 2020, DEPRESS ANXIETY, V37, P706, DOI 10.1002/da.23071; Thaler R.H., 2021, NUDGE FINAL EDITION; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z	65	92	93	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246317	10.1371/journal.pone.0246317	http://dx.doi.org/10.1371/journal.pone.0246317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8ME	33596207	Green Submitted, Green Published, gold			2022-12-26	WOS:000620633200034
J	Bhogal, J; Solevag, AL; O'Reilly, M; Lee, TF; Joynt, C; Hornberger, LK; Schmolzer, GM; Cheung, PY				Bhogal, Jagmeet; Solevag, Anne Lee; O'Reilly, Megan; Lee, Tze-Fun; Joynt, Chloe; Hornberger, Lisa K.; Schmolzer, Georg M.; Cheung, Po-Yin			Hemodynamic effects of high frequency oscillatory ventilation with volume guarantee in a piglet model of respiratory distress syndrome	PLOS ONE			English	Article								Respiratory failure is a common condition faced by critically ill neonates with respiratory distress syndrome (RDS). High frequency oscillatory ventilation (HFOV) is often used for neonates with refractory respiratory failure related to RDS. Volume guarantee (VG) mode has been added to some HFOV ventilators for providing consistent tidal volume. We sought to examine the impact of adding the VG mode during HFOV on systemic and cerebral hemodynamics, which has not been studied to date. A neonatal piglet model of moderate to severe RDS was induced by saline lavage. Piglets (full term, age 1-3 days, weight 1.5-2.4 kg) were randomized to have RDS induced and receive either HFOV or HFOV+VG (n = 8/group) or sham-operation (n = 6) without RDS. Cardiac function measured by a Millar(R) catheter placed in the left ventricle as well as systemic and carotid hemodynamic and oxygen tissue saturation parameters were collected over 240 min of ventilation. Mean airway pressure, alveolar-arterial oxygen difference and left ventricular cardiac index of piglets on HFOV vs. HFOV+VG were not significantly different during the experimental period. Right common carotid artery flow index by in-situ ultrasonic flow measurement and cerebral tissue oxygen saturation (near-infrared spectroscopy) significantly decreased in HFOV+VG at 240 min compared to HFOV (14 vs. 31 ml/kg/min, and 30% vs. 43%, respectively; p<0.05). There were no significant differences in lung, brain and heart tissue markers of oxidative stress, ischemia and inflammation. HFOV+VG compared to HFOV was associated with similar left ventricular function, however HFOV+VG had a negative effect on cerebral blood flow and oxygenation.	[Bhogal, Jagmeet; O'Reilly, Megan; Lee, Tze-Fun; Joynt, Chloe; Hornberger, Lisa K.; Schmolzer, Georg M.; Cheung, Po-Yin] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Solevag, Anne Lee] Akershus Univ Hosp, Dept Paediat & Adolescent Med, Lrenskog, Norway; [Solevag, Anne Lee] Oslo Univ Hosp, Dept Paediat & Adolescent Med, Nydalen, Norway; [O'Reilly, Megan; Lee, Tze-Fun; Schmolzer, Georg M.; Cheung, Po-Yin] Royal Alexandra Hosp, Ctr Studies Asphyxia & Resuscitat, Edmonton, AB, Canada; [Cheung, Po-Yin] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada	University of Alberta; Royal Alexandra Hospital; University of Alberta	Bhogal, J (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	jagmeet.bhogal@ahs.ca	Solevåg, Anne Lee/AAH-9734-2021; Schmölzer, Georg M/E-7883-2010; Cheung, Po-Yin/C-2804-2013	Solevåg, Anne Lee/0000-0002-8009-7169; Schmölzer, Georg M/0000-0001-9798-2415; Cheung, Po-Yin/0000-0002-7141-1523; Bhogal, Jagmeet/0000-0002-1302-6133	Canadian Institutes of Health Research [MOP 130483]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	PYC received funding from the Canadian Institutes of Health Research, grant number MOP 130483 (http://www.cihr-irsc.gc.ca).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XF, 2010, OPEN CARDIOVASC MED, V4, P168, DOI 10.2174/1874192401004010168; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Bronicki RA., 2014, PEDIATR CRIT CARE ME, V2nd ed, P323; CHAN V, 1994, ARCH DIS CHILD-FETAL, V70, pF44, DOI 10.1136/fn.70.1.F44; CHANG HK, 1984, J APPL PHYSIOL, V56, P553, DOI 10.1152/jappl.1984.56.3.553; Cools F, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000104.pub4; Enomoto M, 2017, AM J PERINAT, V34, P26, DOI 10.1055/s-0036-1584141; Gleason C.A., 2012, AVERYS DIS NEWBORN; Goldsmith JP., 2011, ASSISTED VENTILATION, V5th ed; Grazioli S, 2015, RESP CARE, V60, P363, DOI 10.4187/respcare.03048; Gullberg N, 2004, ACTA ANAESTH SCAND, V48, P218, DOI 10.1111/j.1399-6576.2004.00299.x; Henderson-Smart DJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002974.pub2; Iscan B, 2015, NEONATOLOGY, V108, P277, DOI 10.1159/000437204; KAMITSUKA MD, 1990, PEDIATR RES, V27, P64, DOI 10.1203/00006450-199001000-00018; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KINSELLA JP, 1991, PEDIATR RES, V29, P160, DOI 10.1203/00006450-199102000-00012; Klingenberg C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003666.pub4; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kluckow M, 1996, J PEDIATR-US, V129, P506, DOI 10.1016/S0022-3476(96)70114-2; LACHMANN B, 1980, ACTA ANAESTH SCAND, V24, P231, DOI 10.1111/j.1399-6576.1980.tb01541.x; LAPTOOK A, 1982, EARLY HUM DEV, V6, P99, DOI 10.1016/0378-3782(82)90063-9; MIRRO R, 1985, CRIT CARE MED, V13, P724, DOI 10.1097/00003246-198509000-00006; Pillow JJ, 2002, PEDIATR RES, V52, P538, DOI 10.1203/01.PDR.0000030875.20888.64; Richards JG, 2006, RESUSCITATION, V69, P319, DOI 10.1016/j.resuscitation.2005.08.012; Luna MS, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/593915; Simma B, 2000, CRIT CARE MED, V28, P227, DOI 10.1097/00003246-200001000-00038; STANDAERT TA, 1991, PEDIATR PULM, V11, P294, DOI 10.1002/ppul.1950110405; STIRIS T, 1989, PEDIATR RES, V25, P205, DOI 10.1203/00006450-198902000-00025; Sweet DG, 2019, NEONATOLOGY, V115, P432, DOI 10.1159/000499361; van Alfen-van der Velden AAEM, 2006, BIOL NEONATE, V90, P197, DOI 10.1159/000093489; Vanderhaegen J, 2010, NEONATOLOGY, V98, P57, DOI 10.1159/000271224	31	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246996	10.1371/journal.pone.0246996	http://dx.doi.org/10.1371/journal.pone.0246996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592023	gold, Green Published			2022-12-26	WOS:000620632800025
J	Michael, H; Paim, FC; Miyazaki, A; Langel, SN; Fischer, DD; Chepngeno, J; Goodman, SD; Rajashekara, G; Saif, LJ; Vlasova, AN				Michael, Husheem; Paim, Francine C.; Miyazaki, Ayako; Langel, Stephanie N.; Fischer, David D.; Chepngeno, Juliet; Goodman, Steven D.; Rajashekara, Gireesh; Saif, Linda J.; Vlasova, Anastasia Nickolaevna			Escherichia coli Nissle 1917 administered as a dextranomar microsphere biofilm enhances immune responses against human rotavirus in a neonatal malnourished pig model colonized with human infant fecal microbiota	PLOS ONE			English	Article								Human rotavirus (HRV) is a leading cause of diarrhea in children. It causes significant morbidity and mortality, especially in low- and middle-income countries (LMICs), where HRV vaccine efficacy is low. The probiotic Escherichia coli Nissle (EcN) 1917 has been widely used in the treatment of enteric diseases in humans. However, repeated doses of EcN are required to achieve maximum beneficial effects. Administration of EcN on a microsphere biofilm could increase probiotic stability and persistence, thus maximizing health benefits without repeated administrations. Our aim was to investigate immune enhancement by the probiotic EcN adhered to a dextranomar microsphere biofilm (EcN biofilm) in a neonatal, malnourished piglet model transplanted with human infant fecal microbiota (HIFM) and infected with rotavirus. To create malnourishment, pigs were fed a reduced amount of bovine milk. Decreased HRV fecal shedding and protection from diarrhea were evident in the EcN biofilm treated piglets compared with EcN suspension and control groups. Moreover, EcN biofilm treatment enhanced natural killer cell activity in blood mononuclear cells (MNCs). Increased frequencies of activated plasmacytoid dendritic cells (pDC) in systemic and intestinal tissues and activated conventional dendritic cells (cDC) in blood and duodenum were also observed in EcN biofilm as compared with EcN suspension treated pigs. Furthermore, EcN biofilm treated pigs had increased frequencies of systemic activated and resting/memory antibody forming B cells and IgA(+) B cells in the systemic tissues. Similarly, the mean numbers of systemic and intestinal HRV-specific IgA antibody secreting cells (ASCs), as well as HRV-specific IgA antibody titers in serum and small intestinal contents, were increased in the EcN biofilm treated group. In summary EcN biofilm enhanced innate and B cell immune responses after HRV infection and ameliorated diarrhea following HRV challenge in a malnourished, HIFM pig model.	[Michael, Husheem; Paim, Francine C.; Miyazaki, Ayako; Langel, Stephanie N.; Fischer, David D.; Chepngeno, Juliet; Rajashekara, Gireesh; Saif, Linda J.; Vlasova, Anastasia Nickolaevna] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA; [Miyazaki, Ayako] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Div Viral Dis & Epidemiol, Tsukuba, Ibaraki, Japan; [Goodman, Steven D.] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH USA; [Fischer, David D.] Univ Detroit Mercy, Sch Dent, Div Integrated Biomed Sci, Detroit, MI 48221 USA; [Langel, Stephanie N.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC USA	University System of Ohio; Ohio State University; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Detroit Mercy; Duke University	Saif, LJ; Vlasova, AN (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA.	saif.2@osu.edu; vlasova.1@osu.edu		Langel, Stephanie/0000-0002-0467-7874	Bill and Melinda Gates Foundation [OPP 1117467]; NIAID, NIH [R01 A1099451]; NIH Office of Dietary Supplements (ODS) supplemental grant funds	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Office of Dietary Supplements (ODS) supplemental grant funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Bill and Melinda Gates Foundation (OPP 1117467), the NIAID, NIH (R01 A1099451), federal and state funds appropriated to the Ohio Agricultural Research and Development Center, The Ohio State University and from the NIH Office of Dietary Supplements (ODS) supplemental grant funds.	Annamalai T, 2015, VET IMMUNOL IMMUNOP, V168, P193, DOI 10.1016/j.vetimm.2015.09.006; Azevedo MSP, 2004, CLIN DIAGN LAB IMMUN, V11, P12, DOI 10.1128/CDLI.11.1.12-20.2004; Bhadoria P., 2001, EUR J FOOD RES REV, V1, P23; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Carulli AJ, 2014, INTEGR BIOL-UK, V6, P243, DOI 10.1039/c3ib40163d; Chattha KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082966; Chattha KS, 2013, J IMMUNOL, V191, P2446, DOI 10.4049/jimmunol.1300678; Chattha KS, 2013, VACCINE, V31, P1916, DOI 10.1016/j.vaccine.2013.02.020; Clark A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183392; Cogan TM, 2007, J DAIRY SCI, V90, P4005, DOI 10.3168/jds.2006-765; Collado-Romero M, 2010, VET RES, V41, DOI 10.1051/vetres/2009072; Cook MT, 2012, J CONTROL RELEASE, V162, P56, DOI 10.1016/j.jconrel.2012.06.003; Deal EM, 2013, J CLIN INVEST, V123, P2464, DOI 10.1172/JCI60945; Ding WK, 2007, J FOOD SCI, V72, pM446, DOI 10.1111/j.1750-3841.2007.00565.x; Fischer DD, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00172-17; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Gonzalez LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066465; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Hajela N, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-1; Holloway G, 2013, J GEN VIROL, V94, P1151, DOI 10.1099/vir.0.051276-0; Hughes SM, 2009, J IMMUNOL, V183, P2818, DOI 10.4049/jimmunol.0803518; Ibrahim MK, 2017, CLIN MICROBIOL REV, V30, P919, DOI 10.1128/CMR.00119-16; Iyer SS, 2012, J IMMUNOL, V188, P77, DOI 10.4049/jimmunol.1004027; Kailasapathy K, 2014, NANO- AND MICROENCAPSULATION FOR FOODS, P167; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kandasamy S, 2016, J IMMUNOL, V196, P1780, DOI 10.4049/jimmunol.1501705; Kandasamy S, 2014, GUT MICROBES, V5, P639, DOI 10.4161/19490976.2014.969972; Kandasamy S, 2014, VACCINE, V32, P816, DOI 10.1016/j.vaccine.2013.12.039; Kleta S, 2006, J APPL MICROBIOL, V101, P1357, DOI 10.1111/j.1365-2672.2006.03019.x; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Kruis W, 2012, INT J COLORECTAL DIS, V27, P467, DOI 10.1007/s00384-011-1363-9; Li XY, 2011, CARBOHYD POLYM, V83, P1479, DOI 10.1016/j.carbpol.2010.09.053; Liu J, 2016, INFECT IMMUN, V84, P3542, DOI 10.1128/IAI.00705-16; Louis Petra, 2010, Science Progress, V93, P7, DOI 10.3184/003685009X12605525292307; Galdeano CM, 2019, ANN NUTR METAB, V74, P115, DOI 10.1159/000496426; MEYER RC, 1964, APPL MICROBIOL, V12, P295, DOI 10.1128/AEM.12.4.295-300.1964; Muthukumarasamy P, 2006, J FOOD SCI, V71, pM20, DOI 10.1111/j.1365-2621.2006.tb12395.x; Nahaisi MH RS., 2014, J PROB HLTH, V2, P1; Navarro JB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00489; Nelson EAS, 2010, LANCET, V376, P568, DOI 10.1016/S0140-6736(10)60896-3; Ng EW, 2011, INT J FOOD MICROBIOL, V145, P169, DOI 10.1016/j.ijfoodmicro.2010.12.006; Nossol C, 2011, HISTOCHEM CELL BIOL, V136, P103, DOI 10.1007/s00418-011-0826-y; Olson JK, 2018, AM J PHYSIOL-GASTR L, V315, pG408, DOI 10.1152/ajpgi.00078.2018; Olson JK, 2016, J PEDIATR SURG, V51, P936, DOI 10.1016/j.jpedsurg.2016.02.062; Paim FC, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0148-7; Pan D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030247; Prendergast AJ, 2016, CURR OPIN INFECT DIS, V29, P229, DOI 10.1097/QCO.0000000000000261; Rytter MJH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105017; Sanders ME, 2013, GUT, V62, P787, DOI 10.1136/gutjnl-2012-302504; Schlickum S, 2008, BLOOD, V112, P619, DOI 10.1182/blood-2008-01-134833; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377; Shelby RD, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1814119; Skipper M, 2000, NAT GENET, V24, P3, DOI 10.1038/71653; Sugimura T, 2015, BRIT J NUTR, V114, P727, DOI 10.1017/S0007114515002408; Szajewska H, 2001, J PEDIATR GASTR NUTR, V33, pS17, DOI 10.1097/00005176-200110002-00004; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; To TL, 1998, J GEN VIROL, V79, P2661; Underwood MA, 2014, PEDIATR RES, V76, P326, DOI 10.1038/pr.2014.102; UNICEF World Health Organization World Bank Group, 2017, WORLD BANK GROUP JOI; Vlasova AN, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00046-17; Vlasova AN, 2016, EUR J IMMUNOL, V46, P2426, DOI 10.1002/eji.201646498; Vlasova AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076962; Ward LA, 1996, CLIN DIAGN LAB IMMUN, V3, P342, DOI 10.1128/CDLI.3.3.342-350.1996; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Yuan LJ, 1996, J VIROL, V70, P3075, DOI 10.1128/JVI.70.5.3075-3083.1996; Zhang W, 2008, VACCINE, V26, P3655, DOI 10.1016/j.vaccine.2008.04.070	68	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246193	10.1371/journal.pone.0246193	http://dx.doi.org/10.1371/journal.pone.0246193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592026	gold, Green Published			2022-12-26	WOS:000620632800037
J	Pereira-Silva, JW; Rios-Velasquez, CM; de Lima, GR; dos Santos, EFM; Belchior, HCM; Luz, SLB; Naveca, FG; Pessoa, FAC				Pereira-Silva, Jordam William; Rios-Velasquez, Claudia Maria; de Lima, Gervilane Ribeiro; Marialva dos Santos, Eric Fabricio; Matos Belchior, Heliana Christy; Bessa Luz, Sergio Luiz; Naveca, Felipe Gomes; Costa Pessoa, Felipe Arley			Distribution and diversity of mosquitoes and Oropouche-like virus infection rates in an Amazonian rural settlement	PLOS ONE			English	Article							DIPTERA-CULICIDAE; BRAZILIAN AMAZON; MATO-GROSSO; CULEX-QUINQUEFASCIATUS; NATURAL INFECTION; VECTOR COMPETENCE; MAYARO VIRUS; DISEASE RISK; FOREST; TRANSMISSION	Mosquito diversity and disease transmission are influenced by landscape modifications, i.e., vectors and pathogens previously found only in forests are now found close to human environments due to anthropic changes. This study determined the diversity and distribution of mosquitoes in forest environments in order to analyze the potential vectors of Amazonian forest arboviruses. Mosquitoes were collected by 1) vertical stratification from forest canopy and ground areas using Hooper Pugedo (HP) light traps and human attraction and 2) horizontal stratification using HP light traps in peridomicile, forest edge, and forest environments near the Rio Pardo rural settlement, Amazonas, Brazil. A total of 3,750 mosquitoes were collected, representing 46 species. 3,139 individuals representing 46 species were sampled by vertical stratification. Both the Shannon-Weaver diversity index (H') and equitability (J') were higher in the canopy than on the ground. 611 individuals representing 13 species were sampled by horizontal stratification. H' decreased in the following order: forest edge > forest > peridomicile, and J' was greater at the forest edge and smaller in the peridomicile environment. Moreover, H' was higher for the human attraction collection method than the HP traps. A total of 671 pools were analyzed by RT-qPCR; three species were positive for Oropouche-like viruses (Ochlerotatus serratus, Psorophora cingulata, and Haemagogus tropicalis) and the minimum infection rate was 0.8%. The composition of mosquito species did not differ significantly between anthropic and forest environments in Rio Pardo. Some mosquito species, due to their abundance, dispersion in the three environments, and record of natural infection, were hypothesized to participate in the arbovirus transmission cycle in this Amazonian rural settlement.	[Pereira-Silva, Jordam William; Rios-Velasquez, Claudia Maria; de Lima, Gervilane Ribeiro; Marialva dos Santos, Eric Fabricio; Matos Belchior, Heliana Christy; Bessa Luz, Sergio Luiz; Naveca, Felipe Gomes; Costa Pessoa, Felipe Arley] Inst Leonidas & Maria Deane Fiocruz Amazonia, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil; [Pereira-Silva, Jordam William; Rios-Velasquez, Claudia Maria; Bessa Luz, Sergio Luiz; Costa Pessoa, Felipe Arley] Inst Leonidas & Maria Deane Fiocruz Amazonia, Programa Posgrad Condicoes Vida & Situacoes Saude, Manaus, Amazonas, Brazil; [Pereira-Silva, Jordam William] Fdn Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Pereira-Silva, Jordam William; Rios-Velasquez, Claudia Maria] Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil; [Rios-Velasquez, Claudia Maria; Marialva dos Santos, Eric Fabricio; Matos Belchior, Heliana Christy; Bessa Luz, Sergio Luiz; Naveca, Felipe Gomes; Costa Pessoa, Felipe Arley] Inst Leonidas & Maria Deane Fiocruz Amazonia, Programa Posgrad Biol Interacao Patogeno Hosp, Manaus, Amazonas, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade do Estado do Amazonas; Fundacao Oswaldo Cruz	Pereira-Silva, JW; Pessoa, FAC (corresponding author), Inst Leonidas & Maria Deane Fiocruz Amazonia, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.; Pereira-Silva, JW; Pessoa, FAC (corresponding author), Inst Leonidas & Maria Deane Fiocruz Amazonia, Programa Posgrad Condicoes Vida & Situacoes Saude, Manaus, Amazonas, Brazil.; Pereira-Silva, JW (corresponding author), Fdn Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.; Pereira-Silva, JW (corresponding author), Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil.; Pessoa, FAC (corresponding author), Inst Leonidas & Maria Deane Fiocruz Amazonia, Programa Posgrad Biol Interacao Patogeno Hosp, Manaus, Amazonas, Brazil.	jordamwilliam@gmail.com; felipe.pessoa@fiocruz.br	Naveca, Felipe/H-1130-2012	Naveca, Felipe/0000-0002-2888-1060; Marialva, Eric Fabricio/0000-0002-2193-4318; William, Jordam/0000-0002-7716-3970	FAPEAM (Fundacao de Amparo a Pesquisa do Estado do Amazonas); PROEP (Programa de Excelencia em Pesquisa Basica e Aplicada em Saude); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); ILMD (Instituto Leonidas e Maria Deane - Fiocruz Amazonia)	FAPEAM (Fundacao de Amparo a Pesquisa do Estado do Amazonas); PROEP (Programa de Excelencia em Pesquisa Basica e Aplicada em Saude); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ILMD (Instituto Leonidas e Maria Deane - Fiocruz Amazonia)	FAPEAM (Fundacao de Amparo a Pesquisa do Estado do Amazonas), ILMD (Instituto Leonidas e Maria Deane - Fiocruz Amazonia), PROEP (Programa de Excelencia em Pesquisa Basica e Aplicada em Saude), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico).	Abad-Franch F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001846; Auguste AJ, 2010, AM J TROP MED HYG, V83, P1262, DOI 10.4269/ajtmh.2010.10-0280; Barbosa M das GV., 2008, REV SOC BRAS MED TRO, V41, P658, DOI [10.1590/s0037-86822008000600019, DOI 10.1590/S0037-86822008000600019]; Bastos MD, 2012, AM J TROP MED HYG, V86, P732, DOI 10.4269/ajtmh.2012.11-0485; Bastos MS, 2014, J MED VIROL, V86, P1522, DOI 10.1002/jmv.23953; Batista PM, 2013, REV SOC BRAS MED TRO, V46, P684, DOI 10.1590/0037-8682-0181-2013; Brant HL, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1416-1; Cardoso BF, 2015, MEM I OSWALDO CRUZ, V110, P745, DOI 10.1590/0074-02760150123; Confalonieri Ulisses E C, 2012, Interdiscip Perspect Infect Dis, V2012, P741273, DOI 10.1155/2012/741273; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Barbosa LMC, 2016, ACTA TROP, V164, P216, DOI 10.1016/j.actatropica.2016.09.018; Deardorff ER, 2010, AM J TROP MED HYG, V82, P1047, DOI 10.4269/ajtmh.2010.09-0556; Eastwood G, 2016, AM J TROP MED HYG, V94, P786, DOI 10.4269/ajtmh.15-0445; Eastwood G, 2011, AM J TROP MED HYG, V85, P426, DOI 10.4269/ajtmh.2011.10-0739; Farias M.H.C.S., 2018, MERCATOR, V17, P1, DOI [10.4215/rm2018.e17009, DOI 10.4215/RM2018.E17009]; Ferraguti M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29002; Fé Nelson Ferreira, 2003, Rev. Soc. Bras. Med. Trop., V36, P343, DOI 10.1590/S0037-86822003000300005; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; Forattini OP., 1996, CULICIDOLOGIA MED ID, V2; Garcia-Rejon JE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3201; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Hutchings RSG, 2008, ZOOTAXA, P41, DOI 10.11646/zootaxa.1920.1.3; Hutchings RSG, 2018, J MED ENTOMOL, V55, P1188, DOI 10.1093/jme/tjy065; Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013; GROOT H, 1961, AM J TROP MED HYG, V10, P397, DOI 10.4269/ajtmh.1961.10.397; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hutchings RSG, 2016, J MED ENTOMOL, V53, P1330, DOI 10.1093/jme/tjw101; Juliao GR, 2010, J MED ENTOMOL, V47, P121, DOI 10.1603/ME09060; Kuno G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070185; Lira-Vieira AR, 2013, REV SOC BRAS MED TRO, V46, P566, DOI 10.1590/0037-8682-0136-2013; LOPES OD, 1981, AM J EPIDEMIOL, V113, P122; Mendez W, 2001, J MED ENTOMOL, V38, P813, DOI 10.1603/0022-2585-38.6.813; Naveca Felipe Gomes, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.7d65e5eb6ef75664da68905c5582f7f7; Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062; Neto C, 2007, AN 8 C EC BRAS SEP; NMDS Tutorial in R, 2012, SAMPLE ECOLOGY INTER; Nunes MRT, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00131-15; Obara MT, 2012, EPIDEMIOL SERV SAUDE, V21, P457, DOI 10.5123/S1679-49742012000300011; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oliveira-Lima JW., 2000, CAD SAUDE PUBLICA, V16, pS75, DOI [10.1590/S0102-311X2000000800008, DOI 10.1590/S0102-311X2000000800008]; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Pinheiro F. P., 1962, REV SERV ESP SAUDE P, V12, P15; Rodrigues NCP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198357; Primack RB., 2001, BIOL CONSERVACAO; Pugedo H, 2005, REV SOC BRAS MED TRO, V38, P70, DOI 10.1590/S0037-86822005000100017; Goncalves AQ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001943; Ramos WR, 2014, ACTA TROP, V139, P44, DOI 10.1016/j.actatropica.2014.06.017; Ribeiro AF, 2012, J VECTOR ECOL, V37, P316, DOI 10.1111/j.1948-7134.2012.00233.x; Roberts DW, 2019, **DATA OBJECT**; Rocha R, RURAL SETTLEMENTS DE; de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180; Segura M.D.N.D.O., 2007, ATLAS CULICIDEOS AMA; Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270; Shaman J, 2003, J MED ENTOMOL, V40, P547, DOI 10.1603/0022-2585-40.4.547; Steiger DBM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1675-2; da Rosa JFT, 2017, AM J TROP MED HYG, V96, P1019, DOI 10.4269/ajtmh.16-0672; Turell MJ., 2005, J MED ENTOMOL, V42, P9, DOI [10.1603/0022-2585%282005%29042%5B0891%3AIOVFMD%5D2.0.CO%3B2, DOI 10.1603/0022-2585%282005%29042%5B0891%3AIOVFMD%5D2.0.CO%3B2]; Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025; Vasconcelos PFC, 1998, OVERVIEW ARBOVIROLOG, P72; VASCONCELOS PFD, 1989, REV INST MED TROP SP, V31, P271, DOI 10.1590/S0036-46651989000400011; Vitek CJ, 2008, J MED ENTOMOL, V45, P483, DOI 10.1603/0022-2585(2008)45[483:ATBCNI]2.0.CO;2; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Weaver W, 1964, MATH THEORY COMMUNIC, V131; Williams-Linera G, 1998, CONSERV BIOL, V12, P1091, DOI 10.1046/j.1523-1739.1998.97262.x; XAVIER S H, 1976, Mosquito Systematics, V8, P386	66	3	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246932	10.1371/journal.pone.0246932	http://dx.doi.org/10.1371/journal.pone.0246932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592052	gold, Green Published			2022-12-26	WOS:000620632800004
J	Kuper, N; Modersitzki, N; Phan, L; Rauthmann, J				Kuper, Niclas; Modersitzki, Nick; Phan, Le Vy; Rauthmann, John			The situation during the COVID-19 pandemic: A snapshot in Germany	PLOS ONE			English	Article								During government-implemented restrictions in the wake of the COVID-19 pandemic, people's everyday lives changed profoundly. However, there is to date little research chronicling how people perceived their changed everyday lives and which consequences this had. In a two-wave study, we examined the psychological characteristics of people's situations and their correlates during shutdown in a large German sample (N-T1 = 1,353; N-T2 = 446). First, we compared characteristics during government-issued restrictions with retrospective accounts from before and with a follow-up assessment 6 to 7 months later when many restrictions had been lifted. We found that mean levels were lower and variances were higher for most characteristics during the shutdown. Second, the experience of certain situation characteristics was associated in meaningful and theoretically expected ways with people's traits, appraisals of the COVID-19 crisis, and subjective well-being. Lastly, situation characteristics often substantially explained the associations of traits with appraisals and well-being. Our findings highlight the importance of considering perceived situations as these contribute to people's functioning during crises.	[Kuper, Niclas; Modersitzki, Nick; Phan, Le Vy; Rauthmann, John] Bielefeld Univ, Bielefeld, Germany	University of Bielefeld	Kuper, N (corresponding author), Bielefeld Univ, Bielefeld, Germany.	niclas.kuper@uni-bielefeld.de	Kuper, Niclas/AAP-4970-2020	Modersitzki, Nick/0000-0003-4803-806X; Kuper, Niclas/0000-0001-6901-0205				Allport G. W., 1937, PERSONALITY PSYCHOL; Anglim J, 2020, PSYCHOL BULL, V146, P279, DOI 10.1037/bul0000226; Armour C., 2020, UNDERSTANDING LONGIT, DOI [10.1007/s10862-020-09841-4, DOI 10.1007/S10862-020-09841-4]; Ashton MC, 2020, EUR J PERSONALITY, V34, P492, DOI 10.1002/per.2242; Ashton MC, 2009, J PERS ASSESS, V91, P340, DOI 10.1080/00223890902935878; Back MD, 2013, J PERS SOC PSYCHOL, V105, P1013, DOI 10.1037/a0034431; Beierlein C, SINGLE ITEM SKALA ER; Bhanji F, 2012, ACAD EMERG MED, V19, P189, DOI 10.1111/j.1553-2712.2011.01270.x; Bundesregierung, PRESS BUND MERK MIN; Cooper WH, 2009, PERS SOC PSYCHOL REV, V13, P62, DOI 10.1177/1088868308329378; Dheer R., 2020, PSYARXIV PREPRINTS, DOI [10.31234/osf.io/cbxhw, DOI 10.31234/OSF.IO/CBXHW]; Dunning A., 2020, PSYARXIV, DOI [10.31234/osf.io/czskd, DOI 10.31234/OSF.IO/CZSKD]; Eisinga R, 2013, INT J PUBLIC HEALTH, V58, P637, DOI 10.1007/s00038-012-0416-3; Folk DP., 2020, DID SOCIAL CONNECTIO, DOI [10.31234/osf.io/tkr2b, DOI 10.31234/OSF.IO/TKR2B]; Geldhof GJ, 2018, EVAL PROGRAM PLANN, V70, P83, DOI 10.1016/j.evalprogplan.2018.05.002; Gerpott FH, 2018, J PERS SOC PSYCHOL, V115, P716, DOI 10.1037/pspp0000166; Hill LG, 2005, AM J EVAL, V26, P501, DOI 10.1177/1098214005281356; Hong RY, 2020, CLIN PSYCHOL SCI, V8, P333, DOI 10.1177/2167702619894902; Horstmann K. T., 2020, PSYARXIV, DOI [10.31234/osf.io/ztw2n, DOI 10.31234/OSF.IO/ZTW2N]; Horstmann KT, 2019, PERS INDIV DIFFER, V136, P132, DOI 10.1016/j.paid.2018.01.020; Hossain Md Mahbub, 2020, F1000Res, V9, P636, DOI 10.12688/f1000research.24457.1; Huckins JF, 2020, J MED INTERNET RES, V22, DOI 10.2196/20185; Jonason PK, 2009, EUR J PERSONALITY, V23, P5, DOI 10.1002/per.698; Jones DN, 2013, EUR J PERSONALITY, V27, P521, DOI 10.1002/per.1893; Kroencke L, 2020, J Res Pers, V89, P104038, DOI 10.1016/j.jrp.2020.104038; Kufner AC., 2014, DIAGNOSTICA; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lee KB, 2005, PERS INDIV DIFFER, V38, P1571, DOI 10.1016/j.paid.2004.09.016; Mancini AD, 2020, PSYCHOL TRAUMA-US, V12, pS15, DOI 10.1037/tra0000894; Martin C, 2020, PSYARXIV, DOI [10.31234/osf.io/c9gxe, DOI 10.31234/OSF.IO/C9GXE]; McBride O., 2020, PSYARXIV, V30, P1861, DOI [10.31234/OSF.IO/WXE2N, DOI 10.31234/OSF.IO/WXE2N]; Modersitzki N., 2020, SOC PSYCHOL PERS SCI, DOI [10.1177/1948550619865057, DOI 10.1177/1948550619865057]; Moshagen M., 2014, DIAGNOSTICA; Parrigon S, 2017, J PERS SOC PSYCHOL, V112, P642, DOI 10.1037/pspp0000111; Paulhus DL, 2002, J RES PERS, V36, P556, DOI 10.1016/S0092-6566(02)00505-6; Penley JA, 2002, PERS INDIV DIFFER, V32, P1215, DOI 10.1016/S0191-8869(01)00087-3; Pieters R, 2017, J CONSUM RES, V44, P692, DOI 10.1093/jcr/ucx081; Preacher KJ, 2015, ANNU REV PSYCHOL, V66, P825, DOI 10.1146/annurev-psych-010814-015258; R Core Team, R LANGUAGE ENV STAT; Rammstedt B., 2018, EUR J PSYCHOL ASSESS, DOI [10.1027/1015-5759/a000510, DOI 10.1027/1015-5759/A000510]; Rauthmann J.F., 2017, S8 SITUATION 8 DIAMO, DOI [10.23668/psycharchives.782, DOI 10.23668/PSYCHARCHIVES.782]; Rauthmann JF, 2020, CAPTURING INTERACTIO, DOI [10.31234/osf.io/qsntf, DOI 10.31234/OSF.IO/QSNTF]; Rauthmann J, 2019, PERS SOC PSYCHOL REV, V23, P238, DOI 10.1177/1088868318765600; Rauthmann JF, 2020, CURR DIR PSYCHOL SCI, V29, P473, DOI 10.1177/0963721420925546; Rauthmann JF, 2016, PERS SOC PSYCHOL B, V42, P893, DOI 10.1177/0146167216647360; Rauthmann JF, 2016, EUR J PSYCHOL ASSESS, V32, P155, DOI 10.1027/1015-5759/a000246; Rauthmann JF, 2015, J RES PERS, V55, P98, DOI 10.1016/j.jrp.2015.02.003; Rauthmann JF, 2014, J PERS SOC PSYCHOL, V107, P677, DOI 10.1037/a0037250; Rauthmann JF, 2012, SOC PSYCHOL PERS SCI, V3, P519, DOI 10.1177/1948550611427609; Robinson E., 2020, PSYCHOL MED, P1, DOI [10.1017/S0033291720004432, DOI 10.1017/S0033291720004432]; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Schimmack U., 2009, SCHMOLLERS JB, V129, P241, DOI DOI 10.3790/SCHM.129.2.241; Schimmack U, 2008, SOC INDIC RES, V89, P41, DOI 10.1007/s11205-007-9230-3; Serfass DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143051; Sherman RA, 2015, J PERS SOC PSYCHOL, V109, P872, DOI 10.1037/pspp0000036; Soto CJ, 2017, J PERS SOC PSYCHOL, V113, P117, DOI 10.1037/pspp0000096; Srivastava S, 2020, PERSONALITY STRUCTUR, DOI [10.31234/osf.io/dvb4n, DOI 10.31234/OSF.IO/DVB4N, 10.31234/osf.io/ dvb4n]; Sun R., 2020, PSYCHOL WELLBEING GL, DOI [10.31234/osf.io/r7xaz, DOI 10.31234/OSF.IO/R7XAZ]; Sutin AR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237056; Huynh TLD, 2020, SAFETY SCI, V130, DOI 10.1016/j.ssci.2020.104872; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Yamada Y., 2020, COVIDISTRESS GLOBAL, DOI [10.31234/osf.io/v7cep, DOI 10.31234/OSF.IO/V7CEP]; Zajenkowski M, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110199; Zettler I, 2022, SOC PSYCHOL PERS SCI, V13, P299, DOI 10.1177/19485506211001680; Ziegler M, 2019, PSYCHOL ASSESSMENT, V31, P567, DOI 10.1037/pas0000654	65	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0245719	10.1371/journal.pone.0245719	http://dx.doi.org/10.1371/journal.pone.0245719			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK0KW	33577581	Green Submitted, gold, Green Published			2022-12-26	WOS:000620071700020
J	Chen, DB; Zhou, T				Chen, Duanbing; Zhou, Tao			Evaluating the effect of Chinese control measures on COVID-19 via temporal reproduction number estimation	PLOS ONE			English	Article							REAL-TIME; TRANSMISSION DYNAMICS; WUHAN	Control measures are necessary to contain the spread of serious infectious diseases such as COVID-19, especially in its early stage. We propose to use temporal reproduction number an extension of effective reproduction number, to evaluate the efficacy of control measures, and establish a Monte-Carlo method to estimate the temporal reproduction number without complete information about symptom onsets. The province-level analysis indicates that the effective reproduction numbers of the majority of provinces in mainland China got down to < 1 just by one week from the setting of control measures, and the temporal reproduction number of the week [15 Feb, 21 Feb] is only about 0.18. It is therefore likely that Chinese control measures on COVID-19 are effective and efficient, though more research needs to be performed.	[Chen, Duanbing; Zhou, Tao] Univ Elect Sci & Technol China, Big Data Res Ctr, Chengdu, Peoples R China; [Chen, Duanbing] Union Big Data, Chengdu, Peoples R China; [Zhou, Tao] Tianfu Complex Sci Res Ctr, Chengdu, Peoples R China	University of Electronic Science & Technology of China	Zhou, T (corresponding author), Univ Elect Sci & Technol China, Big Data Res Ctr, Chengdu, Peoples R China.; Zhou, T (corresponding author), Tianfu Complex Sci Res Ctr, Chengdu, Peoples R China.	zhutou@ustc.edu	zhou, tao/GQA-3572-2022	Zhou, Tao/0000-0003-0561-2316	National Natural Science Foundation of China [61673085, 11975071, 61433014]; Science Strength Promotion Programme of UESTC [Y03111023901014006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Strength Promotion Programme of UESTC	This work was partially supported by the National Natural Science Foundation of China (61673085, 11975071, 61433014) and by the Science Strength Promotion Programme of UESTC (Y03111023901014006). There was no additional external funding received for this study.	Allen LJS, 2008, J DIFFER EQU APPL, V14, P1127, DOI 10.1080/10236190802332308; ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839; Associated Press, 2014, BLOOMINGTON HER 0602, V6, pB5; Cauchemez S, 2006, EMERG INFECT DIS, V12, P110; Cauchemez S, 2006, AM J EPIDEMIOL, V164, P591, DOI 10.1093/aje/kwj274; Chong YC, 2020, NOVEL METHOD ESTIMAT, DOI [10.1101/2020.02.22.20023267, DOI 10.1101/2020.02.22.20023267]; Codeco CT, 2018, EPIDEMICS-NETH, V25, P101, DOI 10.1016/j.epidem.2018.05.011; Cowling BJ, 2010, EPIDEMIOLOGY, V21, P842, DOI 10.1097/EDE.0b013e3181f20977; CRUTCHER HL, 1975, J APPL METEOROL, V14, P1600, DOI 10.1175/1520-0450(1975)014<1600:ANOTPM>2.0.CO;2; Delamater PL, 2019, EMERG INFECT DIS, V25, P1, DOI 10.3201/eid2501.171901; Eichner M, 2003, AM J EPIDEMIOL, V158, P110, DOI 10.1093/aje/kwg103; Fisman D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0114548, 10.1371/currents.outbreaks.89c0d3783f36958d96ebbae97348d571]; Focardi R, 2019, J INF SECUR APPL, V48, DOI 10.1016/j.jisa.2019.102369; Guerra FM, 2017, LANCET INFECT DIS, V17, pE420, DOI 10.1016/S1473-3099(17)30307-9; Lai AL, 2020, J MED VIROL, V92, P675, DOI 10.1002/jmv.25723; Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Liu QH, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008467; Liu QH, 2018, P NATL ACAD SCI USA, V115, P12680, DOI 10.1073/pnas.1811115115; Magal P, 2019, SIAM J APPL MATH, V79, P284, DOI 10.1137/18M1182243; Perasso Antoine, 2018, ESAIM: Proceedings and Surveys, V62, P123, DOI 10.1051/proc/201862123; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Rinne H., 2008, WEIBULL DISTRIBUTION; Roberts MG, 2007, J MATH BIOL, V55, P803, DOI 10.1007/s00285-007-0112-8; Roberts MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017835; Sanches Rosangela Peregrina, 2016, Infect Dis Model, V1, P88, DOI 10.1016/j.idm.2016.08.002; STACY EW, 1962, ANN MATH STAT, V33, P1187, DOI 10.1214/aoms/1177704481; Tariq A, 2019, EPIDEMICS-NETH, V26, P128, DOI 10.1016/j.epidem.2019.01.003; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Xu ML, 2019, IEEE T MULTIMEDIA, V21, P1960, DOI 10.1109/TMM.2019.2891420; Zhang JJ, 2020, LANCET INFECT DIS, V20, P793, DOI 10.1016/S1473-3099(20)30230-9; Zhao S, 2020, PEERJ, V8, DOI 10.7717/peerj.8601; Zhou T, 2020, J EVID-BASED MED, V13, P3, DOI 10.1111/jebm.12376	35	4	4	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246715	10.1371/journal.pone.0246715	http://dx.doi.org/10.1371/journal.pone.0246715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571273	Green Published, Green Submitted, gold			2022-12-26	WOS:000618274000089
J	Fix, GM; Dryden, EM; Boudreau, J; Kressin, NR; Gifford, AL; Bokhour, BG				Fix, Gemmae M.; Dryden, Eileen M.; Boudreau, Jacqueline; Kressin, Nancy R.; Gifford, Allen L.; Bokhour, Barbara G.			The temporal nature of social context: Insights from the daily lives of patients with HIV	PLOS ONE			English	Article							ADVERSE CHILDHOOD EXPERIENCES; DETERMINANTS; HEALTH; LONELINESS; CARE; COMMUNICATION; INFECTION; IDENTITY; ILLNESS; IMPACT	Background Patients' life contexts are increasingly recognized as important, as evidenced by growing attention to the Social Determinants of Health (SDoH). This attention may be particularly valuable for patients with complex needs, like those with HIV, who are more likely to experience age-related comorbidities, mental health or substance use issues. Understanding patient perceptions of their life context can advance SDoH approaches. Objectives We sought to understand how aging patients with HIV think about their life context and explored if and how their reported context was documented in their electronic medical records (EMRs). Design We combined life story interviews and EMR data to understand the health-related daily life experiences of patients with HIV. Patients over 50 were recruited from two US Department of Veterans Affairs HIV clinics. Narrative analysis was used to organize data by life events and health-related metrics. Key results EMRs of 15 participants documented an average of 19 diagnoses and 10 medications but generally failed to include social contexts salient to patients. In interviews, HIV was discussed primarily in response to direct interviewer questions. Instead, participants raised past trauma, current social engagement, and concern about future health with varying salience. This led us to organize the narratives temporally according to past-, present-, or future-orientation. "Past-focused" narratives dwelled on unresolved experiences with social institutions like the school system, military or marriage. "Present-focused" narratives emphasized daily life challenges, like social isolation. "Future-focused" narratives were dominated by concerns that aging would limit activities. Conclusions A temporally informed understanding of patients' life circumstances that are the foundation of their individualized SDoH could better focus care plans by addressing contextual concerns salient to patients. Trust-building may be a critical first step in caring for past-focused patients. Present-focused patients may benefit from support groups. Future-focused patients may desire discussing long term care options.	[Fix, Gemmae M.; Dryden, Eileen M.; Boudreau, Jacqueline; Kressin, Nancy R.; Gifford, Allen L.; Bokhour, Barbara G.] US Dept Vet Affairs, CHOIR, Bedford, MA 01730 USA; [Fix, Gemmae M.; Dryden, Eileen M.; Boudreau, Jacqueline; Kressin, Nancy R.; Gifford, Allen L.; Bokhour, Barbara G.] US Dept Vet Affairs, CHOIR, Boston, MA 02203 USA; [Fix, Gemmae M.; Kressin, Nancy R.; Gifford, Allen L.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Bokhour, Barbara G.] Univ Massachusetts, Sch Med, Worcester, MA USA	US Department of Veterans Affairs; US Department of Veterans Affairs; Boston University; University of Massachusetts System; University of Massachusetts Worcester	Fix, GM (corresponding author), US Dept Vet Affairs, CHOIR, Bedford, MA 01730 USA.; Fix, GM (corresponding author), US Dept Vet Affairs, CHOIR, Boston, MA 02203 USA.; Fix, GM (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	gemmae.fix@va.gov		Fix, Gemmae/0000-0001-6055-4177	Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service; VA HSR&D Career Development at the Bedford VA [CDA 14-156]	Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service(US Department of Veterans Affairs); VA HSR&D Career Development at the Bedford VA	The research reported here was supported by the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service. Gemmae Fix is a VA HSR&D Career Development awardee at the Bedford VA (CDA 14-156). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. There are no conflicts of interest to report for any authors. https://www.hsrd.research.va.gov/.	Atkinson R., 1998, LIFE STORY INTERVIEW; Bartos M, 2000, AIDS CARE, V12, P299, DOI 10.1080/09540120050042954; Baumgartner LM, 2007, QUAL HEALTH RES, V17, P919, DOI 10.1177/1049732307305881; Berdahl CT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.11390; Blosnich JR, 2014, JAMA PSYCHIAT, V71, P1041, DOI 10.1001/jamapsychiatry.2014.724; Cantor MN, 2018, HEALTH AFFAIR, V37, P585, DOI 10.1377/hlthaff.2017.1252; Chu C, 2011, J URBAN HEALTH, V88, P556, DOI 10.1007/s11524-011-9552-y; Cole MB, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz124; CONRAD P, 1990, SOC SCI MED, V30, P1257, DOI 10.1016/0277-9536(90)90266-U; Cusatis R, 2020, PATIENT EDUC COUNS, V103, P734, DOI 10.1016/j.pec.2019.10.020; Daniel H, 2018, ANN INTERN MED, V168, P577, DOI 10.7326/M17-2441; Davidson KW, 2019, JAMA-J AM MED ASSOC, V322, P1037, DOI 10.1001/jama.2019.10915; Denning Paul H., 2011, Morbidity and Mortality Weekly Report, V60, P1045; Emlet CA, 2017, AGEING SOC, V37, P2128, DOI 10.1017/S0144686X16000878; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Fix GM, 2018, PATIENT EDUC COUNS, V101, P2226, DOI 10.1016/j.pec.2018.08.018; Garg A, 2016, JAMA-J AM MED ASSOC, V316, P813, DOI 10.1001/jama.2016.9282; Gibbs A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195369; Goodwin C, 1992, STUDIES SOCIAL CULTU, P1; Greene M, 2013, JAMA-J AM MED ASSOC, V309, P1397, DOI 10.1001/jama.2013.2963; Gurewich D, 2020, J GEN INTERN MED, V35, P1571, DOI 10.1007/s11606-020-05720-6; Hickey D, 2012, INT J PALLIAT NURS, V18, P241, DOI 10.12968/ijpn.2012.18.5.241; Ho LPP, 2018, HEALTH SOC WORK, V43, P274, DOI 10.1093/hsw/hly023; Holman EA, 1998, J PERS SOC PSYCHOL, V74, P1146, DOI 10.1037/0022-3514.74.5.1146; LeRoy AS, 2017, HEALTH PSYCHOL, V36, P512, DOI 10.1037/hea0000467; Manning PK, 1994, HDB QUALITATIVE RES; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; MATTINGLY C, 1994, SOC SCI MED, V38, P771, DOI 10.1016/0277-9536(94)90149-X; Meddings J, 2017, J GEN INTERN MED, V32, P71, DOI 10.1007/s11606-016-3869-x; Mishler EG, 1984, DISCOURSE MED DIALEC; Mullen RA, 2019, ANN FAM MED, V17, P108, DOI 10.1370/afm.2358; Munoz RT, 2019, J HEALTH CARE POOR U, V30, P238, DOI 10.1353/hpu.2019.0018; Pence BW, 2012, JAIDS-J ACQ IMM DEF, V59, P409, DOI 10.1097/QAI.0b013e31824150bb; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Riessman C.K., 2008, NARRATIVE METHODS HU, P21; Rochon D, 2011, HEALTH COMMUN, V26, P461, DOI 10.1080/10410236.2011.554168; Rubin R, 2017, JAMA-J AM MED ASSOC, V318, P1853, DOI 10.1001/jama.2017.14591; Sontag S., 1989, AIDS ITS METAPHORS; Valtorta NK, 2016, HEART, V102, P1009, DOI 10.1136/heartjnl-2015-308790; Virapongse A, 2018, J GEN INTERN MED, V33, P1959, DOI 10.1007/s11606-018-4615-3; Weiner SJ, 2004, J GEN INTERN MED, V19, P281, DOI 10.1111/j.1525-1497.2004.30261.x; Wise J, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3356; Yates-Doerr E, 2020, MED ANTHROPOL Q, V34, P378, DOI 10.1111/maq.12586	43	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246534	10.1371/journal.pone.0246534	http://dx.doi.org/10.1371/journal.pone.0246534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571283	Green Published, gold			2022-12-26	WOS:000618274000004
J	Korwar, AM; Hossain, A; Lee, TJ; Shay, AE; Basrur, V; Conlon, K; Smith, PB; Carlson, BA; Salis, HM; Patterson, AD; Prabhu, KS				Korwar, Arvind M.; Hossain, Ayaan; Lee, Tai-Jung; Shay, Ashley E.; Basrur, Venkatesha; Conlon, Kevin; Smith, Philip B.; Carlson, Bradley A.; Salis, Howard M.; Patterson, Andrew D.; Prabhu, K. Sandeep			Selenium-dependent metabolic reprogramming during inflammation and resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-KINASE M2; MACROPHAGE POLARIZATION; ALTERNATIVE ACTIVATION; PPAR-GAMMA; EXPRESSION; IMMUNOMETABOLISM; SELENOPROTEINS; DEFICIENCY; IL-1-BETA; SUCCINATE	Trace element selenium (Se) is incorporated as the 21st amino acid, selenocysteine, into selenoproteins through tRNA([Ser]Sec). Selenoproteins act as gatekeepers of redox homeostasis and modulate immune function to effect anti-inflammation and resolution. However, mechanistic underpinnings involving metabolic reprogramming during inflammation and resolution remain poorly understood. Bacterial endotoxin lipopolysaccharide (LPS) activation of murine bone marrow-derived macrophages cultured in the presence or absence of Se (as selenite) was used to examine temporal changes in the proteome and metabolome by multiplexed tandem mass tag-quantitative proteomics, metabolomics, and machine-learning approaches. Kinetic deltagram and clustering analysis indicated that addition of Se led to extensive reprogramming of cellular metabolism upon stimulation with LPS enhancing the pentose phosphate pathway, tricarboxylic acid cycle, and oxidative phosphorylation, to aid in the phenotypic transition toward alternatively activated macrophages, synonymous with resolution of inflammation. Remodeling of metabolic pathways and consequent metabolic adaptation toward pro-resolving phenotypes began with Se treatment at 0 h and became most prominent around 8 h after LPS stimulation that included succinate dehydrogenase complex, pyruvate kinase, and sedoheptulokinase. Se-dependent modulation of these pathways predisposed bone marrow-derived macrophages to preferentially increase oxidative phosphorylation to efficiently regulate inflammation and its timely resolution. The use of macrophages lacking selenoproteins indicated that all three metabolic nodes were sensitive to selenoproteome expression. Furthermore, inhibition of succinate dehydrogenase complex with dimethylmalonate affected the proresolving effects of Se by increasing the resolution interval in a murine peritonitis model. In summary, our studies provide novel insights into the role of cellular Se via metabolic reprograming to facilitate anti-inflammation and proresolution.	[Korwar, Arvind M.; Lee, Tai-Jung; Shay, Ashley E.; Smith, Philip B.; Patterson, Andrew D.; Prabhu, K. Sandeep] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Hossain, Ayaan; Salis, Howard M.] Penn State Univ, Bioinformat & Genom, University Pk, PA 16802 USA; [Hossain, Ayaan; Salis, Howard M.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Hossain, Ayaan; Salis, Howard M.] Penn State Univ, Dept Biol Engn, University Pk, PA 16802 USA; [Hossain, Ayaan; Salis, Howard M.] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA; [Basrur, Venkatesha; Conlon, Kevin] Univ Michigan, Dept Pathol, Med Sch, Prote Resource Facil, Ann Arbor, MI 48109 USA; [Smith, Philip B.] Penn State Univ, Metabol Facil, Huck Inst Life Sci, University Pk, PA 16802 USA; [Carlson, Bradley A.] NCI, Mol Biol Selenium Sect, Mouse Canc Genet Program, NIH, Bethesda, MD 20892 USA; [Korwar, Arvind M.] Univ N Carolina, Greensboro, NC USA; [Shay, Ashley E.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Greensboro; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Prabhu, KS (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	ksp4@psu.edu	Hossain, Ayaan/ABB-9367-2021	Hossain, Ayaan/0000-0002-4781-5501	NIH; Office of Dietary Supplements NIH [DK077152]; USDA-NIFA Hatch Project [4605, 1010021]; Penn State Cancer Institute, Metabolomics Facility; Defense Advanced Research Projects Agency [FA8750-17-C-0254]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA-NIFA Hatch Project; Penn State Cancer Institute, Metabolomics Facility; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	These studies were funded, in part, by grants from the NIH and Office of Dietary Supplements NIH DK077152, USDA-NIFA Hatch Project (Project #4605; Accession #1010021), Penn State Cancer Institute, Metabolomics Facility, and the Defense Advanced Research Projects Agency (FA8750-17-C-0254). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allman Erik L, 2016, Antimicrob Agents Chemother, V60, P6635, DOI 10.1128/AAC.01224-16; Angstwurm MWA, 2007, CRIT CARE MED, V35, P118, DOI 10.1097/01.CCM.0000251124.83436.0E; Avery JC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091203; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Blagih J, 2012, CELL METAB, V15, P793, DOI 10.1016/j.cmet.2012.05.008; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Carlson BA, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-57; Diwakar BT, 2017, ADV CANCER RES, V136, P153, DOI 10.1016/bs.acr.2017.07.003; DOHERTY NS, 1985, PROSTAGLANDINS, V30, P769, DOI 10.1016/0090-6980(85)90006-1; Finch ER, 2017, BLOOD, V129, P1802, DOI 10.1182/blood-2016-08-736405; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Gandhi UH, 2011, J BIOL CHEM, V286, P27471, DOI 10.1074/jbc.M111.260547; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Hawkes WC, 2010, BIOL TRACE ELEM RES, V134, P235, DOI 10.1007/s12011-010-8656-7; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Z, 2012, ANTIOXID REDOX SIGN, V16, P705, DOI 10.1089/ars.2011.4145; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kaushal N, 2014, J IMMUNOL, V193, P3683, DOI 10.4049/jimmunol.1400347; Korwar AM, 2019, J AM SOC MASS SPECTR, V30, P1276, DOI 10.1007/s13361-019-02192-9; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kudva AK, 2015, AM J PHYSIOL-GASTR L, V309, pG71, DOI 10.1152/ajpgi.00379.2014; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Misra S, 2015, NUTRIENTS, V7, P3536, DOI 10.3390/nu7053536; Nelson SM, 2016, J BIOL CHEM, V291, P2787, DOI 10.1074/jbc.M115.684738; Nelson SM, 2011, J NUTR, V141, P1754, DOI 10.3945/jn.111.141176; Nettleford SK, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7030036; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Neill LAJ, 2015, IMMUNITY, V42, P393, DOI 10.1016/j.immuni.2015.02.017; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; O'Neill Luke A J, 2011, Biochem J, V438, pe5, DOI 10.1042/BJ20111386; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Patel U, 2017, DRUG DISCOV TODAY, V22, P186, DOI 10.1016/j.drudis.2016.08.006; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; Price JV, 2014, IMMUNITY, V41, P685, DOI 10.1016/j.immuni.2014.10.015; Remmerie A, 2018, CELL IMMUNOL, V330, P27, DOI 10.1016/j.cellimm.2018.01.020; Schomburg L, 2014, CRIT CARE, V18, DOI 10.1186/cc13963; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Ternette N, 2013, CELL REP, V3, P689, DOI 10.1016/j.celrep.2013.02.013; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Vunta H, 2008, MOL NUTR FOOD RES, V52, P1316, DOI 10.1002/mnfr.200700346; WARBURG O, 1956, SCIENCE, V124, P269; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yim SH, 2019, CELL REP, V27, P2785, DOI 10.1016/j.celrep.2019.05.001	56	5	5	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100410	10.1016/j.jbc.2021.100410	http://dx.doi.org/10.1016/j.jbc.2021.100410			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33581115	Green Submitted, Green Published, gold			2022-12-26	WOS:000672866400384
J	Zhou, RM; Liao, JS; Cai, DP; Tian, Q; Huang, EP; Lu, TM; Chen, SY; Xie, WB				Zhou, Ruimei; Liao, Jiashun; Cai, Dunpeng; Tian, Qin; Huang, Enping; Lu, Tianming; Chen, Shi-You; Xie, Wei-Bing			Nupr1 mediates renal fibrosis via activating fibroblast and promoting epithelial-mesenchymal transition	FASEB JOURNAL			English	Article						epithelial&#8208; mesenchymal transition; fibroblast activation; Nupr1; renal fibrosis	NUCLEAR-PROTEIN; STRESS-RESPONSE; EMERGING ROLE; EXPRESSION; P8; GENE; CONTRIBUTES; CLONING; ORIGIN; CELLS	Renal interstitial fibrosis (RIF) is a pathological process that fibrotic components are excessively deposited in the renal interstitial space due to kidney injury, resulting in impaired renal function and chronic kidney disease. The molecular mechanisms controlling renal fibrosis are not fully understood. In this present study, we identified Nuclear protein 1 (Nupr1), a transcription factor also called p8, as a novel regulator promoting renal fibrosis. Unilateral ureteral obstruction (UUO) time-dependently induced Nupr1 mRNA and protein expression in mouse kidneys while causing renal damage and fibrosis. Nupr1 deficiency (Nupr1(-/-)) attenuated the renal tubule dilatation, tubular epithelial cell atrophy, and interstitial collagen accumulation caused by UUO. Consistently, Nupr1(-/-) significantly decreased the expression of type I collagen, myofibroblast markers smooth muscle alpha-actin (alpha-SMA), fibroblast-specific protein 1 (FSP-1), and vimentin in mouse kidney that were upregulated by UUO. These results suggest that Nupr1 protein was essential for fibroblast activation and/or epithelial-mesenchymal transition (EMT) during renal fibrogenesis. Indeed, Nupr1 was indispensable for TGF-beta-induced myofibroblast activation of kidney interstitial NRK-49F fibroblasts, multipotent mesenchymal C3H10T1/2 cells, and the EMT of kidney epithelial NRK-52E cells. It appears that Nupr1 mediated TGF-beta-induced alpha-SMA expression and collagen synthesis by initiating Smad3 signaling pathway. Importantly, trifluoperazine (TFP), a Nupr1 inhibitor, alleviated UUO-induced renal fibrosis. Taken together, our results demonstrate that Nupr1 promotes renal fibrosis by activating myofibroblast transformation from both fibroblasts and tubular epithelial cells.	[Zhou, Ruimei; Liao, Jiashun; Tian, Qin; Huang, Enping; Xie, Wei-Bing] Southern Med Univ, Sch Forens Med, Guangzhou 510515, Peoples R China; [Zhou, Ruimei; Cai, Dunpeng; Chen, Shi-You] Univ Missouri, Dept Surg, Med Pharmacol & Physiol, Columbia, MO 65212 USA; [Lu, Tianming] Southern Med Univ, Dept Neurol, Affiliated Hosp 3, Guangzhou, Peoples R China	Southern Medical University - China; University of Missouri System; University of Missouri Columbia; Southern Medical University - China	Xie, WB (corresponding author), Southern Med Univ, Sch Forens Med, Guangzhou 510515, Peoples R China.; Chen, SY (corresponding author), Univ Missouri, Sch Med, Dept Surg, Columbia, MO 65212 USA.	scqvd@missouri.edu; xieweib@126.com			Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2019A1515010271]	Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province)	Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2019A1515010271	Barbosa-Sampaio HC, 2013, DIABETOLOGIA, V56, P2477, DOI 10.1007/s00125-013-3006-x; Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Brannon KM, 2007, CANCER LETT, V254, P146, DOI 10.1016/j.canlet.2007.03.011; Bulow RD, 2019, J HISTOCHEM CYTOCHEM, V67, P643, DOI 10.1369/0022155419849388; Chowdhury U, 2009, CANCER METAST REV, V28, P225, DOI 10.1007/s10555-009-9183-x; Galichon P, 2017, J AM SOC NEPHROL, V28, P545, DOI 10.1681/ASN.2015080936; Garcia-Montero AC, 2001, BIOCHEM J, V357, P249, DOI 10.1042/0264-6021:3570249; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kramann Rafael, 2013, Curr Pathobiol Rep, V1, DOI 10.1007/s40139-013-0026-7; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Malicet C, 2006, P NATL ACAD SCI USA, V103, P2671, DOI 10.1073/pnas.0508955103; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; Mohammad HP, 2004, MOL ENDOCRINOL, V18, P2583, DOI 10.1210/me.2004-0163; MuchanetaKubara EC, 1997, NEPHROL DIAL TRANSPL, V12, P904, DOI 10.1093/ndt/12.5.904; Narzt MS, 2019, REDOX BIOL, V20, P467, DOI 10.1016/j.redox.2018.11.006; Neira JL, 2017, SCI REP-UK, V7, DOI 10.1038/srep39732; Ning XX, 2018, J CELL MOL MED, V22, P1383, DOI 10.1111/jcmm.13465; Pommier RM, 2012, BIOCHEM J, V445, P285, DOI 10.1042/BJ20120368; Ree AH, 1999, CANCER RES, V59, P4675; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Rossini M, 2005, KIDNEY INT, V68, P2621, DOI 10.1111/j.1523-1755.2005.00734.x; Santofimia-Castano P, 2019, J CLIN INVEST, V129, P2500, DOI 10.1172/JCI127223; Sharma S, 2011, CURR OPIN NEPHROL HY, V20, P56, DOI 10.1097/MNH.0b013e3283414c88; Vasseur S, 1999, EUR J BIOCHEM, V259, P670, DOI 10.1046/j.1432-1327.1999.00092.x; Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25; Wang BD, 2018, INT J MOL MED, V41, P3278, DOI 10.3892/ijmm.2018.3562; Wang YP, 2018, PROG MOL BIOL TRANSL, V153, P181, DOI 10.1016/bs.pmbts.2017.11.019; Wu YR, 2018, INT UROL NEPHROL, V50, P1347, DOI 10.1007/s11255-018-1820-2; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Xu LL, 2020, AGING-US, V12, P5209, DOI 10.18632/aging.102942; Zhou D, 2016, SCI CHINA LIFE SCI, V59, P920, DOI 10.1007/s11427-016-0020-y	33	3	3	3	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21381	10.1096/fj.202000926RR	http://dx.doi.org/10.1096/fj.202000926RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33617091				2022-12-26	WOS:000629576700002
J	Nattoh, G; Bargul, JL; Magoma, G; Mbaisi, L; Butungi, H; Mararo, E; Teal, E; Herren, JK				Nattoh, Godfrey; Bargul, Joel L.; Magoma, Gabriel; Mbaisi, Lilian; Butungi, Hellen; Mararo, Enock; Teal, Evan; Herren, Jeremy Keith			The fungus Leptosphaerulina persists in Anopheles gambiae and induces melanization	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; GUT MICROBIOTA; MOSQUITOS HOST; BACTERIA; REFRACTORINESS; CONTRIBUTE; CULICIDAE; DIPTERA	Anopheles mosquitoes are colonized by diverse microorganisms that may impact on host biology and vectorial capacity. Eukaryotic symbionts such as fungi have been isolated from Anopheles, but whether they are stably associated with mosquitoes and transmitted transstadially across mosquito life stages or to subsequent generations remains largely unexplored. Here, we show that a Leptosphaerulina sp. fungus isolated from the midgut of An. gambiae can be stably associated with An. gambiae host and that it imposes low fitness cost when re-introduced through co-feeding. This fungus is transstadially transmitted across An. gambiae developmental stages and to their progeny. It is present in field-caught larvae and adult mosquitoes at moderate levels across geographical regions. We observed that Leptosphaerulina sp. induces a distinctive melanotic phenotype across the developmental stages of mosquito. As a eukaryotic symbiont that is stably associated with An. gambiae Leptosphaerulina sp. can be explored for paratransgenesis.	[Nattoh, Godfrey; Bargul, Joel L.; Mbaisi, Lilian; Butungi, Hellen; Mararo, Enock; Teal, Evan; Herren, Jeremy Keith] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Nattoh, Godfrey; Magoma, Gabriel] Pan African Univ, Inst Basic Sci Technol & Innovat, Nairobi, Kenya; [Bargul, Joel L.; Magoma, Gabriel] Jomo Kenyatta Univ Sci & Technol, Dept Biochem, Nairobi, Kenya; [Butungi, Hellen] Univ Witwatersrand, Wits Res Inst Malaria, Johannesburg, South Africa	International Centre of Insect Physiology & Ecology (ICIPE); Jomo Kenyatta University of Agriculture & Technology; University of Witwatersrand	Nattoh, G (corresponding author), Int Ctr Insect Physiol & Ecol, Nairobi, Kenya.; Nattoh, G (corresponding author), Pan African Univ, Inst Basic Sci Technol & Innovat, Nairobi, Kenya.	gindinda@icipe.org	Bargul, Joel L./ABB-5310-2021; Mararo, Enock/N-7232-2016	Bargul, Joel/0000-0001-8573-6807; Nattoh, Godfrey/0000-0003-1573-2477; Mararo, Enock/0000-0002-1324-7825; ANG'ANG'O, LILIAN MBAISI/0000-0001-8573-5417	African Union under Pan African University, Institute for Basic Sciences Technology & Innovation (PAUSTI) Postgraduate Scholarship; UK Aid from the Government of the United Kingdom, Department for Inter-national Development (DFID); UK, Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Federal Democratic Republic of Ethiopia; Kenyan Government; Wellcome Trust [107372]; DELTAS Africa Initiative grant [DEL-15-011]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Welcome Trust [107742/Z/15/Z]; UK government	African Union under Pan African University, Institute for Basic Sciences Technology & Innovation (PAUSTI) Postgraduate Scholarship; UK Aid from the Government of the United Kingdom, Department for Inter-national Development (DFID); UK, Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Federal Democratic Republic of Ethiopia; Kenyan Government; Wellcome Trust(Wellcome TrustEuropean Commission); DELTAS Africa Initiative grant; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Welcome Trust(Wellcome Trust); UK government	G.N. was supported by African Union under the auspice of Pan African University, Institute for Basic Sciences Technology & Innovation (PAUSTI) Postgraduate Scholarship. We also gratefully acknowledge icipe core funding provided by UK Aid from the Government of the United Kingdom, Department for Inter-national Development (DFID); the UK, Swedish International Development Cooperation Agency (Sida); the Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Federal Democratic Republic of Ethiopia; and the Kenyan Government. JKH was funded by the Wellcome Trust [107372] while JLB was supported by DELTAS Africa Initiative grant # DEL-15-011 to THRiVE-2. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Welcome Trust grant # 107742/Z/15/Z and the UK government. The views expressed herein do not necessarily reflect the official opinion of the donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhouayri IG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077619; Anglero-Rodriguez YI, 2017, ELIFE, V6, DOI 10.7554/eLife.28844; Anglero-Rodriguez YI, 2016, SCI REP-UK, V6, DOI 10.1038/srep34084; Bahia AC, 2014, ENVIRON MICROBIOL, V16, P2980, DOI 10.1111/1462-2920.12381; Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Boissiere A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002742; Bozic J, 2017, ENV MICROBIOL REP, V9, P642, DOI 10.1111/1758-2229.12569; Wilke ABB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0959-2; Cappelli A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095988; Chandler JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00185; Chavshin AR, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0635-6; Chrostek E, 2019, MBIO, V10, DOI 10.1128/mBio.00784-19; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Clayton AM, 2013, DEV COMP IMMUNOL, V39, P323, DOI 10.1016/j.dci.2012.10.009; Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877; Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771; Correa MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07014-2; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Duguma D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0475-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Gomes FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007333; Guegan M, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9080628; Guegan M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0435-2; Jimenez-Cortes JG, 2018, ACTA TROP, V186, P69, DOI 10.1016/j.actatropica.2018.07.005; Gulia-Nuss M, 2015, J INSECT PHYSIOL, V82, P8, DOI 10.1016/j.jinsphys.2015.08.001; Herren JK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16121-y; Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115; Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008; Luis P, 2019, FUNGAL ECOL, V39, P257, DOI 10.1016/j.funeco.2019.02.004; Malassigne S, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9070564; Moll RM, 2001, J MED ENTOMOL, V38, P29, DOI 10.1603/0022-2585-38.1.29; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Pereira ED, 2009, NEOTROP ENTOMOL, V38, P352, DOI 10.1590/S1519-566X2009000300009; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Sim C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-231; Strand MR, 2018, CURR OPIN INSECT SCI, V28, P59, DOI 10.1016/j.cois.2018.05.008; Telang A, 2006, J EXP BIOL, V209, P645, DOI 10.1242/jeb.02026; Valzania L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006638; Valzano M, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1059-7; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yadav KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167409	48	2	2	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0246452	10.1371/journal.pone.0246452	http://dx.doi.org/10.1371/journal.pone.0246452			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617536	gold, Green Published			2022-12-26	WOS:000623082400009
J	Venkataraman, AP; Andersson, J; Fivelsdal, L; Nilsson, M; Dominguez-Vicent, A				Venkataraman, Abinaya Priya; Andersson, Josefine; Fivelsdal, Lina; Nilsson, Maria; Dominguez-Vicent, Alberto			Impact of optical coherence tomography scan direction on the reliability of peripapillary retinal nerve fiber layer measurements	PLOS ONE			English	Article							SPECTRAL-DOMAIN; THICKNESS MEASUREMENTS; MULTIPLE-SCLEROSIS; REPRODUCIBILITY; GLAUCOMA; OCT; REPEATABILITY; PROGRESSION; PARAMETERS; ATROPHY	Purpose To evaluate the intradevice repeatability and agreement for peripapillary retinal nerve fiber layer (pRNFL) measurements in healthy eyes with two different scan directions and two different number of B scans. Methods pRNFL was measured with a spectral domain optical coherence tomography on 54 healthy participants. Three-dimensional optic disc scans (6 mm x 6 mm) were performed on the right eye of the participants. Two repeated scans were performed in four different settings: H1: Horizontal scan with 512 A-scans x 96 B-scans; H2: Horizontal scan with 512 A-scans x 128 B-scans; V1: Vertical scan with 512 A-scans x 96 B-scans; V2: Vertical scan with 512 A-scans x 128 B-scans. The pRNFL thickness was evaluated in twelve clock-hour sector in a circle of 3.45 mm diameter centred at the optic disc. Repeatability and agreement were assessed with within subject standard deviation (Sw) and Bland-Altman test respectively. Results The repeatability of pRNFL measurements varied depending on the scan direction and sectors. The repeatability for the horizontal sectors were better with H1 and H2, with sector 9 having the best Sw (< 3 mu m). The repeatability for the vertical sectors were better with V1 and V2 with sector 5 and 9 having the best Sw (< 4 mu m). The repeatability with vertical scan was more symmetric among the sectors than with horizontal scans. The repeatability metrics of the sectors did not vary much between H1 and H2 (difference < 2 mu m) and between V1 and V2 (difference < 3.2 mu m). Comparing horizontal and vertical scans, the vertical sectors had larger limits of agreement of about 45 mu m. Conclusion The reliability of the pRNFL thickness measurements is dependent on the direction of the scan and independent on the numbers of B-scans. Vertical scans for pRNFL gives more homogeneous repeatability across the different sectors.	[Venkataraman, Abinaya Priya; Andersson, Josefine; Fivelsdal, Lina; Nilsson, Maria; Dominguez-Vicent, Alberto] Karolinska Inst, Div Eye & Vis, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet	Venkataraman, AP (corresponding author), Karolinska Inst, Div Eye & Vis, Dept Clin Neurosci, Stockholm, Sweden.	abinaya.venkataraman@ki.se	Dominguez-Vicent, Alberto/GPT-0905-2022	Fivelsdal, Lina/0000-0002-3568-3767	Ogonfonden, Sweden	Ogonfonden, Sweden	ADV: 2018-Promoting vision research fund, Ogonfonden, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi A, 2013, INVEST OPHTH VIS SCI, V54, P6025, DOI 10.1167/iovs.13-12630; Bambo MP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198397; Bayhan HA, 2014, CURR EYE RES, V39, P1117, DOI 10.3109/02713683.2014.894080; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Buchser NM, 2012, INVEST OPHTH VIS SCI, V53, P3742, DOI 10.1167/iovs.11-8432; Budenz DL, 2005, INVEST OPHTH VIS SCI, V46, P2440, DOI 10.1167/iovs.04-1174; Caldito NG, 2018, CURR EYE RES, V43, P415, DOI 10.1080/02713683.2017.1406526; Castillo MM, 2015, OPHTHALMOLOGY, V122, P399, DOI 10.1016/j.ophtha.2014.07.055; Chen TC, 2018, OPHTHALMOLOGY, V125, P1817, DOI 10.1016/j.ophtha.2018.05.008; Cheung CYL, 2015, J ALZHEIMERS DIS, V45, P45, DOI 10.3233/JAD-141659; De Clerck EEB, 2015, LANCET DIABETES ENDO, V3, P653, DOI 10.1016/S2213-8587(15)00136-9; Dominguez-Vicent A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221466; Gonzalez-Garcia AO, 2009, AM J OPHTHALMOL, V147, P1067, DOI 10.1016/j.ajo.2008.12.032; Graham EC, 2016, INVEST OPHTH VIS SCI, V57, P2311, DOI 10.1167/iovs.15-19047; Grewal DS, 2013, CURR OPIN OPHTHALMOL, V24, P150, DOI 10.1097/ICU.0b013e32835d9e27; Hood DC, 2008, J GLAUCOMA, V17, P519, DOI 10.1097/IJG.0b013e3181629a02; Hood DC, 2010, J GLAUCOMA, V19, P158, DOI 10.1097/IJG.0b013e3181af31ec; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; ISO, 1994, ACC TRUEN PREC MEAS, P5725; ISO, 2006, PROB GEN STAT TERMS; Jones AL, 2001, BRIT J OPHTHALMOL, V85, P673, DOI 10.1136/bjo.85.6.673; Kardon RH, 2011, J NEURO-OPHTHALMOL, V31, P353, DOI 10.1097/WNO.0b013e318238b9cb; Lin PW, 2018, INT J OPHTHALMOL-CHI, V11, P1163, DOI 10.18240/ijo.2018.07.15; Liu X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086610, 10.1371/journal.pone.0087996]; Liu YN, 2015, AM J OPHTHALMOL, V159, P565, DOI 10.1016/j.ajo.2014.12.006; Maetschke S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219126; Matlach J, 2014, INVEST OPHTH VIS SCI, V55, P6536, DOI 10.1167/iovs.14-15072; McAlinden C, 2011, OPHTHAL PHYSL OPT, V31, P330, DOI 10.1111/j.1475-1313.2011.00851.x; Pierro L, 2012, INVEST OPHTH VIS SCI, V53, P5912, DOI 10.1167/iovs.11-8644; QUIGLEY HA, 1992, OPHTHALMOLOGY, V99, P19; Saidha S, 2015, ANN NEUROL, V78, P801, DOI 10.1002/ana.24487; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Sung KR, 2012, BRIT J OPHTHALMOL, V96, P1452, DOI 10.1136/bjophthalmol-2012-301845; Toteberg-Harms M, 2012, GRAEF ARCH CLIN EXP, V250, P279, DOI 10.1007/s00417-011-1811-9; Wadhwani M, 2015, J GLAUCOMA, V24, pe109, DOI 10.1097/IJG.0000000000000203; Wu HJ, 2011, J GLAUCOMA, V20, P470, DOI 10.1097/IJG.0b013e3181f3eb64	37	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247670	10.1371/journal.pone.0247670	http://dx.doi.org/10.1371/journal.pone.0247670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617580	Green Published, gold			2022-12-26	WOS:000623082400027
J	Freund, AM; Tomasik, MJ				Freund, Alexandra M.; Tomasik, Martin J.			Managing conflicting goals through prioritization? The role of age and relative goal importance	PLOS ONE			English	Article								Three studies tested the role of prioritization in solving conflict between multiple goals in different age groups. Study 1 (N = 185 young, middle-aged, older adults) stressed the importance to solve two competing tasks equally well within a short time. Older adults prioritized more than younger adults. However, contrary to our expectations, prioritization led to higher perceived conflict, more negative affect, and less control. Study 2 (N = 117 younger and older adults) found that, using a more lenient instruction, deemphasizing the importance of performing equally well on both tasks, prioritization was no longer associated with perceived goal conflict. Study 3 (N = 721 young, middle-aged, older adults) was an online study using hypothetical scenarios. This study was run to substantiate the potential mechanism underlying the differences between Study 1 and 2 and supported the hypothesized effect of the instructional strictness of pursuing two goals. Thus, when encountering conflicting goals older adults prioritize more than younger adults, but prioritization might not be optimal for solving short-term goal conflict when both conflicting goals are equally important.	[Freund, Alexandra M.; Tomasik, Martin J.] Univ Zurich, Dept Psychol, Zurich, Switzerland; [Freund, Alexandra M.; Tomasik, Martin J.] Univ Zurich, Univ Res Prior Program Dynam Hlth Aging, Zurich, Switzerland; [Freund, Alexandra M.] Natl Ctr Competence Res NCCR LIVES Overcoming Vul, Bern, Switzerland	University of Zurich; University of Zurich	Freund, AM (corresponding author), Univ Zurich, Dept Psychol, Zurich, Switzerland.; Freund, AM (corresponding author), Univ Zurich, Univ Res Prior Program Dynam Hlth Aging, Zurich, Switzerland.; Freund, AM (corresponding author), Natl Ctr Competence Res NCCR LIVES Overcoming Vul, Bern, Switzerland.	freund@psychologie.uzh.ch	Tomasik, Martin J./ABH-2675-2021; Tomasik, Martin/HII-4691-2022	Tomasik, Martin J./0000-0001-5235-3551; Tomasik, Martin/0000-0001-5235-3551; Freund, Alexandra M./0000-0001-9953-523X	Swiss National Science Foundation [100014-138045]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation Grant 100014-138045 "Readiness to Disengage from Motivational Conflict: Adult Age Differences and Implications for Emotional Experiences"(PI: Alexandra M. Freund).	Ballard T, 2018, PSYCHON B REV, V25, P1184, DOI 10.3758/s13423-017-1329-1; Baltes P.B., 2006, HDB CHILD PSYCHOL, P569, DOI [10.1002/9780470147658.chpsy0111, DOI 10.1002/9780470147658.CHPSY0111]; Boudreaux MJ, 2013, MOTIV EMOTION, V37, P433, DOI 10.1007/s11031-012-9333-2; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; BRANDTSTADTER J, 1990, PSYCHOL AGING, V5, P58, DOI 10.1037/0882-7974.5.1.58; Freund AM, 2014, GERONTOLOGY, V60, P255, DOI 10.1159/000358756; Freund AM, 2008, RES HUM DEV, V5, P94, DOI 10.1080/15427600802034827; Freund AM, 2002, J PERS SOC PSYCHOL, V82, P642, DOI 10.1037//0022-3514.82.4.642; Gray JS, 2017, J RES PERS, V66, P27, DOI 10.1016/j.jrp.2016.12.003; Greenhaus JH, 2006, RES OCCUP STRESS WEL, V5, P61, DOI 10.1016/S1479-3555(05)05002-X; Grzywacz JG, 2002, FAM RELAT, V51, P28, DOI 10.1111/j.1741-3729.2002.00028.x; King LA, 2000, J RES PERS, V34, P509, DOI 10.1006/jrpe.2000.2285; Lang FR, 2002, PSYCHOL AGING, V17, P125, DOI 10.1037//0882-7974.17.1.125; Li KZH, 2001, PSYCHOL SCI, V12, P230, DOI 10.1111/1467-9280.00341; Lindenberger U, 1997, PSYCHOL AGING, V12, P410, DOI 10.1037/0882-7974.12.3.410; Orehek E, 2013, REV GEN PSYCHOL, V17, P339, DOI 10.1037/a0032584; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; Riediger M, 2006, PSYCHOL AGING, V21, P173, DOI 10.1037/0882-7974.21.1.173; Riediger M, 2005, J GERONTOL B-PSYCHOL, V60, pP84, DOI 10.1093/geronb/60.2.P84; Riediger M, 2004, PERS SOC PSYCHOL B, V30, P1511, DOI 10.1177/0146167204271184; Riediger M, 2008, PSYCHOL AGING, V23, P479, DOI 10.1037/a0013302; Shah JY, 2002, J PERS SOC PSYCHOL, V83, P1261, DOI 10.1037//0022-3514.83.6.1261; Shockley KM, 2011, J MANAGE, V37, P861, DOI 10.1177/0149206310394864; SPECTOR A, 1976, AM J PSYCHOL, V89, P669, DOI 10.2307/1421465; Tomasik MJ, 2012, DEV PSYCHOL, V48, P1785, DOI 10.1037/a0026952; Tomasik MJ, 2012, MOTIV EMOTION, V36, P170, DOI 10.1007/s11031-011-9246-5; Wrosch C, 2007, PERS SOC PSYCHOL B, V33, P251, DOI 10.1177/0146167206294905; Wrosch C, 2003, SELF IDENTITY, V2, P1, DOI 10.1080/15298860309021	28	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247047	10.1371/journal.pone.0247047	http://dx.doi.org/10.1371/journal.pone.0247047			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606772	Green Published, gold			2022-12-26	WOS:000620629200053
J	Herrero, A; Klutsch, CFC; Holmala, K; Maduna, SN; Kopatz, A; Eiken, HG; Hagen, SB				Herrero, Annika; Klutsch, Cornelya F. C.; Holmala, Katja; Maduna, Simo N.; Kopatz, Alexander; Eiken, Hans Geir; Hagen, Snorre B.			Genetic analysis indicates spatial-dependent patterns of sex-biased dispersal in Eurasian lynx in Finland	PLOS ONE			English	Article							POPULATION-STRUCTURE; NATAL DISPERSAL; SOLITARY CARNIVORE; SOFTWARE; CONSEQUENCES; CLUSTERS; BOBCATS; ORGANIZATION; CANADENSIS; PHILOPATRY	Conservation and management of large carnivores requires knowledge of female and male dispersal. Such information is crucial to evaluate the population's status and thus management actions. This knowledge is challenging to obtain, often incomplete and contradictory at times. The size of the target population and the methods applied can bias the results. Also, population history and biological or environmental influences can affect dispersal on different scales within a study area. We have genotyped Eurasian lynx (180 males and 102 females, collected 2003-2017) continuously distributed in southern Finland (similar to 23,000 km(2)) using 21 short tandem repeats (STR) loci and compared statistical genetic tests to infer local and sex-specific dispersal patterns within and across genetic clusters as well as geographic regions. We tested for sex-specific substructure with individual-based Bayesian assignment tests and spatial autocorrelation analyses. Differences between the sexes in genetic differentiation, relatedness, inbreeding, and diversity were analysed using population-based AMOVA, F-statistics, and assignment indices. Our results showed two different genetic clusters that were spatially structured for females but admixed for males. Similarly, spatial autocorrelation and relatedness was significantly higher in females than males. However, we found weaker sex-specific patterns for the Eurasian lynx when the data were separated in three geographical regions than when divided in the two genetic clusters. Overall, our results suggest male-biased dispersal and female philopatry for the Eurasian lynx in Southern Finland. The female genetic structuring increased from west to east within our study area. In addition, detection of male-biased dispersal was dependent on analytical methods utilized, on whether subtle underlying genetic structuring was considered or not, and the choice of population delineation. Conclusively, we suggest using multiple genetic approaches to study sex-biased dispersal in a continuously distributed species in which population delineation is difficult.	[Herrero, Annika; Holmala, Katja] Nat Resources Inst Finland Luke, Helsinki, Finland; [Herrero, Annika] Univ Helsinki, Helsinki, Finland; [Klutsch, Cornelya F. C.; Maduna, Simo N.; Eiken, Hans Geir; Hagen, Snorre B.] Norwegian Inst Bioecon Res, NIBIO Div Environm & Nat Resources, Svanvik, Norway; [Kopatz, Alexander] Norwegian Inst Nat Res NINA, Trondheim, Norway	Natural Resources Institute Finland (Luke); University of Helsinki; Norwegian Institute of Bioeconomy Research; Norwegian Institute Nature Research	Holmala, K (corresponding author), Nat Resources Inst Finland Luke, Helsinki, Finland.; Hagen, SB (corresponding author), Norwegian Inst Bioecon Res, NIBIO Div Environm & Nat Resources, Svanvik, Norway.	katja.holmala@luke.fi; snoree.hagen@nibio.no	Kopatz, Alexander/AAC-3967-2022; Klutsch, Cornelya/G-8944-2019; Kopatz, Alexander/A-3174-2012	Kopatz, Alexander/0000-0002-9139-1179; Klutsch, Cornelya/0000-0001-8238-2484; Kopatz, Alexander/0000-0002-9139-1179; Herrero, Annika/0000-0001-8062-1613; Maduna, Simo/0000-0002-9372-4360; Eiken, Hans Geir/0000-0002-5368-3648	Raija and Ossi Tuuliainen Foundation	Raija and Ossi Tuuliainen Foundation	AH's work has been financed by the Raija and Ossi Tuuliainen Foundation (2014-2018). www.tuuliaisensaatio.fi The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronsson M, 2020, OIKOS, V129, P1174, DOI 10.1111/oik.07258; Aronsson M, 2016, ECOL EVOL, V6, P2957, DOI 10.1002/ece3.2032; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Besnier F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070651; Biek R, 2006, BIOL LETT-UK, V2, P312, DOI 10.1098/rsbl.2005.0437; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; BREITENMOSER U, 1993, J ZOOL, V231, P449, DOI 10.1111/j.1469-7998.1993.tb01931.x; Bunnefeld N, 2006, J ZOOL, V270, P31, DOI 10.1111/j.1469-7998.2006.00107.x; Campbell V, 2006, CAN J ZOOL, V84, P1112, DOI 10.1139/Z06-099; Carmichael LE, 2000, MOL ECOL, V9, P2197, DOI 10.1046/j.1365-294X.2000.105323.x; Cayuela H, 2018, MOL ECOL, V27, P3976, DOI 10.1111/mec.14848; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Costello CM, 2008, MOL ECOL, V17, P4713, DOI 10.1111/j.1365-294X.2008.03930.x; Croteau EK, 2010, CAN J ZOOL, V88, P536, DOI 10.1139/Z10-024; Dharmarajan G, 2009, CAN J ZOOL, V87, P814, DOI 10.1139/Z09-072; Driscoll DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095053; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Fattebert J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122355; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Ferreras P, 2004, BEHAV ECOL, V15, P31, DOI 10.1093/beheco/arg097; FRANKHAM R, 1995, CONSERV BIOL, V9, P792, DOI 10.1046/j.1523-1739.1995.09040792.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; Heikkinen J, ILVESKANTA SUOMESSA; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Herrero A, 2020, MAMMAL RES, V65, P523, DOI 10.1007/s13364-020-00499-7; Holmala K., 2013, STATUS MANAGEMENT DI, P3, DOI [10.1371/journal.pone.0168292, DOI 10.1371/JOURNAL.PONE.0168292]; Holmala K, 2018, ECOL EVOL, V8, P10964, DOI 10.1002/ece3.4562; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Janecka JE, 2007, WILDLIFE BIOL, V13, P38, DOI 10.2981/0909-6396(2007)13[38:EFMDIB]2.0.CO;2; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; Kaczensky P., 2013, STATUS, P72, DOI [10.1371/journal.pone.0168292, DOI 10.1371/JOURNAL.PONE.0168292]; Kareinen I, 2020, EUR J WILDLIFE RES, V66, DOI 10.1007/s10344-019-1350-y; KITCHINGS JT, 1984, J WILDLIFE MANAGE, V48, P957, DOI 10.2307/3801447; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Kokko H, 2001, EVOL ECOL RES, V3, P537; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Krojerova-Prokesova J, 2019, HEREDITY, V122, P785, DOI 10.1038/s41437-018-0167-x; Li XY, 2019, BIOL REV, V94, P721, DOI 10.1111/brv.12475; Li YL, 2018, MOL ECOL RESOUR, V18, P176, DOI 10.1111/1755-0998.12719; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Matson G.M., 1981, WORKBOOK CEMENTUM AN; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Messier GD, 2012, MOL ECOL, V21, P5363, DOI 10.1111/mec.12022; Miller Mark A., 2010, 2010 Gateway Computing Environments Workshop (GCE 2010), DOI 10.1109/GCE.2010.5676129; Morton ER, 2018, ECOLOGY, V99, P938, DOI 10.1002/ecy.2172; Mossman CA, 1999, MOL ECOL, V8, P1063, DOI 10.1046/j.1365-294x.1999.00652.x; Naude VN, 2020, ECOL EVOL, V10, P3605, DOI 10.1002/ece3.6089; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrin N, 2000, AM NAT, V155, P116, DOI 10.1086/303296; Pilgrim KL, 2005, MOL ECOL NOTES, V5, P60, DOI 10.1111/j.1471-8286.2004.00831.x; Poole KG, 1997, J WILDLIFE MANAGE, V61, P497, DOI 10.2307/3802607; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Ratkiewicz M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115160; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rueness EK, 2003, MOL ECOL, V12, P2623, DOI 10.1046/j.1365-294X.2003.01952.x; Saastamoinen M, 2018, BIOL REV, V93, P574, DOI 10.1111/brv.12356; Samelius G, 2012, J ZOOL, V286, P120, DOI 10.1111/j.1469-7998.2011.00857.x; Schmidt K, 1998, ACTA THERIOL, V43, P391, DOI 10.4098/AT.arch.98-50; Schmidt K, 2016, INTEGR ZOOL, V11, P334, DOI 10.1111/1749-4877.12182; Schmidt K, 2011, MAMMAL REV, V41, P112, DOI 10.1111/j.1365-2907.2010.00180.x; Schregel J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180701; Tucker JM, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1839; van Oosterhout C, 2006, MOL ECOL NOTES, V6, P255, DOI 10.1111/j.1471-8286.2005.01082.x; Vangestel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071624; von Arx M., 2004, KORA BERICHT, V19, P1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Zimmermann F, 2005, J ZOOL, V267, P381, DOI 10.1017/S0952836905007545; Zimmermann F, 2007, ORYX, V41, P358, DOI 10.1017/S0030605307000712	78	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246833	10.1371/journal.pone.0246833	http://dx.doi.org/10.1371/journal.pone.0246833			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606691	Green Published, gold			2022-12-26	WOS:000620629200132
J	Jiang, HT; Jin, CH; Yan, L; Li, QN; Lu, W				Jiang, Haotian; Jin, Chenhua; Yan, Lei; Li, Q. N.; Lu, Wei			Design method for the relocation of plastic hinges in prefabricated steel beams with corrugated webs	PLOS ONE			English	Article								The plastic hinge is a key factor in the ductile and plastic design of structures and an important basis for the seismic strengthening of structures. The formation and behavior of plastic hinges is critical for the seismic performance of an entire structure. The relocation of plastic hinges away from the beam end is an effective way of addressing brittle failure. In this paper, the cause of the shear buckling failure of prefabricated steel beams with corrugated webs and the strain variation at the flanges of steel beams are theoretically analyzed through structural tests. Based on the analysis results, a local strengthening method is proposed, and the effects of the beam sizes and the strengthening steel plate on the plastic hinges are obtained. In addition, a calculation method for determining the size of the strengthening steel plate that promotes the relocation of the plastic zone away from the beam end is given, a design method for plastic hinge relocation is proposed based on the test data, and its validity is verified.	[Jiang, Haotian; Jin, Chenhua] Jin Ling Inst Technol, Nanjiang, Peoples R China; [Yan, Lei] Chongqing Three Gorges Univ, Chongqing, Peoples R China; [Li, Q. N.; Lu, Wei] XiAn Univ Architecture & Technol, Xian, Peoples R China	Chongqing Three Gorges University; Xi'an University of Architecture & Technology	Jiang, HT (corresponding author), Jin Ling Inst Technol, Nanjiang, Peoples R China.	316195906@qq.com			Innovation Chongqing Three Gorges reservoir bank slope and engineering structure disaster prevention and control engineering Cover Letter technology research center [SXAPGC18YB05P, jit-b201916]; Jiangsu Province Department of Education [20KJD560003]	Innovation Chongqing Three Gorges reservoir bank slope and engineering structure disaster prevention and control engineering Cover Letter technology research center; Jiangsu Province Department of Education	The authors would like to thank the Innovation Chongqing Three Gorges reservoir bank slope and engineering structure disaster prevention and control engineering Cover Letter technology research center (Grant No. SXAPGC18YB05P), Jin Ling Institute Of Technology (Grant No. jit-b201916) and Jiangsu Province Department of Education (Grant No. 20KJD560003) support of this research work.	Alfarah B, 2017, ENG STRUCT, V132, P70, DOI 10.1016/j.engstruct.2016.11.022; [Anonymous], 2001, REC DES CONN STEEL S; [Anonymous], 2018, CODE DESIGN STEEL ST; [Anonymous], 2000, FEMA2350; Bae SJ, 2008, ACI STRUCT J, V105, P290; Calabrese A, 2010, J EARTHQ ENG, V14, P38, DOI 10.1080/13632461003651869; CECS290, 2011, TECHNICAL SPECIFICAT; Fenwick RC., 2008, ANAL MODEL DUCTILE R; Kamanli M., 2017, ADV ENG FORUM, V21, P45; Khelil N., 2017, ASIAN J CIVIL ENG, V19, P1; Li W, 2020, STRUCT CONCRETE, V21, P2044, DOI 10.1002/suco.201900068; Lopez-Lopez A., 2016, STRUCT CONCRETE; Lopez-Lopez A, 2016, ENG STRUCT, V124, P245, DOI 10.1016/j.engstruct.2016.06.021; Mortezaei A, 2012, SCI IRAN, V19, P1365, DOI 10.1016/j.scient.2012.10.010; [孙国华 Sun Guohua], 2017, [建筑结构学报, Journal of Building Structures], V38, P18; Sun LZ, 2020, ARCH CIV MECH ENG, V20, DOI 10.1007/s43452-020-00118-x; Sun LZ, 2019, STRUCT CONCRETE, V20, P1279, DOI 10.1002/suco.201800229; Wei Lu., 2018, ADV CIV ENG, V2018, pV; Yan Wang., 2006, J QINGDAO TECHNOLOGI, V27, P126	19	0	0	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246439	10.1371/journal.pone.0246439	http://dx.doi.org/10.1371/journal.pone.0246439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606752	Green Published, gold			2022-12-26	WOS:000620629200134
J	Mathulwe, LL; Jacobs, K; Malan, AP; Birkhofer, K; Addison, MF; Addison, P				Mathulwe, Letodi L.; Jacobs, Karin; Malan, Antoinette P.; Birkhofer, Klaus; Addison, Matthew F.; Addison, Pia			Characterisation of Metarhizium majus (Hypocreales: Clavicipitaceae) isolated from the Western Cape Province, South Africa	PLOS ONE			English	Article								Entomopathogenic fungi (EPF) are important soil-dwelling entomopathogens, which can be used as biological control agents against pest insects. EPF are capable of causing lethal epizootics in pest insect populations in agroecosystems. During a survey of the orchard soil at an organic farm, different EPF species were collected and identified to species level, using both morphological and molecular techniques. The EPF were trapped from soil samples taken from an apricot orchard. The traps, which were baited in the laboratory, used susceptible host insects, including the last-instar larvae of Galleria mellonella (wax moth larvae) and Tenebrio molitor (mealworm larvae). The potential pathogenicity of the local Metarhizium majus isolate was tested and verified using susceptible laboratory-reared last-instar T. molitor larvae. The identification of the M. majus isolated from South African soil was verified using both morphological and molecular techniques. The occurrence of M. majus in the South African soil environment had not previously been reported.	[Mathulwe, Letodi L.; Malan, Antoinette P.; Addison, Matthew F.; Addison, Pia] Stellenbosch Univ, Fac AgriSci, Dept Conservat Ecol & Entomol, Stellenbosch, South Africa; [Jacobs, Karin] Stellenbosch Univ, Fac Sci, Dept Microbiol, Stellenbosch, South Africa; [Birkhofer, Klaus] Brandenburg Tech Univ Cottbus, Dept Ecol, Cottbus, Germany	Stellenbosch University; Stellenbosch University; Brandenburg University of Technology Cottbus	Malan, AP (corresponding author), Stellenbosch Univ, Fac AgriSci, Dept Conservat Ecol & Entomol, Stellenbosch, South Africa.	apm@sun.ac.za	Birkhofer, Klaus/AAA-2374-2021	Birkhofer, Klaus/0000-0002-9301-2443; Malan, Antoinette/0000-0002-9257-0312; Jacobs, Karin/0000-0003-3972-5343	Ekhaga foundation [Ansokan 2015-11]	Ekhaga foundation	KB, PA Ansokan 2015-11 Ekhaga (Ansokan 2015-11) foundation The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaajeh AR, 2015, BIOCONTROL SCI TECHN, V25, P828, DOI 10.1080/09583157.2015.1019831; Anitha N., 1998, Insect Environment, V4, P96; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Boni SB, 2021, INT J TROP INSECT SC, V41, P1643, DOI 10.1007/s42690-020-00365-8; Brunner-Mendoza C, 2019, BIOCONTROL SCI TECHN, V29, P83, DOI 10.1080/09583157.2018.1531111; Dlamini BE, 2020, BIOCONTROL SCI TECHN, V30, P1169, DOI 10.1080/09583157.2020.1797633; Driver F, 2000, MYCOL RES, V104, P134, DOI 10.1017/S0953756299001756; Glare TR., 1996, J ORTHOPTERA RES, V5, P19, DOI 10.2307/3503572; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; Humber R.A., 2012, MANUAL TECHNIQUES IN, V2, P151, DOI DOI 10.1016/B978-0-12-386899-2.00006-3; Korosi GA, 2019, J INVERTEBR PATHOL, V164, P69, DOI 10.1016/j.jip.2019.05.002; Luz C, 2019, J INVERTEBR PATHOL, V166, DOI 10.1016/j.jip.2019.107216; Manjeri G., 2014, Annual Research & Review in Biology, V4, P3429; Mathulwe LL, 2019, THESIS STELLENBOSCH; Meyling N.V, 2007, METHODS ISOLATION EN, P1; Meyling NV, 2007, BIOL CONTROL, V43, P145, DOI 10.1016/j.biocontrol.2007.07.007; Nishi O, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-015-1082-7; Oetari A, 2020, IOP C SER EARTH ENV, V483, DOI 10.1088/1755-1315/483/1/012016; Rehner SA, 2017, J INVERTEBR PATHOL, V148, P60, DOI 10.1016/j.jip.2017.05.008; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sayed AMM, 2019, J ECON ENTOMOL, V112, P2584, DOI 10.1093/jee/toz187; Shimizu S., 2010, INCONGRUENCE EF 1A P, V34, P19; Steinwender BM, 2015, J INVERTEBR PATHOL, V132, P142, DOI 10.1016/j.jip.2015.09.007; Stone LBL, 2020, APPL MICROBIOL BIOT, V104, P9935, DOI 10.1007/s00253-020-10968-3; Swofford D. L, 2003, PAUP PHYLOGENETIC AN, DOI [10.1111/j.0014-3820.2002.tb00191.x., DOI 10.1111/J.0014-3820.2002.TB00191.X]; Velavan V., 2017, Journal of Biological Control, V31, P135, DOI 10.18311/jbc/2017/18078; ZIMMERMANN G, 1986, J APPL ENTOMOL, V102, P213, DOI 10.1111/j.1439-0418.1986.tb00912.x; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P879, DOI 10.1080/09583150701593963	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0240955	10.1371/journal.pone.0240955	http://dx.doi.org/10.1371/journal.pone.0240955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606688	Green Published, gold			2022-12-26	WOS:000620629200035
J	Okamoto, A; Imamura, M; Tani, K; Matsumoto, T				Okamoto, Akira; Imamura, Miyuki; Tani, Kazune; Matsumoto, Takeru			The effect of using light emitting diodes and fluorescent lamps as different light sources in growth inhibition tests of green alga, diatom, and cyanobacteria	PLOS ONE			English	Article								Aquatic organisms have been used to investigate the safety of chemicals worldwide. One such assessment is an algal growth inhibition test. Algal growth inhibition tests are commonly performed using a growth chamber with fluorescent lamps as the lighting source, as test guidelines require continuous uniform fluorescent illumination. However, fluorescent lamps contain mercury, which has been identified as hazardous to humans and other organisms. The Minamata Convention (adopted in 2013) requires reduction or prohibition of products containing mercury. On the other hand, light-emitting diodes do not contain mercury and provide a photosynthetically effective wavelength range of 400-700 nm which is an adequate light intensity for algal growth. Light-emitting diodes are thus preferable to fluorescent lamps as a potential light source in algal growth inhibition tests. In this study, we investigated if light-emitting diodes could be substituted for fluorescent lamps in growth inhibition studies with green alga (Pseudokirchneriella subcapitata), diatom (Navicula pelliculosa), and cyanobacteria (Anabaena flos-aquae). Algal growth inhibition tests were performed using five different chemicals known to have different modes of action and are assigned as reference substances in the test guidelines. The results of each algal test showed similar values between light-emitting diodes and fluorescent lamps in terms of conditions for the growth inhibition rate and percent inhibition in yield of each chemical. It was therefore concluded that using light-emitting diodes instead of fluorescent lamps as a lighting source had no effect on the algal growth inhibition test results.	[Okamoto, Akira; Imamura, Miyuki; Tani, Kazune; Matsumoto, Takeru] Nippon Soda Co Ltd, Dept Environm Sci & Toxicol, Odawara, Kanagawa, Japan		Okamoto, A (corresponding author), Nippon Soda Co Ltd, Dept Environm Sci & Toxicol, Odawara, Kanagawa, Japan.	a.okamoto@nippon-soda.co.jp		Okamoto, Akira/0000-0003-2539-7625				Act on the Evaluation of Chemical Substances and Regulation of Their Manufacture, JAPANESE CHEM SUBSTA; Allakhverdiev SI, 2000, PLANT PHYSIOL, V123, P1047, DOI 10.1104/pp.123.3.1047; Chang MH, 2012, MICROELECTRON RELIAB, V52, P762, DOI 10.1016/j.microrel.2011.07.063; *INT ORG STAND, 1989, 8692 ISO; JMAFF, 2014, APPL DATA REQUIREMEN; Katsumata M, 2006, WATER RES, V40, P3393, DOI 10.1016/j.watres.2006.07.016; Krames MR, 2007, J DISP TECHNOL, V3, P160, DOI 10.1109/JDT.2007.895339; Kumar M, 2010, BIOMETALS, V23, P315, DOI 10.1007/s10534-010-9290-8; Lee MY, 2003, J APPL PHYCOL, V15, P13, DOI 10.1023/A:1022903602365; Mathur S, 2016, PHOTOSYNTHETICA, V54, P185, DOI 10.1007/s11099-016-0198-6; Mayer P, 1998, ENVIRON TOXICOL CHEM, V17, P1091, DOI [10.1897/1551-5028(1998)017&lt;1091:IOGCOT&gt;2.3.CO;2, 10.1002/etc.5620170615]; OECD, 2011, ALGA GROWTH INHIBITI; Principi P, 2014, J CLEAN PROD, V83, P96, DOI 10.1016/j.jclepro.2014.07.031; Schubert EF, 2006, REP PROG PHYS, V69, P3069, DOI 10.1088/0034-4885/69/12/R01; Schulze PSC, 2014, TRENDS BIOTECHNOL, V32, P423, DOI 10.1016/j.tibtech.2014.06.001; Singh D, 2015, RENEW SUST ENERG REV, V49, P139, DOI 10.1016/j.rser.2015.04.117; Takami R, 2012, AQUAT TOXICOL, V118, P80, DOI 10.1016/j.aquatox.2012.03.018; The U.S., ENV PROTECTION AGENC; Tsai KP, 2007, ENVIRON TOXICOL CHEM, V26, P1931, DOI 10.1897/06-612R.1; US Environmental Protection Agency, 2002, 821R02013 US EPA; Yorio NC, 2001, HORTSCIENCE, V36, P380, DOI 10.21273/HORTSCI.36.2.380	21	1	1	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247426	10.1371/journal.pone.0247426	http://dx.doi.org/10.1371/journal.pone.0247426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606832	Green Published, gold			2022-12-26	WOS:000620629200089
J	Behbehani, R; Ali, A; Al-Moosa, A				Behbehani, Raed; Ali, Abdullah; Al-Moosa, Ashref			Risk factors and visual outcome of Non-Arteritic Ischemic Optic Neuropathy (NAION): Experience of a tertiary center in Kuwait	PLOS ONE			English	Article								Background Non-arteritic ischemic optic neuropathy (NAION) is the most common acute optic neuropathy over the age of 50 years. NAION is commonly associated with systemic vascular risk factors (diabetes, hypertension, hyperlipidemia) and small cup-to-disc-ratio. We have assessed the prevalence risk factors of NAION and the visual outcome in patients referred to a tertiary ophthalmology center in Kuwait. Materials and methods A retrospective review of new cases of NAION presenting within 2 weeks of onset were included and baseline clinical and demographics characteristic were determined. The prevalence of risk factors and the visual outcome (change in logMAR visual acuity, mean deviation of visual field) was compared between young NAION patients (below 50 years of age) and older NAION patients (over 50 years of age). The odds ratio of a final favorable visual outcome (visual acuity 20/40 or better) by age category was determined. Results Seventy-eight eyes of 78 patients with recent onset NAION were included in the study. The most prevalent risk factors for NAION in our subjects were diabetes (64.1%), small cup-to-disc ratio (61.5%), hyperlipidemia (51.3%) and hypertension (38.5%). Young NAION patients had better final logMAR visual acuity (0.55 +- 0.57) then older NAION patients (0.9 +- 0.73), (p = 0.03). Furthermore, young NAION patients were 2.8 times more likely to have a final visual acuity of 20/40 or better than older NAION patients, odds ratio (OR), 2.87; 95% confidence interval (CI), 1.12-7.40, Chi-square p-value = 0.03). Conclusion There is a high prevalence of systemic vascular risk factors and small cup-to-disc ratio in NAION patients referred to our center across different age groups (below and above 50 years). Patients below the age of 50 years with NAION are more likely to have a final visual acuity of 20/40 or better than NAION patients above the age of 50 years.	[Behbehani, Raed; Ali, Abdullah; Al-Moosa, Ashref] Ibn Sina Hosp, Al Bahar Ophthalmol Ctr, Kuwait, Kuwait		Behbehani, R (corresponding author), Ibn Sina Hosp, Al Bahar Ophthalmol Ctr, Kuwait, Kuwait.	rsbehbehani@gmail.com	Behbehani, Raed/CAF-0180-2022	BEHBEHANI, RAED/0000-0002-6633-3567				Alarouj M, 2013, INT J CLIN PRACT, V67, P89, DOI 10.1111/ijcp.12064; BECK RW, 1984, OPHTHALMOLOGY, V91, P1334; BECK RW, 1984, AM J OPHTHALMOL, V98, P649, DOI 10.1016/0002-9394(84)90276-9; BERI M, 1987, OPHTHALMOLOGY, V94, P1020; Biousse V, 2015, NEW ENGL J MED, V372, P2428, DOI 10.1056/NEJMra1413352; BOGHEN DR, 1975, BRAIN, V98, P689, DOI 10.1093/brain/98.4.689; BORCHERT M, 1988, AM J OPHTHALMOL, V106, P443, DOI 10.1016/0002-9394(88)90881-1; Deramo VA, 2003, OPHTHALMOLOGY, V110, P1041, DOI 10.1016/S0161-6420(03)00079-4; Hamann S, 2020, AM J OPHTHALMOL, V217, P174, DOI 10.1016/j.ajo.2020.03.052; Hayreh SS, 2008, OPHTHALMOLOGY, V115, P298, DOI 10.1016/j.ophtha.2007.05.027; Hayreh SS, 2007, OPHTHALMOLOGY, V114, P804, DOI 10.1016/j.ophtha.2006.07.062; Jacobson DM, 1997, ARCH OPHTHALMOL-CHIC, V115, P1403, DOI 10.1001/archopht.1997.01100160573008; Palombi K, 2006, BRIT J OPHTHALMOL, V90, P879, DOI 10.1136/bjo.2005.087452; Preechawat P, 2007, AM J OPHTHALMOL, V144, P953, DOI 10.1016/j.ajo.2007.07.031; SAWLE GV, 1990, J NEUROL NEUROSUR PS, V53, P830, DOI 10.1136/jnnp.53.10.830; Sharma S, 2017, OPHTHALMOLOGY, V124, P450, DOI 10.1016/j.ophtha.2016.11.029; Sun Ming-Hui, 2017, J Neuroophthalmol, V37, P258, DOI 10.1097/WNO.0000000000000521; Tesser RA, 2003, OPHTHALMOLOGY, V110, P2031, DOI 10.1016/S0161-6420(03)00804-2; YEE RD, 1994, J NEURO-OPHTHALMOL, V14, P70	19	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247126	10.1371/journal.pone.0247126	http://dx.doi.org/10.1371/journal.pone.0247126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600480	gold, Green Published			2022-12-26	WOS:000620625100037
J	Rodriguez-Alcala, L; Martinez, JML; O'Connor-Reina, C; Plaza, G				Rodriguez-Alcala, Laura; Martin-Lagos Martinez, Juan; O'Connor-Reina, Carlos; Plaza, Guillermo			Assessment of muscular tone of the tongue using a digital measure spoon in a healthy population: A pilot study	PLOS ONE			English	Article								The study of the muscles of the tongue forms part of a basic evaluation of upper airway function that includes swallowing, speaking and chewing. It is important because the upper airway presents a region of collapse during sleep. Through the action of the dilator muscles, mainly the genioglossus, such collapse can be prevented. In this study, we present a simple tool that can be used to measure the strength of the tongue. This tool may provide an easy way to measure tongue function and allow a simple evaluation of pathologies that affect the tone of the tongue. We have carried out 20 tongue strength measurements using the Tongue Digital Spoon (TDS) in a healthy adult population, using the Iowa Oral Performance Instrument (IOPI) as the gold standard. To validate the procedure, we performed replicate measurements on 20 individuals aged 20-70 years. We found a mean TDS measurement of 115.99 g/cm(2) in young subjects, 98.47 g/cm(2) in middle-aged subjects and 84.23 g/cm(2) in the elderly. There was a significant difference in the measurements between young and elderly participants. There was also a significant correlation between TDS and IOPI measurements (Pearson correlation coefficient, r = 0.69, P < 0.001). We found the TDS to be a useful tool in daily clinical practice for the measurement of the strength of the tongue in the healthy population. It has potential application in oropharyngeal monitoring and rehabilitation.	[Rodriguez-Alcala, Laura; Martin-Lagos Martinez, Juan] Hosp Univ Clin San Cecilio, Dept Otorhinolaryngol, Granada, Spain; [O'Connor-Reina, Carlos] Hosp Quiron Marbella, Dept Otorhinolaryngol, Marbella, Spain; [O'Connor-Reina, Carlos] Hosp Quiron Campo Gibraltar, Dept Otorhinolaryngol, Marbella, Spain; [Plaza, Guillermo] Univ Rey Juan Carlos, Hosp Univ Fuenlabrada, Dept Otorhinolaryngol, Madrid, Spain; [Plaza, Guillermo] Hosp Sanitas La Zarzuela, Dept Otorhinolaryngol, Madrid, Spain	Hospital Universitario Fuenlabrada; Universidad Rey Juan Carlos	Plaza, G (corresponding author), Univ Rey Juan Carlos, Hosp Univ Fuenlabrada, Dept Otorhinolaryngol, Madrid, Spain.; Plaza, G (corresponding author), Hosp Sanitas La Zarzuela, Dept Otorhinolaryngol, Madrid, Spain.	guillermo.plaza@salud.madrid.org		Rodriguez Alcala, Laura/0000-0002-5148-5111; Martin-Lagos Martinez, Juan/0000-0001-5505-8734				Adams V, 2014, DYSPHAGIA, V29, P83, DOI 10.1007/s00455-013-9486-5; Adams V, 2013, DYSPHAGIA, V28, P350, DOI 10.1007/s00455-013-9451-3; Arakawa I, 2021, J ORAL REHABIL, V48, P430, DOI 10.1111/joor.13076; Arakawa I, 2020, J ORAL REHABIL, V47, P862, DOI 10.1111/joor.12976; Crow HC, 1996, J GERONTOL A-BIOL, V51, pM247, DOI 10.1093/gerona/51A.5.M247; Hwang NK, 2020, J ORAL REHABIL, V47, P606, DOI 10.1111/joor.12944; IOPI Medical LLC, 2008, IOWA PERFORMANCE INS; Kim J, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14175; Komoda Y, 2015, BRAIN RES, V1627, P70, DOI 10.1016/j.brainres.2015.09.016; Lin CH, 2021, AURIS NASUS LARYNX, V48, P116, DOI 10.1016/j.anl.2020.07.014; Malhotra A, 2000, AM J RESP CRIT CARE, V161, P1746, DOI 10.1164/ajrccm.161.5.9907109; Marim GC, 2019, PHYSIOL BEHAV, V210, DOI 10.1016/j.physbeh.2019.112616; Miura K, 2021, DYSPHAGIA, V36, P623, DOI 10.1007/s00455-020-10176-1; Nicosia MA, 2000, J GERONTOL A-BIOL, V55, pM634, DOI 10.1093/gerona/55.11.M634; O'Connor-Reina C, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/23123; Paris-Alemany A, 2021, DYSPHAGIA, V36, P293, DOI 10.1007/s00455-020-10136-9; Park JW, 2020, ARCH ORAL BIOL, V111, DOI 10.1016/j.archoralbio.2019.104636; Stierwalt JAG, 2007, AM J SPEECH-LANG PAT, V16, P148, DOI 10.1044/1058-0360(2007/019); Suzuki M, 2021, J ORAL REHABIL, V48, P176, DOI 10.1111/joor.13119; Van den Steen L, 2021, FOLIA PHONIATR LOGO, V73, P109, DOI 10.1159/000505153; Vanderwegen J, 2013, DYSPHAGIA, V28, P159, DOI 10.1007/s00455-012-9425-x; Wirth M, 2020, J CLIN SLEEP MED, V16, P285, DOI 10.5664/jcsm.8184; Wu SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217904; Yoshikawa M, 2011, DYSPHAGIA, V26, P232, DOI 10.1007/s00455-010-9291-3; Youmans SR, 2006, DYSPHAGIA, V21, P102, DOI 10.1007/s00455-006-9013-z	25	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0245901	10.1371/journal.pone.0245901	http://dx.doi.org/10.1371/journal.pone.0245901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8JB	33600465	Green Published, gold			2022-12-26	WOS:000620625100031
J	Crespo, J; Koh, YT; Hu, NJ; Moore, PA; Bonvini, E; Glasebrook, AL; Martin, AP; Benschop, RJ				Crespo, Joel; Koh, Yi Ting; Hu, Ningjie; Moore, Paul A.; Bonvini, Ezio; Glasebrook, Andrew L.; Martin, Andrea P.; Benschop, Robert J.			A humanized CD3 epsilon-knock-in mouse model for pre-clinical testing of anti-human CD3 therapy	PLOS ONE			English	Article								Pre-clinical murine models are critical for translating drug candidates from the bench to the bedside. There is interest in better understanding how anti-human CD3 therapy works based on recent longitudinal studies of short-term administration. Although several models have been created in this pursuit, each have their own advantages and disadvantages in Type-1 diabetes. In this study, we report a murine genetic knock-in model which expresses both a murine and a humanized-CD3 epsilon-exon, rendering it sensitive to manipulation with anti-human CD3. These huCD3 epsilon(HET) mice are viable and display no gross abnormalities. Specifically, thymocyte development and T cell peripheral homeostasis is unaffected. We tested immune functionality of these mice by immunizing them with T cell-dependent antigens and no differences in antibody titers compared to wild type mice were recorded. Finally, we performed a graft-vs-host disease model that is driven by effector T cell responses and observed a wasting disease upon transfer of huCD3 epsilon(HET) T cells. Our results show a viable humanized CD3 murine model that develops normally, is functionally engaged by anti-human CD3 and can instruct on pre-clinical tests of anti-human CD3 antibodies.	[Crespo, Joel; Koh, Yi Ting; Hu, Ningjie; Glasebrook, Andrew L.; Martin, Andrea P.; Benschop, Robert J.] Eli Lilly & Co, Lilly Res Labs, Immunol Res, Indianapolis, IN 46285 USA; [Moore, Paul A.; Bonvini, Ezio] MacroGen, Rockville, MD USA; [Martin, Andrea P.] Boehinger Ingelheim Pharmaceut Inc, Immunol & Resp Dis Resa, Ridgefield, CT USA	Eli Lilly	Benschop, RJ (corresponding author), Eli Lilly & Co, Lilly Res Labs, Immunol Res, Indianapolis, IN 46285 USA.	benschop_robert@lilly.com						Akkina R, 2016, AIDS RES HUM RETROV, V32, P109, DOI [10.1089/aid.2015.0258, 10.1089/AID.2015.0258]; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Dotan Efrat, 2010, P T, V35, P148; Hagopian W, 2013, DIABETES, V62, P3901, DOI 10.2337/db13-0236; Hall EC, 2015, TRANSPLANTATION, V99, P1051, DOI 10.1097/TP.0000000000000449; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Herold KC, 2019, NEW ENGL J MED, V381, P603, DOI 10.1056/NEJMoa1902226; Herold KC, 2013, DIABETES, V62, P3766, DOI 10.2337/db13-0345; Herold KC, 2009, CLIN IMMUNOL, V132, P166, DOI 10.1016/j.clim.2009.04.007; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; Kim Peter T W, 2011, Proc (Bayl Univ Med Cent), V24, P287; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Kuhn C, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001830; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Long SA, 2017, CELL IMMUNOL, V319, P3, DOI 10.1016/j.cellimm.2017.07.007; Long SA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai7793; Perdigoto AL, 2019, DIABETOLOGIA, V62, P655, DOI 10.1007/s00125-018-4786-9; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Satta A, 2013, FUTURE ONCOL, V9, P527, DOI [10.2217/FON.12.203, 10.2217/fon.12.203]; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Shultz LD, 2019, MAMM GENOME, V30, P123, DOI 10.1007/s00335-019-09796-2; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Strohl WR, 2018, PROTEIN CELL, V9, P86, DOI 10.1007/s13238-017-0457-8; Theocharides APA, 2016, HAEMATOLOGICA, V101, P5, DOI 10.3324/haematol.2014.115212; Tonomura N, 2008, XENOTRANSPLANTATION, V15, P129, DOI 10.1111/j.1399-3089.2008.00450.x; Tonomura N, 2008, BLOOD, V111, P4293, DOI 10.1182/blood-2007-11-121319; Tunnacliffe A, 1989, Int Immunol, V1, P546, DOI 10.1093/intimm/1.5.546; Ueda O, 2017, SCI REP-UK, V7, DOI 10.1038/srep45839; WANG BP, 1994, P NATL ACAD SCI USA, V91, P9402, DOI 10.1073/pnas.91.20.9402; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0245917	10.1371/journal.pone.0245917	http://dx.doi.org/10.1371/journal.pone.0245917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596227	gold, Green Published			2022-12-26	WOS:000620633200008
J	Bintabara, D				Bintabara, Deogratius			Addressing the huge poor-rich gap of inequalities in accessing safe childbirth care: A first step to achieving universal maternal health coverage in Tanzania	PLOS ONE			English	Article								Introduction Despite skilled attendance during childbirth has been linked with the reduction of maternal deaths, equality in accessing this safe childbirth care is highly needed to achieving universal maternal health coverage. However, little information is available regarding the extent of inequalities in accessing safe childbirth care in Tanzania. This study was performed to assess the current extent, trend, and potential contributors of poor-rich inequalities in accessing safe childbirth care among women in Tanzania. Methods This study used data from 2004, 2010, and 2016 Tanzania Demographic Health Surveys. The two maternal health services 1) institutional delivery and 2) skilled birth attendance was used to measures access to safe childbirth care. The inequalities were assessed by using concentration curves and concentration indices. The decomposition analysis was computed to identify the potential contributors to the inequalities in accessing safe childbirth care. Results A total of 8725, 8176, and 10052 women between 15 and 49 years old from 2004, 2010, and 2016 surveys respectively were included in the study. There is an average gap (>50%) between the poorest and richest in accessing safe childbirth care during the study period. The concentration curves were below the line of inequality which means women from rich households have higher access to the institutional delivery and skilled birth attendance inequalities in accessing institutional delivery and skilled birth attendance. These were also, confirmed with their respective positive concentration indices. The decomposition analysis was able to unveil that household's wealth status, place of residence, and maternal education as the major contributors to the persistent inequalities in accessing safe childbirth care. Conclusion The calls for an integrated policy approach which includes fiscal policies, social protection, labor market, and employment policies need to improve education and wealth status for women from poor households. This might be the first step toward achieving universal maternal health coverage.	[Bintabara, Deogratius] Univ Dodoma, Sch Med & Dent, Dept Community Med, Dodoma, Tanzania		Bintabara, D (corresponding author), Univ Dodoma, Sch Med & Dent, Dept Community Med, Dodoma, Tanzania.	bintabaradeo@gmail.com		Bintabara, Deogratius/0000-0001-7877-870X				Alkema L., 2015, GLOBAL, V6736, P13; Alkema L, 2019, TRENDS MATERNAL MORT; Amouzou A, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020504; Bintabara D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2017-020608; Bintabara D, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023013; Bishanga DR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209672; de Bernis L, 2003, BRIT MED BULL, V67, P39, DOI 10.1093/bmb/ldg017; Dutta A., 2015, MATERNAL NEWBORN CHI; Group WB, 2020, MAINLAND POVERTY TAN; Hodge A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3148-0; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Idd A, 2013, INT J HEALTH PLAN M, V28, pE298, DOI 10.1002/hpm.2174; Kakoma JB, 2019, MATERNAL CHILD HLTH, P1, DOI [10.5772/intechopen.89638, DOI 10.5772/INTECHOPEN.89638]; Koblinsky M., 1999, MOTHERCARE MATTERS, V8, P1; Kruk ME, 2010, HEALTH POLICY, V97, P209, DOI 10.1016/j.healthpol.2010.05.002; Maluka SO, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-80; Mamdani M, 2004, REPROD HEALTH MATTER, V12, P138, DOI 10.1016/S0968-8080(04)24135-0; Mezmur M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2298-9; Ministry of Health Community Development MoHCDGEC Ministry of Health National Bureau of Statistics Office of the Chief Government Statistician, 2016, TANZANIA DEMOGRAPHIC; Molina HF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002507; Moshi F, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0397-z; Mpembeni RNM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216027; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; National Bureau of Statistics (NBS) Tanzania Mainland and Office of Chief Government Statistician (OCGS) Zanzibar, 2012, NATL BUR STAT DAR SA; Novignon J, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1043-x; Otolorin E, 2015, INT J GYNECOL OBSTET, V130, pS46, DOI 10.1016/j.ijgo.2015.03.007; Paredes KPP, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0473-y; Saturno-Hernandez PJ, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2173-2; Shibre G, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0768-8; Straneo M, 2016, AFR HEALTH SCI, V16, P420, DOI 10.4314/ahs.v16i2.10; Teplitskaya L., 2004, MATERNAL HLTH SERVIC; The Ministry of Health Community Development Gender Elderly and Children, 2016, NATL ROAD MAP STRATE; Udo IE, 2016, AFR J REPROD HEALTH, V20, P108, DOI 10.29063/ajrh2016/v20i3.15; United Nations, 2018, SUST DEV GOALS REP, P1, DOI [10.18356/3405d09f-en, DOI 10.18356/3405D09F-EN]; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6; Wenban-smith H., 2014, RURAL URBAN LINKAGES; WHO, 2019, MATERNAL MORTALITY K	38	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246995	10.1371/journal.pone.0246995	http://dx.doi.org/10.1371/journal.pone.0246995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592017	Green Published, gold			2022-12-26	WOS:000620632800032
J	Coffin, AW; Olson, DM; Seymour, L; Bosch, DD; Schmidt, JM; Strickland, TC				Coffin, Alisa W.; Olson, Dawn M.; Seymour, Lynne; Bosch, David D.; Schmidt, Jason M.; Strickland, Timothy C.			Responses to environmental variability by herbivorous insects and their natural enemies within a bioenergy crop, Miscanthus x giganteus	PLOS ONE			English	Article							FRANKLINIELLA-OCCIDENTALIS; COASTAL-PLAIN; FIELD-SCALE; DIVERSITY; BIOFUEL; COTTON; APHIDS; POPULATIONS; HEMIPTERA; COMMUNITY	Precision agriculture (PA) is the application of management decisions based on identifying, quantifying, and responding to space-time variability. However, knowledge of crop pest responses to within-field environmental variability, and the spatial distribution of their natural enemies, is limited. Quantitative methods providing insights on how pest-predator relationships vary within fields are potentially important tools. In this study, phloem feeders and their natural enemies, were observed over two years across 81 locations within a field of the perennial feedstock grass in Georgia, USA. Geographically weighted regression (GWR) was used to spatially correlate their abundance with environmental factors. Variables included distance to forest edge, Normalized Difference of Vegetation Index (NDVI), slope, aspect, elevation, soil particle size distribution, and weather values. GWR methods were compared with generalized linear regression methods that do not account for spatial information. Non-spatial models indicated positive relationships between phloem-feeder abundance and wind speed, but negative relationships between elevation, proportions of silt and sand, and NDVI. With data partitioned into three seasonal groups, terrain and soil variables remained significant, and natural enemies and spiders became relevant. Results from GWR indicated that magnitudes and directions of responses varied within the field, and that relationships differed among seasons. Strong negative relationships between response and explanatory factors occurred: with NDVI during mid-season; with percent silt, during mid-, and late seasons; and with spider abundance during early and late seasons. In GWR models, slope, elevation, and aspect were mostly positive indicating further that associations with elevation depended on whether models incorporated spatial information or not. By using spatially explicit models, the analysis provided a complex, nuanced understanding of within-field relationships between phloem feeders and environmental covariates. This approach provides an opportunity to learn about the variability within agricultural fields and, with further analysis, has potential to inform and improve PA and habitat management decisions.	[Coffin, Alisa W.; Olson, Dawn M.; Bosch, David D.; Strickland, Timothy C.] ARS, USDA, Southeast Watershed Res Lab, Tifton, GA 31793 USA; [Seymour, Lynne] Univ Georgia, Dept Stat, Athens, GA 30602 USA; [Schmidt, Jason M.] Univ Georgia, Dept Entomol, Tifton, GA USA	United States Department of Agriculture (USDA); University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Coffin, AW (corresponding author), ARS, USDA, Southeast Watershed Res Lab, Tifton, GA 31793 USA.	alisa.coffin@usda.gov		Strickland, Timothy/0000-0001-6889-503X; Seymour, Lynne/0000-0002-8023-5269; M. Schmidt, Jason/0000-0002-8119-856X; Coffin, Alisa/0000-0003-1608-1776; Bosch, David/0000-0001-9021-8705	Gulf Atlantic Long-Term Agroecosystem Research (LTAR) site; United States Department of Agriculture [58-6048-5-013]	Gulf Atlantic Long-Term Agroecosystem Research (LTAR) site; United States Department of Agriculture(United States Department of Agriculture (USDA))	This project was supported by the Gulf Atlantic Long-Term Agroecosystem Research (LTAR) site. The United States Department of Agriculture funded part of this research under a cooperative agreement with JMS #58-6048-5-013. Employees of the USDA were involved in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Abd-Rabou S, 2010, ENTOMOL NEWS, V121, P456, DOI 10.3157/021.121.0507; Abney MR, 2008, J ECON ENTOMOL, V101, P23, DOI 10.1603/0022-0493(2008)101[23:RAFOCA]2.0.CO;2; Albrecht M, 2020, ECOL LETT, V23, P1488, DOI 10.1111/ele.13576; [Anonymous], 1986, LONDON ACAD PRESS; Axmacher JC, 2009, J BIOGEOGR, V36, P337, DOI 10.1111/j.1365-2699.2008.01997.x; Backoulou GF, 2010, SOUTHWEST ENTOMOL, V35, P11, DOI 10.3958/059.035.0102; Beck J, 2007, J ANIM ECOL, V76, P230, DOI 10.1111/j.1365-2656.2006.01189.x; Boieiro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064591; Bosch DD, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005844; Bosch DD, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005833; Bosch DD, 2012, AGR WATER MANAGE, V111, P40, DOI 10.1016/j.agwat.2012.05.002; Bouycous H, 1951, ANAL CHEM ACTA, V22, P23; Bradshaw JD, 2010, FLA ENTOMOL, V93, P135, DOI 10.1653/024.093.0123; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cavanaugh JE, 1997, STAT PROBABIL LETT, V33, P201, DOI 10.1016/S0167-7152(96)00128-9; Cherry R, 2013, J ENTOMOL SCI, V48, P52; Coffin AW, 2016, BIOENERG RES, V9, P587, DOI 10.1007/s12155-015-9700-4; Coffin AW, 2020, DATA RESPONSES ENV V; Comstock, 2001, ECOREGIONS GEORGIA; Costa HD, 2019, REV BRAS ENTOMOL, V63, P205, DOI 10.1016/j.rbe.2019.04.001; DANIELS RB, 1978, SOIL SCI SOC AM J, V42, P944, DOI 10.2136/sssaj1978.03615995004200060024x; Dixon AFG, 1985, APHID ECOLOGY OPITIM; Finke DL, 2006, OECOLOGIA, V149, P265, DOI 10.1007/s00442-006-0443-y; Foster GN, 2004, PEST MANAG SCI, V60, P113, DOI 10.1002/ps.796; Gibbs KE, 2009, DIVERS DISTRIB, V15, P242, DOI 10.1111/j.1472-4642.2008.00543.x; Gilbertson RL, 2015, ANNU REV VIROL, V2, P67, DOI 10.1146/annurev-virology-031413-085410; Grube A, 2011, PESTICIDE IND SALES; Holguin C. M., 2010, Journal of Agricultural and Urban Entomology, V27, P1; HUBBARD RK, 1983, J ENVIRON QUAL, V12, P291, DOI 10.2134/jeq1983.122291x; Klein ML, 2017, J ECON ENTOMOL, V110, P1899, DOI 10.1093/jee/tox134; Kohno K, 1998, APPL ENTOMOL ZOOL, V33, P227, DOI 10.1303/aez.33.227; Kumar A, 2015, LEGUME RES, V38, P121, DOI 10.5958/0976-0571.2015.00020.X; Landis DA, 2010, INSECT SCI, V17, P220, DOI 10.1111/j.1744-7917.2009.01310.x; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Lassau SA, 2005, ECOGRAPHY, V28, P495, DOI 10.1111/j.0906-7590.2005.04116.x; Leonard EC., 2016, ENCY FOOD GRAINS; LEWIS T, 1969, J APPL ECOL, V6, P453, DOI 10.2307/2401511; LEWIS T, 1965, ANN APPL BIOL, V55, P513, DOI 10.1111/j.1744-7348.1965.tb07964.x; Li C, 2017, APPL GEOGR, V82, P101, DOI 10.1016/j.apgeog.2017.03.007; McMillen DP, 2004, AM J AGR ECON, V86, P554, DOI 10.1111/j.0002-9092.2004.600_2.x; Morse JG, 2006, ANNU REV ENTOMOL, V51, P67, DOI 10.1146/annurev.ento.51.110104.151044; Myers MC, 2015, J APPL ECOL, V52, P1176, DOI 10.1111/1365-2664.12503; Nuessly GS, 2013, FLA ENTOMOL, V96, P512, DOI 10.1653/024.096.0217; Olson DM, 2012, J ENTOMOL SCI, V47, P350; Pimentel R, 2017, INT J PEST MANAGE, V63, P172, DOI 10.1080/09670874.2016.1256512; Prasifka JR, 2009, J ECON ENTOMOL, V102, P2154, DOI 10.1603/029.102.0619; Rains GC., 2000, PRECISION FARMING AN; Robertson BA, 2012, CONDOR, V114, P679, DOI 10.1525/cond.2012.110136; Robertson BA, 2012, BIOENERG RES, V5, P179, DOI 10.1007/s12155-011-9161-3; SAS Institute, 2010, SAS 9 3 WIND; Shafer Zhang, 2020, INTRO STAT; Soil Survey Staff Natural Resources Conservation Service USDoA, OFF SOIL SER DESCR T; Stanley DA, 2013, J APPL ECOL, V50, P335, DOI 10.1111/1365-2664.12060; Tejera MD, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01726; THEILING KM, 1988, AGR ECOSYST ENVIRON, V21, P191, DOI 10.1016/0167-8809(88)90088-6; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; U.S. Department of Energy, 2016, 2016 BILLION TON REP, P448; Vandervoet TF, 2018, J ECON ENTOMOL, V111, P1056, DOI 10.1093/jee/toy049; Weichenthal S, 2010, ENVIRON HEALTH PERSP, V118, P1117, DOI 10.1289/ehp.0901731; Wells ML, 2001, ENVIRON ENTOMOL, V30, P785, DOI 10.1603/0046-225X-30.4.785; Werling BP, 2011, BIOL CONTROL, V59, P304, DOI 10.1016/j.biocontrol.2011.06.014; Werling BP, 2014, P NATL ACAD SCI USA, V111, P1652, DOI 10.1073/pnas.1309492111; Werling BP, 2011, GCB BIOENERGY, V3, P347, DOI 10.1111/j.1757-1707.2011.01092.x; West LT., 2017, SOILS US; WIEGAND CL, 1991, REMOTE SENS ENVIRON, V35, P105, DOI 10.1016/0034-4257(91)90004-P; Woolpert Inc NOAA Office for Coastal Management, 2016, 2015 COOK TIFT COUNT; Xu HF, 2021, SCI TOTAL ENVIRON, V752, DOI 10.1016/j.scitotenv.2020.141977; Yanahan AD, 2014, BIODIVERS CONSERV, V23, P1591, DOI 10.1007/s10531-014-0688-4; Zehnder CB, 2009, ENVIRON ENTOMOL, V38, P1161, DOI 10.1603/022.038.0424	69	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246855	10.1371/journal.pone.0246855	http://dx.doi.org/10.1371/journal.pone.0246855			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592028	Green Published, gold			2022-12-26	WOS:000620632800050
J	Sissay, TM; Tibebu, M; Wasihun, T; Tsegaye, A				Sissay, Teklay Mengistu; Tibebu, Melatwork; Wasihun, Tagesachew; Tsegaye, Aster			Hematological reference intervals for adult population of Dire Dawa town, East Ethiopia	PLOS ONE			English	Article							SEX; HEMOGLOBIN; AGE	Background Reference interval (RI) for hematological parameters is used to interpret laboratory test results in the diagnosis, management and monitoring of hematologic disorders. Several factors including sex, age, dietary patterns, pregnancy status, ethnicity and geographic location affect hematological RIs. However, manufacturers derived reference value is currently in use in most developing countries including Ethiopia. This study aimed to establish hematological RIs for adult population living in Dire Dawa town, East Ethiopia. Methods In this cross-sectional study, 513 apparently healthy adults of Dire Dawa town were enrolled from January to March 2019. From these, 342 (171 males and 171 non-pregnant females) were aged 18-65 years while 171 were pregnant women aged 15-49 years. After obtaining written informed consent, 5ml fresh whole blood was collected of which 2ml was used for hematologic analysis using Mindray BC-3000plus hematology analyzer and 3ml for serological tests. The 2.5(th) and 97.5(th) RI was computed by non-parametric test employing SPSS version 24. P-value Result Males had significantly higher reference value for most of red cell parameters (Hgb, RBC, HCT, MCH and MCHC) than females (p <0.05), while most of the WBC parameters were significantly higher in females than males. Moreover, non-pregnant women had higher values for most of red cell parameters than pregnant women. Pregnant women had higher WBC parameters than their non-pregnant counterparts. Conclusion The hematologic RIs obtained in this study shows variation between genders, between pregnant and non-pregnant women, from the clinical practice currently utilised in Dire Dawa town and from studies conducted in Ethiopia, African countries as well as the Western population. It underscores the need for utilising gender and pregnancy specific, locally derived hematologic RI for better management, diagnosis and monitoring of hematologic disorders for adults of both genders and pregnant women.	[Sissay, Teklay Mengistu; Wasihun, Tagesachew] Dil Chora Hosp, Dire Dawa, Ethiopia; [Tibebu, Melatwork; Tsegaye, Aster] Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia	Addis Ababa University	Sissay, TM (corresponding author), Dil Chora Hosp, Dire Dawa, Ethiopia.	teklaymengistu@gmail.com		Tsegaye, Aster/0000-0002-9026-4629	Addis Ababa University, College of Health Science; Department of Medical Laboratory Science; Dire Dawa Regional Health Bureau	Addis Ababa University, College of Health Science; Department of Medical Laboratory Science; Dire Dawa Regional Health Bureau	The authors would like to thank Addis Ababa University, College of Health Science, and Department of Medical Laboratory Science for the support in conducting this study. We would like also to thank all participants who volunteered to participate in this study. Our appreciation also extends to Dil Chora Hospital CEO, laboratory head, laboratory quality officer, laboratory staffs, clinicians and health extension workers for kindly support in sample collection, processing, analysis, medical assessment and data collection. Finally, we acknowledge Dire Dawa Regional Health Bureau for providing preliminary data and for all the support.	Abera B, 2012, ETHIOP J HEALTH DEV, V26, P152; Akinbami AA, 2013, INT J WOMENS HEALTH, V5, P227, DOI 10.2147/IJWH.S42110; Al-Jafar H., 2016, J HEMATOL THROMB, V2, P04; Al-Mawali A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194497; Ayetekin M., 2008, EJIFCC, V19, P1; Bakrim S, 2018, PAN AFR MED J, V29, DOI [10.11604/pamj.2018.29.205.13043, 10.11604/pamj.2018.29.169.13042]; Bimerew LG, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312118807626; Chandra S, 2012, INDIAN J HEMATOL BLO, V28, P144, DOI 10.1007/s12288-012-0175-6; Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; Eshete Eskedar Awelachew, 2016, Ethiop Med J, V54, P21; Gebreweld Angesom, 2018, BMC Hematol, V18, P15, DOI 10.1186/s12878-018-0111-6; Henny J, 2016, CLIN CHEM LAB MED, V54, P1893, DOI 10.1515/cclm-2016-0793; Higgins C., 2009, INTRO REFERENCE INTE; Jacob EA., 2016, AM J LAB MED, V1, P34, DOI [10.11648/j.ajlm.20160103.12, DOI 10.11648/J.AJLM.20160103.12]; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Katayev A, 2010, AM J CLIN PATHOL, V133, P180, DOI 10.1309/AJCPN5BMTSF1CDYP; Kaur S., 2014, INT J ADV MED, V1, P68; Kone B, 2017, J Blood Lymph, V7, DOI 10.4172/2165-7831.1000154; Laboratory Clinical., 2000, C28A2 CLSI, P13; Li AW, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22150; Luppi P, 2002, J LEUKOCYTE BIOL, V72, P874; Michael OA., 2017, J BLOOD LYMPH, V7, P1; Mulu W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181268; Murphy WG, 2014, BLOOD REV, V28, P41, DOI 10.1016/j.blre.2013.12.003; Samaneka WP., 2016, PLOS ONE, V11, P1; Sanci M, 2017, J OBSTET GYNAECOL, V37, P571, DOI 10.1080/01443615.2016.1268575; Santimone I, 2011, HAEMATOL-HEMATOL J, V96, P1180, DOI 10.3324/haematol.2011.043042; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Siraj Nejat, 2018, BMC Res Notes, V11, P55, DOI 10.1186/s13104-018-3142-y; Stevens W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002043; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; Wang MY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190452; Windsor JS, 2007, POSTGRAD MED J, V83, P148, DOI 10.1136/pgmj.2006.049734; Wongkrajang P, 2018, INT J LAB HEMATOL, V40, P478, DOI 10.1111/ijlh.12843; Yalew Aregawi, 2016, BMC Res Notes, V9, P483; Zeh CE., 2012, LAB REFERENCE INTERV	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0244314	10.1371/journal.pone.0244314	http://dx.doi.org/10.1371/journal.pone.0244314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33591978	Green Published, gold			2022-12-26	WOS:000620632800049
J	Yola, IM; Oh, A; Mitchell, GF; O'Connor, G; Cheng, SS; Vasan, RS; Xanthakis, V				Yola, Ibrahim Musa; Oh, Albin; Mitchell, Gary F.; O'Connor, George; Cheng, Susan; Vasan, Ramachandran S.; Xanthakis, Vanessa			Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study	PLOS ONE			English	Article							VENTRICULAR SYSTOLIC DYSFUNCTION; OBSTRUCTIVE PULMONARY-DISEASE; LEFT ATRIAL SIZE; DIASTOLIC DYSFUNCTION; NATURAL-HISTORY; RECOMMENDATIONS; HYPERTENSION; DEATH; ABNORMALITIES; CONDUCTANCE	Background Lung function abnormalities are ubiquitous in heart failure (HF). It is unclear, however, if abnormal lung diffusion capacity is associated with cardiac remodeling and antedates HF. We hypothesized that lower lung diffusion capacity for carbon monoxide (DLCO) is associated with worse left ventricular (LV) systolic and diastolic function cross-sectionally, and with higher risk of HF prospectively. Methods We evaluated 2423 Framingham Study participants (mean age 66 years, 55% women) free of HF who underwent routine echocardiography and pulmonary function tests. We used multivariable regression models to relate DLCO, forced vital capacity (FVC), and forced expiratory volume in 1 second (FEV1) to left ventricular ejection fraction (LVEF), left atrial (LA) emptying fraction (LAEF), E/e', E/A, LV mass, and LA diameter (LAD). Multivariable-adjusted Cox proportional hazards regression was used to relate DLCO, FEV1, and FVC to incident HF. Results In multivariable-adjusted cross-sectional analyses, DLCO, FEV1, and FVC (dependent variables) were associated positively with LVEF (beta(DLCO) = 0.208, beta(FEV1) = 0.021, and beta(FVC) = 0.025 per 5% increment in LVEF; p<0.005 for all), and LAEF (beta(DLCO) = 0.707, beta(FEV1) = 0.058 and beta(FVC) = 0.058 per 5% increment in LAEF; p<0.002 for all). DLCO and FVC were inversely related to E/A (beta(DLCO) = -0.289, beta(FVC) = -0.047 per SD increment in E/A; p<0.001 for all). Additionally, DLCO, FEV1 and FVC were inversely related to HF risk (108 events, median follow-up 9.7 years; multivariable-adjusted hazard ratios per SD increment 0.90, 95% CI 0.86-0.95; 0.42, 95% CI 0.28-0.65, and 0.51, 95% CI 0.36-0.73, respectively). These results remained robust in analyses restricted to non-smokers. Conclusions Our large community-based observations are consistent with the concept that lower lung diffusion capacity and expiratory flow rates are associated with cardiac remodeling and may antedate HF. Additional studies are needed to confirm our findings and to evaluate the prognostic utility of pulmonary function testing for predicting HF.	[Yola, Ibrahim Musa; Vasan, Ramachandran S.; Xanthakis, Vanessa] Boston Univ, Sch Med, Dept Med, Sect Prevent Med & Epidemiol, Boston, MA 02118 USA; [Oh, Albin] Boston Med Ctr, Dept Med, Boston, MA USA; [Mitchell, Gary F.] Cardiovasc Engn Inc, Norwood, MA USA; [O'Connor, George] Boston Univ, Boston Med Ctr, Pulm Ctr, Dept Med, Boston, MA 02215 USA; [Cheng, Susan] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA; [Vasan, Ramachandran S.; Xanthakis, Vanessa] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Xanthakis, Vanessa] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA	Boston University; Boston Medical Center; Cardiovascular Engineering; Boston Medical Center; Boston University; Cedars Sinai Medical Center; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University	Xanthakis, V (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Prevent Med & Epidemiol, Boston, MA 02118 USA.; Xanthakis, V (corresponding author), NHLBI, Framingham Heart Study, Framingham, MA 01702 USA.; Xanthakis, V (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	vanessax@bu.edu	Musa, Ibrahim/GYJ-0462-2022	Oh, Albin/0000-0002-4211-3113; Ramachandran, Vasan/0000-0001-7357-5970; Cheng, Susan/0000-0002-4977-036X; Musa Yola, Ibrahim/0000-0002-2898-9792; Xanthakis, Vanessa/0000-0002-7352-621X	National Heart, Lung and Blood Institute [NO1-HC-25195, HHSN268201500001I]	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung and Blood Institute contracts NO1-HC-25195, HHSN268201500001I and	Aurigemma GP, 2001, J AM COLL CARDIOL, V37, P1042, DOI 10.1016/S0735-1097(01)01110-X; Benjamin E., 1996, J DIAGN MED SONOG, V12, P157; BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Culver BH, 2017, AM J RESP CRIT CARE, V196, P1463, DOI 10.1164/rccm.201710-1981ST; Curkendall SM, 2006, ANN EPIDEMIOL, V16, P63, DOI 10.1016/j.annepidem.2005.04.008; de Simone G, 2008, EUR HEART J, V29, P741, DOI 10.1093/eurheartj/ehm605; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; FAGGIANO P, 1994, INT J CARDIOL, V44, P1, DOI 10.1016/0167-5273(94)90060-4; Georgiopoulou VV, 2011, AM J MED, V124, P334, DOI 10.1016/j.amjmed.2010.12.006; Goldberg LR, 2006, CIRCULATION, V113, P2851, DOI 10.1161/CIRCULATIONAHA.105.600437; Guazzi M, 2002, EUR HEART J, V23, P467, DOI 10.1053/euhj.2001.2803; Guazzi M, 2008, J CARD FAIL, V14, P695, DOI 10.1016/j.cardfail.2008.06.004; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hoeper MM, 2016, JACC-HEART FAIL, V4, P441, DOI 10.1016/j.jchf.2015.12.016; Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197; Kee K, 2010, CIRC J, V74, P2507, DOI 10.1253/circj.CJ-10-0869; Kjaergaard J, 2007, AM J CARDIOL, V99, P1146, DOI 10.1016/j.amjcard.2006.11.052; Lam CSP, 2011, CIRCULATION, V124, P24, DOI 10.1161/CIRCULATIONAHA.110.979203; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Laukkanen JA, 2005, ARCH INTERN MED, V165, P1788, DOI 10.1001/archinte.165.15.1788; LEE YS, 1979, JPN CIRC J, V43, P945, DOI 10.1253/jcj.43.945; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Mitter SS, 2017, J AM COLL CARDIOL, V69, P1451, DOI 10.1016/j.jacc.2016.12.037; Modena MG, 1997, CLIN CARDIOL, V20, P553, DOI 10.1002/clc.4960200609; Mottram PM, 2005, HEART, V91, P681, DOI 10.1136/hrt.2003.029413; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Ommen SR, 2000, CIRCULATION, V102, P1788; PURI S, 1995, CIRCULATION, V91, P2769, DOI 10.1161/01.CIR.91.11.2769; Puri S, 1999, CIRCULATION, V99, P1190, DOI 10.1161/01.CIR.99.9.1190; RAVENSCRAFT SA, 1993, CHEST, V103, P54, DOI 10.1378/chest.103.1.54; Sardana M, 2017, J AM SOC ECHOCARDIOG, V30, P904, DOI 10.1016/j.echo.2017.05.013; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P1372, DOI 10.1001/jama.2016.2638; Thompson BR, 2008, THORAX, V63, P889, DOI 10.1136/thx.2007.091959; Torchio R, 2006, CHEST, V130, P472, DOI 10.1378/chest.130.2.472; TOWNSLEY MI, 1995, CIRC RES, V77, P317, DOI 10.1161/01.RES.77.2.317; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; Tsao CW, 2015, INT J EPIDEMIOL, V44, P1763, DOI 10.1093/ije/dyv336; Vasan RS, 2018, JACC-CARDIOVASC IMAG, V11, P1, DOI 10.1016/j.jcmg.2017.08.007; von Jeinsen B, 2020, J AM SOC ECHOCARDIOG, V33, P72, DOI 10.1016/j.echo.2019.08.001; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Watson RDS, 2000, BRIT MED J, V320, P236, DOI 10.1136/bmj.320.7229.236; Willens HJ, 2008, J AM SOC ECHOCARDIOG, V21, P715, DOI 10.1016/j.echo.2007.10.003	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246355	10.1371/journal.pone.0246355	http://dx.doi.org/10.1371/journal.pone.0246355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592021	gold, Green Published			2022-12-26	WOS:000620632800029
J	Affandi, T; Ohm, AM; Gaillard, D; Haas, A; Reyland, ME				Affandi, Trisiani; Ohm, Angela M.; Gaillard, Dany; Haas, Ami; Reyland, Mary E.			Tyrosine kinase inhibitors protect the salivary gland from radiation damage by increasing DNA double-strand break repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PKC-DELTA; C-ABL; NUCLEAR IMPORT; ACTIVATION; APOPTOSIS; IMATINIB; PHOSPHORYLATION; IDENTIFICATION; BCR/ABL; PATHWAY	We have previously shown that the tyrosine kinase inhibitors (TKIs) dasatinib and imatinib can protect salivary glands from irradiation (IR) damage without impacting tumor therapy. However, how they induce this protection is unknown. Here we show that TKIs mediate radioprotection by increasing the repair of DNA double-stranded breaks. DNA repair in IR-treated parotid cells, but not oral cancer cells, occurs more rapidly following pretreatment with imatinib or dasatinib and is accompanied by faster formation of DNA damage-induced foci. Similar results were observed in the parotid glands of mice pretreated with imatinib prior to IR, suggesting that TKIs "prime" cells for DNA repair. Mechanistically, we observed that TKIs increased IR-induced activation of DNA-PK, but not ATM. Pretreatment of parotid cells with the DNA-PK inhibitor NU7441 reversed the increase in DNA repair induced by TKIs. Reporter assays specific for homologous recombination (HR) or nonhomologous end joining (NHEJ) verified regulatation of both DNA repair pathways by imatinib. Moreover, TKIs also increased basal and IR-induced expression of genes associated with NHEJ (DNA ligase 4, Artemis, XLF) and HR (Rad50, Rad51 and BRCA1); depletion of DNA ligase 4 or BRCA1 reversed the increase in DNA repair mediated by TKIs. In addition, TKIs increased activation of the ERK survival pathway in parotid cells, and ERK was required for the increased survival of TKI-treated cells. Our studies demonstrate a dual mechanism by which TKIs provide radioprotection of the salivary gland tissues and support exploration of TKIs clinically in head and neck cancer patients undergoing IR therapy.	[Affandi, Trisiani; Ohm, Angela M.; Haas, Ami; Reyland, Mary E.] Univ Colorado, Dept Craniofacial Biol, Sch Dent Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Gaillard, Dany] Univ Colorado, Dept Cell & Dev Biol, Sch Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Gaillard, Dany] Univ Colorado, Rocky Mt Taste & Smell Ctr, Sch Med, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Reyland, ME (corresponding author), Univ Colorado, Dept Craniofacial Biol, Sch Dent Med, Anschutz Med Campus, Aurora, CO 80045 USA.	Mary.Reyland@cuanschutz.edu		Haas, Ami/0000-0001-9815-8954; Reyland, Mary/0000-0002-0747-9603	National Institutes of Health [T32 CA190216-03, F32 DE029116-01, R01DE015648, R01DE027517, R21DC016131]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health: T32 CA190216-03 and F32 DE029116-01 (T. A.), R01DE015648 and R01DE027517 (M. E. R.) and R21DC016131 (D. G.).	Adwan TS, 2011, J BIOL CHEM, V286, P35716, DOI 10.1074/jbc.M111.255950; Anderson SM, 1999, CELL DEATH DIFFER, V6, P454, DOI 10.1038/sj.cdd.4400507; Bhullar KS, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0804-2; Brooks HD, 2011, CANCER-AM CANCER SOC, V117, P2112, DOI 10.1002/cncr.25769; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chou RH, 2014, DEV CELL, V30, P224, DOI 10.1016/j.devcel.2014.06.008; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Collins NL, 2005, MOL CELL BIOL, V25, P5282, DOI 10.1128/MCB.25.12.5282-5291.2005; Cramer K, 2008, CANCER RES, V68, P6884, DOI 10.1158/0008-5472.CAN-08-1101; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Dierov J, 2009, LEUKEMIA, V23, P279, DOI 10.1038/leu.2008.308; Ding D, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.11; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Druker BJ, 2009, NAT MED, V15, P1149, DOI 10.1038/nm1009-1149; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Fernandes MS, 2009, BLOOD, V114, P1813, DOI 10.1182/blood-2008-07-172148; Gaillard D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54216-9; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Gudkov SV, 2010, DOKL BIOCHEM BIOPHYS, V430, P1, DOI 10.1134/S1607672910010011; Hasse HL, 2017, J IMMUNOL METHODS, V451, P71, DOI 10.1016/j.jim.2017.08.007; Hawkins PG, 2018, RADIOTHER ONCOL, V126, P68, DOI 10.1016/j.radonc.2017.08.002; Huang F, 2011, ACS CHEM BIOL, V6, P628, DOI 10.1021/cb100428c; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Ivashkevich AN, 2011, MUTAT RES-FUND MOL M, V711, P49, DOI 10.1016/j.mrfmmm.2010.12.015; Iyer G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43763; Jensen S. B., 2019, J NATL CANCER INST M, V2019; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lindauer M, 2014, RECENT RESULTS CANC, V201, P27, DOI 10.1007/978-3-642-54490-3_2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombaert I, 2017, STEM CELLS, V35, P97, DOI 10.1002/stem.2455; Lombaert IMA, 2008, STEM CELLS, V26, P2595, DOI 10.1634/stemcells.2007-1034; Maiani E, 2011, BIOCHEM PHARMACOL, V82, P1269, DOI 10.1016/j.bcp.2011.07.001; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Masani S, 2016, P NATL ACAD SCI USA, V113, P1261, DOI 10.1073/pnas.1521630113; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Montor WR, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0792-2; Morii M, 2015, CELL BIOL INT, V39, P923, DOI 10.1002/cbin.10460; Ogata K, 2018, DIGESTION, V97, P20, DOI 10.1159/000484102; Ohm AM, 2019, J BIOL CHEM, V294, P4488, DOI 10.1074/jbc.RA118.006944; Pfeffer MR, 2007, ORAL ONCOL, V43, P33, DOI 10.1016/j.oraloncology.2005.12.026; Reyland ME, 2016, PHARMACOL THERAPEUT, V165, P1, DOI 10.1016/j.pharmthera.2016.05.001; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Salles D, 2011, CARCINOGENESIS, V32, P27, DOI 10.1093/carcin/bgq216; Santivasi WL, 2014, ANTIOXID REDOX SIGN, V21, P251, DOI 10.1089/ars.2013.5668; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shimizu H, 2009, BIOCHEM BIOPH RES CO, V382, P286, DOI 10.1016/j.bbrc.2009.03.020; Skorski T, 2008, LEUKEMIA LYMPHOMA, V49, P610, DOI 10.1080/03093640701859089; Soref CM, 2012, INT J RADIAT ONCOL, V82, pE701, DOI 10.1016/j.ijrobp.2011.11.038; Strup-Perrot C, 2016, RADIOTHER ONCOL, V120, P175, DOI 10.1016/j.radonc.2016.06.009; Symonds JM, 2016, ONCOTARGET, V7, P17905, DOI 10.18632/oncotarget.7560; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wie SM, 2017, MOL CANCER THER, V16, P1989, DOI 10.1158/1535-7163.MCT-17-0267; Wie SM, 2014, J BIOL CHEM, V289, P10900, DOI 10.1074/jbc.M114.551366; Yoshida K, 2002, MOL CELL BIOL, V22, P3292, DOI 10.1128/MCB.22.10.3292-3300.2002; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002	62	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100401	10.1016/j.jbc.2021.100401	http://dx.doi.org/10.1016/j.jbc.2021.100401			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33571522	Green Published, gold			2022-12-26	WOS:000672866400375
J	Nogami, M; Miyamoto, K; Hayakawa-Yano, Y; Nakanishi, A; Yano, M; Okano, H				Nogami, Masahiro; Miyamoto, Kazumasa; Hayakawa-Yano, Yoshika; Nakanishi, Atsushi; Yano, Masato; Okano, Hideyuki			DGCR8-dependent efficient pri-miRNA processing of human pri-miR-9-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY TRANSCRIPTS; PRIMARY MICRORNAS; MOUSE MODEL; SCHIZOPHRENIA; BIOGENESIS; NEUROGENESIS; ENVIRONMENT; EXPRESSION; MATURATION; DEFICITS	Microprocessor complex, including DiGeorge syndrome critical region gene 8 (DGCR8) and DROSHA, recognizes and cleaves primary transcripts of microRNAs (pri-miRNAs) in the maturation of canonical miRNAs. The study of DGCR8 haploinsufficiency reveals that the efficiency of this activity varies for different miRNA species. It is thought that this variation might be associated with the risk of schizophrenia with 22q11 deletion syndrome caused by disruption of the DGCR8 gene. However, the underlying mechanism for varying action of DGCR8 with each miRNA remains largely unknown. Here, we used in vivo monitoring to measure the efficiency of DGCR8-dependent microprocessor activity in cultured cells. We confirmed that this system recapitulates the microprocessor activity of endogenous pri-miRNA with expression of a ratio-metric fluorescence reporter. Using this system, we detected mir-9-2 as one of the most efficient targets. We also identified a novel DGCR8-responsive RNA element, which is highly conserved among mammalian species and could be regulated at the epi-transcriptome (RNA modification) level. This unique feature between DGCR8 and pri-miR-9-2 processing may suggest a link to the risk of schizophrenia.	[Nogami, Masahiro] Takeda Pharmaceut Co Ltd, Innovat Biol Labs, Neurosci Drug Discovery Unit, Res, Fujisawa, Kanagawa, Japan; [Nogami, Masahiro; Nakanishi, Atsushi] Takeda Pharmaceut Co Ltd, Shonan Incubat Labs, Fujisawa, Kanagawa, Japan; [Miyamoto, Kazumasa] Takeda Pharmaceut Co Ltd, Drug Safety Res Labs, Fujisawa, Kanagawa, Japan; [Hayakawa-Yano, Yoshika; Yano, Masato] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan; [Nakanishi, Atsushi] Takeda Pharmaceut Co Ltd, Regenerat Med Unit, Fujisawa, Kanagawa, Japan; [Yano, Masato; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Niigata University; Takeda Pharmaceutical Company Ltd; Keio University	Nogami, M (corresponding author), Takeda Pharmaceut Co Ltd, Innovat Biol Labs, Neurosci Drug Discovery Unit, Res, Fujisawa, Kanagawa, Japan.; Nogami, M (corresponding author), Takeda Pharmaceut Co Ltd, Shonan Incubat Labs, Fujisawa, Kanagawa, Japan.; Yano, M (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan.; Yano, M (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo, Japan.	masahiro.nogami@takeda.com; myano@med.niigata-u.ac.jp		Nogami, Masahiro/0000-0002-7027-4766; Yano, Masato/0000-0003-0589-478X	SIL Research Fund from Takeda Pharmaceutical Company, Ltd, Japan; MEXT [JP17H05598, JP19H03543, JP20H00485]; Takeda Science Foundation, Japan; U-go grant at Niigata University, Japan; Serika Fund; Takeda COCKPI-T fund	SIL Research Fund from Takeda Pharmaceutical Company, Ltd, Japan; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation, Japan(Takeda Science Foundation (TSF)); U-go grant at Niigata University, Japan; Serika Fund; Takeda COCKPI-T fund	This work was supported by grants from the SIL Research Fund from Takeda Pharmaceutical Company, Ltd, Japan, and the MEXT Grant-in-Aid, Japan (grant no. JP20H00485) (to M. Y. and H. O.), the MEXT Grant-in-Aid, Japan (grant no. JP17H05598 and JP19H03543), the Takeda Science Foundation, Japan, U-go grant at Niigata University, Japan, the Serika Fund, and Takeda COCKPI-T fund (to M. Y.).	Abernathy DG, 2017, CELL STEM CELL, V21, P332, DOI 10.1016/j.stem.2017.08.002; Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Ambros V, 2011, CURR OPIN GENET DEV, V21, P511, DOI 10.1016/j.gde.2011.04.003; Bassett AS, 2011, J PEDIATR-US, V159, P332, DOI 10.1016/j.jpeds.2011.02.039; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bertolin AP, 2016, NUCLEIC ACIDS RES, V44, P7555, DOI 10.1093/nar/gkw372; Blahna MT, 2013, CURR OPIN CELL BIOL, V25, P233, DOI 10.1016/j.ceb.2012.12.005; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Cheng Y, 2018, NAT NEUROSCI, V21, P1689, DOI 10.1038/s41593-018-0261-7; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Davila JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094348; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Faller M, 2010, RNA, V16, P1570, DOI 10.1261/rna.2111310; Fenelon K, 2013, J NEUROSCI, V33, P14825, DOI 10.1523/JNEUROSCI.1611-13.2013; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hauberg ME, 2016, JAMA PSYCHIAT, V73, P369, DOI 10.1001/jamapsychiatry.2015.3018; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Ouchi Y, 2013, J NEUROSCI, V33, P9408, DOI 10.1523/JNEUROSCI.2700-12.2013; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Sakamoto K, 2018, AM J MED GENET B, V177, P242, DOI 10.1002/ajmg.b.32554; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Toyoshima M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.206; Weitz SH, 2014, P NATL ACAD SCI USA, V111, P1861, DOI 10.1073/pnas.1309915111; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019	47	4	4	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100409	10.1016/j.jbc.2021.100409	http://dx.doi.org/10.1016/j.jbc.2021.100409			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33581109	Green Published, gold			2022-12-26	WOS:000672866400383
J	Issimov, A; Taylor, DB; Shalmenov, M; Nurgaliyev, B; Zhubantayev, I; Abekeshev, N; Kushaliyev, K; Kereyev, A; Kutumbetov, L; Zhanabayev, A; Zhakiyanova, Y; White, PJ				Issimov, Arman; Taylor, David B.; Shalmenov, Malik; Nurgaliyev, Birzhan; Zhubantayev, Izimgali; Abekeshev, Nurzhan; Kushaliyev, Kaissar; Kereyev, Abzal; Kutumbetov, Lespek; Zhanabayev, Assylbek; Zhakiyanova, Yasmin; White, Peter J.			Retention of lumpy skin disease virus in Stomoxys spp (Stomoxys calcitrans, Stomoxys sitiens, Stomoxys indica) following intrathoracic inoculation, Diptera: Muscidae	PLOS ONE			English	Article								Lumpy skin disease (LSD) is an emerging disease of cattle in Kazakhstan and the means of transmission remains uncertain. In the current study, retention of Lumpy Skin Disease Virus (LSDV) by three Stomoxys species following intrathoracic inoculation was demonstrated under laboratory conditions. A virulent LSDV strain was injected into the thorax of flies to bypass the midgut barrier. The fate of the pathogen in the hemolymph of the flies was examined using PCR and virus isolation tests. LSDV was isolated from all three Stomoxys species up to 24h post inoculation while virus DNA was detectable up to 7d post inoculation.	[Issimov, Arman; White, Peter J.] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia; [Taylor, David B.] USDA ARS, Agroecosyst Management Res Unit, Lincoln, NE USA; [Shalmenov, Malik; Nurgaliyev, Birzhan; Zhubantayev, Izimgali; Abekeshev, Nurzhan; Kushaliyev, Kaissar; Kereyev, Abzal] Zhangir Khan West Kazakhstan Agr Tech Univ, Dept Vet Med, Oral, Kazakhstan; [Kutumbetov, Lespek] Minist Educ & Sci Republ Kazakhstan, RGE Res Inst Biol Safety Problems, Comm Sci, Nur Sultan, Kazakhstan; [Zhanabayev, Assylbek; Zhakiyanova, Yasmin] Saken Seifullin Kazakh Agrotech Univ, Dept Vet Med, Astana, Kazakhstan	University of Sydney; United States Department of Agriculture (USDA); Zhangir Khan West Kazakhstan Agrarian Technical University; Saken Seifullin Kazakh Agrotechnical University	Issimov, A (corresponding author), Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia.	aiss0820@uni.sydney.edu.au	Issimov, Arman/HCI-0729-2022; Zhakiyanova, Yasmin/AFJ-9795-2022; Nurgaliyev, Birzhan/AAI-9982-2021; Kushaliyev, Kaissar/ABE-8911-2021; Жанабаев, Асылбек/AAE-1050-2021	Nurgaliyev, Birzhan/0000-0001-5998-8250; Жанабаев, Асылбек/0000-0002-1267-3814; Zhubantayev, Izimgali/0000-0002-9218-5414; Issimov, Arman/0000-0002-0486-0054; White, Peter/0000-0002-9742-4939	"Bolashak" international scholarship program; Science Committee/Ministry of Education and Science/Republic of Kazakhstan [AP05135323]	"Bolashak" international scholarship program; Science Committee/Ministry of Education and Science/Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	Issimov A. This study was funded by "Bolashak" international scholarship program as well as by research project #AP05135323 of the Science Committee/Ministry of Education and Science/Republic of Kazakhstan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiuk S, 2008, TRANSBOUND EMERG DIS, V55, P263, DOI 10.1111/j.1865-1682.2008.01043.x; Babiuk S, 2008, TRANSBOUND EMERG DIS, V55, P299, DOI 10.1111/j.1865-1682.2008.01024.x; Baldacchino F, 2013, PARASITE, V20, DOI 10.1051/parasite/2013026; Boulanger N, 2002, J BIOL CHEM, V277, P49921, DOI 10.1074/jbc.M206296200; Chihota CM, 2003, MED VET ENTOMOL, V17, P294, DOI 10.1046/j.1365-2915.2003.00445.x; Chihota CM, 2001, EPIDEMIOL INFECT, V126, P317, DOI 10.1017/S0950268801005179; Coetzer J., 2004, INFECT DIS LIVESTOCK; De Leon AAP, 2006, J MED ENTOMOL, V43, P323, DOI 10.1603/0022-2585(2006)043[0323:TOVSNJ]2.0.CO;2; Diaz LA, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00493; Fu H, 1999, ARCH VIROL, V144, P747, DOI 10.1007/s007050050540; Ireland DC, 1998, J VIROL METHODS, V74, P1, DOI 10.1016/S0166-0934(98)00035-4; Issimov A, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10030477; Loeb MJ, 2001, J INSECT PHYSIOL, V47, P599, DOI 10.1016/S0022-1910(00)00150-5; Mathijs E, 2020, MICROBIOL RESOUR ANN, V9, DOI 10.1128/MRA.01399-19; MILLER BR, 1991, AM J TROP MED HYG, V45, P399, DOI 10.4269/ajtmh.1991.45.399; OIE, 2010, LUMPY SKIN DIS; OIE, 2018, LUMP SKIN DIS; PLOWRIGHT W., 1959, JOUR COMP PATHOL AND THERAP, V69, P152, DOI 10.1016/S0368-1742(59)80015-1; Rochon K, 2015, J MED ENTOMOL, V52, P1117, DOI 10.1093/jme/tjv096; Schurrer JA, 2005, AM J VET RES, V66, P1517, DOI 10.2460/ajvr.2005.66.1517; Sohier C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56605-6; Tuppurainen ESM, 2017, TRANSBOUND EMERG DIS, V64, P729, DOI 10.1111/tbed.12444; Tuppurainen ESM, 2012, TRANSBOUND EMERG DIS, V59, P40, DOI 10.1111/j.1865-1682.2011.01242.x; Tuppurainen ESM, 2005, ONDERSTEPOORT J VET, V72, P153; Vaughan JA, 1999, J MED ENTOMOL, V36, P758, DOI 10.1093/jmedent/36.6.758; WOODS JA, 1988, TROP ANIM HEALTH PRO, V20, P11, DOI 10.1007/BF02239636	26	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0238210	10.1371/journal.pone.0238210	http://dx.doi.org/10.1371/journal.pone.0238210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606690	gold, Green Published			2022-12-26	WOS:000620629200059
J	Phillips, EM; Horne, JK; Zamon, JE				Phillips, Elizabeth M.; Horne, John K.; Zamon, Jeannette E.			Characterizing juvenile salmon predation risk during early marine residence	PLOS ONE			English	Article							COLUMBIA RIVER PLUME; VISUAL PREY DETECTION; CHINOOK SALMON; COMMON MURRES; ENVIRONMENTAL-CONDITIONS; REDUCES PREDATION; NORTHERN ANCHOVY; DIVING DEPTHS; COHO SALMON; FORAGE FISH	Predation mortality can influence the distribution and abundance of fish populations. While predation is often assessed using direct observations of prey consumption, potential predation can be predicted from co-occurring predator and prey densities under varying environmental conditions. Juvenile Pacific salmon Oncorhynchus spp. (i.e., smolts) from the Columbia River Basin experience elevated mortality during the transition from estuarine to ocean habitat, but a thorough understanding of the role of predation remains incomplete. We used a Holling type II functional response to estimate smolt predation risk based on observations of piscivorous seabirds (sooty shearwater [Ardenna griseus] and common murre [Uria aalge]) and local densities of alternative prey fish including northern anchovy (Engraulis mordax) in Oregon and Washington coastal waters during May and June 2010-2012. We evaluated predation risk relative to the availability of alternative prey and physical factors including turbidity and Columbia River plume area, and compared risk to returns of adult salmon. Seabirds and smolts consistently co-occurred at sampling stations throughout most of the study area (mean = 0.79 +/- 0.41, SD), indicating that juvenile salmon are regularly exposed to avian predators during early marine residence. Predation risk for juvenile coho (Oncorhynchus kisutch), yearling Chinook salmon (O. tshawytscha), and subyearling Chinook salmon was on average 70% lower when alternative prey were present. Predation risk was greater in turbid waters, and decreased as water clarity increased. Juvenile coho and yearling Chinook salmon predation risk was lower when river plume surface areas were greater than 15,000 km(2), while the opposite was estimated for subyearling Chinook salmon. These results suggest that plume area, turbidity, and forage fish abundance near the mouth of the Columbia River, all of which are influenced by river discharge, are useful indicators of potential juvenile salmon mortality that could inform salmonid management.	[Phillips, Elizabeth M.; Horne, John K.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Zamon, Jeannette E.] NOAA Fisheries, Fish Ecol Div, Point Adams Res Stn, Northwest Fisheries Sci Ctr, Hammond, OR USA; [Phillips, Elizabeth M.] NOAA Fisheries, Northwest Fisheries Sci Ctr, Fishery Resource Anal & Monitoring Div, Seattle, WA 98112 USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Phillips, EM (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.; Phillips, EM (corresponding author), NOAA Fisheries, Northwest Fisheries Sci Ctr, Fishery Resource Anal & Monitoring Div, Seattle, WA 98112 USA.	elizabeth.phillips@noaa.gov		Phillips, Elizabeth/0000-0003-2775-2563	BonnevillePower Administration [1998-014-00]	BonnevillePower Administration	This work was supported by the BonnevillePower Administration, project #1998-014-00 (http://www.bpa.gov/).	Adams J, 2016, ECOL INFORM, V34, P44, DOI 10.1016/j.ecoinf.2016.04.010; Adams J, 2012, BIOL CONSERV, V156, P105, DOI 10.1016/j.biocon.2011.12.032; Ahrens RNM, 2012, FISH FISH, V13, P41, DOI 10.1111/j.1467-2979.2011.00432.x; Ainley DG, 1996, CONDOR, V98, P691, DOI 10.2307/1369852; Ainley DG, 2003, ECOLOGY, V84, P709, DOI 10.1890/0012-9658(2003)084[0709:PRCAGS]2.0.CO;2; Bairos-Novak KR, 2015, ANIM BEHAV, V106, P71, DOI 10.1016/j.anbehav.2015.05.002; BALTZ DM, 1977, AUK, V94, P526; Barange M, 1996, ICES J MAR SCI, V53, P225, DOI 10.1006/jmsc.1996.0026; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; BRADFORD MJ, 1995, CAN J FISH AQUAT SCI, V52, P1327, DOI 10.1139/f95-129; Brodeur Richard D., 2003, North Pacific Anadromous Fish Commission Bulletin, V3, P89; Brosnan IG, 2014, MAR ECOL PROG SER, V496, P181, DOI 10.3354/meps10550; Burke BJ, 2013, CAN J FISH AQUAT SCI, V70, P1167, DOI 10.1139/cjfas-2012-0505; Burla M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC004964; CHESSON PL, 1984, THEOR POPUL BIOL, V26, P1, DOI 10.1016/0040-5809(84)90021-2; Chu E.W., 1984, P64; Collis K, 2002, T AM FISH SOC, V131, P537, DOI 10.1577/1548-8659(2002)131<0537:CSADCO>2.0.CO;2; Crook KA, 2014, MAR ECOL PROG SER, V501, P279, DOI 10.3354/meps10696; Dawley EM., 1986, REPORT NO PROJECT 81, P256; De Robertis A, 2005, MAR ECOL PROG SER, V299, P33, DOI 10.3354/meps299033; De Robertis A, 2003, CAN J FISH AQUAT SCI, V60, P1517, DOI 10.1139/F03-123; Emmett RL, 2004, FISH OCEANOGR, V13, P392, DOI 10.1111/j.1365-2419.2004.00294.x; Emmett RL, 1997, P WORKSH US DEP COMM, P313; Emmett RL, 2007, CAL COOP OCEAN FISH, V48, P92; Enstipp MR, 2007, MAR ECOL PROG SER, V331, P267, DOI 10.3354/meps331267; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; Fisher JP, 2014, T AM FISH SOC, V143, P252, DOI 10.1080/00028487.2013.847862; FISHER JP, 1988, CAN J FISH AQUAT SCI, V45, P1036, DOI 10.1139/f88-127; FISHER JP, 1995, FISH B-NOAA, V93, P274; Furey NB, 2016, J ANIM ECOL, V85, P948, DOI 10.1111/1365-2656.12528; Greene CM, 2005, T AM FISH SOC, V134, P1562, DOI 10.1577/T05-037.1; Gregory RS, 1998, T AM FISH SOC, V127, P275, DOI 10.1577/1548-8659(1998)127<0275:TRPOMJ>2.0.CO;2; Gremillet D, 2012, AQUAT BIOL, V15, P187, DOI 10.3354/ab00430; HANEY JC, 1992, ORNIS SCAND, V23, P49, DOI 10.2307/3676427; HANEY JC, 1988, MAR ECOL PROG SER, V49, P1, DOI 10.3354/meps049001; Hansen AG, 2015, J ANIM ECOL, V84, P532, DOI 10.1111/1365-2656.12295; Hansen AG, 2013, T AM FISH SOC, V142, P854, DOI 10.1080/00028487.2013.785978; Hebblewhite M, 2005, OIKOS, V111, P101, DOI 10.1111/j.0030-1299.2005.13858.x; Hickey BM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005452; Hickey BM, 2008, OCEANOGRAPHY, V21, P90, DOI 10.5670/oceanog.2008.07; HOFFMAN W, 1981, AUK, V98, P437; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Horner-Devine AR, 2009, J MARINE SYST, V78, P460, DOI 10.1016/j.jmarsys.2008.11.025; Kaltenberg AM, 2010, MAR ECOL PROG SER, V419, P171, DOI 10.3354/meps08848; Kracker L., 2016, NOAA TECH MEMO NOS N, V96; Lance MM, 2005, AUK, V122, P887, DOI 10.1642/0004-8038(2005)122[0887:OIDAFO]2.0.CO;2; Langbein WB., 1960, PRIMER WATER; Litz MNC, 2014, ICES J MAR SCI, V71, P5, DOI 10.1093/icesjms/fst082; Litz MNC, 2008, CAL COOP OCEAN FISH, V49, P167; Loredo SA, 2019, J EXP MAR BIOL ECOL, V517, P13, DOI 10.1016/j.jembe.2019.05.009; Lovvorn JR, 2001, ECOLOGY, V82, P2342, DOI 10.1890/0012-9658(2001)082[2342:MUVAFF]2.0.CO;2; MACKAS DL, 1988, B MAR SCI, V43, P810; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Margolis L., 1991, LIFE HIST COHO SALMO, P397; Mazur MM, 2003, ENVIRON BIOL FISH, V67, P397, DOI 10.1023/A:1025807711512; McMichael GA., 2013, ANIM BIOTELEMETRY, V1, P14, DOI [10.1186/2050-3385-1-14, DOI 10.1186/2050-3385-1-14]; Miller JA, 2013, CAN J FISH AQUAT SCI, V70, P617, DOI 10.1139/cjfas-2012-0354; Montevecchi WA, 2002, CAN J FISH AQUAT SCI, V59, P602, DOI 10.1139/F02-033; MULDER T, 1995, J GEOL, V103, P285, DOI 10.1086/629747; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; Naughton MB., 2007, USFWS BIOL TECH PUBL; Nevins HM, 2004, THESIS SAN FRANCIAS; Northwest Fisheries Science Center, 2015, STATUS REV UPDATE PA; OATEN A, 1975, AM NAT, V109, P299, DOI 10.1086/282999; Parker-Stetter SL., 2009, STANDARD OPERATING P, P168; Pearcy W. G., 1990, 93 NOAA NMFS; Pearcy WG., 1992, OCEAN ECOLOGY N PACI; Petersen JH, 2000, MATH BIOSCI, V165, P97, DOI 10.1016/S0025-5564(00)00017-1; PETERSEN JH, 1994, J FISH BIOL, V45, P227, DOI 10.1006/jfbi.1994.1225; PFMC Pacific Fishery Management Council, 2013, PACIFIC COAST FISHER; Phillips EM, 2018, MAR ECOL PROG SER, V594, P245, DOI 10.3354/meps12534; Phillips EM, 2017, CAN J FISH AQUAT SCI, V74, P1375, DOI 10.1139/cjfas-2016-0302; PIATT JF, 1985, AUK, V102, P293, DOI 10.2307/4086771; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; Quinn TP., 2005, BEHAV ECOLOGY PACIFI; RCore Team, 2020, R LANG ENV STAT COMP; RICHARDSON SL, 1980, FISH B-NOAA, V78, P855; RICHARDSON SL, 1973, FISH B-NOAA, V71, P697; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; SHEALER DA, 1993, CONDOR, V95, P322, DOI 10.2307/1369355; Skalski GT, 2001, ECOLOGY, V82, P3083; Smith JM, 2015, MAR ECOL PROG SER, V532, P227, DOI 10.3354/meps11360; St John M.A., 1992, Fisheries Oceanography, V1, P153; Swain DP, 2015, J ANIM ECOL, V84, P1286, DOI 10.1111/1365-2656.12391; Szoboszlai AI, 2015, ECOL INFORM, V29, P45, DOI 10.1016/j.ecoinf.2015.07.003; TASKER ML, 1984, AUK, V101, P567, DOI 10.1093/auk/101.3.567; Teel DJ, 2015, MAR COAST FISH, V7, P274, DOI 10.1080/19425120.2015.1045961; Varoujean D., 1983, DISTRIBUTION, P25; Veit RR, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00121; Vogel JL, 1999, CAN J FISH AQUAT SCI, V56, P1293, DOI 10.1139/cjfas-56-7-1293; Wainwright TC., 1998, NMFSNWFSC35 NOAA US, V443; Ward EJ, 2012, CONSERV LETT, V5, P37, DOI 10.1111/j.1755-263X.2011.00210.x; Weimerskirch H, 1996, IBIS, V138, P786, DOI 10.1111/j.1474-919X.1996.tb08837.x; Weitkamp LA, 2012, FISH B-NOAA, V110, P426; Wells BK, 2017, J MARINE SYST, V174, P54, DOI 10.1016/j.jmarsys.2017.05.008; WIENS JA, 1975, CONDOR, V77, P439, DOI 10.2307/1366091; Wood S., 2020, MGCV MIXED GAM COMPU; Wood SN, 2006, GEN ADDITIVE MODELS; Zamon JE, 2014, DEEP-SEA RES PT II, V107, P85, DOI 10.1016/j.dsr2.2013.03.031; Zar J.H., 2010, BIOSTAT ANAL; Zhang YL, 2008, OCEAN MODEL, V21, P71, DOI 10.1016/j.ocemod.2007.11.005; Zuur Alain F., 2009, P1	103	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247241	10.1371/journal.pone.0247241	http://dx.doi.org/10.1371/journal.pone.0247241			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606791	Green Published, gold			2022-12-26	WOS:000620629200140
J	Lebedev, M; McEligot, HA; Mutua, VN; Walsh, P; Chaigneau, FRC; Gershwin, LJ				Lebedev, Maxim; McEligot, Heather A.; Mutua, Victoria N.; Walsh, Paul; Chaigneau, Francisco R. Carvallo; Gershwin, Laurel J.			Analysis of lung transcriptome in calves infected with Bovine Respiratory Syncytial Virus and treated with antiviral and/or cyclooxygenase inhibitor	PLOS ONE			English	Article								Bovine Respiratory Syncytial virus (BRSV) is one of the major infectious agents in the etiology of the bovine respiratory disease complex. BRSV causes a respiratory syndrome in calves, which is associated with severe bronchiolitis. In this study we describe the effect of treatment with antiviral fusion protein inhibitor (FPI) and ibuprofen, on gene expression in lung tissue of calves infected with BRSV. Calves infected with BRSV are an excellent model of human RSV in infants: we hypothesized that FPI in combination with ibuprofen would provide the best therapeutic intervention for both species. The following experimental treatment groups of BRSV infected calves were used: 1) ibuprofen day 3-10, 2) ibuprofen day 5-10, 3) placebo, 4) FPI day 5-10, 5) FPI and ibuprofen day 5-10, 6) FPI and ibuprofen day 3-10. All calves were infected with BRSV on day 0. Daily clinical evaluation with monitoring of virus shedding by qRT-PCR was conducted. On day10 lung tissue with lesions (LL) and non-lesional (LN) was collected at necropsy, total RNA extracted, and RNA sequencing performed. Differential gene expression analysis was conducted with Gene ontology (GO) and KEGG pathway enrichment analysis. The most significant differential gene expression in BRSV infected lung tissues was observed in the comparison of LL with LN; oxidative stress and cell damage was especially noticeable. Innate and adaptive immune functions were reduced in LL. As expected, combined treatment with FPI and Ibuprofen, when started early, made the most difference in gene expression patterns in comparison with placebo, especially in pathways related to the innate and adaptive immune response in both LL and LN. Ibuprofen, when used alone, negatively affected the antiviral response and caused higher virus loads as shown by increased viral shedding. In contrast, when used with FPI Ibuprofen enhanced the specific antiviral effect of FPI, due to its ability to reduce the damaging effect of prostanoids and oxidative stress.	[Lebedev, Maxim; McEligot, Heather A.; Mutua, Victoria N.; Gershwin, Laurel J.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Walsh, Paul] Sutter Med Ctr Sacramento, Pediat Emergency Med, Sacramento, CA USA; [Chaigneau, Francisco R. Carvallo] Virginia Tech, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll Vet Med, Blacksburg, VA USA	University of California System; University of California Davis; Virginia Polytechnic Institute & State University	Gershwin, LJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	ljgershwin@ucdavis.edu		Gershwin, Laurel/0000-0003-4961-9210; Lebedev, Maxim/0000-0003-3188-1595	USDA NIFA [2017-6701526083]; UC Davis Comparative Medical Science Training Program (NIH) [T32 OD011147]; NIH shared Instrumentation Grant [1S10OD010786-01]	USDA NIFA(United States Department of Agriculture (USDA)); UC Davis Comparative Medical Science Training Program (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by USDA NIFA (dual purpose/dual benefit) grant #2017-6701526083 awarded to LJG and PW (http://www.nifa.usda.gov) and UC Davis Comparative Medical Science Training Program (NIH Grant #T32 OD011147) awarded to Nicole Baumgarth, which funded trainee VNM (https://www.nih.gov).The DNA Technologies and Expression Analysis Cores at the UC Davis Genome Center are supported by a NIH shared Instrumentation Grant 1S10OD010786-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A., 2019, RAHNENFUHRER; Arora S, 2018, IMMUNOBIOLOGY, V223, P383, DOI 10.1016/j.imbio.2017.11.001; Ashraf E., 1999, Inflammopharmacology, V7, P219, DOI 10.1007/s10787-999-0005-0; Batra J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19063; Behura SK., 2017, SCI REP-UK, V7, P1, DOI DOI 10.1038/S41598-016-0028-X; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blanco Jorge C G, 2005, Expert Rev Anti Infect Ther, V3, P945, DOI 10.1586/14787210.3.6.945; Chai AC, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-2039-6; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; de Chassey B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003440; DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184; Du E, 2018, CANCER MANAG RES, V10, P3047, DOI 10.2147/CMAR.S175419; Earley B, 2017, ANIMAL, V11, P486, DOI 10.1017/S1751731116001622; Filges I, 2016, HUM MUTAT, V37, P359, DOI 10.1002/humu.22960; FISHAUT M, 1978, J INFECT DIS, V138, P644, DOI 10.1093/infdis/138.5.644; Furihata T, 2014, DRUG METAB PHARMACOK, V29, P211, DOI 10.2133/dmpk.DMPK-13-NT-065; Gershwin LJ, 2012, COMP IMMUNOL MICROB, V35, P253, DOI 10.1016/j.cimid.2012.01.005; Gershwin LJ, 1989, AM J VET RES; Griffin D, 2014, ANIM HEALTH RES REV, V15, P138, DOI 10.1017/S1466252314000255; Gu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047288; Harizi H, 2005, TISSUE ANTIGENS, V65, P507, DOI 10.1111/j.1399-0039.2005.00394.x; HATTORI H, 1992, CELL STRUCT FUNCT, V17, P77, DOI 10.1247/csf.17.77; Hosakote YM, 2009, AM J RESP CELL MOL, V41, P348, DOI 10.1165/rcmb.2008-0330OC; Hossain MK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030712; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Imayoshi M, 2006, J MOL MED, V84, P168, DOI 10.1007/s00109-005-0010-8; Jamaluddin M, 2009, J VIROL, V83, P10605, DOI 10.1128/JVI.01090-09; Jordan R, 2015, ANTIMICROB AGENTS CH, V59, P4889, DOI 10.1128/AAC.00487-15; Kubale J, 2020, CLIN INFECT DIS, V70, P2029, DOI 10.1093/cid/ciz585; Langhendries JP, 2016, MED HYPOTHESES, V87, P90, DOI 10.1016/j.mehy.2015.11.012; Lee GH, 2007, J BIOL CHEM, V282, P21618, DOI 10.1074/jbc.M700053200; Lichtenberger LM, 2012, BBA-MOL CELL BIOL L, V1821, P994, DOI 10.1016/j.bbalip.2012.04.002; Lin C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148551; Liu ZY, 2019, INT IMMUNOL, V31, P715, DOI 10.1093/intimm/dxz041; Maier GU, 2019, J DAIRY SCI, V102, P7288, DOI 10.3168/jds.2018-14773; Mansbach JM, 2007, AMBUL PEDIATR, V7, P304, DOI 10.1016/j.ambp.2007.03.006; Marcelin JR, 2014, TRANSPL INFECT DIS, V16, P242, DOI 10.1111/tid.12194; McGillivary G, 2013, J INNATE IMMUN, V5, P60, DOI 10.1159/000342473; Mosier D, 2014, ANIM HEALTH RES REV, V15, P166, DOI 10.1017/S1466252314000176; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; OHTSUKA K, 1990, BIOCHEM BIOPH RES CO, V166, P642, DOI 10.1016/0006-291X(90)90857-J; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Pang Q, 2001, ABSTRACT EMBO J; Pelletier AJ, 2006, PEDIATRICS, V118, P2418, DOI 10.1542/peds.2006-1193; Radi ZA, 2010, VIRAL IMMUNOL, V23, P43, DOI 10.1089/vim.2009.0042; Richardson JY, 2005, J IMMUNOL, V174, P4356, DOI 10.4049/jimmunol.174.7.4356; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; ROYER GL, 1984, AM J MED, V77, P25, DOI 10.1016/S0002-9343(84)80015-7; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schultz TE, 2017, J LEUKOCYTE BIOL, V101, P183, DOI 10.1189/jlb.2VMR1215-582R; Taylor G, 2017, VACCINE, V35, P469, DOI 10.1016/j.vaccine.2016.11.054; Walsh P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230245; Walsh P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199493; Walsh P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152913; Wang MM, 2018, MOL MED REP, V18, P1867, DOI 10.3892/mmr.2018.9089; Waters AM, 2015, J MED GENET, V52, P147, DOI 10.1136/jmedgenet-2014-102691; Wilkinson BL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.014; Woolums AR, 1999, AM J VET RES; Wyatt TA, 2019, ALCOHOL, V80, P17, DOI 10.1016/j.alcohol.2018.07.010	59	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0246695	10.1371/journal.pone.0246695	http://dx.doi.org/10.1371/journal.pone.0246695			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600498	Green Published, gold			2022-12-26	WOS:000620625100010
J	Stegen, M; Engler, A; Ochsenfarth, C; Manthey, I; Peters, J; Siffert, W; Frey, UH				Stegen, Maike; Engler, Andrea; Ochsenfarth, Crista; Manthey, Iris; Peters, Jurgen; Siffert, Winfried; Frey, Ulrich H.			Characterization of the G protein-coupled receptor kinase 6 promoter reveals a functional CREB binding site	PLOS ONE			English	Article								Background G protein-coupled receptor kinase 6 (GRK6) is part of the G protein-coupled receptor kinase family, whose members act as key regulators of seven-transmembrane receptor signalling. GRK6 seems to play a role in regulation of inflammatory processes, but mechanisms of transcriptional regulation of GRK6 expression in inflammatory cell lines have not been characterized. Protein kinase C (PKC) signalling is also involved in inflammatory regulation and an impact of PKC activation on GRK6 protein expression was described previously. Thus, the aim of this study was to 1) characterize the GRK6 promoter, and 2) investigate a potential influence of PKC on GRK6 expression. Methods Five deletion constructs of the GRK6 promoter were cloned. After transient transfection into a human T cell line, promoter activity was assessed using luciferase reporter gene assays. Putative transcription factor binding sites were identified, mutated, and binding was investigated using electrophoretic mobility shift assays (EMSA). Following stimulation with a PKC activator, GRK6 expression on mRNA and protein levels was assessed by reverse transcriptase qPCR and Western blots. Results Investigation of the GRK6 promoter revealed a putative cAMP responsive element (CRE), whose mutation led to decreased promoter activity (p = 0.0006). Functionality of the CRE binding protein (CREB) binding site was verified in EMSA blots. Stimulation with a PKC activator resulted in decreased GRK6 promoter activity (p = 0.0027), mRNA (p = 0.04) and protein expression. Conclusion We characterized the human GRK6 promoter and identified promoter activity to be influenced by a CREB binding site. PKC might be one determinant contributing to altered GRK6 expression.	[Stegen, Maike; Engler, Andrea; Peters, Jurgen; Frey, Ulrich H.] Essen Univ Hosp, Dept Anaesthesiol & Intens Care Med, Essen, Germany; [Stegen, Maike; Engler, Andrea; Manthey, Iris; Peters, Jurgen; Siffert, Winfried; Frey, Ulrich H.] Univ Duisburg Essen, Essen, Germany; [Ochsenfarth, Crista; Frey, Ulrich H.] Ruhr Univ Bochum, Marien Hosp Herne, Dept Anaesthesiol Operat Intens Care Med Pain & P, Bochum, Germany; [Manthey, Iris; Siffert, Winfried] Essen Univ Hosp, Inst Pharmacogenet, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; Ruhr University Bochum; St. Marien Hospital; University of Duisburg Essen	Stegen, M (corresponding author), Essen Univ Hosp, Dept Anaesthesiol & Intens Care Med, Essen, Germany.; Stegen, M (corresponding author), Univ Duisburg Essen, Essen, Germany.	maike.stegen@uk-essen.de		Frey, Ulrich/0000-0003-2961-6629; Ochsenfarth, Crista/0000-0002-5744-8661	Else Kroner Fresenius Foundation	Else Kroner Fresenius Foundation	MS took part in a student program funded by the Else Kroner Fresenius Foundation (https://www.ekfs.de/en).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENOVIC JL, 1993, J BIOL CHEM, V268, P19521; BULLRICH F, 1995, CYTOGENET CELL GENET, V70, P250, DOI 10.1159/000134045; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Cheneval D, 2010, J BIOMOL SCREEN, V15, P609, DOI 10.1177/1087057110365897; Eijkelkamp N, 2012, MOL MED, V18, P556, DOI 10.2119/molmed.2011.00398; Eijkelkamp N, 2009, BRAIN BEHAV IMMUN, V23, P18, DOI 10.1016/j.bbi.2008.07.006; Gagnon AW, 1997, GENE, V184, P13, DOI 10.1016/S0378-1119(96)00567-7; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Jiang XS, 2007, MOL BIOL CELL, V18, P2960, DOI 10.1091/mbc.E07-01-0013; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Karkoulias G, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109446; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Klenke S, 2018, BASIC CLIN PHARMACOL, V123, P660, DOI 10.1111/bcpt.13055; Klenke S, 2016, N-S ARCH PHARMACOL, V389, P1353, DOI 10.1007/s00210-016-1305-8; Lai WS, 2019, METHODS, V155, P77, DOI 10.1016/j.ymeth.2019.01.003; LEVINTHAL C, 1962, P NATL ACAD SCI USA, V48, P1631, DOI 10.1073/pnas.48.9.1631; Li LY, 2015, J BIOL CHEM, V290, P10775, DOI 10.1074/jbc.M115.644773; Lombardi MS, 1999, FASEB J, V13, P715, DOI 10.1096/fasebj.13.6.715; Loudon RP, 1996, BLOOD, V88, P4547, DOI 10.1182/blood.V88.12.4547.bloodjournal88124547; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Miletic G, 2002, PAIN, V99, P493, DOI 10.1016/S0304-3959(02)00242-7; Premont RT, 1999, J BIOL CHEM, V274, P29381, DOI 10.1074/jbc.274.41.29381; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Qiu XX, 2016, ONCOL REP, V35, P1027, DOI 10.3892/or.2015.4469; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Santos DA, 2019, NUCLEIC ACIDS RES, V47, P4974, DOI 10.1093/nar/gkz205; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Steury MD, 2017, ADV IMMUNOL, V136, P227, DOI 10.1016/bs.ai.2017.05.003; STOFFEL RH, 1994, J BIOL CHEM, V269, P27791; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Xie FC, 2019, J MED CHEM, V62, P11423, DOI 10.1021/acs.jmedchem.9b01207; Xie FC, 2015, J MED CHEM, V58, P5075, DOI 10.1021/acs.jmedchem.5b00468; XIE HJ, 1995, J IMMUNOL, V154, P1717; Yang Q., 2019, INT J MOL SCI, V20; Yao SM, 2019, FEBS OPEN BIO, V9, P605, DOI 10.1002/2211-5463.12606; Zhou Y, 2016, MOL PAIN, V12, DOI 10.1177/1744806916646381	41	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247087	10.1371/journal.pone.0247087	http://dx.doi.org/10.1371/journal.pone.0247087			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600497	Green Published, gold			2022-12-26	WOS:000620625100034
J	Terceno, M; Remollo, S; Silva, Y; Bashir, S; Werner, M; Vera-Monge, VA; Serena, J; Castano, C				Terceno, Mikel; Remollo, Sebastian; Silva, Yolanda; Bashir, Saima; Werner, Mariano; Vera-Monge, Victor A.; Serena, Joaquin; Castano, Carlos			Effect of combined acetylsalicylic acid and statins treatment on intracranial aneurysm rupture	PLOS ONE			English	Article								Background Acetylsalicylic acid (ASA) and statins have been identified as potentially reducing the risk of intracranial aneurysms (IA) rupture. We aim to determine the effect of this drugs on the risk of rupture of IA. Patients and methods We performed a retrospective cohort study from a prospective database of patients with IA treated in our institution between January 2013 and December 2018. Demographics, previous oral treatments, presence of multiple aneurysms, size of aneurysm, lobulation, location and morphology of the aneurysms were recorded. Patients were dichotomized as ruptured and unruptured IA. Results A total of 408 IA were treated, of which 283 (68.6%) were in women. The median age was 53, 194 (47.5%) were ruptured IA. 38 patients (9.3%) were receiving ASA and 84 (20.6%) were receiving statins at the moment of the IA diagnosis. In the multivariable regression analysis, ASA plus statin use and multiple aneurysms were independently associated with unruptured IA (OR 5.01, 95% CI, 1.37-18.33, P = 0.015 and OR 2.72, 95% CI 1.68-4.27, P<0.001, respectively). Whereas, lobulated wall aneurysm and PComA/AComA location were inversely and independently associated with unruptured IA condition (OR 0.34, 95% CI 0.21-0.55, P<0.001 and OR 0.37, 95% CI 0.23-0.60, P<0.001, respectively). However, ASA and statins in monotherapy were not independently associated with unruptured IA condition. Conclusions In our study population ASA plus statins treatment is independently associated with unruptured IA. Larger and prospective studies are required to explore this potential protective effect against IA rupture.	[Terceno, Mikel; Silva, Yolanda; Bashir, Saima; Vera-Monge, Victor A.; Serena, Joaquin; Castano, Carlos] Dr Josep Trueta Univ Hosp, Dept Neurol, Stroke Unit, Girona Biomed Res Inst IDIBGI, Girona, Spain; [Terceno, Mikel; Remollo, Sebastian; Werner, Mariano] Germans Trias & Pujol Univ Hosp, Dept Neurosci, Intervent Neuroradiol Unit, Badalona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI)	Silva, Y (corresponding author), Dr Josep Trueta Univ Hosp, Dept Neurol, Stroke Unit, Girona Biomed Res Inst IDIBGI, Girona, Spain.	ysilva.girona.ics@gencat.cat	Silva, Yolanda/AAB-8655-2021; Remollo, Sebastian/AAU-4803-2021	Silva, Yolanda/0000-0002-9450-8918; Remollo, Sebastian/0000-0002-8514-5529; Bashir Viturro, Saima/0000-0002-2019-467X				Aoki T, 2008, STROKE, V39, P1276, DOI 10.1161/STROKEAHA.107.503086; Aoki T, 2009, NEUROSURGERY, V64, P357, DOI 10.1227/01.NEU.0000336764.92606.1D; Bekelis K, 2015, INT J STROKE, V10, P38, DOI 10.1111/ijs.12559; Bruder M, 2018, WORLD NEUROSURG, V113, pE122, DOI 10.1016/j.wneu.2018.01.188; Can A, 2018, NEUROLOGY, V91, pE1175, DOI 10.1212/WNL.0000000000006200; Can A, 2018, STROKE, V49, P1148, DOI 10.1161/STROKEAHA.117.019972; Chalouhi N, REV CEREBRAL ANEURYS; Chalouhi Nohra, 2016, Hypertension, V68, P411, DOI 10.1161/HYPERTENSIONAHA.116.07515; Chalouhi N, 2013, STROKE, V44, P2594, DOI 10.1161/STROKEAHA.113.002361; Chalouhi N, 2012, J CEREBR BLOOD F MET, V32, P1659, DOI 10.1038/jcbfm.2012.84; de Miguel LS, 1999, EUR J CLIN INVEST, V29, P93, DOI 10.1046/j.1365-2362.1999.00425.x; Duan ZH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24732-1; Fisher CL, 2019, CEREBROVASC DIS EXTR, V9, P31, DOI 10.1159/000499077; Gross BA, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.03.072; Hasan DM, 2011, STROKE, V42, P3156, DOI 10.1161/STROKEAHA.111.619411; Hostettler IC, 2018, NEUROSURGERY, V83, P43, DOI 10.1093/neuros/nyx365; Hua YN, 2009, PHARMACOLOGY, V83, P18, DOI 10.1159/000166183; Ishibashi T, 2009, STROKE, V40, P313, DOI 10.1161/STROKEAHA.108.521674; Kataoka H, 2015, NEUROL MED-CHIR, V55, P214, DOI 10.2176/nmc.ra.2014-0337; Kimura N, 2010, BRAIN RES, V1322, P144, DOI 10.1016/j.brainres.2010.01.044; Li SJ, 2015, NEUROCHEM RES, V40, P1537, DOI 10.1007/s11064-015-1603-4; Lin JH, 2017, J INT MED RES, V45, P2128, DOI 10.1177/0300060517713803; Marbacher S, 2012, J NEUROSURG, V116, P638, DOI 10.3171/2011.10.JNS11153; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Naraoka M, 2018, J CEREBR BLOOD F MET, V38, P1190, DOI 10.1177/0271678X17724682; Oesterle A, 2017, CIRC RES, V120, P229, DOI 10.1161/CIRCRESAHA.116.308537; Pena-Silva RA, 2015, HYPERTENSION, V65, P587, DOI 10.1161/HYPERTENSIONAHA.114.04681; Shackelford RE, 1997, MOL PHARMACOL, V52, P421, DOI 10.1124/mol.52.3.421; Shen J, 2017, J NEUROSURG, V127, P291, DOI 10.3171/2016.5.JNS152900; Starke RM, 2014, TRANSL STROKE RES, V5, P338, DOI 10.1007/s12975-013-0290-1; Starke RM, 2014, TRANSL STROKE RES, V5, P269, DOI 10.1007/s12975-013-0287-9; Suzuki T, 2018, CEREBROVASC DIS, V45, P180, DOI 10.1159/000487812; Tada Y, 2011, STROKE, V42, P2286, DOI 10.1161/STROKEAHA.110.608034; Tai JL, 2019, NEUROL NEUROCHIR POL, V53, P296, DOI 10.5603/PJNNS.a2019.0029; Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070; Vergouwen MDI, 2018, INT J STROKE, V13, P992, DOI 10.1177/1747493018790033; Wei HJ, 2019, MED SCI MONITOR, V25, P928, DOI 10.12659/MSM.915005; Weir B, 2002, J NEUROSURG, V96, P64, DOI 10.3171/jns.2002.96.1.0064; Weng JC, 2020, STROKE, V51, P3045, DOI 10.1161/STROKEAHA.120.029967; Yao YQ, 2009, INFLAMMATION, V32, P233, DOI 10.1007/s10753-009-9125-3; Yoshimura Y, 2014, J STROKE CEREBROVASC, V23, P343, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.022; Zanaty M, 2020, J NEUROSURG, V133, P1478, DOI 10.3171/2019.6.JNS191273	42	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247153	10.1371/journal.pone.0247153	http://dx.doi.org/10.1371/journal.pone.0247153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600491	Green Published, gold			2022-12-26	WOS:000620625100025
J	Guest, C; Harris, R; Sfanos, KS; Shrestha, E; Partin, AW; Trock, B; Mangold, L; Bader, R; Kozak, A; Mclean, S; Simons, J; Soule, H; Johnson, T; Lee, WY; Gao, Q; Aziz, S; Stathatou, PM; Thaler, S; Foster, S; Mershin, A				Guest, Claire; Harris, Rob; Sfanos, Karen S.; Shrestha, Eva; Partin, Alan W.; Trock, Bruce; Mangold, Leslie; Bader, Rebecca; Kozak, Adam; Mclean, Scott; Simons, Jonathan; Soule, Howard; Johnson, Thomas; Lee, Wen-Yee; Gao, Qin; Aziz, Sophie; Stathatou, Patritsia Maria; Thaler, Stephen; Foster, Simmie; Mershin, Andreas			Feasibility of integrating canine olfaction with chemical and microbial profiling of urine to detect lethal prostate cancer	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; VOLATILE ORGANIC-COMPOUNDS; BLADDER-CANCER; OVARIAN-CANCER; DOGS; BLOOD; BIOMARKERS; BREAST; ODOR; LUNG	Prostate cancer is the second leading cause of cancer death in men in the developed world. A more sensitive and specific detection strategy for lethal prostate cancer beyond serum prostate specific antigen (PSA) population screening is urgently needed. Diagnosis by canine olfaction, using dogs trained to detect cancer by smell, has been shown to be both specific and sensitive. While dogs themselves are impractical as scalable diagnostic sensors, machine olfaction for cancer detection is testable. However, studies bridging the divide between clinical diagnostic techniques, artificial intelligence, and molecular analysis remains difficult due to the significant divide between these disciplines. We tested the clinical feasibility of a cross-disciplinary, integrative approach to early prostate cancer biosensing in urine using trained canine olfaction, volatile organic compound (VOC) analysis by gas chromatography-mass spectroscopy (GC-MS) artificial neural network (ANN)-assisted examination, and microbial profiling in a double-blinded pilot study. Two dogs were trained to detect Gleason 9 prostate cancer in urine collected from biopsy-confirmed patients. Biopsy-negative controls were used to assess canine specificity as prostate cancer biodetectors. Urine samples were simultaneously analyzed for their VOC content in headspace via GC-MS and urinary microbiota content via 16S rDNA Illumina sequencing. In addition, the dogs' diagnoses were used to train an ANN to detect significant peaks in the GC-MS data. The canine olfaction system was 71% sensitive and between 70-76% specific at detecting Gleason 9 prostate cancer. We have also confirmed VOC differences by GC-MS and microbiota differences by 16S rDNA sequencing between cancer positive and biopsy-negative controls. Furthermore, the trained ANN identified regions of interest in the GC-MS data, informed by the canine diagnoses. Methodology and feasibility are established to inform larger-scale studies using canine olfaction, urinary VOCs, and urinary microbiota profiling to develop machine olfaction diagnostic tools. Scalable multi-disciplinary tools may then be compared to PSA screening for earlier, non-invasive, more specific and sensitive detection of clinically aggressive prostate cancers in urine samples.	[Guest, Claire; Harris, Rob; Aziz, Sophie] Med Detect Dogs, Milton Keynes, Bucks, England; [Sfanos, Karen S.; Shrestha, Eva] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Sfanos, Karen S.; Partin, Alan W.; Trock, Bruce; Mangold, Leslie] Johns Hopkins Univ, Sch Med, Dept Urol, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; [Bader, Rebecca; Kozak, Adam; Mclean, Scott] Cambridge Polymer Grp, Cambridge, MA USA; [Simons, Jonathan; Soule, Howard; Johnson, Thomas] Prostate Canc Fdn, Santa Monica, CA USA; [Lee, Wen-Yee; Gao, Qin] Univ Texas El Paso, Dept Chem & Biochem, El Paso, TX 79968 USA; [Stathatou, Patritsia Maria; Mershin, Andreas] MIT, Ctr Bits & Atoms, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Thaler, Stephen] Imaginat Engines, St Charles, MO USA; [Foster, Simmie] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Foster, Simmie] Massachusetts Gen Hosp, Boston, MA 02114 USA	Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas El Paso; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Guest, C (corresponding author), Med Detect Dogs, Milton Keynes, Bucks, England.; Mershin, A (corresponding author), MIT, Ctr Bits & Atoms, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	claire.guest@medicaldetectiondongs.org.uk; mershin@mit.edu	Lee, Wen-Yee/AAP-9982-2021	Lee, Wen-Yee/0000-0002-1568-5546; Johnson, Thomas/0000-0003-0835-6418	Prostate Cancer Foundation [18PILO02]; National Cancer Institute of the National Institutes of Health [SC1CA245675]	Prostate Cancer Foundation; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Prostate Cancer Foundation Grant (18PILO02) received by CG, AM, and KS. PCF provided partial salary support for authors CG, RH, PMS, AM, and had a role in the study design and preparation of the manuscript, but had no role in the data collection and analysis or the decision to publish. The National Cancer Institute of the National Institutes of Health provided support for WYL and QG (Award Number SC1CA245675). Imagination Engines, Inc. provided support in the form of salary for ST. The NCI NIH and Imagination Engines, Inc. played a role in study design, analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abernethy MG, 2017, OBSTET GYNECOL, V129, P500, DOI 10.1097/AOG.0000000000001892; Campbell Leon Frederick, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-008566; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Church J, 2001, LANCET, V358, P930, DOI 10.1016/S0140-6736(01)06065-2; Cornu JN, 2011, EUR UROL, V59, P197, DOI 10.1016/j.eururo.2010.10.006; Daiquigan N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02103; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Gadbois S., 2016, Dog Behavior, V2, P26; Gao Q, 2019, CLIN GENITOURIN CANC, V17, P183, DOI 10.1016/j.clgc.2019.02.003; Hackner K, 2017, J BREATH RES, V11, DOI 10.1088/1752-7163/aa5524; Hanser HI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10080-z; Harrison S., 2019, WIRED; Horvath G, 2008, INTEGR CANCER THER, V7, P76, DOI 10.1177/1534735408319058; Horvath G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-396; Horvath G, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-643; Kassiri B., 2019, PROSPECTIVE ST UNPUB, DOI [10.1016/j.urology.2019.05.031, DOI 10.1016/J.UROLOGY.2019.05.031]; Khalid T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143283; Kleinbaum DaK M., 2010, LOGISTIC REGRESSION, V3rd; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lecuyer H, 2007, J CLIN MICROBIOL, V45, P3474, DOI 10.1128/JCM.01373-07; Lima AR, 2019, BRIT J CANCER, V121, P857, DOI 10.1038/s41416-019-0585-4; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; McGinnis WR, 2008, ALTERN THER HEALTH M, V14, P40; Mochalski P, 2016, ANALYST, V141, P4796, DOI 10.1039/c6an00825a; Moran P., 2013, METHODS APPARATUS AR; Murarka M, 2019, J VET BEHAV, V32, P42, DOI 10.1016/j.jveb.2019.04.010; Ottesen A, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0894-1; Pashkovski SL, 2020, NATURE, V583, P253, DOI 10.1038/s41586-020-2451-1; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Pickel D, 2004, APPL ANIM BEHAV SCI, V89, P107, DOI 10.1016/j.applanim.2004.04.008; RCore Team, 2020, R LANG ENV STAT COMP; Ryan S, 2013, PROCEDIA ENGINEER, V58, P31, DOI 10.1016/j.proeng.2013.05.006; Ryan S, 2016, EXPERT SYST APPL, V45, P23, DOI 10.1016/j.eswa.2015.09.038; Schoon GAA, 2020, J VET BEHAV, V35, P38, DOI 10.1016/j.jveb.2019.10.006; Sethi S, 2013, CLIN MICROBIOL REV, V26, P462, DOI 10.1128/CMR.00020-13; Shrestha E, 2018, J UROLOGY, V199, P161, DOI 10.1016/j.juro.2017.08.001; Sonoda H, 2011, GUT, V60, P814, DOI 10.1136/gut.2010.218305; Taverna G, 2015, J UROLOGY, V193, P1382, DOI 10.1016/j.juro.2014.09.099; Thaler S, 2000, USA patent, Patent No. [6,014,653, 6014653]; Thaler SL, 1998, J ALLOY COMPD, V279, P47, DOI 10.1016/S0925-8388(98)00611-2; Thuleau A, 2019, ONCOLOGY-BASEL, V96, P110, DOI 10.1159/000492895; Weiss T, 2012, P NATL ACAD SCI USA, V109, P19959, DOI 10.1073/pnas.1208110109; WILLIAMS H, 1989, LANCET, V1, P734; Willis CM, 2010, CANCER BIOMARK, V8, P145, DOI 10.3233/CBM-2011-0208; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712; Xue RY, 2008, RAPID COMMUN MASS SP, V22, P1181, DOI 10.1002/rcm.3466	49	7	7	19	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0245530	10.1371/journal.pone.0245530	http://dx.doi.org/10.1371/journal.pone.0245530			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596212	gold, Green Published, Green Submitted			2022-12-26	WOS:000620633200021
J	Behera, P; Patro, BK; Singh, AK; Chandanshive, PD; Ravikumar, SR; Pradhan, SK; Pentapati, SSK; Batmanabane, G; Mohapatra, PR; Padhy, BM; Bal, SK; Singh, SR; Mohanty, RR				Behera, Priyamadhaba; Patro, Binod Kumar; Singh, Arvind Kumar; Chandanshive, Pradnya Dilip; Ravikumar, S. R.; Pradhan, Somen Kumar; Pentapati, Siva Santosh Kumar; Batmanabane, Gitanjali; Mohapatra, Prasanta Raghab; Padhy, Biswa Mohan; Bal, Shakti Kumar; Singh, Sudipta Ranjan; Mohanty, Rashmi Ranjan			Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study	PLOS ONE			English	Article							COVID-19	Background Ivermectin is one among several potential drugs explored for its therapeutic and preventive role in SARS-CoV-2 infection. The study was aimed to explore the association between ivermectin prophylaxis and the development of SARS-CoV-2 infection among healthcare workers. Methods A hospital-based matched case-control study was conducted among healthcare workers of AIIMS Bhubaneswar, India, from September to October 2020. Profession, gender, age and date of diagnosis were matched for 186 case-control pairs. Cases and controls were healthcare workers who tested positive and negative, respectively, for COVID-19 by RT-PCR. Exposure was defined as the intake of ivermectin and/or hydroxychloroquine and/or vitamin-C and/or other prophylaxis for COVID-19. Data collection and entry was done in Epicollect5, and analysis was performed using STATA version 13. Conditional logistic regression models were used to describe the associated factors for SARS-CoV-2 infection. Results Ivermectin prophylaxis was taken by 76 controls and 41 cases. Two-dose ivermectin prophylaxis (AOR 0.27, 95% CI, 0.15-0.51) was associated with a 73% reduction of SARS-CoV-2 infection among healthcare workers for the following month. Those involved in physical activity (AOR 3.06 95% CI, 1.18-7.93) for more than an hour/day were more likely to contract SARS-CoV-2 infection. Type of household, COVID duty, single-dose ivermectin prophylaxis, vitamin-C prophylaxis and hydroxychloroquine prophylaxis were not associated with SARS-CoV-2 infection. Conclusion Two-dose ivermectin prophylaxis at a dose of 300 mu g/kg with a gap of 72 hours was associated with a 73% reduction of SARS-CoV-2 infection among healthcare workers for the following month. Chemoprophylaxis has relevance in the containment of pandemic.	[Behera, Priyamadhaba; Patro, Binod Kumar; Singh, Arvind Kumar; Chandanshive, Pradnya Dilip; Ravikumar, S. R.; Pradhan, Somen Kumar; Pentapati, Siva Santosh Kumar] All India Inst Med Sci Bhubaneswar, Dept Community Med & Family Med, Bhubaneswar, India; [Batmanabane, Gitanjali] All India Inst Med Sci Bhubaneswar, Bhubaneswar, India; [Mohapatra, Prasanta Raghab; Bal, Shakti Kumar] All India Inst Med Sci Bhubaneswar, Dept Pulm Med & Crit Care, Bhubaneswar, India; [Padhy, Biswa Mohan] All India Inst Med Sci Bhubaneswar, Dept Pharmacol, Bhubaneswar, India; [Singh, Sudipta Ranjan] All India Inst Med Sci Bhubaneswar, Dept Forens Med & Toxicol, Bhubaneswar, India; [Mohanty, Rashmi Ranjan] All India Inst Med Sci Bhubaneswar, Dept Gen Med, Bhubaneswar, India	All India Institute of Medical Sciences (AIIMS) Bhubaneswar; All India Institute of Medical Sciences (AIIMS) Bhubaneswar; All India Institute of Medical Sciences (AIIMS) Bhubaneswar; All India Institute of Medical Sciences (AIIMS) Bhubaneswar; All India Institute of Medical Sciences (AIIMS) Bhubaneswar; All India Institute of Medical Sciences (AIIMS) Bhubaneswar	Batmanabane, G (corresponding author), All India Inst Med Sci Bhubaneswar, Bhubaneswar, India.	director@aiimsbhubaneswar.edu.in	Mohanty, Rashmi/AAR-5603-2021; Chandanshive, Pradnya/GMX-1884-2022; Pradhan, Somen Kumar/AAP-8719-2021; Pentapati, Siva Santosh Kumar/GNH-2539-2022; Mohapatra, Prasanta Raghab/ABD-2894-2021	Chandanshive, Pradnya/0000-0002-6582-1884; Pradhan, Somen Kumar/0000-0002-4749-9705; Pentapati, Siva Santosh Kumar/0000-0002-6827-6527; Mohapatra, Prasanta Raghab/0000-0002-6625-2417; , S R/0000-0003-0297-0177; Patro, Binod Kumar/0000-0003-0019-4522				Agalar C, 2020, TURK J MED SCI, V50, P578, DOI 10.3906/sag-2004-132; [Anonymous], 2020, HLTH WORKERS EXPOSUR; [Anonymous], 2020, REVISED ADVISORY USE; [Anonymous], 2020, CORONAVIRUS DIS 2019; [Anonymous], 2020, PHASE 3 TRIAL PROMOT; [Anonymous], 2021, WHO CORONAVIRUS DIS; [Anonymous], 2020, CORONAVIRUS DIS COVI; Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638; Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787; Cheng Richard Z, 2020, Glob Adv Health Med, V9, p2164956120934768, DOI 10.1177/2164956120934768; Biancatelli RMLC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01451; De Vito A, 2020, EUR REV MED PHARMACO, V24, P7861, DOI 10.26355/eurrev_202007_22291; Etienne Carrisa F., 2020, COVID 19 HAS INFECTE; Feyaerts AF, 2020, NUTRITION, V79-80, DOI 10.1016/j.nut.2020.110948; Galvin CJ, 2020, INT J INFECT DIS, V98, P18, DOI 10.1016/j.ijid.2020.06.062; Galvis V, 2020, ARCH BRONCONEUMOL, V56, P606, DOI 10.1016/j.arbres.2020.05.008; Geremia N, 2020, INFECT DIS CLIN PRAC, V28, pE30, DOI 10.1097/IPC.0000000000000952; Guarneri C, 2021, LANCET INFECT DIS, V21, P24, DOI 10.1016/S1473-3099(20)30402-3; Lahiri A, 2020, INDIAN J PUBLIC HLTH, V64, P156, DOI 10.4103/ijph.IJPH_464_20; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Qian MR, 2022, J PUBLIC HEALTH-HEID, V30, P259, DOI 10.1007/s10389-020-01321-z; Rajter JC, 2021, CHEST, V159, P85, DOI 10.1016/j.chest.2020.10.009; Sant’Ana Geisa, 2020, Acta paul. enferm., V33, peAPE20200107, DOI 10.37689/acta-ape/2020ao0107; Teslya A., 2020, PLOS MED, V17, DOI DOI 10.1371/JOURNAL.PMED.1003166; Trujillo Figueredo A., 2020, RES GATE; Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1560, DOI 10.1002/hed.26269; Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1252, DOI 10.1002/hed.26204; Wang XT, 2020, EMERG INFECT DIS, V26, P2361, DOI [10.3201/eid2510.201702, 10.3201/eid2610.201702]	28	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247163	10.1371/journal.pone.0247163	http://dx.doi.org/10.1371/journal.pone.0247163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592050	gold, Green Published			2022-12-26	WOS:000620632800038
J	Benmachiche, A; Benbouhedja, S; Zoghmar, A; Al Humaidan, PSH				Benmachiche, Abdelhamid; Benbouhedja, Sebti; Zoghmar, Abdelali; Al Humaidan, Peter Samir Hesjaer			The impact of preovulatory versus midluteal serum progesterone level on live birth rates during fresh embryo transfer	PLOS ONE			English	Article								Background Conflicting evidence still prevails concerning the effect of preovulatory elevated progesterone (EP4) on reproductive outcomes in fresh embryo transfer (ET). However, few studies have analyzed the effect of EP4 on the likelihood of pregnancy using multivariate regression approach. The potential confounding factors tested in these studies were limited to either patient's characteristics or to stimulation related parameters. Yet, several studies have shown that postovulatory parameters such as midluteal progesterone (P-4) level may be considered as a proxy variable of endometrial receptivity as well. Objective The aim of the present study was to estimate the independent effect of preovulatory P-4 effect, if any, on the probability of live birth (LB) by considering the midluteal endocrine profile when controlling for the potential confounding factors. Methods This is a secondary data analysis of a cohort of fresh IVF/ICSI cycles triggered with GnRH agonist (n = 328) performed in a single IVF center during the period 2014-2016. Patients contributed only one cycle and were stratified into four groups according to preovulatory P-4 quartiles. We assessed the association between preovulatory P-4 and the odds of LB calculated by logistic regression analysis after controlling for the most clinically relevant confounders. The primary outcome measure: Live birth rates (LBR). Results Both preovulatory and midluteal P-4 were significantly correlated with the ovarian response. Logistic regression analysis showed that preovulatory serum P-4 did not have a significant impact on LBR. In contrast, midluteal serum P-4 level was an important independent factor associated with LBR. The optimal chance of LBR was achieved with midluteal serum P-4 levels of 41-60 ng/ml, [OR: 2.73 (1.29-5.78); p< 0.008]. Conclusion The multivariate analysis suggests that the midluteal P-4 level seems to impact LBR more than the preovulatory P-4 level in women undergoing IVF treatment followed by fresh ET.	[Benmachiche, Abdelhamid; Benbouhedja, Sebti; Zoghmar, Abdelali] Ibn Rochd, Ctr Reprod Med, Constantine, Algeria; [Al Humaidan, Peter Samir Hesjaer] Skive Reg Hosp, Fertil Clin, Skive, Denmark; [Al Humaidan, Peter Samir Hesjaer] Aarhus Univ, Dept Clin Med, Aarhus C, Denmark	Aarhus University	Benmachiche, A (corresponding author), Ibn Rochd, Ctr Reprod Med, Constantine, Algeria.	benmachiche@gmail.com	Benmachiche, Abdelhamid/AAW-7606-2021; Benmachiche, Abdelhamid/AAV-1671-2021	Benmachiche, Abdelhamid/0000-0003-0996-2559; Humaidan, Peter/0000-0001-6884-5366				ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Andersen CY, 2011, REPROD BIOMED ONLINE, V23, P187, DOI 10.1016/j.rbmo.2011.04.003; Baczkowski Tomasz, 2004, Reprod Biol, V4, P5; Benmachiche A, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00124; Bosch E, 2010, HUM REPROD, V25, P2092, DOI 10.1093/humrep/deq125; BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; BRANNSTROM M, 1989, BIOL REPROD, V40, P1170, DOI 10.1095/biolreprod40.6.1170; Chetkowski RJ, 1997, FERTIL STERIL, V68, P292, DOI 10.1016/S0015-0282(97)81518-X; Ellenbogen A, 2004, FERTIL STERIL, V82, pS205, DOI 10.1016/j.fertnstert.2004.07.543; Esteves SC, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00201; Fanchin R, 1996, FERTIL STERIL, V65, P1178, DOI 10.1016/S0015-0282(16)58335-6; Fanchin R, 1997, FERTIL STERIL, V68, P799, DOI 10.1016/S0015-0282(97)00337-3; Fatemi HM, 2013, FERTIL STERIL, V100, P742, DOI 10.1016/j.fertnstert.2013.05.028; FILICORI M, 1984, J CLIN INVEST, V73, P1638, DOI 10.1172/JCI111370; GIVENS CR, 1994, FERTIL STERIL, V62, P1011; Griesinger G, 2013, FERTIL STERIL, V100, P1622, DOI 10.1016/j.fertnstert.2013.08.045; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Hill MJ, 2018, FERTIL STERIL, V110, P671, DOI 10.1016/j.fertnstert.2018.05.007; HOFF JD, 1983, J CLIN ENDOCR METAB, V57, P792, DOI 10.1210/jcem-57-4-792; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Huang R, 2012, FERTIL STERIL, V98, P664, DOI 10.1016/j.fertnstert.2012.05.024; Humaidan P, 2005, HUM REPROD, V20, P1213, DOI 10.1093/humrep/deh765; Lawrenz B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206098; Leao RDF, 2014, CLINICS, V69, P279, DOI 10.6061/clinics/2014(04)10; Martinez F, 2004, REPROD BIOMED ONLINE, V8, P183, DOI 10.1016/S1472-6483(10)60514-7; Melo MAB, 2006, HUM REPROD, V21, P1503, DOI 10.1093/humrep/dei474; Petersen JF, 2018, REPROD BIOMED ONLINE, V36, P427, DOI 10.1016/j.rbmo.2017.12.019; Psychoyos A, 1985, IMPLANTATION HUMAN E; Requena A, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-69; Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204; Senn S, 2005, P INT STAT I 55 SESS; Shapiro BS, 2011, FERTIL STERIL, V96, P344, DOI 10.1016/j.fertnstert.2011.05.050; Sunkara SK, 2011, HUM REPROD, V26, P1768, DOI 10.1093/humrep/der106; Tabachnick B.G., 2014, USING MULTIVARIATE S, V6th Ed., P659; Thomsen LH, 2018, HUM REPROD, V33, P1506, DOI 10.1093/humrep/dey226; Tu JJ, 2021, GYNECOL ENDOCRINOL, V37, P132, DOI 10.1080/09513590.2020.1756252; Ubaldi F, 1995, HUM REPROD, V10, P3091, DOI 10.1093/oxfordjournals.humrep.a135864; van Loendersloot LL, 2013, HUM REPROD, V28, P2972, DOI 10.1093/humrep/det315; van Loendersloot L, 2014, J ADV RES, V5, P295, DOI 10.1016/j.jare.2013.05.002; Venetis CA, 2007, HUM REPROD UPDATE, V13, P343, DOI 10.1093/humupd/dmm007; Venetis CA, 2013, HUM REPROD UPDATE, V19, P433, DOI 10.1093/humupd/dmt014; Venetis CA, 2018, TRYING DEFINE OPTIMA, DOI [10.1016/j.fertnstert.2018.06.006, DOI 10.1016/J.FERTNSTERT.2018.06.006]; Venetis CA, 2015, HUM REPROD, V30, P684, DOI 10.1093/humrep/deu362; Vuong LN, 2020, HUM REPROD, V35, P157, DOI 10.1093/humrep/dez235; Wang NF., 2019, HUM REPROD, P1, DOI [10.1093/humrep/dey381, DOI 10.1093/HUMREP/DEY381]; Xu B, 2012, FERTIL STERIL, V97, P1321, DOI 10.1016/j.fertnstert.2012.03.014; Yovich JL, 2015, REPROD BIOMED ONLINE, V31, P180, DOI 10.1016/j.rbmo.2015.05.005	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246440	10.1371/journal.pone.0246440	http://dx.doi.org/10.1371/journal.pone.0246440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KQ	33571260	Green Published, gold			2022-12-26	WOS:000620071100008
J	Osborne, TF; Veigulis, ZP; Arreola, DM; Mahajan, SM; Roosli, E; Curtin, CM				Osborne, Thomas F.; Veigulis, Zachary P.; Arreola, David M.; Mahajan, Satish M.; Roosli, Eliane; Curtin, Catherine M.			Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration	PLOS ONE			English	Article								There is growing evidence that thrombotic and inflammatory pathways contribute to the severity of COVID-19. Common medications such as aspirin, that mitigate these pathways, may decrease COVID-19 mortality. This retrospective assessment was designed to quantify the correlation between pre-diagnosis aspirin and mortality for COVID-19 positive patients in our care. Data from the Veterans Health Administration national electronic health record database was utilized for the evaluation. Veterans from across the country with a first positive COVID-19 polymerase chain reaction lab result were included in the evaluation which comprised 35,370 patients from March 2, 2020 to September 13, 2020 for the 14-day mortality cohort and 32,836 patients from March 2, 2020 to August 28, 2020 for the 30-day mortality cohort. Patients were matched via propensity scores and the odds of mortality were then compared. Among COVID-19 positive Veterans, preexisting aspirin prescription was associated with a statistically and clinically significant decrease in overall mortality at 14-days (OR 0.38, 95% CI 0.32-0.46) and at 30-days (OR 0.38, 95% CI 0.33-0.45), cutting the odds of mortality by more than half. Findings demonstrated that pre-diagnosis aspirin prescription was strongly associated with decreased mortality rates for Veterans diagnosed with COVID-19. Prospective evaluation is required to more completely assess this correlation and its implications for patient care.	[Osborne, Thomas F.; Arreola, David M.; Mahajan, Satish M.; Curtin, Catherine M.] Palo Alto Healthcare Syst, US Dept Vet Affairs, Palo Alto, CA 94304 USA; [Osborne, Thomas F.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Veigulis, Zachary P.] Cent Iowa Hlth Care Syst, US Dept Vet Affairs, Des Moines, IA USA; [Roosli, Eliane] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Curtin, Catherine M.] Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Stanford University; Stanford University	Osborne, TF (corresponding author), Palo Alto Healthcare Syst, US Dept Vet Affairs, Palo Alto, CA 94304 USA.; Osborne, TF (corresponding author), Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA.	thomas.osborne@va.gov		Roosli, Eliane/0000-0003-0557-6239; Veigulis, Zachary/0000-0002-9026-1604; Osborne, Thomas/0000-0002-8896-2487; Curtin, Catherine/0000-0003-0850-9277				Albandar HJ, 2018, J GASTROINTEST ONCOL, V9, P1133, DOI 10.21037/jgo.2018.08.13; [Anonymous], 2020, WHO2019NCOVSCIBRIEFN; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Cheruiyot I, 2021, ANN VASC SURG, V70, P273, DOI 10.1016/j.avsg.2020.08.087; Chow JH, 2020, ASPIRIN USE IS ASS D; Diaz T, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.562708; Elgar FJ, 2020, SOC SCI MED, V263, DOI 10.1016/j.socscimed.2020.113365; Glatthaar-Saalmuller B, 2017, INFLUENZA OTHER RESP, V11, P85, DOI 10.1111/irv.12421; India State Level Disease Burden Initiative Road Injury Collaborators, 2020, LANCET PUBLIC HLTH, V5, pe86; Kizer KW, 2000, MED CARE, V38, pS7; Koupenova M, 2017, EUR HEART J, V38, P785, DOI 10.1093/eurheartj/ehw550; Li YN, 2020, STROKE VASC NEUROL, V5, P279, DOI 10.1136/svn-2020-000431; Little P, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1185; Mohamed-Hussein AAR, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.109975; Osborne TF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236554; Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031; Wang JZ, 2019, MAIN RESULTS REPORT; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Yan YL, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001343	19	42	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246825	10.1371/journal.pone.0246825	http://dx.doi.org/10.1371/journal.pone.0246825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571280	Green Published, Green Submitted, gold			2022-12-26	WOS:000618274000020
J	Satti, SH; Raja, NI; Javed, B; Akram, A; Mashwani, ZUR; Ahmad, MS; Ikram, M				Satti, Seema Hassan; Raja, Naveed Iqbal; Javed, Bilal; Akram, Abida; Mashwani, Zia-ur-Rehman; Ahmad, Muhammad Sheeraz; Ikram, Muhammad			Titanium dioxide nanoparticles elicited agro-morphological and physicochemical modifications in wheat plants to control Bipolaris sorokiniana	PLOS ONE			English	Article							SILVER NANOPARTICLES; SELENIUM NANOPARTICLES; OXIDATIVE STRESS; GREEN SYNTHESIS; COLON-CANCER; TIO2; PARAMETERS; EXTRACT; IMPACT; GROWTH	The current study involves the biogenesis of titanium dioxide nanoparticles (TiO2 NPs) by using Moringa oleifera Lam. aqueous leaf extract for the reduction of titanium dioxide salt into TiO2 nanoparticles. The biosynthesized TiO2 nanoparticles were observed by using the UV-visible spectrophotometry, SEM, EDX and XRD analytical methods. It was confirmed that the nanoparticles are crystalline and exist in the size range of 10-100 nm. The FTIR analysis confirmed the presence of O-H (hydrogen bonding), N-H (amide), C-C (alkanes) and C-I (Iodo-stretch) functional groups responsible for the stabilization of nanoparticles. Various concentrations (20, 40, 60 and 80 mg/L) of TiO2 NPs were applied exogenously on wheat plants infected with a fungus Bipolaris sorokiniana responsible to cause spot blotch disease at different time intervals. The measurement of disease incidence and percent disease index showed the time-dependent response and 40 mg/L was reported a stable concentration of TiO2 NPs to reduce the disease severity. The effects of biosynthesized TiO2 NPs were also evaluated for agro-morphological (leaf and root surface area, plant fresh and dry weight and yield parameters), physiological (relative water content, membrane stability index and chlorophyll content) and non-enzymatic metabolites (soluble sugar, protein, soluble phenol and flavonoid content) in wheat plants under biotic stress and 40 mg/L concentration of TiO2 NPs was found to be effective to elicit modifications to reduce biotic stress. The current study highlights the significant role of biosynthesized TiO2 NPs in controlling fungal diseases of wheat plants and thus ultimately improving the quality and yield of wheat plants.	[Satti, Seema Hassan; Raja, Naveed Iqbal; Javed, Bilal; Akram, Abida; Mashwani, Zia-ur-Rehman; Ikram, Muhammad] PMAS Arid Agr Univ, Dept Bot, Rawalpindi, Punjab, Pakistan; [Ahmad, Muhammad Sheeraz] PMAS Arid Agr Univ, Univ Inst Biochem & Biotechnol, Rawalpindi, Punjab, Pakistan	Arid Agriculture University; Arid Agriculture University	Javed, B (corresponding author), PMAS Arid Agr Univ, Dept Bot, Rawalpindi, Punjab, Pakistan.	javedbilal87@gmail.com	Mashwani, Zia-ur-Rehman/N-4498-2015; Raja, Dr. Naveed Iqbal/ABG-6656-2021; Javed, Bilal/AAK-6302-2020	Mashwani, Zia-ur-Rehman/0000-0003-4222-7708; Javed, Bilal/0000-0002-9566-1498				Abd Allah EF, 2018, J PLANT INTERACT, V13, P37, DOI 10.1080/17429145.2017.1414321; Afzal SN, 2008, PAK J BOT, V40, P923; Allahverdiyev AM, 2011, FUTURE MICROBIOL, V6, P933, DOI [10.2217/FMB.11.78, 10.2217/fmb.11.78]; [Anonymous], 2019, PAK EC SURV 2018 19; Antisari LV, 2015, ENVIRON SCI POLLUT R, V22, P1841, DOI 10.1007/s11356-014-3509-0; Behboudi F, 2019, J PLANT NUTR, V42, P1439, DOI 10.1080/01904167.2019.1617308; De Filpo G, 2013, INT BIODETER BIODEGR, V85, P217, DOI 10.1016/j.ibiod.2013.07.007; Duncan TV, 2011, J COLLOID INTERF SCI, V363, P1, DOI 10.1016/j.jcis.2011.07.017; Galvano F, 2001, J FOOD PROTECT, V64, P120, DOI 10.4315/0362-028X-64.1.120; Ganesan S, 2016, ANN PHYTOMEDICINE, V5, P69, DOI 10.21276/ap.2016.5.2.8; Goutam SP, 2018, CHEM ENG J, V336, P386, DOI 10.1016/j.cej.2017.12.029; Haghighi M., 2014, Journal of Crop Science and Biotechnology, V17, P221, DOI 10.1007/s12892-014-0056-7; Hamilton JK, 1951, NATURE, V499, P4265; Hao Y, 2019, ENVIRON RES, V170, P1, DOI 10.1016/j.envres.2018.12.008; Hao Y, 2018, ENVIRON SCI-NANO, V5, P1685, DOI [10.1039/C8EN00014J, 10.1039/c8en00014j]; Iftikhar S, 2006, PAK J BOT, V38, P205; Ikram M, 2021, INT J NANOMED, V16, P249, DOI 10.2147/IJN.S295053; Ikram M, 2020, GREEN PROCESS SYNTH, V9, P706, DOI 10.1515/gps-2020-0067; Iqbal M, 2019, IRAN J SCI TECHNOL A, V43, P387, DOI 10.1007/s40995-017-0417-4; Jaberzadeh A, 2013, NOT BOT HORTI AGROBO, V41, P201; Javed B, 2020, ARTIF CELL NANOMED B, V48, P1340, DOI 10.1080/21691401.2020.1850467; Javed B, 2020, MICROSC RES TECHNIQ, V83, P1299, DOI 10.1002/jemt.23518; Javed B, 2020, MATER RES EXPRESS, V7, DOI 10.1088/2053-1591/abaf19; Javed B, 2020, MATER RES EXPRESS, V7, DOI 10.1088/2053-1591/ab903b; Javed B, 2020, INT J NANOMED, V15, P3621, DOI 10.2147/IJN.S254402; Javed B, 2020, APPL NANOSCI, V10, P3503, DOI 10.1007/s13204-020-01428-5; Javed B, 2020, APPL NANOSCI, V10, P2057, DOI 10.1007/s13204-020-01355-5; Jiang JF, 2014, PLASMA SCI TECHNOL, V16, DOI 10.1088/1009-0630/16/1/12; Khodakovskaya MV, 2014, HANDBOOK OF NANOTOXICOLOGY, NANOMEDICINE AND STEM CELL USE IN TOXICOLOGY, P121; Kinsey N, 2014, OPT EXPRESS, V22, P12238, DOI 10.1364/OE.22.012238; Ma YH, 2011, NANOTOXICOLOGY, V5, P743, DOI 10.3109/17435390.2010.545487; Mankidy BD, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/40/405402; Mehmood A, 2017, CROP BREED APPL BIOT, V17, P334, DOI 10.1590/1984-70332017v17n4a51; Mishra V, 2014, EMERGING TECHNOLOGIES AND MANAGEMENT OF CROP STRESS TOLERANCE, VOL 1: BIOLOGICAL TECHNIQUES, P159, DOI 10.1016/B978-0-12-800876-8.00008-4; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Morteza E, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-247; Nandy S, 2010, MANAGEMENT OF FUNGAL PLANT PATHOGENS, P92, DOI 10.1079/9781845936037.0092; Okupnik A, 2016, ENVIRON TOXICOL CHEM, V35, P2859, DOI 10.1002/etc.3469; OWolade Oluwaferanmi Fortune, 2008, Journal of Plant Protection Research, V48, P329, DOI 10.2478/v10045-008-0042-5; Patsalas P, 2015, MATERIALS, V8, P3128, DOI 10.3390/ma8063128; Pelaez M, 2012, APPL CATAL B-ENVIRON, V125, P331, DOI 10.1016/j.apcatb.2012.05.036; Peng JH, 2011, AUST J CROP SCI, V5, P1127; Rizwan M, 2017, J HAZARD MATER, V322, P2, DOI 10.1016/j.jhazmat.2016.05.061; Rodriguez-Gonzalez V, 2020, APPL CATAL B-ENVIRON, V270, DOI 10.1016/j.apcatb.2020.118853; Rodriguez-Gonzalez V, 2019, J PHOTOCH PHOTOBIO C, V40, P49, DOI 10.1016/j.jphotochemrev.2019.06.001; Ruffini Castiglione M, 2009, CARYOLOGIA, V62, P161, DOI 10.1080/00087114.2004.10589681; Sairam R. K., 1994, Indian Journal of Experimental Biology, V32, P594; Santhoshkumar T, 2014, ASIAN PAC J TROP MED, V7, P968, DOI 10.1016/S1995-7645(14)60171-1; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Sharma P., 2012, J BOT, V2012, P26, DOI [10.1155/2012/217037, DOI 10.1155/2012/217037]; Shen XF, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1778-y; Sohail, 2019, IET NANOBIOTECHNOL, V13, P46, DOI 10.1049/iet-nbt.2018.5012; Waghmode MS, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-0337-3	53	27	28	8	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246880	10.1371/journal.pone.0246880	http://dx.doi.org/10.1371/journal.pone.0246880			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571310	gold, Green Published			2022-12-26	WOS:000618274000051
J	Huang, H; Chamness, LM; Vanoye, CG; Kuenze, G; Meiler, J; George, AL; Schlebach, JP; Sanders, CR				Huang, Hui; Chamness, Laura M.; Vanoye, Carlos G.; Kuenze, Georg; Meiler, Jens; George, Alfred L., Jr.; Schlebach, Jonathan Patrick; Sanders, Charles R.			Disease-linked supertrafficking of a potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; VOLTAGE-SENSOR DOMAIN; KCNQ1 MUTATION CAUSES; ATRIAL-FIBRILLATION; OF-FUNCTION; ELECTROSTATIC INTERACTIONS; MEMBRANE INSERTION; PATHOGENESIS; RECOGNITION; BRADYCARDIA	Gain-of-function (GOF) mutations in the voltage-gated potassium channel subfamilyQmember 1 (KCNQ1) can induce cardiac arrhythmia. In this study, it was tested whether any of the known human GOF disease mutations in KCNQ1 act by increasing the amount of KCNQ1 that reaches the cell surface-"supertrafficking." Seven of the 15 GOF mutants tested were seen to surface trafficmore efficiently than theWTchannel. Among these, wefound that the levels of R231CKCNQ1in the plasmamembrane were fivefold higher than theWT channel. This was shown to arise from the combined effects of enhanced efficiency of translocon-mediated membrane integration of the S4 voltage-sensor helix and fromenhanced post-translational folding/trafficking relatedto the energetic linkage of C231 with the V129 and F166 side chains. Whole-cell electrophysiology recordings confirmed that R231C KCNQ1 in complex with the voltage-gated potassium channel-regulatory subfamily E member 1 not only exhibited constitutive conductance but also revealed that the single-channel activity of this mutant is only20% that ofWT. TheGOFphenotype associated with R231C therefore reflects the effects of supertrafficking and constitutive channel activation, which together offset reduced channel activity. These investigations showthatmembrane protein supertrafficking can contribute to human disease.	[Huang, Hui; Sanders, Charles R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Huang, Hui; Meiler, Jens; Sanders, Charles R.] Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37232 USA; [Chamness, Laura M.; Schlebach, Jonathan Patrick] Indiana Univ, Dept Chem, Bloomington, IN USA; [Vanoye, Carlos G.; George, Alfred L., Jr.] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA; [Kuenze, Georg; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Kuenze, Georg; Meiler, Jens] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Kuenze, Georg; Meiler, Jens] Vanderbilt Univ, Med Ctr, Dept Bioinformat, Nashville, TN USA; [Sanders, Charles R.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Indiana University System; Indiana University Bloomington; Northwestern University; Feinberg School of Medicine; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Sanders, CR (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.; Sanders, CR (corresponding author), Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37232 USA.; Sanders, CR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA.	chuck.sanders@vanderbilt.edu	Huang, Hui/E-3030-2015	Huang, Hui/0000-0003-2958-257X; George, Alfred/0000-0002-3993-966X; Meiler, Jens/0000-0001-8945-193X; Kuenze, Georg/0000-0003-1799-346X; Sanders, Charles/0000-0003-2046-2862	US National Institutes of Health [R01 HL122010, R01 GM129261]; Vanderbilt University Department of Biochemistry William N. Pearson Fellowship	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Department of Biochemistry William N. Pearson Fellowship	This work was supported by US National Institutes of Health grants R01 HL122010 (to C. R. S., J. M., and A. L. G.) and R01 GM129261 (to J. P. S.). H. H. received partial support from a Vanderbilt University Department of Biochemistry William N. Pearson Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott GW, 2016, GENE, V576, P1, DOI 10.1016/j.gene.2015.09.059; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bartos DC, 2013, J CARDIOVASC ELECTR, V24, P562, DOI 10.1111/jce.12068; Bartos DC, 2011, HEART RHYTHM, V8, P48, DOI 10.1016/j.hrthm.2010.09.010; Bellocq C, 2004, CIRCULATION, V109, P2394, DOI 10.1161/01.CIR.0000130409.72142.FE; Bond PJ, 2007, P NATL ACAD SCI USA, V104, P2631, DOI 10.1073/pnas.0606822104; Brewer KR, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00550; Campuzano O, 2019, J CLIN MED, V8, DOI 10.3390/jcm8071035; Chan PJ, 2012, J GEN PHYSIOL, V139, P135, DOI 10.1085/jgp.201110672; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Das S, 2009, HEART RHYTHM, V6, P1146, DOI 10.1016/j.hrthm.2009.04.015; El Harchi A, 2010, J PHYSIOL PHARMACOL, V61, P123; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hasegawa K, 2014, HEART RHYTHM, V11, P67, DOI 10.1016/j.hrthm.2013.09.073; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Henrion U, 2012, CELL PHYSIOL BIOCHEM, V29, P809, DOI 10.1159/000178470; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hong K, 2005, CARDIOVASC RES, V68, P433, DOI 10.1016/j.cardiores.2005.06.023; Huang H, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2631; Itoh H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P511, DOI 10.1161/CIRCEP.109.862649; Kanki H, 2004, J BIOL CHEM, V279, P33976, DOI 10.1074/jbc.M404539200; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Ki CS, 2014, PFLUG ARCH EUR J PHY, V466, P529, DOI 10.1007/s00424-013-1337-6; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Kuenze G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220415; Liin SI, 2015, J PHYSIOL-LONDON, V593, P2605, DOI 10.1113/jphysiol.2014.287607; Lundby A, 2007, HEART RHYTHM, V4, P1532, DOI 10.1016/j.hrthm.2007.07.022; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Lupoglazoff JM, 2004, J AM COLL CARDIOL, V43, P826, DOI 10.1016/j.jacc.2003.09.049; Marinko JT, 2019, CHEM REV, V119, P5537, DOI 10.1021/acs.chemrev.8b00532; Miceli F, 2015, J NEUROSCI, V35, P3782, DOI 10.1523/JNEUROSCI.4423-14.2015; Mishima E, 2016, BIOCHEM J, V473, P4361, DOI 10.1042/BCJ20160746; Moreno C, 2015, CARDIOVASC RES, V107, P613, DOI 10.1093/cvr/cvv196; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Olesen MS, 2014, HEART RHYTHM, V11, P246, DOI 10.1016/j.hrthm.2013.10.034; Otway R, 2007, J AM COLL CARDIOL, V49, P578, DOI 10.1016/j.jacc.2006.09.044; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Peng DG, 2014, BIOCHEMISTRY-US, V53, P2032, DOI 10.1021/bi500102w; Rhodes TE, 2008, J MOL CELL CARDIOL, V44, P571, DOI 10.1016/j.yjmcc.2007.11.015; Roushar FJ, 2019, J AM CHEM SOC, V141, P204, DOI 10.1021/jacs.8b08243; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Satterstrom FK, 2020, CELL, V180, P568, DOI 10.1016/j.cell.2019.12.036; Schlebach JP, 2015, J AM CHEM SOC, V137, P8758, DOI 10.1021/jacs.5b03743; Steffensen AB, 2015, J CARDIOVASC ELECTR, V26, P715, DOI 10.1111/jce.12666; Sun J, 2020, CELL, V180, P340, DOI 10.1016/j.cell.2019.12.003; Sun ZH, 2019, J CELL BIOL, V218, P3171, DOI 10.1083/jcb.201906047; Taylor KC, 2020, ELIFE, V9, DOI 10.7554/eLife.53901; Vanoye CG, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002345; Virkki MT, 2014, PROTEIN SCI, V23, P981, DOI 10.1002/pro.2483; Wang T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18723-y; Wu J, 2016, J ARRYTHM, V32, P381, DOI 10.1016/j.joa.2015.12.006; Yang T, 2009, CIRC-ARRHYTHMIA ELEC, V2, P417, DOI 10.1161/CIRCEP.109.850149; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P8263, DOI 10.1073/pnas.0611007104; Zhou X, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00259	57	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100423	10.1016/j.jbc.2021.100423	http://dx.doi.org/10.1016/j.jbc.2021.100423			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33600800	gold, Green Submitted, Green Published			2022-12-26	WOS:000672866400397
J	Jin, XF; Zhang, ZM; Nie, ZP; Wang, CH; Meng, FL; Yi, QZ; Chen, MQ; Sun, JJ; Zou, J; Jiang, PP; Guan, MX				Jin, Xiaofen; Zhang, Zengming; Nie, Zhipeng; Wang, Chenghui; Meng, Feilong; Yi, Qiuzi; Chen, Mengquan; Sun, Jiji; Zou, Jian; Jiang, Pingping; Guan, Min-Xin			An animal model for mitochondrial tyrosyl-tRNA synthetase deficiency reveals links between oxidative phosphorylation and retinal function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTIC-ACIDOSIS; PHENOTYPIC MANIFESTATION; CAUSES MYOPATHY; MUTATION; YARS2; STRESS; METABOLISM; ACTIVATION; INHIBITION; ZEBRAFISH	Mitochondria maintain a distinct pool of ribosomal machinery, including tRNAs and tRNAs activating enzymes, such as mitochondrial tyrosyl-tRNA synthetase (YARS2). Mutations in YARS2, which typically lead to the impairment of mitochondrial protein synthesis, have been linked to an array of human diseases including optic neuropathy. However, the lack of YARS2 mutation animal model makes us difficult to elucidate the pathophysiology underlying YARS2 deficiency. To explore this system, we generated YARS2 knockout (KO) HeLa cells and zebrafish using CRISPR/Cas9 technology. We observed the aberrant tRNATyr aminoacylation overall and reductions in the levels in mitochondrion- and nucleus-encoding subunits of oxidative phosphorylation system(OXPHOS), which were especially pronounced effects in the subunits of complex I and complex IV. These deficiencies manifested the decreased levels of intact supercomplexes overall. Immunoprecipitation assays showed that YARS2 bound to specific subunits of complex I and complex IV, suggesting the post-translational stabilization of OXPHOS. Furthermore, YARS2 ablation caused defects in the stability and activities of OXPHOS complexes. These biochemical defects could be rescued by the overexpression of YARS2 cDNA in the YARS2(KO) cells. In zebrafish, the yars2(KO) larva conferred deficient COX activities in the retina, abnormal mitochondrial morphology, and numbers in the photoreceptor and retinal ganglion cells. The zebrafish further exhibited the retinal defects affecting both rods and cones. Vision defects in yars2(KO) zebrafish recapitulated the clinical phenotypes in the optic neuropathy patients carrying the YARS2 mutations. Our findings highlighted the critical role of YARS2 in the stability and activity of OXPHOS and its pathological consequence in vision impairments.	[Jin, Xiaofen; Guan, Min-Xin] Zhejiang Univ, Sch Med, Key Lab Reprod Genet, Minist Educ PRC,Womans Hosp, Hangzhou, Zhejiang, Peoples R China; [Jin, Xiaofen; Meng, Feilong; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Sch Med, Div Med Genet & Genom, Childrens Hosp, Hangzhou, Zhejiang, Peoples R China; [Jin, Xiaofen; Meng, Feilong; Jiang, Pingping; Guan, Min-Xin] Natl Clin Res Ctr Child Hlth, Hangzhou, Zhejiang, Peoples R China; [Jin, Xiaofen; Zhang, Zengming; Nie, Zhipeng; Wang, Chenghui; Meng, Feilong; Yi, Qiuzi; Sun, Jiji; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Chen, Mengquan] Wenzhou Hosp Tradit Chinese Med, Dept Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zou, Jian] Zhejiang Univ, Insitute Translat Med, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Zhejiang Prov Key Lab Genet & Dev Disorders, Hangzhou, Zhejiang, Peoples R China; [Guan, Min-Xin] Joint Inst Genet & Genome Med Zhejiang Univ & Uni, Div Mitochondrial Biomed, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Key Lab Reprod Genet, Minist Educ PRC,Womans Hosp, Hangzhou, Zhejiang, Peoples R China.; Jiang, PP; Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Div Med Genet & Genom, Childrens Hosp, Hangzhou, Zhejiang, Peoples R China.; Jiang, PP; Guan, MX (corresponding author), Natl Clin Res Ctr Child Hlth, Hangzhou, Zhejiang, Peoples R China.; Jiang, PP; Guan, MX (corresponding author), Zhejiang Univ, Inst Genet, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Jiang, PP; Guan, MX (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Genet & Dev Disorders, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Joint Inst Genet & Genome Med Zhejiang Univ & Uni, Div Mitochondrial Biomed, Hangzhou, Zhejiang, Peoples R China.	ppjiang@zju.edu.cn; gminxin88@zju.edu.cn		JIANG, PINGPING/0000-0002-4975-4861	National Key Research and Development Program of China, China [2018YFC1004802]; National Natural Science Foundation of China, China [31970557, 31671303]; Zhejiang Provincial Medical and Health Research Program, China [2019RC149]	National Key Research and Development Program of China, China; National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Medical and Health Research Program, China	This work was supported by a grant from the National Key Research and Development Program of China, China (2018YFC1004802 to M.-X. G.), grants from National Natural Science Foundation of China, China (31970557 to M.-X. G., 31671303 to P. J.) and Zhejiang Provincial Medical and Health Research Program, China (2019RC149 to X. J.).	Agnew T, 2018, CELL REP, V25, P3315, DOI 10.1016/j.celrep.2018.11.080; Akaike T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01311-y; AMES A, 1992, CAN J PHYSIOL PHARM, V70, pS158, DOI 10.1139/y92-257; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Boczonadi V, 2018, ESSAYS BIOCHEM, V62, P321, DOI 10.1042/EBC20170103; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; Bonnefond L, 2007, STRUCTURE, V15, P1505, DOI 10.1016/j.str.2007.09.018; Chen DN, 2019, NUCLEIC ACIDS RES, V47, P5341, DOI 10.1093/nar/gkz218; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Collery RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110699; Coughlin CR, 2015, J MED GENET, V52, P532, DOI 10.1136/jmedgenet-2015-103049; Country MW, 2017, BRAIN RES, V1672, P50, DOI 10.1016/j.brainres.2017.07.025; Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590; Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; Escobar-Alvarez S, 2010, MOL CELL BIOL, V30, P5099, DOI 10.1128/MCB.00469-10; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Fan WL, 2019, J BIOL CHEM, V294, P19292, DOI 10.1074/jbc.RA119.010598; Fang PF, 2017, METHODS, V113, P83, DOI 10.1016/j.ymeth.2016.11.014; Fine AS, 2019, J NEURODEV DISORD, V11, DOI 10.1186/s11689-019-9292-y; Finsteree J, 2017, J NEUROL SCI, V376, P117, DOI 10.1016/j.jns.2017.03.006; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Gonzales APW, 2014, METHOD ENZYMOL, V546, P377, DOI 10.1016/B978-0-12-801185-0.00018-0; Gonzalez-Serrano LE, 2019, J BIOL CHEM, V294, P5309, DOI 10.1074/jbc.REV118.002953; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050; Hyeon DY, 2019, J BIOL CHEM, V294, P5340, DOI 10.1074/jbc.REV118.002958; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Ji YC, 2019, HUM MOL GENET, V28, P1515, DOI 10.1093/hmg/ddy450; Jia ZD, 2019, NUCLEIC ACIDS RES, V47, P2056, DOI 10.1093/nar/gky1241; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KING MP, 1993, J BIOL CHEM, V268, P10228; Levi O, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000274; Liu Y, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.8.24; McMillan HJ, 2015, J CHILD NEUROL, V30, P1037, DOI 10.1177/0883073814553272; Meng FL, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1225; Meng FL, 2018, J BIOL CHEM, V293, P3321, DOI 10.1074/jbc.RA117.000530; Mukherjee S, 2020, MITOCHONDRION, V53, P1, DOI 10.1016/j.mito.2020.04.002; Nakajima J, 2014, J HUM GENET, V59, P229, DOI 10.1038/jhg.2013.143; Ognjenovic J, 2018, RNA BIOL, V15, P623, DOI 10.1080/15476286.2017.1330245; Oprescu SN, 2017, METHODS, V113, P139, DOI 10.1016/j.ymeth.2016.11.013; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Peragallo JH, 2018, OPHTHALMIC GENET, V39, P99, DOI 10.1080/13816810.2017.1350723; Phillips MJ, 2010, INVEST OPHTH VIS SCI, V51, P6744, DOI 10.1167/iovs.10-5421; Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007; Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665; Riley LG, 2018, HAEMATOLOGICA, V103, P2008, DOI 10.3324/haematol.2017.182659; Riley LG, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-193; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; Rodina A, 2016, NATURE, V538, P397, DOI 10.1038/nature19807; Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098; Shahni R, 2013, AM J MED GENET A, V161, P2334, DOI 10.1002/ajmg.a.36065; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Signes A, 2018, ESSAYS BIOCHEM, V62, P255, DOI 10.1042/EBC20170098; Simon M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005097; Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002; Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0; Sommerville EW, 2017, JAMA NEUROL, V74, P686, DOI 10.1001/jamaneurol.2016.4357; Son K, 2019, J CLIN INVEST, V129, P2088, DOI 10.1172/JCI122560; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Szczepanowska K, 2016, EMBO J, V35, P2566, DOI 10.15252/embj.201694253; Tarboush R, 2012, TISSUE CELL, V44, P264, DOI 10.1016/j.tice.2012.04.004; Truscott KN, 2010, BIOCHEM CELL BIOL, V88, P97, DOI [10.1139/O09-167, 10.1139/o09-167]; Tyynismaa H, 2014, EMBO MOL MED, V6, P155, DOI 10.1002/emmm.201303586; Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z; Wang M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12061; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Yu JL, 2020, J CLIN INVEST, V130, P4935, DOI 10.1172/JCI134965; Zhang JJ, 2018, MITOCHONDRION, V42, P84, DOI 10.1016/j.mito.2017.12.003; Zhang QH, 2018, NUCLEIC ACIDS RES, V46, P10930, DOI 10.1093/nar/gky758; Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317	79	7	7	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100437	10.1016/j.jbc.2021.100437	http://dx.doi.org/10.1016/j.jbc.2021.100437			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610547	gold, Green Published			2022-12-26	WOS:000672866400411
J	Wang, Y; Li, XY; Ge, JR; Liu, M; Pang, XM; Liu, JP; Luo, C; Xu, YC; Zhao, Q				Wang, Ying; Li, Xinyu; Ge, Jingru; Liu, Ming; Pang, Xiaming; Liu, Jianpeng; Luo, Cheng; Xu, Yichen; Zhao, Quan			The methyltransferase PRMT1 regulates gamma-globin translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FETAL-HEMOGLOBIN; GENE-EXPRESSION; BETA-THALASSEMIA; INITIATION; METHYLATION; INDUCTION; REVEALS; RECOGNITION; EFFICIENCY; INHIBITOR	Induction of fetal hemoglobin to overcome adult beta-globin gene deficiency is an effective therapeutic strategy to ameliorate human beta-hemoglobinopathies. Previous work has revealed that fetal gamma-globin can be translationally induced via integrated stress signaling, but other studies have indicated that activating stress may eventually suppress gamma-globin expression transcriptionally. The mechanism by which gamma-globin expression is regulated at the translational level remains largely unknown, limiting our ability to determine whether activating stress is a realistic therapeutic option for these disorders. In this study, we performed a functional CRISPR screen targeting protein arginine methyltransferases (PRMTs) to look for changes in gamma-globin expression in K562 cells. We not only discovered that several specific PRMTs may block gamma-globin transcription, but also revealed PRMT1 as a unique family member that is able to suppress gamma-globin synthesis specifically at the translational level. We further identified that a non-AUG uORF within the 5' untranslated region of gamma-globin serves as a barrier for translation, which is bypassed upon PRMT1 deficiency. Finally, we found that this novel mechanism of gamma-globin suppression could be pharmacologically targeted by the PRMT1 inhibitor, furamidine dihydrochloride. These data raise new questions regarding methyltransferase function and may offer a new therapeutic direction for beta-hemoglobinopathies.	[Wang, Ying; Li, Xinyu; Ge, Jingru; Liu, Ming; Liu, Jianpeng; Zhao, Quan] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Hematol,Sch Life Sci, Affiliated Drum Tower Hosp,Med Sch,China Australi, Nanjing, Peoples R China; [Wang, Ying; Pang, Xiaming; Xu, Yichen] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94110 USA; [Wang, Ying; Pang, Xiaming; Xu, Yichen] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Luo, Cheng] Chinese Acad Sci, Drug Discovery & Design Ctr, Shanghai Inst Mat Med, CAS Key Lab Receptor Res,State Key Lab Drug Res, Shanghai, Peoples R China; [Xu, Yichen] Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou, Peoples R China	Nanjing University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Zhejiang University	Zhao, Q (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Hematol,Sch Life Sci, Affiliated Drum Tower Hosp,Med Sch,China Australi, Nanjing, Peoples R China.; Xu, YC (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94110 USA.; Xu, YC (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Xu, YC (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou, Peoples R China.	yichen_xu@zju.edu.cn; qzhao@nju.edu.cn	Xinyu, Li/AAG-1655-2021	Xinyu, Li/0000-0003-3694-4188; Zhao, Quan/0000-0002-8533-1938	National Natural Science Foundation of China NSFC [31770809, 31970615]	National Natural Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China NSFC (31770809 and 31970615).	Atkins C., 2020, HAEMATOLOGICA; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bank A, 2005, J CLIN INVEST, V115, P1470, DOI 10.1172/JCI25398; Bol GM, 2015, EMBO MOL MED, V7, P648, DOI 10.15252/emmm.201404368; Chakalova L, 2005, BLOOD, V105, P2154, DOI 10.1182/blood-2003-11-4069; Cui SY, 2017, ADV EXP MED BIOL, V1013, P177, DOI 10.1007/978-1-4939-7299-9_7; DOVER GJ, 1994, BLOOD, V84, P339; Gao GZ, 2017, NUCLEIC ACIDS RES, V45, P4359, DOI 10.1093/nar/gkw1367; Gao J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.444; Ginder GD, 2015, TRANSL RES, V165, P115, DOI 10.1016/j.trsl.2014.05.002; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Guccione E, 2019, NAT REV MOL CELL BIO, V20, P642, DOI 10.1038/s41580-019-0155-x; Guenther UP, 2018, NATURE, V559, P130, DOI 10.1038/s41586-018-0258-0; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Hahn CK, 2014, BLOOD, V124, P2730, DOI 10.1182/blood-2014-03-564302; Hahn CK, 2013, BLOOD, V122, P477, DOI 10.1182/blood-2013-03-491043; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Hsu JHR, 2017, CANCER RES, V77, P4613, DOI 10.1158/0008-5472.CAN-17-0216; Huang P, 2020, BLOOD, V135, P2121, DOI 10.1182/blood.2020005301; Hussain T, 2014, CELL, V159, P597, DOI 10.1016/j.cell.2014.10.001; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Larsen SC, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7329; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; LOWREY CH, 1993, NEW ENGL J MED, V329, P845, DOI 10.1056/NEJM199309163291205; Masuda T, 2016, SCIENCE, V351, P285, DOI 10.1126/science.aad3312; Nie M, 2018, J BIOL CHEM, V293, P17454, DOI 10.1074/jbc.RA118.004028; PERRINE SP, 1993, NEW ENGL J MED, V328, P81, DOI 10.1056/NEJM199301143280202; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Rank G, 2010, BLOOD, V116, P1585, DOI 10.1182/blood-2009-10-251116; Rivers A, 2016, HAEMATOLOGICA, V101, P688, DOI 10.3324/haematol.2015.140749; Samir P, 2019, NATURE, V573, P590, DOI 10.1038/s41586-019-1551-2; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sharma D, 2014, CRIT REV BIOCHEM MOL, V49, P343, DOI 10.3109/10409238.2014.931339; Shi LH, 2013, NAT MED, V19, P291, DOI 10.1038/nm.3101; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; Wang C, 2017, J MED CHEM, V60, P8888, DOI 10.1021/acs.jmedchem.7b01134; Weinberg RS, 2005, BLOOD, V105, P1807, DOI 10.1182/blood-2004-02-0454; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Xu YC, 2020, ANNU REV CANC BIOL, V4, P437, DOI 10.1146/annurev-cancerbio-030419-033420; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhu XG, 2020, EXP BIOL MED, V245, P1308, DOI 10.1177/1535370220945305	48	3	3	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100417	10.1016/j.jbc.2021.100417	http://dx.doi.org/10.1016/j.jbc.2021.100417			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33587951	gold, Green Published			2022-12-26	WOS:000672866400391
J	Canals, D; Salamone, S; Santacreu, BJ; Aguilar, D; Hernandez-Corbacho, MJ; Ostermeyer-Fay, AG; Greene, M; Nemeth, E; Haley, JD; Obeid, LM; Hannun, YA				Canals, Daniel; Salamone, Silvia; Jaime Santacreu, Bruno; Aguilar, Daniel; Hernandez-Corbacho, Maria Jose; Ostermeyer-Fay, Anne G.; Greene, Meaghan; Nemeth, Erika; Haley, John D.; Obeid, Lina M.; Hannun, Yusuf A.			The doxorubicin-induced cell motility network is under the control of the ceramide-activated protein phosphatase 1 alpha	FASEB JOURNAL			English	Article						ceramide; doxorubicin; migration; phosphatase; sphingomyelinase		We have recently reported that a specific pool of ceramide, located in the plasma membrane, mediated the effects of sublethal doses of the chemotherapeutic compound doxorubicin on enhancing cancer cell migration. We identified neutral sphingomyelinase 2 (nSMase2) as the enzyme responsible to generate this bioactive pool of ceramide. In this work, we explored the role of members of the protein phosphatases 1 family (PP1), and we identified protein phosphatase 1 alpha isoform (PP1 alpha) as the specific PP1 isoform to mediate this phenotype. Using a bioinformatics approach, we build a functional interaction network based on phosphoproteomics data on plasma membrane ceramide. This led to the identification of several ceramide-PP1 alpha downstream substrates. Studies on phospho mutants of ezrin (T567) and Scrib (S1378/S1508) demonstrated that their dephosphorylation is sufficient to enhance cell migration. In summary, we identified a mechanism where reduced doses of doxorubicin result in the dysregulation of cytoskeletal proteins and enhanced cell migration. This mechanism could explain the reported effects of doxorubicin worsening cancer metastasis in animal models.	[Canals, Daniel; Salamone, Silvia; Jaime Santacreu, Bruno; Hernandez-Corbacho, Maria Jose; Ostermeyer-Fay, Anne G.; Greene, Meaghan; Nemeth, Erika; Haley, John D.; Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Jaime Santacreu, Bruno] Catedra Biol Celular & Mol, Fac Farm & Bioquim, Buenos Aires, DF, Argentina; [Aguilar, Daniel] Biomed Res Networking Ctr Hepat & Digest Dis CIBE, Barcelona, Spain; [Haley, John D.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport VA Hosp, Northport, NY USA; [Obeid, Lina M.; Hannun, Yusuf A.] Stony Brook Canc Ctr, Stony Brook, NY USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Biochem, Stony Brook, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Buenos Aires; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu	Canals, Daniel/AAW-1998-2021	Canals, Daniel/0000-0002-9293-5123; Haley, John/0000-0002-0283-6413; Santacreu, Bruno/0000-0003-2506-5006	National Cancer Institute (NCI) [CA218678]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute (NCI), Grant/Award Number: CA218678	Barcelo-Coblijn G, 2011, P NATL ACAD SCI USA, V108, P19569, DOI 10.1073/pnas.1115484108; Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Canals D., 2021, FASEB J, V35; Canals D, 2020, FASEB J, V34, P7610, DOI 10.1096/fj.202000205R; Canals D, 2018, CHEM PHYS LIPIDS, V216, P142, DOI 10.1016/j.chemphyslip.2018.09.013; Canals D, 2012, J BIOL CHEM, V287, P10145, DOI 10.1074/jbc.M111.306456; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Elliott A, 2018, BIOINFORMATICS, V34, P64, DOI 10.1093/bioinformatics/btx419; Gandy KAO, 2013, FASEB J, V27, P3155, DOI 10.1096/fj.13-228460; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Harvey RF, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw6763; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; Karagiannis GS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan0026; Khasraw M, 2012, BREAST, V21, P142, DOI 10.1016/j.breast.2011.12.012; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lim Y, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2856-8; Liu CL, 2019, J BREAST CANCER, V22, P185, DOI 10.4048/jbc.2019.22.e22; Marchesini N, 2007, BBA-MOL CELL BIOL L, V1771, P1418, DOI 10.1016/j.bbalip.2007.10.003; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Piccolo SR, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156506; Sakamoto W, 2019, J LIPID RES, V60, P1841, DOI 10.1194/jlr.M094722; Shamseddine AA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.268; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shih YK, 2012, BIOINFORMATICS, V28, pI473, DOI 10.1093/bioinformatics/bts370; Siddiqui RA, 2003, BIOCHEM J, V371, P621, DOI 10.1042/BJ20021667; Tani M, 2007, FEBS LETT, V581, P1323, DOI 10.1016/j.febslet.2007.02.046; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VAN HELVOORT A, 1994, J BIOL CHEM, V269, P1763; Wu S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05467-z	39	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21396	10.1096/fj.202002427R	http://dx.doi.org/10.1096/fj.202002427R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33583073	Green Accepted			2022-12-26	WOS:000629576700046
J	Tan, L; Harper, LR; Armstrong, A; Carlson, CS; Yammani, RR				Tan, Li; Harper, Lindsey R.; Armstrong, Alexandra; Carlson, Cathy S.; Yammani, Raghunatha R.			Dietary saturated fatty acid palmitate promotes cartilage lesions and activates the unfolded protein response pathway in mouse knee joints	PLOS ONE			English	Article								Increased intake of dietary saturated fatty acids has been linked to obesity and the development of Osteoarthritis (OA). However, the mechanism by which these fats promote cartilage degradation and the development of OA is not clearly understood. Here, we report the effects of consumption of common dietary saturated and unsaturated fatty acids, palmitate and oleate, respectively, on body weight, metabolic factors, and knee articular cartilage in a mouse model of diet-induced obesity. Mice fed on a diet rich in saturated or unsaturated fatty acid gained an equal amount of weight; however, mice fed a palmitate diet, but not a control or oleate diet, exhibited more cartilage lesions and increased expression of 1) unfolded protein response (UPR)/endoplasmic reticulum (ER) stress markers including BIP, P-IRE1 alpha, XBP1, ATF4, and CHOP; 2) apoptosis markers CC3 and C-PARP; and 3) negative cell survival regulators Nupr1 and TRB3, in knee articular cartilage. Palmitate-induced apoptosis was confirmed by TUNEL staining. Likewise, dietary palmitate was also increased the circulatory levels of classic proinflammatory cytokines, including IL-6 and TNF-alpha. Taken together, our results demonstrate that increased weight gain is not sufficient for the development of obesity-linked OA and suggest that dietary palmitate promotes UPR/ER stress and cartilage lesions in mouse knee joints. This study validates our previous in vitro findings and suggests that ER stress could be the critical metabolic factor contributing to the development of diet/obesity induced OA.	[Tan, Li; Yammani, Raghunatha R.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27101 USA; [Harper, Lindsey R.; Armstrong, Alexandra; Carlson, Cathy S.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA	Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities	Yammani, RR (corresponding author), Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27101 USA.	ryammnai@wakehealth.edu		Yammani, Raghunatha/0000-0003-2278-8911	National Institute of Arthritis, Musculoskeletal, and Skin Diseases [R01 AR066105]	National Institute of Arthritis, Musculoskeletal, and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Arthritis, Musculoskeletal, and Skin Diseases (R01 AR066105) to R.R.Y.	Alvarez-Garcia O, 2014, ARTHRITIS RHEUMATOL, V66, P1779, DOI 10.1002/art.38399; Asou Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162794; Aspden RM, 2011, NAT REV RHEUMATOL, V7, P65, DOI 10.1038/nrrheum.2010.123; Berenbaum F, 2013, CURR OPIN RHEUMATOL, V25, P114, DOI 10.1097/BOR.0b013e32835a9414; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Brown AL, 2012, ARTERIOSCL THROM VAS, V32, P2122, DOI 10.1161/ATVBAHA.112.253435; Cravero JD, 2009, ARTHRITIS RHEUM-US, V60, P492, DOI 10.1002/art.24225; Darzynkiewicz Z, 2008, METHODS, V44, P250, DOI 10.1016/j.ymeth.2007.11.008; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Fang N, 2014, METABOLISM, V63, P822, DOI 10.1016/j.metabol.2014.03.003; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Forrest LM, 2012, ATHEROSCLEROSIS, V220, P118, DOI 10.1016/j.atherosclerosis.2011.10.025; Fu DP, 2016, ANN CLIN LAB SCI, V46, P353; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332; Griffin TM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3068; Haywood J, 2016, OSTEOARTHR CARTILAGE, V24, P942, DOI 10.1016/j.joca.2015.11.020; Hootman JM, 2006, ARTHRITIS RHEUM-US, V54, P226, DOI 10.1002/art.21562; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Iannone F, 2001, CLIN EXP RHEUMATOL, V19, P139; Issa RI, 2012, PATHOBIOL AGING AGE, V2, DOI 10.3402/pba.v2i0.17470; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Lancaster GI, 2018, CELL METAB, V27, P1096, DOI 10.1016/j.cmet.2018.03.014; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; LIPPIELLO L, 1991, METABOLISM, V40, P571, DOI 10.1016/0026-0495(91)90046-Y; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; McNulty MA, 2011, CARTILAGE, V2, P354, DOI 10.1177/1947603511402665; Nazli SA, 2017, OSTEOARTHR CARTILAGE, V25, P1516, DOI 10.1016/j.joca.2017.05.011; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oliveria SA, 1999, EPIDEMIOLOGY, V10, P161, DOI 10.1097/00001648-199903000-00013; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Qian B, 2008, J ENDOCRINOL, V199, P407, DOI 10.1677/JOE-08-0331; Rowe MA, 2017, ARTHRITIS RHEUMATOL, V69, P352, DOI 10.1002/art.39844; Rudel LL, 1998, ARTERIOSCL THROM VAS, V18, P1818, DOI 10.1161/01.ATV.18.11.1818; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Sekar S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46457; Sekar S, 2017, J CELL BIOCHEM, V118, P453, DOI 10.1002/jcb.25758; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Takada K, 2011, INT J EXP PATHOL, V92, P232, DOI 10.1111/j.1365-2613.2010.00758.x; Tan L, 2020, FASEB J, V34, P5818, DOI 10.1096/fj.201902746R; Tan L, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181473; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Vessby B, 2003, CURR OPIN LIPIDOL, V14, P15, DOI 10.1097/00041433-200302000-00004; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang YQ, 2001, CHINESE MED J-PEKING, V114, P723; Wu CL, 2015, ANN RHEUM DIS, V74, P2076, DOI 10.1136/annrheumdis-2014-205601; Xu X, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00203; Yammani RR, 2014, ARTHRITIS RHEUMATOL, V66, P1266, DOI 10.1002/art.38391	51	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247237	10.1371/journal.pone.0247237	http://dx.doi.org/10.1371/journal.pone.0247237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617553	gold, Green Published			2022-12-26	WOS:000623082400030
J	Kim, SH; Ju, HM; Choi, CH; Park, HR; Shin, S				Kim, Seung Hyun; Ju, Hyang Mi; Choi, Chong-Hyuck; Park, Hae Ri; Shin, Seokyung			Inhalational versus intravenous maintenance of anesthesia for quality of recovery in patients undergoing corrective lower limb osteotomy: A randomized controlled trial	PLOS ONE			English	Article								Background Inhalational anesthesia and propofol-based total intravenous anesthesia (TIVA) are the two most popular methods of general anesthesia with distinct characteristics that may affect quality of recovery (QOR) differently. This study compared QOR after corrective lower limb osteotomy between desflurane-based inhalational anesthesia and propofol-based TIVA. Methods Sixty-eight patients, ASA class I or II who underwent corrective lower limb osteotomy were randomized to receive either desflurane anesthesia or propofol TIVA. The primary outcome was quality of recovery 40 (QoR-40) questionnaire scores on postoperative day (POD) 1 and 2. Postoperative nausea scores, antiemetic requirements, and amount of opioid consumption via intravenous patient-controlled analgesia (IV PCA) were assessed as secondary outcomes. Results Global QoR-40 scores on POD 1 (153.5 (140.3, 171.3) vs. 140.0 (120.0, 173.0), P = 0.056, 95% CI; -22.5, 0.2) and POD 2 (155.5 (146.8, 175.5) vs. 152.0 (134.0, 179.0), P = 0.209, 95% CI; -17.5, 3.9) were comparable between the two groups. Among the five dimensions of QoR-40, physical independence scores were significantly higher in the TIVA group compared to the Desflurane group on POD both 1 and 2. Nausea scores (0.0 (0.0, 0.0) vs. 1.0 (0.0, 3.5), P < 0.001) and number of patients requiring rescue antiemetics (0% vs. 15.2%, P = 0.017) were significantly lower in the TIVA group at the post anesthesia care unit (PACU). Although the number of bolus attempts between 0-24 h and the morphine equivalent dose of analgesics administered via IV PCA between 12-24 h were significantly less in the TIVA group compared to the Desflurane group, there was no significant difference between groups for the overall 48 h postoperative period. Conclusions Propofol-based TIVA did not improve global QoR-40 scores compared with desflurane-based inhalational anesthesia. However, considering the better QoR-40 scores in the domain of physical independence and less nausea in the early postoperative period, propofol TIVA should be considered as a useful option in patients undergoing corrective lower limb osteotomy.	[Kim, Seung Hyun; Shin, Seokyung] Yonsei Univ, Severance Hosp, Coll Med, Dept Anesthesiol & Pain Med,Anesthesia & Pain Res, Seoul, South Korea; [Ju, Hyang Mi] Yonsei Univ, Yongin Severance Hosp, Coll Med, Anesthesia & Pain Res Inst,Dept Anesthesiol & Pai, Seoul, South Korea; [Choi, Chong-Hyuck] Yonsei Univ, Dept Orthoped Surg, Coll Med, Seoul, South Korea; [Park, Hae Ri] Yonsei Univ, Severance Hosp, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Shin, S (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Dept Anesthesiol & Pain Med,Anesthesia & Pain Res, Seoul, South Korea.	skshin@yuhs.ac		Shin, Seokyung/0000-0002-2641-0070; Choi, Chong Hyuk/0000-0002-9080-4904; Kim, Seung Hyun/0000-0003-2127-6324	Department of Anesthesiology, Yonsei University College of Medicine, Seoul, Republic of Korea	Department of Anesthesiology, Yonsei University College of Medicine, Seoul, Republic of Korea	This work was supported by the Department of Anesthesiology, Yonsei University College of Medicine, Seoul, Republic of Korea.	Chen Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004769; COETZEE JF, 1995, ANESTHESIOLOGY, V82, P1328, DOI 10.1097/00000542-199506000-00003; Dahl MT, 2019, J BONE JOINT SURG AM, V101, P1435, DOI 10.2106/JBJS.19.00584; de Carli D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228805; De Oliveira GS, 2017, J CLIN ANESTH, V43, P70, DOI 10.1016/j.jclinane.2017.10.001; Gao L, 2019, J EXP ORTHOP, V6, DOI 10.1186/s40634-019-0177-5; Gauger PG, 2008, WORLD J SURG, V32, P1525, DOI 10.1007/s00268-008-9472-5; Gilliland HE, 1997, ANESTH ANALG, V85, P1394, DOI 10.1097/00000539-199712000-00039; Gornall BF, 2013, BRIT J ANAESTH, V111, P161, DOI 10.1093/bja/aet014; Herling SF, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011387.pub2; Hosny GA, 2020, J ORTHOP TRAUMATOL, V21, DOI 10.1186/s10195-019-0541-3; Hu ZC, 2019, J ORTHOP SURG RES, V14, DOI 10.1186/s13018-019-1116-y; Jaensson M, 2019, PERIOPER MED-LONDON, V8, DOI 10.1186/s13741-019-0115-1; Lee A, 1996, ANAESTH INTENS CARE, V24, P685, DOI 10.1177/0310057X9602400610; Lee WK, 2015, BRIT J ANAESTH, V114, P663, DOI 10.1093/bja/aeu405; Liu TJ, 2019, INT FORUM ALLERGY RH, V9, P248, DOI 10.1002/alr.22246; Ljungqvist O, 2017, JAMA SURG, V152, P292, DOI 10.1001/jamasurg.2016.4952; Mancuso CA, 2001, J BONE JOINT SURG AM, V83A, P1005, DOI 10.2106/00004623-200107000-00005; Marana E, 2010, J CLIN ANESTH, V22, P250, DOI 10.1016/j.jclinane.2009.07.011; Minto CF, 1997, ANESTHESIOLOGY, V86, P24, DOI 10.1097/00000542-199701000-00005; Moro ET, 2016, J CLIN ANESTH, V35, P369, DOI 10.1016/j.jclinane.2016.08.022; Myles PS, 2020, ANAESTHESIA, V75, pE143, DOI 10.1111/anae.14786; Myles PS, 2016, ANESTHESIOLOGY, V125, P39, DOI 10.1097/ALN.0000000000001158; Myles PS, 2000, ANAESTH INTENS CARE, V28, P276, DOI 10.1177/0310057X0002800304; Myles PS, 2001, ANESTHESIOLOGY, V95, P862, DOI 10.1097/00000542-200110000-00013; Myles PS, 2000, BRIT J ANAESTH, V84, P11, DOI 10.1093/oxfordjournals.bja.a013366; Na SH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012699; Powell R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008646.pub2; Qiu Q, 2016, ANAESTHESIA, V71, P1222, DOI 10.1111/anae.13578; Schraag S, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0632-3; Soffin EM, 2016, BRIT J ANAESTH, V117, P62, DOI 10.1093/bja/aew362; Van Herck P, 2010, J EVAL CLIN PRACT, V16, P39, DOI 10.1111/j.1365-2753.2008.01111.x; Vishwanathan Karthik, 2017, Indian J Med Ethics, V2, P45; Visser K, 2001, ANESTHESIOLOGY, V95, P616, DOI 10.1097/00000542-200109000-00012; Wainwright TW, 2020, ACTA ORTHOP, V91, P3, DOI 10.1080/17453674.2019.1683790; Zaballos M, 2018, REV ESP ANEST REANIM, V65, P96, DOI 10.1016/j.redar.2017.09.010	36	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247089	10.1371/journal.pone.0247089	http://dx.doi.org/10.1371/journal.pone.0247089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606764	gold, Green Published			2022-12-26	WOS:000620629200135
J	Kwizera, A; Ntasumumuyange, D; Small, M; Rulisa, S; Moscovitz, AN; Magriples, U				Kwizera, Alfred; Ntasumumuyange, Diomede; Small, Maria; Rulisa, Stephen; Moscovitz, Alexandra N.; Magriples, Urania			Assessment of perinatal outcomes of pregnant women with severe versus simple malaria	PLOS ONE			English	Article							PLACENTAL MALARIA; MORTALITY; IMPACT	Objective Malaria in pregnancy is associated with adverse perinatal outcomes. The objective was to compare outcomes of simple and severe malaria and to determine whether they vary by trimester or severity of infection. Methods Prospective cohort study performed in 3 hospitals in Rwanda. Both hospitalized and non-hospitalized pregnant patients with confirmed malaria were enrolled and followed until 7 days postpartum. Demographic, clinical manifestations and perinatal outcomes were recorded. Results There were 446 pregnant women with confirmed malaria and outcome data; 361 (80.9%) had simple malaria. Severe malaria was more common as pregnancy progressed; out of 85 with severe malaria, 12.9%, 29.4% and 57.6% were in the 1(st), 2(nd) and 3(rd) trimesters (p<0.0001). Overall, a normal term delivery occurred in 57.6%, with preterm delivery in 24.9% and abortion in 13.5%. Adverse perinatal outcomes increased with trimester of infection (p<0.0001). Eight of the 9 early neonatal deaths had 3(rd) trimester infection (p<0.0001). There were 27 stillbirths; 63.7% were associated with 3(rd) trimester infection. A significant difference in perinatal outcomes between simple and severe malaria was seen: 64% of women with simple malaria had a normal term delivery as compared to 30.6% with severe malaria (p<0.0001). All complications were significantly greater with severe malaria. Conclusion Overall poor outcomes are seen in malaria with significant differences in perinatal outcomes between simple and severe malaria and by trimester of infection. In addition to vector control and exposure prevention, efforts need to be made in screening, treatment education and monitoring pregnancies affected by malaria.	[Kwizera, Alfred; Ntasumumuyange, Diomede; Small, Maria; Rulisa, Stephen; Magriples, Urania] Univ Rwanda, Dept Obstet & Gynecol, Coll Med & Hlth Sci, Kigali, Rwanda; [Kwizera, Alfred; Ntasumumuyange, Diomede; Small, Maria; Rulisa, Stephen; Magriples, Urania] Univ Teaching Hosp Kigali, Kigali, Rwanda; [Small, Maria; Magriples, Urania] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06510 USA; [Small, Maria] Duke Univ, Sch Med, Dept Obstet & Gynecol, Durham, NC USA; [Moscovitz, Alexandra N.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	University of Rwanda; Yale University; Duke University; Columbia University	Magriples, U (corresponding author), Univ Rwanda, Dept Obstet & Gynecol, Coll Med & Hlth Sci, Kigali, Rwanda.; Magriples, U (corresponding author), Univ Teaching Hosp Kigali, Kigali, Rwanda.; Magriples, U (corresponding author), Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06510 USA.	urania.magriples@yale.edu		MAGRIPLES, URANIA/0000-0002-9619-0165				[Anonymous], PRESIDENTS MALARIA I; [Anonymous], MATERNAL HLTH TASK F; [Anonymous], 2018, WORLD MALARIA REPORT; Bardaji A, 2011, J INFECT DIS, V203, P691, DOI 10.1093/infdis/jiq049; De Beaudrap P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-139; Desai M, 2018, LANCET INFECT DIS, V18, pE119, DOI 10.1016/S1473-3099(18)30064-1; Gonzalez R, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011444.pub3; Karema C, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03407-1; Kovacs SD, 2015, DRUG SAFETY, V38, P165, DOI 10.1007/s40264-014-0261-9; McDermott JM, 1996, AM J TROP MED HYG, V55, P61, DOI 10.4269/ajtmh.1996.55.61; Ministry of Health of Rwanda, RWANDA INTERIM DEMOG; Moore Kerryn A, 2017, Lancet Glob Health, V5, pe1101, DOI 10.1016/S2214-109X(17)30340-6; National Institute of Statistics of Rwanda (NISR) [Rwanda] Ministry of Health (MOH) [Rwanda] and ICF International ., 2015, RWANDA DEMOGRAPHIC H; Ndeserua R, 2015, AFR HEALTH SCI, V15, P810, DOI 10.4314/ahs.v15i3.15; Rogerson SJ, 2018, LANCET INFECT DIS, V18, pE107, DOI 10.1016/S1473-3099(18)30066-5; Rulisa S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-194; Saba N, 2008, GOMAL J MED SCI, V6, P98; Schantz-Dunn Julianna, 2009, Rev Obstet Gynecol, V2, P186; Sethi R, ROUTINE ANTENATAL CA; Thompson JM, 2020, J TROP PEDIATRICS, V66, P327, DOI 10.1093/tropej/fmz068; Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35, DOI 10.4269/ajtmh.2004.71.35; WHO, 2015, GUIDELINES TREATMENT, V3rd; WHO Regional Strategy on Sexual and Reproductive Health, 2001, DEF IND FAM PLANN MA	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247053	10.1371/journal.pone.0247053	http://dx.doi.org/10.1371/journal.pone.0247053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606775	Green Published, gold			2022-12-26	WOS:000620629200085
J	Saito, K; Sugawara, H; Ichihara, K; Watanabe, T; Ishii, A; Fukuchi, T				Saito, Kai; Sugawara, Hitoshi; Ichihara, Kiyoshi; Watanabe, Tamami; Ishii, Akira; Fukuchi, Takahiko			Prediction of 72-hour mortality in patients with extremely high serum C-reactive protein levels using a novel weighted average of risk scores	PLOS ONE			English	Article								The risk factors associated with mortality in patients with extremely high serum C-reactive protein (CRP) levels are controversial. In this retrospective single-center cross-sectional study, the clinical and laboratory data of patients with CRP levels >= 40 mg/dL treated in Saitama Medical Center, Japan from 2004 to 2017 were retrieved from medical records. The primary outcome was defined as 72-hour mortality after the final CRP test. Forty-four mortal cases were identified from the 275 enrolled cases. Multivariate logistic regression analysis (MLRA) was performed to explore the parameters relevant for predicting mortality. As an alternative method of prediction, we devised a novel risk predictor, "weighted average of risk scores" (WARS). WARS features the following: (1) selection of candidate risk variables for 72-hour mortality by univariate analyses, (2) determination of C-statistics and cutoff value for each variable in predicting mortality, (3) 0-1 scoring of each risk variable at the cutoff value, and (4) calculation of WARS by weighted addition of the scores with weights assigned according to the C-statistic of each variable. MLRA revealed four risk variables associated with 72-hour mortality-age, albumin, inorganic phosphate, and cardiovascular disease-with a predictability of 0.829 in C-statistics. However, validation by repeated resampling of the 275 records showed that a set of predictive variables selected by MLRA fluctuated occasionally because of the presence of closely associated risk variables and missing data regarding some variables. WARS attained a comparable level of predictability (0.837) by combining the scores for 10 risk variables, including age, albumin, electrolytes, urea, lactate dehydrogenase, and fibrinogen. Several mutually related risk variables are relevant in predicting 72-hour mortality in patients with extremely high CRP levels. Compared to conventional MLRA, WARS exhibited a favorable performance with flexible coverage of many risk variables while allowing for missing data.	[Saito, Kai] Nara Med Univ, Kashihara, Nara, Japan; [Sugawara, Hitoshi; Watanabe, Tamami; Ishii, Akira; Fukuchi, Takahiko] Jichi Med Univ, Saitama Med Ctr, Dept Comprehens Med 1, Div Gen Med, Saitama, Japan; [Ichihara, Kiyoshi] Yamaguchi Univ, Fac Hlth Sci, Grad Sch Med, Ube, Yamaguchi, Japan	Nara Medical University; Jichi Medical University; Yamaguchi University	Sugawara, H (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Comprehens Med 1, Div Gen Med, Saitama, Japan.	hsmdfacp@jichi.ac.jp	Sugawara, Hitoshi/Y-5081-2019	Sugawara, Hitoshi/0000-0002-5060-9020	JSPS KAKENHI [26460916]; Pfizer Japan Academic Contribution 2017; Pfizer Japan Academic Contribution 2018; Pfizer Japan Academic Contribution 2019; Astellas Research Support [RS2017A000020, RS2018A000782]; Daiichi Sankyo Research Support Program 2018	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Pfizer Japan Academic Contribution 2017; Pfizer Japan Academic Contribution 2018; Pfizer Japan Academic Contribution 2019; Astellas Research Support(Astellas Pharmaceuticals); Daiichi Sankyo Research Support Program 2018	This work was supported by JSPS KAKENHI (Grant Number: 26460916), Pfizer Japan Academic Contribution 2017, 2018, and 2019, Astellas Research Support (Grant Numbers: RS2017A000020 and RS2018A000782), and Daiichi Sankyo Research Support Program 2018. HS received these grant awards. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Boncler M, 2019, MOLECULES, V24, DOI 10.3390/molecules24112062; Cai ZY, 2019, INT J NEUROSCI, V129, P423, DOI 10.1080/00207454.2018.1538139; Chapman CN, 2011, CANCER CYTOPATHOL, V119, P148, DOI 10.1002/cncy.20158; CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Goltzman G, 2019, ISR MED ASSOC J, V21, P686; Hajek V, 2011, REV MED INTERNE, V32, P663, DOI 10.1016/j.revmed.2011.04.001; Heo NY, 2012, J MED CASES, V3, P370; Ichihara K, 2010, CLIN CHEM LAB MED, V48, P1537, DOI 10.1515/CCLM.2010.319; Jellinge ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105983; Karasahin O, 2018, AGING CLIN EXP RES, V30, P555, DOI 10.1007/s40520-017-0821-9; Kaur Mandeep, 2017, Int J Appl Basic Med Res, V7, P83, DOI 10.4103/ijabmr.IJABMR_63_17; Kaya Z, 2014, TURK J HEMATOL, V31, P49, DOI 10.4274/Tjh.2013.0057; Lasika RADR., 2015, GALLE MED J, V20, P34; Lelubre C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/124021; Levitt DG, 2016, INT J GEN MED, V9, P229, DOI 10.2147/IJGM.S102819; Llor C, 2012, AM J RESP CRIT CARE, V186, P716, DOI 10.1164/rccm.201206-0996OC; Lucero Robert J, 2015, AJOB Empir Bioeth, V6, P12; LUNDBERG GD, 1990, JAMA-J AM MED ASSOC, V263, P709, DOI 10.1001/jama.263.5.709; Mager A, 2019, ISR MED ASSOC J, V21, P747; Meystre S M, 2017, Yearb Med Inform, V26, P38, DOI 10.15265/IY-2017-007; Miravitlles M, 2013, CHEST, V144, P1571, DOI 10.1378/chest.13-0518; Naffaa ME, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1094-6; Nanasaki Y., 2017, J JAPANESE SOC EMERG, V20, P489; Onal Ozkan, 2016, Anesth Pain Med, V6, pe32509, DOI 10.5812/aapm.32509; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; PUTTO A, 1986, ARCH DIS CHILD, V61, P24, DOI 10.1136/adc.61.1.24; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Ryu JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138150; Shaikh N, 2014, JAMA PEDIATR, V168, P893, DOI 10.1001/jamapediatrics.2014.637; Shaikh N, 2012, J UROLOGY, V188, P1895, DOI 10.1016/j.juro.2012.07.013; SHELL W, 1981, AM HEART J, V102, P335, DOI 10.1016/0002-8703(81)90306-9; Shrotriya S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202555; Silvestre J, 2009, INTENS CARE MED, V35, P909, DOI 10.1007/s00134-009-1402-y; Siregar NN, 2018, J ASEAN FED ENDOCR S, V33, P124, DOI 10.15605/jafes.033.02.03; Sproston NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00754; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Sugawara H., 2019, P P 17 AM COLL PHYS; Suki Wadi N, 2016, Methodist Debakey Cardiovasc J, V12, P6, DOI 10.14797/mdcj-12-4s1-6; Sullivan DH, 2018, J NUTR HEALTH AGING, V22, P759, DOI 10.1007/s12603-018-1065-x; Toss H, 1997, CIRCULATION, V96, P4204; Tsalik EL, 2012, J EMERG MED, V43, P97, DOI 10.1016/j.jemermed.2011.05.072; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; Wernly B, 2018, CLIN HEMORHEOL MICRO, V69, P123, DOI 10.3233/CH-189111; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Xiao XG, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016238; Zhou L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12733	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246259	10.1371/journal.pone.0246259	http://dx.doi.org/10.1371/journal.pone.0246259			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606735	Green Published, gold			2022-12-26	WOS:000620629200001
J	Sakuta, S; Hashimoto, M; Ikeda, M; Koyama, A; Takasaki, A; Hotta, M; Fukuhara, R; Ishikawa, T; Yuki, S; Miyagawa, Y; Hidaka, Y; Kaneda, K; Takebayashi, M				Sakuta, Shizuka; Hashimoto, Mamoru; Ikeda, Manabu; Koyama, Asuka; Takasaki, Akihiro; Hotta, Maki; Fukuhara, Ryuji; Ishikawa, Tomohisa; Yuki, Seiji; Miyagawa, Yusuke; Hidaka, Yosuke; Kaneda, Keiichiro; Takebayashi, Minoru			Clinical features of behavioral symptoms in patients with semantic dementia: Does semantic dementia cause autistic traits?	PLOS ONE			English	Article							FRONTOTEMPORAL DEMENTIA; MIND IMPAIRMENTS; TEMPORAL POLE; DEGENERATION; INVENTORY; INTERVIEW	Objective To investigate the behavioral characteristics of semantic dementia (SD) using an instrument originally developed for patients with autism spectrum disorder. Methods The behavioral symptoms of 20 patients with SD and 20 patients with Alzheimer's disease (AD) in both the preclinical state and the dementia state were evaluated using the Pervasive Developmental Disorders Autism Society Japan Rating Scale (PARS). Results The SD group showed high prevalence in four behaviors related to stereotypy and social impairment: eating very few food items, selfishness, difficulty in recognizing others' feeling and thoughts, and interpreting language literally. Scores on the PARS short version, which is sensitive for diagnosis of autism spectrum disorder, were significantly higher in the dementia state than in the preclinical state in both the SD (11.5 +/- 6.0 and 1.7 +/- 2.5, respectively; t (19) = 6.7, p < 0.001) and AD (6.9 +/- 4.6 and 1.7 +/- 2.0, respectively; t (19) = 5.1, p < 0.001) groups. PARS short version scores after dementia onset increased in both the SD and AD groups, although the increase was significantly larger in the SD group (F = 5.6, p = 0.023). Additionally, a significantly higher rate of patients exceeded the cutoff score for autism diagnosis in the dementia state in the SD group (75%) than in the AD group (40%; chi(2) = 5.0, p = 0.025). PARS scores in the dementia state were significantly correlated with illness duration (r = 0.46, p = 0.04) and Mini-Mental State Examination scores (r = -0.75, p < 0.001) in the SD group only. Conclusions Although SD and autism spectrum disorder are etiologically distinct diseases, patients with semantic dementia behave like those with autism spectrum disorder. Our findings suggest the symptomatic similarity of the two disorders.	[Sakuta, Shizuka; Takasaki, Akihiro; Hotta, Maki; Hidaka, Yosuke] Kumamoto Univ, Grad Sch Med Sci, Kumamoto, Japan; [Hashimoto, Mamoru; Koyama, Asuka; Takebayashi, Minoru] Kumamoto Univ, Fac Life Sci, Dept Neuropsychiat, Kumamoto, Japan; [Hashimoto, Mamoru; Ikeda, Manabu] Osaka Univ, Dept Psychiat, Grad Sch Med, Suita, Osaka, Japan; [Takasaki, Akihiro; Fukuhara, Ryuji; Ishikawa, Tomohisa; Yuki, Seiji; Miyagawa, Yusuke] Kumamoto Univ Hosp, Dept Neuropsychiat, Kumamoto, Japan; [Hotta, Maki] Osaka Univ, Dept Behav Neurol & Neuropsychiat, United Grad Sch Child Dev, Suita, Osaka, Japan; [Kaneda, Keiichiro] Kumamoto Seimei Hosp, Kumamoto, Japan; [Takebayashi, Minoru] Natl Hosp Org, Inst Clin Res, Div Psychiat & Neurosci, Kure Med Ctr, Kure, Hiroshima, Japan; [Takebayashi, Minoru] Chugoku Canc Ctr, Kure, Hiroshima, Japan; [Sakuta, Shizuka] Esaka Hosp, Suita, Osaka, Japan	Kumamoto University; Kumamoto University; Osaka University; Kumamoto University; Osaka University	Hashimoto, M (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Neuropsychiat, Kumamoto, Japan.; Hashimoto, M (corresponding author), Osaka Univ, Dept Psychiat, Grad Sch Med, Suita, Osaka, Japan.	mhashimoto@psy.med.osaka-u.ac.jp		Sakuta, Shizuka/0000-0002-1920-165X	JSPS KAKENHI [JP17K10310]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant number JP17K10310 for MH. https://www.jsps.go.jp/j-grantsinaid/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J., 2008, SEISHIN IGAKU, V50, P431, DOI DOI 10.1037/T68535-000; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Bozeat S, 2000, J NEUROL NEUROSUR PS, V69, P178, DOI 10.1136/jnnp.69.2.178; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Cetin I, 2017, NOROPSIKIYATRI ARS, V54, P267, DOI 10.5152/npa.2017.14873; Collins JA, 2017, BRAIN, V140, P457, DOI 10.1093/brain/aww313; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Diehl-Schmid J, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0489-x; Duval C, 2012, BRAIN, V135, P228, DOI 10.1093/brain/awr309; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Hsieh S, 2016, J ALZHEIMERS DIS, V49, P875, DOI 10.3233/JAD-150475; Ikeda M, 2002, J NEUROL NEUROSUR PS, V73, P371, DOI 10.1136/jnnp.73.4.371; Imai M., 2014, J YOKOHAMA CITY REHA, V23, P41; Irish M, 2014, BRAIN, V137, P1241, DOI 10.1093/brain/awu003; Ito H, 2012, RES AUTISM SPECT DIS, V6, P1265, DOI 10.1016/j.rasd.2012.04.002; Kamio Y., 2006, SEISHINIGAKU, V48, P495; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lu PH, 2014, J ALZHEIMERS DIS, V39, P261, DOI 10.3233/JAD-131481; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Midorikawa A, 2012, DEMENT GER COGN D EX, V2, P180, DOI 10.1159/000338174; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Pagnozzi AM, 2018, INT J DEV NEUROSCI, V71, P68, DOI 10.1016/j.ijdevneu.2018.08.010; Pascual-Belda A, 2018, DIAGNOSTICS, V8, DOI 10.3390/diagnostics8030051; Pereira AM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00539; Ralph MAL, 2008, ANN NY ACAD SCI, V1124, P61, DOI 10.1196/annals.1440.006; Rankin KP, 2009, NEUROIMAGE, V47, P2005, DOI 10.1016/j.neuroimage.2009.05.077; Rohrer JD, 2011, BRAIN, V134, P2565, DOI 10.1093/brain/awr198; Rosen HJ, 2006, NEUROLOGY, V67, P1752, DOI 10.1212/01.wnl.0000247630.29222.34; Shigenobu K, 2002, PSYCHIAT RES, V110, P175, DOI 10.1016/S0165-1781(02)00094-X; Snowden JS, 2001, J NEUROL NEUROSUR PS, V70, P323, DOI 10.1136/jnnp.70.3.323; Whitwell JL, 2012, CURR NEUROL NEUROSCI, V12, P715, DOI 10.1007/s11910-012-0317-0; Zablotsky Benjamin, 2015, Natl Health Stat Report, P1	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247184	10.1371/journal.pone.0247184	http://dx.doi.org/10.1371/journal.pone.0247184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8JB	33600474	Green Published, gold			2022-12-26	WOS:000620625100014
J	Agurto, C; Heisig, S; Abrami, A; Ho, BK; Caggiano, V				Agurto, Carla; Heisig, Stephen; Abrami, Avner; Ho, Bryan K.; Caggiano, Vittorio			Parkinson's disease medication state and severity assessment based on coordination during walking	PLOS ONE			English	Article								Walking is a complex motor function requiring coordination of all body parts. Parkinson's disease (PD) motor signs such as rigidity, bradykinesia, and impaired balance affect movements including walking. Here, we propose a computational method to objectively assess the effects of Parkinson's disease pathology on coordination between trunk, shoulder and limbs during the gait cycle to assess medication state and disease severity. Movements during a scripted walking task were extracted from wearable devices placed at six different body locations in participants with PD and healthy participants. Three-axis accelerometer data from each device was synchronized at the beginning of either left or right steps. Canonical templates of movements were then extracted from each body location. Movements projected on those templates created a reduced dimensionality space, where complex movements are represented as discrete values. These projections enabled us to relate the body coordination in people with PD to disease severity. Our results show that the velocity profile of the right wrist and right foot during right steps correlated with the participant's total score on the gold standard Unified Parkinson's Disease Rating Scale (UPRDS) with an r(2) up to 0.46. Left-right symmetry of feet, trunk and wrists also correlated with the total UPDRS score with an r(2) up to 0.3. In addition, we demonstrate that binary dopamine replacement therapy medication states (self-reported 'ON' or 'OFF') can be discriminated in PD participants. In conclusion, we showed that during walking, the movement of body parts individually and in coordination with one another changes in predictable ways that vary with disease severity and medication state.	[Agurto, Carla; Heisig, Stephen; Abrami, Avner; Caggiano, Vittorio] IBM Res Healthcare & Life Sci, Yorktown Hts, NY 10598 USA; [Ho, Bryan K.] Dept Neurol, Boston, MA USA; [Heisig, Stephen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Caggiano, Vittorio] Facebook AI Res, New York, NY 10003 USA	Icahn School of Medicine at Mount Sinai; Facebook Inc	Caggiano, V (corresponding author), IBM Res Healthcare & Life Sci, Yorktown Hts, NY 10598 USA.; Caggiano, V (corresponding author), Facebook AI Res, New York, NY 10003 USA.	caggiano@gmail.com		Caggiano, Vittorio/0000-0002-2186-1550	IBM Inc.; Pfizer Inc.; Tufts University School of Medicine	IBM Inc.; Pfizer Inc.(Pfizer); Tufts University School of Medicine	Tufts University School of Medicine was the sponsor. IBM Inc. and Pfizer Inc. funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64181-3; Ausborn J, 2019, ELIFE, V8, DOI 10.7554/eLife.43587; Bonato P, 2010, IEEE ENG MED BIOL, V29, P25, DOI 10.1109/MEMB.2010.936554; Bruijn SM, 2010, J EXP BIOL, V213, P3945, DOI 10.1242/jeb.045112; Caggiano V, 2018, NATURE, V553, P455, DOI 10.1038/nature25448; Cancela J, 2014, SENSORS-BASEL, V14, P4618, DOI 10.3390/s140304618; Chia N, 2018, MOVEMENT DISORD, V33, pS511; Del Din S, 2016, IEEE J BIOMED HEALTH, V20, P838, DOI 10.1109/JBHI.2015.2419317; Del Din S, 2016, MOVEMENT DISORD, V31, P1293, DOI 10.1002/mds.26718; Dietz V, 2008, BRAIN, V131, P3421, DOI 10.1093/brain/awn263; Djaldetti R, 2006, LANCET NEUROL, V5, P796, DOI 10.1016/S1474-4422(06)70549-X; Donker SF, 2001, J MOTOR BEHAV, V33, P86, DOI 10.1080/00222890109601905; Drew T, 2004, PROG BRAIN RES, V143, P251, DOI 10.1016/S0079-6123(03)43025-2; Erb MK, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-019-0214-x; Erb MK., 2018, MOV DISORD, V33, P2018; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Herman T, 2014, J NEUROL, V261, P2401, DOI 10.1007/s00415-014-7513-6; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Huang XM, 2012, GAIT POSTURE, V35, P373, DOI 10.1016/j.gaitpost.2011.10.180; Josset N, 2018, CURR BIOL, V28, P884, DOI 10.1016/j.cub.2018.02.007; Kagawa T, 2010, HUM MOVEMENT SCI, V29, P964, DOI 10.1016/j.humov.2010.03.007; Lewek MD, 2010, GAIT POSTURE, V31, P256, DOI 10.1016/j.gaitpost.2009.10.013; Li HQ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16053-7; Lin Cheng-Chieh, 2018, J Phys Ther Sci, V30, P658, DOI 10.1589/jpts.30.658; Mancini M, 2016, EXPERT REV MED DEVIC, V13, P455, DOI 10.1586/17434440.2016.1153421; Mazzoni P, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009282; Mirelman A., 2019, LANCET NEUROL, DOI [10.1016/S1474-4422%2819%2930044-4, DOI 10.1016/S1474-4422%2819%2930044-4]; Monje MHG, 2019, ANNU REV BIOMED ENG, V21, P111, DOI 10.1146/annurev-bioeng-062117-121036; Mori F, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00109; Nanhoe-Mahabier W, 2011, NEUROSCIENCE, V182, P217, DOI 10.1016/j.neuroscience.2011.02.061; Parisi F, 2015, IEEE J BIOMED HEALTH, V19, P1777, DOI 10.1109/JBHI.2015.2472640; Park K, 2012, GAIT POSTURE, V36, P120, DOI 10.1016/j.gaitpost.2012.01.016; Penko AL, 2014, CLIN BIOMECH, V29, P1089, DOI 10.1016/j.clinbiomech.2014.10.006; Popovic D., 2008, J AUTOM CONTROL, V18, P11, DOI [10.2298/JAC0802011P, DOI 10.2298/JAC0802011P]; Post B, 2005, MOVEMENT DISORD, V20, P1577, DOI 10.1002/mds.20640; Rodriguez-Molinero A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00431; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Roemmich RT, 2013, CLIN BIOMECH, V28, P93, DOI 10.1016/j.clinbiomech.2012.09.005; Sant'Anna A, 2011, IEEE T BIO-MED ENG, V58, P2127, DOI 10.1109/TBME.2011.2149521; Schlachetzki JCM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183989; Schneider SA, 2012, MOVEMENT DISORD, V27, P1563, DOI 10.1002/mds.25161; Skog I, 2010, IEEE T BIO-MED ENG, V57, P2657, DOI 10.1109/TBME.2010.2060723; Spasojevic S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00388; Sterling NW, 2015, J PARKINSON DIS, V5, P141, DOI 10.3233/JPD-140447; Takakusaki K, 2004, NEUROSCI RES, V50, P137, DOI 10.1016/j.neures.2004.06.015; Thevathasan W, 2018, MOVEMENT DISORD, V33, P10, DOI 10.1002/mds.27098; Weiss A, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/547065; Weiss A, 2011, NEUROREHAB NEURAL RE, V25, P810, DOI 10.1177/1545968311424869; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3	49	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0244842	10.1371/journal.pone.0244842	http://dx.doi.org/10.1371/journal.pone.0244842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596202	Green Published, gold			2022-12-26	WOS:000620633200012
J	Espinet, AN; Huet, T; Trentacoste, A; Guimaraes, S; Orengo, H; Valenzuela-Lamas, S				Nieto Espinet, Ariadna; Huet, Thomas; Trentacoste, Angela; Guimaraes, Silvia; Orengo, Hector; Valenzuela-Lamas, Silvia			Resilience and livestock adaptations to demographic growth and technological change: A diachronic perspective from the Late Bronze Age to Late Antiquity in NE Iberia	PLOS ONE			English	Article							ANIMAL HUSBANDRY; HISPANIA-TARRACONENSIS; IRON-AGE; PIGS; CATTLE; SHEEP	There are strong interactions between an economic system and its ecological context. In this sense, livestock have been an integral part of human economies since the Neolithic, contributing significantly to the creation and maintenance of agricultural anthropized landscapes. For this reason, in the frame of the ERC-StG project 'ZooMWest' we collected and analyzed thousands of zooarchaeological data from NE Iberia. By considering these data in comparison with ecological indicators (archaeobotanical remains) and archaeological evidence (settlement characteristics and their distribution) this paper seeks to characterize changes in animal production and the relationship between people, livestock, and their environment. These methods allow for an investigation of the topic at different scales (site, zone, territory) with a broad diachronic perspective, and for consideration of orography and cultural traditions alongside climatic factors. Through this integration of various streams of evidence, we aim to better understand the structure of ancient economic systems and the way they conditioned human decision-making on animal production. Results show a shifting relationship with the territory between the Bronze Age and Late Antiquity, in which market requirements and an economic model with a higher degree of integration increasingly influenced husbandry strategies. These processes are reflected in changes in land use and forms of territorial occupation, although along different rhythms and trajectories.	[Nieto Espinet, Ariadna; Guimaraes, Silvia; Valenzuela-Lamas, Silvia] Inst Mila & Fontanals, Archaeol Social Dynam, Consejo Super Invest Cient CSIC, Barcelona, Spain; [Huet, Thomas] Archeol Soc Mediterraneennes, CNRS UMR 5140, Montpellier, France; [Trentacoste, Angela] Univ Oxford, Inst Archaeol, Oxford, England; [Guimaraes, Silvia] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Vairao, Portugal; [Orengo, Hector] Inst Catala Arqueol Class ICAC, Tarragona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institucion Mila y Fontanals (IMF); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); University of Oxford; Universidade do Porto	Espinet, AN (corresponding author), Inst Mila & Fontanals, Archaeol Social Dynam, Consejo Super Invest Cient CSIC, Barcelona, Spain.	arinietoespinet@gmail.com	Orengo, Hector A./S-3955-2018; Nieto Espinet, Ariadna/AHE-7861-2022; Valenzuela-Lamas, Silvia/AAH-5668-2020	Orengo, Hector A./0000-0002-9385-2370; Nieto Espinet, Ariadna/0000-0001-6038-995X; Valenzuela-Lamas, Silvia/0000-0001-9886-0372; Thomas, Huet/0000-0002-1112-6122; Guimaraes, Silvia/0000-0002-3778-3315; Trentacoste, Angela/0000-0001-7096-5252	ERC-Starting Grant ZooMWest - Zooarchaeology and Mobility in the Western Mediterranean: Husbandry production from the Late Bronze Age to the Late Antiquity [716298]; European Research Council Agency (ERCEA); MOBICEX (Ministerio de Ciencia e Innovacion) [PID2019-110022GB -100]; GRC-Archaeology of Social Dynamics (ASD)-CSIC (Generalitat de Catalunya) [2017 SGR 995]	ERC-Starting Grant ZooMWest - Zooarchaeology and Mobility in the Western Mediterranean: Husbandry production from the Late Bronze Age to the Late Antiquity; European Research Council Agency (ERCEA); MOBICEX (Ministerio de Ciencia e Innovacion); GRC-Archaeology of Social Dynamics (ASD)-CSIC (Generalitat de Catalunya)	This work was financially supported by the ERC-Starting Grant ZooMWest - Zooarchaeology and Mobility in the Western Mediterranean: Husbandry production from the Late Bronze Age to the Late Antiquity (award number 716298), funded by the European Research Council Agency (ERCEA) under the direction of Silvia Valenzuela-Lamas. In cooperation with PID2019-110022GB -100 MOBICEX (Ministerio de Ciencia e Innovacion, ES); 2017 SGR 995-GRC-Archaeology of Social Dynamics (ASD)-CSIC (Generalitat de Catalunya, ES). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 1993, AVAN PRELIMINAR ESTU; Agusti B., 2002, 12 C ARQ PUIGC PUIGC, P591; Albarella U, 2005, J ARCHAEOL SCI, V32, P589, DOI 10.1016/j.jas.2004.11.008; Allen M, 2011, SUSSEX ARCHAEOLOGICA, V149, P7, DOI [10.5284/1000334, DOI 10.5284/1000334]; Alonso N, 1996, REV ARQUEOLOGIA PONE, P183; Alonso N, 1999, LLAVOR FARINA ELS PR; Alonso N., 2012, CHANGES VEGETATION F, P85; Alonso N., 2015, ANUARIO FACULTAD GEO; Altuna J., 1980, MUNIBE ANTROPOLOGIA, P9; [Anonymous], 2017, EXPLORATORY MULTIVAR; Antolin F., 2015, ESTUDIS HIST AGRARIA, P43; Arrayas I, 2007, PYRENAE, P47; Artigues PL, 2011, ARQUEOLOGIA MEDIEVAL, P8; Asensio D., 1998, IBEROS PRINCIPES OCC, P373; Aubet ME, 1993, POBLAMENT IBERIC CAT, P21; Audoin-Rouzeau F., 1991, FICHES OSTEOL ARCHEO, V3, P3; B?k?nyi S., 1974, HIST DOMESTIC MAMMAL; Banaji J., 2002, AGRARIAN CHANGE LATE; Barbera J., 2005, MON IB PAIS CAT 13 C, P597; Beck HE, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.214; Belarte MC., 2000, ASSENTAMENT BRONZE F; Belarte MC., 2020, ARQUEOMEDITERRANIA, P125; Belarte MC., 2001, REV PREHISTORIA ANTI, P57; Belarte MC., 1997, QUADERNS PREHISTORIA, P7; Bertoncello F., 2011, VARIABILITES ENV MUT, P175; Boone JL, 2002, WORLD ARCHAEOL, V34, P6, DOI 10.1080/00438240220134232; Breuer G., 1999, JAHRESBERICHTE AUGST, V20, P207, DOI 10.5169/seals-395607; Burch J, 1996, REV ARQUEOLOGIA PONE, P207; Buxo R., 1999, REV ARQUEOLOGIA PONE, P7; Carrete J-M., 1995, J ROMAN ARCHAEOLOG S; Casas J, 1995, MON RURAL EPOCA ROMA; Castanyer P., 2016, SEM PAL LIT MED IB E; Castellano Aragones A., 2014, INTRO TORN PLANA OCC; Chavarria A., 1998, ANN I ESTUDIES GIRON, V39, P9; Chavarria A., 2006, VILLAS TARDOANTIGUAS; Chavarria A, 2007, FINAL VILLAE HISPANI; Chavarria A, 2001, ARQUEOLOGIA TERRITOR, V8, P55, DOI [10.17561/aytm.v8i0.1673, DOI 10.17561/AYTM.V8I0.1673]; Christie N, 2017, LANDSCAPES CHANGE RU; Clutton-Brock J, 1981, DOMESTICATED ANIMALS; Coll JM., 2011, ACT 4 C ARQ MED MOD, P161; Collis J., 2003, EUROPEAN IRON AGE; Colominas L., 2013, ARQUEOZOOLOG A ROMAN; Colominas L, 2017, EUR J ARCHAEOL, V20, P510, DOI 10.1017/eaa.2016.30; Colominas L, 2017, ARCHAEOFAUNA, V26, P9; Colominas L, 2014, ARCHAEOL ANTHROP SCI, V6, P1, DOI 10.1007/s12520-013-0116-9; Connor SE, 2019, HOLOCENE, V29, P886, DOI 10.1177/0959683619826652; Cunliffe B., 2018, THE ANCIENT CELTS, VSecond Edition; Curras Dominguez A., 2012, ESTUDIO EVOLUCION PA; Davis SJM, 1996, J ARCHAEOL SCI, V23, P593, DOI 10.1006/jasc.1996.0056; DAVIS SJM, 1981, PALEOBIOLOGY, V7, P101, DOI 10.1017/S0094837300003821; Davis SJM, 1988, ARCHAEOLOGY ANIMALS; De Rensis F, 2003, THERIOGENOLOGY, V60, P1139, DOI 10.1016/S0093-691X(03)00126-2; Decandia M, 2008, DAIRY GOATS FEEDING AND NUTRITION, P161, DOI 10.1079/9781845933487.0161; Dehesa R., 2011, TRIBUNA ARQUEOLOGIA, V2011, P9; Dietler M., 2010, FEASTS, V1; Dupieux N., 1998, GESTION CONSERVATOIR; Duval C, 2018, GALLIA, V75, P141, DOI 10.4000/gallia.3904; Duval C., 2012, GALLIA, V69, P79; Duval C., 2017, NOUVELLES LARCHEOLOG, P56, DOI [10.4000/nda.3730, DOI 10.4000/NDA.3730]; Eisenmann V, 1984, B MUSEUM NATL HIST N, P185; Fatas G., 1987, FONAMENTS PREHISTORI, P11; Ferguson B., 1984, WARFARE CULTURE ENV; Ferrer C., MODELS DOCUPACI TRAN; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Folch C, 2005, ANN I ESTUDIS GIRONI, P37; Forest V., 2002, GALLIA, V59, P273; Frances J., 2005, RAP, P59; Frances J., 1998, CYPSELA, P31; Fremondeau D, 2017, EUR J ARCHAEOL, V20, P494, DOI 10.1017/eaa.2016.10; Gailledrat E., 2014, ESPACES COLONIAUX IN, DOI [10.1038/gt.2013.82, DOI 10.1038/GT.2013.82]; Garces I., 2020, J ARCHAEOLOGICAL SCI, V30, DOI [10.1016/j.jasrep.2019.102173, DOI 10.1016/J.JASREP.2019.102173]; Garcia D., 1987, REV ARCHEOLOGIQUE NA, V20, P43, DOI [10.3406/ran.1987.1306, DOI 10.3406/RAN.1987.1306]; Garcia D, 2000, EC RESEAU URBAIN PRO, P69; Garcia-Alonso F., 2004, CIRCULACIO AMFORES M, P191; Garcia-Ispierto I, 2007, THERIOGENOLOGY, V67, P1379, DOI 10.1016/j.theriogenology.2007.02.009; Garcia-Rubert D., 1999, RAP, P131; Gardes P., 2001, ENTRE CELTAS BEROS P, P161; Gibson DB., 1995, CELTIC CHIEFDOM CELT, P13; Gil I., 2001, ARCH ESPANOL ARQUEOL, V74, P161, DOI [10.3989/aespa.2001.v74.152, DOI 10.3989/AESPA.2001.V74.152]; Graells R., 2004, RAP, P61; Guilaine J., 1994, MER PARTAGEE MEDITER; Guitart J., 2007, PLANIMETRIA ARQUEOLO; Guitart J., 2010, DOCUMENTA, P200; Gurt JM., 2005, COTA ZERO REV ARQUEO, P87, DOI [10.1016/j.antiviral.2005.11.006, DOI 10.1016/J.ANTIVIRAL.2005.11.006]; Hafez ESE., 2013, REPROD FARM ANIMALS; Halstead P, 1996, WORLD ARCHAEOL, V28, P20, DOI 10.1080/00438243.1996.9980329; Halstead P., 2011, ETHNOZOOARCHAEOLOGY, P160, DOI 10.2307/j.ctvh1dwvg.20; Harris M, 2001, CULTURAL MAT; Harris M, 1979, CANNIBALES MONARQUES; Hermon E., 2009, SOC CLIMATS EMPIRE R, P251; Hodder I, 1991, DOMESTICATION EUROPE, DOI [10.1111/j.1432-1033.1991.tb15993.x, DOI 10.1111/J.1432-1033.1991.TB15993.X]; Hollander M., 2013, NONPARAMETRIC STAT M, VVolume 751; Ijzereef GF., 1981, BRONZE AGE ANIMAL BO; Jarrega R, 2000, QUADERNS PRESHISTORI, P271; Johnson Allen, 2000, EVOLUTION HUMAN SOC; Junyent E, 1992, REV ARQUEOLOGIA PONE, P21; Junyent E., 1993, ELS VILARS ARBECA GA, P41; Junyent E., 2003, ANTIGUITAT ILTIRTA L, DOI [10.1016/s0025-7753%2803%2973876-7, DOI 10.1016/S0025-7753%2803%2973876-7]; Keay S., 1998, ARCHAEOLOGY EARLY RO, P183; Keay S., 2012, ROME; Keay SJ., 1987, 6 LANTIGUITAT EC PRO, P383; King A., 1999, J ROMAN ARCHAEOL, V12, P168, DOI 10.1017/S1047759400017979; Kristiansen K., 2000, EUROPE HIST; Kristiansen K, 2016, INTERPRETING BRONZE, P154; La Serna-Ramos, 1994, POLEN ESPORAS CONTRI, P423; Lepetz S., 1996, REV ARCHEOLOGIQUE PI, V11, P317, DOI [10.3406/pica.1996.1903, DOI 10.3406/PICA.1996.1903]; Letalien B., 2008, NEW PERSPECTIVES ANC, P131; Lichardus J., 2018, PROTOHISTOIRE EUROPE; Rodriguez LL, 2016, ARCHAEOFAUNA, V25, P127; Cachero FJL, 2007, TRABAJOS PREHIST, V64, P99; Lopez J., 1998, LOPEZ PODER SIMBOLO, P355; Lopez-Cachero FJ., 2006, APROXIMACIO SOC DURA; Lopez-Cachero FJ., 1999, PYRENAE, V30, P69; Lopez-Cachero J., 2001, REV ARQUEOLOGIA PONE, P151; Lopez-Melcion JB, 2000, THESIS TDX; Lopez-Quiroga J, 2009, ARQUEOLOGIA HABITAT; Lyman RL, 2008, CAMB MAN ARCHAEOL, P1, DOI 10.1017/CBO9780511813863; Mackinnon M, 2004, PRODUCTION CONSUMPTI; Madgwick R, 2019, ARCHAEOL ANTHROP SCI, V11, P223, DOI 10.1007/s12520-017-0539-9; Magueur A., 2012, GUIDE TECHNIQUE DAM; Manning K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141873; Marti R., 2015, ESTUDIS HIST AGRARIA; Martin A, 2000, 3 C ARQ PEN UTAD VIL, P11; Oliveras AMI, 2019, COMPUT SOC SCI, P129, DOI 10.1007/978-3-030-04576-0_8; Martin-Oliveras A., 2019, PAISAJES PRODUCTIVOS; MATOLCSI J, 1970, Zeitschrift fuer Tierzuechtung und Zuechtungsbiologie, V87, P89; Maya JL, 1998, GENO POBLADO BRONCE; Meadow RH., 1999, HISTORICI ANIMALIUM, P285; Mendoni L., 1994, STRUCTURES RURALES S, P339; Meniel P., 1984, REV ARCHEOLOGIQUE PI, V3, P1, DOI [10.3406/pica.1984.3126, DOI 10.3406/PICA.1984.3126]; Mercadal O., 2003, MON IB PAIS CAT 13 C, P117; Mestre J, 1993, C HIST BARC CIUT SEU, P49; Minniti C, 2014, J ARCHAEOL SCI, V42, P305, DOI 10.1016/j.jas.2013.10.008; Miret M., 1995, QUADERNS PREHISTORIA, P189; Molinos M., 1993, IBEROS ANALISIS ARQU; Mordant C., 2007, EDITIONS COMITE TRAV; Nieto-Espinet A., 2014, QUIDES BOVIDES MEDIT, P53; Nieto-Espinet A., 2018, ELEMENT MEASURE STAN, DOI [10.13140/RG.2.2.13512.78081, DOI 10.13140/RG.2.2.13512.78081]; Nieto-Espinet A, 2012, ENTRE CONSUM AFECTE; Nieto-Espinet A, 2020, J ARCHAEOL SCI-REP, V30, DOI 10.1016/j.jasrep.2019.102077; Noguera J., 2009, CITERIOR REV ARQUEOL, P219; Noguera JM., 2010, POBLAMIENTO RURAL RO, P25; Nolla JM, 1987, GIRONA ROMANA FUNDAC; Olesti O., 2010, TIMES CHANGES BEGINI, P11; Olesti O, 2000, EMPURIES, P55; Open Street Map (OSM), 2020, GEOFABRIK DOWNLOAD S; Orengo HA, 2016, J ARCHAEOL SCI, V66, P21, DOI 10.1016/j.jas.2015.12.003; Orengo HA, 2014, J ARCHAEOL SCI, V49, P265, DOI 10.1016/j.jas.2014.05.005; Padros C., 2016, PYRENAE, V47, P39; Palahi L., 2010, OPPIDUM CIUITAS ROMA; Palet JM., 2003, TERRITORIS ANTICS ME, P363; Palet JM., 2003, TERRITORIS ANTICS ME, P393; Palet JM, 2012, LANDSCAPE ARCHEOLOGY, V3, P305; Papachristou TG, 1997, SMALL RUMINANT RES, V24, P85, DOI 10.1016/S0921-4488(96)00942-X; Perez-Martinez M, 2013, REV ARQUEOLOGIA PONE, P237; Pernicka E, 2016, ARCHAEOL AUSTRIACA, P19, DOI 10.1553/archaeologia100s19; Perrier X., 2013, DOCUMENTS ARCHEOLOGI, V33, P235; Peters J, 1998, PASSAUER UNIVERSITAT; Picon P., 1989, STUDIA HIST HIST ANT, P29; Pique R, 2002, CYPSELA, P211; Pires AE., 2020, CATTLE E CATTLE W DI; Plana R., 2001, TERRITORI POLITIC TE, P283; Pons E., 2002, CYPSELA, P125; Pons E., 1977, FONOLLERA TORROELLA; Pons E., 1999, PRODUCTES ALIMENTARI, P31; Pons E., 2007, CYPSELA, P51; Pons E., 2000, ELS PRODUCTES ALIMEN, P269; Pons E, 1994, COTA ZERO, P9; Prats G, 2020, ANTIQUITY, V94, P653, DOI 10.15184/aqy.2019.153; Prevosti M., 2010, B SOC CATALANA ESTUD, P45, DOI [10.2436/20.1001.01.54, DOI 10.2436/20.1001.01.54]; Prevosti M., 1981, CRONOLOGIA POBLAMENT, DOI [10.1007/BF00263726, DOI 10.1007/BF00263726]; Py M., 1993, GAULOIS MIDI; Py M., 1984, COLLECTION I SCI TEC, V290, P171; Rafel-Fontanals N, 1997, PYRENAE, P99; Revilla Calvo V, 1999, LATOMUS, V58, P30; Revilla V., 2006, ARCH ESPAN ARQUEOL, V79, P89, DOI [10.3989/aespa.2006.v79.5, DOI 10.3989/AESPA.2006.V79.5]; Revilla V., 1993, PRODUCCION CERAMICA; Revilla V., 2018, HABITAT RURAL SISTEM, P247; Ribes-Foguet JL., 2002, SALA ARQUEOLOGIA CAT, P119; Riera S, 2005, COTA ZERO REV ARQUEO, V99, P107; RINGROSE TJ, 1992, J ARCHAEOL SCI, V19, P615, DOI 10.1016/0305-4403(92)90032-X; Ripoll G., 2001, ARQUEOLOGIA TERRITOR, V8, P21, DOI [10.17561/aytm.v8i0.1672, DOI 10.17561/AYTM.V8I0.1672]; Rodriguez A., 2002, BOLSKAN, P121; Rodriguez JI., 2006, REV ARQUEOLOGIA PONE, P64; Rogosic J, 2006, SMALL RUMINANT RES, V64, P169, DOI 10.1016/j.smallrumres.2005.04.017; ROMANPONCE H, 1978, J ANIM SCI, V46, P175, DOI 10.2527/jas1978.461175x; Rovira Hortala MC., 2005, PROCESOS CAMBIO CATA, P133; Rovira-Port J., 1996, MODELS OCUPACIO TRAN, P341; Sabate G., 2011, JORNADES ARQUEOLOGIA, P3; Sabate G., 2015, JORNADES ARQUEOLOGIA, P3; Sagrera J., 2007, EMPURES, P185; Sana M., 2009, STUDIES RURAL WORLD; Sanmarti J., 2006, COMUNITATS LOCALS AL, P1; Sanmarti J., 2001, B ARQUEOLOGIC, P101; Sanmarti J., 2006, COMUNITATS LOCALS AL; Sanmarti J., 2011, EC AGROPECUARIA CANV, P11; Sanmarti J., 2015, ESTRUCTURES SOCIALS, P165; Sanmarti J., 2004, PYRENAE, P7; Sanmarti J, 2010, ARQUEOLOGIA ESPACIAL, P91; Santacana J, 2005, ELS IBERS NORD RAFAE; Sarda S., 2009, IDEOLOGIA PRACTIQUES, P239; Sarda S, 2010, THESIS U ROVIRA VIRG; Sarris P, 2004, ENGL HIST REV, V119, P279, DOI 10.1093/ehr/119.481.279; Sireci SG, 2003, J EDUC MEAS, V40, P277, DOI 10.1111/j.1745-3984.2003.tb01108.x; Sperber L., 1999, REUNION MUSEES NATIO, P48; Survey (USGS) USG, 2015, 30 MET RES EL DAT SH; Tremoleda J., 2010, TIME CHANGES BEGINNI, P89; Tremoleda J., 2005, COTA ZERO REV ARQUEO, P67; Trentacoste A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208109; Valenzuela-Lamas S., 2010, AGER TARRACONENSIS, P181; Valenzuela-Lamas S., 2010, CANVIS ALIMENTACIO C, P162; Valenzuela-Lamas S., 2008, ALIMENTACIO RAMADERI; Valenzuela-Lamas S., 2020, DISCRIMINATING MANAG, DOI [10.1016/j.quaint.2020.03.006, DOI 10.1016/J.QUAINT.2020.03.006]; Valenzuela-Lamas S, 2017, EUR J ARCHAEOL, V20, P402, DOI 10.1017/eaa.2017.22; Valenzuela-Oliver A., 2013, BARELY SURVIVING MOR, P201; Vidal A., 2011, URTX REV CULTURAL UR, P211; Vidal-Aixala A., 2005, REV ARQUEOLOGIA PONE, P13; Vigne J-D., 1988, GALLIA PREHISTOIRE; Vignot A., 2002, ANN LIT PRESSES U FR, P291; Vincent C, 2008, SYNTHESE BIBLIO ANS; Viner-Daniels S., 2017, OXFORD HDB ZOOARCHAE, P128; von den Driesch A, 1976, PEABODY MUSEUM B; Ward-Perkins B., 2006, HIST SPEAKING, DOI DOI 10.1353/HSP.2006.0074; Wealleans AL, 2013, J SCI FOOD AGR, V93, P2076, DOI 10.1002/jsfa.6145; Wilson Andrew, 2009, QUANTIFYING ROMAN EC, P213, DOI DOI 10.1093/ACPROF:OSO/9780199562596.003.0009; Wolf ER, 1992, LOS CAMPESINOS	227	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246201	10.1371/journal.pone.0246201	http://dx.doi.org/10.1371/journal.pone.0246201			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8ME	33596208	Green Published, gold			2022-12-26	WOS:000620633200062
J	Flores, AQ; Liza, F; Quteineh, H; Czarnecka, B				Flores, Alejandro Quiroz; Liza, Farhana; Quteineh, Husam; Czarnecka, Barbara			Variation in the timing of Covid-19 communication across universities in the UK	PLOS ONE			English	Article							SOCIAL MEDIA; HIGHER-EDUCATION; CRISIS COMMUNICATION; INFLUENZA A-USSR-77; STUDENTS; COLLEGE; HEALTH; IMPACT; DIFFUSION; OUTBREAK	During the Covid-19 pandemic, universities in the UK used social media to raise awareness and provide guidance and advice about the disease to students and staff. We explain why some universities used social media to communicate with stakeholders sooner than others. To do so, we identified the date of the first Covid-19 related tweet posted by each university in the country and used survival models to estimate the effect of university-specific characteristics on the timing of these messages. In order to confirm our results, we supplemented our analysis with a study of the introduction of coronavirus-related university webpages. We find that universities with large numbers of students are more likely to use social media and the web to speak about the pandemic sooner than institutions with fewer students. Universities with large financial resources are also more likely to tweet sooner, but they do not introduce Covid-19 webpages faster than other universities. We also find evidence of a strong process of emulation, whereby universities are more likely to post a coronavirus-related tweet or webpage if other universities have already done so.	[Flores, Alejandro Quiroz; Liza, Farhana; Quteineh, Husam] Univ Essex, Business & Local Govt Data Res Ctr, Colchester, Essex, England; [Flores, Alejandro Quiroz] Univ Essex, Dept Govt, Colchester, Essex, England; [Flores, Alejandro Quiroz] Univ Essex, Inst Analyt & Data Sci, Colchester, Essex, England; [Czarnecka, Barbara] London South Bank Univ, Business Sch, Div Management Mkt & People, London, England	University of Essex; University of Essex; University of Essex; London South Bank University	Flores, AQ (corresponding author), Univ Essex, Business & Local Govt Data Res Ctr, Colchester, Essex, England.; Flores, AQ (corresponding author), Univ Essex, Dept Govt, Colchester, Essex, England.; Flores, AQ (corresponding author), Univ Essex, Inst Analyt & Data Sci, Colchester, Essex, England.	aquiro@essex.ac.uk		Quiroz Flores, Alejandro/0000-0002-5038-4706; Liza, Farhana Ferdousi/0000-0003-4854-5619	Business and Local Government Data Research Centre - Economic and Social Research Council (ESRC) [ES/S007156/1]; ESRC [ES/S007156/1] Funding Source: UKRI	Business and Local Government Data Research Centre - Economic and Social Research Council (ESRC); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	AQF, FL, and HQ, would like to acknowledge the support of the Business and Local Government Data Research Centre (ES/S007156/1) funded by the Economic and Social Research Council (ESRC) for undertaking this work. https://esrc.ukri.org The funding body did not play a role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adolph C, 2021, J HEALTH POLIT POLIC, V46, P211, DOI 10.1215/03616878-8802162; [Anonymous], ACT BEING TAK U RESP; Aristovnik A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208438; Arpan LM, 2005, PUBLIC RELAT REV, V31, P425, DOI 10.1016/j.pubrev.2005.05.003; Ayman U, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208295; Bao W, 2020, HUM BEHAV EMERG TECH, V2, P113, DOI 10.1002/hbe2.191; Beck N, 1998, AM J POLIT SCI, V42, P1260, DOI 10.2307/2991857; BERRY FS, 1990, AM POLIT SCI REV, V84, P395, DOI 10.2307/1963526; Boehmke FJ, 2004, POLIT RES QUART, V57, P39, DOI 10.2307/3219833; Boehmke FJ, 2009, J POLIT, V71, P1125, DOI 10.1017/S0022381609090926; Boehmke FJ, 2009, STATE POLIT POLICY Q, V9, P229, DOI 10.1177/153244000900900205; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Butler-Henderson K., 2020, J APPL LEARNING TEAC, V3, P1, DOI [10.37074/jalt.2020.3.2.11, DOI 10.37074/JALT.2020.3.2.11]; Carter DB, 2010, POLIT ANAL, V18, P271, DOI 10.1093/pan/mpq013; Cevasco KE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240786; Claeys AS, 2012, PUBLIC RELAT REV, V38, P83, DOI 10.1016/j.pubrev.2011.09.001; Coombs WT, 2007, CORP REPUT REV, V10, P163, DOI 10.1057/palgrave.crr.1550049; Coombs WT, 2015, BUS HORIZONS, V58, P141, DOI 10.1016/j.bushor.2014.10.003; COURTENAY WJ, 1980, SPECULUM, V55, P696, DOI 10.2307/2847661; Crawford J, 2020, J APPL LEARNING TEAC, V3, DOI [10.37074/jalt.2020.3.1.7, DOI 10.37074/JALT.2020.3.1.7]; Drayton E, WILL U NEED BAILOUT; Fernandez AA, 2020, J LEADERSH STUD, V14, P39, DOI 10.1002/jls.21684; FINKELSTEIN S, 1992, ACAD MANAGE J, V35, P505, DOI 10.2307/256485; Flores AQ, 2013, BRIT J POLIT SCI, V43, P821, DOI 10.1017/S0007123412000609; Fung ICH, 2007, INT J ENVIRON HEAL R, V17, P161, DOI 10.1080/09603120701254276; Gilardi F, 2008, SWISS POLIT SCI REV, V14, P413, DOI 10.1002/j.1662-6370.2008.tb00108.x; Gonzalez T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239490; GOV.UK, COR COVID 19 UK; Gov UK, CHECK U COLL IS OFF; Graham ER, 2013, BRIT J POLIT SCI, V43, P673, DOI 10.1017/S0007123412000415; Gressman PT, 2020, MATH BIOSCI, V328, DOI 10.1016/j.mbs.2020.108436; Grunder-Fahrer S, 2018, NAT LANG ENG, V24, P221, DOI 10.1017/S1351324918000025; Guh A, 2011, CLIN INFECT DIS, V52, pS131, DOI 10.1093/cid/ciq029; Handel M, 2020, J RES TECHNOL EDUC, V54, P267, DOI 10.1080/15391523.2020.1846147; Hagar C, 2006, ANN C SIG MULT ETHN; Hagar C., 2014, ENCY INFORM SCI TECH, V3rd, P1350; HAMBRICK DC, 1984, ACAD MANAGE REV, V9, P193, DOI 10.2307/258434; Higher Education Statistics Authority, OP DAT OFF STAT; Huang Y, 2020, PUBLIC RELAT REV, V46, DOI 10.1016/j.pubrev.2020.101909; Hughes A.L., 2018, HDB DISASTER RES, DOI [DOI 10.1007/978-3-319-63254-4_24, 10.1007/978-3-319-63254-4_24]; Imran M, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2771588; Isakov A., 2020, MODEL COVID 19 TRANS; Iuliano AD, 2009, CLIN INFECT DIS, V49, P1811, DOI 10.1086/649555; Jin S, 2017, POLIT ANAL, V25, P138, DOI 10.1017/pan.2016.16; JUNKER D, 1987, REV INFECT DIS, V9, pS439; Keefer P, 2011, WORLD DEV, V39, P1530, DOI 10.1016/j.worlddev.2011.02.010; Keller JJ, 2014, ASIA-PAC J PUBLIC HE, V26, P42, DOI 10.1177/1010539513496842; Knight M, 2020, BUS PROF COMMUN Q, V83, P131, DOI 10.1177/2329490620925418; LAYDE PM, 1980, J INFECT DIS, V142, P347, DOI 10.1093/infdis/142.3.347; Linvill DL, 2012, PUBLIC RELAT REV, V38, P636, DOI 10.1016/j.pubrev.2012.05.010; Lund B, 2019, J MARK HIGH EDUC, V29, P251, DOI 10.1080/08841241.2019.1641875; Luo J., 2020, PR I-A I C AD S N A, DOI DOI 10.1109/ASONAM49781.2020.9381379; Mackert M, 2020, HEALTH COMMUN, V35, P1750, DOI 10.1080/10410236.2020.1839204; Marinoni G., 2020, IAU GLOBAL SURVEY RE; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; McIntyre JJ., 2011, J SCH VIOLENCE, V10, P299; Mitra P., 2011, NISCRAM; Monk-Turner E, 2005, SOC BEHAV PERSONAL, V33, P629, DOI 10.2224/sbp.2005.33.7.629; Mooney CZ, 2001, POLIT RES QUART, V54, P103, DOI 10.1177/106591290105400106; Mossa-Basha M, 2020, RADIOLOGY, V296, pE26, DOI 10.1148/radiol.2019201326; Neumayer E., 2017, ROBUSTNESS TESTS QUA; Neumayer E, 2014, GLOBAL ENVIRON CHANG, V24, P8, DOI 10.1016/j.gloenvcha.2013.03.011; Nichol KL, 2006, VACCINE, V24, P6724, DOI 10.1016/j.vaccine.2006.05.033; Nichol KL, 2005, CLIN INFECT DIS, V40, P1263, DOI 10.1086/429237; Nichol KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009548; Nichol KL, 2008, ARCH PEDIAT ADOL MED, V162, P1113, DOI 10.1001/archpedi.162.12.1113; OBR, 2020, COR REF SCEN OBRS CO; Office of National Statistics, COUNT UN AUTH DEC 20; Padgham M, GEODIST FAST DEPENDE; Palen L., 2020, CRISIS INFORMATICS H; Palen L., 2007, P 3 INT C E SOCIAL S, P7; Palen L, 2009, SOC SCI COMPUT REV, V27, P467, DOI 10.1177/0894439309332302; Palen L, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P727; Park D, 2019, CURR ISSUES TOUR, V22, P1810, DOI 10.1080/13683500.2018.1504900; Park S, 2015, AM J POLIT SCI, V59, P1072, DOI 10.1111/ajps.12176; Pebesma E.J., CLASSES METHODS SPAT; Perez V, 2012, J EPIDEMIOL COMMUN H, V66, P605, DOI 10.1136/jech.2010.117002; Peruta A, 2017, J MARK HIGH EDUC, V27, P131, DOI 10.1080/08841241.2016.1212451; Phungsoonthorn T., 2020, INT J BUS COMMUN, V1, DOI DOI 10.1177/2329488420953188; Plumper T, 2017, GLOBAL ENVIRON CHANG, V44, P49, DOI 10.1016/j.gloenvcha.2017.03.002; PONS VG, 1980, AM J EPIDEMIOL, V111, P23, DOI 10.1093/oxfordjournals.aje.a112871; Pringle J, 2019, J MARK HIGH EDUC, V29, P19, DOI 10.1080/08841241.2018.1486345; Roshan M, 2016, COMPUT HUM BEHAV, V63, P350, DOI 10.1016/j.chb.2016.05.016; Rutter R, 2016, J BUS RES, V69, P3096, DOI 10.1016/j.jbusres.2016.01.025; Sauerbrei W, 1999, BRIT J CANCER, V79, P1752, DOI 10.1038/sj.bjc.6690279; Sergent K, 2020, J APPL PSYCHOL, V105, P771, DOI 10.1037/apl0000577; Shipan CR, 2012, PUBLIC ADMIN REV, V72, P788, DOI 10.1111/j.1540-6210.2012.02610.x; Smelser NJ, 2010, REFLECTIONS ON THE UNIVERSITY OF CALIFORNIA: FROM THE FREE SPEECH MOVEMENT TO THE GLOBAL UNIVERSITY, P1; Sobaih AE, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12166520; SOBAL J, 1982, PUBLIC HEALTH REP, V97, P66; Thumma J, 2009, AM J INFECT CONTROL, V37, P70, DOI 10.1016/j.ajic.2007.12.008; Tom EW, COVID 19 UK DATA; Triantafillidou A, 2020, COMPUT HUM BEHAV, V106, DOI 10.1016/j.chb.2020.106269; Universities UK, OUR MEMB; Veil SR, 2011, J CONTING CRISIS MAN, V19, P110, DOI 10.1111/j.1468-5973.2011.00639.x; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Volden C, 2006, AM J POLIT SCI, V50, P294, DOI 10.1111/j.1540-5907.2006.00185.x; WONKHE, 2020, SHOULD PROV COMM COV; Ye S, 2020, J CHEM EDUC, V97, P3217, DOI 10.1021/acs.jchemed.0c00724	99	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246391	10.1371/journal.pone.0246391	http://dx.doi.org/10.1371/journal.pone.0246391			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8MA	33592014	Green Published, Green Accepted, gold			2022-12-26	WOS:000620632800076
J	Nazneen, A; Tarannum, S; Chowdhury, KIA; Islam, MT; Islam, SMH; Ahmed, S; Banu, S; Islam, MS				Nazneen, Arifa; Tarannum, Sayeeda; Chowdhury, Kamal Ibne Amin; Islam, Mohammad Tauhidul; Islam, S. M. Hasibul; Ahmed, Shahriar; Banu, Sayera; Islam, Md Saiful			Implementation status of national tuberculosis infection control guidelines in Bangladeshi hospitals	PLOS ONE			English	Article								In response to the World Health Organization (WHO) recommendation to reduce healthcare workers' (HCWs') exposure to tuberculosis (TB) in health settings, congregate settings, and households, the national TB control program of Bangladesh developed guidelines for TB infection prevention and control (IPC) in 2011. This study aimed to assess the implementation of the TB IPC healthcare measures in health settings in Bangladesh. Between February and June 2018, we conducted a mixed-method study at 11 health settings. The team conducted 59 key-informant interviews with HCWs to understand the status of and barriers impeding the implementation of the TB IPC guidelines. The team also performed a facility assessment survey and examined TB IPC practices. Most HCWs were unaware of the national TB IPC guidelines. There were no TB IPC plans or committees at the health settings. Further, a presumptive pulmonary TB patient triage checklist was absent in all health settings. However, during facility assessment, we observed patient triaging and separation in the TB specialty hospitals. Routine cough-etiquette advice was provided to the TB patients mentioned during the key-informant interviews, which was consistent with findings from the survey. This study identified poor implementation of TB IPC measures in health settings. Limited knowledge of the guidelines resulted in poor implementation of the recommendations. Interventions focusing on the dissemination of the TB IPC guidelines to HCWs along with regular training may improve compliance. Such initiatives should be taken by hospital senior leadership as well as national policy makers.	[Nazneen, Arifa; Tarannum, Sayeeda; Chowdhury, Kamal Ibne Amin; Islam, Mohammad Tauhidul; Islam, S. M. Hasibul; Ahmed, Shahriar; Banu, Sayera; Islam, Md Saiful] Bangladesh Icddr B, Int Ctr Diarrhoea Dis Res, Programme Emerging Infect, Infect Dis Div, Dhaka, Bangladesh; [Islam, Md Saiful] Univ New South Wales, Fac Med, Sch Publ Hlth & Community Med, Kensington, NSW, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); University of New South Wales Sydney	Nazneen, A (corresponding author), Bangladesh Icddr B, Int Ctr Diarrhoea Dis Res, Programme Emerging Infect, Infect Dis Div, Dhaka, Bangladesh.	arifa.nazneen@icddrb.org	Islam, Saiful/GOH-2641-2022; Ahmed, Shahriar/A-3109-2019	Ahmed, Shahriar/0000-0002-8833-4130; Islam, Md Saiful/0000-0002-5690-5971	USAID [AID-388-A-17-00006]	USAID(United States Agency for International Development (USAID))	Md. Saiful Islam, senior author of this manuscript received the grant from USAID. The grant number was AID-388-A-17-00006. This research activity was made possible by the generous support of the american people through the United States Agency for International Development (USAID).Funding source website: https://www.usaid.gov/bangladesh.icddr,b acknowledges with gratitude the commitment of the USAID to its research efforts. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akosu TJ, 2015, IOSR J DENT MED SCI, V14, P72; Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1; Barker AK, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0189-9; Buregyeya E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-360; Engelbrecht MC., 2018, AFR J PRIM HEALTH CA, V10, pE1, DOI DOI 10.4102/phcfm.vl10il.1628; Gizaw GD, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0062-3; Islam MS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243951; Islam MS., 2014, HLTH SCI B, V12; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kanjee Z, 2012, J Infect Public Health, V5, P67, DOI 10.1016/j.jiph.2011.10.008; Kuyinu YA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1453-y; Naidoo S, 2012, INT J TUBERC LUNG D, V16, P1600, DOI 10.5588/ijtld.12.0041; Nasreen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164034; National Tuberculosis Control Programme, 2013, NAT GUID OP MAN PROG; National Tuberculosis Control Programme, 2011, NAT GUID TUB INF CON; National Tuberculosis Control Programme, 2015, NAT GUID OP MAN TUB; Rahman MS., 2019, I INFECT PREVENTION; Rimi NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089085; Singh TS., 2015, AFRICAN NEWSLETTER, P21; Sissolak D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-262; Tan C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241039; Tiemersma EW, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1993-1; Azeredo ACV, 2020, WORKPLACE HEALTH SAF, V68, P519, DOI 10.1177/2165079920919133; Verkuijl S, 2016, CLIN INFECT DIS, V62, pS231, DOI 10.1093/cid/civ1184; Waheed Y, 2017, PUBLIC HEALTH ACTION, V7, P26, DOI 10.5588/pha.16.0125; WHO, 2020, GLOB TUB REP; Wood R, 2011, SAMJ S AFR MED J, V101, P111, DOI 10.7196/SAMJ.4587; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization, 2009, WHOHTMTB2009; Zhao F, 2015, BIOMED ENVIRON SCI, V28, P848, DOI [10.1016/S0895-3988(15)30117-3, 10.3967/bes2015.118]; Zinatsa F, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3083-0	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246923	10.1371/journal.pone.0246923	http://dx.doi.org/10.1371/journal.pone.0246923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592049	Green Published, gold			2022-12-26	WOS:000620632800042
J	Zhang, T; He, F; Lin, ST; Wang, XY; Li, FD; Zhai, YJ; Gu, X; Wu, MN; Lin, JF				Zhang, Tao; He, Fan; Lin, Shangtong; Wang, Xinyi; Li, Fudong; Zhai, Yujia; Gu, Xue; Wu, Mengna; Lin, Junfen			Does aluminum exposure affect cognitive function? a comparative cross-sectional study	PLOS ONE			English	Article								Objectives This study assessed the cognitive function of aluminum-exposed participants from an alum mining zone, compared them with unexposed subjects, and aimed to elucidate the effect of aluminum exposure on cognition. Design This was a comparative cross-sectional study. Univariate analyses were used to assess the differences between the aluminum-exposed and unexposed groups. Binary logistic regression models were applied to analyze the effect of aluminum exposure. Setting The aluminum-exposed participants were included from an alum mining zone and the unexposed subjects were residents from another district without alum-mine-related factories. Participants We included 539 aluminum-exposed participants (254 men, 285 women) and 1720 unexposed participants (692 men, 1028 women). Results The mean cognition score on Mini-Mental State Examination was 21.34 (+/- 6.81) for aluminum-exposed participants. The exposed group had 6.77 times (95% confidence interval, 5.09-9.00) more risk of cognitive impairment than the unexposed group, after adjusting for age, sex, and educational level. No statistically significant association was found between exposure duration and cognition. Conclusions This study demonstrated a significant association between aluminum exposure and lower cognitive function.	[Zhang, Tao; He, Fan; Wang, Xinyi; Li, Fudong; Zhai, Yujia; Gu, Xue; Wu, Mengna; Lin, Junfen] Zhejiang Prov Ctr Dis Control & Prevent, Dept Publ Hlth Surveillance & Advisory, Hangzhou, Zhejiang, Peoples R China; [Lin, Shangtong] Cangnan Ctr Dis Control & Prevent, Wenzhou, Zhejiang, Peoples R China; [Lin, Shangtong] Cangnan Cty Hlth Bur, Wenzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Lin, JF (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Publ Hlth Surveillance & Advisory, Hangzhou, Zhejiang, Peoples R China.	zjlinjunfen@163.com			Natural Science Foundation of Zhejiang Province [Q19H260001]; Zhejiang Provincial Public Welfare Technology Application Research Project of China [LGF19H260003, LGF21H260002]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Public Welfare Technology Application Research Project of China	This work was supported by Natural Science Foundation of Zhejiang Province (Q19H260001) and Zhejiang Provincial Public Welfare Technology Application Research Project of China (LGF19H260003, LGF21H260002).	Bansal Vinod K, 2014, Handb Clin Neurol, V119, P395, DOI 10.1016/B978-0-7020-4086-3.00025-4; CANDY JM, 1986, LANCET, V1, P354; Colomina Maria Teresa, 2017, Adv Neurobiol, V18, P183, DOI 10.1007/978-3-319-60189-2_9; DAVENPORT A, 1992, LANCET, V339, P1236; EXLEY C, 1993, FEBS LETT, V324, P293, DOI 10.1016/0014-5793(93)80137-J; Exley C, 2017, J ALZHEIMERS DIS REP, V1, P23, DOI 10.3233/ADR-170010; Ghribi O, 2001, NEUROBIOL DIS, V8, P764, DOI 10.1006/nbdi.2001.0429; He X., 1996, ZHEJIANG J PREVENTIV, P3; Hua HY, 2016, FOOD CHEM, V207, P1, DOI 10.1016/j.foodchem.2016.03.067; Huat TJ, 2019, J MOL BIOL, V431, P1843, DOI 10.1016/j.jmb.2019.01.018; Iregren A, 2001, OCCUP ENVIRON MED, V58, P453, DOI 10.1136/oem.58.7.453; Johnson VJ, 2003, NEUROTOXICOLOGY, V24, P261, DOI 10.1016/S0161-813X(02)00194-8; Kandimalla R, 2016, BRAIN PATHOL, V26, P139, DOI 10.1111/bpa.12333; Kawahara M, 2005, J ALZHEIMERS DIS, V8, P171; Kawahara M, 2010, CURR PHARM DESIGN, V16, P2779, DOI 10.2174/138161210793176545; Killin LOJ, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0342-y; Klotz K, 2017, DTSCH ARZTEBL INT, V114, P653, DOI 10.3238/arztebl.2017.0653; Krewski D, 2007, J TOXICOL ENV HEAL B, V10, P1, DOI 10.1080/10937400701597766; LONGSTRETH WT, 1985, ARCH INTERN MED, V145, P1972, DOI 10.1001/archinte.145.11.1972; LOU JZ, 1989, AM J PUBLIC HEALTH, V79, P1613, DOI 10.2105/AJPH.79.12.1613; Lu XT, 2014, J OCCUP ENVIRON MED, V56, P155, DOI 10.1097/JOM.0000000000000100; Lukiw WJ, 2005, J INORG BIOCHEM, V99, P1895, DOI 10.1016/j.jinorgbio.2005.04.021; Luo Y, 2009, MECH AGEING DEV, V130, P248, DOI 10.1016/j.mad.2008.12.005; Lv XZ, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1295-8; MANTYH PW, 1993, J NEUROCHEM, V61, P1171, DOI 10.1111/j.1471-4159.1993.tb03639.x; McLachlan DRC, 2019, MOL NEUROBIOL, V56, P1531, DOI 10.1007/s12035-018-1441-x; Mirza A, 2017, J TRACE ELEM MED BIO, V40, P30, DOI 10.1016/j.jtemb.2016.12.001; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Morris G, 2017, METAB BRAIN DIS, V32, P1335, DOI 10.1007/s11011-017-0077-2; Sakamoto T, 2006, FEBS LETT, V580, P6543, DOI 10.1016/j.febslet.2006.10.075; Shah SA, 2015, NANOSCALE, V7, P15225, DOI 10.1039/c5nr03598h; SHIN RW, 1994, J NEUROSCI, V14, P7221; Sim M, 1997, OCCUP ENVIRON MED, V54, P229, DOI 10.1136/oem.54.4.229; TERRY RD, 1965, J NEUROPATH EXP NEUR, V24, P200, DOI 10.1097/00005072-196504000-00003; Weidenhamer JD, 2017, SCI TOTAL ENVIRON, V579, P805, DOI 10.1016/j.scitotenv.2016.11.023; Xiang YX, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-1003-0; Yang XJ, 2015, J OCCUP ENVIRON MED, V57, P713, DOI 10.1097/JOM.0000000000000474; Zawilla NH, 2014, J INORG BIOCHEM, V139, P57, DOI 10.1016/j.jinorgbio.2014.06.003; Zhang T, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022055	39	1	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246560	10.1371/journal.pone.0246560	http://dx.doi.org/10.1371/journal.pone.0246560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592006	gold, Green Published			2022-12-26	WOS:000620632800079
J	DeJong, AF; Fish, PN; Hertel, J				DeJong, Alexandra F.; Fish, Pamela N.; Hertel, Jay			Running behaviors, motivations, and injury risk during the COVID-19 pandemic: A survey of 1147 runners	PLOS ONE			English	Article								The COVID-19 pandemic has influenced activity behaviors worldwide. Given the accessibility of running as exercise, gaining information on running behaviors, motivations, and running-related injury (RRI) risk during the pandemic is warranted. The purpose of this study was to assess the influence of the COVID-19 pandemic on running volume, behaviors, motives, and RRI changes from the year prior to the pandemic to the timeframe during social isolation restrictions. Runners of all abilities were recruited via social media to complete a custom Qualtrics survey. Demographics, running volume, behaviors, motivations, and injury status were assessed for the year prior to the pandemic, and during social isolation measures. Descriptive statistics and Student's t-tests were used to assess changes in running outcomes during the pandemic. Logistic regressions were used to assess the influence of demographics on running behaviors and injury. Adjusted RRI risk ratios were calculated to determine the odds of sustaining an injury during the pandemic. Alpha was set to.05 for all analyses. A total of 1147 runners (66% females, median age: 35 years) across 15 countries (96% United States) completed the survey. Runners reported increased runs per week (Mean Difference with Standard Error [MD]: 0.30 [0.05], p < .001), sustained runs (MD: 0.44 [0.05], p < .001), mileage (MD: 0.87 [0.33], p = .01), and running times of day (MD: 0.11 [0.03], p < .001) during the pandemic, yet reported less workouts (i.e. sprint intervals; MD: -0.33 [0.06], p < .001), and less motives (MD [SE]: -0.41 [0.04], p < .001). Behavior changes were influenced by running experience and age. There was 1.40 (CI: 1.18,1.61) times the RRI risk during the pandemic compared to prior to the social isolation period. The COVID-19 pandemic influenced runners' behaviors with increased training volume, decreased intensity and motivation, and heightened injury risk. These results provide insights into how physical activity patterns were influenced by large-scale social isolation directives associated with the pandemic.	[DeJong, Alexandra F.; Fish, Pamela N.; Hertel, Jay] Univ Virginia, Exercise & Sport Injury Lab, Charlottesville, VA 22904 USA	University of Virginia	DeJong, AF (corresponding author), Univ Virginia, Exercise & Sport Injury Lab, Charlottesville, VA 22904 USA.	afd4au@virginia.edu		DeJong Lempke, PhD, ATC, Alexandra F/0000-0002-5702-9184				Andersen J.J., 2020, STATE RUNNING 2019; Boey H, 2017, SPORT BIOMECH, V16, P166, DOI 10.1080/14763141.2016.1212918; Boratto L, 2017, PERS UBIQUIT COMPUT, V21, P689, DOI 10.1007/s00779-017-1026-0; Buist I, 2010, AM J SPORT MED, V38, P273, DOI 10.1177/0363546509347985; Fredericson M, 2007, SPORTS MED, V37, P437, DOI 10.2165/00007256-200737040-00043; Ghorbani F, 2014, J RES HEALTH SCI, V14, P264; Hollander K, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2017-000308; Hulteen RM, 2017, PREV MED, V95, P14, DOI 10.1016/j.ypmed.2016.11.027; Janssen M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072276; Kerr ZY, 2016, J ATHL TRAINING, V51, P57, DOI 10.4085/1062-6050-51.1.10; Knaving K, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P2013, DOI 10.1145/2702123.2702542; Knobloch K, 2008, FOOT ANKLE INT, V29, P671, DOI 10.3113/FAI.2008.0671; Lavie CJ, 2015, MAYO CLIN PROC, V90, P1541, DOI 10.1016/j.mayocp.2015.08.001; Pucci GCMF, 2012, REV SAUDE PUBL, V46, P166, DOI 10.1590/S0034-89102012000100021; Mujika I, 2018, INT J SPORT PHYSIOL, V13, P538, DOI 10.1123/ijspp.2018-0093; Nielsen RO, 2012, INT J SPORTS PHYS TH, V7, P58; Nielsen RO, 2013, INT J SPORTS PHYS TH, V8, P172; The Runners World Editors, 2020, CORONAVIRUS IS IMPAC, DOI [1353444/coronavirus-marathons-running-events-postponed-canceled/, DOI 1353444/CORONAVIRUS-MARATHONS-RUNNING-EVENTS-POSTPONED-CANCELED]; van der Worp MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114937; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Yan Z, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101508	21	14	14	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246300	10.1371/journal.pone.0246300	http://dx.doi.org/10.1371/journal.pone.0246300			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577584	gold, Green Published			2022-12-26	WOS:000620071700033
J	Wang, CY; Tee, M; Roy, AE; Fardin, MA; Srichokchatchawan, W; Habib, HA; Tran, BX; Hussain, S; Hoang, MT; Le, XT; Ma, WF; Pham, HQ; Shirazi, M; Taneepanichskul, N; Tan, YL; Tee, C; Xu, LK; Xu, ZQ; Vu, GT; Zhou, DQ; Koh, BJ; McIntyre, RS; Ho, C; Ho, RC; Kuruchittham, V				Wang, Cuiyan; Tee, Michael; Roy, Ashley Edward; Fardin, Mohammad A.; Srichokchatchawan, Wandee; Habib, Hina A.; Tran, Bach X.; Hussain, Shahzad; Hoang, Men T.; Le, Xuan T.; Ma, Wenfang; Pham, Hai Q.; Shirazi, Mahmoud; Taneepanichskul, Nutta; Tan, Yilin; Tee, Cherica; Xu, Linkang; Xu, Ziqi; Vu, Giang T.; Zhou, Danqing; Koh, Bernard J.; McIntyre, Roger S.; Ho, Cyrus; Ho, Roger C.; Kuruchittham, Vipat			The impact of COVID-19 pandemic on physical and mental health of Asians: A study of seven middle-income countries in Asia	PLOS ONE			English	Article							PSYCHOLOGICAL IMPACT	The coronavirus disease (COVID-19) pandemic has impacted the economy, livelihood, and physical and mental well-being of people worldwide. This study aimed to compare the mental health status during the pandemic in the general population of seven middle income countries (MICs) in Asia (China, Iran, Malaysia, Pakistan, Philippines, Thailand, and Vietnam). All the countries used the Impact of Event Scale-Revised (IES-R) and Depression, Anxiety and Stress Scale (DASS-21) to measure mental health. There were 4479 Asians completed the questionnaire with demographic characteristics, physical symptoms and health service utilization, contact history, knowledge and concern, precautionary measure, and rated their mental health with the IES-R and DASS-21. Descriptive statistics, One-Way analysis of variance (ANOVA), and linear regression were used to identify protective and risk factors associated with mental health parameters. There were significant differences in IES-R and DASS-21 scores between 7 MICs (p<0.05). Thailand had all the highest scores of IES-R, DASS-21 stress, anxiety, and depression scores whereas Vietnam had all the lowest scores. The risk factors for adverse mental health during the COVID-19 pandemic include age <30 years, high education background, single and separated status, discrimination by other countries and contact with people with COVID-19 (p<0.05). The protective factors for mental health include male gender, staying with children or more than 6 people in the same household, employment, confidence in doctors, high perceived likelihood of survival, and spending less time on health information (p<0.05). This comparative study among 7 MICs enhanced the understanding of metal health in the general population during the COVID-19 pandemic.	[Wang, Cuiyan; Ma, Wenfang; Tan, Yilin; Xu, Linkang; Xu, Ziqi; Zhou, Danqing] Huaibei Normal Univ, Fac Educ, Inst Cognit Neurosci, Huaibei, Peoples R China; [Tee, Michael; Tee, Cherica] Univ Philippines, Coll Med, Manila, Philippines; [Roy, Ashley Edward] Univ Malaysia Sarawak, Sarawak, Malaysia; [Fardin, Mohammad A.] Islamic Azad Univ, Dept Psychol, Zahedan Branch, Zahedan, Iran; [Srichokchatchawan, Wandee; Taneepanichskul, Nutta] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand; [Habib, Hina A.] Univ Karachi, Inst Clin Psychol, Karachi, Pakistan; [Tran, Bach X.; Le, Xuan T.] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Tran, Bach X.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hussain, Shahzad] DHQ Hosp Jhelum, Jhelum, Pakistan; [Hoang, Men T.] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam; [Pham, Hai Q.] Duy Tan Univ, Fac Med, Da Nang, Vietnam; [Shirazi, Mahmoud] Univ Sistan & Baluchestan, Dept Psychol, Zahedan, Iran; [Vu, Giang T.] Nguyen Tat Thanh Univ, Ctr Excellence Evidence Based Med, Ho Chi Minh City, Vietnam; [Koh, Bernard J.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore; [McIntyre, Roger S.] Univ Toronto, Univ Hlth Network, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada; [Ho, Cyrus] Natl Univ Hlth Syst, Dept Psychol Med, Singapore, Singapore; [Ho, Roger C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Hlth Innovat & Technol iHealthtech, Singapore, Singapore; [Kuruchittham, Vipat] Southeast Asia One Hlth Univ Network SEAOHUN, Chiang Mai, Thailand	Huaibei Normal University; University of the Philippines System; University of the Philippines Manila; University of Malaysia Sarawak; Islamic Azad University; Chulalongkorn University; University of Karachi; Hanoi Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Duy Tan University; Duy Tan University; University of Sistan & Baluchestan; Nguyen Tat Thanh University (NTTU); National University of Singapore; University of Toronto; University Toronto Affiliates; University Health Network Toronto; National University of Singapore; National University of Singapore	Ho, RC (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Hlth Innovat & Technol iHealthtech, Singapore, Singapore.	pcmrhcm@nus.edu.sg	Ho, Roger/ABD-8859-2021; Shirazi, Mahmoud/CAF-7220-2022; Taneepanichskul, Nutta/GMW-8835-2022; Fardin, Mohammadali/AAO-3671-2021; Ho, Roger C./ABD-9061-2021	Ho, Roger C./0000-0001-9629-4493; Taneepanichskul, Nutta/0000-0002-7489-572X; Soosay, Ashley/0000-0002-4080-3196	Huaibei Normal University, China; National University of Singapore iHealthtech Other Operating Expenses [(R-722-000-004-731) 3]; Vingroup Innovation Foundation (VINIF) COVID research grant in Vietnam [VINIF.2020.Covid19.DA07]	Huaibei Normal University, China; National University of Singapore iHealthtech Other Operating Expenses; Vingroup Innovation Foundation (VINIF) COVID research grant in Vietnam	This study has the following funding sources: 1. Author C.W, 1 grant, Huaibei Normal University, China. 2. Author R.H, 1 grant, National University of Singapore iHealthtech Other Operating Expenses (R-722-000-004-731) 3. Author B.X.T, 1 grant, Vingroup Innovation Foundation (VINIF) COVID research grant (VINIF.2020.Covid19.DA07) in Vietnam	Tran BX, 2020, SAFETY SCI, V130, DOI 10.1016/j.ssci.2020.104867; Tran BX, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.011006; Tran BX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114095; Tran BX, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010354; Tran BX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103577; Tran BX, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104811; Buonomo B, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201635; Chew NWS, 2020, BRAIN BEHAV IMMUN, V88, P559, DOI 10.1016/j.bbi.2020.04.049; Desborough J, 2020, AUST J GEN PRACT, V49, P369, DOI 10.31128/AJGP-04-20-5374; Fitzgerald DA, 2020, PAEDIATR RESPIR REV, V35, P75, DOI 10.1016/j.prrv.2020.06.018; Geddie J SJ, 2020, REUTER; Hao F, 2020, BRAIN BEHAV IMMUNITY; Ho CSH, 2020, ANN ACAD MED SINGAP, V49, P155; Ho CSH, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16010163; Khan A, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.613433; Khan YH, 1995, HOSP PRACT 1995, V2020, P1; Le HT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124377; Leung CC, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30520-1; Mallhi TH, 2020, CLIN MICROBIOL INFEC, V26, P1714, DOI 10.1016/j.cmi.2020.07.019; Mallhi TH, 2021, POSTGRAD MED J, V97, P742, DOI 10.1136/postgradmedj-2020-138447; Mallhi TH, 2020, AM J TROP MED HYG, V103, P581, DOI 10.4269/ajtmh.20-0533; McIntyre RS, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113104; Mohd TAMT, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026667; Newnham EA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176144; Okada H, 2019, CLIN EXP NEPHROL, V23, P1, DOI 10.1007/s10157-018-1648-1; Papadakaki M, 2018, J SAFETY RES, V67, P155, DOI 10.1016/j.jsr.2018.10.005; Quek TC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071410; Salman M, 2020, DISASTER MED PUBLIC, V14, pE44, DOI 10.1017/dmp.2020.247; Shahsavari S, 2020, J COMPUT SOC SCI, V3, P279, DOI 10.1007/s42001-020-00086-5; Sharma GD, 2020, J PUBLIC AFF, V20, DOI 10.1002/pa.2195; Tan B.Y.Q., 2020, ANN INTERNAL MED; Tee ML, 2020, J AFFECT DISORDERS, V277, P379, DOI 10.1016/j.jad.2020.08.043; Le TA, 2019, SUBST ABUSE TREAT PR, V14, DOI 10.1186/s13011-019-0223-4; UCLA, 2020, WHAT DOES CRONB AL M; Vannoni M, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00598-9; Vaughan RS, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.590559; Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wong SYS, 2020, CAN MED ASSOC J, V192, pE511, DOI 10.1503/cmaj.200563; Worldbank, 2020, POP FEM TOT POP 2020; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001; Zhai ZQ, 2020, BUILD ENVIRON, V175, DOI 10.1016/j.buildenv.2020.106827; Zhang MWB, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.2827	43	174	176	19	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246824	10.1371/journal.pone.0246824	http://dx.doi.org/10.1371/journal.pone.0246824			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571297	Green Published, gold, Green Accepted			2022-12-26	WOS:000618274000022
J	Biering, K; Vestergaard, JM; Kaergaard, A; Carstensen, O; Nielsen, KJ				Biering, Karin; Vestergaard, Jesper Medom; Kaergaard, Anette; Carstensen, Ole; Nielsen, Kent J.			Mental disorders following electrical injuries-A register-based, matched cohort study	PLOS ONE			English	Article								Introduction Electrical injuries happen every day in homes and workplaces. Not only may these injuries cause physical damage and disability, they may also cause mental disorders. The aim of this study was to investigate if persons with an electrical injury suffer from mental disorders in the following years. Material and methods In a prospective matched cohort design, we identified 14.112 electrical injuries in two Danish registries and matched these with persons with dislocation/sprain injuries or eye injuries, respectively, as well as with persons from the workforce from the same occupation, using year of injury, sex and age as matching variables. We identified possible outcomes in terms of mental diagnoses in the Danish National Patient registry, based on literature, including reviews, original studies and case-reports as well as experiences from clinical praxis. The associations were analyzed using conditional cox- and logistic regression. Results We found that the following of the examined outcomes were associated with exposure to an electrical injury compared to the matched controls. Some of the outcomes showed the strongest associations shortly after the injury, namely 'mental disorders due to known physiological condition', 'anxiety and adjustment disorders', and especially the 'Post Traumatic Stress Disorder (PTSD)' subgroup. The same pattern was seen for 'Depression' although the associations were weaker. Other conditions took time to develop ('Somatoform disorders'), or were only present in the time to event analysis ('other non-psychotic mental disorders' and 'sleep disorders'). The findings were consistent in all three matches, with the highest risk estimates in the occupation match. Conclusion Electrical injuries may result in mental disorders, both acute and several years after. However, the absolute risk is limited as most of the outcomes are rare.	[Biering, Karin; Vestergaard, Jesper Medom; Kaergaard, Anette; Carstensen, Ole; Nielsen, Kent J.] Reg Hosp West Jutland, Univ Res Clin, Danish Ramazzini Ctr, Dept Occupat Med, Herning, Denmark		Biering, K (corresponding author), Reg Hosp West Jutland, Univ Res Clin, Danish Ramazzini Ctr, Dept Occupat Med, Herning, Denmark.	karbie@rm.dk	Nielsen, Kent/CAG-3066-2022	Nielsen, Kent/0000-0002-4643-5697; Vestergaard, Jesper Medom/0000-0002-7435-6566	Danish Working Environment Research Fund [22-2017-09]	Danish Working Environment Research Fund	KB, JMV, OC, AK and KN received funding from the Danish Working Environment Research Fund, grant number 22-2017-09. https://amff.dk/about-the-fund/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews CJ, 2006, IEEE T BIO-MED ENG, V53, P2102, DOI 10.1109/TBME.2006.877117; Andrews CJ, 2017, NEURAL REGEN RES, V12, P1405, DOI 10.4103/1673-5374.215242; [Anonymous], 2020, MIGRATION DENMARK ST; [Anonymous], 2020, INT STAND CLASS OCC; [Anonymous], 2020, OSH SYSTEM NATL LEVE; [Anonymous], 2020, POPULATION STAT DENM; [Anonymous], 2020, DEATHS LIFE EXPECTAN; [Anonymous], REGISTER BASED LABOU; Arnoldo BD, 2004, J BURN CARE REHABIL, V25, P479, DOI 10.1097/01.BCR.0000144536.22284.5C; Bailey B, 2008, AM J EMERG MED, V26, P413, DOI 10.1016/j.ajem.2007.06.021; Biering K, 2021, OCCUP ENVIRON MED, V78, P54, DOI 10.1136/oemed-2020-106858; Chudasama S, 2010, ANN PLAS SURG, V64, P522, DOI 10.1097/SAP.0b013e3181c1ff31; Duff K, 2001, NEUROPSYCHOL REV, V11, P101, DOI 10.1023/A:1016623318049; Fish JS, 2012, J BURN CARE RES, V33, P199, DOI 10.1097/BCR.0b013e3182331e61; Hahn-Ketter A, 2015, J BURN CARE RES, V36, P509, DOI 10.1097/BCR.0000000000000183; Hahn-Ketter AE, 2016, CLIN NEUROPSYCHOL, V30, P216, DOI 10.1080/13854046.2016.1155647; Hansen SM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015967; Karim H, 2015, J ACUTE DIS, V4, P107, DOI 10.1016/S2221-6189(15)30018-4; Kelley KM, 1999, ANN NY ACAD SCI, V888, P356, DOI 10.1111/j.1749-6632.1999.tb07970.x; Koumbourlis AC, 2002, CRIT CARE MED, V30, pS424, DOI 10.1097/00003246-200211001-00007; Lander F, 2014, OCCUP ENVIRON MED, V71, P97, DOI 10.1136/oemed-2013-101559; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Morse JS, 2005, J PSYCHOSOM RES, V58, P51, DOI 10.1016/j.jpsychores.2004.06.001; Morse MS, 2009, IEEE ENG MED BIO, P6522, DOI 10.1109/IEMBS.2009.5333144; Piotrowski A, 2014, BURNS, V40, P480, DOI 10.1016/j.burns.2013.08.008; Pliskin NH, 1998, J TRAUMA, V44, P709, DOI 10.1097/00005373-199804000-00027; Radman L, 2016, INT ARCH OCC ENV HEA, V89, P261, DOI 10.1007/s00420-015-1069-3; Radulovic N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025990; Ramati A, 2009, GEN HOSP PSYCHIAT, V31, P360, DOI 10.1016/j.genhosppsych.2009.03.010; Rothman KJ, 2012, MODERN EPIDEMIOLOGY; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Shih JG, 2017, J BURN CARE RES, V38, pE293, DOI 10.1097/BCR.0000000000000373; Singerman J, 2008, J BURN CARE RES, V29, P773, DOI 10.1097/BCR.0b013e318184815d; Theman K, 2008, J BURN CARE RES, V29, P959, DOI 10.1097/BCR.0b013e31818b9eb6; Thomee S, 2020, INT ARCH OCC ENV HEA, V93, P683, DOI 10.1007/s00420-020-01520-x; Thomee S, 2018, WORK, V60, P573, DOI 10.3233/WOR-182765; Wesner ML, 2013, CAN FAM PHYSICIAN, V59, P935	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247317	10.1371/journal.pone.0247317	http://dx.doi.org/10.1371/journal.pone.0247317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QO3ZL	33617562	gold, Green Published			2022-12-26	WOS:000623082400017
J	Liu, N; Guan, Y; Li, B; Yao, SQ				Liu, Nan; Guan, Yi; Li, Bin; Yao, Sanqiao			Biomonitorization of concentrations of 28 elements in serum and urine among workers exposed to indium compounds	PLOS ONE			English	Article								Many studies have documented the abnormal concentrations of metals/metalloids in serum or urine of occupational workers, but no works systematically analysed the concentrations of elements in serum or urine of indium-exposed workers. This study was aimed to assess 28 elements in serum and urine from 57 individuals with occupational exposure to indium and its compounds. Control subjects were 63 workers without metal exposure. We collected information on occupation and lifestyle habits by questionnaire. Biological samples were collected to quantify elements by inductive coupled plasma-mass spectrometer. Air in the breathing zones was drawn at flow rates of 1.5-3 L/min for a sampling period of 6 to 8 h, using a Model BFC-35 pump. The average ambient indium level was 0.078 mg/m(3). Serum/urine Indium levels were significantly higher in indium-exposed workers than in controls (P < 0.01). Moreover, serum/urine indium concentrations in the group with 6-14 years and >= 15 years of employment were significantly higher than those with <= 5 employment years(P < 0.05). Ten of the other 27 elements/metals measured were higher in serum/urine in indium-exposed workers compared to the controls (aluminum, beryllium, cadmium, cesium, chromium, lithium, manganese, magnesium, molybdenum and vanadium). Zinc levels in serum/urine were significantly decreased in the indium-exposed workers. Additionally, other elements/metals were higher in one specimen (serum or urine) but lower in the other (Selenium was lower in serum but higher in urine in the indium-exposed workers compared with the controls; likewise Thallium and Rubidium were higher in serum but lower in urine). Linear regression analyses, revealed significant correlations between serum and urine for indium, aluminum, arsenic, barium, cadmium, cesium, cobalt, selenium, silver, and zinc (P < 0.05). These data suggest that occupational exposure to indium and its compounds may disturb the homeostasis of trace elements in systemic circulation, indium concentrations in serum or urine appear reflective of workers' exposure to ambient indium and their years of working, respectively. The serum/urine levels of essential metals are modified by exposure to indium in occupationally exposed workers. Further studies including larger sample size and more kinds of biological sample are needed to validate our findings.	[Liu, Nan; Guan, Yi; Yao, Sanqiao] North China Univ Sci & Technol, Sch Publ Hlth, Tangshan, Hebei, Peoples R China; [Li, Bin] Ctr Dis Prevent & Control, Inst Occupat Hlth & Poison Control China, Beijing, Peoples R China; [Yao, Sanqiao] Xinxiang Med Univ, Xinxiang, Henan, Peoples R China	North China University of Science & Technology; Xinxiang Medical University	Yao, SQ (corresponding author), North China Univ Sci & Technol, Sch Publ Hlth, Tangshan, Hebei, Peoples R China.; Yao, SQ (corresponding author), Xinxiang Med Univ, Xinxiang, Henan, Peoples R China.	sanqiaoyao@xxmu.edu.cn	LIU, nan/S-9996-2018	LIU, nan/0000-0002-8613-9745	National Public Welfare Health Industry Scientific Research [201402021]; Graduate Innovation Project [2019B17]	National Public Welfare Health Industry Scientific Research; Graduate Innovation Project	This study was supported by National Public Welfare Health Industry Scientific Research (No. 201402021) and Graduate Innovation Project (No. 2019B17).	Amata A, 2015, THORAX, V70, P1040, DOI 10.1136/thoraxjnl-2014-206380; Bomhard EM, 2018, ENVIRON TOXICOL PHAR, V58, P250, DOI 10.1016/j.etap.2018.02.003; Chang ZhiMin, 2017, Journal of Environmental & Occupational Medicine, V34, P160; Choi S, 2015, AM J IND MED, V58, P61, DOI 10.1002/ajim.22402; Choi S, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-24; Cummings KJ, 2016, AM J IND MED, V59, P522, DOI 10.1002/ajim.22585; Cummings Kristin J, 2014, Ann Am Thorac Soc, V11, P1395, DOI 10.1513/AnnalsATS.201407-346OC; Cummings KJ, 2013, AM J IND MED, V56, P300, DOI 10.1002/ajim.22125; Cummings KJ, 2012, CHEST, V141, P1512, DOI 10.1378/chest.11-1880; Espart A, 2018, METALLOMICS, V10, P1359, DOI [10.1039/c8mt00174j, 10.1039/C8MT00174J]; Harvey RR, 2016, OCCUP ENVIRON MED, V73, P864, DOI 10.1136/oemed-2016-103685; Higashikubo I, 2019, IND HEALTH, V57, P392, DOI 10.2486/indhealth.2018-0116; Higashikubo I, 2018, IND HEALTH, V56, P553, DOI 10.2486/indhealth.2018-0099; Hines CJ, 2013, J OCCUP ENVIRON HYG, V10, P723, DOI 10.1080/15459624.2013.836279; IARC, 2012, IARC MON EV CARC R C, V100C, P41; Ichiro H., 2018, J OCCUP HLTH, V60, P263, DOI [10.1539/joh.2017-0261-BR, DOI 10.1539/JOH.2017-0261-BR]; Iwasawa S, 2017, IND HEALTH, V55, P87, DOI 10.2486/indhealth.2016-0015; Li GJJ, 2004, J OCCUP ENVIRON MED, V46, P241, DOI 10.1097/01.jom.0000116900.49159.03; Liu N, 2017, TOXICOL SCI, V157, P41, DOI 10.1093/toxsci/kfx017; Mitsuhashi T, 2020, PEERJ, V8, DOI 10.7717/peerj.8413; Mulware SJ, 2013, 3 BIOTECH, V3, P85, DOI 10.1007/s13205-012-0072-6; Nakano M, 2019, J OCCUP HEALTH, V61, P251, DOI 10.1002/1348-9585.12050; Nakano M, 2016, J OCCUP HEALTH, V58, P477, DOI 10.1539/joh.16-0076-CS; Omae K, 2011, INT ARCH OCC ENV HEA, V84, P471, DOI 10.1007/s00420-010-0575-6; Unrine JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212340; Wang DX, 2008, TOXICOL LETT, V176, P40, DOI 10.1016/j.toxlet.2007.10.003; Zhou C.L., 2020, IND HLTH OCCUP DIS, V46, P117, DOI [10.1080/15298668191420855, DOI 10.1080/15298668191420855]	28	4	4	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0246943	10.1371/journal.pone.0246943	http://dx.doi.org/10.1371/journal.pone.0246943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617552	gold, Green Published			2022-12-26	WOS:000623082400022
J	Dobenecker, B; Reese, S; Herbst, S				Dobenecker, Britta; Reese, Sven; Herbst, Sarah			Effects of dietary phosphates from organic and inorganic sources on parameters of phosphorus homeostasis in healthy adult dogs	PLOS ONE			English	Article								Background The impact of dietary phosphorus (P) excess, especially on renal and cardiovascular health, has been investigated in several species, but little is known in dogs. Objective The aim of this study was to examine effects of different P sources on concentration and postprandial kinetics of selected parameters of P homeostasis in dogs. Methods Eight beagles received one control diet (P 0.5% dry matter [DM]) and three high P diets (poultry meal, NaH2PO4, and KH2PO4; P 1.7% DM) for 18d. Urine samples were collected pre- and postprandially while faeces were collected quantitatively for 5d and analysed for minerals. On day 18, blood was sampled 1h pre- and 0.5, 1, 1.5, 2, 3, 5 and 7h postprandially. Results Pi (KH2PO4, NaH2PO4) but not organic P caused an increased apparent P digestibility and significantly influenced kinetics of serum FGF23, parathyroid hormone, P, CrossLaps and bonespecific alkaline phosphatase, demonstrating a disrupted calcium (Ca) and P homeostasis with potential harm for renal, cardiovascular and skeletal health. Conclusions Results of feeding Pi to dogs indicate distinct disturbances of Ca and P metabolism, in contrast to organic sources. The use of Pi in food can therefore not be considered as safe. Further research, especially on dose and long-term effects, is warranted.	[Dobenecker, Britta; Herbst, Sarah] Ludwig Maximilians Univ Munchen, Dept Anim Sci, Chair Anim Nutr & Dietet, Munich, Germany; [Reese, Sven] Ludwig Maximilians Univ Munchen, Dept Anim Sci, Chair Anat Histol & Embryol, Munich, Germany	University of Munich; University of Munich	Dobenecker, B (corresponding author), Ludwig Maximilians Univ Munchen, Dept Anim Sci, Chair Anim Nutr & Dietet, Munich, Germany.	dobenecker@lmu.de	Reese, Sven/F-1826-2016	Reese, Sven/0000-0002-4605-9791; Dobenecker, Britta/0000-0003-0534-4219				Allen LCV, 2000, RES VET SCI, V68, P231, DOI 10.1053/rvsc.1999.0369; Allen MJ, 2003, VET CLIN PATH, V32, P101, DOI 10.1111/j.1939-165X.2003.tb00323.x; [Anonymous], 2019, HUNDEFUTTERBARF ODER; ASCHINBERG LC, 1977, J PEDIATR-US, V91, P56, DOI 10.1016/S0022-3476(77)80444-7; Bartges JW, 2012, VET CLIN N AM-SMALL, V42, P669, DOI 10.1016/j.cvsm.2012.04.008; Belic M, 2012, RES VET SCI, V93, P918, DOI 10.1016/j.rvsc.2012.01.008; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Boswald LF, 2018, J ANIM PHYSIOL AN N, V102, P31, DOI 10.1111/jpn.12886; Boswald LF, 2018, J ANIM PHYSIOL AN N, V102, P370, DOI 10.1111/jpn.12844; Bover J, 1999, BONE, V25, P279, DOI 10.1016/S8756-3282(99)00169-6; BREVES G, 1991, Nutrition Research Reviews, V4, P125, DOI 10.1079/NRR19910011; Brunetto MA, 2019, VET MED SCI, V5, P494, DOI 10.1002/vms3.183; Calvo MS, 2013, AM J CLIN NUTR, V98, P6, DOI 10.3945/ajcn.112.053934; Calvo MS, 2013, SEMIN DIALYSIS, V26, P54, DOI 10.1111/sdi.12042; CALVO MS, 1990, J CLIN ENDOCR METAB, V70, P1334, DOI 10.1210/jcem-70-5-1334; CALVO MS, 1993, J NUTR, V123, P1627, DOI 10.1093/jn/123.9.1627; Coltherd JC, 2019, BRIT J NUTR, V121, P270, DOI 10.1017/S0007114518003379; Cortadellas O, 2010, J VET INTERN MED, V24, P73, DOI 10.1111/j.1939-1676.2009.0415.x; Cozzolino M, 2001, J AM SOC NEPHROL, V12, P2511, DOI 10.1681/ASN.V12112511; Dalal M, 2011, EUR J ENDOCRINOL, V165, P797, DOI 10.1530/EJE-11-0577; Davies M., 2017, SCI REP-UK; de Borst MH, 2011, J AM SOC NEPHROL, V22, P1603, DOI 10.1681/ASN.2010121251; de la Horra C, 2000, J BIOL CHEM, V275, P6284, DOI 10.1074/jbc.275.9.6284; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Dobenecker B., 2018, Proceedings of the Society of Nutrition Physiology, V27, P95; Dobenecker B, 2002, J NUTR, V132, p1665S, DOI 10.1093/jn/132.6.1665S; Dobenecker B, 2017, ESVCN C; Dobenecker B, ESVCN C SUBM, P2020; Dobenecker B, 2019, CONCENTRATIONS HIGHL, P110; Dobenecker B, 2018, J FELINE MED SURG, V20, P339, DOI 10.1177/1098612X17710589; El-Abbadi MM, 2009, KIDNEY INT, V75, P1297, DOI 10.1038/ki.2009.83; Eller P, 2011, AM J PATHOL, V178, P1999, DOI 10.1016/j.ajpath.2011.01.024; Estepa JC, 1999, J BONE MINER RES, V14, P1848, DOI 10.1359/jbmr.1999.14.11.1848; European Standard, 2017, 169672017 EN; Evenepoel P, 2016, KIDNEY INT, V90, P1184, DOI 10.1016/j.kint.2016.06.041; Everman DB, 2003, EUR J PEDIATR, V162, P517, DOI 10.1007/s00431-002-0987-8; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Foley RN, 2009, J AM SOC NEPHROL, V20, P397, DOI 10.1681/ASN.2008020141; Fukumoto S, 2011, J BONE MINER METAB, V29, P507, DOI 10.1007/s00774-011-0298-0; Gagne JW, 2013, JAVMA-J AM VET MED A, V243, P658, DOI 10.2460/javma.243.5.658; Galitzer H, 2010, KIDNEY INT, V77, P211, DOI 10.1038/ki.2009.464; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Geddes RF, 2013, J VET EMERG CRIT CAR, V23, P122, DOI 10.1111/vec.12032; GERICKE S, 1952, FRESEN Z ANAL CHEM, V137, P15, DOI 10.1007/BF00452421; GfE, 1989, ENERGIEUND NAHRSTOFF; Giachelli CM, 2001, AM J KIDNEY DIS, V38, pS34, DOI 10.1053/ajkd.2001.27394; Gutierrez OM, 2018, P ESVCN C 2018 MUN, P12; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2013, ADV CHRONIC KIDNEY D, V20, P150, DOI 10.1053/j.ackd.2012.10.008; Hardcastle MR, 2015, VET PATHOL, V52, P770, DOI 10.1177/0300985815586222; Harjes LM, 2017, J VET INTERN MED, V31, P784, DOI 10.1111/jvim.14707; HARRIS WH, 1976, CALC TISS RES, V22, P85; HAUT LL, 1980, KIDNEY INT, V17, P722, DOI 10.1038/ki.1980.85; Herbst S, 2019, P ESVCN C TUR, P23; Hertel-Bohnke P., 2018, THESIS LUDWIG MAXIMI, DOI [10.1111/jpn.12982, DOI 10.1111/JPN.12982]; Hill RC, 2001, J ANIM SCI, V79, P2162; HOLLINGER H Z, 1956, Can Med Assoc J, V74, P912; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; IBELS LS, 1979, AM J MED, V66, P790, DOI 10.1016/0002-9343(79)91118-5; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Jackson HA, 1998, J SMALL ANIM PRACT, V39, P495, DOI 10.1111/j.1748-5827.1998.tb03687.x; Jan&beta;en E., 2006, VDLUFA METHODENBUCH, V10, P1; JENKINS KJ, 1960, J NUTR, V70, P241, DOI 10.1093/jn/70.2.241; Jin H, 2009, AM J RESP CRIT CARE, V179, P59, DOI 10.1164/rccm.200802-306OC; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; JOWSEY J, 1974, ACTA ORTHOP SCAND, V45, P801, DOI 10.3109/17453677408989691; KEGG, 2019, KYOTO ENCY GENES GEN; Kemi VE, 2010, BRIT J NUTR, V103, P561, DOI 10.1017/S0007114509992121; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kiefer-Hecker B., 2018, J ANIM PHYSL ANIM NU, P1; Kienzle E, 2006, J NUTR, V136, p2001S, DOI 10.1093/jn/136.7.2001S; Laflamme D, 1997, CANINE PRACT, V22, P10; LAFLAMME GH, 1972, J CLIN INVEST, V51, P2834, DOI 10.1172/JCI107106; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; LAU K, 1989, KIDNEY INT, V36, P918, DOI 10.1038/ki.1989.281; Lau WL, 2011, ADV CHRONIC KIDNEY D, V18, P105, DOI 10.1053/j.ackd.2010.12.002; Liesegang A, 2007, SCHWEIZ ARCH TIERH, V149, P353, DOI 10.1024/0036-7281.149.8.353; Linefsky JP, 2011, J AM COLL CARDIOL, V58, P291, DOI 10.1016/j.jacc.2010.11.073; Lineva A, 2019, J ANIM PHYSIOL AN N, V103, P317, DOI 10.1111/jpn.12986; Lippi I, 2014, JAVMA-J AM VET MED A, V245, P1135, DOI 10.2460/javma.245.10.1135; Locatelli F, 2002, NEPHROL DIAL TRANSPL, V17, P723, DOI 10.1093/ndt/17.5.723; Luskin AC, 2019, RES VET SCI, V123, P129, DOI 10.1016/j.rvsc.2019.01.001; Mack JK, 2015, J ANIM PHYSIOL AN N, V99, P801, DOI 10.1111/jpn.12294; Marks J, 2010, AM J PHYSIOL-RENAL, V299, pF285, DOI 10.1152/ajprenal.00508.2009; Marraffa JM, 2004, PEDIATR EMERG CARE, V20, P453, DOI 10.1097/01.pec.0000132217.65600.52; MARTIN RR, 1987, JAMA-J AM MED ASSOC, V257, P2190, DOI 10.1001/jama.257.16.2190; Moe SM, 2007, ADV CHRONIC KIDNEY D, V14, P3, DOI 10.1053/j.ackd.2006.10.005; Molins RA, 1991, PHOSPHATES IN FOOD, DOI [10.1002/food.19910350903, DOI 10.1002/FOOD.19910350903]; Moritz A, 2013, KLIN LABORDIAGNOSTIK, V7; Murer H, 1998, KIDNEY INT, pS2; Murer H, 2000, PHYSIOL REV, V80, P1373, DOI 10.1152/physrev.2000.80.4.1373; Nadkarni GN, 2014, ADV NUTR, V5, P98, DOI 10.3945/an.113.004655; Narang R, 1997, INT J CARDIOL, V60, P73, DOI 10.1016/S0167-5273(97)02971-9; National Research Council, 2006, NUTR REQ DOGS CATS; Noori N, 2010, IRAN J KIDNEY DIS, V4, P89; O'Neill DG, 2013, J VET INTERN MED, V27, P814, DOI 10.1111/jvim.12090; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Osuka S, 2012, J BONE MINER METAB, V30, P10, DOI 10.1007/s00774-011-0343-z; Parker V., 2012, J VET INTERN MED; PASTOOR FJH, 1995, J NUTR, V125, P1334; Pastoor FJH., 1993, INTERACTIONS DIETARY; PEI Y, 1992, KIDNEY INT, V42, P960, DOI 10.1038/ki.1992.374; Perwad F, 2007, AM J PHYSIOL-RENAL, V293, pF1577, DOI 10.1152/ajprenal.00463.2006; Pessinger C, 1996, UNTERSUCHUNGEN ZUM P; Pesti G. M., 1987, Recent advances in animal nutrition in Australia 1987, P176; Prins, 2008, P COMP NUTR SOC; QUAMME GA, 1985, AM J PHYSIOL, V249, pG168, DOI 10.1152/ajpgi.1985.249.2.G168; Ritz E, 2012, DTSCH ARZTEBL INT, V109, P49, DOI 10.3238/arztebl.2012.0049; Schmitt S, 2018, J ANIM PHYSIOL AN N, V102, pE798, DOI 10.1111/jpn.12837; Schmitt S, 2020, J ANIM PHYSIOL AN N, V104, P707, DOI 10.1111/jpn.13310; SCHNEIDER P, 1980, VET PATHOL, V17, P699, DOI 10.1177/030098588001700607; SCHNEIDER P, 1980, VET PATHOL, V17, P720, DOI 10.1177/030098588001700608; Schoppet M, 2012, J CLIN ENDOCR METAB, V97, pE575, DOI 10.1210/jc.2011-2836; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shimada T, 2002, J AM SOC NEPHROL, V13, p28A; Shimada T, 2001, J BONE MINER RES, V16, pS151; Shimada T, 2010, J CLIN ENDOCR METAB, V95, P578, DOI 10.1210/jc.2009-1603; Siedler S., 2018, THESIS LUDWIG MAXIMI; Silver J, 2013, NAT REV NEPHROL, V9, P641, DOI 10.1038/nrneph.2013.147; SLATOPOLSKY E, 1971, J CLIN INVEST, V50, P492, DOI 10.1172/JCI106517; Streiff EL, 2002, J NUTR, V132, p1698S, DOI 10.1093/jn/132.6.1698S; Tenenhouse HS, 2003, J AM SOC NEPHROL, V14, P240, DOI 10.1097/01.ASN.0000045045.47494.71; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Uribarri J, 2003, SEMIN DIALYSIS, V16, P186, DOI 10.1046/j.1525-139X.2003.16037.x; Uribarri J, 2013, ANN NY ACAD SCI, V1301, pIII, DOI 10.1111/nyas.12302; Walker HK., 1990, METHODS CLIN HIST PH, V3rd ed; Zhou C, 2010, CASE CONTROL STUDY R	129	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246950	10.1371/journal.pone.0246950	http://dx.doi.org/10.1371/journal.pone.0246950			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606750	Green Accepted, gold, Green Published			2022-12-26	WOS:000620629200148
J	Manishin, KA; Cunningham, CJ; Westley, PAH; Seitz, AC				Manishin, Kaitlyn A.; Cunningham, Curry J.; Westley, Peter A. H.; Seitz, Andrew C.			Can late stage marine mortality explain observed shifts in age structure of Chinook salmon?	PLOS ONE			English	Article								Chinook salmon (Oncorhynchus tshawytscha) populations have experienced widespread declines in abundance and abrupt shifts toward younger and smaller adults returning to spawn in rivers. The causal agents underpinning these shifts are largely unknown. Here we investigate the potential role of late-stage marine mortality, defined as occurring after the first winter at sea, in driving this species' changing age structure. Simulations using a stage-based life cycle model that included additional mortality during after the first winter at sea better reflected observed changes in the age structure of a well-studied and representative population of Chinook salmon from the Yukon River drainage, compared with a model estimating environmentally-driven variation in age-specific survival alone. Although the specific agents of late-stage mortality are not known, our finding is consistent with work reporting predation by salmon sharks (Lamna ditropis) and marine mammals including killer whales (Orcinus orca). Taken as a whole, this work suggests that Pacific salmon mortality after the first winter at sea is likely to be higher than previously thought and highlights the need to investigate selective sources of mortality, such as predation, as major contributors to rapidly changing age structure of spawning adult Chinook salmon.	[Manishin, Kaitlyn A.; Westley, Peter A. H.; Seitz, Andrew C.] Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Fairbanks, AK 99775 USA; [Cunningham, Curry J.] NOAA, Juneau, AK USA; [Manishin, Kaitlyn A.] Alaska Dept Fish & Game, Homer, AK USA; [Cunningham, Curry J.] Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Juneau, AK USA	University of Alaska System; University of Alaska Fairbanks; National Oceanic Atmospheric Admin (NOAA) - USA; Alaska Department of Fish & Game; University of Alaska System; University of Alaska Fairbanks	Seitz, AC (corresponding author), Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Fairbanks, AK 99775 USA.	acseitz@alaska.edu			Pollock Conservation Cooperative Research Center at the University of Alaska Fairbanks	Pollock Conservation Cooperative Research Center at the University of Alaska Fairbanks	KAM received a Graduate Student Fellowship from the Pollock Conservation Cooperative Research Center at the University of Alaska Fairbanks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens RNM, 2012, FISH FISH, V13, P41, DOI 10.1111/j.1467-2979.2011.00432.x; Baranov F.I., 1918, NAUCHN ISSLED IKHTIO, V1, P81; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bromaghin JF, 2008, 100 US FISH WILDL SE; Brown RJ, 2017, J FISH WILDL MANAG, V8, P558, DOI 10.3996/052017-JFWM-045; Chasco B, 2017, CAN J FISH AQUAT SCI, V74, P1173, DOI 10.1139/cjfas-2016-0203; CLARKE WC, 1994, AQUACULTURE, V121, P95, DOI 10.1016/0044-8486(94)90011-6; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Cunningham CJ, 2018, GLOBAL CHANGE BIOL, V24, P4399, DOI 10.1111/gcb.14315; Enberg K, 2009, EVOL APPL, V2, P394, DOI 10.1111/j.1752-4571.2009.00077.x; Gates KS, 2016, ALASKA FISH DATA SER; Groot C., 1991, PACIFIC SALMON LIFE; Halupka KC, 2000, PNWGTR468; Harper KC, 2018, ALASKA FISH DATA SER; Healey M.C., 1991, P311; Jackson T., 2018, CF18003 AL DEP FISH; JTC, 2012, 3A1201 JTC AL DEP FI; JTC, 2014, 3A1401 JTC AL DEP FI; JTC, 2013, 3A1301 JTC AL DEP FI; JTC, 2009, 3A0901 JTC AL DEP FI; JTC, 2017, 3A1701 JTC AL DEP FI; JTC, 2008, 3A0801 JTC AL DEP FI; JTC, 2011, 3A1101 JTC AL DEP FI; JTC, 2015, 341501 JTC AL DEP FI; JTC, 2007, 3A0701 JTC AL DEP FI; JTC (Joint Technical Committee), 2016, 3A1601 JTC AL DEP FI; Kotwicki S, 2014, ICES J MAR SCI, V71, P1107, DOI 10.1093/icesjms/fst208; Lewis B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130184; MOUSSALLI E, 1986, CAN J FISH AQUAT SCI, V43, P135, DOI 10.1139/f86-014; Murawski SA, 2001, ICES J MAR SCI, V58, P1002, DOI 10.1006/jmsc.2001.1097; Nagler JJ, 02097 US FISH WILDL; Ohlberger J, 2019, P NATL ACAD SCI USA, V116, P26682, DOI 10.1073/pnas.1910930116; Ohlberger J, 2018, FISH FISH, V19, P533, DOI 10.1111/faf.12272; Ohlberger J, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1333; Oke KB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17726-z; Palkovacs EP, 2011, TRENDS ECOL EVOL, V26, P616, DOI 10.1016/j.tree.2011.08.004; Reznick DN, 2005, CAN J FISH AQUAT SCI, V62, P791, DOI 10.1139/F05-079; Ruggerone GT, 2018, MAR COAST FISH, V10, P152, DOI 10.1002/mcf2.10023; Ruggerone GT, 2017, 17 ANN SALM OC EC M; Seitz AC, 2019, CAN J FISH AQUAT SCI, V76, P1608, DOI 10.1139/cjfas-2018-0490; Siegel JE, 2018, MAR ECOL PROG SER, V595, P187, DOI 10.3354/meps12564; Sturdivant R.X., 2013, APPL LOGISITIC REGRE; Wells BK, 2007, FISH OCEANOGR, V16, P363, DOI 10.1111/j.1365-2419.2007.00437.x; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696	45	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247370	10.1371/journal.pone.0247370	http://dx.doi.org/10.1371/journal.pone.0247370			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606847	Green Published, gold			2022-12-26	WOS:000620629200175
J	Plarre, R; Zocca, A; Spitzer, A; Benemann, S; Gorbushina, AA; Li, YX; Waske, A; Funk, A; Wilbig, J; Gunster, J				Plarre, Rudy; Zocca, Andrea; Spitzer, Andrea; Benemann, Sigrid; Gorbushina, Anna A.; Li, Yuexuan; Waske, Anja; Funk, Alexander; Wilbig, Janka; Guenster, Jens			Searching for biological feedstock material: 3D printing of wood particles from house borer and drywood termite frass	PLOS ONE			English	Article							LAYER THICKNESS; POWDER; MOLDS	Frass (fine powdery refuse or fragile perforated wood produced by the activity of boring insects) of larvae of the European house borer (EHB) and of drywood termites was tested as a natural and novel feedstock for 3D-printing of wood-based materials. Small particles produced by the drywood termite Incisitermes marginipennis and the EHB Hylotrupes bajulus during feeding in construction timber, were used. Frass is a powdery material of particularly consistent quality that is essentially biologically processed wood mixed with debris of wood and faeces. The filigree-like particles flow easily permitting the build-up of wood-based structures in a layer wise fashion using the Binder Jetting printing process. The quality of powders produced by different insect species was compared along with the processing steps and properties of the printed parts. Drywood termite frass with a Hausner Ratio HR = 1.1 with rho Bulk = 0.67 g/cm(3) and rho Tap = 0.74 g/cm(3) was perfectly suited to deposition of uniformly packed layers in 3D printing. We suggest that a variety of naturally available feedstocks could be used in environmentally responsible approaches to scientific material sciences/additive manufacturing.	[Plarre, Rudy; Zocca, Andrea; Spitzer, Andrea; Benemann, Sigrid; Gorbushina, Anna A.; Li, Yuexuan; Waske, Anja; Funk, Alexander; Wilbig, Janka; Guenster, Jens] Bundesanstalt Mat Forsch & Prufung BAM, Berlin, Germany; [Gorbushina, Anna A.] Free Univ Berlin, Inst Geol Sci, Berlin, Germany; [Li, Yuexuan] Xi An Jiao Tong Univ, Sch Mech Engn, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China; [Guenster, Jens] Tech Univ Clausthal, Inst Nonmetall Mat, Clausthal Zellerfeld, Germany	Federal Institute for Materials Research & Testing; Free University of Berlin; Xi'an Jiaotong University; TU Clausthal	Gunster, J (corresponding author), Bundesanstalt Mat Forsch & Prufung BAM, Berlin, Germany.; Gunster, J (corresponding author), Tech Univ Clausthal, Inst Nonmetall Mat, Clausthal Zellerfeld, Germany.	jens.guenster@bam.de	Funk, Alexander/ABE-5083-2020	Gorbushina, Anna A./0000-0001-7685-7797				Almaghariz ES, 2016, INT J METALCAST, V10, P240, DOI 10.1007/s40962-016-0027-5; Ayrilmis N, 2019, INT J ADV MANUF TECH, V102, P2195, DOI 10.1007/s00170-019-03299-9; Ayrilmis N, 2018, POLYM TEST, V71, P163, DOI 10.1016/j.polymertesting.2018.09.009; Bai Y, 2019, J MANUF SCI E-T ASME, V141, DOI 10.1115/1.4041624; Bai Y, 2017, J MANUF SCI E-T ASME, V139, DOI 10.1115/1.4036640; Chavez LA, 2020, CERAMICS-BASEL, V3, P65, DOI 10.3390/ceramics3010008; Fleisher A, 2019, CERAM INT, V45, P18023, DOI 10.1016/j.ceramint.2019.06.021; Gibson I., 2015, ADDITIVE MANUFACTURI, P205, DOI DOI 10.1007/978-1-4939-2113-3_8; Gu H, 2019, ADDIT MANUF, V28, P194, DOI 10.1016/j.addma.2019.05.004; Guessasma S, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11111778; Gunster J., Patent No. [2900455 B1, 2900455]; HAUSNER HH, 1981, POWDER TECHNOL, V30, P3, DOI 10.1016/0032-5910(81)85021-8; Henke K, 2013, EUR J WOOD WOOD PROD, V71, P139, DOI 10.1007/s00107-012-0658-z; Kam D, 2019, ADV MATER TECHNOL-US, V4, DOI 10.1002/admt.201900158; KANG HR, 1991, J IMAGING SCI, V35, P179; Kariz M, 2018, WOOD RES-SLOVAKIA, V63, P917; Kariz M, 2016, EUR J WOOD WOOD PROD, V74, P123, DOI 10.1007/s00107-015-0987-9; Markstedt K, 2019, APPL MATER TODAY, V15, P280, DOI 10.1016/j.apmt.2019.02.005; Meteyer S, 2014, PROC CIRP, V15, P19, DOI 10.1016/j.procir.2014.06.030; Park SJ, 2020, ADDIT MANUF, V31, DOI 10.1016/j.addma.2019.100974; Petchwattana N, 2019, J PHYS SCI, V30, P169, DOI 10.21315/jps2019.30.2.10; Pringle AM, 2018, FOREST PROD J, V68, P86, DOI 10.13073/FPJ-D-17-00042; Rosenthal M, 2018, EUR J WOOD WOOD PROD, V76, P797, DOI 10.1007/s00107-017-1274-8; SCHELLNHUBER HJ, 1998, EARTH SYSTEM ANAL IN; Upadhyay M, 2017, J MANUF PROCESS, V29, P211, DOI 10.1016/j.jmapro.2017.07.017; Wahab Md Saidin, 2013, Applied Mechanics and Materials, V315, P987, DOI 10.4028/www.scientific.net/AMM.315.987; Walker J, 2018, INT J METALCAST, V12, P785, DOI 10.1007/s40962-018-0211-x; Wimmer R., 2015, Pro Ligno, V11, P144; Xu WY, 2019, ACS APPL MATER INTER, V11, P12389, DOI 10.1021/acsami.9b03442; Ziaee M, 2019, ADDIT MANUF, V28, P781, DOI 10.1016/j.addma.2019.05.031; Zocca A, 2015, J AM CERAM SOC, V98, P1983, DOI 10.1111/jace.13700	31	4	6	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246511	10.1371/journal.pone.0246511	http://dx.doi.org/10.1371/journal.pone.0246511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606771	Green Published, gold, Green Submitted			2022-12-26	WOS:000620629200055
J	Seitz, BM; McCune, K; MacPherson, M; Bergeron, L; Blaisdell, AP; Logan, CJ				Seitz, Benjamin M.; McCune, Kelsey; MacPherson, Maggie; Bergeron, Luisa; Blaisdell, Aaron P.; Logan, Corina J.			Using touchscreen equipped operant chambers to study animal cognition. Benefits, limitations, and advice	PLOS ONE			English	Article							TESTING METHOD; PERFORMANCE; PIGEONS; ASSAYS; WILD	Operant chambers are small enclosures used to test animal behavior and cognition. While traditionally reliant on simple technologies for presenting stimuli (e.g., lights and sounds) and recording responses made to basic manipulanda (e.g., levers and buttons), an increasing number of researchers are beginning to use Touchscreen-equipped Operant Chambers (TOCs). These TOCs have obvious advantages, namely by allowing researchers to present a near infinite number of visual stimuli as well as increased flexibility in the types of responses that can be made and recorded. We trained wild-caught adult and juvenile great-tailed grackles (Quiscalus mexicanus) to complete experiments using a TOC. We learned much from these efforts, and outline the advantages and disadvantages of our protocols. Our training data are summarized to quantify the variables that might influence participation and success, and we discuss important modifications to facilitate animal engagement and participation in various tasks. Finally, we provide a "training guide" for creating experiments using PsychoPy, a free and open-source software that was incredibly useful during these endeavors. This article, therefore, should serve as a resource to those interested in switching to or maintaining a TOC, or who similarly wish to use a TOC to test the cognitive abilities of non-model species or wild-caught individuals.	[Seitz, Benjamin M.; Blaisdell, Aaron P.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [McCune, Kelsey; MacPherson, Maggie; Bergeron, Luisa] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Logan, Corina J.] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	University of California System; University of California Los Angeles; University of California System; University of California Santa Barbara; Max Planck Society	Seitz, BM (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.; Logan, CJ (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	bseitz1@ucla.edu; corina_logan@eva.mpg.de	MacPherson, Maggie/AAQ-9801-2021	MacPherson, Maggie/0000-0002-9522-5688; McCune, Kelsey/0000-0003-0951-0827; Logan, Corina/0000-0002-5944-906X; Seitz, Benjamin/0000-0001-8046-7011	Department of Human Behavior, Ecology and Culture at the Max Planck Institute for Evolutionary Anthropology; Leverhulme Early Career Research Fellowship; National Science Foundation [DGE-1650604, BCS-1844144]	Department of Human Behavior, Ecology and Culture at the Max Planck Institute for Evolutionary Anthropology; Leverhulme Early Career Research Fellowship(Leverhulme Trust); National Science Foundation(National Science Foundation (NSF))	This research is funded by the Department of Human Behavior, Ecology and Culture at the Max Planck Institute for Evolutionary Anthropology (https://www.eva.mpg.de/index.html) (2017-current), and by a Leverhulme Early Career Research Fellowship (https://www.leverhulme.ac.uk/early-career-fellowships) to CJL (2017-2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Benjamin Seitz is supported by National Science Foundation grant DGE-1650604 and Aaron P. Blaisdell is supported by National Science Foundation research grant BCS-1844144.	Aplin L., 2018, F LAB METHODS ANIM A, P92; Blaisdell A., 2019, PCI ECOL; Bridges D, 2020, PEERJ, V8, DOI 10.7717/peerj.9414; BROWN PL, 1968, J EXP ANAL BEHAV, V11, P1, DOI 10.1901/jeab.1968.11-1; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Bussey TJ, 2008, LEARN MEMORY, V15, P516, DOI 10.1101/lm.987808; Cauchoix M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13179-5; Chow PKY, 2017, ANIM COGN, V20, P459, DOI 10.1007/s10071-017-1072-z; Cook RG, 2004, BEHAV RES METH INS C, V36, P101, DOI 10.3758/BF03195555; Deffner D., 2019, PCI ECOL; Dumont JR, 2021, GENES BRAIN BEHAV, V20, DOI 10.1111/gbb.12650; Guigueno MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128302; KAMIL AC, 1988, NEBR SYM MOTIV, V35, P257; Kangas BD, 2017, BEHAV PHARMACOL, V28, P623, DOI 10.1097/FBP.0000000000000356; Logan C., 2019, PCI ECOL; McCune KB, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.181311; Mery F, 2013, CURR OPIN NEUROBIOL, V23, P52, DOI 10.1016/j.conb.2012.09.001; Morand-Ferron J, 2016, BIOL REV, V91, P367, DOI 10.1111/brv.12174; Morand-Ferron J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133821; MORRISON SK, 1990, BEHAV RES METH INSTR, V22, P123, DOI 10.3758/BF03203131; Mueller-Paul J, 2014, BEHAV PROCESS, V106, P187, DOI 10.1016/j.beproc.2014.06.003; Niemela PT, 2014, TRENDS ECOL EVOL, V29, P245, DOI 10.1016/j.tree.2014.02.007; Peirce J., 2018, BUILDING EXPT PSYCHO, DOI [10.1177/0301006618823976, DOI 10.1177/0301006618823976]; Peirce J, 2019, BEHAV RES METHODS, V51, P195, DOI 10.3758/s13428-018-01193-y; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Perdue BM, 2016, BEHAV SCI, V6, DOI 10.3390/bs6040019; Perovic M, 1991, Southeast Asian J Trop Med Public Health, V22 Suppl, P135; Sawa K, 2005, J EXP PSYCHOL-ANIM B, V31, P368, DOI 10.1037/0097-7403.31.3.368; Schmitt V., 2018, 316042 BIORXIV, DOI 10.1101/316042; Schroeder J, 2018, BEHAV RES METHODS, V50, P773, DOI 10.3758/s13428-017-0904-8; Seitz B., 2020, KNOWL NETW BIOCOMPLE, DOI [10.5063/222S6Q, DOI 10.5063/222S6Q]; SKINNER BF, 1948, J EXP PSYCHOL, V38, P168, DOI 10.1037//0096-3445.121.3.273; Stahlman WD, 2010, LEARN BEHAV, V38, P111, DOI 10.3758/LB.38.2.111; Thornton A, 2012, PHILOS T R SOC B, V367, P2773, DOI 10.1098/rstb.2012.0214; Vardi R, 2020, BEHAV ECOL SOCIOBIOL, V74, DOI 10.1007/s00265-020-2805-6; Vonk J, 2012, ANIM BEHAV, V84, P231, DOI 10.1016/j.anbehav.2012.05.001; Wolf JE, 2014, BEHAV RES METHODS, V46, P206, DOI 10.3758/s13428-013-0366-6; Zeagler C., 2016, 3 INT C AN COMP INT, P1, DOI [10.1145/2995257.2995384, DOI 10.1145/2995257.2995384]	39	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246446	10.1371/journal.pone.0246446	http://dx.doi.org/10.1371/journal.pone.0246446			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606723	Green Published, Green Submitted, gold			2022-12-26	WOS:000620629200154
J	Snyder, K; Thomas, B; Lu, ML; Jha, R; Barim, MS; Hayden, M; Werren, D				Snyder, Kristian; Thomas, Brennan; Lu, Ming-Lun; Jha, Rashmi; Barim, Menekse S.; Hayden, Marie; Werren, Dwight			A deep learning approach for lower back-pain risk prediction during manual lifting	PLOS ONE			English	Article							ACTIVITY RECOGNITION	Occupationally-induced back pain is a leading cause of reduced productivity in industry. Detecting when a worker is lifting incorrectly and at increased risk of back injury presents significant possible benefits. These include increased quality of life for the worker due to lower rates of back injury and fewer workers' compensation claims and missed time for the employer. However, recognizing lifting risk provides a challenge due to typically small datasets and subtle underlying features in accelerometer and gyroscope data. A novel method to classify a lifting dataset using a 2D convolutional neural network (CNN) and no manual feature extraction is proposed in this paper; the dataset consisted of 10 subjects lifting at various relative distances from the body with 720 total trials. The proposed deep CNN displayed greater accuracy (90.6%) compared to an alternative CNN and multilayer perceptron (MLP). A deep CNN could be adapted to classify many other activities that traditionally pose greater challenges in industrial environments due to their size and complexity.	[Snyder, Kristian; Thomas, Brennan; Jha, Rashmi] Univ Cincinnati, Dept Elect Engn & Comp Syst, Cincinnati, OH 45221 USA; [Lu, Ming-Lun; Barim, Menekse S.; Hayden, Marie; Werren, Dwight] Natl Inst Occupat Safety & Hlth, Cincinnati, OH 45226 USA	University System of Ohio; University of Cincinnati; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Snyder, K (corresponding author), Univ Cincinnati, Dept Elect Engn & Comp Syst, Cincinnati, OH 45221 USA.	snyderks@mail.uc.edu		Snyder, Kristian/0000-0002-3448-2381	National Institute for Occupational Safety and Health [75D30119P05031]; Research Experiences for Undergraduates Program of the National Science Foundation (REU NSF) [ECCS 1556294]	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Research Experiences for Undergraduates Program of the National Science Foundation (REU NSF)	Funder 1 Funding was provided by the National Institute for Occupational Safety and Health. Recipient: K.S. Research contract number: 75D30119P05031 https://www.cdc.gov/niosh/index.htm This funder provided the data collection used and approved of publishing. They had no role in study design, data analysis, or preparation of the manuscript. Funder 2 Funding was provided by the Research Experiences for Undergraduates Program of the National Science Foundation (REU NSF). Grant number: ECCS 1556294. Recipients: K.S., B.T. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Arif M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130851; Bao L, 2004, LECT NOTES COMPUT SC, V3001, P1, DOI 10.1007/978-3-540-24646-6_1; Barim Menekse S., 2019, Proceedings of the Human Factors and Ergonomics Society Annual Meeting, V63, P1105, DOI 10.1177/1071181319631367; Bernhard BP, 1997, MUSCULOSKELETAL DISO; Cook D, 2013, KNOWL INF SYST, V36, P537, DOI 10.1007/s10115-013-0665-3; Cortes C, 2012, OPTIMIZATION; Council NR., 2001, MUSC DIS WORKPL LOW; Delgado R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222916; Dempsey PG, 2005, APPL ERGON, V36, P489, DOI 10.1016/j.apergo.2005.01.007; Erer KS, 2007, J BIOMECH, V40, P2934, DOI 10.1016/j.jbiomech.2007.02.019; Gorodkin J, 2004, COMPUT BIOL CHEM, V28, P367, DOI 10.1016/j.compbiolchem.2004.09.006; Hammerla N. Y., 2016, P 25 INT JOINT C ART, P1533; Hinton G. E., 2012, ARXIV12070580, DOI DOI 10.9774/GLEAF.978-1-909493-38-42; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Jalal A, 2017, PATTERN RECOGN, V61, P295, DOI 10.1016/j.patcog.2016.08.003; Kingma DP., 2014, ADAM METHOD STOCHAST; Kotsiantis S., 2006, GESTS INT T COMPUTER, V30, P25, DOI DOI 10.1007/978-0-387-09823-4_45; Kwapisz JR., 2011, ACM SIGKDD EXPLORATI, V12, P74, DOI [10.1145/1964897.1964918, DOI 10.1145/1964897.1964918]; Kwon S, 2011, IEEE ENG MED BIO, P5260, DOI 10.1109/IEMBS.2011.6091301; Liberty Mutual Research Institute for Safety, LIBERTY MUTUAL WORKP; Liu Y, 2016, NEUROCOMPUTING, V181, P108, DOI 10.1016/j.neucom.2015.08.096; Maurer U, 2006, BSN 2006: INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P113; Mayagoitia RE, 2002, J BIOMECH, V35, P537, DOI 10.1016/S0021-9290(01)00231-7; Mayer JM, 2006, ARCH PHYS MED REHAB, V87, P1310, DOI 10.1016/j.apmr.2006.07.259; Music J, 2013, IEEE SYMP COMP COMMU; Nagi J., 2011, 2011 IEEE International Conference on Signal and Image Processing Applications (ICSIPA 2011), P342, DOI 10.1109/ICSIPA.2011.6144164; Olson M, 2018, ADV NEUR IN, V31; Ordonez FJ, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010115; Pratkanis T., 2013, CLASSIFICATION MOBIL; Preece SJ, 2009, PHYSIOL MEAS, V30, pR1, DOI 10.1088/0967-3334/30/4/R01; Sak H, 2014, INTERSPEECH, P338; Simonyan K., 2014, ICLR, P1; Waters T., 1994, DHHS NIOSH, V94, P1; Waters TR, 2011, J OCCUP ENVIRON MED, V53, P1061, DOI 10.1097/JOM.0b013e31822cfe5e; Weiss GM, 2016, PROCEEDINGS OF 3RD IEEE/ACM INTERNATIONAL CONFERENCE ON DATA SCIENCE AND ADVANCED ANALYTICS, (DSAA 2016), P682, DOI 10.1109/DSAA.2016.89	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247162	10.1371/journal.pone.0247162	http://dx.doi.org/10.1371/journal.pone.0247162			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606783	gold, Green Published, Green Submitted			2022-12-26	WOS:000620629200056
J	Kitanishi, Y; Fujiwara, M; Binkowitz, B				Kitanishi, Yoshitake; Fujiwara, Masakazu; Binkowitz, Bruce			Patient journey through cases of depression from claims database using machine learning algorithms	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; RISK	Health insurance and acute hospital-based claims have recently become available as real-world data after marketing in Japan and, thus, classification and prediction using the machine learning approach can be applied to them. However, the methodology used for the analysis of real-world data has been hitherto under debate and research on visualizing the patient journey is still inconclusive. So far, to classify diseases based on medical histories and patient demographic background and to predict the patient prognosis for each disease, the correlation structure of real-world data has been estimated by machine learning. Therefore, we applied association analysis to real-world data to consider a combination of disease events as the patient journey for depression diagnoses. However, association analysis makes it difficult to interpret multiple outcome measures simultaneously and comprehensively. To address this issue, we applied the Topological Data Analysis (TDA) Mapper to sequentially interpret multiple indices, thus obtaining a visual classification of the diseases commonly associated with depression. Under this approach, the visual and continuous classification of related diseases may contribute to precision medicine research and can help pharmaceutical companies provide appropriate personalized medical care.	[Kitanishi, Yoshitake; Fujiwara, Masakazu] Shion & Co Ltd, Data Sci Off, Osaka, Japan; [Binkowitz, Bruce] Shion Inc, Biometr, Florham Pk, NJ USA		Fujiwara, M (corresponding author), Shion & Co Ltd, Data Sci Off, Osaka, Japan.	masakazu.fujiwara@shionogi.co.jp		, Masakazu/0000-0002-0451-6894				Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Agrawal R., 1994, P 20 INT C VER LARG, P487; [Anonymous], 2019, NATURE, V566, P7, DOI 10.1038/d41586-019-00483-5; Chazal F., 2017, ARXIV PREPRINT ARXIV; Chen M, 2017, IEEE COMMUN MAG, V55, P54, DOI 10.1109/MCOM.2017.1600410CM; Curtis JR, 2019, ARTHRIT CARE RES, V71, P1249, DOI 10.1002/acr.23769; Hahsler M, 2005, J STAT SOFTW, V14; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Kitanishi Y, C P IFCS 2019 THESS; Lenca P, 2008, EUR J OPER RES, V184, P610, DOI 10.1016/j.ejor.2006.10.059; Li J, 2016, BRIEF BIOINFORM, V17, P2, DOI 10.1093/bib/bbv020; M~ullner D., 2013, PYTHON MAPPER OPEN S; Mamlin BW, 2016, AM J MED SCI, V351, P59, DOI 10.1016/j.amjms.2015.10.015; Moran LV, 2019, NEW ENGL J MED, V380, P1128, DOI 10.1056/NEJMoa1813751; Nakaoka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099021; Napolitano F, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-30; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Ohisa M, 2015, HEPATOL RES, V45, P1228, DOI 10.1111/hepr.12497; Oquendo MA, 2012, MOL PSYCHIATR, V17, P956, DOI 10.1038/mp.2011.173; Rey JM, 2015, IACAPAP E TXB CHILD; Sakamoto M, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/7642049; Singh Gurjeet, 2007, EUR S POINT BAS GRAP, DOI [10.2312/SPBG/SPBG07/091-100, DOI 10.2312/SPBG/SPBG07/091-100]; Torres-Tramon Pablo, 2015, Current Trends in Web Engineering. 15th International Conference, ICWE 2015. Workshops NLPIT, PEWET, SoWEMine. Revised Selected Papers: LNCS 9396, P186, DOI 10.1007/978-3-319-24800-4_16; Vamathevan J, 2019, NAT REV DRUG DISCOV, V18, P463, DOI 10.1038/s41573-019-0024-5; Wake M, 2018, ATHEROSCLEROSIS, V272, P145, DOI 10.1016/j.atherosclerosis.2018.03.023; Weeke P, 2012, CLIN PHARMACOL THER, V92, P72, DOI 10.1038/clpt.2011.368; Yamanaka H, 2014, MOD RHEUMATOL, V24, P33, DOI 10.3109/14397595.2013.854059; Ye W., 2011, CNPT, V2, P1; Zhou FL, 2019, DIABETES OBES METAB, V21, P1925, DOI 10.1111/dom.13753	29	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247059	10.1371/journal.pone.0247059	http://dx.doi.org/10.1371/journal.pone.0247059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592062	gold, Green Published			2022-12-26	WOS:000620632800046
J	Orvieto, R; Farhi, J; Nahum, R; Basch, S; Haas, J; Aizer, A				Orvieto, Raoul; Farhi, Jacob; Nahum, Ravit; Basch, Shani; Haas, Jigal; Aizer, Adva			Future fertility of patients with zero oocytes yield in their first IVF cycle attempt	PLOS ONE			English	Article								Purpose We aim to estimate the future fertility of patient undergoing their first IVF cycle attempt with no oocyte retrieved, and to identify factors that might predict those who will conceive in subsequent IVF cycle attempt. Methods A cohort retrospective study of all consecutive women attending our IVF unit, for their first IVF cycle attempt, between January 2013 to December 2019, who reached the ovum pick-up (OPU) stage with zero oocyte retrieved. Patients' characteristics and infertility-treatment-related variables in the first IVF cycle attempt were compared between those who conceived in a subsequent cycle and those who did not. Moreover, infertility-treatment-related variables during successful cycles resulting in pregnancy were compared to those without. Results 59 met the study inclusion criteria, yielding zero oocytes. During the follow-up period, 12 (20.3%) women conceived (one conceived twice), and 8 (14%) gave birth to a live infant. Cumulative live-birth rate per OPU and per patients were 4% and 14%, respectively. Clinical pregnancies were achieved after 3.61+1.4 cycle attempts (range: 1-6), with no live-births following the fifth IVF cycle attempt. No in-between group differences were observed in ovarian stimulation variables of their first IVF cycle attempt. Moreover, in those cycles resulting in pregnancy, patients achieved a significantly higher number of fertilized oocytes (2.15+1.5 vs 0.94+1.5, respectively; p<0.01) and a higher mean top-quality embryos (TQE) (1.76+0.9 vs 0.73+1.2, respectively; p<0.003). Conclusion Women yielding zero oocytes at their first IVF cycle attempt, may achieve 14% cumulative live-birth rate after 5 IVF cycle attempts. Moreover, those who conceived in subsequent IVF cycle attempts were those achieving 2 or more fertilized oocytes/TQE.	[Orvieto, Raoul; Nahum, Ravit; Basch, Shani; Haas, Jigal; Aizer, Adva] Chaim Sheba Med Ctr Tel Hashomer, Dept Obstet & Gynecol, Ramat Gan, Israel; [Orvieto, Raoul; Farhi, Jacob; Nahum, Ravit; Haas, Jigal; Aizer, Adva] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Orvieto, Raoul] Tel Aviv Univ, Sackler Fac Med, Tarnesby Tarnowski Chair Family Planning & Fertil, Tel Aviv, Israel; [Farhi, Jacob] Wolfson Med Ctr, IVF Unit, Holon, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Orvieto, R (corresponding author), Chaim Sheba Med Ctr Tel Hashomer, Dept Obstet & Gynecol, Ramat Gan, Israel.; Orvieto, R (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.; Orvieto, R (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tarnesby Tarnowski Chair Family Planning & Fertil, Tel Aviv, Israel.	raoul.orvieto@sheba.health.gov.il		aizer, adva/0000-0003-0820-8079; Orvieto, Raoul/0000-0002-0865-1196				BENRAFAEL Z, 1994, GYNECOL ENDOCRINOL, V8, P277, DOI 10.3109/09513599409023632; Drakopoulos P, 2016, HUM REPROD, V31, P370, DOI 10.1093/humrep/dev316; Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092; Homburg R, 2009, FERTIL STERIL, V91, P1311, DOI 10.1016/j.fertnstert.2008.01.094; Humaidan P, 2017, HUM REPROD, V32, P544, DOI 10.1093/humrep/dew360; Lebovitz O, 2018, REPROD BIOMED ONLINE, V37, P533, DOI 10.1016/j.rbmo.2018.08.014; Polyzos NP, 2018, FERTIL STERIL, V110, P661, DOI 10.1016/j.fertnstert.2018.04.039; Polyzos NP, 2014, REPROD BIOMED ONLINE, V28, P469, DOI 10.1016/j.rbmo.2013.11.010; Sunkara SK, 2011, HUM REPROD, V26, P1768, DOI 10.1093/humrep/der106; Ziebe S, 2007, HUM REPROD, V22, P2404, DOI 10.1093/humrep/dem221	10	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246889	10.1371/journal.pone.0246889	http://dx.doi.org/10.1371/journal.pone.0246889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592057	Green Published, gold			2022-12-26	WOS:000620632800041
J	Jung, SJ; Lim, SS; Yoon, JH				Jung, Sun Jae; Lim, Sung-Shil; Yoon, Jin-Ha			Fluctuations in influenza-like illness epidemics and suicide mortality: A time-series regression of 13-year mortality data in South Korea	PLOS ONE			English	Article								Aims We explored the association between influenza epidemic and suicide mortality rates in a large population using a time-series regression of 13-year mortality data in South Korea. Methods Weekly suicide mortalities and influenza-like illness (ILI) were analyzed using time series regression. Regression coefficient for suicide mortality based on percentage change of ILI was calculated using a quasi-Poisson regression. Non-linear distributed lag models with quadratic function up to 24 weeks were constructed. Results The association between ILI and suicide mortality increased significantly up to 8 weeks post-influenza diagnosis. A significant positive association between ILI and suicide mortality was observed from 2009, when a novel influenza A(H1N1)pdm09 virus provoked a worldwide pandemic. No meaningful association between these factors was observed before 2009. Conclusion There was a significant positive relationship between ILI and suicide mortality after 2009, when a novel influenza A(H1N1)pdm09 virus provoked a worldwide pandemic.	[Jung, Sun Jae; Yoon, Jin-Ha] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Jung, Sun Jae] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Lim, Sung-Shil; Yoon, Jin-Ha] Yonsei Univ, Coll Med, Inst Occupat Hlth, Seoul, South Korea	Yonsei University; Yonsei University Health System; Harvard University; Harvard T.H. Chan School of Public Health; Yonsei University; Yonsei University Health System	Yoon, JH (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.; Yoon, JH (corresponding author), Yonsei Univ, Coll Med, Inst Occupat Hlth, Seoul, South Korea.	flyinyou@gmail.com	Jung, Sun Jae/GVU-7200-2022	Jung, Sun Jae/0000-0002-5194-7339; Yoon, Jin-Ha/0000-0003-4198-2955	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science and ICT [NRF-2019R1A4A1028155]; Korea Health Industry Development Institute through "Social and Environmental Risk Research" - Ministry of Health Welfare [HI19C0052]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science and ICT(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Health Industry Development Institute through "Social and Environmental Risk Research" - Ministry of Health Welfare	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) and funded by the Ministry of Science and ICT (NRF-2019R1A4A1028155) (to SJJ). This work was supported by Korea Health Industry Development Institute through "Social and Environmental Risk Research" funded by Ministry of Health & Welfare (HI19C0052) (to JHY). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer R, 1997, J FORENSIC SCI, V42, P157; Baldo V, 2016, J Prev Med Hyg, V57, pE19; Bohmwald K, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00386; Bornand D, 2016, BRAIN BEHAV IMMUN, V53, P131, DOI 10.1016/j.bbi.2015.12.005; Brundin L, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.133; Casscells S Ward, 2009, Int J Adolesc Med Health, V21, P79, DOI 10.1515/IJAMH.2009.21.1.79; Centers for Disease CaP, 2017, FLU VACC SAF INF DO; Deshmukh IS, 2015, J PEDIATR NEUROSCI, V10, P61, DOI 10.4103/1817-1745.154357; Fonken LK, 2018, BRAIN BEHAV IMMUN, V73, P133, DOI 10.1016/j.bbi.2018.07.012; Gharbawy D, 2012, J AFFECT DISORDERS, V138, P41, DOI 10.1016/j.jad.2011.12.037; Glaser R, 2003, ARCH GEN PSYCHIAT, V60, P1009, DOI 10.1001/archpsyc.60.10.1009; Hansen HG, 2019, BIOL PSYCHIAT, V85, P744, DOI 10.1016/j.biopsych.2018.11.008; Harrington R, 2018, ANN FAM MED, V16, P145, DOI 10.1370/afm.2183; Hiltunen Laura, 2011, J Circadian Rhythms, V9, P10, DOI 10.1186/1740-3391-9-10; Jefferson T, 2014, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20141324T2, 10.1002/14651858.CD008965.pub4]; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Kitcharoen S, 2010, EMERG INFECT DIS, V16, P569, DOI 10.3201/eid1603.091699; Lee SJ, 2017, ALLERGY ASTHMA RESPI, V5, P320, DOI 10.4168/aard.2017.5.6.320; Lund-Sorensen H, 2016, JAMA PSYCHIAT, V73, P912, DOI 10.1001/jamapsychiatry.2016.1594; Moller-Leimkuhler AM, 2003, EUR ARCH PSY CLIN N, V253, P1, DOI 10.1007/s00406-003-0397-6; Okusaga O, 2016, J PSYCHIATR RES, V72, P74, DOI 10.1016/j.jpsychires.2015.10.002; Okusaga O, 2011, J AFFECT DISORDERS, V130, P220, DOI 10.1016/j.jad.2010.09.029; Oquendo MA, 2014, AM J PSYCHIAT, V171, P1259, DOI 10.1176/appi.ajp.2014.14020194; Pariante CM, 1999, LANCET, V354, P131, DOI 10.1016/S0140-6736(98)04793-X; Park M, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017033; Qin P, 2011, ALLERGY, V66, P658, DOI 10.1111/j.1398-9995.2010.02523.x; Ryu S, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0347-8; Sapuan S, 2007, MALAYS J MED SCI, V14, P71; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Sublette ME, 2011, BRAIN BEHAV IMMUN, V25, P1272, DOI 10.1016/j.bbi.2011.05.002; Tan K, 2010, LANCET NEUROL, V9, P142, DOI 10.1016/S1474-4422(10)70015-6; Vaccines IoMCtRAEo, 2012, INFLUENZA VACCINE; van Eijk LT, 2007, CRIT CARE MED, V35, P1464, DOI 10.1097/01.CCM.0000266534.14262.E8; Vaswani M, 2003, PROG NEURO-PSYCHOPH, V27, P85, DOI 10.1016/S0278-5846(02)00338-X; Woo JM, 2012, ACTA PSYCHIAT SCAND, V125, P168, DOI 10.1111/j.1600-0447.2011.01813.x; 손병우, 2019, [Korean Journal of Clinical Pharmacy, 한국임상약학회지], V29, P56; Yoon JH, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16112007; Yuan N, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0570-y	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0244596	10.1371/journal.pone.0244596	http://dx.doi.org/10.1371/journal.pone.0244596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK0KW	33577567	Green Published, gold			2022-12-26	WOS:000620071700013
J	Zhou, M; Wong, CK; Un, KC; Lau, YM; Lee, JCY; Tam, FCC; Lau, YM; Lai, WH; Tam, AR; Lam, YY; Pang, P; Tong, T; Tang, M; Tse, HF; Ho, D; Ng, MY; Chan, EW; Wong, ICK; Lau, CP; Hung, IFN; Siu, CW				Zhou, Mi; Wong, Chun-Ka; Un, Ka-Chun; Lau, Yuk-Ming; Lee, Jeffrey Chun-Yin; Tam, Frankie Chor-Cheung; Lau, Yee-Man; Lai, Wing-Hon; Tam, Anthony Raymond; Lam, Yat-Yin; Pang, Polly; Tong, Teresa; Tang, Milky; Tse, Hung-Fat; Ho, Deborah; Ng, Ming-Yen; Chan, Esther W.; Wong, Ian C. K.; Lau, Chu-Pak; Hung, Ivan Fan-Ngai; Siu, Chung-Wah			Cardiovascular sequalae in uncomplicated COVID-19 survivors	PLOS ONE			English	Article							PREVALENCE; DIAGNOSIS; INFLUENZA; DISEASES; SOCIETY; ADULTS	Background A high proportion of COVID-19 patients were reported to have cardiac involvements. Data pertaining to cardiac sequalae is of urgent importance to define subsequent cardiac surveillance. Methods We performed a systematic cardiac screening for 97 consecutive COVID-19 survivors including electrocardiogram (ECG), echocardiography, serum troponin and NT-proBNP assay 1-4 weeks after hospital discharge. Treadmill exercise test and cardiac magnetic resonance imaging (CMR) were performed according to initial screening results. Results The mean age was 46.5 +/- 18.6 years; 53.6% were men. All were classified with non-severe disease without overt cardiac manifestations and did not require intensive care. Median hospitalization stay was 17 days and median duration from discharge to screening was 11 days. Cardiac abnormalities were detected in 42.3% including sinus bradycardia (29.9%), newly detected T-wave abnormality (8.2%), elevated troponin level (6.2%), newly detected atrial fibrillation (1.0%), and newly detected left ventricular systolic dysfunction with elevated NT-proBNP level (1.0%). Significant sinus bradycardia with heart rate below 50 bpm was detected in 7.2% COVID-19 survivors, which appeared to be self-limiting and recovered over time. For COVID-19 survivors with persistent elevation of troponin level after discharge or newly detected T wave abnormality, echocardiography and CMR did not reveal any evidence of infarct, myocarditis, or left ventricular systolic dysfunction. Conclusion Cardiac abnormality is common amongst COVID-survivors with mild disease, which is mostly self-limiting. Nonetheless, cardiac surveillance in form of ECG and/or serum biomarkers may be advisable to detect more severe cardiac involvement including atrial fibrillation and left ventricular dysfunction.	[Zhou, Mi; Wong, Chun-Ka; Un, Ka-Chun; Lau, Yuk-Ming; Tam, Frankie Chor-Cheung; Lau, Yee-Man; Lai, Wing-Hon; Tse, Hung-Fat; Lau, Chu-Pak; Siu, Chung-Wah] Univ Hong Kong, Dept Med, Cardiol Div, Hong Kong, Peoples R China; [Lee, Jeffrey Chun-Yin] Grantham Hosp, Cardiac Med Unit, Hong Kong, Peoples R China; [Tam, Anthony Raymond; Pang, Polly; Tong, Teresa; Tang, Milky; Ho, Deborah; Hung, Ivan Fan-Ngai] Univ Hong Kong, Dept Med, Infect Dis Div, Hong Kong, Peoples R China; [Lam, Yat-Yin] Asian Heart Ctr, Hong Kong, Peoples R China; [Ng, Ming-Yen] Univ Hong Kong, Dept Diagnost Radiol, Hong Kong, Peoples R China; [Chan, Esther W.; Wong, Ian C. K.] Univ Hong Kong, Ctr Safe Medicat Practice & Res, Dept Pharmacol & Pharm, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Siu, CW (corresponding author), Univ Hong Kong, Dept Med, Cardiol Div, Hong Kong, Peoples R China.; Hung, IFN (corresponding author), Univ Hong Kong, Dept Med, Infect Dis Div, Hong Kong, Peoples R China.	ivanhung@hku.hk; cwdsiu@hku.hk	Ng, Ming Yen/AFO-0008-2022; Siu, Chung Wah/C-6947-2011; Tse, Hung-Fat/C-4426-2009; Hung, Ivan FN/ABD-5916-2021; Chan, Esther Wai Yin/B-3522-2012	Ng, Ming Yen/0000-0001-9533-3892; Tse, Hung-Fat/0000-0002-9578-7808; Hung, Ivan FN/0000-0002-1556-2538; Wong, Chun-Ka/0000-0001-5205-9440; Chan, Esther Wai Yin/0000-0002-7602-9470; zhou, Mi/0000-0002-0864-9512				Ajam M, 2019, CUREUS, V11, DOI 10.7759/cureus.3821; [Anonymous], 2020, REPORT WHO CHINA JOI; Aro AL, 2012, CIRCULATION, V125, P2572, DOI 10.1161/CIRCULATIONAHA.112.098681; Basso C, 2020, EUR HEART J, V41, P3827, DOI 10.1093/eurheartj/ehaa664; Cellarier G, 2016, MED SANTE TROP, V26, P283, DOI 10.1684/mst.2016.0586; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106; Harris JE, 2019, IJC HEART VASC, V22, P145, DOI 10.1016/j.ijcha.2018.12.013; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kytomaa S, 2019, JAMA CARDIOL, V4, P363, DOI 10.1001/jamacardio.2019.0549; Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9; Lippi G, 2020, PROG CARDIOVASC DIS, V63, P390, DOI 10.1016/j.pcad.2020.03.001; Marcus FI, 2005, AM J CARDIOL, V95, P1070, DOI 10.1016/j.amjcard.2004.12.060; Metlay JP, 2019, AM J RESP CRIT CARE, V200, pE45, DOI 10.1164/rccm.201908-1581ST; Mitchell C, 2019, J AM SOC ECHOCARDIOG, V32, P1, DOI 10.1016/j.echo.2018.06.004; Muller MP, 2007, PHARMACOTHERAPY, V27, P494, DOI 10.1592/phco.27.4.494; Paul JF, 2020, EUR HEART J-CARD IMG, V21, P776, DOI 10.1093/ehjci/jeaa107; Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6; Pelliccia A, 2007, EUR HEART J, V28, P2006, DOI 10.1093/eurheartj/ehm219; POLLOCK S, 1986, J NEUROL NEUROSUR PS, V49, P331, DOI 10.1136/jnnp.49.3.331-a; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Smith BK, 2008, J CLIN NEUROSCI, V15, P1053, DOI 10.1016/j.jocn.2006.06.017; Tam CCF, 2021, CATHETER CARDIO INTE, V97, pE194, DOI 10.1002/ccd.28943; Tam CCF, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.120.006631; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Warren-Gash C, 2009, LANCET INFECT DIS, V9, P601, DOI 10.1016/S1473-3099(09)70233-6; Wilkoff BL, 1989, J ELECTROPHYSIOL, V3, P176, DOI DOI 10.1111/J.1540-8167.1989.TB01549.X; Yu CM, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.12.004; Yu CM, 2006, POSTGRAD MED J, V82, P140, DOI 10.1136/pgmj.2005.037515; Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	33	27	26	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246732	10.1371/journal.pone.0246732	http://dx.doi.org/10.1371/journal.pone.0246732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571321	Green Published, gold			2022-12-26	WOS:000618274000056
J	Guerrina, N; Traboulsi, H; de Souza, AR; Bosse, Y; Thatcher, TH; Robichaud, A; Ding, J; Li, PZ; Simon, L; Pareek, S; Bourbeau, J; Tan, WC; Benedetti, A; Obeidat, M; Sin, DD; Brandsma, CA; Nickle, DC; Sime, PJ; Phipps, RP; Nair, P; Zago, M; Hamid, Q; Smith, BM; Eidelman, DH; Baglole, CJ				Guerrina, Necola; Traboulsi, Hussein; de Souza, Angela Rico; Bosse, Yohan; Thatcher, Thomas H.; Robichaud, Annette; Ding, Jun; Li, Pei Z.; Simon, Leora; Pareek, Swati; Bourbeau, Jean; Tan, Wan C.; Benedetti, Andrea; Obeidat, Ma'en; Sin, Don D.; Brandsma, Corry-Anke; Nickle, David C.; Sime, Patricia J.; Phipps, Richard P.; Nair, Parameswaran; Zago, Michela; Hamid, Qutayba; Smith, Benjamin M.; Eidelman, David H.; Baglole, Carolyn J.			Aryl hydrocarbon receptor deficiency causes the development of chronic obstructive pulmonary disease through the integration of multiple pathogenic mechanisms	FASEB JOURNAL			English	Article								Emphysema, a component of chronic obstructive pulmonary disease (COPD), is characterized by irreversible alveolar destruction that results in a progressive decline in lung function. This alveolar destruction is caused by cigarette smoke, the most important risk factor for COPD. Only 15%-20% of smokers develop COPD, suggesting that unknown factors contribute to disease pathogenesis. We postulate that the aryl hydrocarbon receptor (AHR), a receptor/transcription factor highly expressed in the lungs, may be a new susceptibility factor whose expression protects against COPD. Here, we report that Ahr-deficient mice chronically exposed to cigarette smoke develop airspace enlargement concomitant with a decline in lung function. Chronic cigarette smoke exposure also increased cleaved caspase-3, lowered SOD2 expression, and altered MMP9 and TIMP-1 levels in Ahr-deficient mice. We also show that people with COPD have reduced expression of pulmonary and systemic AHR, with systemic AHR mRNA levels positively correlating with lung function. Systemic AHR was also lower in never-smokers with COPD. Thus, AHR expression protects against the development of COPD by controlling interrelated mechanisms involved in the pathogenesis of this disease. This study identifies the AHR as a new, central player in the homeostatic maintenance of lung health, providing a foundation for the AHR as a novel therapeutic target and/or predictive biomarker in chronic lung disease.	[Guerrina, Necola; Traboulsi, Hussein; de Souza, Angela Rico; Ding, Jun; Pareek, Swati; Bourbeau, Jean; Benedetti, Andrea; Hamid, Qutayba; Smith, Benjamin M.; Baglole, Carolyn J.] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Guerrina, Necola; Pareek, Swati; Baglole, Carolyn J.] McGill Univ, Dept Pathol, Montreal, PQ, Canada; [Bosse, Yohan] Laval Univ, Inst Univ Cardiol & Pneumol Quebec, Dept Mol Med, Quebec City, PQ, Canada; [Thatcher, Thomas H.; Sime, Patricia J.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA; [Robichaud, Annette] SCIREQ Sci Resp Equipment Inc, Montreal, PQ, Canada; [Ding, Jun; Simon, Leora; Bourbeau, Jean; Benedetti, Andrea; Hamid, Qutayba; Smith, Benjamin M.; Eidelman, David H.; Baglole, Carolyn J.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Li, Pei Z.; Bourbeau, Jean; Benedetti, Andrea; Smith, Benjamin M.] McGill Univ, Resp Epidemiol & Clin Res Unit, Hlth Ctr, Montreal, PQ, Canada; [Tan, Wan C.] Univ British Columbia UBC, UBC, James Hogg Res Ctr, Vancouver, BC, Canada; [Benedetti, Andrea] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Benedetti, Andrea] McGill Univ, Dept Biostat, Montreal, PQ, Canada; [Benedetti, Andrea] McGill Univ, Dept Occupat Hlth, Montreal, PQ, Canada; [Obeidat, Ma'en; Sin, Don D.] Univ British Columbia, Ctr Heart Lung Innovat, St Pauls Hosp, Vancouver, BC, Canada; [Obeidat, Ma'en; Sin, Don D.] Univ British Columbia, Div Resp Med, Vancouver, BC, Canada; [Brandsma, Corry-Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Nickle, David C.] Merck & Co Inc, Rahway, NJ 07065 USA; [Phipps, Richard P.] Univ Rochester, Dept Environm Med, Rochester, NY 14642 USA; [Nair, Parameswaran] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Nair, Parameswaran] St Josephs Healthcare, Hamilton, ON, Canada; [Zago, Michela] Klox Technol, Laval, PQ, Canada; [Hamid, Qutayba] Univ Sharjah, Coll Med, Sharjah, U Arab Emirates; [Baglole, Carolyn J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	McGill University; McGill University; Laval University; Virginia Commonwealth University; McGill University; McGill University; University of British Columbia; McGill University; McGill University; McGill University; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; University of Groningen; Merck & Company; University of Rochester; McMaster University; University of Sharjah; McGill University	Baglole, CJ (corresponding author), MUHC, Res Inst, Ctr Translat Biol CTB, Block E,1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.	carolyn.baglole@mcgill.ca	Sin, Don/AAC-2219-2021; Ding, Jun/ABH-1012-2021	Ding, Jun/0000-0001-5183-6885	Canada Foundation for Innovation (CFI); Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); Gouvernement du Canada \ CIHR \ Institute of Circulatory and Respiratory Health (ICRH) [PJT-168836]; Canada Research Chairs (Chaires de recherche du Canada); Fonds de Recherche du Quebec - Sante (FRQS); HHS \ National Institutes of Health (NIH) [HL075432, HL120908]	Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); Gouvernement du Canada \ CIHR \ Institute of Circulatory and Respiratory Health (ICRH); Canada Research Chairs (Chaires de recherche du Canada)(Canada Research Chairs); Fonds de Recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Canada Foundation for Innovation (CFI); Gouvernement du Canada vertical bar Natural Sciences and Engineering Research Council of Canada (NSERC); Gouvernement du Canada vertical bar CIHR vertical bar Institute of Circulatory and Respiratory Health (ICRH), Grant/Award Number: PJT-168836; Canada Research Chairs (Chaires de recherche du Canada); Fonds de Recherche du Quebec - Sante (FRQS); Fonds de Recherche du Quebec - Sante (FRQS); HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: HL075432; HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: HL120908	Adams TS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1983; Adeloye D, 2015, J GLOB HEALTH, V5, P186, DOI 10.7189/jogh.05.020415; Akool ES, 2003, MOL CELL BIOL, V23, P4901, DOI 10.1128/MCB.23.14.4901-4916.2003; Angelis N, 2014, J THORAC DIS, V6, pS167, DOI 10.3978/j.issn.2072-1439.2014.03.07; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; Baglole CJ, 2018, PEDIATR RES, V83, P1165, DOI 10.1038/pr.2018.36; Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; Boschetto P, 2006, THORAX, V61, P1037, DOI 10.1136/thx.2006.058321; Bourbeau J, 2014, COPD, V11, P125, DOI 10.3109/15412555.2012.665520; Busch R, 2017, AM J RESP CELL MOL, V57, P35, DOI 10.1165/rcmb.2016-0331OC; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; de Souza AR, 2014, TOXICOL SCI, V140, P204, DOI 10.1093/toxsci/kfu068; de Souza AR, 2011, J BIOL CHEM, V286, P43214, DOI 10.1074/jbc.M111.258764; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Evans BR, 2008, MOL PHARMACOL, V73, P387, DOI 10.1124/mol.107.040204; Ghio AJ, 2014, INFECTION, V42, P459, DOI 10.1007/s15010-014-0592-6; Guerassimov A, 2004, AM J RESP CRIT CARE, V170, P974, DOI 10.1164/rccm.200309-1270oc; Guerrina N., 2021, FASEB J, V35; Guerrina N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123882; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hecht E, 2014, TOXICOL APPL PHARM, V280, P511, DOI 10.1016/j.taap.2014.08.023; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P542, DOI 10.1164/ajrccm.155.2.9032192; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Martey CA, 2005, AM J PHYSIOL-LUNG C, V289, pL391, DOI 10.1152/ajplung.00062.2005; Martey CA, 2004, AM J PHYSIOL-LUNG C, V287, pL981, DOI 10.1152/ajplung.00239.2003; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; National Research Council, REV DEP DEF ENH PART, P85; Nemmar A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/279371; Viet NN, 2015, RESPIROLOGY, V20, P602, DOI 10.1111/resp.12507; Papandrinopoulou D, 2012, PULM MED, V2012, DOI 10.1155/2012/542769; POLAND A, 1976, J BIOL CHEM, V251, P4936; Robichaud A, 2017, J APPL PHYSIOL, V123, P746, DOI 10.1152/japplphysiol.00856.2016; Rogers S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40539; Sarill M, 2015, FREE RADICAL BIO MED, V89, P342, DOI 10.1016/j.freeradbiomed.2015.08.007; Sharafkhaneh Amir, 2008, Proc Am Thorac Soc, V5, P475, DOI 10.1513/pats.200708-126ET; Sheridan JA, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0214-6; Steiling K, 2013, AM J RESP CRIT CARE, V187, P933, DOI 10.1164/rccm.201208-1449OC; Stejskalova L, 2013, TOXICOL LETT, V223, P183, DOI 10.1016/j.toxlet.2013.09.014; Tammemagi MC, 2011, CANCER PREV RES, V4, P552, DOI 10.1158/1940-6207.CAPR-10-0183; Tan WC, 2015, THORAX, V70, P822, DOI 10.1136/thoraxjnl-2015-206938; Taylor SC, 2015, J VIROL METHODS, V224, P58, DOI 10.1016/j.jviromet.2015.08.014; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; van den Bogaard EH, 2013, J CLIN INVEST, V123, P917, DOI 10.1172/JCI65642; van der Vaart H, 2005, AM J RESP CRIT CARE, V172, P465, DOI 10.1164/rccm.200501-147OC; Van Pottelberge GR, 2011, AM J RESP CRIT CARE, V183, P898, DOI 10.1164/rccm.201002-0304OC; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; Vrzal R, 2009, CHEM-BIOL INTERACT, V179, P288, DOI 10.1016/j.cbi.2008.10.035; Wain LV, 2017, NAT GENET, V49, P416, DOI 10.1038/ng.3787; Wang CK, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/195094; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wu R, 2007, J PHARMACOL EXP THER, V320, P448, DOI 10.1124/jpet.106.111773; Zago M, 2014, TOXICOL LETT, V226, P107, DOI 10.1016/j.toxlet.2014.01.020; Zago M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074953	59	8	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21376	10.1096/fj.202002350R	http://dx.doi.org/10.1096/fj.202002350R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33605487	Green Published			2022-12-26	WOS:000629576700022
J	Tang, Q; Liu, QH; Yang, XP; Wu, T; Huang, CY; Zhang, JH; Zhang, ZJ; Zhang, GR; Zhao, YN; Zhou, J; Huang, H; Xia, Y; Yan, JM; Li, YP; He, JH				Tang, Qin; Liu, Qinhui; Yang, Xuping; Wu, Tong; Huang, Cuiyuan; Zhang, Jinhang; Zhang, Zijing; Zhang, Guorong; Zhao, Yingnan; Zhou, Jian; Huang, Hui; Xia, Yan; Yan, Jiamin; Li, Yanping; He, Jinhan			Sirtuin 6 supra-physiological overexpression in hypothalamic pro-opiomelanocortin neurons promotes obesity via the hypothalamus-adipose axis	FASEB JOURNAL			English	Article						obesity; overexpression; POMC neurons; Sirt6; sympathetic nervous system	POMC NEURONS; LEPTIN; WHITE; MICE; PREDISPOSES; HOMEOSTASIS; DELETION; TISSUE; BROWN	Sirtuin 6 (Sirt6), a member of the Sirtuin family, has important roles in maintaining glucose and lipid metabolism. Our previous studies demonstrated that the deletion of Sirt6 in pro-opiomelanocortin (POMC)-expressing cells by the loxP-Cre system resulted in severe obesity and hepatic steatosis. However, whether overexpression of Sirt6 in hypothalamic POMC neurons could ameliorate diet-induced obesity is still unknown. Thus, we generated mice specifically overexpressing Sirt6 in hypothalamic POMC neurons (PSOE) by stereotaxic injection of Cre-dependent adeno-associated viruses into the arcuate nucleus of Pomc-Cre mice. PSOE mice showed increased adiposity and decreased energy expenditure. Furthermore, thermogenesis of BAT and lipolysis of WAT were both impaired, caused by reduced sympathetic nerve innervation and activity in adipose tissues. Mechanistically, Sirt6 overexpression decreasing STAT3 acetylation, thus lowering POMC expression in the hypothalamus underlined the observed phenotypes in PSOE mice. These results demonstrate that Sirt6 overexpression specifically in the hypothalamic POMC neurons exacerbates diet-induced obesity and metabolic disorders via the hypothalamus-adipose axis.	[Tang, Qin; Liu, Qinhui; Yang, Xuping; Wu, Tong; Huang, Cuiyuan; Zhang, Jinhang; Zhang, Zijing; Zhang, Guorong; Zhao, Yingnan; Zhou, Jian; Huang, Hui; Xia, Yan; Yan, Jiamin; Li, Yanping; He, Jinhan] Sichuan Univ, Lab Clin Pharm & Adverse Drug React, West China Hosp, Chengdu, Peoples R China; [Yang, Xuping; Wu, Tong; Huang, Cuiyuan; Zhang, Jinhang; Zhang, Zijing; Zhang, Guorong; Zhao, Yingnan; Zhou, Jian; Huang, Hui; Xia, Yan; Yan, Jiamin; He, Jinhan] Sichuan Univ, Dept Pharm, West China Hosp, Chengdu, Peoples R China	Sichuan University; Sichuan University	He, JH (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy,Lab Clin Pharm & Adverse, Chengdu 610041, Sichuan, Peoples R China.; He, JH (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Canc Ctr, Chengdu 610041, Sichuan, Peoples R China.	jinhanhe@scu.edu.cn	li, yan/GTI-4638-2022		National Natural Science Foundation of China (NSFC) [81930020, 81873662, 81870599, 82025007]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81930020, 81873662, 81870599 and 82025007	Anderson JG, 2015, MOL METAB, V4, P846, DOI 10.1016/j.molmet.2015.09.003; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; Cakir I, 2019, TRENDS ENDOCRIN MET, V30, P163, DOI 10.1016/j.tem.2019.01.002; Chang AR, 2020, PHYSIOL REV, V100, P145, DOI 10.1152/physrev.00030.2018; Chen L, 2019, J BIOL CHEM, V294, P1579, DOI 10.1074/jbc.RA118.005309; Chen Y, 2015, DIABETES, V64, P2069, DOI 10.2337/db14-1206; Cui XN, 2017, AM J PHYSIOL-ENDOC M, V313, pE493, DOI 10.1152/ajpendo.00122.2017; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Dorfman MD, 2017, DIABETES, V66, P920, DOI 10.2337/db16-0482; Favero G, 2014, ACTA HISTOCHEM, V116, P272, DOI 10.1016/j.acthis.2013.08.006; Grundy SM, 2015, EUR J CLIN INVEST, V45, P1209, DOI 10.1111/eci.12519; Guo DF, 2019, DIABETES, V68, P1591, DOI 10.2337/db18-1088; Hayes MR, 2010, CELL METAB, V11, P77, DOI 10.1016/j.cmet.2009.10.009; Jiang HC, 2017, CELL METAB, V26, P686, DOI 10.1016/j.cmet.2017.08.016; Ka SO, 2017, FASEB J, V31, P3999, DOI 10.1096/fj.201700098RR; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kuang JY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00135; Kuang JY, 2017, DIABETES, V66, P1159, DOI 10.2337/db16-1225; Mark AL, 2009, HYPERTENSION, V53, P375, DOI 10.1161/HYPERTENSIONAHA.108.124255; Messina G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00137; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nadal A, 2017, NAT REV ENDOCRINOL, V13, P536, DOI 10.1038/nrendo.2017.51; Nguyen NLT, 2017, AM J PHYSIOL-REG I, V312, pR132, DOI 10.1152/ajpregu.00344.2016; Nguyen NLT, 2014, AM J PHYSIOL-REG I, V306, pR375, DOI 10.1152/ajpregu.00552.2013; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Padilla SL, 2012, ENDOCRINOLOGY, V153, P1219, DOI 10.1210/en.2011-1665; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Petridou A, 2019, METABOLISM, V92, P163, DOI 10.1016/j.metabol.2018.10.009; Ramadori G, 2010, CELL METAB, V12, P78, DOI 10.1016/j.cmet.2010.05.010; Scherer PE, 2016, DIABETES, V65, P1452, DOI 10.2337/db16-0339; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Shen KL, 2020, WORLD J PEDIATR, V16, P219, DOI 10.1007/s12519-020-00344-6; Sociali G, 2017, FASEB J, V31, P3138, DOI 10.1096/fj.201601294R; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tang CF, 2019, J CELL PHYSIOL, V234, P18615, DOI 10.1002/jcp.28500; Tang Q, 2020, MOL METAB, V37, DOI 10.1016/j.molmet.2020.100994; Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002; Timper K, 2017, DIS MODEL MECH, V10, P679, DOI 10.1242/dmm.026609; Toda C, 2017, ANNU REV PHYSIOL, V79, P209, DOI 10.1146/annurev-physiol-022516-034110; Tupone D, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00014; Villarroya F, 2018, J INTERN MED, V284, P492, DOI 10.1111/joim.12803; Wang DQ, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00040; Wang PTQ, 2020, NATURE, V583, P839, DOI 10.1038/s41586-020-2527-y; Wen S, 2019, SCI CHINA LIFE SCI, V62, P771, DOI 10.1007/s11427-018-9371-4; Xiao YZ, 2017, DIABETES, V66, P1146, DOI 10.2337/db16-1546; Xiong XW, 2016, DIABETOLOGIA, V59, P151, DOI 10.1007/s00125-015-3778-2; Yao L, 2017, CELL REP, V20, P641, DOI 10.1016/j.celrep.2017.06.069; Yuan FX, 2020, MOL METAB, V42, DOI 10.1016/j.molmet.2020.101084; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055	49	3	3	5	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21408	10.1096/fj.202002607	http://dx.doi.org/10.1096/fj.202002607			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33583107	Bronze			2022-12-26	WOS:000629576700031
J	Butt, S; Jeppesen, JL; Iversen, LV; Fenger, M; Eugen-Olsen, J; Andersson, C; Jacobsen, S				Butt, Sheraz; Jeppesen, Jorgen L.; Iversen, Line Vinderslev; Fenger, Mogens; Eugen-Olsen, Jesper; Andersson, Charlotte; Jacobsen, Soren			Association of soluble urokinase plasminogen activator receptor levels with fibrotic and vascular manifestations in systemic sclerosis	PLOS ONE			English	Article								Objective We assessed the association of suPAR (soluble urokinase plasminogen activator receptor) plasma levels with fibrotic and vascular manifestations in patients with systemic sclerosis (SSc). Methods suPAR plasma levels were measured in 121 consecutive patients with SSc and correlated to pulmonary and vascular features of SSc, including interstitial lung disease as characterized by percentage of predicted CO diffusing capacity (DLco) and forced vital capacity (FVC), pulmonary fibrosis by computed tomography, and pulmonary arterial hypertension, telangiectasias, and digital ulcers. Results Overall, 121 SSc patients (84% females; mean age, 57 +/- 12 [range: 22-79] years) were enrolled; 35% had diffuse cutaneous SSc. suPAR plasma levels ranged from 1.3-10.2 [median: 2.9 (p25-p75: 2.3-3.9)] ng/mL. Log(suPAR) levels correlated with DLco (r = -0.41, p <0.0001) and FVC (r = -0.26, p = 0.004), also when adjusted for age, sex, and pulmonary hypertension. A suPAR cut-off level of >2.5 ng/mL showed a sensitivity of 91% for identifying patients with either DLco <50% or FVC < 60% of the predicted values. Similarly, 19 (90%) had a suPAR >2.5 ng/mL among those diagnosed with pulmonary fibrosis vs. 59 (60%) among those who did not (p = 0.008). suPAR values were not associated with vascular manifestations. Conclusion suPAR levels strongly correlated with pulmonary involvement in SSc. Future studies should test if suPAR estimation can be used for surveillance of severe pulmonary involvement in SSc.	[Butt, Sheraz; Jeppesen, Jorgen L.] Amager & Hvidovre Univ Hosp, Dept Internal Med, Glostrup, Denmark; [Iversen, Line Vinderslev] Bispebjerg Hosp, Dept Dermatol, Copenhagen, Denmark; [Iversen, Line Vinderslev] Odense Univ Hosp, Dept Dermatol & Allergy, Odense, Denmark; [Fenger, Mogens] Amager & Hvidovre Univ Hosp, Dept Clin Biochem, Hvidovre, Denmark; [Eugen-Olsen, Jesper] Amager & Hvidovre Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Andersson, Charlotte] Herlev Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Jacobsen, Soren] Copenhagen Univ Hosp, Rigshosp, Copenhagen Lupus & Vasculitis Clin, Ctr Rheumatol & Spine Dis, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen	Butt, S (corresponding author), Amager & Hvidovre Univ Hosp, Dept Internal Med, Glostrup, Denmark.	sherazab@gmail.com		Jacobsen, Soren/0000-0002-5654-4993				Affandi AJ, 2015, SEMIN IMMUNOPATHOL, V37, P475, DOI 10.1007/s00281-015-0506-4; Andersen O, 2008, J MED VIROL, V80, P209, DOI 10.1002/jmv.21114; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Augustine DX, 2018, ECHO RES PRACT, V5, pG11, DOI 10.1530/ERP-17-0071; Bandinelli F, 2005, CLIN EXP RHEUMATOL, V23, P671; Bernstein AM, 2007, MOL BIOL CELL, V18, P2716, DOI 10.1091/mbc.E06-10-0912; Butt SA, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013405; Butt SA, 2018, BMC RHEUMATOL, V2, DOI 10.1186/s41927-018-0043-6; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; D'Alessio S, 2004, ARTHRITIS RHEUM-US, V50, P3275, DOI 10.1002/art.20562; Enocsson H, 2013, TRANSL RES, V162, P287, DOI 10.1016/j.trsl.2013.07.003; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Eugen-Olsen J, 2015, INT J ANTIMICROB AG, V46, pS33, DOI 10.1016/j.ijantimicag.2015.10.011; Godtfredsen NS, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0803-2; Hamie L, 2018, POSTGRAD MED J, V94, P517, DOI 10.1136/postgradmedj-2018-135839; Hanitsch LG, 2009, RHEUMATOLOGY, V48, P70, DOI 10.1093/rheumatology/ken408; Hayes DF, 2015, MOL ONCOL, V9, P960, DOI 10.1016/j.molonc.2014.10.004; Iversen LV, 2013, SCAND J RHEUMATOL, V42, P473, DOI 10.3109/03009742.2013.796403; Iversen LV, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0653-8; Jog NR, 2017, J ALLERGY CLIN IMMUN, V140, P1473, DOI 10.1016/j.jaci.2017.10.003; Kanno Y, 2008, J INVEST DERMATOL, V128, P2792, DOI 10.1038/jid.2008.157; Kofoed K, 2006, CLIN CHEM, V52, P1284, DOI 10.1373/clinchem.2006.067595; Kumanovics G, 2014, CLIN EXP RHEUMATOL, V32, pS138; Kuzumi A, 2018, J DERMATOL, V45, P1216, DOI 10.1111/1346-8138.14538; Legany N, 2015, CLIN CHEM LAB MED, V53, P1799, DOI 10.1515/cclm-2015-0079; LEROY EC, 1988, J RHEUMATOL, V15, P202; Lis-Swiety A, 2018, J INT MED RES, V46, P1634, DOI 10.1177/0300060518760955; Liu XC, 2013, ARTHRIT CARE RES, V65, P1375, DOI 10.1002/acr.21968; Loosen Sven H, 2018, Oncotarget, V9, P27027, DOI 10.18632/oncotarget.25471; Lyngbaek S, 2013, INT J CARDIOL, V167, P2904, DOI 10.1016/j.ijcard.2012.07.018; Lyngbaek S, 2013, INT J CARDIOL, V167, P781, DOI 10.1016/j.ijcard.2012.03.040; Manetti M, 2016, CURR OPIN RHEUMATOL, V28, P606, DOI 10.1097/BOR.0000000000000324; Manetti M, 2014, ANN RHEUM DIS, V73, P1700, DOI 10.1136/annrheumdis-2013-203706; Manetti M, 2011, ARTHRITIS RHEUM-US, V63, P247, DOI 10.1002/art.30101; Margheri F, 2006, ARTHRITIS RHEUM-US, V54, P3926, DOI 10.1002/art.22263; Meyer J, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0478-1; Muangchan C, 2012, ARTHRIT CARE RES, V64, P1405, DOI 10.1002/acr.21716; Muangchant Chayawee, 2013, Clin Exp Rheumatol, V31, P122; Ross Laura, 2018, Clin Exp Rheumatol, V36 Suppl 113, P126; Slot O, 1999, ANN RHEUM DIS, V58, P488, DOI 10.1136/ard.58.8.488; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Toldi G, 2013, CLIN CHEM LAB MED, V51, P327, DOI 10.1515/cclm-2012-0221; Toldi G, 2012, BIOMARKERS, V17, P758, DOI 10.3109/1354750X.2012.728623; Wen S, 2018, CLIN EXP RHEUMATOL, V36, P36; Zhang GQ, 2003, J AM SOC NEPHROL, V14, P1254, DOI 10.1097/01.ASN.0000064292.37793.FB; Zimmermann HW, 2012, LIVER INT, V32, P500, DOI 10.1111/j.1478-3231.2011.02665.x	46	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247256	10.1371/journal.pone.0247256	http://dx.doi.org/10.1371/journal.pone.0247256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617568	Green Published, gold			2022-12-26	WOS:000623082400055
J	Huang, H; Dong, LL; Xue, ZS; Liu, XF; Hua, CJ				Huang, Hui; Dong, Linlu; Xue, Zhishuang; Liu, Xiaofang; Hua, Caijian			Fusion algorithm of visible and infrared image based on anisotropic diffusion and image enhancement (capitalize only the first word in a title (or heading), the first word in a subtitle (or subheading), and any proper nouns)	PLOS ONE			English	Article								Aiming at the situation that the existing visible and infrared images fusion algorithms only focus on highlighting infrared targets and neglect the performance of image details, and cannot take into account the characteristics of infrared and visible images, this paper proposes an image enhancement fusion algorithm combining Karhunen-Loeve transform and Laplacian pyramid fusion. The detail layer of the source image is obtained by anisotropic diffusion to get more abundant texture information. The infrared images adopt adaptive histogram partition and brightness correction enhancement algorithm to highlight thermal radiation targets. A novel power function enhancement algorithm that simulates illumination is proposed for visible images to improve the contrast of visible images and facilitate human observation. In order to improve the fusion quality of images, the source image and the enhanced images are transformed by Karhunen-Loeve to form new visible and infrared images. Laplacian pyramid fusion is performed on the new visible and infrared images, and superimposed with the detail layer images to obtain the fusion result. Experimental results show that the method in this paper is superior to several representative image fusion algorithms in subjective visual effects on public data sets. In terms of objective evaluation, the fusion result performed well on the 8 evaluation indicators, and its own quality was high.	[Huang, Hui; Xue, Zhishuang; Liu, Xiaofang] Sichuan Univ Sci & Engn, Artificial Intelligence Key Lab Sichuan Prov Auto, Zigong, Peoples R China; [Dong, Linlu] Southwest Univ Sci & Technol, Sch Informat Engn, Mianyang, Sichuan, Peoples R China; [Liu, Xiaofang; Hua, Caijian] Sichuan Univ Sci & Engn, Sch Comp Sci & Engn, Zigong, Peoples R China	Sichuan University of Science & Engineering; Southwest University of Science & Technology - China; Sichuan University of Science & Engineering	Liu, XF (corresponding author), Sichuan Univ Sci & Engn, Artificial Intelligence Key Lab Sichuan Prov Auto, Zigong, Peoples R China.; Liu, XF (corresponding author), Sichuan Univ Sci & Engn, Sch Comp Sci & Engn, Zigong, Peoples R China.	150507076@qq.com			Science and Technology Department Project of Sichuan Provincial of China [2017GZ0303]; Academician (Expert) Workstation Fund Project of Sichuan Province of China [2016YSGZZ01]; Special Fund for Training High Level Innovative Talents of Sichuan University of Science and Engineering [B12402005]; Academician Workstation Project of Sichuan Province of China [2017YSGZZ04]; Sichuan University of Science and Engineering for Talent introduction project [2017RCL59]	Science and Technology Department Project of Sichuan Provincial of China; Academician (Expert) Workstation Fund Project of Sichuan Province of China; Special Fund for Training High Level Innovative Talents of Sichuan University of Science and Engineering; Academician Workstation Project of Sichuan Province of China; Sichuan University of Science and Engineering for Talent introduction project	This work is supported in part by the Science and Technology Department Project of Sichuan Provincial of China, under Grant 2017GZ0303, in part by Academician (Expert) Workstation Fund Project of Sichuan Province of China, under Grant 2016YSGZZ01, in part by Special Fund for Training High Level Innovative Talents of Sichuan University of Science and Engineering, under Grant B12402005, in part by the Academician Workstation Project of Sichuan Province of China, under Grant 2017YSGZZ04, and Sichuan University of Science and Engineering for Talent introduction project, under Grant 2017RCL59.	Adu JH, 2013, INFRARED PHYS TECHN, V61, P94, DOI 10.1016/j.infrared.2013.07.010; Ahmed KT, 2019, INFORM FUSION, V51, P76, DOI 10.1016/j.inffus.2018.11.004; ARCE GR, 1987, IEEE T ACOUST SPEECH, V35, P60, DOI 10.1109/TASSP.1987.1165036; Bavirisetti DP, 2016, IEEE SENS J, V16, P203, DOI 10.1109/JSEN.2015.2478655; Bjoern M., 2018, ARXIV PREPRINT ARXIV; Chabi N, 2013, IRAN CONF MACH, P403, DOI 10.1109/IranianMVIP.2013.6780019; Chai PF, 2017, IEEE ACCESS, V5, P6724, DOI 10.1109/ACCESS.2017.2685178; Chao Rui, 2004, Acta Electronica Sinica, V32, P750; Chen J, 2020, INFORM SCIENCES, V508, P64, DOI 10.1016/j.ins.2019.08.066; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; DENG G, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1615, DOI 10.1109/NSSMIC.1993.373563; Ding WS, 2017, ACTA OPT SINICA, V37, DOI 10.3788/AOS201737.1010002; Do MN, 2005, IEEE T IMAGE PROCESS, V14, P2091, DOI 10.1109/TIP.2005.859376; Dogra A, 2017, IEEE ACCESS, V5, P16040, DOI 10.1109/ACCESS.2017.2735865; Feng X, 2020, IEEE ACCESS, V8, P2348, DOI 10.1109/ACCESS.2019.2962560; Fu Bin, 2011, 2011 IEEE/ICME International Conference on Complex Medical Engineering - CME 2011, P466, DOI 10.1109/ICCME.2011.5876785; Fu ZZ, 2016, INFRARED PHYS TECHN, V77, P114, DOI 10.1016/j.infrared.2016.05.012; GAUSS J, 1991, J CHEM PHYS, V95, P2623, DOI 10.1063/1.460915; Hou RC, 2020, IEEE T COMPUT IMAG, V6, P640, DOI 10.1109/TCI.2020.2965304; Hou RC, 2019, MULTIMED TOOLS APPL, V78, P28609, DOI 10.1007/s11042-018-6099-x; Hu, 2012, INT J ADV COMPUT TEC, V4, P114; Huang Y, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18041169; Jin HY, 2014, INFRARED PHYS TECHN, V64, P134, DOI 10.1016/j.infrared.2014.02.013; LI H, 1995, GRAPH MODEL IM PROC, V57, P235, DOI 10.1006/gmip.1995.1022; Li H.-X., 2020, INT ACAD C FRONTIERS, P24; Li H, 2018, INT C PATT RECOG, P2705, DOI 10.1109/ICPR.2018.8546006; Li M, 2019, IEEE ACCESS, V7, P180134, DOI 10.1109/ACCESS.2019.2958370; Li ST, 2013, IEEE T IMAGE PROCESS, V22, P2864, DOI 10.1109/TIP.2013.2244222; Liang HY, 2015, LECT NOTES COMPUT SC, V9198, P507, DOI 10.1007/978-3-319-21398-9_40; Liu D, 2018, J ELECTRON IMAGING, V27, DOI 10.1117/1.JEI.27.6.063036; Luo XQ, 2017, J VIS COMMUN IMAGE R, V45, P46, DOI 10.1016/j.jvcir.2017.02.006; Ma JY, 2020, INFORM FUSION, V54, P85, DOI 10.1016/j.inffus.2019.07.005; Ma JY, 2019, INFORM FUSION, V48, P11, DOI 10.1016/j.inffus.2018.09.004; Ma JY, 2019, INFORM FUSION, V45, P153, DOI 10.1016/j.inffus.2018.02.004; Ma JY, 2016, INFORM FUSION, V31, P100, DOI 10.1016/j.inffus.2016.02.001; Naidu VPS, 2011, DEFENCE SCI J, V61, P479, DOI 10.14429/dsj.61.705; Noushad M., 2017, INT J SCI TECHNOL EN, V3, P397; Pan B, 2010, OPT LASER ENG, V48, P469, DOI 10.1016/j.optlaseng.2009.08.010; Paul J, 2020, ISPRS INT J GEO-INF, V9, DOI 10.3390/ijgi9070462; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Petrovic V, 2005, IEEE I CONF COMP VIS, P1866; Qu Xiao-Bo, 2008, Acta Automatica Sinica, V34, P1508, DOI 10.3724/SP.J.1004.2008.01508; Seetha M, 2005, INT GEOSCI REMOTE SE, P2842; SHAPLEY R, 1985, ANNU REV NEUROSCI, V8, P547, DOI 10.1146/annurev.ne.08.030185.002555; Shen R, 2011, IEEE T IMAGE PROCESS, V20, P3634, DOI 10.1109/TIP.2011.2150235; Sun Feng, 2016, Journal of Computer Aided Design & Computer Graphics, V28, P1679; Toet A, 2014, FIGSHARE DATA, DOI 10.6084/m9.figshare.1008029.v1; Wan MJ, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10050682; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wencheng Wang, 2011, Journal of Computers, V6, P2559, DOI 10.4304/jcp.6.12.2559-2566; Xydeas CS, 2000, ELECTRON LETT, V36, P308, DOI 10.1049/el:20000267; Yin M, 2017, NEUROCOMPUTING, V226, P182, DOI 10.1016/j.neucom.2016.11.051; Zeng Y., 2010, 2010 18 INT C GEOINF, P1, DOI DOI 10.1109/GEOINFORMATICS.2010.5568105; Zhang H, 2020, MATH PROBL ENG, V2020; [张强 ZHANG Qiang], 2006, [光电子·激光, Journal of Optoelectronics·Laser], V17, P1123	55	4	4	8	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0245563	10.1371/journal.pone.0245563	http://dx.doi.org/10.1371/journal.pone.0245563			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606680	gold, Green Published			2022-12-26	WOS:000620629200009
J	Yuen, CM; Millones, AK; Puma, D; Jimenez, J; Galea, JT; Calderon, R; Pages, GS; Brooks, MB; Lecca, L; Nicholson, T; Becerra, MC; Keshavjee, S				Yuen, Courtney M.; Millones, Ana Karina; Puma, Daniela; Jimenez, Judith; Galea, Jerome T.; Calderon, Roger; Pages, Gabriela S.; Brooks, Meredith B.; Lecca, Leonid; Nicholson, Tom; Becerra, Mercedes C.; Keshavjee, Salmaan			Closing delivery gaps in the treatment of tuberculosis infection: Lessons from implementation research in Peru	PLOS ONE			English	Article								Background Targeted testing and treatment of TB infection to prevent disease is a pillar of TB elimination. Despite recent global commitments to greatly expand access to preventive treatment for TB infection, there remains a lack of research on how best to expand preventive treatment programs in settings with high TB burdens. Methods We conducted implementation research in Lima, Peru, around a multifaceted intervention to deliver TB preventive treatment to close contacts of all ages, health care workers, and people in congregate settings. Key interventions included use of the interferon gamma release assay (IGRA), specialist support for generalist physicians at primary-level health facilities, and treatment support by community health workers. We applied a convergent mixed methods approach to evaluate feasibility and acceptability based on a care cascade framework. Findings During April 2019-January 2020, we enrolled 1,002 household contacts, 148 non-household contacts, 107 residents and staff of congregate settings, and 357 health care workers. Cumulative completion of the TB preventive care cascade was 34% for contacts <5 years old, 28% for contacts 5-19 years old, 18% for contacts >= 20 years old, 0% for people in congregate settings, and 4% of health care workers. IGRA testing was acceptable to adults exposed to TB. Preventive treatment was acceptable to contacts, but less acceptable to physicians, who frequently had doubts about prescribing preventive treatment for adults. Community-based treatment support was both acceptable and feasible, and periodic home-visits or calls were identified as facilitators of adherence. Conclusions We attempted to close the gap in TB preventive treatment in Peru by expanding preventive services to adult contacts and other risk groups. While suboptimal, care cascade completion for adult contacts was consistent with what has been observed in high-income settings. The major losses in the care cascade occurred in completing evaluations and having doctors prescribe preventive treatment.	[Yuen, Courtney M.; Becerra, Mercedes C.; Keshavjee, Salmaan] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Yuen, Courtney M.; Brooks, Meredith B.; Lecca, Leonid; Becerra, Mercedes C.; Keshavjee, Salmaan] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Yuen, Courtney M.; Brooks, Meredith B.; Becerra, Mercedes C.; Keshavjee, Salmaan] Harvard Med Sch, Ctr Global Hlth Delivery, Boston, MA 02115 USA; [Millones, Ana Karina; Puma, Daniela; Jimenez, Judith; Calderon, Roger; Pages, Gabriela S.; Lecca, Leonid] Socios Salud Sucursal Peru, Lima, Peru; [Galea, Jerome T.] Univ S Florida, Sch Social Work, Tampa, FL USA; [Galea, Jerome T.] Univ S Florida, Coll Publ Hlth, Tampa, FL USA; [Nicholson, Tom] Duke Univ, Duke Ctr Int Dev, Sanford Sch Publ Policy, Durham, NC USA; [Nicholson, Tom; Becerra, Mercedes C.; Keshavjee, Salmaan] Adv Access & Delivery, Durham, NC USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Duke University	Yuen, CM (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.; Yuen, CM (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA.; Yuen, CM (corresponding author), Harvard Med Sch, Ctr Global Hlth Delivery, Boston, MA 02115 USA.	Courtney_Yuen@hms.harvard.edu	Galea, Jerome T/HGV-0203-2022; Galea, Jerome T./AAF-2172-2019	Galea, Jerome T/0000-0001-8732-6959; Galea, Jerome T./0000-0001-8732-6959; Lecca, Leonid/0000-0003-1363-3985; Yuen, Courtney/0000-0002-5219-2599; Calderon, Roger I./0000-0001-8932-0489; Keshavjee, Salmaan/0000-0002-6967-3305	Dubai Harvard Foundation for Medical Research; Qiagen; National Institutes of Health [1DP2MD015102]; Brigham and Women's Hospital (Innovation Evergreen Fund award)	Dubai Harvard Foundation for Medical Research; Qiagen; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham and Women's Hospital (Innovation Evergreen Fund award)	This study was funded by a grant from the Dubai Harvard Foundation for Medical Research to the Harvard Medical School for Global Health Delivery - Dubai, and a grant from Qiagen to Advanced Access & Delivery. Qiagen donated the IGRA kits. CMY was supported by the National Institutes of Health (1DP2MD015102) and the Brigham and Women's Hospital (Innovation Evergreen Fund award). The funders had no role in study design, data collection, data analysis, data interpretation, writing of the report, or in the decision to submit for publication. The content is solely the responsibility of the authors and does not necessarily represent the views of the funders.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Agins BD, 2019, LANCET INFECT DIS, V19, pE437, DOI 10.1016/S1473-3099(19)30420-7; Alsdurf H, 2016, LANCET INFECT DIS, V16, P1269, DOI 10.1016/S1473-3099(16)30216-X; [Anonymous], 2020, GLOBAL TUBERCULOSIS; [Anonymous], 2018, DEDOOSE VERSION 8035; Barss L, 2020, INT J TUBERC LUNG D, V24, P100, DOI 10.5588/ijtld.19.0185; Campbell JR, 2020, LANCET INFECT DIS, V20, P318, DOI 10.1016/S1473-3099(19)30575-4; Chiang SS, 2017, INT J TUBERC LUNG D, V21, P154, DOI 10.5588/ijtld.16.0624; Cobelens F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001358; Cruz AT, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2838; Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015; Houben RMGJ, 2016, LANCET GLOB HEALTH, V4, pE806, DOI [10.1016/s2214-109x(16)30199-1, 10.1016/S2214-109X(16)30199-1]; Jacobson KB, 2017, AIDS CARE, V29, P936, DOI 10.1080/09540121.2017.1283390; Joseph HA, 2004, AM J INFECT CONTROL, V32, P456, DOI 10.1016/j.ajic.2004.06.004; Keshavjee S, 2015, LANCET, V386, pE46, DOI 10.1016/S0140-6736(15)00320-7; Macaraig MM, 2018, INT J TUBERC LUNG D, V22, P1344, DOI 10.5588/ijtld.18.0035; McMillen C., 2015, DISCOVERING TUBERCUL; Ministerio de Salud, NORM TECN SAL AT ING; Nienhaus A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-247; Otero L, 2020, TROP MED INT HEALTH, V25, P346, DOI 10.1111/tmi.13350; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Puma Abarca DV., 2019, INT J TUBERC LUNG D, V22, pS63; Quispe N, 2020, INT J TUBERC LUNG D, V24, P207, DOI 10.5588/ijtld.19.0186; Rangaka MX, 2015, LANCET, V386, P1, DOI 10.1016/S0140-6736(15)00323-2; Ronald LA, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.02048-2019; Rowe AK, 2018, LANCET GLOB HEALTH, V6, pE1163, DOI 10.1016/S2214-109X(18)30398-X; Shu E, 2017, INT J TUBERC LUNG D, V21, P1288, DOI 10.5588/ijtld.17.0116; Smith BM, 2011, CAN MED ASSOC J, V183, pE173, DOI 10.1503/cmaj.091824; Smith Joanna, 2011, Nurse Res, V18, P52; Surie D, 2019, INT J TUBERC LUNG D, V23, P1308, DOI 10.5588/ijtld.19.0018; Szkwarko D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182185; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; United Nations high-level meeting on the fight against tuberculosis, 2018, POL DECL UN GEN ASS; World health Organization, 2011, INT TUB CAS FIND IS; World Health Organization, 2015, GUIDELINES MANAGEMEN; World Health Organization, 2012, REC INV CONT INF TUB; World Health Organization, 2018, LAT TUB INF UPD CONS; Yuen CM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217104; Zero TB Initiative, 2017, BEST PRACT FRAM PROG; Zero TB Initiative, 2019, SYNTH GUID TB INF TR	40	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247411	10.1371/journal.pone.0247411	http://dx.doi.org/10.1371/journal.pone.0247411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606824	gold, Green Published			2022-12-26	WOS:000620629200169
J	Zhu, ML; Sun, BH; Nevius, E; Kaplan, J; Pereira, J; Insogna, K				Zhu, Meiling; Sun, Ben-hua; Nevius, Erin; Kaplan, Jared; Pereira, Joao; Insogna, Karl			Selective deletion of the receptor for CSF1, c-fms, in osteoclasts results in a high bone mass phenotype, smaller osteoclasts in vivo and an impaired response to an anabolic PTH regimen	PLOS ONE			English	Article								The receptor for Colony Stimulating Factor 1 (CSF1), c-fms, is highly expressed on mature osteoclasts suggesting a role for this cytokine in regulating the function of these cells. Consistent with this idea, in vitro studies have documented a variety of effects of CSF1 in mature osteoclasts. To better define the role of CSF1 in these cells, we conditionally deleted c-fms in osteoclasts (c-fms-OC-/-) by crossing c-fms(flox/flox) mice with mice expressing Cre under the control of the cathepsin K promoter. The c-fms-OC-/- mice were of normal weight and had normal tooth eruption. However, when quantified by DXA, bone mass was significantly higher in the spine and femur of female knock out mice and in the femurs of male knock out mice. MicroCT analyses of femurs showed that female c-fms-OC-/- mice had significantly increased trabecular bone mass with a similar trend in males and both sexes demonstrated significantly increased trabecular number and reduced trabecular spacing. Histomorphometric analysis of the femoral trabecular bone compartment demonstrated a trend towards increased numbers of osteoclasts, +26% in Noc/BPm and +22% in OcS/BS in the k/o animals but this change was not significant. However, when the cellular volume of osteoclasts was quantified, the c-fms-OC-/- cells were found to be significantly smaller than controls. Mature osteoclasts show a marked spreading response when exposed to CSF1 in a non-gradient fashion. However, osteoclasts freshly isolated from c-fms-OC-/- mice had a near complete abrogation of this response. C-fms-OC-/- mice treated with (1-34)hPTH 80 ng/kg/d in single daily subcutaneous doses for 29 days showed an attenuated anabolic response in trabecular bone compared to wild-type animals. Taken together, these data indicate an important non-redundant role for c-fms in regulating mature osteoclast function in vivo.	[Zhu, Meiling; Sun, Ben-hua; Kaplan, Jared; Insogna, Karl] Yale Sch Med, Dept Med, New Haven, CT 06510 USA; [Nevius, Erin; Pereira, Joao] Yale Sch Med, Dept Immunobiol, New Haven, CT USA	Yale University; Yale University	Zhu, ML (corresponding author), Yale Sch Med, Dept Med, New Haven, CT 06510 USA.	Meiling.zhu@yale.edu		Zhu, Meiling/0000-0002-6227-9858; Kaplan, Jared/0000-0001-9541-4844	NIH [DE12459]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant DE12459 (to KLI).	Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Bouyer P., 2006, ENDOCRINOLOGY; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Haas AV, 2018, MENOPAUSE, V25, P197, DOI 10.1097/GME.0000000000000974; Insogna K, 1997, MOL REPROD DEV, V46, P104; Insogna KL, 1997, J CLIN INVEST, V100, P2476, DOI 10.1172/JCI119790; Itokowa T, 2011, CALCIFIED TISSUE INT, V88, P75, DOI 10.1007/s00223-010-9435-3; Kawano T, 2008, ENDOCRINOLOGY, V149, P4009, DOI 10.1210/en.2008-0034; Kawano T, 2013, BONE, V52, P70, DOI 10.1016/j.bone.2012.09.024; Keller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6215; Lees RL, 1999, J BONE MINER RES, V14, P937, DOI 10.1359/jbmr.1999.14.6.937; Li J, 2006, GENESIS, V44, P328, DOI 10.1002/dvg.20219; Lloyd SA, 2009, J BONE MINER METAB, V27, P546, DOI 10.1007/s00774-009-0071-9; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nevius E, 2015, J EXP MED, V212, P1931, DOI 10.1084/jem.20150088; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Razzouk S, 1999, EUR J CELL BIOL, V78, P249, DOI 10.1016/S0171-9335(99)80058-2; Sakai H, 2004, 50 ANN M ORTH RES SO, P27; Sakai H, 2006, BONE, V39, P1290, DOI 10.1016/j.bone.2006.06.012; WEIR EC, 1993, J BONE MINER RES, V8, P1507; Weir EC, 1996, J BONE MINER RES, V11, P1474; Winkeler CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042005; Yao GQ, 2020, CALCIFIED TISSUE INT, V107, P52, DOI 10.1007/s00223-020-00685-4; Yao GQ, 2005, CALCIFIED TISSUE INT, V76, P371, DOI 10.1007/s00223-004-0099-8; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Yu KP, 2007, J BONE MINER RES, V22, P628, DOI 10.1359/JBMR.070105; Zhu ML, 2016, J BONE MINER RES, V31, P864, DOI 10.1002/jbmr.2733	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247199	10.1371/journal.pone.0247199	http://dx.doi.org/10.1371/journal.pone.0247199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33607650	gold, Green Published			2022-12-26	WOS:000620629200023
J	Long, YQ; Chen, YG				Long, Yuqing; Chen, Yanguang			Multifractal scaling analyses of urban street network structure: The cases of twelve megacities in China	PLOS ONE			English	Article								Traffic networks have been proved to be fractal systems. However, previous studies mainly focused on monofractal networks, while complex systems are of multifractal structure. This paper is devoted to exploring the general regularities of multifractal scaling processes in the street network of 12 Chinese cities. The city clustering algorithm is employed to identify urban boundaries for defining comparable study areas; box-counting method and the direct determination method are utilized to extract spatial data; the least squares calculation is employed to estimate the global and local multifractal parameters. The results showed multifractal structure of urban street networks. The global multifractal dimension spectrums are inverse S-shaped curves, while the local singularity spectrums are asymmetric unimodal curves. If the moment order q approaches negative infinity, the generalized correlation dimension will seriously exceed the embedding space dimension 2, and the local fractal dimension curve displays an abnormal decrease for most cities. The scaling relation of local fractal dimension gradually breaks if the q value is too high, but the different levels of the network always keep the scaling reflecting singularity exponent. The main conclusions are as follows. First, urban street networks follow multifractal scaling law, and scaling precedes local fractal structure. Second, the patterns of traffic networks take on characteristics of spatial concentration, but they also show the implied trend of spatial deconcentration. Third, the development space of central area and network intensive areas is limited, while the fringe zone and network sparse areas show the phenomenon of disordered evolution. This work may be revealing for understanding and further research on complex spatial networks by using multifractal theory.	[Long, Yuqing; Chen, Yanguang] Peking Univ, Coll Urban & Environm Sci, Dept Geog, Beijing, Peoples R China	Peking University	Chen, YG (corresponding author), Peking Univ, Coll Urban & Environm Sci, Dept Geog, Beijing, Peoples R China.	chenyg@pku.edu.cn		Chen, Yanguang/0000-0002-7804-9993	National Natural Science Foundation of China [41671167]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant number: 41671167. The project title is Modeling geographical systems of cities using spatial correlation functions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, POPULATION; Appleby S, 1996, GEOGR ANAL, V28, P147; Arcaute E, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150691; Ariza-Villaverde AB, 2013, COMPUT ENVIRON URBAN, V38, P1, DOI 10.1016/j.compenvurbsys.2012.11.001; Bak P., 1996, NATURE WORKS SCI SEL; Barabasi A. L., 2002, FORMULA UNIVERSAL LA; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batty M., 1994, FRACTAL CITIES; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; BENGUIGUI L, 1991, GEOGR ANAL, V23, P362; Cao WP, 2020, REMOTE SENS ENVIRON, V241, DOI 10.1016/j.rse.2020.111730; Chen T, 1995, THESIS NE NORMAL U C; Chen Y, 2004, CHAOS SOLITON FRACT, V22, P793, DOI 10.1016/j.chaos.2004.02.059; Chen Y.G., 2008, FRACTAL URBAN SYSTEM; Chen Y.-G., 2019, HUMAN GEOGRAPHY, V34, P115; Chen YG, 2019, CHAOS SOLITON FRACT, V126, P122, DOI 10.1016/j.chaos.2019.05.029; Chen YG, 2019, PHYSICA A, V523, P1038, DOI 10.1016/j.physa.2019.04.165; [陈彦光 Chen Yanguang], 2019, [地理科学进展, Progress in Geography], V38, P38; Chen YG, 2017, DISCRETE DYN NAT SOC, V2017, DOI 10.1155/2017/5243287; Chen YG, 2014, PHYSICA A, V402, P266, DOI 10.1016/j.physa.2014.01.061; Chen YG, 2013, ENVIRON PLANN B, V40, P884, DOI 10.1068/b36155; Chen YG., 1999, J XINYANG TEACHERS C, V12, P426; Chen YG., 1999, SCI GEOGRAPHICA SINI, V19, P114; Corral A, 2020, PHYS REV E, V101, DOI 10.1103/PhysRevE.101.042312; Feder J, 1988, FRACTALS PHYS SOLIDS; Feng JA, 2010, ENVIRON PLANN B, V37, P838, DOI 10.1068/b35078; Frankhauser P, 1990, ESPACE GEOGRAPHIQUE, V19, P45, DOI [DOI 10.3406/spgeo.1990.2943, DOI 10.3406/SPGEO.1990.2943]; Frankhauser P., 1994, FRACTALITE STRUCTURE; Frankhauser P., 1991, FRACTAL ANAL AGGLOME; Frisch U, 1985, SINGULARITY STRUCTUR; Gaudio R, 2006, J HYDROL, V327, P365, DOI 10.1016/j.jhydrol.2005.11.025; GRASSBERGER P, 1983, PHYS LETT A, V97, P227, DOI 10.1016/0375-9601(83)90753-3; HALSEY TC, 1986, PHYS REV A, V33, P1141, DOI 10.1103/PhysRevA.33.1141; Hao BL., 2004, CHAOS FRACTALS COLLE; Henry John, 2002, SCI REVOLUTION ORIGI; HENTSCHEL HGE, 1983, PHYSICA D, V8, P435, DOI 10.1016/0167-2789(83)90235-X; Holland JH., 1998, EMERGENCE CHAOS ORDE; Hu SG, 2012, APPL GEOGR, V34, P161, DOI 10.1016/j.apgeog.2011.10.016; Huang LS, 2018, FRACTALS, V26, DOI 10.1142/S0218348X18500196; Jiang B, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11154091; Jiang B, 2015, PROF GEOGR, V67, P295, DOI 10.1080/00330124.2014.968886; Jiang B, 2015, CITIES, V43, P69, DOI 10.1016/j.cities.2014.11.013; Jiang B, 2013, PROF GEOGR, V65, P482, DOI 10.1080/00330124.2012.700499; Jiang B, 2011, INT J GEOGR INF SCI, V25, P1269, DOI 10.1080/13658816.2010.510801; Kane G, 2005, SCI AM, V293, P40, DOI 10.1038/scientificamerican0705-40; Knox PL, 2016, PLACES REGIONS GLOBA, V7; Lan T, 2019, ANN AM ASSOC GEOGR, V109, P943, DOI 10.1080/24694452.2018.1492898; LIU JS, 1999, ACTA GEOGRAPHICA SIN, V54, P471; Liu S.-D., 1993, INTRO FRACTALS FRACT; Loder A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51539-5; LONGLEY PA, 1991, T I BRIT GEOGR, V16, P75, DOI 10.2307/622907; Lu ZM, 2016, ECOL INDIC, V70, P285, DOI 10.1016/j.ecolind.2016.06.016; Man W, 2019, PHYSICA A, V520, P44, DOI 10.1016/j.physa.2018.12.041; Masucci AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069469; Murcio R, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062130; Ortigosa J, 2019, TRANSPORTMETRICA B, V7, P61, DOI 10.1080/21680566.2017.1337528; Ortigosa J, 2015, TRANSPORT RES REC, P12, DOI 10.3141/2491-02; Pavon-Dominguez P, 2017, COMPUT ENVIRON URBAN, V64, P229, DOI 10.1016/j.compenvurbsys.2017.03.003; Rozenfeld HD, 2011, AM ECON REV, V101, P2205, DOI 10.1257/aer.101.5.2205; Rozenfeld HD, 2008, P NATL ACAD SCI USA, V105, P18702, DOI 10.1073/pnas.0807435105; Salat H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196737; Santos ADF, 2019, TRANSPORTATION, V46, P1893, DOI 10.1007/s11116-018-9906-3; Semecurbe F, 2016, GEOGR ANAL, V48, P292, DOI 10.1111/gean.12099; Smeed R.J., 1963, J I HIGHWAY ENG, V10, P5; STANLEY HE, 1988, NATURE, V335, P405, DOI 10.1038/335405a0; Takayasu H., 1990, FRACTALS PHYS SCI; Tannier C, 2011, GEOGR ANAL, V43, P211, DOI 10.1111/j.1538-4632.2011.00814.x; Thibault S, 1987, RESEAUX TOPOLOGIE; Thomas I, 2008, LANDSCAPE URBAN PLAN, V84, P99, DOI 10.1016/j.landurbplan.2007.07.002; Thomas I, 2013, ENVIRON PLANN B, V40, P310, DOI 10.1068/b38218; Vicsek T., 1989, FRACTAL GROWTH PHENO; WHITE R, 1994, CHAOS SOLITON FRACT, V4, P563, DOI 10.1016/0960-0779(94)90066-3	75	3	3	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0246925	10.1371/journal.pone.0246925	http://dx.doi.org/10.1371/journal.pone.0246925			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8JB	33600472	Green Published, Green Submitted, gold			2022-12-26	WOS:000620625100046
J	Solan, JL; Hingorani, SR; Lampe, PD				Solan, Joell L.; Hingorani, Sunil R.; Lampe, Paul D.			Cx43 phosphorylation sites regulate pancreatic cancer metastasis	ONCOGENE			English	Article								Pancreatic ductal adenocarcinoma (PDA) is aggressive, highly metastatic and characterized by a robust desmoplasia. Connexin proteins that form gap junctions have been implicated in tumor suppression for over 30 years. Cx43, the most widely expressed connexin, regulates cell behaviors, including migration and proliferation. Thus, we hypothesized that Cx43 could regulate PDA progression. Phosphorylation of Cx43 by Casein Kinase 1 (CK1) regulates gap junction assembly. We interbred the well-established Kras(LSL-G12D/+;p48Cre/+) (KC) mouse model of PDA with homozygous "knock-in" mutant Cx43 mice bearing amino acid substitution at CK1 sites (Cx43(CK1A)) and found profound and surprising effects on cancer progression. Crossing the Cx43(CK1A) mouse onto the KC background (termed KC;Cx(CK1A)) led to significant extension of lifespan, from a median of 370 to 486 days (p = 0.03) and a decreased incidence of metastasis (p = 0.045). However, when we examined early stages of disease, we found more rapid onset of tissue remodeling in the KC;Cx(CK1A) mouse followed by divergence to a cystic phenotype. During tumorigenesis, gap junctions are increasingly present in stromal cells of the KC mice but are absent from the KC;Cx43(CK1A) mice. Tail vein metastasis assays with cells derived from KC or KC;Cx(CK1A) tumors showed that KC;Cx(CK1A) cells could efficiently colonize the lung and downregulate Cx43 expression, arguing that inhibition of metastasis was not occurring at the distal site. Instead, stromal gap junctions, their associated signaling events or other unknown Cx43-dependent events facilitate metastatic capacity in the primary tumor.	[Solan, Joell L.; Hingorani, Sunil R.; Lampe, Paul D.] Publ Hlth Sci Div, Translat Res Program, Seattle, WA 98109 USA; [Solan, Joell L.; Lampe, Paul D.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; [Hingorani, Sunil R.] Fred Hutchinson Canc Res Ctr, Clin Div, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Lampe, PD (corresponding author), Publ Hlth Sci Div, Translat Res Program, Seattle, WA 98109 USA.; Lampe, PD (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA.	plampe@fredhutch.org		Lampe, Paul/0000-0002-1399-2761; Hingorani, Sunil/0000-0002-3869-8729	National Institutes of Health [R21CA149554, GM55632]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	H & E pathology analysis was performed by Sue Knoblaugh, DVM, Diplomate ACVP. Yutaka Yasui, PhD performed power calculations and aided in the experimental design of the mouse experiments. This work was supported by grants R21CA149554 and GM55632 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aasen T, 2016, NAT REV CANCER, V16, P775, DOI 10.1038/nrc.2016.105; Angst E, 2006, BRIT J CANCER, V95, P307, DOI 10.1038/sj.bjc.6603256; Barrett R, 2020, CURR OPIN IMMUNOL, V64, P80, DOI 10.1016/j.coi.2020.03.004; Best SA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12164-y; Biffi G, 2019, CANCER DISCOV, V9, P282, DOI 10.1158/2159-8290.CD-18-0710; Cen G, 2017, ONCOL REP, V37, P1189, DOI 10.3892/or.2017.5355; Chen XM, 2019, NAT REV DRUG DISCOV, V18, P99, DOI 10.1038/s41573-018-0004-1; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Cigliola V, 2015, PANCREAS, V44, P1234, DOI 10.1097/MPA.0000000000000378; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; Daley D, 2017, J EXP MED, V214, P1711, DOI 10.1084/jem.20161707; Dvorak HF, 2015, CANCER IMMUNOL RES, V3, P1, DOI 10.1158/2326-6066.CIR-14-0209; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; Garcia-Rodriguez L, 2011, MOL CANCER THER, V10, P505, DOI 10.1158/1535-7163.MCT-10-0693; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Grek CL, 2015, WOUND REPAIR REGEN, V23, P203, DOI 10.1111/wrr.12275; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Helms E, 2020, CANCER DISCOV, V10, P648, DOI 10.1158/2159-8290.CD-19-1353; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Huang Guo-Ying, 2011, J Cardiovasc Dis Res, V2, P206, DOI 10.4103/0975-3583.89804; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; King TJ, 2005, BBA-BIOMEMBRANES, V1719, P24, DOI 10.1016/j.bbamem.2005.07.010; King TJ, 2004, CARCINOGENESIS, V25, P669, DOI 10.1093/carcin/bgh071; King TJ, 2005, ONCOGENE, V24, P1718, DOI 10.1038/sj.onc.1208355; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Kyo N, 2008, ONCOL REP, V19, P627; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lampe PD, 2006, J CELL SCI, V119, P3435, DOI 10.1242/jcs.03089; Lastwika KJ, 2019, J CELL SCI, V132, DOI 10.1242/jcs.234633; Lo A, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92232; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; Maitra A, 2005, ADV ANAT PATHOL, V12, P81, DOI 10.1097/01.pap.0000155055.14238.25; Mann KM, 2016, PHARMACOL THERAPEUT, V168, P29, DOI 10.1016/j.pharmthera.2016.09.003; Masamune A, 2013, PANCREAS, V42, P308, DOI 10.1097/MPA.0b013e31825c51d6; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; Mugisho OO, 2018, BBA-GEN SUBJECTS, V1862, P385, DOI 10.1016/j.bbagen.2017.11.015; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Remo BF, 2011, CIRC RES, V108, P1459, DOI 10.1161/CIRCRESAHA.111.244046; Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Salameh A, 2013, BBA-BIOMEMBRANES, V1828, P147, DOI 10.1016/j.bbamem.2011.12.030; Schofield HK, 2018, CELL MOL GASTROENTER, V5, P169, DOI 10.1016/j.jcmgh.2017.10.008; Sin WC, 2016, ONCOGENE, V35, P1504, DOI 10.1038/onc.2015.210; Solan JL, 2019, J BIOL CHEM, V294, P11762, DOI 10.1074/jbc.RA119.009162; Solan JL, 2016, SEMIN CELL DEV BIOL, V50, P40, DOI 10.1016/j.semcdb.2015.12.010; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Solan JL, 2012, J MEMBRANE BIOL, V245, P255, DOI 10.1007/s00232-012-9446-2; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Song MB, 2009, EXP BIOL MED, V234, P1192, DOI 10.3181/0902-RM-80; TROSKO JE, 1990, PATHOBIOLOGY, V58, P265, DOI 10.1159/000163596; Vickman Renee E, 2020, Oncotarget, V11, P3621, DOI 10.18632/oncotarget.27736; Whittle MC, 2019, GASTROENTEROLOGY, V156, P2085, DOI 10.1053/j.gastro.2018.12.044; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Yang WD, 2019, ISCIENCE, V19, P450, DOI 10.1016/j.isci.2019.07.033; Yen TNF, 2002, SURGERY, V131, P129, DOI 10.1067/msy.2002.119192; Zhang XH, 2015, LEUKEMIA LYMPHOMA, V56, P211, DOI 10.3109/10428194.2014.913289; Zhang ZQ, 2016, CELL PHYSIOL BIOCHEM, V39, P423, DOI 10.1159/000445636	59	2	3	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2021	40	10					1909	1920		10.1038/s41388-021-01668-x	http://dx.doi.org/10.1038/s41388-021-01668-x		FEB 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QU6VJ	33603164	Green Accepted			2022-12-26	WOS:000619433100006
J	Dewolf, AH; Sylos-Labini, F; Cappellini, G; Ivanenko, Y; Lacquaniti, F				Dewolf, Arthur H.; Sylos-Labini, Francesca; Cappellini, Germana; Ivanenko, Yury; Lacquaniti, Francesco			Age-related changes in the neuromuscular control of forward and backward locomotion	PLOS ONE			English	Article								Previous studies found significant modification in spatiotemporal parameters of backward walking in healthy older adults, but the age-related changes in the neuromuscular control have been considered to a lesser extent. The present study compared the intersegmental coordination, muscle activity and corresponding modifications of spinal montoneuronal output during both forward and backward walking in young and older adults. Ten older and ten young adults walked forward and backward on a treadmill at different speeds. Gait kinematics and EMG activity of 14 unilateral lower-limb muscles were recorded. As compared to young adults, the older ones used shorter steps, a more in-phase shank and foot motion, and the activity profiles of muscles innervated from the sacral segments were significantly wider in each walking condition. These findings highlight age-related changes in the neuromuscular control of both forward and backward walking. A striking feature of backward walking was the differential organization of the spinal output as compared to forward gait. In addition, the resulting spatiotemporal map patterns also characterized age-related changes of gait. Finally, modifications of the intersegmental coordination with aging were greater during backward walking. On the whole, the assessment of backward walk in addition to routine forward walk may help identifying or unmasking neuromuscular adjustments of gait to aging.	[Dewolf, Arthur H.; Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Dewolf, Arthur H.; Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy; [Sylos-Labini, Francesca; Cappellini, Germana; Ivanenko, Yury; Lacquaniti, Francesco] IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Cappellini, Germana] IRCCS Santa Lucia Fdn, Dept Pediat Neurorehabil, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; IRCCS Santa Lucia; IRCCS Santa Lucia	Dewolf, AH (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy.; Dewolf, AH (corresponding author), Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy.	arthur.dewolf@uclouvain.be		Cappellini, Germana/0000-0001-9110-3870; Sylos Labini, Francesca/0000-0002-8116-3375; Dewolf, Arthur/0000-0003-1498-3987	Italian Ministry of Health (Ricerca corrente, IRCCS Fondazione Santa Lucia); Italian Space Agency [I/006/06/0, ASI-MARS-PRE DC-VUM-2017-006]; Italian University Ministry [2017CBF8NJ_005]; EUROBENCH FSTP-1 grant (sub-project PEPATO) [H2020-779963]	Italian Ministry of Health (Ricerca corrente, IRCCS Fondazione Santa Lucia); Italian Space Agency(Agenzia Spaziale Italiana (ASI)); Italian University Ministry(Ministry of Education, Universities and Research (MIUR)); EUROBENCH FSTP-1 grant (sub-project PEPATO)	This work was supported by the Italian Ministry of Health (Ricerca corrente, IRCCS Fondazione Santa Lucia), Italian Space Agency (grants I/006/06/0 and ASI-MARS-PRE DC-VUM-2017-006), the H2020-779963 EUROBENCH FSTP-1 grant (sub-project PEPATO), and Italian University Ministry (PRIN grant 2017CBF8NJ_005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2014, J BIOMECH, V47, P1104, DOI 10.1016/j.jbiomech.2013.12.024; BADKE MB, 1987, PHYS THER, V67, P1495, DOI 10.1093/ptj/67.10.1495; Baudry S, 2015, EXP GERONTOL, V69, P62, DOI 10.1016/j.exger.2015.06.006; Bianchi L, 1998, J NEUROPHYSIOL, V79, P2155, DOI 10.1152/jn.1998.79.4.2155; Bleyenheuft C, 2012, CLIN BIOMECH, V27, P568, DOI 10.1016/j.clinbiomech.2012.01.010; Borghese NA, 1996, J PHYSIOL-LONDON, V494, P863, DOI 10.1113/jphysiol.1996.sp021539; Browne MG, 2019, GAIT POSTURE, V71, P44, DOI 10.1016/j.gaitpost.2019.04.011; Cappellini G, 2018, J NEUROPHYSIOL, V119, P1153, DOI 10.1152/jn.00679.2017; Cappellini G, 2010, J NEUROPHYSIOL, V104, P3064, DOI 10.1152/jn.00318.2010; Cheung VCK, 2009, P NATL ACAD SCI USA, V106, P19563, DOI 10.1073/pnas.0910114106; Choi JT, 2007, NAT NEUROSCI, V10, P1055, DOI 10.1038/nn1930; Chung T, 2017, MUSCLE NERVE, V55, P894, DOI 10.1002/mus.25267; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; de Groot M, 2015, ALZHEIMERS DEMENT, V11, P321, DOI 10.1016/j.jalz.2014.06.011; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; Dewolf AH, 2020, EUR J APPL PHYSIOL, V120, P91, DOI 10.1007/s00421-019-04251-1; Dewolf AH, 2019, J NEUROPHYSIOL, V122, P872, DOI 10.1152/jn.00167.2019; Dewolf AH, 2019, GAIT POSTURE, V70, P156, DOI 10.1016/j.gaitpost.2019.03.001; Dewolf AH, 2020, EUR J APPL PHYSIOL, V120, P1841, DOI 10.1007/s00421-020-04415-4; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Duysens J, 1996, J NEUROPHYSIOL, V76, P301, DOI 10.1152/jn.1996.76.1.301; Earhart GM, 2001, J NEUROPHYSIOL, V86, P1666, DOI 10.1152/jn.2001.86.4.1666; Franz JR, 2016, EXERC SPORT SCI REV, V44, P129, DOI 10.1249/JES.0000000000000086; Franz JR, 2015, HUM MOVEMENT SCI, V40, P381, DOI 10.1016/j.humov.2015.01.012; Franz JR, 2014, CLIN BIOMECH, V29, P68, DOI 10.1016/j.clinbiomech.2013.10.018; Fritz NE, 2013, GAIT POSTURE, V37, P593, DOI 10.1016/j.gaitpost.2012.09.022; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grasso R, 1998, J NEUROPHYSIOL, V80, P1868, DOI 10.1152/jn.1998.80.4.1868; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; Gueugnon M, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00173; Hackney ME, 2009, MOVEMENT DISORD, V24, P218, DOI 10.1002/mds.22330; Hafer JF, 2018, GAIT POSTURE, V62, P92, DOI 10.1016/j.gaitpost.2018.02.021; HAUG H, 1991, NEUROBIOL AGING, V12, P336, DOI 10.1016/0197-4580(91)90013-A; Hawkins KA, 2019, TOP STROKE REHABIL, V26, P382, DOI 10.1080/10749357.2019.1609182; HENDERSON G, 1980, J NEUROL SCI, V46, P113, DOI 10.1016/0022-510X(80)90048-9; Herssens N, 2018, GAIT POSTURE, V64, P181, DOI 10.1016/j.gaitpost.2018.06.012; Hoogkamer W, 2014, EXERC SPORT SCI REV, V42, P23, DOI 10.1249/JES.0000000000000000; Hortobagyi T, 2016, EUR J APPL PHYSIOL, V116, P805, DOI 10.1007/s00421-015-3312-8; Ivanenko YP, 2008, EUR J NEUROSCI, V27, P3351, DOI 10.1111/j.1460-9568.2008.06289.x; Ivanenko YP, 2008, J NEUROPHYSIOL, V99, P1890, DOI 10.1152/jn.01308.2007; Ivanenko YP, 2006, J NEUROPHYSIOL, V95, P602, DOI 10.1152/jn.00767.2005; Ivanenko YP, 2007, EXERC SPORT SCI REV, V35, P67; Ivanenko YP, 2013, J NEUROSCI, V33, P3025, DOI 10.1523/JNEUROSCI.2722-12.2013; Jansen K, 2012, J NEUROPHYSIOL, V107, P3385, DOI 10.1152/jn.01156.2011; Jeka JJ, 2010, J MOTOR BEHAV, V42, P197, DOI 10.1080/00222895.2010.481693; Kendall F., 2005, TESTING FUNCTION POS; Kim CY, 2017, AM J PHYS MED REHAB, V96, P61, DOI 10.1097/PHM.0000000000000541; Kuhman D, 2018, J BIOMECH, V69, P90, DOI 10.1016/j.jbiomech.2018.01.006; Kurz MJ, 2012, NEUROIMAGE, V59, P1602, DOI 10.1016/j.neuroimage.2011.08.084; La Scaleia V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00305; Lam T, 2000, J NEUROPHYSIOL, V83, P2814, DOI 10.1152/jn.2000.83.5.2814; Laufer Y, 2005, J GERONTOL A-BIOL, V60, P627, DOI 10.1093/gerona/60.5.627; Laufer Yocheved, 2003, Physiother Res Int, V8, P131, DOI 10.1002/pri.281; Lee S, 2018, KOREAN J ANESTHESIOL, V71, P353, DOI 10.4097/kja.d.18.00242; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Makino Misato, 2017, J Phys Ther Sci, V29, P187, DOI 10.1589/jpts.29.187; Martino G, 2018, CLIN NEUROPHYSIOL, V129, P516, DOI 10.1016/j.clinph.2017.11.028; Martino G, 2015, J NEUROPHYSIOL, V114, P2867, DOI 10.1152/jn.00029.2015; Martino G, 2014, J NEUROPHYSIOL, V112, P2810, DOI 10.1152/jn.00275.2014; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Mau-Moeller A, 2013, J ELECTROMYOGR KINES, V23, P640, DOI 10.1016/j.jelekin.2013.01.009; McGibbon CA, 2003, EXERC SPORT SCI REV, V31, P102, DOI 10.1097/00003677-200304000-00009; Monaco V, 2008, IEEE ENG MED BIO, P5370, DOI 10.1109/IEMBS.2008.4650428; Monaco V, 2010, J NEUROPHYSIOL, V104, P2092, DOI 10.1152/jn.00525.2009; Monaco V, 2009, CLIN BIOMECH, V24, P493, DOI 10.1016/j.clinbiomech.2009.04.004; Noble JW, 2008, EXP BRAIN RES, V189, P249, DOI 10.1007/s00221-008-1464-z; NUTT JG, 1993, NEUROLOGY, V43, P268, DOI 10.1212/WNL.43.2.268; O'Connor KW, 2008, GAIT POSTURE, V28, P385, DOI 10.1016/j.gaitpost.2008.01.010; Payne VG, 2017, HUMAN MOTOR DEV; Perry MC, 2007, EUR J APPL PHYSIOL, V100, P553, DOI 10.1007/s00421-006-0247-0; Protas EJ, 2005, NEUROREHABILITATION, V20, P183; Rose DK, 2018, J NEUROL PHYS THER, V42, P12, DOI 10.1097/NPT.0000000000000210; Salvadores N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00451; Samson MM, 2001, AGING CLIN EXP RES, V13, P16, DOI 10.1007/BF03351489; Santuz A, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2019.100796; Santuz A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21018-4; Schmitz A, 2009, J ELECTROMYOGR KINES, V19, P1085, DOI 10.1016/j.jelekin.2008.10.008; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; SEPIC SB, 1986, AM J PHYS MED REHAB, V65, P75; SHARRARD W J, 1964, Ann R Coll Surg Engl, V35, P106; SKINNER HB, 1984, CLIN ORTHOP RELAT R, P208; Soda N, 2013, J PHYS THER SCI, V25, P747, DOI 10.1589/jpts.25.747; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; THORSTENSSON A, 1986, EXP BRAIN RES, V61, P664; TOMLINSON BE, 1977, J NEUROL SCI, V34, P213, DOI 10.1016/0022-510X(77)90069-7; WINTER DA, 1989, J MOTOR BEHAV, V21, P291; WINTER DA, 1990, PHYS THER, V70, P340, DOI 10.1093/ptj/70.6.340; Winter DA., 1987, BIOMECHANICS MOTOR C; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X; Yeh TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091554; Yue GH, 1999, J GERONTOL A-BIOL, V54, pM249, DOI 10.1093/gerona/54.5.M249	91	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246372	10.1371/journal.pone.0246372	http://dx.doi.org/10.1371/journal.pone.0246372			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8ME	33596223	Green Published, gold			2022-12-26	WOS:000620633200002
J	Hu, JL; Tan, YZ; Zou, WJ				Hu, Jilei; Tan, Yunzhi; Zou, Wenjun			Key factors influencing earthquake-induced liquefaction and their direct and mediation effects	PLOS ONE			English	Article								Many factors impact earthquake-induced liquefaction, and there are complex interactions between them. Therefore, rationally identifying the key factors and clarifying their direct and indirect effects on liquefaction help to reduce the complexity of the predictive model and improve its predictive performance. This information can also help researchers understand the liquefaction phenomenon more clearly. In this paper, based on a shear wave velocity (V-s) database, 12 key factors are quantitatively identified using a correlation analysis and the maximum information coefficient (MIC) method. Subsequently, the regression method combined with the MIC method is used to construct a multiple causal path model without any assumptions based on the key factors for clarifying their direct and mediation effects on liquefaction. The results show that earthquake parameters produce more important influences on the occurrence of liquefaction than soil properties and site conditions, whereas deposit type, soil type, and deposit age produce relatively small impacts on liquefaction. In the multiple causal path model, the influence path of each factor on liquefaction becomes very clear. Among the key factors, in addition to the duration of the earthquake and V-s, other factors possess multiple mediation paths that affect liquefaction; the thickness of the critical layer and thickness of the unsaturated zone between the groundwater table and capping layer are two indirect-only mediators, and the fines content and thickness of the impermeable capping layer induce suppressive effects on liquefaction. In addition, the constructed causal model can provide a logistic regression model and a structure of the Bayesian network for predicting liquefaction. Five-fold cross-validation is used to compare and verify their predictive performances.	[Hu, Jilei; Tan, Yunzhi] China Three Gorges Univ, Coll Civil Engn & Architecture, Yichang, Hubei, Peoples R China; [Zou, Wenjun] China Three Gorges Univ, Med Coll, Yichang, Hubei, Peoples R China	China Three Gorges University; China Three Gorges University	Hu, JL (corresponding author), China Three Gorges Univ, Coll Civil Engn & Architecture, Yichang, Hubei, Peoples R China.; Zou, WJ (corresponding author), China Three Gorges Univ, Med Coll, Yichang, Hubei, Peoples R China.	hujl@ctgu.edu.cn; zouwenjun.123@163.com	Hu, Jilei/AGH-7791-2022	Hu, Jilei/0000-0003-4673-0845	Young Scientists Fund of National Natural Science Foundation of China, China [41702303]	Young Scientists Fund of National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC))	This work was supported by the Young Scientists Fund of National Natural Science Foundation of China, China (Grant No. 41702303).	Chen LW, 2018, EARTHQ SPECTRA, V34, P1091, DOI 10.1193/032017EQS050M; Dalvi AN, 2014, GEOMECH GEOENGIN, V9, P1, DOI 10.1080/17486025.2013.805255; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hu JL, 2017, INT J GEOMECH, V17, DOI 10.1061/(ASCE)GM.1943-5622.0000808; Hu JL, 2019, ENG GEOL, V248, P34, DOI 10.1016/j.enggeo.2018.11.006; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hussien M.N., 2015, CAN GEOTECH J, V52, P1; Iacobucci D, 2012, J CONSUM PSYCHOL, V22, P582, DOI 10.1016/j.jcps.2012.03.006; Kanai K, 1961, B EARTHQ RES I TOKYO, V39, P86; Kennedy PE, 2005, J ECON EDUC, V36, P77, DOI 10.3200/JECE.36.1.77-92; Kline R.B., 2011, PRINCIPLES PRACTICE; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Lee CJ, 2009, COMPUT GEOTECH, V36, P1157, DOI 10.1016/j.compgeo.2009.05.002; MacKinnon DP, 2007, CLIN TRIALS, V4, P499, DOI 10.1177/1740774507083434; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; McGuire RK, 1979, P 2 US INT C EARTHQ, P713; MULAIK SA, 1989, PSYCHOL BULL, V105, P430, DOI 10.1037/0033-2909.105.3.430; Pearson K., 1895, Proceedings of the Royal Society London, Vlviii, P240; Puth MT, 2015, ANIM BEHAV, V102, P77, DOI 10.1016/j.anbehav.2015.01.010; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Robinson K., 2013, P 19 NZGS GEOT S; Saikia R., 2014, ENG TECHNOLOGY, V3, P110; Seed H.B., 1971, ASCE J SOIL MECH FDN, V97, P1249, DOI [10.1061/jsfeaq.0001662, DOI 10.1061/JSFEAQ.0001662, 10.1061/JSFEAQ.0001662]; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Tang XW, 2016, KSCE J CIV ENG, V20, P2655, DOI 10.1007/s12205-016-0339-2; TRIFUNAC MD, 1975, B SEISMOL SOC AM, V65, P581; Wright S, 1920, J AGRIC RES, V20, P0557; Yao CR, 2019, J MAR SCI ENG, V7, DOI 10.3390/jmse7110411; Zhang YH, 2012, 2012 IEEE FIFTH INTERNATIONAL CONFERENCE ON ADVANCED COMPUTATIONAL INTELLIGENCE (ICACI), P862, DOI 10.1109/ICACI.2012.6463292; Zhu Shulian, 1981, Seismology and Geology, V3, P71	32	2	2	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246387	10.1371/journal.pone.0246387	http://dx.doi.org/10.1371/journal.pone.0246387			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8ME	33596213	Green Published, gold			2022-12-26	WOS:000620633200023
J	Mather-Gratton, ZJ; Larsen, S; Bentsen, NS				Mather-Gratton, Zachary James; Larsen, Soren; Bentsen, Niclas Scott			Understanding the sustainability debate on forest biomass for energy in Europe: A discourse analysis	PLOS ONE			English	Article							CARBON DEBT; BIOENERGY; EMISSIONS	The legislative process before the adoption of the revised European Union renewable energy directive mobilised various actors around the forest biomass issue in Europe. Which storylines do actors use to discuss and define the sustainability of forest biomass, how are the differences between the existing storylines explained, and can distinct 'discourse coalitions' of actors be observed as following each storyline? These questions are addressed through a discourse analysis to critically evaluate the debate around the utilisation of forest biomass for European renewable energy to identify persistent storylines adopted by discourse coalitions as they communicate their understanding of the issue, and compete to influence the policymaking and public perception. The hypotheses are that there are more than the hypothetical binary arrangement of pro versus anti storylines, and that some actors follow multiple storylines. Locating the methodological approach on the two dimensions; text versus context and critical versus constructivist, this study pays closer attention to context rather than on individual linguistic elements of texts. Regarding the second dimension, this study builds upon constructivist epistemology, being concerned with understanding which truths these storylines produce for their speakers, and their external influences upon alternative storylines and actors. The three storylines presented here represent three competing discourses regarding forest biomass usage in European renewable energy: forestry prioritised, climate focussed and critical. Each of these are promoted by actors aiming to gain discursive hegemony on the issue, both in terms of the impact of their discourse upon EU policy making and in the eyes of the public. Despite the discursive differences created by these deeply held opposing views of what sustainability and nature are and what this means for forest biomass, there were several points where narrative elements overlapped. These can provide insight for developing a more constructive debate on the sustainability of forest biomass.	[Mather-Gratton, Zachary James] Georg August Univ, Fac Forest Sci & Forest Ecol, Gottingen, Germany; [Mather-Gratton, Zachary James; Bentsen, Niclas Scott] Univ Copenhagen, Dept Geosci & Nat Resource Management, Frederiksberg, Denmark; [Larsen, Soren] Danish Energy, Frederiksberg, Denmark; [Mather-Gratton, Zachary James] Frome, Somerset, England; [Larsen, Soren] Orsted AS, Gentofte, Denmark	University of Gottingen; University of Copenhagen	Bentsen, NS (corresponding author), Univ Copenhagen, Dept Geosci & Nat Resource Management, Frederiksberg, Denmark.	nb@ign.ku.dk	Bentsen, Niclas Scott/E-4766-2010	Bentsen, Niclas Scott/0000-0002-5130-0818	Danish Energy; utility company Orsted; Innovation Fund Denmark [5190-00014B]	Danish Energy; utility company Orsted; Innovation Fund Denmark	Dr. Soren Larsen's work was financially supported by Danish Energy, the utility company Orsted and Innovation Fund Denmark (grant number 5190-00014B).	2018, PITFALLS POTENTIALS; AEBIOM, 2010, BIOMASS SUSTAINABLE; AEBIOM, 2017, AEBIOM 1 REACTION RE; AEBIOM, 2017, EICKHOUT PARADOX REA; AEBIOM, 2016, AEBIOM POSITION A SU; AEBIOM, 2018, SMOKE MIRRORS PRIOR; AEBIOM, 2017, AH ENVI COMM VOT BIO; AEBIOM, 2017, FACTSHEET SOLID BIOE; AEBIOM, 2017, BURNING ISSUE WHEN A; [Anonymous], 2016, ECOLOGIST; Arts B. J. M., 2010, IUFRO World Series, V28, P57; Beck Ulrich., 1992, RISK SOC NEW MODERNI; Beddington J., 2017, GUARDIAN; Beddington J., 2018, LETT SCIENTISTS EU P; Bentsen NS, 2017, RENEW SUST ENERG REV, V73, P1211, DOI 10.1016/j.rser.2017.02.004; Bentsen NS, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-25; Berndes G., 2016, SCI POLICY 3, DOI DOI 10.1111/GCBB.12338; Bioenergy Europe,, 2020, STAT REP 2019 BIOM S; Biofuelwatch, 2016, BIOENERGY EUROPEAN C; BirdLife and Transport & Environment, 2017, BIOENERGY UGLY TRUTH; BirdLife and Transport & Environment, 2016, MUCH SUSTAINABLE BIO; BirdLife Europe Fern and Transport & Environment, 2017, ENSURING BIOENERGY C; Bocher, 2007, P INT C GOTT; Brack D., 2017, WOODY BIOMASS POWER; Brand F, 2009, ECOL ECON, V68, P605, DOI 10.1016/j.ecolecon.2008.09.013; Brundtland G.H., 1987, OUR COMMON FUTURE, DOI DOI 10.1080/07488008808408783; Bryman A, 2012, SOCIAL RES METHODS, Vfourth, DOI [10.1016/j.ymeth.2012.10.003, DOI 10.1016/J.YMETH.2012.10.003]; Buchholz T, 2016, GCB BIOENERGY, V8, P281, DOI 10.1111/gcbb.12245; CEPF, 2018, KEY WAYS MAXIMIZE PO; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Darier E., 1999, DISCOURSES ENV; De Gemeynt and MSG Sustainable Strategies, 2020, BIOMASSA PERSPECTIEF; Dobson A, 2012, GREEN POLITICAL THOU; Douglas Mary., 1966, PURITY DANGER ANAL C; Drax, 2018, IS BIOMASS DEMAND OU; Drax, 2016, 5 THINGS YOU NEVER K; Drax and Robertsbridge, 2017, BIOMASS SUSTAINABILI; EASAC, 2017, MULTIFUNCTIONALITY S; EC, 2017, SUSTAINABLE OPTIMAL; EFI, 2016, FOREST BIOMASS CARBO; Ekins P, 2003, ECOL ECON, V44, P165, DOI 10.1016/S0921-8009(02)00272-0; EUBIA, BIOMASS ENERGY FACTS; European Commission, 2010, REPORT COMMISSION CO; European Commission, 2005, SEC20051573; European Commission, 2018, COMMUNICATION COMMIS; EUSTAFOR, 2017, SUSTAINABLE FORESTRY; 2017, SUSTAINABLY MANAGED; Fairclough N., 2003, ANAL DISCOURSE TEXTU; Fairclough N., 2013, MEDIA DISCOURSE; Feindt P.H., 2005, J ENV POLICY PLAN, V7, P161, DOI [DOI 10.1080/15239080500339638, https://doi.org/10.1080/15239080500339638]; Fern, 2018, COVERED SMOKE WHY BU; Fern, 2016, BRIEFING NOTE BURNIN; Fern, 2016, DANGEROUS DELUSION D; Fern, 2018, EUROPEAN PARLIAMENT; Fern, 2018, FERNS ANAL AGREEMENT; Fischer K, 2020, SOC NATUR RESOUR, V33, P896, DOI 10.1080/08941920.2020.1725202; FoEE, 2012, BIOMASS DIRTIER COAL; FoEE, 2014, WORLDS LAND FORESTS; Forest Europe UNECE and FAO State of Europe's Forests, 2015, STAT EUR FOR 2015 ST; Gamborg C, 2012, J AGR ENVIRON ETHIC, V25, P909, DOI 10.1007/s10806-011-9351-1; Gill R., 2000, QUALITATIVE RES TEXT, P172, DOI [DOI 10.4135/9781849209731, 10.4135/9781849209731]; Greenpeace, 2018, MAKE BREAK RENEWABLE; Hajer M., 2005, J ENV POLICY PLANNIN, V7, P175, DOI [10.1080/15239080500339646, DOI 10.1080/15239080500339646, DOI 10.1016/j.forpol.2009.08.001]; Hajer Maarten., 1995, POLITICS ENV DISCOUR; Healy S., 2005, J ENVIRON POL PLAN, V7, P239, DOI DOI 10.1080/15239080500339745; IEA Bioenergy, 2017, RESPONSE CHATHAM HOU; IEEP, 2016, SUSTAINABLE BIOENERG; Juniper T., 2017, GUARDIAN; Kangas HL, 2018, BIOMASS BIOENERG, V118, P65, DOI 10.1016/j.biombioe.2018.08.006; Lamers P, 2013, BIOFUEL BIOPROD BIOR, V7, P373, DOI 10.1002/bbb.1407; Larsen S, 2019, ENERGY SUSTAIN SOC, V9, DOI 10.1186/s13705-019-0209-0; Mackie, 2018, CARBON IMPACTS BIOMA; Mai-Moulin T, 2019, BIOFUEL BIOPROD BIOR, V13, P405, DOI 10.1002/bbb.1822; Matthews R, 2014, FOR RES; Nabuurs GJ, 2017, FOREST POLICY ECON, V75, P120, DOI 10.1016/j.forpol.2016.10.009; NOAH Biofuelwatch Econexus GFC WRM Rainforest Rescue CEO, 2015, BIOENERGY OUT WHY BI; Pachauri RK, 2014, 2014 IEEE STUDENTS' CONFERENCE ON ELECTRICAL, ELECTRONICS AND COMPUTER SCIENCE (SCEECS); Pelenc J, 2015, BRIEF GSDR UN; Phillips N., 2002, DISCOURSE ANAL INVES, V10, P89; Pulzl H, 2014, SCAND J FOREST RES, V29, P386, DOI 10.1080/02827581.2014.920044; Rivers M. and Drax, 2018, WORKING FOREST IS CA; Robledo-Abad C, 2017, GCB BIOENERGY, V9, P541, DOI 10.1111/gcbb.12338; Rutherford P., 1999, DISCOURSES ENV; Scarlat N, 2015, RENEW SUST ENERG REV, V51, P969, DOI 10.1016/j.rser.2015.06.062; Searchinger TD, 2009, SCIENCE, V326, P527, DOI 10.1126/science.1178797; Seghezzo L, 2009, ENVIRON POLIT, V18, P539, DOI 10.1080/09644010903063669; Sengers F, 2010, ENERG POLICY, V38, P5013, DOI 10.1016/j.enpol.2010.04.030; Soderberg C, 2013, FOREST POLICY ECON, V33, P112, DOI 10.1016/j.forpol.2012.09.015; Ter-Mikaelian MT, 2015, J FOREST, V113, P57, DOI 10.5849/jof.14-016; Union E., 2009, OFFICIAL J EUR UNION, P5; Upham P, 2011, ENVIRON SCI POLICY, V14, P510, DOI 10.1016/j.envsci.2011.02.010; van Dam J, 2008, BIOMASS BIOENERG, V32, P749, DOI 10.1016/j.biombioe.2008.01.018; van der Horst D, 2010, LANDSCAPE RES, V35, P173, DOI 10.1080/01426390903564879; Wood LA, 2000, DOING DISCOURSE ANAL, DOI 10.4135/9781452233291; WWF, 2017, EU BIOENERGY POLICY; Zanchi G, 2012, GCB BIOENERGY, V4, P761, DOI 10.1111/j.1757-1707.2011.01149.x; Zschache U, 2010, BER LANDWIRTSCH, V88, P502	97	10	10	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246873	10.1371/journal.pone.0246873	http://dx.doi.org/10.1371/journal.pone.0246873			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8ME	33596217	Green Published, gold			2022-12-26	WOS:000620633200049
J	Clink, DJ; Groves, T; Ahmad, AH; Klinck, H				Clink, Dena J.; Groves, Tom; Ahmad, Abdul Hamid; Klinck, Holger			Not by the light of the moon: Investigating circadian rhythms and environmental predictors of calling in Bornean great argus	PLOS ONE			English	Article							ORANGUTAN PONGO-PYGMAEUS; RAIN-FOREST; SPECIES RICHNESS; DAWN CHORUS; BIRD; BEHAVIOR; ABUNDANCE; PATTERNS; SONG; CONSERVATION	Great argus pheasants are known for their elaborate visual mating displays, but relatively little is known about their general ecology. The use of passive acoustic monitoring-which relies on long-term autonomous recorders-can provide insight into the behavior of visually cryptic, yet vocal species such as the great argus. Here we report the results of an analysis of vocal behavior of the Bornean great argus (Argusianus argus grayi) in Sabah, Malaysia, using data collected with 11 autonomous recording units. Great argus regularly emitted two call types, the long call and the short call, and we found that although both call types were emitted throughout the day, the short calls were more likely to occur during the morning hours (06:00-12:00LT). Great argus were less likely to call if there was rain, irrespective of the time of day. A substantial portion of calls at our site (similar to 20%) were emitted between the hours of 18:00-06:00LT. We found that for nighttime calls, calling activity increased during new moon periods and decreased during periods of rain. We attribute the negative influence of rain on calling to increased energetic costs of thermoregulation during wet periods, and propose that the influence of the lunar cycle may be related to increased predation risk during periods with high levels of moonlight. Little is known about the behavioral ecology of great argus on Borneo, so it is difficult to know if the results we report are typical, or if we would see differences in calling activity patterns depending on breeding season or changes in food availability. We advocate for future studies of great argus pheasant populations using paired camera and acoustic recorders, which can provide further insight into the behavior of this cryptic species.	[Clink, Dena J.; Klinck, Holger] Cornell Univ, Ctr Conservat Bioacoust, Cornell Lab Ornithol, Ithaca, NY 14850 USA; [Groves, Tom] Univ St Andrews, Sch Phys & Astron, St Andrews, Fife, Scotland; [Ahmad, Abdul Hamid] Univ Malaysia Sabah, Fac Sustainable Agr, Kota Kinabalu, Sabah, Malaysia	Cornell University; University of St Andrews; Universiti Malaysia Sabah	Clink, DJ (corresponding author), Cornell Univ, Ctr Conservat Bioacoust, Cornell Lab Ornithol, Ithaca, NY 14850 USA.	dena.clink@cornell.edu		Ahmad, Abdul Hamid/0000-0001-9658-8600; Klinck, Holger/0000-0003-1078-7268	Fulbright ASEAN Research Award for U.S. Scholars	Fulbright ASEAN Research Award for U.S. Scholars	The Fulbright ASEAN Research Award for U.S. Scholars (no award number given) provided funding for this work.	Alessi MG, 2010, WILSON J ORNITHOL, V122, P780, DOI 10.1676/10-040.1; Ancrenaz M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04024; Barton K., 2013, MUMIN MULTIMODEL INF; Berg KS, 2006, P ROY SOC B-BIOL SCI, V273, P999, DOI 10.1098/rspb.2005.3410; Bolker B., 2014, BBMLE TOOLS GEN MAXI; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Bruni A, 2014, J ORNITHOL, V155, P877, DOI 10.1007/s10336-014-1071-7; Burivalova Z, 2019, J APPL ECOL, V56, P2493, DOI 10.1111/1365-2664.13481; Buxton RT, 2012, J FIELD ORNITHOL, V83, P47, DOI 10.1111/j.1557-9263.2011.00355.x; Campos-Cerqueira M, 2016, METHODS ECOL EVOL, V7, P1340, DOI 10.1111/2041-210X.12599; Celis-Murillo A, 2016, J ORNITHOL, V157, P853, DOI 10.1007/s10336-015-1318-y; Cleary DFR, 2007, ECOL APPL, V17, P1184, DOI 10.1890/05-0878; Cleary DFR, 2005, LANDSCAPE ECOL, V20, P989, DOI 10.1007/s10980-005-7754-y; Clink DJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57976-x; Clink DJ, 2017, INT J PRIMATOL, V38, P656, DOI 10.1007/s10764-017-9972-y; Clink DJ, 2019, J ACOUST SOC AM, V146, P2855, DOI [10.1121/1.5136908, DOI 10.1121/1.5136908]; Darras K, 2019, ECOL APPL, V29, DOI 10.1002/eap.1954; DAVISON GWH, 1981, IBIS, V123, P485, DOI 10.1111/j.1474-919X.1981.tb04052.x; DAVISON GWH, 1981, BIOL J LINN SOC, V15, P91, DOI 10.1111/j.1095-8312.1981.tb00751.x; Dawrueng T, 2017, BIRD CONSERV INT, V27, P282, DOI 10.1017/S0959270916000277; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Dorado-Correa AM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160231; Edwards DP, 2013, CONSERV BIOL, V27, P1079, DOI 10.1111/cobi.12059; Enari H, 2017, ECOL INDIC, V79, P155, DOI 10.1016/j.ecolind.2017.04.004; Estoque RC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09646-4; Farina A, 2015, BIOACOUSTICS, V24, P269, DOI 10.1080/09524622.2015.1070282; Fitzpatrick JW, 2005, SCIENCE, V308, P1460, DOI 10.1126/science.1114103; Foote JR, 2017, BEHAVIOUR, V154, P1275, DOI 10.1163/1568539X-00003468; Fuller RA, 2007, BIOLOGY LETT, V3, P368, DOI 10.1098/rsbl.2007.0134; Gasc A, 2013, ECOL INDIC, V25, P279, DOI 10.1016/j.ecolind.2012.10.009; Gil D, 1999, ANIM BEHAV, V58, P995, DOI 10.1006/anbe.1999.1211; HANSKI IK, 1993, ETHOLOGY, V93, P161; Hartig F., 2022, DHARMA RESIDUAL DIAG; HENWOOD K, 1979, AM NAT, V114, P260, DOI 10.1086/283473; IUCN Red List of Threatened Species, 2016, BIRDLIFE INT 2016; Johnsgard P., 1999, PHEASANTS WORLD, V2nd; Kempenaers B, 2010, CURR BIOL, V20, P1735, DOI 10.1016/j.cub.2010.08.028; Kirschel ANG, 2011, IBIS, V153, P255, DOI 10.1111/j.1474-919X.2011.01102.x; Kirschel ANG, 2009, BEHAV ECOL, V20, P1089, DOI 10.1093/beheco/arp101; Koch R, 2016, N AM ORN C WASH DC, P619; L?decke D., 2019, J OPEN SOURCE SOFTW, V4, DOI [10.21105/joss.01412, DOI 10.21105/JOSS.01412]; La VT, 2012, CONDOR, V114, P245, DOI 10.1525/cond.2012.100193; Lang AB, 2006, OECOLOGIA, V146, P659, DOI 10.1007/s00442-005-0131-3; Lazaridis E., 2014, LUNAR LUNAR PHASE DI; Lengagne T, 2002, P ROY SOC B-BIOL SCI, V269, P2121, DOI 10.1098/rspb.2002.2115; Loveridge Robin, 2017, Cambodian Journal of Natural History, V2, P157; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; Measey GJ, 2017, J APPL ECOL, V54, P894, DOI 10.1111/1365-2664.12810; Mennill DJ, 2008, CURR BIOL, V18, P1314, DOI 10.1016/j.cub.2008.07.073; Mitchell SL, 2018, J APPL ECOL, V55, P2744, DOI 10.1111/1365-2664.13233; Sugai LSM, 2019, BIOSCIENCE, V69, P15, DOI 10.1093/biosci/biy147; MORRISON DW, 1978, ANIM BEHAV, V26, P852, DOI 10.1016/0003-3472(78)90151-3; MYERS S., 2009, BIRDS BORNEO BRUNEI; Nijman V, 1998, J ORNITHOL, V139, P313, DOI 10.1007/BF01653342; Nijman V, 2007, ACTA ORNITHOL, V42, P186, DOI 10.3161/068.042.0201; O'Brien TG, 2008, BIRD CONSERV INT, V18, pS144, DOI 10.1017/S0959270908000348; Odom KJ, 2010, BEHAVIOUR, V147, P619, DOI 10.1163/000579510X12632972452424; Perrault K, 2014, J ORNITHOL, V155, P1059, DOI 10.1007/s10336-014-1077-1; Puan CL, 2015, FORKTAIL, P82; Quispe R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08800-6; R Core Team, 2013, R LANG ENV STAT COMP; Saldana-Vazquez RA, 2013, MAMM BIOL, V78, P216, DOI 10.1016/j.mambio.2012.08.004; Sanders CE, 2014, CONDOR, V116, P371, DOI 10.1650/CONDOR-13-098.1; Schmidt KA, 2013, BEHAV ECOL SOCIOBIOL, V67, P1837, DOI 10.1007/s00265-013-1593-7; Seth-Smith D, 1925, P ZOOL SOC LOND, V1925, P323; Sethi SS, 2020, P NATL ACAD SCI USA, V117, P17049, DOI 10.1073/pnas.2004702117; Sheldon FH, 2011, RAFFLES B ZOOL, V59, P295; Slik JWF, 2006, BIODIVERS CONSERV, V15, P4425, DOI 10.1007/s10531-005-4385-1; Sozer R, 2005, ANIM CONSERV, V8, P27, DOI 10.1017/S1367943004001787; Spillmann B, 2017, BIOACOUSTICS, V26, P109, DOI 10.1080/09524622.2016.1216802; Spillmann B, 2015, AM J PRIMATOL, V77, P767, DOI 10.1002/ajp.22398; Vu TT, 2020, J NAT CONSERV, V56, DOI 10.1016/j.jnc.2020.125843; Vu TT, 2019, INT J PRIMATOL, V40, P169, DOI 10.1007/s10764-018-0073-3; Thomas RJ, 2003, BIRD STUDY, V50, P84, DOI 10.1080/00063650309461295; Towsey M, 2014, ECOL INFORM, V21, P110, DOI 10.1016/j.ecoinf.2013.11.007; Walsh RPD, 1999, PHILOS T R SOC B, V354, P1869, DOI 10.1098/rstb.1999.0528; WATANUKI Y, 1986, AUK, V103, P14, DOI 10.1093/auk/103.1.14; Wich SA, 2000, J TROP ECOL, V16, P563, DOI 10.1017/S0266467400001577; Wiggins S, 2003, MAR TECHNOL SOC J, V37, P13, DOI 10.4031/002533203787537375; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; Wimmer J, 2013, ECOL APPL, V23, P1419, DOI 10.1890/12-2088.1; Winarni NL, 2009, AUK, V126, P341, DOI 10.1525/auk.2009.07162; Wood CM, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2764; York JE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0970; Yorzinski JL, 2013, BEHAVIOUR, V150, P61, DOI 10.1163/1568539X-00003037	86	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246564	10.1371/journal.pone.0246564	http://dx.doi.org/10.1371/journal.pone.0246564			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592004	gold, Green Published			2022-12-26	WOS:000620632800083
J	da Cruz, DG; de Magalhaes, RF; Padilha, GA; da Silva, MC; Braga, CL; Silva, AR; de Albuquerque, CFG; Capelozzi, VL; Samary, CS; Pelosi, P; Rocco, PRM; Silva, PL				da Cruz, Daniela G.; de Magalhaes, Raquel F.; Padilha, Gisele A.; da Silva, Mariana C.; Braga, Cassia L.; Silva, Adriana R.; Goncalves de Albuquerque, Cassiano F.; Capelozzi, Vera L.; Samary, Cynthia S.; Pelosi, Paolo; Rocco, Patricia R. M.; Silva, Pedro L.			Impact of positive biphasic pressure during low and high inspiratory efforts in Pseudomonas aeruginosa-induced pneumonia	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; PARTIAL VENTILATORY SUPPORT; END-EXPIRATORY PRESSURE; MECHANICAL VENTILATION; RAT MODEL; PROTECTIVE VENTILATION; TIDAL VOLUME; EXPRESSION; PULMONARY	Background During pneumonia, normal alveolar areas coexist adjacently with consolidated areas, and high inspiratory efforts may predispose to lung damage. To date, no study has evaluated different degrees of effort during Biphasic positive airway pressure (BIVENT) on lung and diaphragm damage in experimental pneumonia, though largely used in clinical setting. We aimed to evaluate lung damage, genes associated with ventilator-induced lung injury (VILI) and diaphragmatic injury, and blood bacteria in pressure-support ventilation (PSV), BIVENT with low and high inspiratory efforts in experimental pneumonia. Material and methods Twenty-eight male Wistar rats (mean +/- SD weight, 333 +/- 78g) were submitted Pseudomonas aeruginosa-induced pneumonia. After 24-h, animals were ventilated for 1h in: 1) PSV; 2) BIVENT with low (BIVENTLow-Effort); and 3) BIVENT with high inspiratory effort (BIVENTHigh-Effort). BIVENT was set at P-high to achieve V-T = 6 ml/kg and P-low at 5 cmH(2)O (n = 7/group). High- and low-effort conditions were obtained through anaesthetic infusion modulation based on neuromuscular drive (P-0.1). Lung mechanics, histological damage score, blood bacteria, and expression of genes related to VILI in lung tissue, and inflammation in diaphragm tissue. Results Transpulmonary peak pressure and histological damage score were higher in BIVENTHigh-Effort compared to BIVENTLow-Effort and PSV [16.1 +/- 1.9cmH(2)O vs 12.8 +/- 1.5cmH(2)O and 12.5 +/- 1.6cmH(2)O, p = 0.015, and p = 0.010; median (interquartile range) 11 (9-13) vs 7 (6-9) and 7 (6-9), p = 0.021, and p = 0.029, respectively]. BIVENTHigh-Effort increased interleukin-6 expression compared to BIVENTLow-Effort (p = 0.035) as well as expressions of cytokine-induced neutrophil chemoattractant-1, amphiregulin, and type III procollagen compared to PSV (p = 0.001, p = 0.001, p = 0.004, respectively). Tumour necrosis factor-alpha expression in diaphragm tissue and blood bacteria were higher in BIVENTHigh-Effort than BIVENTLow-Effort (p = 0.002, p = 0.009, respectively). Conclusion BIVENT requires careful control of inspiratory effort to avoid lung and diaphragm damage, as well as blood bacteria. P-0.1 might be considered a helpful parameter to optimize inspiratory effort.	[da Cruz, Daniela G.; de Magalhaes, Raquel F.; Padilha, Gisele A.; da Silva, Mariana C.; Braga, Cassia L.; Samary, Cynthia S.; Rocco, Patricia R. M.; Silva, Pedro L.] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Lab Pulm Invest, Rio De Janeiro, RJ, Brazil; [Silva, Adriana R.; Goncalves de Albuquerque, Cassiano F.] Fundacao Oswaldo Cruz, Lab Immunopharmacol, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Capelozzi, Vera L.] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Pelosi, Paolo] San Martino Policlin Hosp, IRCCS Oncol & Neurosci, Anesthesiol & Intens Care, Genoa, Italy; [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; University of Genoa	Silva, PL (corresponding author), Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Lab Pulm Invest, Rio De Janeiro, RJ, Brazil.	pedroleme@biof.ufrj.br	Silva, Pedro Leme/AAD-8236-2019; Silva, Adriana/U-7811-2019; , Capelozzi/N-1737-2019; Gonçalves-de-Albuquerque, Cassiano Felippe/N-2815-2014; Rocco, Patricia/I-7460-2012; Gonçalves-de-Albuquerque, Cassiano Felippe/ABH-2409-2020	Silva, Pedro Leme/0000-0001-5838-4949; Silva, Adriana/0000-0002-5137-4251; , Capelozzi/0000-0001-9732-5853; Gonçalves-de-Albuquerque, Cassiano Felippe/0000-0002-4458-3055; Rocco, Patricia/0000-0003-1412-7136; Gonçalves-de-Albuquerque, Cassiano Felippe/0000-0002-4458-3055; samary, cynthia/0000-0002-1860-4166	Brazilian Council for Scientific and Technological Development (CNPq) [405686/2018-8]; Rio de Janeiro State Research Foundation (FAPERJ) [E-26/202.651/2018]; Coordination for the Improvement of Higher Education Personnel (CAPES); Department of Science and Technology -Brazilian Ministry of Health (DECIT/MS)	Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Research Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Department of Science and Technology -Brazilian Ministry of Health (DECIT/MS)	This study was supported by the Brazilian Council for Scientific and Technological Development (CNPq, 405686/2018-8). http://www.cnpq.br/.PLS: Rio de Janeiro State Research Foundation (FAPERJ, E-26/202.651/2018), Coordination for the Improvement of Higher Education Personnel (CAPES) https://www.capes.gov.br/, and the Department of Science and Technology -Brazilian Ministry of Health (DECIT/MS) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008; BAYDUR A, 1982, AM REV RESPIR DIS, V126, P788; Bertoni M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2777-y; Brochard L, 2017, INTENS CARE MED, V43, P250, DOI 10.1007/s00134-016-4645-4; Chiumello D, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1820-0; Curran CS, 2018, AM J RESP CRIT CARE, V197, P708, DOI 10.1164/rccm.201705-1043SO; de Magalhaes RF, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0476-7; Denning GM, 1998, INFECT IMMUN, V66, P5777, DOI 10.1128/IAI.66.12.5777-5784.1998; Dolinay T, 2006, PHYSIOL GENOMICS, V26, P68, DOI 10.1152/physiolgenomics.00110.2005; Doorduin J, 2017, AM J RESP CRIT CARE, V195, P1033, DOI 10.1164/rccm.201605-1016OC; Felix NS, 2019, ANESTHESIOLOGY, V130, P767, DOI 10.1097/ALN.0000000000002630; Ganesan SL, 2018, AM J RESP CRIT CARE, V198, P1199, DOI 10.1164/rccm.201705-0989OC; Henzler D, 2019, INTENS CARE MED EXP, V7, DOI 10.1186/s40635-019-0272-z; Kalil AC, 2016, CLIN INFECT DIS, V63, P575, DOI 10.1093/cid/ciw504; Kallet RH, 1999, CHEST, V116, P1826, DOI 10.1378/chest.116.6.1826; Khramtsova EA, 2019, NAT REV GENET, V20, P173, DOI 10.1038/s41576-018-0083-1; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Lee SK, 2018, BMB REP, V51, P167, DOI 10.5483/BMBRep.2018.51.4.034; Li Bassi G, 2019, BRIT J ANAESTH, V122, P269, DOI 10.1016/j.bja.2018.07.039; Magalhaes PAF, 2018, EUR J ANAESTH, V35, P298, DOI 10.1097/EJA.0000000000000763; McMullen SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040190; Mizgerd JP, 2008, AM J PHYSIOL-LUNG C, V294, pL387, DOI 10.1152/ajplung.00330.2007; Moraes L, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0474-4; MORTOLA JP, 1983, J APPL PHYSIOL, V55, P250, DOI 10.1152/jappl.1983.55.1.250; Muller-Redetzky HC, 2014, CRIT CARE, V18, DOI 10.1186/cc13830; Nieman GF, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-019-0619-3; Orozco-Levi M, 2001, AM J RESP CRIT CARE, V164, P1734, DOI 10.1164/ajrccm.164.9.2011150; Parameswaran H, 2006, J APPL PHYSIOL, V100, P186, DOI 10.1152/japplphysiol.00424.2005; Penuelas O, 2020, INTENS CARE MED, V46, P444, DOI 10.1007/s00134-019-05867-9; Pinto EF, 2020, ANESTHESIOLOGY, V132, P307, DOI 10.1097/ALN.0000000000003060; Restrepo MI, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01190-2017; Saddy F, 2014, SEMIN RESP CRIT CARE, V35, P409, DOI 10.1055/s-0034-1382153; Saddy F, 2013, CRIT CARE, V17, DOI 10.1186/cc13051; Saddy F, 2010, INTENS CARE MED, V36, P1417, DOI 10.1007/s00134-010-1808-6; Silva PL, 2013, ANESTHESIOLOGY, V118, P395, DOI 10.1097/ALN.0b013e31827e554c; Sperber J, 2017, INTENS CARE MED EXP, V5, DOI 10.1186/s40635-017-0152-3; Suki B, 2011, J APPL PHYSIOL, V110, P1111, DOI 10.1152/japplphysiol.01244.2010; Telias I, 2020, AM J RESP CRIT CARE, V201, P1086, DOI 10.1164/rccm.201907-1425OC; Uhlig C, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-56; van Haren F, 2019, CRIT CARE MED, V47, P229, DOI 10.1097/CCM.0000000000003519; Vermillion MS, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0184-8; Wen J, 2014, INFLAMMATION, V37, P933, DOI 10.1007/s10753-014-9813-5; Wierzchon CGRS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01071; Yoshida T, 2020, CURR OPIN CRIT CARE, V26, P59, DOI 10.1097/MCC.0000000000000691; Yoshida T, 2016, CRIT CARE MED, V44, pE678, DOI 10.1097/CCM.0000000000001649; Yoshida T, 2013, AM J RESP CRIT CARE, V188, P1420, DOI 10.1164/rccm.201303-0539OC; Yoshida T, 2012, CRIT CARE MED, V40, P1578, DOI 10.1097/CCM.0b013e3182451c40; Zhao T, 2014, RESP RES, V15, P1, DOI 10.1186/s12931-014-0158-2	48	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246891	10.1371/journal.pone.0246891	http://dx.doi.org/10.1371/journal.pone.0246891			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577592	gold, Green Published			2022-12-26	WOS:000620071700009
J	Rafi, SK; Goering, JP; Olm-Shipman, AJ; Hipp, LA; Ernst, NJ; Wilson, NR; Hall, EG; Gunewardena, S; Saadi, I				Rafi, Syed K.; Goering, Jeremy P.; Olm-Shipman, Adam J.; Hipp, Lauren A.; Ernst, Nicholas J.; Wilson, Nathan R.; Hall, Everett G.; Gunewardena, Sumedha; Saadi, Irfan			Anti-epileptic drug topiramate upregulates TGF beta 1 and SOX9 expression in primary embryonic palatal mesenchyme cells: Implications for teratogenicity	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; TGF-BETA; CAMPOMELIC DYSPLASIA; CLEFT-PALATE; DOUBLE-BLIND; ORAL CLEFTS; PREGNANCY; EPILEPSY; MECHANISMS; MUTATIONS	Topiramate is an anti-epileptic drug that is commonly prescribed not just to prevent seizures but also migraine headaches, with over 8 million prescriptions dispensed annually. Topiramate use during pregnancy has been linked to significantly increased risk of babies born with orofacial clefts (OFCs). However, the exact molecular mechanism of topiramate teratogenicity is unknown. In this study, we first used an unbiased antibody array analysis to test the effect of topiramate on human embryonic palatal mesenchyme (HEPM) cells. This analysis identified 40 differentially expressed proteins, showing strong connectivity to known genes associated with orofacial clefts. However, among known OFC genes, only TGF beta 1 was significantly upregulated in the antibody array analysis. Next, we validated that topiramate could increase expression of TGF beta 1 and of downstream target phospho-SMAD2 in primary mouse embryonic palatal mesenchyme (MEPM) cells. Furthermore, we showed that topiramate treatment of primary MEPM cells increased expression of SOX9. SOX9 overexpression in chondrocytes is known to cause cleft palate in mouse. We propose that topiramate mediates upregulation of TGF beta 1 signaling through activation of gamma-aminobutyric acid (GABA) receptors in the palate. TGF beta 1 and SOX9 play critical roles in orofacial morphogenesis, and their abnormal overexpression provides a plausible etiologic molecular mechanism for the teratogenic effects of topiramate.	[Rafi, Syed K.; Goering, Jeremy P.; Olm-Shipman, Adam J.; Hipp, Lauren A.; Ernst, Nicholas J.; Wilson, Nathan R.; Hall, Everett G.; Saadi, Irfan] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Gunewardena, Sumedha] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Wilson, Nathan R.] Harvard Med Sch, Ctr Regenerat Med, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Hall, Everett G.] Washington Univ, Clin Res Training Ctr, Inst Clin & Translat Sci, St Louis, MO 63110 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; Washington University (WUSTL)	Rafi, SK; Saadi, I (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA.	rafigene@yahoo.com; isaadi@kumc.edu	Saadi, Irfan/I-5989-2019	Saadi, Irfan/0000-0002-6250-6651; RAFI, SYED/0000-0002-1797-1925	National Institutes of Health Center of Biomedical Research Excellence (COBRE) grant (National Institute of General Medical Sciences) [P20 GM104936, P30 GM122731]; Kansas IDeA Network for Biomedical Research Excellence grant (National Institute of General Medical Sciences) [P20 GM103418]; Kansas Intellectual and Developmental Disabilities Research Center grant (U54 Eunice Kennedy Shriver National Institute of Child Health and Human Development) [HD090216]; National Institute of Dental and Craniofacial Research grant [DE026172]	National Institutes of Health Center of Biomedical Research Excellence (COBRE) grant (National Institute of General Medical Sciences); Kansas IDeA Network for Biomedical Research Excellence grant (National Institute of General Medical Sciences); Kansas Intellectual and Developmental Disabilities Research Center grant (U54 Eunice Kennedy Shriver National Institute of Child Health and Human Development); National Institute of Dental and Craniofacial Research grant	This project was supported in part by the National Institutes of Health Center of Biomedical Research Excellence (COBRE) grant (National Institute of General Medical Sciences P20 GM104936 and P30 GM122731, I.S.), Kansas IDeA Network for Biomedical Research Excellence grant (National Institute of General Medical Sciences P20 GM103418, I.S.), Kansas Intellectual and Developmental Disabilities Research Center grant (U54 Eunice Kennedy Shriver National Institute of Child Health and Human Development, HD090216, I.S. and S.G.), and a National Institute of Dental and Craniofacial Research grant (DE026172, I.S.).	Aggarwal K, 2012, NAT CELL BIOL, V14, P656, DOI 10.1038/ncb2534; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Alsaad AMS, 2015, REPROD TOXICOL, V53, P45, DOI 10.1016/j.reprotox.2015.03.003; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Berry DJ, 2000, THER DRUG MONIT, V22, P460, DOI 10.1097/00007691-200008000-00016; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bialer M, 2010, NAT REV DRUG DISCOV, V9, P68, DOI 10.1038/nrd2997; Bissell DM, 2001, EXP MOL MED, V33, P179, DOI 10.1038/emm.2001.31; BORMANN J, 1991, NEUROPHARMACOLOGY, V30, P1387, DOI 10.1016/S0028-3908(11)80006-7; Braga MFM, 2009, J PHARMACOL EXP THER, V330, P558, DOI 10.1124/jpet.109.153908; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chetaille P, 2014, NAT GENET, V46, P1245, DOI 10.1038/ng.3113; Chung YT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0084980, 10.1371/journal.pone.0070128]; Cordero DR, 2011, AM J MED GENET A, V155A, P270, DOI 10.1002/ajmg.a.33702; Coricor G, 2016, SCI REP-UK, V6, DOI 10.1038/srep38616; Craig John J, 2009, Pract Neurol, V9, P268, DOI 10.1136/jnnp.2009.187898; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Eickelberg O, 1999, AM J PHYSIOL-LUNG C, V276, pL814, DOI 10.1152/ajplung.1999.276.5.L814; Gahllo EM, 2014, J CLIN INVEST, V124, P448, DOI 10.1172/JCI69666; Hagiwara N, 2003, DEV BIOL, V254, P93, DOI 10.1016/S0012-1606(02)00030-1; HASSAN JH, 1992, THROMB HAEMOSTASIS, V67, P478; He HJ, 2009, PROTEOM CLIN APPL, V3, P1440, DOI 10.1002/prca.200900020; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Hernandez-Diaz S, 2018, NEUROLOGY, V90, pE342, DOI 10.1212/WNL.0000000000004857; Hill DS, 2010, EXPERT REV NEUROTHER, V10, P943, DOI 10.1586/ERN.10.57; Holmes LB, 2004, ARCH NEUROL-CHICAGO, V61, P673, DOI 10.1001/archneur.61.5.673; Hoopes SP, 2003, J CLIN PSYCHIAT, V64, P1335, DOI 10.4088/JCP.v64n1109; Hunt S, 2008, NEUROLOGY, V71, P272, DOI 10.1212/01.wnl.0000318293.28278.33; Iordanskaia T, 2011, J CELL PHYSIOL, V226, P1415, DOI 10.1002/jcp.22477; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwata J, 2011, ORAL DIS, V17, P733, DOI 10.1111/j.1601-0825.2011.01806.x; Jara CP, 2018, ARCH DERMATOL RES, V310, P363, DOI 10.1007/s00403-018-1822-z; Johnson BA, 2003, LANCET, V361, P1677, DOI 10.1016/S0140-6736(03)13370-3; Kist R, 2002, GENESIS, V32, P121, DOI 10.1002/gene.10050; Ko YH, 2005, CLIN NEUROPHARMACOL, V28, P169, DOI 10.1097/01.wnf.0000172994.56028.c3; Koo J, 2013, ORAL DIS, V19, P712, DOI 10.1111/odi.12061; KWOK C, 1995, AM J HUM GENET, V57, P1028; Li HN, 2018, BBA-MOL BASIS DIS, V1864, P520, DOI 10.1016/j.bbadis.2017.11.011; MacDonald SC, 2015, JAMA NEUROL, V72, P981, DOI 10.1001/jamaneurol.2015.1017; Margulis AV, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.008; May TW, 2002, THER DRUG MONIT, V24, P366, DOI 10.1097/00007691-200206000-00007; McElroy SL, 2003, AM J PSYCHIAT, V160, P255, DOI 10.1176/appi.ajp.160.2.255; McKean DM, 2012, BIOL OPEN, V1, P874, DOI 10.1242/bio.20121982; Meador KJ, 2008, NEUROLOGY, V71, P1109, DOI 10.1212/01.wnl.0000316199.92256.af; Noh MR, 2006, EXP NEUROL, V201, P470, DOI 10.1016/j.expneurol.2006.04.038; Ondo WG, 2006, NEUROLOGY, V66, P672, DOI 10.1212/01.wnl.0000200779.03748.0f; Ozturk F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-113; Prud'homme GJ, 2013, TRANSPLANTATION, V96, P616, DOI 10.1097/TP.0b013e31829c24be; Sachdeo RC, 1996, EPILEPSIA, V37, P774, DOI 10.1111/j.1528-1157.1996.tb00651.x; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Tennis P, 2015, BIRTH DEFECTS RES A, V103, P269, DOI 10.1002/bdra.23357; Uckun FM, 2014, EBIOMEDICINE, V1, P141, DOI 10.1016/j.ebiom.2014.10.013; Van Laer L, 2014, ADV EXP MED BIOL, V802, P95, DOI 10.1007/978-94-007-7893-1_7; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WEE EL, 1986, J CRAN GENET DEV BIO, V6, P53; White HS, 1997, EPILEPSY RES, V28, P167, DOI 10.1016/S0920-1211(97)00045-4; Zhu XJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00085	62	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246989	10.1371/journal.pone.0246989	http://dx.doi.org/10.1371/journal.pone.0246989			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577554	gold, Green Submitted, Green Published			2022-12-26	WOS:000620071700024
J	Shimizu, K; Imamura, H; Tani, S; Adachi, H; Sakai, C; Ishii, A; Kataoka, H; Miyamoto, S; Aoki, T; Sakai, N				Shimizu, Kampei; Imamura, Hirotoshi; Tani, Shoichi; Adachi, Hidemitsu; Sakai, Chiaki; Ishii, Akira; Kataoka, Hiroharu; Miyamoto, Susumu; Aoki, Tomohiro; Sakai, Nobuyuki			Candidate drugs for preventive treatment of unruptured intracranial aneurysms: A cross-sectional study	PLOS ONE			English	Article							SUBARACHNOID HEMORRHAGE; CEREBRAL ANEURYSMS; RISK; ASPIRIN; RUPTURE; ROSUVASTATIN; PITAVASTATIN; SCORE	Background and purpose Establishment of drug therapy to prevent rupture of unruptured intracranial aneurysms (IAs) is needed. Previous human and animal studies have gradually clarified candidate drugs for preventive treatment of IA rupture. However, because most of these candidates belong to classes of drugs frequently co-administered to prevent cardiovascular diseases, epidemiological studies evaluating these drugs simultaneously should be performed. Furthermore, because drugs included in the same class may have different effects in terms of disease prevention, drug-by-drug assessments are important for planning intervention trials. Materials and methods We performed a cross-sectional study enrolling patients diagnosed with IAs between July 2011 and June 2019 at our institution. Patients were divided into ruptured or unruptured groups. The drugs investigated were selected according to evidence suggested by either human or animal studies. Univariate and multivariate logistic regression analyses were performed to assess the association of drug treatment with rupture status. We also performed drug-by-drug assessments of the association, including dose-response relationships, with rupture status. Results In total, 310 patients with ruptured and 887 patients with unruptured IAs were included. Multivariate analysis revealed an inverse association of statins (odds ratio (OR), 0.54; 95% confidence interval (CI) 0.38-0.77), calcium channel blockers (OR, 0.41; 95% CI 0.30-0.58), and angiotensin II receptor blockers (ARBs) (OR, 0.67; 95% CI 0.48-0.93) with ruptured IAs. Moreover, inverse dose-response relationships with rupture status were observed for pitavastatin and rosuvastatin among statins, benidipine, cilnidipine, and amlodipine among calcium channel blockers, and valsartan, azilsartan, candesartan, and olmesartan among ARBs. Only non-aspirin non-steroidal anti-inflammatory drugs were positively associated with ruptured IAs (OR, 3.24; 95% CI 1.71-6.13). Conclusions The present analysis suggests that several types of statins, calcium channel blockers, and ARBs are candidate drugs for preventive treatment of unruptured IAs.	[Shimizu, Kampei; Imamura, Hirotoshi; Tani, Shoichi; Adachi, Hidemitsu; Sakai, Chiaki; Sakai, Nobuyuki] Kobe City Med Ctr Gen Hosp, Dept Neurosurg, Kobe, Hyogo, Japan; [Shimizu, Kampei; Ishii, Akira; Kataoka, Hiroharu; Miyamoto, Susumu] Kyoto Univ, Dept Neurosurg, Grad Sch Med, Kyoto, Japan; [Shimizu, Kampei; Aoki, Tomohiro] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Mol Pharmacol, Osaka, Japan	Kobe City Medical Center General Hospital; Kyoto University; National Cerebral & Cardiovascular Center - Japan	Imamura, H (corresponding author), Kobe City Med Ctr Gen Hosp, Dept Neurosurg, Kobe, Hyogo, Japan.	i-hiro@zg7.so-net.ne.jp	Kataoka, Hiroharu/GPT-3596-2022	Sakai, Nobuyuki/0000-0002-3289-1210; Ishii, Akira/0000-0003-4234-2749; Shimizu, Kampei/0000-0003-4952-0608				Abekura Y, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01802-8; Aoki T, 2009, NEUROSURGERY, V64, P357, DOI 10.1227/01.NEU.0000336764.92606.1D; Can A, 2018, NEUROLOGY, V91, pE1175, DOI 10.1212/WNL.0000000000006200; Can A, 2018, STROKE, V49, P1148, DOI 10.1161/STROKEAHA.117.019972; Can A, 2018, STROKE, V49, P34, DOI 10.1161/STROKEAHA.117.019249; Corman SL, 2005, ANN PHARMACOTHER, V39, P1073, DOI 10.1345/aph.1E514; Cortese F, 2016, PHARMACOL RES, V107, P1, DOI 10.1016/j.phrs.2016.02.012; Etminan N, 2015, NEUROLOGY, V85, P881, DOI 10.1212/WNL.0000000000001891; Fukuda M, 2021, J NEUROSURG, V134, P102, DOI 10.3171/2019.9.JNS19270; Furukawa T, 1999, J PHARMACOL EXP THER, V291, P464; Garbe E, 2013, STROKE, V44, P2422, DOI 10.1161/STROKEAHA.111.000811; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; Gross BA, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.03.072; Hasan DM, 2011, STROKE, V42, P3156, DOI 10.1161/STROKEAHA.111.619411; Huang WY, 2019, JAMA NEUROL, V76, P906, DOI 10.1001/jamaneurol.2019.1120; Ishii M, 2015, CIRC J, V79, P1115, DOI 10.1253/circj.CJ-14-0789; Li SJ, 2015, NEUROCHEM RES, V40, P1537, DOI 10.1007/s11064-015-1603-4; Lindbohm J, 2018, ATHEROSCLEROSIS, V274, P112, DOI 10.1016/j.atherosclerosis.2018.05.011; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Phan K, 2017, STROKE, V48, P1210, DOI 10.1161/STROKEAHA.116.015674; Saku K, 2011, CIRC J, V75, P1493, DOI 10.1253/circj.CJ-10-1281; Shimizu K, 2016, AM J NEURORADIOL, V37, P679, DOI 10.3174/ajnr.A4577; Shimizu K, 2019, J NEUROPATH EXP NEUR, V78, P798, DOI 10.1093/jnen/nlz057; Shimizu K, 2019, NEUROL MED-CHIR, V59, P126, DOI 10.2176/nmc.st.2018-0326; Tada Y, 2014, STROKE, V45, P579, DOI 10.1161/STROKEAHA.113.003072; Ungprasert P, 2016, STROKE, V47, P356, DOI 10.1161/STROKEAHA.115.011678; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Vergouwen MDI, 2018, INT J STROKE, V13, P992, DOI 10.1177/1747493018790033; Yoshimura Y, 2014, J STROKE CEREBROVASC, V23, P343, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.022	29	4	4	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246865	10.1371/journal.pone.0246865	http://dx.doi.org/10.1371/journal.pone.0246865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577580	gold, Green Published			2022-12-26	WOS:000620071700021
J	Vogl, TJ; Riegelbauer, LJ; Oppermann, E; Kostantin, M; Ackermann, H; Trzmiel, A; Stein, S; Eichler, K; Zharov, VP; Roy, D; Schnitzbauer, AA; Strucker, B; Pascher, A; Bechstein, WO; Juratli, MA				Vogl, Thomas J.; Riegelbauer, Linda J.; Oppermann, Elsie; Kostantin, Michel; Ackermann, Hanns; Trzmiel, Annette; Stein, Stefan; Eichler, Katrin; Zharov, Vladimir P.; Roy, Dhruvajyoti; Schnitzbauer, Andreas A.; Strucker, Benjamin; Pascher, Andreas; Bechstein, Wolf O.; Juratli, Mazen A.			Early dynamic changes in circulating tumor cells and prognostic relevance following interventional radiological treatments in patients with hepatocellular carcinoma	PLOS ONE			English	Article								The aim of this study was to investigate the dynamic changes of circulating tumor cells (CTCs) in patients with hepatocellular carcinoma (HCC) before and immediately after conducting a microwave ablation (MWA) and conventional transarterial chemoembolization (C-TACE). Additionally, the CTCs short-term dynamics were compared with the clinical course of the HCC-patients. Blood samples from 17 patients with HCC who underwent MWA (n = 10) or C-TACE (n = 7) were analyzed. Venous blood was taken before and immediately after the radiological interventions to isolate and quantify CTCs using flow cytometry. CTCs were identified as CD45- and positive for the markers ASGPR, CD146 and CD274 (PD-L1). Patients were followed of up to 2.2 years after the radiological intervention. CTCs were detected in 13 HCC patients (76%) prior to the radiological interventions. The rate of CTCs was significantly decreased after the intervention in patients treated with MWA (0.4 CTCs/mL of blood, p = 0.031). However, no significant differences were observed in patients who received C-TACE (0.3 CTCs/mL of blood, p = 0.300). Overall, no correlation was found between the CTCs rate before and after the radiological intervention and recurrence rate of HCC. This preliminary data could confirm the tumoricidal effects of MWA in patients with HCC by significantly decreasing CTCs rate. In our study, we were able to detect CTCs in HCC patients using 3 different tumor markers. This preliminary data shows significant lower CTCs detected in response to MWA. However, large-scale randomized clinical trials are needed to determine the future role and the prognostic relevance of CTCs following this treatment.	[Vogl, Thomas J.; Eichler, Katrin] Goethe Univ, Frankfurt Univ Hosp, Inst Diagnost & Intervent Radiol, Frankfurt, Germany; [Riegelbauer, Linda J.; Oppermann, Elsie; Kostantin, Michel; Schnitzbauer, Andreas A.; Bechstein, Wolf O.; Juratli, Mazen A.] Goethe Univ, Frankfurt Univ Hosp, Dept Gen Visceral & Transplant Surg, Frankfurt, Germany; [Ackermann, Hanns] Goethe Univ, Frankfurt Univ Hosp, Dept Biomed Stat, Frankfurt, Germany; [Trzmiel, Annette; Stein, Stefan] Georg Speyer Haus, Flow Cytometry Unit, Frankfurt, Germany; [Zharov, Vladimir P.] Univ Arkansas Med Sci, Arkansas Nanomed Ctr, Little Rock, AR 72205 USA; [Roy, Dhruvajyoti] Lab Adv Med Inc, Irvine, CA USA; [Strucker, Benjamin; Pascher, Andreas; Juratli, Mazen A.] Muenster Univ Hosp, Dept Gen Visceral & Transplant Surg, Munster, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Octapharma; University of Arkansas System; University of Arkansas Medical Sciences; University of Munster	Juratli, MA (corresponding author), Goethe Univ, Frankfurt Univ Hosp, Dept Gen Visceral & Transplant Surg, Frankfurt, Germany.; Juratli, MA (corresponding author), Muenster Univ Hosp, Dept Gen Visceral & Transplant Surg, Munster, Germany.	mazen.juratli@ukmuenster.de	Juratli, Mazen/ABH-2883-2021; Roy, Dhruvajyoti/O-2418-2017	Juratli, Mazen/0000-0002-1793-0672; Roy, Dhruvajyoti/0000-0002-9202-6720; Kostantin, Michel/0000-0002-0928-9002; Zharov, Vladimir/0000-0003-4773-0548	Rudolf Geissendorfer-Stiftung; Frankfurter Forschungs Foerderung (FFF); B. Braun-Stiftung	Rudolf Geissendorfer-Stiftung; Frankfurter Forschungs Foerderung (FFF); B. Braun-Stiftung	This work was supported by Rudolf Geissendorfer-Stiftung in the form of a grant awarded to MAJ (2015), Frankfurter Forschungs Foerderung in the form of a grant awarded to MAJ (FFF 2017), B. Braun-Stiftung in the form of a grant awarded to MAJ (2018), Laboratory for Advanced Medicine, Inc. in the form of a salary for DR. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2014, RSC ADV, V4, P4334, DOI 10.1039/c3ra46839a; Alix-Panabieres C, 2014, NAT REV CANCER, V14, P623, DOI 10.1038/nrc3820; Amabile C, 2017, INT J HYPERTHER, V33, P34, DOI 10.1080/02656736.2016.1196830; Baek MY, 2019, KOREAN J INTERN MED, V34, P1223, DOI 10.3904/kjim.2018.058; Cha C, 2003, J AM COLL SURGEONS, V197, P753, DOI 10.1016/j.jamcollsurg.2003.07.003; Chiappini F, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/684802; Court CM, 2018, LIVER TRANSPLANT, V24, P946, DOI 10.1002/lt.25062; DeGIR Schneider F, 2017, FORTSCHR R NTGENSTR, V189, P268, DOI [10.1055/s-0043-102926, DOI 10.1055/S-0043-102926]; Fang ZT, 2014, ONCOTARGETS THER, V7, P1311, DOI 10.2147/OTT.S62605; Gorges TobiasM, 2016, DTSCH RZTEBLATT, V2016, P8; Harrison TR, 1962, HARRISONS PRINCIPLES, V4th ed; Herzenberg LA, 2000, IMMUNOL TODAY, V21, P383, DOI 10.1016/S0167-5699(00)01678-9; Hong B, 2013, THERANOSTICS, V3, P377, DOI 10.7150/thno.5195; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Juratli MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137613; Juratli MA, 2014, CANCERS, V6, P128, DOI 10.3390/cancers6010128; Juratli MA, 2014, HEAD NECK-J SCI SPEC, V36, P1207, DOI 10.1002/hed.23439; Juratli MazenA., 2017, PERIOPERATIVE INFLAM, P109; Kanda M, 2008, LIVER INT, V28, P1256, DOI 10.1111/j.1478-3231.2008.01864.x; Kowalik A, 2017, TRANSL RES, V185, P58, DOI 10.1016/j.trsl.2017.04.002; Lanza E, 2017, LIVER CANCER, V6, P27, DOI 10.1159/000449347; Liang P, 2007, ONCOLOGY-BASEL, V72, P124, DOI 10.1159/000111718; Liu WW, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5069-z; NAKANO A, 1990, ACTA PATHOL JAPON, V40, P107; Poon RTP, 2002, J CLIN ONCOL, V20, P1775, DOI 10.1200/JCO.2002.07.089; Rofstad EK, 2010, INT J CANCER, V127, P1535, DOI 10.1002/ijc.25176; Rostami P, 2019, J SCI-ADV MATER DEV, V4, P1, DOI 10.1016/j.jsamd.2019.01.006; Sempokuya Tomoki, 2019, Hepatoma Res, V5, DOI 10.20517/2394-5079.2019.013; Toyosaka A, 1996, AM J GASTROENTEROL, V91, P1610; Vogl TJ, 2014, ONKOLOGE, V20, P746, DOI 10.1007/s00761-014-2669-3; von Felden J, 2017, ONCOTARGET, V8, P89978, DOI 10.18632/oncotarget.21208; Yan WT, 2017, SCI REP-UK, V7, DOI 10.1038/srep43464; Ye QW, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1043-x	33	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246527	10.1371/journal.pone.0246527	http://dx.doi.org/10.1371/journal.pone.0246527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577574	Green Published, gold			2022-12-26	WOS:000620071700048
J	Parker, ET; Lollar, P				Parker, Ernest T.; Lollar, Pete			Conformation of the von Willebrand factor/factor VIII complex in quasi-static flow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEDIMENTATION COEFFICIENT DISTRIBUTIONS; ANALYTICAL ULTRACENTRIFUGATION; SELF-ASSOCIATION; FACTOR MULTIMERS; HYDRODYNAMIC PROPERTIES; VONWILLEBRAND-FACTOR; ELECTRON-MICROSCOPY; SIZE-DISTRIBUTION; DILUTE-SOLUTION; A1 DOMAIN	Von Willebrand factor (VWF) is a plasma glycoprotein that circulates noncovalently bound to blood coagulation factor VIII (fVIII). VWF is a population of multimers composed of a variable number of similar to 280 kDa monomers that is activated in shear flow to bind collagen and platelet glycoprotein Ib alpha. Electron microscopy, atomic force microscopy, small-angle neutron scattering, and theoretical studies have produced a model in which the conformation of VWF under static conditions is a compact, globular "ball-of-yarn," implying strong, attractive forces between monomers. We performed sedimentation velocity (SV) analytical ultracentrifugation measurements on unfractionated VWF/fVIII complexes. There was a 20% per mg/ml decrease in the weight-average sedimentation coefficient, s(w), in contrast to the similar to 1% per mg/ml decrease observed for compact globular proteins. SV and dynamic light scattering measurements were performed on VWF/fVIII complexes fractionated by size-exclusion chromatography to obtain s(w) values and z-average diffusion coefficients, D-z. Molecular weights estimated using these values in the Svedberg equation ranged from 1.7 to 4.1 MDa. Frictional ratios calculated from D-z and molecular weights ranged from 2.9 to 3.4, in contrast to values of 1.1-1.3 observed for globular proteins. The Mark-Houwink-Kuhn-Sakurada scaling relationships between s(w), D-z and molecular weight, s = k' M-alpha s and D = k '' M-alpha D, yielded estimates of 0.51 and -0.49 for alpha(s) and alpha(D), respectively, consistent with a random coil, in contrast to the alpha(s) value of 0.65 observed for globular proteins. These results indicate that interactions between monomers are weak or nonexistent and that activation of VWF is intramonomeric.	[Lollar, Pete] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30307 USA; Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	Children's Healthcare of Atlanta (CHOA); Emory University	Lollar, P (corresponding author), Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30307 USA.	jlollar@emory.edu			National Institutes of Health/National Heart, Lung and Blood Institute [U54HL141981]	National Institutes of Health/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health/National Heart, Lung and Blood Institute (award number U54HL141981 to P. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amoros D, 2011, MACROMOLECULES, V44, P5788, DOI 10.1021/ma102697q; Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001; BATCHELOR GK, 1972, J FLUID MECH, V52, P245, DOI 10.1017/S0022112072001399; Bienkowska J, 1997, J BIOL CHEM, V272, P25162, DOI 10.1074/jbc.272.40.25162; Brautigam CA, 2019, BIOMOLECULAR AND BIOANALYTICAL TECHNIQUES: THEORY, METHODOLOGY AND APPLICATIONS, P255; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Budde U, 2006, SEMIN THROMB HEMOST, V32, P514, DOI 10.1055/s-2006-947866; Cantor C. R., 1980, ULTRACENTRIFUGATION, P591; Cantor C. R., 1980, BIOPHYSICAL CHEM 2, P539; Chaturvedi SK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06902-x; CHOPEK MW, 1986, BIOCHEMISTRY-US, V25, P3146, DOI 10.1021/bi00359a012; Cohn E. J., 1943, PROTEINS AMINO ACIDS; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; CROTHERS DM, 1965, J MOL BIOL, V12, P525, DOI 10.1016/S0022-2836(65)80310-2; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Dam J, 2004, METHOD ENZYMOL, V384, P185; Deng W, 2018, J THROMB HAEMOST, V16, P2097, DOI 10.1111/jth.14251; Deng W, 2017, J THROMB HAEMOST, V15, P1867, DOI 10.1111/jth.13775; Doering CB, 2004, J BIOL CHEM, V279, P6546, DOI 10.1074/jbc.M312451200; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Dong XC, 2019, BLOOD, V133, P1523, DOI 10.1182/blood-2018-10-876300; Einstein A, 1926, INVESTIGATIONS THEOR, DOI DOI 10.2307/2298685; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Federici AB, 2010, HAEMOPHILIA, V16, P101, DOI 10.1111/j.1365-2516.2009.02088.x; Flory P. J, 1953, PRINCIPLES POLYM CHE; FOWLER WE, 1985, J CLIN INVEST, V76, P1491, DOI 10.1172/JCI112129; Fu HX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00230-2; FUJII M, 1973, BIOPOLYMERS, V12, P1177, DOI 10.1002/bip.1973.360120520; de la Torre JG, 2020, J MOL BIOL, V432, P2930, DOI 10.1016/j.jmb.2019.12.027; Garland C. W., 2009, EXPT PHYS CHEM, V8th; Ghirlando R, 2014, ANAL BIOCHEM, V458, P37, DOI 10.1016/j.ab.2014.04.029; Gillis RB, 2014, BIOTECHNOL GENET ENG, V30, P142, DOI 10.1080/02648725.2014.994870; Harding SE, 2005, ADV POLYM SCI, V186, P211, DOI 10.1007/b136821; Javitt G, 2020, CELL, V183, P717, DOI 10.1016/j.cell.2020.09.021; Johnsen J., 2016, WILLIAMS HEMATOLOGY, V9th, P2163; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Lippok S, 2013, BIOPHYS J, V105, P1208, DOI 10.1016/j.bpj.2013.07.037; Lodge T. P., 2007, POLYM CHEM-UK; LOSCALZO J, 1985, BIOCHEMISTRY-US, V24, P4468, DOI 10.1021/bi00337a031; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; Morris GA, 2008, CARBOHYD POLYM, V71, P101, DOI 10.1016/j.carbpol.2007.05.029; Muller JP, 2016, P NATL ACAD SCI USA, V113, P1208, DOI 10.1073/pnas.1516214113; NISHIHARA T, 1958, P NATL ACAD SCI USA, V44, P411, DOI 10.1073/pnas.44.5.411; OHMORI K, 1982, J CELL BIOL, V95, P632, DOI 10.1083/jcb.95.2.632; Oncley J. L., 1941, ANN NY ACAD SCI, V41, P121; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Patel TR, 2018, EUR BIOPHYS J BIOPHY, V47, P291, DOI 10.1007/s00249-017-1259-x; Pavlov G, 2003, EUR BIOPHYS J BIOPHY, V32, P437, DOI 10.1007/s00249-003-0316-9; Prakash JR, 2019, CURR OPIN COLLOID IN, V43, P63, DOI 10.1016/j.cocis.2019.03.001; ROTBLAT F, 1985, BIOCHEMISTRY-US, V24, P4294, DOI 10.1021/bi00337a007; ROWE AJ, 1977, BIOPOLYMERS, V16, P2595, DOI 10.1002/bip.1977.360161202; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Savage B, 2002, P NATL ACAD SCI USA, V99, P425, DOI 10.1073/pnas.012459599; Schachman H.K., 1959, ULTRACENTRIFUGATION; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2001, J BIOL CHEM, V276, P9679, DOI 10.1074/jbc.M009398200; Schuck P., 2017, SEDIMENTATION VELOCI; Schuck P, 2016, BASIC PRINCIPLES ANA; SHOGREN RL, 1986, BIOPOLYMERS, V25, P1505, DOI 10.1002/bip.360250809; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Sing CE, 2010, BIOPHYS J, V98, pL35, DOI 10.1016/j.bpj.2010.01.032; Singh I, 2006, J BIOL CHEM, V281, P38266, DOI 10.1074/jbc.M607123200; SLAYTER H, 1985, J BIOL CHEM, V260, P8559; Springer TA, 2011, J THROMB HAEMOST, V9, P130, DOI 10.1111/j.1538-7836.2011.04320.x; Stetefeld Jorg, 2016, Biophys Rev, V8, P409, DOI 10.1007/s12551-016-0218-6; Stockschlaeder M, 2014, BLOOD COAGUL FIBRIN, V25, P206, DOI 10.1097/MBC.0000000000000065; TANFORD C, 1967, J AM CHEM SOC, V89, P729, DOI 10.1021/ja00980a001; Tanford C., 1961, PHYS CHEM MACROMOLEC; Teller D C, 1979, Methods Enzymol, V61, P103; THORELL L, 1984, THROMB RES, V35, P431, DOI 10.1016/0049-3848(84)90235-4; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; YAMAKAWA H, 1973, MACROMOLECULES, V6, P407, DOI 10.1021/ma60033a018; YANAKI T, 1980, MACROMOLECULES, V13, P1462, DOI 10.1021/ma60078a019; Zaccai N. R., 2017, HYDRODYNAMICS METHOD, V2nd, P159; Zhang CJ, 2019, BLOOD ADV, V3, P957, DOI 10.1182/bloodadvances.2018030122; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhao HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126420; Zhao Huaying, 2013, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2012s71; Zhou YF, 2011, EMBO J, V30, P4098, DOI 10.1038/emboj.2011.297; Zimm B H, 1974, Biophys Chem, V1, P279, DOI 10.1016/0301-4622(74)80014-1	86	6	6	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100420	10.1016/j.jbc.2021.100420	http://dx.doi.org/10.1016/j.jbc.2021.100420			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33600794	Green Published, gold			2022-12-26	WOS:000672866400394
J	Chatroudi, AH; Rostami, R; Nasrabadi, AM; Yotsumoto, Y				Houshmand Chatroudi, Amirmahmoud; Rostami, Reza; Nasrabadi, Ali Motie; Yotsumoto, Yuko			Effect of inhibition indexed by auditory P300 on transmission of visual sensory information	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; MEDIAL TEMPORAL-LOBE; ALPHA-OSCILLATIONS; WORKING-MEMORY; BRAIN; EEG; MECHANISMS; ATTENTION; CONTEXT; TARGET	Early electroencephalographic studies that focused on finding brain correlates of psychic events led to the discovery of the P300. Since then, the P300 has become the focus of many basic and clinical neuroscience studies. However, despite its wide applications, the underlying function of the P300 is not yet clearly understood. One line of research among the many studies that have attempted to elucidate the underlying subroutine of the P300 in the brain has suggested that the physiological function of the P300 is related to inhibition. While some intracranial, behavioral, and event-related potential studies have provided support for this theory, little is known about the inhibitory mechanism. In this study, using alpha event-related desynchronization (ERD) and effective connectivity, based on the causal (one-way directed) relationship between alpha ERD and P300 sources, we demonstrated that P300's associated inhibition is implemented at a higher information processing stage in a localized brain region. We discuss how inhibition as the primary function of the P300 is not inconsistent with 'resource allocation' and 'working memory updating' theories about its cognitive function. In light of our findings regarding the scope and information processing stage of inhibition of the P300, we reconcile the inhibitory account of the P300 with working memory updating theory. Finally, based on the compensatory behavior of alpha ERD at the time of suppression of the P300, we propose two distinct yet complementary working memory mechanisms (inhibition and desynchronizing excitation) that render target perception possible.	[Houshmand Chatroudi, Amirmahmoud; Yotsumoto, Yuko] Univ Tokyo, Dept Life Sci, Tokyo, Tokyo, Japan; [Houshmand Chatroudi, Amirmahmoud; Rostami, Reza] Univ Tehran, Fac Psychol & Educ Sci, Tehran, Iran; [Nasrabadi, Ali Motie] Shahed Univ, Dept Biomed Engn, Tehran, Iran	University of Tokyo; University of Tehran; Shahed University	Rostami, R (corresponding author), Univ Tehran, Fac Psychol & Educ Sci, Tehran, Iran.	rrostami@ut.ac.ir	Motie Nasrabadi, Ali/ABC-1687-2021	Motie Nasrabadi, Ali/0000-0002-3702-8547	Japan Society for the Promotion of Science KAKENHI [19H01771]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by Japan Society for the Promotion of Science KAKENHI (Grant #19H01771) to YY. https://www.jsps.go.jp/english/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTAFULLAH I, 1986, ELECTROEN CLIN NEURO, V63, P503, DOI 10.1016/0013-4694(86)90138-0; Azizian A, 2006, BIOL PSYCHOL, V71, P278, DOI 10.1016/j.biopsycho.2005.05.002; Bachanas PJ, 1989, THESIS FLORIDA ATLAN; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; BIRBAUMER N, 1988, BEHAV BRAIN SCI, V11, P375, DOI 10.1017/S0140525X00058040; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; BOITEN F, 1992, ELECTROEN CLIN NEURO, V82, P302, DOI 10.1016/0013-4694(92)90110-4; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Desmedt J E, 1980, Prog Brain Res, V54, P682, DOI 10.1016/S0079-6123(08)61690-8; DESMEDT JE, 1979, ELECTROEN CLIN NEURO, V47, P648, DOI 10.1016/0013-4694(79)90293-1; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; ELBERT T, 1993, NATO ADV SCI INST SE, V254, P235; Elbert T., 1987, J PSYCHOPHYSIOL, V1, P317; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Giraudet L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118556; Haegens S, 2011, P NATL ACAD SCI USA, V108, P19377, DOI 10.1073/pnas.1117190108; Halgren M, 2019, P NATL ACAD SCI USA, V116, P23772, DOI 10.1073/pnas.1913092116; Handel BF, 2011, J COGNITIVE NEUROSCI, V23, P2494, DOI 10.1162/jocn.2010.21557; HEIT G, 1990, BRAIN, V113, P1093, DOI 10.1093/brain/113.4.1093; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Hughes SW, 2004, NEURON, V42, P253, DOI 10.1016/S0896-6273(04)00191-6; Huster RJ, 2010, HUM BRAIN MAPP, V31, P1260, DOI 10.1002/hbm.20933; ISREAL JB, 1980, HUM FACTORS, V22, P211, DOI 10.1177/001872088002200210; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Kleiner M, 2007, PERCEPTION, V36, P14; Klimesch W, 2006, PROG BRAIN RES, V159, P151, DOI 10.1016/S0079-6123(06)59010-7; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Korzeniewska A, 2003, J NEUROSCI METH, V125, P195, DOI 10.1016/S0165-0270(03)00052-9; Krause Christina M., 1994, Brain Topography, V7, P107, DOI 10.1007/BF01186768; Krause CM, 1999, J NEW MUSIC RES, V28, P257, DOI 10.1076/jnmr.28.3.257.3113; Krol M, 2015, Q J EXP PSYCHOL, V68, P1723, DOI 10.1080/17470218.2014.996166; Lenartowicz A, 2010, COGN AFFECT BEHAV NE, V10, P298, DOI 10.3758/CABN.10.2.298; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Mathewson KE, 2014, J COGNITIVE NEUROSCI, V26, P2400, DOI 10.1162/jocn_a_00637; Mathewson KE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00099; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; McArthur G, 1999, NEUROREPORT, V10, P3691, DOI 10.1097/00001756-199911260-00042; Mullen TR, 2014, DYNAMIC BRAIN MODELI; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; NASH AJ, 1982, BIOL PSYCHOL, V15, P15, DOI 10.1016/0301-0511(82)90028-X; Nash AJ, 1996, INT J PSYCHOPHYSIOL, V23, P171, DOI 10.1016/S0167-8760(96)00049-9; Odierna LA, 1987, THESIS FLORIDA ATLAN; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peng WW, 2015, BEHAV BRAIN RES, V295, P71, DOI 10.1016/j.bbr.2015.04.051; Peng WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034163; Pfurtscheller G, 2003, EPILEPSIA, V44, P2, DOI 10.1111/j.0013-9580.2003.12001.x; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pineda JA, 1982, THESIS FLORIDA ATLAN; Polich J., 2012, OXFORD HDB EVENT REL, P159, DOI [DOI 10.1093/OXFORDHB/9780195374148.013.0089, 10.1093/oxfordhb/9780195374148.013.0089]; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; ROCKSTROH B, 1992, J PSYCHOPHYSIOL, V6, P175; Rosler Frank, 2005, Hist Psychol, V8, P95, DOI 10.1037/1093-4510.8.1.95; Rossion B., 2012, OXFORD HDB ERP COMPO, P115, DOI [10.1093/oxfordhb/9780195374148.013.0064, DOI 10.1093/OXFORDHB/9780195374148.013.0064]; Rutkove S. B., 2007, INTRO VOLUME CONDUCT, P43, DOI DOI 10.1007/978-1-59745-271-7%5F4; SERGEANT J, 1987, PSYCHOPHYSIOLOGY, V24, P272, DOI 10.1111/j.1469-8986.1987.tb00294.x; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sharma Rohan, 2020, eNeuro, V7, DOI 10.1523/ENEURO.0293-19.2020; SQUIRES KC, 1976, SCIENCE, V193, P1142, DOI 10.1126/science.959831; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Taylor MJ, 2002, CLIN NEUROPHYSIOL, V113, P1903, DOI 10.1016/S1388-2457(02)00309-7; Traub RD, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0947-8; Vazquez-Marrufo M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223055; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Wickens CD., 1977, P HUMAN FACTORS SOC, V21, P282, DOI [10.1177/107118137702100404, DOI 10.1177/107118137702100404]; WOODWARD SH, 1991, PSYCHOPHYSIOLOGY, V28, P609, DOI 10.1111/j.1469-8986.1991.tb01003.x; Yordanova J, 2001, PSYCHOPHYSIOLOGY, V38, P143, DOI 10.1017/S0048577201990079; Zhang WW, 2009, NAT NEUROSCI, V12, P24, DOI 10.1038/nn.2223	84	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247416	10.1371/journal.pone.0247416	http://dx.doi.org/10.1371/journal.pone.0247416			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QO3ZL	33617549	Green Published, gold			2022-12-26	WOS:000623082400045
J	Huang, ZY; Kampfen, F				Huang, Zhiyong; Kampfen, Fabrice			The association between depressive symptoms and self-reported sleep difficulties among college students: Truth or reporting bias?	PLOS ONE			English	Article							QUALITY-OF-LIFE; DATA RESOURCE PROFILE; ANCHORING VIGNETTES; SUBJECTIVE SLEEP; YOUNG-ADULTS; MENTAL-DISORDERS; RATED HEALTH; INSOMNIA; HETEROGENEITY; ANXIETY	The strong association between self-reported sleep difficulties and depressive symptoms is well documented. However, individuals who suffer from depressive symptoms could potentially interpret the values attached to a subjective scale differently from others, making comparisons of sleep difficulties across individuals with different depressive symptoms problematic. The objective of this study is to determine the existence and magnitude of reporting heterogeneity in subjective assessment of sleep difficulties by those who have depressive symptoms. We implement an online survey using Visual Analogue Scales and anchoring vignettes to study the comparability of subjective assessments of sleep difficulties among college students in Switzerland (N = 1, 813). Using multivariate linear regressions and double-index models, our analysis shows that reporting heterogeneity plays only a marginal role in moderating the association between sleep difficulties and depression, irrespective of the severity of the depressive symptoms of the individuals. This suggests that unadjusted comparisons of self-reported sleep difficulties between college students are meaningful, even among individuals with depressive symptoms.	[Huang, Zhiyong] Southwestern Univ Finance & Econ, Chengdu, Peoples R China; [Kampfen, Fabrice] Univ Penn, Populat Studies Ctr, Philadelphia, PA 19104 USA	Southwestern University of Finance & Economics - China; University of Pennsylvania	Kampfen, F (corresponding author), Univ Penn, Populat Studies Ctr, Philadelphia, PA 19104 USA.	kampfenf@sas.upenn.edu		Kampfen, Fabrice/0000-0001-7304-7473	HEC Research Fund 2017 - University of Lausanne, Switzerland; National Natural Science Foundation of China under the project "Quality of Life Research: Based on Capacity Approach: A Population Study in Southwestern China" [71804151]	HEC Research Fund 2017 - University of Lausanne, Switzerland; National Natural Science Foundation of China under the project "Quality of Life Research: Based on Capacity Approach: A Population Study in Southwestern China"	This study was funded by the HEC Research Fund 2017 - University of Lausanne, Switzerland (https://www.unil.ch/hec/en/home.html) awarded to FK and ZH. This study was also supported by the National Natural Science Foundation of China under the project "Quality of Life Research: Based on Capacity Approach: A Population Study in Southwestern China" (Project number 71804151) awarded to ZH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2006, J AFFECT DISORDERS, V96, P89, DOI 10.1016/j.jad.2006.05.021; AKERSTEDT T, 1994, PERCEPT MOTOR SKILL, V79, P287, DOI 10.2466/pms.1994.79.1.287; Algul A, 2009, INT J PSYCHIAT MED, V39, P297, DOI 10.2190/PM.39.3.f; Angelini V, 2014, OXFORD B ECON STAT, V76, P643, DOI 10.1111/obes.12039; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Arrieta J, 2017, J CLIN PSYCHOL, V73, P1076, DOI 10.1002/jclp.22390; Asarnow LD, 2014, J ADOLESCENT HEALTH, V54, P350, DOI 10.1016/j.jadohealth.2013.09.004; Au N, 2014, QUAL LIFE RES, V23, P1721, DOI 10.1007/s11136-013-0615-2; Augner C, 2011, CENT EUR J PUBL HEAL, V19, P115, DOI 10.21101/cejph.a3647; Avenevoli S, 2008, HDB DEPRESSION CHILD; Baglioni C, 2016, PSYCHOL BULL, V142, P969, DOI 10.1037/bul0000053; Baker FC, 1999, J PSYCHOSOM RES, V47, P335, DOI 10.1016/S0022-3999(99)00017-3; Becker SP, 2018, J PSYCHIATR RES, V99, P122, DOI 10.1016/j.jpsychires.2018.01.009; Blackwell TL, 2014, REHABIL COUNS BULL, V57, P246, DOI 10.1177/0034355213515305; BLIWISE DL, 1993, J CLIN PSYCHOL, V49, P471, DOI 10.1002/1097-4679(199307)49:4<471::AID-JCLP2270490403>3.0.CO;2-7; Bobes J., 1998, EUR NEUROPSYCHOPHARM, V8, pS162, DOI [10.1016/S0924-977X(98)80198-3, DOI 10.1016/S0924-977X(98)80198-3, 10.1016/S0924-977X(98)80199-5]; Borsch-Supan A, 2013, INT J EPIDEMIOL, V42, P992, DOI 10.1093/ije/dyt088; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Crane M, 2016, QUAL LIFE RES, V25, P257, DOI 10.1007/s11136-015-1090-8; D'Uva TB, 2008, HEALTH ECON, V17, P351, DOI 10.1002/hec.1269; d'Uva TB, 2011, J R STAT SOC A STAT, V174, P639, DOI 10.1111/j.1467-985X.2011.00706.x; de Niet GJ, 2008, J PSYCHIATR MENT HLT, V15, P465, DOI 10.1111/j.1365-2850.2008.01250.x; Erbe Doris, 2016, Internet Interv, V5, P1, DOI 10.1016/j.invent.2016.06.006; Feige B, 2013, INT J PSYCHOPHYSIOL, V89, P171, DOI 10.1016/j.ijpsycho.2013.04.002; Furr SR, 2001, PROF PSYCHOL-RES PR, V32, P97, DOI 10.1037/0735-7028.32.1.97; Garlow SJ, 2008, DEPRESS ANXIETY, V25, P482, DOI 10.1002/da.20321; Glozier N, 2010, SLEEP, V33, P1139, DOI 10.1093/sleep/33.9.1139; Grol-Prokopczyk H, 2011, J HEALTH SOC BEHAV, V52, P246, DOI 10.1177/0022146510396713; Hanandita W, 2016, QUAL LIFE RES, V25, P1137, DOI 10.1007/s11136-015-1152-y; Harvey AG, 2008, SLEEP, V31, P383, DOI 10.1093/sleep/31.3.383; Hayashino Y, 2010, SLEEP MED, V11, P366, DOI 10.1016/j.sleep.2009.05.021; Hopkins DJ, 2010, PUBLIC OPIN QUART, V74, P201, DOI 10.1093/poq/nfq011; Huang ZY, 2020, COMMUNITY MENT HLT J, V56, P355, DOI 10.1007/s10597-019-00469-7; HYYPPA MT, 1989, J CLIN EPIDEMIOL, V42, P633, DOI 10.1016/0895-4356(89)90006-1; Jackson CL, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy057; Jean-Louis G, 2000, SLEEP, V23, P1115; JOHNS MW, 1971, BRIT J PREV SOC MED, V25, P236; Jurges H, 2007, HEALTH ECON, V16, P163, DOI 10.1002/hec.1134; Jurges H, 2013, HEALTH ECON, V22, P1, DOI 10.1002/hec.1806; Kampfen F, 2019, 201926 PSCPARC U PEN; Kaplan KA, 2017, BIOL PSYCHOL, V123, P37, DOI 10.1016/j.biopsycho.2016.11.010; Kapteyn A, 2007, AM ECON REV, V97, P461, DOI 10.1257/aer.97.1.461; Kapteyn A, 2013, REV INCOME WEALTH, V59, P44, DOI 10.1111/j.1475-4991.2012.00532.x; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; King G, 2004, AM POLIT SCI REV, V98, P191, DOI 10.1017/S000305540400108X; Knott RJ, 2017, SOC SCI MED, V190, P247, DOI 10.1016/j.socscimed.2017.08.033; Knott RJ, 2017, HEALTH ECON, V26, P387, DOI 10.1002/hec.3313; Kohler IV, 2017, DEMOGRAPHY, V54, P1529, DOI 10.1007/s13524-017-0596-9; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kristensen N, 2008, LABOUR ECON, V15, P96, DOI 10.1016/j.labeco.2006.11.001; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LeBlanc M, 2007, J PSYCHOSOM RES, V63, P157, DOI 10.1016/j.jpsychores.2007.03.004; Lemola S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071292, 10.1371/journal.pone.0082059]; Lombardi DA, 2010, CHRONOBIOL INT, V27, P1013, DOI 10.3109/07420528.2010.489466; Lomeli HA, 2008, ACTAS ESP PSIQUIATRI, V36, P50; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Malhotra C, 2013, HEALTH POLICY PLANN, V28, P197, DOI 10.1093/heapol/czs051; Manzar MD, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0915-x; Mayers AG, 2009, HUM PSYCHOPHARM CLIN, V24, P495, DOI 10.1002/hup.1041; Milette K, 2011, RHEUMATOLOGY, V50, P921, DOI 10.1093/rheumatology/keq411; Mojtabai R, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1878; Molina T, 2016, DEMOGRAPHY, V53, P295, DOI 10.1007/s13524-016-0456-z; Monk TH, 2003, SLEEP, V26, P208, DOI 10.1093/sleep/26.2.208; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Ohayon M, 2017, SLEEP HEALTH, V3, P6, DOI 10.1016/j.sleh.2016.11.006; Oyane NMF, 2005, AUTISM, V9, P83, DOI 10.1177/1362361305049031; Ravallion M, 2016, ECON DEV CULT CHANGE, V64, P697, DOI 10.1086/686793; Rice N, 2012, J R STAT SOC A STAT, V175, P337, DOI 10.1111/j.1467-985X.2011.01021.x; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Sabate E., 2004, PRIORITY MED EUROPE, V6; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Sawyer SM, 2018, LANCET CHILD ADOLESC, V2, P223, DOI 10.1016/S2352-4642(18)30022-1; Schulenberg JE, 2004, DEV PSYCHOPATHOL, V16, P799, DOI 10.1017/S0954579404040015; Schwartz S, 1999, J PSYCHOSOM RES, V47, P313, DOI 10.1016/S0022-3999(99)00029-X; Shrivastava D, 2014, J COMMUNITY HOSP INT, V4, DOI 10.3402/jchimp.v4.24983; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067; Stein MB, 2001, ARCH GEN PSYCHIAT, V58, P251, DOI 10.1001/archpsyc.58.3.251; Stone LB, 2011, J ABNORM PSYCHOL, V120, P752, DOI 10.1037/a0023384; Studer R, 2011, WORKING PAPER SERIES; Suzuki H, 2011, PSYCHIAT RES, V188, P138, DOI 10.1016/j.psychres.2010.10.025; Tareque MI, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0733-9; Tarrasch R, 2003, HUM PSYCHOPHARM CLIN, V18, P603, DOI 10.1002/hup.534; van Soest A, 2011, J R STAT SOC A STAT, V174, P575, DOI 10.1111/j.1467-985X.2011.00694.x; Wang J., 2016, SOC INDIC RES; WEBB WB, 1976, PERCEPT MOTOR SKILL, V43, P987, DOI 10.2466/pms.1976.43.3.987; Weiss TM, 2005, OTOLARYNG HEAD NECK, V133, P966, DOI 10.1016/j.otohns.2005.07.018; Wong ML, 2013, J PSYCHOSOM RES, V74, P271, DOI 10.1016/j.jpsychores.2012.08.014; World Health Organization, 2002, WORLD HLTH SURV 2002; World Health Organization (WHO), 2019, ADOLESCENT MENTAL HL; Zhao YH, 2014, INT J EPIDEMIOL, V43, P61, DOI 10.1093/ije/dys203	92	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246370	10.1371/journal.pone.0246370	http://dx.doi.org/10.1371/journal.pone.0246370			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606696	Green Published, gold			2022-12-26	WOS:000620629200014
J	Sajjad, A; Liu, JH; Wang, YS; Farooqi, MA; Zhao, ZH; Ahmad, A; Akram, W; Ali, M; Ali, A				Sajjad, Asif; Liu, Junhe; Wang, Yusha; Farooqi, Muhammad Aslam; Zhao, Zihua; Ahmad, Ammad; Akram, Waseem; Ali, Mudssar; Ali, Abid			Plant communities exhibit low resource partitioning for pollinator guilds under sub-tropical conditions of Pakistan	PLOS ONE			English	Article								Assessment of resource partitioning in pollinators at a particular place can be used to conserve plant communities by minimizing their inter-specific competition. Current study was conducted to investigate the occurrence of this phenomenon among plant communities under sub-tropical conditions for the first time in Pakistan. We considered the entire available flowering plant and floral visitor communities in the study area-Lal Suhanra forest of Bahawalpur, Pakistan- along with different variations among them based on morphology, color and symmetry (functional groups) i.e. four functional groups among insects and nine among plants. Weekly floral visitor censuses were conducted during spring season -from the first week of March to the fourth week of May 2018. Thirty individuals of each plant species -in bloom- were observed for floral visitors in each census. Plant species with different floral shapes, colors and symmetry did not show any significant resource partitioning. The Non-metric multidimensional scaling analysis followed by one-way ANOSIM test showed non- significant differences among all the pair of floral shapes, colors (except white and yellow) and symmetry (R-value < 0.168). However, SIMPER test suggested that flies were the most common group that contributed more towards within group similarities of different floral shapes (19 to 21% similarity), colors (16 to 30%) and symmetry (19%) followed by long-tongue bees i.e. 14 to 21%, 9 to 19% and 18%, respectively. Our results suggest that plant communities under sub-tropical conditions of Pakistan exhibit a generalist pollination system with no significant resource partitioning in pollinator species. Therefore, plant communities may have high competition for pollinator species which exhibits fewer implications of species loss on overall pollination process. Our study provides the basis for understanding the partitioning of pollinator guilds under sub-tropical conditions. Future studies should focus on functional traits in more detail at the community and the population scales for their possible impact on resource partitioning.	[Sajjad, Asif; Farooqi, Muhammad Aslam; Ahmad, Ammad; Akram, Waseem] Islamia Univ Bahawalpur, Fac Agr & Environm, Dept Entomol, Bahawalpur, Pakistan; [Liu, Junhe] Huanghuai Univ, Coll Biol & Food Engn, Zhumadian, Henan, Peoples R China; [Wang, Yusha] Univ Cote dAzur, UMR ISA, CNRS, INRAE, Nice, France; [Zhao, Zihua] China Agr Univ, Coll Plant Protect, Dept Entomol, Beijing, Peoples R China; [Ali, Mudssar] Muhammad Nawaz Sharif Univ Agr, Dept Entomol, Multan, Pakistan; [Ali, Abid] Shenyang Normal Univ, Coll Life Sci, Shenyang, Peoples R China; [Ali, Abid] Univ Agr Faisalabad, Dept Entomol, Faisalabad, Pakistan	Islamia University of Bahawalpur; Huanghuai University; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; China Agricultural University; Shenyang Normal University; University of Agriculture Faisalabad	Sajjad, A (corresponding author), Islamia Univ Bahawalpur, Fac Agr & Environm, Dept Entomol, Bahawalpur, Pakistan.; Liu, JH (corresponding author), Huanghuai Univ, Coll Biol & Food Engn, Zhumadian, Henan, Peoples R China.; Wang, YS (corresponding author), Univ Cote dAzur, UMR ISA, CNRS, INRAE, Nice, France.; Ali, A (corresponding author), Shenyang Normal Univ, Coll Life Sci, Shenyang, Peoples R China.; Ali, A (corresponding author), Univ Agr Faisalabad, Dept Entomol, Faisalabad, Pakistan.	asifsajjad@gmail.com; liujunhe@huanghuai.edu.cn; shannv0922@163.com; abid_ento74@yahoo.com	Sajjad, Asif/AFQ-0406-2022; Ali, Abid/S-7218-2019	Ali, Abid/0000-0003-3674-7811; Akram, Waseem/0000-0001-8478-2588; Sajjad, Asif/0000-0002-4246-1484	National Natural Science Foundation of China [31770453]; Henan Province Science and Technology Projects [132102110021, 182107000035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Province Science and Technology Projects	Junhe Liu received funding by National Natural Science Foundation of China (31770453) and the Henan Province Science and Technology Projects (132102110021, 182107000035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner PA, 2001, OIKOS, V95, P177, DOI 10.1034/j.1600-0706.2001.950121.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Armbruster WS, 2017, FUNCT ECOL, V31, P88, DOI 10.1111/1365-2435.12783; Bari A., BALW 2010 C OHR REP, P1; Benadi G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0117; Blondel J, 2003, OIKOS, V100, P223, DOI 10.1034/j.1600-0706.2003.12152.x; Bonsall MB, 2012, ECOL EVOL, V2, P515, DOI 10.1002/ece3.206; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., CHANGE MARINE COMMUN, DOI [10.1371/journal.pone.0184275, DOI 10.1371/JOURNAL.PONE.0184275]; Faegri K., 2013, PRINCIPLES POLLINATI; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Griffin J., 2012, NAT ED KNOWL, V3, P49; Griffin JN, 2008, ECOLOGY, V89, P298, DOI 10.1890/07-1220.1; Hanna C, 2014, ECOLOGY, V95, P1622, DOI 10.1890/13-1276.1; Hart Georgia M., 2010, Journal of Pollination Ecology, V2, P13; Heystek A, 2014, J VEG SCI, V25, P648, DOI 10.1111/jvs.12127; Hicks DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158117; Hingston AB, 2000, AUSTRAL ECOL, V25, P600, DOI 10.1111/j.1442-9993.2000.tb00065.x; Junker RR, 2010, ECOL ENTOMOL, V35, P760, DOI 10.1111/j.1365-2311.2010.01237.x; Kantsa A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03448-w; Kozuharova EK, 2018, ACTA ZOOL BULGAR, P87; LAROCA S, 1989, J KANSAS ENTOMOL SOC, V62, P400; Lau JY., 2016, SCI REP-UK, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Lucas A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23103-0; Michener C.D., 1986, Contributions of the American Entomological Institute, V22, P1; Moreira-Hernandez JI, 2019, ANNU REV ECOL EVOL S, V50, P191, DOI 10.1146/annurev-ecolsys-110218-024804; Nagamitsu T, 1997, OECOLOGIA, V110, P432, DOI 10.1007/s004420050178; Olesen JN, 2007, TAXON, V56, P729, DOI 10.2307/25065857; Ollerton J, 2007, TAXON, V56, P717, DOI 10.2307/25065856; POSSINGHAM HP, 1992, ECOLOGY, V73, P1903, DOI 10.2307/1940041; Reverte S, 2016, ANN BOT-LONDON, V118, P249, DOI 10.1093/aob/mcw103; Rodriguez-Girones MA, 2005, P ROY SOC B-BIOL SCI, V272, P187, DOI 10.1098/rspb.2005.2936; Ruiz-Guajardo JC, 2008, COMMUNITY PLANT POLL; Sajjad Asif, 2012, Pakistan Entomologist, V34, P105; Sajjad A, 2010, PAK J BOT, V42, P1187; Song ZY, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2437; Stone G, 1996, P ROY SOC B-BIOL SCI, V263, P1389, DOI 10.1098/rspb.1996.0203; Stone GN, 2003, AUST SYST BOT, V16, P103, DOI 10.1071/SB02024; Temeles EJ, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2358-5; Temeles EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146431; Tylianakis JM, 2017, ANNU REV ECOL EVOL S, V48, P25, DOI 10.1146/annurev-ecolsys-110316-022821; VANDERPIJL L, 1961, EVOLUTION, V15, P44, DOI 10.2307/2405842; WALTER GH, 1991, J THEOR BIOL, V150, P137, DOI 10.1016/S0022-5193(05)80327-3; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857	46	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247124	10.1371/journal.pone.0247124	http://dx.doi.org/10.1371/journal.pone.0247124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606792	gold, Green Published			2022-12-26	WOS:000620629200147
J	Van Ginderdeuren, E; Bassett, J; Hanrahan, CF; Mutunga, L; Van Rie, A				Van Ginderdeuren, Eva; Bassett, Jean; Hanrahan, Colleen F.; Mutunga, Lillian; Van Rie, Annelies			Novel health system strategies for tuberculin skin testing at primary care clinics: Performance assessment and health economic evaluation	PLOS ONE			English	Article								Background Tuberculin skin test (TST) for guiding initiation of tuberculosis preventive therapy poses major challenges in high tuberculosis burden settings. Methods At a primary care clinic in Johannesburg, South Africa, 278 HIV-positive adults self-read their TST by reporting if they felt a bump (any induration) at the TST placement site. TST reading (in mm) was fast-tracked to reduce patient wait time and task-shifted to delegate tasks to lower cadre healthcare workers, and result was compared to TST reading by high cadre research staff. TST reading and placement cost to the health system and patients were estimated. Simulations of health system costs were performed for 5 countries (USA, Germany, Brazil, India, Russia) to evaluate generalizability. Results Almost all participants (269 of 278, 97%) correctly self-identified the presence or absence of any induration [sensitivity 89% (95% CI 80,95) and specificity 99.5% (95% CI 97,100)]. For detection of a positive TST (induration >= 5mm), sensitivity was 90% (95% CI 81,96) and specificity 99% (95% CI 97,100). TST reading agreement between low and high cadre staff was high (kappa 0.97, 95% CI 0.94, 1.00). Total TST cost was 2066 I$ (95% UI 594, 5243) per 100 patients, 87% (95% UI 53, 95) of which were patient costs. Combining fast-track and task-shifting, reduced total costs to 1736 I$ (95% UI 497, 4300) per 100 patients, with 31% (95% UI 15, 42) saving in health system costs. Combining fast-tracking, task-shifting and self-reading, lowered the TST health system costs from 16% (95% UI 8, 26) in Russia to 40% (95% UI 18, 54) in the USA. Conclusion A TST strategy where only patients with any self-read induration are asked to return for fast-tracked TST reading by lower cadre healthcare workers is a promising strategy that could be effective and cost-saving, but real-life cost-effectiveness should be further examined.	[Van Ginderdeuren, Eva; Bassett, Jean; Mutunga, Lillian] Witkoppen Clin, Johannesburg, South Africa; [Van Ginderdeuren, Eva; Van Rie, Annelies] Univ Antwerp, Fac Med & Hlth Sci, Family Med & Populat Hlth, Antwerp, Belgium; [Hanrahan, Colleen F.] Johns Hopkins Bloomberg Sch Publ Hlth, Epidemiol, Baltimore, MD USA	University of Antwerp; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Van Ginderdeuren, E (corresponding author), Witkoppen Clin, Johannesburg, South Africa.; Van Ginderdeuren, E (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Family Med & Populat Hlth, Antwerp, Belgium.	eva.vanginderdeuren@student.uantwerpen.be			United States Agency for International Development (USAID) [AID-674-A-12-00033]; Vlaamse Interuniversitaire Raad (VLIR) [NDOC2016PR001]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Vlaamse Interuniversitaire Raad (VLIR)	This study was funded by the United States Agency for International Development (USAID, https://www.usaid.gov) under award number AID-674-A-12-00033 [EV, JB, CH, LM, AVR], with additional funding from Vlaamse Interuniversitaire Raad (VLIR, https://www.vliruos.be) under award number NDOC2016PR001 [EV]. The content is solely the responsibility of the authors and does not necessarily represent the views of USAID or VLIR. The funders provided salary support [EV, JB, CH, LM, AVR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the `author contributions' section.	Alsdurf H, 2016, LANCET INFECT DIS, V16, P1269, DOI 10.1016/S1473-3099(16)30216-X; [Anonymous], 2011, GUID INT TUB CAS FIN; Ayele HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142290; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; CDC, 2019, MANT TUB SKIN TEST; CDC, 2016, MANT TUB SKIN TEST; Chaisson RE, 1996, J ACQ IMMUN DEF SYND, V11, P455, DOI 10.1097/00042560-199604150-00005; Cox V, 2015, INT J TUBERC LUNG D, V19, P1300, DOI 10.5588/ijtld.15.0015; Department of Health, 2015, NAT CONS GUID PREV; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Gabriel AP, 2011, THESCIENTIFICWORLDJO, V11, P2178, DOI 10.1100/2011/984321; Gourevitch MN, 1999, INT J TUBERC LUNG D, V3, P321; Institute NJMSGT, MANT TUB SKIN TEST T; Joshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103754; Kerkhoff AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049928; KNCV Tuberculosis Foundation, 2008, TOOL EST PAT COSTS; Luetkemeyer AF, 2007, AM J RESP CRIT CARE, V175, P737, DOI 10.1164/rccm.200608-1088OC; Navin J A, 1994, J Am Coll Health, V43, P37; Pascoe SJS, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25409; Prezant DJ, 1996, ANN INTERN MED, V125, P280, DOI 10.7326/0003-4819-125-4-199608150-00004; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; RISSER NL, 1985, PUBLIC HEALTH REP, V100, P439; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Seidman G, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0200-9; Statistics South Africa, 2011, DIEPSLOOT; Stephan C, 2008, AIDS, V22, P2471, DOI 10.1097/QAD.0b013e3283188415; Stop TB Partnership, 2015, GLOBAL PLAN END TB 2; Tijdens K, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-11; United Nations General Assembly, 2018, POL DECL HIGH LEV M; Van Ginderdeuren E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212035; WHO, 2019, GLOB TUB REP; WHO, 2003, WHO GUIDE COST EFFEC; Wood R, 2014, SAMJ S AFR MED J, V104, P174, DOI [10.7196/SAMJ.7968, 10.7196/samj.7968]; World Health Organization, 2018, 9241550236 WHO; World Health Organization, 2020, WHO CONS GUI TUB TUB	36	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246523	10.1371/journal.pone.0246523	http://dx.doi.org/10.1371/journal.pone.0246523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596215	Green Published, Green Submitted, gold			2022-12-26	WOS:000620633200053
J	Alterman, N; Kurinczuk, JJ; Quigley, MA				Alterman, Neora; Kurinczuk, Jennifer J.; Quigley, Maria A.			Caesarean section and severe upper and lower respiratory tract infections during infancy: Evidence from two UK cohorts	PLOS ONE			English	Article							EARLY-TERM BIRTH; GESTATIONAL-AGE; SYNCYTIAL VIRUS; CHILDREN BORN; RISK-FACTOR; DELIVERY; MODE; HOSPITALIZATION; BRONCHIOLITIS; CHILDHOOD	Background Several studies have reported that birth by caesarean section is associated with increased risk of lower respiratory tract infections in the child, but it is unclear whether this applies to any caesarean section or specifically to planned caesareans. Furthermore, although infections of the upper respiratory tract are very common during childhood, there is a scarcity of studies examining whether caesarean is also a risk factor for this site of infection. Methods We obtained data from two UK cohorts: the Millennium Cohort Study (MCS) and linked administrative datasets of the population of Wales through the Secure Anonymised Information Linkage (SAIL) databank. The study focused on term-born singleton infants and included 15,580 infants born 2000-2002 (MCS) and 392,145 infants born 2002-2016 (SAIL). We used information about mode of birth (vaginal delivery, assisted vaginal delivery, planned caesarean and emergency caesarean) from maternal report in the MCS and from hospital birth records in SAIL. Unplanned hospital admission for lower respiratory tract infection (LRTI) was ascertained from maternal report in the MCS and from hospital record ICD codes in SAIL. Information about admissions for upper respiratory tract infection (URTI) was available from SAIL only. Cox regression was used to estimate hazard ratios for each outcome and cohort separately while accounting for a wide range of confounders. Gestational age at birth was further examined as a potential added, indirect risk of planned caesarean birth due to the early delivery. Findings The rate of hospital admission for LRTI was 4.6 per 100 child years in the MCS and 5.9 per 100 child years in SAIL. Emergency caesarean was not associated with LRTI admission during infancy in either cohort. In the MCS, planned caesarean was associated with a hazard ratio of 1.39 (95% CI 1.03, 1.87) which further increased to 1.65 (95% CI 1.24, 2.19) when gestational age was not adjusted for. In SAIL, the adjusted hazard ratio was 1.10 (95% CI 1.05, 1.15), which increased to 1.17 (95% CI 1.12, 1.22) when gestational age was not adjusted for. The rate of hospital admission for URTI was 5.9 per 100 child years in SAIL. Following adjustments, emergency caesarean was found to have a hazard ratio of 1.09 (95% CI 1.05, 1.14) for hospital admission for URTI. Planned caesarean was associated with a hazard ratio of 1.11 (95% CI 1.06, 1.16) which increased to 1.17 (95% CI 1.12, 1.22) when gestational age was not adjusted for. Conclusions The risk of severe LRTIs during infancy is moderately elevated in infants born by planned caesarean compared to those born vaginally. Infants born by any type of caesarean may also be at a small increased risk of severe URTIs. The estimated effect sizes are stronger if including the indirect effect arising from planning the caesarean birth for an earlier gestation than would have occurred spontaneously. Further studies are needed to confirm these results.	[Alterman, Neora; Kurinczuk, Jennifer J.; Quigley, Maria A.] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England; [Kurinczuk, Jennifer J.; Quigley, Maria A.] Univ Oxford, Nuffield Dept Populat Hlth, NIHR Policy Res Unit Maternal Hlth & Care, Natl Perinatal Epidemiol Unit, Oxford, England	University of Oxford; University of Oxford	Alterman, N (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England.	neora.alterman@gmail.com		Quigley, Maria/0000-0002-8058-6181; Alterman, Neora/0000-0001-8027-4164	National Institute for Health Research (NIHR) Policy Research Programme [108/0001]; Clarendon Fund Scholarships; Nuffield Department of Population Health	National Institute for Health Research (NIHR) Policy Research Programme(National Institute for Health Research (NIHR)); Clarendon Fund Scholarships; Nuffield Department of Population Health	JJK and MAQ: This research is part funded by the National Institute for Health Research (NIHR) Policy Research Programme, conducted through the Policy Research Unit in Maternal Health and Care, 108/0001. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. NA: DPhil studies funded through the support of the Clarendon Fund Scholarships and the Nuffield Department of Population Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Betran AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148343; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Bosch AATM, 2016, EBIOMEDICINE, V9, P336, DOI 10.1016/j.ebiom.2016.05.031; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Cullis A, 2007, TECHNICAL REPORT INF; D'Souza-Vazirani D, 2005, ARCH PEDIAT ADOL MED, V159, P167, DOI 10.1001/archpedi.159.2.167; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Duijts L, 2009, MATERN CHILD NUTR, V5, P199, DOI 10.1111/j.1740-8709.2008.00176.x; Edwards MO, 2015, J ALLERGY CLIN IMMUN, V136, P581, DOI 10.1016/j.jaci.2015.05.005; Essex HN, 2013, BJOG-INT J OBSTET GY, V120, P732, DOI 10.1111/1471-0528.12177; Fonseca W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00226; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Green CA, 2016, ARCH DIS CHILD, V101, P140, DOI 10.1136/archdischild-2015-308723; Gurol-Urganci I, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-43; Haataja P, 2018, PEDIATR PULM, V53, P209, DOI 10.1002/ppul.23908; Inoue Y, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00391; Jain L, 2006, SEMIN PERINATOL, V30, P34, DOI 10.1053/j.semperi.2006.01.006; Keag OE, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002494; Kotecha SJ, 2016, PAEDIATR RESPIR REV, V19, P49, DOI 10.1016/j.prrv.2015.12.002; Kristensen K, 2016, J ALLERGY CLIN IMMUN, V137, P587, DOI 10.1016/j.jaci.2015.07.040; Kristensen K, 2015, PEDIATR INFECT DIS J, V34, P145, DOI 10.1097/INF.0000000000000552; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Magnus MC, 2011, AM J EPIDEMIOL, V174, P1275, DOI 10.1093/aje/kwr242; Miller EK, 2013, PEDIATR INFECT DIS J, V32, P950, DOI 10.1097/INF.0b013e31829b7e43; Miller JE, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003429; Miller JE, 2016, LANCET INFECT DIS, V16, P952, DOI 10.1016/S1473-3099(16)00150-X; Moore HC, 2012, ARCH DIS CHILD, V97, P410, DOI 10.1136/archdischild-2011-300607; Moore HC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-757; Paranjothy S, 2013, PEDIATRICS, V132, pE1562, DOI 10.1542/peds.2013-1737; Payne S, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12263; Peters LL, 2018, BIRTH-ISS PERINAT C, V45, P347, DOI 10.1111/birt.12348; Plewis I, 2007, CTR LONGITUDINAL STU; Poulsen G, 2011, J CLIN EPIDEMIOL, V64, P1444, DOI 10.1016/j.jclinepi.2011.03.007; Quigley MA, 2007, BJOG-INT J OBSTET GY, V114, P195, DOI 10.1111/j.1471-0528.2006.01203.x; Quigley MA, 2007, PEDIATRICS, V119, pE837, DOI 10.1542/peds.2006-2256; Ramachandrappa A, 2008, CLIN PERINATOL, V35, P373, DOI 10.1016/j.clp.2008.03.006; Roberts CL, 2012, ARCH DIS CHILD, V97, P759, DOI 10.1136/archdischild-2011-301458; Shao Y, 2019, NATURE, V574, P117, DOI 10.1038/s41586-019-1560-1; Shepherd P., 2019, MILLENNIUM COHORT ST; Tickell KD, 2016, J MATERN-FETAL NEO M, V29, P1871, DOI 10.3109/14767058.2015.1066774; Unger SA, 2017, J INFECTION, V74, pS84, DOI 10.1016/S0163-4453(17)30196-2; Vissing NH, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0933; Zanardo V, 2004, ACTA PAEDIATR, V93, P643, DOI [10.1080/08035250410026671, 10.1111/j.1651-2227.2004.tb02990.x]	44	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246832	10.1371/journal.pone.0246832	http://dx.doi.org/10.1371/journal.pone.0246832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592033	Green Published, gold			2022-12-26	WOS:000620632800063
J	Hassanin, A; Veron, G; Ropiquet, A; van Vuuren, BJ; Lecu, A; Goodman, SM; Haider, J; Nguyen, TT				Hassanin, Alexandre; Veron, Geraldine; Ropiquet, Anne; van Vuuren, Bettine Jansen; Lecu, Alexis; Goodman, Steven M.; Haider, Jibran; Trung Thanh Nguyen			Evolutionary history of Carnivora (Mammalia, Laurasiatheria) inferred from mitochondrial genomes	PLOS ONE			English	Article							DNA CONTROL REGION; PHYLOGENETIC INFERENCE; GENETIC-STRUCTURE; RAPID EVOLUTION; SEA LIONS; ORIGIN; PHYLOGEOGRAPHY; REVEALS; PATTERN; HYBRIDIZATION	The order Carnivora, which currently includes 296 species classified into 16 families, is distributed across all continents. The phylogeny and the timing of diversification of members of the order are still a matter of debate. Here, complete mitochondrial genomes were analysed to reconstruct the phylogenetic relationships and to estimate divergence times among species of Carnivora. We assembled 51 new mitogenomes from 13 families, and aligned them with available mitogenomes by selecting only those showing more than 1% of nucleotide divergence and excluding those suspected to be of low-quality or from misidentified taxa. Our final alignment included 220 taxa representing 2,442 mitogenomes. Our analyses led to a robust resolution of suprafamilial and intrafamilial relationships. We identified 21 fossil calibration points to estimate a molecular timescale for carnivorans. According to our divergence time estimates, crown carnivorans appeared during or just after the Early Eocene Climatic Optimum; all major groups of Caniformia (Cynoidea/Arctoidea; Ursidae; Musteloidea/Pinnipedia) diverged from each other during the Eocene, while all major groups of Feliformia (Nandiniidae; Feloidea; Viverroidea) diversified more recently during the Oligocene, with a basal divergence of Nandinia at the Eocene/Oligocene transition; intrafamilial divergences occurred during the Miocene, except for the Procyonidae, as Potos separated from other genera during the Oligocene.	[Hassanin, Alexandre; Veron, Geraldine; Haider, Jibran; Trung Thanh Nguyen] Sorbonne Univ, Inst Systernat Evolut Biodiversite ISYEB, UA, MNHN,CNRS,EPHE, Paris, France; [Ropiquet, Anne] Middlesex Univ, Fac Sci & Technol, Dept Nat Sci, London, England; [van Vuuren, Bettine Jansen] Univ Johannesburg, Ctr Ecol Genom & Wildlife Conservat, Dept Zool, Johannesburg, South Africa; [Lecu, Alexis] Museum Natl Hist Nat, Parc Zool Paris, Paris, France; [Goodman, Steven M.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Haider, Jibran] Arid Agr Univ Rawalpindi, Dept Wildlife Management, Pir Mehr Ali Shah, Rawalpindi, Pakistan; [Haider, Jibran] Forest Pk & Wildlife Dept Gilgit Baltistan, Skardu, Pakistan	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Middlesex University; University of Johannesburg; Museum National d'Histoire Naturelle (MNHN); Field Museum of Natural History (Chicago); Arid Agriculture University	Hassanin, A (corresponding author), Sorbonne Univ, Inst Systernat Evolut Biodiversite ISYEB, UA, MNHN,CNRS,EPHE, Paris, France.	alexandre.hassanin@mnhn.fr	Jansen van Vuuren, Bettine/E-6227-2013; HASSANIN, Alexandre/AAO-3327-2021; Ropiquet, Anne/E-6154-2011; Ropiquet, Anne/AAC-5042-2021; Hassanin, Alexandre/P-3329-2014	Jansen van Vuuren, Bettine/0000-0002-5334-5358; Ropiquet, Anne/0000-0003-3755-5467; Hassanin, Alexandre/0000-0002-4905-8540	MNHN; CNRS; PPF Biodiversite actuelle et fossile; Consortium national de recherche en genomique; 'Action Transversale du Museum' (ATM 2017: project RaPyD)	MNHN; CNRS(Centre National de la Recherche Scientifique (CNRS)); PPF Biodiversite actuelle et fossile; Consortium national de recherche en genomique(General Electric); 'Action Transversale du Museum' (ATM 2017: project RaPyD)	This work was supported by the MNHN, CNRS, 'PPF Biodiversite actuelle et fossile', 'Consortium national de recherche en genomique', and the 'Action Transversale du Museum' (ATM 2017: project RaPyD).	Abella J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048985; Abramov AV, 2016, ZOOL STUD, V55, DOI 10.6620/ZS.2016.55-01; Acquarone Mario, 2006, Aquatic Mammals, V32, P363, DOI 10.1578/AM.32.3.2006.363; Arabi J, 2012, J MOL EVOL, V74, P81, DOI 10.1007/s00239-012-9490-7; Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Aurioles-Gamboa D, 2015, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2015-4.RLTS.T41666A45230310.EN; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Banyue Wang, 2003, Bulletin of the American Museum of Natural History, V279, P116, DOI 10.1206/0003-0090(2003)279<0116:C>2.0.CO;2; Barnett Ross, 2016, Open Quaternary, V2, P4, DOI 10.5334/oq.24; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Berta A, 2018, ANNU REV EARTH PL SC, V46, P203, DOI 10.1146/annurev-earth-082517-010009; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Bromham L, 2011, PHILOS T R SOC B, V366, P2503, DOI 10.1098/rstb.2011.0014; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Cabria MT, 2011, MOL ECOL, V20, P1176, DOI 10.1111/j.1365-294X.2010.04988.x; Coissac E, 2016, MOL ECOL, V25, P1423, DOI 10.1111/mec.13549; Cordes LS, 2017, ECOL EVOL, V7, P1725, DOI 10.1002/ece3.2774; Crees JJ, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2019.0216; de Bonis L, 2019, GEODIVERSITAS, V41, P601, DOI 10.5252/geodiversitas2019v41a15; Dewaele L, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171669; Dobson FS, 2013, ANIM BEHAV, V85, P299, DOI 10.1016/j.anbehav.2012.11.014; Driscoll CA, 2007, SCIENCE, V317, P519, DOI 10.1126/science.1139518; Eizirik E, 1998, J MOL EVOL, V47, P613, DOI 10.1007/PL00006418; Eizirik E, 2010, MOL PHYLOGENET EVOL, V56, P49, DOI 10.1016/j.ympev.2010.01.033; Emami-Khoyi A, 2018, MITOCHONDRIAL DNA A, V29, P567, DOI 10.1080/24701394.2017.1325478; Finstermeier K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069504; Flynn John J., 2010, P25; Gaubert P, 2003, P ROY SOC B-BIOL SCI, V270, P2523, DOI 10.1098/rspb.2003.2521; Gaubert P, 2017, J HERED, V108, P270, DOI 10.1093/jhered/esw085; Gibb GC, 2016, MOL BIOL EVOL, V33, P621, DOI 10.1093/molbev/msv250; Gopalakrishnan S, 2019, CURR BIOL, V29, P4152, DOI 10.1016/j.cub.2019.11.009; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Grohe C, 2013, PALAEONTOL ELECTRON, V16; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Harding LE, 2009, MOL PHYLOGENET EVOL, V52, P632, DOI 10.1016/j.ympev.2009.05.036; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Hassanin A, 2020, J ZOOL SYST EVOL RES, V58, P1395, DOI 10.1111/jzs.12373; Hassanin A, 2016, MITOCHONDRIAL DNA A, V27, P904, DOI 10.3109/19401736.2014.926478; Hassanin A, 2016, MITOCHONDRIAL DNA A, V27, P912, DOI 10.3109/19401736.2014.926482; Hassanin A, 2015, CR BIOL, V338, P494, DOI 10.1016/j.crvi.2015.04.008; Hassanin A, 2015, CR BIOL, V338, P260, DOI 10.1016/j.crvi.2015.02.003; Hassanin A, 2015, CR BIOL, V338, P197, DOI 10.1016/j.crvi.2014.12.003; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hassanin A, 2010, MITOCHONDR DNA, V21, P68, DOI 10.3109/19401736.2010.490583; Higdon JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-216; Hirata D, 2013, MOL BIOL EVOL, V30, P1644, DOI 10.1093/molbev/mst077; HOELZEL AR, 1994, J MOL EVOL, V39, P191; Hofman CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118240; Hooker JJ, 2015, NEWSL STRATIGR, V48, P201, DOI 10.1127/nos/2015/0060; HUNT RM, 1993, MAMMAL PHYLOGENY : PLACENTALS, P53; Hunt Robert M. Jr, 2001, American Museum Novitates, V3330, P1, DOI 10.1206/0003-0082(2001)330<0001:BAOTLL>2.0.CO;2; Kitchener A.C., 2017, Cat News, P3; Koepfli KP, 2015, CURR BIOL, V25, P2158, DOI 10.1016/j.cub.2015.06.060; Koepfli KP, 2006, MOL PHYLOGENET EVOL, V38, P603, DOI 10.1016/j.ympev.2005.10.017; Kutschera VE, 2014, MOL BIOL EVOL, V31, P2004, DOI 10.1093/molbev/msu186; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Law CJ, 2018, SYST BIOL, V67, P127, DOI 10.1093/sysbio/syx047; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Li G, 2016, GENOME RES, V26, P1, DOI 10.1101/gr.186668.114; Li S, 2019, ZOOL RES, V40, P575, DOI 10.24272/j.issn.2095-8137.2019.067; Li XY, 2019, BIOL REV, V94, P721, DOI 10.1111/brv.12475; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; LOBRY JR, 1995, J MOL EVOL, V40, P326, DOI 10.1007/BF00163237; Lowry L, 2016, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2016-1.RLTS.T15106A45228501.EN; Luo SJ, 2014, MOL ECOL, V23, P2072, DOI 10.1111/mec.12716; Mattucci F, 2016, ECOL EVOL, V6, P3, DOI 10.1002/ece3.1815; McKenna Malcolm C., 1997, pi; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Miller M.A., 2010, P GAT COMP ENV WORKS; Mitchell KJ, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0062; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nadler Tilo, 2011, Zoologische Garten, V80, P271; Nakagawa E, 2010, ZOOL SCI, V27, P263, DOI 10.2108/zsj.27.263; Nascimento FO, 2010, THESIS U SAO PAULO S, DOI [10.11606/T.41.2010.tde-09122010-104050, DOI 10.11606/T.41.2010.TDE-09122010-104050]; Nyakatura K, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-12; Paijmans JLA, 2017, CURR BIOL, V27, P3330, DOI 10.1016/j.cub.2017.09.033; Patel RP, 2017, J HERED, V108, P349, DOI 10.1093/jhered/esx017; Patou ML, 2010, J BIOGEOGR, V37, P2077, DOI 10.1111/j.1365-2699.2010.02364.x; Patou ML, 2009, MOL PHYLOGENET EVOL, V53, P69, DOI 10.1016/j.ympev.2009.05.038; Petzold A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0217956; Philippe H, 1999, J MOL EVOL, V49, P509, DOI 10.1007/PL00006573; Pozzi L, 2014, MOL PHYLOGENET EVOL, V75, P165, DOI 10.1016/j.ympev.2014.02.023; Pross J, 2012, NATURE, V488, P73, DOI 10.1038/nature11300; Quaglietta L, 2013, J MAMMAL, V94, P561, DOI 10.1644/12-MAMM-A-171.1; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Ropiquet A, 2009, CR BIOL, V332, P832, DOI 10.1016/j.crvi.2009.05.001; Rozhnov V., 2019, Doklady Biological Sciences, V485, P47, DOI [10.1134/S001249661902008X, 10.31857/S0869-56524854523-528]; Rozhnov VV, 2010, RUSS J GENET+, V46, P488, DOI 10.1134/S1022795410040150; Russell D.E., 1986, Developments in Palaeontology and Stratigraphy, V9, P299; Rybczynski N, 2009, NATURE, V458, P1021, DOI 10.1038/nature07985; Sato JJ, 2009, MOL PHYLOGENET EVOL, V53, P907, DOI 10.1016/j.ympev.2009.08.019; Schramm Y, 2009, MAR BIOL, V156, P1375, DOI 10.1007/s00227-009-1178-1; Schutz H, 2009, BIOL J LINN SOC, V96, P339, DOI 10.1111/j.1095-8312.2008.01132.x; Sluijs A, 2006, NATURE, V441, P610, DOI 10.1038/nature04668; Soibelzon LH, 2005, J S AM EARTH SCI, V20, P105, DOI 10.1016/j.jsames.2005.07.005; Sole F, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1082480; Sole F, 2014, J VERTEBR PALEONTOL, V34, P1, DOI 10.1080/02724634.2013.793195; Spaulding M, 2012, J SYST PALAEONTOL, V10, P653, DOI 10.1080/14772019.2011.630681; Steyaert SMJG, 2012, MAMMAL REV, V42, P12, DOI 10.1111/j.1365-2907.2011.00184.x; Storz JF, 1999, MAMMALIAN SPECIES, V631, P1, DOI [10.2307/3504333, DOI 10.2307/3504333]; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2002, MOL BIOL EVOL, V19, P1727, DOI 10.1093/oxfordjournals.molbev.a003995; Tedford Richard H., 2009, Bulletin of the American Museum of Natural History, V325, P1, DOI 10.1206/574.1; Tseng Z Jack, 2014, Proc Biol Sci, V281, P20132686, DOI 10.1098/rspb.2013.2686; Turner SK, 2014, NAT GEOSCI, V7, P748, DOI [10.1038/NGEO2240, 10.1038/ngeo2240]; Valenciano A, 2020, J MAMM EVOL, V27, P73, DOI 10.1007/s10914-018-9445-x; Veron G, 2017, MAMM BIOL, V87, P62, DOI 10.1016/j.mambio.2017.05.006; Veron G, 2015, J ZOOL SYST EVOL RES, V53, P161, DOI 10.1111/jzs.12085; Veron Geraldine, 2010, P64; Viranta S, 2017, BMC ZOOL, V2, DOI 10.1186/s40850-017-0015-0; Waku D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149341; Walker J., 2018, GEOLOGICAL SOC AM, DOI DOI 10.1130/2018.CTS005R3C; Warnock RCM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1013; Werdelin L, 2010, CENOZOIC MAMMALS AFR, P603, DOI DOI 10.1525/CALIF0RNIA/9780520257214.003.0032; Werdelin Lars, 2010, P59; Wolf JBW, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-20; Wu JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136398; Wultsch C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151043; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yepes J., 1960, MAMIFEROS SUD AM; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zhou Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174902	128	15	16	9	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0240770	10.1371/journal.pone.0240770	http://dx.doi.org/10.1371/journal.pone.0240770			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33591975	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000620632800035
J	Yousefi-Mashouf, N; Mehrabani-Yeganeh, H; Nejati-Javaremi, A; Bailey, E; Petersen, JL				Yousefi-Mashouf, Navid; Mehrabani-Yeganeh, Hassan; Nejati-Javaremi, Ardeshir; Bailey, Ernest; Petersen, Jessica L.			Genomic comparisons of Persian Kurdish, Persian Arabian and American Thoroughbred horse populations	PLOS ONE			English	Article							GENETIC DIVERSITY	The present research aimed to characterize the Persian Kurdish horse population relative to the Persian Arabian and American Thoroughbred populations using genome-wide SNP data. Fifty-eight Kurdish, 38 Persian Arabian and 83 Thoroughbred horses were genotyped across 670,796 markers. After quality control and pruning to eliminate linkage disequilibrium between loci which resulted in 13,554 SNPs in 52 Kurdish, 24 Persian Arabian and 58 Thoroughbred horses, the Kurdish horses were generally distinguished from the Persian Arabian samples by Principal Component Analyses, cluster analyses and calculation of pairwise F-ST. Both Persian breeds were discriminated from the Thoroughbred. Pairwise F-ST between the two Persian samples (0.013) was significantly greater than zero and several fold less than those found between the Thoroughbred and Kurdish (0.052) or Thoroughbred and Persian Arabian (0.057). Cluster analysis assuming three genetic clusters assigned the Kurdish horse and Thoroughbred to distinct clusters (0.942 in cluster 2 and 0.953 in cluster 3 respectively); the Persian Arabian was not in a distinct cluster (0.519 in cluster 1), demonstrating shared ancestry or recent admixture with the Kurdish breed. Diversity as quantified by expected heterozygosity was the highest in the Kurdish horse (0.342), followed by the Persian Arabian (0.328) and the Thoroughbred (0.326). Analysis of Molecular Variance showed that 4.47% of the genetic variation was present among populations (P<0.001). Population-specific inbreeding indices (F-IS) were not significantly different from zero in any of the populations. Analysis of individual inbreeding based on runs of homozygosity using a larger SNP set suggested greater diversity in both the Kurdish and Persian Arabian than in the Thoroughbred. These results have implications for developing conservation strategies to achieve sound breeding goals while maintaining genetic diversity.	[Yousefi-Mashouf, Navid; Bailey, Ernest] Univ Kentucky, MH Gluck Equine Res Ctr, Lexington, KY 40506 USA; [Mehrabani-Yeganeh, Hassan; Nejati-Javaremi, Ardeshir] Univ Tehran, Dept Anim Sci, Karaj, Iran; [Petersen, Jessica L.] Univ Nebraska, Dept Anim Sci, Lincoln, NE 68588 USA	University of Kentucky; University of Tehran; University of Nebraska System; University of Nebraska Lincoln	Yousefi-Mashouf, N (corresponding author), Univ Kentucky, MH Gluck Equine Res Ctr, Lexington, KY 40506 USA.; Petersen, JL (corresponding author), Univ Nebraska, Dept Anim Sci, Lincoln, NE 68588 USA.	navid.yousefi@uky.edu; jessica.petersen@unl.edu	Petersen, Jessica/ABF-2462-2020	Petersen, Jessica/0000-0001-5438-8555; YousefiMashouf, Navid/0000-0003-3853-2697	Ava Tejarat Saba	Ava Tejarat Saba	NYM and HMY, The fund was provided by a private company, Ava Tejarat Saba for nonprofit purposes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirinia Cyrus, 2007, Pak J Biol Sci, V10, P1540, DOI 10.3923/pjbs.2007.1540.1543; Biscarini F., 2018, CRAN THE COMPREHENSI; Cosgrove EJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66232-1; Diakonoff IM., 1956, HIST MEDIA MOSCOW LE; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Golden Helix I., SNP VARIATION SUITE; Khanshour A, 2013, J HERED, V104, P386, DOI 10.1093/jhered/est003; Mashouf NY, 2020, J AGR SCI TECH-IRAN, V22, P1219; Ovchinnikov IV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200795; Petersen JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054997, 10.1371/journal.pone.0069819]; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafeie F, 2011, AFR J BIOTECHNOL, V10, P17347, DOI 10.5897/AJB11.1430; Rahimi-Mianji G, 2015, RUSS J GENET+, V51, P916, DOI 10.1134/S1022795415090082; Sadeghi R, 2019, J HERED, V110, P173, DOI 10.1093/jhered/esy061; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; Schaefer RJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3943-8; Shahsavarani H., 2010, ANAL GENETIC DIVERSI, V9; Vahedi VJJoEVS., 2018, GENETIC DIVERSITY ST, V64, P107	20	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247123	10.1371/journal.pone.0247123	http://dx.doi.org/10.1371/journal.pone.0247123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592064	Green Published, gold			2022-12-26	WOS:000620632800072
J	Oliveira, WL; Medeiros, MB; Moser, P; Simon, MF				Oliveira, Washington Luis; Medeiros, Marcelo Brilhante; Moser, Pamela; Simon, Marcelo Fragomeni			Mega-dams and extreme rainfall: Disentangling the drivers of extensive impacts of a large flooding event on Amazon Forests	PLOS ONE			English	Article							HYDROELECTRIC DEVELOPMENT; SPECIES DISTRIBUTION; UNLEARNED LESSONS; TREE MORTALITY; BASIN; WATER; RECRUITMENT; ENVIRONMENT; MODELS; RISK	Extreme weather events and the presence of mega-hydroelectric dams, when combined, present an emerging threat to natural habitats in the Amazon region. To understand the magnitude of these impacts, we used remote sensing data to assess forest loss in areas affected by the extreme 2014 flood in the entire Madeira River basin, the location of two mega-dams. In addition, forest plots (26 ha) were monitored between 2011 and 2015 (14,328 trees) in order to evaluate changes in tree mortality, aboveground biomass (AGB), species composition and community structure around the Jirau reservoir (distance between plots varies from 1 to 80 km). We showed that the mega-dams were the main driver of tree mortality in Madeira basin forests after the 2014 extreme flood. Forest loss in the areas surrounding the reservoirs was 56 km(2) in Santo Antonio, 190 km(2) in Jirau (7.4-9.2% of the forest cover before flooding), and 79.9% above that predicted in environmental impact assessments. We also show that climatic anomalies, albeit with much smaller impact than that created by the mega-dams, resulted in forest loss along different Madeira sub-basins not affected by dams (34-173 km(2); 0.5-1.7%). The impact of flooding was greater in varzea and transitional forests, resulting in high rates of tree mortality (88-100%), AGB decrease (89-100%), and reduction of species richness (78-100%). Conversely, campinarana forests were more flood-tolerant with a slight decrease in species richness (6%) and similar AGB after flooding. Taking together satellite and field measurements, we estimate that the 2014 flood event in the Madeira basin resulted in 8.81-12.47 center dot 10(6) tons of dead biomass. Environmental impact studies required for environmental licensing of mega-dams by governmental agencies should consider the increasing trend of climatic anomalies and the high vulnerability of different habitats to minimize the serious impacts of dams on Amazonian biodiversity and carbon stocks.	[Oliveira, Washington Luis; Moser, Pamela] Univ Brasilia, Programa Posgrad Ecol, Brasilia, DF, Brazil; [Medeiros, Marcelo Brilhante; Simon, Marcelo Fragomeni] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Medeiros, MB (corresponding author), Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil.	marcelo.brilhante@embrapa.br	Simon, Marcelo F./AAA-7161-2019	Simon, Marcelo F./0000-0002-5732-1716; MEDEIROS, MARCELO/0000-0001-7619-6001; Moser, Pamela/0000-0003-1956-9742; Luis de Oliveira, Washington/0000-0002-4834-2910	National Council of Technological and Scientific Development (CNPq) [GM/GD 140353/2014-3, SWE 234262/2014-1]; Energia Sustenta vel do Brasil (ESBR); Fundacao Eliseu Alves; Fundacao Arthur Bernardes	National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Energia Sustenta vel do Brasil (ESBR); Fundacao Eliseu Alves; Fundacao Arthur Bernardes	This article is part of WLO doctoral thesis (University of Brasilia), with support from the National Council of Technological and Scientific Development (CNPq) by a scholarship [GM/GD 140353/2014-3] and a Sandwich Doctorate scholarship [SWE 234262/2014-1]. Embrapa Cenargen provided logistic support to field work and Energia Sustenta vel do Brasil (ESBR), Fundacao Eliseu Alves, and Fundacao Arthur Bernardes provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleixo I, 2019, NAT CLIM CHANGE, V9, P384, DOI 10.1038/s41558-019-0458-0; Ambiental CdGSdEdD COGEO-SEDAM, 2012, B CLIMATOLOGICO ROND; Assahira C, 2017, FOREST ECOL MANAG, V396, P113, DOI 10.1016/j.foreco.2017.04.016; Baker HS, 2018, NAT CLIM CHANGE, V8, P604, DOI 10.1038/s41558-018-0190-1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Espinoza JC, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/12/124007; Castello L, 2016, GLOBAL CHANGE BIOL, V22, P990, DOI 10.1111/gcb.13173; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Cochrane Sheila M. V., 2017, Remote Sensing Applications: Society and Environment, V7, P1, DOI 10.1016/j.rsase.2017.04.005; Cochrane TA., 2011, AMAZON FOREST SAVANN; Costa SilvaRGd., 2018, PORTO VELHO CULTURA, V1a; da Rocha M, 2019, ECOHYDROLOGY, V12, DOI 10.1002/eco.2144; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; de Resende AF, 2019, SCI TOTAL ENVIRON, V659, P587, DOI 10.1016/j.scitotenv.2018.12.208; dos Santos EA, 2020, FOREST ECOL MANAG, V463, DOI 10.1016/j.foreco.2020.118032; Fearnside PM, 2014, ENVIRON SCI POLICY, V38, P164, DOI 10.1016/j.envsci.2013.11.004; Fearnside PM, 2005, ENVIRON MANAGE, V35, P1, DOI 10.1007/s00267-004-0100-3; FEARNSIDE PM, 1989, ENVIRON MANAGE, V13, P401, DOI 10.1007/BF01867675; Fearnside PM, 2001, ENVIRON MANAGE, V27, P377, DOI 10.1007/s002670010156; Fearnside PM., 2014, AN LISIS PRINCIPALES; Feeley KJ, 2009, P NATL ACAD SCI USA, V106, P12382, DOI 10.1073/pnas.0900698106; Fletcher RJ, 2018, BIOL CONSERV, V226, P9, DOI 10.1016/j.biocon.2018.07.022; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.66; FURNAS, 2005, CONSTRUTORA NORBERTO; Gloor M, 2013, GEOPHYS RES LETT, V40, P1729, DOI 10.1002/grl.50377; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hirabayashi Y, 2013, NAT CLIM CHANGE, V3, P816, DOI [10.1038/nclimate1911, 10.1038/NCLIMATE1911]; Intergov Panel Clim Chg, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P1, DOI 10.1017/CBO9781139177245; Jones IL, 2019, J APPL ECOL, V56, P779, DOI 10.1111/1365-2664.13313; Latrubesse EM, 2017, NATURE, V546, P363, DOI 10.1038/nature22333; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Marengo JA, 2016, INT J CLIMATOL, V36, P1033, DOI 10.1002/joc.4420; Marengo JA, 2018, FRONT EARTH SC-SWITZ, V6, DOI 10.3389/feart.2018.00228; Martinelli L. A., 1989, GeoJournal, V19, P381, DOI 10.1007/BF00176907; Mayorga E., 2012, ORNL DISTRIBUTED ACT; McDowell N, 2018, NEW PHYTOL, V219, P851, DOI 10.1111/nph.15027; MEADE RH, 1991, ENVIRON GEOL WATER S, V18, P105, DOI 10.1007/BF01704664; Moser P, 2019, J APPL ECOL, V56, P2641, DOI 10.1111/1365-2664.13498; Moser P, 2014, BIOTROPICA, V46, P367, DOI 10.1111/btp.12111; Oliveira WL, 2018, PLANT ECOL DIVERS, V11, P1, DOI 10.1080/17550874.2018.1474960; Pekel JF, 2016, NATURE, V540, P418, DOI 10.1038/nature20584; Perigolo NA, 2017, BRITTONIA, V69, P423, DOI 10.1007/s12228-017-9505-1; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Piedade M.T.F., 2010, AMAZONIAN FLOODPLAIN, P123, DOI DOI 10.1007/978-90-481-8725-6_6; Pinheiro J, 2020, R PACKAGE VERSION 31; R Development Core Team, 2017, R LANGUAGE ENV STAT; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Resende AF, 2020, NEW PHYTOL, V227, P1790, DOI 10.1111/nph.16665; Ribeiro OM., 2007, BIODIVERSIDADE M DIO, P35; Sheil D, 1996, J ECOL, V84, P91, DOI 10.2307/2261703; Silva TR, 2017, BRAZ J BOT, V40, P963, DOI 10.1007/s40415-017-0413-0; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Stickler CM, 2013, P NATL ACAD SCI USA, V110, P9601, DOI 10.1073/pnas.1215331110; Timpe K, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700611; Vitolo C., 2017, J OPEN SOURCE SOFTW, V2; Wagner H., 2013, PACKAGE VEGAN COMMUN, V2, P1; Wittmann F, 2004, FOREST ECOL MANAG, V196, P199, DOI 10.1016/j.foreco.2004.02.060; Wittmann F., 2010, AMAZONIAN FLOODPLAIN, P61, DOI [DOI 10.1007/978-90-481-8725-6_4, 10.1007/978-90-481-8725-6_4]; Wittmann F, 2013, ECOGRAPHY, V36, P690, DOI 10.1111/j.1600-0587.2012.07723.x; Zuur A, 2009, MIXED EFFECTS MODELS	64	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0245991	10.1371/journal.pone.0245991	http://dx.doi.org/10.1371/journal.pone.0245991			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QI7IP	33578410	Green Published, gold			2022-12-26	WOS:000619155900001
J	Charles, T; Jayankura, M				Charles, Tatiana; Jayankura, Marc			Evaluation of hip arthroscopy using a hip-specific distractor for the treatment of femoroacetabular impingement	PLOS ONE			English	Article							COMPLICATIONS; SURGERY	Background and study aims Hip arthroscopy using an orthopaedic traction table has been associated with traction-related neurovascular complications. Since the use of a hip-specific distractor for performing hip arthroscopy hasn't been associated with those specific complications we hypothesized that a hip-specific distractor might facilitate the learning curve of hip arthroscopy for beginner surgeons. Material and methods We reviewed retrospectively the first 56 hip arthroscopies performed to treat femoro-acetabular impingement using a hip-specific distractor. We tried to analyse the learning curve of this procedure using operative time, peri- and postoperative complications, hospital stay and patient satisfaction. We also evaluated pre- and postoperative sports activities and tried to identify some factors as poor postoperative prognostic factors. Results Only 1 major complication occurred. No traction-related complications have been encountered. The curves analysing intervention time and postoperative satisfaction rate showed improvement after 30 cases performed. In all cases, we were able to perform the whole planned gesture without difficulties accessing the hip joint. Conclusion The hip-specific distractor is a safe and reproducible method in performing hip arthroscopy without any traction-related complications or time limits.	[Charles, Tatiana; Jayankura, Marc] Hop Univ Erasme, Dept Orthopaed Surg & Traumatol, Clin Hip & Pelvis, Brussels, Belgium	Universite Libre de Bruxelles	Jayankura, M (corresponding author), Hop Univ Erasme, Dept Orthopaed Surg & Traumatol, Clin Hip & Pelvis, Brussels, Belgium.	mjayanku@ulb.ac.be		Jayankura, Marc/0000-0002-5854-7071; Charles, Tatiana/0000-0003-4505-7628				Bushnell BD, 2007, ARTHROSCOPY, V23, DOI 10.1016/j.arthro.2006.07.028; Byrd JWT, 2009, CLIN ORTHOP RELAT R, V467, P739, DOI 10.1007/s11999-008-0659-8; Dietrich F, 2014, KNEE SURG SPORT TR A, V22, P953, DOI 10.1007/s00167-014-2893-9; Fayad TE, 2013, BONE JOINT J, V95B, P26, DOI 10.1302/0301-620X.95B11.33016; Flecher X, 2011, ORTHOP TRAUMATOL-SUR, V97, P381, DOI 10.1016/j.otsr.2011.02.007; Gedouin JE, 2010, ORTHOP TRAUMATOL-SUR, V96, pS59, DOI 10.1016/j.otsr.2010.08.002; Gedouin JE, 2010, ORTHOP TRAUMATOL-SUR, V96, P222, DOI 10.1016/j.otsr.2009.12.002; Hanke MS, 2017, CLIN ORTHOP RELAT R, V475, P1192, DOI 10.1007/s11999-016-5040-8; Hoppe DJ, 2014, ARTHROSCOPY, V30, P389, DOI 10.1016/j.arthro.2013.11.012; Ilizaliturri VM, 2009, CLIN ORTHOP RELAT R, V467, P760, DOI 10.1007/s11999-008-0618-4; Konan S, 2011, J BONE JOINT SURG AM, V93A, P52, DOI 10.2106/JBJS.J.01587; Lee YK, 2013, KNEE SURG SPORT TR A, V21, P1940, DOI 10.1007/s00167-012-2241-x; OUTERBRIDGE RE, 1961, J BONE JOINT SURG BR, V43, P752; Papavasiliou AV, 2012, BONE JOINT RES, V1, P131, DOI 10.1302/2046-3758.17.2000108; Park MS, 2014, ARTHROSCOPY, V30, P957, DOI 10.1016/j.arthro.2014.03.017; Philippon MJ, 2009, J BONE JOINT SURG BR, V91B, P16, DOI 10.1302/0301-620X.91B1.21329; Sadri H ., 2011, TECHNIQUES HIP ARTHR, P113; Souza BGSE, 2010, ARTHROSCOPY, V26, P1053, DOI 10.1016/j.arthro.2009.12.021; Tonnis D, 1999, J BONE JOINT SURG AM, V81A, P1747	19	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246655	10.1371/journal.pone.0246655	http://dx.doi.org/10.1371/journal.pone.0246655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571305	gold, Green Published			2022-12-26	WOS:000618274000003
J	Ramirez, J; Morales, M; Osinalde, N; Martinez-Padron, I; Mayor, U; Ferrus, A				Ramirez, Juanma; Morales, Miguel; Osinalde, Nerea; Martinez-Padron, Imanol; Mayor, Ugo; Ferrus, Alberto			The ubiquitin ligase Ariadne-1 regulates neurotransmitter release via ubiquitination of NSF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; PROTEIN; GENE; TRAFFICKING; MUTATIONS; RECEPTOR; PARKIN; LRRK2; BRAIN; QUANTIFICATION	Ariadne-1 (Ari-1) is an E3 ubiquitin-ligase essential for neuronal development, but whose neuronal substrates are yet to be identified. To search for putative Ari-1 substrates, we used an in vivo ubiquitin biotinylation strategy coupled to quantitative proteomics of Drosophila heads. We identified 16 candidates that met the established criteria: a significant change of at least twofold increase on ubiquitination, with at least two unique peptides identified. Among those candidates, we identified Comatose (Comt), the homologue of the N-ethylmaleimide sensitive factor (NSF), which is involved in neurotransmitter release. Using a pull-down approach that relies on the over-expression and stringent isolation of a GFP-fused construct, we validate Comt/NSF to be an ubiquitination substrate of Ari-1 in fly neurons, resulting in the preferential monoubiquitination of Comt/NSF. We tested the possible functional relevance of this modification using Ari-1 loss-of-function mutants, which displayed a lower rate of spontaneous neurotransmitter release due to failures at the presynaptic side. By contrast, evoked release in Ari-1 mutants was enhanced compared with controls in a Ca2+-dependent manner without modifications in the number of active zones, indicating that the probability of release per synapse is increased in these mutants. This phenotype distinction between spontaneous and evoked release suggests that NSF activity may discriminate between these two types of vesicle fusion. Our results thus provide a mechanism to regulate NSF activity in the synapse through Ari-1-dependent ubiquitination.	[Ramirez, Juanma; Mayor, Ugo] Univ Basque Country, Dept Biochem & Mol Biol, Fac Sci & Technol, Leioa, Bizkaia, Spain; [Morales, Miguel; Martinez-Padron, Imanol; Ferrus, Alberto] CSIC, Cajal Inst, Madrid, Spain; [Osinalde, Nerea] Univ Basque Country, Dept Biochem & Mol Biol, Fac Pharm, Vitoria, Araba, Spain; [Mayor, Ugo] Basque Fdn Sci, Ikerbasque, Bilbao, Bizkaia, Spain	University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); University of Basque Country; Basque Foundation for Science	Mayor, U (corresponding author), Univ Basque Country, Dept Biochem & Mol Biol, Fac Sci & Technol, Leioa, Bizkaia, Spain.; Ferrus, A (corresponding author), CSIC, Cajal Inst, Madrid, Spain.; Mayor, U (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao, Bizkaia, Spain.	ugo.mayor@ehu.eus; aferrus@cajal.csic.es	Ramírez, Juanma/AAZ-8953-2021	Osinalde, Nerea/0000-0001-8850-7794; Ramirez, Juanma/0000-0002-8500-7521; Ferrus, Alberto/0000-0002-0346-0489	Spanish Ministry of Economy [BFU2015-65685, PGC2018-094630-B-100, SAF2016-76898-P]; FEDER funds; University of the Basque Country (UPV/EHU)	Spanish Ministry of Economy(Spanish Government); FEDER funds(European Commission); University of the Basque Country (UPV/EHU)	This research was funded by grants BFU2015-65685 and PGC2018-094630-B-100 from the Spanish Ministry of Economy to A. F. and grant SAF2016-76898-P from the Spanish Ministry of Economy cofinanced with FEDER funds to U. M. J. R. was supported with a postdoctoral research fellowship from the University of the Basque Country (UPV/EHU).	Aguilera M, 2000, GENETICS, V155, P1231; Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Babcock DT, 2015, GENETICS, V199, P511, DOI 10.1534/genetics.114.172403; Bar S, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036954; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Belluzzi E, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-015-0066-z; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Blard O, 2007, HUM MOL GENET, V16, P555, DOI 10.1093/hmg/ddm011; Bridi JC, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00080; Brunger AT, 2019, CURR OPIN STRUC BIOL, V54, P179, DOI 10.1016/j.sbi.2019.03.007; BUCHNER E, 1988, CELL TISSUE RES, V253, P357, DOI 10.1007/BF00222292; Burre J, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024091; CHANDLER CS, 1985, BIOCHEM J, V232, P385, DOI 10.1042/bj2320385; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Curry RJ, 2018, J NEUROSCI, V38, P8187, DOI 10.1523/JNEUROSCI.0603-18.2018; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Elu N, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00534; Franco M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002188; Garcia-Barcena C, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00039; Goda Y, 1998, P NATL ACAD SCI USA, V95, P1283, DOI 10.1073/pnas.95.3.1283; Gradilla AC, 2011, GENETICS, V189, P871, DOI 10.1534/genetics.111.132191; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hallengren J, 2013, CELL BIOCHEM BIOPHYS, V67, P67, DOI 10.1007/s12013-013-9634-4; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kavalali ET, 2015, NAT REV NEUROSCI, V16, P5, DOI 10.1038/nrn3875; Kawasaki F, 1998, J NEUROSCI, V18, P10241; Lee SY, 2014, CELL MOL LIFE SCI, V71, P2747, DOI 10.1007/s00018-013-1526-7; Li XQ, 2012, DEV COMP IMMUNOL, V36, P648, DOI 10.1016/j.dci.2011.11.005; Littleton JT, 2000, J CELL BIOL, V150, pF77, DOI 10.1083/jcb.150.2.F77; Littleton JT, 2001, P NATL ACAD SCI USA, V98, P12233, DOI 10.1073/pnas.221450198; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Liu Y, 2019, J NEUROSCI, V39, P6049, DOI 10.1523/JNEUROSCI.0403-19.2019; MALLART A, 1993, J PHYSIOLOGY-PARIS, V87, P83, DOI 10.1016/0928-4257(93)90002-B; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Martinez A, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0170-3; MartinezPadron M, 1997, J NEUROSCI, V17, P3412; Melom JE, 2013, J NEUROSCI, V33, P17253, DOI 10.1523/JNEUROSCI.3334-13.2013; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Na CH, 2012, J PROTEOME RES, V11, P4722, DOI 10.1021/pr300536k; Oja SS, 2000, NEUROCHEM INT, V37, P299, DOI 10.1016/S0197-0186(00)00031-0; ORDWAY RW, 1994, P NATL ACAD SCI USA, V91, P5715, DOI 10.1073/pnas.91.12.5715; Osinalde N, 2015, DATA BRIEF, V5, P53, DOI 10.1016/j.dib.2015.08.007; Parelkar SS, 2012, J MOL NEUROSCI, V46, P109, DOI 10.1007/s12031-011-9535-1; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Ramirez J, 2018, HUM MOL GENET, V27, P1955, DOI 10.1093/hmg/ddy103; Ramirez J, 2017, NEUROMETHODS, V127, P179, DOI 10.1007/978-1-4939-7119-0_11; Ramirez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139083; Rinetti GV, 2010, J NEUROSCI, V30, P3157, DOI 10.1523/JNEUROSCI.3712-09.2010; Rudenko I, 2014, NEUROTHERAPEUTICS, V11, P738, DOI 10.1007/s13311-014-0284-z; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schwarz LA, 2012, MOL CELL NEUROSCI, V49, P387, DOI 10.1016/j.mcn.2011.08.006; Selvaraj S, 2019, GENES DIS, V6, P120, DOI 10.1016/j.gendis.2019.01.004; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tan KL, 2018, DEV CELL, V45, P226, DOI 10.1016/j.devcel.2018.03.020; Tan NGS, 2003, FEBS LETT, V554, P501, DOI 10.1016/S0014-5793(03)01235-3; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Wang C, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120258; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yu WH, 2011, MOL CELL NEUROSCI, V47, P19, DOI 10.1016/j.mcn.2011.02.002; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	75	1	1	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100408	10.1016/j.jbc.2021.100408	http://dx.doi.org/10.1016/j.jbc.2021.100408			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33581113	Green Published, gold			2022-12-26	WOS:000672866400382
J	Brown, R; Moore, L; Mani, A; Patel, S; Salinas, I				Brown, Ryan; Moore, Lindsey; Mani, Amir; Patel, Sonal; Salinas, Irene			Effects of ploidy and salmonid alphavirus infection on the skin and gill microbiome of Atlantic salmon (Salmo salar)	PLOS ONE			English	Article								The microbial communities that live in symbiosis with the mucosal surfaces of animals provide the host with defense strategies against pathogens. These microbial communities are largely shaped by the environment and the host genetics. Triploid Atlantic salmon (Salmo salar) are being considered for aquaculture as they are reproductively sterile and thus cannot contaminate the natural gene pool. It has not been previously investigated how the microbiome of triploid salmon compares to that of their diploid counterparts. In this study, we compare the steady-state skin and gill microbiome of both diploid and triploid salmon, and determine the effects of salmonid alphavirus 3 experimental infection on their microbial composition. Our results show limited differences in the skin-associated microbiome between triploid and diploid salmon, irrespective of infection. In the gills, we observed a high incidence of the bacterial pathogen Candidatus Branchiomonas, with higher abundance in diploid compared to triploid control fish. Diploid salmon infected with SAV3 showed greater histopathological signs of epitheliocystis compared to controls, a phenomenon not observed in triploid fish. Our results indicate that ploidy can affect the alpha diversity of the gills but not the skin-associated microbial community. Importantly, during a natural outbreak of Branchiomonas sp. the gill microbiome of diploid Atlantic salmon became significantly more dominated by this pathogen than in triploid animals. Thus, our results suggest that ploidy may play a role on Atlantic salmon gill health and provide insights into co-infection with SAV3 and C. Branchiomonas in Atlantic salmon.	[Brown, Ryan; Mani, Amir; Salinas, Irene] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol CETI, Albuquerque, NM 87131 USA; [Moore, Lindsey; Patel, Sonal] Inst Marine Res, Nordnes, Bergen, Norway; [Patel, Sonal] Norwegian Vet Inst, Bergen, Norway; [Moore, Lindsey] Univ Bergen, Dept Biol Sci, Bergen, Norway	University of New Mexico; Institute of Marine Research - Norway; Norwegian Veterinary Institute; University of Bergen	Salinas, I (corresponding author), Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol CETI, Albuquerque, NM 87131 USA.; Patel, S (corresponding author), Inst Marine Res, Nordnes, Bergen, Norway.; Patel, S (corresponding author), Norwegian Vet Inst, Bergen, Norway.	sonal.patel@hi.no; isalinas@unm.edu		Salinas, Irene/0000-0002-4802-6571; Mani, Amir/0000-0003-4417-622X	UNM PREP Program - National Insitute of Health; Norwegian Research Council [224885/E40a]	UNM PREP Program - National Insitute of Health; Norwegian Research Council(Research Council of NorwayEuropean Commission)	JFB was funded by the UNM PREP Program funded by the National Insitute of Health. The Norwegian Research Council (224885/E40a) to SP. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Brown RM, 2019, FISH SHELLFISH IMMUN, V86, P497, DOI 10.1016/j.fsi.2018.11.079; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Ching B, 2010, HEREDITY, V104, P224, DOI 10.1038/hdy.2009.108; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; Crane M, 2011, VIRUSES-BASEL, V3, P2025, DOI 10.3390/v3112025; Downes JK, 2018, J FISH DIS, V41, P1217, DOI 10.1111/jfd.12814; Eichmiller JJ, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0190-1; Ezenwa VO, 2012, SCIENCE, V338, P198, DOI 10.1126/science.1227412; Fjelldal PG, 2016, AQUACULT NUTR, V22, P72, DOI 10.1111/anu.12238; Fraser TWK, 2012, FISH SHELLFISH IMMUN, V33, P60, DOI 10.1016/j.fsi.2012.04.001; Fringuelli E, 2008, J FISH DIS, V31, P811, DOI 10.1111/j.1365-2761.2008.00944.x; Galbreath PF, 2006, ENVIRON BIOL FISH, V75, P183, DOI 10.1007/s10641-006-0008-2; Garcia-Rosado E, 2007, INT MICROBIOL, V10, P193, DOI 10.2436/20.1501.01.27; Glover KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043129; Gunnarsson GS, 2017, AQUACULTURE, V468, P126, DOI 10.1016/j.aquaculture.2016.10.011; Hoar W.S., 1988, P275; Hodneland K, 2006, J VIROL METHODS, V131, P184, DOI 10.1016/j.jviromet.2005.08.012; Jansen MD, 2015, J FISH DIS, V38, P343, DOI 10.1111/jfd.12238; Jarungsriapisit J, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0520-8; Jarungsriapisit J, 2016, VET RES, V47, DOI 10.1186/s13567-016-0385-2; JOHNSTONE R, 1995, THEOR APPL GENET, V90, P819, DOI 10.1007/BF00222017; Kotob MH, 2016, VET RES, V47, DOI 10.1186/s13567-016-0383-4; Kumar G, 2015, VET RES, V46, DOI 10.1186/s13567-015-0238-4; Leclercq E, 2011, COMP BIOCHEM PHYS A, V158, P116, DOI 10.1016/j.cbpa.2010.09.018; Lokesh J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19707; McLoughlin MF, 2007, J FISH DIS, V30, P511, DOI 10.1111/j.1365-2761.2007.00848.x; MELINGEN GO, 1995, FISH SHELLFISH IMMUN, V5, P211, DOI 10.1016/S1050-4648(05)80015-4; Mitchell KR, 2008, J IND MICROBIOL BIOT, V35, P1139, DOI 10.1007/s10295-008-0393-y; Mitchell SO, 2013, DIS AQUAT ORGAN, V103, P35, DOI 10.3354/dao02563; Moore LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175468; Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002; Paley RK, 2012, PARASITOLOGY, V139, P904, DOI 10.1017/S0031182012000030; Pettersen EF, 2003, FISH SHELLFISH IMMUN, V15, P373, DOI 10.1016/S1050-4648(02)00185-7; Reid KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172856; Robinson CM, 2014, ANNU REV VIROL, V1, P55, DOI 10.1146/annurev-virology-031413-085550; Sadler J, 2000, COMP ASPECTS PHYSL M; Sambraus F, 2017, J FISH DIS, V40, P1195, DOI 10.1111/jfd.12594; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Taksdal T, 2015, J FISH DIS, V38, P1047, DOI 10.1111/jfd.12312; Taylor JF, 2013, AQUACULTURE, V410, P41, DOI 10.1016/j.aquaculture.2013.06.004; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Toenshoff ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032696; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tucker S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195472; Wilkins LGE, 2016, MOL ECOL, V25, P4930, DOI 10.1111/mec.13798	47	13	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0243684	10.1371/journal.pone.0243684	http://dx.doi.org/10.1371/journal.pone.0243684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606747	Green Submitted, Green Published, gold			2022-12-26	WOS:000620629200150
J	Gaythorpe, K; Morris, A; Imai, N; Stewart, M; Freeman, J; Choi, M				Gaythorpe, Katy; Morris, Aaron; Imai, Natsuko; Stewart, Miles; Freeman, Jeffrey; Choi, Mary			Chainchecker: An application to visualise and explore transmission chains for Ebola virus disease	PLOS ONE			English	Article								2020 saw the continuation of the second largest outbreak of Ebola virus disease (EVD) in history. Determining epidemiological links between cases is a key part of outbreak control. However, due to the large quantity of data and subsequent data entry errors, inconsistencies in potential epidemiological links are difficult to identify. We present chainchecker, an online and offline shiny application which visualises, curates and verifies transmission chain data. The application includes the calculation of exposure windows for individual cases of EVD based on user defined incubation periods and user specified symptom profiles. It has an upload function for viral hemorrhagic fever data and utility for additional entries. This data may then be visualised as a transmission tree with inconsistent links highlighted. Finally, there is utility for cluster analysis and the ability to highlight nosocomial transmission. chainchecker is a R shiny application which has an offline version for use with VHF (viral hemorrhagic fever) databases or linelists. The software is available at which is a web-based application that links to the desktop application available for download and the github repository, https://github.com/ imperialebola2018/chainchecker.	[Gaythorpe, Katy; Imai, Natsuko] Imperial Coll London, London, England; [Morris, Aaron] Univ Cambridge, Cambridge, England; [Stewart, Miles; Freeman, Jeffrey] Johns Hopkins Univ, Appl Phys Lab, Baltimore, MD 21218 USA; [Choi, Mary] Ctr Dis Control & Prevent, Atlanta, GA USA	Imperial College London; University of Cambridge; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Centers for Disease Control & Prevention - USA	Gaythorpe, K (corresponding author), Imperial Coll London, London, England.	k.gaythorpe@imperial.ac.uk	Imai, Natsuko/J-5817-2017	Imai, Natsuko/0000-0002-4218-9716; Gaythorpe, Katy/0000-0003-3734-9081	Medical Research Council UK [MR/R015600/1]	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council UK provided funding for this study in the form of salary support to Imperial College London for KAMG, NI, and AM (MR/R015600/1).	Butts C. T., 2008, J STAT SOFTW, V24, P1, DOI [10.18637/jss.v024.i06, DOI 10.18637/JSS.V024.I06, 10.18637/jss.v024.i02]; CAMPBELL A, 2019, PLOS COMPUT BIOL, V15, P1, DOI DOI 10.1371/journal.pcbi.1006930; Carson Sievert, 2018, PLOTLY R; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Grolemond G, 2011, J STAT SOFTW, V40, P1; Michal Bojanowski, 2015, INTERGRAPH COERCION; Velasquez GE, 2015, CLIN INFECT DIS, V61, P1135, DOI 10.1093/cid/civ531; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organisation, 2019, ROH CRIS WHO INTR NE	10	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247002	10.1371/journal.pone.0247002	http://dx.doi.org/10.1371/journal.pone.0247002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606709	Green Published, gold			2022-12-26	WOS:000620629200138
J	Hasan, MS; Singh, V; Islam, S; Islam, MS; Ahsan, R; Kaundal, A; Islam, T; Ghosh, A				Hasan, Md Soyib; Singh, Vishal; Islam, Shiful; Islam, Md Sifatul; Ahsan, Raju; Kaundal, Amita; Islam, Tahmina; Ghosh, Ajit			Genome-wide identification and expression profiling of glutathione S-transferase family under multiple abiotic and biotic stresses in Medicago truncatula L.	PLOS ONE			English	Article							GENE FAMILY; OXIDATIVE STRESS; CHALCONE SYNTHASE; ARABIDOPSIS; LOCALIZATION; ROLES; BIOSYNTHESIS; METABOLISM; REGULATORS; TOLERANCE	Glutathione transferases (GSTs) constitute an ancient, ubiquitous, multi-functional antioxidant enzyme superfamily that has great importance on cellular detoxification against abiotic and biotic stresses as well as plant development and growth. The present study aimed to a comprehensive genome-wide identification and functional characterization of GST family in one of the economically important legume plants-Medicago truncatula. Here, we have identified a total of ninety-two putative MtGST genes that code for 120 proteins. All these members were classified into twelve classes based on their phylogenetic relationship and the presence of structural conserved domain/motif. Among them, 7 MtGST gene pairs were identified to have segmental duplication. Expression profiling of MtGST transcripts revealed their high level of organ/tissue-specific expression in most of the developmental stages and anatomical tissues. The transcripts of MtGSTU5, MtGSTU8, MtGSTU17, MtGSTU46, and MtGSTU47 showed significant up-regulation in response to various abiotic and biotic stresses. Moreover, transcripts of MtGSTU8, MtGSTU14, MtGSTU28, MtGSTU30, MtGSTU34, MtGSTU46 and MtGSTF8 were found to be highly upregulated in response to drought treatment for 24h and 48h. Among the highly stress-responsive MtGST members, MtGSTU17 showed strong affinity towards its conventional substrates reduced glutathione (GSH) and 1-chloro-2,4-dinitrobenzene (CDNB) with the lowest binding energy of-5.7 kcal/mol and -6.5 kcal/mol, respectively. Furthermore, the substrate-binding site residues of MtGSTU17 were found to be highly conserved. These findings will facilitate the further functional and evolutionary characterization of GST genes in Medicago.	[Hasan, Md Soyib; Islam, Shiful; Islam, Md Sifatul; Ahsan, Raju; Ghosh, Ajit] Shahjalal Univ Sci & Technol, Dept Biochem & Mol Biol, Sylhet, Bangladesh; [Singh, Vishal; Kaundal, Amita] Utah State Univ, Coll Agr & Appl Sci, Dept Plants Soils & Climate, Logan, UT 84322 USA; [Islam, Tahmina] Univ Dhaka, Dept Bot, Dhaka, Bangladesh; [Islam, Shiful] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Shahjalal University of Science & Technology (SUST); Utah System of Higher Education; Utah State University; University of Dhaka; University of Alberta	Ghosh, A (corresponding author), Shahjalal Univ Sci & Technol, Dept Biochem & Mol Biol, Sylhet, Bangladesh.	ajitghoshbd@gmail.com	Islam, Shiful/AAX-7442-2021; Ghosh, Ajit/AAC-5914-2022; Islam, Tahmina/AAU-9539-2021; Kaundal, Amita/AAG-3326-2021	Islam, Shiful/0000-0002-1826-6777; Ghosh, Ajit/0000-0001-9045-3916; Islam, Tahmina/0000-0002-0542-0050; Kaundal, Amita/0000-0002-9154-1173; singh, vishal/0000-0003-4926-7411; Islam, Md. Sifatul/0000-0002-3971-6343	Department of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet, Bangladesh	Department of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet, Bangladesh	Authors acknowledge the support of Department of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet, Bangladesh.	Anderson JV, 2004, PHYSIOL PLANTARUM, V120, P421, DOI 10.1111/j.0031-9317.2004.00249.x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barker D. G., 1990, Plant Molecular Biology Reporter, V8, P40, DOI 10.1007/BF02668879; Beier S, 2017, BIOINFORMATICS, V33, P2583, DOI 10.1093/bioinformatics/btx198; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Cypher JM., 2008, PROCESS EC DEV; Dalton DA, 2009, PLANT PHYSIOL, V150, P521, DOI 10.1104/pp.109.136630; Daudi Arsalan, 2012, Bio Protoc, V2; Deavall DG, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/645460; Deavours BE, 2005, PLANT PHYSIOL, V138, P2245, DOI 10.1104/pp.105.062539; Dixon David P, 2010, Arabidopsis Book, V8, pe0131, DOI 10.1199/tab.0131; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Dixon DP, 2000, ARCH BIOCHEM BIOPHYS, V384, P407, DOI 10.1006/abbi.2000.2125; Dong YT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00139; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; FREAR DS, 1970, PHYTOCHEMISTRY, V9, P2123, DOI 10.1016/S0031-9422(00)85377-7; Frova C, 2003, PHYSIOL PLANTARUM, V119, P469, DOI 10.1046/j.1399-3054.2003.00183.x; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Gao J, 2020, GENE, V743, DOI 10.1016/j.gene.2020.144484; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ghosh A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00836; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Grusak MA, 2002, CURR OPIN BIOTECH, V13, P508, DOI 10.1016/S0958-1669(02)00364-6; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Gupta R., 2004, RESEARCHGATE; Han XM, 2018, PLANT PHYSIOL BIOCH, V126, P126, DOI 10.1016/j.plaphy.2018.03.004; He G, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01325; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Islam MS, 2018, GENE, V639, P149, DOI 10.1016/j.gene.2017.10.007; Islam S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45320-x; Islam S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187504; Islam T., PLANT GENE, V23; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Karavangeli M, 2005, BIOMOL ENG, V22, P121, DOI 10.1016/j.bioeng.2005.03.001; Kayum MA, 2018, GENES-BASEL, V9, DOI 10.3390/genes9020084; Khan Nadeem, 2018, Biomed Res Int, V2018, P6023457, DOI 10.1155/2018/6023457; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lallement PA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00192; LAMOUREU.GL, 1970, J AGR FOOD CHEM, V18, P81, DOI 10.1021/jf60167a029; Le BH, 2007, PLANT PHYSIOL, V144, P562, DOI 10.1104/pp.107.100362; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Liu YJ, 2013, PLANT PHYSIOL, V161, P773, DOI 10.1104/pp.112.205815; Loyall L, 2000, PLANT CELL, V12, P1939, DOI 10.1105/tpc.12.10.1939; McGonigle B, 2000, PLANT PHYSIOL, V124, P1105, DOI 10.1104/pp.124.3.1105; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mohsenzadeh S, 2011, AFR J BIOTECHNOL, V10, P8160; Moons A, 2005, VITAM HORM, V72, P155, DOI 10.1016/S0083-6729(05)72005-7; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mueller LA, 2000, PLANT PHYSIOL, V123, P1561, DOI 10.1104/pp.123.4.1561; Mullineaux PM, 2010, PLANT PHYSIOL, V154, P521, DOI 10.1104/pp.110.161406; Nawaz MA, 2017, BIOCHEM SYST ECOL, V71, P87, DOI 10.1016/j.bse.2017.02.002; Nianiou-Obeidat I, 2017, PLANT CELL REP, V36, P791, DOI 10.1007/s00299-017-2139-7; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Perperopoulou F, 2018, CRIT REV BIOTECHNOL, V38, P511, DOI 10.1080/07388551.2017.1375890; Lopez-Blanco JR, 2014, NUCLEIC ACIDS RES, V42, pW271, DOI 10.1093/nar/gku339; Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x; Rezaei MK, 2013, J PLANT PHYSIOL, V170, P1277, DOI 10.1016/j.jplph.2013.04.005; Roncalli V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123322; Ruddon RW, 1997, J BIOL CHEM, V272, P3125, DOI 10.1074/jbc.272.6.3125; Sandhu D, 2018, FUNCT INTEGR GENOMIC, V18, P141, DOI 10.1007/s10142-017-0581-9; Sappl PG, 2009, PLANT J, V58, P53, DOI 10.1111/j.1365-313X.2008.03761.x; Sato S, 2007, PLANT PHYSIOL, V144, P588, DOI 10.1104/pp.107.097493; Sharma P., 2012, J BOT, V2012, P26, DOI [10.1155/2012/217037, DOI 10.1155/2012/217037]; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shental-Bechor D, 2009, CURR OPIN STRUC BIOL, V19, P524, DOI 10.1016/j.sbi.2009.07.002; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Verdier J., 2019, MODEL LEGUME MEDICAG, P7; Vijayakumar H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081211; Wang LB, 2018, PLANT GROWTH REGUL, V86, P211, DOI 10.1007/s10725-018-0422-4; Wang RB, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6374-x; Wang TL, 2003, PLANT PHYSIOL, V131, P886, DOI 10.1104/pp.102.017665; Yang X, 2020, GENES-BASEL, V11, DOI 10.3390/genes11010025; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018	83	10	10	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247170	10.1371/journal.pone.0247170	http://dx.doi.org/10.1371/journal.pone.0247170			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606812	Green Published, gold			2022-12-26	WOS:000620629200082
J	Muroi, N; Ochi, H; Shimada, M; Asou, Y; Hara, Y				Muroi, Norihiro; Ochi, Hiroki; Shimada, Masakazu; Asou, Yoshinori; Hara, Yasushi			Effects of long-term plate fixation with different fixation modes on the radial cortical bone in dogs	PLOS ONE			English	Article								The aim of this study was to examine the effect of long-term locking plate fixation on the cortical bone of the canine radius. Locking compression plates were fixed to the left and right radius in dogs (n = 3). The left radius was fixed with a locking head screw (Locking Plate group, LP). The locking compression plate was compressed periosteally in the right radius using a cortex screw (Compression Plate group, CP). Radial bones from dogs that were euthanized for other purposes were collected as an untreated control group (Control group). After euthanasia at 36 weeks following plate fixation, radial bones were evaluated for bone mineral density and underwent histological analysis. Bone metabolic markers were analyzed by quantitative polymerase chain reaction (qPCR). Statistical analyses were performed for comparisons between groups. The LP group showed no significant difference in bone mineral density after plate fixation, whereas the CP group showed significantly lower bone mineral density. Histological analysis indicated that the number of osteoclasts and rate of empty lacunae increased significantly in the CP group relative to the Control and LP groups. qPCR analysis indicated increased expression of inflammatory cytokines, such as tumor necrosis factor-alpha, interleukin-6, and tumor necrosis factor ligand superfamily member 11 in the CP group, whereas Runt-related transcription factor 2, an osteoblast marker, was similar in all groups. The expression of hypoxia-inducible factor-1 alpha in the CP group was also increased relative to that in the Control and LP groups. Thus, locking plate fixation is a biologically superior fixation method that does not cause implant-induced osteoporosis in the bone in the long term.	[Muroi, Norihiro; Shimada, Masakazu; Hara, Yasushi] Nippon Vet & Life Sci Univ, Dept Vet Surg, Musashino, Tokyo, Japan; [Ochi, Hiroki] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan; [Asou, Yoshinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Nanomed, Bunkyo Ku, Tokyo, Japan	Nippon Veterinary & Life Science University; Tokyo Medical & Dental University (TMDU)	Muroi, N (corresponding author), Nippon Vet & Life Sci Univ, Dept Vet Surg, Musashino, Tokyo, Japan.	fishertiger.sun@gmail.com		Shimada, Masakazu/0000-0002-9233-2496; Muroi, Norihiro/0000-0002-6320-1294				Ahmad M, 2007, INJURY, V38, P358, DOI 10.1016/j.injury.2006.08.058; Aikawa T, 2018, VET COMP ORTHOPAED, V31, P214, DOI 10.1055/s-0038-1639485; Alique M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010195; Arens S, 1999, J ORTHOP TRAUMA, V13, P470, DOI 10.1097/00005131-199909000-00002; Augustin G, 2007, INJURY, V38, P1115, DOI 10.1016/j.injury.2007.05.017; CARTER DR, 1985, J ORTHOPAED RES, V3, P84, DOI 10.1002/jor.1100030110; Engelke K, 2009, BONE, V45, P110, DOI 10.1016/j.bone.2009.03.669; Field JR, 1997, VET COMP ORTHOPAED, V10, P88; Gauthier CM, 2011, AM J VET RES, V72, P1112, DOI 10.2460/ajvr.72.8.1112; GAUTIER E, 1992, ORTHOPADE, V21, P11; Gibert S, 2015, VET COMP ORTHOPAED, V28, P441, DOI 10.3415/VCOT-15-02-0042; Gill AM S.P.S., 2017, INT J RES ORTHOP, V3, P623, DOI 10.18203/issn.2455-4510.IntJResOrthop20171913; Greiwe R Michael, 2007, J Knee Surg, V20, P50; Haaland PJ, 2009, VET COMP ORTHOPAED, V22, P309, DOI 10.3415/VCOT08-05-0044; Hamilton MH, 2005, VET COMP ORTHOPAED, V18, P18; KESSLER SB, 1992, ARCH ORTHOP TRAUM SU, V111, P96, DOI 10.1007/BF00443475; Kim Todd, 2007, J Foot Ankle Surg, V46, P2, DOI 10.1053/j.jfas.2006.09.009; Kirkpatrick D, 2003, J ORAL MAXIL SURG, V61, P462, DOI 10.1053/joms.2003.50089; Knowles HJ, 2015, HYPOXIA, V3, P73, DOI 10.2147/HP.S95960; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Larsen LJ, 1999, J AM ANIM HOSP ASSOC, V35, P243, DOI 10.5326/15473317-35-3-243; LIPPUNER K, 1992, ARCH ORTHOP TRAUM SU, V111, P78, DOI 10.1007/BF00443472; Morita M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46322; Pathak JL, 2016, CALCIFIED TISSUE INT, V98, P596, DOI 10.1007/s00223-016-0116-8; Perren SM, 2002, J BONE JOINT SURG BR, V84B, P1093, DOI 10.1302/0301-620X.84B8.13752; PERREN SM, 1988, CLIN ORTHOP RELAT R, P139; Ramirez JM, 2016, AUST VET J, V94, P76, DOI 10.1111/avj.12408; SLATIS P, 1978, J BONE JOINT SURG AM, V60, P516, DOI 10.2106/00004623-197860040-00014; Steeve KT, 2004, CYTOKINE GROWTH F R, V15, P49, DOI 10.1016/j.cytogfr.2003.10.005; Strehl C, 2014, J LEUKOCYTE BIOL, V95, P233, DOI 10.1189/jlb.1212627; Welch JA, 1997, VET SURG, V26, P57, DOI 10.1111/j.1532-950X.1997.tb01463.x; Zhang C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00650	33	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247410	10.1371/journal.pone.0247410	http://dx.doi.org/10.1371/journal.pone.0247410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606794	gold, Green Published			2022-12-26	WOS:000620629200167
J	Wang, KK; Wang, ZF; Zeng, QZ; Zhu, LJ; Gao, JY; Wang, ZQ; Zhang, SS; Yang, F; Shen, DH; Wang, Y; Liu, YY				Wang, Kunkun; Wang, Zhenfan; Zeng, Qiaozhu; Zhu, Lijuan; Gao, Jingyuan; Wang, Ziqiao; Zhang, Shanshan; Yang, Fei; Shen, Danhua; Wang, Yi; Liu, Yanying			Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis	PLOS ONE			English	Article								Retroperitoneal fibrosis (RPF) is an uncommon condition characterized by inflammation and fibrosis in the retroperitoneal space. More than two-thirds of RPF are idiopathic, with the remaining stemed from a variety of secondary causes. It was suggested that IgG4-related RPF is a secondary form of RPF. We undertook this study to compare detailed demographic, clinical and laboratory characteristics of IgG4-related RPF and IRPF in a large Chinese cohort. We retrospectively reviewed the medical records of 132 RPF patients diagnosed at Peking University People's Hospital between March 2010 and March 2018. Among the 132 patients, the mean age at disease onset was 54.8 years. IgG4-related RPF group showed greater male predominance compared to IRPF group. IgG4-related RPF patients showed a longer interval between symptom onset and diagnosis, and allergic diseases were more common in this group. Sixty-four patients (48.4%) had lower back pain, which was more common in IRPF group than that in IgG4-related RPF patients. In terms of organ involvement, although 42 of 47 patients (89.3%) with IgG4-related RPF had other organ involvement, there were no patients in the IRPF group with other organ involvement. In addition, the serum IgG4 level, elevated eosinophils counts and IgE level were significantly higher in IgG4-related RPF patients. We described the demographic, clinical and laboratory differences between IgG4-related RPF and IRPF patients, indicating their potential differences in pathogenesis, which was of great importance to diagnose and manage the two phenotypes.	[Wang, Kunkun; Wang, Zhenfan; Zeng, Qiaozhu; Wang, Ziqiao; Liu, Yanying] Peking Univ Peoples Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China; [Wang, Kunkun] Tengzhou Cent Peoples Hosp, Dept Rheumatol & Immunol, Tengzhou, Peoples R China; [Zhu, Lijuan] Zhengzhou Univ, Zhengzhou Cent Hosp, Dept Rheumatol & Immunol, Zhengzhou, Peoples R China; [Gao, Jingyuan] North China Univ Technol, Affiliated Hosp, Dept Geriatr, Tangshan, Peoples R China; [Zhang, Shanshan] Peking Univ Peoples Hosp, Dept Ultrasound, Beijing, Peoples R China; [Yang, Fei; Shen, Danhua] Peking Univ Peoples Hosp, Dept Pathol, Beijing, Peoples R China; [Wang, Yi] Peking Univ Peoples Hosp, Dept Radiol, Beijing, Peoples R China	Peking University; Zhengzhou University; North China University of Technology; Peking University; Peking University	Liu, YY (corresponding author), Peking Univ Peoples Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China.	liuyanying20030801@msn.com			Peking University People's Hospital Research and Development Funds [RDH2020-03]	Peking University People's Hospital Research and Development Funds	YY-L receive the fund: Peking University People's Hospital Research and Development Funds (RDX 2019-02), and Peking University People's Hospital Research and Development Funds (RDH2020-03), The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castelein T, 2015, RHEUMATOLOGY, V54, P1250, DOI 10.1093/rheumatology/keu462; Choi YK, 2019, KIDNEY RES CLIN PRAC, V38, P42, DOI 10.23876/j.krcp.18.0052; Ebbo Mikael, 2013, Rev Prat, V63, P605; Garcia IG, 2013, SCAND J UROL, V47, P370, DOI 10.3109/00365599.2012.747564; Kamisawa T, 2009, GUT, V58, P1504, DOI 10.1136/gut.2008.172908; Kamisawa T, 2015, LANCET, V385, P1460, DOI 10.1016/S0140-6736(14)60720-0; Kasashima S, 2018, HEART VESSELS, V33, P1471, DOI 10.1007/s00380-018-1203-8; Khosroshahi A, 2013, MEDICINE, V92, P82, DOI 10.1097/MD.0b013e318289610f; Khosroshahi A, 2011, CURR OPIN RHEUMATOL, V23, P57, DOI 10.1097/BOR.0b013e3283418057; KOEP L, 1977, SURGERY, V81, P250; Koo BS, 2015, MOD RHEUMATOL, V25, P194, DOI 10.3109/14397595.2014.931908; Lee HW, 2018, J GASTROENTEROL, V53, P967, DOI 10.1007/s00535-018-1434-6; Liu YY, 2020, RHEUMATOLOGY, V59, P2115, DOI 10.1093/rheumatology/kez669; Mahajan VS, 2014, ANNU REV PATHOL-MECH, V9, P315, DOI 10.1146/annurev-pathol-012513-104708; Majumder S, 2018, CLIN GASTROENTEROL H, V16, P1947, DOI 10.1016/j.cgh.2018.02.049; Maritati F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00693; Rossi GM, 2017, INTERN EMERG MED, V12, P287, DOI 10.1007/s11739-016-1599-z; Scheel PJ, 2013, RHEUM DIS CLIN N AM, V39, P365, DOI 10.1016/j.rdc.2013.02.004; Scheel PJ, 2009, MEDICINE, V88, P202, DOI 10.1097/MD.0b013e3181afc439; Shirakashi M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28405-x; Stone JR, 2011, CURR OPIN RHEUMATOL, V23, P88, DOI 10.1097/BOR.0b013e3283412f7c; Stone JH, 2012, SEMIN DIAGN PATHOL, V29, P177, DOI 10.1053/j.semdp.2012.08.002; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Vaglio A, 2006, LANCET, V367, P241, DOI 10.1016/S0140-6736(06)68035-5; Vaglio A, 2005, ARTHRIT RHEUM-ARTHR, V53, P122, DOI 10.1002/art.20914; Vaglio A, 2016, J AM SOC NEPHROL, V27, P1880, DOI 10.1681/ASN.2015101110; Vaglio A, 2011, LANCET, V378, P338, DOI 10.1016/S0140-6736(11)60934-3; van Bommel EFH, 2009, MEDICINE, V88, P193, DOI 10.1097/MD.0b013e3181afc420; van Bommel EFH, 2007, AM J KIDNEY DIS, V49, P615, DOI 10.1053/j.ajkd.2007.02.268; Wallace ZS, 2018, ARTHRIT CARE RES, V70, P1671, DOI 10.1002/acr.23543; Wallace ZS, 2015, ARTHRITIS RHEUMATOL, V67, P2466, DOI 10.1002/art.39205; Wallwork R, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012631; Yamashita K, 2008, HISTOPATHOLOGY, V52, P404, DOI 10.1111/j.1365-2559.2007.02959.x; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Zen Y, 2009, AM J SURG PATHOL, V33, P1833, DOI 10.1097/PAS.0b013e3181b72882	36	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0245601	10.1371/journal.pone.0245601	http://dx.doi.org/10.1371/journal.pone.0245601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600452	gold, Green Published			2022-12-26	WOS:000620625100004
J	Yang, IS; Bae, SW; Park, B; Kim, S				Yang, In Seok; Bae, Sang Won; Park, BeumJin; Kim, Sangwoo			Development of a program for in silico optimized selection of oligonucleotide-based molecular barcodes	PLOS ONE			English	Article							HIGH-THROUGHPUT; GENERATION; DNA; MUTATIONS; ABSOLUTE; RARE	Short DNA oligonucleotides (similar to 4 mer) have been used to index samples from different sources, such as in multiplex sequencing. Presently, longer oligonucleotides (8-12 mer) are being used as molecular barcodes with which to distinguish among raw DNA molecules in many high-tech sequence analyses, including low-frequent mutation detection, quantitative transcriptome analysis, and single-cell sequencing. Despite some advantages of using molecular barcodes with random sequences, such an approach, however, makes it impossible to know the exact sequences used in an experiment and can lead to inaccurate interpretation due to misclustering of barcodes arising from the occurrence of unexpected mutations in the barcodes. The present study introduces a tool developed for selecting an optimal barcode subset during molecular barcoding. The program considers five barcode factors: GC content, homopolymers, simple sequence repeats with repeated units of dinucleotides, Hamming distance, and complementarity between barcodes. To evaluate a selected barcode set, penalty scores for the factors are defined based on their distributions observed in random barcodes. The algorithm employed in the program comprises two steps: i) random generation of an initial set and ii) optimal barcode selection via iterative replacement. Users can execute the program by inputting barcode length and the number of barcodes to be generated. Furthermore, the program accepts a user's own values for other parameters, including penalty scores, for advanced use, allowing it to be applied in various conditions. In many test runs to obtain 100000 barcodes with lengths of 12 nucleotides, the program showed fast performance, efficient enough to generate optimal barcode sequences with merely the use of a desktop PC. We also showed that VFOS has comparable performance, flexibility in program running, consideration of simple sequence repeats, and fast computation time in comparison with other two tools (DNABarcodes and FreeBarcodes). Owing to the versatility and fast performance of the program, we expect that many researchers will opt to apply it for selecting optimal barcode sets during their experiments, including next-generation sequencing.	[Yang, In Seok; Park, BeumJin; Kim, Sangwoo] Yonsei Univ, Dept Biomed Syst Informat, Coll Med, Seoul, South Korea; [Yang, In Seok; Park, BeumJin; Kim, Sangwoo] Yonsei Univ, Brain Korea 21 PLUS Project Med Sci, Coll Med, Seoul, South Korea; [Bae, Sang Won] Kyonggi Univ, Dept Comp Sci, Suwon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Kyonggi University	Kim, S (corresponding author), Yonsei Univ, Dept Biomed Syst Informat, Coll Med, Seoul, South Korea.; Kim, S (corresponding author), Yonsei Univ, Brain Korea 21 PLUS Project Med Sci, Coll Med, Seoul, South Korea.	swkim@yuhs.ac		Yang, In Seok/0000-0001-5224-2587; Kim, Sangwoo/0000-0001-5356-0827	National Research Foundation of Korea (NRF) - Korea government(MSIT) [2019R1A2C2008050]; Yonsei University College of Medicine [6-2016-0081]	National Research Foundation of Korea (NRF) - Korea government(MSIT); Yonsei University College of Medicine(General Electric)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government(MSIT) (No. 2019R1A2C2008050). SK was additionally funded by a faculty research grant from Yonsei University College of Medicine [6-2016-0081]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buschmann T, 2017, BIOINFORMATICS, V33, P920, DOI 10.1093/bioinformatics/btw759; Buschmann T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-272; Bystrykh LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036852; Fan Hao, 2007, Genomics Proteomics & Bioinformatics, V5, P7, DOI 10.1016/S1672-0229(07)60009-6; Fazekas AJ, 2010, BIOTECHNIQUES, V48, P277, DOI 10.2144/000113369; Fu GK, 2014, P NATL ACAD SCI USA, V111, P1891, DOI 10.1073/pnas.1323732111; Fujimoto A, 2020, GENOME RES, V30, P334, DOI 10.1101/gr.255026.119; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Guido N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156478; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hawkins JA, 2018, P NATL ACAD SCI USA, V115, pE6217, DOI 10.1073/pnas.1802640115; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kou RQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146638; Krishnan AR, 2011, ELECTRON LETT, V47, P236, DOI 10.1049/el.2010.3546; Kukita Y, 2015, DNA RES, V22, P269, DOI 10.1093/dnares/dsv010; Lan F, 2017, NAT BIOTECHNOL, V35, P640, DOI 10.1038/nbt.3880; Lyons E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12825-2; MacConaill LE, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4428-5; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Ogawa T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13529-3; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Roy S, 2016, ARCH PATHOL LAB MED, V140, P958, DOI 10.5858/arpa.2015-0507-RA; Salk JJ, 2018, NAT REV GENET, V19, P269, DOI 10.1038/nrg.2017.117; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Tulpan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-105; Xu C, 2018, COMPUT STRUCT BIOTEC, V16, P15, DOI 10.1016/j.csbj.2018.01.003; Yohe S, 2017, ARCH PATHOL LAB MED, V141, P1544, DOI 10.5858/arpa.2016-0501-RA; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103207	30	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0246354	10.1371/journal.pone.0246354	http://dx.doi.org/10.1371/journal.pone.0246354			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600481	gold, Green Published			2022-12-26	WOS:000620625100038
J	Mazzarelli, A; Giancola, ML; Farina, A; Marchioni, L; Rueca, M; Gruber, CEM; Bartolini, B; Bartoli, TA; Maffongelli, G; Capobianchi, MR; Ippolito, G; Di Caro, A; Nicastri, E; Pazienza, V				Mazzarelli, Antonio; Giancola, Maria Letizia; Farina, Anna; Marchioni, Luisa; Rueca, Martina; Maria Gruber, Cesare Ernesto; Bartolini, Barbara; Bartoli, Tommaso Ascoli; Maffongelli, Gaetano; Capobianchi, Maria Rosaria; Ippolito, Giuseppe; Di Caro, Antonino; Nicastri, Emanuele; Pazienza, Valerio		INMI COVID-19 Study Grp	16S rRNA gene sequencing of rectal swab in patients affected by COVID-19	PLOS ONE			English	Article							GUT MICROBIOTA; LUNG	COronaVIrus Disease-2019 (COVID-19) is a pandemic respiratory infection caused by a new betacoronavirus, the Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV-2). Few data are reported on the gut microbiota in COVID-19 patients. 16S rRNA gene sequencing was performed to reveal an altered composition of the gut microbiota in patients with COVID-19 pneumonia admitted in intensive care unit (ICU) (i-COVID19), or in infectious disease wards (w-COVID19) as compared to controls (CTRL). i-COVID19 patients showed a decrease of Chao1 index as compared to CTRL and w-COVID19 patients indicating that patients in ICU displayed a lower microbial richness while no change was observed as for Shannon Index. At the phylum level, an increase of Proteobacteria was detected in w-COVID19 patients as compared to CTRL. A decrease of Fusobacteria and Spirochetes has been found, with the latter decreased in i-COVID19 patients as compared to CTRL. Significant changes in gut microbial communities in patients with COVID-19 pneumonia with different disease severity compared to CTRL have been identified. Our preliminary data may provide valuable information and promising biomarkers for the diagnosis of the disease and, when validated in larger cohort, it could facilitate the stratification of patients based on the microbial signature.	[Mazzarelli, Antonio; Giancola, Maria Letizia; Farina, Anna; Marchioni, Luisa; Rueca, Martina; Maria Gruber, Cesare Ernesto; Bartolini, Barbara; Bartoli, Tommaso Ascoli; Maffongelli, Gaetano; Capobianchi, Maria Rosaria; Ippolito, Giuseppe; Di Caro, Antonino; Nicastri, Emanuele] INMI Lazzaro Spallanzani, IRCCS, Natl Inst Infect Dis, Rome, Italy; [Pazienza, Valerio] Fdn IRCCS Casa Sollievo della Sofferenza Hosp, Div Gastroenterol, San Giovanni Rotondo, FG, Italy	IRCCS Lazzaro Spallanzani	Di Caro, A (corresponding author), INMI Lazzaro Spallanzani, IRCCS, Natl Inst Infect Dis, Rome, Italy.	antonio.dicaro@inmi.it	Marchioni, Luisa/AGK-4889-2022; Di Caro, Antonino/K-6854-2016; Maffongelli, Gaetano/AAB-8651-2022; Gruber, Cesare E.M./B-4705-2017; Ascoli Bartoli, Tommaso/AAC-7647-2022; Pazienza, Valerio/K-5073-2012	Marchioni, Luisa/0000-0003-3273-7309; Di Caro, Antonino/0000-0001-6027-3009; Gruber, Cesare E.M./0000-0002-8831-3380; Pazienza, Valerio/0000-0002-3492-1153; Giancola, Maria Letizia/0000-0003-2481-6621; MAFFONGELLI, GAETANO/0000-0001-7784-2511	Ministero della Salute [COVID-2020-12371817]; European Commission - Horizon 2020 (EU) [101003544, 101003551, 101005111, 101005075]; European Virus Archive - GLOBAL [653316, 871029]; Italian Association for Cancer Research (AIRC) [23006]	Ministero della Salute(Ministry of Health, Italy); European Commission - Horizon 2020 (EU); European Virus Archive - GLOBAL; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This study was supported by funds to the Istituto Nazionale per le Malattie Infettive (INMI) Lazzaro Spallanzani IRCCS, Rome, Italy, from the Ministero della Salute (Ricerca Corrente, linea 1; COVID-2020-12371817), the European Commission - Horizon 2020 (EU project 101003544 - CoNVat; EU project 101003551 - EXSCALATE4CoV; EU project 101005111 DECISION; EU project 101005075-Unita Operativa Complessa Microbiologia e Banca Biologica Direttore: Dr. Antonino Di Caro-Tel. 0655170685 Fax 065594555 KRONO) and the European Virus Archive - GLOBAL (grants no. 653316 and no. 871029). Valerio Pazienza is supported by Italian Association for Cancer Research (AIRC) under IG 2019 - ID. 23006 project - P.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirian ES, 2020, INT J INFECT DIS, V95, P363, DOI 10.1016/j.ijid.2020.04.057; Bassis CM, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0983-9; Bradley KC, 2019, CELL REP, V28, P245, DOI 10.1016/j.celrep.2019.05.105; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Dumas A, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12966; Esquivel-Elizondo S, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00051-17; Fontana A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16214065; Gao QY, 2020, J DIGEST DIS, V21, P125, DOI 10.1111/1751-2980.12851; Groves HT, 2020, MBIO, V11, DOI 10.1128/mBio.03236-19; Iebba V, 2016, NEW MICROBIOL, V39, P1; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lange K, 2016, DIGEST DIS, V34, P260, DOI 10.1159/000443360; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liang WC, 2020, GUT, V69, P1141, DOI 10.1136/gutjnl-2020-320832; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Marsland BJ, 2015, ANN AM THORAC SOC, V12, pS150, DOI 10.1513/AnnalsATS.201503-133AW; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Mottawea W, 2019, PEDIATR RES, V85, P895, DOI 10.1038/s41390-019-0326-7; Numberger D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46015-z; Ong J, 2020, GUT, V69, P1144, DOI [10.1136/gutjnl-2020-321154, 10.1136/gutjnl-2020-321051]; Pickard JM, 2017, IMMUNOL REV, V279, P70, DOI 10.1111/imr.12567; Ravi A, 2019, MICROB GENOMICS, V5, DOI 10.1099/mgen.0.000293; Reyman M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52549-z; Robinson CM, 2014, ANNU REV VIROL, V1, P55, DOI 10.1146/annurev-virology-031413-085550; Samuelson DR, 2015, FRONT MICROBIOL, V6, DOI [10.5389/fmicb.2015.01085, 10.3389/fmicb.2015.01085]; Shoenfeld Y, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102538; Wang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3106; Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786; Yi Y, 2020, INT J BIOL SCI, V16, P1753, DOI 10.7150/ijbs.45134; Zhang DP, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00301; Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071; Zuo T, 2021, GUT, V70, P276, DOI 10.1136/gutjnl-2020-322294; Zuo T, 2020, GASTROENTEROLOGY, V159, P944, DOI 10.1053/j.gastro.2020.05.048	35	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247041	10.1371/journal.pone.0247041	http://dx.doi.org/10.1371/journal.pone.0247041			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596245	Green Published, gold			2022-12-26	WOS:000620633200050
J	Xu, MX; Lee, P; Collins, D				Xu, Mingxin; Lee, Peter; Collins, David			The critical importance of mask seals on respirator performance: An analytical and simulation approach	PLOS ONE			English	Article							FILTERING FACEPIECE RESPIRATORS; N95 RESPIRATORS; PENETRATION; PROTECTION; LEAKAGE	Filtering facepiece respirators (FFRs) and medical masks are widely used to reduce the inhalation exposure of airborne particulates and biohazardous aerosols. Their protective capacity largely depends on the fraction of these that are filtered from the incoming air volume. While the performance and physics of different filter materials have been the topic of intensive study, less well understood are the effects of mask sealing. To address this, we introduce an approach to calculate the influence of face-seal leakage on filtration ratio and fit factor based on an analytical model and a finite element method (FEM) model, both of which take into account time-dependent human respiration velocities. Using these, we calculate the filtration ratio and fit factor for a range of ventilation resistance values relevant to filter materials, 500-2500 Pa center dot s center dot m(-1), where the filtration ratio and fit factor are calculated as a function of the mask gap dimensions, with good agreement between analytical and numerical models. The results show that the filtration ratio and fit factor are decrease markedly with even small increases in gap area. We also calculate particle filtration rates for N95 FFRs with various ventilation resistances and two commercial FFRs exemplars. Taken together, this work underscores the critical importance of forming a tight seal around the face as a factor in mask performance, where our straightforward analytical model can be readily applied to obtain estimates of mask performance.	[Xu, Mingxin; Lee, Peter; Collins, David] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic, Australia	University of Melbourne	Collins, D (corresponding author), Univ Melbourne, Dept Biomed Engn, Melbourne, Vic, Australia.	david.collins@unimelb.edu.au	Collins, David/D-3439-2015	Collins, David/0000-0001-5382-9718; Xu, Mingxin/0000-0001-6228-5759				Ali M., 2020, ACTA CHEM MALAYSIA, V4, P40, DOI [10.2478/acmy-2020-0007, DOI 10.2478/ACMY-2020-0007]; [Anonymous], 2020, RES SOC ADMIN PHARM, DOI [DOI 10.1016/j.sapharm.2020.02.003, 10.1016/j.sapharm.2020.02.003]; Australian Bureau of Statistics, 2012, PROFILES HLTH; Balhoff M, 2010, TRANSPORT POROUS MED, V81, P35, DOI 10.1007/s11242-009-9388-z; Biscotto CR, 2005, INT J TUBERC LUNG D, V9, P545; Breul S, 2020, EUR J ORAL SCI, V128, P233, DOI 10.1111/eos.12697; Bulletin T, 2020, COMP FFP2 KN95 N95 O; Buonanno G, 2020, ENVIRON INT, V141, DOI 10.1016/j.envint.2020.105794; CHEN CC, 1992, AM IND HYG ASSOC J, V53, P533, DOI 10.1202/0002-8894(1992)053<0533:COFSLI>2.0.CO;2; Cho KJ, 2010, ANN OCCUP HYG, V54, P68, DOI 10.1093/annhyg/mep062; Degesys NF, 2020, JAMA-J AM MED ASSOC, V324, P94, DOI 10.1001/jama.2020.9843; e-CFR, 2020, TITLE 42 PUBLIC HLTH; Firdaouss M, 1997, J FLUID MECH, V343, P331, DOI 10.1017/S0022112097005843; GEHAN EA, 1970, CANCER CHEMOTH REP 1, V54, P225; Gupta JK, 2010, INDOOR AIR, V20, P31, DOI 10.1111/j.1600-0668.2009.00623.x; Hon CY, 2017, J OCCUP ENVIRON HYG, V14, P175, DOI 10.1080/15459624.2016.1237030; Hui DS, 2006, CHEST, V130, P822, DOI 10.1378/chest.130.3.822; Hung CH., 2008, FILTRATION, V8, P154; Jaksic D, 2010, WOVEN FABRIC ENGINEERING, P255; Kim H, 2015, IND HEALTH, V53, P553, DOI 10.2486/indhealth.2014-0259; Kim JH, 2015, INT J OCCUP MED ENV, V28, P71, DOI 10.13075/ijomeh.1896.00153; Konda A, 2020, ACS NANO, V14, P6339, DOI 10.1021/acsnano.0c03252; Laing RM, 2008, INT J OCCUP SAF ERGO, V14, P107, DOI 10.1080/10803548.2008.11076753; Lei Z, 2010, COMPUT AIDED DESIGN, V7, P847, DOI DOI 10.3722/CADAPS.2010.847-861; Maranhao Bruno, 2020, Br J Anaesth, V125, pe322, DOI 10.1016/j.bja.2020.06.023; McMahon E, 2008, AM J INFECT CONTROL, V36, P298, DOI 10.1016/j.ajic.2007.10.014; Munson B.R., 2013, FLUID MECH-SOV RES; National Institute for Occupational Safety and Health (NIOSH), 1996, DEP HLTH HUM SERV DH, V6101; Neupane BB, 2019, PEERJ, V7, DOI 10.7717/peerj.7142; Plana Deborah, 2020, medRxiv, DOI 10.1101/2020.07.25.20161968; Ramos Rodrigo Felippe, 2020, Rev Col Bras Cir, V47, pe20202570, DOI 10.1590/0100-6991e-20202570; Rengasamy S, 2012, ANN OCCUP HYG, V56, P568, DOI 10.1093/annhyg/mer122; Sandaradura I, 2020, J HOSP INFECT, V104, P529, DOI 10.1016/j.jhin.2020.01.006; Shokri A., 2015, INT J OCCUPATIONAL H, V7, P10; Suen LKP, 2020, J HOSP INFECT, V104, P336, DOI 10.1016/j.jhin.2019.09.014; Suen LKP, 2017, AM J INFECT CONTROL, V45, P974, DOI 10.1016/j.ajic.2017.03.028; Tebyetekerwa M, 2020, ADV FIBER MATER, V2, P161, DOI 10.1007/s42765-020-00049-5; Ullah S, 2020, ACS APPL NANO MATER, V3, P7231, DOI 10.1021/acsanm.0c01562; WEBER A, 1993, AM J INFECT CONTROL, V21, P167, DOI 10.1016/0196-6553(93)90027-2; Wong P, 2020, BRIT J ANAESTH, V125, pE319, DOI 10.1016/j.bja.2020.05.008; World Health Organization, 2014, INF PREV CONTR EP PA; World Health Organization, 2020, GUIDING PRINCIPLES I; Zadeh, 2014, ANAT SCI, V11, P175; Zhao M, 2020, NANO LETT, V20, P5544, DOI 10.1021/acs.nanolett.0c02211; Zhou SS, 2018, J THORAC DIS, V10, P2059, DOI 10.21037/jtd.2018.03.103; Zhu JT, 2020, ANN WORK EXPOS HEAL, V64, P202, DOI 10.1093/annweh/wxz086	46	8	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246720	10.1371/journal.pone.0246720	http://dx.doi.org/10.1371/journal.pone.0246720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596228	gold, Green Published			2022-12-26	WOS:000620633200066
J	Eyayu, T; Kiros, T; Workineh, L; Sema, M; Damtie, S; Hailemichael, W; Dejen, E; Tiruneh, T				Eyayu, Tahir; Kiros, Teklehaimanot; Workineh, Lemma; Sema, Meslo; Damtie, Shewaneh; Hailemichael, Wasihun; Dejen, Eninur; Tiruneh, Tegenaw			Prevalence of intestinal parasitic infections and associated factors among patients attending at Sanja Primary Hospital, Northwest Ethiopia: An institutional-based cross-sectional study	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; HEALTH-CENTER; INTEGRATED CONTROL	Background Intestinal Parasitic Infections are the most prevalent diseases in the world, predominantly in developing countries. It is estimated that more than two billion people are affected globally, mostly in tropical and sub-tropical parts of the world. Ethiopia is one of the countries in Africa with a high prevalence of intestinal parasites. However, there is a limited study conducted in the study area. Hence, this study was to assess the prevalence and associated factors of intestinal parasitosis among patients attending at Sanja Primary Hospital, Northwest Ethiopia. Methods An institutional-based cross-sectional study was conducted at Sanja Primary Hospital from January 1 to August 20, 2019. Stool samples were collected from 1240 study participants and analyzed by direct wet mount and formal ether concentration techniques. Furthermore, sociodemographic and explanatory variables were collected using a face-to-face interview. Data were entered into Epi data version 4.4.2.1 and transferred to SPSS version 23 for analysis. Bivariate and multivariate binary logistic regression models were fitted to identify associated factors of intestinal parasitic infections. Adjusted Odds Ratio (AOR) with 95% confidence interval (CI) was considered to ascertain the significance of the association. Results The overall prevalence of intestinal parasitic infection was 52.9% (95% CI: 50.2%-55.5%). Entamoeba histolytica/dispar (21.5%) was the leading cause of intestinal parasitosis followed by Hookworm species (13.3%). Furthermore, the rate of double and triple parasitic infections was observed in 6.1% and 0.5% of study participants respectively. Being Illiterate (AOR: 2.87, 95% CI: 1.06-7.47, p = 0.038), swimming habits of more than 4 times a month (AOR = 2.91, 95% CI 1.62-5.24, p< 0.001) and not washing hands before a meal (AOR: 3.92, 95% CI: 1.74-8.83, p = 0.001) were the key factors significantly associated with intestinal parasitic infection. Conclusions The present study showed that the prevalence of intestinal parasitosis is high in the study area. Therefore, there is a need for an integrated control program, including improving personal, environmental sanitation and health education should be given to have a lasting impact on transmission.	[Eyayu, Tahir; Kiros, Teklehaimanot; Workineh, Lemma; Sema, Meslo; Damtie, Shewaneh; Hailemichael, Wasihun; Dejen, Eninur; Tiruneh, Tegenaw] Debre Tabor Univ, Coll Hlth Sci, Dept Med Lab Sci, Debre Tabor, Ethiopia		Eyayu, T (corresponding author), Debre Tabor Univ, Coll Hlth Sci, Dept Med Lab Sci, Debre Tabor, Ethiopia.	zakir8285@gmail.com	Damtie, Shewaneh/AIE-5657-2022; Workineh, Lemma/AAR-9228-2021; kalkay, Teklehaimanot Kiros/AAL-1862-2021; Eyayu, Tahir/AAQ-3695-2021	Damtie, Shewaneh/0000-0002-2156-2438; kalkay, Teklehaimanot Kiros/0000-0002-3107-4833; Eyayu, Tahir/0000-0002-2041-7183; Hailemichael, Wasihun/0000-0003-2721-7632; Berhanu, Meslo Sema/0000-0002-2135-4196				Ababa A., 2014, FEDERAL DEMOCRATIC R; Abate A., 2013, INT SCHOLARLY RES NO, V2013; Agrawal P K, 2012, Nepal Med Coll J, V14, P80; Alemu Megbaru, 2017, BMC Res Notes, V10, P632, DOI 10.1186/s13104-017-2957-2; Amer OH, 2016, ASIAN PAC J TROP MED, V9, P41, DOI 10.1016/j.apjtm.2015.12.009; Ayelgn M, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4735-9; Blum AJ, 2018, GLOBAL WORMING CLIMA; Cheesbrough M, 2009, DISTRICT LAB PRACTIC; Chelkeba L, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8222-y; Committee WHOE, 2002, WHO TECHN REP SER, V912; Davane M., 2012, INT J RECENT TRENDS, V2, P1; Deribe K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-240; Faria CP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005445; Fentahun AA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4165-2; Gebru AA., 2015, SCI J PUBLIC HLTH, V3, P445; Hailu T., 2014, CLIN MICROBIOLOGY OP; Hailu T, 2020, J PARASITOL RES, V2020, DOI 10.1155/2020/8855362; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Karou SD, 2011, ASIAN PAC J TROP MED, V4, P401, DOI 10.1016/S1995-7645(11)60112-0; Mehran S., 2017, NOVELTY BIOMEDICINE, V5, P119; Mohammed K., 2019, ASIAN J RES INFECT D, V1, P9; Muhammad IM., 2014, AM J RES COMMUN, V2, P88; Norhayati M, 2003, Med J Malaysia, V58, P296; Organization WH, 1991, BAS LAB METH MED PAR; Organization WH, 1987, WHO EXP COMM M HELD; Ostan I, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-342; Ramana KV, 2012, ANN TROP MED PUBLIC, V5, P279, DOI 10.4103/1755-6783.101988; Sangare I, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0065-x; Speich B, 2016, LANCET INFECT DIS, V16, P87, DOI 10.1016/S1473-3099(15)00349-7; Tadesse Z, 2008, T ROY SOC TROP MED H, V102, P213, DOI 10.1016/j.trstmh.2007.09.005; Tigabu A, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4377-y	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247075	10.1371/journal.pone.0247075	http://dx.doi.org/10.1371/journal.pone.0247075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592071	gold, Green Published			2022-12-26	WOS:000620632800023
J	Heymann, AK; Schnabel, K; Billenkamp, F; Buhler, S; Frahm, J; Kersten, S; Huther, L; Meyer, U; von Soosten, D; Trakooljul, N; Teifke, JP; Danicke, S				Heymann, Ann-Katrin; Schnabel, Karina; Billenkamp, Fabian; Buehler, Susanne; Frahm, Jana; Kersten, Susanne; Huether, Liane; Meyer, Ulrich; von Soosten, Dirk; Trakooljul, Nares; Teifke, Jens Peter; Daenicke, Sven			Effects of glyphosate residues and different concentrate feed proportions in dairy cow rations on hepatic gene expression, liver histology and biochemical blood parameters	PLOS ONE			English	Article							AMINOMETHYLPHOSPHONIC ACID; ROUNDUP HERBICIDE; FATTY-ACIDS; MILK UREA; GLUCOSE; ENERGY; METABOLISM; TOXICITY; COMPLEX; PROTEIN	Glyphosate (GLY) is worldwide one of the most used active substances in non-selective herbicides. Although livestock might be orally exposed via GLY-contaminated feedstuffs, not much is known about possible hepatotoxic effects of GLY. As hepatic xenobiotic and nutrient metabolism are interlinked, toxic effects of GLY residues might be influenced by hepatic nutrient supply. Therefore, a feeding trial with lactating dairy cows was conducted to investigate effects of GLY-contaminated feedstuffs and different concentrate feed proportions (CFP) in the diets as tool for varying nutrient supply to the liver. For this, 61 German Holstein cows (207 +/- 49 days in milk; mean +/- standard deviation) were either fed a GLY-contaminated total mixed ration (TMR, GLY groups, mean GLY intake 122.7 mu g/kg body weight/day) or control TMR (CON groups, mean GLY intake 1.2 mu g/kg body weight/day) for 16 weeks. Additionally, both groups were further split into subgroups fed a lower (LC, 30% on dry matter basis) or higher (HC, 60% on dry matter basis) CFP resulting in groups CONHC (n = 16), CONLC (n = 16), GLY(HC) (n = 15), GLY(LC) (n = 14). Blood parameters aspartate aminotransferase, gamma-glutamyltransferase, glutamate dehydrogenase, cholesterol, triglyceride, total protein, calcium, phosphorus, acetic acid and urea and histopathological evaluation were not influenced by GLY, whereas all mentioned parameters were at least affected by time, CFP or an interactive manner between time and CFP. Total bilirubin blood concentration was significantly influenced by an interaction between GLY and CFP with temporarily elevated concentrations in GLY(HC), whereas the biological relevance remained unclear. Gene expression analysis indicated 167 CFP-responsive genes, while seven genes showed altered expression in GLY groups compared to CON groups. Since expression changes of GLY-responsive genes were low and liver-related blood parameters changed either not at all or only slightly, the tested GLY formulation was considered to have no toxic effects on the liver of dairy cows.	[Heymann, Ann-Katrin; Schnabel, Karina; Billenkamp, Fabian; Buehler, Susanne; Frahm, Jana; Kersten, Susanne; Huether, Liane; Meyer, Ulrich; von Soosten, Dirk; Daenicke, Sven] Friedrich Loeffler Inst FLI, Inst Anim Nutr, Fed Res Inst Anim Hlth, Braunschweig, Germany; [Trakooljul, Nares] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany; [Teifke, Jens Peter] Friedrich Loeffler Inst FLI, Fed Res Inst Anim Hlth, Dept Expt Anim Facil & Bior Management, Greifswald, Germany	Friedrich Loeffler Institute; Forschungsinstitut fur Nutztierbiologie (FBN); Friedrich Loeffler Institute	Billenkamp, F (corresponding author), Friedrich Loeffler Inst FLI, Inst Anim Nutr, Fed Res Inst Anim Hlth, Braunschweig, Germany.	Fabian.Billenkamp@fli.de		Heymann, Ann-Katrin/0000-0003-1913-6795; Trakooljul, Nares/0000-0002-3214-2498; Billenkamp, Fabian/0000-0001-5415-7669; Teifke, Jens/0000-0001-7168-4970				Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; Benedetti AL, 2004, TOXICOL LETT, V153, P227, DOI 10.1016/j.toxlet.2004.04.008; Buhler S, 2016, VET IMMUNOL IMMUNOP, V179, P36, DOI 10.1016/j.vetimm.2016.07.007; Buffler M., 2019, ADV ANIMAL BIOSCIENC; Chang GJ, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0376-y; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen Yunshun, 2016, F1000Res, V5, P1438, DOI 10.12688/f1000research.8987.2; Dedeke GA, 2018, INT J TOXICOL, V37, P285, DOI 10.1177/1091581818779553; Deryugina EI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/564259; DIJKSTRA J, 1994, LIVEST PROD SCI, V39, P61, DOI 10.1016/0301-6226(94)90154-6; Drong C, 2017, J ANIM PHYSIOL AN N, V101, P791, DOI 10.1111/jpn.12494; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Eaton DL, 2010, COMPREHENSIVE TOXICOLOGY, VOL 1: GENERAL PRINCIPLES , 2ND EDITION, P1; EFSA, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4303; Fu HY, 2020, J HAZARD MATER, V387, DOI 10.1016/j.jhazmat.2019.121707; Gauvrit C, 2001, WEED RES, V41, P433, DOI 10.1046/j.1365-3180.2001.00248.x; Gene, 2004, SULT2A1 SULF FAM 2A; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Guo JF, 2017, ONCOTARGET, V8, P46769, DOI 10.18632/oncotarget.18151; Guo Y, 2015, XENOBIOTICA, V45, P586, DOI 10.3109/00498254.2015.1006300; Hackel PO, 2001, BIOL CHEM, V382, P1649, DOI 10.1515/BC.2001.200; Han HS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.122; HANSON RW, 1967, BIOCHEM J, V105, P529, DOI 10.1042/bj1050529; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jasper Raquel, 2012, Interdiscip Toxicol, V5, P133, DOI 10.2478/v10102-012-0022-5; JUNGERMANN K, 1989, PHYSIOL REV, V69, P708, DOI 10.1152/physrev.1989.69.3.708; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2019, PROTEIN SCI, V28, P1947, DOI 10.1002/pro.3715; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; KNELL AJ, 1980, J ROY COLL PHYS LOND, V14, P205; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kristensen NB, 2000, ACTA AGR SCAND A-AN, V50, P231, DOI 10.1080/090647000750069421; Krueger F., 2015, TRIM GALORE WRAPPER; Kruger M., 2013, J ENV ANAL TOXICOL, V03; Kruger M, 2014, J ENV ANAL TOXICOL, V4, P1, DOI [10.4172/2161-0525.1000210, DOI 10.4172/2161-0525.1000210]; Littell RC, 1998, J ANIM SCI, V76, P1216; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MADSEN HEL, 1978, ACTA CHEM SCAND A, V32, P79, DOI 10.3891/acta.chem.scand.32a-0079; Mao SY, 2016, ENVIRON MICROBIOL, V18, P525, DOI 10.1111/1462-2920.12724; Mertens M, 2018, ENVIRON SCI POLLUT R, V25, P5298, DOI 10.1007/s11356-017-1080-1; Mesnage R, 2018, TOXICOL REP, V5, P819, DOI 10.1016/j.toxrep.2018.08.005; Mesnage R, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0056-1; Minuti A, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12388; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; Owagboriaye F, 2019, ENVIRON SCI POLLUT R, V26, P14502, DOI 10.1007/s11356-019-04759-1; R Core Team, 2021, R LANGUAGE ENV STAT; Ramin AG, 2010, ACTA VET BRNO, V79, P369, DOI 10.2754/avb201079030369; Resnik DB, 2015, J AGR ENVIRON ETHIC, V28, P621, DOI 10.1007/s10806-015-9546-y; dos Santos APR, 2017, CHEMOSPHERE, V168, P933, DOI 10.1016/j.chemosphere.2016.10.116; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Rolf B. Melsungen, 1976, CHEM UNTERSUCHUNG; Roy B, 2011, ASIAN J ANIM VET ADV, V6, P1, DOI 10.3923/ajava.2011.1.19; Rstudio Team, 2019, RSTUDIO INTEGRATED D; Sayers E., 2010, ENTREZ PROGRAMMING U; Schnabel K, 2020, ARCH ANIM NUTR, V74, P87, DOI 10.1080/1745039X.2020.1718474; Schnabel K, 2017, ARCH ANIM NUTR, V71, P413, DOI 10.1080/1745039X.2017.1391487; Schonherr J, 2004, J AGR FOOD CHEM, V52, P6546, DOI 10.1021/jf049500s; Seralini Gilles-Eric, 2014, Environmental Sciences Europe, V26, DOI 10.1186/s12302-014-0014-5; Shi HT, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4529-9; Silva V, 2018, SCI TOTAL ENVIRON, V621, P1352, DOI 10.1016/j.scitotenv.2017.10.093; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; TIBCO Software Inc, 2020, STATISTICA DATA ANAL; Topal A, 2015, ECOTOX ENVIRON SAFE, V111, P206, DOI 10.1016/j.ecoenv.2014.09.027; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; von Soosten D, 2016, J DAIRY SCI, V99, P5318, DOI 10.3168/jds.2015-10585; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; WICK M, 1995, EXP CELL RES, V219, P527, DOI 10.1006/excr.1995.1261; Xu JQ, 2016, CHEMOSPHERE, V145, P487, DOI 10.1016/j.chemosphere.2015.11.062; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200; Zoller O, 2018, FOOD ADDIT CONTAM B, V11, P83, DOI 10.1080/19393210.2017.1419509; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	78	7	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246679	10.1371/journal.pone.0246679	http://dx.doi.org/10.1371/journal.pone.0246679			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577576	gold, Green Published			2022-12-26	WOS:000620071700039
J	Paciorek, CJ; Cogbill, CV; Peters, JA; Williams, JW; Mladenoff, DJ; Dawson, A; McLachlan, JS				Paciorek, Christopher J.; Cogbill, Charles, V; Peters, Jody A.; Williams, John W.; Mladenoff, David J.; Dawson, Andria; McLachlan, Jason S.			The forests of the midwestern United States at Euro-American settlement: Spatial and physical structure based on contemporaneous survey data	PLOS ONE			English	Article							ZERO-INFLATED POISSON; HISTORICAL LAND-USE; OLD-GROWTH; BIOMASS; REGRESSION; VEGETATION; PATTERNS; MODELS; USA	We present gridded 8 km-resolution data products of the estimated stem density, basal area, and biomass of tree taxa at Euro-American settlement of the midwestern United States during the middle to late 19th century for the states of Minnesota, Wisconsin, Michigan, Illinois, and Indiana. The data come from settlement-era Public Land Survey (PLS) data (ca. 0.8-km resolution) of trees recorded by land surveyors. The surveyor notes have been transcribed, cleaned, and processed to estimate stem density, basal area, and biomass at individual points. The point-level data are aggregated within 8 km grid cells and smoothed using a generalized additive statistical model that accounts for zero-inflated continuous data and provides approximate Bayesian uncertainty estimates. The statistical modeling smooths out sharp spatial features (likely arising from statistical noise) within areas smaller than about 200 km(2). Based on this modeling, presettlement Midwestern landscapes supported multiple dominant species, vegetation types, forest types, and ecological formations. The prairies, oak savannas, and forests each had distinctive structures and spatial distributions across the domain. Forest structure varied from savanna (averaging 27 Mg/ha biomass) to northern hardwood (104 Mg/ha) and mesic southern forests (211 Mg/ha). The presettlement forests were neither unbroken and massively-statured nor dominated by young forests constantly structured by broad-scale disturbances such as fire, drought, insect outbreaks, or hurricanes. Most forests were structurally between modern second growth and old growth. We expect the data product to be useful as a baseline for investigating how forest ecosystems have changed in response to the last several centuries of climate change and intensive Euro-American land use and as a calibration dataset for paleoecological proxy-based reconstructions of forest composition and structure for earlier time periods. The data products (including raw and smoothed estimates at the 8-km scale) are available at the LTER Network Data Portal as version 1.0.	[Paciorek, Christopher J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Cogbill, Charles, V] Harvard Univ, Harvard Forest, Petersham, MA USA; [Peters, Jody A.; McLachlan, Jason S.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Williams, John W.] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Williams, John W.] Univ Wisconsin, Ctr Climat Res, Madison, WI USA; [Mladenoff, David J.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA; [Dawson, Andria] Mt Royal Univ, Dept Gen Educ, Calgary, AB, Canada	University of California System; University of California Berkeley; Harvard University; University of Notre Dame; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Mount Royal University	Paciorek, CJ (corresponding author), Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.	paciorek@stat.berkeley.edu		Paciorek, Christopher/0000-0001-5317-968X	National Science Foundation [1241874, 1241868]	National Science Foundation(National Science Foundation (NSF))	The authors acknowledge support from the National Science Foundation (nsf.gov) from grants 1241874 (CJP, CVC, JAP, AD, JSM) and 1241868 (CVC, JWW, AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Teixeira KJ, 2018, ECOLOGY, V99, P1507, DOI 10.1002/ecy.2229; Ash JD, 2017, GLOBAL CHANGE BIOL, V23, P1305, DOI 10.1111/gcb.13429; Bengtsson MM, 2012, ISME J, V6, P2188, DOI 10.1038/ismej.2012.67; Black BA, 2006, CAN J FOREST RES, V36, P1266, DOI 10.1139/X06-027; Bouldin J, 2008, J BIOGEOGR, V35, P2000, DOI 10.1111/j.1365-2699.2008.01940.x; Bouldin J, 2010, ECOL APPL, V20, P1183; BOURDO EA, 1956, ECOLOGY, V37, P754, DOI 10.2307/1933067; Braun E.L, 1950, SOIL SCI, V71, P155, DOI [10.1097/00010694-195102000-00012, DOI 10.1097/00010694-195102000-00012]; Campbell JL, 2000, ECOSYSTEMS, V3, P185, DOI 10.1007/s100210000018; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Chojnacky DC, 2014, FORESTRY, V87, P129, DOI 10.1093/forestry/cpt053; Cogbill CV, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2187; Cogbill CV, 2002, J BIOGEOGR, V29, P1279, DOI 10.1046/j.1365-2699.2002.00757.x; Comer P.J., 2008, ATLAS EARLY MICHIGAN; Curtis JT, 1959, VEGETATION WISCONSIN; Danz NP, 2013, J VEG SCI, V24, P1129, DOI 10.1111/jvs.12028; Dawson A, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2856; Dietze MC, 2013, PLANT CELL ENVIRON, V36, P1575, DOI 10.1111/pce.12043; Finley RW, 1976, ORIGINAL VEGETATION; Fisk MC, 2002, ECOLOGY, V83, P73, DOI 10.1890/0012-9658(2002)083[0073:NSACIO]2.0.CO;2; Goring SJ, 2017, ECOL LETT, V20, P461, DOI 10.1111/ele.12747; Goring SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151935; GRIMM EC, 1984, ECOL MONOGR, V54, P291, DOI 10.2307/1942499; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Halpin CR, 2016, ECOL MONOGR, V86, P78, DOI 10.1890/15-0392.1; Hanberry BB, 2015, LANDSCAPE ECOL, V30, P1473, DOI 10.1007/s10980-015-0201-9; Hoef JMV, 2012, AM STAT, V66, P124, DOI 10.1080/00031305.2012.687494; Jenkins JC, 2003, FOREST SCI, V49, P12; JORGENSEN B, 1987, J ROY STAT SOC B MET, V49, P127; Kronenfeld BJ, 2015, ECOGRAPHY, V38, P41, DOI 10.1111/ecog.00617; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Lawrence DM, 2016, GEOSCI MODEL DEV, V9, P2973, DOI 10.5194/gmd-9-2973-2016; LINDSEY AA, 1965, BOT GAZ, V126, P155, DOI 10.1086/336312; Marschner FJ, 1946, ORIGINAL FORESTS MIC; McAndrews JH, 1988, VEGETATION HIST, P673; Munoz SE, 2014, J BIOGEOGR, V41, P2195, DOI 10.1111/jbi.12386; Paciorek CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150087; Pattison W.D., 1957, BEGINNINGS AM RECTAN; Rhemtulla JM, 2009, ECOL APPL, V19, P1061, DOI 10.1890/08-1453.1; Rhemtulla JM, 2009, P NATL ACAD SCI USA, V106, P6082, DOI 10.1073/pnas.0810076106; Rollinson CR, 2021, ECOL LETT, V24, P498, DOI 10.1111/ele.13667; Schulte LA, 2001, J FOREST, V99, P5; Schulte LA, 2007, LANDSCAPE ECOL, V22, P1089, DOI 10.1007/s10980-007-9095-5; Shea M. E., 2014, Ecological Restoration, V32, P417, DOI 10.3368/er.32.4.417; Stewart LO., 1935, PUBLIC LAND SURVEYS; Thompson JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072540; Trachsel M, 2020, QUATERNARY RES, V95, P23, DOI 10.1017/qua.2019.81; Transeau EN, 1935, ECOLOGY, V16, P423, DOI 10.2307/1930078; Tyrrell L.E., 1998, NC197 USDA FOR SERV; Vestal AG, 1926, T ILL STATE ACAD SCI, V19, P204; Waller Donald M., 2008, VANISHING PRESENT WI; White C.A., 1983, HIST RECTANGULAR SUR; Whitney GG, 1984, COASTAL WILDERNESS F; Wood S.N., 2017, GEN ADDITIVE MODELS; Wood SN, 2015, J R STAT SOC C-APPL, V64, P139, DOI 10.1111/rssc.12068; Woods KD, 2014, PEERJ, V2, DOI 10.7717/peerj.598	56	2	2	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246473	10.1371/journal.pone.0246473	http://dx.doi.org/10.1371/journal.pone.0246473			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571316	Green Published, gold			2022-12-26	WOS:000618274000035
J	Lin, KF; Fry, MY; Saladi, SM; Clemons, WM				Lin, Ku-Feng; Fry, Michelle Y.; Saladi, Shyam M.; Clemons, William M., Jr.			Molecular basis of tail-anchored integral membrane protein recognition by the cochaperone Sgt2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; RICH TETRATRICOPEPTIDE REPEAT; CYTOSOLIC QUALITY-CONTROL; UBIQUITIN-LIKE DOMAIN; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; PROSTATE-CANCER; COMPLEX; INSERTION; CHAPERONE	The targeting and insertion of tail-anchored (TA) integral membrane proteins (IMPs) into the correct membrane is critical for cellular homeostasis. The fungal protein Sgt2, and its human homolog SGTA, is the entry point for clients to the guided entry of tail-anchored protein (GET) pathway, which targets endoplasmic reticulum-bound TA IMPs. Consisting of three structurally independent domains, the C terminus of Sgt2 binds to the hydrophobic transmembrane domain (TMD) of clients. However, the exact binding interface within Sgt2 and molecular details that underlie its binding mechanism and client preference are not known. Here, we reveal the mechanism of Sgt2 binding to hydrophobic clients, including TA IMPs. Through sequence analysis, biophysical characterization, and a series of capture assays, we establish that the Sgt2 C-terminal domain is flexible but conserved and sufficient for client binding. A molecular model for this domain reveals a helical hand forming a hydrophobic groove approximately 15 A long that is consistent with our observed higher affinity for client TMDs with a hydrophobic face and a minimal length of 11 residues. This work places Sgt2 into a broader family of TPR-containing cochaperone proteins, demonstrating structural and sequence-based similarities to the DP domains in the yeast Hsp90 and Hsp70 coordinating protein, Sti1.	[Lin, Ku-Feng; Fry, Michelle Y.; Saladi, Shyam M.; Clemons, William M., Jr.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Clemons, WM (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	clemons@caltech.edu	Clemons, William M/D-1026-2009	Clemons, William M/0000-0002-0021-889X; Fry, Michelle/0000-0002-3209-5492	National Institutes of Health [GM105385, GM097572]; NIH/National Research Service Award Training Grant [GM07616]; National Science Foundation [1144469]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Research Service Award Training Grant; National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institutes of Health grants GM105385 and GM097572 (to W. M. C.), NIH/National Research Service Award Training Grant GM07616 (to S. M. S. and M. Y. F.), and a National Science Foundation Graduate Research fellowship Grant 1144469 (to S. M. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anishchenko I., 2019, IMPROVED PROTEIN STR, V13; Aviram N, 2017, J CELL SCI, V130, P4079, DOI 10.1242/jcs.204396; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Buchanan G, 2007, CANCER RES, V67, P10087, DOI 10.1158/0008-5472.CAN-07-1646; Callahan MA, 1998, J VIROL, V72, P5189, DOI 10.1128/JVI.72.6.5189-5197.1998; Chartron JW, 2012, CELL REP, V2, P1620, DOI 10.1016/j.celrep.2012.10.010; Chartron JW, 2012, CURR OPIN STRUC BIOL, V22, P217, DOI 10.1016/j.sbi.2012.03.001; Chartron JW, 2011, J BIOL CHEM, V286, P34325, DOI 10.1074/jbc.M111.277798; Chio US, 2019, CELL REP, V26, P37, DOI 10.1016/j.celrep.2018.12.035; Chio US, 2017, ANNU REV CELL DEV BI, V33, P417, DOI 10.1146/annurev-cellbio-100616-060839; Cho HJ, 2018, EMBO J, V37, DOI 10.15252/embj.201899264; Chu R, 2002, J MOL BIOL, V323, P253, DOI 10.1016/S0022-2836(02)00884-7; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Clemons WM, 1999, J MOL BIOL, V292, P697, DOI 10.1006/jmbi.1999.3090; Coto ALS, 2018, INT J BIOL MACROMOL, V118, P693, DOI 10.1016/j.ijbiomac.2018.06.123; Cziepluch C, 1998, J VIROL, V72, P4149, DOI 10.1128/JVI.72.5.4149-4156.1998; Darby JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113281; Denic V, 2012, TRENDS BIOCHEM SCI, V37, P411, DOI 10.1016/j.tibs.2012.07.004; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dupzyk A, 2017, J VIROL, V91, DOI 10.1128/JVI.00232-17; Dutta S, 2008, BIOCHEMISTRY-US, V47, P10123, DOI 10.1021/bi800758a; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; FERNANDEZPATRON C, 1995, ANAL BIOCHEM, V224, P263, DOI 10.1006/abio.1995.1039; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gristick HB, 2014, NAT STRUCT MOL BIOL, V21, P437, DOI 10.1038/nsmb.2813; Guna A, 2018, CURR BIOL, V28, pR498, DOI 10.1016/j.cub.2018.02.004; Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Leznicki P, 2015, J CELL SCI, V128, P3187, DOI 10.1242/jcs.165209; Leznicki P, 2012, P NATL ACAD SCI USA, V109, P19214, DOI 10.1073/pnas.1209997109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li Z, 2013, NAT STRUCT MOL BIOL, V20, P929, DOI 10.1038/nsmb.2608; Liou ST, 2005, ARCH BIOCHEM BIOPHYS, V435, P253, DOI 10.1016/j.abb.2004.12.020; Long P, 2012, EUR J NEUROSCI, V36, P2733, DOI 10.1111/j.1460-9568.2012.08189.x; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Martinez-Lumbreras S, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0542-3; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mock JY, 2015, P NATL ACAD SCI USA, V112, P106, DOI 10.1073/pnas.1402745112; Nelson GM, 2003, CELL STRESS CHAPERON, V8, P125, DOI 10.1379/1466-1268(2003)008<0125:COTCDR>2.0.CO;2; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pieper U, 2013, NAT STRUCT MOL BIOL, V20, P135, DOI 10.1038/nsmb.2508; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Rao M, 2016, ELIFE, V5, DOI 10.7554/eLife.21301; Reisser S, 2014, BIOPHYS J, V106, P2385, DOI 10.1016/j.bpj.2014.04.020; Rodrigo-Brenni MC, 2014, MOL CELL, V55, P227, DOI 10.1016/j.molcel.2014.05.025; Rohl A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7655; Rome ME, 2014, P NATL ACAD SCI USA, V111, pE4929, DOI 10.1073/pnas.1411284111; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shao SC, 2017, SCIENCE, V355, P298, DOI 10.1126/science.aah6130; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Simon AC, 2013, P NATL ACAD SCI USA, V110, P1327, DOI 10.1073/pnas.1207518110; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suloway CJM, 2012, EMBO J, V31, P707, DOI 10.1038/emboj.2011.433; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Trotta AP, 2013, INT J CANCER, V133, P2812, DOI 10.1002/ijc.28310; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Voorhees RM, 2015, ELIFE, V4, DOI 10.7554/eLife.07975; Waheed A. A., 2016, SCI REP-UK, V6, P1; Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wang HX, 2003, BIOCHEM BIOPH RES CO, V311, P877, DOI 10.1016/j.bbrc.2003.10.080; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Webb B., 2002, COMP PROTEIN STRUCTU, V235; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Wunderley L, 2014, J CELL SCI, V127, P4728, DOI 10.1242/jcs.155648; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu Y, 2013, J BIOL CHEM, V288, P18068, DOI 10.1074/jbc.M112.449199; Xu Y, 2012, CELL REP, V2, P1633, DOI 10.1016/j.celrep.2012.11.010; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	87	10	10	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100441	10.1016/j.jbc.2021.100441	http://dx.doi.org/10.1016/j.jbc.2021.100441			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610544	Green Published, gold, Green Accepted			2022-12-26	WOS:000672866400415
J	Tamura, K; Dejean, G; Van Petegem, F; Brumer, H				Tamura, Kazune; Dejean, Guillaume; Van Petegem, Filip; Brumer, Harry			Distinct protein architectures mediate species-specific beta-glucan binding and metabolism in the human gut microbiota	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; LIGAND-BINDING; DENSITY MODIFICATION; MIXED-LINKAGE; RECOGNITION; MODULE; BACTERIA; REVEALS; REFINEMENT; MECHANISM	Complex glycans that evade our digestive system are major nutrients that feed the human gut microbiota (HGM). The prevalence of Bacteroidetes in the HGM of populations worldwide is engendered by the evolution of polysaccharide utilization loci (PULs), which encode concerted protein systems to utilize the myriad complex glycans in our diets. Despite their crucial roles in glycan recognition and transport, cell-surface glycan-binding proteins (SGBPs) remained understudied cogs in the PUL machinery. Here, we report the structural and biochemical characterization of a suite of SGBP-A and SGBP-B structures from three syntenic beta(1,3)-glucan utilization loci (1,3GULs) from Bacteroides thetaiotaomicron (Bt), Bacteroides uniformis (Bu), and B. fluxus (Bf), which have varying specificities for distinct beta-glucans. Ligand complexes provide definitive insight into beta(1,3)-glucan selectivity in the HGM, including structural features enabling dual beta(1,3)-glucan/mixed-linkage beta(1,3)/beta(1,4)-glucan-binding capability in some orthologs. The tertiary structural conservation of SusD-like SGBPs-A is juxtaposed with the diverse architectures and binding modes of the SGBPs-B. Specifically, the structures of the trimodular BtSGBP-B and BuSGBP-B revealed a tandem repeat of carbohydrate-binding module-like domains connected by long linkers. In contrast, BfSGBP-B comprises a bimodular architecture with a distinct beta-barrel domain at the C terminus that bears a shallow binding canyon. The molecular insights obtained here contribute to our fundamental understanding of HGM function, which in turn may inform tailored microbial intervention therapies.	[Tamura, Kazune; Dejean, Guillaume; Brumer, Harry] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Tamura, Kazune; Van Petegem, Filip; Brumer, Harry] Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Inst, Vancouver, BC, Canada; [Brumer, Harry] Univ British Columbia, Dept Chem, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Brumer, H (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada.; Brumer, H (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Inst, Vancouver, BC, Canada.; Brumer, H (corresponding author), Univ British Columbia, Dept Chem, Vancouver, BC, Canada.	brumer@msl.ubc.ca	Dejean, Guillaume/AAU-8207-2021; Van petegem, Filip/M-6061-2016	Tamura, Kazune/0000-0003-4393-5554; Dejean, Guillaume/0000-0003-1950-5693; Van petegem, Filip/0000-0003-2728-8537; Brumer, Harry/0000-0002-0101-862X	Canadian Institutes of Health Research [MOP-119404, MOP-137134, MOP-142472]; Canadian Foundation for Innovation [30663]; British Columbia Knowledge Development Fund; University of British Columbia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; University of British Columbia	Work in the Brumer Lab was supported by operating grants from the Canadian Institutes of Health Research (MOP-137134 and MOP-142472) and infrastructure support from the Canadian Foundation for Innovation (Project #30663) and the British Columbia Knowledge Development Fund. Work in the Van Petegem Lab was supported by the Canadian Institutes of Health Research (MOP-119404). K. T. was partially supported by a 4-year doctoral fellowship from the University of British Columbia.	Abbott W, 2018, GLYCOBIOLOGY, V28, P3, DOI 10.1093/glycob/cwx089; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; Bacic A, 2009, CHEMISTRY, BIOCHEMISTRY, AND BIOLOGY OF (1-->3)-BETA-GLUCANS AND RELATED POLYSACCHARIDES, P1; Bolam DN, 2012, CURR OPIN STRUC BIOL, V22, P563, DOI 10.1016/j.sbi.2012.06.006; Boraston AB, 2003, J MOL BIOL, V327, P659, DOI 10.1016/S0022-2836(03)00152-9; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P14679, DOI 10.1021/bi015760g; Briliute J, 2019, NAT MICROBIOL, V4, P1571, DOI 10.1038/s41564-019-0466-x; Cameron EA, 2014, MBIO, V5, DOI 10.1128/mBio.01441-14; Cameron EA, 2012, J BIOL CHEM, V287, P34614, DOI 10.1074/jbc.M112.397380; Cartmell A, 2018, NAT MICROBIOL, V3, P1314, DOI 10.1038/s41564-018-0258-8; Cartmell A, 2017, P NATL ACAD SCI USA, V114, P7037, DOI 10.1073/pnas.1704367114; Cockburn D, 2017, METHODS MOL BIOL, V1588, P119, DOI 10.1007/978-1-4939-6899-2_9; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Davies G. J., 2008, BIOCHEMIST, V30, P26, DOI DOI 10.1042/BJ20080382; Dejean G, 2020, MBIO, V11, DOI 10.1128/mBio.00095-20; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; El Khoury D, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/851362; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ficko-Blean E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01832-6; Foley MH, 2018, MOL MICROBIOL, V108, P551, DOI 10.1111/mmi.13949; Fujimura KE, 2015, CELL HOST MICROBE, V17, P592, DOI 10.1016/j.chom.2015.04.007; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Glenwright AJ, 2017, NATURE, V541, P407, DOI 10.1038/nature20828; Gray DA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20285-y; Grondin JM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00860-16; Gunness P, 2016, FASEB J, V30, P4227, DOI 10.1096/fj.201600465R; Hehemann JH, 2012, P NATL ACAD SCI USA, V109, P19786, DOI 10.1073/pnas.1211002109; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hemsworth GR, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160142; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Hettle AG, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0721-y; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karunatilaka K, 2013, BIOPHYS J, V104, p526A, DOI 10.1016/j.bpj.2012.11.2909; Kolodziejczyk AA, 2019, NAT REV MICROBIOL, V17, P742, DOI 10.1038/s41579-019-0256-8; Koropatkin N, 2009, BIOCHEMISTRY-US, V48, P1532, DOI 10.1021/bi801942a; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lazaridou A, 2004, FOOD HYDROCOLLOID, V18, P837, DOI 10.1016/j.foodhyd.2004.01.002; Legentil L, 2015, MOLECULES, V20, P9745, DOI 10.3390/molecules20069745; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luis AS, 2018, NAT MICROBIOL, V3, P210, DOI 10.1038/s41564-017-0079-1; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Mystkowska AA, 2018, FEBS J, V285, P4465, DOI 10.1111/febs.14674; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Nilsson U, 2008, EUR J CLIN NUTR, V62, P978, DOI 10.1038/sj.ejcn.1602816; Pires VMR, 2004, J BIOL CHEM, V279, P21560, DOI 10.1074/jbc.M401599200; Pluvinage B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03366-x; Porter NT, 2017, ANNU REV MICROBIOL, V71, P349, DOI 10.1146/annurev-micro-102215-095316; Potterton L, 2018, ACTA CRYSTALLOGR D, V74, P68, DOI 10.1107/S2059798317016035; Ribeiro DO, 2020, FEBS J, V287, P2723, DOI 10.1111/febs.15162; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Tamura K, 2021, CURR OPIN STRUC BIOL, V68, P26, DOI 10.1016/j.sbi.2020.11.001; Tamura K, 2019, CELL MOL LIFE SCI, V76, P4319, DOI 10.1007/s00018-019-03115-3; Tamura K, 2017, CELL REP, V21, P417, DOI 10.1016/j.celrep.2017.09.049; Tauzin AS, 2016, MBIO, V7, DOI 10.1128/mBio.02134-15; Taylor ME, 2014, CURR OPIN STRUC BIOL, V28, P14, DOI 10.1016/j.sbi.2014.07.003; Temple MJ, 2017, J BIOL CHEM, V292, P10639, DOI 10.1074/jbc.M117.787606; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Tuson HH, 2018, BIOPHYS J, V115, P242, DOI 10.1016/j.bpj.2017.12.015; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Yaoi K, 2004, STRUCTURE, V12, P1209, DOI 10.1016/j.str.2004.04.020; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zmora N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1815; Zmora N, 2019, NAT REV GASTRO HEPAT, V16, P35, DOI 10.1038/s41575-018-0061-2	90	5	5	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100415	10.1016/j.jbc.2021.100415	http://dx.doi.org/10.1016/j.jbc.2021.100415			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33587952	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400389
J	Miller, ZD; Freimund, W; Dalenberg, D; Vega, M				Miller, Zachary D.; Freimund, Wayne; Dalenberg, Douglas; Vega, Madison			Observing COVID-19 related behaviors in a high visitor use area of Arches National Park	PLOS ONE			English	Article								Introduction Visitation to parks and protected areas is a common COVID-19 coping strategy promoted by state and national public health officials and political leadership. Crowding and congestions in parks has been a perennial problem and the ability to socially distance within them is an unproven assumption. Is it possible to socially distance in a busy national park that has been designed to concentrate use? Methodology/Principal findings An observational study was conducted in July 2020 at the outside foyer of the Visitor Center of Arches National Park. Motion sensor cameras were placed to record one-minute videos when a person entered the field of view. Number of groups, group size, facial coverings and encounters within 6 feet (1.83 meters) of other groups were recorded. Groups were smaller on average than recorded in previous studies. Approximately 61% of the visitors wore masks. Most groups (69%) were able to experience the visitor center with no intergroup encounters. We model the probability of intergroup encounters and find as group size and number of groups increases, the probability of encounters rises. With four groups present, the probability of one or more encounters ranges from 19% to 40% for common group sizes, while if eight groups are present, the probability of one or more encounters increases from 34% to 64% for common group sizes. Conclusions/Significance Under conditions in which park visitors have the physical space to avoid close encounters with other groups they are taking advantage of the opportunity. Visitors are minimizing group size, wearing masks, and remaining socially distant. However, encounters increase as the number or the size of the groups increases. In other areas of the parks this ability to avoid encounters may not be as possible. We recommend that park managers continue to appeal for compliance with CDC guidelines, especially the wearing of masks and encouraging visitors to split up into small groups when visiting.	[Miller, Zachary D.; Vega, Madison] Utah State Univ, Dept Environm & Soc, Logan, UT 84322 USA; [Miller, Zachary D.; Freimund, Wayne] Utah State Univ, Inst Outdoor Recreat & Tourism, Logan, UT 84322 USA; [Miller, Zachary D.; Freimund, Wayne] Utah State Univ, Ecol Ctr, Logan, UT 84322 USA; [Freimund, Wayne] Utah State Univ, Dept Environm & Soc, Moab, UT USA; [Dalenberg, Douglas] Univ Montana, Dept Econ, Missoula, MT 59812 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Montana System; University of Montana	Miller, ZD (corresponding author), Utah State Univ, Dept Environm & Soc, Logan, UT 84322 USA.; Miller, ZD (corresponding author), Utah State Univ, Inst Outdoor Recreat & Tourism, Logan, UT 84322 USA.; Miller, ZD (corresponding author), Utah State Univ, Ecol Ctr, Logan, UT 84322 USA.	zachary.miller@usu.edu						Board of Health In and For Southeast Utah Health Department, 2020, COVID 19 PAND UT; Brune M., 2020, PULLING OUR MONUMENT; CDC Centers for Disease Control and Prevention-USA, 2020, VISITING PARKS RECRE; Lawson SR, 2003, J ENVIRON MANAGE, V68, P305, DOI 10.1016/S0301-4797(03)00094-X; Leaver J, 2020, STATE UTAHS TRAVEL T; Manning RE, 1995, G WRIGHT FORUM, V12, P41; Muir J., 1901, OUR NATL PARKS; National Park Service, 2020, NPS PUBLIC HLTH UPDA; Podmore Z., 2020, CROWDS CAUSE ARCHES; Rice W. L., 2020, Recreation, Parks and Tourism in Public Health, V4, P5, DOI 10.2979/rptph.4.1.02; Rott N., 2020, WE HAD GET OUTDESPIT; RSG Environmental Consulting, 2017, ARCH NAT PARK VIS ST; Wiley M, 2020, WHAT 10 MOST VISITED	13	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247315	10.1371/journal.pone.0247315	http://dx.doi.org/10.1371/journal.pone.0247315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617574	Green Published, gold			2022-12-26	WOS:000623082400020
J	Dobos, RR; Benedict, K; Jackson, BR; McCotter, OZ				Dobos, Robert R.; Benedict, Kaitlin; Jackson, Brendan R.; McCotter, Orion Z.			Using soil survey data to model potential Coccidioides soil habitat and inform Valley fever epidemiology	PLOS ONE			English	Article							CLIMATE	Coccidioidomycosis, also known as Valley fever, is a disease that can result in substantial illness and death. It is most common in the southwestern United States and areas of Latin America with arid climates, though reports increasingly suggest its range is wider than previously recognized. The natural habitat of the causative organisms, Coccidioides spp., have been associated with certain soil properties and climatic conditions. Current understanding of its geographic range is primarily defined by skin test studies and outbreak locations. We developed a fuzzy system model to predict suitable soil habitats for Coccidioides across the western United States based on parameters (electrical conductivity, organic matter content, pH, water holding capacity, temperature, and precipitation) from sites where soil sampling has confirmed the presence of Coccidioides. The model identified high coccidioidomycosis incidence areas as having high suitability and identified pockets of elevated suitability corresponding with outbreak locations outside the traditional range. By providing high-resolution estimates of Coccidioides suitability, including areas without public health surveillance for coccidioidomycosis, this model may be able to aid public health and clinical provider decision making. Awareness of possible Coccidioides soil habitats could help mitigate risk during soil-disturbing activities and help providers improve coccidioidomycosis diagnosis and treatment.	[Dobos, Robert R.] USDA, Soil & Plant Sci Div, Nat Resources Conservat Serv, Washington, DC 20250 USA; [Benedict, Kaitlin; Jackson, Brendan R.; McCotter, Orion Z.] Ctr Dis Control & Prevent, Atlanta, GA USA; [McCotter, Orion Z.] Oregon Hlth Author, Salem, OR USA	United States Department of Agriculture (USDA); Centers for Disease Control & Prevention - USA	Dobos, RR (corresponding author), USDA, Soil & Plant Sci Div, Nat Resources Conservat Serv, Washington, DC 20250 USA.	Bob.dobos@usda.gov						ALBERT BL, 1963, ARCH INTERN MED, V112, P253, DOI 10.1001/archinte.1963.03860020151021; [Anonymous], [No title captured]; Baptista-Rosas RC, 2007, ANN NY ACAD SCI, V1111, P35, DOI 10.1196/annals.1406.003; Benedict K, 2019, MMWR SURVEILL SUMM, V68, P1, DOI 10.15585/mmwr.ss6807a1; Bowers JR, 2019, MED MYCOL, V57, P246, DOI 10.1093/mmy/myy007; CDC, AVERAGE INCIDENCE RE; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P1005; Colson AJ, 2017, MYCOPATHOLOGIA, V182, P439, DOI 10.1007/s11046-016-0105-5; Comrie AC, 2005, ENVIRON HEALTH PERSP, V113, P688, DOI 10.1289/ehp.7786; Comrie AC, 2007, ANN NY ACAD SCI, V1111, P83, DOI 10.1196/annals.1406.024; Coopersmith EJ, 2017, GEOHEALTH, V1, P51, DOI 10.1002/2016GH000033; Cox E, 1994, FUZZY SYSTEMS HDB PR; EDWARDS PQ, 1957, DIS CHEST, V31, P35, DOI 10.1378/chest.31.1.35; EGEBERG RO, 1956, AM J MED SCI, V231, P151, DOI 10.1097/00000441-195623120-00005; EGEBERG RO, 1964, J BACTERIOL, V88, P473, DOI 10.1128/JB.88.2.473-476.1964; ELCONIN AF, 1964, J BACTERIOL, V87, P500, DOI 10.1128/JB.87.3.500-503.1964; Fisher FS, 2007, ANN NY ACAD SCI, V1111, P47, DOI 10.1196/annals.1406.031; Fisher FS, 2000, OPERATIONAL GUIDELIN; Fortner J, 2012, HOSSRM ENV ASPECTS, P28; Freedman M, 2018, EMERG INFECT DIS, V24, P417, DOI 10.3201/eid2403.170623; Gautam R, 2013, ZOONOSES PUBLIC HLTH, V60, P174, DOI 10.1111/j.1863-2378.2012.01526.x; Gorris ME, 2018, GEOHEALTH, V2, P6, DOI 10.1002/2017GH000095; Health KCDoP, KERN COUNTY INCIDENC; Johnson SM, 2014, MED MYCOL, V52, P610, DOI 10.1093/mmy/myu004; Kolivras KN, 2001, AEROBIOLOGIA, V17, P31, DOI DOI 10.1023/A:1007619813435; Lauer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111921; Lauer A, 2012, MYCOLOGIA, V104, P62, DOI 10.3852/11-127; Li WSC, 2015, J PRIM HEALTH CARE, V5; Litvintseva AP, 2015, CLIN INFECT DIS, V60, pE1, DOI 10.1093/cid/ciu681; MADDY K T, 1958, Ariz Med, V15, P178; MADDY KT, 1954, J AM VET MED ASSOC, V124, P456; MADDY KT, 1960, PUBLIC HEALTH REP, V75, P955, DOI 10.2307/4590968; Marsden-Haug N, 2013, CLIN INFECT DIS, V56, P847, DOI 10.1093/cid/cis1028; McBratney AB, 1997, GEODERMA, V77, P85, DOI 10.1016/S0016-7061(97)00017-7; Morrow W, 2006, MYCOLOGIA, V98, P669, DOI 10.3852/mycologia.98.5.669; Paetzold R, 2002, TEMPERATURE REGIME S; Petersen LR, 2004, EMERG INFECT DIS, V10, P637, DOI 10.3201/eid1004.030446; Plunkett OA, 1965, 2 S COCC PHOEN AZ; RICHARDSON JL, 1992, GEODERMA, V53, P65, DOI 10.1016/0016-7061(92)90021-X; Schneider E, 1997, JAMA-J AM MED ASSOC, V277, P904, DOI 10.1001/jama.277.11.904; Schofield R, 2001, LAND DEGRAD DEV, V12, P163, DOI 10.1002/ldr.446; SOIL SURVEY STAFF, 1999, SOIL TAX BAS SYST SO, V2nd; Staff SS, 2018, SOIL HABITAT SAPROPH; Staff SS, 2018, GRIDDED SOIL SURVEY; SWATEK FE, 1970, MYCOPATH MYCOL APPL, V41, P3, DOI 10.1007/BF02051479; Talamantes J, 2007, ANN NY ACAD SCI, V1111, P73, DOI 10.1196/annals.1406.028; Taylor JW, 2019, MED MYCOL, V57, pS16, DOI 10.1093/mmy/myy039; Weaver E, 2020, SPAT SPATIO-TEMPORAL, V32, DOI 10.1016/j.sste.2019.100317; Weaver EA, 2018, ECOHEALTH, V15, P840, DOI 10.1007/s10393-018-1375-9; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	50	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247263	10.1371/journal.pone.0247263	http://dx.doi.org/10.1371/journal.pone.0247263			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606807	gold, Green Published			2022-12-26	WOS:000620629200095
J	Hallakou-Bozec, S; Kergoat, M; Fouqueray, P; Bolze, S; Moller, DE				Hallakou-Bozec, Sophie; Kergoat, Micheline; Fouqueray, Pascale; Bolze, Sebastien; Moller, David E.			Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action	PLOS ONE			English	Article								Pancreatic islet beta-cell dysfunction is characterized by defective glucose-stimulated insulin secretion (GSIS) and is a predominant component of the pathophysiology of diabetes. Imeglimin, a novel first-in-class small molecule tetrahydrotriazine drug candidate, improves glycemia and GSIS in preclinical models and clinical trials in patients with Type 2 diabetes; however, the mechanism by which it restores beta-cell function is unknown. Here, we show that imeglimin acutely and directly amplifies GSIS in islets isolated from rodents with Type 2 diabetes via a mode of action that is distinct from other known therapeutic approaches. The underlying mechanism involves increases in the cellular nicotinamide adenine dinucleotide (NAD(+)) pool-potentially via the salvage pathway and induction of nicotinamide phosphoribosyltransferase (NAMPT) along with augmentation of glucose-induced ATP levels. Further, additional results suggest that NAD(+) conversion to a second messenger, cyclic ADP ribose (cADPR), via ADP ribosyl cyclase/cADPR hydrolase (CD38) is required for imeglimin's effects in islets, thus representing a potential link between increased NAD(+) and enhanced glucose-induced Ca2+ mobilization which-in turn-is known to drive insulin granule exocytosis. Collectively, these findings implicate a novel mode of action for imeglimin that explains its ability to effectively restore-beta-cell function and provides for a new approach to treat patients suffering from Type 2 diabetes.	[Hallakou-Bozec, Sophie; Fouqueray, Pascale; Bolze, Sebastien; Moller, David E.] Poxel SA, Lyon, France; [Kergoat, Micheline] Metabrain Res, Maisons Alfort, France	Ecole Nationale Veterinaire d'Alfort (ENVA)	Moller, DE (corresponding author), Poxel SA, Lyon, France.	david.moller@poxelpharma.com			Poxel SA; Metabrain	Poxel SA; Metabrain	Authors S H-B, PF, SB and DM are salaried employees of Poxel SA which funded the work described in this manuscript. The funder provided support in the form of research materials (supply of compound) and paying for research costs -including supplies and materials for animal care, equipment maintenance and reagents -paid according to a contract to Metabrain Research (Maisons Alfort, France). Author MK is a salaried employee of Metabrain Research; a portion of her salary was paid by the funder via the sponsored research contract between Poxel SA and Metabrain. The funder also provided salaries for authors S H-B, PF, SB and DM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of each of these authors are articulated in the `author contributions' section.	Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; BURR IM, 1971, J CLIN INVEST, V50, P1444, DOI 10.1172/JCI106628; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; DEERY DJ, 1973, BIOCHEM J, V134, P557, DOI 10.1042/bj1340557; DEFRONZO RA, 1991, J CLIN ENDOCR METAB, V73, P1294, DOI 10.1210/jcem-73-6-1294; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Drucker DJ, 2018, CELL METAB, V27, P740, DOI 10.1016/j.cmet.2018.03.001; Efanov AM, 2001, DIABETES, V50, P797, DOI 10.2337/diabetes.50.4.797; Efendic S, 2002, DIABETES, V51, pS448, DOI 10.2337/diabetes.51.2007.S448; Fouqueray P, 2014, DIABETES CARE, V37, P1924, DOI 10.2337/dc13-2349; Fouqueray P, 2013, DIABETES CARE, V36, P565, DOI 10.2337/dc12-0453; Fouqueray P, 2011, J DIABETES METAB, V2, DOI 10.4172/2155-6156.1000126; GIROIX MH, 1993, ENDOCRINOLOGY, V132, P815, DOI 10.1210/en.132.2.815; Graves TK, 2003, ENDOCRINOLOGY, V144, P3565, DOI 10.1210/en.2002-0104; Haythorne E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10189-x; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Islam MS, 1997, DIABETOLOGIA, V40, P1480, DOI 10.1007/s001250050853; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Kahn SE, 2009, DIABETOLOGIA, V52, P1003, DOI 10.1007/s00125-009-1321-z; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kang GX, 2003, J PHYSIOL-LONDON, V546, P175, DOI 10.1113/jphysiol.2002.029959; KATO I, 1995, J BIOL CHEM, V270, P30045, DOI 10.1074/jbc.270.50.30045; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Katsyuba E, 2020, NAT METAB, V2, P9, DOI 10.1038/s42255-019-0161-5; Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6; Kover K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058767; LEE HC, 1989, J BIOL CHEM, V264, P1608; Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018; Ma ZA, 2012, EXP DIABETES RES, DOI 10.1155/2012/703538; MacDonald PE, 2007, PLOS BIOL, V5, P1236, DOI 10.1371/journal.pbio.0050143; Meloni AR, 2013, DIABETES OBES METAB, V15, P15, DOI 10.1111/j.1463-1326.2012.01663.x; MESZAROS LG, 1993, NATURE, V364, P76, DOI 10.1038/364076a0; Okamoto H, 1997, DIABETOLOGIA, V40, P1485, DOI 10.1007/s001250050854; OTONKOSKI T, 1993, J CLIN INVEST, V92, P1459, DOI 10.1172/JCI116723; Pacini G, 2015, DIABETES OBES METAB, V17, P541, DOI 10.1111/dom.12452; Park DR, 2015, DIABETES, V64, P1224, DOI 10.2337/db14-0939; Perry RJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE461, DOI 10.1152/ajpendo.00009.2016; Petrelli R, 2011, CURR MED CHEM, V18, P1973, DOI 10.2174/092986711795590048; Pirags V, 2012, DIABETES OBES METAB, V14, P852, DOI 10.1111/j.1463-1326.2012.01611.x; PORTHA B, 1974, DIABETES, V23, P889, DOI 10.2337/diab.23.11.889; PORTHA B, 1979, DIABETOLOGIA, V17, P371, DOI 10.1007/BF01236272; Portha Bernard, 2012, Methods Mol Biol, V933, P125, DOI 10.1007/978-1-62703-068-7_9; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Sasaki M, 2013, DIABETES, V62, P1996, DOI 10.2337/db12-0903; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; TSUURA Y, 1993, DIABETES, V42, P1446, DOI 10.2337/diabetes.42.10.1446; Vial G, 2015, DIABETES, V64, P2254, DOI 10.2337/db14-1220; Yajima H, 1999, DIABETES, V48, P1006, DOI 10.2337/diabetes.48.5.1006; Yamashita H, 2016, SCI REP-UK, V6, DOI 10.1038/srep33003; ZAWALICH WS, 1979, HORM METAB RES, V11, P469, DOI 10.1055/s-0028-1092763; Zhao YJ, 2015, BBA-MOL CELL RES, V1853, P2095, DOI 10.1016/j.bbamcr.2014.10.028; Zhao YJ, 2012, ACTA BIOCH BIOPH SIN, V44, P719, DOI 10.1093/abbs/gms044	58	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0241651	10.1371/journal.pone.0241651	http://dx.doi.org/10.1371/journal.pone.0241651			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606677	gold, Green Submitted, Green Published			2022-12-26	WOS:000620629200031
J	Humphrey, G; Dobson, R; Parag, V; Hiemstra, M; Howie, S; Marsh, S; Morton, S; Mordaunt, D; Wadham, A; Bullen, C				Humphrey, Gayl; Dobson, Rosie; Parag, Varsha; Hiemstra, Marion; Howie, Stephen; Marsh, Samantha; Morton, Susan; Mordaunt, Dylan; Wadham, Angela; Bullen, Chris			See How They Grow: Testing the feasibility of a mobile app to support parents' understanding of child growth charts	PLOS ONE			English	Article							WEIGHT STATUS; MOTHERS PERCEPTIONS; HEALTHY GROWTH; BODY-WEIGHT; OBESITY; OVERWEIGHT; PROGRAM; INFANCY; GAIN	Background Mobile devices provide new opportunities for the prevention of overweight and obesity in children. We aimed to co-create and test an app that offered comprehensible feedback to parents on their child's growth and delivered a suite of age-specific information about nutrition and activity. Methods A two-phased approach was used to co-create the digital growth tool-See How They Grow-and test its feasibility. Phase one used focus groups (parents and professionals such as paediatricians and midwives) and a national on-line survey to gather requirements and build the app. Phase two involved testing the app over 12-weeks, with parents or carers of children aged <= 2-years. All research activities were undertaken exclusively through the app, and participants were recruited using social media and hard copy materials given to patents at a child health visit. Findings Four focus groups and 101 responses to the national survey informed the features and functions to include in the final app. Two hundred and twenty-five participants downloaded the app, resulting in 208 eligible participants. Non-Maori/Non-Pacific (78%) and Maori (14%) had the highest downloads. Fifty-four per cent of participants were parents of children under 6-months. These participants were more likely to regularly use the app than those with children older than 6-months (64% vs 36%, P = 0.011). Over half of the participants entered three measures (n = 101, 48%). Of those that completed the follow-up survey (n = 101, 48%), 72 reported that the app helped them better understand how to interpret growth charts. Conclusion The app was acceptable and with minor modifications, has the potential to be an effective tool to support parents understanding of growth trajectories for their children. A larger trial is needed to evaluate if the app can have a measurable impact on increasing knowledge and behaviour, and therefore on preventing childhood overweight and obesity.	[Humphrey, Gayl; Dobson, Rosie; Parag, Varsha; Marsh, Samantha; Wadham, Angela; Bullen, Chris] Univ Auckland, Fac Med & Hlth Sci, Natl Inst Hlth Innovat, Auckland, New Zealand; [Hiemstra, Marion] Natl Educ, Plunket, Auckland, New Zealand; [Howie, Stephen] Univ Auckland, Fac Med & Hlth Sci, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Morton, Susan] Univ Auckland, Fac Med & Hlth Sci, Growing New Zealand, Auckland, New Zealand; [Mordaunt, Dylan] Univ Adelaide, Adelaide, SA, Australia; [Mordaunt, Dylan] Flinders Univ S Australia, Adelaide, SA, Australia	University of Auckland; University of Auckland; University of Auckland; University of Adelaide; Flinders University South Australia	Humphrey, G (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Natl Inst Hlth Innovat, Auckland, New Zealand.	g.humphrey@auckland.ac.nz	Marsh, Samantha/AEQ-0515-2022; Bullen, Chris/E-4594-2017; Mordaunt, Dylan A/B-1022-2012	Marsh, Samantha/0000-0001-8129-0350; Bullen, Chris/0000-0001-6807-2930; Mordaunt, Dylan A/0000-0002-9775-0603; Dobson, Rosie/0000-0003-0122-1000	New Zealand Cure Kids; National Science Challenge: a Better Start; Precision Driven Health [7006]	New Zealand Cure Kids; National Science Challenge: a Better Start; Precision Driven Health	This study was funded through a contestable funding round by New Zealand Cure Kids (https://curekids.org.nz/), the National Science Challenge: a Better Start (https://www.abetterstart.nz/) and Precision Driven Health (https://precisiondrivenhealth.com/), grant reference 7006. The funders had no influence on the design, implementation, interpretation or reporting of the study findings.	Abroms LC, 2015, JMIR MHEALTH UHEALTH, V3, DOI [10.2196/mhealth.4917, 10.2196/mhealth.3846]; Ansari Z, DESIGN EFFECTIVE CHI; Appleton J, 2017, CONTEMP NURSE, V53, P410, DOI 10.1080/10376178.2017.1358650; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Baur LA, 2018, NAT REV ENDOCRINOL, V15, P5, DOI 10.1038/s41574-018-0131-0; Ben-Joseph EP, 2007, PATIENT EDUC COUNS, V65, P288, DOI 10.1016/j.pec.2006.09.001; Ben-Joseph EP, 2009, PEDIATRICS, V124, P1100, DOI 10.1542/peds.2008-0797; Blake-Lamb TL, 2016, AM J PREV MED, V50, P780, DOI 10.1016/j.amepre.2015.11.010; Brown T, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001871.pub4; Burke MA, 2010, OBESITY, V18, P1226, DOI 10.1038/oby.2009.369; Butler EM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225212; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Denney-Wilson E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009258; Dobson Rosie, 2017, JMIR Mhealth Uhealth, V5, pe49, DOI 10.2196/mhealth.7205; Freyne J, 2017, INT J HUM-COMPUT INT, V33, P833, DOI 10.1080/10447318.2017.1289725; Gallegos D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0374-2; Glavin K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-160; Glover M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092145; Hankey C., 2018, ADV NUTR DIETETICS O; Jeffery AN, 2015, CHILD CARE HLTH DEV, V41, P434, DOI 10.1111/cch.12167; Jones AR, 2011, INT J OBESITY, V35, P953, DOI 10.1038/ijo.2011.106; Kickbusch I., 2005, NAVIGATING HLTH ROLE; Lakshman R, 2012, CHILD CARE HLTH DEV, V38, P675, DOI 10.1111/j.1365-2214.2011.01283.x; Laraway KA, 2010, CLIN PEDIATR, V49, P343, DOI 10.1177/0009922809343717; Lundahl A, 2014, PEDIATRICS, V133, pE689, DOI 10.1542/peds.2013-2690; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Manios Y, 2015, PUBLIC HEALTH NUTR, V18, P2183, DOI 10.1017/S136898001400305X; McKee C, 2016, J PEDIATR NURS, V31, P196, DOI 10.1016/j.pedn.2015.10.003; Mead E, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012651; Michie S., 2014, GREAT BRITAIN; Michie S, 2011, PSYCHOL HEALTH, V26, P1479, DOI 10.1080/08870446.2010.540664; Miller JC, 2007, OBESITY, V15, P165, DOI 10.1038/oby.2007.558; Ministry of Health, 2010, WELL CHILD TAM OR MY; Nnyanzi LA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3481-3; Parkinson KN, 2017, INT J OBESITY, V41, P801, DOI 10.1038/ijo.2017.20; Pryke R, 2018, BRIT J GEN PRACT, V68, P358, DOI 10.3399/bjgp18X698009; Pryor LE, 2011, ARCH PEDIAT ADOL MED, V165, P906, DOI 10.1001/archpediatrics.2011.153; Public Health England, 2017, PATT TRENDS CHILD OB; Sachs M, 2012, CHILD CARE HLTH DEV, V38, P435, DOI 10.1111/j.1365-2214.2011.01256.x; Shackleton N, 2019, INT J OBESITY, V43, P1951, DOI 10.1038/s41366-019-0390-4; Taki Sarah, 2017, JMIR Mhealth Uhealth, V5, pe89, DOI 10.2196/mhealth.7236; Templin T, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002968; Turner T, 2015, PEDIATR OBES, V10, P403, DOI 10.1111/ijpo.12002; Valencia AC, 2016, MATERN CHILD HLTH J, V20, P525, DOI 10.1007/s10995-015-1850-7; Wang YF, 2017, ADV NUTR, V8, P436, DOI 10.3945/an.116.013235; Webster J, 1996, AUST NZ J OBSTET GYN, V36, P11, DOI 10.1111/j.1479-828X.1996.tb02912.x; World Health Organisation, 2018, WHO REC HOM BAS REC WHO REC HOM BAS REC; World Health Organisation , 2017, WHONMHPNDECHO171	49	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246045	10.1371/journal.pone.0246045	http://dx.doi.org/10.1371/journal.pone.0246045			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606687	Green Published, gold			2022-12-26	WOS:000620629200163
J	Hwang, YM; Na, Y; Pyun, SB				Hwang, Yu Mi; Na, Yoonhye; Pyun, Sung-Bom			Development of a categorical naming test in Korean: Standardization and clinical application for patients with stroke	PLOS ONE			English	Article								Purpose The purpose of this study was to develop and standardize a new categorical naming test, titled the Categorical Naming Test (CNT), for stroke patients, and to investigate its validity and clinical usefulness for patients with stroke. Materials and methods The CNT was developed based on semantic category, imageability, and psycholinguistic factors such as word frequency and word length. The test materials included two main semantic categories (living objects and artificial objects) comprising 60 items. We standardized the CNT on 221 healthy adults and administered the CNT to 112 stroke patients. Results Internal consistency and concurrent validity of the test were high. The mean total CNT scores varied significantly according to participants' age, sex, and education. Among healthy controls, the scores for naming living objects were significantly higher than those for artificial objects. The analysis of stroke patients showed that the total CNT score revealed a statistically significant difference based on the patients' lesion laterality and presence of aphasia, after controlling for age, sex, and education. However, the categorical scores achieved by comparing the naming scores for living and artificial objects showed no significant differences according to lesion laterality, stroke type, and presence of aphasia. Conclusion The CNT is a newly developed version of an overt naming task with high internal consistency validity for stroke patients in Korea. The newly developed CNT can prove useful in evaluating naming ability in stroke patients.	[Hwang, Yu Mi; Na, Yoonhye; Pyun, Sung-Bom] Korea Univ, Brain Convergence Res Ctr, Coll Med, Seoul, South Korea; [Na, Yoonhye] Korea Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Pyun, Sung-Bom] Korea Univ, Dept Phys Med & Rehabil, Coll Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Pyun, SB (corresponding author), Korea Univ, Brain Convergence Res Ctr, Coll Med, Seoul, South Korea.; Pyun, SB (corresponding author), Korea Univ, Dept Phys Med & Rehabil, Coll Med, Seoul, South Korea.	rmpyun@korea.ac.kr	Pyun, Sung-Bom/ADY-9496-2022	Pyun, Sung-Bom/0000-0002-1933-038X	National Research Foundation of Korea - Korean government (MSIT) [2019R1A2C2003020]	National Research Foundation of Korea - Korean government (MSIT)	This work was supported by the National Research Foundation of Korea funded by the Korean government (MSIT) (No. 2019R1A2C2003020).	Ardila A, 2007, ARCH CLIN NEUROPSYCH, V22, P297, DOI 10.1016/j.acn.2007.01.016; BASSO A, 1988, J NEUROL NEUROSUR PS, V51, P1201, DOI 10.1136/jnnp.51.9.1201; BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; Benson D.F., 1996, APHASIA CLIN PERSPEC; Bradshaw AR, 2017, PEERJ, V5, DOI 10.7717/peerj.3929; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; CARAMAZZA A, 1990, COGNITIVE NEUROPSYCH, V7, P161, DOI 10.1080/02643299008253441; Coppens P, 2005, BRAIN LANG, V94, P61, DOI 10.1016/j.bandl.2004.11.008; Cree GS, 2003, J EXP PSYCHOL GEN, V132, P163, DOI 10.1037/0096-3445.132.2.163; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; de la Plata CM, 2008, CLIN NEUROPSYCHOL, V22, P288, DOI 10.1080/13854040701250470; Devlin JT, 1998, J COGNITIVE NEUROSCI, V10, P77, DOI 10.1162/089892998563798; Dixon M, 1997, COGNITIVE NEUROPSYCH, V14, P1085, DOI 10.1080/026432997381286; Ellis A. W., 2013, HUMAN COGNITIVE NEUR; FARAH MJ, 1991, J EXP PSYCHOL GEN, V120, P339, DOI 10.1037/0096-3445.120.4.339; Fukatsu R, 1999, NEUROLOGY, V52, P1096, DOI 10.1212/WNL.52.5.1096; FUNNELL E, 1992, COGNITIVE NEUROPSYCH, V9, P135, DOI 10.1080/02643299208252056; Gollan TH, 2012, BILING-LANG COGN, V15, P594, DOI 10.1017/S1366728911000332; Goodglass H., 1997, ANOMIA NEUROANATOMIC; Goodglass H., 1993, UNDERSTANDING APHASI; Humphreys GW, 2001, BEHAV BRAIN SCI, V24, P453, DOI 10.1017/S0140525X01004150; Im JR., 1991, J KOREAN LANGUAGE LI, V23, P87; Institute of Language and Information Studies, 1998, I LANG INF STUD PUBL; Kang Y., 1997, J KOREAN NEUROL ASS, V15, P300; Kaplan E, 2001, BOSTON NAMING TEST; KAY J, 1987, BRAIN, V110, P613, DOI 10.1093/brain/110.3.613; Kim HH, 1999, J CLIN EXP NEUROPSYC, V21, P127, DOI 10.1076/jcen.21.1.127.942; KOHN SE, 1985, BRAIN LANG, V24, P266, DOI 10.1016/0093-934X(85)90135-X; LAIACONA M, 1993, CORTEX, V29, P727, DOI 10.1016/S0010-9452(13)80293-6; Laws KR, 2007, NEUROPSYCHOLOGIA, V45, P2674, DOI 10.1016/j.neuropsychologia.2007.04.003; Laws KR, 1999, NEUROPSYCHOLOGIA, V37, P1263, DOI 10.1016/S0028-3932(99)00018-4; LAWS KR, 1995, MEMORY, V3, P397, DOI 10.1080/09658219508253158; Levelt WJ, 1989, SPEAKING FORM INTENT, DOI [10.1016/0010-0277%2889%2990017-6, DOI 10.1016/0010-0277%2889%2990017-6]; Fernandez AL, 2013, CLIN NEUROPSYCHOL, V27, P1179, DOI 10.1080/13854046.2013.822931; Na D., 2001, PARADISE KOREAN VERS; Noggle C., 2011, HEMISPHERES BRAIN LA, P740; Noppeney U, 2007, BRAIN, V130, P1138, DOI 10.1093/brain/awl344; Nozari N, 2010, J MEM LANG, V63, P541, DOI 10.1016/j.jml.2010.08.001; Papagno C, 1998, NEUROPSYCHOLOGIA, V36, P669, DOI 10.1016/S0028-3932(97)00142-5; Ralph MAL, 2007, BRAIN, V130, P1127, DOI 10.1093/brain/awm025; Raymer AM, 1997, BRAIN LANG, V58, P137, DOI 10.1006/brln.1997.1786; Rhee K., 1991, KOREAN J EXP COGN PS, V3, P131; Rohrer JD, 2008, BRAIN, V131, P8, DOI 10.1093/brain/awm251; Rothi L J, 1991, Clin Commun Disord, V1, P7; Stern RA., 2003, NAB NAMING TEST PROF; Tyler LK, 2001, TRENDS COGN SCI, V5, P244, DOI 10.1016/S1364-6613(00)01651-X; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525	49	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247118	10.1371/journal.pone.0247118	http://dx.doi.org/10.1371/journal.pone.0247118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606717	Green Published, gold			2022-12-26	WOS:000620629200020
J	Sy, KTL; Tariq, S; Ramjee, G; Blanchard, K; Leu, CS; Kelvin, EA; Exner, TM; Gandhi, AD; Lince-Deroche, N; Mantell, JE; O'Sullivan, LF; Hoffman, S				Sy, Karla Therese L.; Tariq, Shema; Ramjee, Gita; Blanchard, Kelly; Leu, Cheng-Shiun; Kelvin, Elizabeth A.; Exner, Theresa M.; Gandhi, Anisha D.; Lince-Deroche, Naomi; Mantell, Joanne E.; O'Sullivan, Lucia F.; Hoffman, Susie			Predictors of antiretroviral therapy initiation in eThekwini (Durban), South Africa: Findings from a prospective cohort study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV-RELATED STIGMA; ADOLESCENT GIRLS; YOUNG-WOMEN; CARE; INFECTION; ART; CONTINUUM; BARRIERS; ASSOCIATION	Despite expanded antiretroviral therapy (ART) eligibility in South Africa, many people diagnosed with HIV do not initiate ART promptly, yet understanding of the reasons is limited. Using data from an 8-month prospective cohort interview study of women and men newly-diagnosed with HIV in three public-sector primary care clinics in the eThekwini (Durban) region, South Africa, 2010-2014, we examined if theoretically-relevant social-structural, social-cognitive, psychosocial, and health status indicators were associated with time to ART initiation. Of 459 diagnosed, 350 returned to the clinic for their CD4+ test results (linkage); 153 (33.3%) were ART-eligible according to treatment criteria at the time; 115 (75.2% of those eligible) initiated ART (median = 12.86 weeks [95% CI: 9.75, 15.97] after linkage). In adjusted Cox proportional hazard models, internalized stigma was associated with a 65% decrease in the rate of ART initiation (Adjusted hazard ratio [AHR] 0.35, 95% CI: 0.19-0.80) during the period less than four weeks after linkage to care, but not four or more weeks after linkage to care, suggesting that stigma-reduction interventions implemented shortly after diagnosis may accelerate ART uptake. As reported by others, older age was associated with more rapid ART initiation (AHR for 1-year age increase: 1.04, 95% CI: 1.01-1.07) and higher CD4+ cell count (>= 300 mu L vs. <150 mu L) was associated with a lower rate of initiation (AHR 0.38, 95% CI: 0.19-0.80). Several other factors that were assessed prior to diagnosis, including stronger belief in traditional medicine, higher endorsement of stigma toward people living with HIV, food insecurity, and higher psychological distress, were found to be in the expected direction of association with ART initiation, but confidence intervals were wide and could not exclude a null finding.	[Sy, Karla Therese L.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; [Tariq, Shema] UCL, Inst Global Hlth, London, England; [Ramjee, Gita] South African Med Res Council, HIV Prevent Res Unit, Durban, South Africa; [Blanchard, Kelly; Lince-Deroche, Naomi] Ibis Reprod Hlth, Cambridge, MA USA; [Blanchard, Kelly; Lince-Deroche, Naomi] Ibis Reprod Hlth, Johannesburg, South Africa; [Leu, Cheng-Shiun; Exner, Theresa M.; Gandhi, Anisha D.; Mantell, Joanne E.; Hoffman, Susie] New York State Psychiat Inst & Hosp, Div Gender Sexual & Hlth, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA; [Leu, Cheng-Shiun; Exner, Theresa M.; Gandhi, Anisha D.; Mantell, Joanne E.; Hoffman, Susie] Columbia Univ, New York, NY USA; [Leu, Cheng-Shiun] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Kelvin, Elizabeth A.] CUNY, Dept Epidemiol & Biostat, CUNY Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Kelvin, Elizabeth A.] CUNY, CUNY Inst Implementat Sci Populat Hlth, New York, NY 10021 USA; [O'Sullivan, Lucia F.] Univ New Brunswick, Dept Psychol, Fredericton, NB, Canada; [Hoffman, Susie] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Boston University; University of London; University College London; South African Medical Research Council; New York State Psychiatry Institute; Columbia University; Columbia University; City University of New York (CUNY) System; City University of New York (CUNY) System; University of New Brunswick; Columbia University	Sy, KTL (corresponding author), Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA.	rsy@bu.edu	Sy, Karla Therese/AAV-3945-2021	Sy, Karla Therese/0000-0003-0608-9811; Lince-Deroche, Naomi/0000-0003-3689-4205	National Institute of Mental Health [R01 MH83561, R01 MH083561-03S1, P30-MH43520, 19872013, T32 MH19139]; South African Medical Research Council HIV Prevention Research Unit (MRC HPRU)	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); South African Medical Research Council HIV Prevention Research Unit (MRC HPRU)	Support for this work was provided by the National Institute of Mental Health, (R01 MH83561 and R01 MH083561-03S1; Principal Investigator: SH, DrPH; by a center grant from the National Institute of Mental Health to the HIV Center for Clinical and Behavioral Studies at NY State Psychiatric Institute and Columbia University [P30-MH43520; Principal Investigators: Anke A. Ehrhardt (19872013)/Robert H. Remien, Ph.D. (2013-2018)]. ADG was supported by a training grant from the National Institute of Mental Health (T32 MH19139, Behavioral Sciences Research in HIV Infection; Principal Investigator: Theo Sandfort, Ph.D.). Additional support was provided by the South African Medical Research Council HIV Prevention Research Unit (MRC HPRU). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIMH or the MRC HPRU.	Ahmed S, 2018, SOC SCI MED, V213, P72, DOI 10.1016/j.socscimed.2018.05.048; Andersen LS, 2011, INT J METH PSYCH RES, V20, P215, DOI 10.1002/mpr.351; [Anonymous], 2011, BASE SAS 94 PROCEDUR; Birdthistle I, 2019, LANCET GLOB HEALTH, V7, pE1521, DOI 10.1016/S2214-109X(19)30410-3; Bor J, 2018, TROP MED INT HEALTH, V23, P206, DOI 10.1111/tmi.13013; Boyer S, 2016, AIDS CARE, V28, P39, DOI 10.1080/09540121.2016.1164808; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Chan BT, 2015, AIDS, V29, P83, DOI 10.1097/QAD.0000000000000495; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corp I., 2016, IBM SPSS STAT WINDOW; Dahab M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-63; Denison JA, 2015, AIDS, V29, P361, DOI 10.1097/QAD.0000000000000543; Earnshaw VA, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25198; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Fisher JD, 2000, HDB HIV PREVENTION; Genberg BL, 2008, AIDS BEHAV, V12, P772, DOI 10.1007/s10461-007-9340-6; Glymour MM., 2017, METHODS SOCIAL EPIDE, V2nd Edition, P458; Grant PM, 2013, HIV CLIN TRIALS, V14, P284, DOI [10.1310/hct1406-284, 10.1310/hct1403-284]; Hayes RJ, 2019, NEW ENGL J MED, V381, P207, DOI 10.1056/NEJMoa1814556; Heestermans T, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000125; Hoffman S, 2020, AIDS BEHAV, V24, P1181, DOI 10.1007/s10461-019-02688-1; Hoffman S, 2017, JAIDS-J ACQ IMM DEF, V76, P382, DOI 10.1097/QAI.0000000000001530; Hoffman S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162085; Holzemer WL, 2007, AIDS CARE, V19, P1002, DOI 10.1080/09540120701245999; Jewkes R, BASELINE WOMENS QUES; Joint United Nations Programme on HIV/AIDS, 2017, COUNTRY FACTSHEETS S; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Kesselring S, 2019, AIDS CARE, V31, P885, DOI 10.1080/09540121.2018.1549722; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Khan R, 2015, AIDS CARE, V27, P198, DOI 10.1080/09540121.2014.951308; Kluberg SA, 2018, TROP MED INT HEALTH, V23, P968, DOI 10.1111/tmi.13122; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Kulkarni Sarah, 2016, J Int Assoc Provid AIDS Care, V15, P291, DOI 10.1177/2325957415593635; Liddell C, 2008, PSYCHOSOM MED, V70, P496, DOI 10.1097/PSY.0b013e31816fdf0e; Lippman SA, 2016, JAIDS-J ACQ IMM DEF, V73, P91, DOI 10.1097/QAI.0000000000001026; Littlewood Rae A, 2011, Curr HIV/AIDS Rep, V8, P257, DOI 10.1007/s11904-011-0090-8; Mabaso M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5051-3; Maskew M, 2019, LANCET HIV, V6, pE760, DOI 10.1016/S2352-3018(19)30234-6; Mbonye M, 2016, AIDS CARE, V28, P33, DOI 10.1080/09540121.2016.1164804; Mehraj V, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25034; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Odeny TA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20019; Patel RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168057; Pillay Y, 2016, DEPUTY DIRECTOR GEN; Plazy M, 2015, HIV MED, V16, P521, DOI 10.1111/hiv.12253; Plazy M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1207-2; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sabapathy K, 2017, J INT AIDS SOC, V20, DOI 10.1002/jia2.25037; Shisana O., 2014, AFRICAN NATL HIV P; Simbayi L, BEHAVIOUR COMMUNICAT, P20172019, DOI [10.2989/16085906.2016.1153491, DOI 10.2989/16085906.2016.1153491]; Treves-Kagan S, 2017, AIDS BEHAV, V21, P2579, DOI 10.1007/s10461-016-1671-8; Treves-Kagan S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2753-2; Tymejczyk O, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002534; UNICEF. Global and Regional Trends, KEY HIV EPIDEMIOLOGY; Wanyama JN, 2017, INT J STD AIDS, V28, P1018, DOI 10.1177/0956462416685890; WHO, CONSOLIDATED GUIDELI; World Health Organization, 2015, GUIDELINE START ANTI	57	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246744	10.1371/journal.pone.0246744	http://dx.doi.org/10.1371/journal.pone.0246744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606712	Green Published, gold			2022-12-26	WOS:000620629200111
J	Valli, AT; Koumandou, VL; Iatrou, G; Andreou, M; Papasotiropoulos, V; Trigas, P				Valli, Anna-Thalassini; Koumandou, Vassiliki Lila; Iatrou, Gregoris; Andreou, Marios; Papasotiropoulos, Vasileios; Trigas, Panayiotis			Conservation biology of threatened Mediterranean chasmophytes: The case of Asperula naufraga endemic to Zakynthos island (Ionian islands, Greece)	PLOS ONE			English	Article								Asperula naufraga is a rare and threatened obligate chasmophyte, endemic to Zakynthos island (Ionian islands, Greece). In this study, we provide a combined approach (including monitoring of demographic and reproductive parameters and study of genetic diversity) to assess the current conservation status of the species and to estimate its future extinction risk. The five subpopulations of A. naufraga were monitored for five years (2014-2018). Population size markedly fluctuated between 68-130 mature individuals during the monitoring period. The extent of occurrence (EOO) was estimated at 28.7 km(2) and the area of occupancy (AOO) was 8 km(2). Stage-structure recordings were similar for all subpopulations, characterized by high proportions of adult and senescent individuals, following a common pattern, which has been observed in other cliff-dwelling plants. Preliminary genetic analysis with SSRs markers revealed low heterozygosity within subpopulations and significant departure from H-W equilibrium, which combined with small population size suggest increased threat of genetic diversity loss. Our results indicate that the species should be placed in the Critically Endangered (CR) IUCN threat category, while according to Population Viability Analysis results its extinction risk increases to 47.8% in the next 50 years. The small population size combined with large fluctuations in its size, low recruitment and low genetic diversity, indicate the need of undertaking effective in situ and ex situ conservation measures.	[Valli, Anna-Thalassini; Trigas, Panayiotis] Agr Univ Athens, Sch Plant Sci, Dept Crop Sci, Lab Systemat Bot, Athens, Greece; [Koumandou, Vassiliki Lila] Agr Univ Athens, Sch Appl Biol & Biotechnol, Dept Biotechnol, Genet Lab, Athens, Greece; [Iatrou, Gregoris] Univ Patras, Dept Biol, Div Plant Biol, Lab Bot, Patras, Greece; [Andreou, Marios] Frederick Univ, Nat Conservat Unit, Nicosia, Cyprus; [Papasotiropoulos, Vasileios] Univ Patras, Dept Agr, Amaliada, Greece	Agricultural University of Athens; Agricultural University of Athens; University of Patras; University of Patras	Valli, AT (corresponding author), Agr Univ Athens, Sch Plant Sci, Dept Crop Sci, Lab Systemat Bot, Athens, Greece.	thalassinivalli@yahoo.gr	Valli, Anna-Thalassini/GYU-6141-2022; Koumandou, V. Lila/AAP-4224-2021	Koumandou, V. Lila/0000-0002-0624-0190; Andreou, Marios/0000-0003-3175-457X; Papasotiropoulos, Vasileios/0000-0002-0292-6793; Valli, Anna-Thalassini/0000-0002-2085-1174	General Secretariat for Research and Technology (GSRT); Hellenic Foundation for Research and Innovation (HFRI) [1585]; project "PlantUP" - Operational Programme "Competitiveness, Entrepreneurship and Innovation" (NSRF 2014-2020) [MIS 5002803]; European Union (European Regional Development Fund)	General Secretariat for Research and Technology (GSRT)(Greek Ministry of Development-GSRT); Hellenic Foundation for Research and Innovation (HFRI); project "PlantUP" - Operational Programme "Competitiveness, Entrepreneurship and Innovation" (NSRF 2014-2020); European Union (European Regional Development Fund)(European Commission)	This study was supported by grants from the General Secretariat for Research and Technology (GSRT) and the Hellenic Foundation for Research and Innovation (HFRI) (grant number 1585 to Valli A.T.). We acknowledge support part of this work by the project "PlantUP" (MIS 5002803) which is implemented under the Action "Reinforcement of the Research and Innovation Infrastructure", funded by the Operational Programme "Competitiveness, Entrepreneurship and Innovation" (NSRF 2014-2020) and co-fnanced by Greece and the European Union (European Regional Development Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2008, ECOLOGY, V89, P3049, DOI 10.1890/07-1569.1; Akû║akaya H.R., 1999, APPL POPULATION ECOL; ANDERSON W R, 1973, Taxon, V22, P537, DOI 10.2307/1218628; Andreou M, 2011, ACTA OECOL, V37, P239, DOI 10.1016/j.actao.2011.02.007; Andreou M, 2015, GLOB ECOL CONSERV, V3, P511, DOI 10.1016/j.gecco.2015.02.004; Antonsson H, 2012, THESIS U GOTHENBURG; Armstrong TTJ, 2005, BOT J LINN SOC, V149, P229, DOI 10.1111/j.1095-8339.2005.00437.x; Arroyo MTK, 2013, NEW PHYTOL, V200, P1260, DOI 10.1111/nph.12443; Augustinos A, 2014, FOLIA GEOBOT, V49, P603, DOI 10.1007/s12224-014-9196-2; Ayele TB, 2011, J NAT CONSERV, V19, P8, DOI 10.1016/j.jnc.2010.03.001; Bahadur B., 1968, OSMANIA U J SCI GOLD, V4, P207; Barrett SCH, 2001, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Bedini G, 2011, PLANT SYST EVOL, V294, P273, DOI 10.1007/s00606-011-0469-4; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bozzuto C, 2019, NAT ECOL EVOL, V3, P1359, DOI 10.1038/s41559-019-0968-1; Brian FD., 2018, ENCY ECOLOGY, V2; Burns JH, 2013, ECOLOGY, V94, P995, DOI 10.1890/12-1310.1; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Colas B, 1997, P NATL ACAD SCI USA, V94, P3471, DOI 10.1073/pnas.94.7.3471; Constantinidis T., 2009, RED DATA BOOK RARE T, VI, P120; Couvet D, 2002, CONSERV BIOL, V16, P369, DOI 10.1046/j.1523-1739.2002.99518.x; De Micco V, 2012, SCI WORLD J, DOI 10.1100/2012/471814; De Vitis M, 2018, PLANT BIOLOGY, V20, P203, DOI 10.1111/plb.12637; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Field SA, 2007, AUSTRAL ECOL, V32, P485, DOI 10.1111/j.1442-9993.2007.01715.x; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Garcia D, 2003, J VEG SCI, V14, P921, DOI 10.1111/j.1654-1103.2003.tb02227.x; Garcia MB, 2008, AM J BOT, V95, P258, DOI 10.3732/ajb.95.2.258; Garcia MB, 2003, CONSERV BIOL, V17, P1672, DOI 10.1111/j.1523-1739.2003.00030.x; Gargiulo R, 2019, PLANT SYST EVOL, V305, P181, DOI 10.1007/s00606-018-1561-9; Gargiulo R, 2015, TAXON, V64, P754, DOI 10.12705/644.7; Gargiulo R, 2015, CONSERV GENET RESOUR, V7, P187, DOI 10.1007/s12686-014-0328-z; Garner BA, 2020, CONSERV GENET, V21, P795, DOI 10.1007/s10592-020-01301-6; Gaston K.J., 1994, RARITY, P1; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Gucel S, 2009, TURK J BOT, V33, P257, DOI 10.3906/bot-0806-7; Gutermann W., 2000, BOT, V13, P61; Hadjou Belaid A, 2018, BIOL CONSERV, V223, P19, DOI 10.1016/j.biocon.2018.04.019; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; Heywood VH, 2003, BIOL CONSERV, V113, P321, DOI 10.1016/S0006-3207(03)00121-6; IUCN, 2012, THREATS CLASS SCHEM; IUCN Standards and Petitions Subcommittee, 2019, GUID US IUCN RED LIS; King R, 2012, INTERFACE FOCUS, V2, P190, DOI 10.1098/rsfs.2011.0078; Kontopanou A, 2020, DIVERSITY-BASEL, V12, DOI 10.3390/d12010033; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Korica B. D., 1992, FL MEDIT, V2, P65; LACY R C, 1987, Conservation Biology, V1, P143, DOI 10.1111/j.1523-1739.1987.tb00023.x; Larusson J.A., 2014, LEARNING ANAL RES PR, DOI [10.1063/1.4869240, DOI 10.1063/1.4869240]; Lavergne S, 2004, OIKOS, V107, P505, DOI 10.1111/j.0030-1299.2004.13423.x; Lucas RW, 2008, J ECOL, V96, P514, DOI 10.1111/j.1365-2745.2007.01350.x; Maunder M, 2004, SCI PRAC ECOL REST, P389; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Medail F, 1997, BIOL CONSERV, V80, P269, DOI 10.1016/S0006-3207(96)00055-9; Morris WF, 1998, AM J BOT, V85, P784, DOI 10.2307/2446413; Nei M., 1987, MOL EVOLUTIONARY GEN; Nicoletti F, 2012, FOLIA GEOBOT, V47, P249, DOI 10.1007/s12224-012-9127-z; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Panitsa M, 2017, BOT SERB, V41, P199, DOI 10.5281/zenodo.1026483; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pico FX, 2002, PLANT ECOL, V161, P1; Pritchard JK, 2000, GENETICS, V155, P945; Raimondo FM, 2012, PLANT BIOSYST, V146, P847, DOI 10.1080/11263504.2012.706237; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Root W., 2007, RAMAS RED LIST PROFE; Ryu HY, 2016, BIOL CONSERV, V197, P190, DOI 10.1016/j.biocon.2016.02.031; Salinas MJ, 2003, ACTA BOT GALLICA, V150, P137, DOI 10.1080/12538078.2003.10515414; SCHEMSKE DW, 1994, ECOLOGY, V75, P584, DOI 10.2307/1941718; Sera B, 2005, BIOLOGIA, V60, P17; Silva JL, 2015, BASIC APPL ECOL, V16, P316, DOI 10.1016/j.baae.2015.02.009; Snogerup S, 1971, PLANT LIFE S W ASIA, P151; Soriano P, 2012, PLANT BIOSYST, V146, P143, DOI 10.1080/11263504.2011.652208; Teskey HJ., 1990, INSECTS ARACHNIDS CA; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Van Oosterhout C, 2004, MOL ECOL, V13, P1025, DOI 10.1111/j.1365-294X.2004.02114.x; von Arx G, 2006, ECOLOGY, V87, P665, DOI 10.1890/05-1041; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang X, 2018, J PLANT BIOL, V61, P159, DOI 10.1007/s12374-017-0373-8	82	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246706	10.1371/journal.pone.0246706	http://dx.doi.org/10.1371/journal.pone.0246706			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606745	gold, Green Published			2022-12-26	WOS:000620629200022
J	Kuan, IHS; Wilson, LC; Leishman, JC; Cosgrove, S; Walker, RJ; Putt, TL; Schollum, JBW; Wright, DFB				Kuan, Isabelle H. S.; Wilson, Luke C.; Leishman, Jed C.; Cosgrove, Samuel; Walker, Robert J.; Putt, Tracey L.; Schollum, John B. W.; Wright, Daniel F. B.			Metformin doses to ensure efficacy and safety in patients with reduced kidney function	PLOS ONE			English	Article							LACTIC-ACIDOSIS; CLINICAL PHARMACOKINETICS; HEALTHY-SUBJECTS; DISEASE; EQUATION	We aimed to develop a metformin dosing strategy to optimise efficacy and safety in patients with reduced kidney function. Metformin data from two studies stratified by kidney function were analysed. The relationship between metformin clearance and kidney function estimates was explored using a regression analysis. The maintenance dose range was predicted at different bands of kidney function to achieve an efficacy target of 1 mg/L for steady-state plasma concentrations. The dosing strategy was evaluated using simulations from a published metformin pharmacokinetic model to determine the probability of concentrations exceeding those associated with lactic acidosis risk, i.e. a steady-state average concentration of 3 mg/L and a maximum (peak) concentration of 5 mg/L. A strong relationship between metformin clearance and estimated kidney function using the Cockcroft and Gault (r(2) = 0.699), MDRD (r(2) = 0.717) and CKD-Epi (r(2) = 0.735) equations was found. The probability of exceeding the safety targets for plasma metformin concentration was <5% for most doses and kidney function levels. The lower dose of 500 mg daily was required to maintain concentrations below the safety limits for patients with an eGFR of 15-29 mL/min. Our analysis suggests that a maximum daily dose of 2250, 1700, 1250, 1000, and 500 in patients with normal kidney function, CKD stage 2, 3a, 3b and 4, respectively, will provide a reasonable probability of achieving efficacy and safety. Our results support the cautious of use metformin at appropriate doses in patients with impaired kidney function.	[Kuan, Isabelle H. S.; Wright, Daniel F. B.] Univ Otago, Sch Pharm, Dunedin, New Zealand; [Wilson, Luke C.; Leishman, Jed C.; Cosgrove, Samuel; Walker, Robert J.; Putt, Tracey L.; Schollum, John B. W.] Univ Otago, Dept Med, Dunedin, New Zealand	University of Otago; University of Otago	Wright, DFB (corresponding author), Univ Otago, Sch Pharm, Dunedin, New Zealand.	dan.wright@otago.ac.nz	Wilson, Luke Charles/H-9787-2019; Wright, Daniel F.B./P-2513-2018	Wilson, Luke Charles/0000-0003-2636-098X; Wright, Daniel F.B./0000-0001-9313-9252; Kuan, Isabelle/0000-0003-3186-8040	University of Otago Research Grant (UORG) - University of Otago Special Health Research Scholarship; Otago Medical Research Foundation	University of Otago Research Grant (UORG) - University of Otago Special Health Research Scholarship; Otago Medical Research Foundation	The Dunedin Hospital study was funded a University of Otago Research Grant (UORG). I.K. was funded by the University of Otago Special Health Research Scholarship. S.C. and J.L were funded by Otago Medical Research Foundation (summer studentships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennis Y., 2020, CRIT CARE MED, DOI [10.1097/ccm.0000000000004589 33003077, DOI 10.1097/CCM.000000000000458933003077]; Boucaud-Maitre D, 2016, DIABETIC MED, V33, P1536, DOI 10.1111/dme.13098; Briston-Meyers Squibb Company, 2017, GLUCOPHAGE METFORMIN; CAMPBELL IW, 1995, DIABETES METAB REV, V11, pS57, DOI 10.1002/dmr.5610110509; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Dissanayake AM, 2017, KIDNEY INT REP, V2, P705, DOI 10.1016/j.ekir.2017.03.005; Duong JK, 2017, EUR J CLIN PHARMACOL, V73, P981, DOI 10.1007/s00228-017-2251-1; Duong JK, 2013, CLIN PHARMACOKINET, V52, P373, DOI 10.1007/s40262-013-0046-9; European Medicines Agency, 2016, US METF TREAT DIAB N; Golay A, 2008, INT J OBESITY, V32, P61, DOI 10.1038/sj.ijo.0803695; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; Kajbaf F, 2016, CLIN PHARMACOKINET, V55, P439, DOI 10.1007/s40262-015-0323-x; Kuan IHS., 2020, BRIT J CLIN PHARMACO, DOI [10.1111/bcp.14394 32519376, DOI 10.1111/BCP.1439432519376]; Kuan IHS, 2019, DRUG SAFETY, V42, P1449, DOI 10.1007/s40264-019-00854-x; Lalau JD, 2003, DIABETES OBES METAB, V5, P93, DOI 10.1046/j.1463-1326.2003.00241.x; LALAU JD, 1995, DIABETES CARE, V18, P779, DOI 10.2337/diacare.18.6.779; Lalau JD, 2018, DIABETES CARE, V41, P547, DOI 10.2337/dc17-2231; Lalau JD, 2017, DIABETES OBES METAB, V19, P1502, DOI 10.1111/dom.12974; Lalau JD, 2011, CLIN DRUG INVEST, V31, P435, DOI 10.2165/11588310-000000000-00000; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Salpeter SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002967.pub3; Sambol NC, 1996, BRIT J CLIN PHARMACO, V42, P510, DOI 10.1111/j.1365-2125.1996.tb00017.x; Scheen AJ, 1996, CLIN PHARMACOKINET, V30, P359, DOI 10.2165/00003088-199630050-00003; Smith FC, 2020, ALIMENT PHARM THER, V51, P565, DOI 10.1111/apt.15635; Stades AME, 2004, J INTERN MED, V255, P179, DOI 10.1046/j.1365-2796.2003.01271.x; TUCKER GT, 1981, BRIT J CLIN PHARMACO, V12, P235; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0246247	10.1371/journal.pone.0246247	http://dx.doi.org/10.1371/journal.pone.0246247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600406	gold, Green Published			2022-12-26	WOS:000620625100054
J	Bunten, A; Porter, L; Sanders, JG; Sallis, A; Riches, SP; Van Schaik, P; Gonzalez-Iraizoz, M; Chadborn, T; Forwood, S				Bunten, Amanda; Porter, Lucy; Sanders, Jet G.; Sallis, Anna; Riches, Sarah Payne; Van Schaik, Paul; Gonzalez-Iraizoz, Marta; Chadborn, Tim; Forwood, Suzanna			A randomised experiment of health, cost and social norm message frames to encourage acceptance of swaps in a simulation online supermarket	PLOS ONE			English	Article							SOCIOECONOMIC DIFFERENCES; ENERGY IMBALANCE; FOOD SWAPS; OBESITY; CHOICE; INTERVENTIONS; OVERWEIGHT; PURCHASES; BEHAVIOR; REDUCE	Offering lower-energy food swaps to customers of online supermarkets could help to decrease energy (kcal) purchased and consumed. However, acceptance rates of such food swaps tend to be low. This study aimed to see whether framing lower-energy food swaps in terms of cost savings or social norms could improve likelihood of acceptance relative to framing swaps in terms of health benefits. Participants (n = 900) were asked to shop from a 12-item shopping list in a simulation online supermarket. When a target high-energy food was identified in the shopping basket at check-out, one or two lower-energy foods would be suggested as an alternative (a "swap"). Participants were randomised to only see messages emphasising health benefits (fewer calories), cost benefits (lower price) or social norms (others preferred this product). Data were analysed for 713 participants after exclusions. Participants were offered a mean of 3.17 swaps (SD = 1.50), and 12.91% of swaps were accepted (health = 14.31%, cost = 11.49%, social norms = 13.18%). Swap acceptance was not influenced by the specific swap frame used (all p > .170). Age was significantly and positively associated with swap acceptance (b = 0.02, SE = 0.00, p < .001), but was also associated with smaller decreases in energy change (b = 0.46, SE = .19, p = .014). Overall, offering swaps reduced both energy (kcal) per product (b = -9.69, SE = 4.07, p = .017) and energy (kcal) per shopping basket (t(712) = 11.09, p < .001) from pre- to post-intervention. Offering lower-energy food swaps could be a successful strategy for reducing energy purchased by customers of online supermarkets. Future research should explore alternative solutions for increasing acceptance rates of such swaps.	[Bunten, Amanda; Porter, Lucy; Sanders, Jet G.; Sallis, Anna; Riches, Sarah Payne; Chadborn, Tim] Publ Hlth England Behav Insights, London, England; [Sanders, Jet G.] London Sch Econ & Polit Sci, Dept Psychol & Behav Sci, London, England; [Riches, Sarah Payne] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Van Schaik, Paul] Teesside Univ, Sch Social Sci Humanities & Law, Middlesbrough, Cleveland, England; [Gonzalez-Iraizoz, Marta] Univ Warwick, Warwick Business Sch, Coventry, W Midlands, England; [Forwood, Suzanna] Anglia Ruskin Univ, Sch Psyhol & Sport Sci, Cambridge, England	University of London; London School Economics & Political Science; University of Oxford; University of Teesside; University of Warwick; Anglia Ruskin University	Porter, L (corresponding author), Publ Hlth England Behav Insights, London, England.	L.Porter@exeter.ac.uk	Forwood, Suzanna/A-5376-2008	Forwood, Suzanna/0000-0002-8406-5121; Porter, Lucy/0000-0001-8277-4138; Payne Riches, Sarah/0000-0001-8804-9500				Adam A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3985-x; Aggarwal A, 2016, PREV MED, V90, P184, DOI 10.1016/j.ypmed.2016.06.030; Bassett R, 2008, BRIT FOOD J, V110, P206, DOI 10.1108/00070700810849916; Bleich SN, 2012, ANNU REV PUBL HEALTH, V33, P7, DOI 10.1146/annurev-publhealth-031811-124658; Bucher T, 2016, BRIT J NUTR, V115, P2252, DOI 10.1017/S0007114516001653; Burger JM, 2010, J SOC CLIN PSYCHOL, V29, P228, DOI 10.1521/jscp.2010.29.2.228; Burgoon M., 2002, PERSUASION HDB DEV T, P213, DOI DOI 10.4135/9781412976046.N12; Butte NF, 2007, OBESITY, V15, P3056, DOI 10.1038/oby.2007.364; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Forwood SE, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0241-1; Forwood SE, 2015, APPETITE, V89, P93, DOI 10.1016/j.appet.2015.01.018; Glanz K, 1998, J AM DIET ASSOC, V98, P1118, DOI 10.1016/S0002-8223(98)00260-0; Guh Daphne P, 2009, BMC Public Health, V9, P88, DOI 10.1186/1471-2458-9-88; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hartmann-Boyce J, 2018, AM J CLIN NUTR, V107, P1004, DOI 10.1093/ajcn/nqy045; Higgs S, 2016, CURR OPIN BEHAV SCI, V9, P1, DOI 10.1016/j.cobeha.2015.10.005; Higgs S, 2015, APPETITE, V86, P38, DOI 10.1016/j.appet.2014.10.021; Hoek AC, 2017, FOOD QUAL PREFER, V58, P94, DOI 10.1016/j.foodqual.2016.12.008; Hollands GJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1218; Huang A, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010022; Kantar, UK GROC SAL ACC REST; Konttinen H, 2013, PUBLIC HEALTH NUTR, V16, P873, DOI 10.1017/S1368980012003540; Koutoukidis DA, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0810-9; Lennernas M, 1997, EUR J CLIN NUTR, V51, pS8; Manore MM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080905; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Miller CH, 2007, HUM COMMUN RES, V33, P219, DOI 10.1111/j.1468-2958.2007.00297.x; Mintel Press Office, 2019, BRITS SPENT 123 BILL; NHS Digital Stats Team, 2017, HLTH SURVEY ENGLAND; Papies EK, 2014, INT J OBESITY, V38, P597, DOI 10.1038/ijo.2013.136; Pechey R, 2015, APPETITE, V84, P271, DOI 10.1016/j.appet.2014.10.022; PwC, LOCKD SHAK NEW NORM; Raghunathan R, 2006, J MARKETING, V70, P170, DOI 10.1509/jmkg.70.4.170; Riches SP, 2019, APPETITE, V133, P378, DOI 10.1016/j.appet.2018.11.028; Robinson E, 2014, HEALTH PSYCHOL, V33, P1057, DOI 10.1037/a0034213; Robinson E, 2014, J ACAD NUTR DIET, V114, P414, DOI 10.1016/j.jand.2013.11.009; Romieu I, 2017, CANCER CAUSE CONTROL, V28, P247, DOI 10.1007/s10552-017-0869-z; Sallis A, 2019, PREV MED, V121, P128, DOI 10.1016/j.ypmed.2019.01.023; Statista, 2019, RET SAL VAL MONTHL P; STEPTOE A, 1995, APPETITE, V25, P267, DOI 10.1006/appe.1995.0061; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Turrell G, 2002, J HUM NUTR DIET, V15, P355, DOI 10.1046/j.1365-277X.2002.00384.x; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3	43	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246455	10.1371/journal.pone.0246455	http://dx.doi.org/10.1371/journal.pone.0246455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8ME	33596251	Green Published, Green Accepted, gold			2022-12-26	WOS:000620633200004
J	Kobayashi, Y; Kumamoto, K; Okayama, H; Matsumoto, T; Nakano, H; Saito, K; Matsumoto, Y; Endo, E; Kanke, Y; Watanabe, Y; Onozawa, H; Fujita, S; Sakamoto, W; Saito, M; Momma, T; Takenoshita, S; Kono, K				Kobayashi, Yusuke; Kumamoto, Kensuke; Okayama, Hirokazu; Matsumoto, Takuro; Nakano, Hiroshi; Saito, Katsuharu; Matsumoto, Yoshiko; Endo, Eisei; Kanke, Yasuyuki; Watanabe, Yohei; Onozawa, Hisashi; Fujita, Shotaro; Sakamoto, Wataru; Saito, Motonobu; Momma, Tomoyuki; Takenoshita, Seiichi; Kono, Koji			Downregulation of PAICS due to loss of chromosome 4q is associated with poor survival in stage III colorectal cancer	PLOS ONE			English	Article							COLON-CANCER; EXPRESSION; INSTABILITY; PROGRESSION; ENZYME; GENE	Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS) encodes an enzyme that catalyzes de novo purine biosynthesis. Although PAICS has been implicated as a potential therapeutic target in several cancers, its clinical and prognostic significance in colorectal cancer (CRC) is not fully understood. To elucidate the roles of PAICS in CRC, we investigated PAICS expression in four cohorts consisting of a total of 1659 samples based on quantitative RT-PCR, microarray and RNA-seq analysis. Despite upregulated PAICS levels in tumor compared to those of normal mucosa, we found a decreasing trend of PAICS expression during tumor progression and metastasis. We conducted immunohistochemistry on 252 specimens, showing that PAICS protein was strongly expressed in the majority of CRCs, but not in adjacent mucosa. Notably, 29.0% of tumors lacked PAICS staining, and PAICS-negative expression in tumor had significant prognostic impact on poor cancer-specific survival in stage III CRC. Correspondingly, decreased levels of PAICS transcript were also correlated with poor relapse-free survival particularly in stage III patients, and this finding was robustly confirmed in three microarray datasets of a total of 802 stage II-III patients. Bioinformatics analysis of CRC tissues and cell lines consistently indicated a correlation between decreased PAICS expression and copy number loss of chromosome arm 4q. In conclusion, our results suggest that PAICS expression is downregulated during tumor progression due to genetic deletion of chromosome 4q in microsatellite stable but chromosomally unstable tumors. Furthermore, decreased expression of PAICS transcript or loss of PAICS protein may provide prognostic stratification for postoperative patients with stage III CRC.	[Kobayashi, Yusuke; Okayama, Hirokazu; Matsumoto, Takuro; Nakano, Hiroshi; Saito, Katsuharu; Endo, Eisei; Kanke, Yasuyuki; Watanabe, Yohei; Onozawa, Hisashi; Fujita, Shotaro; Sakamoto, Wataru; Saito, Motonobu; Momma, Tomoyuki; Kono, Koji] Fukushima Med Univ, Dept Gastrointestinal Tract Surg, Sch Med, Fukushima, Japan; [Kumamoto, Kensuke] Kagawa Univ, Fac Med, Dept Gastroenterol Surg, Takamatsu, Kagawa, Japan; [Matsumoto, Yoshiko] Fukushima Med Univ, Dept Thyroid & Endocrinol, Sch Med, Fukushima, Japan; [Takenoshita, Seiichi] Fukushima Med Univ, Sch Med, Fukushima, Japan	Fukushima Medical University; Kagawa University; Fukushima Medical University; Fukushima Medical University	Okayama, H (corresponding author), Fukushima Med Univ, Dept Gastrointestinal Tract Surg, Sch Med, Fukushima, Japan.	okayama@fmu.ac.jp		Okayama, Hirokazu/0000-0003-0966-4746	Japan Society for the Promotion of Science (JSPS) KAKENHI [18K08546, 20K08963]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 18K08546 (H.O and W.S) and 20K08963 (H.O and S.F) (https://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2020, TRANSL ONCOL, V13, DOI 10.1016/j.tranon.2020.100776; Agarwal S, 2020, CANCERS, V12, DOI 10.3390/cancers12040772; Al-Mulla F, 2006, J CLIN PATHOL, V59, P624, DOI 10.1136/jcp.2005.033167; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Arribas R, 1999, CLIN CANCER RES, V5, P3454; Ashizawa M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43293-5; Bardi G, 2004, J CLIN ONCOL, V22, P2623, DOI 10.1200/JCO.2004.11.014; Barfeld SJ, 2015, ONCOTARGET, V6, P12587, DOI 10.18632/oncotarget.3494; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brosens RPM, 2011, CELL ONCOL, V34, P215, DOI 10.1007/s13402-011-0042-8; Cai YY, 2016, CANCER CELL, V29, P751, DOI 10.1016/j.ccell.2016.04.003; Camici M, 2019, CANCERS, V11, DOI 10.3390/cancers11091354; Carethers JM, 2015, GASTROENTEROLOGY, V149, P1177, DOI 10.1053/j.gastro.2015.06.047; Chakravarthi BVSK, 2018, NEOPLASIA, V20, P894, DOI 10.1016/j.neo.2018.07.006; Chakravarthi BVSK, 2017, PROSTATE, V77, P10, DOI 10.1002/pros.23243; Danner BC, 2011, CANCER GENET-NY, V204, P122, DOI 10.1016/j.cancergen.2010.12.003; Dekker E, 2019, LANCET, V394, P1467, DOI 10.1016/S0140-6736(19)32319-0; Dienstmann R, 2015, J CLIN ONCOL, V33, P1787, DOI 10.1200/JCO.2014.60.0213; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goswami MT, 2015, ONCOTARGET, V6, P23445, DOI 10.18632/oncotarget.4352; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kotake K, 2019, J ANUS RECTUM COLON, V3, P175, DOI 10.23922/jarc.2019-018; Kurashina K, 2008, CANCER SCI, V99, P1835, DOI 10.1111/j.1349-7006.2008.00881.x; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Medico E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8002; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Satoh K, 2017, P NATL ACAD SCI USA, V114, pE7697, DOI 10.1073/pnas.1710366114; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Sveen A, 2012, CLIN CANCER RES, V18, P6001, DOI 10.1158/1078-0432.CCR-11-3302; Taylor AM, 2018, CANCER CELL, V33, P676, DOI 10.1016/j.ccell.2018.03.007; Xue W, 2012, P NATL ACAD SCI USA, V109, P8212, DOI 10.1073/pnas.1206062109; Yin J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01697	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247169	10.1371/journal.pone.0247169	http://dx.doi.org/10.1371/journal.pone.0247169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596246	Green Published, gold			2022-12-26	WOS:000620633200046
J	Milani, V; Zara, ALDA; da Silva, EN; Cardoso, LB; Curado, MP; Ribeiro-Rotta, RF				Milani, Vanessa; de Sene Amancio Zara, Ana Laura; da Silva, Everton Nunes; Cardoso, Larissa Barbosa; Curado, Maria Paula; Ribeiro-Rotta, Rejane Faria			Direct healthcare costs of lip, oral cavity and oropharyngeal cancer in Brazil	PLOS ONE			English	Article								The efficiency of public policies includes the measurement of the health resources used and their associated costs. There is a lack of studies evaluating the economic impact of oral cancer (OC). This study aims to estimate the healthcare costs of OC in Brazil from 2008 to 2016. This is a partial economic evaluation using the gross costing top-down method, considering the direct healthcare costs related to outpatients, inpatients, intensive care units, and the number of procedures, from the perspective of the public health sector. The data were extracted from the Outpatient and Inpatient Information System of the National Health System, by diagnosis according to the 10(th) Revision of the International Classification of Diseases, according to sites of interest: C00 to C06, C09 and C10. The values were adjusted for annual accumulated inflation and expressed in 2018 I$ (1 I$ = R$2,044). Expenditure on OC healthcare in Brazil was I$495.6 million, which was composed of 50.8% (I$251.6 million) outpatient and 49.2% (I$244.0 million) inpatient healthcare. About 177,317 admissions and 6,224,236 outpatient procedures were registered. Chemotherapy and radiotherapy comprised the largest number of procedures (88.8%) and costs (94.9%). Most of the costs were spent on people over 50 years old (72.9%) and on males (75.6%). Direct healthcare costs in Brazil for OC are substantial. Outpatient procedures were responsible for the highest total cost; however, inpatient procedures had a higher cost per procedure. Men over 50 years old consumed most of the cost and procedures for OC. The oropharynx and tongue were the sites with the highest expenditure. Further studies are needed to investigate the cost per individual, as well as direct non-medical and indirect costs of OC.	[Milani, Vanessa; de Sene Amancio Zara, Ana Laura; Ribeiro-Rotta, Rejane Faria] Univ Fed Goias UFG, Sch Dent, Goiania, Go, Brazil; [da Silva, Everton Nunes] Univ Brasilia UnB, Brasilia, DF, Brazil; [Cardoso, Larissa Barbosa] Univ Fed Goias UFG, Fac Adm Accounting & Econ Sci, Goiania, Go, Brazil; [Curado, Maria Paula] AC Camargo, Sao Paulo, SP, Brazil	Universidade Federal de Goias; Universidade de Brasilia; Universidade Federal de Goias; A.C.Camargo Cancer Center	Ribeiro-Rotta, RF (corresponding author), Univ Fed Goias UFG, Sch Dent, Goiania, Go, Brazil.	rejanefrr@ufg.br	Curado, Maria Paula/M-6200-2013	Curado, Maria Paula/0000-0001-8172-2483; Silva, Everton/0000-0001-8747-4185				Abrahao R, 2018, INT J CANCER, V143, P32, DOI 10.1002/ijc.31294; Aguiar ZN., 2015, SISTEMA NICO SAUDE A, V2nd ed; Andrade Jarielle Oliveira Mascarenhas, 2015, Rev. bras. epidemiol., V18, P894, DOI 10.1590/1980-5497201500040017; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Bonfant, 2014, CAD SAUDE PUBLICA RI, V30, P983; Brasil. Ministerio da Saude, 2015, SIST INF AT SAUD CON; Brasil. Ministerio da Saude, CONS NAC SAUD RES 51; Brocklehurst PR, 2018, BRIT DENT J, V225, P815, DOI 10.1038/sj.bdj.2018.918; Campolina AG, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00205; Chauhan AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191132; Conway DI, 2006, ORAL ONCOL, V42, P586, DOI 10.1016/j.oraloncology.2005.10.018; Dantas TS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002314; de Janeiro R., 2019, ESTIMATED 2018 CANC; Denaro N, 2018, ONCOLOGY-BASEL, V95, P202, DOI 10.1159/000490415; Divi V, 2016, ORAL ONCOL, V61, P83, DOI 10.1016/j.oraloncology.2016.08.018; Feldman F Bárbara, 2016, Rev. Otorrinolaringol. Cir. Cabeza Cuello, V76, P173; Antunes JLF, 2015, EPIDEMIOL SERV SAUDE, V24, P565, DOI 10.5123/S1679-49742015000300024; Forman D, 2013, CANC INCIDENCE 5 CON, VX; Gillison ML, 2015, J CLIN ONCOL, V33, P3235, DOI 10.1200/JCO.2015.61.6995; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Hollenbeak CS, 2015, JAMA OTOLARYNGOL, V141, P628, DOI 10.1001/jamaoto.2015.0940; IBGE. Instituto Brasileiro de Geografia e Estatistica, 2014, PESQ NAC SAUD 2013 P; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Kodriati Nurul, 2018, Glob Health Action, V11, P1589763, DOI 10.1080/16549716.2019.1589763; Kohler HF, 2021, EUR ARCH OTO-RHINO-L, V278, P2961, DOI 10.1007/s00405-020-06423-8; Kowalski LP, 2020, CLINICS SAO PAULO, V6, P1507; Llewellyn CD, 2001, ORAL ONCOL, V37, P401, DOI 10.1016/S1368-8375(00)00135-4; Mandal R, 2018, BUNDESGESUNDHEITSBLA, V61, P1505, DOI 10.1007/s00103-018-2833-9; Menzin Joseph, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P68, DOI 10.1097/MOO.0b013e328017f669; National Institute of Dental and Craniofacial Research, 2018, OR CANC INC NEW CAS; Nita ME., 2010, AVALIACAO TECNOLOGIA, P600; Vasconcelos AMN, 2012, EPIDEMIOL SERV SAUDE, V21, P539, DOI 10.5123/S1679-49742012000400003; O'Sullivan B, 2016, LANCET ONCOL, V17, P440, DOI 10.1016/S1470-2045(15)00560-4; Organization WH, 2018, NONCOMMUNICABLE DIS; Janovsky CCPS, 2018, ARCH ENDOCRIN METAB, V62, P537, DOI 10.20945/2359-3997000000074; Sankaranarayanan R, 2015, CANC DIS CONTROL PRI; de Souza RJSP, 2009, AN BRAS DERMATOL, V84, P237, DOI 10.1590/S0365-05962009000300004; Speight PM, 2006, HEALTH TECHNOL ASSES, V10, P1; The World Bank Group, WORLD DEV IND PPP CO; Ukpo OC, 2011, AM J SURG PATHOL, V35, P1343, DOI 10.1097/PAS.0b013e318220e59d; Viacava F., 2002, CIENC SAUDE COLETIVA, V7, P607; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; World Health Organization, 2019, INT STAT CLASS DIS R, V11th	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246475	10.1371/journal.pone.0246475	http://dx.doi.org/10.1371/journal.pone.0246475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596233	Green Published, gold			2022-12-26	WOS:000620633200044
J	Nadin-Davis, SA; Falardeau, E; Flynn, A; Whitney, H; Marshall, HD				Nadin-Davis, Susan A.; Falardeau, Emilie; Flynn, Alex; Whitney, Hugh; Marshall, H. Dawn			Relationships between fox populations and rabies virus spread in northern Canada	PLOS ONE			English	Article							VULPES-VULPES; RED FOXES; TERRESTRIAL RABIES; ARCTIC RABIES; VARIANTS; SOFTWARE; ONTARIO; PHYLOGEOGRAPHY; EPIDEMIOLOGY; NEWFOUNDLAND	Rabies spreads in both Arctic (Vulpes lagopus) and red foxes (Vulpes vulpes) throughout the Canadian Arctic but limited wildlife disease surveillance, due to the extensive landmass of the Canadian north and its small widely scattered human population, undermines our knowledge of disease transmission patterns. This study has explored genetic population structure in both the rabies virus and its fox hosts to better understand factors that impact rabies spread. Phylogenetic analysis of 278 samples of the Arctic lineage of rabies virus recovered over 40 years identified four sub-lineages, A1 to A4. The A1 lineage has been restricted to southern regions of the Canadian province of Ontario. The A2 lineage, which predominates in Siberia, has also spread to northern Alaska while the A4 lineage was recovered from southern Alaska only. The A3 sub-lineage, which was also found in northern Alaska, has been responsible for virtually all cases across northern Canada and Greenland, where it further differentiated into 18 groups which have systematically evolved from a common predecessor since 1975. In areas of Arctic and red fox sympatry, viral groups appear to circulate in both hosts, but both mitochondrial DNA control region sequences and 9-locus microsatellite genotypes revealed contrasting phylogeographic patterns for the two fox species. Among 157 Arctic foxes, 33 mitochondrial control region haplotypes were identified but little genetic structure differentiating localities was detected. Among 162 red foxes, 18 control region haplotypes delineated three groups which discriminated among the Churchill region of Manitoba, northern Quebec and Labrador populations, and the coastal Labrador locality of Cartwright. Microsatellite analyses demonstrated some genetic heterogeneity among sampling localities of Arctic foxes but no obvious pattern, while two or three clusters of red foxes suggested some admixture between the Churchill and Quebec-Labrador regions but uniqueness of the Cartwright group. The limited population structure of Arctic foxes is consistent with the rapid spread of rabies virus subtypes throughout the north, while red fox population substructure suggests that disease spread in this host moves most readily down certain independent corridors such as the northeastern coast of Canada and the central interior. Interestingly the evidence suggests that these red fox populations have limited capacity to maintain the virus over the long term, but they may contribute to viral persistence in areas of red and Arctic fox sympatry.	[Nadin-Davis, Susan A.; Falardeau, Emilie] Canadian Food Inspect Agcy, Ottawa Lab Fallowfield, Natl Reference Ctr Rabies, Ottawa, ON, Canada; [Flynn, Alex; Whitney, Hugh; Marshall, H. Dawn] Mem Univ Newfoundland, Biol Dept, St John, NF, Canada; [Falardeau, Emilie] Publ Hlth Agcy Canada, Ctr Biosecur, Ottawa, ON, Canada	Canadian Food Inspection Agency; Memorial University Newfoundland; Public Health Agency of Canada	Nadin-Davis, SA (corresponding author), Canadian Food Inspect Agcy, Ottawa Lab Fallowfield, Natl Reference Ctr Rabies, Ottawa, ON, Canada.	nadindavis@gmail.com			Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN2014-05265]; NSERC-USRA (Undergraduate Student Research Award) [483239]; Animal Health Division of the Government of Newfoundland and Labrador	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC-USRA (Undergraduate Student Research Award); Animal Health Division of the Government of Newfoundland and Labrador	HM received a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant #RGPIN2014-05265 which supported this study (https://www.nserc-crsng.gc.ca) and AF was supported by an NSERC-USRA (Undergraduate Student Research Award), #483239 - 2015. SND received funds from the Animal Health Division of the Government of Newfoundland and Labrador. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aenishaenslin C, 2014, ECOHEALTH, V11, P343, DOI 10.1007/s10393-014-0923-1; An JH, 2010, MOL ECOL RESOUR, V10, P404, DOI 10.1111/j.1755-0998.2009.02827.x; [Anonymous], 2011, D248717E1 ASTM, DOI DOI 10.1520/D2487-17E01; [Anonymous], NATURAL EARTH; Aubry KB, 2009, MOL ECOL, V18, P2668, DOI 10.1111/j.1365-294X.2009.04222.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Berteaux D, 2017, POLAR RES, V36, DOI 10.1080/17518369.2017.1319602; Berteaux D, 2017, POLAR RES, V36, DOI 10.1080/17518369.2017.1347411; Calvelage S, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010115; Dalen L, 2005, BIOL J LINN SOC, V84, P79, DOI 10.1111/j.1095-8312.2005.00415.x; Dean D. J., 1996, P88; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fehiner-Gardiner C, 2008, J WILDLIFE DIS, V44, P71, DOI 10.7589/0090-3558-44.1.71; Forestry and Agrifoods Agency, RAB NEWF NEWF LABR U; FREDHOLM M, 1995, MAMM GENOME, V6, P11, DOI 10.1007/BF00350887; Fuglei E, 2019, POLAR RES-SWEDEN, V38, DOI 10.33265/polar.v38.3512; Garrott R, 1987, WILD FURBEARER MANAG, P395; Goldsmith EW, 2016, MOL ECOL, V25, P675, DOI 10.1111/mec.13509; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hanke D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004779; Henry JD, 1998, NAT HIST, V107, P60; HERSTEINSSON P, 1992, OIKOS, V64, P505, DOI 10.2307/3545168; Hueffer K, 2018, INT J CIRCUMPOL HEAL, V77, DOI 10.1080/22423982.2018.1475185; Jackson AC, 2013, RABIES: SCIENTIFIC BASIS OF THE DISEASE AND ITS MANAGEMENT, 3RD EDITION, P299, DOI 10.1016/B978-0-12-396547-9.00008-0; Kirschning J, 2007, BIOCHEM GENET, V45, P409, DOI 10.1007/s10528-007-9082-1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuzmin IV, 2008, EPIDEMIOL INFECT, V136, P509, DOI 10.1017/S095026880700903X; Kuzmin IV, 2004, J WILDLIFE DIS, V40, P617, DOI 10.7589/0090-3558-40.4.617; Lagace F., 1998, MEDECIN VET QUEBEC, V28, P106; Langille BL, 2014, J MAMMAL, V95, P772, DOI 10.1644/13-MAMM-A-221; MacInnes CD, 2001, J WILDLIFE DIS, V37, P119, DOI 10.7589/0090-3558-37.1.119; McClure E., 1975, CLARENCE BIRDSEYE LA, V72, P1; Mediouni S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08606-8; Mork T, 2004, ACTA VET SCAND, V45, P1, DOI 10.1186/1751-0147-45-1; Muller T, 2015, VET J, V203, P10, DOI 10.1016/j.tvjl.2014.10.026; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nadin-Davis SA, 2006, CAN J VET RES, V70, P11; Nadin-Davis SA, 1999, EPIDEMIOL INFECT, V123, P325, DOI 10.1017/S0950268899002885; Nadin-Davis S, 2008, J WILDLIFE DIS, V44, P86, DOI 10.7589/0090-3558-44.1.86; Nadin-Davis S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005541; Nadin-Davis SA, 2007, EMERG INFECT DIS, V13, P111, DOI 10.3201/eid1301.060702; Nadin-Davis SA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007699; Nadin-Davis SA, 2017, VIRUS RES, V232, P123, DOI 10.1016/j.virusres.2017.02.007; Nadin-Davis SA, 2012, VIRUS RES, V163, P352, DOI 10.1016/j.virusres.2011.10.026; NADINDAVIS SA, 1993, J GEN VIROL, V74, P829, DOI 10.1099/0022-1317-74-5-829; NADINDAVIS SA, 1994, J GEN VIROL, V75, P2575, DOI 10.1099/0022-1317-75-10-2575; Parkinson Alan J, 2005, Int J Circumpolar Health, V64, P478; PLUMMER P.J.G, 1954, BULL WORLD HEALTH ORGAN, V10, P767; Plummer P. J. G., 1947, CANADIAN JOUR COMP MED, V11, P330; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., FIGTREE V 1 4 3; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rupprecht CE, 2018, VET SCI, V5, DOI 10.3390/vetsci5020059; Simon A, 2019, POLAR RES, V38, DOI 10.33265/polar.v38.3366; Statham MJ, 2012, J MAMMAL, V93, P52, DOI 10.1644/11-MAMM-A-033.1; TABEL H, 1974, CAN VET J, V15, P271; Troupin C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006041; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wunner WH., 2013, RABIES SCI BASIS DIS, Vthird ed, P17	66	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246508	10.1371/journal.pone.0246508	http://dx.doi.org/10.1371/journal.pone.0246508			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592018	Green Published, gold			2022-12-26	WOS:000620632800061
J	Reinhard, K; Munch, TA				Reinhard, Katja; Munch, Thomas A.			Visual properties of human retinal ganglion cells	PLOS ONE			English	Article							PRIMATE RETINA; RECEPTIVE-FIELDS; OPPONENT PATHWAY; PARASOL; MIDGET; SENSITIVITY; RESPONSES; CHANNELS; CONE; INFORMATION	The retinal output is the sole source of visual information for the brain. Studies in non-primate mammals estimate that this information is carried by several dozens of retinal ganglion cell types, each informing the brain about different aspects of a visual scene. Even though morphological studies of primate retina suggest a similar diversity of ganglion cell types, research has focused on the function of only a few cell types. In human retina, recordings from individual cells are anecdotal or focus on a small subset of identified types. Here, we present the first systematic ex-vivo recording of light responses from 342 ganglion cells in human retinas obtained from donors. We find a great variety in the human retinal output in terms of preferences for positive or negative contrast, spatio-temporal frequency encoding, contrast sensitivity, and speed tuning. Some human ganglion cells showed similar response behavior as known cell types in other primate retinas, while we also recorded light responses that have not been described previously. This first extensive description of the human retinal output should facilitate interpretation of primate data and comparison to other mammalian species, and it lays the basis for the use of ex-vivo human retina for in-vitro analysis of novel treatment approaches.	[Reinhard, Katja; Munch, Thomas A.] Univ Tubingen, Ctr Integrat Neurosci & Bernstein Ctr Computat Ne, Retinal Circuits & Optogenet, Tubingen, Germany; [Reinhard, Katja] Univ Tubingen, Neurosci Grad Sch, Tubingen, Germany; [Munch, Thomas A.] Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany; [Reinhard, Katja] Neuroelect Res Flanders, Leuven, Belgium	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Reinhard, K; Munch, TA (corresponding author), Univ Tubingen, Ctr Integrat Neurosci & Bernstein Ctr Computat Ne, Retinal Circuits & Optogenet, Tubingen, Germany.; Reinhard, K (corresponding author), Univ Tubingen, Neurosci Grad Sch, Tubingen, Germany.; Munch, TA (corresponding author), Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany.; Reinhard, K (corresponding author), Neuroelect Res Flanders, Leuven, Belgium.	katja.r@gmx.ch; thomas.munch@gmail.com	Reinhard, Katja/AAA-9104-2022	Reinhard, Katja/0000-0002-8719-7445	Deutsche Forschungsgemeinschaft (DFG) [DFG EXC 307]; Bundesministerium fur Bildung and Forschung (BMBF) [FKZ 01GQ1002]; Pro-Retina Stipend; Lush Prize 2015 for young investigators	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung and Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Pro-Retina Stipend; Lush Prize 2015 for young investigators	This research was supported by funds of the Deutsche Forschungsgemeinschaft (DFG, https://www.dfg.de/en/) to the Werner Reichardt Centre for Integrative Neuroscience (DFG EXC 307), by the Bundesministerium fur Bildung and Forschung (BMBF, https://www.bmbf.de/en/index.html) to the Bernstein Center for Computational Neuroscience (FKZ 01GQ1002), a Pro-Retina Stipend (https://www.pro-retina-stiftung.de/) to KR, and the Lush Prize 2015 for young investigators (https://lushprize.org/) to KR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Busskamp V, 2011, CURR OPIN NEUROBIOL, V21, P942, DOI 10.1016/j.conb.2011.06.001; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chiao CC, 2003, NAT NEUROSCI, V6, P1251, DOI 10.1038/nn1147; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; Cowan CS, 2020, CELL, V182, P1623, DOI 10.1016/j.cell.2020.08.013; Cowan CS., 2019, CELL TYPES HUMAN RET, DOI [10.1101/703348, DOI 10.1101/703348]; Crook JD, 2014, VISUAL NEUROSCI, V31, P57, DOI 10.1017/S0952523813000461; Crook JD, 2009, J NEUROSCI, V29, P8372, DOI 10.1523/JNEUROSCI.1218-09.2009; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; Dacey DM, 2014, VISUAL NEUROSCI, V31, P139, DOI 10.1017/S0952523813000230; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; DACEY DM, 1992, VISUAL NEUROSCI, V9, P279, DOI 10.1017/S0952523800010695; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P167, DOI 10.1113/jphysiol.1975.sp011086; Detwiler PB, 2019, INVEST OPHTH VIS SCI, V60; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Diller L, 2004, J NEUROSCI, V24, P1079, DOI 10.1523/JNEUROSCI.3828-03.2004; Doi E, 2012, J NEUROSCI, V32, P16256, DOI 10.1523/JNEUROSCI.4036-12.2012; Dorn JD, 2013, JAMA OPHTHALMOL, V131, P183, DOI 10.1001/2013.jamaophthalmol.221; DRASDO N, 1974, BRIT J OPHTHALMOL, V58, P709, DOI 10.1136/bjo.58.8.709; Farrow K, 2013, NEURON, V78, P325, DOI 10.1016/j.neuron.2013.02.014; Farrow K, 2011, J NEUROPHYSIOL, V105, P1516, DOI 10.1152/jn.00331.2010; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; Field GD, 2007, J NEUROSCI, V27, P13261, DOI 10.1523/JNEUROSCI.3437-07.2007; Field GD, 2009, NAT NEUROSCI, V12, P1159, DOI 10.1038/nn.2353; Fiscella M, 2012, J NEUROSCI METH, V211, P103, DOI 10.1016/j.jneumeth.2012.08.017; Frey U, 2009, BIOSENS BIOELECTRON, V24, P2191, DOI 10.1016/j.bios.2008.11.028; Gauthier JL, 2009, J NEUROSCI, V29, P4675, DOI 10.1523/JNEUROSCI.5294-08.2009; Greschner M, 2011, J PHYSIOL-LONDON, V589, P75, DOI 10.1113/jphysiol.2010.193888; Grubb MS, 2005, J NEUROPHYSIOL, V93, P3224, DOI 10.1152/jn.00445.2004; Hashimoto T, 2013, J PHYSIOL-LONDON, V591, P327, DOI 10.1113/jphysiol.2012.243683; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; Kling A., 2020, BIORXIV, DOI 10.1101/2020.08.07.240762; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; LEE BB, 1994, VISION RES, V34, P3081, DOI 10.1016/0042-6989(94)90074-4; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; Marre O, 2012, J NEUROSCI, V32, P14859, DOI 10.1523/JNEUROSCI.0723-12.2012; Masri RA, 2019, J COMP NEUROL, V527, P236, DOI 10.1002/cne.24157; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Moritoh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054667; Mutter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081278; Nelidova D, 2020, SCIENCE, V368, P1108, DOI 10.1126/science.aaz5887; Peng YR, 2019, CELL, V176, P1222, DOI 10.1016/j.cell.2019.01.004; Peterson BB, 1998, VISUAL NEUROSCI, V15, P377, DOI 10.1017/S0952523898152161; Petrusca D, 2007, J NEUROSCI, V27, P11019, DOI 10.1523/JNEUROSCI.2836-07.2007; Polyak SL., 1941, RETINA-J RET VIT DIS; Reinhard K, 2016, INVEST OPHTH VIS SCI, V57, P658, DOI 10.1167/iovs.15-17751; Reinhard K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106148; RODIECK RW, 1985, J COMP NEUROL, V233, P115, DOI 10.1002/cne.902330107; ROVAMO J, 1978, NATURE, V271, P54, DOI 10.1038/271054a0; Russell TL, 2010, J NEUROPHYSIOL, V103, P2757, DOI 10.1152/jn.00987.2009; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; SCHILLER PH, 1977, J NEUROPHYSIOL, V40, P428, DOI 10.1152/jn.1977.40.2.428; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; Shlens J, 2009, J NEUROSCI, V29, P5022, DOI 10.1523/JNEUROSCI.5187-08.2009; Soto F, 2020, NEURON, V107, P656, DOI 10.1016/j.neuron.2020.05.030; Tibbetts MD, 2012, CURR OPIN OPHTHALMOL, V23, P226, DOI 10.1097/ICU.0b013e328352407d; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; van Wyk M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002143; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; WEINSTEIN GW, 1971, SCIENCE, V171, P1021, DOI 10.1126/science.171.3975.1021; Wong RCS, 2012, J NEUROPHYSIOL, V108, P2008, DOI 10.1152/jn.01091.2011; Yamada ES, 2005, VISUAL NEUROSCI, V22, P383, DOI 10.1017/S095252380522401X; Zeck GM, 2007, EUR J NEUROSCI, V26, P367, DOI 10.1111/j.1460-9568.2007.05670.x; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	72	8	8	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246952	10.1371/journal.pone.0246952	http://dx.doi.org/10.1371/journal.pone.0246952			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592045	gold, Green Submitted, Green Published			2022-12-26	WOS:000620632800064
J	Hwang, JH; Piao, HL; Jang, JY; Lee, SK; Han, D; Lee, GM; Go, C; Kim, YJ; Oh, KI; Kang, JS; Yan, JJ; Yang, J				Hwang, Ju Hee; Piao, Honglin; Jang, Joon Young; Lee, Sun-Kyung; Han, Dongkyu; Lee, Gwang-Min; Go, Cheolhyeon; Kim, Yejin; Oh, Kwon Ik; Kang, Jae Seung; Yan, Ji-Jing; Yang, Jaeseok			Suppressive effects of vitamin C-treated induced-regulatory T cells on heart allograft rejection under vitamin C-deficient or -sufficient conditions	PLOS ONE			English	Article							FOXP3 EXPRESSION; IN-VIVO; STABILITY; DIFFERENTIATION; DEMETHYLATION; MECHANISMS; CONVERSION	Foxp3 stability of vitamin C-treated induced-regulatory T cells (V-iTregs) is superior to that of conventional iTregs (C-iTregs). However, the role of V-iTregs in allograft rejection under vitamin C-deficient conditions, such as those seen in humans, remains unclear. We aimed to elucidate the role of vitamin C treatment on generation and maintenance of iTregs from gulo knockout (Gulo-KO) mice as well as wild type (WT) mice, and in vitro and in vivo suppressive effects of V-iTregs on heart allograft rejection in either Gulo-KO or WT recipient mice. Conversion efficiency of iTregs was similar between C- and V-iTregs in both WT and Gulo-KO mice. V-iTregs from WT or Gulo-KO mice showed better in vitro Foxp3 stability than C-iTregs, although there was no difference between WT V-iTregs and Gulo-KO V-iTregs. Furthermore, V-iTregs from WT or Gulo-KO mice suppressed in vitro T cell proliferation better than C-iTregs. Heterotrophic heart transplantation from BALB/c mice to WT or vitamin C-deficient Gulo-KO C57BL/6J mice was performed following adoptive transfer of C- or V-iTregs. V-iTregs as well as C-iTregs prolonged heart allograft survival in WT and Gulo-KO mice. However, there was no difference between the C- and V-iTreg groups. Supplementation of low- or high-dose vitamin C did not induce significant changes in heart allograft survival in Gulo-KO recipients that had received V-iTregs. In conclusion, V-iTregs do not exert better suppressive effects on heart allograft survival than C-iTregs in either WT or vitamin C-deficient recipients.	[Hwang, Ju Hee; Piao, Honglin; Jang, Joon Young; Lee, Sun-Kyung; Han, Dongkyu; Lee, Gwang-Min; Yan, Ji-Jing] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Piao, Honglin; Lee, Sun-Kyung] Seoul Natl Univ, Grad Sch, Dept Med, Coll Med, Seoul, South Korea; [Go, Cheolhyeon; Kim, Yejin; Kang, Jae Seung] Seoul Natl Univ, Dept Anat & Cell Biol, Coll Med, Seoul, South Korea; [Kim, Yejin; Kang, Jae Seung] Seoul Natl Univ, Inst Allergy & Clin Immunol, Med Res Ctr, Seoul, South Korea; [Oh, Kwon Ik] Hallym Univ, Dept Pathol, Coll Med, Chunchon, South Korea; [Yang, Jaeseok] Seoul Natl Univ Hosp, Transplantat Ctr, Seoul, South Korea; [Yang, Jaeseok] Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Hallym University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Yan, JJ (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea.; Yang, J (corresponding author), Seoul Natl Univ Hosp, Transplantat Ctr, Seoul, South Korea.; Yang, J (corresponding author), Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea.	jcyjs@snu.ac.kr; jjyanpharm@gmail.com	Kang, Jae Seung/J-5363-2012	Piao, Honglin/0000-0003-4829-6157; Lee, Gwangmin/0000-0002-9323-3334	Ministry of Health and Welfare [HI18C0532]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a grant from the Ministry of Health and Welfare (J.Y., HI18C0532). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Brender C, 2007, BLOOD, V110, P2528, DOI 10.1182/blood-2006-08-041541; BURNS JJ, 1957, NATURE, V180, P552, DOI 10.1038/180553a0; Chen SQ, 2020, AM J TRANSPLANT, V20, P2366, DOI 10.1111/ajt.15845; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Colamatteo A, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03136; D'Addio F, 2018, J CLIN INVEST, V128, P3490, DOI 10.1172/JCI94524; Dons EM, 2012, HUM IMMUNOL, V73, P328, DOI 10.1016/j.humimm.2011.12.011; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Kanamori M, 2016, TRENDS IMMUNOL, V37, P803, DOI 10.1016/j.it.2016.08.012; Kasahara H, 2017, INT IMMUNOL, V29, P457, DOI 10.1093/intimm/dxx060; Kim Hyemin, 2012, Immune Netw, V12, P18, DOI 10.4110/in.2012.12.1.18; Koenecke C, 2009, EUR J IMMUNOL, V39, P3091, DOI 10.1002/eji.200939432; Koo TY, 2017, KIDNEY INT, V92, P415, DOI 10.1016/j.kint.2017.01.031; Maeng HG, 2009, IMMUNOBIOLOGY, V214, P311, DOI 10.1016/j.imbio.2008.09.003; Nair VS, 2016, J IMMUNOL, V196, P2119, DOI 10.4049/jimmunol.1502352; Nair VS, 2014, BIOCHEM BIOPH RES CO, V450, P918, DOI 10.1016/j.bbrc.2014.06.110; Nikolouli E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00748; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Oyarce K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00112; Park S, 2019, TRANSPLANTATION, V103, pE248, DOI 10.1097/TP.0000000000002808; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Raffin C, 2020, NAT REV IMMUNOL, V20, P158, DOI 10.1038/s41577-019-0232-6; Romano M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00043; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; Takasato F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087722; Tang QZ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015552; Tao R, 2007, CURR OPIN IMMUNOL, V19, P589, DOI 10.1016/j.coi.2007.07.015; Vergani A, 2013, CIRCULATION, V127, P463, DOI 10.1161/CIRCULATIONAHA.112.123653; Yue XJ, 2016, J EXP MED, V213, P377, DOI 10.1084/jem.20151438	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246967	10.1371/journal.pone.0246967	http://dx.doi.org/10.1371/journal.pone.0246967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577562	gold, Green Published			2022-12-26	WOS:000620071700047
J	Gebuhr, C; Sheward, RM; Herrle, JO; Bollmann, J				Gebuehr, Christina; Sheward, Rosie M.; Herrle, Jens O.; Bollmann, Jorg			Strain-specific morphological response of the dominant calcifying phytoplankton species Emiliania huxleyi to salinity change	PLOS ONE			English	Article							COCCOLITH MORPHOLOGY; ISOTOPIC COMPOSITION; CARBONATE CHEMISTRY; OCEAN SALINITIES; GROWTH-RATE; CALCIFICATION; TEMPERATURE; SEA; PHOSPHORUS; NITROGEN	The future physiology of marine phytoplankton will be impacted by a range of changes in global ocean conditions, including salinity regimes that vary spatially and on a range of short- to geological timescales. Coccolithophores have global ecological and biogeochemical significance as the most important calcifying marine phytoplankton group. Previous research has shown that the morphology of their exoskeletal calcified plates (coccoliths) responds to changing salinity in the most abundant coccolithophore species, Emiliania huxleyi. However, the extent to which these responses may be strain-specific is not well established. Here we investigated the growth response of six strains of E. huxleyi under low (ca. 25) and high (ca. 45) salinity batch culture conditions and found substantial variability in the magnitude and direction of response to salinity change across strains. Growth rates declined under low and high salinity conditions in four of the six strains but increased under both low and high salinity in strain RCC1232 and were higher under low salinity and lower under high salinity in strain PLYB11. When detailed changes in coccolith and coccosphere size were quantified in two of these strains that were isolated from contrasting salinity regimes (coastal Norwegian low salinity of ca. 30 and Mediterranean high salinity of ca. 37), the Norwegian strain showed an average 26% larger mean coccolith size at high salinities compared to low salinities. In contrast, coccolith size in the Mediterranean strain showed a smaller size trend (11% increase) but severely impeded coccolith formation in the low salinity treatment. Coccosphere size similarly increased with salinity in the Norwegian strain but this trend was not observed in the Mediterranean strain. Coccolith size changes with salinity compiled for other strains also show variability, strongly suggesting that the effect of salinity change on coccolithophore morphology is likely to be strain specific. We propose that physiological adaptation to local conditions, in particular strategies for plasticity under stress, has an important role in determining ecotype responses to salinity.	[Gebuehr, Christina; Sheward, Rosie M.; Herrle, Jens O.] Goethe Univ Frankfurt, Inst Geosci, Frankfurt, Germany; [Gebuehr, Christina; Herrle, Jens O.] Biodivers & Climate Res Ctr BIK F, Frankfurt, Germany; [Bollmann, Jorg] Univ Toronto, Dept Earth Sci, Toronto, ON, Canada	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Toronto	Sheward, RM (corresponding author), Goethe Univ Frankfurt, Inst Geosci, Frankfurt, Germany.	sheward@em.uni-frankfurt.de		Sheward, Rosie/0000-0001-6857-2038	State of Hesse (Germany) in the framework of the Initiative for the Development of Scientific and Economic Excellence (LOEWE) the Biodiversity and Climate Centre Frankfurt (BIK-F) [R2107]; DAAD-Programm Strategische Partnerschaften of the Goethe-University Frankfurt [UoT6]; Freunde und Forderer der Goethe-Universitat Frankfurt am Main	State of Hesse (Germany) in the framework of the Initiative for the Development of Scientific and Economic Excellence (LOEWE) the Biodiversity and Climate Centre Frankfurt (BIK-F); DAAD-Programm Strategische Partnerschaften of the Goethe-University Frankfurt; Freunde und Forderer der Goethe-Universitat Frankfurt am Main	This research was financially supported by grants awarded to J.O.H by the State of Hesse (Germany) in the framework of the Initiative for the Development of Scientific and Economic Excellence (LOEWE) the Biodiversity and Climate Centre Frankfurt (BIK-F) grant number R2107 Project PB A, the DAAD-Programm Strategische Partnerschaften of the Goethe-University Frankfurt (grant number UoT6), and the Freunde und Forderer der Goethe-Universitat Frankfurt am Main (funding awarded to J.O.H in 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adloff F, 2015, CLIM DYNAM, V45, P2775, DOI 10.1007/s00382-015-2507-3; Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; [Anonymous], 2019, WATER SUI, DOI DOI 10.3390/W11091741; Arz HW, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000864; Bach LT, 2012, BIOGEOSCIENCES, V9, P3449, DOI 10.5194/bg-9-3449-2012; Berelson WM, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002803; BISSON MA, 1995, NATURWISSENSCHAFTEN, V82, P461, DOI 10.1007/s001140050216; Blanco-Ameijeiras S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157697; Bollmann J, 1997, MAR MICROPALEONTOL, V29, P319, DOI 10.1016/S0377-8398(96)00028-X; Bollmann J, 2008, PROTIST, V159, P369, DOI 10.1016/j.protis.2008.02.001; Bollmann J, 2007, EARTH PLANET SC LETT, V255, P273, DOI 10.1016/j.epsl.2006.12.029; Bollmann J, 2010, PROTIST, V161, P78, DOI 10.1016/j.protis.2009.08.002; Bollmann J, 2009, EARTH PLANET SC LETT, V284, P320, DOI 10.1016/j.epsl.2009.05.003; Borghini M, 2014, OCEAN SCI, V10, P693, DOI 10.5194/os-10-693-2014; Bown PR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P481; BRAND LE, 1984, ESTUAR COAST SHELF S, V18, P543, DOI 10.1016/0272-7714(84)90089-1; Broecker W, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2009PA001731; Burky D., 1974, BLACK SEA GEOL CHEM, V20, P353; CONAB-Companhia Nacional de Abastecimento, 2017, AC SAFR BRAS GRAOS 2, V5, P1, DOI DOI 10.3389/fnut.2018.00001; D'Amario B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201161; Danovaro R, 2007, IMPACTS CLIMATE CHAN; De Bodt C, 2010, BIOGEOSCIENCES, V7, P1401, DOI 10.5194/bg-7-1401-2010; DICKSON DMJ, 1987, NEW PHYTOL, V106, P645, DOI 10.1111/j.1469-8137.1987.tb00165.x; Durack PJ, 2015, OCEANOGRAPHY, V28, P20, DOI 10.5670/oceanog.2015.03; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; Durack PJ, 2010, J CLIMATE, V23, P4342, DOI 10.1175/2010JCLI3377.1; Evans D, 2018, GEOCHIM COSMOCHIM AC, V236, P198, DOI 10.1016/j.gca.2018.02.048; Faucher G, 2020, CLIM PAST, V16, P1007, DOI 10.5194/cp-16-1007-2020; Faucher G, 2017, BIOGEOSCIENCES, V14, P3603, DOI 10.5194/bg-14-3603-2017; Fenton M, 2000, MAR MICROPALEONTOL, V40, P277, DOI 10.1016/S0377-8398(00)00042-6; Fernandez E, 1996, J PLANKTON RES, V18, P2349, DOI 10.1093/plankt/18.12.2349; Fielding SR, 2013, LIMNOL OCEANOGR, V58, P663, DOI 10.4319/lo.2013.58.2.0663; Fielding SR, 2009, LIMNOL OCEANOGR, V54, P1475, DOI 10.4319/lo.2009.54.5.1475; Fielding SR, 2010, EMILIANIA HUXLEYI CU; Franklin DJ, 2010, MAR ECOL PROG SER, V410, P13, DOI 10.3354/meps08596; Frieder CA, 2017, ICES J MAR SCI, V74, P941, DOI 10.1093/icesjms/fsw213; Furevik T, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001118; Gebser B, 2013, MAR DRUGS, V11, P2168, DOI 10.3390/md11062168; Gerecht AC, 2015, J EXP MAR BIOL ECOL, V472, P24, DOI 10.1016/j.jembe.2015.06.019; Gibbs SJ, 2013, NAT GEOSCI, V6, P218, DOI 10.1038/ngeo1719; Green JC, 1998, PHYCOLOGIA, V37, P121, DOI 10.2216/i0031-8884-37-2-121.1; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hemleben C, 1996, PALEOCEANOGRAPHY, V11, P147, DOI 10.1029/95PA03838; Henehan MJ, 2017, BIOGEOSCIENCES, V14, P3287, DOI 10.5194/bg-14-3287-2017; Herrle JO, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22453-z; Israelson C, 1999, PALAEOGEOGR PALAEOCL, V153, P93, DOI 10.1016/S0031-0182(99)00068-1; Jones BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061868; KIRST GO, 1990, ANNU REV PLANT PHYS, V41, P21, DOI 10.1146/annurev.pp.41.060190.000321; KLEIJNE A, 1990, MAR MICROPALEONTOL, V16, P293, DOI 10.1016/0377-8398(90)90008-A; Kniebusch M, 2019, GEOPHYS RES LETT, V46, P9739, DOI 10.1029/2019GL083902; KRISTIANSEN S, 1994, SARSIA, V79, P357, DOI 10.1080/00364827.1994.10413567; Lamoureux SF, 2004, IMAGE ANAL SEDIMENTS, P330, DOI [10.1007/1-4020-2122-4, DOI 10.1007/1-4020-2122-4]; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Langer Gerald, 2011, Journal of Nannoplankton Research, V32, P29; LaRoche J, 2011, GUIDE BEST PRACTICES, P81, DOI [DOI 10.2777/66906, 10.2777/66906]; Lekha JS, 2018, J GEOPHYS RES-OCEANS, V123, P6330, DOI 10.1029/2018JC014181; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/ngeo1441, 10.1038/NGEO1441]; Lubke N, 2015, MAR MICROPALEONTOL, V117, P25, DOI 10.1016/j.marmicro.2015.03.002; Malin G, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P127; Monteiro FM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501822; Muller MN, 2012, BIOGEOSCIENCES, V9, P4155, DOI 10.5194/bg-9-4155-2012; Muller MN, 2008, LIMNOL OCEANOGR, V53, P506, DOI 10.4319/lo.2008.53.2.0506; Nederbragt AJ, 2004, IMAGE ANAL SEDIMENTS, P330, DOI [10.1007/1-4020-2122-4, DOI 10.1007/1-4020-2122-4]; O'Dea SA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6363; OKADA H, 1975, MAR BIOL, V31, P271, DOI 10.1007/BF00387154; Oviedo AM, 2014, J EXP MAR BIOL ECOL, V459, P105, DOI 10.1016/j.jembe.2014.04.021; Paasche E, 1996, PHYCOLOGIA, V35, P394, DOI 10.2216/i0031-8884-35-5-394.1; Paasche E, 1998, EUR J PHYCOL, V33, P33, DOI 10.1017/S0967026297001480; Perrin L, 2016, BIOGEOSCIENCES, V13, P5983, DOI 10.5194/bg-13-5983-2016; Poloczanska ES, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00062; Poulton AJ, 2011, MAR ECOL PROG SER, V443, P1, DOI 10.3354/meps09445; Qiu Y, 2019, J PHYS OCEANOGR, V49, P1201, DOI 10.1175/JPO-D-18-0228.1; Raffi I, 2006, QUATERNARY SCI REV, V25, P3113, DOI 10.1016/j.quascirev.2006.07.007; Rasul NMA, 2019, SPR OCEANOGR, P1, DOI 10.1007/978-3-319-99417-8_1; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Reusch TBH, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8195; Rhein M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P255; Rosas-Navarro A, 2016, BIOGEOSCIENCES, V13, P2913, DOI 10.5194/bg-13-2913-2016; Saruwatari K, 2016, BIOGEOSCIENCES, V13, P2743, DOI 10.5194/bg-13-2743-2016; Schafer-Neth C, 2004, SOUTH ATLANTIC IN THE LATE QUATERNARY: RECONSTRUCTION OF MATERIAL BUDGETS AND CURRENT SYSTEMS, P531; Schouten S, 2006, BIOGEOSCIENCES, V3, P113, DOI 10.5194/bg-3-113-2006; Sheward RM, 2017, BIOGEOSCIENCES, V14, P1493, DOI 10.5194/bg-14-1493-2017; Smith HEK, 2012, P NATL ACAD SCI USA, V109, P8845, DOI 10.1073/pnas.1117508109; Steinke M, 1998, MAR ECOL PROG SER, V175, P215, DOI 10.3354/meps175215; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Supraha L, 2020, BIOGEOSCIENCES, V17, P2955, DOI 10.5194/bg-17-2955-2020; THIERSTEIN HR, 1977, GEOLOGY, V5, P400, DOI 10.1130/0091-7613(1977)5<400:GSOLQC>2.0.CO;2; VAIRAVAMURTHY A, 1985, LIMNOL OCEANOGR, V30, P59, DOI 10.4319/lo.1985.30.1.0059; VIA S, 1993, AM NAT, V142, P352, DOI 10.1086/285542; von Dassow P, 2018, BIOGEOSCIENCES, V15, P1515, DOI 10.5194/bg-15-1515-2018; WATABE N, 1966, LIMNOL OCEANOGR, V11, P567, DOI 10.4319/lo.1966.11.4.0567; WESTBROEK P, 1993, GLOBAL PLANET CHANGE, V8, P27, DOI 10.1016/0921-8181(93)90061-R; WINTER A, 1979, MAR MICROPALEONTOL, V4, P197, DOI 10.1016/0377-8398(79)90017-3; Wit JC, 2013, BIOGEOSCIENCES, V10, P6375, DOI 10.5194/bg-10-6375-2013; Wolff T, 1999, USE PROXIES PALEOCEA, P207, DOI [DOI 10.1007/978-3-642-58646-0_8, 10.1007/978-3-642-58646-0_8]; Young J, 2003, J NANNOPLANKT RES; YOUNG JR, 1991, MAR MICROPALEONTOL, V18, P5, DOI 10.1016/0377-8398(91)90004-P; Young JR, 2000, DEEP-SEA RES PT II, V47, P1679, DOI 10.1016/S0967-0645(00)00003-5; Zhang Y., 2008, PLOS ONE, V3, pe3933; Ziveri P, 2007, DEEP-SEA RES PT II, V54, P659, DOI 10.1016/j.dsr2.2007.01.006; Zonneveld KAF, 2001, PROG OCEANOGR, V48, P25, DOI 10.1016/S0079-6611(00)00047-1; Zweng M.M., 2013, SALINITY, V2, P39, DOI [10.7289/V5251G4D, DOI 10.7289/V5251G4D]	103	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246745	10.1371/journal.pone.0246745	http://dx.doi.org/10.1371/journal.pone.0246745			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571269	gold, Green Published			2022-12-26	WOS:000618274000072
J	Maeda, S; Sakurai, K; Akamatsu, T; Matsuda, A; Yamamura, O; Kobayashi, M; Matsuishi, TF				Maeda, Saki; Sakurai, Kenji; Akamatsu, Tomonari; Matsuda, Ayaka; Yamamura, Orio; Kobayashi, Mari; Matsuishi, Takashi Fritz			Foraging activity of harbour porpoises around a bottom-gillnet in a coastal fishing ground, under the risk of bycatch	PLOS ONE			English	Article							PHOCOENA-PHOCOENA BYCATCH; LONG-TERM EFFECTIVENESS; DIVING BEHAVIOR; NOSED DOLPHINS; SEA-TURTLE; PINGERS; PATTERNS; HOKKAIDO; POPULATION; MORTALITY	Bycatch of harbour porpoises (Phocoena phocoena) by gillnets is a recognised threat to populations. To develop effective mitigation measures, understanding the mechanics of bycatch is essential. Previous studies in experimental conditions suggested foraging activity is an important factor influencing porpoises' reaction to gillnets. We acoustically observed the behaviour of wild harbour porpoises around a bottom-gillnet set-up in a commercial fishing ground, especially foraging activity. Passive acoustic event recorders (A-tags) were fixed to the ends of the gillnet, and recorded for 1 392 hours. Although harbour porpoises frequently and repeatedly appeared around the net each day, incidental bycatch occurred only three times during the observations. The stomach contents of two individuals contained mainly Ammodytes sp., which were observable around the bottom-gillnet but not targeted by the fishery. A total of 276 foraging incidents were acoustically detected, and 78.2% of the foraging activity was in the bottom layer (deeper than 25 m). Porpoises appeared around the net with more frequency on the day of a bycatch incident than on the days without bycatch. These results suggest that the harbour porpoises appeared around the bottom-gillnet to forage on fish distributed in the fishing ground, but not captured by this bottom-gillnet. Thus, porpoises face the risk of becoming entangled when foraging near a gillnet, with the probability of bycatch simply increasing with the length of time spent near the net. Bycatch mitigation measures are discussed.	[Maeda, Saki] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan; [Sakurai, Kenji] Rausu Fisheries Cooperat Assoc, Rausu, Hokkaido, Japan; [Akamatsu, Tomonari] Sasakawa Peace Fdn, Ocean Policy Res Inst, Minato Ku, Tokyo, Japan; [Matsuda, Ayaka; Yamamura, Orio; Matsuishi, Takashi Fritz] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido, Japan; [Kobayashi, Mari] Tokyo Univ Agr, Fac Bioind, Abashiri, Hokkaido, Japan	Hokkaido University; Hokkaido University; Tokyo University of Agriculture	Matsuishi, TF (corresponding author), Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido, Japan.	catm@fish.hokudai.ac.jp	Matsuishi, Takashi Fritz/C-7005-2012	Matsuishi, Takashi Fritz/0000-0003-0884-3523	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); JSPS KAKENHI [26450255, 18J30013]	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) to a project on Joint Usage/Research Center-Leading Academia in Marine and Environmet Pollution Research (LaMer) http://lamer-cmes.jp/ MATSUISHI Takashi Fritz JSPS KAKENHI Grant Number 26450255 https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-26450255/ (MATSUISHI Takashi Fritz, AKAMATSU Tomonari) JSPS KAKENHI Grant Number 18J30013 https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-18J30013/ (MATSUDA Ayaka) For all the funds above, the funders did not play a role in the study design, data collection and analysis, decision to publish, nor preparation of the manuscript.	Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Amano M, 2017, ENDANGER SPECIES RES, V32, P35, DOI 10.3354/esr00776; Bisack Kathryn D., 1997, Report of the International Whaling Commission, V47, P705; Bjorge A, 2013, BIOL CONSERV, V161, P164, DOI 10.1016/j.biocon.2013.03.009; Bostrom MK, 2013, AQUAT MAMM, V39, P389, DOI 10.1578/AM.39.4.2013.389; Campbell E, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.534507; Cantor AB., 2003, SAS SURVIVAL ANAL TE; Carretta JV, 2011, MAR TECHNOL SOC J, V45, P7, DOI 10.4031/MTSJ.45.5.3; Clarke M.R., 1986, P281; Clay TA, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00220; Davoren GK, 2007, CONSERV BIOL, V21, P1032, DOI 10.1111/j.1523-1739.2007.00694.x; Dawson SM, 1998, BIOL CONSERV, V84, P141, DOI 10.1016/S0006-3207(97)00127-4; Dawson SM, 2013, ENDANGER SPECIES RES, V19, P201, DOI 10.3354/esr00464; Dede A, 2014, J MAR BIOL ASSOC UK, V94, P1195, DOI 10.1017/S0025315413000568; DeRuiter SL, 2009, J EXP BIOL, V212, P3100, DOI 10.1242/jeb.030825; GASKIN DE, 1993, FISH B-NOAA, V91, P440; Gilman E, 2010, FISH FISH, V11, P57, DOI 10.1111/j.1467-2979.2009.00342.x; Higashisaka H, 2018, FISH RES, V204, P269, DOI 10.1016/j.fishres.2018.03.003; Iizuka Keiki, 2008, Bulletin of Fisheries Research Agency, P1; JEFFERSON TA, 1994, BIOL CONSERV, V67, P167, DOI 10.1016/0006-3207(94)90363-8; Kastelein R.A., 1995, P91; Kindt-Larsen L, 2019, MAR MAMMAL SCI, V35, P552, DOI 10.1111/mms.12552; Kraus SD, 1997, NATURE, V388, P525, DOI 10.1038/41451; Kubodera T., 2005, MANUAL IDENTIFICATIO; Larsen F, 2007, FISH RES, V85, P270, DOI 10.1016/j.fishres.2007.02.011; Larsen F, 2013, ENDANGER SPECIES RES, V20, P147, DOI 10.3354/esr00494; Leeney RH, 2015, HUM ECOL, V43, P105, DOI 10.1007/s10745-015-9727-3; Linnenschmidt M, 2013, MAR MAMMAL SCI, V29, pE77, DOI 10.1111/j.1748-7692.2012.00592.x; Lopez BD, 2006, ICES J MAR SCI, V63, P946, DOI 10.1016/j.icesjms.2005.06.012; Matsui N, 2021, AQUAT MAMM, V47; Matsui N, 2020, AQUAT MAMM, V46, P183, DOI 10.1578/AM.46.2.2020.183; Ministry of Agriculture Forestry and Fisheries, 2013, FISH CENS 2013; Mintzer VJ, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00191; Moore JE, 2009, MAR POLICY, V33, P435, DOI 10.1016/j.marpol.2008.09.003; Murray Kimberly T., 2000, Journal of Cetacean Research and Management, V2, P135; Nedelec C, 1990, FISHING MANUALS FISH; Nielsen TP, 2012, MAR ECOL PROG SER, V453, P241, DOI 10.3354/meps09630; Ohizumi H, 2000, MAR ECOL PROG SER, V200, P265, DOI 10.3354/meps200265; Otani S, 2000, MAR MAMMAL SCI, V16, P811, DOI 10.1111/j.1748-7692.2000.tb00973.x; Otani S, 1998, MAR MAMMAL SCI, V14, P209, DOI 10.1111/j.1748-7692.1998.tb00711.x; Palka Debra L., 2008, Journal of Cetacean Research and Management, V10, P217; Perrin WF, 1994, REP INT WHAL COMM SP; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Read AJ, 2003, P ROY SOC B-BIOL SCI, V270, pS90, DOI 10.1098/rsbl.2003.0021; Reeves R.R., 2001, WORKSH INT DOLPH FIS; Rihan Dominic, 2010, P315, DOI 10.1002/9780813810966.ch13; Schaffeld T, 2016, MAR ECOL PROG SER, V547, P257, DOI 10.3354/meps11627; Suuronen P, 2012, FISH RES, V119, P135, DOI 10.1016/j.fishres.2011.12.009; Taguchi M, 2010, MAMM STUDY, V35, P133, DOI 10.3106/041.035.0204; Trippel EA, 2003, MAR MAMMAL SCI, V19, P240, DOI 10.1111/j.1748-7692.2003.tb01106.x; Trippel EA, 1996, CAN J FISH AQUAT SCI, V53, P1294, DOI 10.1139/cjfas-53-6-1294; Verfuss UK, 2005, J EXP BIOL, V208, P3385, DOI 10.1242/jeb.01786; Villadsgaard A, 2007, J EXP BIOL, V210, P56, DOI 10.1242/jeb.02618; Vinther Morten, 2004, Journal of Cetacean Research and Management, V6, P19; Wright AJ, 2017, ANIM BEHAV, V133, P211, DOI 10.1016/j.anbehav.2017.09.015; Yoshida YM, 2014, BEHAV PROCESS, V108, P11, DOI 10.1016/j.beproc.2014.08.017	56	2	2	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246838	10.1371/journal.pone.0246838	http://dx.doi.org/10.1371/journal.pone.0246838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571306	Green Published, gold			2022-12-26	WOS:000618274000091
J	Gorski, JP; Franz, NT; Pernoud, D; Keightley, A; Eyre, DR; Oxford, JT				Gorski, Jeff P.; Franz, Nichole T.; Pernoud, Daniel; Keightley, Andrew; Eyre, David R.; Oxford, Julia Thom			A repeated triple lysine motif anchors complexes containing bone sialoprotein and the type XI collagen A1 chain involved in bone mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCOLLAGENOUS MATRIX PROTEINS; ACIDIC GLYCOPROTEIN-75; IN-VITRO; PHOSPHOPROTEIN COMPLEXES; BINDING DOMAIN; V COLLAGEN; HYDROXYAPATITE; NUCLEATION; EXPRESSION; COL11A1	While details remain unclear, initiation of woven bone mineralization is believed to be mediated by collagen and potentially nucleated by bone sialoprotein (BSP). Interestingly, our recent publication showed that BSP and type XI collagen form complexes in mineralizing osteoblastic cultures. To learn more, we examined the protein composition of extracellular sites of de novo hydroxyapatite deposition which were enriched in BSP and Col11a1 containing an alternatively spliced "6b" exonal sequence. An alternate splice variant "6a" sequence was not similarly co-localized. BSP and Col11a1 co-purify upon ion-exchange chromatography or immunoprecipitation. Binding of the Col11a1 "6b" exonal sequence to bone sialoprotein was demonstrated with overlapping peptides. Peptide 3, containing three unique lysine-triplet sequences, displayed the greatest binding to osteoblastic cultures; peptides containing fewer lysine triplet motifs or derived from the "6a" exon yielded dramatically lower binding. Similar results were obtained with 6-carboxyfluorescein (FAM)-conjugated peptides and western blots containing extracts from osteoblastic cultures. Mass spectroscopic mapping demonstrated that FAM-peptide 3 bound to 90 kDa BSP and its 18 to 60 kDa fragments, as well as to 110 kDa nucleolin. In osteoblastic cultures, FAM-peptide 3 localized to biomineralization foci (site of BSP) and to nucleoli (site of nucleolin). In bone sections, biotin-labeled peptide 3 bound to sites of new bone formation which were co-labeled with anti-BSP antibodies. These results establish the fluorescent peptide 3 conjugate as the first nonantibody-based method to identify BSP on western blots and in/on cells. Further examination of the "6b" splice variant interactions will likely reveal new insights into bone mineralization during development.	[Gorski, Jeff P.; Franz, Nichole T.] Univ Missouri, Sch Dent, Ctr Excellence Mineralized Tissue Res, Kansas City, MO 64110 USA; [Gorski, Jeff P.; Franz, Nichole T.; Pernoud, Daniel] Univ Missouri, Dept Oral & Craniofacial Sci, Sch Dent, Kansas City, MO 64110 USA; [Keightley, Andrew] Univ Missouri, Sch Med, Dept Ophthalmol & Prote Core Facil, Kansas City, MO 64110 USA; [Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Oxford, Julia Thom] Boise State Univ, Ctr Biomed Res Excellence Matrix Biol, Dept Biol Sci, Boise, ID 83725 USA; [Gorski, Jeff P.] Univ Missouri, Dept Oral & Craniofacial Sci, Ctr Excellence Mineralized Tissue Res, Sch Dent, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Washington; University of Washington Seattle; Idaho; Boise State University; University of Missouri System; University of Missouri Kansas City	Gorski, JP (corresponding author), Univ Missouri, Sch Dent, Ctr Excellence Mineralized Tissue Res, Kansas City, MO 64110 USA.; Gorski, JP (corresponding author), Univ Missouri, Dept Oral & Craniofacial Sci, Sch Dent, Kansas City, MO 64110 USA.; Gorski, JP (corresponding author), Univ Missouri, Dept Oral & Craniofacial Sci, Ctr Excellence Mineralized Tissue Res, Sch Dent, Kansas City, MO 64110 USA.	gorskij@umsytem.edu		Oxford, Julia/0000-0002-4850-3569	NIH [R21 DE14619, R01 AR052775, P20GM109095, P20GM103408]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support for this project was begun with funding from NIH (R21 DE14619; R01 AR052775) and finished with ancillary funds and personal contributions (J. P. G.). J. T. O. was supported by NIH P20GM109095 and P20GM103408. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aghajanian P, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0021-z; ARSENAULT AL, 1984, J CELL BIOL, V98, P911, DOI 10.1083/jcb.98.3.911; Baht GS, 2010, BIOCHEM J, V428, P385, DOI 10.1042/BJ20091864; BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854; Bilezikian J., 2019, PRINCIPLES BONE BIOL; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; BIRK DE, 1990, J CELL SCI, V95, P649; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; Booth KT, 2019, GENET MED, V21, P948, DOI 10.1038/s41436-018-0285-0; BOSKEY AL, 1989, CONNECT TISSUE RES, V21, P501; Bouleftour W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095144; Brown RJ, 2011, PROTEOMICS, V11, P4660, DOI 10.1002/pmic.201100058; CARMICHAEL DJ, 1971, CALC TISS RES, V7, P331, DOI 10.1007/BF02062622; CHEN J, 1994, HISTOCHEM J, V26, P67; CHEN Y, 1992, J BIOL CHEM, V267, P24871; Davies GBM, 1998, DEV DYNAM, V213, P12, DOI 10.1002/(SICI)1097-0177(199809)213:1<12::AID-AJA2>3.0.CO;2-0; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Fallahi A, 2005, PROTEIN SCI, V14, P1526, DOI 10.1110/ps.051363105; FICHARD A, 1995, MATRIX BIOL, V14, P515, DOI 10.1016/S0945-053X(05)80001-0; Fujiwara Y, 2011, J BIOL CHEM, V286, P21732, DOI 10.1074/jbc.M110.174680; GLIMCHER MJ, 1990, BIOMATERIALS, V11, P7; GLIMCHER MJ, 1989, ANAT REC, V224, P139, DOI 10.1002/ar.1092240205; Goldberg HA, 1996, CONNECT TISSUE RES, V35, P385, DOI 10.3109/03008209609029216; Gorski JP, 2011, J BIOL CHEM, V286, P1836, DOI 10.1074/jbc.M110.151647; Gorski JP, 2011, FRONT BIOSCI-LANDMRK, V16, P2598, DOI 10.2741/3875; GORSKI JP, 1992, CALCIFIED TISSUE INT, V50, P391, DOI 10.1007/BF00296767; Gorski JP, 2004, J BIOL CHEM, V279, P25455, DOI 10.1074/jbc.M312408200; GORSKI JP, 1990, J BIOL CHEM, V265, P14956; Gorski JP, 1998, CRIT REV ORAL BIOL M, V9, P201, DOI 10.1177/10454411980090020401; Griffith AJ, 1998, AM J HUM GENET, V62, P816, DOI 10.1086/301789; Hafez A, 2015, J DEV BIOL, V3, P158, DOI 10.3390/jdb3040158; Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495; Hansen U, 2003, J BIOL CHEM, V278, P37352, DOI 10.1074/jbc.M304325200; Holm E, 2015, BONE, V71, P145, DOI 10.1016/j.bone.2014.10.007; Huffman NT, 2007, J BIOL CHEM, V282, P26002, DOI 10.1074/jbc.M701332200; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Jiang CY, 2018, CONNECT TISSUE RES, V59, P274, DOI 10.1080/03008207.2017.1379514; Kahler RA, 2008, MATRIX BIOL, V27, P330, DOI 10.1016/j.matbio.2008.01.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDIS WJ, 1991, CONNECT TISSUE RES, V25, P181, DOI 10.3109/03008209109029155; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Magnuson SK, 1997, J BONE MINER RES, V12, P200, DOI 10.1359/jbmr.1997.12.2.200; Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294; Medeck RJ, 2003, BIOCHEM J, V376, P361, DOI 10.1042/BJ20030894; Midura RJ, 2004, J BIOL CHEM, V279, P25464, DOI 10.1074/jbc.M312409200; Millan JL, 2016, CALCIFIED TISSUE INT, V98, P398, DOI 10.1007/s00223-015-0079-1; Moradi-Ameli M, 1998, MATRIX BIOL, V17, P393, DOI 10.1016/S0945-053X(98)90091-9; Morris NP, 2000, J HISTOCHEM CYTOCHEM, V48, P725, DOI 10.1177/002215540004800601; Nisole S, 2002, J BIOL CHEM, V277, P20877, DOI 10.1074/jbc.M110024200; OXFORD JT, 1995, J BIOL CHEM, V270, P9478, DOI 10.1074/jbc.270.16.9478; Riminucci M, 1998, J BONE MINER RES, V13, P1852, DOI 10.1359/jbmr.1998.13.12.1852; Rousseau JC, 1996, J BIOL CHEM, V271, P23743, DOI 10.1074/jbc.271.39.23743; SEEGMILLER R, 1971, J CELL BIOL, V48, P580, DOI 10.1083/jcb.48.3.580; Sirko-Osadsa D, 1998, J PEDIATR-US, V132, P368, DOI 10.1016/S0022-3476(98)70466-4; Smith SM, 2012, EXP EYE RES, V98, P105, DOI 10.1016/j.exer.2010.08.003; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Tompson SW, 2010, AM J HUM GENET, V87, P708, DOI 10.1016/j.ajhg.2010.10.009; Tye CE, 2003, J BIOL CHEM, V278, P7949, DOI 10.1074/jbc.M211915200; Tye CE, 2005, J BIOL CHEM, V280, P13487, DOI 10.1074/jbc.M408923200; Vaughan-Thomas A, 2001, J BIOL CHEM, V276, P5303, DOI 10.1074/jbc.M008764200; Wang CY, 2009, J BIOL CHEM, V284, P7100, DOI 10.1074/jbc.M805898200; Warner LR, 2007, PROTEIN EXPRES PURIF, V52, P403, DOI 10.1016/j.pep.2006.10.016; Wenstrup RJ, 2011, J BIOL CHEM, V286, P20455, DOI 10.1074/jbc.M111.223693; Whyte MP, 2016, J CLIN ENDOCR METAB, V101, P333, DOI 10.1210/jc.2015-3462; Whyte MP, 2012, NEW ENGL J MED, V366, P904, DOI 10.1056/NEJMoa1106173	66	4	4	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100436	10.1016/j.jbc.2021.100436	http://dx.doi.org/10.1016/j.jbc.2021.100436			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610546	Green Published, gold			2022-12-26	WOS:000672866400410
J	Wang, XJ; Wu, HJ; Zhao, LL; Liu, ZY; Qi, MZ; Jin, YP; Liu, W				Wang, Xiaojuan; Wu, Hanjie; Zhao, Lingling; Liu, Zeyao; Qi, Maozhen; Jin, Yaping; Liu, Wei			FLCN regulates transferrin receptor 1 transport and iron homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIRT-HOGG-DUBE; TUMOR-SUPPRESSOR; MTOR ACTIVATION; DOWN-REGULATION; MESSENGER-RNA; FOLLICULIN; GENE; PROTEIN; KIDNEY; METABOLISM	Birt-Hogg-Dube (BHD) syndrome is a multiorgan disorder caused by inactivation of the folliculin (FLCN) protein. Previously, we identified FLCN as a binding protein of Rab11A, a key regulator of the endocytic recycling pathway. This finding implies that the abnormal localization of specific proteins whose transport requires the FLCN-Rab11A complex may contribute to BHD. Here, we used human kidney-derived HEK293 cells as a model, and we report that FLCN promotes the binding of Rab11A with transferrin receptor 1 (TfR1), which is required for iron uptake through continuous trafficking between the cell surface and the cytoplasm. Loss of FLCN attenuated the Rab11A-TfR1 interaction, resulting in delayed recycling transport of TfR1. This delay caused an iron deficiency condition that induced hypoxia-inducible factor (HIF) activity, which was reversed by iron supplementation. In a Drosophila model of BHD syndrome, we further demonstrated that the phenotype of BHD mutant larvae was substantially rescued by an iron-rich diet. These findings reveal a conserved function of FLCN in iron metabolism and may help to elucidate the mechanisms driving BHD syndrome.	[Wang, Xiaojuan; Wu, Hanjie; Zhao, Lingling; Liu, Zeyao; Qi, Maozhen; Jin, Yaping; Liu, Wei] Northwest A&F Univ, Coll Vet Med, Yangling, Shanxi, Peoples R China; [Wang, Xiaojuan] Pulike Biol Engn Inc, Natl Res Ctr Vet Med, Luoyang 471000, Henan, Peoples R China; [Zhao, Lingling] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou 325035, Zhejiang, Peoples R China	Northwest A&F University - China; Wenzhou Medical University	Jin, YP; Liu, W (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shanxi, Peoples R China.	yapingjin@163.com; wliu20cn@nwafu.edu.cn	qi, maozhen/HIA-0257-2022	Zhao, Lingling/0000-0002-8907-6495	National Natural Science Foundation of China [31372256]; Program of Shaanxi Province Science and Technology Innovation Team [2019TD-036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shaanxi Province Science and Technology Innovation Team	This work was supported by the National Natural Science Foundation of China (31372256) to W. L. and was partly supported by Program of Shaanxi Province Science and Technology Innovation Team (2019TD-036).	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Baba M, 2016, STEM CELLS, V34, P1068, DOI 10.1002/stem.2293; Baba M, 2012, BLOOD, V120, P1254, DOI 10.1182/blood-2012-02-410407; Barbeito AG, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-50; Bianchi L, 1999, NUCLEIC ACIDS RES, V27, P4223, DOI 10.1093/nar/27.21.4223; Chaston TB, 2003, AM J HEMATOL, V73, P200, DOI 10.1002/ajh.10348; Chen CY, 2013, CELL METAB, V17, P343, DOI 10.1016/j.cmet.2013.01.013; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; Cui C, 2019, CANCER MANAG RES, V11, P6323, DOI 10.2147/CMAR.S198911; Fujita H, 2013, J CELL SCI, V126, P2798, DOI 10.1242/jcs.119909; Ghio AJ, 2009, BBA-GEN SUBJECTS, V1790, P731, DOI 10.1016/j.bbagen.2008.11.004; Gijezen LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099071; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Greene CJ, 2017, ONCOTARGET, V8, P107052, DOI 10.18632/oncotarget.22323; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Hasumi H, 2015, P NATL ACAD SCI USA, V112, pE1624, DOI 10.1073/pnas.1419502112; Hasumi H, 2012, JNCI-J NATL CANCER I, V104, P1750, DOI 10.1093/jnci/djs418; Hasumi Y, 2014, HUM MOL GENET, V23, P5706, DOI 10.1093/hmg/ddu286; Hong SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015793; Hong SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-160; Kawabata H, 2019, FREE RADICAL BIO MED, V133, P46, DOI 10.1016/j.freeradbiomed.2018.06.037; Kennedy JC, 2019, HUM MOL GENET, V28, P3270, DOI 10.1093/hmg/ddz158; Klomp JA, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-59; Kuhn LC, 2015, METALLOMICS, V7, P232, DOI [10.1039/c4mt00164h, 10.1039/C4MT00164H]; Laviolette LA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15866; Li S, 2010, CELL RES, V20, P1148, DOI 10.1038/cr.2010.102; Lim JE, 2005, NAT GENET, V37, P1270, DOI 10.1038/ng1659; Liu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065869; Mathieu J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08020-0; Matsui T, 2011, TRAFFIC, V12, P1432, DOI 10.1111/j.1600-0854.2011.01240.x; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Nookala RK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120071; OWEN D, 1987, EMBO J, V6, P1287, DOI 10.1002/j.1460-2075.1987.tb02366.x; Pacitto A, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150174; Peli-Gulli MP, 2015, CELL REP, V13, P1, DOI 10.1016/j.celrep.2015.08.059; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Possik E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004273; Preston RS, 2011, ONCOGENE, V30, P1159, DOI 10.1038/onc.2010.497; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Riedelberger M, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3552; Roberg KJ, 1997, GENETICS, V147, P1569; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; Starling GP, 2016, EMBO REP, V17, P823, DOI 10.15252/embr.201541382; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takagi Y, 2008, ONCOGENE, V27, P5339, DOI 10.1038/onc.2008.261; Tong XJ, 2002, BRIT J HAEMATOL, V116, P458, DOI 10.1046/j.0007-1048.2001.03289.x; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van Slegtenhorst M, 2007, J BIOL CHEM, V282, P24583, DOI 10.1074/jbc.M700857200; van Swelm RPL, 2020, NAT REV NEPHROL, V16, P77, DOI 10.1038/s41581-019-0197-5; Wada S, 2016, GENE DEV, V30, P2551, DOI 10.1101/gad.287953.116; Wang D, 2010, IUBMB LIFE, V62, P629, DOI 10.1002/iub.363; WANG GL, 1993, BLOOD, V82, P3610; Wright JA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00156; Wu MS, 2015, ONCOTARGET, V6, P32761, DOI 10.18632/oncotarget.5018; Wu XC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157100; Yan M, 2016, GENE DEV, V30, P1034, DOI 10.1101/gad.281410.116; Yan M, 2014, J CLIN INVEST, V124, P2640, DOI 10.1172/JCI71749; Yu SY, 2014, J BIOL CHEM, V289, P32030, DOI 10.1074/jbc.M113.538223; Zhao LL, 2018, J CELL SCI, V131, DOI 10.1242/jcs.218792; Zheng JC, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00688	65	0	0	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100426	10.1016/j.jbc.2021.100426	http://dx.doi.org/10.1016/j.jbc.2021.100426			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33609526	Green Published, gold			2022-12-26	WOS:000672866400400
J	Lima, RDL; Bocker, U; McDougall, GJ; Allwood, JW; Afseth, NK; Wubshet, SG				Lima, Rita de Cassia Lemos; Bocker, Ulrike; McDougall, Gordon J.; Allwood, J. William; Afseth, Nils Kristian; Wubshet, Sileshi Gizachew			Magnetic ligand fishing using immobilized DPP-IV for identification of antidiabetic ligands in lingonberry extract	PLOS ONE			English	Article								In this work, a new magnetic ligand fishing probe for discovery of DPP-IV inhibitory ligands was developed and it was tested as a proof of concept on the fruit extract of Vaccinium vitis-idaea (lingonberry). The ligands were shown to have appreciable dipeptidyl peptidase IV (DPP-IV) inhibitory activity (IC50: 31.8 mu g mL-1).) Inhibition of DPP-IV is a well-known therapeutic approach for management of type 2 diabetes (T2D). DPP-IV was successfully immobilized onto magnetic beads and was shown to retain its catalytic activity and selectivity over a model mixture. A total of four ligands were successfully fished out and identified as cyanidin-3-galactoside (2), cyanidin-3-arabinoside (3), proanthocynidin A (4), and 10-carboxyl-pyranopeonidin 3-O-(6 ''-O-p-coumaroyl)-glucoside (5) using HPLC/HRMS.	[Lima, Rita de Cassia Lemos; Bocker, Ulrike; Afseth, Nils Kristian; Wubshet, Sileshi Gizachew] NOFIMA AS, As, Norway; [McDougall, Gordon J.; Allwood, J. William] James Hutton Inst, Environm & Biochem Sci Dept, Plant Biochem & Food Qual Grp, Invergowrie, Dundee, Scotland	Nofima; James Hutton Institute	Lima, RDL; Wubshet, SG (corresponding author), NOFIMA AS, As, Norway.	ritalemosrm@gmail.com; sileshi.wubshet@nofima.no			Research Council of Norway [261849/F20, 262300/F40]; Rural Affairs Food and Environment Strategic Research Group of the Scottish Government	Research Council of Norway(Research Council of Norway); Rural Affairs Food and Environment Strategic Research Group of the Scottish Government	The Research Council of Norway is greatly acknowledged for the financial support for R.C.L.L. and S.G.W. (Project no. 261849/F20) and U.B. and N.K.A. (Project no.262300/F40). The Hutton authors gratefully acknowledge support for G.J.M. and J.W.A. through Strategic Research Portfolio funding from the Rural Affairs Food and Environment Strategic Research Group of the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-masri IM, 2009, J ENZYM INHIB MED CH, V24, P1061, DOI 10.1080/14756360802610761; Barbosa O, 2014, RSC ADV, V4, P1583, DOI 10.1039/c3ra45991h; Berger Joel P, 2018, Endocrinol Diabetes Metab, V1, pe00002, DOI 10.1002/edm2.2; Boath AS, 2012, FOOD CHEM, V135, P929, DOI 10.1016/j.foodchem.2012.06.065; Capeletti LB, 2012, FOURIER TRANSFORM IN, V1st, P13; Casedas G, 2019, S AFR J BOT, V120, P241, DOI 10.1016/j.sajb.2018.07.001; Ciesla L, 2016, NAT PROD REP, V33, P1131, DOI 10.1039/c6np00016a; Cornell S, 2020, J CLIN PHARM THER, V45, P17, DOI 10.1111/jcpt.13230; Denny PW, 2018, EXPERT OPIN DRUG DIS, V13, P1153, DOI 10.1080/17460441.2018.1534826; Edirisinghe I, 2016, J BERRY RES, V6, P237, DOI 10.3233/JBR-160137; Ek S, 2006, J AGR FOOD CHEM, V54, P9834, DOI 10.1021/jf0623687; Fan JF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/479505; Hansen KB, 2005, ORG PROCESS RES DEV, V9, P634, DOI 10.1021/op0500786; Hsu K-C, 2013, BIOACTIVE FOOD PEPTI, V3rd, P13; Hussain H., 2019, EXPERT OPIN THER PAT, V29, P7, DOI [10.1080/13543776.2019.1549230, DOI 10.1080/13543776.2019.1549230]; Jain MR, 2017, BRIT J PHARMACOL, V174, P2346, DOI 10.1111/bph.13842; Jiang JB, 2019, TALANTA, V195, P127, DOI 10.1016/j.talanta.2018.11.009; Johnson MH, 2013, MOL NUTR FOOD RES, V57, P1182, DOI 10.1002/mnfr.201200678; Kylli P, 2011, J AGR FOOD CHEM, V59, P3373, DOI 10.1021/jf104621e; Liu DM, 2017, TALANTA, V164, P548, DOI 10.1016/j.talanta.2016.12.028; Liu R, 2017, MOLECULES, V22, DOI 10.3390/molecules22101714; McDougall GJ, 2008, J AGR FOOD CHEM, V56, P3016, DOI 10.1021/jf073469n; McDougall GJ, 2009, FOOD CHEM, V115, P193, DOI 10.1016/j.foodchem.2008.11.093; Patil PD, 2017, DRUG DES DEV THER, V11, P1567, DOI 10.2147/DDDT.S133453; Petersen MJ, 2019, PHYTOCHEMISTRY, V164, P94, DOI 10.1016/j.phytochem.2019.04.016; Rodrigues T, 2016, NAT CHEM, V8, P531, DOI [10.1038/NCHEM.2479, 10.1038/nchem.2479]; ShibuyaSaruta H, 1996, J CLIN LAB ANAL, V10, P435, DOI 10.1002/(SICI)1098-2825(1996)10:6<435::AID-JCLA21>3.0.CO;2-X; Tao Y, 2013, J PHARMACEUT BIOMED, V78-79, P190, DOI 10.1016/j.jpba.2013.02.024; Tella H, 2015, THER ADV ENDOCRINOL, V6, P109, DOI 10.1177/2042018815580257; Torronen R, 2012, BRIT J NUTR, V107, P1445, DOI 10.1017/S0007114511004557; Virtanen JK, 2015, AM J CLIN NUTR, V101, P1088, DOI 10.3945/ajcn.114.104109; Wang HB, 2015, J CHROMATOGR A, V1392, P20, DOI 10.1016/j.chroma.2015.03.002; Wubshet SG, 2019, TALANTA, V200, P279, DOI 10.1016/j.talanta.2019.03.047; Wubshet SG, 2015, J NAT PROD, V78, P2657, DOI 10.1021/acs.jnatprod.5b00603; Zheng YX, 2021, FOOD CHEM, V335, DOI 10.1016/j.foodchem.2020.127666; Zhu WJ, 2018, J FOOD SCI, V83, P1131, DOI 10.1111/1750-3841.14087; Zhuo RJ, 2016, MOLECULES, V21, DOI 10.3390/molecules21111516	37	2	2	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247329	10.1371/journal.pone.0247329	http://dx.doi.org/10.1371/journal.pone.0247329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617581	Green Published, gold			2022-12-26	WOS:000623082400034
J	Mohammadi, E; Ghasemi, E; Azadnajafabad, S; Rezaei, N; Moghaddam, SS; Meimand, SE; Fattahi, N; Habibi, Z; Yarandi, KK; Amirjamshidi, A; Nejat, F; Kompani, F; Mokdad, AH; Larijani, B; Farzadfar, F				Mohammadi, Esmaeil; Ghasemi, Erfan; Azadnajafabad, Sina; Rezaei, Negar; Saeedi Moghaddam, Sahar; Ebrahimi Meimand, Sepideh; Fattahi, Nima; Habibi, Zohreh; Karimi Yarandi, Kourosh; Amirjamshidi, Abbas; Nejat, Farideh; Kompani, Farzad; Mokdad, Ali H.; Larijani, Bagher; Farzadfar, Farshad			A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017	PLOS ONE			English	Article							GENDER-DIFFERENCES; TUMORS; HEALTH; SURVIVAL; ACCESS; MORTALITY; ADULTS; TRENDS; RISK; LIFE	Primary brain and other central nervous system (CNS) cancers cause major burdens. In this study, we introduced a measure named the Quality of Care Index (QCI), which indirectly evaluates the quality of care given to patients with this group of cancers. Here we aimed to compare different geographic and socioeconomic patterns of CNS cancer care according to the novel measure introduced. In this regard, we acquired age-standardized primary epidemiologic measures were acquired from the Global Burden of Disease (GBD) study 1990-2017. The primary measures were combined to make four secondary indices which all of them indirectly show the quality of care given to patients. Principal Component Analysis (PCA) method was utilized to calculate the essential component named QCI. Further analyses were made based on QCI to assess the quality of care globally, regionally, and nationally (with a scale of 0-100 which higher values represent better quality of care). For 2017, the global calculated QCI was 55.0. QCI showed a desirable condition in higher socio-demographic index (SDI) quintiles. Oppositely, low SDI quintile countries (7.7) had critically worse care quality. Western Pacific Region with the highest (76.9) and African Region with the lowest QCIs (9.9) were the two WHO regions extremes. Singapore was the country with the maximum QCI of 100, followed by Japan (99.9) and South Korea (98.9). In contrast, Swaziland (2.5), Lesotho (3.5), and Vanuatu (3.9) were countries with the worse condition. While the quality of care for most regions was desirable, regions with economic constraints showed to have poor quality of care and require enforcements toward this lethal diagnosis.	[Mohammadi, Esmaeil; Ghasemi, Erfan; Azadnajafabad, Sina; Rezaei, Negar; Saeedi Moghaddam, Sahar; Ebrahimi Meimand, Sepideh; Fattahi, Nima; Farzadfar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran; [Mohammadi, Esmaeil] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Rezaei, Negar; Larijani, Bagher; Farzadfar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Habibi, Zohreh; Nejat, Farideh] Univ Tehran Med Sci, Childrens Hosp Med Ctr, Dept Neurosurg, Tehran, Iran; [Karimi Yarandi, Kourosh; Amirjamshidi, Abbas] Univ Tehran Med Sci, Sina Hosp, Dept Neurosurg, Tehran, Iran; [Kompani, Farzad] Univ Tehran Med Sci, Div Hematol & Oncol, Pediat Ctr Excellence, Childrens Med Ctr, Tehran, Iran; [Mokdad, Ali H.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Mokdad, Ali H.] Univ Washington, Dept Hlth Metr Sci, Seattle, WA 98195 USA	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Farzadfar, F (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran.; Farzadfar, F (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran.	f-farzadfar@tums.ac.ir	Saeedi Moghaddam, Sahar/AGX-5835-2022; Mohammadi, Esmaeil/AAO-6835-2020; Azadnajafabad, Sina/ABC-5770-2020; Mokdad, Ali H./AAD-1232-2022; Fattahi, Nima/ABG-6252-2021; Saeedi Moghaddam, Sahar/AEO-8071-2022; Rezaei, Negar/AAS-8147-2020; fattahi, nima/Q-2280-2016; Habibi, Zohreh/B-6693-2018	Saeedi Moghaddam, Sahar/0000-0002-3112-9179; Mohammadi, Esmaeil/0000-0001-9592-2611; Azadnajafabad, Sina/0000-0003-0105-3801; Mokdad, Ali H./0000-0002-4994-3339; Saeedi Moghaddam, Sahar/0000-0002-3112-9179; Rezaei, Negar/0000-0001-7047-7638; fattahi, nima/0000-0002-5518-3129; Habibi, Zohreh/0000-0002-5771-1167; Larijani, Bagher/0000-0001-5386-7597; Farzadfar, Farshad/0000-0001-8288-4046				Ahmadi N., 2020, PLOS ONE 2020 NOV 20, DOI [doi.org/10.17504/protocols.io.bprjmm4n, DOI 10.17504/PROTOCOLS.IO.BPRJMM4N]; Andrulis DP, 1998, ANN INTERN MED, V129, P412, DOI 10.7326/0003-4819-129-5-199809010-00012; Anisimov VN, 2001, EXP GERONTOL, V36, P1101, DOI 10.1016/S0531-5565(01)00114-0; Bohn A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198581; Brustugun OT, 2014, BRIT J CANCER, V111, P1014, DOI 10.1038/bjc.2014.364; Davis FG, 2001, NEURO-ONCOLOGY, V3, P152, DOI 10.1093/neuonc/3.3.152; Dirven L., 2016, EXPERT REV QUAL LIFE, V1, P37, DOI [10.1080/23809000.2016.1136793, DOI 10.1080/23809000.2016.1136793]; Dover LL, 2018, NEURO-ONCOLOGY, V20, P986, DOI 10.1093/neuonc/nox220; Duflo E, 2012, J ECON LIT, V50, P1051, DOI 10.1257/jel.50.4.1051; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fullman N, 2018, LANCET, V391, P2236, DOI [10.1016/S0140-6736(18)30994-2, 10.1016/s0140-6736(18)30994-2]; Goins RT, 2005, J RURAL HEALTH, V21, P206, DOI 10.1111/j.1748-0361.2005.tb00084.x; Gurney JG, 1996, CANCER, V78, P532; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Harris MI, 2001, DIABETES CARE, V24, P454, DOI 10.2337/diacare.24.3.454; Institute for Health Metrics and Evaluation (IHME), 2020, GBD COMP DAT VIS; Kelly Patrick J, 2010, Surg Neurol Int, V1, P96, DOI 10.4103/2152-7806.74243; Khalilabad MR, 2020, J DIABETES METAB DIS, P1; Kline Nancy E, 2003, J Pediatr Nurs, V18, P96, DOI 10.1053/jpdn.2003.12; Linet MS, 1999, JNCI-J NATL CANCER I, V91, P1051, DOI 10.1093/jnci/91.12.1051; Liu R, 2009, NEURO-ONCOLOGY, V11, P330, DOI 10.1215/15228517-2008-093; Mauvais-Jarvis F, 2020, LANCET, V396, P565, DOI 10.1016/S0140-6736(20)31561-0; McKinney PA, 2004, J NEUROL NEUROSUR PS, V75, P12, DOI 10.1136/jnnp.2004.040741; Merzel C, 2000, AM J PUBLIC HEALTH, V90, P909, DOI 10.2105/AJPH.90.6.909; MODAN B, 1992, AM J EPIDEMIOL, V135, P1349, DOI 10.1093/oxfordjournals.aje.a116246; Mohammadi E, 2021, J DIABETES METAB DIS, V20, P825, DOI 10.1007/s40200-020-00654-6; Moore KA, 2006, SOC INDIC RES, V75, P45, DOI 10.1007/s11205-004-6398-7; Naghavi Mohsen, 2009, Popul Health Metr, V7, P9, DOI 10.1186/1478-7954-7-9; Ostrom QT, 2018, NEURO-ONCOLOGY, V20, P576, DOI 10.1093/neuonc/noy002; Ostrom QT, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00019; Owens GM, 2008, J MANAGE CARE PHARM, V14, pS2; Patel AP, 2019, LANCET NEUROL, V18, P376, DOI 10.1016/S1474-4422(18)30468-X; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Permanyer I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215742; Ray S, 2014, AM HEALTH DRUG BENEF, V7, P140; Rencher A.C., 2005, IIE T, V37, P1083, DOI DOI 10.1080/07408170500232784; RIGGS JE, 1995, ARCH NEUROL-CHICAGO, V52, P571, DOI 10.1001/archneur.1995.00540300043011; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Sorenson SB, 2011, AM J PUBLIC HEALTH, V101, pS353, DOI 10.2105/AJPH.2010.300029; Stevens GA., 2016, LANCET LONDON ENGLAN, V388, P23, DOI [10.1016/s0140-6736%2816%2930388-9, DOI 10.1016/S0140-6736%2816%2930388-9]; Tamimi AF, 2015, NEUROEPIDEMIOLOGY, V45, P100, DOI 10.1159/000438926; Vaidya V, 2012, J WOMENS HEALTH, V21, P140, DOI 10.1089/jwh.2011.2876; Villano JL, 2011, BRIT J CANCER, V105, P1414, DOI 10.1038/bjc.2011.357; Vostakolaei FA, 2011, EUR J PUBLIC HEALTH, V21, P573, DOI 10.1093/eurpub/ckq120; Yari KK., 2020, ASIAN SPINE J	46	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247120	10.1371/journal.pone.0247120	http://dx.doi.org/10.1371/journal.pone.0247120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QO3ZL	33617563	Green Published, gold			2022-12-26	WOS:000623082400039
J	Ali, AA; Mukhtar, MM; Shaheen, S; Mohamed, AO				Ali, Amin Ahmed; Mukhtar, Muawia Mohamed; Shaheen, Samir; Mohamed, Abdelrahim Osman			Assessment of plasma BMP-2, BMP-7, BMP-10, vitamin D, and TGF beta 1 in simple fractures among Sudanese patients	PLOS ONE			English	Article								Background Bone morphogenetic proteins (BMP) are multifunctional proteins. They work as cytokines regulating osteogenesis during fracture healing process. The objectives of this study were to assess changes in BMPs during fracture and their correlations to Fracture's healing. Methods Case-Control hospital-based study conducted from January 2018 to January 2019. Demographic data, anthropometric measurements, and blood samples were collected from patients and controls (18-65 years old). Plasma concentrations of selected BMPs and vitamin D were measured using quantitative enzyme linked immunosorbent assay (ELISA). SPSS version 25 was used to calculate frequencies, Pearson correlation tests, chi-square and unpaired t-test. Results Sixty-five patients with fractures and Sixty-five controls were studied. Means of plasma concentrations were (TGF beta 1 = 21.07 ng/ml +/- 8.49 and 19.8 ng/ml +/- 7.2) (BMP-2 = 76.3 pg/ml +/- 156.6 and 55.5 ng/ml +/- 127.9) (BMP-7 = 13.02 pg/ml +/- 43.5 and 64.6pg/ml +/- 250) (BMP-10 = 8.14 pg/ml +/- 12.7 and 5.48 pg/ml +/- 11.3) (Vitamin D mean was 24.94 ng/ml +/- 13.2 and 26.2 ng/ml +/- 11.6) in patients and controls, respectively. Forty-five subjects were enrolled into follow up study: 30 males, 15 females. Healing time mean was 4.13 +/- 2.6 months. No significant correlation between BMP-2/BMP-7 with healing time. Conclusions BMP-7 was significantly lowers in the plasma of patients that controls (P = 0.042). Low Vitamin D was observed among Sudanese participants.	[Ali, Amin Ahmed; Mohamed, Abdelrahim Osman] Univ Khartoum, Dept Biochem, Fac Med, Khartoum, Sudan; [Mukhtar, Muawia Mohamed] Univ Khartoum, Dept Immunol, Inst Endem Dis, Khartoum, Sudan; [Shaheen, Samir] Univ Khartoum, Dept Orthoped & Trauma Surg, Fac Med, Khartoum, Sudan	University of Khartoum; University of Khartoum; University of Khartoum	Ali, AA (corresponding author), Univ Khartoum, Dept Biochem, Fac Med, Khartoum, Sudan.	amin_ahmed_ali@yahoo.com		ali, amin/0000-0002-5746-7707	Deutscher Akademischer Austauschdienst (DAAD) In-Country Scholarship program [57377187]	Deutscher Akademischer Austauschdienst (DAAD) In-Country Scholarship program(Deutscher Akademischer Austausch Dienst (DAAD))	This project was funded by Deutscher Akademischer Austauschdienst (DAAD) In-Country Scholarship program 2017. Awarded to A.A. (ref. no. 57377187). The funding party at any part of the study formulation, methodology, data analysis, or interpretation attempted no intervention.	Bakheit KH, 2010, J OBSTET GYNAECOL, V30, P151, DOI 10.3109/01443610903391005; Bikbov MM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25928-1; Cauley JA, 2011, CLIN ORTHOP RELAT R, V469, P1891, DOI 10.1007/s11999-011-1863-5; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Driver J, 2015, J BIOL CHEM, V290, P9959, DOI 10.1074/jbc.M114.616888; Foulke BA, 2016, MATURITAS, V92, P49, DOI 10.1016/j.maturitas.2016.07.014; Garrison KR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006950.pub2; He WB, 2019, CYTOKINE, V120, P1, DOI 10.1016/j.cyto.2019.03.020; Huo T, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0858-2; Husain N., 2019, J FAM MED PRIM CARE; Karpouzos A, 2017, J OSTEOPOROS, V2017, DOI 10.1155/2017/4218472; Katagiri T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021899; Kuster RP, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18114010; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Myers G, 2015, AM J CLIN NUTR, V102, P958, DOI 10.3945/ajcn.115.109892; Rajaei S., 2016, INT J REPROD BIOMED; Rausch V, 2017, ORTHOPADE, V46, P640, DOI 10.1007/s00132-017-3449-8; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Santos TS, 2015, J CELL BIOCHEM, V116, P2896, DOI 10.1002/jcb.25237; Sogayar MC., 2014, J DENT RES; Steeves JA, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0235-z; Talati M., 2014, PLOS ONE; Taormina DP., 2014, GERIATR ORTHOP SURG; The British Editorial Society of Bone Joint Surgery, 2012, INFL HEM AN FRACT HE; Timur UT, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040795; van Baardewijk LJ, 2013, INT ORTHOP, V37, P523, DOI 10.1007/s00264-012-1750-z	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247472	10.1371/journal.pone.0247472	http://dx.doi.org/10.1371/journal.pone.0247472			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606840	Green Published, gold			2022-12-26	WOS:000620629200025
J	Bierlein, M; Hedgespeth, BA; Azcarate-Peril, MA; Stauffer, SH; Gookin, JL				Bierlein, Metzere; Hedgespeth, Barry A.; Azcarate-Peril, M. Andrea; Stauffer, Stephen H.; Gookin, Jody L.			Dysbiosis of fecal microbiota in cats with naturally occurring and experimentally induced Tritrichomonas foetus infection	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TRICHOMONAS-VAGINALIS; HEALTHY CATS; DIARRHEA; DOGS; CARBOHYDRATE; DIET; METABOLISM; DIVERSITY; APOPTOSIS	The protozoal pathogen Tritrichomonas foetus infects the colon of domestic cats and is a major cause of chronic colitis and diarrhea. Treatment failure is common, but antibiotics may improve clinical signs in a subset of cats, leading researchers to question involvement of the colonic microbiota in disease pathogenesis. Studies performed in women with venereal Trichomonas vaginalis infections have revealed that dysbiosis of host microbiota contributes to pathogenicity with similar findings also found in mice with intestinal Tritrichomonas musculis The aim of this study was to characterize differences in the fecal microbiota of cats with and without naturally occurring T. foetus infection and in a group of kittens prior to and after experimentally induced infection. Archived fecal DNA from cats undergoing testing for T. foetus infection (n = 89) and experimentally infected kittens (n = 4; at pre-, 2 weeks, and 9 weeks post-infection) were analyzed by sequencing of 16S rRNA genes. Amongst the naturally infected population, the genera Megamonas and Helicobacter were significantly increased in prevalence and abundance in cats testing positive for T. foetus infection. In the group of four experimentally infected kittens, fecal samples post-infection had significantly lower abundance of genus Dialister and Megamonas and greater abundance of the class Betaproteobacteria and family Succinivibrionaceae. We hypothesize that T. foetus promotes dysbiosis by competition for fermentable substrates used by these bacteria and that metabolic byproducts may contribute to the pathogenesis of colonic inflammation and diarrhea. Future studies are warranted for the measurement of fecal concentrations of microbial and protozoal metabolites in cats with T. foetus infection for the identification of potential therapeutic targets.	[Bierlein, Metzere; Hedgespeth, Barry A.; Stauffer, Stephen H.; Gookin, Jody L.] North Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27695 USA; [Bierlein, Metzere; Hedgespeth, Barry A.; Stauffer, Stephen H.; Gookin, Jody L.] North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA; [Azcarate-Peril, M. Andrea] Univ N Carolina, Div Gastroenterol & Hepatol, Dept Med,Sch Med, UNC Microbiome Core,Ctr Gastrointestinal Biol & D, Chapel Hill, NC 27515 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Gookin, JL (corresponding author), North Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27695 USA.; Gookin, JL (corresponding author), North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA.	Jody_Gookin@ncsu.edu	Azcarate-Peril, M. Andrea/AAA-9056-2022; Azcarate-Peril, M. Andrea/AFO-7157-2022; Core, UNC Microbiome/AAB-3304-2022	Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Gookin, Jody/0000-0002-2911-0874; Hedgespeth, Barry/0000-0002-0399-7163	Paul and Lea Levine Foundation; North Carolina Veterinary Medical Foundation's Support for T. foetus Research and Innovation in Veterinary Education fund (NCVMF-STRIVE); Center for Gastrointestinal Biology and Disease (CGIBD) [P30 DK034987]; UNC Nutrition Obesity Research Center (NORC) [P30 DK056350]	Paul and Lea Levine Foundation; North Carolina Veterinary Medical Foundation's Support for T. foetus Research and Innovation in Veterinary Education fund (NCVMF-STRIVE); Center for Gastrointestinal Biology and Disease (CGIBD); UNC Nutrition Obesity Research Center (NORC)	These studies were supported by the Paul and Lea Levine Foundation (JLG) and the North Carolina Veterinary Medical Foundation's Support for T. foetus Research and Innovation in Veterinary Education fund (NCVMF-STRIVE)(JLG). The UNC Microbiome Core is supported in part by P30 DK034987 Center for Gastrointestinal Biology and Disease (CGIBD) and P30 DK056350 UNC Nutrition Obesity Research Center (NORC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071630; Ahn MH, 2008, PARASITE IMMUNOL, V30, P410, DOI 10.1111/j.1365-3024.2008.01037.x; Beloshapka AN, 2013, FEMS MICROBIOL ECOL, V84, P532, DOI 10.1111/1574-6941.12081; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bermingham EN, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01231; Bermingham EN, 2013, MICROBIOLOGYOPEN, V2, P173, DOI 10.1002/mbo3.60; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brotman RM, 2012, SEX TRANSM DIS, V39, P807, DOI 10.1097/OLQ.0b013e3182631c79; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chang JH, 2004, MOL CELLS, V18, P177; Chudnovskiy A, 2016, CELL, V167, P444, DOI 10.1016/j.cell.2016.08.076; da Costa RFM, 2005, CELL RES, V15, P704, DOI 10.1038/sj.cr.7290340; Deusch O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144881; Fernandez-Veledo S, 2019, REV ENDOCR METAB DIS, V20, P439, DOI 10.1007/s11154-019-09513-z; Figueroa-Angulo EE, 2012, MICROBES INFECT, V14, P1411, DOI 10.1016/j.micinf.2012.09.004; Foster DM, 2004, JAVMA-J AM VET MED A, V225, P888, DOI 10.2460/javma.2004.225.888; Garcia-Mazcorro JF, 2017, PEERJ, V5, DOI 10.7717/peerj.3184; Garcia-Mazcorro JF, 2011, FEMS MICROBIOL ECOL, V78, P542, DOI 10.1111/j.1574-6941.2011.01185.x; Gookin JL, 2010, VET PARASITOL, V172, P139, DOI 10.1016/j.vetpar.2010.04.014; Gookin JL, 2010, J VET INTERN MED, V24, P1003, DOI 10.1111/j.1939-1676.2010.0534.x; Gookin JL, 2004, J CLIN MICROBIOL, V42, P2707, DOI 10.1128/JCM.42.6.2707-2710.2004; Gookin JL, 2002, J CLIN MICROBIOL, V40, P4126, DOI 10.1128/JCM.40.11.4126-4130.2002; Gookin JL, 2001, AM J VET RES, V62, P1690, DOI 10.2460/ajvr.2001.62.1690; Gookin JL, 1999, J AM VET MED ASSOC, V215, P1450; Gookin JL, 2007, AM J VET RES, V68, P1085, DOI 10.2460/ajvr.68.10.1085; Gookin JL, 2017, J FELINE MED SURG, V19, P261, DOI 10.1177/1098612X17693499; Gunn-Moore DA, 2007, J FELINE MED SURG, V9, P214, DOI 10.1016/j.jfms.2007.01.003; Hedgespeth BA, 2020, J VET INTERN MED, V34, P734, DOI 10.1111/jvim.15727; Hinderfeld AS, 2020, MICROB PATHOGENESIS, V138, DOI 10.1016/j.micpath.2019.103820; Hinderfeld AS, 2019, INFECT IMMUN, V87, DOI [10.1128/IAI.00141-19, 10.1128/iai.00141-19]; Hooda S, 2013, BRIT J NUTR, V109, P1637, DOI 10.1017/S0007114512003479; Jackson MI, 2019, GUT MICROBES, V10, P298, DOI 10.1080/19490976.2018.1526580; Jarrett OD, 2019, J INFECT DIS, V220, P1503, DOI 10.1093/infdis/jiz354; Jia J, 2011, LETT APPL MICROBIOL, V53, P288, DOI 10.1111/j.1472-765X.2011.03105.x; Jia J, 2011, FEMS MICROBIOL ECOL, V78, P395, DOI 10.1111/j.1574-6941.2011.01172.x; Kather EJ, 2007, J VET INTERN MED, V21, P966, DOI 10.1892/0891-6640(2007)21[966:DOTIVS]2.0.CO;2; Kerr KR, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.21; Li GP, 2015, J MICROBIOL BIOTECHN, V25, P1136, DOI 10.4014/jmb.1412.12047; LINDMARK DG, 1989, J PROTOZOOL, V36, P214, DOI 10.1111/j.1550-7408.1989.tb01076.x; Macias-Ceja DC, 2019, MUCOSAL IMMUNOL, V12, P178, DOI 10.1038/s41385-018-0087-3; Marsilio S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55691-w; Midlej V, 2010, PARASITOLOGY, V137, P65, DOI 10.1017/S0031182009991041; Minamoto Y, 2015, GUT MICROBES, V6, P33, DOI 10.1080/19490976.2014.997612; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Sandri M, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0981-z; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Singh BN, 2004, INFECT IMMUN, V72, P4151, DOI 10.1128/IAI.72.7.4151-4158.2004; Sommer U, 2005, J BIOL CHEM, V280, P23853, DOI 10.1074/jbc.M501752200; Stauffer SH, 2008, J VET DIAGN INVEST, V20, P639, DOI 10.1177/104063870802000518; Suchodolski JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127378; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Tolbert MK, 2016, J VET INTERN MED, V30, P516, DOI 10.1111/jvim.13920; Vogt AH, 2010, J AM ANIM HOSP ASSOC, V46, P70, DOI 10.5326/0460070; Wei YX, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.00303-20; Yaeger MJ, 2005, VET PATHOL, V42, P797, DOI 10.1354/vp.42-6-797; Yao CQ, 2015, VET RES, V46, DOI 10.1186/s13567-015-0169-0; Young WN, 2016, SCI REP-UK, V6, DOI 10.1038/srep34668	60	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246957	10.1371/journal.pone.0246957	http://dx.doi.org/10.1371/journal.pone.0246957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606740	Green Published, gold			2022-12-26	WOS:000620629200133
J	Zeng, FF				Zeng, Fangfang			Measuring convergence in the sugarcane industry in China's Guangxi province	PLOS ONE			English	Article								Using the agricultural industry convergence framework, we analyzed the main sugarcane producing areas in China's Guangxi province from 2010 to 2017. We selected the key elements on sugarcane industry convergence and on the benefit derived from industry convergence and development. We selected six secondary indexes and 18 tertiary indexes and used them to construct an overarching index system for measuring the convergence degree of sugarcane in the primary, secondary, and tertiary industries. We calculated the index's system weight using the AHP and entropy method, and then the integrated development indicator of the sugarcane industry. Finally, we analyzed the convergence the development stage, achievements, and benefits of the sugarcane industry, as well as the shortage of convergence development. Our findings can provide guidance for the future development of the sugarcane industry in China from the perspective of industry convergence.	[Zeng, Fangfang] Fujian Agr & Forestry Univ, Rural Dev Inst, Fuzhou, Fujian, Peoples R China; [Zeng, Fangfang] Fujian Agr & Forestry Univ, Jinshan Coll, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Zeng, FF (corresponding author), Fujian Agr & Forestry Univ, Rural Dev Inst, Fuzhou, Fujian, Peoples R China.; Zeng, FF (corresponding author), Fujian Agr & Forestry Univ, Jinshan Coll, Fuzhou, Fujian, Peoples R China.	13960757675@139.com			Construction of Modern Agriculture (Sugarcane) Industry Technology System [CARS-20-11B]	Construction of Modern Agriculture (Sugarcane) Industry Technology System	This work was supported by The Construction of Modern Agriculture (Sugarcane) Industry Technology System (CARS-20-11B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldarelli CE, 2018, LAND USE POLICY, V76, P264, DOI 10.1016/j.landusepol.2018.05.008; Dlamini M.M, 2019, S AFR J AGRIC EXT, V32, P36; Farzad Somayeh, 2017, ECOL MODEL, V29, P17; Gomez Sal Antonio, 2016, AGR ECOSYSTEMS ENV, V39, P83; Gomez-Sal Antonio, 2013, ECOL MODEL, V25, P72; Jolly L, 2018, SUGAR TECH, V45, P94; Li Xiang-mei, 2015, ECOL MODEL, V27, P68; Mhlanga-Ndlovu BFN, 2019, JAMBA-J DISASTER RIS, V11, DOI 10.4102/jamba.v11i2.697; Ndlangamandla Knowledge., 2017, STUD AGRIC ECON, V26, P93; Nieder-Heitmann M, 2019, J CLEAN PROD, V239, DOI 10.1016/j.jclepro.2019.118039; Patil Dilip S., 2017, SSRN ELECT J, V26, P769; Sahu Omprakash, 2018, ANN AGRARIAN SCI, V16, P121; Sarker TC, 2017, WASTE BIOMASS VALORI, V8, P241, DOI 10.1007/s12649-016-9665-3; Soltangheisi A, 2019, GCB BIOENERGY, V11, P1444, DOI 10.1111/gcbb.12650; Vieira A.L, 2018, REV ENGENHARIA TERMI, V15, P9; Weeks M, 2017, WESTERN HIST QUART, V48, P367, DOI 10.1093/whq/whx004; Xu DongDong, 2016, Journal of Landscape Research, V8, P137; Yafei-Ma, 2019, PRODUCTIVITY RES, P39	18	0	0	7	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0244617	10.1371/journal.pone.0244617	http://dx.doi.org/10.1371/journal.pone.0244617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606674	gold, Green Published			2022-12-26	WOS:000620629200086
J	Dhakulkar, S; Das, M; Sutar, N; Oswal, V; Shah, D; Ravi, S; Vengurlekar, D; Chavan, V; Rebello, L; Meneguim, AC; Iyer, A; Mansoor, H; Kalon, S; Acharya, S; Ferlazzo, G; Isaakidis, P; Thakur, HP				Dhakulkar, Shubhangi; Das, Mrinalini; Sutar, Narendra; Oswal, Vikas; Shah, Daksha; Ravi, Shilpa; Vengurlekar, Dipa; Chavan, Vijay; Rebello, Lorraine; Meneguim, Augusto C.; Iyer, Aparna; Mansoor, Homa; Kalon, Stobdan; Acharya, Shrikala; Ferlazzo, Gabriella; Isaakidis, Petros; Thakur, Harshad P.			Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India	PLOS ONE			English	Article								Background Childhood and adolescent drug-resistant TB (DR-TB) is one of the neglected infectious diseases. Limited evidence exists around programmatic outcomes of children and adolescents receiving DR-TB treatment. The study aimed to determine the final treatment outcomes, culture conversion rates and factors associated with unsuccessful treatment outcome in children and adolescents with DR-TB. Methods This is a descriptive study including children (0-9 years) and adolescents (10-19 years) with DR-TB were who were initiated on ambulatory based treatment between January 2017-June 2018 in Shatabdi hospital, Mumbai, India where National TB elimination programme(NTEP) Mumbai collaborates with chest physicians and Medecins Sans Frontieres(MSF) in providing comprehensive care to DR-TB patients. The patients with available end-of-treatment outcomes were included. The data was censored on February 2020. Result A total of 268 patients were included; 16 (6%) of them were children (0-9 years). The median(min-max) age was 17(4-19) years and 192 (72%) were females. Majority (199, 74%) had pulmonary TB. Most (58%) had MDR-TB while 42% had fluoroquinolone-resistant TB. The median(IQR) duration of treatment (n = 239) was 24(10-25) months. Median(IQR) time for culture-conversion (n = 128) was 3(3-4) months. Of 268 patients, 166(62%) had successful end-of-treatment outcomes (cured-112; completed treatment-54). Children below 10 years had higher proportion of successful treatment outcomes (94% versus 60%) compared to adolescents. Patients with undernutrition [adjusted odds-ratio, aOR (95% Confidence Interval, 95%CI): 2.5 (1.3-4.8) or those with XDR-TB [aOR (95% CI): 4.3 (1.3-13.8)] had higher likelihood of having unsuccessful DR-TB treatment outcome. Conclusion High proportion of successful treatment outcome was reported, better than global reports. Further, the nutritional support and routine treatment follow up should be strengthened. All oral short and long regimens including systematic use of new TB drugs (Bedaquiline and Delamanid) should be rapidly scaled up in routine TB programme, especially for the paediatric and adolescent population.	[Dhakulkar, Shubhangi; Sutar, Narendra; Oswal, Vikas; Shah, Daksha] Natl TB Eliminat Programme, Mumbai, Maharashtra, India; [Das, Mrinalini; Ravi, Shilpa; Vengurlekar, Dipa; Chavan, Vijay; Rebello, Lorraine; Meneguim, Augusto C.; Iyer, Aparna; Mansoor, Homa; Kalon, Stobdan] Medecins Sans Frontieres Doctors Borders, Mumbai, Maharashtra, India; [Das, Mrinalini; Thakur, Harshad P.] Tata Inst Social Sci, Mumbai, Maharashtra, India; [Acharya, Shrikala] Mumbai Dist AIDS Control Soc, Mumbai, Maharashtra, India; [Ferlazzo, Gabriella; Isaakidis, Petros] Medecins Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa; [Thakur, Harshad P.] Natl Inst Hlth & Family Welfare, New Delhi, India	Tata Institute of Social Sciences	Das, M (corresponding author), Medecins Sans Frontieres Doctors Borders, Mumbai, Maharashtra, India.; Das, M (corresponding author), Tata Inst Social Sci, Mumbai, Maharashtra, India.	msfocb-delhi-epi@brussels.msf.org		Isaakidis, Petros/0000-0002-7881-1554; Thakur, Harshad/0000-0003-3597-7113; Das, Mrinalini/0000-0002-1354-4299; Acharya, Shrikala/0000-0001-8968-4258				Abebe G, 2017, INTERNAT J MYCOBACTE, V6, P239; [Anonymous], 2017, NATL STRATEGIC PLAN; Bhering M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218299; Brigden G, 2015, EXPERT REV ANTI-INFE, V13, P451, DOI 10.1586/14787210.2015.1015991; Central TB Division, INDIA TB REP 2020 NA; Central TB Division, GUID PROGR MAN DRUG; Central TB Division, 2019, REV NAT TUB CONTR PR; Dalal A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116798; Dodd PJ, 2016, LANCET INFECT DIS, V16, P1193, DOI 10.1016/S1473-3099(16)30132-3; Garcia-Prats A J, 2018, Int J Tuberc Lung Dis, V22, P15, DOI 10.5588/ijtld.17.0355; Harausz EP, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002591; International Union Against Tuberculosis and Lung Disease, 2019, INT J TUBERC LUNG D, V23; Isaakidis P, 2015, INT J TUBERC LUNG D, V19, P969, DOI 10.5588/ijtld.15.0123; Isaakidis P., 2013, PLOS ONE, V8; Isaakidis P, 2015, ARCH PEDIATR INFECT, V3, DOI 10.5812/pedinfect.30400v2; Kalra A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236057; Mistry N, 2012, OPER RES HEALTH CARE, V1, P45, DOI 10.1016/j.orhc.2012.06.001; Mohr-Holland E, 2020, ECLINICALMEDICINE, V20, DOI 10.1016/j.eclinm.2020.100290; Moyo S, 2015, ARCH PEDIATR INFECT, V3, DOI 10.5812/pedinfect.17934; Osman M, 2019, EMERG INFECT DIS, V25, P441, DOI 10.3201/eid2503.180852; Padmapriyadarsini C, 2016, INDIAN J MED RES, V143, P11, DOI 10.4103/0971-5916.193278; Raizada N., 2018, ACCELERATING ACCESS, V340, P1; Revised National TB Control Programme, 2018, NIKSH 20 INT ICT SYS; Samuel Blesson, 2016, J Tuberc Res, V4, P213, DOI 10.4236/jtr.2016.44023; Schaaf HS, 2019, INDIAN J PEDIATR, V86, P717, DOI 10.1007/s12098-018-02846-8; Schaaf HS, 2014, CURR OPIN INFECT DIS, V27, P211, DOI 10.1097/QCO.0000000000000062; Seddon JA, 2018, LANCET RESP MED, V6, P662, DOI 10.1016/S2213-2600(18)30329-1; Shah MA, 2018, PEDIATR INFECT DIS J, V37, P1261, DOI 10.1097/INF.0000000000002040; Snow KJ, 2020, LANCET CHILD ADOLESC, V4, P68, DOI 10.1016/S2352-4642(19)30337-2; Tans-Kersten J, 2016, PUBLIC HEALTH REP, V131, P117, DOI 10.1177/003335491613100118; Tata Institute of Social Sciences, 2015, SOC COND VULN; The Sentinel Project for Pediatric Drug-Resistant Tuberculosis, 2018, MAN DRUG RES TUB CHI, V4th; Tierney DB., 2016, GLOB PEDIAT HLTH, V3, DOI [10.1177/2333794X16674382, DOI 10.1177/2333794X16674382]; Udwadia ZF, 2016, LUNG INDIA, V33, P253, DOI 10.4103/0970-2113.180800; WHO, 2019, GLOB TUB REP; World Health Organization, 2018, ROADM END TB CHILDR, V2nd; World Health Organization, 2020, WHO CONS GUID TUB MO; World Health Organization (WHO), 2019, WHO CONS GUID DRUG D	38	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0246639	10.1371/journal.pone.0246639	http://dx.doi.org/10.1371/journal.pone.0246639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600431	gold, Green Published			2022-12-26	WOS:000620625100033
J	Niu, GL; Hellmuth, I; Flisikowska, T; Pausch, H; Rieblinger, B; Carrapeiro, A; Schade, B; Bohm, B; Kappe, E; Fischer, K; Klinger, B; Steiger, K; Burgkart, R; Bourdon, JC; Saur, D; Kind, A; Schnieke, A; Flisikowski, K				Niu, Guanglin; Hellmuth, Isabel; Flisikowska, Tatiana; Pausch, Hubert; Rieblinger, Beate; Carrapeiro, Alexander; Schade, Benjamin; Boehm, Brigitte; Kappe, Eva; Fischer, Konrad; Klinger, Bernhard; Steiger, Katja; Burgkart, Reiner; Bourdon, Jean-Christophe; Saur, Dieter; Kind, Alexander; Schnieke, Angelika; Flisikowski, Krzysztof			Porcine model elucidates function of p53 isoform in carcinogenesis and reveals novel circTP53 RNA	ONCOGENE			English	Article							MUTANT P53; BREAST-CANCER; MESSENGER-RNA; DELTA-133P53; OSTEOSARCOMA; P63; P73; EXPRESSION; MUTATIONS; MOUSE	Recent years have seen an increasing number of genetically engineered pig models of human diseases including cancer. We previously generated pigs with a modified TP53 allele that carries a Cre-removable transcriptional stop signal in intron 1, and an oncogenic mutation TP53(R167H) (orthologous to human TP53(R175H)) in exon 5. Pigs with the unrecombined mutant allele (flTP53(R167H)) develop mainly osteosarcoma but also nephroblastomas and lymphomas. This observation suggested that TP53 gene dysfunction is itself the key initiator of bone tumorigenesis, but raises the question which aspects of the TP53 regulation lead to the development of such a narrow tumour spectrum. Molecular analysis of p53 revealed the presence of two internal TP53 promoters (Pint and P2) equivalent to those found in human. Consequently, both pig and human express TP53 isoforms. Data presented here strongly suggest that P2-driven expression of the mutant R167H-Delta 152p53 isoform (equivalent to the human R175H-Delta 160p53 isoform) and its circular counterpart circTP53 determine the tumour spectrum and play a critical role in the malignant transformation in flTP53(R167H) pigs. The detection of Delta 152p53 isoform mRNA in serum is indicative of tumorigenesis. Furthermore, we showed a tissue-specific p53-dependent deregulation of the p63 and p73 isoforms in these tumours. This study highlights important species-specific differences in the transcriptional regulation of TP53. Considering the similarities of TP53 regulation between pig and human, these observations provide useful pointers for further investigation into isoform function including the novel circTP53 in both the pig model and human patients.	[Niu, Guanglin; Hellmuth, Isabel; Flisikowska, Tatiana; Rieblinger, Beate; Carrapeiro, Alexander; Fischer, Konrad; Klinger, Bernhard; Kind, Alexander; Schnieke, Angelika; Flisikowski, Krzysztof] Tech Univ Munich, Chair Livestock Biotechnol, Munich, Germany; [Pausch, Hubert] Swiss Fed Inst Technol, Anim Genom, Zurich, Switzerland; [Schade, Benjamin; Boehm, Brigitte; Kappe, Eva] Bavarian Anim Hlth Serv, Dept Pathol, Poing, Germany; [Steiger, Katja] Tech Univ Munich, Inst Pathol, Sch Med, Munich, Germany; [Burgkart, Reiner] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Orthopad & Sportorthopad, Munich, Germany; [Bourdon, Jean-Christophe] Univ Dundee, Sch Med, Jacqui Wood Canc Ctr, Dundee, Scotland; [Saur, Dieter] Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med 2, Munich, Germany	Technical University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Munich; Technical University of Munich; University of Dundee; Technical University of Munich	Flisikowski, K (corresponding author), Tech Univ Munich, Chair Livestock Biotechnol, Munich, Germany.	flisikowski@wzw.tum.de	JC, Bourdon/A-4439-2008; Pausch, Hubert/U-5934-2019; Saur, Dieter/O-8355-2015	JC, Bourdon/0000-0003-4623-9386; Pausch, Hubert/0000-0002-0501-6760; Saur, Dieter/0000-0001-5874-0210	German Research Foundation [SCHN 971/3-2, SFB 1321]; China Scholarship Council (CSC)	German Research Foundation(German Research Foundation (DFG)); China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by the German Research Foundation grant nos. SCHN 971/3-2, SFB 1321 and China Scholarship Council (CSC). Open Access funding enabled and organized by Projekt DEAL.	Anbarasan T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246257; Avery-Kiejda KA, 2014, CARCINOGENESIS, V35, P586, DOI 10.1093/carcin/bgt411; Bernard H, 2013, ONCOGENE, V32, P2150, DOI 10.1038/onc.2012.242; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Blackburn J, 2016, MOL CARCINOGEN, V55, P1940, DOI 10.1002/mc.22441; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bykov VJN, 2018, NAT REV CANCER, V18, P89, DOI 10.1038/nrc.2017.109; Campbell HG, 2012, CELL CYCLE, V11, P446, DOI 10.4161/cc.11.3.19054; Candeias MM, 2016, EMBO REP, V17, P1542, DOI 10.15252/embr.201541956; Chen NF, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1594-y; Chen S, 2008, CLIN EXP DERMATOL, V33, P634, DOI 10.1111/j.1365-2230.2008.02851.x; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Conforti F, 2012, AGING-US, V4, P202, DOI 10.18632/aging.100441; Denny SK, 2016, CELL, V166, P328, DOI 10.1016/j.cell.2016.05.052; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Durfee RA, 2016, RHEUMATOL THER, V3, P221, DOI 10.1007/s40744-016-0046-y; Fane M, 2017, INT J CANCER, V140, P2634, DOI 10.1002/ijc.30603; Flisikowska T, 2016, THERIOGENOLOGY, V86, P433, DOI 10.1016/j.theriogenology.2016.04.058; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Fragou A, 2017, MOL MED REP, V15, P1455, DOI 10.3892/mmr.2017.6162; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Gonfloni S, 2015, INT J DEV BIOL, V59, P87, DOI 10.1387/ijdb.150045sg; Guijarro MV, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00189; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hofstetter G, 2011, BRIT J CANCER, V105, P1593, DOI 10.1038/bjc.2011.433; Irwin MS, 2006, CANCER BIOL THER, V5, P804, DOI 10.4161/cbt.5.7.3023; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson JG, 2013, ONCOGENE, V32, P4325, DOI 10.1038/onc.2012.610; Joruiz SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026039; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kalla D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020488; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee DS, 2014, STEM CELLS, V32, P2467, DOI 10.1002/stem.1733; Leuchs S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043323; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; Lucena-Araujo AR, 2015, BLOOD, V126, P2302, DOI 10.1182/blood-2015-01-623330; Marcel V, 2010, FEBS LETT, V584, P4463, DOI 10.1016/j.febslet.2010.10.005; Mirabello L, 2009, INT J CANCER, V125, P229, DOI 10.1002/ijc.24320; Moll UM, 2003, CLIN CANCER RES, V9, P5437; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nutthasirikul N, 2013, INT J ONCOL, V42, P1181, DOI 10.3892/ijo.2013.1818; Ognjanovic S, 2012, CANCER-AM CANCER SOC, V118, P1387, DOI 10.1002/cncr.26390; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Peng YH, 2001, J BIOL CHEM, V276, P6874, DOI 10.1074/jbc.C000781200; Poole LA, 2017, CRIT REV BIOCHEM MOL, V52, P696, DOI 10.1080/10409238.2017.1380597; Robertson N, 2020, EXPERT OPIN DRUG DIS, V15, P893, DOI 10.1080/17460441.2020.1757644; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rogalla S, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201904992; Saalfrank A, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.19; Seki M, 2017, NAT GENET, V49, P1274, DOI 10.1038/ng.3900; Seva J, 2001, VET REC, V148, P147, DOI 10.1136/vr.148.5.147; Sieren JC, 2014, J CLIN INVEST, V124, P4052, DOI 10.1172/JCI75447; Slatter TL, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.149; Slatter TL, 2011, BLOOD, V117, P5166, DOI 10.1182/blood-2010-11-321851; Stindt MH, 2015, ONCOGENE, V34, P4300, DOI 10.1038/onc.2014.359; TORNALETTI S, 1995, ONCOGENE, V10, P1493; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Zhang J, 2019, P NATL ACAD SCI USA, V116, P24259, DOI 10.1073/pnas.1913919116; Zhang J, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0719-3	59	13	13	1	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2021	40	10					1896	1908		10.1038/s41388-021-01686-9	http://dx.doi.org/10.1038/s41388-021-01686-9		FEB 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QU6VJ	33603167	Green Published, hybrid			2022-12-26	WOS:000619405600001
J	Siland, JE; Nguyen, BO; de With, RR; Van Gelder, IC; van der Harst, P; Rienstra, M				Siland, J. E.; Nguyen, B. O.; de With, R. R.; Van Gelder, I. C.; van der Harst, P.; Rienstra, M.			Genetically-determined body mass index and the risk of atrial fibrillation progression in men and women	PLOS ONE			English	Article								Aims Limited causal evidence is available on the relationship between body mass index (BMI) and atrial fibrillation (AF) progression. Sex differences have been noted and may be relevant for AF progression. We investigated the association between the BMI Genetic Risk Score (GRS) and AF progression in men and women of the Groningen Genetic Atrial Fibrillation (GGAF) cohort. Methods and results The GGAF cohort (n = 2207) is a composite of 5 prospective cohorts with individuals of European ancestry. AF patients with genetic information, with at least 12 months follow-up and AF progression data were included. AF progression was defined as progression from paroxysmal to persistent/permanent AF, or persistent to permanent AF. A BMI GRS was constructed of genetic variants associated with BMI. Univariate and multivariate Cox proportional hazard regression analyses were performed in the total population and in men and women, separately. During a median follow-up of 34 [interquartile range 19-48] months 630 AF patients (mean age 62 +/- 11, 36% women, BMI of 28 +/- 5) were analyzed, and men and women developed similar AF progression rates (respectively 6.5% versus 6.1%). The BMI GRS was not associated with AF progression either as a continuous variable or in tertiles in the overall population. However, the BMI GRS was associated with the tertile of the highest BMI GRS in women (n = 225), also after multivariable adjustments of clinical risk factors (Hazard ratio 2.611 (95% confidence interval 1.151-5.924) p = 0.022). Conclusions Genetically-determined BMI is only associated with women at risk of AF progression. The results may be supporting evidence for a causal link between observed BMI and AF progression in women. We emphasize the need for further investigation of genetically determined BMI and observed BMI to optimize AF management in women with increased risk for AF progression.	[Siland, J. E.; Nguyen, B. O.; de With, R. R.; Van Gelder, I. C.; van der Harst, P.; Rienstra, M.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [van der Harst, P.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van der Harst, P.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Heart & Lungs, Utrecht, Netherlands	University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center	Rienstra, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	m.rienstra@umcg.nl		de With, Ruben/0000-0003-0866-1295; Rienstra, Michiel/0000-0002-2581-070X	Netherlands Heart Foundation [NHS2010B233, NHS2010B280]; Netherlands Organization for Health Research and Develothe Dutch Kidney Foundation [E0.13, 95103007]	Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Health Research and Develothe Dutch Kidney Foundation	This work was supported by funding received by prof. dr. M. Rienstra and prof. dr. I. C. van Gelder. Funding was received from the Netherlands Heart Foundation [grant NHS2010B233 and grant NHS2010B280](https://www.heart-institute.nl); the Netherlands Organization for Health Research and Develothe Dutch Kidney Foundation [grant E0.13] (https://nierstichting.nl).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.pment [grant 95103007] (https://www.zonmw.nl/en/); and	Ball J, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008414; Ball J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065795; Blum S, 2019, HEART RHYTHM, V16, P502, DOI 10.1016/j.hrthm.2018.10.022; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; de Vos CB, 2010, J AM COLL CARDIOL, V55, P725, DOI 10.1016/j.jacc.2009.11.040; De With RR, 2020, EUROPACE, V22, P352, DOI 10.1093/europace/euz339; De With RR, 2018, EUROPACE, V20, P1750, DOI 10.1093/europace/euy028; Elagizi A, 2018, PROG CARDIOVASC DIS, V61, P142, DOI 10.1016/j.pcad.2018.07.003; Halland H, 2018, NUTR METAB CARDIOVAS, V28, P1054, DOI 10.1016/j.numecd.2018.06.014; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Kloosterman M, 2019, EUROPACE EUROPEAN PA, V11; Lavie CJ, 2017, J AM COLL CARDIOL, V70, P2022, DOI 10.1016/j.jacc.2017.09.002; Mahajan R, 2015, J AM COLL CARDIOL, V66, P1, DOI 10.1016/j.jacc.2015.04.058; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Pulit SL, 2019, HUM MOL GENET, V28, P166, DOI 10.1093/hmg/ddy327; Roselli C, 2018, NAT GENET, V50, P1225, DOI 10.1038/s41588-018-0133-9; Sandhu RK, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000916; Schnabel RB, 2018, HEART, V104, P1608, DOI 10.1136/heartjnl-2017-312569; Tsang TSM, 2008, EUR HEART J, V29, P2227, DOI 10.1093/eurheartj/ehn324; Vermond RA, 2015, J AM COLL CARDIOL, V66, P1000, DOI 10.1016/j.jacc.2015.06.1314; Wanahita N, 2008, AM HEART J, V155, P310, DOI 10.1016/j.ahj.2007.10.004; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0246907	10.1371/journal.pone.0246907	http://dx.doi.org/10.1371/journal.pone.0246907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600500	Green Published, Green Submitted, gold			2022-12-26	WOS:000620625100044
J	Berry, HD; Mumford, TF; Christiaen, B; Dowty, P; Calloway, M; Ferrier, L; Grossman, EE; VanArendonk, NR				Berry, Helen D.; Mumford, Thomas F.; Christiaen, Bart; Dowty, Pete; Calloway, Max; Ferrier, Lisa; Grossman, Eric E.; VanArendonk, Nathan R.			Long-term changes in kelp forests in an inner basin of the Salish Sea	PLOS ONE			English	Article								Kelp forests form an important biogenic habitat that responds to natural and human drivers. Global concerns exist about threats to kelp forests, yet long-term information is limited and research suggests that trends are geographically distinct. We examined distribution of the bull kelp Nereocystis luetkeana over 145 years in South Puget Sound (SPS), a semi-protected inner basin in a fjord estuary complex in the northeast Pacific Ocean. We synthesized 48 historical and modern Nereocystis surveys and examined presence/absence within 1-km segments along 452 km of shoreline. Compared to the earliest baseline in 1878, Nereocystis extent in 2017 decreased 63%, with individual sub-basins showing up to 96% loss. Losses have persisted for decades, across a range of climate conditions. In recent decades, Nereocystis predominantly occurred along shorelines with intense currents and mixing, where temperature and nutrient concentrations did not reach thresholds for impacts to Nereocystis performance, and high current speeds likely excluded grazers. Losses predominated in areas with elevated temperature, lower nutrient concentrations, and relatively low current velocities. The pattern of long-term losses in SPS contrasts with stability in floating kelp abundance during the last century in an area of the Salish Sea with greater wave exposure and proximity to oceanic conditions. These findings support the hypothesis that kelp beds along wave-sheltered shorelines exhibit greater sensitivity to environmental stressors. Additionally, shorelines with strong currents and deep-water mixing may provide refugia within sheltered systems.	[Berry, Helen D.; Christiaen, Bart; Dowty, Pete; Calloway, Max; Ferrier, Lisa] Washington State Dept Nat Resources, Olympia, WA 98504 USA; [Grossman, Eric E.; VanArendonk, Nathan R.] US Geol Survey, Pacific Coastal & Marine Sci Ctr, Santa Cruz, CA USA	United States Department of the Interior; United States Geological Survey	Berry, HD (corresponding author), Washington State Dept Nat Resources, Olympia, WA 98504 USA.	helen.berry@dnr.wa.gov		Berry, Helen/0000-0002-4414-3914; Mumford, Thomas/0000-0003-0894-9221	Washington State Department of Natural Resources' Aquatic Resources Division, Washington Coastal Resilience Project; U.S. Geological Survey's Coastal Habitats in Puget Sound Project	Washington State Department of Natural Resources' Aquatic Resources Division, Washington Coastal Resilience Project; U.S. Geological Survey's Coastal Habitats in Puget Sound Project	This work was supported by funding from: the Washington State Department of Natural Resources' Aquatic Resources Division, Washington Coastal Resilience Project, and U.S. Geological Survey's Coastal Habitats in Puget Sound Project. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the Washington State or U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Airoldi L, 1997, J EXP MAR BIOL ECOL, V215, P269, DOI 10.1016/S0022-0981(96)02770-0; Albertson SL, 2002, ENV ASSESSMENT PROGR, P224; Amos CL, 2015, J COASTAL RES, V31, P434, DOI 10.2112/JCOASTRES-D-14-00114.1; Anecdotes PaulyD, 1995, Trends in Ecology and Evolution, V10, P1, DOI 10.1016/s0169-5347%2800%2989171-5; [Anonymous], 2020, COLD WARM EPISODES S; [Anonymous], 1994, ASS B KELP SQUAX ISL, P39; [Anonymous], 2019, ENSEMBLE OCEANIC NIN; Berry H., 2017, ASSESSMENT B KELP SQ, P39; Berry H, 2001, WASHINGTON STATE SHO; Berry H., 2004, ASSESSMENT B KELP SQ, P39; Berry H., 2019, B KELP MONITORING S, P72; Berry HD., 2001, WASHINGTON STATE SHO; Bos J., 2015, QUALITY ASSURANCE MO, P200; Britton-Simmons K, 2008, MAR ECOL PROG SER, V355, P95, DOI 10.3354/meps07209; Britton-Simmons KH, 2004, MAR ECOL PROG SER, V277, P61, DOI 10.3354/meps277061; Burns R., 1985, SHAPE FORM PUGET SOU; Calloway M., 2020, PUGET SOUND KELP CON, P52; Cameron FK, 1915, POTASH KELP; Capone DG, 2013, NAT GEOSCI, V6, P711, DOI 10.1038/NGEO1916; Carney Laura T., 2006, Algae, V21, P161; Cavanaugh KC, 2011, MAR ECOL PROG SER, V429, P1, DOI 10.3354/meps09141; Collins B.D., 2005, HIST RECONSTRUCTION; Connell SD, 2010, P ROY SOC B-BIOL SCI, V277, P1409, DOI 10.1098/rspb.2009.2069; Davenport AC, 2007, ECOLOGY, V88, P1548, DOI 10.1890/06-0880; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Dayton PK, 1999, ECOL MONOGR, V69, P219, DOI 10.1890/0012-9615(1999)069[0219:TASSOK]2.0.CO;2; DEAN TA, 1986, MAR BIOL, V90, P597, DOI 10.1007/BF00409280; Dethier M, 1990, MARINE ESTUARINE HAB, P56; Gaitan-Espitia JD, 2014, J EXP MAR BIOL ECOL, V457, P51, DOI 10.1016/j.jembe.2014.03.018; Dobkowski K, 2017, PEERJ, V5, DOI 10.7717/peerj.3372; Dobkowski KA, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3244-4; DRUEHL L D, 1970, Phycologia, V9, P237, DOI 10.2216/i0031-8884-9-3-237.1; DRUEHL LD, 1967, J PHYCOL, V3, P103, DOI 10.1111/j.1529-8817.1967.tb04641.x; DRUEHL LD, 1978, CAN J BOT, V56, P69, DOI 10.1139/b78-007; Duggins D, 2001, MAR ECOL PROG SER, V223, P143, DOI 10.3354/meps223143; DUGGINS DO, 1980, ECOLOGY, V61, P447, DOI 10.2307/1937405; Ebbesmeyer CC, 1988, HYDRODYNAMICS ESTUAR; ECKMAN JE, 1989, J EXP MAR BIOL ECOL, V129, P173, DOI 10.1016/0022-0981(89)90055-5; Filbee-Dexter K, 2018, BIOSCIENCE, V68, P64, DOI 10.1093/biosci/bix147; Filbee-Dexter K, 2016, MAR ECOL PROG SER, V543, P141, DOI 10.3354/meps11554; FOREMAN RE, 1984, HYDROBIOLOGIA, V116, P325, DOI 10.1007/BF00027696; Frolicher TL, 2018, NATURE, V560, P360, DOI 10.1038/s41586-018-0383-9; Gabrielson PW., 2018, KEYS SEAWEEDS SEAGRA; Gaylord B, 2012, J EXP BIOL, V215, P997, DOI 10.1242/jeb.059824; Gentemann CL, 2017, GEOPHYS RES LETT, V44, P312, DOI 10.1002/2016GL071039; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; Greene C, 2015, MAR ECOL PROG SER, V525, P153, DOI 10.3354/meps11251; Grossman EE, 2020, MAR GEOL, V430, DOI 10.1016/j.margeo.2020.106336; Hamilton SL, 2020, ECOLOGY, V101, DOI 10.1002/ecy.3031; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; HARLIN M M, 1969, Syesis, V2, P257; HODGSON LM, 1979, SYESIS, V12, P107; Howarth RW, 2002, ESTUARIES, V25, P656, DOI 10.1007/BF02804898; Hurd CL, 2014, SEAWEED ECOLOGY AND PHYSIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9781139192637; Jepsen DJ, 2017, CONTESTED BOUNDARIES; Khangaonkar T, 2018, J GEOPHYS RES-OCEANS, V123, P4735, DOI 10.1029/2017JC013650; Khangaonkar T, 2017, OCEAN MODEL, V109, P11, DOI 10.1016/j.ocemod.2016.11.004; Khangaonkar T, 2012, OCEAN DYNAM, V62, P1353, DOI 10.1007/s10236-012-0562-4; Krembs C, STATE PHYS BIOL SELE; Krembs C M., 2014, SAL SEA EC C APR 30; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; Krumhansl KA, 2012, MAR ECOL PROG SER, V467, P281, DOI 10.3354/meps09940; Mackas DL, 1997, ESTUAR COAST SHELF S, V44, P1, DOI 10.1006/ecss.1996.0110; MANN KH, 1973, SCIENCE, V182, P975, DOI 10.1126/science.182.4116.975; Masson D, 2007, CONT SHELF RES, V27, P634, DOI 10.1016/j.csr.2006.10.009; Maxell BA, 1996, BOT MAR, V39, P479, DOI 10.1515/botm.1996.39.1-6.479; Mofjeld H, 1984, TIDES TIDAL CURRENTS, P52; Mohamedali F., 2011, S PUGET SOUND DISSOL, P179; Mohamedali T., 2011, PUGET SOUND DISSOLVE, P144; Moy FE, 2012, MAR BIOL RES, V8, P309, DOI 10.1080/17451000.2011.637561; Mumford TF, 2007, KELP EELGRASS PUGET, P27; Muth AF, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2594; National Centers for Environmental Prediction/National Weather Service/NOAA US Department of Commerce, 1996, NCEP/NCAR Reanalysis Monthly Mean Subsets (from D5090.0), 1948-continuing: Research Data Archive at the National Center for Atmospheric Research, Computational and Information Systems Laboratory; National Marine Fisheries Service, 2005, END THREAT SPEC FIN; National Ocean Service, 1996, HYDR SHEET DESCR REP; National Ocean Service, 2001, HYDR SHEET DESCR REP; National Ocean Service, 1996, HYDR SHEET REG NO 10; National Ocean Service, 2008, HYDR SHEET DESCR REP; Nijland W, 2019, REMOTE SENS ENVIRON, V220, P41, DOI 10.1016/j.rse.2018.10.032; Nysewander DR., 2005, REPORT MARINE BIRD M, P194; ORTH RJ, 1984, ESTUARIES, V7, P531, DOI 10.2307/1352058; Palsson WA., 2009, BIOL ASSESSMENT ROCK; Palsson WayneA, 1998, PUGET SOUND GROUNDFI, P48; Pfister CA, 2007, LIMNOL OCEANOGR, V52, P1767, DOI 10.4319/lo.2007.52.5.1767; Pfister CA, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2798; Pfister CA, 2018, J ECOL, V106, P1520, DOI 10.1111/1365-2745.12908; Pfister CA, 2014, ECOLOGY, V95, P2803, DOI 10.1890/13-1825.1; Phillips R, SHALLOW SUBTIDAL SUR, P146; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Pratchett MS, 2014, CURR OPIN ENV SUST, V7, P37, DOI 10.1016/j.cosust.2013.11.022; R CoreTeam, 2016, R LANGUAGE ENV STAT; Riche O, 2014, J MARINE SYST, V131, P36, DOI 10.1016/j.jmarsys.2013.11.003; Roberts MJ, 2008, S PUGET SOUND DISSOL; Rubin SP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187742; Russell L, 2019, EMMEANS ESTIMATED MA; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Schiel DR, 2004, ECOLOGY, V85, P1833, DOI 10.1890/03-3107; Schiel DR, 2015, BIOL ECOLOGY GIANT K; Schiltroth B, 2018, SAL SEA EC C 2018 AP; Schroeder SB, 2020, REMOTE SENS ECOL CON, V6, P327, DOI 10.1002/rse2.142; SEAPY RR, 1982, MAR BIOL, V71, P87, DOI 10.1007/BF00396995; Shalowitz A. L., 1964, SHORE SEA BOUNDARIES; Shelton AO, 2018, OECOLOGIA, V188, P1105, DOI 10.1007/s00442-018-4263-7; Simenstad C., 2011, HIST CHANGE IMPAIRME, P313; Skamarock W. C., 2008, NCARTN475STR; Smale DA, 2019, NAT CLIM CHANGE, V9, P306, DOI 10.1038/s41558-019-0412-1; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Springer YP, 2010, OCEANOGR MAR BIOL, V48, P1; Starko S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213191; Steneck RS, 2013, B MAR SCI, V89, P31, DOI 10.5343/bms.2011.1148; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stephens TA, 2016, OECOLOGIA, V182, P71, DOI 10.1007/s00442-016-3641-2; Straub SC, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00763; Strickland RM., 1983, FERTILE FJORD; Tegner M.J., 1987, Advances in Ecological Research, V17, P243, DOI 10.1016/S0065-2504(08)60247-0; ters G-J, 2018, USERFRIENDLYSCIENCE; Thom RM, FRIUW9008 US EPA WET; Thom RonaldM., 1875, LONG TERM CHANGES AR, P116; Thom RonaldM., 1978, LONG TERM CHANGES AR, P116; U.S. Census Office, 1895, REP POP US 11 CENS 1; US Coast and Geodetic Survey, 1935, HYDR SHEET REG NO 61; US Coast and Geodetic Survey, 1936, HYDR SURV NO 6197; US Coast and Geodetic Survey, TOP SHEET REG NO 152; US Coast and Geodetic Survey, 1935, HYDR SURV NO 5931; US Coast Survey, 1853, SAIL DIR W COAST N A, P239; US Coast Survey, TOP SHEET REG NO 132; US Coast Survey, 1878, TOP SHEET REG NO 167; VanArendonk NR, 2019, ASSESSING COASTAL VU; Washington State Office of Financial Management, 2019, STAT WASH 2019 POP T, P50; Wernberg T, 2019, WORLD SEAS: AN ENVIRONMENTAL EVALUATION, VOL III: ECOLOGICAL ISSUES AND ENVIRONMENTAL IMPACTS, 2ND EDITION, P57, DOI 10.1016/B978-0-12-805052-1.00003-6; Wernberg T, 2016, SCIENCE, V353, P169, DOI 10.1126/science.aad8745; West JE, 1992, PERSONAL COMMUNICATI; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Youngmann C, 1978, COASTAL ZONE ATLAS W	135	8	8	10	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0229703	10.1371/journal.pone.0229703	http://dx.doi.org/10.1371/journal.pone.0229703			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596204	Green Published, Green Submitted, gold			2022-12-26	WOS:000620633200016
J	Negisho, K; Shibru, S; Pillen, K; Ordon, F; Wehner, G				Negisho, Kefyalew; Shibru, Surafel; Pillen, Klaus; Ordon, Frank; Wehner, Gwendolin			Genetic diversity of Ethiopian durum wheat landraces	PLOS ONE			English	Article							POPULATION-STRUCTURE; HEXAPLOID WHEAT; DOMESTICATION; POLYMORPHISM; INFERENCE; SOFTWARE; REVEALS; MARKERS; NUMBER	Genetic diversity and population structure assessment in crops is essential for marker trait association, marker assisted breeding and crop germplasm conservation. We analyzed a set of 285 durum wheat accessions comprising 215 Ethiopian durum wheat landraces, 10 released durum wheat varieties, 10 advanced durum wheat lines from Ethiopia, and 50 durum wheat lines from CIMMYT. We investigated the genetic diversity and population structure for the complete panel as well as for the 215 landraces, separately based on 11,919 SNP markers with known physical positions. The whole panel was clustered into two populations representing on the one hand mainly the landraces, and on the other hand mainly released, advanced and CIMMYT lines. Further population structure analysis of the landraces uncovered 4 subgroups emphasizing the high degree of genetic diversity within Ethiopian durum landraces. Population structure based AMOVA for both sets unveiled significant (P < 0.001) variation between populations and within populations. Total variation within population accessions (81%, 76%) was higher than total variation between populations (19%, 24%) for both sets. Population structure analysis based genetic differentiation (FST) and gene flow (Nm) for the whole set and the Ethiopian landraces were 0.19 and 0.24, 1.04, and 0.81, respectively indicating high genetic differentiation and limited gene flow. Diversity indices verify that the landrace panel was more diverse with (I = 0.7, He = 0.46, uHe = 0.46) than the advanced lines (I = 0.6, He = 0.42, uHe = 0.42). Similarly, differences within the landrace clusters were observed. In summary a high genetic diversity within Ethiopian durum wheat landraces was detected, which may be a target for national and international wheat improvement programs to exploit valuable traits for biotic and abiotic stresses.	[Negisho, Kefyalew] Natl Agr Biotechnol Res Ctr, Ethiopian Inst Agr Res EIAR, Holeta, Ethiopia; [Shibru, Surafel] Melkassa Res Ctr, Ethiopian Inst Agr Res EIAR, Melkassa, Ethiopia; [Pillen, Klaus] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Halle, Saale, Germany; [Ordon, Frank; Wehner, Gwendolin] Julius Kuhn Inst JKI, Inst Resistance Res & Stress Tolerance, Quedlinburg, Germany	Ethiopian Institute of Agricultural Research (EIAR); Ethiopian Institute of Agricultural Research (EIAR); Martin Luther University Halle Wittenberg; Julius Kuhn-Institut	Wehner, G (corresponding author), Julius Kuhn Inst JKI, Inst Resistance Res & Stress Tolerance, Quedlinburg, Germany.	gwendolin.wehner@julius-kuehn.de	Pillen, Klaus/I-6511-2012	Pillen, Klaus/0000-0003-4646-6351; Wehner, Gwendolin/0000-0003-3248-8517	Federal Ministry of Food and Agriculture (Bundesministerium fur Ernahrung und Landwirtschaft (BMEL)) [FKZ 2813FS01]	Federal Ministry of Food and Agriculture (Bundesministerium fur Ernahrung und Landwirtschaft (BMEL))	The research was funded by the Federal Ministry of Food and Agriculture (Bundesministerium fur Ernahrung und Landwirtschaft (BMEL), FKZ 2813FS01), Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gallegos JA, 2007, CROP SCI, V47, pS44, DOI 10.2135/cropsci2007.04.0008IPBS; Acquaah G., 2012, PRINCIPLES PLANT GEN; Alemu A, 2020, BMC GENET, V21, DOI 10.1186/s12863-020-0825-x; Alemu SK., 2019, J PLANT PATHOLOGY MI, V10, DOI [10.35248/2157-7471.19.10.483, DOI 10.35248/2157-7471.19.10.483]; Alipour H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01293; [Anonymous], 2015, FOOD AGR ORG UN FAOS; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Asefa A., 2019, 126 ETH I AGR RES; Asmare M, 2019, AM J ENERGY ENG, V7, P1, DOI [10.4172/2329-8863.1000413, DOI 10.4172/2329-8863.1000413]; Badaeva ED, 2018, RUSS J GENET+, V54, P629, DOI [10.1134/S1022795418060029, 10.7868/S0016675818060048]; Bhandari H.R., 2017, ADV PLANTS AGR RES, V7, P00255, DOI DOI 10.15406/APAR.2017.07.00255; Bishaw Z., 2004, Wheat and barley seed systems in Ethiopia and Syria; Brown A. H. D., 1983, Isozymes in plant genetics and breeding. Part A., P219; Brown AHD, 2000, GENES IN THE FIELD, P29; Browning SR, 2008, HUM GENET, V124, P439, DOI 10.1007/s00439-008-0568-7; Caballero A, 2002, CONSERV GENET, V3, P289, DOI 10.1023/A:1019956205473; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Central Statistical Agency (CSA), 2018, FED DEM REP ETH CENT, V586; Desta ZA, 2014, PLANT GENET RESOUR-C, V12, P151, DOI 10.1017/S1479262113000324; DVORAK J, 1988, GENOME, V30, P680, DOI 10.1139/g88-115; Eltaher S, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00076; Eticha F, 2006, GENET RESOUR CROP EV, V53, P387, DOI 10.1007/s10722-004-6095-z; Eticha Firdissa, 2005, Plant Genetic Resources Characterization and Utilization, V3, P35, DOI 10.1079/PGR200457; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fu YB, 2015, THEOR APPL GENET, V128, P2131, DOI 10.1007/s00122-015-2585-y; Geleta N., 2013, AGR SCI RES J, V3, P229; GILL BS, 1987, P NATL ACAD SCI USA, V84, P6800, DOI 10.1073/pnas.84.19.6800; Gioia T, 2015, J EXP BOT, V66, P5519, DOI 10.1093/jxb/erv289; Govindaraj M, 2015, GENET RES INT, V2015, DOI 10.1155/2015/431487; Habtamu A., 2019, INT J ADV SCI RES EN, DOI [10.31695/IJASRE.33073, DOI 10.31695/IJASRE.33073]; Haile JK, 2013, GENET RESOUR CROP EV, V60, P513, DOI 10.1007/s10722-012-9855-1; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; IBC (Institute of Biodiversity Conservation), 2013, ETH 2 COUNTR REP STA; Jost L, 2018, EVOL APPL, V11, P1139, DOI 10.1111/eva.12590; Kabbaj H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01277; KERBY K, 1987, GENOME, V29, P722, DOI 10.1139/g87-124; Klindworth DL, 2007, CROP SCI, V47, P1441, DOI 10.2135/cropsci2006.05.0345; KONAREV V G, 1976, Sel'skokhozyaistvennaya Biologiya, V11, P656; Kumar Santosh, 2012, Int J Plant Genomics, V2012, P831460, DOI 10.1155/2012/831460; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Lopes MS, 2015, J EXP BOT, V66, P3477, DOI 10.1093/jxb/erv122; Luo ZN, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00184; Maccaferri M, 2019, NAT GENET, V51, P885, DOI 10.1038/s41588-019-0381-3; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; Marees AT, 2018, INT J METH PSYCH RES, V27, DOI 10.1002/mpr.1608; Meirmans PG, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00066; Mengistu DK, 2018, PLANT GENET RESOUR-C, V16, P39, DOI 10.1017/S1479262116000393; Mengistu DK, 2015, CROP J, V3, P190, DOI 10.1016/j.cj.2015.04.003; Mengistu DK, 2016, PLANT BIOTECHNOL J, V14, P1800, DOI 10.1111/pbi.12538; Mohammadi R, 2015, CROP J, V3, P423, DOI 10.1016/j.cj.2015.03.008; Naz AA, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00711; Negassa A, 2013, POTENTIAL WHEAT PROD; NEI M, 1978, GENETICS, V89, P583; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Reynolds M, 2007, J EXP BOT, V58, P177, DOI 10.1093/jxb/erl250; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Stein N, 2001, PLANT BREEDING, V120, P354, DOI 10.1046/j.1439-0523.2001.00615.x; Teklu Y, 2006, GENET RESOUR CROP EV, V53, P1115, DOI 10.1007/s10722-005-1146-7; Teklu Yifru, 2009, Plant Genetic Resources Characterization and Utilization, V7, P1, DOI 10.1017/S1479262108994223; Tesemma T, 1998, EUPHYTICA, V102, P323, DOI 10.1023/A:1018360432426; Sall AT, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9050263; Tsegaye B, 2007, AGR HUM VALUES, V24, P219, DOI 10.1007/s10460-006-9055-8; Vavilov NI, 1951, CHRON BOT, V13, P1, DOI DOI 10.1097/00010694-195112000-00018; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wayima EF, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9080440; Wehner G., 2016, BIO-PROTOCOL, V6; Winfield MO, 2016, PLANT BIOTECHNOL J, V14, P1195, DOI 10.1111/pbi.12485; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S., 1969, EVOLUTION GENETICS P; Yalew A., 1998, FARMERS WHEAT SEED S, V32	78	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247016	10.1371/journal.pone.0247016	http://dx.doi.org/10.1371/journal.pone.0247016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596260	gold, Green Published			2022-12-26	WOS:000620633200063
J	Schai-Braun, SC; Steiger, P; Ruf, T; Arnold, W; Hacklander, K				Schai-Braun, Stephanie C.; Steiger, Peter; Ruf, Thomas; Arnold, Walter; Hacklaender, Klaus			Maternal effects on reproduction in the precocial European hare (Lepus europaeus)	PLOS ONE			English	Article							FEMALE BODY-SIZE; LITTER-SIZE; RED DEER; INDIVIDUAL-DIFFERENCES; LACTATION ENERGETICS; FITNESS COSTS; CALF GROWTH; AGE; GESTATION; MASS	In female mammals, reproduction, and in particular lactation, is the energetically most exigent life-history phase. Reproduction is strongly controlled by body reserves and food availability, so females with better body condition or food supply are believed to have higher reproductive output. Additionally, the growth and mortality of young mammals depends on their postnatal development. Therefore, the degree of precociality affects energetic demands for both mothers and young. To study the reproductive performance of the precocial European hare (Lepus europaeus), we analysed relationships between six predictor variables describing maternal and environmental effects and nine response variables relating to reproduction from 217 captive females. We compared the data with those of precocial and altricial mammal species from an extensive literature search. For hares, we found: (1) Heavier females had heavier litters at birth. (2) In summer and spring, total litter mass was larger than in winter. (3) At the end of lactation, the litters of multiparous females were heavier than those of primiparous females. (4) Both older females and females giving birth for the first time had relatively high leveret mortality during lactation. Comparing our results with the literature for other mammals revealed that the body condition (i.e., body mass) of females before birth is predictive of reproductive parameters in both precocial and altricial species. In the precocial hare, female body condition is no longer predictive of reproductive parameters at the end of lactation, whereas in altricial species, female body condition remains predictive of reproduction (litter mass at the end of lactation, offspring mortality) until the end of lactation. We conclude that these effects are caused by precocial offspring feeding on solid food soon after birth and, thus, being less dependent on the mother's body condition during lactation than altricial offspring. In line with this, precociality might have evolved as a way of buffering offspring against maternal effects.	[Schai-Braun, Stephanie C.; Hacklaender, Klaus] Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, Vienna, Austria; [Steiger, Peter; Ruf, Thomas; Arnold, Walter] Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria; [Hacklaender, Klaus] Deutsch Wildtier Stiftung German Wildlife Fdn, Hamburg, Germany	University of Natural Resources & Life Sciences, Vienna; University of Veterinary Medicine Vienna	Schai-Braun, SC (corresponding author), Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, Vienna, Austria.	stephanie.schai-braun@boku.ac.at	Arnold, Walter/C-3394-2013	Arnold, Walter/0000-0001-6785-5685	German Academic Exchange Service (DAAD); Deutsche Wildtier Stiftung; Austrian Federal Ministry of Education, Science and Culture; Austrian hunting associations; City of Vienna; Department of Science and Culture of the Government of Lower Austria; BOKU Vienna	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Wildtier Stiftung; Austrian Federal Ministry of Education, Science and Culture; Austrian hunting associations; City of Vienna; Department of Science and Culture of the Government of Lower Austria; BOKU Vienna	This study was supported by a PhD grant to KH from the German Academic Exchange Service (DAAD), by a grant to KH from the Deutsche Wildtier Stiftung, by the Austrian Federal Ministry of Education, Science and Culture, the Austrian hunting associations, the City of Vienna, and the Department of Science and Culture of the Government of Lower Austria. Open access funding was provided by BOKU Vienna Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2013, P NATL ACAD SCI USA, V110, P13440, DOI 10.1073/pnas.1311857110; Arking R, 1998, BIOL AGING OBSERVATI, V2nd ed; Bensinger S, 2000, Z JAGDWISS, V46, P73, DOI 10.1007/BF02241570; Berube CH, 1999, ECOLOGY, V80, P2555, DOI 10.1890/0012-9658(1999)080[2555:IDLARS]2.0.CO;2; Birgersson B, 1997, BEHAV ECOL, V8, P493, DOI 10.1093/beheco/8.5.493; BLAXTER KL, 1980, J AGR SCI, V95, P275, DOI 10.1017/S0021859600039290; Blomquist GE, 2013, J EVOLUTION BIOL, V26, P756, DOI 10.1111/jeb.12096; BROEKHUIZEN S, 1981, J ZOOL, V193, P499; BROEKHUIZEN S, 1980, J ZOOL, V191, P487, DOI 10.1111/j.1469-7998.1980.tb01480.x; Bronson FH, 1989, MAMMALIAN REPROD BIO; Brull U., 1976, P93; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; CAMPBELL MT, 1995, CAN J ZOOL, V73, P133, DOI 10.1139/z95-015; Caroli L, 2000, ZOOL SCI, V17, P209, DOI 10.2108/zsj.17.209; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Cichon M, 1998, IBIS, V140, P128, DOI 10.1111/j.1474-919X.1998.tb04549.x; Clutton-Brock T.H., 1988, REPROD SUCCESS STUDI; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Debeffe L, 2017, ECOL EVOL, V7, P5580, DOI 10.1002/ece3.3082; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; DERRICKSON EM, 1992, FUNCT ECOL, V6, P57, DOI 10.2307/2389771; DOBSON FS, 1995, ECOLOGY, V76, P851, DOI 10.2307/1939350; DOBSON FS, 1989, J MAMMAL, V70, P142, DOI 10.2307/1381677; DRENT RH, 1980, ARDEA, V68, P225; Eloranta E., 1986, RANGIFER, V6, P115, DOI 10.7557/2.6.2.635; Ericsson G, 2001, ECOLOGY, V82, P1613, DOI 10.1890/0012-9658(2001)082[1613:ARREAS]2.0.CO;2; Festa-Bianchet M, 1998, AM NAT, V152, P367, DOI 10.1086/286175; FESTABIANCHET M, 1995, ECOLOGY, V76, P871, DOI 10.2307/1939352; Finch CE, 1990, LONGEVITY SENESCENCE; Flux J., 1981, P WORLD LAG C U GUEL, P155; FLUX JEC, 1967, NEW ZEAL J SCI, V10, P357; Fokidis HB, 2007, ANIM BEHAV, V73, P479, DOI 10.1016/j.anbehav.2006.08.010; Fox J., 2019, R COMPANION APPL REG, VThird; FRYLESTAM B, 1980, HOLARCTIC ECOL, V3, P74; Gelin U, 2015, J ANIM ECOL, V84, P239, DOI 10.1111/1365-2656.12266; Gelman A., 2021, BAYESIAN DATA ANAL; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; Hacklander K, 2011, MAMM BIOL, V76, P662, DOI 10.1016/j.mambio.2011.05.001; Hacklander K, 2002, PHYSIOL BIOCHEM ZOOL, V75, P19, DOI 10.1086/324770; Hacklander K, 2018, LAGOMORPHS PIKAS RAB; Hamel S, 2010, ECOL LETT, V13, P915, DOI 10.1111/j.1461-0248.2010.01478.x; HANSEN K, 1992, ACTA THERIOL, V37, P27, DOI 10.4098/AT.arch.92-3; Holand O, 2006, P ROY SOC B-BIOL SCI, V273, P293, DOI 10.1098/rspb.2005.3330; Holliday R, 2006, ANN NY ACAD SCI, V1067, P1, DOI 10.1196/annals.1354.002; Janova E, 2008, ANN ZOOL FENN, V45, P39, DOI 10.5735/086.045.0104; Karniski C, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1123; Kasparian K, 2005, OIKOS, V111, P271, DOI 10.1111/j.0030-1299.2005.13973.x; Kauffman AS, 2010, PHYSIOL BEHAV, V99, P100, DOI 10.1016/j.physbeh.2009.10.017; Knobil E, 1988, PHYSL REPROD, V2nd ed; KOJOLA I, 1993, CAN J ZOOL, V71, P753, DOI 10.1139/z93-099; Kruschke J. K., 2015, DOING BAYESIAN DATA, V2nd, DOI 10.1016/B978-0-12-405888-0.00010-6; Kunkele J, 2000, J MAMMAL, V81, P691, DOI 10.1644/1545-1542(2000)081&lt;0691:EOLSOT&gt;2.3.CO;2; Kunkele J, 1997, PHYSIOL ZOOL, V70, P589; Landete-Castillejos TS, 2003, PHYSIOL BIOCHEM ZOOL, V76, P594, DOI 10.1086/375660; LINCOLN GA, 1974, J ZOOL, V174, P1, DOI 10.1111/j.1469-7998.1974.tb03140.x; MacKay AE, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-017-2419-9; Michel ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136034; MILLAR JS, 1978, ECOLOGY, V59, P1055, DOI 10.2307/1938558; Monteith KL, 2013, J ANIM ECOL, V82, P377, DOI 10.1111/1365-2656.12016; MOORE GH, 1988, NEW ZEAL J AGR RES, V31, P279, DOI 10.1080/00288233.1988.10423416; Moyes K, 2011, J ANIM ECOL, V80, P456, DOI 10.1111/j.1365-2656.2010.01789.x; MUKASAMUGERWA E, 1994, PREV VET MED, V19, P45, DOI 10.1016/0167-5877(94)90014-0; MYERS P, 1983, J MAMMAL, V64, P1, DOI 10.2307/1380746; Mysterud A, 2009, J ANIM ECOL, V78, P1002, DOI 10.1111/j.1365-2656.2009.01553.x; Nemeth M, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0158-4; Nespolo RF, 2009, ECOL RES, V24, P997, DOI 10.1007/s11284-008-0570-5; ONDERSCHEKA K, 1982, WIEN TIERARZTL MONAT, V69, P274; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; Paul A, 1996, BEHAV ECOL SOCIOBIOL, V39, P133, DOI 10.1007/s002650050275; Prendergast BJ, 2005, HORM BEHAV, V48, P503, DOI 10.1016/j.yhbeh.2005.05.013; Proaktor G, 2008, ECOLOGY, V89, P2604, DOI 10.1890/07-0833.1; Qu JP, 2012, EUR J WILDLIFE RES, V58, P269, DOI 10.1007/s10344-011-0574-2; R Core Team, 2020, R LANG ENV STAT COMP; Raczynski J., 1964, Acta Theriologica, V9, P305; Richard Q, 2017, J ANIM ECOL, V86, P1497, DOI 10.1111/1365-2656.12736; Risch TS, 2007, ECOLOGY, V88, P306, DOI 10.1890/06-0249; Rodel HG, 2008, PHYSIOL BEHAV, V93, P826, DOI 10.1016/j.physbeh.2007.11.047; Rodel HG, 2016, BEHAV ECOL, V27, P748, DOI 10.1093/beheco/arv217; Rodel HG, 2009, MAMM BIOL, V74, P200, DOI 10.1016/j.mambio.2008.04.003; Roff Derek, 2002, pi; Rognmo A., 1983, Rangifer, V3, P10; Ronget V, 2018, BIOL REV, V93, P1, DOI 10.1111/brv.12329; Sale MG, 2009, J ZOOL, V277, P119, DOI 10.1111/j.1469-7998.2008.00514.x; Schai-Braun S.C., 2016, P62; Sharp SP, 2010, J ANIM ECOL, V79, P176, DOI 10.1111/j.1365-2656.2009.01616.x; Simard MA, 2014, J MAMMAL, V95, P311, DOI 10.1644/13-MAMM-A-036; Singh MD, 2018, BRAZ J BIOL, V78, P540, DOI 10.1590/1519-6984.172814; Skibiel AL, 2009, ECOL MONOGR, V79, P325, DOI 10.1890/08-0718.1; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Stearns S.C., 1992, pi; Testa JW, 1998, J MAMMAL, V79, P1345, DOI 10.2307/1383026; Valencak TG, 2009, J COMP PHYSIOL B, V179, P933, DOI 10.1007/s00360-009-0376-y; VANJAARSVELD AS, 1993, T ROY SOC S AFR, V48, P219, DOI 10.1080/00359199309520272; Vehtari A., 2019, LOO EFFICIENT LEAVE; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; vom Saal F., 1988, PHYSL REPROD, V2nd ed; Zedrosser A, 2009, OECOLOGIA, V160, P847, DOI 10.1007/s00442-009-1343-8	97	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247174	10.1371/journal.pone.0247174	http://dx.doi.org/10.1371/journal.pone.0247174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596263	gold, Green Published			2022-12-26	WOS:000620633200068
J	Vundavilli, H; Datta, A; Sima, C; Hua, JP; Lopes, R; Bittner, M				Vundavilli, Haswanth; Datta, Aniruddha; Sima, Chao; Hua, Jianping; Lopes, Rosana; Bittner, Michael			Targeting oncogenic mutations in colorectal cancer using cryptotanshinone	PLOS ONE			English	Article							INHIBITOR; PATHWAY; EGFR; PREVENTION; LAPATINIB; THERAPY; PIK3CA; GENE; HER2	Colorectal cancer (CRC) is one of the most prevalent types of cancer in the world and ranks second in cancer deaths in the US. Despite the recent improvements in screening and treatment, the number of deaths associated with CRC is still very significant. The complexities involved in CRC therapy stem from multiple oncogenic mutations and crosstalk between abnormal pathways. This calls for using advanced molecular genetics to understand the underlying pathway interactions responsible for this cancer. In this paper, we construct the CRC pathway from the literature and using an existing public dataset on healthy vs tumor colon cells, we identify the genes and pathways that are mutated and are possibly responsible for the disease progression. We then introduce drugs in the CRC pathway, and using a boolean modeling technique, we deduce the drug combinations that produce maximum cell death. Our theoretical simulations demonstrate the effectiveness of Cryptotanshinone, a traditional Chinese herb derivative, achieved by targeting critical oncogenic mutations and enhancing cell death. Finally, we validate our theoretical results using wet lab experiments on HT29 and HCT116 human colorectal carcinoma cell lines.	[Vundavilli, Haswanth; Datta, Aniruddha] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; [Vundavilli, Haswanth; Datta, Aniruddha; Sima, Chao; Hua, Jianping; Lopes, Rosana; Bittner, Michael] TEES AgriLife Ctr Bioinformat & Genom Syst Engn C, College Stn, TX 77845 USA	Texas A&M University System; Texas A&M University College Station	Vundavilli, H (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.; Vundavilli, H (corresponding author), TEES AgriLife Ctr Bioinformat & Genom Syst Engn C, College Stn, TX 77845 USA.	hashwanthvv@tamu.edu		Vundavilli, Haswanth/0000-0002-3283-7732	US National Science Foundation [ECCS-1609236, ECCS-1917166]; TEES-AgriLife Center for Bioinformatics and Genomic Systems Engineering (CBGSE) startup funds	US National Science Foundation(National Science Foundation (NSF)); TEES-AgriLife Center for Bioinformatics and Genomic Systems Engineering (CBGSE) startup funds	This work was supported in part by the US National Science Foundation under Grants ECCS-1609236 and ECCS-1917166 and in part by the TEES-AgriLife Center for Bioinformatics and Genomic Systems Engineering (CBGSE) startup funds to A.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Arshad OA, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1522-2; Bittner ML., 2018, IEEE ACM T COMPUTATI; Bixel K, 2017, INT J CANCER, V141, P1856, DOI 10.1002/ijc.30847; Cai XY, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S71034; Chen JJ., 1984, J ED STAT, V9, P163, DOI [10.3102/10769986009002163, DOI 10.3102/10769986009002163]; Chen WX, 2013, ANTI-CANCER AGENT ME, V13, P979, DOI 10.2174/18715206113139990115; Chen ZG, 2017, ONCOTARGET, V8, P50023, DOI 10.18632/oncotarget.18483; Danielsen SA, 2015, BBA-REV CANCER, V1855, P104, DOI 10.1016/j.bbcan.2014.09.008; Day FL, 2013, CLIN CANCER RES, V19, P3285, DOI 10.1158/1078-0432.CCR-12-3614; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; Delgado FM, 2019, ARTIF INTELL MED, V95, P133, DOI 10.1016/j.artmed.2018.10.006; Elhenawy AA, 2017, BIOMED PHARMACOTHER, V95, P1346, DOI 10.1016/j.biopha.2017.09.015; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Fenerich BA, 2017, BLOOD, V130; Gong Y, 2011, INT J CANCER, V129, P1042, DOI 10.1002/ijc.25678; Hlubek F, 2007, INT J CANCER, V121, P1941, DOI 10.1002/ijc.22916; Hoff PD, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-92407-6_1; Hua JP, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.046008; Huerta S, 2006, AM J SURG, V191, P517, DOI 10.1016/j.amjsurg.2005.11.009; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Ke FY, 2017, DRUG DES DEV THER, V11, P1753, DOI 10.2147/DDDT.S132488; Kim JH, 2011, APOPTOSIS, V16, P696, DOI 10.1007/s10495-011-0605-1; Konecny GE, 2008, BRIT J CANCER, V98, P1076, DOI 10.1038/sj.bjc.6604278; Lahiri A, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1684-3; Lampropoulos P, 2012, CANCER LETT, V314, P1, DOI 10.1016/j.canlet.2011.09.041; Layek R, 2011, BIOINFORMATICS, V27, P548, DOI 10.1093/bioinformatics/btq703; Li WD, 2015, MOL CELL BIOCHEM, V406, P63, DOI 10.1007/s11010-015-2424-0; Malizzia LJ, 2008, CLIN J ONCOL NURS, V12, P639, DOI 10.1188/08.CJON.639-646; Mattiuzzi C, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.07.91; Misale S, 2014, CANCER DISCOV, V4, P1269, DOI 10.1158/2159-8290.CD-14-0462; Montemurro F, 2007, EXPERT OPIN BIOL TH, V7, P257, DOI 10.1517/14712598.7.2.257; Pandurangan AK, 2013, ASIAN PAC J CANCER P, V14, P2201, DOI 10.7314/APJCP.2013.14.4.2201; Reddy D, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9120792; Rose HM, 2013, BBA-PROTEINS PROTEOM, V1834, P1396, DOI 10.1016/j.bbapap.2013.01.023; Shmulevich I, 2002, P IEEE, V90, P1778, DOI 10.1109/JPROC.2002.804686; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Sole X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106748; Spano JP, 2006, EUR J CANCER, V42, P2668, DOI 10.1016/j.ejca.2006.07.006; Sridharan S, 2017, IEEE J BIOMED HEALTH, V21, P875, DOI 10.1109/JBHI.2016.2559460; Stillwell AP, 2010, WORLD J SURG, V34, P797, DOI 10.1007/s00268-009-0366-y; Su SP, 2018, MOL CANCER THER, V17, P931, DOI 10.1158/1535-7163.MCT-17-0377; Szymanska Z., 2003, International Journal of Applied Mathematics and Computer Science, V13, P407; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Vundavilli H, 2019, IEEE T BIO-MED ENG, V66, P2684, DOI 10.1109/TBME.2019.2894980; Wang WZ, 2019, J CELL BIOCHEM, V120, P7333, DOI 10.1002/jcb.28008; Wei YH, 2015, J HUAZHONG U SCI-MED, V35, P834, DOI 10.1007/s11596-015-1515-1; Ye Q, 2014, ONCOGENE, V33, P1828, DOI 10.1038/onc.2013.122; Zhang BX, 2009, CANCER LETT, V277, P114, DOI 10.1016/j.canlet.2008.11.035; Zhang S, 2006, STAT MED, V25, P285, DOI 10.1002/sim.2221	50	3	3	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247190	10.1371/journal.pone.0247190	http://dx.doi.org/10.1371/journal.pone.0247190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596259	gold, Green Submitted, Green Published			2022-12-26	WOS:000620633200026
J	Marusic, C; Touzani, CD; Bortolami, A; Donini, M; Zanardello, C; Lico, C; Rage, E; Fellahi, S; El Houadfi, M; Terregino, C; Baschieri, S				Marusic, Carla; Touzani, Charifa Drissi; Bortolami, Alessio; Donini, Marcello; Zanardello, Claudia; Lico, Chiara; Rage, Emile; Fellahi, Siham; El Houadfi, Mohammed; Terregino, Calogero; Baschieri, Selene			The expression in plants of an engineered VP2 protein of Infectious Bursal Disease Virus induces formation of structurally heterogeneous particles that protect from a very virulent viral strain	PLOS ONE			English	Article								Infectious Bursal Disease Virus (IBDV), the etiological agent of Gumboro disease, causes mortality and immunosuppression in chickens and major losses to poultry industry worldwide. The IBDV major capsid protein VP2 is considered the best candidate for the production of novel subunit vaccines. This structural protein contains the major conformational epitopes responsible for the induction of IBDV neutralizing antibodies in chickens and has been demonstrated able to form supramolecular structures in yeast and insect cells. The aim of this study was to express an engineered version of the VP2 protein (His-pVP2) to verify its ability to self-assemble into virus-like particles in plants. The recombinant VP2 was transiently expressed by agroinfiltration in Nicotiana benthamiana and transmission electron microscopy of sucrose density gradient fractions revealed the presence of a mixed population of differently shaped particles ranging from spherical capsids, with a diameter between similar to 25 and similar to 70 nm, to tubular structures, with variable length (from 100 to 400 nm). The recombinant VP2-based particles when used for the intramuscular immunization of specific-pathogen-free chicks resulted able to induce the production of anti-IBDV specific antibodies at titers comparable to those induced by a commercial vaccine. Moreover, all the immunized birds survived to the challenge with a Moroccan very virulent IBDV strain with no major histomorphological alterations of the Bursa of Fabricius, similarly to what obtained with the commercial inactivated vaccine.	[Marusic, Carla; Donini, Marcello; Lico, Chiara; Rage, Emile; Baschieri, Selene] ENEA Casaccia Res Ctr, Lab Biotechnol, Rome, Italy; [Touzani, Charifa Drissi; Fellahi, Siham; El Houadfi, Mohammed] Agron & Vet Inst Hassan II, Pathol & Vet Publ Hlth Dept, Avian Pathol Unit, Rabat, Morocco; [Bortolami, Alessio; Terregino, Calogero] Ist Zooprofilatt Sperimentale Venezie, Specialized Virol & Expt Res Dept, Legnaro, Italy; [Zanardello, Claudia] Ist Zooprofilatt Sperimentale Venezie, Diagnost Serv, Histopathol, Parasitol Dept, Legnaro, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; IZS delle Venezie; IZS delle Venezie	Marusic, C (corresponding author), ENEA Casaccia Res Ctr, Lab Biotechnol, Rome, Italy.	carla.marusic@enea.it	Zanardello, Claudia/M-2119-2019; FELLAHI, Siham/AIE-4427-2022	Zanardello, Claudia/0000-0003-2852-3842; Bortolami, Alessio/0000-0003-3381-8354; Terregino, Calogero/0000-0002-7727-3336; Baschieri, Selene/0000-0001-7147-7840; Donini, Marcello/0000-0001-9183-0728; Lico, Chiara/0000-0001-8475-5141	Italian Ministry of Agricultural, Food and Forestry Policies (MIPAAF); Ministry of Higher Education, Scientific Research and Professional Training of Morocco (MESRSFC); European Union's Seventh Framework Programme for research, technological development and demonstration [618127/182]	Italian Ministry of Agricultural, Food and Forestry Policies (MIPAAF); Ministry of Higher Education, Scientific Research and Professional Training of Morocco (MESRSFC); European Union's Seventh Framework Programme for research, technological development and demonstration	This work was funded by AVIAMED project through the ARIMNet2 2015 Call by the following funding agencies: Italian Ministry of Agricultural, Food and Forestry Policies (MIPAAF) and Ministry of Higher Education, Scientific Research and Professional Training of Morocco (MESRSFC). ARIMNet2 (ERA-NET) has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 618127/182. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkie TN, 2016, VET MED-RES REP, V7, P9, DOI 10.2147/VMRR.S68905; BAYLISS CD, 1991, ARCH VIROL, V120, P193, DOI 10.1007/BF01310475; Bottcher B, 1997, J VIROL, V71, P325; Caston JR, 2001, J VIROL, V75, P10815, DOI 10.1128/JVI.75.22.10815-10828.2001; CHETTLE N, 1989, VET REC, V125, P271, DOI 10.1136/vr.125.10.271; Chevalier C, 2005, J VIROL, V79, P12253, DOI 10.1128/JVI.79.19.12253-12263.2005; Dey S, 2019, VET MED-RES REP, V10, P85, DOI 10.2147/VMRR.S185159; Touzani CD, 2019, ARCH VIROL, V164, P381, DOI 10.1007/s00705-018-4076-3; FAHEY KJ, 1989, J GEN VIROL, V70, P1473, DOI 10.1099/0022-1317-70-6-1473; Fernandez-Arias A, 1998, J GEN VIROL, V79, P1047, DOI 10.1099/0022-1317-79-5-1047; Gomez E, 2020, AMB EXPRESS, V10, DOI 10.1186/s13568-020-01029-z; Gomez E, 2013, VACCINE, V31, P2623, DOI 10.1016/j.vaccine.2013.03.064; HEINE HG, 1993, ARCH VIROL, V131, P277, DOI 10.1007/BF01378632; Islam MR, 2012, ARCH VIROL, V157, P333, DOI 10.1007/s00705-011-1159-9; Jackwood DJ, 2007, VIROLOGY, V365, P369, DOI 10.1016/j.virol.2007.03.046; Jackwood DJ, 2011, VIROLOGY, V420, P98, DOI 10.1016/j.virol.2011.08.023; Kurukulasuriya S, 2017, VACCINE, V35, P882, DOI 10.1016/j.vaccine.2017.01.005; Lombardi R, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-96; Lucero MS, 2019, VACCINE, V37, P5203, DOI 10.1016/j.vaccine.2019.07.069; Martinez-Torrecuadrada JL, 2003, VACCINE, V21, P3342, DOI 10.1016/S0264-410X(02)00804-6; Marusic C, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-12; MAZARIEGOS LA, 1990, AVIAN DIS, V34, P203, DOI 10.2307/1591353; Muller H, 2012, AVIAN PATHOL, V41, P133, DOI 10.1080/03079457.2012.661403; MULLER H, 1979, J VIROL, V31, P584; MUSKETT JC, 1979, VET REC, V104, P332, DOI 10.1136/vr.104.15.332; Peters MA, 2005, J VIROL METHODS, V127, P87, DOI 10.1016/j.jviromet.2005.03.009; Pitcovski J, 2003, VACCINE, V21, P4736, DOI 10.1016/S0264-410X(03)00525-5; Pitcovski J, 1996, AVIAN DIS, V40, P753, DOI 10.2307/1592294; Rage E, 2020, APPL MICROBIOL BIOT, V104, P2287, DOI 10.1007/s00253-020-10397-2; Rage E, 2019, APPL MICROBIOL BIOT, V103, P7491, DOI 10.1007/s00253-019-09992-9; Ramirez-Nieto G, 2010, AVIAN DIS, V54, P513, DOI 10.1637/8902-042809-Reg.1; Saugar I, 2005, STRUCTURE, V13, P1007, DOI 10.1016/j.str.2005.04.012; Sedeik ME, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9030072; Taghavian O., 2013, THESIS, DOI [10.13140/2.1.3393.1846, DOI 10.13140/2.1.3393.1846]; Taghavian O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083210; Tsukamoto K, 2000, VIROLOGY, V269, P257, DOI 10.1006/viro.2000.0184; Tsukamoto K, 1999, VIROLOGY, V257, P352, DOI 10.1006/viro.1999.9641; Tsukamoto K, 2002, J VIROL, V76, P5637, DOI 10.1128/JVI.76.11.5637-5645.2002; van den Berg TP, 2004, AVIAN PATHOL, V33, P470, DOI 10.1080/03079450400003650; van den Berg TP, 2000, REV SCI TECH OIE, V19, P527; Villegas P, 2008, AVIAN DIS, V52, P670, DOI 10.1637/8289-032008-ResNote.1; Wu H, 2004, AVIAN DIS, V48, P663, DOI 10.1637/7074; Wu H, 2004, BIOTECHNOL LETT, V26, P787, DOI 10.1023/B:BILE.0000025878.30350.d5; Wu JX, 2007, PLANT BIOTECHNOL J, V5, P570, DOI 10.1111/j.1467-7652.2007.00270.x; Zavala G, 2006, AVIAN DIS, V50, P209, DOI 10.1637/7444-092405R.1	45	3	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247134	10.1371/journal.pone.0247134	http://dx.doi.org/10.1371/journal.pone.0247134			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592038	gold, Green Published			2022-12-26	WOS:000620632800080
J	Mhlongo, G; Mnisi, CM; Mlambo, V				Mhlongo, Godfrey; Mnisi, Caven Mguvane; Mlambo, Victor			Cultivating oyster mushrooms on red grape pomace waste enhances potential nutritional value of the spent substrate for ruminants	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; VITRO GAS-PRODUCTION; CHEMICAL-COMPOSITION; WHEAT-STRAW; BY-PRODUCTS; PLEUROTUS-OSTREATUS; RUMEN; DIGESTIBILITY; FEED; POLYSACCHARIDES	The use of red grape pomace (GP; Vitis vinifera L. var. Shiraz) as a source of beneficial bioactive compounds in ruminant diets is limited by high levels of indigestible compounds in the grape skin matrix. This problem demands innovative, inexpensive, and easy-to-use strategies that improve the digestibility of GP. The bioconversion of GP using edible oyster mushrooms (Pleurotus ostreatus) is one such strategy that has not been previously explored. Therefore, this study evaluated the effect of cultivating oyster mushrooms on GP on chemical composition and in vitro ruminal fermentation parameters of the spent mushroom substrate. The GP was inoculated with oyster mushroom spawns at 0, 200, 300, 400, or 500 g/kg, and incubated for 4 weeks. Organic matter, acid detergent lignin, sodium, manganese, cobalt, and copper linearly declined (P < 0.05) as spawn rates increased. A quadratic trend was observed for crude protein, neutral detergent fibre, acid detergent fibre, magnesium, phosphorus, and calcium content in response to increasing spawn rates. Higher spawning rates (20-50%) had a positive effect (P < 0.05) on gas production from the immediately fermentable fraction (a), rate of gas production from the slowly fermentable fraction (c) and effective gas production. However, gas production from the slowly fermentable fraction (b) and potential gas production linearly declined in response to increasing spawning rates. There was a linear increase (P < 0.05) in the immediately degradable fraction (a), while quadratic effects were observed for partition factors, effective degradability, and in vitro organic matter degradability at 48 h in response to spawning rates. It can be concluded that inoculating GP with oyster mushroom spawn reduced fibre content while increasing crude protein content and in vitro ruminal fermentation efficiency of red grape pomace. Based on the quadratic responses of partition factors at 48 hours post-inoculation, the optimum spawning rate for maximum ruminal fermentation efficiency of GP was determined to be 300 g/kg.	[Mhlongo, Godfrey; Mnisi, Caven Mguvane] North West Univ, Fac Nat & Agr Sci, Dept Anim Sci, Mafikeng, South Africa; [Mnisi, Caven Mguvane] North West Univ, Fac Nat & Agr Sci, Food Secur & Safety Niche Area, Mafikeng, South Africa; [Mlambo, Victor] Univ Mpumalanga, Fac Agr & Nat Sci, Sch Agr Sci, Nelspruit, South Africa	North West University - South Africa; North West University - South Africa	Mnisi, CM (corresponding author), North West Univ, Fac Nat & Agr Sci, Dept Anim Sci, Mafikeng, South Africa.; Mnisi, CM (corresponding author), North West Univ, Fac Nat & Agr Sci, Food Secur & Safety Niche Area, Mafikeng, South Africa.	mnisiecm@gmail.com	Mnisi, Caven Mguvane/L-7199-2019	Mnisi, Caven Mguvane/0000-0003-1385-1093	National Research Foundation [117384]	National Research Foundation	The financial support received from the National Research Foundation for the first author (NRF grant number: 117384) is hereby acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Azim S. N., 2011, Egyptian Journal of Sheep and Goat Sciences, V6, P1; Agri-Laboratory Association of Southern Africa, 1998, FEED PLANT ANAL METH; Akinfemi A., 2012, Slovak Journal of Animal Science, V45, P14; Akinfemi A., 2010, AFRICAN J FOOD AGR N, V10, P1; Akinfemi A., 2010, AFR J BIOTECHNOL, V9, P709; Alipour D, 2007, ANIM FEED SCI TECH, V137, P138, DOI 10.1016/j.anifeedsci.2006.09.020; AOAC International, 2016, OFFICIAL METHODS ANA; Barnes RF, 2007, SCI GRASSLAND AGR, V2, P467; Baumgartel T, 2007, SMALL RUMINANT RES, V67, P302, DOI 10.1016/j.smallrumres.2005.11.002; Beres C, 2017, WASTE MANAGE, V68, P581, DOI 10.1016/j.wasman.2017.07.017; Bustamante MA, 2008, WASTE MANAGE, V28, P372, DOI 10.1016/j.wasman.2007.01.013; Colombatto D, 2003, ANIM FEED SCI TECH, V107, P201, DOI 10.1016/S0377-8401(03)00126-3; Cone JW, 1996, ANIM FEED SCI TECH, V61, P113, DOI 10.1016/0377-8401(96)00950-9; Dwyer K., 2014, Journal of Food Research, V3, P91; El-Rahman HH., 2014, GLOB VET, V13, P47; Fontana AR, 2013, J AGR FOOD CHEM, V61, P8987, DOI 10.1021/jf402586f; Guerra-Rivas C, 2017, J SCI FOOD AGR, V97, P1885, DOI 10.1002/jsfa.7991; Gutierrez A, 1996, CARBOHYD RES, V281, P143, DOI 10.1016/0008-6215(95)00342-8; Khattab HM, 2013, ANIM NUTR FEED TECHN, V13, P507; Kumanda C, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11071931; Lee Chang-Yun, 2009, Mycobiology, V37, P109, DOI 10.4489/MYCO.2009.37.2.109; Lynch JP, 2014, J ANIM PHYSIOL AN N, V98, P731, DOI 10.1111/jpn.12131; Machado AD, 2017, BIORESOURCE TECHNOL, V225, P17, DOI 10.1016/j.biortech.2016.11.053; Mauricio RM, 1999, ANIM FEED SCI TECH, V79, P321, DOI 10.1016/S0377-8401(99)00033-4; Mlambo V, 2008, ANIM FEED SCI TECH, V140, P402, DOI 10.1016/j.anifeedsci.2007.03.001; Mnisi CM, 2017, J ANIM PHYSIOL AN N, V101, P994, DOI 10.1111/jpn.12535; Nasehi M, 2017, J APPL ANIM RES, V45, P221, DOI 10.1080/09712119.2016.1150850; NRC, 2005, MIN TOL AN, V2nd, P13; ORSKOV ER, 1979, J AGR SCI, V92, P499, DOI 10.1017/S0021859600063048; Raghuwanshi S, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-13; Sales-Campos C, 2009, INTERCIENCIA, V34, P432; Sallam S. M. A., 2007, Journal of Applied Sciences Research, P34; Samsudin A. A., 2013, Malaysian Journal of Animal Science, V16, P97; Saratale GD, 2008, J SCI IND RES INDIA, V67, P962; SAS, 2010, SAS US GUID STAT VER; Shen Q, 2001, APPL MICROBIOL BIOT, V57, P74; Shrivastava B, 2014, SCI REP-UK, V4, DOI 10.1038/srep06360; Shrivastava B, 2011, BIODEGRADATION, V22, P823, DOI 10.1007/s10532-010-9408-2; Teixeira A, 2014, INT J MOL SCI, V15, P15638, DOI 10.3390/ijms150915638; Valizadeh R, 2009, J ANIM VET ADV, V8, P2375; VALMASEDA M, 1991, BIOMASS BIOENERG, V1, P261, DOI 10.1016/0961-9534(91)90037-D; Tuyen VD, 2012, BIORESOURCE TECHNOL, V111, P336, DOI 10.1016/j.biortech.2012.02.001; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Yilkal T., 2015, Scholarly Journal of Agricultural Sciences, V5, P247; Yu JM, 2013, INT J FOOD SCI TECH, V48, P221, DOI 10.1111/j.1365-2621.2012.03197.x	45	5	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246992	10.1371/journal.pone.0246992	http://dx.doi.org/10.1371/journal.pone.0246992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592025	Green Published, gold			2022-12-26	WOS:000620632800031
J	Ulyanov, EV; Vinogradov, DS; McIntosh, JR; Gudimchuk, NB				Ulyanov, Evgeniy, V; Vinogradov, Dmitrii S.; McIntosh, J. Richard; Gudimchuk, Nikita B.			Brownian dynamics simulation of protofilament relaxation during rapid freezing	PLOS ONE			English	Article								Electron cryo-microscopy (Cryo-EM) is a powerful method for visualizing biological objects with up to near-angstrom resolution. Instead of chemical fixation, the method relies on very rapid freezing to immobilize the sample. Under these conditions, crystalline ice does not have time to form and distort structure. For many practical applications, the rate of cooling is fast enough to consider sample immobilization instantaneous, but in some cases, a more rigorous analysis of structure relaxation during freezing could be essential. This difficult yet important problem has been significantly under-reported in the literature, despite spectacular recent developments in Cryo-EM. Here we use Brownian dynamics modeling to examine theoretically the possible effects of cryo-immobilization on the apparent shapes of biological polymers. The main focus of our study is on tubulin protofilaments. These structures are integral parts of microtubules, which in turn are key elements of the cellular skeleton, essential for intracellular transport, maintenance of cell shape, cell division and migration. We theoretically examine the extent of protofilament relaxation within the freezing time as a function of the cooling rate, the filament's flexural rigidity, and the effect of cooling on water's viscosity. Our modeling suggests that practically achievable cooling rates are not rapid enough to capture tubulin protofilaments in conformations that are incompletely relaxed, suggesting that structures seen by cryo-EM are good approximations to physiological shapes. This prediction is confirmed by our analysis of curvatures of tubulin protofilaments, using samples, prepared and visualized with a variety of methods. We find, however, that cryofixation may capture incompletely relaxed shapes of more flexible polymers, and it may affect Cryo-EM-based measurements of their persistence lengths. This analysis will be valuable for understanding of structures of different types of biopolymers, observed with Cryo-EM.	[Ulyanov, Evgeniy, V; Gudimchuk, Nikita B.] Lomonosov Moscow State Univ, Dept Phys, Moscow, Russia; [Vinogradov, Dmitrii S.] Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia; [McIntosh, J. Richard; Gudimchuk, Nikita B.] Univ Colorado, Dept MCD Biol, Boulder, CO 80309 USA; [Gudimchuk, Nikita B.] Dmitry Rogachev Natl Med Res Ctr Pediat Hematol O, Moscow, Russia	Lomonosov Moscow State University; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; University of Colorado System; University of Colorado Boulder; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology	Gudimchuk, NB (corresponding author), Lomonosov Moscow State Univ, Dept Phys, Moscow, Russia.; Gudimchuk, NB (corresponding author), Univ Colorado, Dept MCD Biol, Boulder, CO 80309 USA.; Gudimchuk, NB (corresponding author), Dmitry Rogachev Natl Med Res Ctr Pediat Hematol O, Moscow, Russia.	nikita_gb@mail.ru	McIntosh, Richard/GLN-3533-2022; Gudimchuk, Nikita/E-5679-2014	Gudimchuk, Nikita/0000-0002-7283-8959	Russian Foundation for Basic Research [20-34-70159]; Russian Federation Presidents' grant from the Ministry of Science and Higher Education of the Russian Federation [1869.2020.4]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation Presidents' grant from the Ministry of Science and Higher Education of the Russian Federation	Russian Foundation for Basic Research grant #20-34-70159 to N.B.G. https://www.rfbr.ru/rffi/eng Russian Federation Presidents' grant #1869.2020.4 from the Ministry of Science and Higher Education of the Russian Federation to N.B. G. http://government.ru/en/department/388/events/Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Asbury CL, 2011, TRENDS CELL BIOL, V21, P38, DOI 10.1016/j.tcb.2010.09.003; Atherton J, 2018, ACTA CRYSTALLOGR D, V74, P572, DOI 10.1107/S2059798318001948; BEDNAR J, 1995, J MOL BIOL, V254, P579, DOI 10.1006/jmbi.1995.0640; Brouhard GJ, 2018, NAT REV MOL CELL BIO, V19, P451, DOI 10.1038/s41580-018-0009-y; Chang SW, 2014, MATER TODAY, V17, P70, DOI 10.1016/j.mattod.2014.01.019; Dehaoui A, 2015, P NATL ACAD SCI USA, V112, P12020, DOI 10.1073/pnas.1508996112; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; DUBOCHET J, 1994, NAT STRUCT BIOL, V1, P361, DOI 10.1038/nsb0694-361; ERMAK DL, 1978, J CHEM PHYS, V69, P1352, DOI 10.1063/1.436761; Geggier S, 2011, NUCLEIC ACIDS RES, V39, P1419, DOI 10.1093/nar/gkq932; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Gudimchuk NB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17553-2; Haren Jvan., 2019, BIOESSAYS, V41, DOI [10.1002/bies.201800194, DOI 10.1002/BIES.201800194]; HASTED JB, 1976, NATURE, V262, P777, DOI 10.1038/262777b0; Hawkins T, 2010, J BIOMECH, V43, P23, DOI 10.1016/j.jbiomech.2009.09.005; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hoog JL, 2011, J CELL SCI, V124, P693, DOI 10.1242/jcs.072967; Jo W, 2020, ACS APPL MATER INTER, V12, P5058, DOI 10.1021/acsami.9b19420; Kononova O, 2014, J AM CHEM SOC, V136, P17036, DOI 10.1021/ja506385p; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Manka SW, 2018, NAT STRUCT MOL BIOL, V25, P607, DOI 10.1038/s41594-018-0087-8; McIntosh JR, 2020, METHODS MOL BIOL, V2101, P191, DOI 10.1007/978-1-0716-0219-5_13; McIntosh JR, 2018, J CELL BIOL, V217, P2691, DOI 10.1083/jcb.201802138; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; OWEN BB, 1961, J PHYS CHEM-US, V65, P2065, DOI 10.1021/j100828a035; Rezaei N, 2018, BIOPHYS J, V115, P1457, DOI 10.1016/j.bpj.2018.09.003; Singh LP, 2017, P NATL ACAD SCI USA, V114, P4312, DOI 10.1073/pnas.1619501114; Skolnick J, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4962258; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; Wolgemuth CW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.248101; Zakharov P, 2015, BIOPHYS J, V109, P2574, DOI 10.1016/j.bpj.2015.10.048; Zhang R, 2018, P NATL ACAD SCI USA, V115, pE6191, DOI 10.1073/pnas.1802637115; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012; Zovko S, 2008, MOL BIOL CELL, V19, P3138, DOI 10.1091/mbc.E07-07-0681	35	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0247022	10.1371/journal.pone.0247022	http://dx.doi.org/10.1371/journal.pone.0247022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577570	Green Published, gold			2022-12-26	WOS:000620071700008
J	Alupo, P; Wosu, AC; Mahofa, A; Mugenyi, L; Semakula, D; Katagira, W; Kirenga, B				Alupo, Patricia; Wosu, Adaeze C.; Mahofa, Abdallah; Mugenyi, Levicatus; Semakula, Daniel; Katagira, Winceslaus; Kirenga, Bruce			Incidence and predictors of COPD mortality in Uganda: A 2-year prospective cohort study	PLOS ONE			English	Article								Background Data is lacking on outcomes among COPD patients in sub-Saharan Africa. The objective of the study was to assess the incidence and predictors of mortality among COPD patients enrolled in the Uganda Registry for Asthma and COPD. Research question What is the Incidence and predictors of mortality among COPD patients in Uganda? Study design and methods Individuals with a diagnosis of COPD at six hospitals in Uganda were enrolled into the registry, and followed every six months. Mortality was ascertained through post-mortem reports and verbal autopsies. Mortality rates (MR), mortality rate ratios (MRR), and hazard ratios (HR) were computed to assess associations between socio-demographic, behavioural, and clinical characteristics at enrolment into the registry and mortality up to two years after. Results We enrolled 296 COPD patients. Median age was 60 years, and 51 center dot 3% were male. The overall mortality rate was 95 center dot 90 deaths/1000 person-years. COPD severity by post-bronchodilator FEV1 was the strongest risk factor for mortality. Compared to stage 1, adjusted hazard ratios were as follows for stage 4: 9 center dot 86 (95%CI: 1 center dot 70-57 center dot 14, p = 0 center dot 011), stage 3: 6 center dot 16 (95%CI: 1 center dot 25-30 center dot 32, p = 0 center dot 025), and stage 2: 1 center dot 76 (95%CI: 0 center dot 33-9 center dot 48, p = 0 center dot 51). Underweight patients had a higher incidence of mortality compared to normal weight patients (MRR: 3 center dot 47 (95%CI: 1 center dot 45-8 center dot 31, p = 0 center dot 0026). Conclusion Among COPD patients in Uganda, two-year mortality is high, and disease severity at baseline was the strongest risk factor for mortality. Our findings suggest the need for early, accurate, diagnosis and management of COPD, to potentially improve survival.	[Alupo, Patricia; Wosu, Adaeze C.; Mugenyi, Levicatus; Katagira, Winceslaus; Kirenga, Bruce] Makerere Univ, Coll Hlth Sci, Lung Inst, Kampala, Uganda; [Wosu, Adaeze C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Mahofa, Abdallah; Semakula, Daniel; Kirenga, Bruce] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda	Makerere University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University	Kirenga, B (corresponding author), Makerere Univ, Coll Hlth Sci, Lung Inst, Kampala, Uganda.; Kirenga, B (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda.	brucekirenga@yahoo.co.uk		Alupo, Patricia/0000-0001-8946-0940	GSK's Trust In Science Africa Project	GSK's Trust In Science Africa Project	JBK got an award for the grant. This study was funded by the GSK's Trust In Science Africa Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwood BW, 2018, SAMJ S AFR MED J, V108, P138, DOI [10.7196/samj.2018.v108i2.12688, 10.7196/SAMJ.2018.v108i2.12688, 10.7196/SAMJ.2017.v108i2.12688]; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Candidate R., 2012, VERBAL AUTOPSY STAND; Cardoso J, 2018, INT J CHRONIC OBSTR, V13, P1105, DOI 10.2147/COPD.S155848; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; de Torres JP, 2009, EUR RESPIR J, V33, P528, DOI 10.1183/09031936.00096108; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Fong P., 2010, SCIENCE, V1, P609, DOI [10.1056/NEJMoa1109071, DOI 10.1056/NEJMOA1109071]; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Guo Y., 2016, BODY MASS INDEX MORT, P1; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; KANNEL WB, 1983, AM HEART J, V105, P311, DOI 10.1016/0002-8703(83)90532-X; Lange P, 2012, AM J RESP CRIT CARE, V186, P975, DOI 10.1164/rccm.201207-1299OC; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; McGarvey LP, 2007, THORAX, V62, P411, DOI 10.1136/thx.2006.072348; Minas M, 2012, INT J GEN MED, V5, P815, DOI 10.2147/IJGM.S27411; de Oca MM, 2017, RESP CARE, V62, P1058, DOI 10.4187/respcare.05440; Mufunda J, 2006, ETHNIC DIS, V16, P521; Olloquequi J, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0718-y; Ringbaek T, 2005, EUR RESPIR J, V25, P891, DOI 10.1183/09031936.05.00099204; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Siddharthan T, 2019, B WORLD HEALTH ORGAN, V97, P318, DOI 10.2471/BLT.18.216523; Siddharthan T, 2018, AM J RESP CRIT CARE, V197, P611, DOI 10.1164/rccm.201709-1861OC; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Strategy G., GLOBAL INITIATIVE CH; van Gemert F, 2015, LANCET GLOB HEALTH, V3, pE44, DOI 10.1016/S2214-109X(14)70337-7	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246850	10.1371/journal.pone.0246850	http://dx.doi.org/10.1371/journal.pone.0246850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KQ	33571315	gold, Green Published			2022-12-26	WOS:000620071100004
J	Flynn, CM; Kespohl, B; Daunke, T; Garbers, Y; Dusterhoft, S; Rose-John, S; Haybaeck, J; Lokau, J; Aparicio-Siegmund, S; Garbers, C				Flynn, Charlotte M.; Kespohl, Birte; Daunke, Tina; Garbers, Yvonne; Dusterhoft, Stefan; Rose-John, Stefan; Haybaeck, Johannes; Lokau, Juliane; Aparicio-Siegmund, Samadhi; Garbers, Christoph			Interleukin-6 controls recycling and degradation, but not internalization of its receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-INDUCED ENDOCYTOSIS; TRANSDUCER GP130 IMPORTANT; CYTOPLASMIC DOMAIN; DOWN-REGULATION; SIGNAL; CLATHRIN; IL-6; CYTOKINE; ASSOCIATION; PROTEIN	Interleukin-6 (IL-6) is a cytokine implicated in proinflammatory as well as regenerative processes and acts via receptor complexes consisting of the ubiquitously expressed, signal-transducing receptor gp130 and the IL-6 receptor (IL-6R). The IL-6R is expressed only on hepatocytes and subsets of leukocytes, where it mediates specificity of the receptor complex to IL-6 as the subunit gp130 is shared with all other members of the IL-6 cytokine family such as IL-11 or IL-27. The amount of IL-6R at the cell surface thus determines the responsiveness of the cell to the cytokine and might therefore be decisive in the development of inflammatory disorders. However, how the expression levels of IL-6R and gp130 at the cell surface are controlled is largely unknown. Here, we show that IL-6R and gp130 are constitutively internalized independent of IL-6. This process depends on dynamin and clathrin and is temporally controlled by motifs within the intracellular region of gp130 and IL-6R. IL-6 binding and internalization of the receptors is a prerequisite for activation of the Jak/STAT signaling cascade. Targeting of gp130, but not of the IL-6R, to the lysosome for degradation depends on stimulation with IL-6. Furthermore, we show that after internalization and activation of signaling, both the IL-6R and gp130 are recycled back to the cell surface, a process that is enhanced by IL-6. These data reveal an important function of IL-6 beyond the pure activation of signaling.	[Flynn, Charlotte M.; Daunke, Tina; Rose-John, Stefan; Aparicio-Siegmund, Samadhi] Univ Kiel, Inst Biochem, Kiel, Germany; [Kespohl, Birte; Lokau, Juliane; Garbers, Christoph] Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany; [Garbers, Yvonne] Univ Kiel, Inst Psychol, Kiel, Germany; [Dusterhoft, Stefan] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Aachen, Germany; [Haybaeck, Johannes] Med Univ Innsbruck, Dept Pathol Neuropathol & Mol Pathol, Innsbruck, Austria; [Haybaeck, Johannes] Med Univ Graz, Diagnost & Res Ctr Mol Biomed, Inst Pathol, Graz, Austria	University of Kiel; Otto von Guericke University; University of Kiel; RWTH Aachen University; Medical University of Innsbruck; Medical University of Graz	Garbers, C (corresponding author), Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany.	christoph.garbers@med.ovgu.de	Garbers, Christoph/D-9932-2015	Garbers, Christoph/0000-0003-4939-6950; Dusterhoft, Stefan/0000-0002-6926-136X	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [125440785-SFB 877]; Bundesministerium fur Bildung und Forschung (BMBF)	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors thank Alyn Gerneth and Christian Bretscher for excellent technical assistance. This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Projektnummer 125440785-SFB 877 (project A14) and by the Bundesministerium fur Bildung und Forschung (BMBF grant "InTraSig", project B). The expression plasmid encoding DN-AP180_BFP2 was kindly provided by Harvey McMahoon (MRC Laboratory of Molecular Biology, Cambridge), and the expression plasmids encoding the different endophilin constructs were kindly provided by Emmanuel Boucrot (MRC Laboratory of Molecular Biology, Cambridge).	Basagiannis D, 2016, J BIOL CHEM, V291, P16892, DOI 10.1074/jbc.M116.730309; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Cendrowski J, 2016, CYTOKINE GROWTH F R, V32, P63, DOI 10.1016/j.cytogfr.2016.07.002; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; DITTRICH E, 1994, J BIOL CHEM, V269, P19014; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; Dittrich E, 1995, ANN NY ACAD SCI, V762, P410; Doumanov JA, 2006, CELL SIGNAL, V18, P1140, DOI 10.1016/j.cellsig.2005.09.006; Fujimoto K, 2015, MOL PHARMACOL, V88, P660, DOI 10.1124/mol.115.099184; Garbers C, 2018, NAT REV DRUG DISCOV, V17, P395, DOI 10.1038/nrd.2018.45; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; GERHARTZ C, 1994, EUR J BIOCHEM, V223, P265, DOI 10.1111/j.1432-1033.1994.tb18991.x; Hermanns HM, 2016, BIOL CHEM, V397, P695, DOI 10.1515/hsz-2015-0277; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Martens AS, 2000, J CELL SCI, V113, P3593; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Monhasery N, 2016, CELL REP, V16, P1067, DOI 10.1016/j.celrep.2016.06.062; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Renard HF, 2015, NATURE, V517, P493, DOI 10.1038/nature14064; Riethmueller S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000080; Riethmueller S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25550; Rinis N, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-14; Schmidt-Arras D, 2014, J CELL SCI, V127, P341, DOI 10.1242/jcs.130294; Schumacher N, 2015, J BIOL CHEM, V290, P26059, DOI 10.1074/jbc.M115.649509; Sommer J, 2012, J BIOL CHEM, V287, P13743, DOI 10.1074/jbc.M111.349167; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Stautz D, 2012, TRAFFIC, V13, P1532, DOI 10.1111/j.1600-0854.2012.01405.x; Suthaus J, 2010, MOL BIOL CELL, V21, P2797, DOI 10.1091/mbc.E10-03-0240; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; Thiel S, 2000, FEBS LETT, V470, P15, DOI 10.1016/S0014-5793(00)01276-X; Thiel S, 1998, FEBS LETT, V441, P231, DOI 10.1016/S0014-5793(98)01559-2; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wilkinson AN, 2018, J IMMUNOL, V200, P3547, DOI 10.4049/jimmunol.1701191; Wolf J, 2014, CYTOKINE, V70, P11, DOI 10.1016/j.cyto.2014.05.024; Zhao XH, 2001, J CELL SCI, V114, P353; ZOHLNHOFER D, 1992, FEBS LETT, V306, P219, DOI 10.1016/0014-5793(92)81004-6	42	8	9	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100434	10.1016/j.jbc.2021.100434	http://dx.doi.org/10.1016/j.jbc.2021.100434			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610555	Green Published, gold			2022-12-26	WOS:000672866400408
J	Zhang, HL; Li, YM; Sun, J; Zhang, YY; Wang, TY; Sun, MX; Wang, MH; Yang, YL; Hu, XL; Tang, YD; Zhao, JC; Cai, XH				Zhang, Hong-Liang; Li, Yu-Ming; Sun, Jing; Zhang, Yu-Yuan; Wang, Tong-Yun; Sun, Ming-Xia; Wang, Meng-Hang; Yang, Yue-Lin; Hu, Xiao-Liang; Tang, Yan-Dong; Zhao, Jincun; Cai, Xuehui			Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SARS-LIKE CORONAVIRUS; FUNCTIONAL RECEPTOR; CELL ENTRY; INSIGHT; USAGE; ACE2	The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic represents a global threat, and the interaction between the virus and angiotensin-converting enzyme 2 (ACE2), the primary entry receptor for SARS-CoV-2, is a key determinant of the range of hosts that can be infected by the virus. However, the mechanisms underpinning ACE2-mediated viral entry across species remains unclear. Using infection assay, we evaluated SARS-CoV-2 entry mediated by ACE2 of 11 different animal species. We discovered that ACE2 of Rhinolophus sinicus (Chinese rufous horseshoe bat), Felis catus (domestic cat), Canis lupus familiaris (dog), Sus scrofa (wild pig), Capra hircus (goat), and Manis javanica(Malayan pangolin) facilitated SARS-CoV-2 entry into nonsusceptible cells. Moreover, ACE2 of the pangolin also mediated SARS-CoV-2 entry, adding credence to the hypothesis that SARS-CoV-2 may have originated from pangolins. However, the ACE2 proteins of Rhinolophus ferrumequinum (greater horseshoe bat), Gallus gallus (red junglefowl), Notechis scutatus (mainland tiger snake), or Mus musculus (house mouse) did not facilitate SARS-CoV-2 entry. In addition, a natural isoform of the ACE2 protein of Macaca mulatta (rhesus monkey) with the Y217N mutation was resistant to SARS-CoV-2 infection, highlighting the possible impact of this ACE2 mutation on SARS-CoV-2 studies in rhesus monkeys. We further demonstrated that the Y217 residue of ACE2 is a critical determinant for the ability of ACE2 to mediate SARS-CoV-2 entry. Overall, these results clarify that SARS-CoV-2 can use the ACE2 receptors of multiple animal species and show that tracking the natural reservoirs and intermediate hosts of SARS-CoV-2 is complex.	[Zhang, Hong-Liang; Zhang, Yu-Yuan; Wang, Tong-Yun; Sun, Ming-Xia; Wang, Meng-Hang; Yang, Yue-Lin; Tang, Yan-Dong; Cai, Xuehui] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Peoples R China; [Li, Yu-Ming; Sun, Jing; Zhao, Jincun] Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Hu, Xiao-Liang] Yibin Univ, Sch Life Sci & Food Engn, Yibin Key Lab Zool Divers & Ecol Conservat, Yibin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Yibin University	Tang, YD; Cai, XH (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Peoples R China.; Zhao, JC (corresponding author), Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	tangyandong@caas.cn; zhaojincun@gird.cn; caixuehui139@163.com	Tang, Yan-Dong/ABE-7678-2021; sun, jing/GWQ-6926-2022; Zhao, Jincun/ABD-8679-2021; zhang, hongliang/HDM-5116-2022	Tang, Yan-Dong/0000-0002-5690-2690; Zhao, Jincun/0000-0003-2515-5589; 	National Key Research and Development Program of China [2018YFC1200100, 2018ZX10301403]; emergency grants for prevention and control of SARS-CoV-2 of Ministry of Science and Technology [2020YFC0841400]; Guangdong Province [2020B111108001, 2018B020207013]	National Key Research and Development Program of China; emergency grants for prevention and control of SARS-CoV-2 of Ministry of Science and Technology; Guangdong Province	This study was funded by grants from The National Key Research and Development Program of China (2018YFC1200100, 2018ZX10301403), the emergency grants for prevention and control of SARS-CoV-2 of Ministry of Science and Technology (2020YFC0841400) and Guangdong Province (2020B111108001, 2018B020207013).	Chen YX, 2008, VIROLOGY, V381, P89, DOI 10.1016/j.virol.2008.08.016; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hou YX, 2010, ARCH VIROL, V155, P1563, DOI 10.1007/s00705-010-0729-6; Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682; Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lau SKP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0208-9; Li F, 2008, J VIROL, V82, P6984, DOI 10.1128/JVI.00442-08; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Liu YH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025373118; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lu S, 2020, COMP SARS COV 2 INFE, DOI 10.1101/2020.04.08.031807; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu KL, 2012, J BIOL CHEM, V287, P8904, DOI 10.1074/jbc.M111.325803; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111; Yang YL, 2020, EMERG MICROBES INFEC, V9, P457, DOI 10.1080/22221751.2020.1730245; Zhai XF, 2020, J VIROL, V94, DOI 10.1128/JVI.00831-20; Zhang C, 2018, ONCOTARGET, V9, P2175, DOI [10.18632/oncotarget.23299, 10.18632/oncotarget.25667]; Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022; Zhao XS, 2020, J VIROL, V94, DOI 10.1128/JVI.00940-20; Zheng Y, 2018, J VIROL, V92, DOI 10.1128/JVI.01504-18; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	31	15	15	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100435	10.1016/j.jbc.2021.100435	http://dx.doi.org/10.1016/j.jbc.2021.100435			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610551	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400409
J	Zheng, WW; Chu, Q; Xu, TJ				Zheng, Weiwei; Chu, Qing; Xu, Tianjun			The long noncoding RNA NARL regulates immune responses via microRNA-mediated NOD1 downregulation in teleost fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B PATHWAY; RAPID EVOLUTION; PEPTIDOGLYCAN; CONSERVATION; EXPRESSION	Increasing evidence shows that the long noncoding RNA (lncRNA) is a major regulator and participates in the regulation of various physiological and pathological processes, such as cell proliferation, differentiation, metastasis, and apoptosis. Unlike mammals, however, the study of lncRNA in lower invertebrates is just beginning and the extent of lncRNA-mediate regulation remains unclear. Here, we for the first time identify an lncRNA, termed nucleotide oligomerization domain 1 (NOD1) anti-bacterial and antiviral-related lncRNA (NARL), as a key regulator for innate immunity in teleost fish. We found that NOD1 plays an important role in the antibacterial and antiviral process in fish and that the microRNA miR-217-5p inhibits NOD1 expression and thus weakens the NF-kappa B and the IRF3-driven signaling pathway. Furthermore, our results indicated that NARL functions as a competing endogenous RNA (ceRNA) for miR-217-5p to regulate protein abundance of NOD1; thus, invading microorganisms are eliminated and immune responses are promoted. Our study also demonstrates the regulation mechanism that lncRNA NARL can competitive adsorption miR-217-5p to regulate the miR-217-5p/NOD1 axis is widespread in teleost fish. Taken together, our results reveal that NARL in fish is a critical positive regulator of innate immune responses to viral and bacterial infection by suppressing a feedback to NOD1-NF-kappa B/IRF3-mediated signaling.	[Zheng, Weiwei; Chu, Qing; Xu, Tianjun] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China; [Zheng, Weiwei; Chu, Qing; Xu, Tianjun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Xu, Tianjun] Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China; [Xu, Tianjun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China	Shanghai Ocean University; Qingdao National Laboratory for Marine Science & Technology; Shanghai Ocean University; Shanghai Ocean University	Xu, TJ (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China.	tianjunxu@163.com			National Natural Science Foundation of China [31822057]; National Key Research and Development Project [2018YFD0900503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project	This study was supported by National Natural Science Foundation of China (31822057) and National Key Research and Development Project (2018YFD0900503).	Bi DK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01413; Bi DK, 2017, DEV COMP IMMUNOL, V76, P238, DOI 10.1016/j.dci.2017.06.012; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chu Q, 2021, SCI CHINA LIFE SCI, V64, P803, DOI 10.1007/s11427-020-1777-y; Chu Q, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008670; Chu Q, 2017, J IMMUNOL, V198, P3274, DOI 10.4049/jimmunol.1602064; Correia JD, 2007, P NATL ACAD SCI USA, V104, P6764, DOI 10.1073/pnas.0610926104; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fritz T, 2011, GUT, V60, P1580, DOI 10.1136/gut.2009.206466; Fu T, 2021, GASTRIC CANCER, V24, P45, DOI 10.1007/s10120-020-01096-y; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Hahn JS, 2005, FEBS LETT, V579, P4513, DOI 10.1016/j.febslet.2005.07.024; Hoang M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115428; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Jing ZT, 2018, J IMMUNOL, V201, P2303, DOI 10.4049/jimmunol.1800732; Kang H, 2017, BIOCHEM BIOPH RES CO, V482, P28, DOI 10.1016/j.bbrc.2016.11.032; Li CL, 2021, J CELL PHYSIOL, V236, P653, DOI 10.1002/jcp.29892; Li JR, 2015, FISH SHELLFISH IMMUN, V46, P387, DOI 10.1016/j.fsi.2015.06.026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luis AIS, 2020, ACS OMEGA, V5, P15557, DOI 10.1021/acsomega.0c01716; Marques AC, 2014, CURR OPIN GENET DEV, V27, P48, DOI 10.1016/j.gde.2014.03.009; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Nie W, 2016, CANCER LETT, V371, P99, DOI 10.1016/j.canlet.2015.11.024; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Park SB, 2012, DEV COMP IMMUNOL, V36, P680, DOI 10.1016/j.dci.2011.11.007; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Swain B, 2013, J BIOSCIENCES, V38, P533, DOI 10.1007/s12038-013-9330-y; Wu XM, 2020, J IMMUNOL, V204, P2216, DOI 10.4049/jimmunol.1900667; Xu TJ, 2018, J IMMUNOL, V201, P982, DOI 10.4049/jimmunol.1800377; Xu TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21902; Yamamoto-Furusho JK, 2006, J BIOL CHEM, V281, P36060, DOI 10.1074/jbc.M602383200; Yang XZ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0874-1; Zhang L, 2020, J IMMUNOL, V205, P1620, DOI 10.4049/jimmunol.2000341; Zhang R, 2014, CELL PHYSIOL BIOCHEM, V33, P1954, DOI 10.1159/000362972; Zhu SM, 2020, INFLAMMATION, V43, P2256, DOI 10.1007/s10753-020-01293-y; Zhu XH, 2016, EUR REV MED PHARMACO, V20, P3653	43	21	23	11	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100414	10.1016/j.jbc.2021.100414	http://dx.doi.org/10.1016/j.jbc.2021.100414			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33581111	Green Published, gold			2022-12-26	WOS:000672866400388
J	Wasson, K; Tanner, KE; Woofolk, A; McCain, S; Suraci, JP				Wasson, Kerstin; Tanner, Karen E.; Woofolk, Andrea; McCain, Sean; Suraci, Justin P.			Top-down and sideways: Herbivory and cross-ecosystem connectivity shape restoration success at the salt marsh-upland ecotone	PLOS ONE			English	Article							CONSUMER CONTROL; TIDAL MARSH; DIE-OFF; HABITAT; VEGETATION; CALIFORNIA; RESILIENCE; MOVEMENTS; RESPONSES; DYNAMICS	Wetland restoration provides remarkable opportunities to understand vegetation dynamics and to inform success of future projects through rigorous restoration experiments. Salt marsh restoration typically focuses on physical factors such as sediment dynamics and elevation. Despite many demonstrations of strong top-down effects on salt marshes, the potential for consumers to affect salt marsh restoration projects has rarely been quantified. Recently, major restoration projects at the Elkhorn Slough National Estuarine Research Reserve in central California, USA provided an opportunity to examine how herbivory influences restoration success. We quantified the strength of consumer effects by comparing caged to uncaged plantings, and compared effects among plant species and sites. We used camera traps to detect which herbivores were most common and how their abundance varied spatially. Beyond characterizing consumer effects, we also tested management strategies for reducing negative effects of herbivory at the restoration sites, including caging, mowing, and acoustic playbacks of predator sounds. We found extremely strong consumer effects at sites with extensive stands of exotic forbs upland of the high marsh; uncaged restoration plants suffered heavy herbivory and high mortality, while most caged plants survived. Brush rabbits (Sylvilagus bachmani) were by far the most frequent consumers of these high marsh plants. Our work thus provides the first evidence of mammal consumers affecting salt marsh restoration success. Mowing of tall exotic forb cover adjacent to the marsh at one restoration site greatly reduced consumption, and nearly all monitored plantings survived at a second restoration site where construction had temporarily eliminated upland cover. Playbacks of predator sounds did not significantly affect restoration plantings, but restoration efforts in marsh communities vulnerable to terrestrial herbivory may benefit from concurrent restoration of predator communities in the upland habitats surrounding the marsh. A landscape approach is thus critical for recognizing linkages between terrestrial and marine vegetation.	[Wasson, Kerstin; Woofolk, Andrea] Elkhorn Slough Natl Estuarine Res Reserve, Royal Oaks, CA 95076 USA; [Wasson, Kerstin; Tanner, Karen E.] Univ Calif Santa Cruz, Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [McCain, Sean] Calif Dept Fish & Wildlife, Sacramento, CA USA; [Suraci, Justin P.] Univ Calif Santa Cruz, Environm Studies, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Wasson, K (corresponding author), Elkhorn Slough Natl Estuarine Res Reserve, Royal Oaks, CA 95076 USA.; Wasson, K (corresponding author), Univ Calif Santa Cruz, Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	wasson@ucsc.edu		Wasson, Kerstin/0000-0002-1858-4505; McCain, Sean/0000-0003-4522-6110; Tanner, Karen/0000-0001-7952-1658	NOAA's Office for Coastal Management; California Department of Water Resources; California Department of Fish and Wildlife; California Coastal Conservancy; USFW National Coastal Wetlands Conservation; Ocean Protection Council; Wildlife Conservation Board; ESNERR; Ecology and Evolutionary Biology Department at the University of California, Santa Cruz (UCSC); Future Leaders in Coastal Science Award (Division of Physical & Biological Sciences, UCSC); Jean H. Langenheim Graduate Fellowship; Hardman Native Plant Award	NOAA's Office for Coastal Management; California Department of Water Resources; California Department of Fish and Wildlife; California Coastal Conservancy; USFW National Coastal Wetlands Conservation; Ocean Protection Council; Wildlife Conservation Board; ESNERR; Ecology and Evolutionary Biology Department at the University of California, Santa Cruz (UCSC); Future Leaders in Coastal Science Award (Division of Physical & Biological Sciences, UCSC); Jean H. Langenheim Graduate Fellowship; Hardman Native Plant Award	Funding of ESNERR staff (KW, AW, and others who supported the project) was provided by a grant from NOAA's Office for Coastal Management. Whistlestop and Hester Marsh restoration projects were coordinated by ESNERR's Tidal Wetland Program and funded by grants from California Department of Water Resources, California Department of Fish and Wildlife, California Coastal Conservancy, USFW National Coastal Wetlands Conservation, Ocean Protection Council, and the Wildlife Conservation Board to the Elkhorn Slough Foundation on behalf of ESNERR. Funding for KET was provided by ESNERR, the Ecology and Evolutionary Biology Department at the University of California, Santa Cruz (UCSC), the Future Leaders in Coastal Science Award (Division of Physical & Biological Sciences, UCSC), the Jean H. Langenheim Graduate Fellowship, and the Hardman Native Plant Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti J, 2015, ESTUAR COAST, V38, P1178, DOI 10.1007/s12237-014-9836-z; Alberti J, 2011, J VEG SCI, V22, P216, DOI 10.1111/j.1654-1103.2010.01240.x; Altieri AH, 2012, ECOLOGY, V93, P1402, DOI 10.1890/11-1314.1; Bates D., 2014, ARXIV, DOI [10.18637/jss.v067.i01, DOI 10.18637/JSS.V067.I01]; Bertness MD, 2008, CONSERV BIOL, V22, P618, DOI 10.1111/j.1523-1739.2008.00962.x; Boerema A, 2016, ECOL SOC, V21, DOI 10.5751/ES-08372-210210; Boyer KE, 2005, OECOLOGIA, V143, P619, DOI 10.1007/s00442-005-0015-6; Boyer KE, 1996, ESTUARIES, V19, P1, DOI 10.2307/1352646; Burdick DM., 2020, MARSHES FUNCTION DYN; Cahoon DR, 2019, ESTUAR COAST, V42, P1, DOI 10.1007/s12237-018-0448-x; Canepuccia AD, 2010, J EXP MAR BIOL ECOL, V396, P42, DOI 10.1016/j.jembe.2010.09.013; Coverdale TC, 2013, FRONT ECOL ENVIRON, V11, P69, DOI 10.1890/120130; Daleo P, 2014, OECOLOGIA, V175, P335, DOI 10.1007/s00442-014-2903-0; Day JW, 2008, ESTUAR COAST, V31, P477, DOI 10.1007/s12237-008-9047-6; Elschot K, 2013, ESTUAR COAST SHELF S, V133, P109, DOI 10.1016/j.ecss.2013.08.021; Forys EA, 1996, J MAMMAL, V77, P1042, DOI 10.2307/1382784; Fox J., 2019, R COMPANION APPL REG, V.; Freitas RF, 2016, MAR ECOL PROG SER, V547, P79, DOI 10.3354/meps11624; Garvey PM., 2020, TRENDS ECOL EVOL; Gaynor KM., 2020, ANIM CONSERV; Gedan KB, 2009, ECOLOGY, V90, P430, DOI 10.1890/08-0417.1; Grace JB., 2000, P INV SPEC WORKSH RO, P40; Harding EK, 2002, BIOL CONSERV, V104, P227, DOI 10.1016/S0006-3207(01)00169-0; Harding EK, 2001, OECOLOGIA, V129, P436, DOI 10.1007/s004420100729; He Q, 2017, ECOL LETT, V20, P194, DOI 10.1111/ele.12721; He Q, 2016, ECOL MONOGR, V86, P278, DOI 10.1002/ecm.1221; Himes-Cornell A, 2018, ECOSYST SERV, V30, P36, DOI 10.1016/j.ecoser.2018.01.006; Holdredge C, 2009, CONSERV BIOL, V23, P672, DOI 10.1111/j.1523-1739.2008.01137.x; Howison RA, 2015, J VEG SCI, V26, P1159, DOI 10.1111/jvs.12317; Janousek CN, 2019, ESTUAR COAST, V42, P85, DOI 10.1007/s12237-018-0420-9; Jefferies RL, 2006, J ECOL, V94, P234, DOI 10.1111/j.1365-2745.2005.01086.x; Kassambara A, **DATA OBJECT**; Kennish MJ, 2001, J COASTAL RES, V17, P731; Kirwan M, 2009, QUATERNARY SCI REV, V28, P1801, DOI 10.1016/j.quascirev.2009.02.022; Kruchek BL, 2004, J MAMMAL, V85, P569, DOI 10.1644/BEH-016; Kuijper D. P. J., 2003, Journal of Coastal Conservation, V9, P179, DOI 10.1652/1400-0350(2003)009[0179:LEOASH]2.0.CO;2; Kuijper DPJ, 2005, ECOLOGY, V86, P914, DOI 10.1890/04-0693; Lindig-Cisneros R, 2002, ESTUARIES, V25, P1174, DOI 10.1007/BF02692214; Liu ZZ, 2020, J ENVIRON MANAGE, V274, DOI 10.1016/j.jenvman.2020.111110; Long JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110419; McFalls TB, 2010, J COASTAL RES, V26, P901, DOI 10.2112/JCOASTRES-D-09-00037.1; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Peters DPC, 2006, LANDSCAPE ECOL, V21, P19, DOI 10.1007/s10980-005-1063-3; R Core Team, 2020, R LANG ENV STAT COMP; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; Roman CT., 2012, TIDAL MARSH RESTORAT, DOI [10.5822/978-1-61091-229-7, DOI 10.5822/978-1-61091-229-7]; Schile LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088760; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Slocum MG, 2005, ESTUARIES, V28, P519, DOI 10.1007/BF02696063; Suraci JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10698; Swanson KM, 2014, ESTUAR COAST, V37, P476, DOI 10.1007/s12237-013-9694-0; Thorne K, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao3270; Thorne KM, 2019, ECOL ENG, V136, P197, DOI 10.1016/j.ecoleng.2019.05.011; Van Dyke E, 2005, ESTUARIES, V28, P173, DOI 10.1007/BF02732853; Wasson K, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2813; Wasson K, 2011, WETLANDS, V31, P1, DOI 10.1007/s13157-011-0153-z; Weinstein Michael P., 2001, Wetlands Ecology and Management, V9, P387, DOI 10.1023/A:1012058713910; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams P., 2001, J COASTAL RES, V27, P203; Yarrow MM, 2007, ECOSYSTEMS, V10, P462, DOI 10.1007/s10021-007-9036-9; Zanette LY, 2019, CURR BIOL, V29, pR309, DOI 10.1016/j.cub.2019.02.042; Zedler JB, 2001, BIOSCIENCE, V51, P1005, DOI 10.1641/0006-3568(2001)051[1005:DBWSMA]2.0.CO;2; Zedler JB, 2000, TRENDS ECOL EVOL, V15, P402, DOI 10.1016/S0169-5347(00)01959-5	65	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247374	10.1371/journal.pone.0247374	http://dx.doi.org/10.1371/journal.pone.0247374			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617558	Green Published, gold			2022-12-26	WOS:000623082400049
J	Chaves, OM; Fortes, VB; Hass, GP; Azevedo, RB; Stoner, KE; Bicca-Marques, JC				Chaves, Oscar M.; Fortes, Vanessa B.; Hass, Gabriela P.; Azevedo, Renata B.; Stoner, Kathryn E.; Bicca-Marques, Julio Cesar			Flower consumption, ambient temperature and rainfall modulate drinking behavior in a folivorous-frugivorous arboreal mammal	PLOS ONE			English	Article							CAPUCHINS CEBUS-CAPUCINUS; BROWN HOWLER MONKEY; BODY-TEMPERATURE; ALOUATTA-CARAYA; ACTIVITY BUDGET; WATER SOURCES; PLANT; THERMOREGULATION; AGE; NUTRIENT	Water is vital for the survival of any species because of its key role in most physiological processes. However, little is known about the non-food-related water sources exploited by arboreal mammals, the seasonality of their drinking behavior and its potential drivers, including diet composition, temperature, and rainfall. We investigated this subject in 14 wild groups of brown howler monkeys (Alouatta guariba clamitans) inhabiting small, medium, and large Atlantic Forest fragments in southern Brazil. We found a wide variation in the mean rate of drinking among groups (range = 0-16 records/day). Streams (44% of 1,258 records) and treeholes (26%) were the major types of water sources, followed by bromeliads in the canopy (16%), pools (11%), and rivers (3%). The type of source influenced whether howlers used a hand to access the water or not. Drinking tended to be evenly distributed throughout the year, except for a slightly lower number of records in the spring than in the other seasons, but it was unevenly distributed during the day. It increased in the afternoon in all groups, particularly during temperature peaks around 15:00 and 17:00. We found via generalized linear mixed modelling that the daily frequency of drinking was mainly influenced negatively by flower consumption and positively by weekly rainfall and ambient temperature, whereas fragment size and the consumption of fruit and leaves played negligible roles. Overall, we confirm the importance of preformed water in flowers to satisfy the howler's water needs, whereas the influence of the climatic variables is compatible with the 'thermoregulation/dehydration-avoiding hypothesis'. In sum, we found that irrespective of habitat characteristics, brown howlers seem to seek a positive water balance by complementing the water present in the diet with drinking water, even when it is associated with a high predation risk in terrestrial sources.	[Chaves, Oscar M.; Hass, Gabriela P.; Bicca-Marques, Julio Cesar] Pontificia Univ Catolica Rio Grande Do Sul, Escola Ciencias Saude & Vida, Porto Alegre, RS, Brazil; [Chaves, Oscar M.] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; [Fortes, Vanessa B.] Univ Fed Santa Maria, Dept Zootecnia & Ciencias Biol, Santa Maria, RS, Brazil; [Azevedo, Renata B.] Ctr Nacl Pesquisa & Conserv Primatas Brasileiros, Inst Chico Mendes Conserv Biodiversidade, Joao Pessoa, Paraiba, Brazil; [Stoner, Kathryn E.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO USA	Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidad Costa Rica; Universidade Federal de Santa Maria (UFSM); Colorado State University	Chaves, OM (corresponding author), Pontificia Univ Catolica Rio Grande Do Sul, Escola Ciencias Saude & Vida, Porto Alegre, RS, Brazil.; Chaves, OM (corresponding author), Univ Costa Rica, Escuela Biol, San Jose, Costa Rica.	ochaba@gmail.com	Bicca-Marques, Júlio César/F-7487-2012	Bicca-Marques, Júlio César/0000-0002-5400-845X; Chaves, Oscar M./0000-0001-6246-1265	Programa Nacional de Pos-Doutorado of the Brazilian Higher Education Authority/CAPES (PNPD) [2755/2010]; PNPD postdoctoral fellowship; Brazilian National Research Council/CNPq [303306/2013-0, 304475/2018-1]; CNPq [140641/2016-5]	Programa Nacional de Pos-Doutorado of the Brazilian Higher Education Authority/CAPES (PNPD); PNPD postdoctoral fellowship; Brazilian National Research Council/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by a grant from the Programa Nacional de Pos-Doutorado of the Brazilian Higher Education Authority/CAPES (PNPD grant #2755/2010). OMC was supported by a PNPD postdoctoral fellowship. JCBM thanks the Brazilian National Research Council/CNPq for research fellowships (PQ#303306/2013-0 and 304475/2018-1). GPH was supported by a doctoral fellowship from CNPq (GD#140641/2016-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaby M., 2006, TROPICAL FORESTS; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Barton K., 2022, MULTIMODEL INFERENCE; Bicca-Marques JC, 2004, FOLIA PRIMATOL, V75, P236; Bicca-Marques JC, 1998, AM J PHYS ANTHROPOL, V106, P533, DOI 10.1002/(SICI)1096-8644(199808)106:4<533::AID-AJPA8>3.0.CO;2-J; Bicca-Marques JC., 2007, PRIMATOLOGIA BRASIL, P353; Bicca-Marques JC, 2020, AM J PRIMATOL, V82, DOI 10.1002/ajp.23089; BICCAMARQUES JC, 1992, FOLIA PRIMATOL, V58, P107, DOI 10.1159/000156616; BICCAMARQUES JC, 1994, FOLIA PRIMATOL, V63, P216, DOI 10.1159/000156823; Bonvicino CR, 1988, THESIS U FEDERAL PAR; Burnham K P, 2003, MODEL SELECT MULTIMO; Buss G., 2012, THESIS U FEDERAL RIO; Campbell CJ, 2005, INT J PRIMATOL, V26, P1039, DOI 10.1007/s10764-005-6457-1; Campos FA, 2009, AM J PHYS ANTHROPOL, V138, P101, DOI 10.1002/ajpa.20908; CHAPMAN C, 1988, PRIMATES, V29, P177, DOI 10.1007/BF02381121; Chaves OM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145819; Chaves OM, 2013, AM J PRIMATOL, V75, P16, DOI 10.1002/ajp.22075; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Bianchi RD, 2007, AM J PRIMATOL, V69, P1173, DOI 10.1002/ajp.20415; Dias PAD, 2014, PRIMATES, V55, P1, DOI 10.1007/s10329-013-0383-1; Castro SCD, 2017, FOLIA PRIMATOL, V88, P267, DOI 10.1159/000479106; Ellis W., 2010, Australian Zoologist, V35, P369; Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946; Ferrari SF, 2012, PRIMATES, V53, P65, DOI 10.1007/s10329-011-0277-z; Fitzsimons J.T., 1991, THIRST PHYSL PSYCHOL, P3; Fortes VB, 2008, THESIS PONTIFICIA U; FREESE C H, 1978, Primates, V19, P275, DOI 10.1007/BF02382797; Gilmore DP, 2000, BRAZ J MED BIOL RES, V33, P129, DOI 10.1590/S0100-879X2000000200001; Glander K.E., 1978, P561; GLANDER KE, 1978, FOLIA PRIMATOL, V29, P206, DOI 10.1159/000155840; Goncalves AS, 2006, THESIS U VALE RIO DO; Grandjean AC, 2004, MONOGRAPH N AM BRANC; Green Brian, 1997, P143; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hillyer AP., 2015, PRIMATE BIOL, V2, P21; HOBAN TM, 1985, PHYSIOL BEHAV, V34, P513, DOI 10.1016/0031-9384(85)90042-3; Hogan JD, 2016, AM J PHYS ANTHROPOL, V161, P591, DOI 10.1002/ajpa.23059; INMET, 2019, BANC DAD MET PAR ENS; Jequier E, 2010, EUR J CLIN NUTR, V64, P115, DOI 10.1038/ejcn.2009.111; Lopes KGD, 2017, J THERM BIOL, V69, P104, DOI 10.1016/j.jtherbio.2017.06.010; Marsh LK, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P381; Martinez N., 2004, REV B ECOL, V16, P1; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; Mella VSA, 2020, ETHOLOGY, V126, P858, DOI 10.1111/eth.13032; MILTON K, 1981, AM NAT, V117, P496, DOI 10.1086/283730; Moles AT, 2011, FUNCT ECOL, V25, P380, DOI 10.1111/j.1365-2435.2010.01814.x; Moro-Rios RF, 2008, REV BRAS ZOOL, V25, P558, DOI 10.1590/S0101-81752008000300024; Nagy K.A., 1988, SCALING WATER FLUX R; NAGY KA, 1979, OECOLOGIA, V39, P249, DOI 10.1007/BF00345437; National Research Council US, 2003, NUTR REQ NONH PRIM; Nimer E., 1989, CLIMATOLOGIA BRASIL, Vsecond; OATES JF, 1978, BIOTROPICA, V10, P241, DOI 10.2307/2387676; PATERSON JD, 1981, CAN REV PHYS ANTHR, V3, P3; Payne EH, 2018, COMMUN STAT-SIMUL C, V47, P1722, DOI 10.1080/03610918.2017.1323223; Pozo-Montuy G, 2007, PRIMATES, V48, P102, DOI 10.1007/s10329-006-0026-x; Prates HM, 2008, INT J PRIMATOL, V29, P703, DOI 10.1007/s10764-008-9257-6; R Core Team, 2020, R LANG ENV STAT COMP; Richard AF, 1985, PRIMATES NATURE; Sharma N, 2016, BEHAV PROCESS, V129, P18, DOI 10.1016/j.beproc.2016.05.006; Silver SC, 1998, AM J PRIMATOL, V45, P263, DOI 10.1002/(SICI)1098-2345(1998)45:3<263::AID-AJP3>3.0.CO;2-U; Steinmetz Sandra, 2001, Neotropical Primates, V9, P111; SULZMAN FM, 1977, PHYSIOL BEHAV, V18, P775, DOI 10.1016/0031-9384(77)90182-2; Thompson CL, 2014, AM J PHYS ANTHROPOL, V154, P1, DOI 10.1002/ajpa.22505; Wickham H, 2018, **DATA OBJECT**; Williamson Elizabeth A., 2011, P33; Xu MM, 2016, COMP BIOCHEM PHYS A, V194, P37, DOI 10.1016/j.cbpa.2016.01.015; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	68	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0236974	10.1371/journal.pone.0236974	http://dx.doi.org/10.1371/journal.pone.0236974			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606693	gold, Green Published			2022-12-26	WOS:000620629200016
J	Hansen, NC; Reymore, L				Hansen, Niels Chr; Reymore, Lindsey			Articulatory motor planning and timbral idiosyncrasies as underlying mechanisms of instrument-specific absolute pitch in expert musicians	PLOS ONE			English	Article							MUSICAL EXPERTISE; IDENTIFICATION; PERCEPTION	The study of musical expertise illustrates how intense training in a specialized domain may instigate development of implicit skills. While absolute pitch, or the ability to identify musical pitches without external reference, is rare even in professional musicians and is understood to have a genetic component, anecdotal evidence and pilot data suggest that some musicians without traditional absolute pitch are nonetheless better able to name notes played on their musical instrument of expertise than notes played on less familiar instruments. We have previously termed this particular gain in absolute pitch identification ability "instrument-specific absolute pitch" (ISAP) and have proposed that this skill is related to learned instrument type-specific timbral and intonational idiosyncrasies and articulatory motor planning activated by the timbre of the instrument. In this Registered Report Protocol, we describe two experiments designed to investigate ISAP in professional oboists. Experiment 1 tests for ISAP ability by comparing oboists' pitch identification accuracies for notes played on the oboe and on the piano. A subset of the participants from Experiment 1 who demonstrate this ability will be recruited for Experiment 2; the purpose of Experiment 2 is to test hypotheses concerning a mechanistic explanation for ISAP. The outcome of these experiments may provide support for the theory that some individuals have ISAP and that the underlying mechanisms of this ability may rely on the perception of subtle timbral/intonational idiosyncrasies and on articulatory motor planning developed through intensive long-term training. In general, this work will contribute to the understanding of specialized expertise, specifically of implicit abilities and biases that are not addressed directly in training, but that may yet develop through practice of a related skill set.	[Hansen, Niels Chr] Aarhus Univ, Aarhus Inst Adv Studies, Aarhus, Denmark; [Hansen, Niels Chr] Aarhus Univ, Ctr Mus Brain, Aarhus, Denmark; [Hansen, Niels Chr] Royal Acad Mus Aarhus Aalborg, Aarhus, Denmark; [Reymore, Lindsey] McGill Univ, Schulich Sch Mus, Montreal, PQ, Canada	Aarhus University; Aarhus University; McGill University	Hansen, NC (corresponding author), Aarhus Univ, Aarhus Inst Adv Studies, Aarhus, Denmark.; Hansen, NC (corresponding author), Aarhus Univ, Ctr Mus Brain, Aarhus, Denmark.; Hansen, NC (corresponding author), Royal Acad Mus Aarhus Aalborg, Aarhus, Denmark.	nchansen@aias.au.dk		Hansen, Niels Chr./0000-0003-2142-6484; Reymore, Lindsey/0000-0003-2063-3166	Lundbeck Foundation [R266-2017-3339]; Carlsberg Foundation [CF18-0668]; European Union [754513]; Aarhus University Research Foundation; McGill University	Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); European Union(European Commission); Aarhus University Research Foundation; McGill University	While conducting this work, NCH received funding from Lundbeck Foundation (R266-2017-3339), Carlsberg Foundation (CF18-0668), and from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 754513 and The Aarhus University Research Foundation. This project also received funding from McGill University. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, R LANG ENV STAT COMP; Anwyl-Irvine AL, 2020, BEHAV RES METHODS, V52, P388, DOI 10.3758/s13428-019-01237-x; Athos EA, 2007, P NATL ACAD SCI USA, V104, P14795, DOI 10.1073/pnas.0703868104; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beaman CP, 2015, Q J EXP PSYCHOL, V68, P1049, DOI 10.1080/17470218.2015.1034142; Choi US, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00597; Christensen RHB, **DATA OBJECT**, P12; D'Ausilio A, 2006, EUR J NEUROSCI, V24, P955, DOI 10.1111/j.1460-9568.2006.04960.x; Eerola T, 2008, MUSIC PERCEPT, V25, P253, DOI 10.1525/MP.2008.25.3.253; Ericsson KA, 2010, WIRES COGN SCI, V1, P404, DOI 10.1002/wcs.47; Ericsson KA, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P1, DOI 10.2277/ 0521600812; Fitzgerald L., 2019, J ACOUST SOC AM, V145, P1709, DOI [10.1121/1.5101268, DOI 10.1121/1.5101268]; Francois C, 2011, CEREB CORTEX, V21, P2357, DOI 10.1093/cercor/bhr022; Furukawa Y, 2017, NEUROSCI LETT, V650, P97, DOI 10.1016/j.neulet.2017.04.033; Gratton I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163558; Gruhn W, 2018, EMPIR MUSICOL REV, V13, P110; Hansen N, 2014, FRONT NEUROL, V5, DOI [10.3389/fneur.2014.00080, 10.3389/fpsyg.2014.01052]; Hansen NC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163584; Hsieh IH, 2009, ACOUST PHYS+, V55, P232, DOI 10.1134/S1063771009020134; Kim S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175103; Krishnan S, 2018, CEREB CORTEX, V28, P4063, DOI 10.1093/cercor/bhy208; Leite RBC, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00447; Levitin DJ, 2005, TRENDS COGN SCI, V9, P26, DOI 10.1016/j.tics.2004.11.007; Li XN, 2021, PSYCHOL MUSIC, V49, P704, DOI 10.1177/0305735619893437; Loui P., 2016, OXFORD HDB MUSIC PSY, V2nd ed, DOI [10.1093/oxfordhb/9780198722946.013.10, DOI 10.1093/OXFORDHB/9780198722946.013.10]; Margulis EH, 2009, HUM BRAIN MAPP, V30, P267, DOI 10.1002/hbm.20503; Marvin EW, 2000, MUSIC PERCEPT, V18, P111; MIYAZAKI K, 1989, MUSIC PERCEPT, V7, P1; Ollen J.E., 2006, THESIS OHIO STATE U; Opolko F., 2006, MCGILL U MASTER SAMP; Page JK., 2001, GROVE MUSIC ONLINE; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Proverbio AM, 2016, MUSIC PERCEPT, V33, P446, DOI 10.1525/MP.2016.33.4.446; Reymore L, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.560877; Schaefer RS, 2014, EMPIR MUSICOL REV, V9, P161; Schlemmer KB, 2005, PSYCHOPHYSIOLOGY, V42, P465, DOI 10.1111/j.1469-8986.2005.00306.x; Shahin AJ, 2008, NEUROIMAGE, V41, P113, DOI 10.1016/j.neuroimage.2008.01.067; Snow DB, 2006, THESIS U SO MISSIPPI; Van Hedger SC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223047; Vanzella P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015449; Ward W.D., 1999, PSYCHOL MUSIC PP, P265, DOI DOI 10.1016/B978-012213564-4/50009-3; Wilson SJ, 2009, CEREB CORTEX, V19, P724, DOI 10.1093/cercor/bhn121; Wong YK, 2014, PSYCHON B REV, V21, P534, DOI 10.3758/s13423-013-0487-z; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zhang JD, 2019, MUSIC PERCEPT, V36, P457, DOI 10.1525/MP.2019.36.5.457	46	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247136	10.1371/journal.pone.0247136	http://dx.doi.org/10.1371/journal.pone.0247136			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606800	gold, Green Published			2022-12-26	WOS:000620629200170
J	Lindborg, A; Andersen, TS				Lindborg, Alma; Andersen, Tobias S.			Bayesian binding and fusion models explain illusion and enhancement effects in audiovisual speech perception	PLOS ONE			English	Article							VISUAL SPEECH; INTEGRATION; ATTENTION; HEARING; FACILITATION; CONFUSIONS; INFERENCE	Speech is perceived with both the ears and the eyes. Adding congruent visual speech improves the perception of a faint auditory speech stimulus, whereas adding incongruent visual speech can alter the perception of the utterance. The latter phenomenon is the case of the McGurk illusion, where an auditory stimulus such as e.g. "ba" dubbed onto a visual stimulus such as "ga" produces the illusion of hearing "da". Bayesian models of multisensory perception suggest that both the enhancement and the illusion case can be described as a two-step process of binding (informed by prior knowledge) and fusion (informed by the information reliability of each sensory cue). However, there is to date no study which has accounted for how they each contribute to audiovisual speech perception. In this study, we expose subjects to both congruent and incongruent audiovisual speech, manipulating the binding and the fusion stages simultaneously. This is done by varying both temporal offset (binding) and auditory and visual signal-to-noise ratio (fusion). We fit two Bayesian models to the behavioural data and show that they can both account for the enhancement effect in congruent audiovisual speech, as well as the McGurk illusion. This modelling approach allows us to disentangle the effects of binding and fusion on behavioural responses. Moreover, we find that these models have greater predictive power than a forced fusion model. This study provides a systematic and quantitative approach to measuring audiovisual integration in the perception of the McGurk illusion as well as congruent audiovisual speech, which we hope will inform future work on audiovisual speech perception.	[Lindborg, Alma] Univ Potsdam, Dept Psychol, Potsdam, Germany; [Lindborg, Alma; Andersen, Tobias S.] Tech Univ Denmark, Dept Appl Math & Comp Sci, Sect Cognit Syst, Lyngby, Denmark	University of Potsdam; Technical University of Denmark	Lindborg, A (corresponding author), Univ Potsdam, Dept Psychol, Potsdam, Germany.; Lindborg, A (corresponding author), Tech Univ Denmark, Dept Appl Math & Comp Sci, Sect Cognit Syst, Lyngby, Denmark.	lindborg@uni-potsdam.de	; Andersen, Tobias/I-5317-2013	Lindborg, Alma/0000-0002-7578-3826; Andersen, Tobias/0000-0002-0263-1354				Aller M, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000210; Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; Alsius A, 2007, EXP BRAIN RES, V183, P399, DOI 10.1007/s00221-007-1110-1; Alsius A, 2018, MULTISENS RES, V31, P111, DOI 10.1163/22134808-00002565; Andersen TS, 2020, J MATH PSYCHOL, V98, DOI 10.1016/j.jmp.2020.102404; Andersen TS, 2015, J ACOUST SOC AM, V137, P2884, DOI 10.1121/1.4916691; Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Baart M, 2014, NEUROPSYCHOLOGIA, V53, P115, DOI 10.1016/j.neuropsychologia.2013.11.011; Bejjanki VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019812; Bresciani JP, 2006, J VISION, V6, P554, DOI 10.1167/6.5.2; Ernst MO, 2007, J VISION, V7, DOI 10.1167/7.5.7; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Ernst MO., 2006, HUMAN BODY PERCEPTIO, P105; Eskelund K, 2011, EXP BRAIN RES, V208, P447, DOI 10.1007/s00221-010-2495-9; Ganesh AC., 2014, FRONT PSYCHOL, P5, DOI [10.3389/fpsyg.2014.00005, DOI 10.3389/FPSYG.2014.00005]; Grant KW, 1998, J ACOUST SOC AM, V104, P2438, DOI 10.1121/1.423751; Hawley ML, 2004, J ACOUST SOC AM, V115, P833, DOI 10.1121/1.1639908; Keil J, 2012, CEREB CORTEX, V22, P221, DOI 10.1093/cercor/bhr125; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Magnotti JF, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005229; Magnotti JF, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00798; Massaro DW, 1996, J ACOUST SOC AM, V100, P1777, DOI 10.1121/1.417342; Massaro DW., 1998, PERCEIVING TALKING F; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Nahorna O, 2012, J ACOUST SOC AM, V132, P1061, DOI 10.1121/1.4728187; Nath AR, 2012, NEUROIMAGE, V59, P781, DOI 10.1016/j.neuroimage.2011.07.024; Parise CV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11543; Rohe T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09664-2; Rohe T, 2015, J VISION, V15, DOI 10.1167/15.5.22; Rohe T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002073; Schwartz JL, 2010, J ACOUST SOC AM, V127, P1584, DOI 10.1121/1.3293001; Shahin AJ, 2017, LANG COGN NEUROSCI, V32, P1102, DOI 10.1080/23273798.2017.1283428; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; Shatzer H, 2018, EUR J NEUROSCI, V48, P2836, DOI 10.1111/ejn.13843; SOLOMON JA, 1994, NATURE, V369, P395, DOI 10.1038/369395a0; Soto-Faraco S, 2009, J EXP PSYCHOL HUMAN, V35, P580, DOI 10.1037/a0013483; Strand J, 2014, J SPEECH LANG HEAR R, V57, P2322, DOI 10.1044/2014_JSLHR-H-14-0059; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Tiippana K, 2004, EUR J COGN PSYCHOL, V16, P457, DOI 10.1080/09541440340000268; Tuomainen J, 2005, COGNITION, V96, pB13, DOI 10.1016/j.cognition.2004.10.004; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P744, DOI 10.3758/BF03193776; Vatakis A, 2008, J VISION, V8, DOI 10.1167/8.9.14; Zaar J, 2017, J ACOUST SOC AM, V141, P1051, DOI 10.1121/1.4976054	46	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246986	10.1371/journal.pone.0246986	http://dx.doi.org/10.1371/journal.pone.0246986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606815	gold, Green Published			2022-12-26	WOS:000620629200112
J	Nyarko, SH; Potter, L				Nyarko, Samuel H.; Potter, Lloyd			Levels and socioeconomic correlates of nonmarital fertility in Ghana	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; PREMARITAL FERTILITY; DETERMINANTS; TRANSITION; TRENDS; WOMEN	Childbirth outside marriage has several negative implications for the well-being of children, women, and families globally. In sub-Saharan Africa, however, the phenomenon appears to be under-studied. In this study, we examine the levels and socioeconomic correlates of nonmarital fertility in Ghana. Using pooled data from the 2003, 2008, and the 2014 Ghana Demographic and Health Surveys, logistic regression models were used in determining significantly predictive factors of nonmarital fertility. The results show that nonmarital fertility levels have been on the rise over time without any sign of reduction (24.0%, 33.0%, and 40.0% for 2003, 2008, and 2014, respectively). Some socioeconomic characteristics are linked to nonmarital fertility levels with women without formal education, women from poor households, and self-employed women having significantly higher nonmarital fertility risks. Also, older unmarried women, women who have an early sexual debut, cohabiters, women with unmet need for family planning are all associated with considerably higher risks of nonmarital childbearing. A few significant regional disparities also exist, with the Central Region having higher whereas the Upper West Region has lower risks of nonmarital fertility compared to the Greater Accra Region. Childbirth outside marriage is a social concern among women in Ghana. The findings have possible implications for bridging socioeconomic disparities among unmarried women.	[Nyarko, Samuel H.] Univ Texas San Antonio, Coll Hlth Community & Policy, Dept Demog, San Antonio, TX 78249 USA; [Nyarko, Samuel H.; Potter, Lloyd] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Populat & Behav Sci, Hohoe, Ghana	University of Texas System; University of Texas at San Antonio (UTSA)	Nyarko, SH (corresponding author), Univ Texas San Antonio, Coll Hlth Community & Policy, Dept Demog, San Antonio, TX 78249 USA.; Nyarko, SH (corresponding author), Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Populat & Behav Sci, Hohoe, Ghana.	samharrenson@gmail.com		Nyarko, Samuel/0000-0002-6999-351X				Adhikari R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-19; Alaba OO, 2017, S AFR FAM PRACT, V59, P143, DOI 10.1080/20786190.2017.1292693; Bongaarts J., 2008, 7 POP COUNC; Bongaarts J, 2013, POPUL DEV REV, V38, P153, DOI 10.1111/j.1728-4457.2013.00557.x; Clark S, 2017, J MARRIAGE FAM, V79, P1186, DOI 10.1111/jomf.12404; Clark S, 2017, STUD FAMILY PLANN, V48, P3, DOI 10.1111/sifp.12013; Clark S, 2013, DEMOGRAPHY, V50, P1521, DOI 10.1007/s13524-013-0220-6; Garenne M, 2006, J BIOSOC SCI, V38, P145, DOI 10.1017/S0021932005007261; Garenne M., 2006, DHS COMP REPORTS, V13; Garenne M., 2004, S AFRI J DEMOGR, V9, P27; Ghana Statistical Service G.S.S. Ghana Health Service G.H.S. International I.C.F., 2015, GHAN DEM HLTH SURV 2; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF Macro, 2009, GHAN DEM HLTH SURV 2; Ghana Statistical Service (GSS) Noguchi Memorial Institute for Medical Research (NMIMR) ORC Macro, 2004, GHAN DEM HLTH SURV 2; Johnson-Hanks J, 2002, SOC SCI MED, V55, P1337, DOI 10.1016/S0277-9536(01)00276-3; Kiernan K., 2004, LAW POLICY, V26, P33, DOI DOI 10.1111/J.0265-8240.2004.00162.X; Ndahindwa V, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-87; Nyarko SH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230139; Nyarko SH, 2019, J PREGNANCY, V2019, DOI 10.1155/2019/2920491; Nyarko SH., 2019, GENUS, V75, P22, DOI DOI 10.1186/S41118-019-0069-7; Nyiko TM, 2017, INT UN SCI STUD POP; Nzimande N, 2005, INT UN SCI STUD POP; Oluwatobi A., 2019, POP ASS AM ANN M 201; Palamuleni ME, 2014, SCI RES ESSAYS, V9, DOI 10.5897/SRE2013.5529; Pazvakawambwa L., 2014, J MATH SYSTEM SCI, V4, P498; R Core Team, 2020, R LANG ENV STAT COMP; Shapiro DCPE., 2013, ELECTROMYOGR NEUROMU; Smith-Greenaway E, 2018, J MARRIAGE FAM, V80, P256, DOI 10.1111/jomf.12433; Smith-Greenaway E, 2016, SSM-POPUL HLTH, V2, P164, DOI 10.1016/j.ssmph.2016.02.001; Soura AB, 2018, COGENT SOC SCI, V4, DOI 10.1080/23311886.2018.1514688; U.S. Census Bureau Population Division, 2019, GHAN ANN 5 YEAR AG G; Zwang Julien, 2008, Afr J Reprod Health, V12, P98	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247189	10.1371/journal.pone.0247189	http://dx.doi.org/10.1371/journal.pone.0247189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606834	gold, Green Published			2022-12-26	WOS:000620629200005
J	Sanchez-Gonzalez, L; Quandelacy, TM; Johansson, M; Torres-Velasquez, B; Lorenzi, O; Tavarez, M; Torres, S; Alvarado, LI; Paz-Bailey, G				Sanchez-Gonzalez, Liliana; Quandelacy, Talia M.; Johansson, Michael; Torres-Velasquez, Brenda; Lorenzi, Olga; Tavarez, Mariana; Torres, Sanet; Alvarado, Luisa, I; Paz-Bailey, Gabriela			Viral etiology and seasonal trends of pediatric acute febrile illness in southern Puerto Rico; a seven-year review	PLOS ONE			English	Review								Background Acute febrile illness (AFI) is an important cause for seeking health care among children. Knowledge of the most common etiologic agents of AFI and its seasonality is limited in most tropical regions. Methodology/Principal findings To describe the viral etiology of AFI in pediatric patients (<= 18 years) recruited through a sentinel enhanced dengue surveillance system (SEDSS) in Southern Puerto Rico, we analyzed data for patients enrolled from 2012 to May 2018. To identify seasonal patterns, we applied time-series analyses to monthly arboviral and respiratory infection case data. We calculated coherence and phase differences for paired time-series to quantify the association between each time series. A viral pathogen was found in 47% of the 14,738 patients. Influenza A virus was the most common pathogen detected (26%). The incidence of Zika and dengue virus etiologies increased with age. Arboviral infections peaked between June and September throughout the times-series. Respiratory infections have seasonal peaks occurring in the fall and winter months of each year, though patterns vary by individual respiratory pathogen. Conclusions/Significance Distinct seasonal patterns and differences in relative frequency by age groups seen in this study can guide clinical and laboratory assessment in pediatric patients with AFI in Puerto Rico.	[Sanchez-Gonzalez, Liliana; Quandelacy, Talia M.; Johansson, Michael; Torres-Velasquez, Brenda; Lorenzi, Olga; Paz-Bailey, Gabriela] CDC, Dengue Branch, Ctr Dis Control & Prevent, San Juan, PR 00920 USA; [Tavarez, Mariana; Torres, Sanet; Alvarado, Luisa, I] Ponce Hlth Sci Univ, St Lukes Episcopal Hosp Consortium, Ponce, PR USA	Centers for Disease Control & Prevention - USA; Ponce Health Sciences University	Sanchez-Gonzalez, L (corresponding author), CDC, Dengue Branch, Ctr Dis Control & Prevent, San Juan, PR 00920 USA.	naq@cdc.gov	Sánchez-González, Liliana/GZK-6297-2022; Quandelacy, Talia/AAD-2347-2022	Sánchez-González, Liliana/0000-0001-8289-8587; 	Centers for Disease Control and Prevention [5U01CK000437]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Centers for Disease Control and Prevention Grant 5U01CK000437		0	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247481	10.1371/journal.pone.0247481	http://dx.doi.org/10.1371/journal.pone.0247481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606839	gold, Green Published			2022-12-26	WOS:000620629200151
J	Serrano-Lomelin, J; Hicks, A; Kumar, M; Johnson, DW; Chari, R; Osornio-Vargas, A; Crawford, S; Bakal, J; Ospina, MB				Serrano-Lomelin, Jesus; Hicks, Anne; Kumar, Manoj; Johnson, David W.; Chari, Radha; Osornio-Vargas, Alvaro; Crawford, Susan; Bakal, Jeffrey; Ospina, Maria B.			Patterns of respiratory health services utilization from birth to 5 years of children who experienced adverse birth outcomes	PLOS ONE			English	Article							GESTATIONAL-AGE STATUS; ADULT LUNG-FUNCTION; PRETERM BIRTH; PERINATAL FACTORS; DEPRIVATION INDEX; THORACIC SOCIETY; ASTHMA; CHILDHOOD; WEIGHT; RISK	Introduction Adverse birth outcomes have important consequences for future lung health. We evaluated patterns of respiratory health services utilization in early childhood among children born preterm (PTB), small and large for gestational age at term (SGA and LGA, respectively), and appropriate-for-gestational age at term. Materials and methods We conducted a population-based retrospective cohort study using administrative health data of all singleton live births in Alberta, Canada between 2005-2010. Data on hospitalizations and emergency department (ED) visits from birth to 5 years were collected for asthma, bronchitis, bronchiolitis, croup, influenza, pneumonia, and other acute upper and lower respiratory tract infections (other URTI and other LRTI, respectively). Adjusted rate ratios were estimated for respiratory ED visits and hospitalizations for adverse birth outcomes using the appropriate-for-gestational age at term group as reference. Age-specific trajectories of total respiratory health services utilization rates for each group were estimated in Poisson models. Results A total of 293,764 episodes of respiratory care from 206,994 children were analyzed. Very PTB children had the highest rates of health services use for all respiratory conditions, particularly for asthma, pneumonia, and bronchiolitis hospitalizations. Moderate/late PTB children also had elevated ED visits and hospitalizations for all respiratory conditions. Children born SGA showed high rates of ED visits for other LRTI, and of hospitalizations for bronchitis, bronchiolitis, and other URTI. Children born LGA had high rates of croup and other URTI ED visits, and of bronchiolitis and bronchiolitis hospitalizations. Age-specific trajectories showed a decreasing trend in the rates of total respiratory health service utilization from birth to five years of age for all groups studied. Children born PTB and LGA at term significantly required more respiratory health services over time compared to the reference group. Conclusion Patterns of paediatric respiratory health services utilization vary according to gestational age and fetal growth.	[Serrano-Lomelin, Jesus; Chari, Radha; Ospina, Maria B.] Univ Alberta, Fac Med & Dent, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Hicks, Anne; Kumar, Manoj; Osornio-Vargas, Alvaro] Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB, Canada; [Johnson, David W.] Univ Calgary, Cumming Sch Med, Dept Pediat Emergency Med & Physiol & Pharmacol, Calgary, AB, Canada; [Crawford, Susan; Bakal, Jeffrey] Alberta Hlth Serv, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Calgary; Alberta Health Services (AHS)	Ospina, MB (corresponding author), Univ Alberta, Fac Med & Dent, Dept Obstet & Gynecol, Edmonton, AB, Canada.	mospina@ualberta.ca	Bakal, Jeff/ABE-4051-2021; Osornio Vargas, Alvaro Roman/B-4645-2010	Osornio Vargas, Alvaro Roman/0000-0001-8287-7102; Ospina, Maria/0000-0001-9305-7521; Bakal, Jeffrey/0000-0002-3658-2554; SERRANO-LOMELIN, JESUS/0000-0003-1627-3647	Lois Hole Hospital for Women through a Women and Children's Health Research Institute Recruitment Award (MBO); Lung Association Alberta & NWT through the 2017-2018 National Grant Review program; Canada Research Chair Program (Government of Canada; Ottawa, Canada)	Lois Hole Hospital for Women through a Women and Children's Health Research Institute Recruitment Award (MBO); Lung Association Alberta & NWT through the 2017-2018 National Grant Review program; Canada Research Chair Program (Government of Canada; Ottawa, Canada)	This research was funded by the Lois Hole Hospital for Women through a Women and Children's Health Research Institute Recruitment Award (MBO) (https://www.wchri.org), and the Lung Association Alberta & NWT through the 2017-2018 National Grant Review program (https://www.ab.lung.ca/what-we-do/research/grant-opportunities/national-grant-review).MBO's research is supported by the Canada Research Chair Program (Government of Canada; Ottawa, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Perinatal Health Program, 2016, ALBERTA PERINATAL HL; Algert CS, 2011, PEDIAT ALLERG IMM-UK, V22, P836, DOI 10.1111/j.1399-3038.2011.01206.x; [Anonymous], 2015, Obstet Gynecol, V126, pe52, DOI 10.1097/AOG.0000000000001108; BARKER DJP, 1991, BRIT MED J, V303, P671, DOI 10.1136/bmj.303.6804.671; Baxter D, 2010, HUM VACCINES, V6, P494, DOI 10.4161/hv.6.6.12008; Been JV, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001596; Belon AP, 2020, PAEDIATR PERINAT EP, V34, P150, DOI 10.1111/ppe.12639; Bjornson CL, 2013, CAN MED ASSOC J, V185, P1317, DOI 10.1503/cmaj.121645; Boonyaratanakornkit J, 2020, J PEDIAT INF DIS SOC, V9, P21, DOI 10.1093/jpids/piy107; Brew BK, 2012, CLIN EXP ALLERGY, V42, P1621, DOI 10.1111/j.1365-2222.2012.04056.x; Britt RD, 2013, EXPERT REV RESP MED, V7, P515, DOI 10.1586/17476348.2013.838020; Canadian Institute for Health Information, 2015, ICD 10 CA INT STAT C; Canadian Institute for Health Information, 2018, ASTHMA HOSPITALIZATI; Carraro S, 2014, EUR RESPIR J, V44, P1682, DOI 10.1183/09031936.00084114; Cosmi E, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/364381; Davidson R, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-14; den Dekker HT, 2016, J ALLERGY CLIN IMMUN, V137, P1026, DOI 10.1016/j.jaci.2015.08.050; Douros K, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00218; Ducharme FM, 2015, CAN RESPIR J, V22, P135, DOI 10.1155/2015/101572; Duijts L, 2012, EUR J EPIDEMIOL, V27, P5, DOI 10.1007/s10654-012-9657-y; Edwards CA, 2003, THORAX, V58, P1061, DOI 10.1136/thorax.58.12.1061; Fiorino EK, 2009, CLIN CHEST MED, V30, P601, DOI 10.1016/j.ccm.2009.05.010; Gessner BD, 2007, THORAX, V62, P231, DOI 10.1136/thx.2005.053363; Government of Alberta, 2009, INT MIGRATION ALBERT; Government of Alberta, 2020, ALBERTA POPULATION E; Haataja P, 2018, PEDIATR PULM, V53, P209, DOI 10.1002/ppul.23908; Heaman M, 2013, PAEDIATR PERINAT EP, V27, P54, DOI 10.1111/ppe.12016; Henderson AJ, 2012, SEMIN FETAL NEONAT M, V17, P82, DOI 10.1016/j.siny.2012.01.006; Hinds A, 2016, CAN J PUBLIC HEALTH, V107, pE56, DOI [10.17269/cjph.107.5244, 10.17269/CJPH.107.5244]; Jaakkola JJK, 2006, J ALLERGY CLIN IMMUN, V118, P823, DOI 10.1016/j.jaci.2006.06.043; Johnson J, 2015, J PERINATOL, V35, P72, DOI 10.1038/jp.2014.142; Johnston KM, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-93; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Liu XQ, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-13; Mitanchez D, 2015, WORLD J DIABETES, V6, P734, DOI 10.4239/wjd.v6.i5.734; Mu M, 2014, HEART LUNG CIRC, V23, P511, DOI 10.1016/j.hlc.2013.11.018; Nissen F, 2017, CLIN EPIDEMIOL, V9, P643, DOI 10.2147/CLEP.S143718; Pampalon R, 2009, CHRONIC DIS CAN, V29, P178; Pampalon R, 2012, CAN J PUBLIC HEALTH, V103, pS17, DOI 10.1007/BF03403824; Paranjothy S, 2013, PEDIATRICS, V132, pE1562, DOI 10.1542/peds.2013-1737; Patelarou E, 2009, INT J ENV RES PUB HE, V6, P2752, DOI 10.3390/ijerph6112752; Pike KC, 2015, PAEDIATR RESPIR REV, V16, P182, DOI 10.1016/j.prrv.2014.12.001; Quinn JA, 2016, VACCINE, V34, P6047, DOI 10.1016/j.vaccine.2016.03.045; Rao DP, 2016, HEALTH PROMOT CHRON, V36, P194, DOI 10.24095/hpcdp.36.9.03; Ren CL, 2016, AM J RESP CRIT CARE, V194, P356, DOI 10.1164/rccm.201604-0694ST; Serrano-Lomelin J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17238973; Sharma D, 2016, CLIN MED INSIGHTS-PE, V10, P67, DOI 10.4137/CMPed.S40070; StataCorp, 2017, STAT REL 15 STAT SOF, DOI DOI 10.2307/2234838; Statistics Canada, TABLE 13 10 0745 01; Townsi N, 2018, EUR CLIN RESPIR J, V5, DOI 10.1080/20018525.2018.1487214; Turner S, 2011, AM J RESP CRIT CARE, V184, P407, DOI 10.1164/rccm.201012-2075OC; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Voort AMMSVD, 2014, J ALLERGY CLIN IMMUN, V133, P1317, DOI 10.1016/j.jaci.2013.12.1082; Weschenfelder F, 2019, GEBURTSH FRAUENHEILK, V79, P1183, DOI 10.1055/a-0891-0919; Yoshimoto J, 2019, ACTA PAEDIATR, V108, P473, DOI 10.1111/apa.14507; Zar HJ, 2014, PEDIATR PULM, V49, P430, DOI 10.1002/ppul.23030	56	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247527	10.1371/journal.pone.0247527	http://dx.doi.org/10.1371/journal.pone.0247527			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606848	gold, Green Published			2022-12-26	WOS:000620629200129
J	Triukose, S; Nitinawarat, S; Satian, P; Somboonsavatdee, A; Chotikarn, P; Thammasanya, T; Wanlapakorn, N; Sudhinaraset, N; Boonyamalik, P; Kakhong, B; Poovorawan, Y				Triukose, Sipat; Nitinawarat, Sirin; Satian, Ponlapat; Somboonsavatdee, Anupap; Chotikarn, Ponlachart; Thammasanya, Thunchanok; Wanlapakorn, Nasamon; Sudhinaraset, Natthinee; Boonyamalik, Pitakpol; Kakhong, Bancha; Poovorawan, Yong			Effects of public health interventions on the epidemiological spread during the first wave of the COVID-19 outbreak in Thailand	PLOS ONE			English	Article								A novel infectious respiratory disease was recognized in Wuhan (Hubei Province, China) in December 2019. In February 2020, the disease was named "coronavirus disease 2019" (COVID-19). COVID-19 became a pandemic in March 2020, and, since then, different countries have implemented a broad spectrum of policies. Thailand is considered to be among the top countries in handling its first wave of the outbreak-12 January to 31 July 2020. Here, we illustrate how Thailand tackled the COVID-19 outbreak, particularly the effects of public health interventions on the epidemiological spread. This study shows how the available data from the outbreak can be analyzed and visualized to quantify the severity of the outbreak, the effectiveness of the interventions, and the level of risk of allowed activities during an easing of a "lockdown." This study shows how a well-organized governmental apparatus can overcome the havoc caused by a pandemic.	[Triukose, Sipat; Nitinawarat, Sirin] Chulalongkorn Univ, Res Grp Appl Digital Technol Med ATM, Bangkok, Thailand; [Triukose, Sipat] Chulalongkorn Univ, Chulalongkorn Univ Big Data Analyt & IoT Ctr CUBI, Bangkok, Thailand; [Nitinawarat, Sirin] Chulalongkorn Univ, Fac Engn, Int Sch Engn, Bangkok, Thailand; [Satian, Ponlapat] Minist Publ Hlth, Lansaka Hosp, Off Permanent Secretary, Bangkok, Thailand; [Somboonsavatdee, Anupap] Chulalongkorn Univ, Chulalongkorn Business Sch, Dept Stat, Greater Data Sci Lab, Bangkok, Thailand; [Chotikarn, Ponlachart] Prince Songkla Univ, Fac Environm Management, Marine & Coastal Resources Inst, Hat Yai, Thailand; [Chotikarn, Ponlachart] Prince Songkla Univ, Coastal Oceanog & Climate Change Res Ctr, Hat Yai, Thailand; [Thammasanya, Thunchanok] TrueEye Co Ltd, Bangkok, Thailand; [Wanlapakorn, Nasamon; Sudhinaraset, Natthinee; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok, Thailand; [Boonyamalik, Pitakpol] Minist Publ Hlth, Off Permanent Secretary, Bangkok, Thailand; [Kakhong, Bancha] Minist Publ Hlth, Dept Hlth, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Ministry of Public Health - Thailand; Chulalongkorn University; Prince of Songkla University; Prince of Songkla University; Chulalongkorn University; Ministry of Public Health - Thailand; Ministry of Public Health - Thailand	Nitinawarat, S (corresponding author), Chulalongkorn Univ, Res Grp Appl Digital Technol Med ATM, Bangkok, Thailand.; Nitinawarat, S (corresponding author), Chulalongkorn Univ, Fac Engn, Int Sch Engn, Bangkok, Thailand.	sirin.n@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Thammasanya, Thunchanok/0000-0003-2193-6046; SATIAN, PONLAPAT/0000-0002-5575-047X	National Research Council of Thailand; Center of Excellence in Clinical Virology, Chulalongkorn University and Hospital, Bangkok, Thailand	National Research Council of Thailand(National Research Council of Thailand (NRCT)); Center of Excellence in Clinical Virology, Chulalongkorn University and Hospital, Bangkok, Thailand	This study was supported by The National Research Council of Thailand and the Center of Excellence in Clinical Virology, Chulalongkorn University and Hospital, Bangkok, Thailand. TrueEye Company Limited provided support in the form of salaries for authors Ms. Thunchanok Thammasany, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	[Anonymous], 2021, CLIN INFECT DIS, DOI [DOI 10.1093/cid/ciaa1130, 10.1093/cid/ciaa1130]; Bureau of Information Office Of The Permanent Secretary Of MOPH, ON PROV ON LAB ON DA; Centers for Disease Control and Prevention, 2020, COVID VIEW SUMM END; Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133; Department of Disease Control of Thailand, 2020, MEAS COMM DIS ACT B; Department of Disease Control of Thailand, 2020, COVID 19 EAS MEAS; Department of Medical Sciences National Research Council of Thailand, 2020, COVID 19 DAIL REP; European Centre for Disease Prevention and Control, 2020, NUMB TESTS CONF CAS; European Centre for Disease Prevention and Control, 2020, TOT CONF COVID 19 CA; European Commission, 2020, EUR EC FOR SUMM 2020; Ho K., 2020, THAIS MOST LIKELY WE; International Monetary Fund, 2020, WORLD EC OUTL GREAT; Joinup European Comission, 2022, GOV RESP GLOB LANDSC; McAleer M, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13030046; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; PEMANDU Associates, 2020, GLOB COVID 19 IND GC; Pollack T, 2020, EMERGING COVID 19; Suntronwong N, 2020, PATHOG GLOB HEALTH, V114, P225, DOI 10.1080/20477724.2020.1777803; The Ministry of Public Health, 2020, COR DIS 2019 COVID 1; Villarreal D., 2020, TEXAS DOCTORS RANK 1; Wipatayotin A., 2020, BANGKOK POST; World Health Organization, COR DIS 2019 COVID 1; World Health Organization, 193 WHO; World Health Organization, 2020, NOV COR THAIL EX CHI; World Health Organization Thailand, 2020, NOV COR 2019 NCOV SI; World Health Organization (WHO), 2020, COR DIS COVID 19 SIT; World Travel Tourism Council, 2020, LOC EC IMP REP SEPT; Wu YC, 2020, J CHIN MED ASSOC, V83, P217, DOI 10.1097/JCMA.0000000000000270	28	20	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246274	10.1371/journal.pone.0246274	http://dx.doi.org/10.1371/journal.pone.0246274			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606734	gold, Green Published, Green Submitted			2022-12-26	WOS:000620629200137
J	Anagbogu, CF; Zhou, JQ; Olasupo, FO; Nitsa, MB; Beckles, DM				Anagbogu, Chinyere F.; Zhou, Jiaqi; Olasupo, Festus O.; Nitsa, Mohammed Baba; Beckles, Diane M.			Lipidomic and metabolomic profiles of Coffea canephora L. beans cultivated in Southwestern Nigeria	PLOS ONE			English	Article								Coffee (Coffea spp.) is one of the most popular refreshing beverages globally. Coffee lipid diversity has untapped potential for improving coffee marketability because lipids contribute significantly to both the health benefits and cup quality of coffee. However, in spite of its potential importance, there have not been extensive studies of lipids among C. canephora genotypes. In this study, ultra-performance liquid chromatography coupled with mass spectrometry (UPLC-MS) profiling of lipid molecules was performed for 30 genotypes consisting of 15 cultivated and 15 conserved genotypes of C. canephora in Southwestern Nigeria. We identified nine classes of lipids in the 30 genotypes which belong to the 'Niaouli', 'Kouillou' and 'Java Robusta' group: among these, the most abundant lipid class was the triacylglycerols, followed by the fatty acyls group. Although 'Niaouli' diverged from the 'Kouillou' and 'Java Robusta' genotypes when their lipid profiles were compared, there was greater similarity in their lipid composition by multivariate analysis, compared to that observed when their primary metabolites and especially their secondary metabolite profiles were examined. However, distinctions could be made among genotypes. Members of the fatty acyls group had the greatest power to discriminate among genotypes, however, lipids that were low in abundance e.g. a cholesterol ester (20:3), and phosphotidylethanolamine (34:0) were also helpful to understand the relationships among C. canephora genotypes. The divergent lipid profiles identified among the C. canephora genotypes, correlated with their Single Nucleotide Polymorphism grouping as assessed by genotype-by-sequencing, and will be exploited to improve coffee cup quality.	[Anagbogu, Chinyere F.; Zhou, Jiaqi; Beckles, Diane M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Anagbogu, Chinyere F.; Olasupo, Festus O.] Univ Ibadan, Dept Crop Protect & Environm Biol, Ibadan, Nigeria; [Anagbogu, Chinyere F.; Olasupo, Festus O.; Nitsa, Mohammed Baba] Cocoa Res Inst Nigeria, Crop Improvement Div, Ibadan, Nigeria	University of California System; University of California Davis; University of Ibadan	Anagbogu, CF; Beckles, DM (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.; Anagbogu, CF (corresponding author), Univ Ibadan, Dept Crop Protect & Environm Biol, Ibadan, Nigeria.; Anagbogu, CF (corresponding author), Cocoa Res Inst Nigeria, Crop Improvement Div, Ibadan, Nigeria.	florana@yahoo.com; dmbeckles@ucdavis.edu		Anagbogu, Florence/0000-0002-0901-4367; Beckles, Diane/0000-0001-6336-1186	Norman E. Borlaug Leadership Enhancement in Agriculture Program (Borlaug LEAP) through the United States Agency for International Development; Ministry of Agriculture in Nigeria	Norman E. Borlaug Leadership Enhancement in Agriculture Program (Borlaug LEAP) through the United States Agency for International Development; Ministry of Agriculture in Nigeria	Funding was provided in part by the Norman E. Borlaug Leadership Enhancement in Agriculture Program (Borlaug LEAP) through a grant to the University of California-Davis by the United States Agency for International Development and, the Ministry of Agriculture in Nigeria through a grant to the Cocoa Research Institute of Nigeria. The funders had no role in the study design, data collection or analysis. The funders had no role in decision to publish, or in the preparation of the manuscript.	Agatonovic-Kustrin S, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/6741518; Amorim ACL, 2009, J BRAZIL CHEM SOC, V20, P313, DOI 10.1590/S0103-50532009000200017; Anagbogu CF, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8100425; Anagbogu CF, 2019, GENET RESOUR CROP EV, V66, P685, DOI 10.1007/s10722-019-00744-2; Atwood T., 2006, OXFORD DICT BIOCH MO; Basu S, 2017, BIOINFORMATICS, V33, P1545, DOI 10.1093/bioinformatics/btx012; Beckles DM, 2012, PLANT BIOTECHNOLOGY AND AGRICULTURE: PROSPECTS FOR THE 21ST CENTURY, P67, DOI 10.1016/B978-0-12-381466-1.00005-5; Bertrand B, 2008, J AGR FOOD CHEM, V56, P2273, DOI 10.1021/jf073314f; Cajka T, 2017, ANAL CHEM, V89, P12360, DOI 10.1021/acs.analchem.7b03404; Cajka T, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0929-x; Camacho D, 2005, METABOLOMICS, V1, P53, DOI 10.1007/s11306-005-1107-3; Caspi R, 2018, NUCLEIC ACIDS RES, V46, pD633, DOI 10.1093/nar/gkx935; Chen MJ, 2013, PLANT CELL, V25, P1430, DOI 10.1105/tpc.113.111179; Cossignani L, 2016, J ANAL METHODS CHEM, V2016, DOI 10.1155/2016/7482620; de Lima MSA, 2008, QUIM NOVA, V31, P527, DOI 10.1590/S0100-40422008000300012; Scholz MBD, 2016, EUPHYTICA, V209, P429, DOI 10.1007/s10681-016-1653-y; Du ZY, 2016, SUBCELL BIOCHEM, V86, P179, DOI 10.1007/978-3-319-25979-6_8; Fahy E, 2011, BBA-MOL CELL BIOL L, V1811, P637, DOI 10.1016/j.bbalip.2011.06.009; Farah A, 2006, FOOD CHEM, V98, P373, DOI 10.1016/j.foodchem.2005.07.032; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Figueiredo L. P., 2015, African Journal of Agricultural Research, V10, P3484; Folstar P., 1989, CHEMISTRY, VI, P203; Franca AS, 2005, LWT-FOOD SCI TECHNOL, V38, P709, DOI 10.1016/j.lwt.2004.08.014; Gamboa-Becerra R, 2019, METABOLITES, V9, DOI 10.3390/metabo9100214; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Harrigan GG, 2007, METABOLOMICS, V3, P259, DOI 10.1007/s11306-007-0076-0; Joet T, 2010, FOOD CHEM, V118, P693, DOI 10.1016/j.foodchem.2009.05.048; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Korber M, 2017, BBA-MOL CELL BIOL L, V1862, P1534, DOI 10.1016/j.bbalip.2017.09.002; Liu Y, 2015, PLANT CELL, V27, P1512, DOI 10.1105/tpc.15.00180; Martin MJ, 2001, TALANTA, V54, P291, DOI 10.1016/S0039-9140(00)00647-0; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mehari B, 2019, J SCI FOOD AGR, V99, P3811, DOI 10.1002/jsfa.9603; Novaes FJM, 2015, TALANTA, V139, P159, DOI 10.1016/j.talanta.2014.12.025; Morgenthal K, 2005, METABOLOMICS, V1, P109, DOI 10.1007/s11306-005-4430-9; Navarini L, 2004, FOOD HYDROCOLLOID, V18, P387, DOI 10.1016/S0268-005X(03)00126-7; Nebesny E, 2006, EUR FOOD RES TECHNOL, V224, P159, DOI 10.1007/s00217-006-0308-y; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Piazza L, 2008, J FOOD ENG, V84, P420, DOI 10.1016/j.jfoodeng.2007.06.001; Revelle W., 2018, USE PSYCH PACKAGE FA; Romano R, 2014, J FOOD COMPOS ANAL, V35, P1, DOI 10.1016/j.jfca.2014.04.001; Sant'Ana GC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18800-1; Scalabrin S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61216-7; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Sonawane P.D., 2017, NAT PLANTS, P3, DOI [10.1038/nplants.2016.1205, DOI 10.1038/NPLANTS.2016.1205]; Speer Karl, 2006, Braz. J. Plant Physiol., V18, P201, DOI 10.1590/S1677-04202006000100014; Stamova BS, 2009, METABOLOMICS, V5, P239, DOI 10.1007/s11306-008-0146-y; Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009; Wickham H, 2007, J STAT SOFTW, V21, P1; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yang H, 2018, BRIT J PHARMACOL, V175, P3610, DOI 10.1111/bph.14434; Zhou L, 2013, FOOD CHEM, V141, P3846, DOI 10.1016/j.foodchem.2013.06.056; Zhou XR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00419	54	2	3	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0234758	10.1371/journal.pone.0234758	http://dx.doi.org/10.1371/journal.pone.0234758			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596203	gold, Green Published, Green Submitted			2022-12-26	WOS:000620633200007
J	Delabre, RM; Bernier, A; Sanchez, F; Vilotitch, A; Chanos, S; Cosmaro, ML; Langanke, H; Mey, C; James, C; Duken, SB; Schlegel, V; Stranz, R; Jonas, KJ; Spire, B; Castro, DR				Delabre, Rosemary M.; Bernier, Adeline; Sanchez, Flor; Vilotitch, Antoine; Chanos, Sophocles; Cosmaro, Maria Luisa; Langanke, Harriet; Mey, Coline; James, Cary; Duken, Sascha B.; Schlegel, Vincent; Stranz, Richard; Jonas, Kai J.; Spire, Bruno; Castro, Daniela Rojas			"Yes, I'm interested in taking PrEP!": PrEP interest among women respondents to the European community-based survey "Flash! PrEP in Europe"	PLOS ONE			English	Article							FEMALE SEX WORKERS; ORAL PREEXPOSURE PROPHYLAXIS; RISK SCORING TOOL; GENDER-BASED VIOLENCE; HIV PREVENTION; ANTIRETROVIRAL PROPHYLAXIS; US WOMEN; INFECTION; MEN; TRANSMISSION	The World Health Organization recommends pre-exposure prophylaxis (PrEP) for all populations at substantial risk of HIV infection, including women. However, data regarding PrEP interest among women is lacking, particularly in Europe. Factors associated with interest in using PrEP were assessed among women respondents to the Flash! PrEP in Europe (FPIE) survey. This community-based cross-sectional study, conducted in 12 European countries, aimed to assess PrEP knowledge and interest. "High objective risk" (HOR) was assessed using established risk criteria following EACS and CDC guidelines. Factors associated with interest in using PrEP were assessed in univariable and multivariable logistic regression models. Among 678 women, 12.5% (n = 85) were considered at HOR, 46.8% (n = 317) indicated prior PrEP knowledge and 18.0% (n = 122) reported interest in using PrEP. Among women at HOR, 40.0% (n = 34) were interested in PrEP. Factors significantly associated with PrEP interest in the final multivariable model were: younger age (18-29 years) (aOR 1.91[95CI: 1.07; 3.41]), bad self-perceived financial status (1.84[1.09; 3.11]), migrant status (south to north) (2.87[1.05; 7.89]), single or dating relationship status (1.93[1.23; 3.03]), sexual abuse history (1.86[1.17; 2.97]), "rather high"/ "high" self-perceived HIV risk (3.21[1.32; 7.81]), and HOR (2.49[1.42; 4.35]). These results show that women at HOR and those who perceived themselves to be at high risk are interested in using PrEP. There is a critical need for targeted information and improved access to PrEP to increase uptake of this HIV prevention tool to meet PrEP interest among women.	[Delabre, Rosemary M.; Bernier, Adeline; Castro, Daniela Rojas] Community Based Res Lab, Coalit PLUS, Pantin, France; [Sanchez, Flor] Univ Autonoma Madrid, Dept Social Psychol, Madrid, Spain; [Vilotitch, Antoine; Spire, Bruno; Castro, Daniela Rojas] Aix Marseille Univ, Sci Econ & Sociales Sante & Traitement Informat M, SESSTIM, INSERM,IRD, Marseille, France; [Vilotitch, Antoine] Observ Reg Sante Provence Alpes Cote dAzur, ORS PACA, Marseille, France; [Chanos, Sophocles] Ath & Thess Checkpoints, Athens, Greece; [Cosmaro, Maria Luisa] Fdn LILA Milano, Milan, Italy; [Langanke, Harriet] GSSG Gemeinnutzige Stiftung Sexualitat & Gesundhe, Cologne, Germany; [Mey, Coline; Schlegel, Vincent; Stranz, Richard; Spire, Bruno] AIDES, Pantin, France; [James, Cary] Terrence Higgins Trust, London, England; [Duken, Sascha B.] Univ Amsterdam, Amsterdam, Netherlands; [Jonas, Kai J.] Maastricht Univ, Maastricht, Netherlands	Autonomous University of Madrid; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Amsterdam; Maastricht University	Delabre, RM (corresponding author), Community Based Res Lab, Coalit PLUS, Pantin, France.	rdelabre@coalitionplus.org	Duken, Sascha Béla/GOJ-7261-2022; Spire, Bruno/F-5546-2013; Sanchez, Flor/E-8343-2012	Duken, Sascha Béla/0000-0001-6380-7651; Spire, Bruno/0000-0002-3546-8020; Sanchez, Flor/0000-0002-8058-5584; ROJAS CASTRO, Daniela/0000-0002-5379-1438; Jonas, Kai/0000-0001-6607-1993	Dutch AIDS Fonds [P-11302]; Hornet(R)	Dutch AIDS Fonds; Hornet(R)	KJJ received a grant from Dutch AIDS Fonds (Grant P-11302).; This study was endorsed by UNAIDS and the EATG and supported by Hornet (R). The authors thank the respondents and the following NGOs and Universities: Aids Fondet, Deutsche AIDS Hilfe, GSSG, ATH Checkpoint, HIV Ireland, Plus Onlus, Fondazione LILA Milano, Soa aids Nederland, University of Amsterdam, GAT, ARAS, Check Point Barcelona, Apoyo positivo, Adhara Sevilla, Universidad Autonoma de Madrid, Groupe Sida Geneve, and Terrence Higgins Trust. This study would not have been possible without their active participation. Preliminary results of this study analysis were presented at AIDS Impact Conference which was held November 13-15 2017 in Cape Town, South Africa.	Aaron E, 2018, AIDS PATIENT CARE ST, V32, P16, DOI 10.1089/apc.2017.0201; Aaron E, 2013, AIDS, V27, pF1, DOI 10.1097/QAD.0b013e32835917b4; Amico KR, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25247; [Anonymous], WORLDS LEADING RES I; Auerbach JD, 2015, AIDS PATIENT CARE ST, V29, P102, DOI 10.1089/apc.2014.0142; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bailey JL, 2017, INFECT DIS THER, V6, P363, DOI 10.1007/s40121-017-0159-9; Balkus JE, 2016, JAIDS-J ACQ IMM DEF, V72, P333, DOI 10.1097/QAI.0000000000000974; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI; Corneli A, 2016, JAIDS-J ACQ IMM DEF, V71, P452, DOI 10.1097/QAI.0000000000000880; Corneli A, 2014, JAIDS-J ACQ IMM DEF, V67, P555, DOI 10.1097/QAI.0000000000000362; Decker MR, 2016, SEX TRANSM INFECT, V92, P599, DOI 10.1136/sextrans-2015-052463; Decker MR, 2016, AM J PREV MED, V51, P731, DOI 10.1016/j.amepre.2016.07.005; Durevall D, 2015, LANCET GLOB HEALTH, V3, pE34, DOI 10.1016/S2214-109X(14)70343-2; Edwards Arlene E, 2014, J Health Dispar Res Pract, V7, P141; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; European AIDS Clinical Society, 2019, EACS GUIDELINES VERS; European Centers for Disease Control, 2019, PREEXP PROPH HIV PRE; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2019, HIV AIDS SURV EUR 20; Ferrer L, 2016, AIDS BEHAV, V20, P1423, DOI 10.1007/s10461-016-1379-9; Flash CA, 2017, INT J WOMENS HEALTH, V9, DOI 10.2147/IJWH.S113675; Garfinkel DB, 2017, AIDS CARE, V29, P751, DOI 10.1080/09540121.2016.1234679; Gomez CA, 2011, WOMEN HEALTH ISS, V21, pS287, DOI 10.1016/j.whi.2011.07.012; Goparaju Lakshmi, 2017, J AIDS Clin Res, V8, DOI 10.4172/2155-6113.1000730; Hoagland B, 2016, AIDS BEHAV, P1, DOI [10.1007/s10461-015-1193-9, DOI 10.1007/S10461-015-1193-9]; Hodges-Mameletzis I, 2018, SEX HEALTH, V15, P489, DOI 10.1071/SH18125; Irungu EM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1899-y; Kahle EM, 2013, JAIDS-J ACQ IMM DEF, V62, P339, DOI 10.1097/QAI.0b013e31827e622d; Khawcharoenporn T, 2012, AIDS PATIENT CARE ST, V26, P222, DOI 10.1089/apc.2011.0202; Koechlin FM, 2017, AIDS BEHAV, V21, P1325, DOI 10.1007/s10461-016-1627-z; Koren DE, 2018, AIDS PATIENT CARE ST, V32, P490, DOI 10.1089/apc.2018.0030; Lang DL, 2013, AIDS BEHAV, V17, P551, DOI 10.1007/s10461-012-0245-7; Li Y, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18845; Liu A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001613; Mack Natasha, 2014, J Int AIDS Soc, V17, P19157, DOI 10.7448/IAS.17.3.19157; Maman S, 2000, SOC SCI MED, V50, P459, DOI 10.1016/S0277-9536(99)00270-1; Mannell J, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25380; Marcus JL, 2019, LANCET HIV, V6, pE688, DOI 10.1016/S2352-3018(19)30137-7; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Meyer JP, 2011, J WOMENS HEALTH, V20, P991, DOI 10.1089/jwh.2010.2328; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Mugo NR, 2016, CURR OPIN HIV AIDS, V11, P80, DOI 10.1097/COH.0000000000000224; Namey E, 2016, CULT HEALTH SEX, V18, P1081, DOI 10.1080/13691058.2016.1164899; Palummieri A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2819-5; Peitzmeier SM, 2017, AIDS CARE, V29, P1453, DOI 10.1080/09540121.2017.1300628; Pintye J., 2016, CLIN INFECT DIS; Quilligan JB., 2002, BRANDT EQUATION 21 C; Raifman J, 2018, SEX TRANSM DIS, V45, pE38, DOI 10.1097/OLQ.0000000000000811; Richardson ET, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19035; Roberts ET, 2012, SOC SCI MED, V75, P1555, DOI 10.1016/j.socscimed.2012.02.016; Sheth AN, 2016, J VIRUS ERAD, V2, P149; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Thomson KA, 2016, CURR OPIN HIV AIDS, V11, P18, DOI 10.1097/COH.0000000000000207; Toledo Lauren, 2015, World J AIDS, V5, P10; UNAIDS, 2015, AIDS CHANG EV MDG6 1; UNAIDS, 2012, WOM OUT LOUD WOM LIV; USPHS-CDC, 2017, PREEXP PROPH PREV HI; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Wechsberg WM, 2010, J PREV INTERV COMMUN, V38, P85, DOI 10.1080/10852351003640559; Willie TC, 2018, ANN EPIDEMIOL, V28, P881, DOI 10.1016/j.annepidem.2018.07.008; Wingood GM, 2013, JAIDS-J ACQ IMM DEF, V63, pS95, DOI 10.1097/QAI.0b013e3182920126; World Health Organization, 2014, POL BRIEF CONS GUID; World Health Organization, 2015, PREEXP PROPH WHO EXP; Yun K, 2018, SEX TRANSM INFECT, V94, P163, DOI 10.1136/sextrans-2017-053217	66	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246037	10.1371/journal.pone.0246037	http://dx.doi.org/10.1371/journal.pone.0246037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8ME	33596225	Green Published, gold			2022-12-26	WOS:000620633200047
J	Hillaert, A; Liu, DJX; Daminet, S; Broeckx, BJG; Stock, E; Paepe, D; Hesta, M; Vanderperren, K				Hillaert, Amber; Liu, Daisy J. X.; Daminet, Sylvie; Broeckx, Bart J. G.; Stock, Emmelie; Paepe, Dominique; Hesta, Myriam; Vanderperren, Katrien			Serum symmetric dimethylarginine shows a relatively consistent long-term concentration in healthy dogs with a significant effect of increased body fat percentage	PLOS ONE			English	Article								Symmetric dimethylarginine (SDMA) is a promising renal marker that correlates well with the glomerular filtration rate and could allow earlier detection of impaired renal function. The main objectives of this study were to assess the long-term variability of SDMA in healthy dogs and examine the influence of an increased body fat percentage on the level of SDMA. Sixteen lean Beagles were randomly assigned to the control group or weight-change group in age- and gender-matched pairs. The energy intake of the control group (n = 8) was strictly regulated to maintain an ideal body weight for 83 weeks, while the weight-change group (n = 8) was fed to induce weight gain (week 0-47), to maintain stable excessive body weight (week 47-56) and to lose weight (week 56-83), consecutively. At 8 specified time points, the body condition score, body composition, glomerular filtration rate, serum concentration of SDMA and creatinine were analyzed. In the control group, the within-subject coefficient of variation, between-subject coefficient of variation, reference change value (type I error = 5%) and index of individuality were 0.16, 0.22, 0.43 and 0.73, respectively. The control group and weight-change group did not differ significantly in SDMA concentration. SDMA showed a significant negative association (coefficient = -0.07) with body fat percentage (p<0.01) in the weight-change group and a significant positive association (coefficient = 7.79) with serum creatinine (p<0.01) in the entire study population. In conclusion, SDMA concentration has high long-term stability in healthy adult dogs. For the evaluation of SDMA concentrations, subject-specific reference values are preferred over a population-based reference value seen their higher sensitivity. Moreover, an increased body fat percentage does seem to affect the serum SDMA concentration of otherwise healthy dogs, but its clinical relevance has to be clarified in further research.	[Hillaert, Amber; Liu, Daisy J. X.; Stock, Emmelie; Hesta, Myriam; Vanderperren, Katrien] Univ Ghent, Fac Vet Med, Dept Med Imaging Domest Anim & Orthoped Small Ani, Merelbeke, Belgium; [Daminet, Sylvie; Paepe, Dominique] Univ Ghent, Fac Vet Med, Small Anim Dept, Merelbeke, Belgium; [Broeckx, Bart J. G.] Univ Ghent, Fac Vet Med, Dept Nutr, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University	Vanderperren, K (corresponding author), Univ Ghent, Fac Vet Med, Dept Med Imaging Domest Anim & Orthoped Small Ani, Merelbeke, Belgium.	Katrien.Vanderperren@ugent.be		Hillaert, Amber/0000-0003-3262-8495; Hesta, Myriam/0000-0001-9423-9765; Daminet, Sylvie/0000-0001-6733-7925	Special Research Fund of Ghent University, Belgium (BOF) [01N02215]; IDEXX Laboratories, Inc.; Virbac	Special Research Fund of Ghent University, Belgium (BOF); IDEXX Laboratories, Inc.; Virbac	This work was funded by the Special Research Fund of Ghent University, Belgium (BOF grant 01N02215). IDEXX Laboratories, Inc. (https://www.idexx.com/en/) financially supported and performed SDMA analyses. Virbac (https://fr.virbac.com/) financially supported blood and urine analyses and the diet used in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlouskaya Y, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060897; Bourges-Abella NH, 2015, J AM ASSOC LAB ANIM, V54, P17; Braun JP, 2003, VET CLIN PATH, V32, P162, DOI 10.1111/j.1939-165X.2003.tb00332.x; Canadell NI, 2004, CLIN CHEM LAB MED, V42, P415, DOI 10.1515/CCLM.2004.073; Cetinalp-Demircan P, 2007, ENDOCRINE, V31, P100, DOI 10.1007/s12020-007-0005-z; Chandler M, 2017, J COMP PATHOL, V156, P296, DOI 10.1016/j.jcpa.2017.03.006; Chen LK, 2006, DIABETES RES CLIN PR, V71, P170, DOI 10.1016/j.diabres.2005.05.010; Cline MG., 2019, OBESITY DOG CAT; Colliard L, 2006, J NUTR, V136, p1951S, DOI 10.1093/jn/136.7.1951S; COTLOVE E, 1970, CLIN CHEM, V16, P1028; Courcier EA, 2010, J SMALL ANIM PRACT, V51, P362, DOI 10.1111/j.1748-5827.2010.00933.x; De Baere S, 2012, J PHARMACEUT BIOMED, V61, P50, DOI 10.1016/j.jpba.2011.11.022; de Jong PE, 2002, INT J OBESITY, V26, pS21, DOI 10.1038/sj.ijo.0802213; Ernst R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205030; Ferrier L, 2002, J NUTR, V132, p1725S, DOI 10.1093/jn/132.6.1725S; Fleck C, 2001, KIDNEY INT, V59, pS14, DOI 10.1046/j.1523-1755.2001.59780014.x; FRASER CG, 1989, CRIT REV CL LAB SCI, V27, P409; Fraser CG, 2004, CLIN CHEM LAB MED, V42, P758, DOI 10.1515/CCLM.2004.128; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Garland JS, 2014, DIABET METAB SYND OB, V7, P347, DOI 10.2147/DMSO.S46674; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; Gruber HJ, 2008, EXP CLIN ENDOCR DIAB, V116, P520, DOI 10.1055/s-2008-1062712; Hall JA, 2016, J VET INTERN MED, V30, P794, DOI 10.1111/jvim.13942; Hall JA, 2014, J VET INTERN MED, V28, P1676, DOI 10.1111/jvim.12445; Hall JA, 2015, J VET INTERN MED, V29, P808, DOI 10.1111/jvim.12607; HARRIS EK, 1983, CLIN CHEM, V29, P25; HARRIS EK, 1974, CLIN CHEM, V20, P1535; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; Hokamp JA, 2016, VET CLIN PATH, V45, P28, DOI 10.1111/vcp.12333; International Renal Interest Society, IRIS STAG CKD MOD 20; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Kjelgaard-Hansen M., 2010, REFERENCE INTERVALS, V6th, P1034; Kopke MA, 2018, J VET INTERN MED, V32, P736, DOI 10.1111/jvim.15050; Laflamme D, 1997, CANINE PRACT, V22, P10; Liu DJX, 2018, J VET INTERN MED, V32, P1659, DOI 10.1111/jvim.15293; Liu DJX, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231662; Lund E. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P177; Lund EM, 1999, J AM VET MED ASSOC, V214, P1336; Marescau B, 1997, METABOLISM, V46, P1024, DOI 10.1016/S0026-0495(97)90273-0; Marliss EB, 2006, DIABETOLOGIA, V49, P351, DOI 10.1007/s00125-005-0066-6; MCDERMOTT JR, 1976, BIOCHEM J, V154, P179, DOI 10.1042/bj1540179; McGreevy PD, 2005, VET REC, V156, P695, DOI 10.1136/vr.156.22.695; Moesgaard SG, 2007, RES VET SCI, V82, P409, DOI 10.1016/j.rvsc.2006.09.003; Nabity MB, 2015, J VET INTERN MED, V29, P1036, DOI 10.1111/jvim.12835; Navarro-Diaz M, 2008, KIDNEY INT, V74, pS15, DOI 10.1038/ki.2008.518; Nijveldt RJ, 2002, NEPHROL DIAL TRANSPL, V17, P1999, DOI 10.1093/ndt/17.11.1999; Obare, 2015, CLIN CHEM, V16, pS135; OGAWA T, 1987, ARCH BIOCHEM BIOPHYS, V252, P526, DOI 10.1016/0003-9861(87)90060-9; Omar F, 2012, CONTINUING MED ED, V30, P244; Pedersen LG, 2006, RES VET SCI, V80, P336, DOI 10.1016/j.rvsc.2005.07.005; Petersen PH, 2001, CLIN CHEM LAB MED, V39, P160, DOI 10.1515/CCLM.2001.027; Pistrosch F, 2005, DIABETES, V54, P2206, DOI 10.2337/diabetes.54.7.2206; Pressler BM, 2013, VET CLIN N AM-SMALL, V43, P1193, DOI 10.1016/j.cvsm.2013.07.011; Prieto JM, 2020, VET CLIN PATH, V49, P401, DOI 10.1111/vcp.12884; Quan H, 1996, BIOMETRICS, V52, P1195, DOI 10.2307/2532835; Rajendran S, 2009, ATHEROSCLEROSIS, V204, P509, DOI 10.1016/j.atherosclerosis.2008.09.010; Relford R, 2016, VET CLIN N AM-SMALL, V46, P941, DOI 10.1016/j.cvsm.2016.06.010; Rentko V, 2013, J VET INTERN MED, V27, P750; Ricos C, 2007, ANN CLIN BIOCHEM, V44, P343, DOI 10.1258/000456307780945633; Schutte AE, 2010, EUR J ENDOCRINOL, V162, P525, DOI 10.1530/EJE-09-0865; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; Smets PMY, 2012, VET J, V192, P532, DOI 10.1016/j.tvjl.2011.05.027; Thomas MV, 2009, J PERIODONTOL, V80, P1146, DOI 10.1902/jop.2009.080654; Van de Velde H, 2013, VET IMMUNOL IMMUNOP, V152, P237, DOI [10.1016/j.vetimm.2012.12.01.1, 10.1016/j.vetimm.2012.12.011]; van Hoek I, 2007, J VET INTERN MED, V21, P950, DOI 10.1892/0891-6640(2007)21[950:CAROPC]2.0.CO;2; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Walton RM, 2012, VET CLIN PATH, V41, P175, DOI 10.1111/j.1939-165X.2012.00414.x; Zsuga J, 2007, METABOLISM, V56, P394, DOI 10.1016/j.metabol.2006.10.023	69	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247049	10.1371/journal.pone.0247049	http://dx.doi.org/10.1371/journal.pone.0247049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596230	Green Published, gold			2022-12-26	WOS:000620633200042
J	Dite, GS; Murphy, NM; Allman, R				Dite, Gillian S.; Murphy, Nicholas M.; Allman, Richard			An integrated clinical and genetic model for predicting risk of severe COVID-19: A population-based case-control study	PLOS ONE			English	Article							CANCER RISK; ALLELES; CARE	Up to 30% of people who test positive to SARS-CoV-2 will develop severe COVID-19 and require hospitalisation. Age, gender, and comorbidities are known to be risk factors for severe COVID-19 but are generally considered independently without accurate knowledge of the magnitude of their effect on risk, potentially resulting in incorrect risk estimation. There is an urgent need for accurate prediction of the risk of severe COVID-19 for use in workplaces and healthcare settings, and for individual risk management. Clinical risk factors and a panel of 64 single-nucleotide polymorphisms were identified from published data. We used logistic regression to develop a model for severe COVID-19 in 1,582 UK Biobank participants aged 50 years and over who tested positive for the SARS-CoV-2 virus: 1,018 with severe disease and 564 without severe disease. Model discrimination was assessed using the area under the receiver operating characteristic curve (AUC). A model incorporating the SNP score and clinical risk factors (AUC = 0.786; 95% confidence interval = 0.763 to 0.808) had 111% better discrimination of disease severity than a model with just age and gender (AUC = 0.635; 95% confidence interval = 0.607 to 0.662). The effects of age and gender are attenuated by the other risk factors, suggesting that it is those risk factors-not age and gender-that confer risk of severe disease. In the whole UK Biobank, most are at low or only slightly elevated risk, but one-third are at two-fold or more increased risk. We have developed a model that enables accurate prediction of severe COVID-19. Continuing to rely on age and gender alone (or only clinical factors) to determine risk of severe COVID-19 will unnecessarily classify healthy older people as being at high risk and will fail to accurately quantify the increased risk for younger people with comorbidities.	[Dite, Gillian S.; Murphy, Nicholas M.; Allman, Richard] Genet Technol Ltd, Fitzroy, Vic, Australia		Dite, GS (corresponding author), Genet Technol Ltd, Fitzroy, Vic, Australia.	gillian.dite@gtglabs.com		Dite, Gillian/0000-0002-2448-2548				Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chan WM, 2004, BRIT J OPHTHALMOL, V88, P968, DOI 10.1136/bjo.2003.039461; Covid 19 Host Genetics Initiative, 2020, EUR J HUM GENET, V28, P715, DOI 10.1038/s41431-020-0636-6; COVID-19 Host Genetics Initiative, 2020, COVID 19 HOST GEN IN; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; European Centre for Disease Prevention and Control, ECDC ANN EP REP 2017; Hopper JL, 2015, AM J EPIDEMIOL, V182, P863, DOI 10.1093/aje/kwv193; KIM L, 2020, CLIN INFECT DIS, DOI DOI 10.1093/CID/CIAA1012; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Mealiffe ME, 2010, JNCI-J NATL CANCER I, V102, P1618, DOI 10.1093/jnci/djq388; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Moreno C, 2020, LANCET PSYCHIAT, V7, P813, DOI 10.1016/S2215-0366(20)30307-2; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Shovlin CL, 2020, EMERG MED J, V37, P332, DOI 10.1136/emermed-2020-209791; StataCorp, 2019, STAT REL 16 STAT SOF; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; UK Biobank, 2020, UK BIOB MAK HLTH DAT; Ullah AZD, 2018, NUCLEIC ACIDS RES, V46, pW109, DOI 10.1093/nar/gky399; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wolpin BM, 2010, CANCER RES, V70, P1015, DOI 10.1158/0008-5472.CAN-09-2993; World Bank, 2008, GLOBAL ECONOMIC PROSPECTS: TECHNOLOGY DIFFUSION IN THE DEVELOPING WORLD, P1, DOI 10.1596/978-0-8213-7365-1; World Resources Institutes, 2020, WORLD GREENH GAS EM	22	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247205	10.1371/journal.pone.0247205	http://dx.doi.org/10.1371/journal.pone.0247205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592063	Green Published, gold			2022-12-26	WOS:000620632800026
J	Wood, J; Quinn-Nilas, C; Milhausen, R; Desmarais, S; Muise, A; Sakaluk, J				Wood, Jessica; Quinn-Nilas, Christopher; Milhausen, Robin; Desmarais, Serge; Muise, Amy; Sakaluk, John			A dyadic examination of self-determined sexual motives, need fulfillment, and relational outcomes among consensually non-monogamous partners	PLOS ONE			English	Article							RELATIONSHIP QUALITY; MALE COUPLES; AGREEMENT TYPE; NON-MONOGAMY; SATISFACTION; MOTIVATION; ASSOCIATIONS; REFLECTIONS; ATTACHMENT; RULES	Intimate and sexual relationships provide opportunity for emotional and sexual fulfillment. In consensually non-monogamous (CNM) relationships, needs are dispersed among multiple partners. Using Self-Determination Theory (SDT) and dyadic data from 56 CNM partnerships (112 individuals), we tested how sexual motives and need fulfillment were linked to relational outcomes. We drew from models of need fulfillment to explore how sexual motives with a second partner were associated with satisfaction in the primary relationship. In a cross-sectional and daily experience study we demonstrated that self-determined reasons for sex were positively associated with sexual satisfaction and indirectly linked through sexual need fulfillment. Self-determined reasons for sex predicted need fulfillment for both partners at a three-month follow up. The association between sexual motives and need fulfillment was stronger on days when participants engaged in sex with an additional partner, though this was not related to satisfaction in the primary relationship. Implications for need fulfillment are discussed.	[Wood, Jessica; Desmarais, Serge] Univ Guelph, Dept Psychol, Guelph, ON, Canada; [Wood, Jessica; Muise, Amy] York Univ, Dept Psychol, Toronto, ON, Canada; [Wood, Jessica] Sex Informat & Educ Council Canada, Toronto, ON, Canada; [Quinn-Nilas, Christopher] Univ Waterloo, Dept Psychol, Waterloo, ON, Canada; [Milhausen, Robin] Dept Family Relat & Appl Nutr, Guelph, ON, Canada; [Sakaluk, John] Univ Victoria, Dept Psychol, Victoria, BC, Canada; [Sakaluk, John] Western Univ, Dept Psychol, London, ON, Canada	University of Guelph; York University - Canada; University of Waterloo; University of Victoria; Western University (University of Western Ontario)	Wood, J (corresponding author), Univ Guelph, Dept Psychol, Guelph, ON, Canada.; Wood, J (corresponding author), York Univ, Dept Psychol, Toronto, ON, Canada.; Wood, J (corresponding author), Sex Informat & Educ Council Canada, Toronto, ON, Canada.	jessicawood@sieccan.org			Humanities Research Council Doctoral Award: Joseph-Armand Bombardier Canada Graduate Scholarship	Humanities Research Council Doctoral Award: Joseph-Armand Bombardier Canada Graduate Scholarship	Jessica Wood: Social Sciences and Humanities Research Council Doctoral Award: Joseph-Armand Bombardier Canada Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman RA, 2016, APIMPOWERR INTERACTI; Andersen J.P., 2015, HLTH SCI J, V9, P1; Balzarini RN, 2019, SOC PSYCHOL-GERMANY, V50, P185, DOI 10.1027/1864-9335/a000378; Barker M, 2010, SEXUALITIES, V13, P748, DOI 10.1177/1363460710384645; Bauer Robin, 2005, INT C POL MON U HAMB; BLAIS MR, 1990, J PERS SOC PSYCHOL, V59, P1021, DOI 10.1037/0022-3514.59.5.1021; Bonello K, 2010, J HOMOSEXUAL, V57, P117, DOI 10.1080/00918360903445962; Brunell AB, 2013, PERS SOC PSYCHOL B, V39, P970, DOI 10.1177/0146167213485442; Conley TD, 2018, J SOC PERS RELAT, V35, P509, DOI 10.1177/0265407517743078; Conley TD, 2017, PERSPECT PSYCHOL SCI, V12, P205, DOI 10.1177/1745691616667925; Conley TD, 2014, PSYCHOL INQ, V25, P56, DOI 10.1080/1047840X.2014.876908; Conley TD, 2013, ANAL SOC ISS PUB POL, V13, P1, DOI 10.1111/j.1530-2415.2012.01286.x; Conley TD, 2013, PERS SOC PSYCHOL REV, V17, P124, DOI 10.1177/1088868312467087; Deci E.L., 2012, HDB THEORIES SOCIAL, P416, DOI [10.4135/9781446201022, DOI 10.4135/9781446249215.N21]; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Fairbrother N, 2019, J SEX RES, V56, P695, DOI 10.1080/00224499.2019.1580667; Finkel EJ, 2014, PSYCHOL INQ, V25, P1, DOI 10.1080/1047840X.2014.863723; Finn M, 2008, BRIT J SOC PSYCHOL, V47, P519, DOI 10.1348/014466607X248921; Finn MD., 2010, UNDERSTANDING NONMON; Fisher TD, 2011, HDB SEXUALITY RELATE, DOI 10.4324/9781315881089; Fleckenstein JR, 2015, SEX RELATSH THER, V30, P94, DOI 10.1080/14681994.2014.976997; Guo Y, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-100; Hardy JW., 2017, THE ETHICAL SLUT; Haupert ML, 2017, J SEX MARITAL THER, V43, P424, DOI 10.1080/0092623X.2016.1178675; Haupert ML., 2017, CURRENT SEXUAL HLTH, V9, P155, DOI [10.1007/s11930-017-0121-6, DOI 10.1007/S11930-017-0121-6]; Hoff CC, 2010, AIDS CARE, V22, P827, DOI 10.1080/09540120903443384; Hoff CC, 2010, ARCH SEX BEHAV, V39, P774, DOI 10.1007/s10508-008-9393-2; Hosking W, 2014, ARCH SEX BEHAV, V43, P823, DOI 10.1007/s10508-013-0197-7; Hosking W, 2013, J HOMOSEXUAL, V60, P711, DOI 10.1080/00918369.2013.773819; IBM Corp, IBM SPSS STAT WINDOW; Jenkins SS., 2004, DISSERTATION ABSTRAC, V64, P6330; Jenks RJ, 1998, ARCH SEX BEHAV, V27, P507, DOI 10.1023/A:1018708730945; Kenny D. A., 2006, DYADIC DATA ANAL; Klesse C, 2014, INT J POLITICS CULT, V27, P203, DOI 10.1007/s10767-013-9157-4; Knee CR, 2013, PERS SOC PSYCHOL REV, V17, P307, DOI 10.1177/1088868313498000; Knee CR, 2002, PERS SOC PSYCHOL B, V28, P609, DOI 10.1177/0146167202288005; Knee CR, 2005, J PERS SOC PSYCHOL, V89, P997, DOI 10.1037/0022-3514.89.6.997; La Guardia JG, 2008, CAN PSYCHOL, V49, P201, DOI 10.1037/a0012760; La Guardia JG, 2000, J PERS SOC PSYCHOL, V79, P367, DOI 10.1037//0022-3514.79.3.367; LaSala MC, 2004, FAM SOC-J CONTEMP H, V85, P405, DOI 10.1606/1044-3894.1502; Magontier C, 2016, SEXUALITIES, V20, P1; McNulty JK, 2016, ARCH SEX BEHAV, V45, P85, DOI 10.1007/s10508-014-0444-6; Mitchell JW, 2014, AIDS BEHAV, V18, P1454, DOI 10.1007/s10461-013-0673-z; Mitchell JW, 2014, J SEX RES, V51, P316, DOI 10.1080/00224499.2012.727915; Mitchell JW, 2013, ARCH SEX BEHAV, V42, P1337, DOI 10.1007/s10508-012-9985-8; Mitchell JW, 2012, AIDS BEHAV, V16, P1560, DOI 10.1007/s10461-011-0064-2; Mitchell ME, 2014, J SEX RES, V51, P329, DOI 10.1080/00224499.2012.742998; Mogilski JK, 2017, ARCH SEX BEHAV, V46, P407, DOI 10.1007/s10508-015-0658-2; Moors AC, 2014, SEX RELATSH THER, V29, P476, DOI 10.1080/14681994.2014.941347; Muise A, 2019, J SOC PERS RELAT, V36, P1917, DOI 10.1177/0265407518774638; Muise A, 2013, PERS SOC PSYCHOL B, V39, P1320, DOI 10.1177/0146167213490963; NORTON R, 1983, J MARRIAGE FAM, V45, P141, DOI 10.2307/351302; Parsons JT, 2012, J FAM PSYCHOL, V26, P669, DOI 10.1037/a0029561; Preacher K. J., 2008, MONTE CARLO METHOD A; Ramirez OM, 2010, AUST NZ J FAM THER, V31, P202, DOI 10.1375/anft.31.2.202; Raudenbush SW., 2004, HLM6 HIERARCHICAL LI, DOI [10.1146/annurev.publhealth.25.050503.153925, DOI 10.1146/ANNUREV.PUBLHEALTH.25.050503.153925]; Rios-Spicer R, 2019, AIDS BEHAV, V23, P259, DOI 10.1007/s10461-018-2212-4; Ritchie A., 2006, SEXUALITIES, V9, P584, DOI [10.1177/1363460706069987, DOI 10.1177/1363460706069987]; Rogers E, 2020, AIDS BEHAV, V24, P3107, DOI 10.1007/s10461-020-02865-7; Rubel AN, 2015, J SEX RES, V52, P961, DOI 10.1080/00224499.2014.942722; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sakaluk JK, 2021, ARCH SEX BEHAV, V50, P1341, DOI 10.1007/s10508-020-01794-9; Seguin LJ., 2017, SEXUALITIES; Smith CV, 2007, J SOC PERS RELAT, V24, P69, DOI 10.1177/0265407507072589; Stulhofer A, 2010, J SEX RES, V47, P257, DOI 10.1080/00224490903100561; Taormino T., 2008, OPENING GUIDE CREATI; Vallerand RJ, 2008, CAN PSYCHOL, V49, P257, DOI 10.1037/a0012804; Vrangalova Z, 2015, ARCH SEX BEHAV, V44, P945, DOI 10.1007/s10508-013-0255-1; Wagner GJ, 2000, J HOMOSEXUAL, V39, P31, DOI 10.1300/J082v39n02_02; Weis DL, 1998, J SEX RES, V35, P1, DOI 10.1080/00224499809551912; Whitton SW, 2015, J COUPLE RELATSH THE, V14, P39, DOI 10.1080/15332691.2014.953649; Wood J., ARCH SEX BEHAV; Wood J, 2018, J SOC PERS RELAT, V35, P632, DOI 10.1177/0265407517743082; Wood JV., 2007, SELF RELATIONSHIPS; Wosick-Correa K, 2010, PSYCHOL SEX, V1, P44, DOI 10.1080/19419891003634471; Zhang Z, 2009, ORGAN RES METHODS, V12, P695, DOI 10.1177/1094428108327450	76	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247001	10.1371/journal.pone.0247001	http://dx.doi.org/10.1371/journal.pone.0247001			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8MA	33592016	Green Published, gold			2022-12-26	WOS:000620632800071
J	Jermy, MC; Spence, CJT; Kirton, R; O'Donnell, JF; Kabaliuk, N; Gaw, S; Hockey, H; Jiang, Y; Abidin, ZZ; Dougherty, RL; Rowe, P; Mahaliyana, AS; Gibbs, A; Roberts, SA				Jermy, M. C.; Spence, C. J. T.; Kirton, R.; O'Donnell, J. F.; Kabaliuk, N.; Gaw, S.; Hockey, H.; Jiang, Y.; Abidin, Z. Zulkhairi; Dougherty, R. L.; Rowe, P.; Mahaliyana, A. S.; Gibbs, A.; Roberts, S. A.			Assessment of dispersion of airborne particles of oral/nasal fluid by high flow nasal cannula therapy	PLOS ONE			English	Article								Background Nasal High Flow (NHF) therapy delivers flows of heated humidified gases up to 60 LPM (litres per minute) via a nasal cannula. Particles of oral/nasal fluid released by patients undergoing NHF therapy may pose a cross-infection risk, which is a potential concern for treating COVID-19 patients. Methods Liquid particles within the exhaled breath of healthy participants were measured with two protocols: (1) high speed camera imaging and counting exhaled particles under high magnification (6 participants) and (2) measuring the deposition of a chemical marker (riboflavin-5-monophosphate) at a distance of 100 and 500 mm on filter papers through which air was drawn (10 participants). The filter papers were assayed with HPLC. Breathing conditions tested included quiet (resting) breathing and vigorous breathing (which here means nasal snorting, voluntary coughing and voluntary sneezing). Unsupported (natural) breathing and NHF at 30 and 60 LPM were compared. Results Imaging: During quiet breathing, no particles were recorded with unsupported breathing or 30 LPM NHF (detection limit for single particles 33 mu m). Particles were detected from 2 of 6 participants at 60 LPM quiet breathing at approximately 10% of the rate caused by unsupported vigorous breathing. Unsupported vigorous breathing released the greatest numbers of particles. Vigorous breathing with NHF at 60 LPM, released half the number of particles compared to vigorous breathing without NHF. Chemical marker tests: No oral/nasal fluid was detected in quiet breathing without NHF (detection limit 0.28 mu L/m3). In quiet breathing with NHF at 60 LPM, small quantities were detected in 4 out of 29 quiet breathing tests, not exceeding 17 mu L/m3. Vigorous breathing released 200-1000 times more fluid than the quiet breathing with NHF. The quantities detected in vigorous breathing were similar whether using NHF or not. Conclusion During quiet breathing, 60 LPM NHF therapy may cause oral/nasal fluid to be released as particles, at levels of tens of mu L per cubic metre of air. Vigorous breathing (snort, cough or sneeze) releases 200 to 1000 times more oral/nasal fluid than quiet breathing (p < 0.001 with both imaging and chemical marker methods). During vigorous breathing, 60 LPM NHF therapy caused no statistically significant difference in the quantity of oral/nasal fluid released compared to unsupported breathing. NHF use does not increase the risk of dispersing infectious aerosols above the risk of unsupported vigorous breathing. Standard infection prevention and control measures should apply when dealing with a patient who has an acute respiratory infection, independent of which, if any, respiratory support is being used.	[Jermy, M. C.; Kabaliuk, N.; Abidin, Z. Zulkhairi] Univ Canterbury, Dept Mech Engn, Christchurch, New Zealand; [Spence, C. J. T.; Kirton, R.; O'Donnell, J. F.; Rowe, P.] Fisher & Paykel Healthcare, Auckland, New Zealand; [O'Donnell, J. F.] Massey Univ, Sch Nursing, Coll Hlth, Auckland, New Zealand; [Gaw, S.; Mahaliyana, A. S.; Gibbs, A.] Univ Canterbury, Sch Phys & Chem Sci, Christchurch, New Zealand; [Hockey, H.] Biometr Matters Ltd, Hamilton, New Zealand; [Jiang, Y.] Univ Auckland, Dept Stat, Auckland, New Zealand; [Dougherty, R. L.] Univ Kansas, Dept Mech Engn, Lawrence, KS 66045 USA; [Roberts, S. A.] Auckland Dist Hlth Board, Dept Microbiol Lab Plus, Auckland, New Zealand	University of Canterbury; Haier; Massey University; University of Canterbury; University of Auckland; University of Kansas; Auckland District Health Board	Jermy, MC (corresponding author), Univ Canterbury, Dept Mech Engn, Christchurch, New Zealand.	mark.jermy@canterbury.ac.nz	ODonnell, Jane/GEX-9181-2022	ODonnell, Jane/0000-0002-9554-5497	Fisher & Paykel Healthcare Ltd; NHF cannulae (Optiflow); NHF source (Airvo/Airvo2); Malaysian Ministry of Higher Education; University of Canterbury Erskine Fellowship	Fisher & Paykel Healthcare Ltd; NHF cannulae (Optiflow); NHF source (Airvo/Airvo2); Malaysian Ministry of Higher Education; University of Canterbury Erskine Fellowship	This study was partially funded by Fisher & Paykel Healthcare Ltd, who also provided the NHF cannulae (Optiflow) and the NHF source (Airvo/Airvo2). The funder provided support in the form of salaries for authors CJS, JFO, RK and PR, but did not take part in the data collection or reduction. None of the data obtained was excluded from the manuscript. The specific roles of these authors are articulated in the `author contributions' section. YJ and HH carried out statistical analyses under consulting service agreements with Fisher & Paykel Healthcare Ltd; ZZA was supported by a scholarship from the Malaysian Ministry of Higher Education; RD was on sabbatical from the University of Kansas and was partly supported by a University of Canterbury Erskine Fellowship.	Anfinrud P, 2020, NEW ENGL J MED, V382, P2061, DOI 10.1056/NEJMc2007800; Bahl P, 2022, J INFECT DIS, V225, P1561, DOI 10.1093/infdis/jiaa189; Chia PY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16670-2; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Gaeckle NT, 2020, AM J RESP CRIT CARE, V202, P1115, DOI 10.1164/rccm.202006-2309OC; Guo ZD, 2020, EMERG INFECT DIS, V26, P1586, DOI 10.3201/eid2607.200885; Hui D S C, 2014, Hong Kong Med J, V20 Suppl 4, P9; Hui DS, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.02339-2018; Johnson GR, 2011, J AEROSOL SCI, V42, P839, DOI 10.1016/j.jaerosci.2011.07.009; Kotoda M, 2020, J HOSP INFECT, V104, P534, DOI 10.1016/j.jhin.2019.11.010; Lauc G, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010344; Lefebvre A.H., 1989, ATOMIZATION SPRAYS; Leung CCH, 2019, J HOSP INFECT, V101, P84, DOI 10.1016/j.jhin.2018.10.007; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3; Loh NHW, 2020, CAN J ANESTH, V67, P893, DOI 10.1007/s12630-020-01634-3; Mittal R, 2020, J FLUID MECH, V894, DOI 10.1017/jfm.2020.330; Mundel T, 2013, J APPL PHYSIOL, V114, P1058, DOI 10.1152/japplphysiol.01308.2012; Raboud J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010717; Rochwerg B, 2019, INTENS CARE MED, V45, P563, DOI 10.1007/s00134-019-05590-5; Spence CJT, 2011, EXP FLUIDS, V50, P1005, DOI 10.1007/s00348-010-0984-z; Spence CJT, 2012, EXP FLUIDS, V52, P569, DOI 10.1007/s00348-011-1044-z; Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y; TOBIN MJ, 1983, CHEST, V84, P202, DOI 10.1378/chest.84.2.202; Tran K, 2013, CADTH Technol Overv, V3, pe3201; Wang K, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00653-z; Wilson NM, 2020, ANAESTHESIA, V75, P1086, DOI 10.1111/anae.15093; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x	28	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246123	10.1371/journal.pone.0246123	http://dx.doi.org/10.1371/journal.pone.0246123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577565	Green Published, Green Submitted, gold			2022-12-26	WOS:000620071700052
J	Lu, JQ; Hu, ZH; Deng, YJ; Wu, QZ; Wu, M; Song, H				Lu, Jinqiu; Hu, Zonghao; Deng, Yujie; Wu, Qingzhe; Wu, Ming; Song, Hai			MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; AMPK-MEDIATED REGULATION; TOLL-LIKE-RECEPTOR; N-TERMINAL KINASE; KAPPA-B; CONTACT INHIBITION; TISSUE-GROWTH; SIZE-CONTROL; YAP; PHOSPHORYLATION	The Hippo pathway is an evolutionarily conserved signaling pathway that controls organ size in animals via the regulation of cell proliferation and apoptosis. It consists of a kinase cascade, in which MST1/2 and MAP4Ks phosphorylate and activate LATS1/2, which in turn phosphorylate and inhibit YAP/TAZ activity. A variety of signals can modulate LATS1/2 kinase activity to regulate Hippo pathway. However, the full mechanistic details of kinase-mediated regulation of Hippo pathway signaling remain elusive. Here, we report that TNF activates LATS1/2 and inhibits YAP/TAZ activity through MEKK2/3. Furthermore, MEKK2/3 act in parallel to MST1/2 and MAP4Ks to regulate LATS1/2 and YAP/TAZ in response to various signals, such as serum and actin dynamics. Mechanistically, we show that MEKK2/3 interact with LATS1/2 and YAP/TAZ and phosphorylate them. In addition, Striatin-interacting phosphatase and kinase (STRIPAK) complex associates with MEKK3 via CCM2 and CCM3 to inactivate MEKK3 kinase activity. Upstream signals of Hippo pathway trigger the dissociation of MEKK3 from STRIPAK complex to release MEKK3 activity. Our work has uncovered a previous unrecognized regulation of Hippo pathway via MEKK2/3 and provides new insights into molecular mechanisms for the interplay between Hippo-YAP and NF-kappa B signaling and the pathogenesis of cerebral cavernous malformations.	[Lu, Jinqiu; Hu, Zonghao; Deng, Yujie; Wu, Qingzhe; Song, Hai] Zhejiang Univ, MOE Key Lab Biosyst Homeostasis & Protect, Zhejiang Prov Key Lab Canc Mol Cell Biol, Affiliated Hosp 2,Sch Med, Hangzhou, Zhejiang, Peoples R China; [Lu, Jinqiu; Hu, Zonghao; Deng, Yujie; Wu, Qingzhe; Song, Hai] Zhejiang Univ, Sch Med, Innovat Ctr Cell Signaling Network, Life Sci Inst,Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Wu, Ming; Song, Hai] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Song, H (corresponding author), Zhejiang Univ, MOE Key Lab Biosyst Homeostasis & Protect, Zhejiang Prov Key Lab Canc Mol Cell Biol, Affiliated Hosp 2,Sch Med, Hangzhou, Zhejiang, Peoples R China.; Song, H (corresponding author), Zhejiang Univ, Sch Med, Innovat Ctr Cell Signaling Network, Life Sci Inst,Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China.; Song, H (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China.	haisong@zju.edu.cn		DNEG, Yujie/0000-0002-8842-4267	National Key Research and Development Program of China [2019YFA0802003]; National Natural Science Foundation of China [31970727, 81700002]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Research and Development Program of China (No. 2019YFA0802003 to H. S.) and the National Natural Science Foundation of China (No. 31970727 to H. S., No. 81700002 to Y. D.).	Bae SJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30278.001, 10.7554/eLife.30278]; Bae SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7314; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Cavalcanti DD, 2012, J NEUROSURG, V116, P122, DOI 10.3171/2011.8.JNS101241; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chen R, 2019, NAT CELL BIOL, V21, P1565, DOI 10.1038/s41556-019-0426-y; Chen TH, 2017, FASEB J, V31, P2963, DOI 10.1096/fj.201601090R; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Deng YJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07022-2; Deran M, 2014, CELL REP, V9, P495, DOI 10.1016/j.celrep.2014.09.036; Dey A, 2020, NAT REV DRUG DISCOV, V19, P480, DOI 10.1038/s41573-020-0070-z; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gill MK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05939-2; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hong AW, 2017, EMBO REP, V18, P72, DOI 10.15252/embr.201642681; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; LaCanna R, 2019, J CLIN INVEST, V129, P2107, DOI 10.1172/JCI125014; Lee IY, 2019, MOL CELL, V73, P1138, DOI 10.1016/j.molcel.2019.01.022; Li W, 2014, CANCER CELL, V26, P48, DOI 10.1016/j.ccr.2014.05.001; Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029; Lu JQ, 2018, ONCOGENE, V37, P3864, DOI 10.1038/s41388-018-0249-5; Lv Y, 2018, CIRC RES, V123, P43, DOI 10.1161/CIRCRESAHA.118.313143; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Plummer Nicholas W, 2005, Curr Neurol Neurosci Rep, V5, P391, DOI 10.1007/s11910-005-0063-7; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Si Y, 2017, CANCER RES, V77, P4868, DOI 10.1158/0008-5472.CAN-17-0391; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00323; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yuan WC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07394-5; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng YG, 2017, CELL REP, V21, P3612, DOI 10.1016/j.celrep.2017.11.076; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014; Zhong J, 2004, MOL CELL BIOL, V24, P9165, DOI 10.1128/MCB.24.20.9165-9175.2004; Zhou ZN, 2016, NATURE, V532, P122, DOI 10.1038/nature17178	55	4	4	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100400	10.1016/j.jbc.2021.100400	http://dx.doi.org/10.1016/j.jbc.2021.100400			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33571521	gold, Green Published			2022-12-26	WOS:000672866400374
J	Noor, SI; Hoffmann, M; Rinis, N; Bartels, MF; Winterhalter, PR; Hoelscher, C; Hennig, R; Himmelreich, N; Thiel, C; Ruppert, T; Rapp, E; Strahl, S				Noor, Sina Ibne; Hoffmann, Marcus; Rinis, Natalie; Bartels, Markus F.; Winterhalter, Patrick R.; Hoelscher, Christina; Hennig, Rene; Himmelreich, Nastassja; Thiel, Christian; Ruppert, Thomas; Rapp, Erdmann; Strahl, Sabine			Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell-cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROTEIN O-MANNOSYLATION; GLYCOSYLATION PATHWAY; BASEMENT-MEMBRANE; DYSTROGLYCAN; EXPRESSION; MIGRATION; LAMININ; MUSCLE; CONTRIBUTES	Defects in protein O-mannosylation lead to severe congenital muscular dystrophies collectively known as alpha-dystroglycanopathy. A hallmark of these diseases is the loss of the O-mannose-bound matriglycan on alpha-dystroglycan, which reduces cell adhesion to the extracellular matrix. Mutations in protein O-mannose beta 1,2-N-acetylglucosaminyltransferase 1 (POMGNT1), which is crucial for the elongation of O-mannosyl glycans, have mainly been associated with muscle-eye-brain (MEB) disease. In addition to defects in cell-extracellular matrix adhesion, aberrant cell-cell adhesion has occasionally been observed in response to defects in POMGNT1. However, specific molecular consequences of POMGNT1 deficiency on cell-cell adhesion are largely unknown. We used POMGNT1 knockout HEK293T cells and fibroblasts from an MEB patient to gain deeper insight into the molecular changes in POMGNT1 deficiency. Biochemical and molecular biological techniques combined with proteomics, glycoproteomics, and glycomics revealed that a lack of POMGNT1 activity strengthens cell-cell adhesion. We demonstrate that the altered intrinsic adhesion properties are due to an increased abundance of N-cadherin (N-Cdh). In addition, site-specific changes in the N-glycan structures in the extracellular domain of N-Cdh were detected, which positively impact on homotypic interactions. Moreover, in POMGNT1-deficient cells, ERK1/2 and p38 signaling pathways are activated and transcriptional changes that are comparable with the epithelial-mesenchymal transition (EMT) are triggered, defining a possible molecular mechanism underlying the observed phenotype. Our study indicates that changes in cadherin-mediated cell-cell adhesion and other EMT-related processes may contribute to the complex clinical symptoms of MEB or alpha-dystroglycanopathy in general and suggests that the impact of changes in O-mannosylation on N-glycosylation has been underestimated.	[Noor, Sina Ibne; Rinis, Natalie; Bartels, Markus F.; Winterhalter, Patrick R.; Hoelscher, Christina; Strahl, Sabine] Heidelberg Univ, Ctr Organismal Studies COS, Glycobiol, Heidelberg, Germany; [Hoffmann, Marcus; Hennig, Rene; Rapp, Erdmann] Max Planck Inst Dynam Complex Tech Syst, Bioproc Engn, Magdeburg, Germany; [Hennig, Rene; Rapp, Erdmann] GlyXera GmbH, Magdeburg, Germany; [Himmelreich, Nastassja; Thiel, Christian] Heidelberg Univ, Ctr Child & Adolescent Med, Dept Pediat 1, Heidelberg, Germany; [Ruppert, Thomas] Ctr Mol Biol Heidelberg Univ ZMBH, DKFZ ZMBH Alliance, Heidelberg, Germany; [Winterhalter, Patrick R.] Martin Luther Univ Halle Wittenberg, Clin Heart Surg, Halle, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Martin Luther University Halle Wittenberg	Strahl, S (corresponding author), Heidelberg Univ, Ctr Organismal Studies COS, Glycobiol, Heidelberg, Germany.	sabine.strahl@cos.uni-heidelberg.de		Himmelreich, Nastassja/0000-0002-1895-625X; Thiel, Christian/0000-0001-6419-8747	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [STR 443/6-1, RA2992/1-1, RU 747/1-1, TH1461/7-1]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Project-ID STR 443/6-1 (to S. S.), RA2992/1-1 (to E. R.), RU 747/1-1 (to T. R.), TH1461/7-1 (to C. T.)-Forschungsgruppe FOR 2509. P. R. W. is currently founded by the GRK 2155 ProMoAge.	Abbott KL, 2006, EXP CELL RES, V312, P2837, DOI 10.1016/j.yexcr.2006.05.022; Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Aikawa R, 2002, HYPERTENSION, V39, P233, DOI 10.1161/hy0202.102699; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Arpino V, 2015, MATRIX BIOL, V44-46, P247, DOI 10.1016/j.matbio.2015.03.005; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Bozzi M, 2015, MATRIX BIOL, V44-46, P130, DOI 10.1016/j.matbio.2015.02.005; Carvalho S, 2016, ONCOTARGET, V7, P65231, DOI 10.18632/oncotarget.11245; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Corfield AP, 2015, TRENDS BIOCHEM SCI, V40, P351, DOI 10.1016/j.tibs.2015.04.004; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Day BW, 2019, ACTA NEUROPATHOL, V138, P1033, DOI 10.1007/s00401-019-02069-x; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Emond MR, 2014, JOVE-J VIS EXP, DOI 10.3791/51762; Endo T, 2019, P JPN ACAD B-PHYS, V95, P39, DOI 10.2183/pjab.95.004; Endo T, 2015, J BIOCHEM, V157, P1, DOI 10.1093/jb/mvu066; Ferletta M, 2003, MOL BIOL CELL, V14, P2088, DOI 10.1091/mbc.E03-01-0852; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Graham JB, 2020, MOL BIOL CELL, V31, P167, DOI 10.1091/mbc.E19-07-0408; Gui Ting, 2012, J Signal Transduct, V2012, P289243, DOI 10.1155/2012/289243; Guo HB, 2009, J BIOL CHEM, V284, P34986, DOI 10.1074/jbc.M109.060806; Haensel D, 2018, DEV DYNAM, V247, P473, DOI 10.1002/dvdy.24561; Hennig R, 2016, BBA-GEN SUBJECTS, V1860, P1728, DOI 10.1016/j.bbagen.2016.03.035; Hoffmann M, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800282; Hu HY, 2007, J COMP NEUROL, V501, P168, DOI 10.1002/cne.21238; Huang Q, 2015, CANCER BIOL THER, V16, P125, DOI 10.4161/15384047.2014.987078; Ivaska Johanna, 2011, Small GTPases, V2, P51; Khoder-Agha F, 2019, J BIOL CHEM, V294, P14383, DOI 10.1074/jbc.RA119.009539; Konze SA, 2017, CHEMBIOCHEM, V18, P1317, DOI 10.1002/cbic.201700100; Kuwabara N, 2016, P NATL ACAD SCI USA, V113, P9280, DOI 10.1073/pnas.1525545113; Kwon Munjin, 2013, Methods Mol Biol, V1018, P107, DOI 10.1007/978-1-62703-444-9_10; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lan J, 2015, NEURO-ONCOLOGY, V17, P211, DOI 10.1093/neuonc/nou151; Langer MD, 2012, J CELL SCI, V125, P2478, DOI 10.1242/jcs.101147; Larsen ISB, 2017, P NATL ACAD SCI USA, V114, P11163, DOI 10.1073/pnas.1708319114; Lavoie H, 2020, NAT REV MOL CELL BIO, V21, P607, DOI 10.1038/s41580-020-0255-7; LeBert DC, 2015, DEVELOPMENT, V142, P2136, DOI 10.1242/dev.121160; Li X, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00033; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Liu Q, 2017, ONCOL REP, V38, P2911, DOI 10.3892/or.2017.5964; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; Nakaya Y, 2011, CELLS TISSUES ORGANS, V193, P64, DOI 10.1159/000320165; Narimatsu Y, 2019, MOL CELL PROTEOMICS, V18, P1396, DOI 10.1074/mcp.RA118.001121; Neubert P, 2016, CURR OPIN CELL BIOL, V41, P100, DOI 10.1016/j.ceb.2016.04.010; Olea-Flores M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20122885; Pereira MS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02754; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Pioch M, 2018, ANAL CHEM, V90, P11908, DOI 10.1021/acs.analchem.8b02087; Qi F, 2020, FASEB J, V34, P881, DOI 10.1096/fj.201901793R; Ruhaak LR, 2010, J PROTEOME RES, V9, P6655, DOI 10.1021/pr100802f; Schaeffer D, 2014, MOL CELL BIOL, V34, P3486, DOI 10.1128/MCB.00694-14; Shay G, 2015, MATRIX BIOL, V44-46, P200, DOI 10.1016/j.matbio.2015.01.019; Smorodinsky-Atias K, 2016, MOL BIOL CELL, V27, P1026, DOI 10.1091/mbc.E15-07-0521; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Theodore M, 2011, CURR OPIN PEDIATR, V23, P581, DOI 10.1097/MOP.0b013e32834cd693; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thoeni C, 2019, CAN J GASTROENTEROL, V2019, DOI 10.1155/2019/1085717; VANHOOF J, 1986, DIFFERENTIATION, V32, P120, DOI 10.1111/j.1432-0436.1986.tb00563.x; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Winterhalter PR, 2013, FEBS LETT, V587, P3715, DOI 10.1016/j.febslet.2013.09.041; Xiong H, 2006, BIOCHEM BIOPH RES CO, V350, P935, DOI 10.1016/j.bbrc.2006.09.129; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2015, GLYCOBIOLOGY, V25, P702, DOI 10.1093/glycob/cwv021; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	75	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100433	10.1016/j.jbc.2021.100433	http://dx.doi.org/10.1016/j.jbc.2021.100433			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610554	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400407
J	Combes, G; Owen, G; Damery, S; Flanagan, S; Brown, C; Currie, G				Combes, Gill; Owen, Gareth; Damery, Sarah; Flanagan, Sarah; Brown, Celia; Currie, Graeme			Implementing a new clinical pathway in a non-receptive context: Mixed methods evaluation of a new fracture pathway for older people in a hospital Trust in the West Midlands, UK	PLOS ONE			English	Article								Objectives This paper reports a mixed methods evaluation of a new pathway to improve clinical outcomes for older people with fractures treated at a hospital Trust in the West Midlands, UK. The paper focuses specifically on the context surrounding the translation of the new pathway into practice and the way that external and internal factors influenced its adaptation and implementation. Methods Quantitative analysis used a controlled Interrupted Time Series (ITS) to estimate the effect of the new pathway on patient complication rate, median length of hospital stay and 30-day mortality by comparing the pre- and post-intervention periods. ITS data were extracted from the UK Trauma Audit and Research Network (TARN) database and a patient-level control group identified using propensity score matching. Parallel qualitative analysis aimed to examine the context surrounding the new pathway and how external and internal factors might influence its adaption and implementation into clinical practice. Data were collected via semi-structured interviews (n = 16) undertaken with staff and clinical stakeholders within the Trust and were analysed using the COM-B (Capability, Opportunity, Motivation) model of behaviour. Results No statistically significant effects were found for any of the patient outcomes studied in the controlled ITS analysis. Qualitative data suggest that the lack of effectiveness of the new initiative can be explained with reference to the capability, opportunity and motivation of internal Trust stakeholders to engage with the pathway, which created a non-receptive environment within the Trust. Conclusions Successfully implementing new care pathways in environments that may be non-receptive to change requires efforts to be put into winning 'hearts and minds' within the organisation to ensure engagement from key stakeholders during intervention development. Evidence must be provided internally of the way that a given intervention will alleviate the problematic issues being experienced within the organisation, and external dissemination of results should be avoided until there is evidence of a positive effect within the organisation where the new care pathway is first implemented.	[Combes, Gill; Damery, Sarah; Flanagan, Sarah] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Owen, Gareth; Currie, Graeme] Univ Warwick, Warwick Business Sch, Coventry, W Midlands, England; [Brown, Celia] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England	University of Birmingham; University of Warwick; University of Warwick	Damery, S (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England.	s.l.damery@bham.ac.uk	Damery, Sarah/ABA-8641-2021	Damery, Sarah/0000-0003-3681-8608	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West Midlands (NIHR CLAHRC WM)	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West Midlands (NIHR CLAHRC WM)	All authors were funded by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West Midlands (NIHR CLAHRC WM), now recommissioned as NIHR Applied Research Collaboration West Midlands (https://warwick.ac.uk/fac/sci/med/about/centres/arc-wm/).This is an infrastructure grant and has no specific grant number. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	British Geriatrics Society, 2012, QUAL CAR OLD PEOPL U; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Clement ND, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-26; Creswell J. W., 2013, QUALITATIVE INQUIRY; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Ferrera PC, 2000, AM J EMERG MED, V18, P575, DOI 10.1053/ajem.2000.9266; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Greenhalgh T, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.8775; HINDS P, 1995, ORGAN SCI, V6, P373, DOI 10.1287/orsc.6.4.373; Huy QN, 1999, ACAD MANAGE REV, V24, P325, DOI 10.2307/259085; JICK TD, 1979, ADMIN SCI QUART, V24, P602, DOI 10.2307/2392366; Kroll T., 2009, MIXED METHODS RES NU; Leech N. L., 2005, INT J SOC RES METHOD, V8, P375, DOI DOI 10.1080/13645570500402447; Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208; McNulty T, 2004, ORGAN STUD, V25, P1389, DOI 10.1177/0170840604046349; McNulty T, 2003, BRIT J MANAGE, V14, pS31, DOI 10.1111/j.1467-8551.2003.00391.x; Meldon SW, 2002, J TRAUMA, V52, P79, DOI 10.1097/00005373-200201000-00014; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Morgan DL, 2007, J MIX METHOD RES, V1, P48, DOI 10.1177/2345678906292462; National Institute for Health and Care Excellence (NICE), 2012, CG103 DEL; NUTT PC, 1993, J MANAGE, V19, P299, DOI 10.1016/0149-2063(93)90056-S; Onwuegbuzie A. J., 2003, HDB MIXED METHODS SO, P351, DOI DOI 10.1080/13645570305055; Pettigrew A., 1992, PUBLIC MONEY MANAGE, V12, P27, DOI [DOI 10.1080/09540969209387719, 10.1080/09540969209387719]; Pope C, 2006, QUALITATIVE RES HLTH; Robert G, 2014, PERSPECTIVES CONTEXT; Tasselli S, 2015, ORGAN STUD, V36, P841, DOI 10.1177/0170840614556917; Tonkin-Crine S, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0436-0; Walsh IJ, 2011, ACAD MANAGE J, V54, P1017, DOI 10.5465/amj.2008.0658; Williams I, 2011, HEALTH SERV MANAG RE, V24, P213, DOI 10.1258/hsmr.2011.011014	29	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247455	10.1371/journal.pone.0247455	http://dx.doi.org/10.1371/journal.pone.0247455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QO3ZL	33617583	Green Published, gold			2022-12-26	WOS:000623082400056
J	Conley, KJ; Seimon, TA; Popescu, IS; Wellehan, JFX; Fox, JG; Shen, ZL; Haakonsson, J; Seimon, A; Brown, AT; King, V; Burton, F; Calle, PP				Conley, Kenneth J.; Seimon, Tracie A.; Popescu, Ioana S.; Wellehan, James F. X., Jr.; Fox, James G.; Shen, Zeli; Haakonsson, Jane; Seimon, Anton; Brown, Ania Tomaszewicz; King, Veronica; Burton, Fred; Calle, Paul P.			Systemic Helicobacter infection and associated mortalities in endangered Grand Cayman blue iguanas (Cyclura lewisi) and introduced green iguanas (Iguana iguana)	PLOS ONE			English	Article								The Blue Iguana Recovery Programme maintains a captive breeding and head-starting program for endangered Grand Cayman blue iguanas (Cyclura lewisi) on Grand Cayman, Cayman Islands. In May 2015, program staff encountered two lethargic wild Grand Cayman blue iguanas within the Queen Elizabeth II Botanic Park (QEIIBP). Spiral-shaped bacteria were identified on peripheral blood smears from both animals, which molecular diagnostics identified as a novel Helicobacter species (provisionary name Helicobacter sp. GCBI1). Between March 2015 and February 2017, 11 Grand Cayman blue iguanas were identified with the infection. Two of these were found dead and nine were treated; five of the nine treated animals survived the initial infection. Phylogenetic analysis of the 16S rRNA gene suggests Helicobacter sp. GCBI1 is most closely related to Helicobacter spp. in chelonians. We developed a Taqman qPCR assay specific for Helicobacter sp. GCBI1 to screen tissue and/or blood samples from clinical cases, fecal and cloacal samples from clinically healthy Grand Cayman blue iguanas, including previously infected and recovered iguanas, and iguanas housed adjacent to clinical cases. Fecal and/or cloacal swab samples were all negative, suggesting that Grand Cayman blue iguanas do not asymptomatically carry this organism nor shed this pathogen per cloaca post infection. Retrospective analysis of a 2014 mortality event affecting green iguanas (Iguana iguana) from a separate Grand Cayman location identified Helicobacter sp. GCBI1 in two of three cases. The source of infection and mode of transmission are yet to be confirmed. Analysis of rainfall data reveal that all infections occurred during a multi-year dry period, and most occurred shortly after the first rains at the end of seasonal drought. Additionally, further screening has identified Helicobacter sp. GCBI1 from choanal swabs of clinically normal green iguanas in the QEIIBP, suggesting they could be asymptomatic carriers and a potential source of the pathogen.	[Conley, Kenneth J.; Seimon, Tracie A.; Brown, Ania Tomaszewicz; Calle, Paul P.] Wildlife Conservat Soc, Zool Hlth Program, New York, NY 10460 USA; [Popescu, Ioana S.] Isl Vet Serv, George Town, Cayman Islands; [Wellehan, James F. X., Jr.] Univ Florida, Dept Comparat Diagnost & Populat Med, Gainesville, FL USA; [Fox, James G.; Shen, Zeli] MIT, Div Comparat Med, Cambridge, MA USA; [Fox, James G.] MIT, Dept Biol Engn, Cambridge, MA USA; [Haakonsson, Jane; Burton, Fred] Cayman Isl Govt, Dept Environm, Grand Cayman, Cayman Islands; [Seimon, Anton] Bard Coll, Ctr Environm Policy, New York, NY USA; [King, Veronica] St Matthews Univ, Sch Vet Med, Grand Cayman, Cayman Islands; [Popescu, Ioana S.] Newmarket Vets4Pets, Newmarket, Suffolk, England; [Brown, Ania Tomaszewicz] European Assoc Zoos & Aquaria, Amsterdam, Netherlands; [King, Veronica] Lincoln Mem Univ, Coll Vet Med, Harrogate, TN USA	Wildlife Conservation Society; State University System of Florida; University of Florida; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Conley, KJ (corresponding author), Wildlife Conservat Soc, Zool Hlth Program, New York, NY 10460 USA.	kconley@wcs.org		Conley, Kenneth/0000-0002-3101-4451; Wellehan, Jim/0000-0001-5692-6134	Wildlife Conservation Society's Zoological Health Program; Cayman Islands Government; National Trust for the Cayman Islands; Derald H Ruttenberg Memorial Fund;  [P30-ES0002109];  [R01OD011141];  [T32-OD010978]	Wildlife Conservation Society's Zoological Health Program; Cayman Islands Government; National Trust for the Cayman Islands; Derald H Ruttenberg Memorial Fund; ; ; 	Funding for this project was provided by the Wildlife Conservation Society's Zoological Health Program, the Cayman Islands Government, the National Trust for the Cayman Islands, the Derald H Ruttenberg Memorial Fund (PPC), and the following grants (JGF): P30-ES0002109, R01OD011141, and T32-OD010978. One author (ISP) was commercially employed through the duration of the study and manuscript preparation (Island Veterinary Services and Newmarket Vets4Pets); funding was limited to salary. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the "author contributions" section.	Azevedo NF, 2008, APPL ENVIRON MICROB, V74, P1805, DOI 10.1128/AEM.02241-07; BURMAN WJ, 1995, CLIN INFECT DIS, V20, P564, DOI 10.1093/clinids/20.3.564; Burton FJ., 2011, REPTILES AUSTRALASIA, V1, P35; Cray C, 2011, J AVIAN MED SURG, V25, P14, DOI 10.1647/2010-004.1; Dewhirst FE, 2005, J BACTERIOL, V187, P6106, DOI 10.1128/JB.187.17.6106-6118.2005; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; French SS, 2007, AM NAT, V170, P79, DOI 10.1086/518569; Gilbert MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09091-7; Gilbert MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101599; Gill J, 2016, J VET DIAGN INVEST, V28, P225, DOI 10.1177/1040638716638704; Graham SP, 2011, GEN COMP ENDOCR, V174, P348, DOI 10.1016/j.ygcen.2011.09.015; Hsueh PR, 1999, J CLIN MICROBIOL, V37, P2084, DOI 10.1128/JCM.37.6.2084-2086.1999; Isaza R, 2013, ANTIMICROBIAL THERAPY IN VETERINARY MEDICINE, 5TH EDITION, P623; JACOBSON E, 1980, J AM VET MED ASSOC, V177, P918; Lawson A., 2015, MANUAL CLIN MICROBIO, V11th ed, P1013; Lucas LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049895; Maurer JK, 2020, J ZOO WILDLIFE MED, V50, P947, DOI 10.1638/2019-0038; Mishima K, 2015, WORLD J GASTROENTERO, V21, P7911, DOI 10.3748/wjg.v21.i25.7911; Muller K, 2010, VET CLIN PATH, V39, P79, DOI 10.1111/j.1939-165X.2009.00177.x; Nukui Y, 2020, HELICOBACTER, V25, DOI 10.1111/hel.12675; Popescu IS, 2018, THESIS U EDINBURGH; Powell DM., J ZOO WILDLIFE MED; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prud'homme Y, 2018, J ZOO WILDLIFE MED, V49, P959, DOI 10.1638/2017-0234.1; Rivera-Milan FF, 2020, BIOL INVASIONS, V22, P1879, DOI 10.1007/s10530-020-02233-5; Schuurman T, 2004, J CLIN MICROBIOL, V42, P734, DOI 10.1128/JCM.42.2.734-740.2004; Shen Z., 2017, HELICOBACTER, V22, P111; SIMPSON CF, 1981, CAN J COMP MED, V45, P388; Stacy BA, 2010, J VET DIAGN INVEST, V22, P660, DOI 10.1177/104063871002200431; Tee W, 2001, CLIN INFECT DIS, V33, P1789, DOI 10.1086/323983; Terio KA, 2005, J CLIN MICROBIOL, V43, P229, DOI 10.1128/JCM.43.1.229-234.2005; Uckay I, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-86; Wellehan JFX, 2016, P 65 INT C WILDL DIS, P104; ZIMS Expected Test Results for Cyclura lewisi, 2019, SPECIES360 ZOOLOGICA	34	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247010	10.1371/journal.pone.0247010	http://dx.doi.org/10.1371/journal.pone.0247010			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606766	Green Published, gold			2022-12-26	WOS:000620629200162
J	Zhao, YQ; Norton, D; Hanrahan, L				Zhao, Ying-Qi; Norton, Derek; Hanrahan, Larry			Small area estimation and childhood obesity surveillance using electronic health records	PLOS ONE			English	Article							PREVALENCE; OVERWEIGHT	There is an urgent need for childhood surveillance systems to design, implement, and evaluate interventions at the local level. We estimated obesity prevalence for individuals aged 5-17 years using a southcentral Wisconsin EHR data repository, Public Health Information Exchange (PHINEX, 2007-2012). The prevalence estimates were calculated by aggregating the estimated probability of each individual being obese, which was obtained via a generalized linear mixed model. We incorporated the random effects at the area level into our model. A weighted procedure was employed to account for missingness in EHR data. A non-parametric kernel smoothing method was used to obtain the prevalence estimates for locations with no or little data (<20 individuals) from the EHR. These estimates were compared to results from newly available obesity atlas (2015-2016) developed from various EHRs with greater statewide representation. The mean of the zip code level obesity prevalence estimates for males and females aged 5-17 years is 16.2% (SD 2.72%); 17.9% (SD 2.14%) for males and 14.4% (SD 2.00%) for females. The results were comparable to the Wisconsin Health Atlas (WHA) estimates, a much larger dataset of local community EHRs in Wisconsin. On average, prevalence estimates were 2.12% lower in this process than the WHA estimates, with lower estimation occurring more frequently for zip codes without data in PHINEX. Using this approach, we can obtain estimates for local areas that lack EHRs data. Generally, lower prevalence estimates were produced for those locations not represented in the PHINEX database when compared to WHA estimates. This underscores the need to ensure that the reference EHRs database can be made sufficiently similar to the geographic areas where synthetic estimates are being created.	[Zhao, Ying-Qi] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Norton, Derek] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Hanrahan, Larry] Univ Wisconsin, Dept Family Med & Community Hlth, Madison, WI USA	Fred Hutchinson Cancer Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhao, YQ (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	yqzhao@frechutch.org			National Institute of Child Health and Human Development [R21HD086754]	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funding from the National Institute of Child Health and Human Development (grant no. R21HD086754), received by Yingqi Zhao.	[Anonymous], WCHQ WISCONSIN COLLA; [Anonymous], 2015 ANN REP WISC PA; Bates D., 2014, ARXIV, DOI [10.18637/jss.v067.i01, DOI 10.18637/JSS.V067.I01]; CDC, CDC BMI CALC CHILDR; County Health Rankings for Dane County Wisconsin, COUNT HLTH RANK ROAD; Esri ArcUser Online, DET DAT PROF CUST CO; Flood TL, 2015, AM J PREV MED, V48, P234, DOI 10.1016/j.amepre.2014.10.020; Friedman DJ, 2013, AM J PUBLIC HEALTH, V103, P1560, DOI 10.2105/AJPH.2013.301220; Funk LM, 2017, MED CARE, V55, P598, DOI 10.1097/MLR.0000000000000693; Guilbert Theresa W, 2012, WMJ, V111, P124; Klish WJ., DEFINITION EPIDEMIOL; Lager ACJ, 2009, SCAND J PUBLIC HEALT, V37, P201, DOI 10.1177/1403494808098507; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; NATHAN RP, 1989, POLIT SCI QUART, V104, P483, DOI 10.2307/2151275; | Obesity and overweight [Internet]. World Health Organization . [cited 2018 Feb 16]. Available from:, OB OV; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Original S code by Richard A. Becker Allan R. Wilks. R version by Ray Brownrigg. Enhancements by Thomas P Minka and Alex Deckmyn, 2018, **DATA OBJECT**; Original S code by Richard A. Becker and Allan R. Wilks. R version by Ray Brownrigg, 2018, **DATA OBJECT**; Pierannunzi C, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150480; R Core Team, 2020, R LANG ENV STAT COMP; Roger Bivand and Nicholas Lewin-Koh, 2019, **DATA OBJECT**; Tatem KS, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160516; Tomayko EJ, 2015, PEDIATR OBES, V10, P436, DOI 10.1111/ijpo.12003; US Census Bureau, AM COMMUNITY SURVEY; Wand MP., 1994, KERNEL SMOOTHING; Wang Y, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.180313; Ward ZJ, 2017, NEW ENGL J MED, V377, P2145, DOI [10.1056/NEJMoa1703860, 10.1056/nejmoa1703860]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wisconsin Health Atlas, OB 2015 2016 FIND; Zhang Z, 2011, PREV CHRONIC DIS, V8	31	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247476	10.1371/journal.pone.0247476	http://dx.doi.org/10.1371/journal.pone.0247476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606784	Green Published, gold			2022-12-26	WOS:000620629200030
J	Hashiguchi, T; Hashiguchi, M; Tanaka, H; Fukushima, K; Gondo, T; Akashi, R				Hashiguchi, Takuyu; Hashiguchi, Masatsugu; Tanaka, Hidenori; Fukushima, Koki; Gondo, Takahiro; Akashi, Ryo			Quantitative analysis of seven plant hormones in Lotus japonicus using standard addition method	PLOS ONE			English	Article							LIQUID	Plant hormones have been identified to be versatile signaling molecules essential for plant growth, development, and stress response. Their content levels vary depending on the species, and they also change in response to any external stimuli. Thus, simultaneous quantification of multiple plant hormones is required to understand plant physiology. Sensitive and quantitative analysis using liquid chromatography-linked mass spectrometry (LC-MS/MS) has been used in detecting plant hormones; however, quantification without stable isotopes is yet to be established. In this study, we quantified seven representative plant hormones of Lotus japonicus, which is a model legume for standard addition method. Accurate masses for monoisotopic ions of seven phytohormones were determined for high-resolution mass spectrometry (HR-MS). Selected ion monitoring (SIM) mode based on accurate masses was used in detecting phytohormones in the roots, stems, and leaves. Evaluation of matrix effects showed ion suppression ranging from 10.2% to 87.3%. Both stable isotope dilution and standard addition methods were able to detect plant hormones in the roots, stems, and leaves, with no significant differences in using both approaches and thus a standard addition method can be used to quantify phytohormones in L. japonicus. The method will be effective, especially when stable isotopes are not available to correct for matrix effects.	[Hashiguchi, Takuyu; Hashiguchi, Masatsugu; Tanaka, Hidenori; Fukushima, Koki; Gondo, Takahiro; Akashi, Ryo] Univ Miyazaki, Dept Anim & Grassland Sci, Miyazaki, Japan	University of Miyazaki	Akashi, R (corresponding author), Univ Miyazaki, Dept Anim & Grassland Sci, Miyazaki, Japan.	rakashi@cc.miyazaki-u.ac.jp			National BioResource Project (NBRP) of the Japan Agency for Medical Research and Development (AMED)	National BioResource Project (NBRP) of the Japan Agency for Medical Research and Development (AMED)	This work was supported by the National BioResource Project (NBRP) of the Japan Agency for Medical Research and Development (AMED). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami T, 2018, J PESTIC SCI, V43, P154, DOI 10.1584/jpestics.M18-02; Balcke GU, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-47; Chawla S, 2017, J AOAC INT, V100, P616, DOI 10.5740/jaoacint.17-0048; Cheng SY, 2017, J ANAL SCI TECHNOL, V8, DOI 10.1186/s40543-017-0128-7; Garcia-Rodriguez A, 2014, INT J ENVIRON AN CH, V94, P1199, DOI 10.1080/03067319.2014.921292; Gergov M, 2015, J ANAL TOXICOL, V39, P359, DOI 10.1093/jat/bkv020; Gosetti F, 2010, J CHROMATOGR A, V1217, P3929, DOI 10.1016/j.chroma.2009.11.060; Hashiguchi Masatsugu, 2018, Curr Protoc Plant Biol, V3, pe20070, DOI 10.1002/cppb.20070; Hoogstraten CG, 2008, CONCEPT MAGN RESON A, V32A, P34, DOI 10.1002/cmr.a.20103; Jaderson M, 2019, SAF HEALTH WORK-KR, V10, P196, DOI 10.1016/j.shaw.2018.12.004; Kaufmann A, 2010, ANAL CHIM ACTA, V673, P60, DOI 10.1016/j.aca.2010.05.020; Kaufmann A, 2020, J MASS SPECTROM, V55, DOI 10.1002/jms.4533; Kobata K, 2011, BIOSCI BIOTECH BIOCH, V75, P1611, DOI 10.1271/bbb.110187; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; Kwon H, 2012, J CHROMATOGR A, V1270, P235, DOI 10.1016/j.chroma.2012.10.059; Lehotay SJ, 2005, J AOAC INT, V88, P595; Muller M, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-37; Muller A, 2002, PLANTA, V216, P44, DOI 10.1007/s00425-002-0866-6; Murphy A, 2015, J EXP BOT, V66, P4853, DOI 10.1093/jxb/erv339; Pan XQ, 2008, PHYTOCHEMISTRY, V69, P1773, DOI 10.1016/j.phytochem.2008.02.008; Rinkel J, 2015, BEILSTEIN J ORG CHEM, V11, P2493, DOI 10.3762/bjoc.11.271; Simura J, 2018, PLANT PHYSIOL, V177, P476, DOI 10.1104/pp.18.00293; Stahnke H, 2012, ANAL CHEM, V84, P1474, DOI 10.1021/ac202661j; Stark T, 2011, ANAL CHEM, V83, P3398, DOI 10.1021/ac103305s; Steiner D, 2020, J AGR FOOD CHEM, V68, P3868, DOI 10.1021/acs.jafc.9b07706; Takeda N, 2015, PLANT PHYSIOL, V167, P545, DOI 10.1104/pp.114.247700; Trapp MA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00417; Van Eeckhaut A, 2009, J CHROMATOGR B, V877, P2198, DOI 10.1016/j.jchromb.2009.01.003; Wang LY, 2020, PLANT METHODS, V16, DOI 10.1186/s13007-020-00595-4; Wilkinson S, 2012, J EXP BOT, V63, P3499, DOI 10.1093/jxb/ers148; Zhou WL, 2017, BIOANALYSIS, V9, P1839, DOI 10.4155/bio-2017-0214	31	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247276	10.1371/journal.pone.0247276	http://dx.doi.org/10.1371/journal.pone.0247276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600422	gold, Green Published			2022-12-26	WOS:000620625100021
J	Kirpich, A; Koniukhovskii, V; Shvartc, V; Skums, P; Weppelmann, TA; Imyanitov, E; Semyonov, S; Barsukov, K; Gankin, Y				Kirpich, Alexander; Koniukhovskii, Vladimir; Shvartc, Vladimir; Skums, Pavel; Weppelmann, Thomas A.; Imyanitov, Evgeny; Semyonov, Semyon; Barsukov, Konstantin; Gankin, Yuriy			Development of an interactive, agent-based local stochastic model of COVID-19 transmission and evaluation of mitigation strategies illustrated for the state of Massachusetts, USA	PLOS ONE			English	Article							DISEASE; EPIDEMIC; CHINA	Since its discovery in the Hubei province of China, the global spread of the novel coronavirus SARS-CoV-2 has resulted in millions of COVID-19 cases and hundreds of thousands of deaths. The spread throughout Asia, Europe, and the Americas has presented one of the greatest infectious disease threats in recent history and has tested the capacity of global health infrastructures. Since no effective vaccine is available, isolation techniques to prevent infection such as home quarantine and social distancing while in public have remained the cornerstone of public health interventions. While government and health officials were charged with implementing stay-at-home strategies, many of which had little guidance as to the consequences of how quickly to begin them. Moreover, as the local epidemic curves have been flattened, the same officials must wrestle with when to ease or cease such restrictions as to not impose economic turmoil. To evaluate the effects of quarantine strategies during the initial epidemic, an agent based modeling framework was created to take into account local spread based on geographic and population data with a corresponding interactive desktop and web-based application. Using the state of Massachusetts in the United States of America, we have illustrated the consequences of implementing quarantines at different time points after the initial seeding of the state with COVID-19 cases. Furthermore, we suggest that this application can be adapted to other states, small countries, or regions within a country to provide decision makers with critical information necessary to best protect human health.	[Kirpich, Alexander] Georgia State Univ, Dept Populat Hlth Sci, Atlanta, GA 30303 USA; [Kirpich, Alexander] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA; [Koniukhovskii, Vladimir; Shvartc, Vladimir; Barsukov, Konstantin] EPAM Syst, St Petersburg, Russia; [Skums, Pavel] Georgia State Univ, Dept Comp Sci, Atlanta, GA 30303 USA; [Weppelmann, Thomas A.] Univ S Florida, Dept Internal Med, Tampa, FL 33620 USA; [Imyanitov, Evgeny] NN Petrov Res Inst Oncol, St Petersburg, Russia; [Semyonov, Semyon; Gankin, Yuriy] Quantori, Cambridge, MA 02139 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; State University System of Florida; University of South Florida; N.N. Petrov Research Institute of Oncology	Gankin, Y (corresponding author), Quantori, Cambridge, MA 02139 USA.	yuriy.gankin@quantori.com	Imyanitov, Evgeny/ABG-8619-2021	Skums, Pavel/0000-0003-4007-5624				Aleta A, 2020, NAT HUM BEHAV, V4, P964, DOI 10.1038/s41562-020-0931-9; Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007; [Anonymous], WALL STR J; [Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; [Anonymous], ATLANTIC; [Anonymous], GUARDIAN; [Anonymous], NEW YORK TIMES; Barrett AD., 2015, ESSENTIAL GUIDE; Bernheim A, 2020, RADIOLOGY, V295, P685, DOI 10.1148/radiol.2020200463; Bicher MR., 2020, AGENT BASED SIMULATI, DOI [10.1101/2020.05.12.20098970, DOI 10.1101/2020.05.12.20098970]; Brauer F, 2008, LECT NOTES MATH, V1945, P19; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Chao DL, 2020, MODELING LAYERED NON, DOI [10.1101/2020.04.08. 20058487, DOI 10.1101/2020.04.08.20058487]; Chen WH, 2020, CURR TROP MED REP, V7, P61, DOI 10.1007/s40475-020-00201-6; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Chowell G, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1406-6; Edemekong P. F., 2019, HLTH INSURANCE PORTA; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Hoertel N, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1001-6; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6; Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m641; MS N., 2020, AGENT BASED MODEL ME, DOI [10.1101/2020.06.04.20121848, DOI 10.1101/2020.06.04.20121848]; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Roosa K, 2020, INFECT DIS MODEL, V5, P256, DOI 10.1016/j.idm.2020.02.002; Roosa K, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020596; Silva PCL, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110088; Venkatramanan S, 2018, EPIDEMICS-NETH, V22, P43, DOI 10.1016/j.epidem.2017.02.010; Yu F, 2020, MICROBES INFECT, V22, P74, DOI 10.1016/j.micinf.2020.01.003; Zhu H, 2020, ESTIMATING NUMBER IN, DOI [10.25561/77731, DOI 10.25561/77731]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	35	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247182	10.1371/journal.pone.0247182	http://dx.doi.org/10.1371/journal.pone.0247182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596247	Green Published, Green Submitted, gold			2022-12-26	WOS:000620633200006
J	Maia, AG; Marteleto, L; Rodrigues, CG; Sereno, LG				Maia, Alexandre Gori; Marteleto, Leticia; Rodrigues, Cristina Guimaraes; Sereno, Luiz Gustavo			The short-term impacts of coronavirus quarantine in Sao Paulo: The health-economy trade-offs	PLOS ONE			English	Article							COVID-19	We analyze the trade-offs between health and the economy during the period of social distancing in Sao Paulo, the state hardest hit by the COVID-19 pandemic in Brazil. We use longitudinal data with municipal-level information and check the robustness of our estimates to several sources of bias, including spatial dependence, reverse causality, and time-variant omitted variables. We use exogenous climate shocks as instruments for social distancing since people are more likely to stay home in wetter and colder periods. Our findings suggest that the health benefits of social distancing differ by levels of municipal development and may have vanished if the COVID-19 spread was not controlled in neighboring municipalities. In turn, we did not find evidence that municipalities with tougher social distancing performed worse economically. Our results also highlight that estimates that do not account for endogeneity may largely underestimate the benefits of social distancing on reducing the spread of COVID-19.	[Maia, Alexandre Gori; Sereno, Luiz Gustavo] Univ Estadual Campinas, Ctr Appl Econ Agr & Environm, Campinas, SP, Brazil; [Marteleto, Leticia] Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA; [Marteleto, Leticia] Univ Texas Austin, Dept Sociol, Austin, TX 78712 USA; [Rodrigues, Cristina Guimaraes] Univ Sao Paulo, Inst Econ Res Fdn, Sao Paulo, Brazil	Universidade Estadual de Campinas; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Universidade de Sao Paulo	Maia, AG (corresponding author), Univ Estadual Campinas, Ctr Appl Econ Agr & Environm, Campinas, SP, Brazil.	gori@unicamp.br	Maia, Alexandre Gori/Q-5222-2019	Maia, Alexandre Gori/0000-0003-0075-5094; Marteleto, Leticia/0000-0003-4234-0129; Fernandes Sereno, Luis Gustavo/0000-0001-9490-2379	Brazilian National Council for Scientific and Technological Development; Ministry of Health in Brazil (CNPq) [401935/2020-5]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P2CHD042849, R01HD091257]	Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health in Brazil (CNPq); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by Brazilian National Council for Scientific and Technological Development, and the Ministry of Health in Brazil (CNPq, grant number 401935/2020-5). This research was also funded by the grant number R01HD091257, Reproductive Responses to the Zika Virus Epidemic in Brazil, awarded to P.I. L. J. Marteleto in the Population Research Center at The University of Texas at Austin by the Eunice Kennedy Shriver National Institute of Child Health and Human Development. This research was also supported by the grant number P2CHD042849, awarded to L. J. Marteleto in the Population Research Center at The University of Texas at Austin by the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The content is solely the authors' responsibility and does not necessarily represent the official views of the institutions.	Abrucio FL, 2020, REV ADM PUBL-RIO JAN, V54, P663, DOI [10.1590/0034-761220200354x, 10.1590/0034-761220200354]; Acemoglu D., 2020, OPTIMAL TARGETED LOC, DOI [10.7326/M20-0418, DOI 10.7326/M20-0418]; Agencia Nacional de Saude Suplementar, 2020, DAD IND SET; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2020, DECRETO NO 64 879 20; [Anonymous], 2020, SECR VIG SAUD PLAN C; [Anonymous], 2020, DECRETO NO 64 862 13; [Anonymous], 2020, TELECO; Aquino EML, 2020, CIENC SAUDE COLETIVA, V25, P2423, DOI 10.1590/1413-81232020256.1.10502020; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; Aum S, 2020, INEQUALITY FEAR SELF, DOI [10.3386/w27100, DOI 10.3386/W27100]; Baltagi BH, 2014, OXFORD B ECON STAT, V76, P112, DOI 10.1111/obes.12011; Belotti F, 2017, STATA J, V17, P139, DOI 10.1177/1536867X1701700109; Blundell R, 1998, J ECONOMETRICS, V87, P115, DOI 10.1016/S0304-4076(98)00009-8; Brasil, 2018, LEI GERAL PROTECAO D; Alves SMC, 2020, CAD SAUDE PUBLICA, V36, DOI 10.1590/0102-311X00116020; Candido DS, 2020, SCIENCE, V369, P1255, DOI 10.1126/science.abd2161; Centro de Informacao do medo, 2020, PLAN CONT COV 19 FAR; da Silva BP, 2016, CIENC SAUDE COLETIVA, V21, P2899, DOI 10.1590/1413-81232015219.15552016; de Moraes RF, 2020, CIENC SAUDE COLETIVA, V25, P3393, DOI 10.1590/1413-81232020259.21892020; de Oliveira SB., 2020, MONITORING SOCIAL DI, DOI [10.2139/ssrn.3640544, DOI 10.1101/2020.04.30.20082172]; Elhorst JP, 2014, SPRINGERBR REG SCI, P1, DOI 10.1007/978-3-642-40340-8; Farboodi M., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Figueiredo P., GLOBO 0504; Fundacao Seade, 2020, PORT EST EST SAO PAU; Fundacao Seade, 2020, AN MET NOT VAR FONT; Fundacao Seade, 2020, OB TOT EST SAO PAUL; Governo do Estado de Sao Paulo, 2020, PLAC TEST; Greenstone M., 2020, DOES SOCIAL DISTANCI, DOI DOI 10.2139/SSRN.3561244; Iezadi S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239554; Instituto Brasileiro de Geografia e Estatistica, 2010, CENS DEM 2010 NOT ME; Instituto Brasileiro de Geografia e Estatistica, 2020, REC FIS HUM RED ASS; Jamshidi S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217847; Johns Hopkins University, 2020, CUM CAS DAYS 50 CONF; Karaye IM, 2020, AM J PREV MED, V59, P317, DOI 10.1016/j.amepre.2020.06.006; Lin ZhiXian, 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts), DOI 10.3386/w27099; Ma YL, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138226; Noronha KVMD, 2020, CAD SAUDE PUBLICA, V36, DOI 10.1590/0102-311X00115320; Peixoto PS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235732; Pindyck R, 2020, 27121 NBER, DOI [10.3386/w27121, DOI 10.3386/W27121]; Roodman D, 2009, STATA J, V9, P86, DOI 10.1177/1536867X0900900106; Scherbina A., 2020, 202003 AEI, DOI [10.2139/ssrn.3562053, DOI 10.2139/SSRN.3562053]; Seade Fundacao., 2020, PORT EST EST SAO PAU; Secretaria da Fazenda e Planejamento, 2020, REL REC TRIB; Sistema IBGE de Recupera?ao Autom?tica, 2019, MUN AGR PROD; Terza JV, 2008, J HEALTH ECON, V27, P531, DOI 10.1016/j.jhealeco.2007.09.009; Wooldridge JM, 2015, J HUM RESOUR, V50, P420, DOI 10.3368/jhr.50.2.420	47	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0245011	10.1371/journal.pone.0245011	http://dx.doi.org/10.1371/journal.pone.0245011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8ME	33596219	gold, Green Published			2022-12-26	WOS:000620633200017
J	Seoane, B				Seoane, Beatriz			A scaling approach to estimate the age-dependent COVID-19 infection fatality ratio from incomplete data	PLOS ONE			English	Article							RATES	SARS-CoV-2 has disrupted the life of billions of people around the world since the first outbreak was officially declared in China at the beginning of 2020. Yet, important questions such as how deadly it is or its degree of spread within different countries remain unanswered. In this work, we exploit the 'universal' increase of the mortality rate with age observed in different countries since the beginning of their respective outbreaks, combined with the results of the antibody prevalence tests in the population of Spain, to unveil both unknowns. We test these results with an analogous antibody rate survey in the canton of Geneva, Switzerland, showing a good agreement. We also argue that the official number of deaths over 70 years old might be importantly underestimated in most of the countries, and we use the comparison between the official records with the number of deaths mentioning COVID-19 in the death certificates to quantify by how much. Using this information, we estimate the infection fatality ratio (IFR) for the different age segments and the fraction of the population infected in different countries assuming a uniform exposure to the virus in all age segments. We also give estimations for the non-uniform IFR using the sero-epidemiological results of Spain, showing a very similar increase of the fatality ratio with age. Only for Spain, we estimate the probability (if infected) of being identified as a case, being hospitalized or admitted in the intensive care units as function of age. In general, we observe a nearly exponential increase of the fatality ratio with age, which anticipates large differences in total IFR in countries with different demographic distributions, with numbers that range from 1.82% in Italy, to 0.62% in China or even 0.14% in middle Africa.	[Seoane, Beatriz] Univ Complutense, Dept Fis Teor, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT)	Seoane, B (corresponding author), Univ Complutense, Dept Fis Teor, Madrid, Spain.	beseoane@ucm.es	Seoane, Beatriz/A-5553-2012	Seoane, Beatriz/0000-0003-4007-9406	Comunidad de Madrid; Complutense University of Madrid (Spain) through the Atraccion de Talento program [2019-T1/TIC-12776]; Ministerio de Economia, Industria y Competitividad (MINECO) (Spain) [PGC2018-094684-B-C21]; EU through the FEDER program	Comunidad de Madrid(Comunidad de Madrid); Complutense University of Madrid (Spain) through the Atraccion de Talento program; Ministerio de Economia, Industria y Competitividad (MINECO) (Spain)(Spanish Government); EU through the FEDER program	Beatriz Seoane was supported by the Comunidad de Madrid and the Complutense University of Madrid (Spain) through the Atraccion de Talento program (Ref. 2019-T1/TIC-12776) and partially supported by Ministerio de Economia, Industria y Competitividad (MINECO) (Spain) through Grant PGC2018-094684-B-C21 (also partly funded by the EU through the FEDER program).	Abate SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235653; Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Angelopoulos AN, 2020, ARXIV PREPRINT ARXIV; Araujo MPD, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245432; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; Baysson H., 2020, REPEATED SEROPREVALE; Bendavid E., 2020, MEDRXIV; Bennett ST., 2020, ESTIMATING COVID 19; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Bottcher L, 2020, ARXIV PREPRINT ARXIV; Neto RAB, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244532; Buonanno P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239569; Cao JL, 2020, CLIN INFECT DIS, V71, P748, DOI 10.1093/cid/ciaa243; Chidambaram V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241541; Chirico F, 2020, J INFECT DEV COUNTR, V14, P438, DOI 10.3855/jidc.12787; Christey G, 2020, NEW ZEAL MED J, V133, P81; de Sanidad M, 2020, ESTUDIO ENE COVID19; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Dudel C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238904; Erikstrup C., 2020, ESTIMATION SARS COV; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Flaxman S, 2020, REPORT13 ESTIMATING; for National Statistics (UK) O, 2020, COR COVID 19 INF SUR; Gomes M Gabriela M, 2022, medRxiv, DOI 10.1101/2020.04.27.20081893; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Harahsheh AS, 2020, J PEDIATR-US, V222, P261, DOI 10.1016/j.jpeds.2020.04.052; Hayashi H., 2020, ESTIMATION TRUE INFE; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Jones Veena G, 2020, Hosp Pediatr, V10, P537, DOI 10.1542/hpeds.2020-0123; Jung SM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020523; Leon DA, 2020, LANCET, V395, pE81, DOI 10.1016/S0140-6736(20)30933-8; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Lipsitch M, 2020, LANCET INFECT DIS, V20, P775, DOI [10.1016/S1473-3099(20)30246-2, 10.1016/S1473-3099(20)30245-0]; Mallapaty S, 2020, NATURE, V582, P467, DOI 10.1038/d41586-020-01738-2; Modi C., 2020, DEADLY IS COVID 19 R; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Narayanan CS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233146; Nunez JH, 2020, INJURY, V51, P1414, DOI 10.1016/j.injury.2020.05.016; Oguzoglu U, IZA DISCUSSION PAPER; Phipps SJ., 2020, ESTIMATING TRUE POPU; Ricci-Tersenghi F, 2020, MEDIUM; Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/50140-6736(20)31094-1, 10.1016/S0140-6736(20)31094-1]; Rosado J., 2020, FORTALECIMIENTO INCL; Rosakis P, 2020, J INFECTION, V81, pE162, DOI 10.1016/j.jinf.2020.06.010; Ruan SG, 2020, LANCET INFECT DIS, V20, P630, DOI 10.1016/S1473-3099(20)30257-7; Russell Timothy W, 2020, Euro Surveill, V25, DOI 10.2807/1560-7917.ES.2020.25.12.2000256; Saladie Oscar, 2020, Transp Res Interdiscip Perspect, V8, P100218, DOI 10.1016/j.trip.2020.100218; Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517; Sempos CT, 2021, AM J EPIDEMIOL, V190, P109, DOI 10.1093/aje/kwaa174; Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259; Vahidy FS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245556; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Verma V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233074; Whitman JD, 2020, NAT BIOTECHNOL, V38, P1174, DOI [10.1038/s41587-020-0659-0, 10.1101/2020.04.25.20074856]; Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1080/10408398.2020.1828813, 10.1038/s41591-020-0822-7]; Yasinski E, 2020, SCIENTIST	57	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246831	10.1371/journal.pone.0246831	http://dx.doi.org/10.1371/journal.pone.0246831			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596249	Green Submitted, Green Published, gold			2022-12-26	WOS:000620633200033
J	Tusifujiang, Y; Zhang, XN; Gong, L				Tusifujiang, Yelike; Zhang, Xueni; Gong, Lu			The relative contribution of intraspecific variation and species turnover to the community-level foliar stoichiometric characteristics in different soil moisture and salinity habitats	PLOS ONE			English	Article							TRAIT VARIATION; NITROGEN DEPOSITION; FUNCTIONAL COMPOSITION; PLANT-COMMUNITIES; RESPONSES; WATER; VARIABILITY; DIVERSITY; PHOSPHORUS; TEMPERATE	Background Trait-based approaches have been used to demonstrate the responses of plant functional traits to environmental change may manifest both among- and/or within-species. However, how community-level foliar stoichiometric characteristic variations respond to aridity and salinity is still not well-known. Methods We calculated community weighted means (CWMs) and non-weighted means (CMs) of foliar C, N, and P concentrations (and their ratios) in a dryland plant community respond to high (HSW) and low soil moisture and salinity (LSW). Based on a sum of squares decomposition method, we determined the relative contributions of intraspecific variation and species turnover in both HSW and LSW habitats. Results The CWMs of foliar C, C:N and C:P, and CM of N in the HSW habitat were significantly greater than those in the LSW habitat. The trait variations in two habitats were mainly driven by intraspecific variation, and its contribution to trait variation mostly declined with the decrease of soil moisture and salinity. The CWMs of foliar C-related stoichiometric characteristics were mainly dominated by species turnover in both habitats. Moreover, the contribution of species turnover to C and C:P variations showed an increasing trend in the LSW habitat. For CWMs, negative covariations between intraspecific variation and turnover occurred in HSW and positive covariations (except N:P) occurred in LSW; however, CMs were generally positively correlated in both habitats. Conclusions The intraspecific variation declined as drought stress intensified, which indicates that the adaptability of desert plants declined when the stress changed from salinity to aridity. The total variation of C-related traits in both habitats were mainly dominated by species turnover. These findings highlight the importance of intraspecific variation in driving desert plant response of community functional composition to salt stress, and the joint role of intraspecific variation and species turnover in resisting drought stress.	[Tusifujiang, Yelike; Zhang, Xueni; Gong, Lu] Xinjiang Univ, Coll Resources & Environm Sci, Urumqi, Peoples R China; [Tusifujiang, Yelike; Zhang, Xueni; Gong, Lu] Xinjiang Univ, Xinjiang Key Lab Oasis Ecol, Urumqi, Peoples R China	Xinjiang University; Xinjiang University	Zhang, XN; Gong, L (corresponding author), Xinjiang Univ, Coll Resources & Environm Sci, Urumqi, Peoples R China.; Zhang, XN; Gong, L (corresponding author), Xinjiang Univ, Xinjiang Key Lab Oasis Ecol, Urumqi, Peoples R China.	xnzhang@yeah.net; gonglu721@163.com			National Nature Science Foundation of China [31700354]; National Nature Science Foundation of Xinjiang Uygur Autonomous Region [2017D01C081]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of Xinjiang Uygur Autonomous Region	1. National Nature Science Foundation of China (Grant No. 31700354). 2. National Nature Science Foundation of Xinjiang Uygur Autonomous Region (Grant No.2017D01C081).	Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; Auger S, 2013, J VEG SCI, V24, P419, DOI 10.1111/j.1654-1103.2012.01473.x; Bar Lamas MI., 2016, J PLANT RES, V129, P1, DOI [10.1007/s10265-015-0774-z, DOI 10.1007/S10265-015-0774-Z]; Bohnert HJ, 1996, TRENDS BIOTECHNOL, V14, P89, DOI 10.1016/0167-7799(96)80929-2; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Carlucci MB, 2015, J VEG SCI, V26, P21, DOI 10.1111/jvs.12223; Carmona CP, 2015, FUNCT ECOL, V29, P579, DOI 10.1111/1365-2435.12366; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Cingolani AM, 2007, J VEG SCI, V18, P911, DOI 10.1111/j.1654-1103.2007.tb02607.x; Costa DS, 2018, DIVERS DISTRIB, V24, P1869, DOI 10.1111/ddi.12815; Crawford M, 2019, OIKOS, V128, P441, DOI 10.1111/oik.05567; Davis SE, 2006, HYDROBIOLOGIA, V569, P87, DOI 10.1007/s10750-006-0124-1; de Bello F, 2011, METHODS ECOL EVOL, V2, P163, DOI 10.1111/j.2041-210X.2010.00071.x; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Fajardo A, 2018, ECOLOGY, V99, P1024, DOI 10.1002/ecy.2194; Fajardo A, 2011, NEW PHYTOL, V189, P259, DOI 10.1111/j.1469-8137.2010.03468.x; Funk JL, 2017, BIOL REV, V92, P1156, DOI 10.1111/brv.12275; Gallien L, 2018, ECOL EVOL, V8, P2171, DOI 10.1002/ece3.3855; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; Gong YM, 2019, SCI TOTAL ENVIRON, V653, P409, DOI 10.1016/j.scitotenv.2018.10.358; Gross N, 2013, J ECOL, V101, P637, DOI 10.1111/1365-2745.12063; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; He D, 2018, ANN BOT-LONDON, V121, P1173, DOI 10.1093/aob/mcx222; Henry HAL, 2006, ECOSYSTEMS, V9, P1066, DOI 10.1007/s10021-005-0077-7; Hou SL, 2019, SCI TOTAL ENVIRON, V666, P887, DOI 10.1016/j.scitotenv.2019.02.322; Jung V, 2014, J ECOL, V102, P45, DOI 10.1111/1365-2745.12177; Jung V, 2010, J ECOL, V98, P1134, DOI 10.1111/j.1365-2745.2010.01687.x; Kichenin E, 2013, FUNCT ECOL, V27, P1254, DOI 10.1111/1365-2435.12116; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kumordzi BB, 2015, J ECOL, V103, P1610, DOI 10.1111/1365-2745.12458; Lajoie G, 2018, ECOL EVOL, V8, P3895, DOI 10.1002/ece3.3947; Le Bagousse-Pinguet Y, 2014, J ECOL, V102, P466, DOI 10.1111/1365-2745.12201; Leps J, 2011, ECOGRAPHY, V34, P856, DOI 10.1111/j.1600-0587.2010.06904.x; Li CJ., 2012, XINJIANG ACTA ECOLOG, V32, P3069; [李从娟 Li Congjuan], 2014, [干旱区地理, Arid Land Geography], V37, P996; Liu ZeBin, 2017, Journal of Nanjing Forestry University (Natural Sciences Edition), V41, P27; Lu XT, 2018, PLANT SOIL, V423, P307, DOI 10.1007/s11104-017-3519-z; Luo Yahuang, 2016, Plant Diversity, V38, P303, DOI 10.1016/j.pld.2016.11.002; [罗艳 Luo Yan], 2017, [生态学报, Acta Ecologica Sinica], V37, P8326; Mariotte P, 2017, J ECOL, V105, P958, DOI 10.1111/1365-2745.12731; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Niu KC, 2016, J APPL ECOL, V53, P1554, DOI 10.1111/1365-2664.12727; Pakeman RJ, 2008, J VEG SCI, V19, P201, DOI 10.3170/2007-8-18353; [郄亚栋 Qie Yadong], 2019, [生态学报, Acta Ecologica Sinica], V39, P2899; R Core Team, 2021, R LANGUAGE ENV STAT; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Siefert A, 2016, OECOLOGIA, V181, P245, DOI 10.1007/s00442-016-3563-z; Siefert A, 2015, ECOL LETT, V18, P1406, DOI 10.1111/ele.12508; [宋一凡 Song Yifan], 2020, [生态学报, Acta Ecologica Sinica], V40, P4011; Survey DongM., 1997, OBSERVATION ANAL TER; Vila-Cabrera A, 2015, GLOBAL ECOL BIOGEOGR, V24, P1377, DOI 10.1111/geb.12379; Volf M, 2016, OECOLOGIA, V180, P941, DOI 10.1007/s00442-016-3548-y; Wang HY, 2018, ENVIRON POLLUT, V242, P82, DOI 10.1016/j.envpol.2018.06.088; Wang JZ, 2019, GEODERMA, V353, P172, DOI 10.1016/j.geoderma.2019.06.040; Wang XP, 2017, ECOL INDIC, V81, P222, DOI 10.1016/j.ecolind.2017.05.071; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yang HuiMin, 2011, Acta Prataculturae Sinica, V20, P244; [张雪妮 Zhang Xueni], 2019, [生态学报, Acta Ecologica Sinica], V39, P1541; Zheng SX, 2007, TREES-STRUCT FUNCT, V21, P357, DOI 10.1007/s00468-007-0129-z; Zhou XL, 2018, PLANT SOIL, V431, P289, DOI 10.1007/s11104-018-3771-x; Zuo XA, 2017, ECOL EVOL, V7, P1125, DOI 10.1002/ece3.2711	65	1	2	12	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246672	10.1371/journal.pone.0246672	http://dx.doi.org/10.1371/journal.pone.0246672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596232	Green Published, gold			2022-12-26	WOS:000620633200036
J	Maleitzke, T; Pumberger, M; Gerlach, UA; Herrmann, C; Slagman, A; Henriksen, LS; von Mauchenheim, F; Huttermann, N; Santos, AN; Fleckenstein, FN; Rauch, G; Mardian, S; Perka, C; Stockle, U; Mockel, M; Lindner, T; Winkler, T				Maleitzke, Tazio; Pumberger, Matthias; Gerlach, Undine A.; Herrmann, Carolin; Slagman, Anna; Henriksen, Louise S.; von Mauchenheim, Frederic; Huettermann, Nils; Santos, Anabel N.; Fleckenstein, Florian N.; Rauch, Geraldine; Maerdian, Sven; Perka, Carsten; Stoeckle, Ulrich; Moeckel, Martin; Lindner, Tobias; Winkler, Tobias			Impact of the COVID-19 shutdown on orthopedic trauma numbers and patterns in an academic Level I Trauma Center in Berlin, Germany	PLOS ONE			English	Article							HEALTH; VIOLENCE	Background The COVID-19 pandemic led to the implementation of drastic shutdown measures worldwide. While quarantine, self-isolation and shutdown laws helped to effectively contain and control the spread of SARS-CoV-2, the impact of COVID-19 shutdowns on trauma care in emergency departments (EDs) remains elusive. Methods All ED patient records from the 35-day COVID-19 shutdown (SHUTDOWN) period were retrospectively compared to a calendar-matched control period in 2019 (CTRL) as well as to a pre (PRE)- and post (POST)-shutdown period in an academic Level I Trauma Center in Berlin, Germany. Total patient and orthopedic trauma cases and contacts as well as trauma causes and injury patterns were evaluated during respective periods regarding absolute numbers, incidence rate ratios (IRRs) and risk ratios (RRs). Findings Daily total patient cases (SHUTDOWN vs. CTRL, 106.94 vs. 167.54) and orthopedic trauma cases (SHUTDOWN vs. CTRL, 30.91 vs. 52.06) decreased during the SHUTDOWN compared to the CTRL period with IRRs of 0.64 and 0.59. While absolute numbers decreased for most trauma causes during the SHUTDOWN period, we observed increased incidence proportions of household injuries and bicycle accidents with RRs of 1.31 and 1.68 respectively. An RR of 2.41 was observed for injuries due to domestic violence. We further recorded increased incidence proportions of acute and regular substance abuse during the SHUTDOWN period with RRs of 1.63 and 3.22, respectively. Conclusions While we observed a relevant decrease in total patient cases, relative proportions of specific trauma causes and injury patterns increased during the COVID-19 shutdown in Berlin, Germany. As government programs offered prompt financial aid during the pandemic to individuals and businesses, additional social support may be considered for vulnerable domestic environments.	[Maleitzke, Tazio; Pumberger, Matthias; von Mauchenheim, Frederic; Huettermann, Nils; Santos, Anabel N.; Maerdian, Sven; Perka, Carsten; Stoeckle, Ulrich; Winkler, Tobias] Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Berlin, Germany; [Maleitzke, Tazio; Winkler, Tobias] Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany; [Maleitzke, Tazio; Fleckenstein, Florian N.; Winkler, Tobias] Berlin Inst Hlth BIH, Berlin, Germany; [Gerlach, Undine A.; Slagman, Anna; Moeckel, Martin; Lindner, Tobias] Div Emergency & Acute Med, Campus Charite Mitte, Berlin, Germany; [Gerlach, Undine A.; Slagman, Anna; Moeckel, Martin; Lindner, Tobias] Charite Univ Med Berlin, Virchow Klinikum, Berlin, Germany; [Herrmann, Carolin; Rauch, Geraldine] Charite Univ Med Berlin, Inst Biometry & Clin Epidemiol, Berlin, Germany; [Henriksen, Louise S.] Univ Copenhagen, Rigshosp, Dept Growth & Reprod, Copenhagen, Denmark; [Fleckenstein, Florian N.] Charite Univ Med Berlin, Dept Diagnost & Intervent Radiol, Berlin, Germany; [Winkler, Tobias] Charite Univ Med Berlin, Berlin Inst Hlth, Ctr Regenerat Therapies, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rigshospitalet; University of Copenhagen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Maleitzke, T (corresponding author), Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Berlin, Germany.; Maleitzke, T (corresponding author), Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany.; Maleitzke, T (corresponding author), Berlin Inst Hlth BIH, Berlin, Germany.	tazio.maleitzke@charite.de	Perka, Carsten/ABG-6505-2021; Mardian, Sven/F-3614-2014	Tobias, Lindner/0000-0003-4010-3445; Fleckenstein, Florian Nima/0000-0003-1088-1721; Perka, Carsten/0000-0002-0993-581X; Winkler, Tobias/0000-0003-0727-4680; Pumberger, Matthias/0000-0002-0885-7370; Maleitzke, Tazio/0000-0003-2924-7384; stockle, ulrich/0000-0002-6419-2203; Herrmann, Carolin/0000-0003-2384-7303; Mockel, Martin/0000-0002-7691-3709; Mardian, Sven/0000-0003-4220-2797				Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092; [Anonymous], 2020, UN NEWS; Aragon TJ., 2020, EPITOOLS EPIDEMIOLOG; Bauerle A, 2020, J PUBLIC HEALTH-UK, V42, P649, DOI 10.1093/pubmed/fdaa053; Bekkers E, 2022, WORLD ECON, V45, P445, DOI 10.1111/twec.13063; Bhattacharyya T, 2001, J TRAUMA, V51, P118, DOI 10.1097/00005373-200107000-00019; Black JRM, 2020, LANCET, V395, P1418, DOI 10.1016/S0140-6736(20)30917-X; Bradbury-Jones C, 2020, J CLIN NURS, V29, P2047, DOI 10.1111/jocn.15296; Bram JT, 2020, J PEDIATR ORTHOPED, V40, P373, DOI 10.1097/BPO.0000000000001600; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Campbell A.M., 2020, FORENSIC SCI INT REP, V2, DOI [10.1016/j.fsir.2020.100089, DOI 10.1016/J.FSIR.2020.100089]; Chang SS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5239; Christey G, 2020, NEW ZEAL MED J, V133, P81; De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Enarson E., 1999, VIOLENCE AGAINST WOM, V5, P742, DOI [10.1177/10778019922181464, DOI 10.1177/10778019922181464]; Finset A, 2020, PATIENT EDUC COUNS, V103, P873, DOI 10.1016/j.pec.2020.03.027; Fisher S, 2010, VIOLENCE AGAINST WOM, V16, P902, DOI 10.1177/1077801210377649; Giebel C, 2021, INT J GERIATR PSYCH, V36, P393, DOI 10.1002/gps.5434; Grierson J, 2020, THE GUARDIAN; Gumina S, 2020, J SHOULDER ELB SURG, V29, P1737, DOI 10.1016/j.jse.2020.05.003; Kawohl W, 2020, LANCET PSYCHIAT, V7, P389, DOI 10.1016/S2215-0366(20)30141-3; Kothari CL, 2006, ANN EMERG MED, V47, P190, DOI 10.1016/j.annemergmed.2005.10.016; Krug EG, 1998, NEW ENGL J MED, V338, P373, DOI 10.1056/NEJM199802053380607; Maniscalco Pietro, 2020, Acta Biomed, V91, P89, DOI 10.23750/abm.v91i2.9636; Nahmias Jeffry, 2017, Trauma Surg Acute Care Open, V2, pe000120, DOI 10.1136/tsaco-2017-000120; Nordt C, 2015, LANCET PSYCHIAT, V2, P239, DOI 10.1016/S2215-0366(14)00118-7; Nunez JH, 2020, INJURY, V51, P1414, DOI 10.1016/j.injury.2020.05.016; Parkinson D, 2019, J INTERPERS VIOLENCE, V34, P2333, DOI 10.1177/0886260517696876; R Core Team, 2020, R LANG ENV STAT COMP; Schumacher JA, 2010, VIOLENCE VICTIMS, V25, P588, DOI 10.1891/0886-6708.25.5.588; Serrano F, 2020, J AIR TRANSP MANAG, V89, DOI 10.1016/j.jairtraman.2020.101900; Slagman A, 2020, DTSCH ARZTEBL INT, V117, P545, DOI 10.3238/arztebl.2020.0545; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Soklaridis S, 2020, GEN HOSP PSYCHIAT, V66, P133, DOI 10.1016/j.genhosppsych.2020.08.007; Stonko DP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207766; Thakur V, 2020, BRAIN BEHAV IMMUN, V88, P952, DOI 10.1016/j.bbi.2020.04.062; The Lancet, 2020, Lancet, V395, P537, DOI 10.1016/S0140-6736(20)30379-2; Treves-Kagan S, 2022, J FAM VIOLENCE, V37, P1, DOI 10.1007/s10896-020-00218-5; Uscher-Pines L, 2013, AM J MANAG CARE, V19, P47; van Gelder N, 2020, EClinicalMedicine, V21, P100348, DOI 10.1016/j.eclinm.2020.100348; Wu P, 2008, ALCOHOL ALCOHOLISM, V43, P706, DOI 10.1093/alcalc/agn073; Xu SQ, 2020, LANCET, V395, P1321, DOI 10.1016/S0140-6736(20)30845-X; Zahran S., 2009, INT J MASS EMERGENCI, V27, P26; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	45	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246956	10.1371/journal.pone.0246956	http://dx.doi.org/10.1371/journal.pone.0246956			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8MA	33592046	Green Published, gold			2022-12-26	WOS:000620632800068
J	Sharma, T; Morassut, RE; Langlois, C; Meyre, D				Sharma, Tanmay; Morassut, Rita E.; Langlois, Christine; Meyre, David			Effect of sex/gender on obesity traits in Canadian first year university students: The GENEiUS study	PLOS ONE			English	Article							FRESHMAN WEIGHT-GAIN; BODY-MASS INDEX; SEXUAL-DIMORPHISM; PHYSICAL-ACTIVITY; DIETARY-INTAKE; HIGH-SCHOOL; COLLEGE; TRANSITION; ADULTHOOD; BEHAVIOR	Background While weight gain during first year of university has been well documented in North America, literature on sex-specific effects is scarce and inconsistent. The objective of this investigation was to explore sex-specific changes in obesity traits during first year of university at McMaster University (Ontario, Canada). Methods 245 first-year students (80.4% females) were followed longitudinally with data collected early in the academic year and towards the end of the year. Obesity parameters including weight, waist and hip circumferences, BMI, and waist to hip ratio were investigated. The Mann-Whitney U test and the Wilcoxon signed-rank test were used for pairwise comparison of traits in the absence of adjustments. Additionally, the repeated-measures ANOVA test was used with covariate adjustments to investigate the interaction between sex and time. Results Overall sample trends indicated a significant increase in mean weight by 1.55 kg (95% CI: 1.24-1.86) over the school year (p<0.001). This was accompanied by significant gains in BMI, and waist and hip circumferences (p<0.001) in the overall sample. At baseline, males presented with higher body weight, BMI, waist and hip circumferences, and WHR, as compared to their females counterparts (p<0.01). Additionally, sex-stratified analysis indicated significant gains in weight, BMI, and waist and hip circumferences in both males and females (p<0.01). However, a comparison of the magnitude of change over time between the two sex groups revealed no significant difference for any of the investigated traits (p>0.05). Conclusion While our study confirms significant weight gain in both male and female first year university students in Ontario, Canada, it does not show sex specific differences within this context. Our investigation highlights the importance of accounting for sex and gender in health research and supports the need of further studies in this area.	[Sharma, Tanmay; Morassut, Rita E.; Langlois, Christine; Meyre, David] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Meyre, David] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University	Meyre, D (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.; Meyre, D (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	meyred@mcmaster.ca		Morassut, Rita/0000-0001-5617-4366	Canadian Institutes of Health Research Canada Graduate Scholarship	Canadian Institutes of Health Research Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	DM holds a Canada Research Chair in Genetics of Obesity. TS is supported by the Canadian Institutes of Health Research Canada Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Baum CL, 2017, DEMOGRAPHY, V54, P311, DOI 10.1007/s13524-016-0530-6; Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Beaudry KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218554; Bloor ID, 2014, HORM BEHAV, V66, P95, DOI 10.1016/j.yhbeh.2014.02.007; Castaner O, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/4095789; Cluskey M, 2009, J AM DIET ASSOC, V109, P325, DOI 10.1016/j.jada.2008.10.045; Coen S., 2012, WHAT DIFFERENCE SEX; Crombie AP, 2009, NUTR REV, V67, P83, DOI 10.1111/j.1753-4887.2008.00143.x; Deforche B, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0173-9; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Frehlich LC, 2017, ECOL FOOD NUTR, V56, P205, DOI 10.1080/03670244.2017.1284066; Gero D, 2019, APPETITE, V133, P47, DOI 10.1016/j.appet.2018.08.012; Guo SS, 1999, AM J CLIN NUTR, V70, p145S; Hirko KA, 2015, AM J EPIDEMIOL, V182, P441, DOI 10.1093/aje/kwv084; Hoffman DJ, 2006, J AM COLL HEALTH, V55, P41, DOI 10.3200/JACH.55.1.41-46; Holm-Denoma JM, 2008, HEALTH PSYCHOL, V27, pS3, DOI 10.1037/0278-6133.27.1.S3; Janssen I, 2013, CAN J DIABETES, V37, P90, DOI 10.1016/j.jcjd.2013.02.059; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Leon AC, 2007, STAT MED, V26, P1712, DOI 10.1002/sim.2795; Levitsky DA, 2004, INT J OBESITY, V28, P1435, DOI 10.1038/sj.ijo.0802776; Link JC, 2017, ANNU REV NUTR, V37, P225, DOI 10.1146/annurev-nutr-071816-064827; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mifsud G, 2009, BRIT J NUTR, V101, P1406, DOI 10.1017/S0007114508067639; Miller KJ, 2000, INT J EAT DISORDER, V27, P310, DOI 10.1002/(SICI)1098-108X(200004)27:3&lt;310::AID-EAT8&gt;3.0.CO;2-Q; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Morassut RE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-019365; Nelson MC, 2008, OBESITY, V16, P2205, DOI 10.1038/oby.2008.365; Nieves JW, 2005, J BONE MINER RES, V20, P529, DOI 10.1359/JBMR.041005; Orpana HM., 2006, TRENDS WEIGHT CHANGE; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Peirson Leslea, 2014, CMAJ Open, V2, pE306, DOI 10.9778/cmajo.20140012; Pigeyre M, 2016, CLIN SCI, V130, P943, DOI 10.1042/CS20160136; Pliner P, 2008, PHYSIOL BEHAV, V93, P76, DOI 10.1016/j.physbeh.2007.07.017; Provencher V, 2009, PHYSIOL BEHAV, V96, P135, DOI 10.1016/j.physbeh.2008.09.011; Pullman AW, 2009, APPL PHYSIOL NUTR ME, V34, P162, DOI 10.1139/H09-007; Sharma T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242714; Sharma T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241744; Vadeboncoeur Claudia, 2015, BMC Obes, V2, P22, DOI 10.1186/s40608-015-0051-7; Vella-Zarb RA, 2010, HEALTH EDUC J, V69, P321, DOI 10.1177/0017896910369416; Vella-Zarb RA, 2009, J AM COLL HEALTH, V58, P161, DOI 10.1080/07448480903221392; Wansink B, 2013, PUBLIC HEALTH NUTR, V16, P1291, DOI 10.1017/S136898001200328X; Wengreen HJ, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-32; Zheng Y, 2017, JAMA-J AM MED ASSOC, V318, P255, DOI 10.1001/jama.2017.7092	45	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247113	10.1371/journal.pone.0247113	http://dx.doi.org/10.1371/journal.pone.0247113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8MA	33592058	gold, Green Published			2022-12-26	WOS:000620632800020
J	Kutal, D; Kunwar, RM; Baral, K; Sapkota, P; Sharma, HP; Rimal, B				Kutal, Durga; Kunwar, Ripu M.; Baral, Kedar; Sapkota, Prabhat; Sharma, Hari P.; Rimal, Bhagawat			Factors that influence the plant use knowledge in the middle mountains of Nepal	PLOS ONE			English	Article							MEDICINAL-PLANTS; SPECIES RICHNESS; PEOPLE; ETHNOBOTANY; HYPOTHESIS; VEGETATION; TAMBOPATA; DISTRICT; AREA; PERU	An account of total of 58 plant species including 57 genera and 43 families was reported as useful in ethnomedicine from semi-structured questionnaire survey to the 76 participants of Kaski and Baitadi districts, Nepal. Fieldwork and participatory meetings were carried out between September 2017 and January 2018. A total of 419 emic use reports including 150 from Kaski and 269 from Baitadi were reported from 58 ethnomedicinal plant species. Each species was reported for 2-43 use reports and each participant recorded 1-12 use reports. About 25% (n = 104) use reports were associated with the treatment of digestive system disorders followed by 83 for general complaints. Of the species assessed, 53 species had IASc value < 0.25 and only five species had > 0.25. Species Swertia chirayita, Paris polyphylla, Bergenia ciliata, Valeriana jatamansi and Centella asiatica with > 0.25 IASc were found to be highly consented; however they were incongruent between the sample groups and sites. Divergent plant use knowledge specific to each sample district and group was corresponding to the heterogeneity of socio-economy and culture of the sites. Gender, ethnicity, household economy and food availability of the respondents were leading factors affecting the plant use knowledge. Despite the sites were relatively homogenous in eco-physiography, they possessed the distinct plant use knowledge, hinted that the socio-economic factors are more explanatory in plant use knowledge.	[Kutal, Durga] Univ Wisconsin, Whitewater, WI 53190 USA; [Kunwar, Ripu M.] Ethnobot Soc Nepal, Kathmandu, Nepal; [Baral, Kedar] Massey Univ, Palmerston North, New Zealand; [Baral, Kedar; Sapkota, Prabhat] Dept Forest & Soil Conservat, Kathmandu, Nepal; [Sharma, Hari P.] Tribhuvan Univ, Inst Sci & Technol, Cent Dept Zool, Kathmandu, Nepal; [Rimal, Bhagawat] Tribhuvan Univ, Coll Appl Sci CAS Nepal, Kathmandu, Nepal	University of Wisconsin System; Massey University; Tribhuvan University; Institute of Science & Technology (IoST) - Nepal; Tribhuvan University	Kunwar, RM (corresponding author), Ethnobot Soc Nepal, Kathmandu, Nepal.	ripukunwar@gmail.com	Sharma, Hari Prasad/AFM-2895-2022; Sharma, Hari Prasad/AAT-6094-2021; Sharma, Hari Prasad/GOJ-7665-2022; Kunwar, Ripu/AAR-8887-2021	Sharma, Hari Prasad/0000-0002-0708-1769; Sharma, Hari Prasad/0000-0002-0708-1769; Kunwar, Ripu/0000-0002-9303-0932	National Geographic Society (USA) [EC-212R-18]	National Geographic Society (USA)(National Geographic Society)	Ripu Kunwar received an Early Career Grant (EC-212R-18) from National Geographic Society (USA) for field travel in Baitadi. Kedar Baral and Prabhat Sapkota received grants from divisional forest offices for field visits. But the grants did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are given in the `author contributions'.	ADB, 2017, COUNTRY POVERTY ANAL; Adhikari Mahendra, 2019, Medicines (Basel), V6, DOI 10.3390/medicines6020069; Albuquerque UP., 2014, METHODS TECHNIQUES E, V1, DOI [10.1007/978-1-4614-8636-7, DOI 10.1007/978-1-4614-8636-7]; Alencar NL, 2010, ECON BOT, V64, P68, DOI 10.1007/s12231-009-9104-5; Amouei A, 2015, FUTUR MED ED J; [Anonymous], 2013, GASTROENTEROL HEP S3, P1, DOI DOI 10.1017/S1743923X12000670; Atreya K, 2018, ENVIRON MANAGE, V61, P741, DOI 10.1007/s00267-018-1009-6; Baral S., 2017, Banko Janakari, V27, P31, DOI 10.3126/banko.v27i1.18547; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Bhandari P., 2018, J NAT HIST MUS, V30, P55, DOI [10.3126/jnhm.v30i0.27538, DOI 10.3126/JNHM.V30I0.27538]; Bhatt V., 2002, ZOOS PRINT J, P17; Bhatta D., 2003, COMMUNITY APPROACHES; Bhattarai K. R., 2018, Our Nature, V16, P55, DOI 10.3126/on.v16i1.22123; Bhattarai K. R., 2011, Banko Janakari, V21, P31; Bhuju U.R., 2007, NEPAL BIODIVERSITY R; Buchanan Hamilton F., 1971, ACCOUNT KINGDOM NEPA; Cameron MM, 1996, HUM ORGAN, V55, P84, DOI 10.17730/humo.55.1.g206551211750h58; Charmakar S, 2020, PEERJ; Chhetri Ram B., 1992, USER GROUP FORESTRY; Coburn B., 1984, KAILASH, V11, P55; Devkota R, 2003, BOT ORIENT, V1, P135; DFO, 2017, SIG PROT FOR SIG BAI; Dixit A, 2014, VULNERABILITY IMPACT; Giday M, 2003, J ETHNOPHARMACOL, V85, P43, DOI 10.1016/S0378-8741(02)00359-8; GoN, 2001, FLOW PLANTS NEP PHAN; Grau O, 2007, J BIOGEOGR, V34, P1907, DOI 10.1111/j.1365-2699.2007.01745.x; Gurung LJ., 2017, MED PLANTS NEPAL ANT, P152; Hagen T., 1969, DENCKSCHRIFT DESSCHW, V86, P1; Hasan M. K., 2013, International Journal of Medicinal and Aromatic Plants, V3, P102; ICIMOD, 2010, LAND COV NEP; IOM, 2019, MIGR NEP COUNTR PROF, P155; Koirala R., 1998, BOT DIVERSITY PROJEC; Kunwar RM, 2020, GLOB ECOL CONSERV, V23, DOI 10.1016/j.gecco.2020.e01081; Kunwar RM, 2020, ECOL INDIC, V108, DOI 10.1016/j.ecolind.2019.105679; Kunwar RM, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-018-0242-7; Kunwar RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167812; Kunwar RM, 2015, J ETHNOPHARMACOL, V163, P210, DOI 10.1016/j.jep.2015.01.035; Kunwar RM, 2020, J FORESTRY RES, V31, P1625, DOI 10.1007/s11676-019-00987-w; LRMP, 1986, LAND SYST REP; Mahwasane ST, 2013, S AFR J BOT, V88, P69, DOI 10.1016/j.sajb.2013.05.004; Mainali J, 2019, CLIM DEV, V11, P607, DOI 10.1080/17565529.2018.1521329; Malla B, 2015, J ETHNOPHARMACOL, V165, P103, DOI 10.1016/j.jep.2014.12.057; Manzardo A E, 1976, Contrib Nepalese Stud, V3, P83; Manzardo AE., 1977, CONTRIB NEPALESE STU, V4, P63; Martin G, 1995, ETHNOBOTANY METHOD M, DOI [10.4324/9781849775854, DOI 10.4324/9781849775854]; MESSERSCHMIDT DA, 1976, HUM ECOL, V4, P167, DOI 10.1007/BF01531219; Miller G.C., 2009, M WHO COLL CTR FAM I; Muller JG, 2015, AMBIO, V44, P67, DOI 10.1007/s13280-014-0517-8; Nunes AT, 2016, J ARID ENVIRON, V135, P96, DOI 10.1016/j.jaridenv.2016.08.015; Paniagua-Zambrana NY, 2014, ECOL SOC, V19, DOI 10.5751/ES-06934-190409; Pfeiffer Jeanine M., 2005, Journal of Ethnobiology, V25, P240, DOI 10.2993/0278-0771(2005)25[240:ACAEVI]2.0.CO;2; PHILLIPS O, 1993, ECON BOT, V47, P33, DOI 10.1007/BF02862204; Pokhrel G, 2019, FOR J I FOR NEPAL, V16, P14, DOI [10.3126/forestry.v16i0.28351, DOI 10.3126/FORESTRY.V16I0.28351]; Program WWF, 2005, OV GLAC GLAC RETR SU; Rasul G, 2012, MT RES DEV, V32, P137, DOI 10.1659/MRD-JOURNAL-D-11-00112.1; Reyes-Garcia V, 2006, ECON BOT, V60, P62, DOI 10.1663/0013-0001(2006)60[62:CPAEVO]2.0.CO;2; Rimal B, 2019, ECOSYST SERV, V38, DOI 10.1016/j.ecoser.2019.100963; Rivera D, 2007, ECON BOT, V61, P269, DOI 10.1663/0013-0001(2007)61[269:GFPITM]2.0.CO;2; Salick J, 2014, J ETHNOBIOL, V34, P276, DOI 10.2993/0278-0771-34.3.276; Saslis-Lagoudakis CH, 2011, J ETHNOPHARMACOL, V135, P476, DOI 10.1016/j.jep.2011.03.044; Sati B., 2014, SUSTAINABLE LIVELIHO; Singh V, 2017, J RES PRACT, V13; Skeldon R, 2011, CRIT ASIAN STUD, V43, P310, DOI 10.1080/14672715.2011.570572; Soldati G. T., 2017, Environment, Development and Sustainability, V19, P2143, DOI 10.1007/s10668-016-9844-1; Sousa RD, 2019, ACTA BOT BRAS, V33, P283, DOI 10.1590/0102-33062018abb0320; Staub PO, 2015, J ETHNOPHARMACOL, V174, P514, DOI 10.1016/j.jep.2015.08.051; Subedi A, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-64; Subedi R., 2017, ETHNOBOTANICAL STUDY; Thomas E, 2009, J ARID ENVIRON, V73, P854, DOI 10.1016/j.jaridenv.2009.03.010; Trotter R.T., 1986, PLANTS INDIGENOUS ME, P91, DOI DOI 10.4324/9781315060385-6; Turner NJ, 2009, GLOBAL ENVIRON CHANG, V19, P180, DOI 10.1016/j.gloenvcha.2009.01.005; Vandebroek I, 2010, ECON BOT, V64, P303, DOI 10.1007/s12231-010-9135-y; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Voeks RA, 2007, SINGAPORE J TROP GEO, V28, P7, DOI 10.1111/j.1467-9493.2006.00273.x; Weckerle CS, 2006, ECON BOT, V60, P3, DOI 10.1663/0013-0001(2006)60[3:PKOTSI]2.0.CO;2; World Bank, 2020, LAND NEP	76	10	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246390	10.1371/journal.pone.0246390	http://dx.doi.org/10.1371/journal.pone.0246390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571303	Green Published, gold			2022-12-26	WOS:000618274000099
J	Stirton, H; Meek, BP; Edel, AL; Solati, Z; Surendran, A; Aukema, H; Modirrousta, M; Ravandi, A				Stirton, Hannah; Meek, Benjamin P.; Edel, Andrea L.; Solati, Zahra; Surendran, Arun; Aukema, Harold; Modirrousta, Mandana; Ravandi, Amir			Oxolipidomics profile in major depressive disorder: Comparing remitters and non-remitters to repetitive transcranial magnetic stimulation treatment	PLOS ONE			English	Article							OXIDATIVE STRESS; INFLAMMATION; BRAIN; METAANALYSIS; MATTER	Background Repetitive Transcranial Magnetic Stimulation [rTMS] is increasingly being used to treat Major Depressive Disorder [MDD]. Given that not all patients respond to rTMS, it would be clinically useful to have reliable biomarkers that predict treatment response. Oxidized phosphatidylcholine [OxPC] and some oxylipins are important plasma biomarkers of oxidative stress and inflammation. Not only is depression associated with oxidative stress, but rTMS has been shown to have anti-oxidative effects. Objectives To investigate whether plasma oxolipidomics profiles could predict treatment response in patients with treatment resistant MDD. Methods Fourty-eight patients undergoing rTMS treatment for MDD were recruited along with nine healthy control subjects. Plasma OxPCs and oxylipins were extracted and analyzed through high performance liquid chromatography coupled with mass spectrometry. Patients with a Hamilton Depression Rating Scale score [Ham-D] <= 7 post-treatment were defined as having entered remission. Results Fifty-seven OxPC and 32 oxylipin species were identified in our subjects. MDD patients who entered remission following rTMS had significantly higher pre-rTMS levels of total and fragmented OxPCs compared to non-remitters and controls [one-way ANOVA, p<0.05]. However, no significant changes in OxPC levels were found as a result of rTMS, regardless of treatment response [p>0.05]. No differences in plasma oxylipins were found between remitters and non-remitters at baseline. Conclusion Certain categories of OxPCs may be useful predictive biomarkers for response to rTMS treatment in MDD. Given that elevated oxidized lipids may indicate higher levels of oxidative stress and inflammation in the brain, patients with this phenotype of depression may be more receptive to rTMS treatment.	[Stirton, Hannah; Edel, Andrea L.; Solati, Zahra; Surendran, Arun; Aukema, Harold; Ravandi, Amir] St Boniface Hosp Albrechtsen Res Ctr, Cardiovasc Lipid Lab, Winnipeg, MB, Canada; [Stirton, Hannah; Solati, Zahra; Surendran, Arun; Modirrousta, Mandana; Ravandi, Amir] Univ Manitoba, Max Rady Coll Med, Winnipeg, MB, Canada; [Meek, Benjamin P.; Modirrousta, Mandana] Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Ravandi, A (corresponding author), St Boniface Hosp Albrechtsen Res Ctr, Cardiovasc Lipid Lab, Winnipeg, MB, Canada.; Modirrousta, M; Ravandi, A (corresponding author), Univ Manitoba, Max Rady Coll Med, Winnipeg, MB, Canada.; Modirrousta, M (corresponding author), Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada.	mmodirrousta@sbgh.mb.ca; aravandi@sbgh.mb.ca		/0000-0001-6663-1225; Meek, Benjamin P/0000-0001-8075-1290; Stirton, Hannah/0000-0001-5592-0240; Aukema, Harold/0000-0002-6982-7239	Research Manitoba	Research Manitoba	Funding for this work was provided from Research Manitoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aftanas LI, 2018, B EXP BIOL MED+, V165, P195, DOI 10.1007/s10517-018-4128-4; Al-Orf SM, 2011, INDIAN J CLIN BIOCHE, V26, P154, DOI 10.1007/s12291-010-0064-4; Black CN, 2015, PSYCHONEUROENDOCRINO, V51, P164, DOI 10.1016/j.psyneuen.2014.09.025; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Chervyakov AV, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00303; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Durmaz O, 2018, J ECT, V34, P127, DOI 10.1097/YCT.0000000000000467; Faria R, 2014, NEUROSCIENCE, V273, P1, DOI 10.1016/j.neuroscience.2014.04.042; FOLCH J, 1957, J BIOL CHEM, V226, P497; George MS, 2013, CURR OPIN PSYCHIATR, V26, P13, DOI 10.1097/YCO.0b013e32835ab46d; Grieve SM, 2013, NEUROIMAGE-CLIN, V3, P332, DOI 10.1016/j.nicl.2013.08.016; Guest J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-79; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hasin DS, 2018, JAMA PSYCHIAT, V75, P336, DOI 10.1001/jamapsychiatry.2017.4602; Ihara Y, 2005, NEUROL RES, V27, P310, DOI 10.1179/016164105X39897; Kar SK, 2019, CLIN PSYCHOPHARM NEU, V17, P25, DOI 10.9758/cpn.2019.17.1.25; Kelly MS, 2017, J NEUROPSYCH CLIN N, V29, P179, DOI 10.1176/appi.neuropsych.16100181; Kohler O, 2014, JAMA PSYCHIAT, V71, P1381, DOI 10.1001/jamapsychiatry.2014.1611; Lamers F, 2013, MOL PSYCHIATR, V18, P692, DOI 10.1038/mp.2012.144; Lindqvist D, 2017, PSYCHONEUROENDOCRINO, V76, P197, DOI 10.1016/j.psyneuen.2016.11.031; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P287; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P676, DOI 10.1016/j.pnpbp.2010.05.004; Maher P, 2000, CELL MOL LIFE SCI, V57, P1287, DOI 10.1007/PL00000766; Maia A, 2019, ACTA PSYCHIAT SCAND, V139, P420, DOI 10.1111/acps.13026; Marcourakis Tania, 2008, Dement. neuropsychol., V2, P2, DOI 10.1590/S1980-57642009DN20100002; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Modirrousta M, 2018, NEUROPSYCH DIS TREAT, V14, P309, DOI 10.2147/NDT.S151841; Monirujjaman M, 2017, BBA-MOL CELL BIOL L, V1862, P1562, DOI 10.1016/j.bbalip.2017.08.005; Myint AM, 2009, METAB BRAIN DIS, V24, P55, DOI 10.1007/s11011-008-9114-5; Noda Y, 2015, PSYCHOL MED, V45, P3411, DOI 10.1017/S0033291715001609; OBRIEN JS, 1965, J LIPID RES, V6, P537; Post A, 1999, EUR J NEUROSCI, V11, P3247, DOI 10.1046/j.1460-9568.1999.00747.x; Sawamura J, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0838-6; Solati Z, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051051; Tunez I, 2006, NEUROSCI RES, V56, P91, DOI 10.1016/j.neures.2006.05.012; Wang JF, 2007, CAN J PSYCHIAT, V52, P753; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Whooley MA, 2013, ANNU REV CLIN PSYCHO, V9, P327, DOI 10.1146/annurev-clinpsy-050212-185526; World Health Organization, 2018, DEPRESSION	41	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246592	10.1371/journal.pone.0246592	http://dx.doi.org/10.1371/journal.pone.0246592			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571313	gold, Green Published			2022-12-26	WOS:000618274000033
J	van Haastert, PJM				van Haastert, Peter J. M.			Short- and long-term memory of moving amoeboid cells	PLOS ONE			English	Article								Amoeboid cells constantly change shape and extend protrusions. The direction of movement is not random, but is correlated with the direction of movement in the preceding minutes. The basis of this correlation is an underlying memory of direction. The presence of memory in movement is known for many decades, but its molecular mechanism is still largely unknown. This study reports in detail on the information content of directional memory, the kinetics of learning and forgetting this information, and the molecular basis for memory using Dictyostelium mutants. Two types of memory were characterized. A short-term memory stores for similar to 20 seconds the position of the last pseudopod using a local modification of the branched F-actin inducer SCAR/WAVE, which enhances one new pseudopod to be formed at the position of the previous pseudopod. A long term memory stores for similar to 2 minutes the activity of the last similar to 10 pseudopods using a cGMP-binding protein that induces myosin filaments in the rear of the cell; this inhibits pseudopods in the rear and thereby enhances pseudopods in the global front. Similar types of memory were identified in human neutrophils and mesenchymal stem cells, the protist Dictyostelium and the fungus B.d. chytrid. The synergy of short- and long-term memory explains their role in persistent movement for enhanced cell dispersal, food seeking and chemotaxis.	[van Haastert, Peter J. M.] Univ Groningen, Dept Cell Biochem, Groningen, Netherlands	University of Groningen	van Haastert, PJM (corresponding author), Univ Groningen, Dept Cell Biochem, Groningen, Netherlands.	p.j.m.van.haastert@rug.nl						Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Bolourani P, 2006, MOL BIOL CELL, V17, P4543, DOI 10.1091/mbc.E05-11-1019; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Bosgraaf L, 2006, EUR J CELL BIOL, V85, P969, DOI 10.1016/j.ejcb.2006.04.004; Bosgraaf L, 2010, CELL ADHES MIGR, V4, P46, DOI 10.4161/cam.4.1.9953; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Buracco Simona, 2019, F1000Res, V8, DOI 10.12688/f1000research.18669.1; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Cooper RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033528; Davidson Andrew J., 2013, Communicative & Integrative Biology, V6, pe27033, DOI 10.4161/cib.27033; FUTRELLE RP, 1982, J CELL BIOL, V92, P807, DOI 10.1083/jcb.92.3.807; GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0; Gole L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026901; Golla SSV, 2017, EJNMMI PHYS, V4, DOI 10.1186/s40658-017-0197-0; HALL RL, 1977, J MATH BIOL, V4, P327, DOI 10.1007/BF00275081; Hu W., 2015, ENV SYST RES, V4, P4, DOI [10.1186/s40068-015-0031-4, DOI 10.1186/S40068-015-0031-4]; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006; Jeon TJ, 2007, J CELL BIOL, V179, P833, DOI 10.1083/jcb.200705068; Jeon TJ, 2007, J CELL BIOL, V176, P1021, DOI 10.1083/jcb.200607072; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Laevsky G, 2003, J CELL SCI, V116, P3761, DOI 10.1242/jcs.00684; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Litschko C, 2019, P NATL ACAD SCI USA, V116, P3594, DOI 10.1073/pnas.1821638116; LUDDEN TM, 1994, J PHARMACOKINET BIOP, V22, P431, DOI 10.1007/BF02353864; MANSTEIN DJ, 1989, EMBO J, V8, P923, DOI 10.1002/j.1460-2075.1989.tb03453.x; Moores SL, 1996, P NATL ACAD SCI USA, V93, P443, DOI 10.1073/pnas.93.1.443; PATLAK CLIFFORD S., 1953, BULL MATH BIOPHYS, V15, P311, DOI 10.1007/BF02476407; Plak K, 2014, MOL BIOL CELL, V25, P4195, DOI 10.1091/mbc.E14-08-1285; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POTEL MJ, 1979, J CELL SCI, V36, P281; Pramanik MK, 2009, GENES CELLS, V14, P821, DOI 10.1111/j.1365-2443.2009.01312.x; Sackmann E, 2015, BBA-MOL CELL RES, V1853, P3132, DOI 10.1016/j.bbamcr.2015.06.012; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Skoge M, 2014, P NATL ACAD SCI USA, V111, P14448, DOI 10.1073/pnas.1412197111; SWANSON JA, 1982, CELL, V28, P225, DOI 10.1016/0092-8674(82)90340-3; Tanaka Y, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050473; TOMCHIK KJ, 1981, SCIENCE, V212, P443, DOI 10.1126/science.6259734; Ura S, 2012, CURR BIOL, V22, P553, DOI 10.1016/j.cub.2012.02.020; van Haastert PJM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243442; van Haastert PJM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081809; van Haastert PJM, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208892; van Haastert PJM, 2017, MOL BIOL CELL, V28, P922, DOI 10.1091/mbc.E16-10-0733; Van Haastert PJM, 2010, BIOPHYS J, V99, P3345, DOI 10.1016/j.bpj.2010.09.042; Van Haastert PJM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000874; Van Haastert PJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006814; Van Haastert PJM, 2009, HFSP J, V3, P282, DOI 10.2976/1.3185725; VANHAASTERT PJM, 1986, J BIOL CHEM, V261, P6904; VANHAASTERT PJM, 1982, J CELL BIOL, V94, P271, DOI 10.1083/jcb.94.2.271; Veltman DM, 2005, MOL BIOL CELL, V16, P976, DOI 10.1091/mbc.e04-08-0701; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; Veltman DM, 2008, J CELL SCI, V121, P120, DOI 10.1242/jcs.015602; Veltman DM, 2006, MOL BIOL CELL, V17, P3921, DOI 10.1091/mbc.E06-05-0381; Yang HW, 2016, NAT CELL BIOL, V18, P191, DOI 10.1038/ncb3292; YUMURA S, 1985, NATURE, V314, P194, DOI 10.1038/314194a0; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585	56	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246345	10.1371/journal.pone.0246345	http://dx.doi.org/10.1371/journal.pone.0246345			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KQ	33571271	Green Published, gold			2022-12-26	WOS:000620071100006
J	Wang, SL; Bloomer, C; Civillico, G; Kontson, K				Wang, Sophie L.; Bloomer, Conor; Civillico, Gene; Kontson, Kimberly			Application of machine learning to the identification of joint degrees of freedom involved in abnormal movement during upper limb prosthesis use	PLOS ONE			English	Article							BODY-POWERED PROSTHESIS; DEKA ARM; MUSCULOSKELETAL COMPLAINTS; VETERANS AFFAIRS; CLUSTER-ANALYSIS; MOTION; GAIT; NETHERLANDS; PATTERNS; OPTIMIZE	To evaluate movement quality of upper limb (UL) prosthesis users, performance-based outcome measures have been developed that examine the normalcy of movement as compared to a person with a sound, intact hand. However, the broad definition of "normal movement" and the subjective nature of scoring can make it difficult to know which areas of the body to evaluate, and the expected magnitude of deviation from normative movement. To provide a more robust approach to characterizing movement differences, the goals of this work are to identify degrees of freedom (DOFs) that will inform abnormal movement for several tasks using unsupervised machine learning (clustering methods) and elucidate the variations in movement approach across two upper-limb prosthesis devices with varying DOFs as compared to healthy controls. 24 participants with no UL disability or impairment were recruited for this study and trained on the use of a body-powered bypass (n = 6) or the DEKA limb bypass (n = 6) prosthetic devices or included as normative controls. 3D motion capture data were collected from all participants as they performed the Jebsen-Taylor Hand Function Test (JHFT) and targeted Box and Blocks Test (tBBT). Range of Motion, peak angle, angular path length, mean angle, peak angular velocity, and number of zero crossings were calculated from joint angle data for the right/left elbows, right/left shoulders, torso, and neck and fed into a K-means clustering algorithm. Results show right shoulder and torso DOFs to be most informative in distinguishing between bypass user and norm group movement. The JHFT page turning task and the seated tBBT elicit movements from bypass users that are most distinctive from the norm group. Results can be used to inform the development of movement quality scoring methodology for UL performance-based outcome measures. Identifying tasks across two different devices with known variations in movement can inform the best tasks to perform in a rehabilitation setting that challenge the prosthesis user's ability to achieve normative movement.	[Wang, Sophie L.; Bloomer, Conor; Kontson, Kimberly] US FDA, Div Biomed Phys, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA; [Wang, Sophie L.] Univ Maryland, Dept Bioengn, College Pk, MD USA; [Civillico, Gene] NIH, Bldg 10, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA	Kontson, K (corresponding author), US FDA, Div Biomed Phys, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA.	Kimberly.Kontson@fda.hhs.gov		Wang, Sophie/0000-0003-1439-9203; KONTSON, KIMBERLY/0000-0002-4978-6011	Defense Advanced Research Projects Agency (DARPA) BTO through the DARPA-FDA IAA [224-14-6009]; FDA Critical Path Initiative [CPOSEL13]; Division of Biomedical Physics (FDA)	Defense Advanced Research Projects Agency (DARPA) BTO through the DARPA-FDA IAA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); FDA Critical Path Initiative; Division of Biomedical Physics (FDA)	This work was sponsored by the Defense Advanced Research Projects Agency (DARPA) BTO under the auspices of Dr. Al Emondi through the DARPA-FDA IAA No. 224-14-6009, FDA Critical Path Initiative (CPOSEL13), and base funding from the Division of Biomedical Physics (FDA). All grants were awarded to author KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Razak NA, 2013, DISABIL REHABIL-ASSI, V8, P255, DOI 10.3109/17483107.2012.704654; Alt Murphy M, 2015, PHYS THER REV, V20, P137, DOI 10.1179/1743288X15Y.0000000002; Atkins D., 1992, ATLAS LIMB PROSTHETI; Belter JT, 2014, IEEE ENG MED BIO, P6613, DOI 10.1109/EMBC.2014.6945144; Berning K, 2014, J REHABIL RES DEV, V51, P253, DOI 10.1682/JRRD.2013.05.0123; Biddiss EA, 2007, PROSTHET ORTHOT INT, V31, P236, DOI 10.1080/03093640600994581; Biswas D, 2015, HUM MOVEMENT SCI, V40, P59, DOI 10.1016/j.humov.2014.11.013; Bloomer C, 2020, ARCH REHABILITATION; Bloomer C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226563; Bloomer Conor, 2018, Phys Med Rehabil Res, V3, P1; Bouma SE, 2018, DISABIL REHABIL, V40, P1146, DOI 10.1080/09638288.2017.1289418; Bouwsema H, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-16; Carey SL, 2008, CLIN BIOMECH, V23, P1128, DOI 10.1016/j.clinbiomech.2008.05.008; Carey SL, 2009, PROSTHET ORTHOT INT, V33, P179, DOI 10.1080/03093640802613229; Choi A, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-20; Cowley J, 2017, PROSTHET ORTHOT INT, V41, P33, DOI 10.1177/0309364616631348; Cuesta-Vargas AI, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0957-3; Cutti AG, 2005, GAIT POSTURE, V21, P341, DOI 10.1016/j.gaitpost.2004.04.001; Dakpa R, 1997, CURR ORTHOPAED, V11, P193, DOI 10.1016/S0268-0890(97)90034-7; Reyes-Guzman ADL, 2014, CLIN BIOMECH, V29, P719, DOI 10.1016/j.clinbiomech.2014.06.013; Fitoussi F, 2009, ORTHOP TRAUMATOL-SUR, V95, P336, DOI 10.1016/j.otsr.2009.04.012; Galna B, 2014, GAIT POSTURE, V39, P1062, DOI 10.1016/j.gaitpost.2014.01.008; Haverkate L, 2016, PROSTHET ORTHOT INT, V40, P109, DOI 10.1177/0309364614554030; Hebert JS, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.11197; Huinink LHB, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0197-7; Hussaini A, 2017, PROSTHET ORTHOT INT, V41, P286, DOI 10.1177/0309364616660248; Kapsouras I, 2014, J VIS COMMUN IMAGE R, V25, P1432, DOI 10.1016/j.jvcir.2014.04.007; Kearns NT, 2018, ARCH PHYS MED REHAB, V99, P1789, DOI 10.1016/j.apmr.2018.04.021; Kontson K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177965; Kontson KL, 2020, J HAND THER, V33, P34, DOI 10.1016/j.jht.2018.10.002; Kontson KL, 2017, IEEE T NEUR SYS REH, V25, P1874, DOI 10.1109/TNSRE.2017.2693234; KRUGER LM, 1993, J PEDIATR ORTHOPED, V13, P68, DOI 10.1097/01241398-199301000-00014; Major MJ, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-132; MARSHALL M, 1992, CLIN J PAIN, V8, P351, DOI 10.1097/00002508-199212000-00010; McLeod A, 2016, ARCH PHYS MED REHAB, V97, P224, DOI 10.1016/j.apmr.2015.08.435; Metzger AJ, 2012, ARCH PHYS MED REHAB, V93, P2029, DOI 10.1016/j.apmr.2012.03.011; MILLSTEIN SG, 1986, PROSTHET ORTHOT INT, V10, P27; Muray IA, 1999, DETERMINING UPPER LI; Nayyar A., 2017, REV COMPUT ENG RES, V4, P54; Ostlie K, 2011, ARCH PHYS MED REHAB, V92, P1967, DOI 10.1016/j.apmr.2011.06.026; Pendharkar G, 2014, BIOMED SIGNAL PROCES, V13, P41, DOI 10.1016/j.bspc.2014.02.009; Postema SG, 2016, ARCH PHYS MED REHAB, V97, P1137, DOI 10.1016/j.apmr.2016.01.031; Resnik L, 2014, PROSTHET ORTHOT INT, V38, P492, DOI 10.1177/0309364613506913; Resnik L, 2014, PROSTHET ORTHOT INT, V38, P456, DOI 10.1177/0309364613506914; Resnik L, 2014, DISABIL REHABIL-ASSI, V9, P318, DOI 10.3109/17483107.2013.822024; Resnik L, 2013, ARCH PHYS MED REHAB, V94, P488, DOI 10.1016/j.apmr.2012.10.004; Resnik LJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203987; Rovini E, 2019, INT C REHAB ROBOT, P1167, DOI 10.1109/ICORR.2019.8779543; Rozumalski A, 2009, GAIT POSTURE, V30, P155, DOI 10.1016/j.gaitpost.2009.05.010; Sanchez-Margallo JA, 2017, INT J COMPUT ASS RAD, V12, P307, DOI 10.1007/s11548-016-1459-3; Sensinger JW, 2015, J REHABIL RES DEV, V52, P63, DOI 10.1682/JRRD.2014.03.0087; Stagni R, 2002, GAIT POSTURE SUPPL 1, V16, P211; Valevicius AM, 2020, CLIN BIOMECH, V72, P122, DOI 10.1016/j.clinbiomech.2019.12.002; Valevicius AM, 2019, GAIT POSTURE, V69, P176, DOI 10.1016/j.gaitpost.2019.01.037; van Andel CJ, 2008, GAIT POSTURE, V27, P120, DOI 10.1016/j.gaitpost.2007.03.002; Wang S, 2018, PM R J INJURY FUNCTI; Weeks DL, 2003, ARCH PHYS MED REHAB, V84, P437, DOI 10.1053/apmr.2003.50014; White SG, 2002, CLIN BIOMECH, V17, P177, DOI 10.1016/S0268-0033(02)00007-4; Xiao X, 2019, MATH BIOSCI ENG, V16, P1611, DOI 10.3934/mbe.2019077	59	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246795	10.1371/journal.pone.0246795	http://dx.doi.org/10.1371/journal.pone.0246795			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571311	Green Published, gold			2022-12-26	WOS:000618274000096
J	Deshpande, S; Altermann, E; Sarojini, V; Lott, JS; Lee, TV				Deshpande, Sandesh; Altermann, Eric; Sarojini, Vijayalekshmi; Lott, J. Shaun; Lee, T. Verne			Structural characterization of a PCP-R didomain from an archaeal nonribosomal peptide synthetase reveals novel interdomain interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY CRYSTALLOGRAPHY; REDUCTASE DOMAINS; PROTEIN-STRUCTURE; ADENYLATION; CYCLIZATION; ALIGNMENT; MODULE; ACID; TOOL	Nonribosomal peptide synthetases (NRPSs) are multi-modular enzymes that produce a wide range of bioactive peptides, such as siderophores, toxins, and antibacterial and insecticidal agents. NRPSs are dynamic proteins characterized by extensive interdomain communications as a consequence of their assembly-line mode of synthesis. Hence, crystal structures of multidomain fragments of NRPSs have aided in elucidating crucial interdomain interactions that occur during different steps of the NRPS catalytic cycle. One crucial yet unexplored interaction is that between the reductase (R) domain and the peptide carrier protein (PCP) domain. R domains are members of the short-chain dehydrogenase/reductase family and function as termination domains that catalyze the reductive release of the final peptide product from the terminal PCP domain of the NRPS. Here, we report the crystal structure of an archaeal NRPS PCP-R didomain construct. This is the first NRPS R domain structure to be determined together with the upstream PCP domain and is also the first structure of an archaeal NRPS to be reported. The structure reveals that a novel helix-turn-helix motif, found in NRPS R domains but not in other short-chain dehydrogenase/reductase family members, plays a major role in the interface between the PCP and R domains. The information derived from the described PCP-R interface will aid in gaining further mechanistic insights into the peptide termination reaction catalyzed by the R domain and may have implications in engineering NRPSs to synthesize novel peptide products.	[Deshpande, Sandesh; Lott, J. Shaun; Lee, T. Verne] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Altermann, Eric] AgResearch Ltd, Food Syst Integr, Palmerston North, New Zealand; [Altermann, Eric] Massey Univ, Riddet Inst, Palmerston North, New Zealand; [Sarojini, Vijayalekshmi] Univ Auckland, Sch Chem Sci, Auckland, New Zealand	University of Auckland; AgResearch - New Zealand; Massey University; University of Auckland	Lee, TV (corresponding author), Univ Auckland, Sch Biol Sci, Auckland, New Zealand.	t.lee@auckland.ac.nz	Lee, Verne/M-6283-2014	Lee, Verne/0000-0002-5768-2781; Lott, Shaun/0000-0003-3660-452X	New Zealand Ministry for Business, Innovation and Employment [UOAX1506]	New Zealand Ministry for Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This research was supported by the New Zealand Ministry for Business, Innovation and Employment on contract UOAX1506.	Alphey MS, 2005, J BIOL CHEM, V280, P3068, DOI 10.1074/jbc.M411069200; Barajas JF, 2015, CHEM BIOL, V22, P1018, DOI 10.1016/j.chembiol.2015.06.022; Bozhuyuk KAJ, 2019, NAT CHEM, V11, P653, DOI 10.1038/s41557-019-0276-z; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Chakravarty D, 2015, IUCRJ, V2, P643, DOI 10.1107/S2052252515015250; Chhabra A, 2012, P NATL ACAD SCI USA, V109, P5681, DOI 10.1073/pnas.1118680109; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Drake EJ, 2016, NATURE, V529, P235, DOI 10.1038/nature16163; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fonin AV, 2019, CELL MOL LIFE SCI, V76, P4461, DOI 10.1007/s00018-019-03276-1; Fox Brian G, 2009, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0523s56; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Gahloth D, 2017, NAT CHEM BIOL, V13, P975, DOI [10.1038/nchembio.2434, 10.1038/NCHEMBIO.2434]; Hague AS, 2014, J STRUCT BIOL, V187, P207, DOI 10.1016/j.jsb.2014.07.008; Hur GH, 2012, NAT PROD REP, V29, P1074, DOI 10.1039/c2np20025b; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kallberg Y, 2010, FEBS J, V277, P2375, DOI 10.1111/j.1742-4658.2010.07656.x; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; Kinatukara P, 2016, J STRUCT BIOL, V194, P368, DOI 10.1016/j.jsb.2016.03.014; Koropatkin NM, 2005, ACTA CRYSTALLOGR D, V61, P365, DOI 10.1107/S0907444904033876; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Leahy SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008926; Lee TV, 2010, J BIOL CHEM, V285, P2415, DOI 10.1074/jbc.M109.071324; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Liu Y, 2011, CHEM BIOL, V18, P1482, DOI 10.1016/j.chembiol.2011.09.018; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Miller BR, 2014, PROTEINS, V82, P2691, DOI 10.1002/prot.24635; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mullowney MW, 2018, NAT PROD REP, V35, P847, DOI 10.1039/c8np00013a; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Owen JG, 2016, CELL CHEM BIOL, V23, P1395, DOI 10.1016/j.chembiol.2016.09.014; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; Pluskal T., 2018, BIOSYNTHETIC ORIGIN, DOI [10.1101/294439, DOI 10.1101/294439]; Reimer JM, 2019, SCIENCE, V366, P706, DOI 10.1126/science.aaw4388; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sussmuth RD, 2017, ANGEW CHEM INT EDIT, V56, P3770, DOI 10.1002/anie.201609079; Sundlov JA, 2012, CHEM BIOL, V19, P188, DOI 10.1016/j.chembiol.2011.11.013; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Tarry MJ, 2017, STRUCTURE, V25, P783, DOI 10.1016/j.str.2017.03.014; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Wang H, 2014, P NATL ACAD SCI USA, V111, P9259, DOI 10.1073/pnas.1401734111; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; Weng JW, 2020, CURR OPIN STRUC BIOL, V62, P9, DOI 10.1016/j.sbi.2019.11.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wyatt MA, 2012, CHEMBIOCHEM, V13, P2408, DOI 10.1002/cbic.201200340	55	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100432	10.1016/j.jbc.2021.100432	http://dx.doi.org/10.1016/j.jbc.2021.100432			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610550	gold, Green Published			2022-12-26	WOS:000672866400406
J	Bafna, T; Baekgaard, P; Hansen, JP				Bafna, Tanya; Baekgaard, Per; Hansen, John Paulin			Mental fatigue prediction during eye-typing	PLOS ONE			English	Article								Mental fatigue is a common problem associated with neurological disorders. Until now, there has not been a method to assess mental fatigue on a continuous scale. Camera-based eye-typing is commonly used for communication by people with severe neurological disorders. We designed a working memory-based eye-typing experiment with 18 healthy participants, and obtained eye-tracking and typing performance data in addition to their subjective scores on perceived effort for every sentence typed and mental fatigue, to create a model of mental fatigue for eye-typing. The features of the model were the eye-based blink frequency, eye height and baseline-related pupil diameter. We predicted subjective ratings of mental fatigue on a six-point Likert scale, using random forest regression, with 22% lower mean absolute error than using simulations. When additionally including task difficulty (i.e. the difficulty of the sentences typed) as a feature, the variance explained by the model increased by 9%. This indicates that task difficulty plays an important role in modelling mental fatigue. The results demonstrate the feasibility of objective and non-intrusive measurement of fatigue on a continuous scale.	[Bafna, Tanya; Hansen, John Paulin] Tech Univ Denmark, Dept Management Technol & Econ, Lyngby, Capital Region, Denmark; [Baekgaard, Per] Tech Univ Denmark, Dept Appl Math & Comp Sci, Lyngby, Capital Region, Denmark	Technical University of Denmark; Technical University of Denmark	Bafna, T (corresponding author), Tech Univ Denmark, Dept Management Technol & Econ, Lyngby, Capital Region, Denmark.	taba@dtu.dk		Bafna, Tanya/0000-0002-6607-2643; Baekgaard, Per/0000-0002-6720-1128; Hansen, John Paulin/0000-0001-5594-3645	Bevica Fonden; Horizon 2020 EU project ReHyb [871767]	Bevica Fonden; Horizon 2020 EU project ReHyb	The author(s) received funding for this work from Bevica Fonden and Horizon 2020 EU project ReHyb (ID No 871767).	Aaronson LS, 2003, WESTERN J NURS RES, V25, P419, DOI 10.1177/0193945903025004007; Allen DP, 2009, J NEUROSCI METH, V177, P303, DOI 10.1016/j.jneumeth.2008.10.019; Bafna T, 2020, ETRA'20 FULL PAPERS: ACM SYMPOSIUM ON EYE TRACKING RESEARCH AND APPLICATIONS, DOI 10.1145/3379155.3391333; Ball LJ, 2010, J MED SPEECH-LANG PA, V18, P11; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beatty J, 1977, N000476C0616 DEP NAV; Bjornsson C, 1968, LASBARHET; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Borragan G, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02351; Borragan G, 2017, CORTEX, V89, P71, DOI 10.1016/j.cortex.2017.01.023; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Di Stasi LL, 2014, ANN SURG, V259, P824, DOI 10.1097/SLA.0000000000000260; Di Stasi LL, 2013, EUR J NEUROSCI, V38, P2389, DOI 10.1111/ejn.12248; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Goldhahn D, 2012, LREC 2012 - EIGHTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P759; Grafsgaard JF, 2012, ICMI '12: PROCEEDINGS OF THE ACM INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION, P145; Greenberg S., 2016, OPEN PSYCHOL J, V9, P50, DOI [10.2174/1874350101609010050, DOI 10.2174/1874350101609010050]; Hansen J., 2011, GAZE INTERACTION APP, P197; Herlambang MB, 2019, HUM FACTORS, V61, P1171, DOI 10.1177/0018720819828569; Hockey B, 2013, PSYCHOL FATIGUE WORK; Hopstaken JF, 2015, BIOL PSYCHOL, V110, P100, DOI 10.1016/j.biopsycho.2015.06.013; Hopstaken JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130304; Hopstaken JF, 2015, PSYCHOPHYSIOLOGY, V52, P305, DOI 10.1111/psyp.12339; Horiuchi R, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9060310; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jaeger B., 2017, R2GLMM COMPUTES R SQ; Kahneman D., 1973, ATTENTION EFFORT; Kane SK, 2017, CSCW'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING, P1166, DOI 10.1145/2998181.2998284; Komogortsev OV, 2013, BEHAV RES METHODS, V45, P203, DOI 10.3758/s13428-012-0234-9; Komogortsev OV, 2010, IEEE T BIO-MED ENG, V57, P2635, DOI 10.1109/TBME.2010.2057429; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Li F, 2019, ADV ENG INFORM, V42, DOI 10.1016/j.aei.2019.100987; Maffei A, 2018, INT J PSYCHOPHYSIOL, V123, P58, DOI 10.1016/j.ijpsycho.2017.11.009; Majaranta P., 2011, GAZE INTERACTION APP; Majaranta Paivi, 2006, UNIVERSAL ACCESS INF, V5, P199, DOI [10.1007/s10209-006-0034-z, DOI 10.1007/S10209-006-0034-Z]; Marandi RZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31577-1; Matthews G, 2011, COGNITIVE FATIGUE MU, P209; Mills RJ, 2008, QJM-INT J MED, V101, P49, DOI 10.1093/qjmed/hcm122; Monteiro TG, 2019, IEEE T HUM-MACH SYST, V49, P599, DOI 10.1109/THMS.2019.2938156; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Pattyn N, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01246; Phillips RO, 2015, TRANSPORT RES F-TRAF, V29, P48, DOI 10.1016/j.trf.2015.01.003; Pichora-Fuller MK, 2016, EAR HEARING, V37, p5S, DOI 10.1097/AUD.0000000000000312; R Core Team, 2021, R LANGUAGE ENV STAT; Renata V, 2018, 2018 INTERNATIONAL CONFERENCE ON CYBERWORLDS (CW), P207, DOI 10.1109/CW.2018.00046; Ryu K, 2005, INT J IND ERGONOM, V35, P991, DOI 10.1016/j.ergon.2005.04.005; Samani A., 2019, PLOS ONE, V14; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; STERN JA, 1984, PSYCHOPHYSIOLOGY, V21, P22, DOI 10.1111/j.1469-8986.1984.tb02312.x; Sweetland J., 2020, OPTIKEY; van der Linden D., COGNITIVE FATIGUE MU, P149, DOI [10.1037/12343-007, DOI 10.1037/12343-007]; Yamada Y, 2018, ARTIF INTELL MED, V91, P39, DOI 10.1016/j.artmed.2018.06.005; Zagermann J, 2018, CHI 2018: EXTENDED ABSTRACTS OF THE 2018 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, DOI 10.1145/3170427.3188628	55	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0246739	10.1371/journal.pone.0246739	http://dx.doi.org/10.1371/journal.pone.0246739			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QO3ZL	33617541	Green Published, gold			2022-12-26	WOS:000623082400007
J	Pederson, WP; Cyphert-Daly, JM; Tighe, RM; Que, LG; Ledford, JG				Pederson, William P.; Cyphert-Daly, Jaime M.; Tighe, Robert M.; Que, Loretta G.; Ledford, Julie G.			Genetic variation in surfactant protein-A2 alters responses to ozone	PLOS ONE			English	Article								Background Increased exposure to Ozone (O-3) is associated with adverse health effects in individuals afflicted with respiratory diseases. Surfactant protein-A (SP-A), encoded by SP-A1 and SP-A2, is the largest protein component in pulmonary surfactant and is functionally impaired by O-3-oxidation. Objective We used humanized SP-A2 transgenic mice with allelic variation corresponding to a glutamine (Q) to lysine (K) amino acid substitution at position 223 in the lectin domain to determine the impact of this genetic variation in regards to O-3 exposure. Methods Mice were exposed to 2ppm O-3 or Filtered Air (FA) for 3 hours and 24 hrs post-challenge pulmonary function tests and other parameters associated with inflammation were assessed in the bronchoalveolar lavage (BAL) fluid and lung tissue. Additionally, mouse tracheal epithelial cells were cultured and TEER measurements recorded for each genotype to determine baseline epithelial integrity. Results Compared to FA, O-3 exposure led to significantly increased sensitivity to methacholine challenge in all groups of mice. SP-A2 223Q variant mice were significantly protected from O-3-induced AHR compared to SP-A(-/-) and SP-A2 223K mice. Neutrophilia was observed in all genotypes of mice post O-3-exposure, however, SP-A2 223Q mice had a significantly lower percentage of neutrophils compared to SP-A(-/-) mice. Albumin levels in BAL were unchanged in O-3-exposed SP-A2 223Q mice compared to their FA controls, while levels were significantly increased in all other genotypes of O-3-exposed mice. SP-A 223Q MTECS has significant higher TEER values than all other genotypes, and WT MTECS has significantly higher TEER than the SP-A KO and SP-A 223K MTECS. Significance Taken together, our study suggests that expression of a glutamine (Q) as position 223 in SP-A2, as opposed to expression of lysine (K), is more protective in acute exposures to ozone and results in attenuated O-3-induced AHR, neutrophilia, and vascular permeability.	[Pederson, William P.] Univ Arizona, Dept Physiol, Tucson, AZ USA; [Cyphert-Daly, Jaime M.; Tighe, Robert M.; Que, Loretta G.] Duke Univ, Dept Med, Durham, NC USA; [Ledford, Julie G.] Asthma & Airways Dis Res Ctr, Tucson, AZ 85724 USA; [Ledford, Julie G.] Univ Arizona, Cellular & Mol Med, Tucson, AZ 85721 USA	University of Arizona; Duke University; University of Arizona	Ledford, JG (corresponding author), Asthma & Airways Dis Res Ctr, Tucson, AZ 85724 USA.; Ledford, JG (corresponding author), Univ Arizona, Cellular & Mol Med, Tucson, AZ 85721 USA.	jledford@email.arizona.edu		Pederson, William/0000-0001-9253-1279; Tighe, Robert/0000-0002-3465-9861	National Institutes of Health [NIH HL-125602, AI-135935, ES006694]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were funded by the National Institutes of Health (www.nih.gov) grants NIH HL-125602, AI-135935 and ES006694 (Ledford). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison Kenneth J, 2017, J Infect Pulm Dis, V3, DOI 10.16966/2470-3176.120; [Anonymous], [No title captured]; Bai Y, 2004, PROTEOMICS, V4, P2300, DOI 10.1002/pmic.200400855; Birukova A, 2019, TOXICOL SCI, V169, P499, DOI 10.1093/toxsci/kfz056; Brunekreef B, 2010, EUR RESPIR J, V36, P704, DOI 10.1183/09031936.00081910; Casals C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01998; Center N, 565 BIOTECHNOLOGY IN; Chang EH, 2019, CURR OPIN ALLERGY CL, V19, P26, DOI 10.1097/ACI.0000000000000500; Connor AJ, 2012, EXP MOL PATHOL, V92, P229, DOI 10.1016/j.yexmp.2012.01.004; Dy ABC, 2019, J IMMUNOL, V203, P1122, DOI 10.4049/jimmunol.1900546; Dy Alane Blythe C, 2018, J Clin Cell Immunol, V9, DOI 10.4172/2155-9899.1000553; Francis M, 2017, TOXICOL SCI, V155, P474, DOI 10.1093/toxsci/kfw226; Goto H, 2010, AM J RESP CRIT CARE, V181, P1336, DOI 10.1164/rccm.200907-1002OC; Haataja R, 2000, HUM MOL GENET, V9, P2751, DOI 10.1093/hmg/9.18.2751; Haque R, 2007, TOXICOL APPL PHARM, V220, P72, DOI 10.1016/j.taap.2006.12.017; HATCH GE, 1994, AM J RESP CRIT CARE, V150, P676, DOI 10.1164/ajrccm.150.3.8087337; Korfhagen TR, 2001, AM J RESP CELL MOL, V25, P668, DOI 10.1165/ajrcmb.25.6.f221; Larstad M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144463; Ledford JG, 2016, ANN AM THORAC SOC, V13, pS101, DOI 10.1513/AnnalsATS.201508-520MG; Ledford JG, 2015, J IMMUNOL, V194, P6123, DOI 10.4049/jimmunol.1500104; Lofgren J, 2002, J INFECT DIS, V185, P283, DOI 10.1086/338473; Lugogo N, 2018, J ALLERGY CLIN IMMUN, V141, P918, DOI 10.1016/j.jaci.2017.05.028; Marttila R, 2003, AM J RESP CRIT CARE, V168, P1216, DOI 10.1164/rccm.200304-524OC; Marttila R, 2003, ANN MED, V35, P344, DOI 10.1080/07853890310006389; Michaudel C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28261-9; Mitsuhashi A, 2013, AM J PATHOL, V182, P1843, DOI 10.1016/j.ajpath.2013.01.030; Pettigrew MM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-68; Pettigrew MM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-15; Que LG, 2011, J APPL PHYSIOL, V111, P679, DOI 10.1152/japplphysiol.00337.2011; Ramet M, 2001, J PEDIATR-US, V138, P266, DOI 10.1067/mpd.2001.110133; Ren J, 2013, ANN OTO RHINOL LARYN, V122, P240, DOI 10.1177/000348941312200405; Shalaby KH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-82; Sokolowska M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02169; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Tighe RM, 2011, J IMMUNOL, V187, P4800, DOI 10.4049/jimmunol.1101312; Vlachaki EM, 2010, CHEST, V137, P37, DOI 10.1378/chest.09-1029; Wang GR, 2004, BIOCHEMISTRY-US, V43, P4227, DOI 10.1021/bi036023i; Wang Y, 2011, AM J PHYSIOL-LUNG C, V301, pL598, DOI 10.1152/ajplung.00381.2010; WIESTER MJ, 1988, TOXICOL APPL PHARM, V96, P140, DOI 10.1016/0041-008X(88)90256-6; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247504	10.1371/journal.pone.0247504	http://dx.doi.org/10.1371/journal.pone.0247504			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617569	Green Published, gold			2022-12-26	WOS:000623082400002
J	Arand, K; Bieler, E; Durrenberger, M; Kassemeyer, HH				Arand, Katja; Bieler, Evi; Duerrenberger, Markus; Kassemeyer, Hanns-Heinz			Developmental pattern of grapevine (Vitis vinifera L.) berry cuticular wax: Differentiation between epicuticular crystals and underlying wax	PLOS ONE			English	Article								The grapevine berry surface is covered by a cuticle consisting of cutin and various lipophilic wax compounds. The latter build the main barrier for transpirational water loss and protect the fruit against environmental factors e.g. pests, mechanical impacts or radiation. The integrety of the fruit surface is one important key factor for post-harvest quality and storage of fruits. Nonetheless, the developmental pattern of cuticular wax was so far only investigated for a very limited number of fruits. Therefore, we performed comparative investigations on the compositional and morphological nature of epicuticular wax crystals and underlying wax during fruit development in Vitis vinifera. The main compound oleanolic acid belongs to the pentacyclic triterpenoids, which occur very early in the development in high amounts inside the cuticle. The amount increases until veraison and decreases further during ripening. In general, very-long chain aliphatic (VLCA) compounds are present in much smaller amounts and alcohols and aldehydes follow the same trend during development. In contrast, the amount of fatty acids constantly increases from fruit set to ripening while wax esters only occur in significant amount at veraison and increase further. Wax crystals at the fruit surface are solely composed of VLCAs and the morphology changes during development according to the compositional changes of the VLCA wax compounds. The remarkable compositional differences between epicuticular wax crystals and the underlying wax are important to understand in terms of studying grape-pest interactions or the influence of environmental factors, since only wax crystals directly face the environment.	[Arand, Katja] Univ Wurzburg, Julius von Sachs Inst Biosci, Wurzburg, Germany; [Bieler, Evi; Duerrenberger, Markus] Univ Basel, Swiss Nanosci Inst, Nano Imaging Lab, Basel, Switzerland; [Kassemeyer, Hanns-Heinz] State Inst Viticulture, Freiburg, Germany; [Kassemeyer, Hanns-Heinz] Univ Freiburg, Inst Biol 2, Plant Biomech Grp, Freiburg, Germany; [Arand, Katja] Bavarian State Inst Viticulture & Hort, Inst Urban Green Space & Landscaping, Veitshochheim, Germany	University of Wurzburg; University of Basel; University of Freiburg	Kassemeyer, HH (corresponding author), State Inst Viticulture, Freiburg, Germany.; Kassemeyer, HH (corresponding author), Univ Freiburg, Inst Biol 2, Plant Biomech Grp, Freiburg, Germany.	hanns-heinz.kassemeyer@wbi.bwl.de		Kassemeyer, Hanns-Heinz/0000-0001-8675-787X	European Union [1607]; State Institute for Viticulture Freiburg, Germany; University of Basel, Switzerland	European Union(European Commission); State Institute for Viticulture Freiburg, Germany; University of Basel, Switzerland	This work was partly supported by the European Union program to support crossborder cooperation INTERREG V Upper Rhine 2014-2020 (grant no. 1607) VITIFUTUR - Transnational Platform for Applied Research and Further Training in Viticulture. The institutions of the authors HHK (State Institute for Viticulture Freiburg, Germany) and EB & MD (University of Basel, Switzerland) received funding during conducting the studies for the present manuscript. There was no additional external funding received for this study.	Bargel H, 2006, FUNCT PLANT BIOL, V33, P893, DOI 10.1071/FP06139; Barthlott W, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2016.0191; Barthlott W, 1998, BOT J LINN SOC, V126, P237, DOI 10.1111/j.1095-8339.1998.tb02529.x; Barthlott W, 2017, NANO-MICRO LETT, V9, DOI 10.1007/s40820-016-0125-1; Burghardt M, 2006, ANNU PLANT REV, V23, P292; Buschhaus C, 2007, ANN BOT-LONDON, V100, P1557, DOI 10.1093/aob/mcm255; Casado CG, 2001, PHYSIOL PLANTARUM, V111, P220, DOI 10.1034/j.1399-3054.2001.1110213.x; Chu WJ, 2018, J AGR FOOD CHEM, V66, P2870, DOI 10.1021/acs.jafc.7b05020; Commenil P, 1997, J EXP BOT, V48, P1599, DOI 10.1093/jexbot/48.313.1599; Coombe B. G., 2000, Australian Journal of Grape and Wine Research, V6, P131, DOI 10.1111/j.1755-0238.2000.tb00171.x; COOMBE BG, 1992, AM J ENOL VITICULT, V43, P101; Fich EA, 2016, ANNU REV PLANT BIOL, V67, P207, DOI 10.1146/annurev-arplant-043015-111929; Gabler FM, 2003, PHYTOPATHOLOGY, V93, P1263, DOI 10.1094/PHYTO.2003.93.10.1263; Gee CT, 2008, PLANT DIS, V92, P1067, DOI 10.1094/PDIS-92-7-1067; Holloway P. J., 1982, The plant cuticle, P45; Jetter R, 2016, PLANT PHYSIOL, V170, P921, DOI 10.1104/pp.15.01699; Khanal BP, 2017, J EXP BOT, V68, P5351, DOI 10.1093/jxb/erx265; Khanal BP, 2013, NEW PHYTOL, V200, P134, DOI 10.1111/nph.12355; Koch K, 2004, J EXP BOT, V55, P711, DOI 10.1093/jxb/erh077; Koch K, 2008, MICRON, V39, P759, DOI 10.1016/j.micron.2007.11.010; Koch K, 2009, PHILOS T R SOC A, V367, P1487, DOI 10.1098/rsta.2009.0022; Lara I, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00770; Leide J, 2007, PLANT PHYSIOL, V144, P1667, DOI 10.1104/pp.107.099481; MAROIS JJ, 1986, AM J ENOL VITICULT, V37, P293; Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400; Orban N, 2009, INT J FOOD SCI TECH, V44, P869, DOI 10.1111/j.1365-2621.2008.01902.x; Pensec F, 2014, J AGR FOOD CHEM, V62, P7998, DOI 10.1021/jf502033s; PERCIVAL DC, 1993, VITIS, V32, P87; Peschel S, 2007, PHYTOCHEMISTRY, V68, P1017, DOI 10.1016/j.phytochem.2007.01.008; POSSINGHAM JV, 1967, AUST J BIOL SCI, V20, P1149, DOI 10.1071/BI9671149; RADLER F, 1965, AUST J CHEM, V18, P1059, DOI 10.1071/CH9651059; RADLER F., 1965, AMER J ENOL VITICULT, V16, P159; RADLER F, 1965, AUST J BIOL SCI, V18, P1045, DOI 10.1071/BI9651045; Schuster AC, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw027; Shin KH, 2010, HORTIC ENVIRON BIOTE, V51, P253; Staiger S, 2019, PEST MANAG SCI, V75, P3405, DOI 10.1002/ps.5589; Szakiel A, 2012, J AGR FOOD CHEM, V60, P11839, DOI 10.1021/jf3046895; Tang Y, 2017, J PHYTOPATHOL, V165, P313, DOI 10.1111/jph.12564; Taylor P, 2011, CURR OPIN COLLOID IN, V16, P326, DOI 10.1016/j.cocis.2010.12.003; Tsubaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075275; Vogg G, 2004, J EXP BOT, V55, P1401, DOI 10.1093/jxb/erh149; Weber E, 1994, CODIERUNG BESCHREIBU, V49, P66; YAMAMURA H, 1983, J JPN SOC HORTIC SCI, V52, P266, DOI 10.2503/jjshs.52.266	43	9	9	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246693	10.1371/journal.pone.0246693	http://dx.doi.org/10.1371/journal.pone.0246693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606728	gold, Green Published			2022-12-26	WOS:000620629200097
J	Harrod, VL; Groves, RL; Maurice, MA; Barak, JD				Harrod, Victoria L.; Groves, Russell L.; Maurice, Matthew A.; Barak, Jeri D.			Frankliniella occidentalis facilitate Salmonella enterica survival in the phyllosphere	PLOS ONE			English	Article								The human enteric bacterial pathogen Salmonella enterica causes approximately 1.35 million cases of food borne illnesses annually in the United States. Of these salmonellosis cases, almost half are derived from the consumption of fresh, raw produce. Although epiphytic S. enterica populations naturally decline in the phyllosphere, a subset of phytophagous insects have recently been identified as biological multipliers, consequently facilitating the growth of bacterial populations. We investigated whether tomato leaves with macroscopic feeding damage, caused by infestation of adult Western flower thrips (Frankliniella occidentalis), support higher S. enterica populations. To explore this hypothesis, we assessed S. enterica populations in response to thrips feeding by varying insect density, plant age, and the gender of the insect. As a reference control, direct leaf damage analogous to thrips feeding was also evaluated using directed, hydraulic pressure. In a supplementary set series of experiments, groups of F. occidentalis infested tomato plants were later inoculated with S. enterica to determine how prior insect infestation might influence bacterial survival and persistence. Following an infestation period, leaves visibly damaged by adult F. occidentalis supported significantly higher S. enterica populations and resulted in greater amounts of electrolyte leakage (measured as electrical conductivity) than leaves lacking visible feeding damage. Plant age did not significantly influence S. enterica populations or estimates of electrolyte leakage, independent of initial infestation. Additionally, the gender of the insect did not uniquely influence S. enterica population dynamics. Finally, applications of aggressive water bombardment resulted in more electrolyte leakage than leaves damaged by F. occidentalis, yet supported comparable S. enterica populations. Together, this study indicates that F. occidentalis feeding is one of the many potential biological mechanisms creating a more habitable environment for S. enterica.	[Harrod, Victoria L.; Groves, Russell L.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Maurice, Matthew A.; Barak, Jeri D.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Barak, JD (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	jeri.barak@wisc.edu		Barak, Jeri/0000-0002-8751-9563	USDA-NIFA [2016-67017-24422]; Food Research Institute at the University of Wisconsin-Madison	USDA-NIFA(United States Department of Agriculture (USDA)); Food Research Institute at the University of Wisconsin-Madison	Funding was provided by USDA-NIFA 2016-67017-24422 to JDB and RLG and the Food Research Institute at the University of Wisconsin-Madison to JDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2008, PLANT CELL PHYSIOL, V49, P68, DOI 10.1093/pcp/pcm168; Agarie S, 1995, J FAC AGR KYUSHU U, V40, P233; Bajji M, 2002, PLANT GROWTH REGUL, V36, P61, DOI 10.1023/A:1014732714549; BAKER CJ, 1994, PLANT CELL TISS ORG, V39, P7, DOI 10.1007/BF00037585; Barak JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001657; Barak JD, 2011, APPL ENVIRON MICROB, V77, P498, DOI 10.1128/AEM.01661-10; Beuchat LR, 2006, BRIT FOOD J, V108, P38, DOI 10.1108/00070700610637625; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Boege K, 2007, ECOL LETT, V10, P177, DOI 10.1111/j.1461-0248.2006.01012.x; Burch AY, 2014, ENVIRON MICROBIOL, V16, P2086, DOI 10.1111/1462-2920.12437; Chatzivassiliou EK, 1999, PLANT PATHOL, V48, P700, DOI 10.1046/j.1365-3059.1999.00414.x; CHISHOLM IF, 1984, B ENTOMOL RES, V74, P663, DOI 10.1017/S0007485300014048; Cowles KN, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01987; Demidchik V, 2014, J EXP BOT, V65, P1259, DOI 10.1093/jxb/eru004; Garcia F, 2012, J MED ENTOMOL, V49, P1481, DOI 10.1603/ME12007; HALBERT SE, 1992, ANN APPL BIOL, V121, P105, DOI 10.1111/j.1744-7348.1992.tb03991.x; Haley BJ, 2009, APPL ENVIRON MICROB, V75, P1248, DOI 10.1128/AEM.01648-08; HEMING BS, 1978, J MORPHOL, V156, P1, DOI 10.1002/jmor.1051560102; HIRAO J, 1978, APPL ENTOMOL ZOOL, V13, P264, DOI 10.1303/aez.13.264; Kallenbach M, 2012, P NATL ACAD SCI USA, V109, pE1548, DOI 10.1073/pnas.1200363109; Kawazu K, 2012, ARTHROPOD-PLANT INTE, V6, P221, DOI 10.1007/s11829-011-9174-z; Kessens R, 2018, PLANT DIRECT, V2, DOI 10.1002/pld3.81; KOPANIC RJ, 1994, J FOOD PROTECT, V57, P125, DOI 10.4315/0362-028X-57.2.125; Kwan G, 2015, APPL ENVIRON MICROB, V81, P861, DOI 10.1128/AEM.02985-14; Leimu R, 2006, OIKOS, V112, P1, DOI 10.1111/j.0030-1299.2006.41023.x; Lewis T., 1973, THRIPS THEIR BIOL EC; Mahon BE, 1997, J INFECT DIS, V175, P876, DOI 10.1086/513985; Nyeleti C, 2004, J APPL MICROBIOL, V97, P617, DOI 10.1111/j.1365-2672.2004.02335.x; Ogada PA, 2015, J PLANT DIS PROTECT, V122, P264, DOI 10.1007/BF03356562; Potnis N, 2015, APPL ENVIRON MICROB, V81, P8126, DOI 10.1128/AEM.01926-15; RODRIGUEZ CM, 1993, PLANT DIS, V77, P55, DOI 10.1094/PD-77-0055; Soto-Arias JP, 2014, APPL ENVIRON MICROB, V80, P5447, DOI 10.1128/AEM.01444-14; Soto-Arias JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079404; Stenberg JA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00663; van de Wetering F, 1998, ENTOMOL EXP APPL, V88, P9, DOI 10.1046/j.1570-7458.1998.00340.x; van de Wetering F, 1999, ENTOMOL EXP APPL, V93, P105, DOI 10.1046/j.1570-7458.1999.00567.x; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Zheng J, 2013, APPL ENVIRON MICROB, V79, P2494, DOI 10.1128/AEM.03704-12	38	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247325	10.1371/journal.pone.0247325	http://dx.doi.org/10.1371/journal.pone.0247325			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606799	gold, Green Published			2022-12-26	WOS:000620629200051
J	Loureiro, CL; Jaspe, RC; Angelo, PD; Zambrano, JL; Rodriguez, L; Alarcon, V; Delgado, M; Aguilar, M; Garzaro, D; Rangel, HR; Pujol, FH				Loureiro, Carmen L.; Jaspe, Rossana C.; Angelo, Pierina D.; Zambrano, Jose L.; Rodriguez, Lieska; Alarcon, Victor; Delgado, Mariangel; Aguilar, Marwan; Garzaro, Domingo; Rangel, Hector R.; Pujol, Flor H.			SARS-CoV-2 genetic diversity in Venezuela: Predominance of D614G variants and analysis of one outbreak	PLOS ONE			English	Article								SARS-CoV-2 is the new coronavirus responsible for COVID-19 disease. The first two cases of COVID-19 were detected in Venezuela on March 13, 2020. The aim of this study was the genetic characterization of Venezuelan SARS-CoV-2 isolates. A total of 7 full SARS-CoV-2 genome sequences were obtained by Sanger sequencing, from patients of different regions of Venezuela, mainly from the beginning of the epidemic. Ten out of 11 isolates (6 complete genomes and 4 partial spike genomic regions) belonged to lineage B, bearing the D614G mutation in the Spike protein. Isolates from the first outbreak that occurred in the Margarita Island harbored an in-frame deletion in its sequence, without amino acids 83-85 of the NSP1 of the ORF1. The search for deletions in 48,635 sequences showed that the NSP1 gene exhibit the highest frequency of deletions along the whole genome. Structural analysis suggests a change in the N-terminal domain with the presence of this deletion. In contrast, isolates circulating later in this island lacked the deletion, suggesting new introductions to the island after this first outbreak. In conclusion, a high diversity of SARS-CoV-2 isolates were found circulating in Venezuela, with predominance of the D614G mutation. The first small outbreak in Margarita Island seemed to be associated with a strain carrying a small deletion in the NSP1 protein, but these isolates do not seem to be responsible for the larger outbreak which started in July.	[Loureiro, Carmen L.; Jaspe, Rossana C.; Garzaro, Domingo; Rangel, Hector R.; Pujol, Flor H.] Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Lab Virol Mol, Caracas, Miranda, Venezuela; [Angelo, Pierina D.; Rodriguez, Lieska; Alarcon, Victor; Aguilar, Marwan] Inst Nacl Higiene Rafael Rangel, Caracas, Miranda, Venezuela; [Zambrano, Jose L.] Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Lab Biol Virus, Caracas, Miranda, Venezuela; [Delgado, Mariangel] Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Unidad Unidad Microscopia Elect & Confocal, Caracas, Miranda, Venezuela	Venezuelan Institute Science Research; Venezuelan Institute Science Research; Venezuelan Institute Science Research	Pujol, FH (corresponding author), Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Lab Virol Mol, Caracas, Miranda, Venezuela.	fhpujol@gmail.com	Aguilar Mejia, Marwan Said/GRY-6410-2022; Rangel, Hector R/E-5575-2010	Aguilar Mejia, Marwan Said/0000-0002-7100-3941; Rangel, Hector R/0000-0001-5937-9690; Zambrano-Rouvier, Jose Luis/0000-0001-9884-2940	Ministerio del Poder Popular de Ciencia, Tecnologia e Innovacion of Venezuela	Ministerio del Poder Popular de Ciencia, Tecnologia e Innovacion of Venezuela	This study was supported by Ministerio del Poder Popular de Ciencia, Tecnologia e Innovacion of Venezuela.	[Anonymous], CORONAVIRUS DIS COVI; [Anonymous], JOSHQUICK ARTIC NCOV; Benedetti F, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02507-5; Castillo AE, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.562615; Denison MR, 2011, RNA BIOL, V8, P270, DOI 10.4161/rna.8.2.15013; Di Giorgio S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb5813; Franco-Munoz C, 2020, INFECT GENET EVOL, V85, DOI 10.1016/j.meegid.2020.104557; Grubaugh ND, 2020, CELL, V182, P794, DOI 10.1016/j.cell.2020.06.040; Islam MR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70812-6; Jimenez-Guardeno JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005215; Johnson MC, 2020, J VIROL, V94, DOI 10.1128/JVI.01062-20; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Koyama T, 2020, B WORLD HEALTH ORGAN, V98, P495, DOI 10.2471/BLT.20.253591; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lokugamage KG, 2012, J VIROL, V86, P13598, DOI 10.1128/JVI.01958-12; Menachery VD, 2017, CURR OPIN VIROL, V23, P1, DOI 10.1016/j.coviro.2017.01.002; Mercatelli D, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01800; Ortega JT, 2020, INTERVIROLOGY, V63, P2, DOI 10.1159/000512141; Pachetti M, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02344-6; Peck KM, 2015, ANNU REV VIROL, V2, P95, DOI 10.1146/annurev-virology-100114-055029; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Schubert K, 2020, NAT STRUCT MOL BIOL, V27, P959, DOI 10.1038/s41594-020-0511-8; Simmonds P, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00408-20; Su YCF, 2020, MBIO, V11, DOI 10.1128/mBio.01610-20; Thoms M, 2020, SCIENCE, V369, P1249, DOI 10.1126/science.abc8665; Phan T, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104260; Ugurel OM, 2020, TURK J BIOL, V44, P157, DOI 10.3906/biy-2005-111; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Xavier J, 2020, EMERG MICROBES INFEC, V9, P1824, DOI 10.1080/22221751.2020.1803146; Young BE, 2020, LANCET, V396, P603, DOI 10.1016/S0140-6736(20)31757-8	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247196	10.1371/journal.pone.0247196	http://dx.doi.org/10.1371/journal.pone.0247196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606828	gold, Green Published			2022-12-26	WOS:000620629200033
J	Turgu, B; Zhang, F; El-Naggar, A; Negri, GL; Kogler, M; Tortola, L; Johnson, F; Ng, T; Li, A; Yapp, D; Lockwood, W; Martinez, D; Maris, JM; Daugaard, M; Penninger, JM; Hughes, CS; Sorensen, PH				Turgu, Busra; Zhang, Fan; El-Naggar, Amal; Negri, Gian Luca; Kogler, Melanie; Tortola, Luigi; Johnson, Fraser; Ng, Tony; Li, Amy; Yapp, Donald; Lockwood, William; Martinez, Daniel; Maris, John M.; Daugaard, Mads; Penninger, Josef M.; Hughes, Christopher S.; Sorensen, Poul H.			HACE1 blocks HIF1 alpha accumulation under hypoxia in a RAC1 dependent manner	ONCOGENE			English	Article								Uncovering the mechanisms that underpin how tumor cells adapt to microenvironmental stress is essential to better understand cancer progression. The HACE1 (HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase) gene is a tumor suppressor that inhibits the growth, invasive capacity, and metastasis of cancer cells. However, the direct regulatory pathways whereby HACE1 confers this tumor-suppressive effect remain to be fully elucidated. In this report, we establish a link between HACE1 and the major stress factor, hypoxia-inducible factor 1 alpha (HIF1 alpha). We find that HACE1 blocks the accumulation of HIF1 alpha during cellular hypoxia through decreased protein stability. This property is dependent on HACE1 E3 ligase activity and loss of Ras-related C3 botulinum toxin substrate 1 (RAC1), an established target of HACE1 mediated ubiquitinylation and degradation. In vivo, genetic deletion of Rac1 reversed the increased HIF1 alpha expression observed in Hace1(-/-) mice in murine KRas(G12D)-driven lung tumors. An inverse relationship was observed between HACE1 and HIF1 alpha levels in tumors compared to patient-matched normal kidney tissues, highlighting the potential pathophysiological significance of our findings. Together, our data uncover a previously unrecognized function for the HACE1 tumor suppressor in blocking HIF1 alpha accumulation under hypoxia in a RAC1-dependent manner.	[Turgu, Busra; El-Naggar, Amal; Johnson, Fraser; Li, Amy; Hughes, Christopher S.; Sorensen, Poul H.] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC, Canada; [Turgu, Busra] Univ British Columbia, Interdisciplinary Oncol Grad Program, Fac Med, Vancouver, BC, Canada; [Zhang, Fan; Daugaard, Mads] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC, Canada; [El-Naggar, Amal; Ng, Tony; Lockwood, William; Sorensen, Poul H.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [El-Naggar, Amal] Menoufia Univ, Dept Pathol, Fac Med, Shibin Al Kawm, Egypt; [Negri, Gian Luca] Canadas Michael Smith Genome Sci Ctr, BC Canc, Vancouver, BC, Canada; [Kogler, Melanie; Tortola, Luigi; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, Vienna, Austria; [Tortola, Luigi] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Zurich, Switzerland; [Yapp, Donald] British Columbia Canc Res Ctr, Dept Expt Therapeut, Vancouver, BC, Canada; [Lockwood, William] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC, Canada; [Martinez, Daniel] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA; [Maris, John M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Maris, John M.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Penninger, Josef M.] Univ British Columbia, Life Sci Inst, Dept Med Genet, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia; Egyptian Knowledge Bank (EKB); Menofia University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Swiss Federal Institutes of Technology Domain; ETH Zurich; British Columbia Cancer Agency; British Columbia Cancer Agency; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of British Columbia	Sorensen, PH (corresponding author), British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC, Canada.; Sorensen, PH (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.	psor@mail.ubc.ca	Penninger, Josef M/I-6860-2013; EL-Naggar, Amal/AAE-5565-2022; Daugaard, Mads/Y-6483-2018	Penninger, Josef M/0000-0002-8194-3777; EL-Naggar, Amal/0000-0002-3202-6171; Daugaard, Mads/0000-0001-8383-055X; Negri, Gian Luca/0000-0001-7722-8888; Tortola, Luigi/0000-0002-8480-2080; Turgu, Busra/0000-0002-0207-1115	Canada Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research; CIHR Foundation [FDN-143280]; British Columbia Cancer Foundation; IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; European Research Council (ERC) Advanced Grant; Era of Hope Innovator award; Canada 150 Grant; Swiss National Science Foundation [PBEZP3_145993]; Canadian Institutes of Health Research (CIHR) [377771]	Canada Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR Foundation(Canadian Institutes of Health Research (CIHR)); British Columbia Cancer Foundation; IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; European Research Council (ERC) Advanced Grant(European Research Council (ERC)); Era of Hope Innovator award; Canada 150 Grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The authors thank Joan Mathers, Michelle Pollard and Dr Karl Mechtler for helpful discussions; Dr Michael Ohh (University of Toronto) for providing the VHL-null RCC4 cell line; Dr. Thilo Hagen (National University of Singapore) for mutant HIF1 alpha plasmids; and Dr. Peggy Olive (British Columbia Cancer Research Center) for HRE-GFP plasmids. FZ was supported by fellowships from the Canada Institutes of Health Research (CIHR) and the Michael Smith Foundation for Health Research. This work is supported in part by a grant to PHS from CIHR Foundation [Grant#: FDN-143280], and by the British Columbia Cancer Foundation through generous donations from Team Finn and other riders in the Ride to Conquer Cancer. JMP is supported by grants from IMBA, the Austrian Ministry of Sciences, the Austrian Academy of Sciences, a European Research Council (ERC) Advanced Grant, an Era of Hope Innovator award, and a Canada 150 Grant. LT is supported by the Swiss National Science Foundation [Grant#: PBEZP3_145993]. MD is supported by the Canadian Institutes of Health Research (CIHR) [Grant#: 377771].	Acosta MI, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19471-2; Anglesio MS, 2004, HUM MOL GENET, V13, P2061, DOI 10.1093/hmg/ddh215; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Bouzelfen A, 2017, LEUKEMIA RES, V60, P53, DOI 10.1016/j.leukres.2017.06.006; Cardama GA, 2017, INT J ONCOL, V51, P1025, DOI 10.3892/ijo.2017.4093; Castillo-Lluva S, 2013, ONCOGENE, V32, P1735, DOI 10.1038/onc.2012.189; Chen HY, 2013, EMBO MOL MED, V5, P723, DOI 10.1002/emmm.201202140; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Daugaard M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3180; Day GJ, 1998, MOL CELL BIOL, V18, P7444, DOI 10.1128/MCB.18.12.7444; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Diebold I, 2010, ANTIOXID REDOX SIGN, V13, P399, DOI 10.1089/ars.2009.3013; Du J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025213, 10.1371/journal.pone.0026204]; Duran RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257; El-Naggar AM, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1276-4; El-Naggar AM, 2015, CANCER CELL, V27, P682, DOI 10.1016/j.ccell.2015.04.003; Fernandez CV, 2001, CANCER GENET CYTOGEN, V129, P165, DOI 10.1016/S0165-4608(01)00445-9; Goka ET, 2015, ONCOGENE, V34, P5395, DOI 10.1038/onc.2014.468; Gonzalez N, 2017, CELL SIGNAL, V30, P154, DOI 10.1016/j.cellsig.2016.12.002; Hibi K, 2008, ANTICANCER RES, V28, P1581; Hirota K, 2001, J BIOL CHEM, V276, P21166, DOI 10.1074/jbc.M100677200; Huang YL, 2010, BLOOD, V115, P1226, DOI 10.1182/blood-2009-05-221275; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Kaluz S, 2008, J CELL BIOCHEM, V104, P536, DOI 10.1002/jcb.21644; Karakashev SV, 2015, CANCER MANAG RES, V7, P253, DOI 10.2147/CMAR.S58285; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Kim I, 2019, ONCOGENE, V38, P3651, DOI 10.1038/s41388-019-0676-y; Kimbro KS, 2006, ENDOCR-RELAT CANCER, V13, P739, DOI 10.1677/erc.1.00728; Kogler M, 2020, CANCER RES, V80, P3009, DOI 10.1158/0008-5472.CAN-19-2270; Kohn KW, 2004, MOL BIOL CELL, V15, P3042, DOI 10.1091/mbc.e03-12-0897; Lawson CD, 2018, J CELL BIOL, V217, P447, DOI 10.1083/jcb.201612069; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Maldonado MD, 2018, CANCER RES, V78, P3101, DOI 10.1158/0008-5472.CAN-18-0619; Masson N, 2003, J CELL SCI, V116, P3041, DOI 10.1242/jcs.00655; Mettouchi Amel, 2012, Small GTPases, V3, P102, DOI 10.4161/sgtp.19221; Moroz E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005077; Ohh M, 2006, NEOPLASIA, V8, P623, DOI 10.1593/neo.06442; Onesto C, 2008, METHOD ENZYMOL, V439, P111, DOI 10.1016/S0076-6879(07)00409-0; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Qutub AA, 2006, J CELL SCI, V119, P3467, DOI 10.1242/jcs.03087; Rohwer N, 2009, BRIT J CANCER, V100, P772, DOI 10.1038/sj.bjc.6604919; Rosenblatt AE, 2011, ENDOCR-RELAT CANCER, V18, P207, DOI 10.1677/ERC-10-0049; Rundqvist H, 2010, CURR TOP MICROBIOL, V345, P121, DOI 10.1007/82_2010_77; Sakata M, 2009, ANTICANCER RES, V29, P2231; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shuin T, 2006, JPN J CLIN ONCOL, V36, P337, DOI 10.1093/jjco/hyl052; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Slade I, 2010, J MED GENET, V47, P342, DOI 10.1136/jmg.2009.072983; Stewenius Y, 2008, GENE CHROMOSOME CANC, V47, P845, DOI 10.1002/gcc.20587; Sufan RI, 2006, NEOPLASIA, V8, P956, DOI 10.1593/neo.06520; Thelander EF, 2008, LEUKEMIA LYMPHOMA, V49, P477, DOI 10.1080/10428190701817282; Torrino S, 2011, DEV CELL, V21, P959, DOI 10.1016/j.devcel.2011.08.015; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; Van Welden S, 2017, NAT REV GASTRO HEPAT, V14, P596, DOI 10.1038/nrgastro.2017.101; Wang YY, 2019, CELL MOL BIOL LETT, V24, DOI 10.1186/s11658-019-0180-y; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wigerup C, 2016, PHARMACOL THERAPEUT, V164, P152, DOI 10.1016/j.pharmthera.2016.04.009; Yu ZJ, 2019, ONCOL LETT, V17, P4361, DOI 10.3892/ol.2019.10139; Zhang L, 2007, NAT MED, V13, P1060, DOI 10.1038/nm1621; Zhong H, 2004, CANCER DETECT PREV, V28, P88, DOI 10.1016/j.cdp.2003.12.009	63	1	1	4	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2021	40	11					1988	2001		10.1038/s41388-021-01680-1	http://dx.doi.org/10.1038/s41388-021-01680-1		FEB 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QZ5PE	33603169	hybrid, Green Published			2022-12-26	WOS:000619433100001
J	Kaplin, A; Junker, C; Kumar, A; Ribeiro, MA; Yu, E; Wang, M; Smith, T; Rai, SN; Bhatnagar, A				Kaplin, Adam; Junker, Caesar; Kumar, Anupama; Ribeiro, Mary Anne; Yu, Eileen; Wang, Michael; Smith, Ted; Rai, Shesh N.; Bhatnagar, Aruni			Evidence and magnitude of the effects of meteorological changes on SARS-CoV-2 transmission	PLOS ONE			English	Article							COVID-19; TEMPERATURE; HUMIDITY; DYNAMICS; LEVEL	Importance Intensity and duration of the COVID-19 pandemic, and planning required to balance concerns of saving lives and avoiding economic collapse, could depend significantly on whether SARS-CoV-2 transmission is sensitive to seasonal changes. Objective Hypothesis is that increasing temperature results in reduced SARS CoV-2 transmission and may help slow the increase of cases over time. Setting Fifty representative Northern Hemisphere countries meeting specific criteria had sufficient COVID-19 case and meteorological data for analysis. Methods Regression was used to find the relationship between the log of number of COVID-19 cases and temperature over time in 50 representative countries. To summarize the day-day variability, and reduce dimensionality, we selected a robust measure, Coefficient of Time (CT), for each location. The resulting regression coefficients were then used in a multivariable regression against meteorological, country-level and demographic covariates. Results Median minimum daily temperature showed the strongest correlation with the reciprocal of CT (which can be considered as a rate associated with doubling time) for confirmed cases (adjusted R-2 = 0.610, p = 1.45E-06). A similar correlation was found using median daily dewpoint, which was highly colinear with temperature, and therefore was not used in the analysis. The correlation between minimum median temperature and the rate of increase of the log of confirmed cases was 47% and 45% greater than for cases of death and recovered cases of COVID-19, respectively. This suggests the primary influence of temperature is on SARS-CoV-2 transmission more than COVID-19 morbidity. Based on the correlation between temperature and the rate of increase in COVID-19, it can be estimated that, between the range of 30 to 100 degrees Fahrenheit, a one degree increase is associated with a 1% decrease-and a one degree decrease could be associated with a 3.7% increase-in the rate of increase of the log of daily confirmed cases. This model of the effect of decreasing temperatures can only be verified over time as the pandemic proceeds through colder months. Conclusions The results suggest that boreal summer months are associated with slower rates of COVID-19 transmission, consistent with the behavior of a seasonal respiratory virus. Knowledge of COVID-19 seasonality could prove useful in local planning for phased reductions social interventions and help to prepare for the timing of possible pandemic resurgence during cooler months.	[Kaplin, Adam; Kumar, Anupama; Yu, Eileen; Wang, Michael] Johns Hopkins Univ, Dept Psychiat, SOM, Baltimore, MD 21218 USA; [Kaplin, Adam; Kumar, Anupama; Yu, Eileen; Wang, Michael] Johns Hopkins Univ, Dept Neurol, SOM, Baltimore, MD 21218 USA; [Junker, Caesar] Pentagon, Joint Artificial Intelligence Ctr, Washington, DC USA; [Ribeiro, Mary Anne] PUPA, Sao Paulo, Brazil; [Yu, Eileen] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Smith, Ted; Rai, Shesh N.; Bhatnagar, Aruni] Univ Louisville, Sch Med, Christina Lee Brown Envirome Inst, Louisville, KY 40292 USA; [Rai, Shesh N.] Univ Louisville, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [Kaplin, Adam] MyMD Pharmaceut Inc, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Case Western Reserve University; University of Louisville; University of Louisville	Kaplin, A (corresponding author), Johns Hopkins Univ, Dept Psychiat, SOM, Baltimore, MD 21218 USA.; Kaplin, A (corresponding author), Johns Hopkins Univ, Dept Neurol, SOM, Baltimore, MD 21218 USA.; Kaplin, A (corresponding author), MyMD Pharmaceut Inc, Baltimore, MD 21205 USA.	aikaplin@mymd.com	Smith, Ted/GQQ-7242-2022	Rai, Shesh/0000-0002-8377-353X; Kaplin, Adam/0000-0002-5196-7647; junker, caesar/0000-0002-5037-9026				Alexopoulos EC, 2010, HIPPOKRATIA, V14, P23; Astuti I, 2020, DIABETES METAB SYND, V14, P407, DOI 10.1016/j.dsx.2020.04.020; Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI [10.1016/S2666-5247(20)30003-3, 10.1016/S2666-5247(20)30095-1]; Demongeot J, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9050094; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Eggo RM, 2016, P NATL ACAD SCI USA, V113, P2194, DOI 10.1073/pnas.1518677113; Freedman D.A., 1999, INT ENCY SOCIAL BEHA, V6, P4027; GraphPad, GRAPHPAD PRISM VERS; HOLM S, 1979, SCAND J STAT, V6, P65; ISAAC STONE FISH MKS, 2020, LEAK CHIN VIR DAT CO; Kanzawa M, 2020, J INFECT DIS, V222, P719, DOI 10.1093/infdis/jiaa345; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Krantz SG, 2020, INFECT CONT HOSP EP, V41, P857, DOI 10.1017/ice.2020.116; Lau H, 2021, PULMONOLOGY, V27, P110, DOI 10.1016/j.pulmoe.2020.05.015; Liu Y, 2020, J INFECTION, V81, pE62, DOI 10.1016/j.jinf.2020.04.032; Lurie MN, 2020, J INFECT DIS, V222, P1758, DOI 10.1093/infdis/jiaa506; Mai He MD, 2020, MEDRXIV; Mandal CC, 2020, PUBLIC HEALTH, V185, P72, DOI 10.1016/j.puhe.2020.05.065; Moriyama M, 2020, ANNU REV VIROL, V7, P83, DOI 10.1146/annurev-virology-012420-022445; Muniz-Rodriguez K, 2020, EMERG INFECT DIS, V26, P1912, DOI 10.3201/eid2608.200219; Nechepurenko I., 2020, MIGR RUSS VIR MEANS; Poduri R, 2020, CELL SIGNAL, V74, DOI 10.1016/j.cellsig.2020.109721; Qi HC, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138778; Ray S, 2015, DEV ENVIRON MODEL, V27, P289, DOI 10.1016/B978-0-444-63536-5.00013-2; Sajadi MM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11834; Service NW, 2020, DEW POINT VS HUM; Shi P, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138890; StatPlus, STATPLUS MAC ANALYST; Ujiie M, 2020, INT J INFECT DIS, V95, P301, DOI 10.1016/j.ijid.2020.04.068; wolfinger russell d, 2011, MULTIPLE COMP MULTIP, VSecond Edition; Wu Y, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.139051; Xie JG, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138201; Yao Y, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00517-2020	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246167	10.1371/journal.pone.0246167	http://dx.doi.org/10.1371/journal.pone.0246167			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596214	Green Published, gold			2022-12-26	WOS:000620633200064
J	Tran, DMT; Lekhak, N; Gutierrez, K; Moonie, S				Tran, Dieu-My T.; Lekhak, Nirmala; Gutierrez, Karen; Moonie, Sheniz			Risk factors associated with cardiovascular disease among adult Nevadans	PLOS ONE			English	Article							BODY-MASS INDEX; AMERICAN-COLLEGE; BLOOD-PRESSURE; HEART-DISEASE; TASK-FORCE; GUIDELINE; STROKE	Objective Cardiovascular disease (CVD) remains the number one cause of death in the US and Nevada is ranked 11th highest for CVD mortality. The study sought to examine the association between self-reported risk factors and CVD presence among adult Nevadans, between years 2011 and 2017. Methods This is a cross-sectional, population-based study that utilized the 2011 and 2017 Nevada Behavioral Risk Factor Surveillance System data. Data were analyzed between 2019 and 2020. Results A total of 5,493 and 3,764 subjects in 2011 and 2017, respectively were included. BMI (overweight/obesity) remained the most prevalent CVD risk factor. The second most common CVD risk factor was high cholesterol, followed by hypertension. Compared to females, males were 1.64 times more likely to have reported CVD in 2011, which increased to 1.92 in 2017. Compared to non-smokers, everyday smokers were 1.96 times more likely in 2011 and 3.62 times more likely in 2017. Individuals with high cholesterol status were 2.67 times more likely to have reported CVD compared to those with normal levels in 2011. In 2011, individuals with hypertension were 3.74 times more likely to have reported CVD compared to those who did not have hypertension. This relationship increased its magnitude of risk to 6.18 times more likely in 2017. In 2011, individuals with diabetes were 2.90 times more likely to have reported CVD compared to those without the condition. Conclusions Public health and healthcare providers need to target preventable cardiovascular risk factors and develop recommendations and strategies locally, nationally, and globally.	[Tran, Dieu-My T.; Lekhak, Nirmala] Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA; [Gutierrez, Karen; Moonie, Sheniz] Univ Nevada, Sch Publ Hlth, Las Vegas, NV USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Tran, DMT (corresponding author), Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA.	Dieu-my.tran@unlv.edu						Andersson C, 2018, NAT REV CARDIOL, V15, P230, DOI 10.1038/nrcardio.2017.154; [Anonymous], 2020, Circulation, V141, pe33, DOI 10.1161/CIR.0000000000000746; [Anonymous], 2004, NIH PUBLICATION; Burke GM, 2017, AM J CARDIOL, V120, P1787, DOI 10.1016/j.amjcard.2017.07.087; CDC, 2019, KNOW YOUR RISK HEART; CDC, 2020, SMOK TOB US EXT TOB; Chiva-Blanch G, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010108; Dib JG, 2008, ANN SAUDI MED, V28, P22; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Lavie CJ, 2019, CIRC RES, V124, P799, DOI 10.1161/CIRCRESAHA.118.312669; Loprinzi PD, 2015, AM J PREV MED, V48, P338, DOI 10.1016/j.amepre.2014.08.019; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Parikh PB, 2014, J GEN INTERN MED, V29, P76, DOI 10.1007/s11606-013-2635-6; Park D, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008769; Piano MR, 2017, ALCOHOL RES-CURR REV, V38, P219; Schultz WM, 2018, CIRCULATION, V137, P2166, DOI 10.1161/CIRCULATIONAHA.117.029652; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Teramoto M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128424; Tran DMT, 2018, J NURS MEAS, V26, P470, DOI 10.1891/1061-3749.26.3.470; US Dept. of Health and Human Services/Centers for Disease Control & Prevention, 1984, BRFSS; Whelton Paul K, 2018, J Am Soc Hypertens, V12, DOI [10.1161/HYP.0000000000000065, 10.1016/j.jash.2018.06.010]; Williams B, 2018, BLOOD PRESSURE, V27, P314, DOI [10.1080/08037051.2018.1527177, 10.1097/HJH.0000000000001961]; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0	26	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247105	10.1371/journal.pone.0247105	http://dx.doi.org/10.1371/journal.pone.0247105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596242	Green Published, gold			2022-12-26	WOS:000620633200003
J	Hamooya, BM; Musonda, P; Mutale, W; Masenga, SK; Halwiindi, H; Mutengo, KH; Chiyenu, KOR; Chongwe, G; Koethe, JR; Lipworth, L; Heimburger, DC				Hamooya, Benson M.; Musonda, Patrick; Mutale, Wilbroad; Masenga, Sepiso K.; Halwiindi, Hikabasa; Mutengo, Katongo H.; Chiyenu, Kaseya O. R.; Chongwe, Gershom; Koethe, John R.; Lipworth, Loren; Heimburger, Douglas C.			Prevalence of low high-density lipoprotein among young adults receiving antiretroviral therapy in Zambia: An opportunity to consider non-communicable diseases in resource-limited settings	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; HDL-CHOLESTEROL; LIPID-LEVELS; RISK-FACTORS; ASSOCIATION; DYSLIPIDEMIA; AIDS; MORTALITY; PROFILE; GENDER	Background With the introduction of effective antiretroviral therapy (ART), people living with HIV (PLWH) are surviving longer and are at risk for developing metabolic abnormalities that contribute to cardiovascular disease (CVD). In Sub-Saharan Africa (SSA), there is a paucity of epidemiological data on lipid profiles among young adults receiving ART. This study aimed to estimate the prevalence of low high-density lipoprotein cholesterol (HDL-c), a cardioprotective lipid class, and whether it differed by age among adults on ART in Livingstone, Zambia. Methods From April to December 2019, we conducted a cross-sectional study of 597 PLWH [n = 58 aged 18-24 years (young adults); n = 539 aged >= 25 years (adults)] on ART for >= 6 months. Data collected included demographic and lifestyle information, anthropometrics, viral load (VL), CD4 count, blood pressure, lipid profiles and fasting/random blood glucose. Clinical measures were defined as: low HDL-c [<1.0 mmol/L for men, <1.3 for women], increased waist circumference (WC) [>= 94 cm for men, >= 80 cm for women], high triglycerides (TG) [>= 1.7 mmol/l], and virological failure (VF) [VL >= 1000 copies/mu l]. We used logistic regression to examine the association between age and low HDL-c after adjusting for multiple variables. Results Among the young adults, 60% (35/58) were women, median (25(th), 75(th) percentile) age 21 years (18, 23), and median time on ART 116 months (60, 144). Among adults, 63% (342/539) were women, median age 46 years (40, 53) and median time on ART 108 months (60, 144). Young adults had a lower CD4 count compared to adults (median, 492 vs. 568 cells/mu L, p = 0.010) and higher prevalence of VF (29% vs. 17%, p = 0.016). In young adults, prevalence of low HDL-c was significantly higher than in adults (63 vs. 38%, p<0.001). A high proportion of young adults (75%) and adults (58%) with low HDL-c were on dolutegravir (DTG)-based ART regimens. After adjusting for sex, duration on ART, WC, body mass index, ART regimen, VF, CD4 count, low density lipoprotein cholesterol, blood pressure and smoking, young adults were significantly more likely than adults to have low HDL-c (odds ratio 2.93; 95% confidence interval 1.46-5.86). Conclusion Low HDL-c is highly prevalent among young adult with HIV in SSA independent of other risk factors for metabolic derangements. Lipid abnormalities among young PLWH may contribute to the early development of cardiovascular diseases in this population. This highlights the need to consider low HDL-c in the quest to reduce CVD risk among young adults on ART in SSA.	[Hamooya, Benson M.; Musonda, Patrick; Mutale, Wilbroad; Halwiindi, Hikabasa; Chongwe, Gershom] Univ Zambia, Sch Publ Hlth, Lusaka, Zambia; [Hamooya, Benson M.; Masenga, Sepiso K.] Mulungushi Univ, Sch Med & Hlth Sci, Livingstone, Zambia; [Hamooya, Benson M.; Koethe, John R.; Heimburger, Douglas C.] Vanderbilt Inst Global Hlth, Nashville, TN 37232 USA; [Masenga, Sepiso K.] Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia; [Masenga, Sepiso K.; Koethe, John R.; Lipworth, Loren; Heimburger, Douglas C.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Mutengo, Katongo H.; Chiyenu, Kaseya O. R.] Livingstone Cent Hosp, Livingstone, Zambia; [Mutengo, Katongo H.; Chiyenu, Kaseya O. R.] Minist Hlth, Lusaka, Zambia; [Koethe, John R.; Lipworth, Loren; Heimburger, Douglas C.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Heimburger, Douglas C.] Univ Zambia, Sch Med, Lusaka, Zambia	University of Zambia; Vanderbilt University; University of Zambia; Vanderbilt University; Vanderbilt University; University of Zambia	Hamooya, BM (corresponding author), Univ Zambia, Sch Publ Hlth, Lusaka, Zambia.; Hamooya, BM (corresponding author), Mulungushi Univ, Sch Med & Hlth Sci, Livingstone, Zambia.; Hamooya, BM (corresponding author), Vanderbilt Inst Global Hlth, Nashville, TN 37232 USA.	benmalambo@gmail.com		Hamooya, Benson/0000-0003-1385-0998	Fogarty International Center of the US National Institutes of Health [D43 TW009744]	Fogarty International Center of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Research reported in this publication was supported by the Fogarty International Center of the US National Institutes of Health under Award Number D43 TW009744. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abebe Molla, 2014, BMC Res Notes, V7, P380, DOI 10.1186/1756-0500-7-380; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amberbir A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197728; Anastos K, 2007, JAIDS-J ACQ IMM DEF, V45, P34, DOI 10.1097/QAI.0b013e318042d5fe; Asiki G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126166; Asztalos BF, 2006, ATHEROSCLEROSIS, V184, P72, DOI 10.1016/j.atherosclerosis.2005.04.013; Bagella P, 2019, INFECT DRUG RESIST, V12, P1385, DOI 10.2147/IDR.S203813; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bernal E, 2008, AIDS PATIENT CARE ST, V22, P569, DOI 10.1089/apc.2007.0186; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P304, DOI 10.1097/QAI.0b013e31815e7453; CASTELLI WP, 1988, CAN J CARDIOL, V4, pA5; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Chyu KY, 2011, CURR ATHEROSCLER REP, V13, P405, DOI 10.1007/s11883-011-0189-9; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohan GR, 2000, POSTGRAD MED, V107, P141, DOI 10.3810/pgm.2000.04.986; da Cunha Joel, 2015, World J Virol, V4, P56, DOI 10.5501/wjv.v4.i2.56; Dave JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151911; Dixon P, 2020, J HEALTH ECON, V70, DOI 10.1016/j.jhealeco.2020.102300; Eren Esin, 2012, Open Biochem J, V6, P78, DOI 10.2174/1874091X01206010078; Feeney Eoin R, 2011, Open Cardiovasc Med J, V5, P49, DOI 10.2174/1874192401105010049; Ghehi C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177440; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003; Guaraldi G, 2019, J FRALITY AGING, V8, P88, DOI 10.14283/jfa.2019.6; Guira Oumar, 2016, J Int Assoc Provid AIDS Care, V15, P159, DOI 10.1177/2325957415601503; Hanley TM, 2011, J VIROL, V85, P10834, DOI 10.1128/JVI.00789-11; Hanley TM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000981; Hirigo Agete Tadewos, 2016, BMC Res Notes, V9, P145, DOI 10.1186/s13104-016-1953-2; Hou L, 2020, MOL MED, V26, DOI 10.1186/s10020-019-0133-y; Iwuala SO, 2015, NIGER J CLIN PRACT, V18, P626, DOI 10.4103/1119-3077.154208; Kagaruki GB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-904; Kotani K, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-147; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu E, 2013, CLIN INFECT DIS, V56, P1820, DOI 10.1093/cid/cit120; Liu MH, 2020, NEUROIMAGE, V208, DOI 10.1016/j.neuroimage.2019.116459; Lobo RA, 2019, CLIMACTERIC, V22, P610, DOI 10.1080/13697137.2019.1640197; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Nery MW, 2011, BRAZ J INFECT DIS, V15, P151, DOI 10.1590/S1413-86702011000200010; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Njoroge A, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0503-9; Ombeni Walter, 2016, J Int Assoc Provid AIDS Care, V15, P164, DOI 10.1177/2325957415614642; Ortblad KF, 2013, LANCET, V381, P105; Padmapriyadarsini C, 2017, INDIAN J MED RES, V145, P640, DOI 10.4103/ijmr.IJMR_1611_15; Patel P, 2018, AIDS, V32, pS5, DOI 10.1097/QAD.0000000000001888; Qiao Q, 2007, ANN CLIN BIOCHEM, V44, P232, DOI 10.1258/000456307780480963; Quercia R, 2015, CLIN DRUG INVEST, V35, P211, DOI 10.1007/s40261-014-0266-2; Rossouw JE, 2002, CARDIOVASC RES, V53, P550, DOI 10.1016/S0008-6363(01)00478-3; SCHAEFER EJ, 1994, J LIPID RES, V35, P871; Shah ASV, 2018, CIRCULATION, V138, P1100, DOI 10.1161/CIRCULATIONAHA.117.033369; Sprinz E, 2010, BRAZ J INFECT DIS, V14, P575, DOI 10.1016/S1413-8670(10)70115-X; Vos AG, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0460-z; WHO, 2012, WHO GLOB STRAT SURV; WHO, NCDS STEPWISE APPR S; WILSON PWF, 1988, ARTERIOSCLEROSIS, V8, P737, DOI 10.1161/01.ATV.8.6.737; Wohl DA, 2006, CLIN INFECT DIS, V43, P645, DOI 10.1086/507333; World Health Organization, 2020, LECHASCHI VRACH; Yu H, 2020, EXP MOL PATHOL, V116, DOI 10.1016/j.yexmp.2020.104493; Zhou DT, 2016, BIOCHEM RES INT, V2016, DOI 10.1155/2016/3204818; Zhou JM, 2018, DIABETES-METAB RES, V34, DOI 10.1002/dmrr.2949	60	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247004	10.1371/journal.pone.0247004	http://dx.doi.org/10.1371/journal.pone.0247004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592027	Green Published, gold			2022-12-26	WOS:000620632800075
J	Putcharoen, O; Wacharapluesadee, S; Chia, WN; Paitoonpong, L; Tan, CW; Suwanpimolkul, G; Jantarabenjakul, W; Ruchisrisarod, C; Wanthong, P; Sophonphan, J; Chariyavilaskul, P; Wang, LF; Hemachudha, T				Putcharoen, Opass; Wacharapluesadee, Supaporn; Chia, Wan Ni; Paitoonpong, Leilani; Tan, Chee Wah; Suwanpimolkul, Gompol; Jantarabenjakul, Watsamon; Ruchisrisarod, Chanida; Wanthong, Phanni; Sophonphan, Jiratchaya; Chariyavilaskul, Pajaree; Wang, Lin-Fa; Hemachudha, Thiravat			Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand	PLOS ONE			English	Article								Background The presence of neutralizing antibodies (NAbs) is an indicator of protective immunity for most viral infections. A newly developed surrogate viral neutralization assay (sVNT) offers the ability to detect total receptor binding domain-targeting NAbs in an isotype-independent manner, increasing the test sensitivity. Thus, specimens with low IgM/ IgG antibody levels showed strong neutralization activity in sVNT. Methods This study aimed to measure the %inhibition of NAbs measured by sVNT in PCR-confirmed COVID-19 patients. The sensitivity of sVNT for the diagnosis of SARS-CoV-2 infection and its kinetics were determined. Results Ninety-seven patients with PCR-confirmed SARS-CoV-2 infection were included in this study. Majority of the patients were 21-40 years old (67%) and 63% had mild symptoms. The sensitivity of sVNT for the diagnosis of SARS-CoV-2 infection was 99% (95% confidence interval (CI) 94.4-100%) and the specificity was 100% (95% CI 98.3-100%). The negative predictive value of sVNT from the samples collected before and after 7 days of symptom onset was 99.5% (95% CI 97.4-100%) and 100% (95% CI 93.8-100%), respectively. The level of inhibition at days 8-14 were significantly higher than days 0-7 (p<0.001). The median %inhibition values by severity of COVID-19 symptoms were 79.9% (interquartile range (IQR) 49.7-91.8%); 89.0% (IQR 71.2-92.4%); and 86.6% (IQR 69.5-92.8%), for mild, moderate and severe/critical symptoms respectively. The median level of sVNT %inhibition of severe was significantly higher than the mild group (p = 0.05). Conclusion The sVNT is a practical and robust serological test for SARS-CoV-2 infection and does not require specialized biosafety containment. It can be used clinically to aid diagnosis in both early and late infection especially in cases when the real-time RT-PCR results in weakly negative or weakly positive, and to determine the protective immune response from SARS-CoV-2 infection in patients.	[Putcharoen, Opass; Paitoonpong, Leilani; Suwanpimolkul, Gompol] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Dept Med,Fac Med, Div Infect Dis,Thai Red Cross Emerging Infect Dis, Bangkok, Thailand; [Wacharapluesadee, Supaporn; Ruchisrisarod, Chanida; Wanthong, Phanni; Hemachudha, Thiravat] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, World Hlth Org Collaborating Ctr Res & Training, Fac Med,Thai Red Cross Emerging Infect Dis Hlth S, Bangkok, Thailand; [Chia, Wan Ni; Tan, Chee Wah; Wang, Lin-Fa] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore; [Jantarabenjakul, Watsamon] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Dept Pediat,Fac Med, Div Infect Dis,Thai Red Cross Emerging Infect Dis, Bangkok, Thailand; [Sophonphan, Jiratchaya] HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand; [Chariyavilaskul, Pajaree] Chulalongkorn Univ, Fac Med, Clin Pharmacokinet & Pharmacogen Res Unit, Bangkok, Thailand; [Chariyavilaskul, Pajaree] Chulalongkorn Univ, Fac Med, Dept Pharmacol, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; National University of Singapore; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Putcharoen, O (corresponding author), Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Dept Med,Fac Med, Div Infect Dis,Thai Red Cross Emerging Infect Dis, Bangkok, Thailand.	opassid@gmail.com	wang, lili/HDL-7210-2022; wang, lin/GSE-3040-2022	Tan, Chee Wah/0000-0001-9837-1413; Putcharoen, Opass/0000-0001-8444-8512	King Chulalongkorn Memorial Hospital's Excellence Centre Program [EC-63-30101-29]; Biological Threat Reduction Program (BTRP) of the US Defense Threat Reduction Agency (DTRA) [HDTRA 1-17-C-0004]; NMRC grants [STPRG-FY19-001, COVID19RF-003]	King Chulalongkorn Memorial Hospital's Excellence Centre Program; Biological Threat Reduction Program (BTRP) of the US Defense Threat Reduction Agency (DTRA); NMRC grants	This study was supported by a research grant from the King Chulalongkorn Memorial Hospital's Excellence Centre Program (EC-63-30101-29), and the Biological Threat Reduction Program (BTRP) of the US Defense Threat Reduction Agency (DTRA) (Grant ID HDTRA 1-17-C-0004). The work at Duke-NUS is supported by NMRC grants STPRG-FY19-001 and COVID19RF-003. The sponsors have no role in the study design, data collection, analysis and preparation of the manuscript.	Addetia A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.02107-20; [Anonymous], 2020, CHEE WAH TAN WNC MI, DOI [1021203/rs3rs-24574/v1+, DOI 1021203/RS3RS-24574/V1+]; [Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; Bond K, 2020, J INFECT DIS, V222, P1280, DOI 10.1093/infdis/jiaa467; CDC, TEST COVID 19; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Deeks JJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013652; French MA, 2020, RESPIROLOGY, V25, P680, DOI 10.1111/resp.13852; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang Meei-Li, 2020, NEUTRALIZING ANTIBOD, DOI [10.1101/2020.08.13.20173161, DOI 10.1101/2020.08.13.20173161]; Petherick A, 2020, LANCET, V395, P1101, DOI 10.1016/S0140-6736(20)30788-1; Richardson S, 2020, JAMA, DOI [DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.6775]; Rijkers G MJ., 2020, J INFECT DIS, DOI [10.1093/infdis/jiaa463, DOI 10.1093/INFDIS/JIAA463]; Rijkers G, 2020, J INFECT DIS, V222, P1265, DOI 10.1093/infdis/jiaa463; Tan CW, 2020, NAT BIOTECHNOL, V38, P1073, DOI 10.1038/s41587-020-0631-z; Theel ES, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00797-20; Wang YQ, 2020, J CLIN INVEST, V130, P5235, DOI [10.1172/JCI138759., 10.1172/JCI138759]; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Wu F., 2020, MEDRXIV, DOI [10.1101/2020.03.30.20047365, 10.1101/2020.03.30.20047365v2, 10.1101/2020.03.30.20047365., DOI 10.1101/2020.03.30.20, 10.2139/ssrn.3566211]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344; Zhou GY, 2020, INT J BIOL SCI, V16, P1718, DOI 10.7150/ijbs.45123; Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6	23	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246864	10.1371/journal.pone.0246864	http://dx.doi.org/10.1371/journal.pone.0246864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577615	Green Published, gold			2022-12-26	WOS:000620071700023
J	Smith, EE; Conseil, G; Cole, SPC				Smith, Emma E.; Conseil, Gwenaelle; Cole, Susan P. C.			Conserved amino acids in the region connecting membrane spanning domain 1 to nucleotide binding domain 1 are essential for expression of the MRP1 (ABCC1) transporter	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEIN-1; SUBSTRATE-SPECIFICITY; GLUTATHIONE DISULFIDE; INCREASED SENSITIVITY; INTRACELLULAR LOOP; DRUG-RESISTANCE; MICE LACKING; SALT BRIDGE; ATP; MRP1/ABCC1	Multidrug resistance protein 1 (MRP1) (gene symbol ABCC1) is an ATP-binding cassette (ABC) transporter which effluxes xeno- and endobiotic organic anions including estradiol glucuronide and the pro-inflammatory leukotriene C-4. MRP1 also confers multidrug resistance by reducing intracellular drug accumulation through active efflux. MRP1 has three membrane spanning domains (MSD), and two nucleotide binding domains (NBD). MSD1 and MSD2 are linked to NBD1 and NBD2 by connecting regions (CR) 1 and CR2, respectively. Here we targeted four residues in CR1 (Ser(612), Arg(615), His(622), Glu(624)) for alanine substitution and unexpectedly, found that cellular levels of three mutants (S612A, R615A, E624A) in transfected HEK cells were substantially lower than wild-type MRP1. Whereas CR1-H622A properly trafficked to the plasma membrane and exhibited organic anion transport activity comparable to wild-type MRP1, the poorly expressing R615A and E624A (and to a lesser extent S612A) mutant proteins were retained intracellularly. Analyses of cryogenic electron microscopic and atomic homology models of MRP1 indicated that Arg(615) and Glu(624) might participate in bonding interactions with nearby residues to stabilize expression of the transporter. However, this was not supported by double exchange mutations E624K/K406E, R615D/D430R and R615F/F619R which failed to improve MRP1 levels. Nevertheless, these experiments revealed that the highly conserved CR1-Phe(619) and distal Lys(406) in the first cytoplasmic loop of MSD1 are also essential for expression of MRP1 protein. This study is the first to demonstrate that CR1 contains several highly conserved residues critical for plasma membrane expression of MRP1 but thus far, currently available structures and models do not provide any insights into the underlying mechanism(s). Additional structures with rigorous biochemical validation data are needed to fully understand the bonding interactions critical to stable expression of this clinically important ABC transporter.	[Smith, Emma E.; Cole, Susan P. C.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Smith, Emma E.; Conseil, Gwenaelle; Cole, Susan P. C.] Queens Univ, Div Canc Biol & Genet, Canc Res Inst, Kingston, ON, Canada	McMaster University; Queens University - Canada; Queens University - Canada	Conseil, G (corresponding author), Queens Univ, Div Canc Biol & Genet, Canc Res Inst, Kingston, ON, Canada.	conseilg@queensu.ca			Canadian Institutes of Health Research [MOP 133584]; Queen's University; Queen's University Bracken Chair in Genetics and Molecular Medicine	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Queen's University; Queen's University Bracken Chair in Genetics and Molecular Medicine	This work was funded by a grant from the Canadian Institutes of Health Research (project MOP 133584) to S.P.C.C. and supported by graduate fellowships to E.E.S. from Queen's University and by the Queen's University Bracken Chair in Genetics and Molecular Medicine to S.P.C. C.	Accardi F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/172458; Alam A, 2019, SCIENCE, V363, P753, DOI 10.1126/science.aav7102; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Cao JY, 2019, CELL REP, V26, P1544, DOI 10.1016/j.celrep.2019.01.043; Chandra S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06646-8; COLE SPC, 1994, CANCER RES, V54, P5902; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Cole SPC, 2014, J BIOL CHEM, V289, P30880, DOI 10.1074/jbc.R114.609248; Cole SPC, 2014, ANNU REV PHARMACOL, V54, P95, DOI 10.1146/annurev-pharmtox-011613-135959; Conrad S, 2002, PHARMACOGENETICS, V12, P321, DOI 10.1097/00008571-200206000-00008; Conseil G, 2009, MOL PHARMACOL, V75, P397, DOI 10.1124/mol.108.052860; Conseil G, 2019, FASEB J, V33, P10692, DOI 10.1096/fj.201900140R; Conseil G, 2013, DRUG METAB DISPOS, V41, P2187, DOI 10.1124/dmd.113.054213; Craven TW, 2016, J AM CHEM SOC, V138, P1543, DOI 10.1021/jacs.5b10285; Deeley RG, 2006, FEBS LETT, V580, P1103, DOI 10.1016/j.febslet.2005.12.036; DeGorter MK, 2008, BIOCHEM BIOPH RES CO, V365, P29, DOI 10.1016/j.bbrc.2007.10.141; Dougherty DA, 2013, ACCOUNTS CHEM RES, V46, P885, DOI 10.1021/ar300265y; Dvash E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10112; Ehrhardt A, 2016, J BIOL CHEM, V291, P1854, DOI 10.1074/jbc.M115.704809; Frezza M, 2011, CURR TOP MED CHEM, V11, P2888, DOI 10.2174/156802611798281311; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Graab P, 2019, J BIOL CHEM, V294, P7308, DOI 10.1074/jbc.RA118.007071; Haimeur A, 2004, MOL PHARMACOL, V65, P1375, DOI 10.1124/mol.65.6.1375; Haimeur A, 2002, J BIOL CHEM, V277, P41326, DOI 10.1074/jbc.M206228200; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Hipfner DR, 1998, BRIT J CANCER, V78, P1134, DOI 10.1038/bjc.1998.642; Hipfner DR, 1996, CANCER RES, V56, P3307; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; Iram SH, 2014, BBA-BIOMEMBRANES, V1838, P756, DOI 10.1016/j.bbamem.2013.11.002; Iram SH, 2012, J BIOL CHEM, V287, P7543, DOI 10.1074/jbc.M111.310409; Iram SH, 2011, J BIOL CHEM, V286, P7202, DOI 10.1074/jbc.M110.166959; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Johnson ZL, 2018, CELL, V172, P81, DOI 10.1016/j.cell.2017.12.005; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Khunweeraphong N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13302-2; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Koike K, 2004, J BIOL CHEM, V279, P12325, DOI 10.1074/jbc.M311435200; Koike K, 2002, J BIOL CHEM, V277, P49495, DOI 10.1074/jbc.M206896200; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Laselva O, 2018, MOL PHARMACOL, V93, P612, DOI 10.1124/mol.118.111799; Leier I, 1996, BIOCHEM J, V314, P433, DOI 10.1042/bj3140433; Leslie EM, 2012, J INORG BIOCHEM, V108, P141, DOI 10.1016/j.jinorgbio.2011.11.009; Leslie EM, 2003, J PHARMACOL EXP THER, V304, P643, DOI 10.1124/jpet.102.044073; Leslie EM, 2001, J BIOL CHEM, V276, P27846, DOI 10.1074/jbc.M102453200; Letourneau IJ, 2005, PHARMACOGENET GENOM, V15, P647, DOI 10.1097/01.fpc.0000173484.51807.48; Letourneau IJ, 2008, BIOCHEM PHARMACOL, V75, P1659, DOI 10.1016/j.bcp.2008.01.009; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; Loe DW, 1998, CANCER RES, V58, P5130; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Lok HC, 2016, J BIOL CHEM, V291, P27042, DOI 10.1074/jbc.M116.763714; Loo TW, 2017, BIOCHEM PHARMACOL, V136, P24, DOI 10.1016/j.bcp.2017.03.020; Loo TW, 2013, BIOCHEMISTRY-US, V52, P3194, DOI 10.1021/bi400425k; Lorendeau D, 2014, BIOCHEM PHARMACOL, V90, P235, DOI 10.1016/j.bcp.2014.05.017; Lorico A, 1997, CANCER RES, V57, P5238; Maeno K, 2009, DRUG METAB DISPOS, V37, P1411, DOI 10.1124/dmd.109.026633; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; Mueller CFH, 2005, CIRC RES, V97, P637, DOI 10.1161/01.RES.0000183734.21112.b7; Negoda A, 2018, CELL MOL LIFE SCI, V75, P3027, DOI 10.1007/s00018-018-2777-0; Neuser J, 2016, J DIABETES COMPLICAT, V30, P623, DOI 10.1016/j.jdiacomp.2016.02.002; Preston GM, 2017, BIOCHEM J, V474, P445, DOI 10.1042/BCJ20160582; Qian YM, 2001, J BIOL CHEM, V276, P6404, DOI 10.1074/jbc.M008251200; Qin L, 2008, BIOCHEMISTRY-US, V47, P13952, DOI 10.1021/bi801532g; Rappa G, 1997, CANCER RES, V57, P5232; Rasband W, IMAGEJ; RAVIV Y, 1990, J BIOL CHEM, V265, P3975; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; Robey RW, 2018, NAT REV CANCER, V18, P452, DOI 10.1038/s41568-018-0005-8; Rudashevskaya Elena L, 2014, Drug Discov Today Technol, V12, pe87, DOI 10.1016/j.ddtec.2014.03.009; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Shaw VS, 2019, MOL PHARMACOL, V96, P683, DOI 10.1124/mol.119.117176; Shukalek CB, 2016, MOL PHARMACOL, V90, P127, DOI 10.1124/mol.116.103648; Situ D, 2004, J BIOL CHEM, V279, P38871, DOI 10.1074/jbc.M403832200; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Sreekumar PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033420; Testa B, 2012, DRUG DISCOV TODAY, V17, P549, DOI 10.1016/j.drudis.2012.01.017; Tripathi SC, 2017, CANCER RES, V77, P4414, DOI 10.1158/0008-5472.CAN-16-2874; Vauthier V, 2017, BIOCHEM PHARMACOL, V136, P1, DOI 10.1016/j.bcp.2017.02.020; Verbon A, 2002, CLIN EXP IMMUNOL, V130, P32, DOI 10.1046/j.1365-2249.2002.01952.x; Weigl KE, 2018, MOL PHARMACOL, V94, P1069, DOI 10.1124/mol.118.112615; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; Yang RY, 2008, BBA-BIOMEMBRANES, V1778, P454, DOI 10.1016/j.bbamem.2007.11.010; Yang RY, 2011, BBA-BIOMEMBRANES, V1808, P1790, DOI 10.1016/j.bbamem.2011.02.004; ZAMAN GJR, 1995, P NATL ACAD SCI USA, V92, P7690, DOI 10.1073/pnas.92.17.7690; Zhang DW, 2004, BIOCHEMISTRY-US, V43, P9413, DOI 10.1021/bi0495230; Zhang W, 2016, TOXICOL SCI, V151, P44, DOI 10.1093/toxsci/kfw021	86	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246727	10.1371/journal.pone.0246727	http://dx.doi.org/10.1371/journal.pone.0246727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571281	gold, Green Published			2022-12-26	WOS:000618274000105
J	Wong, SJ; Ringel, AE; Yuan, W; Paulo, JA; Yoon, H; Currie, MA; Haigis, MC				Wong, Samantha J.; Ringel, Alison E.; Yuan, William; Paulo, Joao A.; Yoon, Haejin; Currie, Mark A.; Haigis, Marcia C.			Development of a colorimetric alpha-ketoglutarate detection assay for prolyl hydroxylase domain (PHD) proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR INHIBITING HIF; INDUCIBLE FACTOR HIF; GLUTAMATE-DEHYDROGENASE; BIOCHEMICAL-CHARACTERIZATION; ASCORBATE; 4-HYDROXYLASE; FAMILY; IDENTIFICATION; PURIFICATION; METABOLISM	Since the discovery of the prolyl hydroxylases domain (PHD) proteins and their canonical hypoxia-inducible factor (HIF) substrate two decades ago, a number of in vitro hydroxylation (IVH) assays for PHD activity have been developed to measure the PHD-HIF interaction. However, most of these assays either require complex proteomics mass spectrometry methods that rely on the specific PHD-HIF interaction or require the handling of radioactive material, as seen in the most commonly used assay measuring [C-14]O-2 release from labeled [C-14]alpha-ketoglutarate. Here, we report an alternative rapid, cost-effective assay in which the consumption of a-ketoglutarate is monitored by its derivatization with 2,4-dinitrophenylhydrazine (2,4-DNPH) followed by treatment with concentrated base. We extensively optimized this 2,4-DNPH alpha-ketoglutarate assay to maximize the signal-to-noise ratio and demonstrated that it is robust enough to obtain kinetic parameters of the well-characterized PHD2 isoform comparable with those in published literature. We further showed that it is also sensitive enough to detect and measure the IC50 values of pan-PHD inhibitors and several PHD2 inhibitors in clinical trials for chronic kidney disease (CKD)induced anemia. Given the efficiency of this assay coupled with its multiwell format, the 2,4-DNPH alpha-KG assay may be adaptable to explore non-HIF substrates of PHDs and potentially to high-throughput assays.	[Wong, Samantha J.; Ringel, Alison E.; Paulo, Joao A.; Yoon, Haejin; Currie, Mark A.; Haigis, Marcia C.] Harvard Med Sch, Blavatn Inst, Dept Cell Biol, Boston, MA 02115 USA; [Yuan, William] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Currie, Mark A.] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada; [Currie, Mark A.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Toronto; University Toronto Mississauga; University of Toronto	Haigis, MC (corresponding author), Harvard Med Sch, Blavatn Inst, Dept Cell Biol, Boston, MA 02115 USA.	marcia_haigis@hms.harvard.edu	Yoon, Haejin/ABA-5821-2021	Yoon, Haejin/0000-0002-7139-0419	Agency for Science, Technology and Research, Singapore; American Cancer Society [PF-17-13201-CCG]; National Institutes of Health (NIH)/National Institute of General Medical Sciences [R01GM132129]; American Diabetes Association Fellowship [1-17-PDF-109]; NIH [R01CA213062]; Glenn Foundation for Medical Research	Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); American Cancer Society(American Cancer Society); National Institutes of Health (NIH)/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Diabetes Association Fellowship(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research	S. J. W. is supported by the National Science Scholarship from the Agency for Science, Technology and Research, Singapore. A. E. R. is supported by a postdoctoral fellowship from the American Cancer Society (PF-17-13201-CCG). J. A. P is funded in part by National Institutes of Health (NIH)/National Institute of General Medical Sciences grant R01GM132129. H. Y. is funded by the American Diabetes Association Fellowship (1-17-PDF-109), and M. C. H. is funded by NIH grant R01CA213062 and the Glenn Foundation for Medical Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adusumilli R, 2017, METHODS MOL BIOL, V1550, P339, DOI 10.1007/978-1-4939-6747-6_23; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Briggs KJ, 2016, CELL, V166, P126, DOI 10.1016/j.cell.2016.05.042; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cao J, 2012, ORG BIOMOL CHEM, V10, P3913, DOI 10.1039/c2ob07076f; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Cho H, 2005, BIOCHEM BIOPH RES CO, V337, P275, DOI 10.1016/j.bbrc.2005.09.041; Choudhury R, 2007, FEBS LETT, V581, P2733, DOI 10.1016/j.febslet.2007.05.032; Chowdhury R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12673; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Cockmann ME, 2019, ELIFE, V8, DOI 10.7554/eLife.46490; CONSALVI V, 1994, COMP BIOCHEM PHYS B, V109, P691, DOI 10.1016/0305-0491(94)90132-5; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dao JH, 2009, ANAL BIOCHEM, V384, P213, DOI 10.1016/j.ab.2008.09.052; DEJONG L, 1982, BIOCHIM BIOPHYS ACTA, V704, P326, DOI 10.1016/0167-4838(82)90162-5; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fedulova N, 2007, PROTEIN EXPRES PURIF, V54, P1, DOI 10.1016/j.pep.2007.02.018; Flashman E, 2008, J BIOL CHEM, V283, P3808, DOI 10.1074/jbc.M707411200; Flashman E, 2010, BIOCHEM J, V427, P135, DOI 10.1042/BJ20091609; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; German NJ, 2016, MOL CELL, V63, P1006, DOI 10.1016/j.molcel.2016.08.014; Goda S, 2005, BIOCHEMISTRY-US, V44, P15304, DOI 10.1021/bi050478l; Gorres KL, 2009, ANAL BIOCHEM, V386, P181, DOI 10.1016/j.ab.2008.11.046; Hewitson KS, 2007, METHOD ENZYMOL, V435, P25, DOI 10.1016/S0076-6879(07)35002-7; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Johansson C, 2014, EPIGENOMICS-UK, V6, P89, DOI 10.2217/epi.13.79; Joharapurkar AA, 2018, J MED CHEM, V61, P6964, DOI 10.1021/acs.jmedchem.7b01686; JONES LA, 1956, ANAL CHEM, V28, P191, DOI 10.1021/ac60110a013; Kanelakis KC, 2009, J BIOMOL SCREEN, V14, P627, DOI 10.1177/1087057109333976; Karuppagounder SS, 2012, J CEREBR BLOOD F MET, V32, P1347, DOI 10.1038/jcbfm.2012.28; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Koivunen P, 2018, METHODS MOL BIOL, V1742, P15, DOI 10.1007/978-1-4939-7665-2_2; Koontz L, 2014, METHOD ENZYMOL, V541, P3, DOI 10.1016/B978-0-12-420119-4.00001-X; Li JM, 2020, NAT METHODS, V17, P399, DOI 10.1038/s41592-020-0781-4; Li M, 2011, NEUROCHEM INT, V59, P445, DOI 10.1016/j.neuint.2010.10.017; Li M, 2009, J BIOL CHEM, V284, P22988, DOI 10.1074/jbc.M109.020222; Liu Y, 2010, BIOCHEM BIOPH RES CO, V401, P231, DOI 10.1016/j.bbrc.2010.09.037; Luo WB, 2014, MOL BIOL CELL, V25, P2788, DOI 10.1091/mbc.E14-02-0775; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; McMahon GM, 2019, CURR OPIN NEPHROL HY, V28, P600, DOI 10.1097/MNH.0000000000000554; McNeill LA, 2005, ANAL BIOCHEM, V336, P125, DOI 10.1016/j.ab.2004.09.019; Mesquita CS, 2014, ANAL BIOCHEM, V458, P69, DOI 10.1016/j.ab.2014.04.034; Munawar N, 2012, EXTREMOPHILES, V16, P463, DOI 10.1007/s00792-012-0446-z; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; NIETFELD JJ, 1981, BIOCHIM BIOPHYS ACTA, V657, P159, DOI 10.1016/0005-2744(81)90139-X; Nytko KJ, 2011, BLOOD, V117, P5485, DOI 10.1182/blood-2010-09-307637; Oehme F, 2004, ANAL BIOCHEM, V330, P74, DOI 10.1016/j.ab.2004.03.066; Pappalardi MB, 2011, BIOCHEM J, V436, P363, DOI 10.1042/BJ20101201; PIJOAN M, 1946, SCIENCE, V103, P202, DOI 10.1126/science.103.2668.202; Rabinowitz MH, 2013, J MED CHEM, V56, P9369, DOI 10.1021/jm400386j; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Sim JW, 2018, CELL METAB, V27, P898, DOI 10.1016/j.cmet.2018.02.020; Smirnova NA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1108, DOI 10.1134/S0006297912100033; Strowitzki MJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050384; Tarhonskaya H, 2015, J BIOL CHEM, V290, P19726, DOI 10.1074/jbc.M115.653014; Tennant DA, 2009, ONCOGENE, V28, P4009, DOI 10.1038/onc.2009.250; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Wakamatsu T, 2013, EXTREMOPHILES, V17, P379, DOI 10.1007/s00792-013-0527-7; Xie L, 2012, J CLIN INVEST, V122, P2827, DOI 10.1172/JCI62374; Yeh TL, 2017, CHEM SCI, V8, P7651, DOI 10.1039/c7sc02103h; Yu Z, 2020, CHEM BIOL DRUG DES, V95, P270, DOI 10.1111/cbdd.13640	68	4	4	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100397	10.1016/j.jbc.2021.100397	http://dx.doi.org/10.1016/j.jbc.2021.100397			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33571527	Green Published, gold			2022-12-26	WOS:000672866400371
J	Lan, XY; Liang, Y; Erkut, EJN; Kunze, M; Mulet-Sierra, A; Gong, TX; Osswald, M; Ansari, K; Seikaly, H; Boluk, Y; Adesida, AB				Lan, Xiaoyi; Liang, Yan; Erkut, Esra J. N.; Kunze, Melanie; Mulet-Sierra, Aillette; Gong, Tianxing; Osswald, Martin; Ansari, Khalid; Seikaly, Hadi; Boluk, Yaman; Adesida, Adetola B.			Bioprinting of human nasoseptal chondrocytes-laden collagen hydrogel for cartilage tissue engineering	FASEB JOURNAL			English	Article						bioprinting; chondrocytes; collagen; hydrogel; nasal cartilage; tissue engineering	MESENCHYMAL STEM-CELLS; BIOMATERIALS; SOX9; REPAIR; INDUCTION; HYPERTROPHY; EXPRESSION; SCAFFOLDS; DEFECTS; BIOINK	Skin cancer patients often have tumorigenic lesions on their noses. Surgical resection of the lesions often results in nasal cartilage removal. Cartilage grafts taken from other anatomical sites are used for the surgical reconstruction of the nasal cartilage, but donor-site morbidity is a common problem. Autologous tissue-engineered nasal cartilage grafts can mitigate the problem, but commercially available scaffolds define the shape and sizes of the engineered grafts during tissue fabrication. Moreover, the engineered grafts suffer from the inhomogeneous distribution of the functional matrix of cartilage. Advances in 3D bioprinting technology offer the opportunity to engineer cartilages with customizable dimensions and anatomically shaped configurations without the inhomogeneous distribution of cartilage matrix. Here, we report the fidelity of Freeform Reversible Embedding of Suspended Hydrogel (FRESH) bioprinting as a strategy to generate customizable and homogenously distributed functional cartilage matrix engineered nasal cartilage. Using FRESH and in vitro chondrogenesis, we have fabricated tissue-engineered nasal cartilage from combining bovine type I collagen hydrogel and human nasoseptal chondrocytes. The engineered nasal cartilage constructs displayed molecular, biochemical and histological characteristics akin to native human nasal cartilage.	[Lan, Xiaoyi; Boluk, Yaman] Univ Alberta, Fac Engn, Dept Civil & Environm Engn, Edmonton, AB, Canada; [Liang, Yan; Erkut, Esra J. N.; Kunze, Melanie; Mulet-Sierra, Aillette; Gong, Tianxing; Adesida, Adetola B.] Univ Alberta, Dept Surg, Div Orthoped Surg, Edmonton, AB, Canada; [Liang, Yan; Erkut, Esra J. N.; Kunze, Melanie; Mulet-Sierra, Aillette; Gong, Tianxing; Adesida, Adetola B.] Univ Alberta, Dept Surg, Div Surg Res, Edmonton, AB, Canada; [Osswald, Martin] Misericordia Community Hosp, Inst Reconstruct Sci Med iRSM, Edmonton, AB, Canada; [Osswald, Martin; Ansari, Khalid; Seikaly, Hadi; Adesida, Adetola B.] Univ Alberta, Dept Surg, Div Otolaryngol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Boluk, Y (corresponding author), Univ Alberta, Dept Civil & Environm Engn, 7-273 Donadeo Innovat Ctr Engn, Edmonton, AB T6G 2H9, Canada.; Adesida, AB (corresponding author), Univ Alberta, Fac Med & Dent, Dept Surg, 3-002E Li Ka Shing Ctr Hlth Res Innovat, Edmonton, AB T6G 2E1, Canada.	yaman.boluk@ualberta.ca; adesida@ualberta.ca	/AAE-4337-2022; Lan, Xiaoyi (Michelle)/GNW-4073-2022	Lan, Xiaoyi (Michelle)/0000-0002-0465-1869; Liang, Yan/0000-0002-1847-1703; Erkut, Esra/0000-0003-2027-8344	Canadian Institutes for Health Research [CIHR PS 159661]; Alberta Cancer Foundation-Mickleborough Interfacial Biosciences Research Program [ACF-MIBRP 27128]; Edmonton Civic Employees Charitable Assistance Fund [RES0041788]; Canadian Foundation for Innovation [CFI 33786]; University Hospital Foundation [RES0028185]; Natural Sciences and Engineering Research Council of Canada-Discovery Grant Program [NSERC RGPIN 06431]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation-Mickleborough Interfacial Biosciences Research Program; Edmonton Civic Employees Charitable Assistance Fund; Canadian Foundation for Innovation(Canada Foundation for Innovation); University Hospital Foundation; Natural Sciences and Engineering Research Council of Canada-Discovery Grant Program(Natural Sciences and Engineering Research Council of Canada (NSERC))	Canadian Institutes for Health Research, Grant/Award Number: CIHR PS 159661; Alberta Cancer Foundation-Mickleborough Interfacial Biosciences Research Program, Grant/Award Number: ACF-MIBRP 27128; Edmonton Civic Employees Charitable Assistance Fund, Grant/Award Number: RES0041788; Canadian Foundation for Innovation, Grant/Award Number: CFI 33786; University Hospital Foundation, Grant/Award Number: RES0028185; Natural Sciences and Engineering Research Council of Canada-Discovery Grant Program, Grant/Award Number: NSERC RGPIN 06431	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Andrews SHJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06666-2; Ansari M, 2019, BIO-DES MANUF, V2, P41, DOI 10.1007/s42242-018-0031-0; Austin GK, 2016, CURR OPIN OTOLARYNGO, V24, P453, DOI 10.1097/MOO.0000000000000295; Avila Hector Martinez, 2016, Bioprinting, V1-2, P22, DOI 10.1016/j.bprint.2016.08.003; Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5; BURGET GC, 1985, PLAST RECONSTR SURG, V76, P239, DOI 10.1097/00006534-198508000-00010; Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3; Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686; Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779; Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]; Demirtas TT, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa7b1d; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565; Fulco I, 2014, LANCET, V384, P337, DOI 10.1016/S0140-6736(14)60544-4; Gao T, 2018, BIOFABRICATION, V10, DOI 10.1088/1758-5090/aacdc7; Gatenholm P, 2018, REF SER BIOMED ENG, P331, DOI 10.1007/978-3-319-45444-3_14; Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871; Grogan SP, 2006, TISSUE ENG, V12, P2141, DOI 10.1089/ten.2006.12.2141; Gudmann NS, 2016, BIOCHEMISTRY OF COLLAGENS, LAMININS AND ELASTIN: STRUCTURE, FUNCTION AND BIOMARKERS, P13, DOI 10.1016/B978-0-12-809847-9.00002-7; Gupta N, 2019, ANN OTO RHINOL LARYN, V128, P640, DOI 10.1177/0003489419836667; Guvendiren M, 2012, SOFT MATTER, V8, P260, DOI 10.1039/c1sm06513k; Hinton TJ, 2016, ACS BIOMATER SCI ENG, V2, P1781, DOI 10.1021/acsbiomaterials.6b00170; Hinton TJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500758; Holden PK, 2008, LARYNGOSCOPE, V118, P1153, DOI 10.1097/MLG.0b013e31816ed5ad; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Irawan V, 2018, TISSUE ENG REGEN MED, V15, P673, DOI 10.1007/s13770-018-0135-9; Kafienah W, 2007, ARTHRITIS RHEUM, V56, P177, DOI 10.1002/art.22285; Kajave NS, 2020, MAT SCI ENG C-MATER, V107, DOI 10.1016/j.msec.2019.110290; Kim YB, 2016, ACS APPL MATER INTER, V8, P32230, DOI 10.1021/acsami.6b11669; Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044; Kundu J, 2015, J TISSUE ENG REGEN M, V9, P1286, DOI 10.1002/term.1682; Lee A, 2019, SCIENCE, V365, P482, DOI 10.1126/science.aav9051; Lee YB, 2010, EXP NEUROL, V223, P645, DOI 10.1016/j.expneurol.2010.02.014; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096; Mandrycky C, 2016, BIOTECHNOL ADV, V34, P422, DOI 10.1016/j.biotechadv.2015.12.011; Markstedt K, 2015, BIOMACROMOLECULES, V16, P1489, DOI 10.1021/acs.biomac.5b00188; Menick FJ, 2010, PLAST RECONSTR SURG, V125, p138E, DOI 10.1097/PRS.0b013e3181d0ae2b; Middleman S., 1977, FUNDAMENTALS POLYM P; Miot S, 2012, EUR CELLS MATER, V23, P222, DOI 10.22203/eCM.v023a17; Muller M, 2017, ANN BIOMED ENG, V45, P210, DOI 10.1007/s10439-016-1704-5; Mumme M, 2016, LANCET, V388, P1985, DOI 10.1016/S0140-6736(16)31658-0; Murphy SV, 2013, J BIOMED MATER RES A, V101, P272, DOI 10.1002/jbm.a.34326; Nakamura M, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014110; Ng WL, 2016, INT J BIOPRINTING, V2, P53, DOI 10.18063/IJB.2016.01.009; Nguyen D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00690-y; Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863; Park JY, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035004; Park SH, 2019, NPG ASIA MATER, V11, DOI 10.1038/s41427-019-0130-1; Paxton N, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa8dd8; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Pescosolido L, 2011, BIOMACROMOLECULES, V12, P1831, DOI 10.1021/bm200178w; Radhakrishnan S, 2020, LECT N EARTH SYST SC, P3, DOI 10.1007/978-3-030-21614-6_1; Raimer David W, 2011, Dermatol Online J, V17, P1; Rhee S, 2016, ACS BIOMATER SCI ENG, V2, P1800, DOI 10.1021/acsbiomaterials.6b00288; Romo T 3rd, 1998, Facial Plast Surg, V14, P151, DOI 10.1055/s-2008-1064339; Sayed KE., 2010, TISSUE ENG PART B RE, V16, p603; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarz S, 2020, MAT SCI ENG C-MATER, V116, DOI 10.1016/j.msec.2020.111189; Tew SR, 2005, OSTEOARTHR CARTILAGE, V13, P80, DOI 10.1016/j.joca.2004.10.011; Toriumi DM, 2000, ARCH OTOLARYNGOL, V126, P562, DOI 10.1001/archotol.126.4.562; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Vinatier C, 2016, ANN PHYS REHABIL MED, V59, P139, DOI 10.1016/j.rehab.2016.03.002; Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004; WALLACE DG, 1983, BIOPOLYMERS, V22, P1793, DOI 10.1002/bip.360220713; Yang YL, 2009, BIOPHYS J, V96, P1566, DOI [10.1016/j.bpj.2008.10.063, 10.1016/j.bpj.20()8.10.063]; YOO TJ, 1986, ANN NY ACAD SCI, V475, P341, DOI 10.1111/j.1749-6632.1986.tb20886.x	71	6	6	6	40	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21191	10.1096/fj.202002081R	http://dx.doi.org/10.1096/fj.202002081R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33595884				2022-12-26	WOS:000629576700038
J	Bae, W; Yoon, TY; Jeong, C				Bae, Wooli; Yoon, Tae-Young; Jeong, Cherlhyun			Direct evaluation of self-quenching behavior of fluorophores at high concentrations using an evanescent field	PLOS ONE			English	Article								The quantum yield of a fluorophore is reduced when two or more identical fluorophores are in close proximity to each other. The study of protein folding or particle aggregation is can be done based on this above-mentioned phenomenon-called self-quenching. However, it is challenging to characterize the self-quenching of a fluorophore at high concentrations because of the inner filter effect, which involves depletion of excitation light and re-absorption of emission light. Herein, a novel method to directly evaluate the self-quenching behavior of fluorophores was developed. The evanescent field from an objective-type total internal reflection fluorescence (TIRF) microscope was used to reduce the path length of the excitation and emission light to similar to 100 nm, thereby supressing the inner filter effect. Fluorescence intensities of sulforhodamine B, fluorescein isothiocyanate (FITC), and calcein solutions with concentrations ranging from 1 mu M to 50 mM were directly measured to evaluate the concentration required for 1000-fold degree of self-quenching and to examine the different mechanisms through which the fluorophores undergo self-quenching.	[Bae, Wooli] Imperial Coll London, Imperial Coll Ctr Synthet Biol, South Kensington Campus, London, England; [Bae, Wooli] Imperial Coll London, Dept Bioengn, South Kensington Campus, London, England; [Yoon, Tae-Young] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Yoon, Tae-Young] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul, South Korea; [Jeong, Cherlhyun] Korea Inst Sci & Technol, Ctr Theragnosis, Seoul, South Korea; [Jeong, Cherlhyun] Kyung Hee Univ, KHU KIST Dept Converging Sci & Technol, Seoul, South Korea	Imperial College London; Imperial College London; Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Kyung Hee University	Bae, W (corresponding author), Imperial Coll London, Imperial Coll Ctr Synthet Biol, South Kensington Campus, London, England.; Bae, W (corresponding author), Imperial Coll London, Dept Bioengn, South Kensington Campus, London, England.; Jeong, C (corresponding author), Korea Inst Sci & Technol, Ctr Theragnosis, Seoul, South Korea.; Jeong, C (corresponding author), Kyung Hee Univ, KHU KIST Dept Converging Sci & Technol, Seoul, South Korea.	w.bae@imperial.ac.uk; che.jeong@kist.re.kr	Bae, Wooli/ABA-3745-2020	Bae, Wooli/0000-0001-5396-3263	National Creative Research Initiative Program (Center for Single-Molecule Systems Biology); EPSRC [EP/P02596X/1]; KIST Institutional Program [2E31092]; National Research Foundation of Korea (NRF) - Ministry of Science and ICT of Korea [2017R1A3B1023418]	National Creative Research Initiative Program (Center for Single-Molecule Systems Biology); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); KIST Institutional Program(Korea Institute of Science & Technology (KIST)); National Research Foundation of Korea (NRF) - Ministry of Science and ICT of Korea	W.B. and T.-Y.Y. acknowledge support from National Creative Research Initiative Program (Center for Single-Molecule Systems Biology). W. B. is supported by EPSRC grant EP/P02596X/1. C.J is supported by the KIST Institutional Program (Project No. 2E31092) and the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science and ICT of Korea (Project No. 2017R1A3B1023418).	ARBELOA IL, 1981, J CHEM SOC FARAD T 2, V77, P1735, DOI 10.1039/f29817701735; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; BROWN RS, 1994, J CHEM PHYS, V100, P6019, DOI 10.1063/1.467112; BUDO A, 1956, J CHEM PHYS, V25, P595, DOI 10.1063/1.1742993; Carter BC, 2008, BIOPHYS J, V94, P306, DOI 10.1529/biophysj.107.110601; CHEN RF, 1988, ANAL BIOCHEM, V172, P61, DOI 10.1016/0003-2697(88)90412-5; Chen WY, 2017, NANO LETT, V17, P143, DOI 10.1021/acs.nanolett.6b03686; Cho M, 2007, BIOSENS BIOELECTRON, V22, P1376, DOI 10.1016/j.bios.2006.06.010; COX IJ, 1986, J OPT SOC AM A, V3, P1152, DOI 10.1364/JOSAA.3.001152; EVANS TR, 1971, J AM CHEM SOC, V93, P2081, DOI 10.1021/ja00737a058; Fery-Forgues S, 1999, J CHEM EDUC, V76, P1260, DOI 10.1021/ed076p1260; Fonin AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103878; Gehlen MH, 2020, J PHOTOCH PHOTOBIO C, V42, DOI 10.1016/j.jphotochemrev.2019.100338; Hemmila IA, 1991, APPL FLUORESCENCE IM, Vxi, P343; Jablonski A., 1955, ACTA PHYS POL, V14, P295; KNOX RS, 1968, PHYSICA, V39, P361, DOI 10.1016/0031-8914(68)90090-6; KUBISTA M, 1994, ANALYST, V119, P417, DOI 10.1039/an9941900417; Kyoung M, 2011, P NATL ACAD SCI USA, V108, pE304, DOI 10.1073/pnas.1107900108; Lakowicz JR, 2003, ANAL BIOCHEM, V320, P13, DOI 10.1016/S0003-2697(03)00351-8; MACDONALD RI, 1990, J BIOL CHEM, V265, P13533; Michalet X, 2006, CHEM REV, V106, P1785, DOI 10.1021/cr0404343; Mujumdar SR, 1996, BIOCONJUGATE CHEM, V7, P356, DOI 10.1021/bc960021b; Naumann W, 2004, J CHEM PHYS, V120, P9618, DOI 10.1063/1.1718156; Naumann W, 1999, J CHEM PHYS, V111, P2414, DOI 10.1063/1.479519; Quinn SD, 2014, MOL BIOSYST, V10, P34, DOI 10.1039/c3mb70272c; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Swiecicki JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20237; SZALAY L., 1967, ACTA BIOCHIM BIOPHYS ACAD SCI HUNG, V2, P425; Zhegalova NG, 2014, CONTRAST MEDIA MOL I, V9, P355, DOI 10.1002/cmmi.1585; Zhuang XW, 2000, P NATL ACAD SCI USA, V97, P14241, DOI 10.1073/pnas.97.26.14241	31	16	16	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247326	10.1371/journal.pone.0247326	http://dx.doi.org/10.1371/journal.pone.0247326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606817	Green Published, gold			2022-12-26	WOS:000620629200041
J	Varrecchia, T; Castiglia, SF; Ranavolo, A; Conte, C; Tatarelli, A; Coppola, G; Di Lorenzo, C; Draicchio, F; Pierelli, F; Serrao, M				Varrecchia, Tiwana; Castiglia, Stefano Filippo; Ranavolo, Alberto; Conte, Carmela; Tatarelli, Antonella; Coppola, Gianluca; Di Lorenzo, Cherubino; Draicchio, Francesco; Pierelli, Francesco; Serrao, Mariano			An artificial neural network approach to detect presence and severity of Parkinson's disease via gait parameters	PLOS ONE			English	Article							WALKING SPEED; CLINICAL-FEATURES; PISA SYNDROME; REHABILITATION; CLASSIFICATION; SYSTEM; JOINT; DISORDERS; PATTERNS; COST	Introduction Gait deficits are debilitating in people with Parkinson's disease (PwPD), which inevitably deteriorate over time. Gait analysis is a valuable method to assess disease-specific gait patterns and their relationship with the clinical features and progression of the disease. Objectives Our study aimed to i) develop an automated diagnostic algorithm based on machine-learning techniques (artificial neural networks [ANNs]) to classify the gait deficits of PwPD according to disease progression in the Hoehn and Yahr (H-Y) staging system, and ii) identify a minimum set of gait classifiers. Methods We evaluated 76 PwPD (H-Y stage 1-4) and 67 healthy controls (HCs) by computerized gait analysis. We computed the time-distance parameters and the ranges of angular motion (RoMs) of the hip, knee, ankle, trunk, and pelvis. Principal component analysis was used to define a subset of features including all gait variables. An ANN approach was used to identify gait deficits according to the H-Y stage. Results We identified a combination of a small number of features that distinguished PwPDs from HCs (one combination of two features: knee and trunk rotation RoMs) and identified the gait patterns between different H-Y stages (two combinations of four features: walking speed and hip, knee, and ankle RoMs; walking speed and hip, knee, and trunk rotation RoMs). Conclusion The ANN approach enabled automated diagnosis of gait deficits in several symptomatic stages of Parkinson's disease. These results will inspire future studies to test the utility of gait classifiers for the evaluation of treatments that could modify disease progression.	[Varrecchia, Tiwana; Ranavolo, Alberto; Tatarelli, Antonella; Draicchio, Francesco] INAIL, Dept Occupat & Environm Med Epidemiol & Hyg, Rome, Italy; [Castiglia, Stefano Filippo; Coppola, Gianluca; Di Lorenzo, Cherubino; Pierelli, Francesco; Serrao, Mariano] Univ Rome Sapienza, Dept Med Surg Sci & Biotechnol, Latina, Italy; [Conte, Carmela] IRCSS Fdn Don Carlo Gnocchi, Milan, Italy; [Tatarelli, Antonella] Univ Rome Sapienza, Dept Human Neurosci, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Varrecchia, T (corresponding author), INAIL, Dept Occupat & Environm Med Epidemiol & Hyg, Rome, Italy.	t.varrecchia@inail.it	Ranavolo, Alberto/AAC-7576-2022; Serrao, Mariano/K-6972-2016; Francesco, Draicchio/AAC-7681-2022; Castiglia, Stefano Filippo/AEQ-2147-2022; VARRECCHIA, TIWANA/AAC-7561-2022	Ranavolo, Alberto/0000-0002-0197-6166; Serrao, Mariano/0000-0003-3031-680X; Francesco, Draicchio/0000-0003-0677-2573; Castiglia, Stefano Filippo/0000-0001-5329-5197; VARRECCHIA, TIWANA/0000-0003-3910-2728	European Union [871237]	European Union(European Commission)	The research presented in this article was carried out as part of the SOPHIA project, which has received funding from the European Union's Horizon 2020 research and innovation programme under Grant Agreement No. 871237.	Ahmed FE, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-29; ARENDTNIELSEN L, 1991, J ELECTROMYOGR KINES, V1, P89, DOI 10.1016/1050-6411(91)90002-M; Ashour R, 2006, MOVEMENT DISORD, V21, P1856, DOI 10.1002/mds.21058; Baker R, 2016, EUR J PHYS REHAB MED, V52, P560; Barone P, 2016, LANCET NEUROL, V15, P1063, DOI 10.1016/S1474-4422(16)30173-9; Bartolo M, 2010, MOVEMENT DISORD, V25, P325, DOI 10.1002/mds.23007; Bartosch-Harlid A, 2008, BRIT J SURG, V95, P817, DOI 10.1002/bjs.6239; Begg R. K., 2006, Journal of Medical Engineering & Technology, V30, P382, DOI 10.1080/03091900500445353; Benatru I, 2008, NEUROPHYSIOL CLIN, V38, P459, DOI 10.1016/j.neucli.2008.07.006; Benmalek E, 2017, INT J SPEECH TECHNOL, V20, P179, DOI 10.1007/s10772-017-9401-9; Bhidayasiri R, 2017, INT REV NEUROBIOL, V132, P129, DOI 10.1016/bs.irn.2017.01.001; Borghese NA, 1996, J PHYSIOL-LONDON, V494, P863, DOI 10.1113/jphysiol.1996.sp021539; Buckley C, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9020034; Buongiorno D, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0987-5; Caramia C, 2018, IEEE J BIOMED HEALTH, V22, P1765, DOI 10.1109/JBHI.2018.2865218; Cavallo F, 2019, PARKINSONISM RELAT D, V63, P111, DOI 10.1016/j.parkreldis.2019.02.028; Chen CL, 2004, HUM FACTOR ERGON MAN, V14, P31, DOI 10.1002/hfm.10052; Chen XQ, 2019, ACTA NEUROL SCAND, V140, P268, DOI 10.1111/ane.13140; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Dinov ID, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157077; Djaldetti R, 2004, NEUROLOGY, V62, P2171, DOI 10.1212/01.WNL.0000130455.38550.9D; Durmus B, 2010, J CLIN NEUROSCI, V17, P893, DOI 10.1016/j.jocn.2009.11.014; Ferrarin M, 2012, GAIT POSTURE, V35, P131, DOI 10.1016/j.gaitpost.2011.08.023; Florkowski Christopher M, 2008, Clin Biochem Rev, V29 Suppl 1, pS83; Forsyth D R, 2009, Med J Malaysia, V64, P46; Fukuchi CA, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-1063-z; Gao C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24783-4; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hebenstreit F, 2015, HUM MOVEMENT SCI, V43, P118, DOI 10.1016/j.humov.2015.07.009; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jacobs JV, 2006, NEUROSCIENCE, V141, P999, DOI 10.1016/j.neuroscience.2006.04.014; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kyeong S, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019555; Latt MD, 2009, J GERONTOL A-BIOL, V64, P700, DOI 10.1093/gerona/glp009; Louie S, 2009, MOVEMENT DISORD, V24, P1991, DOI 10.1002/mds.22741; Mancini M, 2011, PARKINSONISM RELAT D, V17, P557, DOI 10.1016/j.parkreldis.2011.05.010; Martinez-Martin P, 2015, CNS DRUGS, V29, P397, DOI 10.1007/s40263-015-0247-x; McCrone P, 2007, MOVEMENT DISORD, V22, P804, DOI 10.1002/mds.21360; Morris M, 2005, MOVEMENT DISORD, V20, P40, DOI 10.1002/mds.20278; Morris ME, 2001, ADV NEUROL, V87, P347; MORRIS ME, 1994, BRAIN, V117, P1169, DOI 10.1093/brain/117.5.1169; Morrone M, 2016, EUR J PHYS REHAB MED, V52, P799; Mortazavi D, 2012, NEURORADIOLOGY, V54, P299, DOI 10.1007/s00234-011-0886-7; Nocera JR, 2010, ADAPT PHYS ACT Q, V27, P87, DOI 10.1123/apaq.27.2.87; Pawlitzki E, 2018, GAIT POSTURE, V60, P50, DOI 10.1016/j.gaitpost.2017.11.011; Perry J, 1990, Instr Course Lect, V39, P325; Pickering RM, 2007, MOVEMENT DISORD, V22, P1892, DOI 10.1002/mds.21598; Pickle NT., 2018, C P IEEE ENG MED ENG, P1202, DOI [10.1109/EMBC.2018.8512530, DOI 10.1109/EMBC.2018.8512530]; Poewe WH, 1996, NEUROLOGY, V47, pS146, DOI 10.1212/WNL.47.6_Suppl_3.146S; Pons JL, 2013, IEEE ENG MED BIO, P6941, DOI 10.1109/EMBC.2013.6611154; POZZO T, 1990, EXP BRAIN RES, V82, P97; PRINCE F, 1994, GAIT POSTURE, V2, P19, DOI 10.1016/0966-6362(94)90013-2; Rehman RZU, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53656-7; REYNOLDS NC, 1987, ARCH NEUROL-CHICAGO, V44, P1013, DOI 10.1001/archneur.1987.00520220019009; Rinaldi M, 2017, CLIN BIOMECH, V48, P63, DOI 10.1016/j.clinbiomech.2017.07.013; Roiz RD, 2010, ARQ NEURO-PSIQUIAT, V68, P81, DOI 10.1590/S0004-282X2010000100018; Romkes J, 2017, GAIT POSTURE, V54, P304, DOI 10.1016/j.gaitpost.2017.03.025; Rovini E, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00555; Salarian A, 2004, IEEE T BIO-MED ENG, V51, P1434, DOI 10.1109/TBME.2004.827933; Sawacha Z, 2020, GAIT POSTURE, V79, P33, DOI 10.1016/j.gaitpost.2020.03.016; Schreiber C, 2018, J BIOMECH, V76, P68, DOI 10.1016/j.jbiomech.2018.05.022; Serrao M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00902; Serrao M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00826; Serrao M, 2018, HUM MOVEMENT SCI, V57, P267, DOI 10.1016/j.humov.2017.09.005; Serrao M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164623; Shankaracharya, 2010, Rev Diabet Stud, V7, P252, DOI 10.1900/RDS.2010.7.252; Siristatidis CS, 2010, MED SCI MONITOR, V16, pRA231; Sofuwa O, 2005, ARCH PHYS MED REHAB, V86, P1007, DOI 10.1016/j.apmr.2004.08.012; Spelt L, 2012, EJSO-EUR J SURG ONC, V38, P16, DOI 10.1016/j.ejso.2011.10.013; Staffen W, 2000, J NEURAL TRANSM, V107, P543, DOI 10.1007/s007020070077; Tassorelli C, 2014, PARKINSONISM RELAT D, V20, P1140, DOI 10.1016/j.parkreldis.2014.07.015; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Varrecchia T, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10061989; Varrecchia T, 2018, INT J IND ERGONOM, V66, P1, DOI 10.1016/j.ergon.2018.02.003; Vieregge P, 1997, J NEURAL TRANSM, V104, P237, DOI 10.1007/BF01273184; VIITANEN M, 1994, J NEUROL NEUROSUR PS, V57, P1203, DOI 10.1136/jnnp.57.10.1203; Wald NJ, 2014, J MED SCREEN, V21, P220, DOI 10.1177/0969141314548908; WINTER DA, 1990, MED PROG TECHNOL, V16, P31; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Yoshii Fumihito, 2016, J Clin Mov Disord, V3, P1, DOI 10.1186/s40734-016-0029-8; Zhang SS, 2019, STUD HEALTH TECHNOL, V264, P477, DOI 10.3233/SHTI190267; Zurada J, 1997, APPL ERGON, V28, P49, DOI 10.1016/S0003-6870(96)00034-8	87	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0244396	10.1371/journal.pone.0244396	http://dx.doi.org/10.1371/journal.pone.0244396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606730	Green Published, gold			2022-12-26	WOS:000620629200098
J	Kiros, M; Geteneh, A; Andualem, H; Alemu, D; Tesfaye, A; Tefera, DA; Mihret, A; Alemayehu, DH; Mulu, A				Kiros, Mulugeta; Geteneh, Alene; Andualem, Henok; Alemu, Derbie; Tesfaye, Abebech; Tefera, Dessalegne Abeje; Mihret, Adane; Alemayehu, Dawit Hailu; Mulu, Andargachew			Human cytomegalovirus infection among treatment-naive HIV-1 infected patients in Ethiopia	PLOS ONE			English	Article							CMV DISEASE; DNA; PCR; INDIVIDUALS; THERAPY; VIREMIA; PLASMA; RISK	Subclinical human cytomegalovirus (HCMV) replication is associated with immune dysfunction in immuno-suppressed antiretroviral therapy (ART) naive HIV infected individuals. No data is documented in Ethiopia so far concerning HCMV co-infection among HIV infected individuals. Hence, this study was aimed at generating data regarding the prevalence of active HCMV infection among treatment-naive HIV-infected individuals from Ethiopia. For this purpose, we enrolled 97 treatment-naive HIV infected study subjects in Addis Ababa from June to December 2018. ELISA and conventional PCR were performed consecutively to detect HCMV specific IgM antibody and HCMV DNA respectively. Of the 97 study subjects, 12 (12.4%) were positive for anti-CMV IgM antibodies but were not confirmed by PCR. With regard to the PCR positivity, 4/97 (4.1%) samples were positive for HCMV DNA. No statically significant associations were found between the dependent and independent variables. The presence of HCMV DNA in the current study highlights the need for a routine laboratory diagnosis for preventing HCMV disease among HIV-infected individuals early. Besides, the use of anti-CMV therapy for these CMV viremic individuals is also recommended as this can reduce the burden of CMV complications and consecutively prolonging the life of HIV infected individuals.	[Kiros, Mulugeta; Andualem, Henok] Debre Tabor Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Debre Tabor, Ethiopia; [Geteneh, Alene] Woldia Univ, Coll Hlth Sci, Dept Med Lab Sci, Woldia, Ethiopia; [Alemu, Derbie] Arba Minch Coll Hlth Sci, Dept Med Lab Sci, Arba Minch, Ethiopia; [Tesfaye, Abebech; Tefera, Dessalegne Abeje; Mihret, Adane; Alemayehu, Dawit Hailu; Mulu, Andargachew] Armauer Hansen Res Inst, Addis Ababa, Ethiopia	University of Gondar	Kiros, M (corresponding author), Debre Tabor Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Debre Tabor, Ethiopia.	mulugetakiros@gmail.com	Andualem, Henok/AHE-2032-2022; Kiros, Mulugeta/ABA-4150-2020; Mulu, Andargachew/GMW-4823-2022; Geteneh, Alene/ABH-1968-2020	Andualem, Henok/0000-0001-6883-9548; Kiros, Mulugeta/0000-0002-7909-7719; Mulu, Andargachew/0000-0003-2862-0175; Geteneh, Alene/0000-0002-7153-4849; Mihret, Adane/0000-0003-3183-4772	Armauer Hansen Research Institute	Armauer Hansen Research Institute	This research project was funded by the Armauer Hansen Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AL-Roubaey DA, 2018, J PHARM SCI RES, V10, P640; Babair MH, 2016, CLIN MICROBIOL INFEC, V1, P67; Bates M, 2016, J VIRUS ERAD, V2, P136; Bieniek R, 2011, LABMEDICINE, V42, P339, DOI 10.1309/LMP4IL3XGU6MQJCE; Bigliano P, 2018, ANTIVIR THER, V23, P451, DOI 10.3851/IMP3221; Brantsaeter AB, 2002, SCAND J INFECT DIS, V34, P50, DOI 10.1080/00365540110076976; Brantsaeter AB, 2012, INT J INFECT DIS, V16, pE879, DOI 10.1016/j.ijid.2012.08.003; Christensen-Quick A, 2019, J VIROL, V93, DOI 10.1128/JVI.00179-19; Dodt KK, 1997, AIDS, V11, pF21, DOI 10.1097/00002030-199703110-00001; DREW WL, 1988, REV INFECT DIS, V10, pS468; Ebrahim Maha G, 2015, Open Virol J, V9, P38, DOI 10.2174/1874357901509010038; Effros RB, 2016, MECH AGEING DEV, V158, P46, DOI 10.1016/j.mad.2015.09.003; Enan KA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-222; Fielding K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025571; Freeman ML, 2016, CURR HIV-AIDS REP, V13, P10, DOI 10.1007/s11904-016-0297-9; Gronborg HL, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1907; Heiden D, 2007, PLOS MED, V4, P1845, DOI 10.1371/journal.pmed.0040334; Heiden D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-327; Hodowanec AC, 2020, J INFECT DIS, V221, P109, DOI 10.1093/infdis/jiz389; Medicines Patent Pool, 2018, AGREEMENT VALGANCICL; Micol R, 2009, JAIDS-J ACQ IMM DEF, V51, P486, DOI 10.1097/QAI.0b013e3181a254c2; Milutinovic A, 2020, MEDICINSKI PREGLED, V73, P43; Murray J, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05579-2; Mustafa M, 2019, J AIDS CLIN RES, V10, P2; Ojide C., 2013, INT J TROP DIS HLTH, V3, P233; Sachithanandham J, 2014, INDIAN J MED MICROBI, V32, P261, DOI 10.4103/0255-0857.136558; Sachithanandham J, 2009, INDIAN J MED MICROBI, V27, P210, DOI 10.4103/0255-0857.53202; Schindele B, 2010, ANTIMICROB AGENTS CH, V54, P5234, DOI 10.1128/AAC.00802-10; Skipper C, 2020, CLIN INFECT DIS, V71, P525, DOI 10.1093/cid/ciz864; Slyker JA, 2009, AIDS, V23, P117, DOI 10.1097/QAD.0b013e32831c8abd; Spector SA, 1998, J CLIN INVEST, V101, P497, DOI 10.1172/JCI1101; Udeze A, 2018, AFR HEALTH SCI, V18, P1057, DOI 10.4314/ahs.v18i4.27; WHO, 2009, WHO TECH REP SER, V958, P1; Zhao M, 2020, ANN PALLIAT MED, V9, P2710, DOI [10.21037/apin-20-1352, 10.21037/apm-20-1352]	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247264	10.1371/journal.pone.0247264	http://dx.doi.org/10.1371/journal.pone.0247264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600457	Green Published, gold			2022-12-26	WOS:000620625100008
J	Murugappan, M; Mutawa, A				Murugappan, M.; Mutawa, A.			Facial geometric feature extraction based emotional expression classification using machine learning algorithms	PLOS ONE			English	Article							RECOGNITION; PATTERN	Emotion plays a significant role in interpersonal communication and also improving social life. In recent years, facial emotion recognition is highly adopted in developing human-computer interfaces (HCI) and humanoid robots. In this work, a triangulation method for extracting a novel set of geometric features is proposed to classify six emotional expressions (sadness, anger, fear, surprise, disgust, and happiness) using computer-generated markers. The subject's face is recognized by using Haar-like features. A mathematical model has been applied to positions of eight virtual markers in a defined location on the subject's face in an automated way. Five triangles are formed by manipulating eight markers' positions as an edge of each triangle. Later, these eight markers are uninterruptedly tracked by Lucas- Kanade optical flow algorithm while subjects' articulating facial expressions. The movement of the markers during facial expression directly changes the property of each triangle. The area of the triangle (AoT), Inscribed circle circumference (ICC), and the Inscribed circle area of a triangle (ICAT) are extracted as features to classify the facial emotions. These features are used to distinguish six different facial emotions using various types of machine learning algorithms. The inscribed circle area of the triangle (ICAT) feature gives a maximum mean classification rate of 98.17% using a Random Forest (RF) classifier compared to other features and classifiers in distinguishing emotional expressions.	[Murugappan, M.] Kuwait Coll Sci & Technol, Dept Elect & Commun Engn, Intelligent Signal Proc ISP Res Lab, Kuwait, Kuwait; [Mutawa, A.] Kuwait Univ, Coll Engn & Petr, Comp Engn Dept, Kuwait, Kuwait	Kuwait College Science & Technology; Kuwait University	Murugappan, M (corresponding author), Kuwait Coll Sci & Technol, Dept Elect & Commun Engn, Intelligent Signal Proc ISP Res Lab, Kuwait, Kuwait.	m.murugappan@gmail.com	Murugappan, M/E-2402-2014; Almutawa, Abdullah/GYQ-5973-2022	Murugappan, M/0000-0002-5839-4589; Almutawa, Abdullah/0000-0002-5707-2692	Kuwait Foundation for the Advancement of Science, Kuwait [PR18-18EE-01]; Kuwait Foundation for the Advancement of Sciences (KFAS), Kuwait [PR18 - 18EE - 01]	Kuwait Foundation for the Advancement of Science, Kuwait(Kuwait Foundation for the Advancement of Sciences (KFAS)); Kuwait Foundation for the Advancement of Sciences (KFAS), Kuwait	Authors: M.M, M.A Grant Number: PR18-18EE-01 Name: Kuwait Foundation for the Advancement of Science, Kuwait. URL: https://www.kfas.org/.This work is financially supported by Kuwait Foundation for the Advancement of Sciences (KFAS), Kuwait. Grant Number: PR18 - 18EE - 01 received by Prof. Murugappan M. The funders had no role in study design, data collection and analysis, decision to publish, preparation of manuscript.	Ali ASO, 2015, INT J PATTERN RECOGN, V29, DOI 10.1142/S0218001415560066; Bartneck C., 2000, AFFECTIVE EXPRESSION; Benoit L, SOFTW KNOWL INF MAN, P1; Bjerregaard M, 2010, FACULTY COMMUNICATIO, P74; Bosch A., 2007, P 6 ACM INT C IM VID, V5, P401, DOI [10.1145/1282280.1282340, DOI 10.1145/1282280, DOI 10.1145/1282280.1282340]; Bouguet J.-Y., 2001, INTEL CORP, V5, P4, DOI DOI 10.1109/HPDC.2004.1323531; Bradski G., 2005, INTEL TECHNOL J, V9, P119; Chaturvedi A., 2014, INT J COMPUT APPL, V93, P25, DOI [10.5120/16260-5920, DOI 10.5120/16260-5920]; EKMAN P, 1980, J PERS SOC PSYCHOL, V39, P1125, DOI 10.1037/h0077722; Ekman P., 2002, FACIAL ACTION CODING; Ekman P., 1997, WHAT FACE REVEALS BA, DOI [10.1093/acprof:oso/9780195179644.001.0001, DOI 10.1093/ACPROF:OSO/9780195179644.001.0001]; Ghandi Bashir Mohammed, 2010, 2010 IEEE Symposium on Industrial Electronics and Applications (ISIEA 2010), P40, DOI 10.1109/ISIEA.2010.5679500; Ghimire D, 2013, SENSORS-BASEL, V13, P7714, DOI 10.3390/s130607714; Gibson J.J, 1950, PERCEPTION VISUAL WO, Vxii, P242; Glocker B, 2008, MED IMAGE ANAL, V12, P731, DOI 10.1016/j.media.2008.03.006; Glowinski D, 2011, IEEE T AFFECT COMPUT, V2, P106, DOI 10.1109/T-AFFC.2011.7; Golzadeh H, 2018, 2018 9TH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS (IS), P789, DOI 10.1109/IS.2018.8710573; Goulart C, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19132844; Nguyen HD, 2019, INT J PATTERN RECOGN, V33, DOI 10.1142/S0218001419400159; Hassouneh A., 2020, INFORM MED UNLOCKED, V20, DOI [10.1016/j.imu.2020.100372, DOI 10.1016/J.IMU.2020.100372]; Horlings R., 2008, INT C COMP SYST TECH; Huang KC, 2012, INT J INNOV COMPUT I, V8, P7729; Jain V, 2010, FDDB BENCHMARK FACE; Kaliouby R.E, 2003, P 5 INT C MULT INT I; Kartali A, 2018, 2018 14TH SYMPOSIUM ON NEURAL NETWORKS AND APPLICATIONS (NEUREL); Ko BC, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020401; Kolakowska A, 2013, C HUM SYST INTERACT, P532, DOI 10.1109/HSI.2013.6577877; Kotsia I, 2005, IEEE IMAGE PROC, P1721; Kulic D, 2007, IEEE T ROBOT, V23, P991, DOI 10.1109/TRO.2007.904899; Lien J.J, 1998, 1998 P 3 IEEE INT C; Liliana D. Y., 2019, Journal of Physics: Conference Series, V1193, DOI 10.1088/1742-6596/1193/1/012004; Lonare A., 2013, INT J ADV RES COMPUT, V2, P4647; Lucas B., 1981, P 1981 DAPRA IM UND; Lucas B.D, P 7 INT JOINT C ART, VVolume 2, P674; Lucey P, 2010, IEEE COMP VIS PATT R; Lyons M, 1998, AUTOMATIC FACE AND GESTURE RECOGNITION - THIRD IEEE INTERNATIONAL CONFERENCE PROCEEDINGS, P200, DOI 10.1109/AFGR.1998.670949; Maaoui Choubeila, 2010, Cutting Edge Robotics 2010, P317; Mahesh VGV., 2017, INT J INTELLIGENT SY, V16, P936; Maruthapillai V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149003; Mehta D, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19081897; Mohammadpour M, 2017, 2017 IEEE 4TH INTERNATIONAL CONFERENCE ON KNOWLEDGE-BASED ENGINEERING AND INNOVATION (KBEI), P17; Monajati M., 2012, INT J INTELL SCI, V02, P166, DOI [10.4236/ijis.2012.224022, DOI 10.4236/IJIS.2012.224022]; Moore S, 2011, COMPUT VIS IMAGE UND, V115, P541, DOI 10.1016/j.cviu.2010.12.001; Murugappan M, 2020, 2020 16TH IEEE INTERNATIONAL COLLOQUIUM ON SIGNAL PROCESSING & ITS APPLICATIONS (CSPA 2020), P261, DOI 10.1109/CSPA48992.2020.9068708; Niese R, 2012, IET COMPUT VIS, V6, P79, DOI 10.1049/iet-cvi.2011.0064; Ojansivu V, 2008, LECT NOTES COMPUT SC, V5099, P236, DOI 10.1007/978-3-540-69905-7_27; Plumb M.D, 2013, NONVERBAL COMMUNICAT, P75; Raj ANJ, 2017, ADV COMPU INTELL ROB, P90, DOI 10.4018/978-1-5225-2053-5.ch004; Rani P, 2006, PATTERN ANAL APPL, V9, P58, DOI 10.1007/s10044-006-0025-y; Rivera AR, 2013, IEEE T IMAGE PROCESS, V22, P1740, DOI 10.1109/TIP.2012.2235848; Robertson M, 2014, GOOGLE PATENTS; Routray A, 2012, HUM COMP INT HCI 201; Ryan Andrew, 2009, 2009 IEEE 43rd International Carnahan Conference on Security Technology. ICCST 2009, P172, DOI 10.1109/CCST.2009.5335546; Saniie J, 2018, 2018 IEEE INT C EL T; Schunck B.G, 1981, INT SOC OPT PHOT; Silva V, 2016, INT C ULTRA MOD TELE, P201, DOI 10.1109/ICUMT.2016.7765357; Suk M, 2014, IEEE COMPUT SOC CONF, P132, DOI 10.1109/CVPRW.2014.25; Tablado A, 2003, ENG MED BIOL SOC ANN, P78; Takahashi K., 2009, IEEE INT C ROB BIOM; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Warren D., 1985, SER NATO SCI SERIES; Zamzmi Ghada, 2018, IEEE Rev Biomed Eng, V11, P77, DOI 10.1109/RBME.2017.2777907; Zhang L., 2014, P 2014 INT C AUT AG; Zhang L, 2008, LECT NOTES COMPUT SC, V5303, P706, DOI 10.1007/978-3-540-88688-4_52	64	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247131	10.1371/journal.pone.0247131	http://dx.doi.org/10.1371/journal.pone.0247131			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600467	gold, Green Published			2022-12-26	WOS:000620625100048
J	Aldossri, M; Okoronkwo, C; Dodd, V; Manson, H; Singhal, S				Aldossri, Musfer; Okoronkwo, Chimere; Dodd, Virginia; Manson, Heather; Singhal, Sonica			Determinants of dentists' readiness to assess HPV risk and recommend immunization: A transtheoretical model of change-based cross-sectional study of Ontario dentists	PLOS ONE			English	Article								Objectives To evaluate dentists' readiness to assess the history of human papilloma virus (HPV) infections and recommend immunization among their patients. Materials and methods A link to a self-administered questionnaire was emailed to Ontario dentists. Dentists' readiness and its determinants were assessed based on Transtheoretical Model's 'stages' and 'processes' of change, respectively. Based on their current practices, dentists were either assigned to 'pre-action' or 'action+' stages. Results Of the 9,975 dentists contacted, 932 completed the survey; 51.9% participants were in action stage to assess the history of HPV infections and 20.5% to recommend immunization. Internationally-trained and those whose office's physical layout was not a concern to discuss patients' sexual history were more likely to assess the history. Dentists with higher knowledge about HPV vaccines, not concerned about the HPV vaccine safety, comfortable discussing sex-related topics with patients, or willing to exceed their scope of practice were more ready to recommend HPV immunization to their patients. Conclusion Improving Ontario dentists' knowledge and communication skills and changing their self-perceived role regarding HPV infections and vaccination can increase their capacity to minimize the burden of HPV infections.	[Aldossri, Musfer; Singhal, Sonica] Univ Toronto, Fac Dent, Discipline Dent Publ Hlth, Toronto, ON, Canada; [Aldossri, Musfer] King Saud Univ, Coll Dent, Dept Periodont & Community Dent, Riyadh, Saudi Arabia; [Okoronkwo, Chimere] Haldimand & Norfolk Counties, Hlth & Social Serv Div, Simcoe, ON, Canada; [Okoronkwo, Chimere] Lakehead Univ, Northern Ontario Sch Med, Thunder Bay, ON, Canada; [Dodd, Virginia] Univ Florida, Dept Community Dent & Behav Sci, Gainesville, FL USA; [Manson, Heather; Singhal, Sonica] Publ Hlth Ontario, Hlth Promot Chron Dis & Injury Prevent Dept, Toronto, ON, Canada; [Manson, Heather] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; King Saud University; Lakehead University; Northern Ontario School of Medicine; State University System of Florida; University of Florida; University of Toronto	Aldossri, M (corresponding author), Univ Toronto, Fac Dent, Discipline Dent Publ Hlth, Toronto, ON, Canada.; Aldossri, M (corresponding author), King Saud Univ, Coll Dent, Dept Periodont & Community Dent, Riyadh, Saudi Arabia.	musfer.aldossri@mail.utoronto.ca		Aldossri, Musfer/0000-0002-5365-1945	Royal College of Dental Surgeons of Ontario	Royal College of Dental Surgeons of Ontario	We acknowledge the support of Dr. Shelley Deeks, Dr. Grace Bradley, Dr. Wanda Wright, Dr. Joanne Clovis, and Dr. Lisa Johnson in reviewing the questionnaire and providing their input. We are grateful for the support of Royal College of Dental Surgeons of Ontario, in sending the survey to the members of the College and sending them reminder emails to complete the survey. We are thankful to Dr. Rachel Laxer for electronic formatting of the survey questionnaire.	Aldossri M, 2020, J CAN DENT ASSOC, V86; American Dental Association, 2012, STAT HUM PAP SQUAM C; [Anonymous], 2017, Pediatr Dent, V39, P81; [Anonymous], 2016, CAN CANC STAT 2016; Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chesson HW, 2014, SEX TRANSM DIS, V41, P660, DOI 10.1097/OLQ.0000000000000193; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; D'Souza G, 2020, JNCI CANCER SPECT, V4, DOI 10.1093/jncics/pkaa047; Daley E, 2014, PUBLIC HEALTH, V128, P231, DOI 10.1016/j.puhe.2013.12.002; Daley E, 2011, J PUBLIC HEALTH DENT, V71, P136, DOI 10.1111/j.1752-7325.2011.00212.x; Garland SM, 2014, CLIN THER, V36, P17, DOI 10.1016/j.clinthera.2013.12.005; Harder T, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1098-3; Hosking YP, 2017, PEDIATR DENT, V39, P383; Hswen Y, 2017, SEX TRANSM DIS, V44, P43, DOI 10.1097/OLQ.0000000000000543; Kessels SJM, 2012, VACCINE, V30, P3546, DOI 10.1016/j.vaccine.2012.03.063; Kline N, 2018, PAPILLOMAVIRUS RES, V5, P104, DOI 10.1016/j.pvr.2018.03.002; Medeiros LR, 2009, INT J GYNECOL CANCER, V19, P1166, DOI 10.1111/IGC.0b013e3181a3d100; Merckx M, 2013, EUR J CANCER PREV, V22, P277, DOI 10.1097/CEJ.0b013e3283592c46; National Advisory Committee on Immunization, 2017, UPD REC HUM PAP HPV; Parashos P, 2005, COMMUNITY DENT ORAL, V33, P9, DOI 10.1111/j.1600-0528.2004.00181.x; Paul P, 2014, VACCINE, V32, P320, DOI 10.1016/j.vaccine.2013.11.070; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Public Health England, HUMAN PAPILLOMAVIRUS; Rozier RG, 2011, J AM DENT ASSOC, V142, P518, DOI 10.14219/jada.archive.2011.0222; Shapiro GK, 2017, VACCINE, V35, P5700, DOI 10.1016/j.vaccine.2017.07.079; Shepperd JA, 2013, AM J HEALTH BEHAV, V37, P755, DOI 10.5993/AJHB.37.6.4; Tam S, 2018, ORAL ONCOL, V82, P91, DOI 10.1016/j.oraloncology.2018.04.005; Virgolino A, 2017, TXB CLIN SEXUAL MED, P53; Wilder RS, 2014, J DENT EDUC, V78, P1252; Wood ZC, 2017, J GEN VIROL, V98, P519, DOI 10.1099/jgv.0.000727	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247043	10.1371/journal.pone.0247043	http://dx.doi.org/10.1371/journal.pone.0247043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8ME	33596237	gold, Green Published			2022-12-26	WOS:000620633200037
J	Gulfo, J; Roman, JPD; Ledda, A; Junyent, F; Ramirez, MJ; Gil-Bea, FJ; Esteve, M; Grasa, M				Gulfo, Jose; de San Roman, Joana Perez; Ledda, Angelo; Junyent, Felix; Ramirez, Maria J.; Gil-Bea, Francisco J.; Esteve, Montserrat; Grasa, Mar			Corticosteroid-binding-globulin (CBG)-deficient mice show high pY216-GSK3 beta and phosphorylated-Tau levels in the hippocampus	PLOS ONE			English	Article								Corticosteroid-binding globulin (CBG) is the specific carrier of circulating glucocorticoids, but evidence suggests that it also plays an active role in modulating tissue glucocorticoid activity. CBG polymorphisms affecting its expression or affinity for glucocorticoids are associated with chronic pain, chronic fatigue, headaches, depression, hypotension, and obesity with an altered hypothalamic pituitary adrenal axis. CBG has been localized in hippocampus of humans and rodents, a brain area where glucocorticoids have an important regulatory role. However, the specific CBG function in the hippocampus is yet to be established. The aim of this study was to investigate the effect of the absence of CBG on hippocampal glucocorticoid levels and determine whether pathways regulated by glucocorticoids would be altered. We used cbg(-/-) mice, which display low total-corticosterone and high free-corticosterone blood levels at the nadir of corticosterone secretion (morning) and at rest to evaluate the hippocampus for total- and free-corticosterone levels; 11 beta-hydroxysteroid dehydrogenase expression and activity; the expression of key proteins involved in glucocorticoid activity and insulin signaling; microtubule-associated protein tau phosphorylation, and neuronal and synaptic function markers. Our results revealed that at the nadir of corticosterone secretion in the resting state the cbg(-/-) mouse hippocampus exhibited slightly elevated levels of free-corticosterone, diminished FK506 binding protein 5 expression, increased corticosterone downstream effectors and altered MAPK and PI3K pathway with increased pY216-GSK3 beta and phosphorylated tau. Taken together, these results indicate that CBG deficiency triggers metabolic imbalance which could lead to damage and long-term neurological pathologies.	[Gulfo, Jose; Ledda, Angelo; Esteve, Montserrat; Grasa, Mar] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biomed, Barcelona, Spain; [Gulfo, Jose; Ledda, Angelo; Esteve, Montserrat; Grasa, Mar] Inst Hlth Carlos III, CIBER Obes & Nutr, Madrid, Spain; [Gulfo, Jose; Ledda, Angelo; Esteve, Montserrat; Grasa, Mar] Univ Barcelona, Inst Biomed, Barcelona, Spain; [de San Roman, Joana Perez; Ramirez, Maria J.] Univ Navarra, Dept Pharmacol & Toxicol, Pamplona, Spain; [de San Roman, Joana Perez; Gil-Bea, Francisco J.] Univ Navarra, Ctr Appl Med Res CIMA, Neurosci, Pamplona, Spain; [Junyent, Felix] Univ Barcelona, Fac Biol, Dept Cellular Biol Physiol & Immunol, Barcelona, Spain; [Ramirez, Maria J.] IdiSNA Navarra Inst Hlth Res, Pamplona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Barcelona; University of Navarra; University of Navarra; University of Barcelona	Esteve, M (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biomed, Barcelona, Spain.; Esteve, M (corresponding author), Inst Hlth Carlos III, CIBER Obes & Nutr, Madrid, Spain.; Esteve, M (corresponding author), Univ Barcelona, Inst Biomed, Barcelona, Spain.	mesteve@ub.edu	Gil-Bea, Francisco Javier/GQY-6096-2022; Gil-Bea, Francisco J/T-8090-2017; Esteve, Montserrat/AAR-4146-2021; Ramirez, Maria J/H-4383-2017; Esteve, Montserrat/L-6272-2014; Grasa Martinez, Maria del Mar/L-8031-2014	Esteve, Montserrat/0000-0003-2128-7859; Ramirez, Maria J/0000-0002-3488-9579; Esteve, Montserrat/0000-0003-2128-7859; Grasa Martinez, Maria del Mar/0000-0001-6362-0504	Instituto de Salud Carlos III [PI09/00505, PI13/00858]; University of Barcelona; European and Sardinian scholarship "Master and Back"	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); University of Barcelona; European and Sardinian scholarship "Master and Back"	The investigation was supported by the Instituto de Salud Carlos III (PI09/00505 and PI13/00858). JG was the recipient of a predoctoral scholarship from the University of Barcelona and AL was the recipient of a European and Sardinian scholarship "Master and Back". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie HC, 2011, J PSYCHIATR RES, V45, P15, DOI 10.1016/j.jpsychires.2010.10.005; Aisa B, 2007, PSYCHONEUROENDOCRINO, V32, P256, DOI 10.1016/j.psyneuen.2006.12.013; AMATRUDA J M, 1985, Diabetes Metabolism Reviews, V1, P293; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; Chun TY, 2005, MOL CELL ENDOCRINOL, V239, P55, DOI 10.1016/j.mce.2005.03.016; Cizza G, 2012, J CLIN ENDOCR METAB, V97, P77, DOI 10.1210/jc.2011-3090; Coluccia D, 2008, J NEUROSCI, V28, P3474, DOI 10.1523/JNEUROSCI.4893-07.2008; Cruz-Topete D, 2015, NEUROIMMUNOMODULAT, V22, P20, DOI 10.1159/000362724; Csernansky JG, 2006, AM J PSYCHIAT, V163, P2164, DOI 10.1176/appi.ajp.163.12.2164; Datson NA, 2001, EUR J NEUROSCI, V14, P675, DOI 10.1046/j.0953-816x.2001.01685.x; de Castro-Catala M, 2017, PSYCHONEUROENDOCRINO, V85, P200, DOI 10.1016/j.psyneuen.2017.08.024; de Kloet ER, 2008, FRONT NEUROENDOCRIN, V29, P268, DOI 10.1016/j.yfrne.2007.10.002; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; de Medeiros GF, 2019, NEUROENDOCRINOLOGY, V109, P322, DOI 10.1159/000499827; Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743; Dobarro M, 2013, INT J NEUROPSYCHOPH, V16, P1351, DOI 10.1017/S1461145712001393; Elgh E, 2006, BIOL PSYCHIAT, V59, P155, DOI 10.1016/j.biopsych.2005.06.017; Gallo LI, 2007, BIOCHEMISTRY-US, V46, P14044, DOI 10.1021/bi701372c; Gil-Bea FJ, 2010, J ALZHEIMERS DIS, V22, P829, DOI 10.3233/JAD-2010-100663; Gomez-Sanchez EP, 2014, STEROIDS, V91, P20, DOI 10.1016/j.steroids.2014.08.014; Grasa MD, 2001, MOL CELL BIOCHEM, V228, P25, DOI 10.1023/A:1013304223967; Gulfo J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50355-1; Gulfo J, 2016, OBESITY, V24, P1677, DOI 10.1002/oby.21543; Gulfo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146497; Hoppstadter J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01446; Kalman BA, 2002, ENDOCRINOLOGY, V143, P4184, DOI 10.1210/en.2002-220375; Kennedy CLM, 2020, J NEUROENDOCRINOL, V32, DOI 10.1111/jne.12820; Ledda Angelo, 2013, OBESITY FACTS, P69; Lewis JG, 2005, CLIN CHIM ACTA, V359, P189, DOI 10.1016/j.cccn.2005.03.044; Li JG, 2019, BEHAV BRAIN RES, V365, P150, DOI 10.1016/j.bbr.2019.03.010; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; Meyer EJ, 2016, HORM METAB RES, V48, P359, DOI 10.1055/s-0042-108071; Mifsud KR, 2016, P NATL ACAD SCI USA, V113, P11336, DOI 10.1073/pnas.1605246113; Minni AM, 2014, PSYCHONEUROENDOCRINO, V50, P252, DOI 10.1016/j.psyneuen.2014.07.029; Minni AM, 2012, ENDOCRINOLOGY, V153, P4766, DOI 10.1210/en.2012-1485; Moisan MP, 2014, STEROIDS, V81, P109, DOI 10.1016/j.steroids.2013.10.013; MOISAN MP, 1990, ENDOCRINOLOGY, V127, P1450, DOI 10.1210/endo-127-3-1450; Nishi M, 2004, J NEUROSCI, V24, P4918, DOI 10.1523/JNEUROSCI.5495-03.2004; Nishi M, 2011, ACTA HISTOCHEM CYTOC, V44, P1, DOI 10.1267/ahc.10028; Perez-Perez B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193044; PERROTAPPLANAT M, 1984, ENDOCRINOLOGY, V115, P559, DOI 10.1210/endo-115-2-559; Petersen HH, 2006, MOL CELL BIOL, V26, P7236, DOI 10.1128/MCB.00400-06; Piroli GG, 2007, NEUROENDOCRINOLOGY, V85, P71, DOI 10.1159/000101694; PREDINE J, 1984, J CLIN ENDOCR METAB, V58, P6, DOI 10.1210/jcem-58-1-6; Radhakutty A, 2016, CLIN ENDOCRINOL, V85, P741, DOI 10.1111/cen.13138; Rafacho A, 2014, J ENDOCRINOL, V223, pR49, DOI 10.1530/JOE-14-0373; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Richard EM, 2010, ENDOCRINOLOGY, V151, P649, DOI 10.1210/en.2009-0862; Sivukhina EV, 2006, HORM METAB RES, V38, P253, DOI 10.1055/s-2006-925346; Sivukhina E, 2013, J EXP BIOL, V216, P245, DOI 10.1242/jeb.076893; Solas M, 2013, J NEUROENDOCRINOL, V25, P350, DOI 10.1111/jne.12006; Solas M, 2013, BBA-MOL BASIS DIS, V1832, P2332, DOI 10.1016/j.bbadis.2013.09.013; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Tchoukaev A, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00545; vanSteensel B, 1996, J CELL SCI, V109, P787; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Whirledge S, 2013, ENDOCRINOLOGY, V154, P4450, DOI 10.1210/en.2013-1652; Yau JLW, 2015, EUR J NEUROSCI, V41, P787, DOI 10.1111/ejn.12836; Zannas AS, 2016, NEUROPSYCHOPHARMACOL, V41, P261, DOI 10.1038/npp.2015.235; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x	63	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246930	10.1371/journal.pone.0246930	http://dx.doi.org/10.1371/journal.pone.0246930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592009	Green Published, gold			2022-12-26	WOS:000620632800001
J	Giron-Calva, PS; Lopez, C; Albacete, A; Albajes, R; Christou, P; Eizaguirre, M				Sarai Giron-Calva, Patricia; Lopez, Carmen; Albacete, Alfonso; Albajes, Ramon; Christou, Paul; Eizaguirre, Matilde			beta-carotene and Bacillus thuringiensis insecticidal protein differentially modulate feeding behaviour, mortality and physiology of European corn borer (Ostrinia nubilalis)	PLOS ONE			English	Article								Maize with enhanced beta-carotene production was engineered to counteract pervasive vitamin A deficiency in developing countries. Second-generation biofortified crops are being developed with additional traits that confer pest resistance. These include crops that can produce Bacillus thuringiensis Berliner (Bt) insecticidal proteins. Currently, it is unknown whether beta-carotene can confer fitness benefits through to insect pests, specifically through altering Ostrinia nubilalis foraging behaviour or development in the presence of Bt insecticidal toxin. Therefore the effects of dietary beta-carotene plus Bt insecticidal protein on feeding behaviour, mortality, and physiology in early and late instars of O. nubilalis larvae were investigated. The results of two-choice experiments showed that irrespective of beta-carotene presence, at day five 68%-90% of neonates and 69%-77% of fifth-instar larvae avoided diets with Cry1A protein. Over 65% of neonate larvae preferred to feed on diets with beta-carotene alone compared to 39% of fifth-instar larvae. Higher mortality (65%-97%) in neonates fed diets supplemented with beta-carotene alone and in combination with Bt protein was found, whereas <36% mortality was observed when fed diets without supplemented beta-carotene or Bt protein. Diets with both beta-carotene and Bt protein extended 25 days the larval developmental duration from neonate to fifth instar (compared to Bt diets) but did not impair larval or pupal weight. Juvenile hormone and 20-hydroxyecdysone regulate insect development and their levels were at least 3-fold higher in larvae fed diets with beta-carotene for 3 days. Overall, these results suggest that the effects of beta-carotene and Bt protein on O. nubilalis is dependent on larval developmental stage. This study is one of the first that provides insight on how the interaction of novel traits may modulate crop susceptibility to insect pests. This understanding will in turn inform the development of crop protection strategies with greater efficacy.	[Sarai Giron-Calva, Patricia; Lopez, Carmen; Albajes, Ramon; Christou, Paul; Eizaguirre, Matilde] Univ Lleida, Dept Plant Prod & Forestry Sci, Agrotecnio Ctr, Lleida, Spain; [Albacete, Alfonso] Inst Murciano Invest & Desarrollo Agrario & Alime, Murcia, Spain; [Christou, Paul] Catalan Inst Res & Adv Studies, ICREA, Barcelona, Spain	Universitat de Lleida; ICREA	Eizaguirre, M (corresponding author), Univ Lleida, Dept Plant Prod & Forestry Sci, Agrotecnio Ctr, Lleida, Spain.	matilde.eizaguirre@udl.net	Lopez, Carmen/K-9280-2014; Eizaguirre, Matilde/B-4109-2011; Albajes, Ramon/AAZ-3784-2021; Albacete, Alfonso/K-6093-2014	Lopez, Carmen/0000-0001-5447-009X; Eizaguirre, Matilde/0000-0001-9371-3314; Albajes, Ramon/0000-0003-3133-7944; Albacete, Alfonso/0000-0003-1332-8593; Giron-Calva, Patricia/0000-0003-0166-8478	Agrotecnio Fellowship [AGL2017-84127-R]; Spanish R&D Agency (Comision Interministerial de Ciencia y Tecnologia)	Agrotecnio Fellowship; Spanish R&D Agency (Comision Interministerial de Ciencia y Tecnologia)	This work was partially supported through an Agrotecnio Fellowship and the AGL2017-84127-R project from the Spanish R&D Agency (Comision Interministerial de Ciencia y Tecnologia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MI, 1999, J CHEM ECOL, V25, P2193, DOI 10.1023/A:1021053226713; Apirajkamol N, 2020, ECOL EVOL, V10, P5680, DOI 10.1002/ece3.6308; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Bernays EA, 2001, J INSECT PHYSIOL, V47, P1029, DOI 10.1016/S0022-1910(01)00079-8; Broderick NA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-129; Browder M. H., 2001, Journal of Insect Science (Tucson), V1, P1; Clark KA, 2018, ENVIRON ENTOMOL, V47, P1618, DOI 10.1093/ee/nvy148; COLL M, 1991, ENVIRON ENTOMOL, V20, P526, DOI 10.1093/ee/20.2.526; Dubovskii I.M., 2005, Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, V41, P18; Dubovskiy IM, 2008, COMP BIOCHEM PHYS C, V148, P1, DOI 10.1016/j.cbpc.2008.02.003; Eichenseer H, 2002, J INSECT PHYSIOL, V48, P311, DOI 10.1016/S0022-1910(01)00178-0; EIZAGUIRRE M, 1992, ENTOMOL GEN, V17, P277; Enya S, 2017, GENETICS, V207, P1519, DOI 10.1534/genetics.117.300391; FELTON GW, 1995, ARCH INSECT BIOCHEM, V29, P187, DOI 10.1002/arch.940290208; FELTWELL J, 1974, J ZOOL, V174, P441; Garg M, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00012; Goggin FL, 2010, BIOESSAYS, V32, P777, DOI 10.1002/bies.200900187; Goldstein JA, 2010, J ECON ENTOMOL, V103, P331, DOI 10.1603/EC09304; Guo W, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008762; Heath JJ, 2013, ARTHROPOD-PLANT INTE, V7, P1, DOI 10.1007/s11829-012-9239-7; Holopainen JK, 2010, TRENDS PLANT SCI, V15, P176, DOI 10.1016/j.tplants.2010.01.006; Honda Y, 2017, GEN COMP ENDOCR, V247, P183, DOI 10.1016/j.ygcen.2017.01.032; Huang FN, 1999, J ECON ENTOMOL, V92, P547, DOI 10.1093/jee/92.3.547; Huang FN, 2001, ENTOMOL EXP APPL, V98, P141, DOI 10.1023/A:1018780325689; Jamieson MA, 2017, CURR OPIN INSECT SCI, V23, P70, DOI 10.1016/j.cois.2017.07.009; Johnson KS, 2001, J CHEM ECOL, V27, P2579, DOI 10.1023/A:1013691802028; Jouni ZE, 1996, J BIOL CHEM, V271, P14722, DOI 10.1074/jbc.271.25.14722; Kodrik D, 2015, INT J MOL SCI, V16, P25788, DOI 10.3390/ijms161025788; Li Z, 2016, PEST MANAG SCI, V72, P1359, DOI 10.1002/ps.4160; Munoz P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099229; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; Ojala K, 2005, EVOL ECOL RES, V7, P1153; Prasifka JR, 2010, J INSECT BEHAV, V23, P1, DOI 10.1007/s10905-009-9190-3; Ryan RO, 2000, ANNU REV ENTOMOL, V45, P233, DOI 10.1146/annurev.ento.45.1.233; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Singer MS, 2002, ANIM BEHAV, V64, P629, DOI 10.1006/anbe.2002.3082; Smilanich AM, 2011, OECOLOGIA, V165, P995, DOI 10.1007/s00442-010-1803-1; Sollai G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100675; Sun YX, 2018, BIOL CONTROL, V123, P105, DOI 10.1016/j.biocontrol.2018.04.010; TRUMAN JW, 1974, J EXP BIOL, V60, P371; von Lintig J, 2001, P NATL ACAD SCI USA, V98, P1130, DOI 10.1073/pnas.031576398; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Watanabe D, 2011, J INSECT PHYSIOL, V57, P791, DOI 10.1016/j.jinsphys.2011.03.005; Wright GA, 2016, CURR OPIN NEUROBIOL, V41, P87, DOI 10.1016/j.conb.2016.09.005; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220; Zanga D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199317; Zheng SJ, 2010, NEW PHYTOL, V186, P733, DOI 10.1111/j.1469-8137.2010.03213.x; Zhou BH, 2001, DEV BIOL, V231, P125, DOI 10.1006/dbio.2000.0143; Zhu C, 2018, PHYTOCHEM REV, V17, P195, DOI 10.1007/s11101-017-9506-4; Zhu CF, 2008, P NATL ACAD SCI USA, V105, P18232, DOI 10.1073/pnas.0809737105; Zou FM, 2011, MOL BIOL REP, V38, P639, DOI 10.1007/s11033-010-0150-y	51	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246696	10.1371/journal.pone.0246696	http://dx.doi.org/10.1371/journal.pone.0246696			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33591990	Green Published, gold			2022-12-26	WOS:000620632800054
J	Schmidt, MM; Griffin, JM; McCabe, P; Stuart-Mullen, L; Branda, M; OByrne, TJ; Bowers, M; Trotter, K; McLeod, C				Schmidt, Monika M.; Griffin, Joan M.; McCabe, Pamela; Stuart-Mullen, Lynette; Branda, Megan; OByrne, Thomas J.; Bowers, Margaret; Trotter, Kathryn; McLeod, Christopher			Shared medical appointments: Translating research into practice for patients treated with ablation therapy for atrial fibrillation	PLOS ONE			English	Article								Background People with atrial fibrillation (AF) have lower reported quality of life and increased risk of heart attack, death, and stroke. Lifestyle modifications can improve arrhythmia-free survival/symptom severity. Shared medical appointments (SMAs) have been effective at targeting lifestyle change in other chronic diseases and may be beneficial for patients with AF. Objective To determine if perceived self-management and satisfaction with provider communication differed between patients who participated in SMAs compared to patients in standard care. Secondary objectives were to examine differences between groups for knowledge about AF, symptom severity, and healthcare utilization. Methods We conducted a retrospective analysis of data collected where patients were assigned to either standard care (n = 62) or a SMA (n = 59). Surveys were administered at pre-procedure, 3, and 6 months. Results Perceived self-management was not significantly different at baseline (p = 0.95) or 6 months (p = 0.21). Patients in SMAs reported more knowledge gain at baseline (p = 0.01), and higher goal setting at 6 months (p = 0.0045). Symptom severity for both groups followed similar trends. Conclusion Patients with AF who participated in SMAs had similar perceived self-management, patient satisfaction with provider communication, symptom severity, and healthcare utilization with their counterparts, but had a statistically significant improvement in knowledge about their disease.	[Schmidt, Monika M.] US Dept Vet Affairs, Nashville, TN 37203 USA; [Griffin, Joan M.; McCabe, Pamela; Stuart-Mullen, Lynette; OByrne, Thomas J.] Mayo Clin, Rochester, MN USA; [Branda, Megan] Univ Colorado Denver, Dept Biostat & Informat, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA; [Bowers, Margaret; Trotter, Kathryn] Duke Univ, Durham, NC USA; [McLeod, Christopher] Mayo Clin, Jacksonville, FL 32224 USA	US Department of Veterans Affairs; Mayo Clinic; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University; Mayo Clinic	Schmidt, MM (corresponding author), US Dept Vet Affairs, Nashville, TN 37203 USA.	monika.schmidt@va.gov		Schmidt, Monika/0000-0001-6414-7974				[Anonymous], 1998, ABSTRACT SESSION 1 T, V21, P790; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; Bos-Touwen I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126400; Calkins H, 2018, EUROPACE, V20, P157, DOI [10.1093/europace/eux275, 10.1016/j.hrthm.2017.05.012, 10.1093/europace/eux274]; Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063; Dimitrov Dimiter M, 2003, Work, V20, P159; Edelman D., 2012, VA EVIDENCE BASED SY; Edelman D, 2015, J GEN INTERN MED, V30, P99, DOI 10.1007/s11606-014-2978-7; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Greene J, 2012, J GEN INTERN MED, V27, P520, DOI 10.1007/s11606-011-1931-2; Haslam SA, 2009, APPL PSYCHOL-INT REV, V58, P1, DOI 10.1111/j.1464-0597.2008.00379.x; Heyworth L, 2014, ANN FAM MED, V12, P324, DOI 10.1370/afm.1660; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Hibbard JH, 2007, HEALTH SERV RES, V42, P1443, DOI 10.1111/j.1475-6773.2006.00669.x; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Jhagroo RA, 2013, J UROLOGY, V190, P1778, DOI 10.1016/j.juro.2013.05.037; Kim MH, 2011, CIRC-CARDIOVASC QUAL, V4, P313, DOI 10.1161/CIRCOUTCOMES.110.958165; Koponen L, 2008, J ADV NURS, V61, P51, DOI 10.1111/j.1365-2648.2007.04465.x; Lane DA., 2015, REV ESP CARDIOL, DOI DOI 10.1093/EUROPACE/EUV233; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Mark DB, 2019, JAMA-J AM MED ASSOC, V321, P1275, DOI 10.1001/jama.2019.0692; McCabe PJ, 2018, PATIENT PREFER ADHER, V12, P1907, DOI 10.2147/PPA.S172970; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Palaniappan LP, 2011, J AM BOARD FAM MED, V24, P326, DOI 10.3122/jabfm.2011.03.100220; Pathak RK, 2015, J AM COLL CARDIOL, V65, P2159, DOI 10.1016/j.jacc.2015.03.002; Pathak RK, 2014, J AM COLL CARDIOL, V64, P2222, DOI 10.1016/j.jacc.2014.09.028; Paul S, 2013, HEART LUNG, V42, P456, DOI 10.1016/j.hrtlng.2013.08.006; Rahaghi FF, 2014, PULM CIRC, V4, P53, DOI 10.1086/674883; Riley SB, 2013, J AM ASSOC NURSE PRA, V25, P466, DOI 10.1111/j.1745-7599.2012.00796.x; Seesing FM, 2014, NEUROLOGY, V83, P240, DOI 10.1212/WNL.0000000000000588; Smith Carol E, 2015, J Cardiovasc Nurs, V30, pS25, DOI 10.1097/JCN.0000000000000255; Trotter Kathryn J, 2013, Nurse Pract, V38, P48, DOI 10.1097/01.NPR.0000428816.72503.49	34	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246861	10.1371/journal.pone.0246861	http://dx.doi.org/10.1371/journal.pone.0246861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK0KW	33577612	gold, Green Published			2022-12-26	WOS:000620071700032
J	Moreno, GL; Nirmala, J; Goodell, C; Culhane, M; Torremorell, M				Moreno, Gustavo Lopez; Nirmala, Jayaveeramuthu; Goodell, Christa; Culhane, Marie; Torremorell, Montserrat			Shedding and transmission of a live attenuated influenza A virus vaccine in pre-weaned pigs under field conditions	PLOS ONE			English	Article							SWINE INFLUENZA; EFFICACY	Influenza A virus (IAV) is one of the most important respiratory viruses affecting pig health and vaccination is the most common strategy to control influenza infections. In this field study we assessed the onset and duration of shedding of a live attenuated influenza virus (LAIV) vaccine, its ability to transmit to non-vaccinated pigs and whether the LAIV could be aerosolized and detected in the environment. Thirty-three litters (n = 33) of a farm using the LAIV vaccine were selected for the study, a subset of them (n = 12) were left unvaccinated and a subset of piglets (n = 3) in vaccinated litters were also left unvaccinated to serve as sentinels. Selected piglets from the litters were sampled multiple days post vaccination (DPV) by collecting nasal swabs and blood, and were tested using a LAIV vaccine specific RT-PCR assay and hemagglutination inhibition assay against the LAIV strains respectively. Environmental specimens consisting of air and surface wipes were also collected. One hundred percent (21/21) of the vaccinated litters tested LAIV positive 1 DPV and until 6 DPV. In contrast, only five (5/33) of the thirty-three non-vaccinated pigs tested positive during the course of the study. Viable LAIV was confirmed in vaccinated pigs by cell culture and whole genome sequencing. In addition, low levels of LAIV RNA (RT-PCR Ct values ranging between 33 and 38) were detected in all air specimens collected on the day of vaccination and until 6 DPV (3/10). Pigs had maternally derived antibodies reactive against the LAIV strains which may have influenced the degree of shedding observed. Under the conditions of this study, shedding of the LAIV from vaccinated pigs was limited in time, resulted in minimal transmission to non-vaccinated pigs and was detected in low levels in aerosols collected in the vaccinated rooms likely influenced by the presence of maternally derived antibodies against the LAIV strains.	[Moreno, Gustavo Lopez; Nirmala, Jayaveeramuthu; Culhane, Marie; Torremorell, Montserrat] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Goodell, Christa] Boehringer Ingelheim Anim Hlth USA Inc, Duluth, GA USA	University of Minnesota System; University of Minnesota Twin Cities	Torremorell, M (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	Torr0033@umn.edu		Culhane, Marie/0000-0002-3547-7576	Boehringer Ingelheim Animal Health USA Inc., Duluth, Georgia, United States of America	Boehringer Ingelheim Animal Health USA Inc., Duluth, Georgia, United States of America	This study was funded by Boehringer Ingelheim Animal Health USA Inc., Duluth, Georgia, United States of America. The funder provided support in the form of salaries for authors [CG] and consulting fees for author [MT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Allerson M, 2013, VACCINE, V31, P500, DOI 10.1016/j.vaccine.2012.11.023; [Anonymous], 2014, REG ANESTH PAIN MED; Bosworth B, 2010, COMP IMMUNOL MICROB, V33, pE99, DOI 10.1016/j.cimid.2010.05.002; Ciacci-Zanella JR, 2010, J VET DIAGN INVEST, V22, P3, DOI 10.1177/104063871002200102; Corzo CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071444; Detmer SE., 2016, ANIMAL INFLUENZA, V2, P439; Garrido-Mantilla J, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1805-0; Genzow M, 2018, INFLUENZA OTHER RESP, V12, P353, DOI 10.1111/irv.12531; Goodell W. C. C, 2018, 2018 ADL SWIN C, P86; Holtkamp DJ, 2011, J SWINE HEALTH PROD, V19, P44; Kaiser TJ, 2019, INFLUENZA OTHER RESP, V13, P274, DOI 10.1111/irv.12630; Lee JH, 2007, CAN J VET RES, V71, P207; MEGURO H, 1979, J CLIN MICROBIOL, V9, P175; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Pardo FOC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210700; Rajao DS, 2018, VIROLOGY, V518, P45, DOI 10.1016/j.virol.2018.02.006; Rajao DS, 2016, J GEN VIROL, V97, P1489, DOI 10.1099/jgv.0.000468; Sharma A, 2020, J VET DIAGN INVEST, V32, P301, DOI 10.1177/1040638720907918; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Sreevatsan S, 2017, J VIROL, V91; Suarez D.L., 2016, ANIMAL INFLUENZA, P1, DOI [10.1002/9781118924341.ch1, DOI 10.1002/9781118924341.CH1]; Torremorell M., 2016, Animal influenza, P452; Torremorell M, 2012, TRANSBOUND EMERG DIS, V59, P68, DOI 10.1111/j.1865-1682.2011.01300.x; USDA, 2016, SWIN 2012 2, P140; Van Reeth K, 2001, VACCINE, V19, P4479, DOI 10.1016/S0264-410X(01)00206-7; van Reeth K., 2012, DIS SWINE, V11; Van Reeth K, 2007, VET RES, V38, P243, DOI 10.1051/vetres:2006062; Van Reeth K, 2013, CURR TOP MICROBIOL, V370, P173, DOI 10.1007/82_2012_266; Vincent AL, 2007, VACCINE, V25, P7999, DOI 10.1016/j.vaccine.2007.09.019; Vincent AL, 2012, J VIROL, V86, P10597, DOI 10.1128/JVI.01439-12; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246690	10.1371/journal.pone.0246690	http://dx.doi.org/10.1371/journal.pone.0246690			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571263	Green Published, gold			2022-12-26	WOS:000618274000066
J	Whisler, A; Dosani, N; To, MJ; O'Brien, K; Young, S; Hwang, SW				Whisler, Adam; Dosani, Naheed; To, Matthew J.; O'Brien, Kristen; Young, Samantha; Hwang, Stephen W.			The effect of a Housing First intervention on primary care retention among homeless individuals with mental illness	PLOS ONE			English	Article							HIV; SERVICES; HEALTH; ADULTS; VETERANS; OUTCOMES; SUPPORT; CHOICE; ACCESS	Background Primary care retention, defined as ongoing periodic contact with a consistent primary care provider, is beneficial for people with serious chronic illnesses. This study examined the effect of a Housing First intervention on primary care retention among homeless individuals with mental illness. Methods Two hundred individuals enrolled in the Toronto site of the At Home Project and randomized to Housing First or Treatment As Usual were studied. Medical records were reviewed to determine if participants were retained in primary care, defined as having at least one visit with the same primary care provider in each of two consecutive six-month periods during the 12 month period preceding and following randomization. Results Medical records were obtained for 47 individuals randomized to Housing First and 40 individuals randomized to Treatment As Usual. During the one year period following randomization, the proportion of Housing First and Treatment As Usual participants retained in primary care was not significantly different (38.3% vs. 47.5%, p = 0.39). The change in primary care retention rates from the year preceding randomization to the year following randomization was +10.6% in the Housing First group and -5.0% in the Treatment As Usual group. Conclusion Among homeless individuals with mental illness, Housing First did not significantly affect primary care retention over the follow-up period. These findings suggest Housing First interventions may need to place greater emphasis on connecting clients with primary care providers.	[Whisler, Adam; To, Matthew J.; O'Brien, Kristen; Young, Samantha; Hwang, Stephen W.] St Michaels Hosp, Li Ka Shing Knowledge Inst, MAP Ctr Urban Hlth Solut, Toronto, ON, Canada; [Dosani, Naheed] Inner City Hlth Associates, Toronto, ON, Canada; [Dosani, Naheed] St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada; [Dosani, Naheed] McMaster Univ, Fac Hlth Sci, Div Palliat Care, Hamilton, ON, Canada; [Dosani, Naheed] William Osler Hlth Syst, Div Palliat Care, Brampton, ON, Canada; [Hwang, Stephen W.] Univ Toronto, Dept Med, Div Gen Internal Med, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; University of Toronto	Dosani, N (corresponding author), Inner City Hlth Associates, Toronto, ON, Canada.; Dosani, N (corresponding author), St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada.; Dosani, N (corresponding author), McMaster Univ, Fac Hlth Sci, Div Palliat Care, Hamilton, ON, Canada.; Dosani, N (corresponding author), William Osler Hlth Syst, Div Palliat Care, Brampton, ON, Canada.	dosanin@smh.ca	Hwang, Stephen W./GVR-7773-2022		Health Canada	Health Canada	This research has been made possible through a financial contribution from Health Canada (https://www.canada.ca/en/health-canada. html). The views expressed herein solely represent the authors. The Mental Health Commission of Canada (https://www.mentalhealthcommission.ca/English) oversaw the conduct of the study and provided training and technical support to the service teams and research staff throughout the project. However, the funder had no role in the analysis and interpretation of the data, preparation, review or approval of the manuscript.	Appel PW, 2012, J ADDICT DIS, V31, P270, DOI 10.1080/10550887.2012.694602; Argintaru N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-577; Cabral HJ, 2007, AIDS PATIENT CARE ST, V21, pS59, DOI 10.1089/apc.2007.9986; Chrystal JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117395; Ciaranello AL, 2006, J HEALTH CARE POOR U, V17, P441, DOI 10.1353/hpu.2006.0056; City of Toronto, 2018, STREET NEEDS ASS RES; Fareed A, 2009, J PSYCHIATR PRACT, V15, P227, DOI 10.1097/01.pra.0000351884.83377.e2; Fekadu A, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0138-x; Frankish CJ, 2005, CAN J PUBLIC HEALTH, V96, pS23, DOI 10.1007/BF03403700; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Goering P, 2002, PSYCHIAT SERV, V53, P1472, DOI 10.1176/appi.ps.53.11.1472; Goering PN, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000323; Greenwood RM, 2005, AM J COMMUN PSYCHOL, V36, P223, DOI 10.1007/s10464-005-8617-z; Havens JR, 2009, J SUBST ABUSE TREAT, V36, P306, DOI 10.1016/j.jsat.2008.07.002; Health Quality Ontario, 2016, Ont Health Technol Assess Ser, V16, P1; Hwang SW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-787; Hwang SW, 2001, CAN MED ASSOC J, V164, P229; Khandor Erika, 2011, Open Med, V5, pe94; Kresky-Wolff M, 2010, J BEHAV HEALTH SER R, V37, P213, DOI 10.1007/s11414-009-9206-y; Kushel MB, 2002, AM J PUBLIC HEALTH, V92, P778, DOI 10.2105/AJPH.92.5.778; Mares AS, 2011, ADM POLICY MENT HLTH, V38, P459, DOI 10.1007/s10488-011-0333-4; Marx KA, 2011, AIDS CARE, V23, P1298, DOI 10.1080/09540121.2011.555942; McCarthy JF, 2007, HEALTH SERV RES, V42, P1042, DOI 10.1111/j.1475-6773.2006.00642.x; McGuire J, 2009, ADM POLICY MENT HLTH, V36, P255, DOI 10.1007/s10488-009-0210-6; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Naar-King S, 2007, AIDS PATIENT CARE ST, V21, pS40, DOI 10.1089/apc.2007.9988; Nelson G, 2007, AM J ORTHOPSYCHIAT, V77, P350, DOI 10.1037/0002-9432.77.3.350; Padgett DK, 2006, RES SOCIAL WORK PRAC, V16, P74, DOI 10.1177/1049731505282593; Sherer R, 2002, AIDS CARE, V14, pS31, DOI 10.1080/09540120220149975; Smartt C, 2019, BJPSYCH OPEN, V5, DOI 10.1192/bjo.2019.32; Tsemberis S, 2004, AM J PUBLIC HEALTH, V94, P651, DOI 10.2105/AJPH.94.4.651; Tsemberis S, 1999, New Dir Ment Health Serv, P9, DOI 10.1002/yd.23319998204; Tsemberis S, 2000, PSYCHIATR SERV, V51, P487, DOI 10.1176/appi.ps.51.4.487; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yehia BR, 2012, AIDS, V26, P1131, DOI 10.1097/QAD.0b013e3283528afa	37	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246859	10.1371/journal.pone.0246859	http://dx.doi.org/10.1371/journal.pone.0246859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571302	gold, Green Published			2022-12-26	WOS:000618274000060
J	Thabault, L; Liberelle, M; Koruza, K; Yildiz, E; Joudiou, N; Messens, J; Brisson, L; Wouters, J; Sonveaux, P; Frederick, R				Thabault, Leopold; Liberelle, Maxime; Koruza, Katarina; Yildiz, Esra; Joudiou, Nicolas; Messens, Joris; Brisson, Lucie; Wouters, Johan; Sonveaux, Pierre; Frederick, Raphael			Discovery of a novel lactate dehydrogenase tetramerization domain using epitope mapping and peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; LUNG-CANCER; INHIBITORS; IDENTIFICATION; TUMORS; VULNERABILITY; DISSOCIATION; METABOLISM; INTERFACE; POTENT	Despite being initially regarded as a metabolic waste product, lactate is now considered to serve as a primary fuel for the tricarboxylic acid cycle in cancer cells. At the core of lactate metabolism, lactate dehydrogenases (LDHs) catalyze the interconversion of lactate to pyruvate and as such represent promising targets in cancer therapy. However, direct inhibition of the LDH active site is challenging from physicochemical and selectivity standpoints. However, LDHs are obligate tetramers. Thus, targeting the LDH tetrameric interface has emerged as an appealing strategy. In this work, we examine a dimeric construct of truncated human LDH to search for new druggable sites. We report the identification and characterization of a new cluster of interactions in the LDH tetrameric interface. Using nanoscale differential scanning fluorimetry, chemical denaturation, and mass photometry, we identified several residues (E62, D65, L71, and F72) essential for LDH tetrameric stability. Moreover, we report a family of peptide ligands based on this cluster of interactions. We next demonstrated these ligands to destabilize tetrameric LDHs through binding to this new tetrameric interface using nanoscale differential scanning fluorimetry, NMR water-ligand observed via gradient spectroscopy, and microscale thermophoresis. Altogether, this work provides new insights on the LDH tetrameric interface as well as valuable pharmacological tools for the development of LDH tetramer disruptors.	[Thabault, Leopold; Liberelle, Maxime; Yildiz, Esra; Frederick, Raphael] Univ Catholique Louvain UCLouvain, Louvain Drug Res Inst LDRI, Brussels, Belgium; [Thabault, Leopold; Sonveaux, Pierre] Univ Catholique Louvain UCLouvain, Inst Rech Expt & Clin IREC, Pole Pharmacol & Therapeut, Brussels, Belgium; [Koruza, Katarina; Messens, Joris] VIB VUB Ctr Struct Biol, Brussels, Belgium; [Koruza, Katarina; Messens, Joris] Brussels Ctr Redox Biol, Redox Signaling Lab, Brussels, Belgium; [Koruza, Katarina; Messens, Joris] Vrije Univ Brussel, Struct Biol Brussels, Brussels, Belgium; [Joudiou, Nicolas] Univ Catholique Louvain UCLouvain, Louvain Drug Res Inst LDRI, Nucl & Electron Spin Technol, Brussels, Belgium; [Brisson, Lucie] Univ Tours, Nutr Growth & Canc, INSERM, UMR1069, Tours, France; [Wouters, Johan] Univ Namur, Dept Chem, UNamur, NARILIS, Namur, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; University of Namur	Frederick, R (corresponding author), Univ Catholique Louvain UCLouvain, Louvain Drug Res Inst LDRI, Brussels, Belgium.; Sonveaux, P (corresponding author), Univ Catholique Louvain UCLouvain, Inst Rech Expt & Clin IREC, Pole Pharmacol & Therapeut, Brussels, Belgium.	pierre.sonveaux@uclouvain.be; raphael.frederick@uclouvain.be	Liberelle, Maxime/AAB-5341-2022; Liberelle, Maxime/ADZ-6254-2022; Brisson, Lucie/R-1179-2016; Liberelle, Maxime/GQH-8403-2022; Messens, Joris/K-5856-2016	Brisson, Lucie/0000-0001-7811-1382; Liberelle, Maxime/0000-0002-8620-9256; Messens, Joris/0000-0002-2128-8264; Koruza, Katarina/0000-0002-7855-9184; Thabault, Leopold/0000-0001-9501-6563; Wouters, Johan/0000-0002-4920-6857	European Research Council [243188]; Belgian Science Policy Office (Belspo) [P7/03]; French Community of Belgium [ARC 14/19-58]; Belgian Fonds National de la Recherche Scientifique (FRS-FNRS) [3.4575.11, 2.5025.12, 31288018]; Belgian Fondation contre le Cancer [FAF-F/2018/1282]; VIB grant; Research Foundation-Flanders-Fonds de la Recherche Scientifique Excellence of Science project [30829584]; Belgian Televie [7.4611.11, 7.4548.13, 7.4507.14, 7.4647.20, 7.8504.18]	European Research Council(European Research Council (ERC)European Commission); Belgian Science Policy Office (Belspo)(Belgian Federal Science Policy Office); French Community of Belgium; Belgian Fonds National de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Belgian Fondation contre le Cancer; VIB grant; Research Foundation-Flanders-Fonds de la Recherche Scientifique Excellence of Science project; Belgian Televie	This work was supported by European Research Council independent researcher starting grant 243188 (TUMETABO), the Belgian Science Policy Office (Belspo; Interuniversity Attraction Pole Grant P7/03), the French Community of Belgium (ARC 14/19-58), the Belgian Fonds National de la Recherche Scientifique (FRS-FNRS; grants 3.4575.11, 2.5025.12, and 31288018), the Belgian Fondation contre le Cancer (Fundamental Research Grant FAF-F/2018/1282), a VIB grant (to J. M.), the Research Foundation-Flanders-Fonds de la Recherche Scientifique Excellence of Science project (30829584 to J. M.), and the Belgian Televie (grants 7.4611.11, 7.4548.13, 7.4507.14, 7.4647.20, and 7.8504.18). P. S. is a research director of the FRS-FNRS. L. T. was a PhD fellow of the FRS-FNRS and is currently a postdoctoral researcher of the Belgian Fondation contre le Cancer.	Altamimi AMS, 2017, J ENZYM INHIB MED CH, V33, P147, DOI 10.1080/14756366.2017.1404593; APPELLA E, 1961, BIOCHEM BIOPH RES CO, V6, P171, DOI 10.1016/0006-291X(61)90123-1; Beckert S, 2006, WOUND REPAIR REGEN, V14, P321, DOI 10.1111/j.1743-6109.2006.00127.x; Billiard J, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-19; Boudreau A, 2016, NAT CHEM BIOL, V12, P779, DOI 10.1038/nchembio.2143; Brisson L, 2016, CANCER CELL, V30, P418, DOI 10.1016/j.ccell.2016.08.005; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Chung TW, 2019, CANCERS, V11, DOI 10.3390/cancers11070963; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Colen CB, 2011, NEOPLASIA, V13, P620, DOI 10.1593/neo.11134; Dalvit C, 2000, J BIOMOL NMR, V18, P65, DOI 10.1023/A:1008354229396; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Dragovich PS, 2014, BIOORG MED CHEM LETT, V24, P3764, DOI 10.1016/j.bmcl.2014.06.076; Dragovich PS, 2013, BIOORG MED CHEM LETT, V23, P3186, DOI 10.1016/j.bmcl.2013.04.001; Friberg A, 2020, ACS OMEGA, V5, P13034, DOI 10.1021/acsomega.0c00715; Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263; Gunderwala AY, 2019, ACS CHEM BIOL, V14, P1471, DOI 10.1021/acschembio.9b00191; Izumi H, 2011, CANCER SCI, V102, P1007, DOI 10.1111/j.1349-7006.2011.01908.x; JAENICKE R, 1981, EUR J BIOCHEM, V114, P525, DOI 10.1111/j.1432-1033.1981.tb05176.x; Jafary F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38854-7; Kohlmann A, 2013, J MED CHEM, V56, P1023, DOI 10.1021/jm3014844; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; McCleland ML, 2012, CANCER RES, V72, P5812, DOI 10.1158/0008-5472.CAN-12-1098; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oshima N, 2020, CELL REP, V30, P1798, DOI 10.1016/j.celrep.2020.01.039; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Payen VL, 2020, MOL METAB, V33, P48, DOI 10.1016/j.molmet.2019.07.006; Qi J, 2016, CANCER RES, V76, P453, DOI 10.1158/0008-5472.CAN-15-1874; Rai G, 2017, J MED CHEM, V60, P9184, DOI 10.1021/acs.jmedchem.7b00941; Rani R, 2016, J MED CHEM, V59, P487, DOI 10.1021/acs.jmedchem.5b00168; Read JA, 2001, PROTEINS, V43, P175, DOI 10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#; Rupiani S, 2015, EUR J MED CHEM, V101, P63, DOI 10.1016/j.ejmech.2015.06.028; San-Millan I, 2017, CARCINOGENESIS, V38, P119, DOI 10.1093/carcin/bgw127; Schmidt RK, 1999, J MOL MODEL, V5, P153, DOI 10.1007/s008940050115; Seetoh WG, 2016, J AM CHEM SOC, V138, P14303, DOI 10.1021/jacs.6b07440; Smith B, 2016, CELL REP, V17, P821, DOI 10.1016/j.celrep.2016.09.045; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Thabault L, 2021, DRUG DISCOV TODAY, V26, P1148, DOI 10.1016/j.drudis.2021.01.028; Thabault L, 2020, J MED CHEM, V63, P4628, DOI 10.1021/acs.jmedchem.9b01955; Vander Jagt DL, 2000, CURR MED CHEM, V7, P479, DOI 10.2174/0929867003375119; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward RA, 2012, J MED CHEM, V55, P3285, DOI 10.1021/jm201734r; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P1772, DOI 10.4161/cc.10.11.15659; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Young G, 2018, SCIENCE, V360, P423, DOI 10.1126/science.aar5839; Zdralevic Masa, 2018, Advances in Biological Regulation, V68, P55, DOI 10.1016/j.jbior.2017.12.002	48	4	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100422	10.1016/j.jbc.2021.100422	http://dx.doi.org/10.1016/j.jbc.2021.100422			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33607109	Green Published, gold			2022-12-26	WOS:000672866400396
J	Pouzol, L; Baumlin, N; Sassi, A; Tunis, M; Marrie, J; Vezzali, E; Farine, H; Mentzel, U; Martinic, MM				Pouzol, Laetitia; Baumlin, Nadege; Sassi, Anna; Tunis, Melanie; Marrie, Julia; Vezzali, Enrico; Farine, Herve; Mentzel, Ulrich; Martinic, Marianne M.			ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases	FASEB JOURNAL			English	Article						CXCR7; experimental autoimmune encephalomyelitis; immunomodulation; myelin repair; demyelinating diseases	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOKINE RECEPTOR; REMYELINATION FAILURE; PROGENITOR CELLS; AXONAL INJURY; VIRAL MODEL; CXCL12; PROMOTES; EXPRESSION; MIGRATION	Current strategies for the treatment of demyelinating diseases such as multiple sclerosis (MS) are based on anti-inflammatory or immunomodulatory drugs. Those drugs have the potential to reduce the frequency of new lesions but do not directly promote remyelination in the damaged central nervous system (CNS). Targeting CXCR7 (ACKR3) has been postulated as a potential therapeutic approach in demyelinating diseases, leading to both immunomodulation by reducing leukocyte infiltrates and promyelination by enhancing myelin repair. ACT-1004-1239 is a potent, selective, insurmountable, and orally available first-in-class CXCR7 receptor antagonist. The effect of ACT-1004-1239 was evaluated in the myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) and the cuprizone-induced demyelination mouse models. In addition, ACT-1004-1239 was assessed in a rat oligodendrocyte precursor cell (OPC) differentiation assay in vitro. In the MOG-induced EAE model, ACT-1004-1239 treatment (10-100 mg/kg, twice daily, orally) showed a significant dose-dependent reduction in disease clinical scores, resulting in increased survival. At the highest dose tested (100 mg/kg, twice daily), ACT-1004-1239 delayed disease onset and significantly reduced immune cell infiltrates into the CNS and plasma neurofilament light chain concentration. Treatment with ACT-1004-1239 dose-dependently increased plasma CXCL12 concentration, which correlated with a reduction of the cumulative disease score. Furthermore, in the cuprizone model, ACT-1004-1239 treatment significantly increased the number of mature myelinating oligodendrocytes and enhanced myelination in vivo. In vitro, ACT-1004-1239 promoted the maturation of OPCs into myelinating oligodendrocytes. These results provide evidence that ACT-1004-1239 both reduces neuroinflammation and enhances myelin repair substantiating the rationale to explore its therapeutic potential in a clinical setting.	[Pouzol, Laetitia; Baumlin, Nadege; Sassi, Anna; Tunis, Melanie; Marrie, Julia; Vezzali, Enrico; Farine, Herve; Mentzel, Ulrich; Martinic, Marianne M.] Idorsia Pharmaceut Ltd, Allschwil, Switzerland	Idorsia Pharmaceuticals Ltd	Pouzol, L (corresponding author), Idorsia Pharmaceut Ltd, Hegenheimermattweg 91, CH-4123 Basel, Switzerland.	laetitia.pouzol@idorsia.com		Martinic, Marianne/0000-0003-4407-3423; Pouzol, Laetitia/0000-0001-8727-1142; Vezzali, Enrico/0000-0002-5550-9387				Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Banisadr G, 2016, J NEUROIMMUNE PHARM, V11, P26, DOI 10.1007/s11481-015-9616-y; Bao JH, 2016, BIOCHEM BIOPH RES CO, V469, P1, DOI 10.1016/j.bbrc.2015.11.059; Berahovich RD, 2014, IMMUNOLOGY, V141, P111, DOI 10.1111/imm.12176; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carbajal KS, 2011, GLIA, V59, P1813, DOI 10.1002/glia.21225; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Cheng WJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/659206; Chu TC, 2017, NEUROSCIENTIST, V23, P627, DOI 10.1177/1073858416685690; Cruz-Orengo L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-170; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Doan V, 2013, J NEUROSCI RES, V91, P363, DOI 10.1002/jnr.23174; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Galli E, 2019, NAT MED, V25, P1290, DOI 10.1038/s41591-019-0521-4; Gottle P, 2010, ANN NEUROL, V68, P915, DOI 10.1002/ana.22214; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Gudi V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00073; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hauser J, 2020, NUTR NEUROSCI, V23, P931, DOI 10.1080/1028415X.2019.1580918; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Huynh C, 2021, CLIN PHARMACOL THER, V109, P1648, DOI 10.1002/cpt.2154; Jakimovski D, 2020, MULT SCLER J, V26, P1670, DOI 10.1177/1352458519881428; Kadi L, 2006, J NEUROIMMUNOL, V174, P133, DOI 10.1016/j.jneuroim.2006.01.011; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kipp M, 2012, CNS NEUROL DISORD-DR, V11, P598, DOI 10.2174/187152712801661257; Kremer D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146503; Kuhle J, 2019, NEUROLOGY, V92, pE1007, DOI 10.1212/WNL.0000000000007032; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lewellis SW, 2012, SEMIN CELL DEV BIOL, V23, P333, DOI 10.1016/j.semcdb.2012.03.009; Li YN, 2015, STEM CELL TRANSL MED, V4, P1122, DOI 10.5966/sctm.2015-0074; Lounsbury N, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13020033; Luker KE, 2012, ONCOGENE, V31, P4750, DOI 10.1038/onc.2011.633; Magalon K, 2012, ANN NEUROL, V71, P213, DOI 10.1002/ana.22593; Martin R, 2016, EUR J IMMUNOL, V46, P2078, DOI 10.1002/eji.201646485; Mason JL, 2004, AM J PATHOL, V164, P1673, DOI 10.1016/S0002-9440(10)63726-1; Maysami S, 2006, NEUROREPORT, V17, P1187, DOI 10.1097/01.wnr.0000227985.92551.9a; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Menhaji-Klotz E., 2020, ACS MED CHEM LETT; Meyrath M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16664-0; Moll NM, 2009, ARCH NEUROL-CHICAGO, V66, P44, DOI 10.1001/archneurol.2008.512; Motavaf M, 2017, CELL MOL NEUROBIOL, V37, P1335, DOI 10.1007/s10571-017-0472-6; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; O'Boyle G, 2009, FASEB J, V23, P3906, DOI 10.1096/fj.09-134643; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Odemis V, 2010, J CELL SCI, V123, P1081, DOI 10.1242/jcs.062810; Oh J, 2014, THER ADV NEUROL DISO, V7, P239, DOI 10.1177/1756285614546855; Patel JR, 2010, P NATL ACAD SCI USA, V107, P11062, DOI 10.1073/pnas.1006301107; Pouzol L, 2021, FASEB J, V35; Puchert M, 2017, MOL CELL NEUROSCI, V85, P105, DOI 10.1016/j.mcn.2017.09.001; Quinn KE, 2018, CYTOKINE, V109, P17, DOI 10.1016/j.cyto.2018.02.024; Richard-Bildstein S, 2020, J MED CHEM, V63, P15864, DOI 10.1021/acs.jmedchem.0c01588; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Sadeghian-Rizi T, 2018, CNS NEUROL DISORD-DR, V17, P496, DOI 10.2174/1871527317666180713111100; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Stritt M, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007313; Wang C, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00641; Williams JL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00154; Williams JL, 2014, J EXP MED, V211, P791, DOI 10.1084/jem.20131224; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zilkha-Falb R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0468-4	67	9	10	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21431	10.1096/fj.202002465R	http://dx.doi.org/10.1096/fj.202002465R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33595155				2022-12-26	WOS:000629576700049
J	Bushuven, S; Dettenkofer, M; Dietz, A; Bushuven, S; Dierenbach, P; Inthorn, J; Beiner, M; Langer, T				Bushuven, Stefan; Dettenkofer, Markus; Dietz, Andreas; Bushuven, Stefanie; Dierenbach, Petra; Inthorn, Julia; Beiner, Matthias; Langer, Thorsten			Interprofessional perceptions of emotional, social, and ethical effects of multidrug-resistant organisms: A qualitative study	PLOS ONE			English	Article								Introduction Multi-drug-resistant organisms (MDRO) are usually managed by separating the infected patients to protect others from colonization and infection. Isolation precautions are associated with negative experiences by patients and their relatives, while hospital staff experience a heavier workload and their own emotional reactions. Methods In 2018, 35 participants (nurses, physicians, pharmacists) in an antimicrobial-stewardship program participated in facilitated discussion groups working on the emotional impact of MDRO. Deductive codings were done by four coders focusing on the five basic emotions described by Paul Ekmans. Results All five emotions revealed four to 11 codes forming several subthemes: Anger is expressed because of incompetence, workflow-impairment and lack of knowledge. Anxiety is provoked by inadequate knowledge, guilt, isolation, bad prognoses, and media-related effects. Enjoyment is seldom. Sadness is experienced in terms of helplessness and second-victim effects. Disgust is attributed to shame and bad associations, but on the other hand MDROs seem to be part of everyday life. Deductive coding yielded additional codes for bioethics and the Calgary Family Assessment Method. Conclusion MDRO are perceived to have severe impact on emotions and may affect bioethical and family psychological issues. Thus, further work should concentrate on these findings to generate a holistic view of MDRO on human life and social systems.	[Bushuven, Stefan; Dietz, Andreas] Hegau Bodensee Hosp Singen, Healthcare Assoc Constance GLKN, Inst Anesthesiol Intens Care Emergency Med & Pain, Singen, Germany; [Bushuven, Stefan; Dettenkofer, Markus] Healthcare Assoc Constance GLKN, Inst Hosp Hyg & Infect Prevent, Radolfzell am Bodensee, Germany; [Bushuven, Stefan] Ludwig Maximilians Univ Munchen, Clin Univ Munich, Inst Didact & Educ Res Med, Munich, Germany; [Bushuven, Stefanie] Hegau Bodensee Hosp Singen, Hlth Care Assoc Dist Constance GLKN, Inst Orthoped Handsurg & Traumatol, Singen, Germany; [Dierenbach, Petra; Beiner, Matthias] Healthcare Assoc Constance GLKN, Dept Paediat Neuropaediat & Neurorehabil Hegau Ju, Gailingen, Germany; [Inthorn, Julia] Ctr Appl Eth Hlth Care, Hannover, Germany; [Langer, Thorsten] Univ Freiburg, Fac Med, Med Ctr, Dept Neuropediat & Muscle Disorders, Freiburg, Germany	University of Munich; University of Freiburg	Bushuven, S (corresponding author), Hegau Bodensee Hosp Singen, Healthcare Assoc Constance GLKN, Inst Anesthesiol Intens Care Emergency Med & Pain, Singen, Germany.; Bushuven, S (corresponding author), Healthcare Assoc Constance GLKN, Inst Hosp Hyg & Infect Prevent, Radolfzell am Bodensee, Germany.; Bushuven, S (corresponding author), Ludwig Maximilians Univ Munchen, Clin Univ Munich, Inst Didact & Educ Res Med, Munich, Germany.	Stefan.bushuven@glkn.de		Bushuven, Stefan/0000-0001-6272-0714	Messmer Foundation	Messmer Foundation	The Messmer Foundation only covers the publication costs only. The whole study itself was conducted without external financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2018, EMOT REV, V10, P191, DOI 10.1177/1754073918765662; Ahmed M, 2013, ANN SURG, V258, P958, DOI 10.1097/SLA.0b013e31828c88fc; [Anonymous], 2009, WHO GUIDELINES HAND; Barratt RL, 2011, CONTEMP NURSE, V39, P180, DOI 10.5172/conu.2011.180; Binrbacher D., 2006, UTILITARISMUS UTILIT, V2, P37; Bittner-Fagan Heather, 2017, FP Essent, V463, P27; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Brown CL, 2018, AM J GERIAT PSYCHIAT, V26, P484, DOI 10.1016/j.jagp.2017.10.012; Bushuven S, 2019, AM J INFECT CONTROL, V47, P876, DOI 10.1016/j.ajic.2019.01.019; Calvi E, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1585; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Chi MTH, 2014, EDUC PSYCHOL-US, V49, P219, DOI 10.1080/00461520.2014.965823; Cluzet VC, 2016, INFECT CONT HOSP EP, V37, P1226, DOI 10.1017/ice.2016.138; Dettenkofer M, 2010, ZBL CHIR, V135, P124, DOI 10.1055/s-0030-1247328; Ekman PE., 2014, ATLAS EMOTIONS PROJE; Elgie R, 2007, NURS ECON, V25, P285; Finset A, 2012, PATIENT EDUC COUNS, V88, P359, DOI 10.1016/j.pec.2012.06.022; Gammon John, 2018, Br J Nurs, V27, P88, DOI 10.12968/bjon.2018.27.2.88; Gilson Lucy, 2006, J Health Organ Manag, V20, P359, DOI 10.1108/14777260610701768; Griffin FA, 2007, JT COMM J QUAL PATIE, V33, P726, DOI 10.1016/S1553-7250(07)33087-0; Heckel M, 2018, SUPPORT CARE CANCER, V26, P3021, DOI 10.1007/s00520-018-4149-6; Hereng O, 2019, AM J INFECT CONTROL, V47, P1077, DOI 10.1016/j.ajic.2019.03.018; Hubner C, 2014, EUR J CLIN MICROBIOL, V33, P1817, DOI 10.1007/s10096-014-2131-x; Janesick V. J, 2003, STRATEGIES QUALITATI, P46; Kang J, 2009, J KOREAN ACAD NURS, V39, P186, DOI 10.4040/jkan.2009.39.2.186; Kaplan M, 2010, CLIN J ONCOL NURS, V14, P514, DOI 10.1188/10.CJON.514-516; Kaye KS, 2015, PHARMACOTHERAPY, V35, P949, DOI 10.1002/phar.1636; KRINKO, 2016, BUNDESGESUNDHEITSBL, V59, P1189; LaLumiere RT, 2017, PHARMACOL REV, V69, P236, DOI 10.1124/pr.116.013474; Leahey M, 2016, J FAM NURS, V22, P450, DOI 10.1177/1074840716667972; Lemmen SW, 2018, INFECTION, V46, P581, DOI 10.1007/s15010-018-1137-1; Lever RA, 2016, BRIT MED BULL, V117, P95, DOI 10.1093/bmb/ldw005; Mayer J, 2019, AM J INFECT CONTROL, V47, P628, DOI 10.1016/j.ajic.2018.10.015; Mozzillo KL, 2010, J HOSP INFECT, V75, P132, DOI 10.1016/j.jhin.2009.10.031; Muzembo BA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241120; Orgaz-Molina J, 2015, ACTAS DERMO-SIFILOGR, V106, P493, DOI 10.1016/j.ad.2015.01.011; Ploug T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2004-y; Rauprich O, 2011, J MED ETHICS, V37, P454, DOI 10.1136/jme.2010.039222; Reeck C, 2016, TRENDS COGN SCI, V20, P47, DOI 10.1016/j.tics.2015.09.003; Sargeant J, 2011, MED TEACH, V33, P744, DOI 10.3109/0142159X.2011.577287; Sened H, 2017, J FAM PSYCHOL, V31, P742, DOI 10.1037/fam0000320; Seys D, 2013, EVAL HEALTH PROF, V36, P135, DOI 10.1177/0163278712458918; Shea JA, 2008, J GEN INTERN MED, V23, P727, DOI 10.1007/s11606-008-0575-3; Skyman E, 2016, SCAND J CARING SCI, V30, P813, DOI 10.1111/scs.12309; Tarzi S, 2001, J HOSP INFECT, V49, P250, DOI 10.1053/jhin.2001.1098; Thomas PA, 2016, CURRICULUM DEV MED E, P3, DOI DOI 10.1111/MEDU.12924; Thomas Sandra P, 2003, Dermatol Nurs, V15, P351; Tran K, 2017, J GEN INTERN MED, V32, P262, DOI 10.1007/s11606-016-3862-4; Vottero Beth, 2012, JBI Libr Syst Rev, V10, P935; Wauben LSGL, 2011, INT J QUAL HEALTH C, V23, P159, DOI 10.1093/intqhc/mzq079	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0246820	10.1371/journal.pone.0246820	http://dx.doi.org/10.1371/journal.pone.0246820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QO3ZL	33617529	gold, Green Published			2022-12-26	WOS:000623082400018
J	Musila, L; Kyany'a, C; Maybank, R; Stam, J; Oundo, V; Sang, W				Musila, Lillian; Kyany'a, Cecilia; Maybank, Rosslyn; Stam, Jason; Oundo, Valerie; Sang, Willie			Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target gram-negative bacteria in Kenya	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; CLASS 1 INTEGRONS; SEQUENCE TYPE 654; PSEUDOMONAS-AERUGINOSA; ACINETOBACTER-BAUMANNII; MOLECULAR EPIDEMIOLOGY; KLEBSIELLA-PNEUMONIAE; ENTEROBACTER-CLOACAE; DISSEMINATION; IDENTIFICATION	Carbapenem-resistant gram-negative bacteria are an increasingly significant clinical threat globally. This risk may be underestimated in Kenya as only four carbapenemase genes in three bacterial species have been described. The study aimed to understand the antibiotic resistance profiles, genes, sequence types, and distribution of carbapenem-resistant gram-negative bacteria from patients in six hospitals across five Kenyan counties by bacterial culture, antibiotic susceptibility testing, and whole-genome sequence analysis. Forty-eight, non-duplicate, carbapenem non-susceptible, clinical isolates were identified across the five counties (predominantly in Nairobi and Kisii): twenty-seven Acinetobacter baumannii, fourteen Pseudomonas aeruginosa, three Escherichia coli, two Enterobacter cloacae, and two Klebsiella pneumoniae. All isolates were non-susceptible to beta-lactam drugs with variable susceptibility to tigecycline (66%), minocycline (52.9%), tetracycline (29.4%), and levofloxacin (22.9%). Thirteen P. aeruginosa isolates were resistant to all antibiotics tested. Eleven carbapenemase genes were identified: bla(NDM-1,) bla(OXA-23, -58, -66, -69, and -91) in A. baumannii (STs 1, 2, 164 and a novel ST1475), bla(NDM-1) in E. cloacae (STs 25,182), bla(NDM-1), bla(VIM-1and -6), bla(OXA-50) in P. aeruginosa (STs 316, 357, 654, and1203), bla(OXA-181,) bla(NDM-1) in K. pneumoniae (STs 147 and 219), and bla(NDM-5) in E. coli (ST164). Five A. baumannii isolates had two carbapenemases, bla(NDM-1,) and either bla(OXA-23) (4) or bla(OXA-58) (1). AmpC genes were detected in A. baumannii (bla(ADC-25)), E. cloacae (bla(DHA-1 and) bla(ACT-6, 16)), and K. pneumoniae (bla(CMY)). Significant multiple-drug resistant genes were the pan-aminoglycoside resistance16srRNA methyltransferase armA, rmtB, rmtC, and rmtF genes. This study is the first to report bla(OXA-420, -58, -181, VIM-6,) and bla(NDM-5) in Kenyan isolates. High-risk STs of A. baumannii (ST1475, ST2), E. cloacae ST182, K. pneumoniae ST147, P. aeruginosa (ST357, 654), and E. coli ST167, ST648 were identified which present considerable therapeutic danger. The study recommends urgent carbapenem use regulation and containment of high-risk carbapenem-resistant bacteria.	[Musila, Lillian; Kyany'a, Cecilia; Oundo, Valerie; Sang, Willie] US Army Med Res Directorate Africa, Dept Emerging Infect Dis, Nairobi, Kenya; [Maybank, Rosslyn; Stam, Jason] Walter Reed Army Inst Res, Multidrug Resistant Organism Repository & Surveil, Bacterial Dis Branch, Silver Spring, MD USA; [Sang, Willie] Kenya Govt Med Res Ctr, Ctr Microbiol, Nairobi, Kenya	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Kenya Medical Research Institute	Musila, L (corresponding author), US Army Med Res Directorate Africa, Dept Emerging Infect Dis, Nairobi, Kenya.	Lillian.musila@usamru-k.org		Musila, Lillian/0000-0003-1418-6523	Armed Forces Health Surveillance Division, Global Emerging Infections Surveillance (GEIS) Branch [20160270153 FY17-19]	Armed Forces Health Surveillance Division, Global Emerging Infections Surveillance (GEIS) Branch	This work was funded by the Armed Forces Health Surveillance Division, Global Emerging Infections Surveillance (GEIS) Branch (PROMIS ID 20160270153 FY17-19 Awarded to LM). The study funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Annavajhala MK, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00044; [Anonymous], 2018, GUIDELINES PREVENTIO; [Anonymous], NTR; Bercot B, 2011, DIAGN MICR INFEC DIS, V71, P442, DOI 10.1016/j.diagmicrobio.2011.08.016; Brolund A, 2019, EUROSURVEILLANCE, V24, P17, DOI 10.2807/1560-7917.ES.2019.24.9.1900123; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Carattoli A, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.46.20633; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; Castanheira M, 2010, CLIN MICROBIOL INFEC, V16, P186, DOI 10.1111/j.1469-0691.2009.02903.x; Chavda KD, 2016, MBIO, V7, DOI 10.1128/mBio.02093-16; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Djahmi N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/305784; Du N, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0232-y; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Founou RC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189621; Giufre M, 2018, INT J ANTIMICROB AG, V52, P76, DOI 10.1016/j.ijantimicag.2018.02.020; Golle A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186736; Gronthal T, 2018, EUROSURVEILLANCE, V23, P13, DOI 10.2807/1560-7917.ES.2018.23.27.1700497; Haller S, 2019, EUROSURVEILLANCE, V24, P2, DOI 10.2807/1560-7917.ES.2019.24.50.1900734; Hammami S, 2010, CLIN MICROBIOL INFEC, V16, P189, DOI 10.1111/j.1469-0691.2009.03023.x; Henson SP, 2017, INT J MED MICROBIOL, V307, P422, DOI 10.1016/j.ijmm.2017.07.006; Huang YL, 2016, ANTIMICROB AGENTS CH, V60, P4364, DOI 10.1128/AAC.00859-16; Huber CA, 2014, J GLOB ANTIMICROB RE, V2, P190, DOI 10.1016/j.jgar.2014.03.007; Jacobson RK, 2012, J ANTIMICROB CHEMOTH, V67, P1797, DOI 10.1093/jac/dks100; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jeannot K, 2013, J ANTIMICROB CHEMOTH, V68, P2952, DOI 10.1093/jac/dkt296; Jolley Keith A, 2018, Wellcome Open Res, V3, P124, DOI 10.12688/wellcomeopenres.14826.1; Jovcic B, 2011, ANTIMICROB AGENTS CH, V55, P3929, DOI 10.1128/AAC.00226-11; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Karah N, 2011, MICROB DRUG RESIST, V17, P545, DOI 10.1089/mdr.2011.0089; Karah N, 2011, J MED MICROBIOL, V60, P515, DOI 10.1099/jmm.0.028340-0; Khajuria A, 2013, J CLIN DIAGN RES, V7, P1328, DOI 10.7860/JCDR/2013/5509.3137; Khan A., 2018, OPEN FORUM INFECT DI, pS254, DOI [10.1093/ofid/ofy210.712, DOI 10.1093/OFID/OFY210.712]; Kiiru J, 2018, IOSR J PHARM BIOL SC, P13; Kiiru J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-155; Koh TH, 2004, ANTIMICROB AGENTS CH, V48, P2334, DOI 10.1128/AAC.48.6.2334-2336.2004; Koh TH, 2010, J CLIN MICROBIOL, V48, P2563, DOI 10.1128/JCM.01905-09; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Manenzhe RI, 2015, J ANTIMICROB CHEMOTH, V70, P23, DOI 10.1093/jac/dku356; Mansour W, 2009, DIAGN MICR INFEC DIS, V64, P458, DOI 10.1016/j.diagmicrobio.2009.04.003; Mariita KM., 2018, INT J BASIC CLIN PHA, P1, DOI [10.18203/2319-2003.ijbcp20185154, DOI 10.18203/2319-2003.IJBCP20185154]; Martinez-Martinez L, 1999, ANTIMICROB AGENTS CH, V43, P1669, DOI 10.1128/AAC.43.7.1669; Mataseje LF, 2016, ANTIMICROB AGENTS CH, V60, P1794, DOI 10.1128/AAC.02591-15; Mathlouthi N, 2018, MICROB DRUG RESIST, V24, P136, DOI 10.1089/mdr.2016.0306; Meletis G, 2016, THER ADV INFECT DIS, V3, P15, DOI 10.1177/2049936115621709; Mitgang EA, 2018, INT J ANTIMICROB AG, V52, P372, DOI 10.1016/j.ijantimicag.2018.05.019; Momanyi L, 2019, J RES PHARM PRACT, V8, P149, DOI 10.4103/jrpp.JRPP_18_68; Moyo S, 2015, ANTIMICROB AGENTS CH, V59, P682, DOI 10.1128/AAC.01436-13; Mushi MF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/303104; Nordmann P, 2014, CLIN MICROBIOL INFEC, V20, P821, DOI 10.1111/1469-0691.12719; Okoche D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135745; Pasteran F, 2012, J ANTIMICROB CHEMOTH, V67, P1291, DOI 10.1093/jac/dks032; Pitout JDD, 2008, CLIN MICROBIOL INFEC, V14, P755, DOI 10.1111/j.1469-0691.2008.02030.x; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Pobiega M, 2015, DIAGN MICR INFEC DIS, V83, P295, DOI 10.1016/j.diagmicrobio.2015.07.022; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P934, DOI 10.1128/AAC.01247-10; Revathi G, 2013, INT J INFECT DIS, V17, pE1255, DOI 10.1016/j.ijid.2013.07.016; Saisi H., 2019, ACTA INFORM MED, V09, P853; Samuelsen O, 2010, ANTIMICROB AGENTS CH, V54, P346, DOI 10.1128/AAC.00824-09; Schaufler K, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00243-19, 10.1128/aac.00243-19]; Shrestha S, 2015, INT J ANTIMICROB AG, V46, P526, DOI 10.1016/j.ijantimicag.2015.07.012; Ssekatawa Kenneth, 2018, BMC Res Notes, V11, P629, DOI 10.1186/s13104-018-3738-2; Storberg Viktor, 2014, Infection Ecology & Epidemiology, V4, P20342, DOI 10.3402/iee.v4.20342; Tang B, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1454-2; Torres-Gonzalez P, 2015, ANTIMICROB AGENTS CH, V59, P7080, DOI 10.1128/AAC.00055-15; Touati M, 2013, ANTIMICROB AGENTS CH, V57, P2426, DOI 10.1128/AAC.00032-13; van Duin D, 2017, VIRULENCE, V8, P460, DOI 10.1080/21505594.2016.1222343; van Duin D, 2016, INFECT DIS CLIN N AM, V30, P377, DOI 10.1016/j.idc.2016.02.004; Whitelaw AC, 2017, MICROBIOLOGIA MED, V32, P7076, DOI [10.4081/mm.2017.7076, DOI 10.4081/MM.2017.7076]; WHO, 2017, WORLD HLTH ORG, P7, DOI DOI 10.1016/S1473-3099(09)70222-1; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; Yin SP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01135; Zafer MM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/101635; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	76	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0246937	10.1371/journal.pone.0246937	http://dx.doi.org/10.1371/journal.pone.0246937			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617559	gold, Green Published			2022-12-26	WOS:000623082400008
J	Ahmed, A; Mulatu, K; Elfu, B				Ahmed, Abdulmuneim; Mulatu, Kebadnew; Elfu, Berhanu			Prevalence of malaria and associated factors among under-five children in Sherkole refugee camp, Benishangul-Gumuz region, Ethiopia. A cross-sectional study	PLOS ONE			English	Article								Background Under-five year children are the most vulnerable group affected by malaria, they accounted for 61% of all malaria deaths worldwide. Sherkole refugee camp is stratified under high risk for malaria. Knowledge on malaria prevalence and associated factors among under-five children in Sherkole refugee camp is lacking. Methods and materials Institution-based cross-sectional survey was conducted among under-five children in Sherkole refugee camp from October to November 2019. Total sample size was 356. Stratified random sampling technique was employed to select the study participants. Standardized questionnaire was used to collect data. Care Start(TM) Malaria Rapid diagnostic test which detect histidine-rich protein 2 of P. falciparum and plasmodium lactate dehydrogenase of P. vivax was used to diagnose malaria. Bivariate and multivariable logistic regression analysis was done to identify factors associated with malaria. Results A total of 356 participants were included in this study with response rate of 97.5%. The prevalence malaria was 3.9% (95% CI = 2.0-6.2). Outdoor stay at night (AOR = 3.9, 95% CI = 1.14-13.8), stagnant water near to house (AOR = 4.0, 95% CI = 1.14-14.6), and the number of under-five children per household (AOR = 3.0, 95% CI = 1.03-13.0) were found to increase the odds of getting malaria. Whereas, insecticide treated net (ITN)utilization (AOR = 0.22, 95% CI = 0.06-0.61) and Health information about malaria (AOR = 0.29, 95% CI = 0.06-0.65) reduce the odds of getting malaria. Conclusions and recommendations Malaria remains the major public health problem in Sherkole Refugee camp. Outdoor stay at night, stagnant water near to house, and number of under-five children per household were the risk factors for malaria. Health information dissemination that focuses on avoiding outdoor stay at night, eliminating stagnant water & using ITN, and considering number of under-five children per household during ITN distribution should be take into account.	[Ahmed, Abdulmuneim; Mulatu, Kebadnew] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Field Epidemiol, Bahir Dar, Ethiopia; [Elfu, Berhanu] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University	Mulatu, K (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Field Epidemiol, Bahir Dar, Ethiopia.	kebadmulatu@gmail.com	; Feleke, Berhanu/L-1457-2016	Mulatu, kebadnew/0000-0002-1057-1267; Feleke, Berhanu/0000-0001-9251-3337	Bahir Dar University	Bahir Dar University	We declare that we do not have any conflict of interests and this study was funded by Bahir Dar University.	Abebaw A, 2019, THESIS ADDIS ABABA U; Agegnehu F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5370-4; Alemu A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-173; ARRA, 2019, SHERK REF CAMP HLTH; Aschale Yibeltal., 2019, DOVE PRESS J; Carlucci JG, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1741-z; CDC, 2018, MAL BIOL AN MOSQ; Ethiopia FMOH, 2012, NAT MAL GUID, V3; Ethiopian Public Health institute, ETH NAT MAL IND SURV, P2016; Getachew Tizazu TA., 2006, INTERNAL MED, V2; Haji Y, 2016, ACTA TROP, V155, P63, DOI 10.1016/j.actatropica.2015.12.009; Ketema Tsige., 2016, SEVERE MALARIA ASS P; Kyu HH, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-14; Belete EM, 2016, J RES HEALTH SCI, V16, P185; Mugwagwa Norma, 2015, BMC Res Notes, V8, P829, DOI 10.1186/s13104-015-1831-3; Nyarko Samuel Harrenson, 2014, SOCIODEMOGRAPHIC DET; Safeukui-Noubissi I, 2004, MICROBES INFECT, V6, P572, DOI 10.1016/j.micinf.2004.02.007; Shiferaw Meresa., 2018, PREVALENCE MALARIA T, P539, DOI [10.4314/ejhs.v28i5.4, DOI 10.4314/EJHS.V28I5.4]; U.S. Presidents malaria initiative, 2014, ETH MAL OP PLAN 2014; U.S. Presidents Malaria Initiative, 2018, ETH MAL OP PLAN; Wanzira H, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1847-3; WHO, 2019, GLOB FACT SHEET MAL; World Health organization(WHO), 2018, WORLD MALARIA REPORT, DOI [10.1016/j.tmaid.2018.03.007, DOI 10.1016/J.TMAID.2018.03.007]; Zgambo M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175537	24	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246895	10.1371/journal.pone.0246895	http://dx.doi.org/10.1371/journal.pone.0246895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606756	gold, Green Published			2022-12-26	WOS:000620629200012
J	Edifor, EE; Brown, R; Smith, P; Kossik, R				Edifor, Ernest Edem; Brown, Regina; Smith, Paul; Kossik, Rick			Non-Adherence Tree Analysis (NATA)-An adherence improvement framework: A COVID-19 case study	PLOS ONE			English	Article							MEDICATION ADHERENCE; OSELTAMIVIR; FAILURE	Poor medication adherence is a global phenomenon that has received a significant amount of research attention yet remains largely unsolved. Medication non-adherence can blur drug efficacy results in clinical trials, lead to substantial financial losses, increase the risk of relapse and hospitalisation, or lead to death. The most common methods of measuring adherence are post-treatment measures; that is, adherence is usually measured after the treatment has begun. What the authors are proposing in this multidisciplinary study is a new technique for predicting the factors that are likely to cause non-adherence before or during medication treatment, illustrated in the context of potential non-adherence to COVID-19 antiviral medication. Fault Tree Analysis (FTA), allows system analysts to determine how combinations of simple faults of a system can propagate to cause a total system failure. Monte Carlo simulation is a mathematical algorithm that depends heavily on repeated random sampling to predict the behaviour of a system. In this study, the authors propose a new technique called Non-Adherence Tree Analysis (NATA), based on the FTA and Monte Carlo simulation techniques, to improve adherence. Firstly, the non-adherence factors of a medication treatment lifecycle are translated into what is referred to as a Non-Adherence Tree (NAT). Secondly, the NAT is coded into a format that is translated into the GoldSim software for performing dynamic system modelling and analysis using Monte Carlo. Finally, the GoldSim model is simulated and analysed to predict the behaviour of the NAT. NATA is dynamic and able to learn from emerging datasets to improve the accuracy of future predictions. It produces a framework for improving adherence by analysing social and non-social adherence barriers. Novel terminologies and mathematical expressions have been developed and applied to real-world scenarios. The results of the application of NATA using data from six previous studies in relation to antiviral medication demonstrate a predictive model which suggests that the biggest factor that could contribute to non-adherence to a COVID-19 antiviral treatment is a therapy-related factor (the side effects of the medication). This is closely followed by a condition-related factor (asymptomatic nature of the disease) then patient-related factors (forgetfulness and other causes). From the results, it appears that side effects, asymptomatic factors and forgetfulness contribute 32.44%, 22.67% and 18.22% respectively to discontinuation of medication treatment of COVID-19 antiviral medication treatment. With this information, clinicians can implement relevant interventions and measures and allocate resources appropriately to minimise non-adherence.	[Edifor, Ernest Edem] Manchester Metropolitan Univ, Operat Technol Events & Hospitality Management, Manchester, Lancs, England; [Brown, Regina] Univ Massachusetts, Med, Med Sch, Worcester, MA 01605 USA; [Smith, Paul] Manchester Metropolitan Univ, Mkt Retail & Tourism, Manchester, Lancs, England; [Kossik, Rick] GoldSim Technol Grp LLC, Res & Dev, Seattle, WA USA	Manchester Metropolitan University; University of Massachusetts System; University of Massachusetts Worcester; Manchester Metropolitan University	Edifor, EE (corresponding author), Manchester Metropolitan Univ, Operat Technol Events & Hospitality Management, Manchester, Lancs, England.	e.edifor@mmu.ac.uk			Goldsim Technology Group LLC.	Goldsim Technology Group LLC.	The author(s) received no specific funding for this work from any organisation including the affiliate organisation Goldsim Technology Group LLC.	Agyepong IA, 2002, SOC SCI MED, V55, P2215, DOI 10.1016/S0277-9536(01)00366-5; Aldeer M, 2018, APPL SYST INNOV, V1, DOI 10.3390/asi1020014; ASA ASCP, 2006, OVERVIEW; Belmaker I, 2009, INT J INFECT DIS, V13, P261, DOI 10.1016/j.ijid.2008.06.037; Brown MT, 2011, MAYO CLIN PROC, V86, P304, DOI 10.4065/mcp.2010.0575; Brussow H, 2020, MICROB BIOTECHNOL, V13, P607, DOI 10.1111/1751-7915.13557; Chishti T, 2010, BRIT J GEN PRACT, V60, P535, DOI 10.3399/bjgp10X514891; Choo D, 2011, NEPHROL DIAL TRANSPL, V26, P2339, DOI 10.1093/ndt/gfq737; Costa E, 2015, PATIENT PREFER ADHER, V9, DOI 10.2147/PPA.S87551; Cutler RL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-016982; De Geest Sabina, 2003, Eur J Cardiovasc Nurs, V2, P323; Goedecke T, 2016, DRUG SAFETY, V39, P491, DOI 10.1007/s40264-016-0410-4; GoldSim Technology Group, DYNAMIC SIMULATION A; Gu LN, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121522; Kim J, 2018, US PHARM, V43, P30; Kleinsinger Fred, 2018, Perm J, V22, P18, DOI 10.7812/TPP/18-033; Lee YY, 2009, SOC SCI MED, V68, P1060, DOI 10.1016/j.socscimed.2008.12.033; Martin Leslie R, 2005, Ther Clin Risk Manag, V1, P189; McVernon J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-257; Mifsud M, 2019, SOC SCI MED, V232, P307, DOI 10.1016/j.socscimed.2019.05.015; Moon SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187139; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Nieuwlaat R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub4; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Ozturk T, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103792; Pereira RM, 2020, COMPUT METH PROG BIO, V194, DOI 10.1016/j.cmpb.2020.105532; Sedik A, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12070769; Shubber Z, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002183; Stamatelatos M, 2002, FAULT TREE HDB AEROS; Strong M, 2010, EUROSURVEILLANCE, V15, P16; Torres-Robles A, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00130; Unni EJ, 2019, PATIENT PREFER ADHER, V13, P993, DOI 10.2147/PPA.S205359; Vernon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002884; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; Wallensten A, 2009, EUROSURVEILLANCE, V14, P6; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Wiecek E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213432; Wu JR, 2018, J CARDIOVASC NURS, V33, P40, DOI 10.1097/JCN.0000000000000427	39	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247109	10.1371/journal.pone.0247109	http://dx.doi.org/10.1371/journal.pone.0247109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606789	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000620629200002
J	Gomez, J; Prieto, J; Leon, E; Rodriguez, A				Gomez, Jonatan; Prieto, Jeisson; Leon, Elizabeth; Rodriguez, Arles			INFEKTA-An agent-based model for transmission of infectious diseases: The COVID-19 case in Bogota, Colombia	PLOS ONE			English	Article							SYSTEMS; EPIDEMIOLOGY	The transmission dynamics of the coronavirus-COVID-19-have challenged humankind at almost every level. Currently, research groups around the globe are trying to figure out such transmission dynamics under special conditions such as separation policies enforced by governments. Mathematical and computational models, like the compartmental model or the agent-based model, are being used for this purpose. This paper proposes an agent-based model, called INFEKTA, for simulating the transmission of infectious diseases, not only the COVID-19, under social distancing policies. INFEKTA combines the transmission dynamic of a specific disease, (according to parameters found in the literature) with demographic information (population density, age, and genre of individuals) of geopolitical regions of the real town or city under study. Agents (virtual persons) can move, according to its mobility routines and the enforced social distancing policy, on a complex network of accessible places defined over an Euclidean space representing the town or city. The transmission dynamics of the COVID-19 under different social distancing policies in Bogota city, the capital of Colombia, is simulated using INFEKTA with one million virtual persons. A sensitivity analysis of the impact of social distancing policies indicates that it is possible to establish a 'medium' (i.e., close 40% of the places) social distancing policy to achieve a significant reduction in the disease transmission.	[Gomez, Jonatan; Leon, Elizabeth] Univ Nacl Colombia, Fac Ingn, Dept Ingn Sistemas & Ind, Bogota, Colombia; [Prieto, Jeisson] Univ Nacl Colombia, Fac Ciencias, Dept Matemat, Bogota, Colombia; [Rodriguez, Arles] Fdn Univ Konrad Lorenz, Ctr Invest Matemat & Ingn, Bogota, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia	Gomez, J (corresponding author), Univ Nacl Colombia, Fac Ingn, Dept Ingn Sistemas & Ind, Bogota, Colombia.	jgomezpe@unal.edu.co		Rodriguez, Arles/0000-0003-4910-6773; Prieto, Jeisson/0000-0002-9259-4699				Adamatzky A., 2014, ARTIFICIAL LIFE MODE, V2; Alcocer-Cuaron C, 2014, BIOENGINEERED, V5, P73, DOI 10.4161/bioe.26570; An G, 2009, WIRES SYST BIOL MED, V1, P159, DOI 10.1002/wsbm.45; Balaji PG, 2010, STUD COMPUT INTELL, V310, P1; Bastian M., 2009, GEPHI OPEN SOURCE SO; Chang SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19393-6; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Cooley P, 2010, INFLUENZA OTHER RESP, V4, P61, DOI 10.1111/j.1750-2659.2009.00122.x; Day M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1375; Enanoria WTA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167160; Epstein JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020139; Escobar-Ospina ME., 2019, ARTIFICIAL LIFE ANDT, P149; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Flaxman S, 2020, REPORT13 ESTIMATING; Galea S, 2010, INT J EPIDEMIOL, V39, P97, DOI 10.1093/ije/dyp296; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; Jit M, 2011, PHARMACOECONOMICS, V29, P371, DOI 10.2165/11539960-000000000-00000; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Ladyman J, 2013, EUR J PHILOS SCI, V3, P33, DOI 10.1007/s13194-012-0056-8; Lessler J, 2015, EPIDEMICS-NETH, V10, P78, DOI 10.1016/j.epidem.2014.12.002; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Merelli E, 2015, ENTROPY-SWITZ, V17, P6872, DOI 10.3390/e17106872; Meyers RA., 2009, ENCY COMPLEXITY SYST; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Murray M, 2002, P NATL ACAD SCI USA, V99, P1538, DOI 10.1073/pnas.022618299; Observatorio de Salud de Bogota, 2020, CAS CONF BOG DC; Pagel M., 2005, COMPLEX SYSTEMS THEO; Rodriguez A, 2015, ECAL 2015: THE THIRTEENTH EUROPEAN CONFERENCE ON ARTIFICIAL LIFE, P448, DOI 10.7551/978-0-262-33027-5-ch080; Rodriguez A, 2017, LECT NOTES ARTIF INT, V10062, P81, DOI 10.1007/978-3-319-62428-0_7; Russell S. J., 2010, ARTIF INTELL, V263, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/AMM.263-266.2829; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Sayama H., 2015, INTRO MODELING ANAL, DOI DOI 10.7551/978-0-262-33027-5-CH009; Secretaria Distrital de Planeacion, 2017, POBL UPZ BOG; Tikkanen T, 2020, AGENT BASED EPIDEMIC; Van Der Hofstad R., 2017, CAMBRIDGE SERIES STA, V1; van Kleef E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-294; Verity R, 2020, ESTIMATES SEVERITY C; Willem L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2699-8; Zhao C., 2020, ARXIV PREPRINT ARXIV	42	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0245787	10.1371/journal.pone.0245787	http://dx.doi.org/10.1371/journal.pone.0245787			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606714	gold, Green Published			2022-12-26	WOS:000620629200039
J	Heo, SK; Choi, Y; Jeong, YK; Ju, LJ; Yu, HM; Kim, DK; Seo, HJ; Lee, YJ; Cheon, J; Koh, S; Min, YJ; Noh, EK; Jo, JC				Heo, Sook-Kyoung; Choi, Yunsuk; Jeong, Yoo Kyung; Ju, Lan Jeong; Yu, Ho-Min; Kim, Do Kyoung; Seo, Hye Jin; Lee, Yoo Jin; Cheon, Jaekyung; Koh, SuJin; Min, Young Joo; Noh, Eui-Kyu; Jo, Jae-Cheol			LIGHT (TNFSF14) enhances osteogenesis of human bone marrow-derived mesenchymal stem cells	PLOS ONE			English	Article								Osteoporosis is a progressive systemic skeletal disease associated with decreased bone mineral density and deterioration of bone quality, and it affects millions of people worldwide. Currently, it is treated mainly using antiresorptive and osteoanabolic agents. However, these drugs have severe adverse effects. Cell replacement therapy using mesenchymal stem cells (MSCs) could serve as a treatment strategy for osteoporosis in the future. LIGHT (HVEM-L, TNFSF14, or CD258) is a member of the tumor necrosis factor superfamily. However, the effect of recombinant LIGHT (rhLIGHT) on osteogenesis in human bone marrow-derived MSCs (hBM-MSCs) is unknown. Therefore, we monitored the effects of LIGHT on osteogenesis of hBM-MSCs. Lymphotoxin-beta receptor (LT beta R), which is a LIGHT receptor, was constitutively expressed on the surface of hBM-MSCs. After rhLIGHT treatment, calcium and phosphate deposition in hBM-MSCs, stained by Alizarin red and von Kossa, respectively, significantly increased. We performed quantitative real-time polymerase chain reaction to examine the expressions of osteoprogenitor markers (RUNX2/CBFA1 and collagen I alpha 1) and osteoblast markers (alkaline phosphatase, osterix/Sp7, and osteocalcin) and immunoblotting to assess the underlying biological mechanisms following rhLIGHT treatment. We found that rhLIGHT treatment enhanced von Kossa- and Alizarin red-positive hBM-MSCs and induced the expression of diverse differentiation markers of osteogenesis in a dose-dependent manner. WNT/beta-catenin pathway activation strongly mediated rhLIGHT-induced osteogenesis of hBM-MSCs, accelerating the differentiation of hBM-MSCs into osteocytes. In conclusion, the interaction between LIGHT and LT beta R enhances osteogenesis of hBM-MSCs. Therefore, LIGHT might play an important role in stem cell therapy.	[Heo, Sook-Kyoung; Jeong, Yoo Kyung; Ju, Lan Jeong; Yu, Ho-Min; Kim, Do Kyoung; Seo, Hye Jin; Jo, Jae-Cheol] Univ Ulsan, Ulsan Univ Hosp, Biomed Res Ctr, Coll Med, Ulsan, South Korea; [Choi, Yunsuk; Lee, Yoo Jin; Cheon, Jaekyung; Koh, SuJin; Min, Young Joo; Noh, Eui-Kyu; Jo, Jae-Cheol] Univ Ulsan, Ulsan Univ Hosp, Dept Hematol & Oncol, Coll Med, Ulsan, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Jo, JC (corresponding author), Univ Ulsan, Ulsan Univ Hosp, Biomed Res Ctr, Coll Med, Ulsan, South Korea.; Noh, EK; Jo, JC (corresponding author), Univ Ulsan, Ulsan Univ Hosp, Dept Hematol & Oncol, Coll Med, Ulsan, South Korea.	jcjo97@hanmail.net; noheuikyu@gmail.com	Jo, Jae-Cheol/CAE-9453-2022	Jo, Jae-Cheol/0000-0001-6014-7977	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2018R1D1A1B07051343, NRF-2017R1A1A3A04069314]; Basic Science Research Program through the Biomedical Research Center - Ulsan University Hospital [UUHBRC-2016-001]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); Basic Science Research Program through the Biomedical Research Center - Ulsan University Hospital	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2018R1D1A1B07051343, NRF-2017R1A1A3A04069314). The research was also supported by the Basic Science Research Program through the Biomedical Research Center, funded by the Ulsan University Hospital (UUHBRC-2016-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao L, 2012, BIOMATERIALS, V33, P5076, DOI 10.1016/j.biomaterials.2012.03.069; Cosman F, 2016, NEW ENGL J MED, V375, P1532, DOI 10.1056/NEJMoa1607948; de Girolamo L, 2013, CURR PHARM DESIGN, V19, P2459, DOI 10.2174/1381612811319130015; De Miguel MP, 2012, CURR MOL MED, V12, P574; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gnecchi Massimiliano, 2009, V482, P281, DOI 10.1007/978-1-59745-060-7_18; Han Y, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080886; Harrop JA, 1998, J IMMUNOL, V161, P1786; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Heo SK, 2008, IMMUNOL LETT, V120, P57, DOI 10.1016/j.imlet.2008.07.002; Heo SK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15492-5; Heo SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166589; Heo SK, 2016, EUR J PHARMACOL, V789, P280, DOI 10.1016/j.ejphar.2016.07.049; Hu LF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020360; Ju C, 2019, BIOMED PHARMACOTHER, V115, DOI 10.1016/j.biopha.2019.108912; Kwon BS, 1997, J BIOL CHEM, V272, P14272, DOI 10.1074/jbc.272.22.14272; Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x; Lin H, 2019, BIOMATERIALS, V203, P96, DOI 10.1016/j.biomaterials.2018.06.026; Lin S, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0672-5; Meng YC, 2020, MOL THER-NUCL ACIDS, V20, P345, DOI 10.1016/j.omtn.2019.11.038; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Ocarino ND, 2010, CONNECT TISSUE RES, V51, P426, DOI 10.3109/03008201003597049; Paino F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.308; Phetfong J, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0013-1; Piters E, 2008, ARCH BIOCHEM BIOPHYS, V473, P112, DOI 10.1016/j.abb.2008.03.006; Shi X, 2020, STEM CELL TRANSL MED, V9, P445, DOI 10.1002/sctm.19-0398; Spahn TW, 2004, GUT, V53, P456, DOI 10.1136/gut.2003.023671; Tu Kristie N, 2018, P T, V43, P92; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; van der Garde M, 2015, STEM CELLS DEV, V24, P2649, DOI 10.1089/scd.2015.0138; Wang J, 2004, IMMUNOL RES, V30, P201, DOI 10.1385/IR:30:2:201; Wang Y, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00353; Wang Z, 2006, TISSUE ENG, V12, P1753, DOI 10.1089/ten.2006.12.1753; Zhu XB, 2018, J CELL BIOCHEM, V119, P8346, DOI 10.1002/jcb.26910	35	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247368	10.1371/journal.pone.0247368	http://dx.doi.org/10.1371/journal.pone.0247368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606781	gold, Green Published			2022-12-26	WOS:000620629200145
J	Januschowski, K; Ihmig, FR; Koch, T; Velten, T; Rickmann, A				Januschowski, Kai; Ihmig, Frank R.; Koch, Timo; Velten, Thomas; Rickmann, Annekatrin			Context-sensitive smart glasses monitoring wear position and activity for therapy compliance-A proof of concept	PLOS ONE			English	Article							LIQUID-CRYSTAL GLASSES; OCCLUSION THERAPY; VISUAL IMPAIRMENT; AMBLYOPIA; VISION; OUTCOMES; RISK; EYE	Purpose To improve the acceptance and compliance of treatment of amblyopia, the aim of this study was to show that it is feasible to design an electronic frame for context-sensitive liquid crystal glasses, which can measure the state of wear position in a robust manner and detect distinct motion patterns for activity recognition. Methods Different temple designs with integrated temperature and capacitive sensors were developed to realize the detection of the state of wear position to distinguish three states (correct position/wrong position/glasses taken off). The electronic glasses frame was further designed as a tool for accelerometer data acquisition, which was used for algorithm development for activity classification. For this purpose, training data of 20 voluntary healthy adult subjects (5 females, 15 males) were recorded and a 10-fold cross-validation was computed for classifier selection. In order to perform functional testing of the electronic glasses frame, a proof of concept study was performed in a small group of healthy adults. Four healthy adult subjects (2 females, 2 males) were included to wear the electronic glasses frame and to protocol their activities in their everyday life according to a defined test protocol. Individual and averaged results for the precision of the state of wear position detection and of the activity recognition were calculated. Results Context-sensitive control algorithms were developed which detected the state of wear position and activity in a proof of concept. The pilot study revealed an average of 91.4% agreement of the detected states of wear position. The activity recognition match was 82.2% when applying an additional filter criterion. Removing the glasses was always detected 100% correctly. Conclusion The principles investigated are suitable for detecting the glasses' state of wear position and for recognizing the wearer's activity in a smart glasses concept.	[Januschowski, Kai; Rickmann, Annekatrin] Knappschaft Hosp Saar, Eye Clin Sulzbach, Sulzbach, Saarland, Germany; [Januschowski, Kai] Univ Tubingen, Ctr Ophthalmol, Tubingen, Baden Wurttembe, Germany; [Ihmig, Frank R.; Koch, Timo; Velten, Thomas] Fraunhofer Inst Biomed Engn IBMT, Sulzbach, Saarland, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Fraunhofer Gesellschaft	Ihmig, FR (corresponding author), Fraunhofer Inst Biomed Engn IBMT, Sulzbach, Saarland, Germany.	frank.ihmig@ibmt.fraunhofer.de		Velten, Thomas/0000-0002-7736-3892	Bundesministerium fur Bildung und Forschung [16SV7757, 16SV7756]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This study was supported by the Bundesministerium fur Bildung und Forschung (Grant number 16SV7757 and 16SV7756). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atallah Louis, 2010, 2010 International Conference on Body Sensor Networks (BSN), P24, DOI 10.1109/BSN.2010.23; Bayat A, 2014, PROCEDIA COMPUT SCI, V34, P450, DOI 10.1016/j.procs.2014.07.009; BenEnra O, 2007, ARCH OPHTHALMOL-CHIC, V125, P580, DOI 10.1001/archopht.125.4.580; Berufsverband der Augenarzte e.V. DOG, 2010, LEITL 26A AMBL; Birch EE, 2013, PROG RETIN EYE RES, V33, P67, DOI 10.1016/j.preteyeres.2012.11.001; Chua B, 2004, BRIT J OPHTHALMOL, V88, P1119, DOI 10.1136/bjo.2004.041863; da Silva FG, 2013, 2013 5TH IEEE INTERNATIONAL WORKSHOP ON ADVANCES IN SENSORS AND INTERFACES (IWASI), P20, DOI 10.1109/IWASI.2013.6576063; Elflein HM, 2015, DTSCH ARZTEBL INT, V112, P338, DOI 10.3238/arztebl.2015.0338; Fronius M, 2006, STRABISMUS, V14, P65, DOI 10.1080/09273970600700962; Fronius M, 2009, GRAEF ARCH CLIN EXP, V247, P1401, DOI 10.1007/s00417-009-1090-x; Hussein R, 2017, 2017 INTERNATIONAL CONFERENCE ON THE FRONTIERS AND ADVANCES IN DATA SCIENCE (FADS), P107; Januschowski K, 2013, ACTA OPHTHALMOL, V91, pE635, DOI 10.1111/aos.12171; Kohavi R, 1995, STUDY CROSS VALIDATI, P1137; Loudon SE, 2009, BRIT J OPHTHALMOL, V93, P1499, DOI 10.1136/bjo.2008.149815; Loudon SE, 2003, GRAEF ARCH CLIN EXP, V241, P176, DOI 10.1007/s00417-002-0570-z; Rahi JS, 2006, BRIT MED J, V332, P820, DOI 10.1136/bmj.38751.597963.AE; Rahi JS, 2002, LANCET, V360, P597, DOI 10.1016/S0140-6736(02)09782-9; Schramm C, 2016, ACTA OPHTHALMOL, V94, pE753, DOI 10.1111/aos.13134; Simonsz H J, 1999, Strabismus, V7, P113, DOI 10.1076/stra.7.2.113.645; Spierer A, 2010, INVEST OPHTH VIS SCI, V51, P3395, DOI 10.1167/iovs.09-4568; TOMMILA V, 1981, BRIT J OPHTHALMOL, V65, P575, DOI 10.1136/bjo.65.8.575; van Leeuwen R, 2007, BRIT J OPHTHALMOL, V91, P1450, DOI 10.1136/bjo.2006.113670; Wallace MP, 2013, INVEST OPHTH VIS SCI, V54, P6158, DOI 10.1167/iovs.13-11861; Wang JY, 2019, J AAPOS, V23, P205, DOI 10.1016/j.jaapos.2019.04.009; Wang JY, 2016, J AAPOS, V20, P326, DOI 10.1016/j.jaapos.2016.05.014; Yang F, 2017, INT CONF SYST INFORM, P469	26	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247389	10.1371/journal.pone.0247389	http://dx.doi.org/10.1371/journal.pone.0247389			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606776	Green Published, gold			2022-12-26	WOS:000620629200105
J	Kardani, K; Bolhassani, A				Kardani, Kimia; Bolhassani, Azam			Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches	PLOS ONE			English	Article							IN-VIVO DELIVERY; THERAPEUTIC PROTEINS; FUSION PROTEIN; VACCINE; PREDICTION; NANOPARTICLES; LOCALIZATION; MOLECULES; MECHANISM; POLYMERS	Among various delivery systems for vaccine and drug delivery, cell-penetrating peptides (CPPs) have been known as a potent delivery system because of their capability to penetrate cell membranes and deliver some types of cargoes into cells. Several CPPs were found in the proteome of viruses such as Tat originated from human immunodeficiency virus-1 (HIV-1), and VP22 derived from herpes simplex virus-1 (HSV-1). In the current study, a wide-range of CPPs was identified in the proteome of SARS-CoV-2, a new member of coronaviruses family, using in silico analyses. These CPPs may play a main role for high penetration of virus into cells and infection of host. At first, we submitted the proteome of SARS-CoV-2 to CellPPD web server that resulted in a huge number of CPPs with ten residues in length. Afterward, we submitted the predicted CPPs to C2Pred web server for evaluation of the probability of each peptide. Then, the uptake efficiency of each peptide was investigated using CPPred-RF and MLCPP web servers. Next, the physicochemical properties of the predicted CPPs including net charge, theoretical isoelectric point (pI), amphipathicity, molecular weight, and water solubility were calculated using protparam and pepcalc tools. In addition, the probability of membrane binding potential and cellular localization of each CPP were estimated by Boman index using APD3 web server, D factor, and TMHMM web server. On the other hand, the immunogenicity, toxicity, allergenicity, hemolytic potency, and half-life of CPPs were predicted using various web servers. Finally, the tertiary structure and the helical wheel projection of some CPPs were predicted by PEP-FOLD3 and Heliquest web servers, respectively. These CPPs were divided into: a) CPP containing tumor homing motif (RGD) and/or tumor penetrating motif (RXXR); b) CPP with the highest Boman index; c) CPP with high half-life (similar to 100 hour) in mammalian cells, and d) CPP with +5.00 net charge. Based on the results, we found a large number of novel CPPs with various features. Some of these CPPs possess tumor-specific motifs which can be evaluated in cancer therapy. Furthermore, the novel and potent CPPs derived from SARS-CoV-2 may be used alone or conjugated to some sequences such as nuclear localization sequence (NLS) for vaccine and drug delivery.	[Kardani, Kimia; Bolhassani, Azam] Pasteur Inst Iran, Dept Hepatitis & AIDS, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Bolhassani, A (corresponding author), Pasteur Inst Iran, Dept Hepatitis & AIDS, Tehran, Iran.	azam.bolhassani@yahoo.co	Bolhassani, Azam/HDN-7200-2022	Bolhassani, Azam/0000-0001-7363-7406; kardani, kimia/0000-0003-0357-6331				Bolhassani A, 2017, PEPTIDES, V87, P50, DOI 10.1016/j.peptides.2016.11.011; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Caesar CEB, 2006, BIOCHEMISTRY-US, V45, P7682, DOI 10.1021/bi052095t; Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266; Chakraborty H, 2020, BIOPHYS CHEM, V265, DOI 10.1016/j.bpc.2020.106438; Chaudhary K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22843; Chen L, 2015, AMINO ACIDS, V47, P1485, DOI 10.1007/s00726-015-1974-5; Dhakal S, 2019, VET RES, V50, DOI 10.1186/s13567-019-0712-5; Dimitrov I, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2278-5; Dimitrov I, 2014, BIOINFORMATICS, V30, P846, DOI 10.1093/bioinformatics/btt619; Dong YT, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00352-y; Du XF, 2018, DRUG DELIV, V25, P1516, DOI 10.1080/10717544.2018.1480674; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Florindo HF, 2020, NAT NANOTECHNOL, V15, P630, DOI 10.1038/s41565-020-0732-3; Freire JM, 2014, FEBS J, V281, P191, DOI 10.1111/febs.12587; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Garg A, 2020, CRIT REV THER DRUG, V37, P183, DOI 10.1615/CritRevTherDrugCarrierSyst.2020033273; Gautam A., 2015, CELL PENETRATING PEP, P59; Gautam A, 2015, EUR J PHARM BIOPHARM, V89, P93, DOI 10.1016/j.ejpb.2014.11.020; Gautam A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-74; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073957; Habault J, 2019, MOLECULES, V24, DOI 10.3390/molecules24050927; Hallbrink M, 2001, BBA-BIOMEMBRANES, V1515, P101, DOI 10.1016/S0005-2736(01)00398-4; Hoffmann K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30790-2; Kadkhodayan S, 2017, CURR DRUG DELIV, V14, P536, DOI 10.2174/1567201813666161006114448; Kajiwara N., 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Kardani K., 2020, CORONAVIRUSES, V1, P1; Kardani K, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2020.11.002; Kardani K, 2020, EXPERT REV CLIN PHAR, V13, P1001, DOI 10.1080/17512433.2020.1814743; Kardani K, 2019, EXPERT OPIN DRUG DEL, V16, P1227, DOI 10.1080/17425247.2019.1676720; Kumar Swatantra, 2020, VirusDisease, V31, DOI 10.1007/s13337-020-00571-5; Kuriakose A, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1298473; Kwon SJ, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-73; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Li YJ, 2019, J PROTEOME RES, V18, P1392, DOI 10.1021/acs.jproteome.9b00012; Liu B, 2019, IEEE ACM T COMPUT BI, V16, P292, DOI 10.1109/TCBB.2017.2765331; Liu ZH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37214-1; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Mahajan M, 2018, BBA-BIOMEMBRANES, V1860, P407, DOI 10.1016/j.bbamem.2017.10.002; Mahajan M, 2015, BBA-BIOMEMBRANES, V1848, P721, DOI 10.1016/j.bbamem.2014.11.025; Maiolo JR, 2005, BBA-BIOMEMBRANES, V1712, P161, DOI 10.1016/j.bbamem.2005.04.010; Manayalan B, 2018, J PROTEOME RES, V17, P2715, DOI 10.1021/acs.jproteome.8b00148; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Nabel GJ, 2013, NEW ENGL J MED, V368, P551, DOI 10.1056/NEJMra1204186; Nevagi RJ, 2019, EUR POLYM J, V114, P397, DOI 10.1016/j.eurpolymj.2019.03.009; Qi XP, 2011, MOL PLANT MICROBE IN, V24, P25, DOI 10.1094/MPMI-07-10-0147; Raagel H, 2011, PEPTIDE AND PROTEIN DELIVERY, P221, DOI 10.1016/B978-0-12-384935-9.10010-0; Rhee M, 2006, J BIOL CHEM, V281, P1233, DOI 10.1074/jbc.M509813200; Rydberg HA, 2012, BIOCHEMISTRY-US, V51, P5531, DOI 10.1021/bi300454k; Senel S, 2020, DRUG DELIV TRANSL RE, V10, P1644, DOI 10.1007/s13346-020-00806-4; Shahbazi S, 2018, INT IMMUNOPHARMACOL, V62, P170, DOI 10.1016/j.intimp.2018.07.006; Shankar G, 2014, AAPS J, V16, P658, DOI 10.1208/s12248-014-9599-2; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tang H, 2016, BIOCHEM BIOPH RES CO, V477, P150, DOI 10.1016/j.bbrc.2016.06.035; Tang J, 2020, BRIEF BIOINFORM, V21, P621, DOI 10.1093/bib/bby127; Wabalo EK., 2020, BIOL PHARM SCI, V12, P117; Wallis J, 2020, EUR J PHARM SCI, V152, DOI 10.1016/j.ejps.2020.105456; Wei LY, 2017, J PROTEOME RES, V16, P2044, DOI 10.1021/acs.jproteome.7b00019; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xia HM, 2012, INT J PHARMACEUT, V436, P840, DOI 10.1016/j.ijpharm.2012.07.029; Yang JR, 2019, CURR DRUG DELIV, V16, P430, DOI 10.2174/1567201816666190123120915; Yin JY, 2020, NUCLEIC ACIDS RES, V48, pD1042, DOI 10.1093/nar/gkz779; Yu R, 2019, J DRUG TARGET, V27, P780, DOI 10.1080/1061186X.2018.1547734; Zareba G, 2006, DRUG TODAY, V42, P321, DOI 10.1358/dot.2006.42.5.973586; Zhang MM, 2017, ACS BIOMATER SCI ENG, V3, P108, DOI 10.1021/acsbiomaterials.6b00418	68	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247396	10.1371/journal.pone.0247396	http://dx.doi.org/10.1371/journal.pone.0247396			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606823	gold, Green Published			2022-12-26	WOS:000620629200119
J	Novais, AK; Deschene, K; Martel-Kennes, Y; Roy, C; Laforest, JP; Lessard, M; Matte, JJ; Lapointe, J				Novais, Aliny K.; Deschene, Karine; Martel-Kennes, Yan; Roy, Caroline; Laforest, Jean-Paul; Lessard, Martin; Matte, J. Jacques; Lapointe, Jerome			Weaning differentially affects mitochondrial function, oxidative stress, inflammation and apoptosis in normal and low birth weight piglets	PLOS ONE			English	Article								Weaning is associated with increased occurrence of infections and diseases in piglets. Recent findings indicate that weaning induces mitochondrial dysfunction and oxidative stress conditions that more severely impact smaller piglets. The objective of this study was to characterize the molecular mechanisms underlying these physiological consequences and the relation with systemic inflammatory status in both normal and low birth weight (NBW and LBW) piglets throughout the peri-weaning period. To conduct the study, 30 sows were inseminated, and specific piglets from their litters were assigned to one of two experimental groups: NBW (n = 60, 1.73 +/- 0.01 kg,) and LBW piglets weighing less than 1.2 kg (n = 60, 1.01 +/- 0.01 kg). Then, 10 piglets from each group were selected at 14, 21 (weaning), 23, 25, 29 and 35 days of age to collect organ and plasma samples. Specific porcine RT2 Profiler (TM) PCR Arrays related to mitochondrial function, oxidative stress, inflammation and apoptosis processes were first used to target genes that are modulated after weaning in NBW piglets (d 23 and d 35 vs. d 14). Expression of selected genes was evaluated by quantitative PCR. These analyses revealed that expression of inflammatory genes CXCL10 and CCL19 increased after weaning in intestinal mucosa, while expression of genes encoding subunits of the mitochondrial respiratory chain was downregulated in liver and kidney of both groups. Interestingly, major modulators of mitophagy (BNIP3), cell survival (BCL2A1) and antioxidant defense system (TXNRD2, GPx3, HMOX1) were found to be highly expressed in NBW piglets. The systemic levels of TNF-alpha and IL1-beta significantly increased following weaning and were higher in NBW piglets. These results provide novel information about the molecular origin of mitochondrial dysfunction and oxidative stress observed in weaned piglets and suggest that clearance of dysfunctional mitochondria, antioxidant defenses and inflammatory response are compromised in LBW piglets.	[Novais, Aliny K.; Deschene, Karine; Martel-Kennes, Yan; Roy, Caroline; Lessard, Martin; Matte, J. Jacques; Lapointe, Jerome] Sherbrooke Res & Dev Ctr, Agr & Agri Food Canada, Sherbrooke, PQ, Canada; [Novais, Aliny K.] Univ Estadual Londrina, Dept Anim Sci, Londrina, Parana, Brazil; [Martel-Kennes, Yan; Laforest, Jean-Paul] Univ Laval, Dept Sci Anim, Ville De Quebec, PQ, Canada	Agriculture & Agri Food Canada; Universidade Estadual de Londrina; Laval University	Lapointe, J (corresponding author), Sherbrooke Res & Dev Ctr, Agr & Agri Food Canada, Sherbrooke, PQ, Canada.	Jerome.lapointe@canada.ca			Agriculture and Agri-Food Canada [1209]	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This work was funded by Agriculture and Agri-Food Canada (#1209).	Agarwal A, 2006, CURR OPIN OBSTET GYN, V18, P325, DOI 10.1097/01.gco.0000193003.58158.4e; [Anonymous], 2017, VET REC, V180, P315, DOI 10.1136/vr.j1602; APPLEGATE LA, 1991, CANCER RES, V51, P974; Barton MD, 2014, CURR OPIN MICROBIOL, V19, P9, DOI 10.1016/j.mib.2014.05.017; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brigelius-Flohe R, 2002, METHOD ENZYMOL, V347, P101; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Buchet A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178487; Campbell JM, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-19; Cao ST, 2018, J ANIM SCI, V96, P1073, DOI 10.1093/jas/skx062; CCAC, 2009, **DROPPED REF**; Chang M, 2015, CELL MOL LIFE SCI, V72, P1161, DOI 10.1007/s00018-014-1790-1; Chiaverini N, 2010, FREE RADICAL RES, V44, P605, DOI 10.3109/10715761003692511; Chiewchengchol D, 2016, IMMUN INFLAMM DIS, V4, P35, DOI 10.1002/iid3.90; Chu B, 2019, NAT CELL BIOL, V21, P579, DOI 10.1038/s41556-019-0305-6; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Collins CL, 2017, ANIM NUTR, V3, P372, DOI 10.1016/j.aninu.2017.01.001; Damgaard LH, 2003, J ANIM SCI, V81, P604; De Vos M, 2014, J ANIM PHYSIOL AN N, V98, P609, DOI 10.1111/jpn.12133; Declerck I, 2016, LIVEST SCI, V183, P48, DOI 10.1016/j.livsci.2015.11.015; Drefs M, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8325754; Gao AB, 2020, CLIN CHIM ACTA, V506, P72, DOI 10.1016/j.cca.2020.02.024; Garaude J, 2016, NAT IMMUNOL, V17, P1037, DOI 10.1038/ni.3509; Glick D, 2012, MOL CELL BIOL, V32, P2570, DOI 10.1128/MCB.00167-12; Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002; Hirschhorn T, 2019, FREE RADICAL BIO MED, V133, P130, DOI 10.1016/j.freeradbiomed.2018.09.043; Jiang BC, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7090122; John LJ, 2011, ANTIOXID REDOX SIGN, V15, P1255, DOI 10.1089/ars.2011.3892; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Lapointe J, 2014, J ANIM PHYSIOL AN N, V98, P809, DOI 10.1111/jpn.12160; Lessard M, 2018, VET IMMUNOL IMMUNOP, V206, P25, DOI 10.1016/j.vetimm.2018.11.005; Li XM, 2019, INT J MOL MED, V44, P503, DOI 10.3892/ijmm.2019.4214; Lopez-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003; Luo Z, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4768541; Matte J. J., 2017, Journees de la Recherche Porcine en France, V49, P69; Melser S, 2015, BBA-MOL CELL RES, V1853, P2812, DOI 10.1016/j.bbamcr.2015.05.010; Moeser AJ, 2017, ANIM NUTR, V3, P313, DOI 10.1016/j.aninu.2017.06.003; Moskovitz J, 2010, ANTIOXID REDOX SIGN, V12, P405, DOI 10.1089/ars.2009.2809; Novais AK, 2020, ANIMAL, V14, P1014, DOI 10.1017/S1751731119002829; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003; Sargeant HR, 2011, MOL IMMUNOL, V48, P2113, DOI 10.1016/j.molimm.2011.07.002; Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x; Stanley BA, 2011, J BIOL CHEM, V286, P33669, DOI 10.1074/jbc.M111.284612; Sutherland DEK, 2011, METALLOMICS, V3, P444, DOI 10.1039/c0mt00102c; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Wijtten PJA, 2011, BRIT J NUTR, V105, P967, DOI 10.1017/S0007114510005660; Zhang H, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600653; Zhang H, 2007, ARCH BIOCHEM BIOPHYS, V465, P119, DOI 10.1016/j.abb.2007.05.001; Zhu LH, 2012, J ANIM SCI, V90, P2581, DOI [10.2527/jas.2011-4444, 10.2527/jas.2012-4444]; Zhu Y, 2019, CELL SIGNAL, V58, P53, DOI 10.1016/j.cellsig.2019.03.006	52	11	15	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247188	10.1371/journal.pone.0247188	http://dx.doi.org/10.1371/journal.pone.0247188			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606751	Green Published, gold			2022-12-26	WOS:000620629200003
J	Wyness, AJ; Fortune, I; Blight, AJ; Browne, P; Hartley, M; Holden, M; Paterson, DM				Wyness, Adam J.; Fortune, Irene; Blight, Andrew J.; Browne, Patricia; Hartley, Morgan; Holden, Matthew; Paterson, David M.			Ecosystem engineers drive differing microbial community composition in intertidal estuarine sediments	PLOS ONE			English	Article							NEREIS-DIVERSICOLOR; NICHE CONSTRUCTION; BIOTURBATION; STABILITY; FLUXES; GROWTH; LIGHT; EPS	Intertidal systems are complex and dynamic environments with many interacting factors influencing biochemical characteristics and microbial communities. One key factor are the actions of resident fauna, many of which are regarded as ecosystem engineers because of their bioturbation, bioirrigation and sediment stabilising activities. The purpose of this investigation was to elucidate the evolutionary implications of the ecosystem engineering process by identifying, if any, aspects that act as selection pressures upon microbial communities. A mesocosm study was performed using the well characterised intertidal ecosystem engineers Corophium volutator, Hediste diversicolor, and microphytobenthos, in addition to manual turbation of sediments to compare effects of bioturbation, bioirrigation and stabilisation. A range of sediment functions and biogeochemical gradients were measured in conjunction with 16S rRNA sequencing and diatom taxonomy, with downstream bacterial metagenome function prediction, to identify selection pressures that incited change to microbial community composition and function. Bacterial communities were predominantly Proteobacteria, with the relative abundance of Bacteroidetes, Alphaproteobacteria and Verrucomicrobia being partially displaced by Deltaproteobacteria, Acidobacteria and Chloroflexi as dissolved oxygen concentration and redox potential decreased. Bacterial community composition was driven strongly by biogeochemistry; surface communities were affected by a combination of sediment functions and overlying water turbidity, and subsurface communities by biogeochemical gradients driven by sediment reworking. Diatom communities were dominated by Nitzschia laevis and Achnanthes sp., and assemblage composition was influenced by overlying water turbidity (manual or biogenic) rather than direct infaunal influences such as grazing.	[Wyness, Adam J.; Fortune, Irene; Blight, Andrew J.; Browne, Patricia; Hartley, Morgan; Paterson, David M.] Univ St Andrews, Scottish Oceans Inst, Sediment Ecol Res Grp, Sch Biol, St Andrews, Fife, Scotland; [Wyness, Adam J.] Rhodes Univ, Dept Zool & Entomol, Coastal Res Grp, Makhanda, South Africa; [Holden, Matthew] Univ St Andrews, Sch Med, Infect Grp, North Haugh, St Andrew, Scotland	University of St Andrews; Rhodes University; University of St Andrews	Wyness, AJ (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sediment Ecol Res Grp, Sch Biol, St Andrews, Fife, Scotland.; Wyness, AJ (corresponding author), Rhodes Univ, Dept Zool & Entomol, Coastal Res Grp, Makhanda, South Africa.	a.wyness@ru.ac.za	Holden, Matthew TG/K-6449-2014; Paterson, David/D-5202-2013	Holden, Matthew TG/0000-0002-4958-2166; Wyness, Adam/0000-0003-1202-6358; Paterson, David/0000-0003-1174-6476; Blight, Andrew John/0000-0002-9665-8813	John Templeton Foundation [60501]; MASTS pooling initiative (Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; MASTS - Scottish Funding Council [HR09011]; MASTS small grant scheme [SG433]	John Templeton Foundation; MASTS pooling initiative (Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; MASTS - Scottish Funding Council; MASTS small grant scheme	This work was funded by the John Templeton Foundation (https://www.templeton.org/) Grant 60501, "Putting the Extended Evolutionary Synthesis to the Test". It also received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, (https://www.masts.ac.uk)) and their support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. DMP received funding from MASTS, funded by the Scottish Funding Council (grant reference HR09011), and AJW received funding under the MASTS small grant scheme (grant reference SG433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Biles CL, 2002, HYDROL EARTH SYST SC, V6, P999, DOI 10.5194/hess-6-999-2002; Boogert NJ, 2006, BIOSCIENCE, V56, P570, DOI 10.1641/0006-3568(2006)56[570:TIONCA]2.0.CO;2; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Christensen B, 2000, MAR ECOL PROG SER, V192, P203, DOI 10.3354/meps192203; Clarke KR, 2006, PRIMER V6 USER MANUA; De Backer A, 2011, ESTUAR COAST SHELF S, V91, P306, DOI 10.1016/j.ecss.2010.10.031; DECHO AW, 1993, LIMNOL OCEANOGR, V38, P1633, DOI 10.4319/lo.1993.38.8.1633; Decleyre H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01124; Douglas GM., 2019, PICRUST2 AN IMPROVEM; Eklof JS, 2015, J SEA RES, V97, P56, DOI 10.1016/j.seares.2014.12.003; Elliot M., 2009, ECOLOGY MARINE SEDIM, V2nd; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Erwin DH, 2008, TRENDS ECOL EVOL, V23, P304, DOI 10.1016/j.tree.2008.01.013; Fath BD., 2008, ENCY ECOLOGY, P2348; Fernandes S, 2006, AQUAT ECOL, V40, P567, DOI 10.1007/s10452-005-8000-z; Foshtomi MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130116; GERDOL V, 1994, MAR ECOL PROG SER, V114, P109, DOI 10.3354/meps114109; Gilbert F, 2016, J EXP MAR BIOL ECOL, V482, P75, DOI 10.1016/j.jembe.2016.05.003; Green, 2004, DELIVERING SUSTAINAB, V1, P273; Hale R, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.52; HENRIKSEN K, 1983, ECOL BULL, P193; Hicks N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01730; Laland K, 2016, EVOL ECOL, V30, P191, DOI 10.1007/s10682-016-9821-z; Lavergne C, 2018, MICROB ECOL, V75, P364, DOI 10.1007/s00248-017-1048-1; Laverock B, 2011, BIOCHEM SOC T, V39, P315, DOI 10.1042/BST0390315; LEWIN J, 1978, MAR BIOL, V47, P1, DOI 10.1007/BF00397012; Liess A, 2009, J ECOL, V97, P326, DOI 10.1111/j.1365-2745.2008.01463.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McCurdy DG, 2000, OIKOS, V88, P301, DOI 10.1034/j.1600-0706.2000.880208.x; Meadows PS, 2012, GEOMORPHOLOGY, V157, P31, DOI 10.1016/j.geomorph.2011.07.007; Mermillod-Blondin F, 2004, AQUAT MICROB ECOL, V36, P271, DOI 10.3354/ame036271; NAIR KKC, 1979, HELGOLAND WISS MEER, V32, P279, DOI 10.1007/BF02189586; Passarelli C., 2018, MUDFLAT ECOLOGY, P243; Paterson DM, 2018, J SOIL SEDIMENT, V18, P3044, DOI 10.1007/s11368-018-2005-4; PATERSON DM, 1989, LIMNOL OCEANOGR, V34, P223, DOI 10.4319/lo.1989.34.1.0223; Perkins RG, 2001, MAR ECOL PROG SER, V223, P101, DOI 10.3354/meps223101; PETERSON CH, 1991, AM SCI, V79, P236; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rossi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066650; Schaller J, 2014, CHEMOSPHERE, V107, P336, DOI 10.1016/j.chemosphere.2013.12.086; Shen H, 2017, J EXP MAR BIOL ECOL, V488, P44, DOI 10.1016/j.jembe.2016.12.010; Simonsen R, 1974, METEOR FORSCHERGEB R, V19; Taylor JD, 2013, LIMNOL OCEANOGR, V58, P1463, DOI 10.4319/lo.2013.58.4.1463; Tolhurst TJ, 2008, HYDROBIOLOGIA, V596, P225, DOI 10.1007/s10750-007-9099-9; Underwood GJC, 1998, EUR J PHYCOL, V33, P173, DOI 10.1017/S0967026298001565; Urban-Malinga B, 2014, MAR BIOL, V161, P195, DOI 10.1007/s00227-013-2329-y; Vardy S, 2007, CONT SHELF RES, V27, P1190, DOI 10.1016/j.csr.2006.01.022; Widdows J, 2009, MAR ECOL PROG SER, V378, P135, DOI 10.3354/meps07864; Wotton RS., 2004, OCEANOGR MAR BIOL, V42, P57; Wrede A, 2018, ECOL INDIC, V91, P737, DOI 10.1016/j.ecolind.2018.04.026	55	4	4	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0240952	10.1371/journal.pone.0240952	http://dx.doi.org/10.1371/journal.pone.0240952			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606695	gold, Green Published			2022-12-26	WOS:000620629200004
J	Qing, YF; Zheng, JX; Tang, YP; Dai, F; Dong, ZR; Zhang, QB				Qing, Yu-Feng; Zheng, Jian-Xiong; Tang, Yi-Ping; Dai, Fei; Dong, Zeng-Rong; Zhang, Quan-Bo			LncRNAs Landscape in the patients of primary gout by microarray analysis	PLOS ONE			English	Article								To determine the expression profile and clinical significance of long non-coding RNAs (lncRNAs) in peripheral blood mononuclear cells (PBMCs) of patients with primary gout and healthy control subjects. Human lncRNA microarrays were used to identify the differentially expressed lncRNAs and mRNAs in primary gout patients (n = 6) and healthy control subjects (n = 6). Bioinformatics analyses were performed to predict the roles of differently expressed lncRNAs and mRNAs. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to detect the expression levels of 8 lnRNAs in 64 primary gout patients and 32 healthy control subjects. Spearman's correlation was used to analyze the correlation between these eight lncRNAs and the laboratory values of gout patients. A receiver operating characteristic (ROC) curve was constructed to evaluate the diagnostic value of the lncRNAs identified in gout. The microarray analysis identified 1479 differentially expressed lncRNAs (879 more highly expressed and 600 more lowly expressed), 862 differentially expressed mRNAs (390 more highly expressed and 472 more lowly expressed) in primary gout (fold change > 2, P < 0.05), respectively. The bioinformatic analysis indicated that the differentially expressed lncRNAs regulated the abnormally expressed mRNAs, which were involved in the pathogenesis of gout through several different pathways. The expression levels of TCONS_00004393 and ENST00000566457 were significantly increased in the acute gout flare group than those in the intercritical gout group or healthy subjects (P<0.01). Moreover, inflammation indicators were positive correlated with TCONS_00004393 and ENST00000566457 expression levels. The areas under the ROC curve of ENST00000566457 and NR-026756 were 0.868 and 0.948, respectively. Our results provide novel insight into the mechanisms of primary gout, and reveal that TCONS_00004393 and ENST00000566457 might be as candidate targets for the treatment of gout flare; ENST00000566457 and NR-026756 could effectively discriminate between the gout and the healthy control groups.	[Qing, Yu-Feng] Sichuan Univ, West China Hosp, Precis Med Key Lab Sichuan Prov, Chengdu, Peoples R China; [Qing, Yu-Feng] Sichuan Univ, West China Hosp, Precis Med Ctr, Chengdu, Peoples R China; [Qing, Yu-Feng; Zheng, Jian-Xiong; Tang, Yi-Ping; Dai, Fei; Dong, Zeng-Rong] North Sichuan Med Coll, Dept Rheumatol & Immunol, Affiliated Hosp, Nanchong, Peoples R China; [Zhang, Quan-Bo] North Sichuan Med Coll, Dept Geriatr, Affiliated Hosp, Nanchong, Peoples R China	Sichuan University; Sichuan University; North Sichuan Medical University; North Sichuan Medical University	Qing, YF (corresponding author), Sichuan Univ, West China Hosp, Precis Med Key Lab Sichuan Prov, Chengdu, Peoples R China.; Qing, YF (corresponding author), Sichuan Univ, West China Hosp, Precis Med Ctr, Chengdu, Peoples R China.; Qing, YF (corresponding author), North Sichuan Med Coll, Dept Rheumatol & Immunol, Affiliated Hosp, Nanchong, Peoples R China.	qingyufengqq@163.com		Qing, Yu-Feng/0000-0001-6709-7570	National Science Foundation of China [81974250]; PostDoctor Research Project, West China Hospital, Sichuan University [2018HXBH017]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); PostDoctor Research Project, West China Hospital, Sichuan University	This work was supported by the National Science Foundation of China (81974250); PostDoctor Research Project, West China Hospital, Sichuan University (2018HXBH017).	Aune TM, 2016, VIRUS RES, V212, P146, DOI 10.1016/j.virusres.2015.07.003; Bursill D, 2019, ARTHRIT CARE RES, V71, P427, DOI 10.1002/acr.23607; Cai Y, 2016, CARDIOVASC RES, V112, P714, DOI 10.1093/cvr/cvw022; Chatenoud L, 2006, CURR OPIN IMMUNOL, V18, P710, DOI 10.1016/j.coi.2006.09.004; Collier SP, 2014, J IMMUNOL, V193, P3959, DOI 10.4049/jimmunol.1401099; Cordero MD, 2018, TRENDS ENDOCRIN MET, V29, P8, DOI 10.1016/j.tem.2017.10.009; Dalbeth N, 2016, LANCET, V388, P2039, DOI 10.1016/S0140-6736(16)00346-9; Ernst EH, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00078; Gao YZ, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00193; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Huntley RP, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-155; Jin CJ, 2016, ONCOTARGET, V7, P51763, DOI 10.18632/oncotarget.10107; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Lee JS, 2020, KOREAN J INTERN MED, V35, P240, DOI 10.3904/kjim.2018.205; Li Z., 2018, CELL PROLIFERAT, V51; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Miao ZM, 2008, J RHEUMATOL, V35, P1859; Min HK, 2020, KOREAN J INTERN MED, V35, P62, DOI 10.3904/kjim.2019.423; Neogi T, 2015, ANN RHEUM DIS, V74, P1789, DOI 10.1136/annrheumdis-2015-208237; Noren Hooten N, 2019, AGING-US, V11, P1189, DOI 10.18632/aging.101823; Sigdel KR, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/848790; So AK, 2017, NAT REV RHEUMATOL, V13, P639, DOI 10.1038/nrrheum.2017.155; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Xu F, 2019, J BIOMED MATER RES A, V107, P468, DOI 10.1002/jbm.a.36562; Xu JF, 2019, CELL MOL IMMUNOL, V16, P1, DOI 10.1038/s41423-018-0042-y; Xu YT, 2020, INT IMMUNOPHARMACOL, V87, DOI 10.1016/j.intimp.2020.106842; Ying L, 2013, MOL BIOSYST, V9, P407, DOI 10.1039/c2mb25386k; Yu YF, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.2149; Zhang MJ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00184; Zhang Y, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1129-4; Zhou M, 2019, BRIEF BIOINFORM, V20, P598, DOI 10.1093/bib/bby021	32	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0232918	10.1371/journal.pone.0232918	http://dx.doi.org/10.1371/journal.pone.0232918			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600466	Green Published, Green Submitted, gold			2022-12-26	WOS:000620625100052
J	Adjerid, K; Mayerl, CJ; Gould, FDH; Edmonds, CE; Stricklen, BM; Bond, LE; German, RZ				Adjerid, Khaled; Mayerl, Christopher J.; Gould, Francois D. H.; Edmonds, Chloe E.; Stricklen, Bethany M.; Bond, Laura E.; German, Rebecca Z.			Does birth weight affect neonatal body weight, growth, and physiology in an animal model?	PLOS ONE			English	Article								Infant birth weight affects neuromotor and biomechanical swallowing performance in infant pig models. Preterm infants are generally born low birth weight and suffer from delayed development and neuromotor deficits. These deficits include critical life skills such as swallowing and breathing. It is unclear whether these neuromotor and biomechanical deficits are a result of low birth weight or preterm birth. In this study we ask: are preterm infants simply low birth weight infants or do preterm infants differ from term infants in weight gain and swallowing behaviors independent of birth weight? We use a validated infant pig model to show that preterm and term infants gain weight differently and that birth weight is not a strong predictor of functional deficits in preterm infant swallowing. We found that preterm infants gained weight at a faster rate than term infants and with nearly three times the variation. Additionally, we found that the number of sucks per swallow, swallow duration, and the delay of the swallows relative to the suck cycles were not impacted by birth weight. These results suggest that any correlation of developmental or swallowing deficits with reduced birth weight are likely linked to underlying physiological immaturity of the preterm infant.	[Adjerid, Khaled; Mayerl, Christopher J.; Edmonds, Chloe E.; Stricklen, Bethany M.; Bond, Laura E.; German, Rebecca Z.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH 44272 USA; [Gould, Francois D. H.] Rowan Univ, Sch Osteopath Med, Dept Cell Biol & Neurosci, Stratford, NJ USA	Northeast Ohio Medical University (NEOMED); Rowan University; Rowan University School of Osteopathic Medicine	Adjerid, K (corresponding author), Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH 44272 USA.	Kadjerid@neomed.edu	Edmonds, Chloe Elise/AHB-0765-2022	Edmonds, Chloe Elise/0000-0001-6150-2221; Adjerid, Khaled/0000-0002-9076-616X	National Institutes of Health [NIH R01 HD088561]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health [NIH R01 HD088561] to R.Z.G. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol CL, 2003, PEDIATR NEPHROL, V18, P887, DOI 10.1007/s00467-003-1186-1; Anesi GL, 2018, ANN AM THORAC SOC, V15, P1328, DOI 10.1513/AnnalsATS.201804-241OC; Arvedson J, 2010, AM J SPEECH-LANG PAT, V19, P321, DOI 10.1044/1058-0360(2010/09-0067); Ballester A, 2018, DYSPHAGIA, V33, P627, DOI 10.1007/s00455-018-9881-z; Barlow SM, 2014, J PERINATOL, V34, P136, DOI 10.1038/jp.2013.149; BARNETT V, 1975, J ROY STAT SOC A STA, V138, P258, DOI 10.2307/2984653; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Catchpole E, 2020, DYSPHAGIA, V35, P334, DOI 10.1007/s00455-019-10033-w; Chabra S, 2018, AM J GASTROENTEROL, V113, P441, DOI 10.1038/ajg.2017.499; Collins RT, 2018, J PEDIATR-US, V203, P170, DOI 10.1016/j.jpeds.2018.08.004; Cutland CL, 2017, VACCINE, V35, P6492, DOI 10.1016/j.vaccine.2017.01.049; DeLozier KR, 2018, J APPL PHYSIOL, V125, P159, DOI 10.1152/japplphysiol.00963.2017; Edmonds CE, 2020, INTEGR ORGANISM BIOL, V2, DOI 10.1093/iob/obaa028; Eiby YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068763; Flamand VH, 2012, CLIN NEUROPHYSIOL, V123, P1191, DOI 10.1016/j.clinph.2011.09.017; German RZ, 2008, INTEGR COMP BIOL, V48, P283, DOI 10.1093/icb/icn022; Gewolb IH, 2001, DEV MED CHILD NEUROL, V43, P22, DOI 10.1017/S0012162201000044; Gewolb IH, 2006, DEV MED CHILD NEUROL, V48, P589, DOI 10.1017/S001216220600123X; Goldfield EC, 1999, DEVELOPMENTAL SCI, V2, P363, DOI 10.1111/1467-7687.00081; Gould FDH, 2016, J APPL PHYSIOL, V120, P495, DOI 10.1152/japplphysiol.00946.2015; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Howson CP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S1; Jadcherla S, 2016, AM J CLIN NUTR, V103, p622S, DOI 10.3945/ajcn.115.110106; Kohn R, 2018, J GEN INTERN MED, V33, P1851, DOI 10.1007/s11606-018-4564-x; Kramer MS, 2013, NESTLE NUTR WORKS SE, V74, P1, DOI 10.1159/000348382; Lau C, 2012, DEV ORAL FEEDING SKI; Mayerl CJ, 2020, J BIOMECH, V105, DOI 10.1016/j.jbiomech.2020.109786; Mayerl CJ, 2021, DYSPHAGIA, V36, P120, DOI 10.1007/s00455-020-10118-x; Mayerl CJ, 2020, PEDIATR RES, V87, P656, DOI 10.1038/s41390-019-0624-0; Mayerl CJ, 2019, J APPL PHYSIOL, V126, P1681, DOI 10.1152/japplphysiol.00101.2019; Oken E, 2013, NESTLE NUTR WORKS SE, V71, P103, DOI 10.1159/000342576; Oudgenoeg-Paz O, 2017, NEUROSCI BIOBEHAV R, V80, P382, DOI 10.1016/j.neubiorev.2017.06.009; Pascal A, 2018, DEV MED CHILD NEUROL, V60, P342, DOI 10.1111/dmcn.13675; Phillips Julie Baker, 2015, Evolution Medicine and Public Health, P136, DOI 10.1093/emph/eov010; Pitcher JB, 2012, J PHYSIOL-LONDON, V590, P5827, DOI 10.1113/jphysiol.2012.239269; Pitcher JB, 2012, J NEUROSCI, V32, P16410, DOI 10.1523/JNEUROSCI.3079-12.2012; Rasch S, 2010, ACTA PAEDIATR, V99, P201, DOI 10.1111/j.1651-2227.2009.01564.x; RStudio, 2020, INT DEV R; Sanchez K, 2016, J PEDIATR-US, V178, P113, DOI 10.1016/j.jpeds.2016.07.044; Sangild PT, 2013, J ANIM SCI, V91, P4713, DOI 10.2527/jas.2013-6359; Stein REK, 2006, PEDIATRICS, V118, P217, DOI 10.1542/peds.2005-2836; Vanden Hole C, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02510; Vanden Hole C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223851; Vanden Hole C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209233; Vanden Hole C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195961; Wildman DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024509; Zaiontz C., 2020, REAL STAT RESOURCE P	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246954	10.1371/journal.pone.0246954	http://dx.doi.org/10.1371/journal.pone.0246954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592070	Green Published			2022-12-26	WOS:000620632800066
J	Wiener, PC; Darwish, A; Friend, E; Kadem, L; Pressman, GS				Wiener, Philip C.; Darwish, Ahmed; Friend, Evan; Kadem, Lyes; Pressman, Gregg S.			Energy loss associated with in-vitro modeling of mitral annular calcification	PLOS ONE			English	Article								Introduction Study aims were to compare hemodynamics and viscous energy dissipation (VED) in 3D printed mitral valves-one replicating a normal valve and the other a valve with severe mitral annular calcification (MAC). Patients with severe MAC develop transmitral gradients, without the commissural fusion typifying rheumatic mitral stenosis (MS), and may have symptoms similar to classical MS. A proposed mechanism relates to VED due to disturbed blood flow through the diseased valve into the ventricle. Methods A silicone model of a normal mitral valve (MV) was created using a transesophageal echocardiography dataset. 3D printed calcium phantoms were incorporated into a second valve model to replicate severe MAC. The synthetic MVs were tested in a left heart duplicator under rest and exercise conditions. Fine particles were suspended in a water/glycerol blood analogue for particle image velocimetry calculation of VED. Results Catheter mean transmitral gradients were slightly higher in the MAC valve compared to the normal MV, both at rest (3.2 vs. 1.3 mm Hg) and with exercise (5.9 vs. 5.0 mm Hg); Doppler gradients were 2.7 vs. 2.1 mm Hg at rest and 9.9 vs 8.2 mm Hg with exercise. VED was similar between the two valves at rest. During exercise, VED increased to a greater extent for the MAC valve (240%) versus the normal valve (127%). Conclusion MAC MS is associated with slightly increased transmitral gradients but markedly increased VED during exercise. These energy losses may contribute to the exercise intolerance and exertional dyspnea present in MAC patients.	[Wiener, Philip C.; Friend, Evan; Pressman, Gregg S.] Einstein Med Ctr, Div Cardiol, Heart & Vasc Inst, Philadelphia, PA 19141 USA; [Darwish, Ahmed; Kadem, Lyes] Concordia Univ, Dept Mech Ind & Aerosp Engn, Montreal, PQ, Canada	Concordia University - Canada	Pressman, GS (corresponding author), Einstein Med Ctr, Div Cardiol, Heart & Vasc Inst, Philadelphia, PA 19141 USA.	PressmanG@einstein.edu	Darwish, Ahmed/AEM-7250-2022; Darwish, Ahmed/AAV-6763-2020	Darwish, Ahmed/0000-0002-4681-7628; Pressman, Gregg/0000-0002-0992-1805	Stephen & Eve Milstein Donor Advised Fund	Stephen & Eve Milstein Donor Advised Fund	This research was supported by a grant from the Stephen & Eve Milstein Donor Advised Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison MA, 2006, CIRCULATION, V113, P861, DOI 10.1161/CIRCULATIONAHA.105.552844; Barasch E, 2006, AM HEART J, V151, P39, DOI 10.1016/j.ahj.2005.03.052; Di Labbio G, 2018, J BIOMECH, V78, P155, DOI 10.1016/j.jbiomech.2018.07.023; Eleid MF, 2016, JACC-CARDIOVASC IMAG, V9, P1318, DOI 10.1016/j.jcmg.2016.09.001; Faludi R, 2010, J THORAC CARDIOV SUR, V139, P1501, DOI 10.1016/j.jtcvs.2009.07.060; Filomena D, 2019, J AM SOC ECHOCARDIOG, V32, P1250, DOI 10.1016/j.echo.2019.05.022; Fox CS, 2006, J AM SOC NEPHROL, V17, P521, DOI 10.1681/ASN.2005060627; Fox CS, 2003, CIRCULATION, V107, P1492, DOI 10.1161/01.CIR.0000058168.26163.BC; Herrmann TA, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024579; Jesri A, 2008, INT J CARDIOL, V128, P193, DOI 10.1016/j.ijcard.2007.05.015; Ji L, 2018, INT J CARDIOVAS IMAG, V34, P1383, DOI 10.1007/s10554-018-1348-7; Kizer JR, 2005, STROKE, V36, P2533, DOI 10.1161/01.STR.0000190005.09442.ad; Kohsaka S, 2008, JACC-CARDIOVASC IMAG, V1, P617, DOI 10.1016/j.jcmg.2008.07.006; Massera D, 2019, CIRC-CARDIOVASC IMAG, V12, DOI 10.1161/CIRCIMAGING.118.008513; Movva R, 2013, J AM SOC ECHOCARDIOG, V26, P1135, DOI 10.1016/j.echo.2013.06.014; Muddassir SM, 2007, INT J CARDIOL, V123, P58, DOI 10.1016/j.ijcard.2006.11.142; NISHIMURA RA, 1994, J AM COLL CARDIOL, V24, P152, DOI 10.1016/0735-1097(94)90556-8; Okafor IU, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0154-9; Oktay AA, 2017, CURR PROB CARDIOLOGY, V42, P71, DOI 10.1016/j.cpcardiol.2017.01.002; Papolla C., 2019, Computer Methods in Biomechanics and Biomedical Engineering, V22, P468, DOI 10.1080/10255842.2020.1714984; Pressman GS, 2020, AM J CARDIOL, V125, P1536, DOI 10.1016/j.amjcard.2020.02.020; Pressman GS, 2010, AM J CARDIOL, V105, P389, DOI 10.1016/j.amjcard.2009.09.042; Reddy YNV, 2019, CIRCULATION, V140, P523, DOI 10.1161/CIRCULATIONAHA.119.040095; Shibata M, 2018, PEDIATR CARDIOL, V39, P731, DOI 10.1007/s00246-018-1813-z; Stugaard M, 2015, EUR HEART J-CARD IMG, V16, P723, DOI 10.1093/ehjci/jev035; Sud K, 2016, CIRCULATION, V133, P1594, DOI 10.1161/CIRCULATIONAHA.115.020185; Tyagi G, 2014, J HEART VALVE DIS, V23, P707; Xu L, 2017, ECHOCARDIOGR-J CARD, V34, P700, DOI 10.1111/echo.13504; Yoshida S, 2019, CIRC J, V83, P130, DOI 10.1253/circj.CJ-18-0625; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhong Y, 2016, J ULTRAS MED, V35, P965, DOI 10.7863/ultra.15.06009	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246701	10.1371/journal.pone.0246701	http://dx.doi.org/10.1371/journal.pone.0246701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33591991	Green Published, gold			2022-12-26	WOS:000620632800014
J	Zambang, MAM; Jiang, HB; Wahab, L				Zambang, Mohammed Abdul Muhsin; Jiang, Haobin; Wahab, Lukuman			Modeling vehicle ownership with machine learning techniques in the Greater Tamale Area, Ghana	PLOS ONE			English	Article								Vehicle ownership modeling and prediction is a crucial task in the transportation planning processes which, traditionally, uses statistical models in the modeling process. However, with the advancement in computing power of computers and Artificial Intelligence, Machine Learning (ML) algorithms are becoming an alternative or a complement to the statistical models in modeling the transportation planning processes. Although the application of ML algorithms to the transportation planning processes-like mode choice, and traffic forecasting and demand modeling-have received much attention in research and abound in literature, scanty attention is paid to its application to vehicle ownership modeling especially in the context of small to medium cities in developing countries. Therefore, this study attempts to fill this gap by modeling vehicle ownership in the Greater Tamale Area (GTA), a typically small to medium city in Ghana. Using a cross sectional survey of formal sectors workers, data was collected between June-August 2018. The study applied nine different ML classification algorithms to the dataset using 10-fold cross-validation technique/s and the Cohen-Kappa static/statistic to evaluate the predictive performance of each of the algorithms, and the Permutation Feature Importance to examine the features that contribute significantly to the prediction of vehicle ownership in GTA. The results showed that Linear Support Vector Classification (LinearSVC) classifier performed well in comparison with the other classifiers with regards to the overall predictive ability of the classifiers. In terms of class predictions, K- Nearest Neighbors (KNN) classifier performs well for no-vehicle class whiles Linear Support Vector Classification (LinearSVC) and GaussianNB classifiers performs well for motorcycle ownership. LinearSVC and Logistic Regression classifiers performed well on the car ownership class. Also, the results indicated that travel mode choice, average monthly income, average travel distance to workplace, average monthly expenditure on transport, duration of travel to workplace, occupational rank, age, household size and marital status were significant in predicting vehicle ownership for most of the classifiers. These findings could help policies makers carve out strategies that would reduce vehicle ownership but improve personal mobility.	[Zambang, Mohammed Abdul Muhsin; Jiang, Haobin] Jiangsu Univ, Sch Automot & Traff Engn, Zhenjiang, Jiangsu, Peoples R China; [Zambang, Mohammed Abdul Muhsin; Wahab, Lukuman] Tamale Tech Univ, Civil Engn Dept, Tamale, Ghana	Jiangsu University	Jiang, HB (corresponding author), Jiangsu Univ, Sch Automot & Traff Engn, Zhenjiang, Jiangsu, Peoples R China.	jianghb@ujs.edu.cn	Zambang, Mohammed Abdul Muhsin/AAG-6076-2021; Wahab, Lukuman/AAO-7774-2020	Zambang, Mohammed Abdul Muhsin/0000-0002-7324-7763; Wahab, Lukuman/0000-0002-5814-8169				Zambang MAM, 2020, TRANSPORT RES REC, V2674, P68, DOI 10.1177/0361198120947714; Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134; Anowar S, 2014, TRANSPORT REV, V34, P441, DOI 10.1080/01441647.2014.915440; Asamoa-Boateng NK., 2018, DAILYGUIDE; Asif MT, 2016, IEEE T INTELL TRANSP, V17, P1816, DOI 10.1109/TITS.2015.2507259; Aslam J., 2012, P 10 ACM C EMBEDDED, P141, DOI [10.1145/2426656.2426671, DOI 10.1145/2426656.2426671]; Brownlee J., 2017, MAT MACHINE LEARNING; Buitinck L., 2013, ECML PKDD WORKSH LAN, DOI DOI 10.48550/ARXIV.1309.0238; Celikoglu HB, 2006, MATH COMPUT MODEL, V44, P640, DOI 10.1016/j.mcm.2006.02.002; de Jong G, 2004, TRANSPORT REV, V24, P379, DOI 10.1080/0144164032000138733; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fleiss JL, 2003, BOOK SERIES WILEY SE, V3rd, DOI [10.1002/0471445428, DOI 10.1198/TECH.2004.S812, DOI 10.1002/0471445428]; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Ghana Statistical Service, 2012, GHANA STAT SERV FINA, DOI [10.1016/j.adolescence.2008.08.001, DOI 10.1016/J.ADOLESCENCE.2008.08.001]; Ghana Statistical Service, 2018, PROJECTED POPULATION; Giot R, 2014, 2014 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN VEHICLES AND TRANSPORTATION SYSTEMS (CIVTS), P22, DOI 10.1109/CIVTS.2014.7009473; Golshani N, 2018, TRAVEL BEHAV SOC, V10, P21, DOI 10.1016/j.tbs.2017.09.003; Hagenauer J, 2017, EXPERT SYST APPL, V78, P273, DOI 10.1016/j.eswa.2017.01.057; Hastie T, 2009, ELEMENTS, V27, P337, DOI DOI 10.1007/B94608; Hensher DA, 2000, TRANSPORT RES E-LOG, V36, P155, DOI 10.1016/S1366-5545(99)00030-7; Herrera JC, 2010, TRANSPORT RES C-EMER, V18, P568, DOI 10.1016/j.trc.2009.10.006; Hillel T., 2019, SYSTEMATIC REV MACHI; Huey J. A., 1996, TRANSPORT RES REC, V1521, P65, DOI [10.3141/ 1521- 09, DOI 10.3141/1521-09]; Kaewwichian P, 2019, INT J GEOMATE, V17, P219, DOI 10.21660/2019.62.94618; Karlaftis MG, 2011, TRANSPORT RES C-EMER, V19, P387, DOI 10.1016/j.trc.2010.10.004; Kipke BG, 1988, 67 ANN M TRANSP RES, P1; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Li WZ, 2017, ACM T GRAPHIC, V36, DOI 10.1145/3130800.3130847; Li WZ, 2017, IEEE INTEL TRANSP SY, V9, P100, DOI 10.1109/MITS.2017.2709804; Lin L, 2018, TRANSPORT RES C-EMER, V97, P258, DOI 10.1016/j.trc.2018.10.011; Mohammadian A, 2002, TRANSPORT RES REC, P92, DOI 10.3141/1807-12; Newman P, 1999, TRANSPORT RES REC, V1670, P17, DOI DOI 10.3141/1670-04; Omrani H, 2015, TRANSP RES PROC, V10, P840, DOI 10.1016/j.trpro.2015.09.037; Omrani H, 2013, TRANSPORT RES REC, P1, DOI 10.3141/2399-01; Paredes M, 2017, 2017 5TH IEEE INTERNATIONAL CONFERENCE ON MODELS AND TECHNOLOGIES FOR INTELLIGENT TRANSPORTATION SYSTEMS (MT-ITS), P780, DOI 10.1109/MTITS.2017.8005618; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Shan ZY, 2013, IEEE INT C INTELL TR, P118, DOI 10.1109/ITSC.2013.6728220; Tang XF, 2019, WEB CONFERENCE 2019: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2019), P1806, DOI 10.1145/3308558.3313621; Train K., 1986, QUALITTIVE CHOICE AN; Ha TV, 2019, J TRANSP GEOGR, V78, P70, DOI 10.1016/j.jtrangeo.2019.05.015; Wahab L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214966; Wang YL, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P25, DOI 10.1145/2623330.2623656; Witten LH., 2011, ENCY ECOLOGY, VThird Edit, DOI 0.1016/B978-008045405-4.00153-1; Xu W, 2011, ASIA-PAC J PUBLIC HE, P1; Yu JR, 2020, TRANSPORT RES C-EMER, V112, P136, DOI 10.1016/j.trc.2020.01.023; Zhang H., 2004, P 17 INT FLOR ART IN, P562; Zhang JD, 2013, IEEE T INTELL TRANSP, V14, P1629, DOI 10.1109/TITS.2013.2264753; Zhang YL, 2008, TRANSPORT RES REC, P141, DOI 10.3141/2076-16; Zhao D., 2010, TRAFFIC TRANSPORTATI, P685; Zhao QK, 2011, IEEE INT C INTELL TR, P272, DOI 10.1109/ITSC.2011.6082829	51	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246044	10.1371/journal.pone.0246044	http://dx.doi.org/10.1371/journal.pone.0246044			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33591977	gold, Green Published			2022-12-26	WOS:000620632800081
J	Gaurav, R; Mikuls, TR; Thiele, GM; Nelson, AJ; Niu, M; Guda, C; Eudy, JD; Barry, AE; Wyatt, TA; Romberger, DJ; Duryee, MJ; England, BR; Poole, JA				Gaurav, Rohit; Mikuls, Ted R.; Thiele, Geoffrey M.; Nelson, Amy J.; Niu, Meng; Guda, Chittibabu; Eudy, James D.; Barry, Austin E.; Wyatt, Todd A.; Romberger, Debra J.; Duryee, Michael J.; England, Bryant R.; Poole, Jill A.			High-throughput analysis of lung immune cells in a combined murine model of agriculture dust-triggered airway inflammation with rheumatoid arthritis	PLOS ONE			English	Article								Rheumatoid arthritis (RA)-associated lung disease is a leading cause of mortality in RA, yet the mechanisms linking lung disease and RA remain unknown. Using an established murine model of RA-associated lung disease combining collagen-induced arthritis (CIA) with organic dust extract (ODE)-induced airway inflammation, differences among lung immune cell populations were analyzed by single cell RNA-sequencing. Additionally, four lung myeloid-derived immune cell populations including macrophages, monocytes/macrophages, monocytes, and neutrophils were isolated by fluorescence cell sorting and gene expression was determined by NanoString analysis. Unsupervised clustering revealed 14 discrete clusters among Sham, CIA, ODE, and CIA+ODE treatment groups: 3 neutrophils (inflammatory, resident/transitional, autoreactive/suppressor), 5 macrophages (airspace, differentiating/recruited, recruited, resident/interstitial, and proliferative airspace), 2 T-cells (differentiating and effector), and a single cluster each of inflammatory monocytes, dendritic cells, B-cells and natural killer cells. Inflammatory monocytes, autoreactive/suppressor neutrophils, and recruited/differentiating macrophages were predominant with arthritis induction (CIA and CIA+ODE). By specific lung cell isolation, several interferon-related and autoimmune genes were disproportionately expressed among CIA and CIA+ODE (e.g. Oasl1, Oas2, Ifit3, Gbp2, Ifi44, and Zbp1), corresponding to RA and RA-associated lung disease. Monocytic myeloid-derived suppressor cells were reduced, while complement genes (e.g. C1s1 and Cfb) were uniquely increased in CIA+ODE mice across cell populations. Recruited and inflammatory macrophages/monocytes and neutrophils expressing interferon-, autoimmune-, and complement-related genes might contribute towards pro-fibrotic inflammatory lung responses following airborne biohazard exposures in setting of autoimmune arthritis and could be predictive and/or targeted to reduce disease burden.	[Gaurav, Rohit; Nelson, Amy J.; Barry, Austin E.; Poole, Jill A.] Univ Nebraska Med Ctr, Dept Internal Med, Div Allergy & Immunol, Omaha, NE 68198 USA; [Mikuls, Ted R.; Thiele, Geoffrey M.; Wyatt, Todd A.; Romberger, Debra J.; Duryee, Michael J.; England, Bryant R.] Vet Affairs Nebraska Western Iowa Hlth Care Syst, Res Serv, Omaha, NE USA; [Mikuls, Ted R.; Thiele, Geoffrey M.; Duryee, Michael J.; England, Bryant R.] Univ Nebraska Med Ctr, Dept Internal Med, Div Rheumatol & Immunol, Omaha, NE USA; [Niu, Meng; Guda, Chittibabu; Eudy, James D.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Wyatt, Todd A.; Romberger, Debra J.] Univ Nebraska Med Ctr, Dept Internal Med, Div Pulm Crit Care & Sleep, Omaha, NE USA; [Wyatt, Todd A.] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Environm Agr & Occupat Hlth, Omaha, NE USA; [Wyatt, Todd A.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Gaurav, R (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Div Allergy & Immunol, Omaha, NE 68198 USA.	rohit.gaurav@unmc.edu		Gaurav, Rohit/0000-0003-4753-2680	Central States Center for Agricultural Safety and Health NIOSH [U54OH010162]; National Institute of Environmental Health Sciences [R01ES019325]; National Institute for Occupational Safety and Health [U54OH010162]; Research Career Scientist Award from the Department of Veterans Affairs [IK6 BX003781]; VA [CX000896, BX004600]; National Institute of General Medical Sciences [U54GM115458]; National Institute on Alcohol Abuse and Alcoholism [R25AA020818]; Rheumatology Research Foundation; VA Merit review [5I01CX001714-02]; Fred & Pamela Buffett Cancer Center Shared Resource; National Cancer Institute [P30CA036727]; National Institute for General Medical Science (NIGMS) NE-INBRE (Nebraska Research Network in Functional Genomics) [P20GM103427]; COBRE [1P30GM110768]	Central States Center for Agricultural Safety and Health NIOSH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Research Career Scientist Award from the Department of Veterans Affairs(US Department of Veterans Affairs); VA(US Department of Veterans Affairs); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Rheumatology Research Foundation; VA Merit review(US Department of Veterans Affairs); Fred & Pamela Buffett Cancer Center Shared Resource; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute for General Medical Science (NIGMS) NE-INBRE (Nebraska Research Network in Functional Genomics); COBRE	RG is supported by Central States Center for Agricultural Safety and Health NIOSH (U54OH010162). Study supported by grants from the National Institute of Environmental Health Sciences (R01ES019325 to JAP), National Institute for Occupational Safety and Health (U54OH010162 to JAP and TAW). TAW is the recipient of a Research Career Scientist Award (IK6 BX003781) from the Department of Veterans Affairs. TRM is supported by VA (CX000896 and BX004600) and grants from the National Institute of General Medical Sciences (U54GM115458) and the National Institute on Alcohol Abuse and Alcoholism (R25AA020818). BRE is supported by grants from the National Institute of General Medical Sciences (U54GM115458) and the Rheumatology Research Foundation. DJR is supported by VA Merit review 5I01CX001714-02. Study also supported by the Fred & Pamela Buffett Cancer Center Shared Resource, supported by the National Cancer Institute under award number P30CA036727. The University of Nebraska DNA Sequencing Core and Bioinformatics Core receive partial support from the National Institute for General Medical Science (NIGMS) NE-INBRE (Nebraska Research Network in Functional Genomics) (P20GM103427) and COBRE (1P30GM110768). This publication's contents are the sole responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	10x Genomics, 2020, WHAT IS LOUP BROWS; Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Abe A, 2004, J BIOL CHEM, V279, P42605, DOI 10.1074/jbc.M407834200; Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Anderson R, 2016, NICOTINE TOB RES, V18, P1556, DOI 10.1093/ntr/ntw030; Aubart F, 2011, J RHEUMATOL, V38, P979, DOI 10.3899/jrheum.101261; Bade B, 2005, INT IMMUNOL, V17, P1419, DOI 10.1093/intimm/dxh320; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Bajpai G, 2019, CIRC RES, V124, P263, DOI 10.1161/CIRCRESAHA.118.314028; Basheer F, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00793-18; Bego MG, 2019, J BIOL CHEM, V294, P10503, DOI 10.1074/jbc.RA119.008481; Bell RD, 2020, ARTHRITIS RHEUMATOL, V72, P1759, DOI 10.1002/art.41309; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Borroto A, 1999, J IMMUNOL, V163, P25; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Botto M, 2002, IMMUNOBIOLOGY, V205, P395, DOI 10.1078/0171-2985-00141; Briseno CG, 2016, CELL REP, V15, P2462, DOI 10.1016/j.celrep.2016.05.025; Bronte V, 2001, J IMMUNOTHER, V24, P431, DOI 10.1097/00002371-200111000-00001; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Cassone G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041082; Chen GB, 2011, J BIOL CHEM, V286, P34941, DOI 10.1074/jbc.M111.286427; Coates BM, 2018, J IMMUNOL, V200, P2391, DOI 10.4049/jimmunol.1701543; Cormier SA, 2002, AM J RESP CELL MOL, V27, P678, DOI 10.1165/rcmb.4882; Damuzzo V, 2015, CYTOM PART B-CLIN CY, V88, P77, DOI [10.1002/cyto.b.21206, 10.1002/cytob.21206]; Doucey MA, 2003, J BIOL CHEM, V278, P3257, DOI 10.1074/jbc.M208119200; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; El Amri M, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0445-1; England BR, 2019, ARTHRITIS RHEUMATOL, V71, P1483, DOI 10.1002/art.40900; Fernandez IE, 2016, EUR RESPIR J, V48, P1171, DOI 10.1183/13993003.01826-2015; Friedlander HM, 2020, EXPERT REV CLIN IMMU, V16, P37, DOI 10.1080/1744666X.2019.1698293; Genomics x, CELL RANGER R KIT TU; Gianchecchi E, 2018, AUTOIMMUN REV, V17, P142, DOI 10.1016/j.autrev.2017.11.018; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Goulart MR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40285-3; Grajkowska LT, 2017, IMMUNITY, V46, P65, DOI 10.1016/j.immuni.2016.11.006; Groth C, 2019, BRIT J CANCER, V120, P16, DOI 10.1038/s41416-018-0333-1; Gu HM, 2016, FASEB J, V30, P2336, DOI 10.1096/fj.201500044; Gu HM, 2014, FASEB J, V28, P4223, DOI 10.1096/fj.13-247650; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gueguen C, 2016, J ALLERGY CLIN IMMUN, V137, P545, DOI 10.1016/j.jaci.2015.09.015; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; Hassan Mirhane, 2018, Open Access Maced J Med Sci, V6, P303, DOI 10.3889/oamjms.2018.080; Hey YY, 2019, J CELL MOL MED, V23, P5128, DOI 10.1111/jcmm.14382; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Hofmann K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00835; Holers VM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01057; Janssen KMJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0690-6; Karlson EW, 2012, RHEUM DIS CLIN N AM, V38, P405, DOI 10.1016/j.rdc.2012.04.002; Keith RC, 2012, EXP LUNG RES, V38, P55, DOI 10.3109/01902148.2011.636139; Kielbassa K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02215; Kirby AC, 2006, J INFECT DIS, V193, P205, DOI 10.1086/498874; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Kulkarni HS, 2018, J ALLERGY CLIN IMMUN, V141, P1582, DOI 10.1016/j.jaci.2017.11.046; Kuroda N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45012-6; Kusuyama J, 2016, J LIPID RES, V57, P1806, DOI 10.1194/jlr.M067207; Laskin DL, 2019, TOXICOL SCI, V168, P287, DOI 10.1093/toxsci/kfy309; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee J, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008621; Li D, 2016, MOL IMMUNOL, V77, P205, DOI 10.1016/j.molimm.2016.08.007; Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003; Long EK, 2013, BBA-MOL CELL BIOL L, V1831, P1199, DOI 10.1016/j.bbalip.2013.04.004; Luisiri P, 1996, J BIOL CHEM, V271, P5158; Maier E, 2011, J BIOL CHEM, V286, P919, DOI 10.1074/jbc.M110.144949; Manley HR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02867; Martin P, 2013, J LEUKOCYTE BIOL, V94, P791, DOI 10.1189/jlb.0113035; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Medley QG, 1996, P NATL ACAD SCI USA, V93, P685, DOI 10.1073/pnas.93.2.685; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Morse C, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02441-2018; Mortaz E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02171; Mould KJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126556; Murphy D, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021754; Murphy D, 2018, LANCET RESP MED, V6, pE36, DOI 10.1016/S2213-2600(18)30188-7; Murphy Dan, 2017, Open Rheumatol J, V11, P88, DOI 10.2174/1874312901711010088; Naito Y, 2014, ARCH BIOCHEM BIOPHYS, V564, P83, DOI 10.1016/j.abb.2014.09.005; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Nelson AJ, 2018, J IMMUNOTOXICOL, V15, P73, DOI 10.1080/1547691X.2018.1460425; Nuncia-Cantarero M, 2018, BREAST CANCER RES TR, V168, P613, DOI 10.1007/s10549-017-4652-3; Ohl K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02499; Okamoto T, 2018, AM J PHYSIOL-LUNG C, V315, pL1, DOI 10.1152/ajplung.00395.2017; Okano S, 2018, AM J TRANSPLANT, V18, P2544, DOI 10.1111/ajt.14718; Osman R, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01034; Ouzounova M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14979; Pardo J, 2002, EUR J IMMUNOL, V32, P2881, DOI 10.1002/1521-4141(2002010)32:10<2881::AID-IMMU2881>3.0.CO;2-K; Patsalos A, 2019, J IMMUNOL, V203, P1532, DOI 10.4049/jimmunol.1900553; Perry E, 2017, INT J RHEUM DIS, V20, P2003, DOI 10.1111/1756-185X.12702; Poole JA, 2020, AM J PHYSIOL-LUNG C, V318, pL180, DOI 10.1152/ajplung.00039.2019; Poole JA, 2019, J BONE MINER RES, V34, P1733, DOI 10.1002/jbmr.3745; Poole JA, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0703-x; Poole JA, 2012, AM J RESP CELL MOL, V47, P652, DOI 10.1165/rcmb.2012-0095OC; Poole JA, 2009, AM J PHYSIOL-LUNG C, V296, pL1085, DOI 10.1152/ajplung.90622.2008; Porrello A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04355-w; Puttur F, 2019, IMMUNOL CELL BIOL, V97, P246, DOI 10.1111/imcb.12235; Raimundo K, 2019, J RHEUMATOL, V46, P360, DOI 10.3899/jrheum.171315; Rawlings DJ, 2017, NAT REV IMMUNOL, V17, P421, DOI 10.1038/nri.2017.24; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Rosales C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00113; Salaffi F, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017088; Sanyal R, 2017, IMMUNOL CELL BIOL, V95, P611, DOI 10.1038/icb.2017.18; Schachtrup C, 2004, INT J BIOCHEM CELL B, V36, P2042, DOI 10.1016/j.biocel.2004.03.008; Segawa S, 2018, J IMMUNOL, V201, P3534, DOI 10.4049/jimmunol.1800667; Sendo S, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1963-2; Shaw M, 2015, EUR RESPIR REV, V24, P1, DOI 10.1183/09059180.00008014; Shayman JA, 2019, BBA-MOL CELL BIOL L, V1864, P932, DOI 10.1016/j.bbalip.2018.07.012; Sheats MK, 2014, VET IMMUNOL IMMUNOP, V160, P167, DOI 10.1016/j.vetimm.2014.04.009; Sheppard S, 2018, CELL REP, V22, P3385, DOI 10.1016/j.celrep.2018.03.023; Shimizu K, 2015, J IMMUNOL, V194, P3156, DOI 10.4049/jimmunol.1402155; Shin JW, 2013, P NATL ACAD SCI USA, V110, P18892, DOI 10.1073/pnas.1304996110; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Sokol CL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016303; Stolt P, 2010, ANN RHEUM DIS, V69, P1072, DOI 10.1136/ard.2009.114694; Szema Anthony M, 2013, Occup Med Health Aff, V1, DOI 10.4172/2329-6879.1000117; Szondy Z, 2003, P NATL ACAD SCI USA, V100, P7812, DOI 10.1073/pnas.0832466100; Taleb K, 2017, J IMMUNOL, V198, P1156, DOI 10.4049/jimmunol.1502638; Tang BM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11249-y; Tang-Huau TL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04985-0; TEDDER TF, 1988, P NATL ACAD SCI USA, V85, P208, DOI 10.1073/pnas.85.1.208; Tian F, 2016, FEBS J, V283, P1465, DOI 10.1111/febs.13684; Too CL, 2016, ANN RHEUM DIS, V75, P997, DOI 10.1136/annrheumdis-2015-208278; Toth B, 2009, J IMMUNOL, V182, P2084, DOI 10.4049/jimmunol.0803444; Trouw LA, 2017, NAT REV RHEUMATOL, V13, DOI 10.1038/nrrheum.2017.125; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; TURMAN MA, 1993, HUM IMMUNOL, V36, P34, DOI 10.1016/0198-8859(93)90006-M; Uhel F, 2017, AM J RESP CRIT CARE, V196, P315, DOI 10.1164/rccm.201606-1143OC; Verneret M, 2014, J INNATE IMMUN, V6, P426, DOI 10.1159/000358834; Wammers M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18305-x; Wang D, 2019, NAT REV RHEUMATOL, V15, P581, DOI 10.1038/s41584-019-0275-x; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Wojcik AJ, 2008, J IMMUNOL, V180, P4273, DOI 10.4049/jimmunol.180.6.4273; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456; Yang JX, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071833; Yu XY, 2017, IMMUNITY, V47, P903, DOI 10.1016/j.immuni.2017.10.007; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842; Zhou YF, 2018, J ALLERGY CLIN IMMUN, V141, P350, DOI 10.1016/j.jaci.2017.04.049; Zhu JQ, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5474828; Zimmermann HW, 2016, HEPATOLOGY, V63, P233, DOI 10.1002/hep.28285; Zmijewski JW, 2009, J BIOL CHEM, V284, P22213, DOI 10.1074/jbc.M109.028902; Zuo Y., 2017, SMALL GTPASES, P1, DOI [10.1080/21541248.2016.1197872, DOI 10.1080/21541248.2016.1197872]	143	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0240707	10.1371/journal.pone.0240707	http://dx.doi.org/10.1371/journal.pone.0240707			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577605	Green Published, gold			2022-12-26	WOS:000620071700016
J	Lopez-Varela, E; Augusto, O; Fuente-Soro, L; Sacoor, C; Nhacolo, A; Casavant, I; Karajeanes, E; Vaz, P; Naniche, D				Lopez-Varela, Elisa; Augusto, Orvalho; Fuente-Soro, Laura; Sacoor, Charfudin; Nhacolo, Ariel; Casavant, Isabelle; Karajeanes, Esmeralda; Vaz, Paula; Naniche, Denise			Quantifying the gender gap in the HIV care cascade in southern Mozambique: We are missing the men	PLOS ONE			English	Article								Background HIV-infected men have higher rates of delayed diagnosis, reduced antiretroviral treatment (ART) retention and mortality than women. We aimed to assess, by gender, the first two UNAIDS 90 targets in rural southern Mozambique. Methods This analysis was embedded in a larger prospective cohort enrolling individuals with new HIV diagnosis between May 2014-June 2015 from clinic and home-based testing (HBT). We assessed gender differences between steps of the HIV-cascade. Adjusted HIV-community prevalence was estimated using multiple imputation (MI). Results Among 11,773 adults randomized in HBT (7084 female and 4689 male), the response rate before HIV testing was 48.7% among eligible men and 62.0% among women (p<0.001). MI did not significantly modify all-age HIV-prevalence for men but did decrease prevalence estimates in women from 36.4%to 33.0%. Estimated proportion of HIV-infected individuals aware of their status was 75.9% for men and 88.9% for women. In individuals <25 years, we observed up to 22.2% disparity in awareness of serostatus between genders. Among individuals eligible for ART, similar proportions of men and women initiated treatment (81.2% and 85.9%, respectively). Fourfold more men than womenwere in WHO stage III/IV AIDS at first clinical visit. Once on ART, men had a twofold higher 18-month loss to follow-up rate than women. Conclusion The contribution of missing HIV-serostatus data differentially impacted indicators of HIV prevalence and of achievement of UNAIDS targets by age and gender and men were missing long before the second 90. Increased efforts to characterize missing men and their needs will and their needs will allow us to urgently address the barriers to men accessing care and ensure men are not left behind in the UNAIDS 90-90-90 targets achievement.	[Lopez-Varela, Elisa; Augusto, Orvalho; Fuente-Soro, Laura; Sacoor, Charfudin; Nhacolo, Ariel; Naniche, Denise] Ctr Invest Saude Manhica CISM, Maputo, Mozambique; [Lopez-Varela, Elisa; Fuente-Soro, Laura; Naniche, Denise] Univ Barcelona, Inst Salud Global Barcelona, ISGlobal, Hosp Clin, Barcelona, Spain; [Augusto, Orvalho] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Casavant, Isabelle] Ctr Dis Control CDC, Maputo, Mozambique; [Karajeanes, Esmeralda; Vaz, Paula] Fundacao Ariel Glaser SIDA Pediat, Maputo, Mozambique	Centro de Investigacao em Saude de Manhica; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Eduardo Mondlane University	Lopez-Varela, E (corresponding author), Ctr Invest Saude Manhica CISM, Maputo, Mozambique.; Lopez-Varela, E (corresponding author), Univ Barcelona, Inst Salud Global Barcelona, ISGlobal, Hosp Clin, Barcelona, Spain.	elisa.lopez@isglobal.org	Augusto, Orvalho/J-8767-2019; Naniche, Denise/S-1814-2018	Augusto, Orvalho/0000-0002-0005-3968; Naniche, Denise/0000-0002-4495-6325; lopez varela, elisa/0000-0002-6725-5687; Fuente-Soro, Laura/0000-0002-8580-5857	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of CoAg [GH000479]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of CoAg	Supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of CoAg GH000479 (Scaling-up HIV counseling and testing services in a rural population by strengthening the health demographic surveillance system, in Manhica, Mozambique). The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the CDC.	[Anonymous], Blind spot-Reaching out to men and boys; [Anonymous], AIDSINFO; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Beckham SW, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21106; Bor J, 2018, TROP MED INT HEALTH, V23, P206, DOI 10.1111/tmi.13013; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; Cornell M, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21902; Dovel K, 2020, LANCET GLOB HEALTH, V8, pE276, DOI 10.1016/S2214-109X(19)30534-0; Floyd S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197904; Gichangi A, 2018, JAIDS-J ACQ IMM DEF, V79, P467, DOI 10.1097/QAI.0000000000001838; Gonzalez R., HIGH HIV PREVALENCE, DOI [10.1111/j.1468-1293.2012.01018.x, DOI 10.1111/J.1468-1293.2012.01018.X]; Grimsrud A, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25526; Grobler A, 2017, LANCET HIV, V4, pE505, DOI 10.1016/S2352-3018(17)30122-4; Hogan DR, 2012, SEX TRANSM INFECT, V88, pI17, DOI 10.1136/sextrans-2012-050636; Huerga H, 2016, JAIDS-J ACQ IMM DEF, V73, P411, DOI 10.1097/QAI.0000000000001081; Kabudula CW, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-71; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Lahuerta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037125; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Lippman SA, 2016, JAIDS-J ACQ IMM DEF, V73, P91, DOI 10.1097/QAI.0000000000001026; Lopez-Varela E, 2018, JAIDS-J ACQ IMM DEF, V78, P527, DOI [10.1097/QAI.0000000000001720, 10.1097/qai.0000000000001720]; MacLeod WB., 2016, ANAL AGEAND SEX SPEC, P183; Ministerio da Saude (MISAU) Instituto Nacional de Estatistica (INE) Com a Assistencia Tecnica de ICF., 2018, INQ IND IM MAL HIV S; Napierala S, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25515; Pati R, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18490; Reniers G, 2014, AIDS, V28, pS533, DOI 10.1097/QAD.0000000000000496; Reniers G, 2009, AIDS, V23, P621, DOI 10.1097/QAD.0b013e3283269e13; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Shapiro AE, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25514; Sharma M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002262; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; UNAIDS, 2017, UNAIDS DATA 2017; Yeatman S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209586	36	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0245461	10.1371/journal.pone.0245461	http://dx.doi.org/10.1371/journal.pone.0245461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577559	gold, Green Published			2022-12-26	WOS:000620071700043
J	Stergiotis, M; Ammann, RA; Droz, S; Koenig, C; Agyeman, PKA				Stergiotis, Melina; Ammann, Roland A.; Droz, Sara; Koenig, Christa; Agyeman, Philipp Kwame Abayie			Pediatric fever in neutropenia with bacteremia-Pathogen distribution and in vitro antibiotic susceptibility patterns over time in a retrospective single-center cohort study	PLOS ONE			English	Article								Background Fever in neutropenia (FN) is a potentially life-threatening complication of chemotherapy in pediatric cancer patients. The current standard of care at most institutions is emergency hospitalization and empirical initiation of broad-spectrum antibiotic therapy. Methods We analyzed in retrospect FN episodes with bacteremia in pediatric cancer patients in a single center cohort from 1993 to 2012. We assessed the distribution of pathogens, the in vitro antibiotic susceptibility patterns, and their trends over time. Results From a total of 703 FN episodes reported, we assessed 134 FN episodes with bacteremia with 195 pathogens isolated in 102 patients. Gram-positive pathogens (124, 64%) were more common than Gram-negative (71, 36%). This proportion did not change over time (p = 0.26). Coagulase-negative staphylococci (64, 32%), viridans group streptococci (42, 22%), Escherichia coli (33, 17%), Klebsiella spp. (10, 5%) and Pseudomonas aeruginosa (nine, 5%) were the most common pathogens. Comparing the in vitro antibiotic susceptibility patterns, the antimicrobial activity of ceftriaxone plus amikacin (64%; 95%CI: 56%-72%), cefepime (64%; 95%CI 56%-72%), meropenem (64%; 95%CI 56%-72), and piperacillin/tazobactam (62%; 95%CI 54%-70%), respectively, did not differ significantly. The addition of vancomycin to those regimens would have increased significantly in vitro activity to 99% for ceftriaxone plus amikacin, cefepime, meropenem, and 96% for piperacillin/tazobactam (p < 0.001). Conclusions Over two decades, we detected a relative stable pathogen distribution and found no relevant trend in the antibiotic susceptibility patterns. Different recommended antibiotic regimens showed comparable in vitro antimicrobial activity.	[Stergiotis, Melina; Ammann, Roland A.; Koenig, Christa] Univ Bern, Bern Univ Hosp, Dept Pediat, Inselspital,Div Pediat Hematol Oncol, Bern, Switzerland; [Ammann, Roland A.] Kinderaerzte Kurwerk, Burgdorf, Switzerland; [Droz, Sara] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Agyeman, Philipp Kwame Abayie] Univ Bern, Bern Univ Hosp, Dept Pediat, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Agyeman, PKA (corresponding author), Univ Bern, Bern Univ Hosp, Dept Pediat, Inselspital, Bern, Switzerland.	philipp.agyeman@insel.ch	Koenig, Christa/U-7838-2019; Agyeman, Philipp/AAG-3510-2019	Koenig, Christa/0000-0002-9965-5183; Agyeman, Philipp Kwame Abayie/0000-0002-8339-5444				Agyeman P, 2014, PEDIATR INFECT DIS J, V33, pE219, DOI 10.1097/INF.0000000000000326; Ammann RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101696; Ammann RA, 2010, J CLIN ONCOL, V28, P2008, DOI 10.1200/JCO.2009.25.8988; [Anonymous], DIAGNOSTIK THERAPIE; Ariffin H, 2000, Int J Infect Dis, V4, P21, DOI 10.1016/S1201-9712(00)90061-4; Binz P, 2013, PEDIATR BLOOD CANCER, V60, P799, DOI 10.1002/pbc.24380; Brack E, 2012, PEDIATR BLOOD CANCER, V59, P423, DOI 10.1002/pbc.24076; Buetti N, 2017, EUR J CLIN MICROBIOL, V36, P537, DOI 10.1007/s10096-016-2830-6; El-Mahallawy HA, 2011, PEDIATR BLOOD CANCER, V57, P283, DOI 10.1002/pbc.22926; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Greenberg D, 2005, INT J ANTIMICROB AG, V25, P469, DOI 10.1016/j.ijantimicag.2005.01.020; Han SB, 2015, MICROB DRUG RESIST, V21, P244, DOI 10.1089/mdr.2014.0092; Kern WV, 1999, NEW ENGL J MED, V341, P312, DOI 10.1056/NEJM199907293410502; Lee JH, 2016, INFECT CHEMOTHER, V48, P181, DOI 10.3947/ic.2016.48.3.181; Lehrnbecher T, 2017, J CLIN ONCOL, V35, P2082, DOI 10.1200/JCO.2016.71.7017; Luhi F, 2012, PEDIATR BLOOD CANCER, V59, P90, DOI 10.1002/pbc.23277; Miedema KGE, 2013, SUPPORT CARE CANCER, V21, P2417, DOI 10.1007/s00520-013-1797-4; National Collaborating Centre for Cancer, 2012, NEUTR SEPS PREV MAN; Neemann K, 2016, J PEDIAT INF DIS SOC, V5, P218, DOI 10.1093/jpids/piu145; Nimah MM, 2006, PEDIATR CRIT CARE ME, V7, P48, DOI 10.1097/01.PCC.0000185476.35550.B2; Paul M, 2003, BRIT MED J, V326, P1111, DOI 10.1136/bmj.326.7399.1111; Petty LA, 2016, PEDIATR BLOOD CANCER, V63, P1244, DOI 10.1002/pbc.25965; Schlapbach LJ, 2007, PEDIATR BLOOD CANCER, V49, P11, DOI 10.1002/pbc.21097; Solis Y, 2012, REV CHIL INFECTOL, V29, P156, DOI 10.4067/S0716-10182012000200006; von Allmen AN, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.38; Weisman LE, 2004, CURR OPIN INFECT DIS, V17, P237, DOI 10.1097/00001432-200406000-00011; Zinner SH, 1999, CLIN INFECT DIS, V29, P490, DOI 10.1086/598620	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246654	10.1371/journal.pone.0246654	http://dx.doi.org/10.1371/journal.pone.0246654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577566	Green Published, gold			2022-12-26	WOS:000620071700012
J	Lloyd, SJ; Chalabi, Z				Lloyd, Simon J.; Chalabi, Zaid			Climate change, hunger and rural health through the lens of farming styles: An agent-based model to assess the potential role of peasant farming	PLOS ONE			English	Article							FOOD SECURITY; CHILD UNDERNUTRITION; IMPACTS; SCENARIOS; QUANTIFY; YIELDS	Undernutrition is a major contributor to the global-burden of disease, and global-level health impact models suggest that climate change-mediated reductions in food quantity and quality will negatively affect it. These models, however, capture just some of the processes that will shape future nutrition. We adopt an alternative standpoint, developing an agent-based model in which producer-consumer smallholders practice different 'styles of farming' in the global food system. The model represents a hypothetical rural community in which 'orphan' (subsistence) farmers may develop by adopting an 'entrepreneurial' style (highly market-dependent) or by maintaining a 'peasant' style (agroecology). We take a first look at the question: how might patterns of farming styles-under various style preference, climate, policy, and price transmission scenarios-impact on hunger and health-supporting conditions (incomes, work, inequality, 'real land productivity') in rural areas? imulations without climate change or agricultural policy found that style preference patterns influence production, food price, and incomes, and there were trade-offs between them. For instance, entrepreneurial-oriented futures had the highest production and lowest prices but were simultaneously those in which farms tended towards crisis. Simulations with climate change and agricultural policy found that peasant-orientated agroecology futures had the highest production, prices equal to or lower than those under entrepreneurial-oriented futures, and better supported rural health. There were, however, contradictory effects on nutrition, with benefits and harms for different groups. Collectively the findings suggest that when attempting to understand how climate change may impact on future nutrition and health, patterns of farming styles-along with the fates of the households that practice them-matter. These issues, including the potential role of peasant farming, have been neglected in previous global-level climate-nutrition modelling but go to the heart of current debates on the future of farming: thus, they should be given more prominence in future work.	[Lloyd, Simon J.; Chalabi, Zaid] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Publ Hlth Environm & Soc, London, England; [Chalabi, Zaid] UCL, Bartlett Sch Environm Energy & Resources, UCL Inst Environm Design & Engn, London, England; [Lloyd, Simon J.] Barcelona Inst Global Hlth ISGlobal, Climate & Hlth Programme CLIMA, Barcelona, Catalonia, Spain	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; ISGlobal	Lloyd, SJ (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Publ Hlth Environm & Soc, London, England.; Lloyd, SJ (corresponding author), Barcelona Inst Global Hlth ISGlobal, Climate & Hlth Programme CLIMA, Barcelona, Catalonia, Spain.	simon.lloyd@isglobal.org	Lloyd, Simon/ABH-8249-2020	Lloyd, Simon/0000-0002-9728-8674	Faculty of Public Health and Policy at the London School of Hygiene and Tropical Medicine	Faculty of Public Health and Policy at the London School of Hygiene and Tropical Medicine	The authors received no specific funding for this research. We are grateful to the Faculty of Public Health and Policy at the London School of Hygiene and Tropical Medicine for providing the funds to cover the publication fees. The views expressed are those of the authors.	Alteri MA, 2002, AGR ECOSYST ENVIRON, V93, P1, DOI 10.1016/S0167-8809(02)00085-3; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2019, GAMB 2 GEN NAT AGR I; Aravindakshan S, 2020, AGR SYST, V177, DOI 10.1016/j.agsy.2019.102695; Bambra C., 2016, HLTH DIVIDES YOU LIV; Bharwani S, 2005, PHILOS T R SOC B, V360, P2183, DOI 10.1098/rstb.2005.1742; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brown C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114213; Bruinsma J, 2003, WORLD AGR 2015 2030; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; Chandio AA, 2018, EMERG MARK FINANC TR, V54, P3401, DOI 10.1080/1540496X.2018.1481743; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Chisasa J, 2012, INT BUSINESS EC RES, V11, P771; Clark MA, 2019, P NATL ACAD SCI USA, V116, P23357, DOI 10.1073/pnas.1906908116; Davis M, 2004, NEW LEFT REV, P5; Debertin DL, 2012, AGR PRODUCTION EC; Dobbie S, 2018, JASSS-J ARTIF SOC S, V21, DOI 10.18564/jasss.3639; Duniya K. P., 2015, Asian Journal of Agricultural Extension, Economics and Sociology, V4, P296, DOI 10.9734/AJAEES/2015/13538; Ellis F., 1993, PEASANT EC; Gelli A., 2015, VALUE CHAINS NUTR FR; Gliessman SR, 2015, AGROECOLOGY: THE ECOLOGY OF SUSTAINABLE FOOD SYSTEMS, 3RD EDITION, P1, DOI 10.1201/b19500; Hales S, 2014, QUANTITATIVE RISK AS; Harper KM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006205; Hasegawa T, 2016, CLIMATIC CHANGE, V136, P189, DOI 10.1007/s10584-016-1606-4; Hasegawa T, 2015, ENVIRON SCI TECHNOL, V49, P7245, DOI 10.1021/es5051748; Hasegawa T, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/1/014010; Hasegawa T, 2014, ENVIRON SCI TECHNOL, V48, P438, DOI 10.1021/es4034149; Hedstrom P, 2005, DISSECTING SOCIAL PR; HLPE, 2019, AGR OTH INN APPR SUS; Holt-Gimenez E., 2009, FOOD REBELLIONS CRIS; IFAD, 2011, P C 2011 ROM IFAD; ILO [International Labor Organization], 2016, GLOB WAG REP 2016 17; Jenkins JC, 2001, AM SOCIOL REV, V66, P718, DOI 10.2307/3088955; Knutti R, 2013, NAT CLIM CHANGE, V3, P369, DOI [10.1038/nclimate1716, 10.1038/NCLIMATE1716]; Krieger N., 2011, EPIDEMIOLOGY PEOPLES, DOI [DOI 10.1093/ACPROF:OSO/9780195383874.001.0001, DOI 10.1007/s10803-010-0982-2]; La Via Campesina, 2019, VIA CAMP INT PEAS MO; Lloyd SJ, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP2916; Lloyd SJ, 2011, ENVIRON HEALTH PERSP, V119, P1817, DOI 10.1289/ehp.1003311; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lopez-Ridaura S, 2018, AGR SYST, V159, P57, DOI 10.1016/j.agsy.2017.09.007; Magliocca NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073241; Marmot M, 2016, ANN EPIDEMIOL, V26, P238, DOI 10.1016/j.annepidem.2016.02.003; Minot N., 2011, 01059 IFPRI; Moore FC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01792-x; Moore Lappe F, 2015, WORLD HUNGER 10 MYTH; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Muller B, 2013, ENVIRON MODELL SOFTW, V48, P37, DOI 10.1016/j.envsoft.2013.06.003; Myers SS, 2017, ANNU REV PUBL HEALTH, V38, P259, DOI 10.1146/annurev-publhealth-031816-044356; Nelson GC, 2010, INT FOOD POL RES I, DOI DOI 10.2499/9780896291867; Nelson J, 2009, CLIMATE CHANGE AND GLOBAL POVERTY: A BILLION LIVES IN THE BALANCE, P223; Parry M, 1999, GLOBAL ENVIRON CHANG, V9, pS51, DOI 10.1016/S0959-3780(99)00018-7; Patel R, 2009, J PEASANT STUD, V36, P663, DOI 10.1080/03066150903143079; Petersen PF, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9040535; Phalkey RK, 2015, P NATL ACAD SCI USA, V112, pE4522, DOI 10.1073/pnas.1409769112; Pimentel D, 2008, FOOD ENERGY SOC; Ploeg JD., 2013, PEASANTS ART FARMING; Pogge T., 2010, POLITICS AS USUAL; Poux X, 2018, AGROECOLOGICAL EUROP; Pretty JN, 2003, AGR ECOSYST ENVIRON, V95, P217, DOI 10.1016/S0167-8809(02)00087-7; Pretty J, 2018, NAT SUSTAIN, V1, P441, DOI 10.1038/s41893-018-0114-0; Railsback S., 2012, AGENT BASED INDIVIDU; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Reganold JP, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.221, 10.1038/nplants.2015.221]; Rieff D, 2016, REPROACH HUNGER FOOD; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Roser M, 2019, FERTILIZER PESTICIDE; Rosset PM., 2017, AGROECOLOGY SCI POLI; Rossett P, 2006, FOOD IS DIFFERENT WH; Roudart Mazoyer Marcel Laurence, 2006, HIST WORLD AGR NEOLI; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Smith LC, 2015, WORLD DEV, V68, P180, DOI 10.1016/j.worlddev.2014.11.014; Sohail Jehangir Malik, 1999, Pakistan Development Review, V38, P699; Springmann M, 2016, LANCET, V387, P1937, DOI 10.1016/S0140-6736(15)01156-3; STRAUSS J, 1986, J POLIT ECON, V94, P297, DOI 10.1086/261375; Timmermann C, 2015, AGR HUM VALUES, V32, P523, DOI 10.1007/s10460-014-9581-8; Tittonell P, 2020, AGR SYST, V178, DOI 10.1016/j.agsy.2019.102714; Tracy M, 2018, ANNU REV PUBL HEALTH, V39, P77, DOI 10.1146/annurev-publhealth-040617-014317; van der Ploeg, 2017, IMPORTANCE PEASANT A; van der Ploeg J.D., 2008, NEW PEASANTRIES STRU; van der Ploeg J.D., 2018, NEW PEASANTRIES RURA, DOI 10.4324/9781315114712; van der Ploeg JD, 2016, FARMING MATTERS, V32; van der Velde M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060075; van Wijk MT, 2014, GLOB FOOD SECUR-AGR, V3, P77, DOI 10.1016/j.gfs.2014.05.001; Wage Indicator Foundation, 2019, WAG IND; Wilensky U., 1999, NETLOGO; WIMBERLEY DW, 1992, SOC FORCES, V70, P895, DOI 10.2307/2580194; World Bank, 2019, WORLD BANK DEV IND; Wright EO, 2010, ENVISIONING REAL UTO; Yamano T, 2011, EMERGING DEVELOPMENT OF AGRICULTURE IN EAST AFRICA: MARKETS, SOIL, AND INNOVATIONS, P39, DOI 10.1007/978-94-007-1201-0_3; Zhao C, 2017, P NATL ACAD SCI USA, V114, P9326, DOI 10.1073/pnas.1701762114	91	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246788	10.1371/journal.pone.0246788	http://dx.doi.org/10.1371/journal.pone.0246788			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571284	gold, Green Published			2022-12-26	WOS:000618274000017
J	Mandic, MR; Oalde, MM; Lunic, TM; Sabovljevic, AD; Sabovljevic, MS; Gasic, UM; Duletic-Lausevic, SN; Bozic, BD; Nedeljkovic, BDB				Mandic, Marija R.; Oalde, Mariana M.; Lunic, Tanja M.; Sabovljevic, Aneta D.; Sabovljevic, Marko S.; Gasic, Uros M.; Duletic-Lausevic, Sonja N.; Bozic, Bojan Dj; Nedeljkovic, Biljana Dj Bozic			Chemical characterization and in vitro immunomodulatory effects of different extracts of moss Hedwigia ciliata (Hedw.) P. Beauv. from the Vrsacke Planine Mts., Serbia	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; NITRIC-OXIDE; INHIBITORY-ACTIVITIES; PROTOCATECHUIC ACID; SIGNALING PATHWAY; ETHANOL EXTRACT; PHENOLIC-ACIDS; HUMAN BREAST; CANCER; BRYOPHYTES	Bioactive compounds from natural sources are of great importance because of their potential pharmacological activity and tremendous structural diversity. In this study, the chemical composition of different moss extracts of Hedwigia ciliata P. Beauv. have been examined, as well as their antioxidant, antineurodegenerative/anti-neuroinflammatory, antidiabetic, and antiproliferative potential. The extracts were prepared by Soxhlet extractor using solvents of different polarity. Chemical characterization of the extracts revealed the presence of phenolics and flavonoid compounds, together with triterpenoids as secondary metabolites of high biological activity. Significant antioxidant properties of all the extracts were exhibited using the beta-carotene assay. The highest activities were found for water:ethanol extract (with the highest inhibition rate of 96%), but also significant inhibition was measured for ethanol and ethyl acetate extracts (80% and 70%, respectively). Confirmation of biocompatibility of investigated moss extracts has been performed using normal human fibroblast cell line, MRC-5. The H. ciliata extracts exhibited significant antiproliferative activity (similar to 50%) against the MDA-MB-231 (human breast adenocarcinoma cell line), which has not previously been reported elsewhere. The Griess assay confirmed the potential anti-neuroinflammatory activity of the extracts, as significant effects in reducing NO production by LPS-stimulated BV2 (normal murine microglia cell line) was observed. This data is in line with noted antineurodegenerative potential measured by the inhibition of acetylcholinesterase (with the highest inhibition rate of 60% for ethyl acetate extract) and tyrosinase (with the highest inhibition rate of 70% for ethanol extract). Additionally, the H. ciliata extracts exhibited significant antidiabetic effect mediated by alpha-glucosidase inhibition (with the highest inhibition rate of 80% for ethyl acetate extract). The obtained data suggest the presence of immunomodulatory effects of the moss extracts in vitro, which allows the design of new experiments aimed at detecting and characterizing bioactive compounds of the extracts and additionally elucidate detailed mechanisms of their effects.	[Mandic, Marija R.; Lunic, Tanja M.; Bozic, Bojan Dj; Nedeljkovic, Biljana Dj Bozic] Univ Belgrade, Fac Biol, Inst Physiol & Biochem Ivan Djaja, Belgrade, Serbia; [Oalde, Mariana M.; Sabovljevic, Aneta D.; Sabovljevic, Marko S.; Duletic-Lausevic, Sonja N.] Univ Belgrade, Fac Biol, Inst Bot & Bot Garden Jevremovac, Belgrade, Serbia; [Gasic, Uros M.] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Natl Inst Republ Serbia, Dept Plant Physiol, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Bozic, BD; Nedeljkovic, BDB (corresponding author), Univ Belgrade, Fac Biol, Inst Physiol & Biochem Ivan Djaja, Belgrade, Serbia.	bbozic@bio.bg.ac.rs; biljana@bio.bg.ac.rs	Gašić, Uroš/P-2239-2016; Sabovljevic, Marko/ABC-8637-2020	Gašić, Uroš/0000-0001-5384-8396; Sabovljevic, Marko/0000-0001-5809-0406; Sabovljevic, Aneta/0000-0003-3092-9972; Bozic Nedeljkovic, Biljana/0000-0002-1238-1731; Oalde Pavlovic, Mariana/0000-0001-9338-7811; Bozic, Bojan/0000-0001-9910-2741	Ministry of Education and Science of the Republic of Serbia [451-03-68/2020-14/200178, 451-03-68/2020-14/200007]	Ministry of Education and Science of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the grant of the Ministry of Education and Science of the Republic of Serbia (Contract numbers: 451-03-68/2020-14/200178 and 451-03-68/2020-14/200007).	Aminudin Nurul Iman, 2015, Journal of Coastal Life Medicine, V3, P126, DOI 10.12980/JCLM.3.2015JCLM-2014-0115; [Anonymous], 2019, CANC DISCOV, V10, pOF5; Asakawa Y, 1998, J HATTORI BOT LAB, V84, P91; Asakawa Y, 2018, J NAT PROD, V81, P641, DOI 10.1021/acs.jnatprod.6b01046; Basile A, 1999, PHYTOCHEMISTRY, V52, P1479, DOI 10.1016/S0031-9422(99)00286-1; Basli A, 2017, PHENOLIC COMPOUNDS B, P193; Bendary E., 2013, Annals of Agricultural Science (Cairo), V58, P173, DOI 10.1016/j.aoas.2013.07.002; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Brune B, 1998, EUR J PHARMACOL, V351, P261, DOI 10.1016/S0014-2999(98)00274-X; Brusselmans K, 2005, J BIOL CHEM, V280, P5636, DOI 10.1074/jbc.M408177200; Canli K, 2014, J PURE APPL MICROBIO, V8, P2987; Carocho M, 2013, ANTI-CANCER AGENT ME, V13, P1236, DOI 10.2174/18715206113139990301; Chobot V, 2008, Z NATURFORSCH C, V63, P476; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Chou TH, 2010, J NAT PROD, V73, P1767, DOI 10.1021/np100281g; Dai J, 2010, MOLECULES, V15, P7313, DOI 10.3390/molecules15107313; Dapkevicius A, 1998, J SCI FOOD AGR, V77, P140, DOI 10.1002/(SICI)1097-0010(199805)77:1&lt;140::AID-JSFA18&gt;3.0.CO;2-K; Garcia-Molina MD, 2012, J AGR FOOD CHEM, V60, P6447, DOI 10.1021/jf301238q; Dey A, 2015, J ACUTE DIS, V4, P236, DOI 10.1016/j.joad.2015.04.011; Dhama K, 2015, INT J PHARMACOL, V11, P253, DOI 10.3923/ijp.2015.253.290; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Gonzalez Mancebo J, 2019, IUCN RED LIST THREAT; Gotoh T, 1999, J CELL BIOL, V144, P427, DOI 10.1083/jcb.144.3.427; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Hodgetts N., 2019, MINIATURE WORLD DECL, DOI DOI 10.2305/IUCN.CH.2019.ERL.2.EN; Huang M, 2012, EXPERT OPIN INV DRUG, V21, P1801, DOI 10.1517/13543784.2012.727395; Jeong JW, 2014, CHEM-BIOL INTERACT, V212, P30, DOI 10.1016/j.cbi.2014.01.012; Kazeem MI, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/527570; Kim JS, 2005, IMMUNOLOGY, V115, P375, DOI 10.1111/j.1365-2567.2005.02156.x; Kim MY, 2018, NUTR RES PRACT, V12, P41, DOI 10.4162/nrp.2018.12.2.129; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; Klavina L, 2018, COMPOSITION MOSSES T; Klavina L, 2015, MOLECULES, V20, P17221, DOI 10.3390/molecules200917221; Kocak MS, 2016, IND CROP PROD, V85, P204, DOI 10.1016/j.indcrop.2016.03.015; Kuo KC, 2012, 2012 IEEE ASIA PACIFIC CONFERENCE ON CIRCUITS AND SYSTEMS (APCCAS), P120, DOI 10.1109/APCCAS.2012.6418986; Li K, 2018, CHEM CENT J, V12, DOI 10.1186/s13065-018-0445-y; Li L, 2007, BRAIN RES, V1159, P8, DOI 10.1016/j.brainres.2007.04.066; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Ludwiczuk A, 2019, FOOD CHEM TOXICOL, V132, DOI 10.1016/j.fct.2019.110649; Lunic TM, 2020, MOLECULES, V25, DOI 10.3390/molecules25153343; Masaki H, 1997, BIOL PHARM BULL, V20, P304; Masuda T, 2005, BIOSCI BIOTECH BIOCH, V69, P197, DOI 10.1271/bbb.69.197; Merkl R, 2010, CZECH J FOOD SCI, V28, P275, DOI 10.17221/132/2010-CJFS; Mihailovic V, 2016, IND CROP PROD, V89, P141, DOI 10.1016/j.indcrop.2016.04.075; Misic D, 2015, PHYTOCHEM ANALYSIS, V26, P72, DOI 10.1002/pca.2538; Miyazawa M, 2003, J AGR FOOD CHEM, V51, P6953, DOI 10.1021/jf030388s; Murad H, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0315-4; Nahas R, 2013, LIPID OXIDATION, P243; Nair S.S., 2013, EUR J EXP BIOL, V3, P128; Neagu E, 2015, J TAIWAN INST CHEM E, V52, P1, DOI 10.1016/j.jtice.2015.01.026; Olajide OA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/459723; Opeyemi RF, 2019, PERTANIKA J TROP AGR, V42, P139; Osterdahl B, 1976, ACTA CHEM SCAND; OSTERDAHL BG, 1978, ACTA CHEM SCAND B, V32, P93, DOI 10.3891/acta.chem.scand.32b-0093; OSTERDAHL BG, 1977, ACTA CHEM SCAND B, V31, P293, DOI 10.3891/acta.chem.scand.31b-0293; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Oyedemi Sunday O, 2017, ScientificWorldJournal, V2017, P3592491, DOI 10.1155/2017/3592491; Park SE, 2014, ONCOL REP, V32, P2461, DOI 10.3892/or.2014.3507; Park YK, 1997, ARQ BIOL TECNOL, V40, P97; Peixoto Sobrinho TJS., 2012, LATEST RES QUALITY C, V1, P47, DOI [https://doi.org/10.5772/45955, DOI 10.5772/45955]; Pereira DM, 2009, MOLECULES; Rabi T, 2009, BREAST CANCER RES TR, V115, P223, DOI 10.1007/s10549-008-0118-y; Rahimifard M, 2017, AGEING RES REV, V36, P11, DOI 10.1016/j.arr.2017.02.004; Sabovljevic A, 2009, METHODS MOL BIOL, V547, P117, DOI 10.1007/978-1-60327-287-2_10; SANTOS-SANCHEZ N. F., 2019, ANTIOXIDANTS-BASEL; Savelev S, 2003, PHARMACOL BIOCHEM BE, V75, P661, DOI 10.1016/S0091-3057(03)00125-4; Sawai S, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00025; Scherrmann JM, 2002, VASC PHARMACOL, V38, P349, DOI 10.1016/S1537-1891(02)00202-1; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Tungmunnithum Duangjai, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5030093; Tusevski O, 2014, CENT EUR J BIOL, V9, P888, DOI 10.2478/s11535-014-0322-1; Wan LS, 2013, J NAT PROD, V76, P1248, DOI 10.1021/np400082g; Wang XN, 2018, BIOCHEM BIOPH RES CO, V504, P812, DOI 10.1016/j.bbrc.2018.08.043; Whitehead James, 2018, LINDBERGIA, V41, DOI 10.25227/linbg.01097; Winter AN, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6297080; Xie CF, 2009, CHEM BIODIVERS, V6, P303, DOI 10.1002/cbdv.200700450; Yang HJ, 2010, CURR DRUG TARGETS, V11, P733, DOI 10.2174/138945010791170842; Yao H, 2011, J ENVIRON SCI HEAL C, V29, P1, DOI 10.1080/10590501.2011.551317; Yaynta OT, 2019, DETERMINATION ANTIOX; Yin MC, 2009, J AGR FOOD CHEM, V57, P6468, DOI 10.1021/jf9004466; Ying YM, 2014, PHYTOCHEMISTRY, V108, P171, DOI 10.1016/j.phytochem.2014.09.022; Zengin G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113527	83	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246810	10.1371/journal.pone.0246810	http://dx.doi.org/10.1371/journal.pone.0246810			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571277	Green Published, gold			2022-12-26	WOS:000618274000001
J	Foley, KP; Chen, Y; Barra, NG; Heal, M; Kwok, K; Tamrakar, AK; Chi, W; Duggan, BM; Henriksbo, BD; Liu, Y; Schertzer, JD				Foley, Kevin P.; Chen, Yong; Barra, Nicole G.; Heal, Mark; Kwok, Kieran; Tamrakar, Akhilesh K.; Chi, Wendy; Duggan, Brittany M.; Henriksbo, Brandyn D.; Liu, Yong; Schertzer, Jonathan D.			Inflammation promotes adipocyte lipolysis via IRE1 kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; NECROSIS-FACTOR-ALPHA; SIGNAL-RELATED KINASE; INSULIN-RESISTANCE; ER STRESS; STIMULATES LIPOLYSIS; NOD1 ACTIVATORS; LINKS OBESITY; CONTRIBUTE; IMMUNITY	Obesity associates with inflammation, insulin resistance, and higher blood lipids. It is unclear if immune responses facilitate lipid breakdown and release from adipocytes via lipolysis in a separate way from hormones or adrenergic signals. We found that an ancient component of ER stress, inositol-requiring protein 1 (IRE1), discriminates inflammation-induced adipocyte lipolysis versus lipolysis from adrenergic or hormonal stimuli. Our data show that inhibiting IRE1 kinase activity was sufficient to block adipocyte-autonomous lipolysis from multiple inflammatory ligands, including bacterial components, certain cytokines, and thapsigargin-induced ER stress. IRE1-mediated lipolysis was specific for inflammatory triggers since IRE1 kinase activity was dispensable for isoproterenol and cAMP-induced lipolysis in adipocytes and mouse adipose tissue. IRE1 RNase activity was not associated with inflammation-induced adipocyte lipolysis. Inhibiting IRE1 kinase activity blocked NF-kappa B activation, interleukin-6 secretion, and adipocyte-autonomous lipolysis from inflammatory ligands. Inflammation-induced lipolysis mediated by IRE1 occurred independently from changes in insulin signaling in adipocytes, suggesting that inflammation can promote IRE1-mediated lipolysis independent of adipocyte insulin resistance. We found no role for canonical unfolded protein responses or ABL kinases in linking ER stress to IRE1-mediated lipolysis. Adiponectin-Cre-mediated IRE1 knockout in mice showed that adipocyte IRE1 was required for inflammatory ligand-induced lipolysis in adipose tissue explants and that adipocyte IRE1 was required for approximately half of the increase in blood triglycerides after a bacterial endotoxin-mediated inflammatory stimulus in vivo. Together, our results show that IRE1 propagates an inflammation-specific lipolytic program independent from hormonal or adrenergic regulation. Targeting IRE1 kinase activity may benefit metabolic syndrome and inflammatory lipid disorders.	[Foley, Kevin P.; Barra, Nicole G.; Heal, Mark; Kwok, Kieran; Tamrakar, Akhilesh K.; Chi, Wendy; Duggan, Brittany M.; Henriksbo, Brandyn D.; Schertzer, Jonathan D.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Foley, Kevin P.; Barra, Nicole G.; Heal, Mark; Kwok, Kieran; Tamrakar, Akhilesh K.; Chi, Wendy; Duggan, Brittany M.; Henriksbo, Brandyn D.; Schertzer, Jonathan D.] McMaster Univ, Ctr Metab Obes & Diabet Res, Hamilton, ON, Canada; [Chen, Yong; Liu, Yong] Wuhan Univ, Coll Life Sci, Inst Adv Studies, Hubei Key Lab Cell Homeostasis, Wuhan, Peoples R China; [Tamrakar, Akhilesh K.] CSIR Cent Drug Res Inst, Div Biochem, Lucknow, Uttar Pradesh, India	McMaster University; McMaster University; Wuhan University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Schertzer, JD (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.; Schertzer, JD (corresponding author), McMaster Univ, Ctr Metab Obes & Diabet Res, Hamilton, ON, Canada.	schertze@mcmaster.ca	Barra, Nicole/ABG-2670-2021; Schertzer, Jonathan/P-3395-2017	Barra, Nicole/0000-0002-2605-0845; Tamrakar, Akhilesh/0000-0003-0554-3779; Chen, Yong/0000-0002-0723-8105; Schertzer, Jonathan/0000-0002-1547-5856; LIU, YONG/0000-0001-7771-4181	Canadian Institutes of Health Research [FDN-154295]; National Natural Science Foundation of China [31690102]; Indian Council of Medical Research, Govt. of India	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Indian Council of Medical Research, Govt. of India(Indian Council of Medical Research (ICMR))	This work was supported by grants to J. D. S. from the Canadian Institutes of Health Research (FDN-154295) and to Y. L. from the National Natural Science Foundation of China (No. 31690102). A. K. T. was supported by ICMR International Fellowship from the Indian Council of Medical Research, Govt. of India. J. D. S. holds a Canada Research Chair in Metabolic Inflammation.	Anhe FF, 2020, NAT METAB, V2, P233, DOI 10.1038/s42255-020-0178-9; Barra NG, 2020, BIOCHEM J, V477, P1089, DOI 10.1042/BCJ20190472; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cavallari JF, 2020, AM J PHYSIOL-ENDOC M, V318, pE579, DOI 10.1152/ajpendo.00033.2020; Cavallari JF, 2017, CELL METAB, V25, P1063, DOI 10.1016/j.cmet.2017.03.021; Chan KL, 2017, CELL REP, V18, P2415, DOI 10.1016/j.celrep.2017.02.027; Chi W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097675; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Deng JN, 2012, J BIOL CHEM, V287, P6240, DOI 10.1074/jbc.M111.299115; Denou E, 2015, EMBO MOL MED, V7, P259, DOI 10.15252/emmm.201404169; Duggan BM, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa086; Duggan BM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01822-0; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Green A, 2004, DIABETES, V53, P74, DOI 10.2337/diabetes.53.1.74; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Harnoss JM, 2019, P NATL ACAD SCI USA, V116, P16420, DOI 10.1073/pnas.1906999116; Herrema H, 2016, J BIOL CHEM, V291, P17394, DOI 10.1074/jbc.M116.728949; Hong S, 2018, MOL METAB, V12, P25, DOI 10.1016/j.molmet.2018.03.012; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang SJ, 2019, J BIOL CHEM, V294, P18726, DOI 10.1074/jbc.REV119.007036; Jo H, 2009, CELL METAB, V9, P440, DOI 10.1016/j.cmet.2009.04.004; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; McPhee JB, 2015, CLIN SCI, V129, P1083, DOI 10.1042/CS20150431; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Morita S, 2017, CELL METAB, V25, P883, DOI 10.1016/j.cmet.2017.03.018; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Olefsky JM, 2008, CELL, V134, P914, DOI 10.1016/j.cell.2008.09.001; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schertzer JD, 2011, DIABETES, V60, P2206, DOI 10.2337/db11-0004; Shao ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4528; Sharma A, 2021, FREE RADICAL BIO MED, V162, P118, DOI 10.1016/j.freeradbiomed.2020.11.036; Sharma A, 2019, BBA-MOL BASIS DIS, V1865, P136, DOI 10.1016/j.bbadis.2018.10.036; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Su AR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9090235; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Yan RQ, 2017, PROTEIN CELL, V8, P55, DOI 10.1007/s13238-016-0326-x; Yang L, 2015, SCIENCE, V349, P500, DOI 10.1126/science.aaa0079; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhang ZF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010031; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	51	8	9	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100440	10.1016/j.jbc.2021.100440	http://dx.doi.org/10.1016/j.jbc.2021.100440			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610548	gold, Green Submitted, Green Published			2022-12-26	WOS:000672866400414
J	Franzen, A; Wohner, F				Franzen, Axel; Woehner, Fabienne			Coronavirus risk perception and compliance with social distancing measures in a sample of young adults: Evidence from Switzerland	PLOS ONE			English	Article							VACCINATION; PUNISHMENT; INFLUENZA; HEALTH	The health risk of the coronavirus pandemic is age-specific. The symptoms of a COVID-19 infection are usually mild in the healthy population below the age of 65; however, the measures laid down to prevent the spread of the virus apply typically to the whole population. Hence, those who have a low risk of severe symptoms face a social dilemma in cooperating and complying with the safety measures: Cooperating in preventing the spread of the disease is good for society but comes with individual costs. These costs provide an incentive not to cooperate with the safety measures. In this paper we analyze via structural equation modelling a sample of young adults (N = 510) who were surveyed right after the end of the first lockdown period in Switzerland. We investigate why and to what extent they cooperated in preventing the epidemic by following the recommendation to stay at home as much as possible. We hypothesize that those respondents who perceive themselves to be personally at risk, or who have relatives belonging to the risk group, complied more often with the safety measures as compared to those without severe risks. Cooperating should also be linked to individuals' pro-social orientation. Furthermore, we hypothesize that those who believe that the virus is dangerous for society or who have a personal interest in protection show higher support for the general safety measures. Our empirical results show that compliance with the coronavirus social distancing measures was generally very high during the first lockdown. Although young adults perceived themselves to be at low personal risk, they still believed that the virus is dangerous for society. Those who had a personal interest in staying at home because they had relatives belonging to the risk group complied more often with the safety measures. Overall, the results suggest that the support of the preventive measures is the most important promoter of cooperation to prevent the spread of COVID-19.	[Franzen, Axel; Woehner, Fabienne] Univ Bern, Inst Sociol, Bern, Switzerland	University of Bern	Franzen, A (corresponding author), Univ Bern, Inst Sociol, Bern, Switzerland.	franzen@soz.unibe.ch	Franzen, Axel/AAV-3583-2021					Acock AC., 2013, DISCOVERING STRUCTUR; Aichholzer J., 2017, EINFUHRUNG LINEARE S; Banker S, 2020, JUDGM DECIS MAK, V15, P1037; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Bollen K. A, 1989, STRUCTURAL EQUATIONS; Brekke KA, 2011, J PUBLIC ECON, V95, P1111, DOI 10.1016/j.jpubeco.2011.05.003; Briscese G., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Cawley J, 2012, HBK ECON, P95, DOI 10.1016/B978-0-444-53592-4.00003-7; Chaudhuri A, 2011, EXP ECON, V14, P47, DOI 10.1007/s10683-010-9257-1; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Di Paolo R, 2020, EFFECT NORM BASED ME, DOI DOI 10.31234/OSF.IO/7863G; Diekmann A, 2003, RATION SOC, V15, P441, DOI 10.1177/1043463103154002; Dratva J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207433; Eastwood K, 2009, B WORLD HEALTH ORGAN, V87, P588, DOI 10.2471/BLT.08.060772; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; FINE PEM, 1986, AM J EPIDEMIOL, V124, P1012, DOI 10.1093/oxfordjournals.aje.a114471; Finney SJ, 2006, QUANT METH EDUC BEHA, P269; FOPH, 2021, WEEKL SIT REP EP SIT; Franzen A, 2019, INT J COMMONS, V13, P1079, DOI 10.5334/ijc.960; Franzen A, 2019, METHODS DATA ANAL, V13, P37, DOI 10.12758/mda.2019.01; Franzen A, 2018, J EXP PSYCHOL GEN, V147, P1950, DOI 10.1037/xge0000422; FSO, 2020, 200D0132 FSO; Fudenberg D, 2006, AM ECON REV, V96, P1449, DOI 10.1257/aer.96.5.1449; Heffner J, 2021, PERS INDIV DIFFER, V170, DOI 10.1016/j.paid.2020.110420; Hiller J, 2017, J PUBLIC HEALTH-HEID, V25, P339, DOI 10.1007/s10389-017-0798-z; Horney JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011226; Hoyle R.H., 2012, HDB STRUCTURAL EQUAT, V1st ed.; Jordan J., 2020, DONT GET IT DONT SPR; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Ling G.H.T., 2020, TECHNIUM SOC SCI J, V7, P312; Lunn PD, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113478; Luttrell A, 2021, SOC PSYCHOL PERS SCI, V12, P946, DOI 10.1177/1948550620947853; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Moussaoui LS, 2020, APPL PSYCHOL-HLTH WE, V12, P1183, DOI 10.1111/aphw.12235; Pedersen MJ, 2020, PUBLIC ADMIN REV, V80, P805, DOI 10.1111/puar.13240; Pfattheicher S, 2020, PSYCHOL SCI, V31, P1363, DOI 10.1177/0956797620964422; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Satorra A., 1994, LATENT VARIABLES ANA, P399, DOI DOI 10.2307/2291370; Schmid P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170550; Shim E, 2012, J R SOC INTERFACE, V9, P2234, DOI 10.1098/rsif.2012.0115; StataCorp, 2021, STATA STAT SOFTWARE; Urban D., 2014, STRUKTURGLEICHUNGSMO; van Ackere A, 2020, SOCIO-ECON PLAN SCI, V71, DOI 10.1016/j.seps.2019.100750; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018; Yu C.Y., 2002, EVALUATING CUTOFF CR	53	32	32	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247447	10.1371/journal.pone.0247447	http://dx.doi.org/10.1371/journal.pone.0247447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606826	Green Published, gold			2022-12-26	WOS:000620629200042
J	Lee, HS; Kang, M; Kim, B; Park, Y				Lee, Hyung Soon; Kang, Minjin; Kim, Banseok; Park, Yongjung			Outcomes of kidney transplantation over a 16-year period in Korea: An analysis of the National Health Information Database	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; CLINICAL-OUTCOMES; DESENSITIZATION; DEFLAZACORT; REJECTION; SURVIVAL	Background This study investigated the outcomes of kidney transplantation (KT) over a 16-year period in Korea and identified risk factors for graft failure using a nationwide population-based cohort. Methods We investigated the Korean National Health Insurance Service-National Health Information Database. Health insurance claims for patients who underwent KT between 2002 and 2017 were analyzed. Results The data from 18,331 patients who underwent their first KT were reviewed. The percentage of antithymocyte globulin (ATG) induction continuously increased from 2.0% in 2002 to 23.5% in 2017. Rituximab began to be used in 2008 and had increased to 141 patients (9.6%) in 2013. Acute rejection occurred in 17.3% of all patients in 2002 but decreased to 6.3% in 2017. The rejection-free survival rates were 78.8% at 6 months after KT, 76.1% after 1 year, 67.5% after 5 years, 61.7% after 10 years, and 56.7% after 15 years. The graft survival rates remained over 80% until 12 years after KT, and then rapidly decreased to 50.5% at 16 years after KT. In Cox's multivariate analysis, risk factors for graft failure included being male, more recent KT, KT from deceased donor, use of ATG, basiliximab, or rituximab, tacrolimus use as an initial calcineurin inhibitor, acute rejection history, and cytomegalovirus infection. Conclusions ATG and rituximab use has gradually increased in Korea and more recent KT is associated with an increased risk of graft failure. Therefore, meticulous preoperative evaluation and postoperative management are necessary in the case of recent KT with high risk of graft failure.	[Lee, Hyung Soon] Natl Hlth Insurance Serv Ilsan Hosp, Dept Surg, Goyang, South Korea; [Kang, Minjin] Natl Hlth Insurance Serv Ilsan Hosp, Res Inst, Goyang, South Korea; [Kim, Banseok; Park, Yongjung] Natl Hlth Insurance Serv Ilsan Hosp, Dept Lab Med, Goyang, South Korea; [Park, Yongjung] Yonsei Univ, Gangnam Severance Hosp, Dept Lab Med, Coll Med, Seoul, South Korea	National Health Insurance Service; National Health Insurance Service; National Health Insurance Service; Yonsei University; Yonsei University Health System	Park, Y (corresponding author), Natl Hlth Insurance Serv Ilsan Hosp, Dept Lab Med, Goyang, South Korea.; Park, Y (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Lab Med, Coll Med, Seoul, South Korea.	ypark119@yuhs.ac		Park, Yongjung/0000-0001-5668-4120; Lee, Hyung Soon/0000-0001-9825-8648	National Health Insurance Service, Ilsan Hospital, Goyang, Republic of Korea [2019-20-002, REQ0000029924]	National Health Insurance Service, Ilsan Hospital, Goyang, Republic of Korea	This study was supported by a grant from the National Health Insurance Service, Ilsan Hospital, Goyang, Republic of Korea. (Study no. 2019-20-002 and data no. REQ0000029924).	Abu Jawdeh BG, 2014, CLIN TRANSPLANT, V28, P494, DOI 10.1111/ctr.12335; [Anonymous], 1999, Drug Ther Bull, V37, P57; Bamoulid J, 2017, NEPHROL DIAL TRANSPL, V32, P1601, DOI 10.1093/ndt/gfw368; Chang JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183826; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; ELLI A, 1993, TRANSPLANTATION, V55, P209; Haririan A, 2009, AM J TRANSPLANT, V9, P536, DOI 10.1111/j.1600-6143.2008.02524.x; Hart A, 2020, AM J TRANSPLANT, V20, DOI 10.1111/ajt.15672; Huh KH, 2012, INT UROL NEPHROL, V44, P1549, DOI 10.1007/s11255-012-0169-1; Kim SJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051320; Kim YC, 2018, CLIN EXP NEPHROL, V22, P179, DOI 10.1007/s10157-017-1424-7; Ko EJ, 2017, TRANSPL INT, V30, P1215, DOI 10.1111/tri.12979; Ko KJ, 2018, TRANSPL P, V50, P3222, DOI 10.1016/j.transproceed.2018.05.028; Kong JM, 2013, CLIN TRANSPLANT, V27, P875, DOI 10.1111/ctr.12249; Lee CH, 2019, TRANSPL P, V51, P2611, DOI 10.1016/j.transproceed.2019.02.061; Lee S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212748; Min SI, 2010, J KOREAN MED SCI, V25, P1122, DOI 10.3346/jkms.2010.25.8.1122; Opelz G, 2008, TRANSPLANTATION, V85, P661, DOI 10.1097/TP.0b013e3181661695; Orandi BJ, 2016, NEW ENGL J MED, V374, P940, DOI 10.1056/NEJMoa1508380; Orandi BJ, 2014, AM J TRANSPLANT, V14, P1573, DOI 10.1111/ajt.12786; SCUDELETTI M, 1990, ANN NY ACAD SCI, V595, P368, DOI 10.1111/j.1749-6632.1990.tb34310.x; Scurt FG, 2019, LANCET, V393, P2059, DOI 10.1016/S0140-6736(18)32091-9; Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253; Song SH, 2018, TRANSPL P, V50, P2363, DOI 10.1016/j.transproceed.2018.04.046; Wan SS, 2018, TRANSPLANTATION, V102, P557, DOI 10.1097/TP.0000000000002049; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Yu JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173878; Yun BH, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1346-6	28	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247449	10.1371/journal.pone.0247449	http://dx.doi.org/10.1371/journal.pone.0247449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606787	gold, Green Published			2022-12-26	WOS:000620629200038
J	Zaibi, N; Li, PY; Xu, SZ				Zaibi, Nawel; Li, Pengyun; Xu, Shang-Zhong			Protective effects of dapagliflozin against oxidative stress-induced cell injury in human proximal tubular cells	PLOS ONE			English	Article								Elevated reactive oxygen species (ROS) in type 2 diabetes cause cellular damage in many organs. Recently, the new class of glucose-lowering agents, SGLT-2 inhibitors, have been shown to reduce the risk of developing diabetic complications; however, the mechanisms of such beneficial effect are largely unknown. Here we aimed to investigate the effects of dapagliflozin on cell proliferation and cell death under oxidative stress conditions and explore its underlying mechanisms. Human proximal tubular cells (HK-2) were used. Cell growth and death were monitored by cell counting, water-soluble tetrazolium-1 (WST-1) and lactate dehydrogenase (LDH) assays, and flow cytometry. The cytosolic and mitochondrial (ROS) production was measured using fluorescent probes (H2DCFDA and MitoSOX) under normal and oxidative stress conditions mimicked by addition of H2O2. Intracellular Ca2+ dynamics was monitored by FlexStation 3 using cell-permeable Ca2+ dye Fura-PE3/AM. Dapagliflozin (0.1-10 mu M) had no effect on HK-2 cell proliferation under normal conditions, but an inhibitory effect was seen at an extreme high concentration (100 mu M). However, dapagliflozin at 0.1 to 5 mu M showed remarkable protective effects against H2O2-induced cell injury via increasing the viable cell number at phase G0/G1. The elevated cytosolic and mitochondrial ROS under oxidative stress was significantly decreased by dapagliflozin. Dapagliflozin increased the basal intracellular [Ca2+](i) in proximal tubular cells, but did not affect calcium release from endoplasmic reticulum and store-operated Ca2+ entry. The H2O2-sensitive TRPM2 channel seemed to be involved in the Ca2+ dynamics regulated by dapagliflozin. However, dapagliflozin had no direct effects on ORAI1, ORAI3, TRPC4 and TRPC5 channels. Our results suggest that dapagliflozin shows anti-oxidative properties by reducing cytosolic and mitochondrial ROS production and altering Ca2+ dynamics, and thus exerts its protective effects against cell damage under oxidative stress environment.	[Zaibi, Nawel; Li, Pengyun; Xu, Shang-Zhong] Univ Hull, Ctr Atherothrombosis & Metab Dis, Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Xu, Shang-Zhong] Univ Hull, Hull York Med Sch, Diabet Endocrinol & Metab, Kingston Upon Hull, N Humberside, England; [Li, Pengyun] Southwest Med Univ, Inst Cardiovasc Res, Key Lab Med Electrophysiol, Minist Educ, Luzhou, Peoples R China	University of Hull; University of York - UK; University of Hull; University of York - UK; Southwest Medical University	Xu, SZ (corresponding author), Univ Hull, Ctr Atherothrombosis & Metab Dis, Hull York Med Sch, Kingston Upon Hull, N Humberside, England.; Xu, SZ (corresponding author), Univ Hull, Hull York Med Sch, Diabet Endocrinol & Metab, Kingston Upon Hull, N Humberside, England.	sam.xu@hyms.ac.uk	Xu, Shang-Zhong/P-2807-2015	Xu, Shang-Zhong/0000-0002-7295-9347; Li, Pengyun/0000-0001-5757-2956	Innovative Medicines Initiative 2 Joint Undertaking [115974]	Innovative Medicines Initiative 2 Joint Undertaking	This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115974. Funder has no role in the study design and data collection and manuscript preparation.	Arow M, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-019-0980-4; Baartscheer A, 2017, DIABETOLOGIA, V60, P568, DOI 10.1007/s00125-016-4134-x; Bertero E, 2018, CARDIOVASC RES, V114, P12, DOI 10.1093/cvr/cvx149; Birkeland KI, 2017, LANCET DIABETES ENDO, V5, P709, DOI 10.1016/S2213-8587(17)30258-9; Bonneau B, 2013, BBA-MOL CELL RES, V1833, P1755, DOI 10.1016/j.bbamcr.2013.01.021; Bonner C, 2015, NAT MED, V21, P512, DOI 10.1038/nm.3828; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Chen GL, 2012, BRIT J PHARMACOL, V167, P1232, DOI 10.1111/j.1476-5381.2012.02058.x; Chernyak BV, 2006, BBA-BIOENERGETICS, V1757, P525, DOI 10.1016/j.bbabio.2006.02.019; Daskoulidou N, 2015, J MOL MED, V93, P511, DOI 10.1007/s00109-014-1234-2; Ghezzi C, 2018, DIABETOLOGIA, V61, P2087, DOI 10.1007/s00125-018-4656-5; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Grupe M, 2010, CELL CALCIUM, V48, P1, DOI 10.1016/j.ceca.2010.05.005; Hamouda NN, 2015, MOL CELL BIOCHEM, V400, P57, DOI 10.1007/s11010-014-2262-5; Hanninen SL, 2010, CARDIOVASC RES, V88, P75, DOI 10.1093/cvr/cvq180; Hatanaka T, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.239; Hawley SA, 2016, DIABETES, V65, P2784, DOI 10.2337/db16-0058; Heerspink HJL, 2016, CIRCULATION, V134, P752, DOI 10.1161/CIRCULATIONAHA.116.021887; Home P, 2019, DIABETOLOGIA, V62, P357, DOI 10.1007/s00125-018-4801-1; Jiang HN, 2012, BIOCHEM PHARMACOL, V83, P923, DOI 10.1016/j.bcp.2012.01.014; Khomitskaya Y, 2018, CLIN THER, V40, P550, DOI 10.1016/j.clinthera.2018.02.006; Kusaka H, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0473-7; Li PY, 2019, BRIT J PHARMACOL, V176, P3845, DOI 10.1111/bph.14788; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Nakano S, 2015, J CLIN EXP HEPATOL, V5, P190, DOI 10.1016/j.jceh.2015.02.005; Plosker G, 2014, DRUGS, V74, P2191, DOI 10.1007/s40265-014-0324-3; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Rieg T, 2018, DIABETOLOGIA, V61, P2079, DOI 10.1007/s00125-018-4654-7; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sa-Nguanmoo P, 2017, TOXICOL APPL PHARM, V333, P43, DOI 10.1016/j.taap.2017.08.005; Scheen AJ, 2018, CIRC RES, V122, P1439, DOI 10.1161/CIRCRESAHA.117.311588; Shen BB, 2016, MED SCI MONITOR, V22, P633, DOI 10.12659/MSM.897353; Tang L, 2017, AM J PHYSIOL-ENDOC M, V313, pE563, DOI 10.1152/ajpendo.00086.2017; Terami N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100777; Turvey MR, 2010, J CELL BIOCHEM, V109, P132, DOI 10.1002/jcb.22390; Uthman L, 2018, DIABETOLOGIA, V61, P722, DOI 10.1007/s00125-017-4509-7; Xu SZ, 2008, J THROMB HAEMOST, V6, P692, DOI 10.1111/j.1538-7836.2008.02913.x; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Xu SZ, 2012, TOXICOL SCI, V125, P56, DOI 10.1093/toxsci/kfr268; Xu SZ, 2009, FREE RADICAL BIO MED, V47, P167, DOI 10.1016/j.freeradbiomed.2009.04.021; Yao D, 2018, MOL MED REP, V18, P3625, DOI 10.3892/mmr.2018.9393; Zeng B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02094-y; Zeng B, 2014, BRIT J PHARMACOL, V171, P1250, DOI 10.1111/bph.12528	44	16	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247234	10.1371/journal.pone.0247234	http://dx.doi.org/10.1371/journal.pone.0247234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606763	Green Published, gold			2022-12-26	WOS:000620629200029
J	Fiorentino, M; Sow, A; Sagaon-Teyssier, L; Mora, M; Mengue, MT; Vidal, L; Kuaban, C; March, L; Laurent, C; Spire, B; Boyer, S				Fiorentino, Marion; Sow, Abdourahmane; Sagaon-Teyssier, Luis; Mora, Marion; Mengue, Marie-Therese; Vidal, Laurent; Kuaban, Christopher; March, Laura; Laurent, Christian; Spire, Bruno; Boyer, Sylvie		EVOLCam Study Grp	Intimate partner violence by men living with HIV in Cameroon: Prevalence, associated factors and implications for HIV transmission risk (ANRS-12288 EVOLCAM)	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; ANTIRETROVIRAL THERAPY; MALE PERPETRATORS; SEXUAL VIOLENCE; UNSAFE SEX; HEALTH; WOMEN; HIV/AIDS; PEOPLE; PREVENTION	Objectives Intimate partner violence (IPV) against women is frequent in Central Africa and may be a HIV infection risk factor. More data on HIV-positive men (MLHIV) committing IPV are needed to develop perpetrator-focused IPV and HIV prevention interventions. We investigated the relationship between IPV and HIV transmission risk and IPV-associated factors. Methods We used data from the cross-sectional survey EVOLCam which was conducted in Cameroonian outpatient HIV structures in 2014. The study population comprised MLHIV declaring at least one sexual partner in the previous year. Using principal component analysis, we built three variables measuring, respectively, self-reported MLHIV-perpetrated psychological and physical IPV (PPV), severe physical IPV (SPV), and sexual IPV (SV). Ordinal logistic regressions helped investigate: i) the relationship between HIV transmission risk (defined as unstable aviremia and inconsistent condom use) and IPV variables, ii) factors associated with each IPV variable. Results PPV, SPV and SV were self-reported by 28, 15 and 11% of the 406 study participants, respectively. IPV perpetrators had a significantly higher risk of transmitting HIV than non-IPV perpetrators. Factors independently associated with IPV variables were: i) socio-demographic, economic and dyadic factors, including younger age (PPV and SPV), lower income (PPV), not being the household head (SPV and SV), living with a main partner (SPV), and having a younger main partner (SPV); ii) sexual behaviors, including >= 2 partners in the previous year (PPV and SPV), lifetime sex with another man (SPV), inconsistent condom use (SV), and >20 partners during lifetime (SV); iii) HIV-related stigma (PPV and SV). Conclusion IPV perpetrators had a higher risk of transmitting HIV and having lifetime and recent risky sexual behaviors. Perpetrating IPV was more frequent in those with socioeconomic vulnerability and self-perceived HIV-related stigma. These findings highlight the need for interventions to prevent IPV by MLHIV and related HIV transmission to their(s) partner(s).	[Fiorentino, Marion; Sow, Abdourahmane; Sagaon-Teyssier, Luis; Mora, Marion; Vidal, Laurent; Spire, Bruno; Boyer, Sylvie] Aix Marseille Univ, Sci Econ & Sociales Sante & Traitement Informat M, SESSTIM, INSERM,IRD, Marseille, France; [Mengue, Marie-Therese] Univ Catholique Afrique Cent, Yaounde, Cameroon; [Kuaban, Christopher] Univ Yaounde I, Dept Internal Med & Subspecialties, Fac Med & Biomed Sci, Yaounde, Cameroon; [March, Laura] Aix Marseille Univ, Lab Populat Environm Dev, UMR 151, IRD, Marseille, France; [Laurent, Christian] Montpellier Univ, IRD UMI 233, INSERM U1175, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Yaounde I; UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Fiorentino, M (corresponding author), Aix Marseille Univ, Sci Econ & Sociales Sante & Traitement Informat M, SESSTIM, INSERM,IRD, Marseille, France.	marion.fiorentino@inserm.fr	Spire, Bruno/F-5546-2013; vidal, laurent/J-1330-2016	Spire, Bruno/0000-0002-3546-8020; vidal, laurent/0000-0001-6936-3326; Sagaon-Teyssier, Luis/0000-0001-7318-6596; fiorentino, marion/0000-0002-1615-4579; Laurent, Christian/0000-0003-2658-7113	French National Agency for Research on AIDS and viral hepatitis (ANRS)	French National Agency for Research on AIDS and viral hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	This study was funded by the French National Agency for Research on AIDS and viral hepatitis (ANRS) (website anrs.fr/en) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Armstrong BK., 1992, MONOGRAPHS EPIDEMIOL, V1; Barker G., 2005, YOUNG MEN CONSTRUCTI; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Betron M, 2012, MEN MASCULINITIES HI; Brandt R, 2009, AJAR-AFR J AIDS RES, V8, P123, DOI 10.2989/AJAR.2009.8.2.1.853; Bravo P, 2010, AIDS REV, V12, P76; Campbell JC, 2008, INT J INJ CONTROL SA, V15, P221, DOI 10.1080/17457300802423224; Campbell JC, 2008, CAN MED ASSOC J, V179, P511, DOI 10.1503/cmaj.081145; Carrieri P, 2001, J ACQ IMMUN DEF SYND, V28, P232, DOI 10.1097/00042560-200111010-00005; Chouala YA, 2008, B APAD; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; Coulaud P, ANRS 12288 EVOLCAM S; Cuadros DF, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090865; Davis KC, 2018, AGGRESS VIOLENT BEH, V40, P83, DOI 10.1016/j.avb.2018.04.001; Dia A, 2010, SEX TRANSM INFECT, V86, P148, DOI 10.1136/sti.2008.035147; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; Durevall D, 2015, LANCET GLOB HEALTH, V3, pE34, DOI 10.1016/S2214-109X(14)70343-2; Fiorentino M., 2020, AIDS; Fiorentino M, 2019, WOMENS HEALTH, V15, DOI 10.1177/1745506519848546; Galvan FH, 2004, AIDS BEHAV, V8, P441, DOI 10.1007/s10461-004-7328-z; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Harling G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014257; Hatcher AM, 2015, AIDS, V29, P2183, DOI 10.1097/QAD.0000000000000842; Hembling J, 2014, AIDS CARE, V26, P1411, DOI 10.1080/09540121.2014.913766; Hinton P., 2004, SPSS EXPLAINED, V2nd ed.; Institut National de la Statistique (INS) et ICF International, 2012, ENQ DEM SANT IND MUL; Jackson JE., 2005, ENCY BIOSTATISTICS, V6; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Klot JF, 2013, AM J REPROD IMMUNOL, V69, P5, DOI 10.1111/aji.12033; Kowal C., 2017, ANN MED PSYCHOL REV, P698; Krahe B, 2018, CURR OPIN PSYCHOL, V19, P6, DOI 10.1016/j.copsyc.2017.03.017; Liegeois F, 2019, HIV MED, V20, P38, DOI 10.1111/hiv.12681; Lynch I, 2010, CULT HEALTH SEX, V12, P15, DOI 10.1080/13691050903082461; Maman S, 2000, SOC SCI MED, V50, P459, DOI 10.1016/S0277-9536(99)00270-1; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Marcellin F, 2010, AIDS, V24, pS17, DOI 10.1097/01.aids.0000366079.83568.a2; McCloskey LA, 2016, PARTN ABUSE, V7, P277, DOI 10.1891/1946-6560.7.3.277; Mullinax M, 2017, AIDS EDUC PREV, V29, P527, DOI 10.1521/aeap.2017.29.6.527; Ndziessi Gilbert, 2013, PLoS One, V8, pe62611, DOI 10.1371/journal.pone.0062611; Nightingale VR, 2011, AIDS BEHAV, V15, P1870, DOI 10.1007/s10461-011-9980-4; Nightingale VR, 2010, J TRAUMA STRESS, V23, P452, DOI 10.1002/jts.20554; Nkuoh GN, 2010, J MIDWIFERY WOM HEAL, V55, P363, DOI 10.1016/j.jmwh.2010.02.009; Norlander B, 2005, CLIN PSYCHOL REV, V25, P119, DOI 10.1016/j.cpr.2004.10.001; Rigby Simon W, 2017, Infect Dis Model, V2, P71, DOI 10.1016/j.idm.2017.02.002; Sabri B, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6909-8; Schraiber LB, 2010, REV SAUDE PUBL, V44, P658, DOI 10.1590/S0034-89102010000400009; Segurado AC, 2008, AIDS CARE, V20, P15, DOI 10.1080/09540120701459657; Sesar K, 2018, MENT HEALTH REV J, V23, P221, DOI 10.1108/MHRJ-08-2017-0028; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Smith-Marek EN, 2015, J FAM THEOR REV, V7, P498, DOI 10.1111/jftr.12113; Stith SM, 2004, AGGRESS VIOLENT BEH, V10, P65, DOI 10.1016/j.avb.2003.09.001; Talbot F., 2015, ANN MED PSYCHOL REV, P193; Tchouwa GF, 2018, ECLINICALMEDICINE, V1, P21, DOI 10.1016/j.eclinm.2018.06.005; Thorndike RM, 1995, APPL PSYCH MEAS, V19, P303, DOI 10.1177/014662169501900308; Tong C, 2018, TROP MED INT HEALTH, V23, P315, DOI 10.1111/tmi.13030; Tsuyuki K, 2019, CURR HIV-AIDS REP, V16, P57, DOI 10.1007/s11904-019-00435-8; Turan JM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001295; Velotti P, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01166; World Health Organization, 2021, VIOL WOM PREV EST 20; Yakubovich AR, 2018, AM J PUBLIC HEALTH, V108, pE1, DOI 10.2105/AJPH.2018.304428	64	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0246192	10.1371/journal.pone.0246192	http://dx.doi.org/10.1371/journal.pone.0246192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8JB	33600445	gold, Green Published			2022-12-26	WOS:000620625100042
J	Leoni, C; Bianchi, N; Vincenzetti, L; Monticelli, S				Leoni, Cristina; Bianchi, Niccolo; Vincenzetti, Lucia; Monticelli, Silvia			An optimized workflow for CRISPR-Cas9 deletion of surface and intracellular factors in primary human T lymphocytes	PLOS ONE			English	Article								The appropriate regulation of T lymphocyte functions is key to achieve protective immune responses, while at the same time limiting the risks of tissue damage and chronic inflammation. Deciphering the mechanisms underpinning T cell responses in humans may therefore be beneficial for a range of infectious and chronic diseases. Recently, the development of methods based on CRISPR-Cas9 gene-editing has greatly expanded the available tool-box for the mechanistic studies of primary human T cell responses. While the deletion of a surface protein has become a relatively straightforward task, as long as an antibody for detection is available, the identification and selection of cells lacking an intracellular protein, a non-coding RNA or a protein for which no antibody is available, remain more problematic. Here, we discuss the options currently available to scientists interested in performing gene-editing in primary human T lymphocytes and we describe the optimization of a workflow for the screening and analysis of lymphocytes following gene-editing with CRISPR-Cas9 based on T cell cloning and T7 endonuclease I cleavage assay.	[Leoni, Cristina; Bianchi, Niccolo; Vincenzetti, Lucia; Monticelli, Silvia] Univ Svizzera Italiana USI, Inst Res Biomed IRB, Bellinzona, Switzerland; [Bianchi, Niccolo] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland	Universita della Svizzera Italiana; University of Bern	Leoni, C; Monticelli, S (corresponding author), Univ Svizzera Italiana USI, Inst Res Biomed IRB, Bellinzona, Switzerland.	cristina.leoni@irb.usi.ch; silvia.monticelli@irb.usi.ch		Leoni, Cristina/0000-0002-4458-1121	Swiss National Science Foundation [175569]; NCCR 'RNA Disease'; Ceresio Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR 'RNA Disease'; Ceresio Foundation	This work was supported by the Swiss National Science Foundation (grant number 175569), the NCCR 'RNA & Disease' and the Ceresio Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Emming S, 2020, NAT IMMUNOL, V21, P388, DOI 10.1038/s41590-020-0622-8; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hultquist JF, 2019, NAT PROTOC, V14, P1, DOI 10.1038/s41596-018-0069-7; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Labun K, 2019, GENOME RES, V29, P843, DOI 10.1101/gr.244293.118; Mele F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7431; Ng MSF, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav5947; Oh Soyoung A, 2019, Curr Protoc Immunol, V124, pe69, DOI 10.1002/cpim.69; Perez AR, 2017, NAT BIOTECHNOL, V35, P347, DOI 10.1038/nbt.3804; Roth TL, 2018, NATURE, V559, P405, DOI 10.1038/s41586-018-0326-5; Sallusto F, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029421; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schumann K, 2020, NAT IMMUNOL, V21, P1456, DOI 10.1038/s41590-020-0784-4; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Seki A, 2018, J EXP MED, V215, P985, DOI 10.1084/jem.20171626; Sharma Arun, 2018, Curr Protoc Hum Genet, V96, DOI 10.1002/cphg.52; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Wawro M, 2017, J CELL BIOCHEM, V118, P487, DOI 10.1002/jcb.25665; Wolf T, 2020, NAT IMMUNOL, V21, P927, DOI 10.1038/s41590-020-0714-5	23	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247232	10.1371/journal.pone.0247232	http://dx.doi.org/10.1371/journal.pone.0247232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600503	gold, Green Published			2022-12-26	WOS:000620625100022
J	Tuohy, JF; Bloomfield, FH; Crowther, CA; Harding, JE				Tuohy, Jeremy F.; Bloomfield, Frank H.; Crowther, Caroline A.; Harding, Jane E.			Maternal and neonatal glycaemic control after antenatal corticosteroid administration in women with diabetes in pregnancy: A retrospective cohort study	PLOS ONE			English	Article							GLUCOSE; INSULIN; HYPOGLYCEMIA; BABIES; BETAMETHASONE; MELLITUS; OUTCOMES; TRENDS	Objective To describe maternal and neonatal glycaemic control following antenatal corticosteroid administration to women with diabetes in pregnancy. Design Retrospective cohort study Setting A tertiary hospital in Auckland, New Zealand Population Women with diabetes in pregnancy who received antenatal corticosteroids from 2006-2016. Methods Corticosteroid administration, maternal and neonatal glycaemia data were retrieved from electronic patient records. Demographic data were downloaded from the hospital database. Relationships between variables were analysed using multivariate analysis. Main outcome measures Maternal hyperglycaemia and neonatal hypoglycaemia Results Corticosteroids were administered to 647 of 7317 of women with diabetes (8.8%) who gave birth to 715 babies. After an initial course of corticosteroids, 92% and 52% of women had blood glucose concentrations > 7 and > 10 mmol/L respectively. Median peak blood glucose concentration of approximately 10 mmol/L occurred 9 hours after corticosteroid administration and hyperglycaemia lasted approximately 72 hours. Thirty percent of women gave birth within 72 hours of the last dose of corticosteroids. Babies of women who were hyperglycaemic within 24 hours of birth were more likely to develop hypoglycaemia (< 2.6 mmol/L, OR 1.51 [95% CI 1.10-2.07], p = 0.01) and severe hypoglycaemia (<= 2.0 mmol/L, OR 2.00 [95% CI 1.41-2.85], p < 0.0001) than babies of non-hyperglycaemic mothers. There was no association between maternal glycaemia within 7 days of the last dose of corticosteroids and neonatal hypoglycaemia. Conclusions Hyperglycaemia is common in women with diabetes in pregnancy following antenatal corticosteroid administration. Maternal hyperglycaemia in the 24 hours prior to birth is associated with increased risk of neonatal hypoglycaemia. Limitations included the retrospective study design, so that not all data were available for all women and babies and the glucose testing schedule was variable.	[Tuohy, Jeremy F.; Bloomfield, Frank H.; Crowther, Caroline A.; Harding, Jane E.] Univ Auckland, Liggins Inst, Auckland, New Zealand	University of Auckland	Harding, JE (corresponding author), Univ Auckland, Liggins Inst, Auckland, New Zealand.	j.harding@auckland.ac.nz			Lotteries Health Research Grant [190606-002467]	Lotteries Health Research Grant	JT received 190606-002467 Lotteries Health Research Grant. https://www.communitymatters.govt.nz/lottery-grants-board/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsweiler JM, 2012, PEDIATRICS, V129, P639, DOI 10.1542/peds.2011-2470; Antenatal Corticosteroids Clinical Practice Guidelines Panel, 2015, ANT CORT GIV WOM PRI; Auckland District Health Board, 2017, NEWB CLIN GUID HYP M; Auckland District Health Board, 2017, DIABETES PREGNANCY; Brownfoot FC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006764.pub3; Dalfra MG, 2016, J MATERN-FETAL NEO M, V29, P2889, DOI 10.3109/14767058.2015.1107903; Fadl HE, 2010, DIABETIC MED, V27, P436, DOI 10.1111/j.1464-5491.2010.02978.x; Feig DS, 2017, LANCET, V390, P2347, DOI 10.1016/S0140-6736(17)32400-5; Gyamfi-Bannerman C, 2016, NEW ENGL J MED, V374, P1311, DOI 10.1056/NEJMoa1516783; Harris DL, 2013, LANCET, V382, P2077, DOI 10.1016/S0140-6736(13)61645-1; Harris DL, 2012, J PEDIATR-US, V161, P787, DOI 10.1016/j.jpeds.2012.05.022; Iafusco Dario, 2008, BMC Pregnancy Childbirth, V8, P23, DOI 10.1186/1471-2393-8-23; Itoh A, 2016, ENDOCR J, V63, P101, DOI 10.1507/endocrj.EJ15-0482; Jolley JA, 2016, DIABETES RES CLIN PR, V118, P98, DOI 10.1016/j.diabres.2016.06.005; KENEPP NB, 1982, LANCET, V1, P1150; KUHL C, 1982, ACTA PAEDIATR SCAND, V71, P19, DOI 10.1111/j.1651-2227.1982.tb09366.x; Mathiesen ER, 2002, ACTA OBSTET GYN SCAN, V81, P835, DOI 10.1034/j.1600-0412.2002.810906.x; National Institute for Health and Care Excellence, 2015, DIAB PREGN MAN PREC; Paul R, 2019, AUST NZ J OBSTET GYN, V59, P463, DOI 10.1111/ajo.12963; Pettit KE, 2014, J MATERN-FETAL NEO M, V27, P683, DOI 10.3109/14767058.2013.832750; Polyakov A, 2007, AUST NZ J OBSTET GYN, V47, P42, DOI 10.1111/j.1479-828X.2006.00677.x; Razaz N, 2015, OBSTET GYNECOL, V125, P288, DOI 10.1097/AOG.0000000000000629; Roberts D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub3; Rowe CW, 2019, DIABETIC MED, V36, P228, DOI 10.1111/dme.13864; Shah R, 2019, NEONATOLOGY, V115, P116, DOI 10.1159/000492859; Star J, 2000, J Matern Fetal Med, V9, P273; Tuohy JF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229014; Tuohy JF, 2019, AUST NZ J OBSTET GYN, V59, P416, DOI 10.1111/ajo.12890; Yamamoto JM, 2018, DIABETIC MED, V35, P173, DOI 10.1111/dme.13546; Yu F, 2014, J CLIN ENDOCR METAB, V99, P4674, DOI 10.1210/jc.2013-4332	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0246175	10.1371/journal.pone.0246175	http://dx.doi.org/10.1371/journal.pone.0246175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600450	Green Published, gold			2022-12-26	WOS:000620625100006
J	Durosini, I; Triberti, S; Savioni, L; Pravettoni, G				Durosini, Ilaria; Triberti, Stefano; Savioni, Lucrezia; Pravettoni, Gabriella			In the eye of a quiet storm: A critical incident study on the quarantine experience during the coronavirus pandemic	PLOS ONE			English	Article							PERSPECTIVES; SARS	Objective In 2020, the COVID-19 appeared in Italy with an exponential transmission capacity and serious consequences for the whole population. To counter the spread of the virus, the Italian government has adopted an extensive lockdown, forcing citizens to stay at home and avoid social contact. The COVID-19 quarantine represents a unique phenomenon in the recent centuries, and its long-term consequences on people's lives and mental health are still to be understood. This study aimed to explore significant experiences of people who did not contract the virus, yet experienced the quarantine as a potentially stressful condition. Methods Italians who did not contract the COVID-19 were invited to participate in semi-structured interviews employing the Critical Incident Technique. Interviews were designed to capture the significant experiences related to the lockdown period in Italy. Participants were asked to describe the most significant (1) negative and (2) positive critical events that they personally experienced during the ongoing quarantine. Such events were meant to provide information on their experience of the quarantine as a whole. The audio-taped interviews were transcribed verbatim and analyzed following Critical Incident Technique's indications. Results Twenty two participants described a total of 43 critical events, including 22 negative episodes and 21 positive events experienced during the COVID-19 quarantine. Three categories emerged from the negative episodes and four categories emerged from the positive events described by the participants. Relevant themes both positive and negative concerned mostly relationships (with partners, family, and friends), and the alteration of everyday activities, Also a specific "sensation of emergency" that the participants felt during the pandemic emerged, as an emotionally-charged response to quarantine-related external stimuli. Conclusions To our knowledge this is the first in-depth qualitative study investigating the significant negative and positive events that people experienced during the COVID-19 quarantine. Future research could employ analogous event recollection methods but focus on other populations (e.g., fragile subjects or on other national contests), in order to extend the information on the quarantine experience and its possible long-lasting effects.	[Durosini, Ilaria; Triberti, Stefano; Savioni, Lucrezia; Pravettoni, Gabriella] European Inst Oncol IRCCS, Appl Res Div Cognit & Psychol Sci, IEO, Milan, Italy; [Triberti, Stefano; Savioni, Lucrezia; Pravettoni, Gabriella] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy	IRCCS European Institute of Oncology (IEO); University of Milan	Durosini, I (corresponding author), European Inst Oncol IRCCS, Appl Res Div Cognit & Psychol Sci, IEO, Milan, Italy.	ilaria.durosini@ieo.it	Pravettoni, Gabriella/C-6915-2011; Pravettoni, Gabriella/AAC-3500-2022; Durosini, Ilaria/ABI-8214-2020	Pravettoni, Gabriella/0000-0002-4843-4663; Durosini, Ilaria/0000-0002-8500-2675; Triberti, Stefano/0000-0001-5691-5531	Fondazione Umberto Veronesi; MIUR Italian Ministry of University and Research	Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); MIUR Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	The authors received no specific funding for this work. However, ID was supported by Fondazione Umberto Veronesi. LS is a PhD Student within the European School of Molecular Medicine (SEMM). ST and GP were supported by MIUR Italian Ministry of University and Research (Departments of Excellence Italian Law n.232, 11th December 2016) for University of Milan.	Albarello F, 2020, INT J INFECT DIS, V93, P192, DOI 10.1016/j.ijid.2020.02.043; Amundson, 2009, CANADIAN J COUNSELLI, V43, P265, DOI DOI 10.1177/1468794105056924; [Anonymous], WEB24NEWS; Archyde, FEAR GOING OUTSIDE; Aschieri F, 2021, J NURS SCHOLARSHIP, V53, P65, DOI 10.1111/jnu.12610; Barbisch D, 2015, DISASTER MED PUBLIC, V9, P547, DOI 10.1017/dmp.2015.38; Bellaiche J-M., 2020, CONTENT SQUARE; Benvenuto D, 2020, DATA BRIEF, V29, DOI 10.1016/j.dib.2020.105340; Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8; Chen WY, 2012, TOURISM ECON, V18, P295, DOI 10.5367/te.2012.0114; Dougall AL, 1999, PSYCHOSOM MED, V61, P38, DOI 10.1097/00006842-199901000-00008; Durosini I, 2017, CLIN CASE STUD, V16, P295, DOI 10.1177/1534650117693942; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Eriksson K, 2016, INT J NURS STUD, V56, P27, DOI 10.1016/j.ijnurstu.2015.12.008; Favieri F., 2020, SSRN J, DOI [10.2139/ssrn.3576804, DOI 10.2139/SSRN.3576804]; Ferrucci R, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.559266; FLANAGAN JC, 1954, PSYCHOL BULL, V51, P327, DOI 10.1037/h0061470; Flanagan JC., 1959, J CLIN PSYCHOL; Gersons BPR, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21369; Goodwill A, 2016, J AGGRESS MALTREAT T, V25, P518, DOI 10.1080/10926771.2015.1129658; Gorini A, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02066; Gremler DD, 2004, J SERV RES-US, V7, P65, DOI 10.1177/1094670504266138; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Holloway BB, 2008, J SERV RES-US, V10, P347, DOI 10.1177/1094670508314266; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Keers RN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206233; Khan S, 2020, J HOSP INFECT, V104, P449, DOI 10.1016/j.jhin.2020.02.002; Khechuashvili L, 2019, J LOSS TRAUMA, V24, P177, DOI 10.1080/15325024.2018.1560903; Kondylakis H, 2017, COMP MED SY, P755, DOI 10.1109/CBMS.2017.62; Maglio A-ST., 2005, QUALITATIVE RES, V5, P475, DOI [10.1177/1468794105056924, DOI 10.1177/1468794105056924]; Masiero M, 2020, J TRAUMA DISSOCIATIO, V21, P513, DOI 10.1080/15299732.2020.1787296; Mazur M., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3586603, DOI 10.2139/SSRN.3586603]; Monzani D, 2021, PERS INDIV DIFFER, V168, DOI 10.1016/j.paid.2020.110388; Mucci F, 2020, CLIN NEUROPSYCHIATR, V17, P63, DOI 10.36131/CN20200205; Piercy FP, 2016, J MARITAL FAM THER, V42, P584, DOI 10.1111/jmft.12176; Rubin GJ, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m313; Saccinto E, 2013, J LOSS TRAUMA, V18, P210, DOI 10.1080/15325024.2012.687321; Sakai Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199944; Sanger PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114016; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Triberti S, 2021, PERS INDIV DIFFER, V170, DOI 10.1016/j.paid.2020.110453; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; World Health Organization, 2020, 29 WHO; World Health Organization, 2020, TECHNICAL REPORT; Yoo JH, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e62; Zhang SX, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112958	47	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247121	10.1371/journal.pone.0247121	http://dx.doi.org/10.1371/journal.pone.0247121			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8ME	33596268	gold, Green Published			2022-12-26	WOS:000620633200038
J	Jani, N; Mathur, S; Kahabuka, C; Makyao, N; Pilgrim, N				Jani, Nrupa; Mathur, Sanyukta; Kahabuka, Catherine; Makyao, Neema; Pilgrim, Nanlesta			Relationship dynamics and anticipated stigma: Key considerations for PrEP use among Tanzanian adolescent girls and young women and male partners	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS PREP; HIV-SERODISCORDANT COUPLES; FRAMEWORK; PREVENTION; NORMS	Objectives We examined key gender, interpersonal and community dynamics influencing PrEP acceptability among adolescent girls and young women (AGYW) and their male partners. Methods We administered 12 in-depth interviews (IDI) to partnered, or married AGYW aged 15-24 years living without HIV, and 16 IDIs to male partners living without HIV aged 18 or older, partnered or married to an AGYW in Tanzania. Card sorting, a participatory qualitative method for facilitating systematic discussion, was used to identify attitudes, values, and desires that would influence PrEP acceptability. Results Relationship distrust, partner communication about HIV risk, and need to control HIV risk were highly influential considerations for PrEP use. AGYW and male partners both wanted to discuss PrEP use amidst relationship distrust, while most male partners encouraged AGYW PrEP use for shared protective benefit. Anticipated stigma of being perceived as a person living with HIV, as a result of PrEP use, was a deterrent for both AGYW and male partners while AGYW also feared additional stigma of being considered sexually promiscuous. Conclusions Couples counseling for PrEP uptake and adherence might be a well-placed strategy for couples who are living without HIV to educate one another about the relationship benefits of using PrEP, thereby increasing its acceptance and adherence, addressing unequal power dynamics, and reducing associated relationship distrust. Community awareness and education about PrEP can help curb persistent PrEP stigma, including intersectional stigma.	[Jani, Nrupa; Mathur, Sanyukta] Populat Council, Washington, DC 20008 USA; [Kahabuka, Catherine] CSK Res Solut, Dar Es Salaam, Tanzania; [Makyao, Neema] Natl AIDS Control Programme, Dar Es Salaam, Tanzania	Population Council	Jani, N (corresponding author), Populat Council, Washington, DC 20008 USA.	njani@popcouncil.org		Jani, Nrupa/0000-0001-6768-9963	Bill & Melinda Gates Foundation [OPP1150068, OPP1136778]; CSK Research Solutions	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); CSK Research Solutions	This research was funded by Bill & Melinda Gates Foundation-OPP1150068-https://www.gatesfoundation.org/Bill & Melinda Gates Foundation-OPP1136778-https://www.gatesfoundation.org/.The funder provided support in the form of salaries for authors [NJ, SM, CK, NP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. The funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. CSK Research Solutions is a private firm that supports design and implementation of research studies and program monitoring and evaluation activities in Tanzania. They did not fund the study. Rather, they served as the Tanzanian research partner in the study. They received a sub-contract from the Population Council to collect data, participate in data analysis and participate in the preparation of the manuscript.; The authors would like to acknowledge the DREAMS program participants and implementing partners in Tanzania, our research partners at CSK Research Solutions, our field data collectors, and all study participants. We would also like to acknowledge support from our colleagues at the Tanzanian Ministry of Health, National AIDS Control Programme, CSK colleague Salum Mshamu, and our Population Council colleagues Lou Apicella, Vaibhav Saria, and Julie Pulerwitz, who provided support and guidance in the study design and analysis of data presented in this manuscript.	Adams LM, 2018, HEALTH EDUC BEHAV, V45, P723, DOI 10.1177/1090198117752789; [Anonymous], 2015, FHI 360 IMPACT RES D; Atujuna M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191251; Baeten J., 2018, UPTAKE PREP CLIN PRO; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Barton-Knott S, 2018, UNAIDS PREEXP PROPH; Carter AJ, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17433; Chakrapani V, 2015, AIDS PATIENT CARE ST, V29, P569, DOI 10.1089/apc.2015.0143; Collier KL, 2017, J HEALTH COMMUN, V22, P183, DOI 10.1080/10810730.2016.1261969; Conrad LY, 2019, J DOC, V75, P397, DOI 10.1108/JD-06-2018-0091; Corneli AL, 2014, JAIDS-J ACQ IMM DEF, V66, P324, DOI 10.1097/QAI.0000000000000158; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Dubov A, 2018, AM J MENS HEALTH, V12, P1843, DOI 10.1177/1557988318797437; Earnshaw VA, 2013, AIDS BEHAV, V17, P1785, DOI 10.1007/s10461-013-0437-9; Falcao J, 2017, CULT HEALTH SEX, V19, P1389, DOI 10.1080/13691058.2017.1316424; Flash CA, 2017, INT J WOMENS HEALTH, V9, DOI 10.2147/IJWH.S113675; Friese S, 2014, QUALITATIVE DATA ANA; Gabler G, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4600-5; Golub SA, 2018, CURR HIV-AIDS REP, V15, P190, DOI 10.1007/s11904-018-0385-0; Govender E, 2018, AIDS CARE, V30, P1311, DOI 10.1080/09540121.2018.1488027; Govender E, 2017, CULT HEALTH SEX, V19, P1268, DOI 10.1080/13691058.2017.1309682; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hagey JM, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20123; Harawa T., 2016, ENGAGING BLACK MEN H; Hoagland B, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21472; Kalembo FW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066517; Karney BR, 2010, AIDS BEHAV, V14, pS189, DOI 10.1007/s10461-010-9802-0; Lachowsky NJ, 2019, SEX HEALTH, V16, P180, DOI 10.1071/SH18115; Logie CH, 2019, SOC SCI MED, V232, P129, DOI 10.1016/j.socscimed.2019.04.044; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Mammen JR, 2016, INT J NURS STUD, V58, P90, DOI 10.1016/j.ijnurstu.2015.12.011; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Matheka J, AIDS 2020 2020 JUL 2; Mathur S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203929; Mathur S, 2016, LANCET HIV, V3, pE406, DOI 10.1016/S2352-3018(16)30115-1; Morton JF, 2017, JAIDS-J ACQ IMM DEF, V74, pS15, DOI 10.1097/qai.0000000000001210; Mukoma W., 2018, LONG WILL THEY TAKE; Ngure K, 2016, AIDS PATIENT CARE ST, V30, P78, DOI 10.1089/apc.2015.0259; O'Brien N, 2017, WOMEN HEALTH ISS, V27, P721, DOI 10.1016/j.whi.2017.08.001; Pilgrim N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196280; Population Council, 2015, INTR ANT ARV BAS PRE; Population Council Council P, 2018, ADDR STIGM GEND IN S; PrEPWatch, COUNTR UPD TANZ 2019; PREPWatch, 2019, GLOB PREP ENR TRACK; Pulerwitz J, 2016, BUILDING EVIDENCE GU, DOI DOI 10.31899/HIV7.1008; Pulerwitz J, 2019, J ADOLESCENT HEALTH, V64, pS7, DOI 10.1016/j.jadohealth.2019.01.014; Quinn K, 2019, SOC SCI MED, V232, P86, DOI 10.1016/j.socscimed.2019.04.042; Schwartz K, 2018, SEX HEALTH, V15, P570, DOI 10.1071/SH18064; Sidebottom D, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3463-4; Silberschmidt M, 2001, SOC SCI MED, V52, P1815, DOI 10.1016/S0277-9536(00)00299-9; Stetler CB, 2006, J GEN INTERN MED, V21, pS1, DOI 10.1111/j.1525-1497.2006.00355.x; TACAIDS TCfA, 2013, TANZ HIV AIDS MAL IN; Tsang EYH, 2019, AM J MENS HEALTH, V13, DOI 10.1177/1557988318823883; UNAIDS, 2016, PREV GAP REP; UNAIDS, AIDSINFO SHEET KEY H; UNAIDS, 2018, COUNTR FACTSH UN REP; Vu L, 2017, J ADOLESCENT HEALTH, V60, pS15, DOI 10.1016/j.jadohealth.2016.09.027; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2015, GLOB STAND QUAL HLTH; Yun K, 2018, SEX TRANSM INFECT, V94, P163, DOI 10.1136/sextrans-2017-053217	61	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246717	10.1371/journal.pone.0246717	http://dx.doi.org/10.1371/journal.pone.0246717			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8ME	33596216	gold, Green Published			2022-12-26	WOS:000620633200035
J	Martinez, YA; Guo, XW; Portales-Perez, DP; Rivera, G; Castaneda-Delgado, JE; Garcia-Perez, CA; Enciso-Moreno, JA; Lara-Ramirez, EE				Martinez, Yamelie A.; Guo, Xianwu; Portales-Perez, Diana P.; Rivera, Gildardo; Castaneda-Delgado, Julio E.; Garcia-Perez, Carlos A.; Enciso-Moreno, Jose A.; Lara-Ramirez, Edgar E.			The analysis on the human protein domain targets and host-like interacting motifs for the MERS-CoV and SARS-CoV/CoV-2 infers the molecular mimicry of coronavirus	PLOS ONE			English	Article							MEMBRANE-PROTEIN; VIRUS; IDENTIFICATION; COVID-19; PROGRAM; PEPTIDE	The MERS-CoV, SARS-CoV, and SARS-CoV-2 are highly pathogenic viruses that can cause severe pneumonic diseases in humans. Unfortunately, there is a non-available effective treatment to combat these viruses. Domain-motif interactions (DMIs) are an essential means by which viruses mimic and hijack the biological processes of host cells. To disentangle how viruses achieve this process can help to develop new rational therapies. Data mining was performed to obtain DMIs stored as regular expressions (regexp) in 3DID and ELM databases. The mined regexp information was mapped on the coronaviruses' proteomes. Most motifs on viral protein that could interact with human proteins are shared across the coronavirus species, indicating that molecular mimicry is a common strategy for coronavirus infection. Enrichment ontology analysis for protein domains showed a shared biological process and molecular function terms related to carbon source utilization and potassium channel regulation. Some of the mapped motifs were nested on B, and T cell epitopes, suggesting that it could be as an alternative way for reverse vaccinology. The information obtained in this study could be used for further theoretic and experimental explorations on coronavirus infection mechanism and development of medicines for treatment.	[Martinez, Yamelie A.; Castaneda-Delgado, Julio E.; Enciso-Moreno, Jose A.; Lara-Ramirez, Edgar E.] Inst Mexicano Seguro Social, Unidad Invest Biomed Zacatecas, Zacatecas, Zacatecas, Mexico; [Martinez, Yamelie A.; Portales-Perez, Diana P.] Univ Autonoma San Luis Potosi, Fac Ciencias Quim, Lab Inmunol & Biol Celular & Mol, San Luis Potosi, San Luis Potosi, Mexico; [Guo, Xianwu] Inst Politecn Nacl, Ctr Biotecnol Genom, Lab Biotecnol Genom, Reynosa, Mexico; [Rivera, Gildardo] Inst Politecn Nacl, Ctr Biotecnol Genom, Lab Biotecnol Farmaceut, Reynosa, Mexico; [Castaneda-Delgado, Julio E.] Inst Mexicano Seguro Social, Catedras CONACYT, Unidad Invest Biomed Zacatecas, Zacatecas, Zacatecas, Mexico; [Garcia-Perez, Carlos A.] Helmholtz Zentrum Munchen, Informat & Commun Technol Dept ICT, Complex Syst, Neuherberg, Germany	Instituto Mexicano del Seguro Social; Universidad Autonoma de San Luis Potosi; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Mexicano del Seguro Social; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lara-Ramirez, EE (corresponding author), Inst Mexicano Seguro Social, Unidad Invest Biomed Zacatecas, Zacatecas, Zacatecas, Mexico.	doc_lara_ram@hotmail.com	Rivera, Gildardo/AGF-2021-2022; Lara-Ramírez, Edgar E./A-6915-2018; Delgado, Julio Enrique Castañeda/AAL-1946-2020	Rivera, Gildardo/0000-0001-9842-4167; Delgado, Julio Enrique Castañeda/0000-0003-2124-2036; Portales-Perez, Diana Patricia/0000-0001-8063-7869; Aguayo Martinez, Elsa Yamelie/0000-0003-4203-9483; Lara-Ramirez, Edgar E./0000-0001-7112-3233	CONACYT [CVU 934987]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors received no specific funding for this work. Yamelie A. Marti ' nez holds a doctoral CONACYT scholarship (No. CVU 934987).	Ahmed SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2354; Apicella M, 2020, LANCET DIABETES ENDO, V8, P782, DOI 10.1016/S2213-8587(20)30238-2; Basu MK, 2009, BRIEF BIOINFORM, V10, P205, DOI 10.1093/bib/bbn057; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Becerra A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1570-7; Berg J.M, 2002, BIOCHEMISTRY-US, Vfifth; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Brister JR, 2014, NUCLEIC ACIDS RES, V42, pD660, DOI 10.1093/nar/gkt1268; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Ehrenfeld M, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102597; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Fang H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003929; Garamszegi S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003778; Garcia-Perez CA, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2237-8; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hagai T, 2014, CELL REP, V7, P1729, DOI 10.1016/j.celrep.2014.04.052; He RT, 2004, VIRUS RES, V105, P121, DOI 10.1016/j.virusres.2004.05.002; He YX, 2005, J CLIN MICROBIOL, V43, P3718, DOI 10.1128/JCM.43.8.3718-3726.2005; Hraber P, 2020, TRENDS BIOTECHNOL, V38, P113, DOI 10.1016/j.tibtech.2019.07.004; Khorsand Babak, 2020, Inform Med Unlocked, V20, P100413, DOI 10.1016/j.imu.2020.100413; Kliche J, 2021, SCI SIGNAL, V14, DOI 10.1126/scisignal.abf1117; Kumar M, 2020, NUCLEIC ACIDS RES, V48, pD296, DOI 10.1093/nar/gkz1030; Lin MM, 2012, P NATL ACAD SCI USA, V109, P9851, DOI 10.1073/pnas.1207382109; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Meszaros B, 2021, SCI SIGNAL, V14, DOI 10.1126/scisignal.abd0334; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Mosca R, 2014, NUCLEIC ACIDS RES, V42, pD374, DOI 10.1093/nar/gkt887; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Perrin-Cocon L, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02480-z; REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rojas M, 2018, J AUTOIMMUN, V95, P100, DOI 10.1016/j.jaut.2018.10.012; Sadegh S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17189-2; Sanchez EL, 2015, VIROLOGY, V479, P609, DOI 10.1016/j.virol.2015.02.038; Sarhan MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02648-6; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Sette A, 2020, NAT REV IMMUNOL, V20, P457, DOI 10.1038/s41577-020-0389-z; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen LW, 2017, BIOCHIMIE, V142, P1, DOI 10.1016/j.biochi.2017.07.016; Steininger C, 2004, J INFECT DIS, V189, P984, DOI 10.1086/382192; Tai WB, 2020, ANTIVIR RES, V179, DOI 10.1016/j.antiviral.2020.104820; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; Vidalain PO, 2015, METHODS MOL BIOL, V1282, P213, DOI 10.1007/978-1-4939-2438-7_18; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wei CH, 2013, NUCLEIC ACIDS RES, V41, pW518, DOI 10.1093/nar/gkt441; Yan T, 2005, NUCLEIC ACIDS RES, V33, pW262, DOI 10.1093/nar/gki368; Yang CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038637; Yi ZG, 2020, EMERG MICROBES INFEC, V9, P1988, DOI 10.1080/22221751.2020.1815591; Yoshimoto FK, 2020, PROTEIN J, V39, P198, DOI 10.1007/s10930-020-09901-4; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang AD, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1500-8; Zhou YD, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0153-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	57	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246901	10.1371/journal.pone.0246901	http://dx.doi.org/10.1371/journal.pone.0246901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596252	Green Published, gold			2022-12-26	WOS:000620633200013
J	Sun, ZY; Nyberg, R; Wu, YP; Bernard, B; Redmond, WL				Sun, Zhaoyu; Nyberg, Richard; Wu, Yaping; Bernard, Brady; Redmond, William L.			Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers	PLOS ONE			English	Article								The TSA Opal multiplex immunohistochemistry (mIHC) protocol (PerkinElmer) has been used to characterize immune infiltration in human cancers. This technique allows multiple biomarkers to be simultaneously stained in a single tissue section, which helps to elucidate the spatial relationship among individual cell types. We developed and optimized two improved mIHC protocols for a 7-color panel containing 6 biomarkers (CD3, CD8, CD163, PD-L1, FoxP3, and cytokeratin (CK)) and DAPI. The only difference between these two protocols was the staining sequence of those 6 biomarkers as the first sequence is PD-L1/CD163/CD8/CK/CD3/FoxP3/DAPI and the second sequence is FoxP3/CD163/CD8/CK/CD3/PD-L1/DAPI. By comparing PD-L1/FoxP3 staining in mIHC and singleplex PD-L1/FoxP3 staining on the adjacent slide, we demonstrated that the staining sequence does not affect the staining intensity of individual biomarkers as long as a proper antigen retrieval method was used. Our study suggests that use of an antigen retrieval buffer with higher pH value (such as Tris-EDTA pH9.0) than that of the stripping buffers (such as citrate buffer pH6.0) is helpful when using this advanced mIHC method to develop panels with multiple biomarkers. Otherwise, individual biomarkers may exhibit different intensities when the staining sequence is changed. By using this protocol, we characterized immune infiltration and PD-L1 expression in head and neck squamous cell carcinoma (HNSCC), breast cancer (BCa), and non-small cell lung cancer (NSCLC) specimens. We observed a statistically significant increase in CD3(+) cell populations within the stroma of NSCLC as compared to BCa and increased PD-L1(+) tumor cells in HNSCC as opposed to BCa.	[Sun, Zhaoyu; Nyberg, Richard; Bernard, Brady; Redmond, William L.] Providence Canc Inst, Earle A Chiles Res Inst, Portland, OR 97213 USA; [Wu, Yaping] Providence Hlth & Serv, Dept Pathol, Portland, OR USA		Redmond, WL (corresponding author), Providence Canc Inst, Earle A Chiles Res Inst, Portland, OR 97213 USA.	william.redmond@providence.org		Redmond, William/0000-0002-2572-1731	GlaxoSmithKline; Providence Portland Medical Foundation	GlaxoSmithKline(GlaxoSmithKline); Providence Portland Medical Foundation	This work was supported by a research grant from GlaxoSmithKline and the Providence Portland Medical Foundation (to WR). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.985930; Anyaegbu CC, 2019, J IMMUNOL METHODS, V472, P25, DOI 10.1016/j.jim.2019.06.011; Balaton AJ, 1996, ANN PATHOL, V16, P144; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; BOBROW MN, 1992, J IMMUNOL METHODS, V150, P145, DOI 10.1016/0022-1759(92)90073-3; Bogen SA, 2010, ANTIGEN RETRIEVAL IM, P287; Campbell JP, 2008, BRAIN BEHAV IMMUN, V22, P375, DOI 10.1016/j.bbi.2007.09.001; EVERS P, 1994, J NEUROSCI METH, V55, P163, DOI 10.1016/0165-0270(94)90208-9; Feng ZP, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93652; Feng ZP, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0091-z; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Gorris MAJ, 2018, J IMMUNOL, V200, P347, DOI 10.4049/jimmunol.1701262; Guo LT, 2017, J CANCER, V8, P410, DOI 10.7150/jca.17144; He JB, 2015, SCI REP-UK, V5, DOI 10.1038/srep13110; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mason JT, 2010, ANTIGEN RETRIEVAL IM, P253; Parra ER, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0368-0; Parra ER, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13942-8; Pirici D, 2009, J HISTOCHEM CYTOCHEM, V57, P567, DOI 10.1369/jhc.2009.953240; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Sanchez K, 2021, BREAST CANCER RES, V23, DOI 10.1186/s13058-020-01378-4; Shi Shan-Rong, 1998, Auris Nasus Larynx, V25, P425, DOI 10.1016/S0385-8146(98)00042-X; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; SHI SR, 1995, J HISTOCHEM CYTOCHEM, V43, P193, DOI 10.1177/43.2.7822775; Shi SR, 1997, J HISTOCHEM CYTOCHEM, V45, P327, DOI 10.1177/002215549704500301; Simpson RJ, 2007, J APPL PHYSIOL, V103, P396, DOI 10.1152/japplphysiol.00007.2007; Sorrelle N, 2019, J IMMUNOL, V202, P292, DOI 10.4049/jimmunol.1800878; Stack EC, 2014, METHODS, V70, P46, DOI 10.1016/j.ymeth.2014.08.016; Taube JM, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000155; Taylor CR, 1996, BIOTECH HISTOCHEM, V71, P263, DOI 10.3109/10520299609117171; Toth ZE, 2007, J HISTOCHEM CYTOCHEM, V55, P545, DOI 10.1369/jhc.6A7134.2007; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Zavala VA, 2015, IMMUNOLOGY, V145, P182, DOI 10.1111/imm.12459	34	9	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247238	10.1371/journal.pone.0247238	http://dx.doi.org/10.1371/journal.pone.0247238			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596250	gold, Green Published			2022-12-26	WOS:000620633200011
J	Roldan, CA; Sibbitt, WL; Greene, ER; Qualls, CR; Jung, RE				Roldan, Carlos A.; Sibbitt, Wilmer L., Jr.; Greene, Ernest R.; Qualls, Clifford R.; Jung, Rex E.			Libman-Sacks endocarditis and associated cerebrovascular disease: The role of medical therapy	PLOS ONE			English	Article								Background Libman-Sacks endocarditis in patients with systemic lupus erythematosus (SLE) is commonly complicated with embolic cerebrovascular disease (CVD) or valve dysfunction for which high-risk valve surgery is frequently performed. However, the role of medical therapy alone for Libman-Sacks endocarditis and associated acute CVD remains undefined. Objective To determine in this cross-sectional and longitudinal study if conventional anti-inflammatory and anti-thrombotic therapy may be an effective therapy in SLE patients with Libman-Sacks endocarditis and associated acute CVD. Methods and materials 17 SLE patients with Libman-Sacks endocarditis detected by two-and-three-dimensional transesophageal echocardiography (TEE) and complicated with acute CVD [stroke/TIA, focal brain injury on MRI, or cognitive dysfunction] were treated with conventional anti-inflammatory and anti-thrombotic therapy for a median of 6 months and then underwent repeat TEE, transcranial Doppler, brain MRI, and neurocognitive testing for re-assessment of Libman-Sacks endocarditis and CVD. Results Valve vegetations decreased in number, diameter, and area (all p <= 0.01); associated valve regurgitation significantly improved (p = 0.04), and valve thickening did not progress (p = 0.56). In 13 (76%) patients, valve vegetations or valve regurgitation resolved or improved in number and size or by >= 1 degree, respectively, as compared to 4 (24%) patients in whom vegetations or valve regurgitation persisted unchanged or increased in size or by >= 1 degree (p = 0.03). Also, cerebromicroembolism, lobar and global gray and white matter cerebral perfusion, ischemic brain lesion load, and neurocognitive dysfunction resolved or significantly improved (all p <= 0.04). Conclusion These preliminary data suggest that combined conventional anti-inflammatory and antithrombotic therapy may be an effective treatment for Libman-Sacks endocarditis and its associated CVD and may obviate the need for high-risk valve surgery.	[Roldan, Carlos A.; Sibbitt, Wilmer L., Jr.; Greene, Ernest R.; Qualls, Clifford R.] Univ New Mexico, Sch Med, Dept Med, Div Cardiol, Albuquerque, NM 87131 USA; [Roldan, Carlos A.; Sibbitt, Wilmer L., Jr.; Greene, Ernest R.; Qualls, Clifford R.] Univ New Mexico, Sch Med, Dept Med, Div Rheumatol, Albuquerque, NM 87131 USA; [Jung, Rex E.] Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico	Roldan, CA (corresponding author), Univ New Mexico, Sch Med, Dept Med, Div Cardiol, Albuquerque, NM 87131 USA.; Roldan, CA (corresponding author), Univ New Mexico, Sch Med, Dept Med, Div Rheumatol, Albuquerque, NM 87131 USA.	croldan@salud.unm.edu		Jung, Rex/0000-0003-3718-0597	National Institutes of Health/National Heart Lung and Blood Institute [RO1-HL04722-01-A6]	National Institutes of Health/National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by the grant RO1-HL04722-01-A6 by the National Institutes of Health/National Heart Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertsias GK, 2012, ANN RHEUM DIS, V71, P1771, DOI 10.1136/annrheumdis-2012-201940; Bouma W, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-13; Chang YS, 2017, LUPUS, V26, P1149, DOI 10.1177/0961203317694260; Choi Y, 2010, J NEUROIMAGING, V20, P359, DOI 10.1111/j.1552-6569.2009.00446.x; Colli A, 2010, EUR J CARDIO-THORAC, V37, P154, DOI 10.1016/j.ejcts.2009.06.046; Crowther MA, 2003, NEW ENGL J MED, V349, P1133, DOI 10.1056/NEJMoa035241; Espinola RG, 2002, THROMB HAEMOSTASIS, V87, P518; Fanouriakis A, 2019, ANN RHEUM DIS, V78, P736, DOI 10.1136/annrheumdis-2019-215089; Finazzi G, 2005, J THROMB HAEMOST, V3, P848, DOI 10.1111/j.1538-7836.2005.01340.x; Foroughi Mahnoosh, 2014, ScientificWorldJournal, V2014, P216291, DOI 10.1155/2014/216291; Gasparovic CM, 2010, J RHEUMATOL, V37, P1834, DOI 10.3899/jrheum.091276; Gordon R J, 1996, J Am Soc Echocardiogr, V9, P104, DOI 10.1016/S0894-7317(96)90112-1; Hojnik M, 1996, CIRCULATION, V93, P1579, DOI 10.1161/01.CIR.93.8.1579; Ishizu K, 2019, EUR HEART J-CASE REP, V3, DOI 10.1093/ehjcr/ytz133; KHAMASHTA MA, 1995, NEW ENGL J MED, V332, P993, DOI 10.1056/NEJM199504133321504; Kozora E, 2004, ARTHRIT RHEUM-ARTHR, V51, P810, DOI 10.1002/art.20692; Morisaki A, 2012, GEN THORAC CARDIOVAS, V60, P822, DOI 10.1007/s11748-012-0091-6; Munoz-Rodriguez FJ, 1999, SEMIN ARTHRITIS RHEU, V29, P182, DOI 10.1016/S0049-0172(99)80029-8; Ohnishi N, 2019, RHEUMATOLOGY, V58, P969, DOI 10.1093/rheumatology/key340; Omarjee L, 2018, CIRC J, V82, P2380, DOI 10.1253/circj.CJ-17-1131; Pamfil C, 2015, RHEUMATOLOGY, V54, P1270, DOI 10.1093/rheumatology/keu482; Rand JH, 2010, BLOOD, V115, P2292, DOI 10.1182/blood-2009-04-213520; ROLDAN CA, 1992, J AM COLL CARDIOL, V20, P1127, DOI 10.1016/0735-1097(92)90368-W; Roldan CA, 1996, NEW ENGL J MED, V335, P1424, DOI 10.1056/NEJM199611073351903; Roldan CA, 2005, AM J CARDIOL, V95, P1441, DOI 10.1016/j.amjcard.2005.02.010; Roldan CA, 2015, J AM SOC ECHOCARDIOG, V28, P770, DOI 10.1016/j.echo.2015.02.011; Roldan CA, 2013, JACC-CARDIOVASC IMAG, V6, P973, DOI 10.1016/j.jcmg.2013.04.012; Romero-Diaz J, 2011, ARTHRIT CARE RES, V63, pS37, DOI 10.1002/acr.20572; Ruiz-Irastorza G, 2006, LUPUS, V15, P577, DOI 10.1177/0961203306071872; Ruiz-Irastorza G, 2007, ARTHRIT RHEUM-ARTHR, V57, P1487, DOI 10.1002/art.23109; Schaefer C, 2006, THROMB HAEMOSTASIS, V95, P949, DOI 10.1160/TH06-02-0108; Scully M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00027; SHAPIRO RF, 1977, ANN RHEUM DIS, V36, P508, DOI 10.1136/ard.36.6.508; Sonsoz MR, 2019, TURK KARDIYOL DERN A, V47, P687, DOI 10.5543/tkda.2019.29213; Tejeda-Maldonado J, 2018, REUMATOL CLIN, V14, P269, DOI 10.1016/j.reuma.2017.01.012; Tektonidou MG, 2019, ANN RHEUM DIS, V78, P1296, DOI 10.1136/annrheumdis-2019-215213; Wallace DJ, 2012, NAT REV RHEUMATOL, V8, P522, DOI 10.1038/nrrheum.2012.106; Wartak S, 2016, CASE REP CARDIOL, V2016, DOI 10.1155/2016/3250845; Ziporen L, 1996, LUPUS, V5, P196, DOI 10.1177/096120339600500306; Zoghbi WA, 2017, J AM SOC ECHOCARDIOG, V30, P303, DOI 10.1016/j.echo.2017.01.007	40	4	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247052	10.1371/journal.pone.0247052	http://dx.doi.org/10.1371/journal.pone.0247052			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592060	gold, Green Published			2022-12-26	WOS:000620632800047
J	Roon, DA; Dunham, JB; Groom, JD				Roon, David A.; Dunham, Jason B.; Groom, Jeremiah D.			Shade, light, and stream temperature responses to riparian thinning in second-growth redwood forests of northern California	PLOS ONE			English	Article							PACIFIC-NORTHWEST; THERMAL REGIMES; HEADWATER FORESTS; WESTERN OREGON; MANAGEMENT; HARVEST; RESTORATION; DISTURBANCE; BUFFERS; MICROCLIMATE	Resource managers in the Pacific Northwest (USA) actively thin second-growth forests to accelerate the development of late-successional conditions and seek to expand these restoration thinning treatments into riparian zones. Riparian forest thinning, however, may impact stream temperatures-a key water quality parameter often regulated to protect stream habitat and aquatic organisms. To better understand the effects of riparian thinning on shade, light, and stream temperature, we employed a manipulative field experiment following a replicated Before-After-Control-Impact (BACI) design in three watersheds in the redwood forests of northern California, USA. Thinning treatments were intended to reduce canopy closure or basal area within the riparian zone by up to 50% on both sides of the stream channel along a 100-200 m stream reach. We found that responses to thinning ranged widely depending on the intensity of thinning treatments. In the watersheds with more intensive treatments, thinning reduced shade, increased light, and altered stream thermal regimes in thinned and downstream reaches. Thinning shifted thermal regimes by increasing maximum temperatures, thermal variability, and the frequency and duration of elevated temperatures. These thermal responses occurred primarily during summer but also extended into spring and fall. Longitudinal profiles indicated that increases in temperature associated with thinning frequently persisted downstream, but downstream effects depended on the magnitude of upstream temperature increases. Model selection analyses indicated that local changes in shade as well as upstream thermal conditions and proximity to upstream treatments explained variation in stream temperature responses to thinning. In contrast, in the study watershed with less intensive thinning, smaller changes in shade and light resulted in minimal stream temperature responses. Collectively, our data shed new light on the stream thermal responses to riparian thinning. These results provide relevant information for managers considering thinning as a viable restoration strategy for second-growth riparian forests.	[Roon, David A.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Dunham, Jason B.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA; [Groom, Jeremiah D.] Groom Analyt LLC, Corvallis, OR USA	Oregon State University; United States Department of the Interior; United States Geological Survey	Roon, DA (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA.	david.roon@oregonstate.edu		Roon, David/0000-0002-3284-5791				Anderson PD, 2007, FOREST SCI, V53, P254; Arismendi I, 2019, SCI TOTAL ENVIRON, V651, P736, DOI 10.1016/j.scitotenv.2018.09.208; Arismendi I, 2013, HYDROBIOLOGIA, V712, P61, DOI 10.1007/s10750-012-1327-2; Arismendi I, 2013, FRESHWATER BIOL, V58, P880, DOI 10.1111/fwb.12094; Benda LE, 2016, J FORESTRY RES, V27, P821, DOI 10.1007/s11676-015-0173-2; Benjamin JR, 2016, T AM FISH SOC, V145, P1318, DOI 10.1080/00028487.2016.1219677; BERG DR, 1995, ECOL APPL, V5, P87, DOI 10.2307/1942054; Bladon KD, 2016, FOREST ECOL MANAG, V379, P153, DOI 10.1016/j.foreco.2016.08.021; Boisjolie BA, 2019, ECOL SOC, V24, DOI 10.5751/ES-10676-240122; Broadmeadow S, 2004, HYDROL EARTH SYST SC, V8, P286, DOI 10.5194/hess-8-286-2004; BROWN GW, 1970, WATER RESOUR RES, V6, P1133, DOI 10.1029/WR006i004p01133; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bury RB, 2008, APPL HERPETOL, V5, P63, DOI 10.1163/157075408783489211; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; California Department of Fish and Wildlife, 2020, CALIFORNIA STREAMS S; California Department of Water Resources, 2020, WATERSHED BOUNDARIES; Canty A., 2020, BOOT BOOTSTRAP FUNCT; Carey AB, 2003, FORESTRY, V76, P221, DOI 10.1093/forestry/76.2.221; Davis LJ, 2016, HYDROL PROCESS, V30, P959, DOI 10.1002/hyp.10641; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; DebRoy S, 2020, R package version 3.1-148; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Gomi T, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004162; Green Diamond Resource Company, 2006, AQUATIC HABITAT CONS, V1; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Groom JD, 2017, J AM WATER RESOUR AS, V53, P761, DOI 10.1111/1752-1688.12529; Groom JD, 2011, FOREST ECOL MANAG, V262, P1618, DOI 10.1016/j.foreco.2011.07.012; Heck MP., 2018, US GEOLOGICAL SURVEY; Huff DD, 2005, N AM J FISH MANAGE, V25, P346, DOI 10.1577/M03-231.1; Isaak DJ., 2020, J AM WATER RESOUR AS, P1; Janisch JE, 2012, FOREST ECOL MANAG, V270, P302, DOI 10.1016/j.foreco.2011.12.035; Johnson SL, 2000, CAN J FISH AQUAT SCI, V57, P30, DOI 10.1139/cjfas-57-S2-30; Johnson SL, 2004, CAN J FISH AQUAT SCI, V61, P913, DOI [10.1139/f04-040, 10.1139/F04-040]; Keyes CR, 2014, FORESTS, V5, P256, DOI 10.3390/f5020256; Koontz ED, 2018, FRESHW SCI, V37, P731, DOI 10.1086/700403; Kreutzweiser DP, 2009, CAN J FOREST RES, V39, P497, DOI 10.1139/X08-191; Leach JA, 2017, AQUAT SCI, V79, P291, DOI 10.1007/s00027-016-0497-9; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Martens KD, 2019, ENVIRON MANAGE, V63, P673, DOI 10.1007/s00267-019-01146-x; Mazerolle MJ, 2020, AICcmodavg: model selection and multimodel inference based on (Q)AIC(c); McIntyre AP, 2018, COOPERATIVE MONITORI; McIntyre PJ, 2015, P NATL ACAD SCI USA, V112, P1458, DOI 10.1073/pnas.1410186112; Moore RD, 2005, J AM WATER RESOUR AS, V41, P813, DOI 10.1111/j.1752-1688.2005.tb04465.x; Naiman R.J., 2010, RIPARIA ECOLOGY CONS; O'Hara KL, 2010, RESTOR ECOL, V18, P125, DOI 10.1111/j.1526-100X.2010.00655.x; Oksanen J., 2019, R PACKAGE VERSION; Olson DH, 2007, FOREST ECOL MANAG, V246, P81, DOI 10.1016/j.foreco.2007.03.053; Pan Y, 2011, BIOGEOSCIENCES, V8, P715, DOI 10.5194/bg-8-715-2011; Pollock MM, 2014, J AM WATER RESOUR AS, V50, P543, DOI 10.1111/jawr.12206; Poole GC, 2004, BIOSCIENCE, V54, P155, DOI 10.1641/0006-3568(2004)054[0155:TCFRWQ]2.0.CO;2; R Core Team, 2020, R LANG ENV STAT COMP; Redwood National Park, 2014, REDWOOD NATL PARK MI; Reeves GH, 2016, GEN TECHNICAL REPORT; Reid L.M., 1998, RIVER ECOLOGY MANAGE, P476; Rex JF, 2012, FOREST ECOL MANAG, V269, P259, DOI 10.1016/j.foreco.2011.12.023; Richardson JS, 2012, FRESHW SCI, V31, P232, DOI 10.1899/11-031.1; Ringold PL, 2003, J AM WATER RESOUR AS, V39, P1373, DOI 10.1111/j.1752-1688.2003.tb04424.x; Russell W, 2009, FOREST ECOL MANAG, V257, P1427, DOI 10.1016/j.foreco.2008.12.014; Sibley PK, 2012, FRESHW SCI, V31, P258, DOI 10.1899/11-094.1; Stankey GH, 2003, J FOREST, V101, P40; Steel EA, 2017, BIOSCIENCE, V67, P506, DOI 10.1093/biosci/bix047; Steel EA, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00255.1; Studinski JM, 2012, HYDROBIOLOGIA, V686, P107, DOI 10.1007/s10750-012-1002-7; Teraoka JR, 2011, WEST J APPL FOR, V26, P91, DOI 10.1093/wjaf/26.2.91; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; WARD JV, 1989, J N AM BENTHOL SOC, V8, P2, DOI 10.2307/1467397; Warren DR, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1435; Wei T., CORRPLOT VISUALIZATI; Welsh Hartwell H. Jr, 2000, P165; Wilzbach MA, 2005, CAN J FISH AQUAT SCI, V62, P58, DOI 10.1139/F04-177; Zuur Alain F., 2009, P1	71	9	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246822	10.1371/journal.pone.0246822	http://dx.doi.org/10.1371/journal.pone.0246822			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592001	Green Published, gold			2022-12-26	WOS:000620632800013
J	Cai, LH; Wu, HL; Zhou, K; Le, KNQ				Cai, Lihua; Wu, Honglong; Zhou, Ke; Le, Khanh N. Q.			Improved cancer biomarkers identification using network-constrained infinite latent feature selection	PLOS ONE			English	Article							VARIABLE SELECTION; GENE; MUTATIONS; REGULARIZATION; INFORMATION; REGRESSION; PROTEIN	Identifying biomarkers that are associated with different types of cancer is an important goal in the field of bioinformatics. Different researcher groups have analyzed the expression profiles of many genes and found some certain genetic patterns that can promote the improvement of targeted therapies, but the significance of some genes is still ambiguous. More reliable and effective biomarkers identification methods are then needed to detect candidate cancer-related genes. In this paper, we proposed a novel method that combines the infinite latent feature selection (ILFS) method with the functional interaction (FIs) network to rank the biomarkers. We applied the proposed method to the expression data of five cancer types. The experiments indicated that our network-constrained ILFS (NCILFS) provides an improved prediction of the diagnosis of the samples and locates many more known oncogenes than the original ILFS and some other existing methods. We also performed functional enrichment analysis by inspecting the over-represented gene ontology (GO) biological process (BP) terms and applying the gene set enrichment analysis (GSEA) method on selected biomarkers for each feature selection method. The enrichments analysis reports show that our network-constraint ILFS can produce more biologically significant gene sets than other methods. The results suggest that network-constrained ILFS can identify cancer-related genes with a higher discriminative power and biological significance.	[Cai, Lihua; Wu, Honglong; Zhou, Ke] Huazhong Univ Sci & Technol, Sch Comp Sci & Technol, Wuhan Natl Lab Optoelect, Wuhan, Hubei, Peoples R China; [Cai, Lihua] Guangdong Ocean Univ, Sch Math & Comp Sci, Zhanjiang, Guangdong, Peoples R China; [Wu, Honglong] BG Shenzhen, Shenzhen Genom Inst, Shenzhen, Peoples R China; [Le, Khanh N. Q.] Taipei Med Univ, Taipei, Taiwan	Huazhong University of Science & Technology; Guangdong Ocean University; Taipei Medical University	Zhou, K (corresponding author), Huazhong Univ Sci & Technol, Sch Comp Sci & Technol, Wuhan Natl Lab Optoelect, Wuhan, Hubei, Peoples R China.	zhke@hust.edu.cn		Cai, Lihua/0000-0002-2916-2025				Barter RL, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S5; Blijlevens M, 2019, ONCOGENE, V38, P4142, DOI 10.1038/s41388-019-0711-z; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; del Rio-Moreno M, 2019, J CLIN ENDOCR METAB, V104, P3389, DOI 10.1210/jc.2019-00021; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Fan YY, 2013, J R STAT SOC B, V75, P531, DOI 10.1111/rssb.12001; Filhol O, 2015, CELL MOL LIFE SCI, V72, P3305, DOI 10.1007/s00018-015-1929-8; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; He HB, 2008, IEEE IJCNN, P1322, DOI 10.1109/IJCNN.2008.4633969; Helsten T, 2016, CLIN CANCER RES, V22, P259, DOI 10.1158/1078-0432.CCR-14-3212; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kim JM, 2018, MOL MED REP, V17, P8397, DOI 10.3892/mmr.2018.8885; Kim M, 2018, GENES-BASEL, V9, DOI 10.3390/genes9100478; Kolluru V, 2019, TOXICOL APPL PHARM, V373, P62, DOI 10.1016/j.taap.2019.04.012; Kononenko I, 1997, APPL INTELL, V7, P39, DOI 10.1023/A:1008280620621; Lee JJ, 2018, HEPATOMA RES, V4, P52, DOI [10.20517/2394-5079.2018.42, DOI 10.20517/2394-5079.2018.42]; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lin E, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00290; Matsuda S, 2000, CANCER RES, V60, P13; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Rahman M, 2015, BIOINFORMATICS, V31, P3666, DOI 10.1093/bioinformatics/btv377; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Roffo G, 2017, IEEE I CONF COMP VIS, P1407, DOI 10.1109/ICCV.2017.156; Romanuik TL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-476; Roy J, 2014, BRIEF BIOINFORM, V15, P612, DOI 10.1093/bib/bbs083; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Singer EA, 2011, CURR OPIN ONCOL, V23, P283, DOI 10.1097/CCO.0b013e32834479c0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tran TN, 2014, CHEMOMETR INTELL LAB, V138, P153, DOI 10.1016/j.chemolab.2014.08.005; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wan SB, 2016, IEEE ACM T COMPUT BI, V13, P706, DOI 10.1109/TCBB.2015.2474407; Wan SB, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0940-x; Winter C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002511; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	43	1	1	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246668	10.1371/journal.pone.0246668	http://dx.doi.org/10.1371/journal.pone.0246668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571282	gold, Green Published			2022-12-26	WOS:000618274000019
J	Ilyaskin, AV; Korbmacher, C; Diakov, A				Ilyaskin, Alexandr, V; Korbmacher, Christoph; Diakov, Alexei			Inhibition of the epithelial sodium channel (ENaC) by connexin 30 involves stimulation of clathrin-mediated endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION HEMICHANNELS; ROMK POTASSIUM CHANNEL; PROTEIN-KINASE-C; NA+-CHANNEL; LIDDLE-SYNDROME; BETA-SUBUNIT; ELECTROPHYSIOLOGICAL CHARACTERIZATION; FEEDBACK INHIBITION; OPEN PROBABILITY; PLASMA-MEMBRANE	Mice lacking connexin 30 (Cx30) display increased epithelial sodium channel (ENaC) activity in the distal nephron and develop salt-sensitive hypertension. This indicates a functional link between Cx30 and ENaC, which remains incompletely understood. Here, we explore the effect of Cx30 on ENaC function using the Xenopus laevis oocyte expression system. Coexpression of human Cx30 with human alpha beta gamma ENaC significantly reduced ENaC-mediated whole-cell currents. The size of the inhibitory effect on ENaC depended on the expression level of Cx30 and required Cx30 ion channel activity. ENaC inhibition by Cx30 was mainly due to reduced cell surface ENaC expression resulting from enhanced ENaC retrieval without discernible effects on proteolytic channel activation and single-channel properties. ENaC retrieval from the cell surface involves the interaction of the ubiquitin ligase Nedd4-2 with PPPxY-motifs in the C-termini of ENaC. Truncating the C-termini of beta- or gamma ENaC significantly reduced the inhibitory effect of Cx30 on ENaC. In contrast, mutating the prolines belonging to the PPPxY-motif in gamma ENaC or coexpressing a dominant-negative Xenopus Nedd4 (xNedd4-CS) did not significantly alter ENaC inhibition by Cx30. Importantly, the inhibitory effect of Cx30 on ENaC was significantly reduced by Pitstop-2, an inhibitor of clathrin-mediated endocytosis, or by mutating putative clathrin adaptor protein 2 (AP-2) recognition motifs (Yxx Phi) in the C termini of beta- or gamma-ENaC. In conclusion, our findings suggest that Cx30 inhibits ENaC by promoting channel retrieval from the plasma membrane via clathrin-dependent endocytosis. Lack of this inhibition may contribute to increased ENaC activity and salt-sensitive hypertension in mice with Cx30 deficiency.	[Ilyaskin, Alexandr, V; Korbmacher, Christoph; Diakov, Alexei] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Zellulare & Mol Physiol, Erlangen, Germany	University of Erlangen Nuremberg	Korbmacher, C (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Zellulare & Mol Physiol, Erlangen, Germany.	christoph.korbmacher@fau.de		Ilyaskin, Alexandr V./0000-0002-2153-7849	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [387509280, SFB 1350]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), project number 387509280, SFB 1350 (subproject A4 to C. K.).	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Awayda MS, 2000, J GEN PHYSIOL, V115, P559, DOI 10.1085/jgp.115.5.559; Awayda MS, 1996, J GEN PHYSIOL, V108, P49, DOI 10.1085/jgp.108.1.49; Bahima L, 2006, J CELL PHYSIOL, V206, P95, DOI 10.1002/jcp.20440; Bao HF, 2014, AM J PHYSIOL-RENAL, V306, pF309, DOI 10.1152/ajprenal.00519.2013; Bhalla V, 2006, AM J PHYSIOL-RENAL, V291, pF714, DOI 10.1152/ajprenal.00061.2006; Bicego M, 2006, HUM MOL GENET, V15, P2569, DOI 10.1093/hmg/ddl184; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bugaj V, 2012, J BIOL CHEM, V287, P38552, DOI 10.1074/jbc.M112.408476; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; DURIEUX ME, 1994, FEBS LETT, V337, P235, DOI 10.1016/0014-5793(94)80198-3; Ebihara L, 1996, BIOPHYS J, V71, P742, DOI 10.1016/S0006-3495(96)79273-1; EBIHARA L, 1989, SCIENCE, V243, P1194, DOI 10.1126/science.2466337; Enkvetchakul D, 2003, J PHYSIOL-LONDON, V553, P95, DOI 10.1113/jphysiol.2003.047910; Eskandari S, 2002, J MEMBRANE BIOL, V185, P93, DOI 10.1007/s00232-001-0115-0; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Fiori MC, 2012, J BIOL CHEM, V287, P40826, DOI 10.1074/jbc.M112.383281; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Flores SY, 2005, J AM SOC NEPHROL, V16, P2279, DOI 10.1681/ASN.2004100828; Frindt G, 2020, AM J PHYSIOL-RENAL, V318, pF1113, DOI 10.1152/ajprenal.00609.2019; Frindt G, 2016, J GEN PHYSIOL, V147, P217, DOI 10.1085/jgp.201511533; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Gu YC, 2008, J EXP BIOL, V211, P3167, DOI 10.1242/jeb.019646; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Hanner F, 2010, AM J PHYSIOL-REG I, V298, pR1143, DOI 10.1152/ajpregu.00808.2009; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Ilyaskin AV, 2019, J GEN PHYSIOL, V151, P820, DOI 10.1085/jgp.201812291; Ilyaskin AV, 2016, J BIOL CHEM, V291, P19835, DOI 10.1074/jbc.M116.726471; Ishikawa T, 1998, J GEN PHYSIOL, V111, P825, DOI 10.1085/jgp.111.6.825; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kar R, 2012, ARCH BIOCHEM BIOPHYS, V524, P2, DOI 10.1016/j.abb.2012.03.008; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Klemens CA, 2017, J BIOL CHEM, V292, P375, DOI 10.1074/jbc.M116.753616; Kleyman TR, 2018, ANNU REV PHYSIOL, V80, P263, DOI 10.1146/annurev-physiol-021317-121143; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; KORBMACHER C, 1995, J MEMBRANE BIOL, V146, P29; Krueger B, 2018, PFLUG ARCH EUR J PHY, V470, P649, DOI 10.1007/s00424-018-2115-2; Kunzelmann K, 2004, FASEB J, V18, P142, DOI 10.1096/fj.04-2314fje; Kurtz A, 2012, BBA-BIOMEMBRANES, V1818, P1903, DOI 10.1016/j.bbamem.2011.05.023; Lefevre CMT, 2014, PFLUG ARCH EUR J PHY, V466, P253, DOI 10.1007/s00424-013-1310-4; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Loffing J, 2009, PFLUG ARCH EUR J PHY, V458, P111, DOI 10.1007/s00424-009-0656-0; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; McCulloch F, 2005, AM J PHYSIOL-RENAL, V289, pF1304, DOI 10.1152/ajprenal.00203.2005; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Michlig S, 2005, J BIOL CHEM, V280, P38264, DOI 10.1074/jbc.M506308200; Mironova E, 2011, J BIOL CHEM, V286, P1054, DOI 10.1074/jbc.M110.176552; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Nesterov V, 2016, HYPERTENSION, V67, P1256, DOI 10.1161/HYPERTENSIONAHA.115.07061; Nesterov V, 2012, AM J PHYSIOL-RENAL, V303, pF1289, DOI 10.1152/ajprenal.00247.2012; Nielsen BS, 2017, J BIOL CHEM, V292, P19999, DOI 10.1074/jbc.M117.805986; Noreng S, 2018, ELIFE, V7, DOI 10.7554/eLife.39340; OGrady SM, 1996, J BIOL CHEM, V271, P29080, DOI 10.1074/jbc.271.46.29080; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Oshima A, 2011, J MOL BIOL, V405, P724, DOI 10.1016/j.jmb.2010.10.032; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; PALMER LG, 1987, AM J PHYSIOL, V253, pF333, DOI 10.1152/ajprenal.1987.253.2.F333; Patel AB, 2014, CHANNELS, V8, P444, DOI 10.4161/19336950.2014.949190; Rauh R, 2006, PFLUG ARCH EUR J PHY, V452, P290, DOI 10.1007/s00424-005-0026-5; Rauh R, 2013, AM J PHYSIOL-LUNG C, V304, pL43, DOI 10.1152/ajplung.00093.2012; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; RIBERA AB, 1987, P NATL ACAD SCI USA, V84, P6577, DOI 10.1073/pnas.84.18.6577; Rossier BC, 2014, CURR OPIN PHARMACOL, V15, P33, DOI 10.1016/j.coph.2013.11.010; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Shi HK, 2002, EUR J BIOCHEM, V269, P4551, DOI 10.1046/j.1432-1033.2002.03154.x; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; SILVER RB, 1993, AM J PHYSIOL, V264, pF557, DOI 10.1152/ajprenal.1993.264.3.F557; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Staruschenko A, 2005, J BIOL CHEM, V280, P39161, DOI 10.1074/jbc.M509608200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Stoessel A, 2010, AM J PHYSIOL-RENAL, V298, pF216, DOI 10.1152/ajprenal.00295.2009; Svenningsen P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00292; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Valiunas V, 2000, PFLUG ARCH EUR J PHY, V440, P366, DOI 10.1007/s004240000294; Volk T, 2004, PFLUG ARCH EUR J PHY, V447, P884, DOI 10.1007/s00424-003-1193-x; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wagner C, 2009, PFLUG ARCH EUR J PHY, V459, P151, DOI 10.1007/s00424-009-0707-6; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Welling PA, 2009, AM J PHYSIOL-RENAL, V297, pF849, DOI 10.1152/ajprenal.00181.2009; White TW, 1998, NATURE, V394, P630, DOI 10.1038/29202; Wiemuth D, 2007, BIOCHEM J, V405, P147, DOI 10.1042/BJ20060747; Willebrords J, 2017, PHARMACOL THERAPEUT, V180, P144, DOI 10.1016/j.pharmthera.2017.07.001; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Wu P, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014996; YAMAZAKI J, 1995, JPN J PHARMACOL, V68, P25, DOI 10.1254/jjp.68.25; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001; Zhang Y, 1998, J PHYSIOL-LONDON, V508, P763, DOI 10.1111/j.1469-7793.1998.763bp.x; Zhou Y, 2012, P NATL ACAD SCI USA, V109, P11413, DOI 10.1073/pnas.1204444109	112	6	6	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100404	10.1016/j.jbc.2021.100404	http://dx.doi.org/10.1016/j.jbc.2021.100404			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33577799	Green Published, gold			2022-12-26	WOS:000672866400378
J	Liu, L; Lauro, BM; Wolfe, MS; Selkoe, DJ				Liu, Lei; Lauro, Bianca M.; Wolfe, Michael S.; Selkoe, Dennis J.			Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate gamma-secretase function in generating Alzheimer-causing A beta peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATORS; A-BETA-42; CLEAVAGE; MECHANISM	gamma-Secretase is responsible for the proteolysis of amyloid precursor protein (APP) into amyloid-beta (A beta) peptides, which are centrally implicated in the pathogenesis of Alzheimer's disease (AD). The biochemical mechanism of how processing by gamma-secretase is regulated, especially as regards the interaction between enzyme and substrate, remains largely unknown. Here, mutagenesis reveals that the hydrophilic loop-1 (HL-1) of presenilin-1 (PS1) is critical for both gamma-secretase step-wise cleavages (processivity) and its allosteric modulation by heterocyclic gamma-modulatory compounds. Systematic mutagenesis of HL-1, including all of its familial AD mutations and additional engineered variants, and quantification of the resultant A beta products show that HL-1 is necessary for proper sequential gamma-secretase processivity. We identify Y106, L113, and Y115 in HL-1 as key targets for heterocyclic gamma-secretase modulators (GSMs) to stimulate processing of pathogenic A beta peptides. Further, we confirm that the GxxxG domain in the APP transmembrane region functions as a critical substrate motif for gamma-secretase processivity: a G29A substitution in APP-C99 mimics the beneficial effects of GSMs. Together, these findings provide a molecular basis for the structural regulation of gamma-processivity by enzyme and substrate, facilitating the rational design of new GSMs that lower AD-initiating amyloidogenic A beta peptides.	[Liu, Lei; Lauro, Bianca M.; Selkoe, Dennis J.] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Wolfe, Michael S.] Univ Kansas, Dept Med Chem, Sch Pharm, Lawrence, KS 66045 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kansas	Selkoe, DJ (corresponding author), Harvard Med Sch, Ann Romney Ctr Neurol Dis, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA.	jselkoe@bwh.harvard.edu	Liu, Lei/R-7673-2017	Liu, Lei/0000-0002-4604-4629; Lauro, Bianca/0000-0003-2461-8481; Wolfe, Michael/0000-0002-5721-9092	NIH [R01 AG006173, P01 AG015379, R03 AG063046]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by NIH grants R01 AG006173 (D. J. S.), P01 AG015379 (M. S. W. and D. J. S.), and R03 AG063046 (L.L).	Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Bolduc DM, 2016, ELIFE, V5, DOI 10.7554/eLife.17578; Cai T, 2019, J NEUROSCI, V39, P8600, DOI 10.1523/JNEUROSCI.0838-19.2019; Cai T, 2017, J NEUROSCI, V37, P12272, DOI 10.1523/JNEUROSCI.1628-17.2017; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Crump CJ, 2013, BIOCHEMISTRY-US, V52, P3197, DOI 10.1021/bi400377p; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Higashide H, 2017, J NEUROCHEM, V140, P955, DOI 10.1111/jnc.13942; Imai S, 2019, J BIOCHEM, V165, P37, DOI 10.1093/jb/mvy081; Johnson DS, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024067; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kretner B, 2013, J NEUROCHEM, V125, P144, DOI 10.1111/jnc.12124; Kretner B, 2011, J BIOL CHEM, V286, P15240, DOI 10.1074/jbc.M110.213587; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Liu L, 2019, J CELL BIOL, V218, P644, DOI 10.1083/jcb.201806205; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Moore BD, 2018, J EXP MED, V215, P283, DOI 10.1084/jem.20170600; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Selkoe D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011460; Struyfs H, 2015, J ALZHEIMERS DIS, V45, P813, DOI 10.3233/JAD-141986; Sun JC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07971-8; Sun LF, 2017, P NATL ACAD SCI USA, V114, pE476, DOI 10.1073/pnas.1618657114; Taghian T, 2020, MOL THER, V28, P411, DOI 10.1016/j.ymthe.2019.11.012; Takagi-Niidome S, 2015, J NEUROSCI, V35, P2646, DOI 10.1523/JNEUROSCI.3164-14.2015; Takeo K, 2014, P NATL ACAD SCI USA, V111, P10544, DOI 10.1073/pnas.1402171111; Tominaga A, 2016, J NEUROSCI, V36, P1362, DOI 10.1523/JNEUROSCI.5090-14.2016; Wagner SL, 2014, BIOCHEMISTRY-US, V53, P702, DOI 10.1021/bi401537v; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Yang GH, 2021, CELL, V184, P521, DOI 10.1016/j.cell.2020.11.049; Zhou R, 2019, SCIENCE, V363, P708, DOI 10.1126/science.aaw0930	35	13	13	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100393	10.1016/j.jbc.2021.100393	http://dx.doi.org/10.1016/j.jbc.2021.100393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33571524	Green Published, gold			2022-12-26	WOS:000672866400367
J	Moseler, A; Dhalleine, T; Rouhier, N; Couturier, J				Moseler, Anna; Dhalleine, Tiphaine; Rouhier, Nicolas; Couturier, Jeremy			Arabidopsis thaliana 3-mercaptopyruvate sulfurtransferases interact with and are protected by reducing systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE; SULFANE SULFUR; L-CYSTEINE; H2S; THIOREDOXIN; ACID; ENCEPHALOPATHY; BIOSYNTHESIS; LOCALIZATION; FLUORESCENCE	The formation of a persulfide group (-SSH) on cysteine residues has gained attention as a reversible posttranslational modification contributing to protein regulation or protection. The widely distributed 3-mercaptopyruvate sulfurtransferases (MSTs) are implicated in the generation of persulfidated molecules and H2S biogenesis through transfer of a sulfane sulfur atom from a suitable donor to an acceptor. Arabidopsis has two MSTs, named STR1 and STR2, but they are poorly characterized. To learn more about these enzymes, we conducted a series of biochemical experiments including a variety of possible reducing systems. Our kinetic studies, which used a combination of sulfur donors and acceptors revealed that both MSTs use 3-mercaptopyruvate efficiently as a sulfur donor while thioredoxins, glutathione, and glutaredoxins all served as high-affinity sulfane sulfur acceptors. Using the redox-sensitive GFP (roGFP2) as a model acceptor protein, we showed that the persulfide-forming MSTs catalyze roGFP2 oxidation and more generally trans-persulfidation reactions. However, a preferential interaction with the thioredoxin system and glutathione was observed in case of competition between these sulfur acceptors. Moreover, we observed that MSTs are sensitive to overoxidation but are protected from an irreversible inactivation by their persulfide intermediate and subsequent reactivation by thioredoxins or glutathione. This work provides significant insights into Arabidopsis STR1 and STR2 catalytic properties and more specifically emphasizes the interaction with cellular reducing systems for the generation of H2S and glutathione persulfide and reactivation of an oxidatively modified form.	[Moseler, Anna; Dhalleine, Tiphaine; Rouhier, Nicolas; Couturier, Jeremy] Univ Lorraine, INRAE, IAM, Nancy, France	INRAE; Universite de Lorraine	Couturier, J (corresponding author), Univ Lorraine, INRAE, IAM, Nancy, France.	jeremy.couturier@univ-lorraine.fr		Couturier, Jeremy/0000-0003-3127-2669; Rouhier, Nicolas/0000-0002-2036-7884; Moseler, Anna/0000-0003-4641-8093	French National Research Agency as part of the "Investissements d'Avenir" program (Lab of Excellence ARBRE) [ANR-11-LABX-0002-01]; SULPAR GrandEst region contract [17_GE2_016]; Alexander von Humboldt Foundation;  [ANR-16-CE20-0012]	French National Research Agency as part of the "Investissements d'Avenir" program (Lab of Excellence ARBRE)(French National Research Agency (ANR)); SULPAR GrandEst region contract; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); 	The salary of A. M. was funded by grants of the French National Research Agency as part of the "Investissements d'Avenir" program (ANR-11-LABX-0002-01, Lab of Excellence ARBRE) and of the SULPAR (17_GE2_016) GrandEst region contract. A.M. is also recipient of a Feodor Lynen Research Fellowship from the Alexander von Humboldt Foundation. This work on plant sulfurtransferases was supported by grant of the ANR-16-CE20-0012 contract.	Akaike T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01311-y; Aller I, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00506; Alvarez C, 2012, PLANT CELL, V24, P4621, DOI 10.1105/tpc.112.105403; Alvarez C, 2010, PLANT PHYSIOL, V152, P656, DOI 10.1104/pp.109.147975; Aroca A, 2017, J EXP BOT, V68, P4915, DOI 10.1093/jxb/erx294; Aroca A, 2015, PLANT PHYSIOL, V168, P334, DOI 10.1104/pp.15.00009; Bailey TS, 2015, FREE RADICAL BIO MED, V89, P662, DOI 10.1016/j.freeradbiomed.2015.08.017; Bauer M, 2004, PLANT PHYSIOL, V135, P916, DOI 10.1104/pp.104.040121; Behm M, 2000, PLANT PHYSIOL BIOCH, V38, P363, DOI 10.1016/S0981-9428(00)00760-9; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Burow M, 2002, BIOL CHEM, V383, P1363, DOI 10.1515/BC.2002.155; Chen J, 2011, J EXP BOT, V62, P4481, DOI 10.1093/jxb/err145; Colnaghi R, 2001, FEBS LETT, V500, P153, DOI 10.1016/S0014-5793(01)02610-2; Coughlin CR, 2015, J MED GENET, V52, P532, DOI 10.1136/jmedgenet-2015-103049; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00518; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00105; Couturier J, 2009, CELL MOL LIFE SCI, V66, P2539, DOI 10.1007/s00018-009-0054-y; Doka E, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax8358; Doka E, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500968; Ezerina D, 2018, CELL CHEM BIOL, V25, P447, DOI 10.1016/j.chembiol.2018.01.011; Filipovic MR, 2018, CHEM REV, V118, P377, DOI 10.1021/acs.chemrev.7b00205; Frasdorf B, 2014, J BIOL CHEM, V289, P34543, DOI 10.1074/jbc.M114.605733; Francoleon NE, 2011, ARCH BIOCHEM BIOPHYS, V516, P146, DOI 10.1016/j.abb.2011.09.015; Fricker MD, 2000, J MICROSC-OXFORD, V198, P162, DOI 10.1046/j.1365-2818.2000.00696.x; Fujii S, 2019, BRIT J PHARMACOL, V176, P607, DOI 10.1111/bph.14356; Gotor C, 2019, J EXP BOT, V70, P4251, DOI 10.1093/jxb/erz225; Hanaoka K, 2017, SCI REP-UK, V7, DOI 10.1038/srep40227; Hartle MD, 2016, CHEM SOC REV, V45, P6108, DOI 10.1039/c6cs00212a; Henne M, 2015, FEBS OPEN BIO, V5, P832, DOI 10.1016/j.fob.2015.10.001; Hofler S, 2016, PHYSIOL PLANTARUM, V157, P352, DOI 10.1111/ppl.12454; Kimura Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11004-7; Kimura Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14774; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Krussel L, 2014, PLANT PHYSIOL, V165, P92, DOI 10.1104/pp.114.239764; Lec JC, 2018, ACS CATAL, V8, P2049, DOI 10.1021/acscatal.7b02432; Li K, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00298; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Longen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29808; Mao GH, 2011, J BIOL CHEM, V286, P7548, DOI 10.1074/jbc.M110.182865; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Mikami Y, 2011, BIOCHEM J, V439, P479, DOI 10.1042/BJ20110841; Millikin R, 2016, FREE RADICAL BIO MED, V97, P136, DOI 10.1016/j.freeradbiomed.2016.05.013; Moseler A, 2020, NEW PHYTOL, V226, P967, DOI 10.1111/nph.15870; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nagahara N, 1998, HISTOCHEM CELL BIOL, V110, P243, DOI 10.1007/s004180050286; Nakai Y, 2012, J BIOL CHEM, V287, P30874, DOI 10.1074/jbc.M112.350090; Nakamura T, 2000, EUR J BIOCHEM, V267, P5621, DOI 10.1046/j.1432-1327.2000.01633.x; Nietzel T, 2020, P NATL ACAD SCI USA, V117, P741, DOI 10.1073/pnas.1910501117; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Papenbrock J, 2000, EUR J BIOCHEM, V267, P145, DOI 10.1046/j.1432-1327.2000.00980.x; Papenbrock J, 2000, EUR J BIOCHEM, V267, P5571, DOI 10.1046/j.1432-1327.2000.01623.x; Rose P, 2017, CELL MOL LIFE SCI, V74, P1391, DOI 10.1007/s00018-016-2406-8; Rouhier N, 2006, J EXP BOT, V57, P1685, DOI 10.1093/jxb/erl001; Selles B, 2019, J EXP BOT, V70, P4139, DOI 10.1093/jxb/erz213; Shen J, 2020, PLANT CELL, V32, P1000, DOI 10.1105/tpc.19.00826; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Stroher E, 2016, PLANT PHYSIOL, V170, P1284, DOI 10.1104/pp.15.01308; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Theissen U, 2003, MOL BIOL EVOL, V20, P1564, DOI 10.1093/molbev/msg174; Wedmann R, 2016, CHEM SCI, V7, P3414, DOI 10.1039/c5sc04818d; Yadav PK, 2020, J BIOL CHEM, V295, P6299, DOI 10.1074/jbc.RA120.012616; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yamaguchi Y, 2000, PLANT CELL PHYSIOL, V41, P465, DOI 10.1093/pcp/41.4.465; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zannini F, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7100142; Zimmermann J, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101598; Zivanovic J, 2019, CELL METAB, V30, P1152, DOI 10.1016/j.cmet.2019.10.007; Zuhra K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080828	68	8	9	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100429	10.1016/j.jbc.2021.100429	http://dx.doi.org/10.1016/j.jbc.2021.100429			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33609525	gold, Green Published			2022-12-26	WOS:000672866400403
J	Takada, YK; Shimoda, M; Maverakis, E; Felding, BH; Cheng, RH; Takada, Y				Takada, Yoko K.; Shimoda, Michiko; Maverakis, Emanual; Felding, Brunie H.; Cheng, R. Holland; Takada, Yoshikazu			Soluble CD40L activates soluble and cell-surface integrin alpha v beta 3, alpha 5 beta 1, and alpha 4 beta 1 by binding to the allosteric ligandbinding site (site 2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELETS; EXPRESSION; LIGAND; CD154	CD40L is a member of the TNF superfamily that participates in immune cell activation. It binds to and signals through several integrins, including alpha v beta 3 and alpha 5 beta 1, which bind to the trimeric interface of CD40L. We previously showed that several integrin ligands can bind to the allosteric site (site 2), which is distinct from the classical ligand-binding site (site 1), raising the question of if CD40L activates integrins. In our explorations of this question, we determined that integrin alpha 4 beta 1, which is prevalently expressed on the same CD4+ T cells as CD40L, is another receptor for CD40L. Soluble (s)CD40L activated soluble integrins alpha v beta 3, alpha 5 beta 1, and alpha 4 beta 1 in cell-free conditions, indicating that this activation does not require inside-out signaling. Moreover, sCD40L activated cell-surface integrins in CHO cells that do not express CD40. To learn more about the mechanism of binding, we determined that sCD40L bound to a cyclic peptide from site 2. Docking simulations predicted that the residues of CD40L that bind to site 2 are located outside of the CD40L trimer interface, at a site where four HIGM1 (hyper-IgM syndrome type 1) mutations are clustered. We tested the effect of these mutations, finding that the K143T and G144E mutants were the most defective in integrin activation, providing support that this region interacts with site 2. We propose that allosteric integrin activation by CD40L also plays a role in CD40L signaling, and defective site 2 binding may be related to the impaired CD40L signaling functions of these HIGM1 mutants.	[Takada, Yoko K.; Shimoda, Michiko; Maverakis, Emanual; Takada, Yoshikazu] UC Davis Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Takada, Yoko K.; Takada, Yoshikazu] UC Davis Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Felding, Brunie H.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA; [Cheng, R. Holland] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; Scripps Research Institute; University of California System; University of California Davis	Takada, Y (corresponding author), UC Davis Sch Med, Dept Dermatol, Sacramento, CA 95817 USA.; Takada, Y (corresponding author), UC Davis Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu			NCI [R01 CA208669-01A1, 3R01CA232845-02S1]; UCDCCC Pilot Funding; NIH [UG3TR002866]; NIFA [CADMCB-7399-H]; UC Davis Comprehensive Cancer Center Support Grant (CCSG) - National Cancer Institute [NCI P30CA093373]; UC Davis STAIR grant	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UCDCCC Pilot Funding; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIFA(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); UC Davis Comprehensive Cancer Center Support Grant (CCSG) - National Cancer Institute; UC Davis STAIR grant	This work was supported by UC Davis STAIR grant (Y. T., M. S.), NCI R01 CA208669-01A1 (B. H. F), 3R01CA232845-02S1 (M. S.), and UCDCCC Pilot Funding (Y. T., M. S.) and NIH UG3TR002866 and NIFA CADMCB-7399-H (R. H. C.). This work is partly supported by the UC Davis Comprehensive Cancer Center Support Grant (CCSG) awarded by the National Cancer Institute (NCI P30CA093373).	Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Bunch TA, 2010, J BIOL CHEM, V285, P1841, DOI 10.1074/jbc.M109.057349; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Cha JK, 2000, J KOREAN MED SCI, V15, P273, DOI 10.3346/jkms.2000.15.3.273; Chatzigeorgiou A, 2009, BIOFACTORS, V35, P474, DOI 10.1002/biof.62; Craig DB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-346; Crow MK, 2001, CURR OPIN RHEUMATOL, V13, P361, DOI 10.1097/00002281-200109000-00004; Daub K, 2006, FASEB J, V20, P2559, DOI 10.1096/fj.06-6265fje; Delmas Y, 2005, KIDNEY INT, V68, P2068, DOI 10.1111/j.1523-1755.2005.00663.x; El Fakhry Y, 2012, J BIOL CHEM, V287, P18055, DOI 10.1074/jbc.M111.333989; Fujita M, 2018, BIOCHEM J, V475, P723, DOI 10.1042/BCJ20170867; Fujita M, 2015, J BIOL CHEM, V290, P259, DOI 10.1074/jbc.M114.579946; Fujita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096372; Fujita M, 2012, J IMMUNOL, V189, P5809, DOI 10.4049/jimmunol.1200889; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Pokharel SM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09453-x; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Takada YK, 2019, J IMMUNOL, V203, P1383, DOI 10.4049/jimmunol.1801630; Takada YK, 2017, J BIOL CHEM, V292, P20067, DOI 10.1074/jbc.M117.818302; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Yokoyama K, 1999, BIOCHEMISTRY-US, V38, P5872, DOI 10.1021/bi9827619	31	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100399	10.1016/j.jbc.2021.100399	http://dx.doi.org/10.1016/j.jbc.2021.100399			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33571526	Green Published, gold			2022-12-26	WOS:000672866400373
J	Namgyal, J; Tenzin, T; Checkley, S; Lysyk, TJ; Rinchen, S; Gurung, RB; Dorjee, S; Couloigner, I; Cork, SC				Namgyal, Jamyang; Tenzin, Tenzin; Checkley, Sylvia; Lysyk, Tim J.; Rinchen, Sangay; Gurung, Ratna B.; Dorjee, Sithar; Couloigner, Isabelle; Cork, Susan C.			A knowledge, attitudes, and practices study on ticks and tick-borne diseases in cattle among farmers in a selected area of eastern Bhutan	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; PERCEPTIONS; INFESTATION; GUIDELINES; ACARICIDES; DIAGNOSIS; KINGDOM	Livestock farming plays an important role in supporting the livelihood of resource-poor subsistence farmers in Bhutan. However, ticks and tick-borne diseases (TBDs) are one of the major constraints to livestock farming due to their negative effect on health and production. To date, no study has been conducted in Bhutan to assess farmers' knowledge, attitude, and practices (KAP) about ticks and TBDs in cattle, although such information is essential in ensuring the development and adoption of effective prevention and control measures. Therefore, a KAP survey was conducted among 246 cattle owners in the Samkhar sub-district of eastern Bhutan in June 2019, using a structured questionnaire. Based on our scoring criteria, 52% [95%CI: 45.5-58.4] had adequate knowledge about ticks as potential vectors of diseases. Logistic regression analysis showed that the individuals who practiced a stall-feeding system of cattle rearing were 2.8 times [OR = 2.8 (95%CI: 1.66-4.78)] more likely to have adequate knowledge than others. Sixty-eight percent [95%CI: 62.5-74.4] had a favorable attitude toward tick prevention and control programs. Men were 1.95 times [OR = 1.95 (95%CI: 1.09-3.55)] more likely to have a favorable attitude than women, and the individuals who practiced a stall-feeding system were 2.59 times [OR = 2.59 95%CI: 1.45-4.78)] more likely to have a favorable attitude than others, after adjusting for the effect of other variables in the model. Overall, only 38% [95%CI 32.5-45] of the respondents reported tick infestation as one of the most important animal health problems, but 100% reported using acaricides to control ticks in cattle. Despite a high level of acaricide usage, the level of knowledge was low among the farmers interviewed. Findings from this study underline the importance of considering identified knowledge gaps and initiating education efforts to improve the adoption of effective tick prevention and control measures among farmers.	[Namgyal, Jamyang] Dist Vet Hosp, Minist Agr & Forests, Dept Livestock, Trashigang, Bhutan; [Namgyal, Jamyang; Checkley, Sylvia; Lysyk, Tim J.; Couloigner, Isabelle; Cork, Susan C.] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada; [Tenzin, Tenzin; Rinchen, Sangay; Gurung, Ratna B.] Minist Agr & Forests, Natl Ctr Anim Hlth, Dept Livestock, Thimphu, Bhutan; [Dorjee, Sithar] Khesar Gyalpo Univ Med Sci Bhutan, Thimphu, Bhutan; [Couloigner, Isabelle] Univ Calgary, Dept Geog, Calgary, AB, Canada	University of Calgary; University of Calgary	Namgyal, J (corresponding author), Dist Vet Hosp, Minist Agr & Forests, Dept Livestock, Trashigang, Bhutan.; Namgyal, J (corresponding author), Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada.	drjamyang@gmail.com	Lysyk, Timothy/Q-2495-2018	Lysyk, Timothy/0000-0001-7591-0648	One Health Graduate Training Award, Faculty of Veterinary Medicine, University of Calgary, Alberta, Canada	One Health Graduate Training Award, Faculty of Veterinary Medicine, University of Calgary, Alberta, Canada	This work was a part of JN's MSc thesis titled "Identification and Distribution of Tick Species in Cattle in Eastern Bhutan" that was funded by One Health Graduate Training Award, Faculty of Veterinary Medicine, University of Calgary, Alberta, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Adehan SB, 2018, ECOHEALTH, V15, P437, DOI 10.1007/s10393-018-1323-8; Allison P., 2012, STAT HORIZONS, V5, P1; [Anonymous], 2016, KUENSEL; Brouqui P, 2004, CLIN MICROBIOL INFEC, V10, P1108, DOI 10.1111/j.1469-0691.2004.01019.x; Butler AD, 2016, TICKS TICK-BORNE DIS, V7, P331, DOI 10.1016/j.ttbdis.2015.12.003; Chhogyel N., 2018, Agriculture and Food Security, V7, DOI 10.1186/s40066-018-0229-6; Debbarma A, 2018, BIOL RHYTHM RES, V49, P655, DOI 10.1080/09291016.2017.1395527; deCastro JJ, 1997, VET PARASITOL, V71, P77, DOI 10.1016/S0304-4017(97)00033-2; Dhimal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102028; DoL, 2018, LIV STAT; Dorji L., 2003, ASIAN STUD REV, V27, P341, DOI [10.1080/10357820308713382, DOI 10.1080/10357820308713382]; Estrada-Pena A, 2015, REV SCI TECH OIE, V34, P53, DOI 10.20506/rst.34.1.2345; Eyo Joseph Effiong, 2014, Global Veterinaria, V12, P479; Fiji Bureau of Statistics, 2018, CENSUS 2017 POPULATI; Green EC., 2001, FIELD METHOD, V13, P3, DOI 10.1177/1525822X0101300101; Gupta S, 2018, TICKS TICK-BORNE DIS, V9, P615, DOI 10.1016/j.ttbdis.2018.01.006; Hidano A, 2017, PREV VET MED, V140, P10, DOI 10.1016/j.prevetmed.2017.02.011; Hidano A, 2016, PREV VET MED, V130, P1, DOI 10.1016/j.prevetmed.2016.05.012; Jonsson NN, 2014, PARASITE IMMUNOL, V36, P551, DOI 10.1111/pim.12140; Kabir MHB, 2011, AFR J MICROBIOL RES, V5, P346; Kemal Jelalu, 2016, J Vet Med, V2016, P9618291, DOI 10.1155/2016/9618291; KUNZ SE, 1994, REV SCI TECH OIE, V13, P1249, DOI 10.20506/rst.13.4.816; Laisser E., 2015, LIVEST RES RURAL DEV, V27; Launiala A., 2009, ANTHR MATTERS, V11, P1, DOI [https://doi.org/10.22582/am.v11i1.31, DOI 10.22582/AM.V11I1.31]; Lindahl E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117318; Linske MA, 2019, INSECTS, V10, DOI 10.3390/insects10080227; Mans BJ., 2013, BIOL TICKS, V2, P313; Martin, 2003, VET EPIDEMIOLOGIC RE, P31; Minjauw B., 2003, TICK BORNE DIS POVER; National Statistics Bureau, 2018, PHCB TRASH; NCAH, 2013, STAT NOT AN DIS BHUT; NCAH, 2013, NAT VET DRUG FORM, P35; Niesobecki S, 2019, TICKS TICK-BORNE DIS, V10, DOI 10.1016/j.ttbdis.2019.07.008; Nogueira J, 2014, J MED ENTOMOL, V51, P971, DOI 10.1603/ME13236; Pelden K., 2007, SMALLHOLDER DAIRY FA; Phuyal N, 2019, J ETHNOPHARMACOL, V229, P326, DOI 10.1016/j.jep.2018.08.010; Rahi M, 2015, INDIAN J MED RES, V141, P417, DOI 10.4103/0971-5916.159279; Raynal JT, 2013, REV BRAS PARASITOL V, V22, P71, DOI 10.1590/S1984-29612013005000006; Rehman A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2138-0; Rinchen S, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007305; Samdup T, 2010, LIVEST SCI, V132, P126, DOI 10.1016/j.livsci.2010.05.014; Sindhu ZUD, 2010, INT J AGRIC BIOL, V12, P353; Spickler AR, 2018, BOVINE BABESIOSIS; Suss J, 2008, J TRAVEL MED, V15, P39, DOI 10.1111/j.1708-8305.2007.00176.x; Sungirai M, 2016, TICKS TICK-BORNE DIS, V7, P1, DOI 10.1016/j.ttbdis.2015.07.015; Tack DM, 2013, JAVMA-J AM VET MED A, V242, P1279, DOI 10.2460/javma.242.9.1279; Tshokey T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006107; Tshokey Tshokey, 2016, WHO South East Asia J Public Health, V5, P117, DOI 10.4103/2224-3151.206248; WILKINSON P. R., 1957, AUSTRALIAN JOUR AGRIC RES, V8, P414, DOI 10.1071/AR9570414; Zoldi V, 2017, TICKS TICK-BORNE DIS, V8, P872, DOI 10.1016/j.ttbdis.2017.07.004	50	4	4	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247302	10.1371/journal.pone.0247302	http://dx.doi.org/10.1371/journal.pone.0247302			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617588	gold, Green Published			2022-12-26	WOS:000623082400010
J	Tokumitsu, K; Yasui-Furukori, N; Takeuchi, J; Yachimori, K; Sugawara, N; Terayama, Y; Tanaka, N; Naraoka, T; Shimoda, K				Tokumitsu, Keita; Yasui-Furukori, Norio; Takeuchi, Junko; Yachimori, Koji; Sugawara, Norio; Terayama, Yoshio; Tanaka, Nobuyuki; Naraoka, Tatsunori; Shimoda, Kazutaka			The combination of MMSE with VSRAD and eZIS has greater accuracy for discriminating mild cognitive impairment from early Alzheimer's disease than MMSE alone	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; MINI-MENTAL-STATE; STRUCTURAL MRI; DEMENTIA; DIAGNOSIS; SYSTEM	Background Alzheimer's disease (AD) is assessed by carefully examining a patient's cognitive impairment. However, previous studies reported inadequate diagnostic accuracy for dementia in primary care settings. Many hospitals use the automated quantitative evaluation method known as the Voxel-based Specific Regional Analysis System for Alzheimer's Disease (VSRAD), wherein brain MRI data are used to evaluate brain morphological abnormalities associated with AD. Similarly, an automated quantitative evaluation application called the easy Z-score imaging system (eZIS), which uses brain SPECT data to detect regional cerebral blood flow decreases associated with AD, is widely used. These applications have several indicators, each of which is known to correlate with the degree of AD. However, it is not completely known whether these indicators work better when used in combination in real-world clinical practice. Methods We included 112 participants with mild cognitive impairment (MCI) and 128 participants with early AD in this study. All participants underwent MRI, SPECT, and the Mini-Mental State Examination (MMSE). Demographic and clinical characteristics were assessed by univariate analysis, and logistic regression analysis with a combination of MMSE, VSRAD and eZIS indicators was performed to verify whether the diagnostic accuracy in discriminating between MCI and early AD was improved. Results The area under the receiver operating characteristic curve (AUC) for the MMSE score alone was 0.835. The AUC was significantly improved to 0.870 by combining the MMSE score with two quantitative indicators from the VSRAD and eZIS that assessed the extent of brain abnormalities. Conclusion Compared with the MMSE score alone, the combination of the MMSE score with the VSRAD and eZIS indicators significantly improves the accuracy of discrimination between patients with MCI and early AD. Implementing VSRAD and eZIS does not require professional clinical experience in the treatment of dementia. Therefore, the accuracy of dementia diagnosis by physicians may easily be improved in real-world primary care settings.	[Tokumitsu, Keita; Takeuchi, Junko; Yachimori, Koji] Towada City Hosp, Dept Neuropsychiat, Towada, Aomori, Japan; [Tokumitsu, Keita; Yasui-Furukori, Norio; Sugawara, Norio; Shimoda, Kazutaka] Dokkyo Med Univ, Dept Psychiat, Sch Med, Mibu, Tochigi, Japan; [Terayama, Yoshio; Tanaka, Nobuyuki; Naraoka, Tatsunori] Towada City Hosp, Dept Radiol, Towada, Aomori, Japan	Dokkyo Medical University	Yasui-Furukori, N (corresponding author), Dokkyo Med Univ, Dept Psychiat, Sch Med, Mibu, Tochigi, Japan.	furukori@dokkyomed.ac.jp	Tokumitsu, Keita/AHC-1832-2022	TOKUMITSU, KEITA/0000-0001-6747-4348				BENTON AL, 1945, ARCH NEURO PSYCHIATR, V54, P212, DOI 10.1001/archneurpsyc.1945.02300090051008; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Cacho J, 2010, J ALZHEIMERS DIS, V22, P889, DOI 10.3233/JAD-2010-101182; Dukart J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002987; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Hirata Y, 2005, NEUROSCI LETT, V382, P269, DOI 10.1016/j.neulet.2005.03.038; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kaneta T, 2016, CLIN NUCL MED, V41, pe1, DOI 10.1097/RLU.0000000000000976; Kanetaka H, 2004, EUR J NUCL MED MOL I, V31, P975, DOI 10.1007/s00259-004-1491-3; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Katoh S, 1991, JPNJ GERIAT PSYCHIAT, V2, P1339; Kogure D, 2000, J NUCL MED, V41, P1155; Kohs SC, 1923, INTELLIGENCE MEASURE; Leifer BP, 2003, J AM GERIATR SOC, V51, pS281, DOI 10.1046/j.1532-5415.5153.x; Li FZ, 2019, PSYCHOGERIATRICS, V19, P95, DOI 10.1111/psyg.12370; Li X, 2010, PSYCHIAT CLIN NEUROS, V64, P284, DOI 10.1111/j.1440-1819.2010.02076.x; Malek-Ahmadi M, 2016, ALZ DIS ASSOC DIS, V30, P324, DOI 10.1097/WAD.0000000000000145; Matsuda H, 2007, AM J NEURORADIOL, V28, P731; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; Matsuda H, 2007, J NUCL MED, V48, P1289, DOI 10.2967/jnumed.106.037218; Matsuda H, 2019, NEUROPSYCH DIS TREAT, V15, P2715, DOI 10.2147/NDT.S222966; Matsuda H, 2016, AGEING RES REV, V30, P17, DOI 10.1016/j.arr.2016.01.003; Matsuda H, 2013, AGING DIS, V4, P29; Mayeux R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006239; Ministry of Health Labour and Welfare, 2020, LIST EX FOOD ADD; Ministry of Health LaW, MEAS DEM; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Mizumura S, 2003, ANN NUCL MED, V17, P289, DOI 10.1007/BF02988523; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; Oshikubo G, 2020, J INT MED RES, V48, DOI 10.1177/0300060520917270; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Sachdev PS, 2014, NAT REV NEUROL, V10, P634, DOI 10.1038/nrneurol.2014.181; Sado M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206508; Shimada H, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.05.017; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Sone D, 2018, AGING DIS, V9, P755, DOI 10.14336/AD.2017.0818; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Valcour VG, 2000, ARCH INTERN MED, V160, P2964, DOI 10.1001/archinte.160.19.2964; Wattmo C, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0174-1; Whitwell JL, 2012, LANCET NEUROL, V11, P868, DOI 10.1016/S1474-4422(12)70200-4	48	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247427	10.1371/journal.pone.0247427	http://dx.doi.org/10.1371/journal.pone.0247427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QO3ZL	33617587	Green Published, gold			2022-12-26	WOS:000623082400001
J	Wood, SA; Robinson, PW; Costa, DP; Beltran, RS				Wood, Sarah A.; Robinson, Patrick W.; Costa, Daniel P.; Beltran, Roxanne S.			Accuracy and precision of citizen scientist animal counts from drone imagery	PLOS ONE			English	Article								Repeated counts of animal abundance can reveal changes in local ecosystem health and inform conservation strategies. Unmanned aircraft systems (UAS), also known as drones, are commonly used to photograph animals in remote locations; however, counting animals in images is a laborious task. Crowd-sourcing can reduce the time required to conduct these censuses considerably, but must first be validated against expert counts to measure sources of error. Our objectives were to assess the accuracy and precision of citizen science counts and make recommendations for future citizen science projects. We uploaded drone imagery from Ano Nuevo Island (California, USA) to a curated Zooniverse website that instructed citizen scientists to count seals and sea lions. Across 212 days, over 1,500 volunteers counted animals in 90,000 photographs. We quantified the error associated with several descriptive statistics to extract a single citizen science count per photograph from the 15 repeat counts and then compared the resulting citizen science counts to expert counts. Although proportional error was relatively low (9% for sea lions and 5% for seals during the breeding seasons) and improved with repeat sampling, the 12+ volunteers required to reduce error was prohibitively slow, taking on average 6 weeks to estimate animals from a single drone flight covering 25 acres, despite strong public outreach efforts. The single best algorithm was 'Median without the lowest two values', demonstrating that citizen scientists tended to under-estimate the number of animals present. Citizen scientists accurately counted adult seals, but accuracy was lower when sea lions were present during the summer and could be confused for seals. We underscore the importance of validation efforts and careful project design for researchers hoping to combine citizen science with imagery from drones, occupied aircraft, and/or remote cameras.	[Wood, Sarah A.; Robinson, Patrick W.; Costa, Daniel P.; Beltran, Roxanne S.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Costa, Daniel P.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Beltran, RS (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	roxanne@ucsc.edu	wood, sarah/GRR-3687-2022	Beltran, Roxanne/0000-0002-8520-1105	Google Global Impact Award; Alfred P. Sloan Foundation; Friends of the Seymour Marine Discovery Center Student Research and Education Award; Center to Advance Mentored, Inquiry-Based Opportunities in Ecology and Conservation; Packard Ocean Science and Technology Endowment; National Science Foundation Postdoctoral Research Fellowship in Biology	Google Global Impact Award(Google Incorporated); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Friends of the Seymour Marine Discovery Center Student Research and Education Award; Center to Advance Mentored, Inquiry-Based Opportunities in Ecology and Conservation; Packard Ocean Science and Technology Endowment; National Science Foundation Postdoctoral Research Fellowship in Biology	This publication uses data generated via the Zooniverse.org platform funded by generous support from a Google Global Impact Award and from the Alfred P. Sloan Foundation. Financial support for this research was provided by the Friends of the Seymour Marine Discovery Center Student Research and Education Award (to SAW), the Center to Advance Mentored, Inquiry-Based Opportunities in Ecology and Conservation (to SAW), the Packard Ocean Science and Technology Endowment (to DPC), and a National Science Foundation Postdoctoral Research Fellowship in Biology (to RSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame K, 2017, MAR MAMMAL SCI, V33, P913, DOI 10.1111/mms.12403; Arona L, 2018, PEERJ, V6, DOI 10.7717/peerj.4467; Bonney R, 2016, PUBLIC UNDERST SCI, V25, P2, DOI 10.1177/0963662515607406; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; BOYD I, 1993, PHYSIOL ZOOL, V66, P43, DOI 10.1086/physzool.66.1.30158286; Christiansen F., 2020, J EXP BIOL, V223; Conrad CC., 2011, Environmental Monitoring and Assessment, V176, P273, DOI 10.1007/s10661-010-1582-5; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dutton PH, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00693; EBERHARDT LL, 1985, J WILDLIFE MANAGE, V49, P997, DOI 10.2307/3801386; Francis RJ, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12071185; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; Gonzalez LF, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010097; Hodgson JC, 2018, METHODS ECOL EVOL, V9, P1160, DOI 10.1111/2041-210X.12974; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Kays R, 2019, INT J REMOTE SENS, V40, P407, DOI 10.1080/01431161.2018.1523580; Kuhn CE, 2014, MAR MAMMAL SCI, V30, P1297, DOI 10.1111/mms.12110; Kullenberg C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147152; LaRue MA, 2020, REMOTE SENS ECOL CON, V6, P70, DOI 10.1002/rse2.124; LaRue MA, 2019, MAR ECOL PROG SER, V612, P193, DOI 10.3354/meps12877; Le Boeuf B.J., 1994, ELEPHANT SEALS POPUL; Le Boeuf BJ, 2011, AQUAT MAMM, V37, P486, DOI 10.1578/AM.37.4.2011.486; Linchant J, 2015, MAMMAL REV, V45, P239, DOI 10.1111/mam.12046; Lowry MS, 2017, NOAATM NMFSSWFSC578; Lowry MS., 2014, AQUAT MAMM, V40; Moore SE, 2008, J MAMMAL, V89, P534, DOI 10.1644/07-MAMM-S-312R1.1; Morris DW, 2009, ANN NY ACAD SCI, V1162, P334, DOI 10.1111/j.1749-6632.2009.04494.x; Mulero-Pazmany M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178448; Norouzzadeh MS, 2018, P NATL ACAD SCI USA, V115, pE5716, DOI 10.1073/pnas.1719367115; Nov O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090375; Raoult V, 2020, DRONES-BASEL, V4, DOI 10.3390/drones4040064; ROWLEY JOHN, 1929, JOUR MAMMALOGY, V10, P1, DOI 10.2307/1374097; Silvertown J., 2013, CONSERV BIOL, V2, P127; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Landeo-Yauri SS, 2020, ENDANGER SPECIES RES, V41, P79, DOI 10.3354/esr01007; Sorrell KJ, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2812; Swanson A, 2016, CONSERV BIOL, V30, P520, DOI 10.1111/cobi.12695; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; vanGemert JC, 2014, EUR C COMP VIS; Vukelic M, 2018, REND LINCEI-SCI FIS, V29, P53, DOI 10.1007/s12210-017-0657-4; Wege M., DIVERS DISTRIB; Weinstein BG, 2018, J ANIM ECOL, V87, P533, DOI 10.1111/1365-2656.12780; Westlake RL, 1997, MAR MAMMAL SCI, V13, P207, DOI 10.1111/j.1748-7692.1997.tb00628.x	44	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0244040	10.1371/journal.pone.0244040	http://dx.doi.org/10.1371/journal.pone.0244040			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617554	Green Published, gold, Green Submitted			2022-12-26	WOS:000623082400026
J	Brandtner, C; Bettencourt, LMA; Berman, MG; Stier, AJ				Brandtner, Christof; Bettencourt, Luis M. A.; Berman, Marc G.; Stier, Andrew J.			Creatures of the state? Metropolitan counties compensated for state inaction in initial US response to COVID-19 pandemic	PLOS ONE			English	Article							DIFFUSION; HETEROGENEITY; GOVERNANCE; ADOPTION; CITIES; REFORM	Societal responses to crises require coordination at multiple levels of organization. Exploring early efforts to contain COVID-19 in the U.S., we argue that local governments can act to ensure systemic resilience and recovery when higher-level governments fail to do so. Event history analyses show that large, more urban areas experience COVID-19 more intensely due to high population density and denser socioeconomic networks. But metropolitan counties were also among the first to adopt shelter-in-place orders. Analyzing the statistical predictors of when counties moved before their states, we find that the hierarchy of counties by size and economic integration matters for the timing of orders, where both factors predict earlier shelter-in-place orders. In line with sociological theories of urban governance, we also find evidence of an important governance dimension to the timing of orders. Liberal counties in conservative states were more than twice as likely to adopt a policy and implement one earlier in the pandemic, suggesting that tensions about how to resolve collective governance problems are important in the socio-temporal dynamic of responses to COVID-19. We explain this behavior as a substitution effect in which more urban local governments, driven by risk and necessity, step up into the action vacuum left by higher levels of government and become national policy leaders and innovators.	[Brandtner, Christof] EM Lyon Business Sch, Ecully, France; [Brandtner, Christof] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA; [Brandtner, Christof] Stanford Univ, Ctr Philanthropy & Civil Soc, Stanford, CA 94305 USA; [Brandtner, Christof; Bettencourt, Luis M. A.] Univ Chicago, Mansueto Inst Urban Innovat, Chicago, IL 60637 USA; [Bettencourt, Luis M. A.] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA; [Berman, Marc G.; Stier, Andrew J.] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA	EMLYON Business School; University of Chicago; Stanford University; University of Chicago; University of Chicago; University of Chicago	Brandtner, C (corresponding author), EM Lyon Business Sch, Ecully, France.; Brandtner, C (corresponding author), Univ Chicago, Dept Sociol, Chicago, IL 60637 USA.; Brandtner, C (corresponding author), Stanford Univ, Ctr Philanthropy & Civil Soc, Stanford, CA 94305 USA.; Brandtner, C (corresponding author), Univ Chicago, Mansueto Inst Urban Innovat, Chicago, IL 60637 USA.	brandtner@uchicago.edu	Brandtner, Christof/J-9713-2019	Brandtner, Christof/0000-0002-7484-464X; Berman, Marc/0000-0002-7087-3697	National Science Foundation Soc-DDRI grant [1801677]; National Science Foundation SCC grant [1952050]	National Science Foundation Soc-DDRI grant; National Science Foundation SCC grant(National Science Foundation (NSF))	Christof Brandtner acknowledges support by National Science Foundation Soc-DDRI grant #1801677. Marc G. Berman acknowledges support by National Science Foundation S&CC grant #1952050.	Adolph C, 2021, J HEALTH POLIT POLIC, V46, P211, DOI 10.1215/03616878-8802162; Allcott H, W26946 NBER; Berry F.S., 2018, THEORIES POLICY PROC, P263; Bettencourt LMA, 2014, P IEEE, V102, P1878, DOI 10.1109/JPROC.2014.2367132; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2011, SCI AM, V305, DOI 10.1038/scientificamerican0911-52; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Bischof D, 2017, STATA J, V17, P748, DOI 10.1177/1536867X1701700313; Boehmke FJ, 2012, STATE POLIT POLICY Q, V12, P303, DOI 10.1177/1532440012438890; Box-Steffensmeier J. M., 2004, EVENT HIST MODELING; Brandtner C., 2019, THE NONPROFIT SECTOR; Brandtner C, 2020, AM REV PUBLIC ADM; Brandtner C, 2017, URBAN STUD, V54, P1075, DOI 10.1177/0042098015624871; Brelsford C, 2017, P NATL ACAD SCI USA, V114, P8963, DOI 10.1073/pnas.1606033114; Brenner N., 2004, NEW STATE SPACES URB; Broto VC, 2013, GLOBAL ENVIRON CHANG, V23, P92, DOI 10.1016/j.gloenvcha.2012.07.005; Brzezinski A., 2020, COVID 19 PANDEMIC GO; Burns N, 1997, URBAN AFF REV, V33, P59, DOI 10.1177/107808749703300103; Coase RH, 1937, ECONOMICA-NEW SER, V4, P386, DOI 10.1111/j.1468-0335.1937.tb00002.x; Dave D, 2022, J URBAN ECON, V127, DOI 10.1016/j.jue.2020.103294; Dobbin F, 2007, ANNU REV SOCIOL, V33, P449, DOI 10.1146/annurev.soc.33.090106.142507; Dobbin F, 2015, AM SOCIOL REV, V80, P1014, DOI 10.1177/0003122415596416; Dokshin FA, 2016, AM SOCIOL REV, V81, P921, DOI 10.1177/0003122416663929; Drori GS, 2006, ADMIN SCI QUART, V51, P205, DOI 10.2189/asqu.51.2.205; Ebell MH, 2020, AM J PREV MED, V59, P140, DOI 10.1016/j.amepre.2020.04.006; Frank DJ, 2000, AM SOCIOL REV, V65, P96, DOI 10.2307/2657291; Frug GE., 2013, CITY BOUND STATES ST; Gupta S., ARXIV2020200302838; Ingram DD, 2014, NCHS URBAN RURAL CLA; Jann B, 2014, STATA J, V14, P708, DOI 10.1177/1536867X1401400402; Jessop B., 1999, NEW POLITICS LOCAL G, P11; KNOKE D, 1982, AM J SOCIOL, V87, P1314, DOI 10.1086/227595; Kwon M, 2009, J PUBL ADM RES THEOR, V19, P967, DOI 10.1093/jopart/mun026; Laumann EO., 1987, ORG STATE SOCIAL CHO; Lawrence RJ., 2020, J URBAN HLTH; Leip D, 2020, DAVE LEIPS ATLAS US; Martin I, 2001, URBAN AFF REV, V36, P470, DOI 10.1177/10780870122184966; Mazyavkina Nina, 2020, EUR J NEUROSCI, DOI [10.1016/j.medj.2022.03.004, DOI 10.1016/0735-1933(85)90003-X]; Painter M, 2020, SSRN 2020; Peterson P., 1981, CITY LIMITS; Pierre J, 1999, URBAN AFF REV, V34, P372, DOI 10.1177/10780879922183988; Rao H, 2018, ACAD MANAGE J, V61, P5, DOI 10.5465/amj.2016.0054; Ribeiro HV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239699; Schneiberg M, 2020, RES SOCIOLOGY ORG; Schragger R., 2016, CITY POWER URBAN GOV; Smith R, 2007, BRIT MED J, V334, P1341, DOI 10.1136/bmj.39255.606713.DB; Sorensen E, 2009, PUBLIC ADMIN, V87, P234, DOI 10.1111/j.1467-9299.2009.01753.x; Steil JP, 2014, AM J SOCIOL, V119, P1104, DOI 10.1086/675301; Stier A, 2020, COVID 19 ATTACK RATE; Strang D, 1998, ANNU REV SOCIOL, V24, P265, DOI 10.1146/annurev.soc.24.1.265; STRANG D, 1993, THEOR SOC, V22, P487, DOI 10.1007/BF00993595; STRANG D, 1993, AM J SOCIOL, V99, P614, DOI 10.1086/230318; Tausanovitch C, 2014, AM POLIT SCI REV, V108, P605, DOI 10.1017/S0003055414000318; TOLBERT PS, 1983, ADMIN SCI QUART, V28, P22, DOI 10.2307/2392383; United Nations Development Programme (UNDP), 2019, HUM DEV REP 2019 INC; Vasi IB, 2007, SOC FORCES, V86, P113, DOI 10.1353/sof.2007.0112; Vasi IB, 2009, AM J SOCIOL, V114, P1716, DOI 10.1086/597177; WALKER JL, 1969, AM POLIT SCI REV, V63, P880, DOI 10.2307/1954434; Weisbrod B. A., 1972, EC NONPROFIT I; WILLIAMSON OE, 1971, AM ECON REV, V61, P112; Wright AL, 2020102 U CHIC BECK; Youn H, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.0937	62	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246249	10.1371/journal.pone.0246249	http://dx.doi.org/10.1371/journal.pone.0246249			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606725	Green Submitted, gold, Green Published			2022-12-26	WOS:000620629200060
J	Jayanama, K; Srichatrapimuk, S; Thammavaranucupt, K; Kirdlarp, S; Suppadungsuk, S; Wongsinin, T; Nanthatanti, N; Phusanti, S; Pitidhammabhorn, D; Sungkanuparph, S				Jayanama, Kulapong; Srichatrapimuk, Sirawat; Thammavaranucupt, Kanin; Kirdlarp, Suppachok; Suppadungsuk, Supawadee; Wongsinin, Thananya; Nanthatanti, Nithita; Phusanti, Sithakom; Pitidhammabhorn, Dhanesh; Sungkanuparph, Somnuek			The association between body mass index and severity of Coronavirus Disease 2019 (COVID-19): A cohort study	PLOS ONE			English	Article							HOSPITALIZED-PATIENTS; ADIPOSE-TISSUE; OBESITY	Objectives The coronavirus disease 2019 (COVID-19) has become a worst pandemic. The clinical characteristics vary from asymptomatic to fatal. This study aims to examine the association between body mass index (BMI) levels and the severity of COVID-19. Methods and study design A cohort study included 147 adult patients with confirmed COVID-19 were categorized into 4 groups by BMI levels on admission: <18.5 (underweight), 18.5-22.9 (normal weight), 23.0-24.9 (overweight), and >= 25.0 kg/m(2) (obese). Rates of pneumonia, severe pneumonia, acute kidney injury (AKI), and ICU stay during hospitalization across BMI group was determined. Logistic regression analysis was used to determine the association between BMI and severe pneumonia. Results Of the totals, patients having a BMI <18.5, 18.5-22.9, 23.0-24.9, and >= 25.0 kg/m(2) were 12.9%, 38.1%, 17.7%, and 31.3%, respectively. The rates of pneumonia and severe pneumonia tended to be higher in patients with higher BMI, whereas the rates of AKI and ICU stay were higher in patients with BMI <18.5 kg/m(2) and >= 25 kg/m(2), when compared to patients with normal BMI. After controlling for age, sex, diabetes, hypertension and dyslipidemia in the logistic regression analysis, having a BMI >= 25.0 kg/m(2) was associated with higher risk of severe pneumonia (OR 4.73; 95% CI, 1.50-14.94; p = 0.003) compared to having a BMI 18.5-22.9 kg/m(2). During admission, elevated hemoglobin and alanine aminotransferase levels on day 7 and 14 of illness were associated with higher BMI levels. In contrast, rising of serum creatinine levels was observed in underweight patients on days 12 and 14 of illness. Conclusions Obesity in patients with COVID-19 was associated with severe pneumonia and adverse outcomes such as AKI, transaminitis and ICU stay. Underweight patients should be closely monitored for AKI. Further studies in body composition are warranted to explore the links between adiposity and COVID-19 pathogenesis.	[Jayanama, Kulapong; Srichatrapimuk, Sirawat; Thammavaranucupt, Kanin; Kirdlarp, Suppachok; Suppadungsuk, Supawadee; Wongsinin, Thananya; Nanthatanti, Nithita; Phusanti, Sithakom; Pitidhammabhorn, Dhanesh; Sungkanuparph, Somnuek] Mahidol Univ, Fac Med, Chakri Naruebodindra Med Inst, Ramathibodi Hosp, Samut Prakan, Thailand	Mahidol University	Sungkanuparph, S (corresponding author), Mahidol Univ, Fac Med, Chakri Naruebodindra Med Inst, Ramathibodi Hosp, Samut Prakan, Thailand.	somnuek.sun@mahidol.ac.th		Suppadungsuk, Supawadee/0000-0003-1597-2411; Kirdlarp, Suppachok/0000-0003-3444-4796				[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; Batlle D, 2020, J AM SOC NEPHROL, V31, P1380, DOI 10.1681/ASN.2020040419; Center for systems science and engineering (CSSE) at Johns Hopkins University, COR COVID 19 GLOB CA; Cox AJ, 2015, LANCET DIABETES ENDO, V3, P207, DOI 10.1016/S2213-8587(14)70134-2; Dietrich P, 2014, BEST PRACT RES CL GA, V28, P637, DOI 10.1016/j.bpg.2014.07.008; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Ghoorah K, 2016, EUR HEART J-ACUTE CA, V5, P77, DOI 10.1177/2048872614523349; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Huttunen R, 2013, INT J OBESITY, V37, P333, DOI 10.1038/ijo.2012.62; Joannidis M, 2020, INTENS CARE MED, V46, P654, DOI 10.1007/s00134-019-05869-7; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1; Li CY, 2020, BRIT J NUTR, V123, P337, DOI 10.1017/S000711451900271X; McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537; Misumi I, 2019, CELL REP, V27, P514, DOI 10.1016/j.celrep.2019.03.030; Murugan A T, 2008, Chron Respir Dis, V5, P233, DOI 10.1177/1479972308096978; Nimptsch K, 2019, METABOLISM, V92, P61, DOI 10.1016/j.metabol.2018.12.006; Pranata R, 2021, DIABETES METAB, V47, DOI 10.1016/j.diabet.2020.07.005; Stefan N, 2020, NAT REV ENDOCRINOL, V16, P341, DOI 10.1038/s41574-020-0364-6; Strissel KJ, 2010, OBESITY, V18, P1918, DOI 10.1038/oby.2010.1; Sun J, 2020, LIVER INT, V40, P1278, DOI 10.1111/liv.14470; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang TB, 2020, LANCET, V395, pE52, DOI 10.1016/S0140-6736(20)30558-4; WHO IOTF/IASO, 2000, AS PAC PERSP RED OBS; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; World Health Organization, 2020, 124 WHO; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994	27	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247023	10.1371/journal.pone.0247023	http://dx.doi.org/10.1371/journal.pone.0247023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592042	Green Published, gold			2022-12-26	WOS:000620632800051
J	Brunaugh, AD; Seo, H; Warnken, Z; Ding, L; Seo, SH; Smyth, HDC				Brunaugh, Ashlee D.; Seo, Hyojong; Warnken, Zachary; Ding, Li; Seo, Sang Heui; Smyth, Hugh D. C.			Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae	PLOS ONE			English	Article							DRUG; IMMUNOGENICITY; PEPTIDES; DELIVERY; REVEALS; TARGET; FLUID	Niclosamide (NIC) has demonstrated promising in vitro antiviral efficacy against SARS-CoV-2, the causative agent of the COVID-19 pandemic. Though NIC is already FDA-approved, administration of the currently available oral formulation results in systemic drug levels that are too low for the inhibition of SARS-CoV-2. We hypothesized that the co-formulation of NIC with an endogenous protein, human lysozyme (hLYS), could enable the direct aerosol delivery of the drug to the respiratory tract as an alternative to oral delivery, thereby effectively treating COVID-19 by targeting the primary site of SARS-CoV-2 acquisition and spread. To test this hypothesis, we engineered and optimized composite particles containing NIC and hLYS suitable for delivery to the upper and lower airways via dry powder inhaler, nebulizer, and nasal spray. The novel formulation demonstrates potent in vitro and in vivo activity against two coronavirus strains, MERS-CoV and SARS-CoV-2, and may offer protection against methicillin-resistance staphylococcus aureus pneumonia and inflammatory lung damage occurring secondary to SARS-CoV-2 infections. The suitability of the formulation for all stages of the disease and low-cost development approach will ensure rapid clinical development and wide-spread utilization.	[Brunaugh, Ashlee D.; Seo, Hyojong; Warnken, Zachary; Ding, Li; Smyth, Hugh D. C.] Univ Texas Austin, Coll Pharm, Div Mol Pharmaceut & Drug Delivery, Austin, TX 78712 USA; [Seo, Sang Heui] Chungnam Natl Univ, Coll Vet Med, Lab Influenza Res, Dajeon, South Korea	University of Texas System; University of Texas Austin; Chungnam National University	Smyth, HDC (corresponding author), Univ Texas Austin, Coll Pharm, Div Mol Pharmaceut & Drug Delivery, Austin, TX 78712 USA.	hugh.smyth@austin.utexas.edu	Ding, Li/GNH-6271-2022	Smyth, Hugh/0000-0002-6582-5869; Brunaugh, Ashlee/0000-0001-5456-5427	National Heart, Lung and Blood Institute of the National Institutes of Health [F31HL146178]; Via Therapeutics, LLC	National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Via Therapeutics, LLC	Research reported in this publication is supported by the National Heart, Lung and Blood Institute of the National Institutes of Health under Award Number F31HL146178. The content reported herein is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Via Therapeutics, LLC provided support in the form of salaries for authors ADB and ZW but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	ANDREWS P, 1982, PHARMACOL THERAPEUT, V19, P245, DOI 10.1016/0163-7258(82)90064-X; [Anonymous], 2014, BMJ-BRIT MED J, V349, P8; [Anonymous], 2020, DIR GEN OP REM MISS; [Anonymous], 2019, INACTIVE INGREDIENTS; Arora D, 2010, PHARM RES-DORDR, V27, P786, DOI 10.1007/s11095-010-0070-5; Ayerbe-Algaba R, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00348; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Brunaugh AD, 2019, MOL PHARMACEUT, V16, P4165, DOI 10.1021/acs.molpharmaceut.9b00496; Cabrita I, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128414; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; Chen W, 2017, CELL SIGNAL, V41, P89, DOI 10.1016/j.cellsig.2017.04.001; Circu ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146931; Clay CC, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-4; Costabile G, 2015, MOL PHARMACEUT, V12, P2604, DOI 10.1021/acs.molpharmaceut.5b00098; Del Valle D.M., 2020, NAT MED, V26, P1636, DOI DOI 10.1038/s41591-020-1051-9; Domalaon R, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02574-18; Doughty DV, 2011, DRUG DEV IND PHARM, V37, P359, DOI 10.3109/03639045.2010.520321; Dufes C, 2003, INT J PHARMACEUT, V255, P87, DOI 10.1016/S0378-5173(03)00039-5; Elkordy AA, 2002, INT J PHARMACEUT, V247, P79, DOI 10.1016/S0378-5173(02)00379-4; Elshikh M, 2016, BIOTECHNOL LETT, V38, P1015, DOI 10.1007/s10529-016-2079-2; FERRARI R, 1959, NATURE, V183, P548, DOI 10.1038/183548a0; Ferrati S, 2018, AAPS PHARMSCITECH, V19, P2755, DOI 10.1208/s12249-018-0980-9; Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638; Frohlich E, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00181; Gassen NC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13659-4; Guobis Z, 2012, J ORAL MAXILLOFAC RE, V3, pe2; Gwisai T, 2017, BIOMED MATER, V12, DOI 10.1088/1748-605X/aa7105; Hassoun M, 2018, J DRUG DELIV SCI TEC, V47, P485, DOI 10.1016/j.jddst.2018.08.006; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Ibrahim HR, 2011, J AGR FOOD CHEM, V59, P10336, DOI 10.1021/jf2020396; Imperi F, 2013, ANTIMICROB AGENTS CH, V57, P996, DOI 10.1128/AAC.01952-12; Ippolito JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159675; Jackson SN, 2019, J AM SOC MASS SPECTR, V30, P1199, DOI 10.1007/s13361-019-02166-x; Jeon S, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00819-20; Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976; Kanth PM, 2018, RESP CARE, V63, P1407, DOI 10.4187/respcare.06153; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Koskela HO, 2005, RESPIROLOGY, V10, P442, DOI 10.1111/j.1440-1843.2005.00724.x; Lai CC, 2020, J MICROBIOL IMMUNOL, V53, P404, DOI 10.1016/j.jmii.2020.02.012; Lee W, 2015, INFLAMMATION, V38, P1911, DOI 10.1007/s10753-015-0171-8; Lee-Huang S, 2005, BIOCHEMISTRY-US, V44, P4648, DOI 10.1021/bi0477081; Lenth RV, 2018, PACKAGE RSM; Li RR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8297; Malaczewska J, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2067-6; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Marple VA, 2003, J AEROSOL MED, V16, P301, DOI 10.1089/089426803769017668; Miller IF, 2020, NAT MED, V26, P1212, DOI 10.1038/s41591-020-0952-y; Mook RA, 2015, BIOORGAN MED CHEM, V23, P5829, DOI 10.1016/j.bmc.2015.07.001; Moussa EM, 2016, J PHARM SCI-US, V105, P417, DOI 10.1016/j.xphs.2015.11.002; Neffen H, 2010, ALLERGY ASTHMA PROC, V31, pS29, DOI 10.2500/aap.2010.31.3348; Orzalli MH, 2018, MOL CELL, V71, P825, DOI 10.1016/j.molcel.2018.07.009; Pawar S, 2020, SPECTROCHIM ACTA A, V227, DOI 10.1016/j.saa.2019.117623; Phillips DJ, 2012, J PHARM PHARMACOL, V64, P1549, DOI 10.1111/j.2042-7158.2012.01523.x; Piccaro G, 2013, ANTIMICROB AGENTS CH, V57, P1428, DOI 10.1128/AAC.02154-12; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; R Development Core Team, 2019, R LANG ENV STAT COMP; Ragland SA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006512; Rajamuthiah R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124595; Ratanji KD, 2014, J IMMUNOTOXICOL, V11, P99, DOI 10.3109/1547691X.2013.821564; Rohrschneider M, 2015, MOL PHARMACEUT, V12, P2618, DOI 10.1021/acs.molpharmaceut.5b00221; Sahakijpijarn S, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12111002; Sahakijpijarn S, 2020, ADV DRUG DELIVER REV, V165-166, P127, DOI 10.1016/j.addr.2020.05.003; Sanphui P, 2012, CRYST GROWTH DES, V12, P4588, DOI 10.1021/cg300784v; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schweizer MT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198389; Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6; Stout-Delgado HW, 2012, J IMMUNOL, V188, P2815, DOI 10.4049/jimmunol.1103051; Sun Z., 1999, Tubercle and Lung Disease, V79, P319, DOI 10.1054/tuld.1999.0212; Tam J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07705-w; Tharmalingam N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22037-x; Torres NS, 2016, ANTIMICROB AGENTS CH, V60, P5663, DOI 10.1128/AAC.00377-16; Travis SM, 1999, AM J RESP CELL MOL, V20, P872, DOI 10.1165/ajrcmb.20.5.3572; Wang W, 2012, INT J PHARMACEUT, V431, P1, DOI 10.1016/j.ijpharm.2012.04.040; Warnken ZN, 2018, MOL PHARMACEUT, V15, P1392, DOI 10.1021/acs.molpharmaceut.7b00702; Weers J, 2017, PHARM RES-DORDR, V34, P507, DOI 10.1007/s11095-016-2050-x; Wu FG, 2015, J PHYS CHEM B, V119, P14382, DOI 10.1021/acs.jpcb.5b07277; Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031; Xu JM, 2020, ACS INFECT DIS, V6, P909, DOI 10.1021/acsinfecdis.0c00052; Zhang Xiu, 2008, Agricultural Sciences in China, V7, P112, DOI 10.1016/S1671-2927(08)60029-2; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhurina MV, 2017, MICROBIOLOGY+, V86, P455, DOI 10.1134/S0026261717040154	84	23	23	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246803	10.1371/journal.pone.0246803	http://dx.doi.org/10.1371/journal.pone.0246803			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571320	Green Published, gold			2022-12-26	WOS:000618274000044
J	Hull, DM; Harrell, E; van Vliet, AHM; Correa, M; Thakur, S				Hull, Dawn M.; Harrell, Erin; van Vliet, Arnoud H. M.; Correa, Maria; Thakur, Siddhartha			Antimicrobial resistance and interspecies gene transfer in Campylobacter coli and Campylobacter jejuni isolated from food animals, poultry processing, and retail meat in North Carolina, 2018-2019	PLOS ONE			English	Article							EFFLUX PUMP; IDENTIFICATION; MECHANISMS; PATHOGEN; CMEABC; TOOL	The Center for Disease Control and Prevention identifies antimicrobial resistant (AMR) Campylobacter as a serious threat to U.S. public health due to high community burden, increased transmissibility, and limited treatability. The National Antimicrobial Resistance Monitoring System (NARMS) plays an important role in surveillance of AMR bacterial pathogens in humans, food animals and retail meats. This study investigated C. coli and C. jejuni from live food animals, poultry carcasses at production, and retail meat in North Carolina between January 2018-December 2019. Whole genome sequencing and bioinformatics were used for phenotypic and genotypic characterization to compare AMR profiles, virulence factors associated with Guillain-Barre Syndrome (GBS) (neuABC and cst-II or cst-III), and phylogenic linkage between 541 Campylobacter isolates (C. coli n = 343, C. jejuni n = 198). Overall, 90.4% (489/541) Campylobacter isolates tested positive for AMR genes, while 43% (233/541) carried resistance genes for three or more antibiotic classes and were classified molecularly multidrug resistant. AMR gene frequencies were highest against tetracyclines (64.3%), beta-lactams (63.6%), aminoglycosides (38.6%), macrolides (34.8%), quinolones (24.4%), lincosamides (13.5%), and streptothricins (5%). A total of 57.6% (114/198) C. jejuni carried GBS virulence factors, while three C. coli carried the C. jejuni-like lipooligosaccharide locus, neuABC and cst-II. Further evidence of C. coli and C. jejuni interspecies genomic exchange was observed in identical multilocus sequence typing, shared sequence type (ST) 7818 clonal complex 828, and identical species-indicator genes mapA, ceuE, and hipO. There was a significant increase in novel STs from 2018 to 2019 (2 in 2018 and 21 in 2019, p<0.002), illustrating variable Campylobacter genomes within food animal production. Introgression between C. coli and C. jejuni may aid pathogen adaption, lead to higher AMR and increase Campylobacter persistence in food processing. Future studies should further characterize interspecies gene transfer and evolutionary trends in food animal production to track evolving risks to public health.	[Hull, Dawn M.; Harrell, Erin; Correa, Maria; Thakur, Siddhartha] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA; [van Vliet, Arnoud H. M.] Univ Surrey, Sch Vet Med, Guildford, Surrey, England	University of North Carolina; North Carolina State University; University of Surrey	Thakur, S (corresponding author), North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.	sthakur@ncsu.edu		Thakur, Siddhartha/0000-0003-3787-9939; , Dawn/0000-0002-2065-7400	National Antimicrobial Resistance Monitoring System [1U01FD007145-01]; National Institutes of Health/ Food and Drug Administration [5U 18FD006194-02]	National Antimicrobial Resistance Monitoring System; National Institutes of Health/ Food and Drug Administration(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	ST Grant #-1U01FD007145-01 Funder name: National Antimicrobial Resistance Monitoring System URL: https://www.cdc.gov/narms/index.html Whole genome sequencing work is supported by the National Institutes of Health/ Food and Drug Administration under award number 5U 18FD006194-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock BP, 2020, NUCLEIC ACIDS RES, V48, pD517, DOI 10.1093/nar/gkz935; [Anonymous], 2018, CANCER DISCOV, V8, P9; [Anonymous], 2014, APF, VLX, P12; [Anonymous], 2010, BACT IS GEN SEQ DAT; Bolinger H, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00416-17, 10.1128/aem.00416-17]; Cagliero C, 2007, FEMS MICROBIOL LETT, V267, P89, DOI 10.1111/j.1574-6968.2006.00558.x; Cagliero C, 2006, ANTIMICROB AGENTS CH, V50, P3893, DOI 10.1128/AAC.00616-06; Campylobacter Multilocus Sequence Typing, 2018, CAMP MULT SEQ TYP; Chai S, 2011, MEMORANDUM FOODBORNE; Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239; Chen SH, 2020, FOOD MICROBIOL, V86, DOI 10.1016/j.fm.2019.103350; Corcoran D, 2006, INT J ANTIMICROB AG, V27, P40, DOI 10.1016/j.ijantimicag.2005.08.019; D'lima CB, 2007, APPL ENVIRON MICROB, V73, P2156, DOI 10.1128/AEM.02346-06; Wurfel SDR, 2020, MOL BIOL REP, V47, P671, DOI 10.1007/s11033-019-05174-y; Doyle ME, 2015, FOODBORNE PATHOG DIS, V12, P261, DOI 10.1089/fpd.2014.1865; Ellington MJ, 2017, CLIN MICROBIOL INFEC, V23, P2, DOI 10.1016/j.cmi.2016.11.012; Fabre A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00390-18, 10.1128/jcm.00390-18]; FDA) U.S. Food and Drug Administration, 2016, NARMS INT LAB MAN PR; Feldgarden M, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00483-19; Food and Drug Administration, 2020, NARMS METH FDA; Gebreyes WA, 2020, MICROBIOL SPECTR, V8, DOI 10.1128/microbiolspec.AME-0011-2019; Giacomelli M, 2014, MICROB DRUG RESIST, V20, P181, DOI 10.1089/mdr.2013.0110; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Golz JC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60320-y; Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172; Gras LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042599; Grinnage-Pulley T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131534; Gunther R, 2015, MABS, V7, P13; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hameed A, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00677; Han J, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00021; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Houliston RS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181750; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Kniel KE, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.PFS-0021-2017; Kolehmainen A, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00759-18; Korinthenberg R, 2013, HAND CLINIC, V112, P1157, DOI 10.1016/B978-0-444-52910-7.00036-2; Ladely SR, 2009, FOODBORNE PATHOG DIS, V6, P91, DOI 10.1089/fpd.2008.0098; Lang P, 2010, APPL ENVIRON MICROB, V76, P1913, DOI 10.1128/AEM.01753-09; Laughlin ME, 2019, CDC YELLOW BOOK 2020; Lurchachaiwong W, 2020, GUT PATHOG, V12, DOI 10.1186/s13099-020-00356-7; MedCalc Software Ltd, WIND XP SOFTW; Mourkas E, 2020, P NATL ACAD SCI USA, V117, P11018, DOI 10.1073/pnas.1917168117; Neal-McKinney JM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00408; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Olkkola S, 2010, MICROB DRUG RESIST, V16, P105, DOI 10.1089/mdr.2009.0128; Richards VP, 2013, INFECT GENET EVOL, V14, P200, DOI 10.1016/j.meegid.2012.12.010; Roberts T, 2009, LONG TERM HLTH OUTCO; Seemann T, 2020, SHOVILL FASTER SPADE; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; Tack DM, 2020, MMWR-MORBID MORTAL W, V69, P509, DOI 10.15585/mmwr.mm6917a1; Tang YZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00584-z; Thakur S, 2019, AM J TROP MED HYG, V100, P227, DOI 10.4269/ajtmh.18-0973; Tyson GH, 2016, J FOOD PROTECT, V79, P1891, DOI 10.4315/0362-028X.JFP-16-195; [U.S. Food and Drug Administration (FDA) Medicine CfV], 2018, SUMM REP ANT SOLD DI, P49; U.S. Food and Drug Administration (FDA), 2019, NARMS NOW INT DAT; [U.S. Food and Drug Administration (FDA) Services U. S. Department of Health and Human Services], 2017, NAT ANT RES MON SYST, P14; US FDA, 2019, NAT ANT RES MON SYST; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; Whelan MVX, 2019, SCI REPORTS, V9, P13; World Health Organization, 2017, PRIOR PATH GUID DISC; Xanthopoulou K, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9100675; Zahin M, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/340605, 10.1155/2013/263509, 10.1155/2013/605831, 10.1155/2013/510736]; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhao S, 2010, APPL ENVIRON MICROB, V76, P7949, DOI 10.1128/AEM.01297-10; 2016, CONFID BIOL MED, V44, P5	68	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246571	10.1371/journal.pone.0246571	http://dx.doi.org/10.1371/journal.pone.0246571			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571292	Green Published, gold			2022-12-26	WOS:000618274000061
J	Ahn, HS; Kim, SH; Kim, JY; Park, CS; Grimm, R; Son, Y				Ahn, Hye Shin; Kim, Sung Hun; Kim, Ji Youn; Park, Chang Suk; Grimm, Robert; Son, Yohan			Image quality and diagnostic value of diffusion-weighted breast magnetic resonance imaging: Comparison of acquired and computed images	PLOS ONE			English	Article								Purpose To compare the image quality of acquired diffusion-weighted imaging (DWI) and computed DWI and evaluate the lesion detectability and likelihood of malignancy in these datasets. Materials and methods This prospective study was approved by our institutional review board. A total of 29 women (mean age, 43.5 years) underwent DWI between August 2018 and April 2019 for 32 breast cancers and 16 benign breast lesions. Three radiologists independently reviewed the acquired DWI with b-values of 1000 and 2000 s/mm(2) (A-b1000 and A-b2000) and the computed DWI with a b-value of 2000 s/mm(2) (C-b2000). Image quality was scored and compared between the three DWI datasets. Lesion detectability was recorded, and the lesion's likelihood for malignancy was scored using a five-point scale. Results The A-b1000 images were superior to the A-b2000 and C-b2000 images in chest distinction, fat suppression, and overall image quality. The A-b2000 and C-b2000 images showed comparable scores for all image quality parameters. C-b2000 showed the highest values for lesion detection among all readers, although there was no statistical difference in sensitivity, specificity, positive predictive value, negative predictive value, and accuracy between the DWI datasets. The malignancy scores of the DWI images were not significantly different among the three readers. Conclusions A-b1000 DWI is suitable for breast lesion evaluations, considering its better image quality and comparable diagnostic values compared to that of A-b2000 and C-b2000 images. The additional use of computed high b-value DWI may have the potential to increase the detectability of breast masses.	[Ahn, Hye Shin] Chung Ang Univ, Chung Ang Univ Hosp, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Sung Hun] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Ji Youn] Catholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea; [Park, Chang Suk] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Radiol, Icheon, South Korea; [Grimm, Robert] Siemens Healthcare, MR Applicat Dev, Erlangen, Germany; [Son, Yohan] Siemens Healthineers Ltd, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Siemens AG; Siemens Germany	Kim, SH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea.	rad-ksh@catholic.ac.kr	Park, Changsuk/HGC-8334-2022	Kim, Sung Hun/0000-0003-4478-9720; Grimm, Robert/0000-0002-1233-8215	Reyon Pharmaceutical, Co., Ltd. (Seoul, Korea)	Reyon Pharmaceutical, Co., Ltd. (Seoul, Korea)	This study (S.H.K) was funded by Reyon Pharmaceutical, Co., Ltd. (Seoul, Korea). The funder provided support in the form of Research expenses for authors (S.H.K), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We note that one or more of the authors are employed by a commercial company: MR Applications Development, Siemens Healthcare and Siemens Healthinners Ltd.	Baltzer P, 2020, EUR RADIOL, V30, P1436, DOI 10.1007/s00330-019-06510-3; Baltzer PAT, 2018, INVEST RADIOL, V53, P229, DOI 10.1097/RLI.0000000000000433; Baltzer PAT, 2010, EUR RADIOL, V20, P1101, DOI 10.1007/s00330-009-1654-5; Bath M, 2007, BRIT J RADIOL, V80, P169, DOI 10.1259/bjr/35012658; Bickel H, 2019, J MAGN RESON IMAGING, V50, P1754, DOI 10.1002/jmri.26809; Blackledge MD, 2011, RADIOLOGY, V261, P573, DOI 10.1148/radiol.11101919; Chen X, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-693; Cho N, 2017, JAMA ONCOL, V3, P1495, DOI 10.1001/jamaoncol.2017.1256; Clauser P, 2014, EUR RADIOL, V24, P2213, DOI 10.1007/s00330-014-3189-7; DelPriore MR, 2021, ACAD RADIOL, V28, P1108, DOI 10.1016/j.acra.2020.03.011; Han XW, 2017, ACAD RADIOL, V24, P418, DOI 10.1016/j.acra.2016.11.006; Kang JW, 2017, BREAST CANCER RES TR, V165, P119, DOI 10.1007/s10549-017-4322-5; Katahira K, 2011, EUR RADIOL, V21, P188, DOI 10.1007/s00330-010-1883-7; Kitajima Kazuhiro, 2008, Magn Reson Med Sci, V7, P93, DOI 10.2463/mrms.7.93; Kuhl C, 2010, J CLIN ONCOL, V28, P1450, DOI 10.1200/JCO.2009.23.0839; Maas MC, 2013, INVEST RADIOL, V48, P779, DOI 10.1097/RLI.0b013e31829705bb; McDonald RJ, 2015, RADIOLOGY, V275, P772, DOI 10.1148/radiol.15150025; Nilsson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141825; Norris DG, 2001, NMR BIOMED, V14, P77, DOI 10.1002/nbm.682; O'Flynn EAM, 2016, J MAGN RESON IMAGING, V44, P130, DOI 10.1002/jmri.25131; Park JH, 2019, J MAGN RESON IMAGING, V49, P857, DOI 10.1002/jmri.26259; Partridge SC, 2009, AM J ROENTGENOL, V193, P1716, DOI 10.2214/AJR.08.2139; Riedl CC, 2015, J CLIN ONCOL, V33, P1128, DOI 10.1200/JCO.2014.56.8626; Rosenkrantz AB, 2013, J MAGN RESON IMAGING, V38, P694, DOI 10.1002/jmri.24016; Sardanelli F, 2011, INVEST RADIOL, V46, P94, DOI 10.1097/RLI.0b013e3181f3fcdf; Seo HS, 2008, AM J NEURORADIOL, V29, P458, DOI 10.3174/ajnr.A0842; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tamura T, 2019, MAGN RESON MED SCI, V18, P119, DOI 10.2463/mrms.mp.2018-0011; Verma S, 2016, ABDOM RADIOL, V41, P934, DOI 10.1007/s00261-015-0619-1; Woodhams R, 2013, MAGN RESON MED SCI, V12, P229, DOI 10.2463/mrms.2012-0028; Yabuuchi H, 2011, EUR RADIOL, V21, P11, DOI 10.1007/s00330-010-1890-8	31	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247379	10.1371/journal.pone.0247379	http://dx.doi.org/10.1371/journal.pone.0247379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617567	gold, Green Published			2022-12-26	WOS:000623082400051
J	Mohammad, H; Abutaleb, NS; Dieterly, AM; Lyle, LT; Seleem, MN				Mohammad, Haroon; Abutaleb, Nader S.; Dieterly, Alexandra M.; Lyle, L. Tiffany; Seleem, Mohamed N.			Evaluation of ebselen in resolving a methicillin-resistant Staphylococcus aureus infection of pressure ulcers in obese and diabetic mice	PLOS ONE			English	Article							MUPIROCIN RESISTANCE; DOUBLE-BLIND; THIOREDOXIN REDUCTASE; FOOT ULCERS; EFFICACY; RISK; COLONIZATION; PREVALENCE; OINTMENT; STRAINS	Pressure ulcers (PUs) are a source of morbidity in individuals with restricted mobility including individuals that are obese or diabetic. Infection of PUs with pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), impairs ulcers from healing. The present study evaluated ebselen as a topical antibacterial to treat MRSA-infected PUs. Against two different S. aureus strains, including MRSA USA300, resistance to ebselen did not emerge after 14 consecutive passages. Resistance to mupirocin emerged after only five passages. Additionally, ebselen was found to exert a modest postantibiotic effect of five hours against two MRSA strains. Ebselen was subsequently evaluated in MRSA-infected PUs in two models using obese and diabetic mice. In obese mice, topical ebselen (89.2% reduction) and oral linezolid (84.5% reduction) similarly reduced the burden of MRSA in infected PUs. However, in diabetic mice, topical ebselen (45.8% reduction in MRSA burden) was less effective. Histopathological evaluation of ulcers in diabetic mice determined that ebselen treatment resulted in fewer bacterial colonies deep within the dermis and that the treatment exhibited evidence of epithelial regeneration. Topical mupirocin was superior to ebselen in reducing MRSA burden in infected PUs both in obese (98.7% reduction) and diabetic (99.3% reduction) mice. Ebselen's antibacterial activity was negatively impacted as the bacterial inoculum was increased from 10(5) CFU/mL to 10(7) CFU/mL. These results suggest that a higher dose of ebselen, or a longer course of treatment, may be needed to achieve a similar effect as mupirocin in topically treating MRSA-infected pressure ulcers.	[Mohammad, Haroon; Abutaleb, Nader S.; Dieterly, Alexandra M.; Lyle, L. Tiffany; Seleem, Mohamed N.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Abutaleb, Nader S.; Seleem, Mohamed N.] Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Lyle, L. Tiffany] Purdue Univ, Ctr Comparat Translat Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Virginia Polytechnic Institute & State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Seleem, MN (corresponding author), Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.; Seleem, MN (corresponding author), Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	seleem@vt.edu		Mohammad, Haroon/0000-0002-8843-8933	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI130186]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (URL: https://www.niaid.nih.gov/) awarded to MNS (grant number R01AI130186). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelKhalek A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199710; Adult Obesity Facts Centers for Disease Control and Prevention (CDC), 2017, NAT CTR CHRON DIS PR; Antonoy NK, 2015, ANTIMICROB AGENTS CH, V59, P3350, DOI 10.1128/AAC.00079-15; Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Beckman JA, 2016, AM J PHYSIOL-HEART C, V311, pH1431, DOI 10.1152/ajpheart.00504.2016; Beckrich K, 1999, NURS ECON, V17, P263; Bender KO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac9103; Bermudez DM, 2011, AM J PATHOL, V178, P2215, DOI 10.1016/j.ajpath.2011.01.015; Bi CL, 2016, EUR J PHARMACOL, V780, P159, DOI 10.1016/j.ejphar.2016.03.044; Bien Malgorzata, 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P185; BORK K, 1989, BRIT J CLIN PRACT, V43, P284; Boulton A.J., 2018, COMPENDIA, V2018, DOI [10.2337/db20182-1, DOI 10.2337/DB20182-1]; Braga IA, 2013, J HOSP INFECT, V83, P314, DOI 10.1016/j.jhin.2012.11.008; Braga IA, 2017, BRAZ J INFECT DIS, V21, P171, DOI 10.1016/j.bjid.2016.11.007; Brown ML, 2012, J CLIN MICROBIOL, V50, P86, DOI 10.1128/JCM.05564-11; Bruun C, 2013, DIABETIC MED, V30, P964, DOI 10.1111/dme.12196; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V9th; Crawford F, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19570; Dayal N, 2019, ACS INFECT DIS, V5, P1820, DOI 10.1021/acsinfecdis.9b00022; Dong CJ, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.03016; dosSantos KRN, 1996, INFECT CONT HOSP EP, V17, P813; Farrell DJ, 2011, ANTIMICROB AGENTS CH, V55, P1177, DOI 10.1128/AAC.01285-10; Fish D.N, 2016, INFECT PRIMARY CARE, P7; Gustafsson TN, 2016, BBA-GEN SUBJECTS, V1860, P1265, DOI 10.1016/j.bbagen.2016.03.013; Honiden S, 2009, CLIN CHEST MED, V30, P581, DOI 10.1016/j.ccm.2009.05.007; Jones EM, 2015, ADV WOUND CARE, V4, P431, DOI 10.1089/wound.2014.0538; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Kil J, 2017, LANCET, V390, P969, DOI 10.1016/S0140-6736(17)31791-9; Konig C, 1998, J ANTIMICROB CHEMOTH, V42, P227, DOI 10.1093/jac/42.2.227; Kosowska-Shick K, 2006, ANTIMICROB AGENTS CH, V50, P765, DOI 10.1128/AAC.50.2.765-769.2006; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lowe Jeanne Redlin, 2009, Crit Care Nurs Clin North Am, V21, P311, DOI 10.1016/j.ccell.2009.07.007; Lu J, 2013, FASEB J, V27, P1394, DOI 10.1096/fj.12-223305; Ramirez-Acuna JM, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8040193; Miller MA, 1996, INFECT CONT HOSP EP, V17, P811; Mohammad H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64352-2; Mohammad H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182821; Ngo HX, 2016, BIOORGAN MED CHEM, V24, P6298, DOI 10.1016/j.bmc.2016.03.060; Nimmo GR, 2012, CLIN MICROBIOL INFEC, V18, P725, DOI 10.1111/j.1469-0691.2012.03822.x; NOZAWA R, 1989, ANTIMICROB AGENTS CH, V33, P1388, DOI 10.1128/AAC.33.8.1388; ODOM RB, 1989, CUTIS, V43, P599; Ogawa A, 1999, CEREBROVASC DIS, V9, P112, DOI 10.1159/000015908; Oliveira D, 2018, TOXINS, V10, DOI 10.3390/toxins10060252; Parnham MJ, 2013, BIOCHEM PHARMACOL, V86, P1248, DOI 10.1016/j.bcp.2013.08.028; Peek ME, 2011, CLIN ORTHOP RELAT R, V469, P1951, DOI 10.1007/s11999-010-1735-4; Pence BD, 2014, ADV WOUND CARE, V3, P71, DOI 10.1089/wound.2012.0377; Preventing Pressure Ulcers in Hospitals, CONT LAST REV OCT 20; Sato T, 2018, WOUND REPAIR REGEN, V26, P284, DOI 10.1111/wrr.12675; Simor AE, 2007, ANTIMICROB AGENTS CH, V51, P3880, DOI 10.1128/AAC.00846-07; Skrepnek GH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134914; Smith Kenneth P, 2018, Antimicrob Agents Chemother, V62, DOI [10.1128/AAC.00433-18, 10.1128/aac.00433-18]; SUTHERLAND R, 1985, ANTIMICROB AGENTS CH, V27, P495, DOI 10.1128/AAC.27.4.495; Thangamani S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133877; Thangamani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11596; van Bambeke F., 2017, INFECT DIS-NOR, VFourth, DOI [10.1016/S1473-3099%2817%2930487-5, DOI 10.1016/S1473-3099%2817%2930487-5]; VanGilder C, 2009, OSTOMY WOUND MANAG, V55, P39; Vanhommerig E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104561; Williamson Deborah A, 2017, Clin Microbiol Rev, V30, P827, DOI 10.1128/CMR.00112-16; Wojtowicz H., 2003, Farmaco (Lausanne), V58, P1235, DOI 10.1016/j.farmac.2003.08.003; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12	60	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247508	10.1371/journal.pone.0247508	http://dx.doi.org/10.1371/journal.pone.0247508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617589	Green Published, gold			2022-12-26	WOS:000623082400004
J	Mugisha, JYT; Ssebuliba, J; Nakakawa, JN; Kikawa, CR; Ssematimba, A				Mugisha, Joseph Y. T.; Ssebuliba, Joseph; Nakakawa, Juliet N.; Kikawa, Cliff R.; Ssematimba, Amos			Mathematical modeling of COVID-19 transmission dynamics in Uganda: Implications of complacency and early easing of lockdown	PLOS ONE			English	Article							CHINA; WUHAN; NUMBERS	Background Uganda has a unique set up comprised of resource-constrained economy, social-economic challenges, politically diverse regional neighborhood and home to long-standing refuge crisis that comes from long and protracted conflicts of the great lakes. The devastation of the on-going global pandemic outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is likely to be escalated by these circumstances with expectations of the impact of the disease being severe. Materials and methods In this study, we formulate a mathematical model that incorporates the currently known disease characteristics and tracks various intervention measures that the government of Uganda has implemented since the reporting of the first case in March 2020. We then evaluate these measures to understand levels of responsiveness and adherence to standard operating procedures and quantify their impact on the disease burden. Novel in this model was the unique aspect of modeling the trace-and-isolate protocol in which some of the latently infected individuals tested positive while in strict isolation centers thereby reducing their infectious period. Results The study findings show that even with elimination of all imported cases at any given time it would take up to nine months to rid Uganda of the disease. The findings also show that the optimal timing of easing of lockdowns while mitigating the possibility of re-emergence of a second epidemic wave requires avoiding the scenario of releasing too-many-too-soon. It is even more worrying that enhancing contact tracing would only affect the magnitude and timing of the second wave but cannot prevent it altogether. Conclusion We conclude that, given the prevailing circumstances, a phased-out lifting of lockdown measures, minimization of COVID-19 transmissibility within hospital settings, elimination of recruitment of infected individuals as well as enhanced contact tracing would be key to preventing overwhelming of the healthcare system that would come with dire consequences.	[Mugisha, Joseph Y. T.; Ssebuliba, Joseph; Nakakawa, Juliet N.] Makerere Univ, Coll Nat Sci, Dept Math, Kampala, Uganda; [Kikawa, Cliff R.] Kabale Univ, Fac Econ & Management Sci, Dept Econ & Stat, Kabale, Uganda; [Ssematimba, Amos] Gulu Univ, Dept Math, Fac Sci, Gulu, Uganda	Makerere University	Ssematimba, A (corresponding author), Gulu Univ, Dept Math, Fac Sci, Gulu, Uganda.	amos.ssematimba@gmail.com	Ssematimba, Amos/S-3217-2019	Ssematimba, Amos/0000-0002-5407-2478	Makerere University Research and Innovation Fund	Makerere University Research and Innovation Fund	JYTM was funded through Makerere University Research and Innovation Fund.	Acuna-Zegarra MA, 2020, MATH BIOSCI, V325, DOI 10.1016/j.mbs.2020.108370; [Anonymous], 2019, STATISTICS-ABINGDON; [Anonymous], COV 19 INF; Atumanya P, 2020, J CRIT CARE, V55, P95, DOI 10.1016/j.jcrc.2019.10.019; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Brand SPC, 2020, FORECASTING SCALE CO, DOI [10.1101/2020.04.09.20059865, DOI 10.1101/2020.04.09.20059865]; Carcione JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00230; Chen TM, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00640-3; Chintalapudi N, 2020, J MICROBIOL IMMUNOL, V53, P396, DOI 10.1016/j.jmii.2020.04.004; De Jong M., 1995, EPIDEMIC MODELS THEI, P84; Hu H, 2013, MATH BIOSCI, V244, P125, DOI 10.1016/j.mbs.2013.04.013; Ing AJ, 2020, THORAX, V75, P693, DOI 10.1136/thoraxjnl-2020-215091; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kirenga B, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000646; Kretzschmar ME., 2020, EFFECTIVENESS ISOLAT; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lalwani S, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109939; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058; Liu Z, 2020, INFECT DIS MODEL, V5, P323, DOI 10.1016/j.idm.2020.03.003; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Meng H, 2020, J INFECTION, V81, pE33, DOI 10.1016/j.jinf.2020.04.004; Migisha R, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00643-7; Ministry of Health Uganda, 2020, COR PAND COVID 19 UP; Ministry of Health Uganda, CLIN INFECT DIS; Ministry of Health-Uganda, 2020, UPD COVID 19 OUTBR U; Ministry of Health-Uganda, 2021, COVID 19 RESP INF HU; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Mubayi A, 2010, MATH BIOSCI ENG, V7, P687, DOI 10.3934/mbe.2010.7.687; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Rawson T, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00262; Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4; Ssematimba A, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/s0950268819000633, 10.1017/S0950268819000633]; THRALL PH, 1995, AM NAT, V145, P43, DOI 10.1086/285727; van Bunnik B, 2020, SEGMENTATION SHIELDI, DOI [10.1101/2020.05.04.20090597, DOI 10.1101/2020.05.04.20090597]; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; WHO-China, REP WHO CHIN JOINT M; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64; Zhao SL, 2020, QUANT BIOL, V8, P11, DOI 10.1007/s40484-020-0199-0; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	44	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247456	10.1371/journal.pone.0247456	http://dx.doi.org/10.1371/journal.pone.0247456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617579	Green Published, gold			2022-12-26	WOS:000623082400052
J	Omoto, T; Asahina, Y; Zhou, HP; Fujino, R; Takao, M; Obata, R; Inoue, T; Asaoka, R; Maruyama-Inoue, M; Yanagi, Y; Kadonosono, K				Omoto, Takashi; Asahina, Yuichi; Zhou, Han Peng; Fujino, Ryosuke; Takao, Muneyuki; Obata, Ryo; Inoue, Tatsuya; Asaoka, Ryo; Maruyama-Inoue, Maiko; Yanagi, Yasuo; Kadonosono, Kazuaki			Visual outcomes and prognostic factors of vitrectomy for lamellar macular holes and epiretinal membrane foveoschisis	PLOS ONE			English	Article								Purpose To evaluate the visual outcomes of vitrectomy for lamellar macular hole (LMH) and epiretinal membrane (ERM) foveoschisis and to investigate the prognostic factor for postoperative visual acuity. Methods We retrospectively reviewed 15 LMH and 17 ERM foveoschisis eyes that had undergone a standard three-port pars plana vitrectomy with (12 eyes) or without (20 eyes) cataract surgery. Best-corrected visual acuity (BCVA) at postoperative three months and the final visit were compared to the preoperative measurements. We investigated the relationship between BCVA at the final visit and baseline parameters (age, preoperative BCVA, the presence of epiretinal proliferation [EP] and ellipsoid zone [EZ] disruption). The best explanatory variables for the final BCVA were investigated using the corrected Akaike information criterion (AICc) model selection. Results The mean age was 67.2 years. The mean follow-up duration was 30.7 months. Fifteen of 32 examined eyes were diagnosed as LMH and 17 eyes as ERM foveoschisis. Twelve eyes in LMH had EP and 13 eyes showed the disruption of EZ integrity. In total, BCVA significantly improved at 3 months postoperatively (p = 0.0013). A significant improvement was observed in ERM foveoschisis (p = 0.0085) but not in LMH group (p = 0.071). Comparing the BCVA between the baseline and the final visit, significant improvements were observed in total, ERM foveoschisis and LMH group (p<0.001, p<0.001 and p = 0.026, respectively). The optimal model for BCVA at the final visit included preoperative BCVA and the presence of EZ disruption (p<0.001 and p<0.001, respectively). Conclusion Our results suggested that the final BCVA was dependent on preoperative BCVA and the presence of EZ disruption. Surgical indications might be warranted for LMHs with EZ disruption.	[Omoto, Takashi; Asahina, Yuichi; Zhou, Han Peng; Fujino, Ryosuke; Takao, Muneyuki; Obata, Ryo; Inoue, Tatsuya; Asaoka, Ryo] Univ Tokyo, Dept Ophthalmol, Tokyo, Japan; [Inoue, Tatsuya; Maruyama-Inoue, Maiko; Yanagi, Yasuo; Kadonosono, Kazuaki] Yokohama City Univ, Dept Ophthalmol & Microtechnol, Yokohama, Kanagawa, Japan	University of Tokyo; Yokohama City University	Inoue, T (corresponding author), Univ Tokyo, Dept Ophthalmol, Tokyo, Japan.; Inoue, T (corresponding author), Yokohama City Univ, Dept Ophthalmol & Microtechnol, Yokohama, Kanagawa, Japan.	inouet-tky@umin.ac.jp	Yanagi, Yasuo/AAA-5441-2022	Asahina, Yuichi/0000-0001-8711-282X; Omoto, Takashi/0000-0002-2120-6839				Androudi S, 2009, AM J OPHTHALMOL, V148, P420, DOI 10.1016/j.ajo.2009.04.009; Casparis H, 2011, RETINA-J RET VIT DIS, V31, P1783, DOI 10.1097/IAE.0b013e31820a6818; Choi WS, 2018, RETINA-J RET VIT DIS, V38, P664, DOI 10.1097/IAE.0000000000001591; Compera D, 2015, AM J OPHTHALMOL, V160, P373, DOI 10.1016/j.ajo.2015.05.010; Figueroa MS, 2019, RETINA-J RET VIT DIS, V39, P2090, DOI 10.1097/IAE.0000000000002326; Figueroa MS, 2011, CAN J OPHTHALMOL, V46, P491, DOI 10.1016/j.jcjo.2011.09.011; Garretson BR, 2008, OPHTHALMOLOGY, V115, P884, DOI 10.1016/j.ophtha.2007.06.029; Gaudric A, 2013, AM J OPHTHALMOL, V155, P733, DOI 10.1016/j.ajo.2012.10.021; Govetto A, 2016, AM J OPHTHALMOL, V164, P99, DOI 10.1016/j.ajo.2016.02.008; Ho TC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52447-4; Hubschman JP, 2020, BRIT J OPHTHALMOL, V104, P1741, DOI 10.1136/bjophthalmol-2019-315432; Ko J, 2017, ACTA OPHTHALMOL, V95, pE221, DOI 10.1111/aos.13245; Lee CS, 2012, ACTA OPHTHALMOL, V90, pe597, DOI 10.1111/j.1755-3768.2012.02456.x; Mirza RG, 2007, SURV OPHTHALMOL, V52, P397, DOI 10.1016/j.survophthal.2007.04.007; Morescalchi F, 2020, RETINA-J RET VIT DIS, V40, P1087, DOI 10.1097/IAE.0000000000002559; Takahashi K, 2019, GRAEF ARCH CLIN EXP, V257, P2147, DOI 10.1007/s00417-019-04425-9; Witkin AJ, 2006, OPHTHALMOLOGY, V113, P388, DOI 10.1016/j.ophtha.2005.10.047; Witkin AJ., 2009, INVEST OPHTH VIS SCI, V50, P6052; Xu HY, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01617-4	19	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247509	10.1371/journal.pone.0247509	http://dx.doi.org/10.1371/journal.pone.0247509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617584	Green Published, gold			2022-12-26	WOS:000623082400006
J	Shi, XH; Wang, H; Wang, X; Jing, HQ; Duan, R; Qin, S; Lv, DY; Fan, YF; Huang, ZZ; Stirling, K; Zhang, L; Wang, JZ				Shi, Xiaohong; Wang, Hong; Wang, Xin; Jing, Huaiqi; Duan, Ran; Qin, Shuai; Lv, Dongyue; Fan, Yufeng; Huang, Zhenzhou; Stirling, Kyle; Zhang, Lei; Wang, Jiazheng			Molecular characterization and antibiotic resistance of Acinetobacter baumannii in cerebrospinal fluid and blood	PLOS ONE			English	Article							CARBAPENEM-RESISTANT; CLONAL DISSEMINATION; DRUG-RESISTANCE; CRITICAL-VALUES; MULTIPLEX PCR; EPIDEMIOLOGY; MEROPENEM; IMIPENEM; EMERGENCE; GENES	The increasing prevalence of carbapenem-resistant Acinetobacter baumannii (CRAB) caused nosocomial infections generate significant comorbidity and can cause death among patients. Current treatment options are limited. These infections pose great difficulties for infection control and clinical treatment. To identify the antimicrobial resistance, carbapenemases and genetic relatedness of Acinetobacter baumannii isolates from cerebrospinal fluid (CSF) and blood, a total of 50 nonrepetitive CSF isolates and 44 blood isolates were collected. The resistance phenotypes were determined, and polymerase chain reaction (PCR) was performed to examine the mechanisms of carbapenem resistance. Finally, multilocus sequence typing (MLST) was conducted to determine the genetic relatedness of these isolates. It was observed that 88 of the 94 collected isolates were resistant to imipenem or meropenem. Among them, the bla(OXA-23) gene was the most prevalent carbapenemase gene, with an observed detection rate of 91.5% (86/94), followed by the bla(OXA-24) gene with a 2.1% detection rate (2/94). Among all carbapenem-resistant Acinetobacter baumannii (CRAB) observations, isolates with the bla(OXA-23) gene were resistant to both imipenem and meropenem. Interestingly, isolates positive for the bla(OXA-24) gene but negative for the bla(OXA-23) gene showed an imipenem-sensitive but meropenem-resistant phenotype. The MLST analysis identified 21 different sequence types (STs), with ST195, ST540 and ST208 most frequently detected (25.5%, 12.8% and 11.7%, respectively). 80 of the 94 isolates (85.1%) were clustered into CC92 which showed a carbapenem resistance phenotype (except AB13). Five novel STs were detected, and most of them belong to CRAB. In conclusion, these findings provide additional observations and epidemiological data of CSF and blood A. baumannii strains, which may improve future infection-control measures and aid in potential clinical treatments in hospitals and other clinical settings.	[Shi, Xiaohong; Wang, Hong; Wang, Jiazheng] Shandong First Med Univ, Affiliated Hosp 1, Shandong Prov Qianfoshan Hosp, Dept Clin Lab, Jinan, Shandong, Peoples R China; [Wang, Xin; Jing, Huaiqi; Duan, Ran; Qin, Shuai; Lv, Dongyue; Fan, Yufeng; Huang, Zhenzhou] Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Stirling, Kyle; Zhang, Lei] Shandong Univ, Cheeloo Coll Med, Sch Publ Hlth, Dept Biostat, Jinan, Peoples R China; [Stirling, Kyle] Indiana Univ, Luddy Sch Informat Comp & Engn, Bloomington, IN USA; [Zhang, Lei] Shandong Univ, Inst Med Dataol, Cheeloo Coll Med, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shandong University; Indiana University System; Indiana University Bloomington; Shandong University	Wang, JZ (corresponding author), Shandong First Med Univ, Affiliated Hosp 1, Shandong Prov Qianfoshan Hosp, Dept Clin Lab, Jinan, Shandong, Peoples R China.	wangjiazheng1210@163.com			National Sci-Tech Key Project [2018ZX10713-003-002, 2018ZX10713-001-002]	National Sci-Tech Key Project	This work was supported by the National Sci-Tech Key Project (2018ZX10713-003-002, 2018ZX10713-001-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimi L, 2015, INT J MOL CELL MED, V4, P46; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Biglari S, 2015, J MED MICROBIOL, V64, P53, DOI 10.1099/jmm.0.082263-0; Castanheira M, 2008, J CLIN MICROBIOL, V46, P3179, DOI 10.1128/JCM.00988-08; Chang YW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00910; Chapman CN, 2011, CANCER CYTOPATHOL, V119, P148, DOI 10.1002/cncy.20158; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Dandouh E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176824; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; El Bannah AMS, 2018, MICROB DRUG RESIST, V24, P269, DOI 10.1089/mdr.2017.0057; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Fu YQ, 2010, J ANTIMICROB CHEMOTH, V65, P644, DOI 10.1093/jac/dkq027; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hao HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147639; Howanitz PJ, 2002, ARCH PATHOL LAB MED, V126, P663; Hu FP, 2019, EUR J CLIN MICROBIOL, V38, P2275, DOI 10.1007/s10096-019-03673-1; Hu FP, 2018, CLIN INFECT DIS, V67, pS128, DOI 10.1093/cid/ciy657; Hu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32066; Huang GT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01717; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Kayama S, 2015, ANTIMICROB AGENTS CH, V59, P1379, DOI 10.1128/AAC.04330-14; Kayama S, 2013, ANN LAB MED, V33, P383, DOI 10.3343/alm.2013.33.5.383; Kuti JL, 2004, PHARMACOTHERAPY, V24, P8, DOI 10.1592/phco.24.1.8.34804; Li Y, 2015, J MICROBIOL IMMUNOL, V48, P101, DOI 10.1016/j.jmii.2014.04.005; Loho T, 2015, ACTA MED INDONES, V47, P157; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Merino M, 2014, MICROB DRUG RESIST, V20, P259, DOI 10.1089/mdr.2013.0127; Novelli A, 2005, CLIN PHARMACOKINET, V44, P539, DOI 10.2165/00003088-200544050-00007; Nowak P, 2016, FOLIA HISTOCHEM CYTO, V54, P61, DOI 10.5603/FHC.a2016.0009; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pagano M, 2016, BRAZ J MICROBIOL, V47, P785, DOI 10.1016/j.bjm.2016.06.005; Partridge SR, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00088-17; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Qu JY, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9254907; Ruan Z, 2013, INT J ANTIMICROB AG, V42, P322, DOI 10.1016/j.ijantimicag.2013.06.019; Runnegar N, 2010, J CLIN MICROBIOL, V48, P4051, DOI 10.1128/JCM.01208-10; Todorova B, 2014, WORLD J MICROB BIOT, V30, P1427, DOI 10.1007/s11274-013-1562-3; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Xiao YH, 2011, DRUG RESIST UPDATE, V14, P236, DOI 10.1016/j.drup.2011.07.001; Zowawi HM, 2015, J CLIN MICROBIOL, V53, P896, DOI 10.1128/JCM.02784-14	42	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247418	10.1371/journal.pone.0247418	http://dx.doi.org/10.1371/journal.pone.0247418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617547	Green Submitted, gold, Green Published			2022-12-26	WOS:000623082400047
J	Ziemba, M; Barkhouse, M; Uaesoontrachoon, K; Giri, M; Hathout, Y; Dang, UJ; Gordish-Dressman, H; Nagaraju, K; Hoffman, EP				Ziemba, Michael; Barkhouse, Molly; Uaesoontrachoon, Kitipong; Giri, Mamta; Hathout, Yetrib; Dang, Utkarsh J.; Gordish-Dressman, Heather; Nagaraju, Kanneboyina; Hoffman, Eric P.			Biomarker-focused multi-drug combination therapy and repurposing trial in mdx mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; HYPERTROPHY; DISCOVERY; MUSCLE	Duchenne muscular dystrophy is initiated by dystrophin deficiency, but downstream pathophysiological pathways such as membrane instability, NFB activation, mitochondrial dysfunction, and induction of TGF beta fibrosis pathways are thought to drive the disability. Dystrophin replacement strategies are hopeful for addressing upstream dystrophin deficiency; however, all methods to date use semi-functional dystrophin proteins that are likely to trigger downstream pathways. Thus, combination therapies that can target multiple downstream pathways are important in treating DMD, even for dystrophin-replacement strategies. We sought to define blood pharmacodynamic biomarkers of drug response in the mdx mouse model of Duchenne muscular dystrophy using a series of repurposed drugs. Four-week-old mdx mice were treated for four weeks with four different drugs singly and in combination: vehicle, prednisolone, vamorolone, rituximab, beta-aminoisobutyric acid (BAIBA) (11 treatment groups; n = 6/group). Blood was collected via cardiac puncture at study termination, and proteomic profiling was carried out using SOMAscan aptamer panels (1,310 proteins assayed). Prednisolone was tested alone and in combination with other drugs. It was found to have a good concordance of prednisolone-responsive biomarkers (56 increased by prednisolone, 39 decreased) focused on NF kappa B and TGF beta cascades. Vamorolone shared 45 (80%) of increased biomarkers and 13 (33%) of decreased biomarkers with prednisolone. Comparison of published human corticosteroid-responsive biomarkers to our mdx data showed 14% (3/22) concordance between mouse and human. Rituximab showed fewer drug-associated biomarkers, with the most significant being human IgG. On the other hand, BAIBA treatment (high and low dose) showed a drug-associated increase in 40 serum proteins and decreased 5 serum proteins. Our results suggest that a biomarker approach could be employed for assessing drug combinations in both mouse and human studies.	[Ziemba, Michael] SUNY Binghamton, Dept Biomed Engn, Binghamton, NY USA; [Barkhouse, Molly; Uaesoontrachoon, Kitipong; Nagaraju, Kanneboyina; Hoffman, Eric P.] AGADA Biosci, Halifax, NS, Canada; [Giri, Mamta] Mt Sinai Hosp, Dept Genet & Genom Sci, New York, NY 10029 USA; [Hathout, Yetrib; Nagaraju, Kanneboyina; Hoffman, Eric P.] SUNY Binghamton, Dept Pharmaceut Sci, Sch Pharm & Pharmaceut Sci, Binghamton, NY 13902 USA; [Dang, Utkarsh J.] SUNY Binghamton, Dept Hlth Outcomes & Adm Sci, Sch Pharm & Pharmaceut Sci, Binghamton, NY USA; [Gordish-Dressman, Heather] Childrens Natl Med Ctr, Ctr Translat Sci, Washington, DC 20010 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Children's National Health System	Nagaraju, K (corresponding author), AGADA Biosci, Halifax, NS, Canada.; Nagaraju, K (corresponding author), SUNY Binghamton, Dept Pharmaceut Sci, Sch Pharm & Pharmaceut Sci, Binghamton, NY 13902 USA.	nagaraju@binghamton.edu	Nagaraju, Kanneboyina/ABA-6525-2021; Nagaraju, Kanneboyina/AAV-7684-2021	nagaraju, kanneboyina/0000-0002-1601-8489; Dang, Utkarsh/0000-0003-4120-2015	Foundation to Eradicate Duchenne	Foundation to Eradicate Duchenne	Funded by the Foundation to Eradicate Duchenne. The authors would like to thank the Foundation to Eradicate Duchenne for financial support of this study. The financers had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell EL, 2019, MITOCHONDRION, V46, P51, DOI 10.1016/j.mito.2018.02.006; Bello L, 2015, NEUROLOGY, V85, P1048, DOI 10.1212/WNL.0000000000001950; BIEBER FR, 1989, AM J HUM GENET, V45, P362; Conklin LS, 2018, PHARMACOL RES, V136, P140, DOI 10.1016/j.phrs.2018.09.007; Conklin LS., 2018, SERUM BIOMARKERS GLU, P1; Dadgar S, 2014, J CELL BIOL, V207, P139, DOI 10.1083/jcb.201402079; Fiorillo AA, 2018, PHYSIOL GENOMICS, V50, P735, DOI 10.1152/physiolgenomics.00134.2017; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; George AP, 2019, COMPUT STRUCT BIOTEC, V17, P484, DOI 10.1016/j.csbj.2019.03.015; Hathout Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31727; Hathout Y, 2014, HUM MOL GENET, V23, P6458, DOI 10.1093/hmg/ddu366; Heier Christopher R, 2019, Life Sci Alliance, V2, DOI 10.26508/lsa.201800186; Heier CR, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.49; Heier CR, 2013, EMBO MOL MED, V5, P1569, DOI 10.1002/emmm.201302621; Hoffman EP, 2020, HANDB EXP PHARMACOL, V261, P25, DOI 10.1007/164_2019_256; Hoffman EP, 2019, NEUROLOGY, V93, pE1312, DOI 10.1212/WNL.0000000000008168; Hoffman EP, 2018, STEROIDS, V134, P43, DOI 10.1016/j.steroids.2018.02.010; Hudson WH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03780-1; Jung TW, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0431-7; Kornegay JN, 2012, PHYS MED REH CLIN N, V23, P149, DOI 10.1016/j.pmr.2011.11.014; Kraemer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026332; Kuno A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33930-w; Lee S, 2019, BIODRUGS, V33, P469, DOI 10.1007/s40259-019-00376-z; Mitrofanova A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10584-4; Nghiem PP, 2013, AM J PATHOL, V183, P1411, DOI 10.1016/j.ajpath.2013.07.013; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Rosenberg AS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7322; Scheschowitsch K, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00016; SomaLogic, 2016, SOMASCAN QUAL STAT; Sreetama SC, 2018, MOL THER, V26, P2231, DOI 10.1016/j.ymthe.2018.07.021; Zhang WC, 2018, CELL MOL IMMUNOL, V15, P756, DOI 10.1038/cmi.2017.149	31	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0246507	10.1371/journal.pone.0246507	http://dx.doi.org/10.1371/journal.pone.0246507			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617542	gold, Green Published			2022-12-26	WOS:000623082400024
J	de Castro, ACV; Araujo, A; Fonseca, A; Olsson, IAS				Vieira de Castro, Ana Catarina; Araujo, Angelo; Fonseca, Andre; Olsson, I. Anna S.			Improving dog training methods: Efficacy and efficiency of reward and mixed training methods	PLOS ONE			English	Article								Dogs play an important role in our society as companions and work partners, and proper training of these dogs is pivotal. For companion dogs, training helps preventing or managing dog behavioral problems-the most frequently cited reason for relinquishing and euthanasia, and it promotes successful dog-human relationships and thus maximizes benefits humans derive from bonding with dogs. For working dogs, training is crucial for them to successfully accomplish their jobs. Dog training methods range widely from those using predominantly aversive stimuli (aversive methods), to those combining aversive and rewarding stimuli (mixed methods) and those focusing on the use of rewards (reward methods). The use of aversive stimuli in training is highly controversial and several veterinary and animal protection organizations have recommended a ban on pinch collars, e-collars and other techniques that induce fear or pain in dogs, on the grounds that such methods compromise dog welfare. At the same time, training methods based on the use of rewards are claimed to be more humane and equally or more effective than aversive or mixed methods. This important discussion, however, has not always been based in solid scientific evidence. Although there is growing scientific evidence that training with aversive stimuli has a negative impact on dog welfare, the scientific literature on the efficacy and efficiency of the different methodologies is scarce and inconsistent. Hence, the goal of the current study is to investigate the efficacy and efficiency of different dog training methods. To that end, we will apply different dog training methods in a population of working dogs and evaluate the outcome after a period of training. The use of working dogs will allow for a rigorous experimental design and control, with randomization of treatments. Military (n = 10) and police (n = 20) dogs will be pseudo-randomly allocated to two groups. One group will be trained to perform a set of tasks (food refusal, interrupted recall, dumbbell retrieval and placing items in a basket) using reward methods and the other group will be trained for the same tasks using mixed methods. Later, the dogs will perform a standardized test where they will be required to perform the trained behaviors. The reliability of the behaviors and the time taken to learn them will be assessed in order to evaluate the efficacy and efficiency, respectively, of the different training methods. This study will be performed in collaboration with the Portuguese Army and with the Portuguese Public Security Police (PSP) and integrated with their dog training programs.	[Vieira de Castro, Ana Catarina; Olsson, I. Anna S.] Univ Porto, Inst Biol Mol & Celular, Porto, Portugal; [Vieira de Castro, Ana Catarina; Olsson, I. Anna S.] Univ Porto, i3S Inst Invest & Inovacao Saude, Porto, Portugal; [Araujo, Angelo] Policia Seguranca Publ, Lisbon, Portugal; [Fonseca, Andre] Mil Acad, CINAMIL, Res Ctr Portuguese Army, Lisbon, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto	de Castro, ACV (corresponding author), Univ Porto, Inst Biol Mol & Celular, Porto, Portugal.; de Castro, ACV (corresponding author), Univ Porto, i3S Inst Invest & Inovacao Saude, Porto, Portugal.	ana.castro@ibmc.up.pt		Vieira de Castro, Ana/0000-0002-3357-7282				Barker SB, 2008, J VET MED EDUC, V35, P487, DOI 10.3138/jvme.35.4.487; Blackwell EJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-93; Chiandetti C, 2016, APPL ANIM BEHAV SCI, V184, P109, DOI 10.1016/j.applanim.2016.08.006; China L, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00508; Cooper JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102722; Cornu JN, 2011, EUR UROL, V59, P197, DOI 10.1016/j.eururo.2010.10.006; Crawford EK, 2006, ANTHROZOOS, V19, P98, DOI 10.2752/089279306785593757; D'Onofrio J., 2015, MEASURING EFFICIENCY; Dale AR, 2017, APPL ANIM BEHAV SCI, V191, P59, DOI 10.1016/j.applanim.2017.03.003; de Castro ACV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0225023; Dorey NR, 2020, J VET BEHAV, V39, P57, DOI 10.1016/j.jveb.2020.07.005; Fernandes JG, 2017, APPL ANIM BEHAV SCI, V196, P1, DOI 10.1016/j.applanim.2017.07.001; Haverbeke A, 2008, APPL ANIM BEHAV SCI, V113, P110, DOI 10.1016/j.applanim.2007.11.010; Haverbeke A, 2010, J VET BEHAV, V5, P112, DOI 10.1016/j.jveb.2009.08.008; Hendriksen P, 2011, J VET BEHAV, V6, P261, DOI 10.1016/j.jveb.2011.02.007; Hiby EF, 2004, ANIM WELFARE, V13, P63; Mazur J., 2006, LEARN BEHAV, V6; Payne E, 2015, PSYCHOL RES BEHAV MA, V8, P71, DOI 10.2147/PRBM.S74972; Pryor K, 1999, DONT SHOOT DOG NEW A; Reisner I, 2017, DOMESTIC DOG: ITS EVOLUTION, BEHAVIOR AND INTERACTIONS WITH PEOPLE, 2ND EDITION, P210; Salgirli Y, 2012, REV MED VET-TOULOUSE, V163, P530; Sankey C, 2010, ANIM COGN, V13, P753, DOI 10.1007/s10071-010-0326-9; Suresh Kp, 2011, J Hum Reprod Sci, V4, P8, DOI 10.4103/0974-1208.82352; de Castro ACV, 2019, APPL ANIM BEHAV SCI, V219, DOI 10.1016/j.applanim.2019.104831; Visser EK, 2009, VET J, V181, P48, DOI 10.1016/j.tvjl.2009.03.009; Williams JL, 2004, APPL ANIM BEHAV SCI, V88, P331, DOI 10.1016/j.applanim.2004.03.008; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712; Yin S, 2008, APPL ANIM BEHAV SCI, V113, P123, DOI 10.1016/j.applanim.2007.11.001	28	2	2	9	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247321	10.1371/journal.pone.0247321	http://dx.doi.org/10.1371/journal.pone.0247321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606822	Green Published, gold			2022-12-26	WOS:000620629200046
J	Butti, R; Nimma, R; Kundu, G; Bulbule, A; Kumar, TVS; Gunasekaran, VP; Tomar, D; Kumar, D; Mane, A; Gill, SS; Patil, T; Weber, GF; Kundu, GC				Butti, Ramesh; Nimma, Ramakrishna; Kundu, Gautam; Bulbule, Anuradha; Kumar, Totakura V. S.; Gunasekaran, Vinoth Prasanna; Tomar, Deepti; Kumar, Dhiraj; Mane, Anupama; Gill, Satyajit S.; Patil, Tushar; Weber, Georg F.; Kundu, Gopal C.			Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression	ONCOGENE			English	Article								Tumor-stroma interactions are important determinants for the disease course in cancer. While stromal influence has been known to often play a tumor-promoting role, incomplete mechanistic insight into this phenomenon has prevented its therapeutic targeting. Stromal fibroblasts can be activated by tumor cells to differentiate into cancer-associated fibroblasts (CAFs), that exhibit the traits of myofibroblasts, and in turn, they increase cancer aggressiveness. Here, we report the crosstalk between the cancer cells and stromal fibroblasts that leads to tumor progression. The process is initiated by secretion of a chemokine like protein, osteopontin (OPN) from the cancer cells that differentiates the fibroblasts to myofibroblasts. Tumor-derived OPN achieves this transition by engaging CD44 and alpha v beta 3 integrins on the fibroblast surface, which mediates signaling via Akt and ERK to induce Twist1-dependent gene expression. The OPN-driven CAFs then secrete CXCL12, which in turn triggers epithelial to mesenchymal transition (EMT) in the tumor cells. OPN, produced by the cancer cells, and CXCL12, secreted by activated fibroblasts, are necessary and sufficient to perpetuate the crosstalk. Knocking out OPN in carcinogen-induced mammary tumors or knocking down OPN in cancer cells and fibroblast co-implanted xenografts abrogates myofibroblast differentiation, Twist1, and CXCL12 expression. OPN expression is correlated with CAF-specific gene signature as shown by breast tumor tissue microarray consisting of 100 patient specimens. Bioinformatics analyses have confirmed that the expression of OPN is significantly correlated with the expression of myofibroblast-specific markers as demonstrated in human breast carcinoma dataset of 2509 patients. Our findings describe OPN and CXCL12 act as compelling targets to curb the tumor-promoting features of the stromal components and further suggested that OPN-regulated CXCL12 network might act as potential therapeutic target for the management of CAF-mediated breast cancer progression.	[Butti, Ramesh; Nimma, Ramakrishna; Bulbule, Anuradha; Kumar, Totakura V. S.; Gunasekaran, Vinoth Prasanna; Tomar, Deepti; Kundu, Gopal C.] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Kundu, Gautam] NIA, Baltimore, MD 21224 USA; [Mane, Anupama; Gill, Satyajit S.] Jehangir Hosp, Pune, Maharashtra, India; [Patil, Tushar] Yashwantrao Chavan Mem Hosp, Pune, Maharashtra, India; [Weber, Georg F.] Univ Cincinnati, Cincinnati, OH USA; [Kundu, Gopal C.] KIIT Deemed Univ, Inst Eminence, Sch Biotechnol, Bhubaneswar, Odisha, India; [Kundu, Gopal C.] KIIT Deemed Univ, Inst Eminence, Kalinga Inst Med Sci KIMS, Bhubaneswar, Odisha, India; [Kumar, Dhiraj] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Ohio; University of Cincinnati; Kalinga Institute of Industrial Technology (KIIT); Kalinga Institute of Industrial Technology (KIIT); University of Texas System; UTMD Anderson Cancer Center	Kundu, GC (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.; Kundu, GC (corresponding author), KIIT Deemed Univ, Inst Eminence, Sch Biotechnol, Bhubaneswar, Odisha, India.; Kundu, GC (corresponding author), KIIT Deemed Univ, Inst Eminence, Kalinga Inst Med Sci KIMS, Bhubaneswar, Odisha, India.	gopalc.kundu@kiit.ac.in	Kumar, Dhiraj/AAJ-6305-2020; Butti, Ramesh/ABF-7762-2021	Kumar, Dhiraj/0000-0002-6085-5911; Gunasekaran, Vinoth prasanna/0000-0001-5610-0770	National Centre for Cell Science, Pune, India; Council of Scientific and Industrial Research (CSIR), Govt. of India; Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Govt. of India; Intramural Research Program of the NIH, National Institute of Ageing	National Centre for Cell Science, Pune, India; Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Govt. of India; Intramural Research Program of the NIH, National Institute of Ageing	This work was primarily supported by National Centre for Cell Science, Pune, India (to GCK). RB, RN, and DT were supported by Council of Scientific and Industrial Research (CSIR), Govt. of India. VPG is supported by Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Govt. of India. This research was supported in part by the Intramural Research Program of the NIH, National Institute of Ageing.	Avgustinova A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10305; Bandopadhyay M, 2014, EXPERT OPIN THER TAR, V18, P883, DOI 10.1517/14728222.2014.925447; Belev B, 2012, PERIOD BIOL, V114, P511; Bossung V, 2010, CURR OPIN OBSTET GYN, V22, P79, DOI 10.1097/GCO.0b013e328334e462; Bremnes RM, 2011, J THORAC ONCOL, V6, P209, DOI 10.1097/JTO.0b013e3181f8a1bd; Butti R, 2015, MULTITARGETED APPROA, P113; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Cao HM, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8090985; Castello LM, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4049098; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Chakraborty G, 2008, J CELL MOL MED, V12, P2305, DOI 10.1111/j.1582-4934.2008.00263.x; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; Das S, 2013, J BIOL CHEM, V288, P11824, DOI 10.1074/jbc.M112.432302; Dine J, 2017, ASIA-PAC J ONCOL NUR, V4, P127, DOI 10.4103/apjon.apjon_4_17; Dong CY, 2014, STEM CELLS, V32, P3173, DOI 10.1002/stem.1803; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Graessmann M, 2007, ONCOGENE, V26, P2840, DOI 10.1038/sj.onc.1210096; Hellerstedt BA, 2002, CA-CANCER J CLIN, V52, P154, DOI 10.3322/canjclin.52.3.154; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; Johnson GA, 2003, BIOL REPROD, V69, P1458, DOI 10.1095/biolreprod.103.020651; Kale S, 2014, ONCOGENE, V33, P2295, DOI 10.1038/onc.2013.184; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Klement JD, 2018, J CLIN INVEST, V128, P5549, DOI 10.1172/JCI123360; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Kothari AN, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040039; Kumar D, 2016, J INVEST DERMATOL, V136, P2462, DOI 10.1016/j.jid.2016.07.024; Kumar S, 2012, CURR MOL MED, V12, P952, DOI 10.2174/156652412802480826; Kumar V, 2010, CANCER RES, V70, P10381, DOI 10.1158/0008-5472.CAN-10-1470; Kuo PC, 2015, J AM COLL SURGEONS, V221, P642; Lee KW, 2015, CANCER RES, V75, P73, DOI 10.1158/0008-5472.CAN-14-0350; Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; Madar S, 2013, TRENDS MOL MED, V19, P447, DOI 10.1016/j.molmed.2013.05.004; Martin MA, 2005, STEM CELLS DEV, V14, P493, DOI 10.1089/scd.2005.14.493; McCarthy JB, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00048; Mi ZY, 2011, CARCINOGENESIS, V32, P477, DOI 10.1093/carcin/bgr009; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Ng L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126219; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pang H, 2011, CANCER BIOTHER RADIO, V26, P165, DOI 10.1089/cbr.2010.0838; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Pio GM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177640; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Ray P, 2015, ONCOGENE, V34, P2043, DOI 10.1038/onc.2014.157; Sangaletti S, 2014, CANCER RES, V74, P4706, DOI 10.1158/0008-5472.CAN-13-3334; Sharon Y, 2015, CANCER RES, V75, P963, DOI 10.1158/0008-5472.CAN-14-1990; Sung CO, 2011, AM J PATHOL, V179, P1827, DOI 10.1016/j.ajpath.2011.06.032; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Xu K, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0674-8; Xu YY, 2015, MOL CLIN ONCOL, V3, P357, DOI 10.3892/mco.2014.480; Zhang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023831	58	12	12	2	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2021	40	11					2002	2017		10.1038/s41388-021-01663-2	http://dx.doi.org/10.1038/s41388-021-01663-2		FEB 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QZ5PE	33603163				2022-12-26	WOS:000619433100004
J	Keles, HO; Cengiz, C; Demiral, I; Ozmen, MM; Omurtag, A				Keles, Hasan Onur; Cengiz, Canberk; Demiral, Irem; Ozmen, Mehmet Mahir; Omurtag, Ahmet			High density optical neuroimaging predicts surgeons's subjective experience and skill levels	PLOS ONE			English	Article								Measuring cognitive load is important for surgical education and patient safety. Traditional approaches of measuring cognitive load of surgeons utilise behavioural metrics to measure performance and surveys and questionnaires to collect reports of subjective experience. These have disadvantages such as sporadic data, occasionally intrusive methodologies, subjective or misleading self-reporting. In addition, traditional approaches use subjective metrics that cannot distinguish between skill levels. Functional neuroimaging data was collected using a high density, wireless NIRS device from sixteen surgeons (11 attending surgeons and 5 surgery resident) and 17 students while they performed two laparoscopic tasks (Peg transfer and String pass). Participant's subjective mental load was assessed using the NASA-TLX survey. Machine learning approaches were used for predicting the subjective experience and skill levels. The Prefrontal cortex (PFC) activations were greater in students who reported higher-than-median task load, as measured by the NASA-TLX survey. However in the case of attending surgeons the opposite tendency was observed, namely higher activations in the lower v higher task loaded subjects. We found that response was greater in the left PFC of students particularly near the dorso- and ventrolateral areas. We quantified the ability of PFC activation to predict the differences in skill and task load using machine learning while focussing on the effects of NIRS channel separation distance on the results. Our results showed that the classification of skill level and subjective task load could be predicted based on PFC activation with an accuracy of nearly 90%. Our finding shows that there is sufficient information available in the optical signals to make accurate predictions about the surgeons' subjective experiences and skill levels. The high accuracy of results is encouraging and suggest the integration of the strategy developed in this study as a promising approach to design automated, more accurate and objective evaluation methods.	[Keles, Hasan Onur] Ankara Univ, Dept Biomed Engn, Ankara, Turkey; [Cengiz, Canberk] Istinye Univ, Dept Electroneurophysiol, Istanbul, Turkey; [Demiral, Irem] 29 May State Hosp, Dept OB&GYN, Ankara, Turkey; [Ozmen, Mehmet Mahir] Istinye Univ, Dept Surg, Istanbul, Turkey; [Omurtag, Ahmet] Nottingham Trent Univ, Dept Engn, Nottingham, England	Ankara University; Istinye University; TDV 29 Mayis Hospital; Istinye University; Nottingham Trent University	Keles, HO (corresponding author), Ankara Univ, Dept Biomed Engn, Ankara, Turkey.	hokeles@ankara.edu.tr	Keles, Hasan Onur/AAJ-6014-2021; ozmen, mehmet mahir/AAO-2321-2020; Cengiz, Canberk/AAO-5573-2020	Keles, Hasan Onur/0000-0001-8493-2582; ozmen, mehmet mahir/0000-0003-0649-0111; Cengiz, Canberk/0000-0001-7444-7874				Aghajani H, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00359; [Anonymous], 2018, Proceedings of the Human Factors and Ergonomics Society Annual Meeting, V62, P44, DOI 10.1177/1541931218621010; Armougum A, 2020, COMPUT HUM BEHAV, V111, DOI 10.1016/j.chb.2020.106406; Boas DA, 2001, NEUROIMAGE, V13, P76, DOI 10.1006/nimg.2000.0674; Brigadoi S, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.2.025005; Carswell C Melody, 2005, Surg Innov, V12, P80, DOI 10.1177/155335060501200112; Charles RL, 2019, APPL ERGON, V74, P221, DOI 10.1016/j.apergo.2018.08.028; Choi JK, 2013, IEEE T BIOMED CIRC S, V7, P169, DOI 10.1109/TBCAS.2013.2255052; Chrouser KL, 2018, AM J SURG, V216, P573, DOI 10.1016/j.amjsurg.2018.02.017; de Roever I, 2017, ADV EXP MED BIOL, V977, P141, DOI 10.1007/978-3-319-55231-6_19; de Winter JCF, 2014, COGN TECHNOL WORK, V16, P289, DOI 10.1007/s10111-014-0275-1; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Dias RD, 2018, BRIT J SURG, V105, P491, DOI 10.1002/bjs.10795; Fekete T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024322; Gagnon L, 2012, NEUROIMAGE, V59, P2518, DOI 10.1016/j.neuroimage.2011.08.095; Gregg Nicholas M, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00014; Guru KA, 2015, UROLOGY, V86, P751, DOI 10.1016/j.urology.2015.07.028; Haeussinger FB, 2014, NEUROIMAGE, V95, P69, DOI 10.1016/j.neuroimage.2014.02.035; Hardy DJ, 2018, J CLIN EXP NEUROPSYC, V40, P1022, DOI 10.1080/13803395.2018.1473343; Holper L, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-34; Jancke L, 2000, NEUROPSYCHOLOGIA, V38, P164, DOI 10.1016/S0028-3932(99)00062-7; Keehner MM, 2004, AM J SURG, V188, P71, DOI 10.1016/j.amjsurg.2003.12.059; Keshmiri S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00079; Keshmiri S, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00033; Khoe HCH, 2020, SURG ENDOSC, V34, P5604, DOI 10.1007/s00464-019-07331-7; Kohno S, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2814249; Leff DR, 2008, NEUROIMAGE, V39, P805, DOI 10.1016/j.neuroimage.2007.09.032; Modi HN, 2018, ANN SURG, V267, P683, DOI 10.1097/SLA.0000000000002289; Modi HN, 2017, SURGERY, V162, P1130, DOI 10.1016/j.surg.2017.09.002; Naseer N, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00003; Nemani A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat3807; Omurtag A, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa814b; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pan YF, 2019, BRAIN TOPOGR, V32, P998, DOI 10.1007/s10548-019-00740-w; Patil PV, 2004, SURG ENDOSC, V18, P111, DOI 10.1007/s00464-002-8769-y; Prabhu A, 2010, SURGERY, V147, P640, DOI 10.1016/j.surg.2010.01.007; Proverbio AM, 2013, NEUROPSYCHOLOGIA, V51, P2690, DOI 10.1016/j.neuropsychologia.2013.09.023; Rieger A, 2014, INT ARCH OCC ENV HEA, V87, P165, DOI 10.1007/s00420-013-0847-z; Rushworth MFS, 2001, J COGNITIVE NEUROSCI, V13, P698, DOI 10.1162/089892901750363244; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Scholkmann F, 2010, PHYSIOL MEAS, V31, P649, DOI 10.1088/0967-3334/31/5/004; Serrien DJ, 2016, BRAIN COGNITION, V108, P42, DOI 10.1016/j.bandc.2016.07.005; Shetty K, 2016, JAMA SURG, V151, P682, DOI 10.1001/jamasurg.2016.0050; Strangman GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066319; Tai K, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-39; Tak S, 2014, NEUROIMAGE, V85, P72, DOI 10.1016/j.neuroimage.2013.06.016; Vermeij A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00303; Yurko YY, 2010, SIMUL HEALTHC, V5, P267, DOI 10.1097/SIH.0b013e3181e3f329; Zakeri Z, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69553-3; Zhang L, 2014, PROC SPIE, V8928, DOI 10.1117/12.2039712; Zhang YH, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852552	51	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247117	10.1371/journal.pone.0247117	http://dx.doi.org/10.1371/journal.pone.0247117			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8JB	33600502	gold, Green Published, Green Accepted			2022-12-26	WOS:000620625100020
J	Martinez, ME; Gonzalez, CC; Huey, D; Peeples, ME; McCarty, D; Niewiesk, S				Martinez, Margaret E.; Gonzalez, Cristina Capella; Huey, Devra; Peeples, Mark E.; McCarty, Douglas; Niewiesk, Stefan			Immunogenicity and inflammatory properties of respiratory syncytial virus attachment G protein in cotton rats	PLOS ONE			English	Article							ANTIBODY-MEDIATED RESTRICTION; INTRAEPITHELIAL LYMPHOCYTES; CX3C-CX3CR1 BINDING; SIGMODON-HISPIDUS; IMMUNE-RESPONSES; RSV CHALLENGE; INFECTION; FRACTALKINE; CELLS; CHEMOKINE	Human respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection in infants and young children worldwide. The attachment (G) protein of RSV is synthesized by infected cells in both a membrane bound (mG) and secreted form (sG) and uses a CX3C motif for binding to its cellular receptor. Cell culture and mouse studies suggest that the G protein mimics the cytokine CX3CL1 by binding to CX3CR1 on immune cells, which is thought to cause increased pulmonary inflammation in vivo. However, because these studies have used RSV lacking its G protein gene or blockade of the G protein with a G protein specific monoclonal antibody, the observed reduction in inflammation may be due to reduced virus replication and spread, and not to a direct role for G protein as a viral chemokine. In order to more directly determine the influence of the soluble and the membrane-bound forms of G protein on the immune system independent of its attachment function for the virion, we expressed the G protein in cotton rat lungs using adeno-associated virus (AAV), a vector system which does not itself induce inflammation. We found no increase in pulmonary inflammation as determined by histology and bronchoalveolar lavage after inoculation of AAVs expressing the membrane bound G protein, the secreted G protein or the complete G protein gene which expresses both forms. The long-term low-level expression of AAV-G did, however, result in the induction of non-neutralizing antibodies, CD8 T cells and partial protection from challenge with RSV. Complete protection was accomplished through co-immunization with AAV-G and an AAV expressing cotton rat interferon alpha.	[Martinez, Margaret E.; Huey, Devra; Niewiesk, Stefan] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [Gonzalez, Cristina Capella] Battelle Mem Inst, Biomed Res Ctr, 505 King Ave, Columbus, OH 43201 USA; [Peeples, Mark E.] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Vaccines & Immun, Columbus, OH USA; [Peeples, Mark E.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [McCarty, Douglas] Pfizer, Rare Dis Res Unit, Morrisville, NC USA	University System of Ohio; Ohio State University; Battelle Memorial Institute; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Pfizer	Martinez, ME (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA.	martinez.610@osu.edu	Peeples, Mark E./AAX-5193-2021	Peeples, Mark E./0000-0002-4582-317X	Genetech Fellowship from Genentech [GRT00044407]; National Institute of Health National Institute of Allergy and Infectious Diseases [P01AI112524, P01 AI112524, R01 AI093848]; Genentech	Genetech Fellowship from Genentech; National Institute of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Genentech(Roche HoldingGenentech)	M.E.M. was funded through the Genetech Fellowship under grant number GRT00044407 from Genentech (https://urldefense.com/v3/__ https://www.gene.com/__;!!KGKeukY!kK079 YjJDBxIYb4cCd4SEhIt14tL5fghqOewU8tfu KWiRtOTljnrsH7ujR1LFKsMRVtl$). D.H. and S.N. were funded through grant number P01AI112524 from the National Institute of Health National Institute of Allergy and Infectious Diseases (https://urldefense.com/v3/__https://www.niaid.nih.gov/__;!!KGKeukY!kK079YjJDBxIYb4cCd4SEhIt14tL5f ghqOewU8tfuKWiRtOTljnrsH7ujR1LFHaJx-S8$). M.P and C.C-P. were funded through grant number P01 AI112524 and R01 AI093848 rom the National Institute of Health National Institute of Allergy and Infectious Diseases (https://urldefense.com/v3/__ https://www.niaid.nih.gov/__;!!KGKeukY!kK079 YjJDBxIYb4cCd4SEhIt14tL5fghqOewU8 tfuKWiRtOTljnrsH7ujR1LFHaJx-S8$). Genentech provided the corresponding author with a research fellowship that aided in the following research to be conducted. Dr. Douglas McCarty developed and provided the adeno-associated virus vectors used for the experiments in the following manuscript, as well as edited the manuscript for publication. Though Dr. Douglas McCarty is now employed by Pfizer, he did not conduct studies nor contribute to the study plan while at Pfizer. Only editing of the manuscript was performed while he was employed by Pfizer. Therefore, Pfizer did not contribute funding towards study design, materials, data collection or the majority of the salary for Dr. Douglas McCarty for the research presented in the following manuscript. The funder provided support in the form of salaries for authors [DM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Arunkumar GA, 2019, J VIROL, V93, DOI 10.1128/JVI.01696-18; Biacchesi S, 2005, J VIROL METHODS, V128, P192, DOI 10.1016/j.jviromet.2005.05.005; Blanco JCG, 2002, J INFECT DIS, V185, P1780, DOI 10.1086/340823; Bockstael O, 2012, HUM GENE THER, V23, P742, DOI 10.1089/hum.2011.216; Boukhvalova MS, 2009, BIOLOGICALS, V37, P152, DOI 10.1016/j.biologicals.2009.02.017; Boyoglu-Barnum S, 2017, J VIROL, V91, DOI 10.1128/JVI.02059-16; Bukreyev A, 2012, J VIROL, V86, P10880, DOI 10.1128/JVI.01162-12; Bukreyev A, 2008, J VIROL, V82, P12191, DOI 10.1128/JVI.01604-08; Caidi H, 2018, ANTIVIR RES, V154, P149, DOI 10.1016/j.antiviral.2018.04.014; Caidi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051485; Capella C, 2017, J INFECT DIS, V216, P1398, DOI 10.1093/infdis/jix489; Carsillo M, 2009, J VIROL, V83, P7244, DOI 10.1128/JVI.00148-09; Chirkova T, 2015, J GEN VIROL, V96, P2543, DOI 10.1099/vir.0.000218; Choi Y, 2012, VIRAL IMMUNOL, V25, P193, DOI 10.1089/vim.2011.0094; Fedechkin SO, 2020, J VIROL, V94, DOI 10.1128/JVI.01879-19; Fuentes S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42428; Fuentes S, 2015, J VIROL, V89, P8193, DOI 10.1128/JVI.00133-15; FULGINITI VA, 1969, AM J EPIDEMIOL, V89, P435, DOI 10.1093/oxfordjournals.aje.a120956; Green MG, 2018, COMPARATIVE MED, V68, P31; Grieves JL, 2018, VACCINE, V36, P3842, DOI 10.1016/j.vaccine.2018.04.089; Grieves JL, 2015, COMPARATIVE MED, V65, P315; Hancock GE, 2003, J MED VIROL, V70, P301, DOI 10.1002/jmv.10395; Harcourt J, 2006, J IMMUNOL, V176, P1600, DOI 10.4049/jimmunol.176.3.1600; Harcourt JL, 2004, J INFECT DIS, V190, P1936, DOI 10.1086/425516; Haynes LM, 2009, J INFECT DIS, V200, P439, DOI 10.1086/600108; Heidema J, 2007, J IMMUNOL, V179, P8410, DOI 10.4049/jimmunol.179.12.8410; Hughes PM, 2002, GLIA, V37, P314, DOI 10.1002/glia.10037; Hussell T, 2000, J IMMUNOL, V165, P7109, DOI 10.4049/jimmunol.165.12.7109; Isse K, 2005, HEPATOLOGY, V41, P506, DOI 10.1002/hep.20582; Jeong KI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130517; Johnson LA, 2013, J CELL SCI, V126, P5259, DOI 10.1242/jcs.135343; Johnson SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005318; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kim KW, 2011, BLOOD, V118, pE156, DOI 10.1182/blood-2011-04-348946; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032226; Kittel B, 2004, EXP TOXICOL PATHOL, V55, P413, DOI 10.1078/0940-2993-00349; Lee J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007262; Liang B, 2019, J VIROL, V93, DOI 10.1128/JVI.02043-18; Lu Y, 2016, HUM GENE THER, V27, P598, DOI 10.1089/hum.2015.167; Malykhina O, 2011, J VIROL, V85, P4792, DOI 10.1128/JVI.02399-10; Martinez ME, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237404; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4; Moore EC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-116; Muehlhoefer A, 2000, J IMMUNOL, V164, P3368, DOI 10.4049/jimmunol.164.6.3368; Nguyen TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034331; Niewiesk S, 2002, LAB ANIM-UK, V36, P357, DOI 10.1258/002367702320389026; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Pozsgai ER, 2017, MOL THER, V25, P855, DOI 10.1016/j.ymthe.2017.02.013; PRINCE GA, 1978, AM J PATHOL, V93, P771; Quirin KA, 2018, MOL THER-METH CLIN D, V8, P8, DOI 10.1016/j.omtm.2017.09.006; Radu GU, 2010, J VIROL, V84, P9632, DOI 10.1128/JVI.00451-10; Rey GU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083075; ROBERTS SR, 1994, J VIROL, V68, P4538, DOI 10.1128/JVI.68.7.4538-4546.1994; Rosas LE, 2012, MOL THER, V20, P2098, DOI 10.1038/mt.2012.197; Rossey I, 2014, VACCINE, V32, P6130, DOI 10.1016/j.vaccine.2014.08.063; Samulski RJ, 2014, ANNU REV VIROL, V1, P427, DOI 10.1146/annurev-virology-031413-085355; Schmidt ME, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00678; Sparer TE, 1998, J EXP MED, V187, P1921, DOI 10.1084/jem.187.11.1921; Stein RT, 2017, PEDIATR PULM, V52, P556, DOI 10.1002/ppul.23570; Stokes KL, 2011, J VIROL, V85, P5782, DOI 10.1128/JVI.01693-10; Streif S, 2004, VIRAL IMMUNOL, V17, P604, DOI 10.1089/vim.2004.17.604; Strobel B, 2015, AM J RESP CELL MOL, V53, P291, DOI 10.1165/rcmb.2014-0338MA; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; Tripp RA, 1999, J VIROL, V73, P7099, DOI 10.1128/JVI.73.9.7099-7107.1999; Wang D, 2017, J VIROL, V91, DOI 10.1128/JVI.00066-17; Wethington D, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0389; White GE, 2012, ARTERIOSCL THROM VAS, V32, P589, DOI 10.1161/ATVBAHA.111.237412; White GE, 2009, BLOOD, V113, P767, DOI 10.1182/blood-2008-11-189860; Wojdasiewicz P, 2014, ARCH IMMUNOL THER EX, V62, P395, DOI 10.1007/s00005-014-0275-0; Zhang WL, 2010, J VIROL, V84, P1148, DOI 10.1128/JVI.01755-09; Zhang YH, 2001, J VIROL, V75, P9044, DOI 10.1128/JVI.75.19.9044-9058.2001; Zhang Y, 2015, FEBS J, V282, P891, DOI 10.1111/febs.13187	73	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0246770	10.1371/journal.pone.0246770	http://dx.doi.org/10.1371/journal.pone.0246770			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600439	Green Published, gold			2022-12-26	WOS:000620625100007
J	Yoon, H; Tang, CM; Banerjee, S; Yebra, M; Noh, S; Burgoyne, AM; Torre, JD; De Siena, M; Liu, MY; Klug, LR; Choi, YY; Hosseini, M; Delgado, AL; Wang, ZY; French, RP; Lowy, A; DeMatteo, RP; Heinrich, MC; Molinolo, AA; Gutkind, JS; Harismendy, O; Sicklick, JK				Yoon, Hyunho; Tang, Chih-Min; Banerjee, Sudeep; Yebra, Mayra; Noh, Sangkyu; Burgoyne, Adam M.; Torre, Jorge De la; Siena, Martina De; Liu, Mengyuan; Klug, Lillian R.; Choi, Yoon Young; Hosseini, Mojgan; Delgado, Antonio L.; Wang, Zhiyong; French, Randall P.; Lowy, Andrew; DeMatteo, Ronald P.; Heinrich, Michael C.; Molinolo, Alfredo A.; Gutkind, J. Silvio; Harismendy, Olivier; Sicklick, Jason K.			Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis	ONCOGENE			English	Article							IMATINIB MESYLATE; C-KIT; RECEPTOR; COMBINATION; ACTIVATION; MUTATIONS; MULTICENTER; INHIBITOR; KINASE; LIGAND	Targeted therapies for gastrointestinal stromal tumor (GIST) are modestly effective, but GIST cannot be cured with single agent tyrosine kinase inhibitors. In this study, we sought to identify new therapeutic targets in GIST by investigating the tumor microenvironment. Here, we identified a paracrine signaling network by which cancer-associated fibroblasts (CAFs) drive GIST growth and metastasis. Specifically, CAFs isolated from human tumors were found to produce high levels of platelet-derived growth factor C (PDGFC), which activated PDGFC-PDGFRA signal transduction in GIST cells that regulated the expression of SLUG, an epithelial-mesenchymal transition (EMT) transcription factor and downstream target of PDGFRA signaling. Together, this paracrine induce signal transduction cascade promoted tumor growth and metastasis in vivo. Moreover, in metastatic GIST patients, SLUG expression positively correlated with tumor size and mitotic index. Given that CAF paracrine signaling modulated GIST biology, we directly targeted CAFs with a dual PI3K/mTOR inhibitor, which synergized with imatinib to increase tumor cell killing and in vivo disease response. Taken together, we identified a previously unappreciated cellular target for GIST therapy in order to improve disease control and cure rates.	[Yoon, Hyunho; Tang, Chih-Min; Banerjee, Sudeep; Yebra, Mayra; Noh, Sangkyu; Burgoyne, Adam M.; Torre, Jorge De la; Siena, Martina De; Delgado, Antonio L.; French, Randall P.; Lowy, Andrew; Sicklick, Jason K.] Univ Calif San Diego, Dept Surg, Div Surg Oncol, Moores Canc Ctr, San Diego, CA 92103 USA; [Banerjee, Sudeep] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA; [Siena, Martina De] Fdn Policlin A Gemelli Catholic Univ Rome, Gastroenterol & Digest Endoscopy, Rome, Italy; [Liu, Mengyuan; DeMatteo, Ronald P.] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Klug, Lillian R.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Klug, Lillian R.; Heinrich, Michael C.] Oregon Hlth & Sci Univ, Portland VA Hlth Care Syst, Knight Canc Inst, Portland, OR 97201 USA; [Choi, Yoon Young; Harismendy, Olivier] Univ Calif San Diego, Moores Canc Ctr, Div Biomed Informat, San Diego, CA 92103 USA; [Choi, Yoon Young] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Hosseini, Mojgan; Molinolo, Alfredo A.] Univ Calif San Diego, Dept Pathol, Moores Canc Ctr, San Diego, CA 92103 USA; [Wang, Zhiyong; Gutkind, J. Silvio] Univ Calif San Diego, Dept Pharmacol, Moores Canc Ctr, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of Pennsylvania; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California San Diego; Yonsei University; Yonsei University Health System; University of California System; University of California San Diego; University of California System; University of California San Diego	Sicklick, JK (corresponding author), Univ Calif San Diego, Dept Surg, Div Surg Oncol, Moores Canc Ctr, San Diego, CA 92103 USA.	jsicklick@health.ucsd.edu	Gutkind, J. Silvio/J-1201-2016; Harismendy, Olivier/AAM-2072-2021; De Siena, Martina/AAB-8566-2022	Gutkind, J. Silvio/0000-0002-5150-4482; Harismendy, Olivier/0000-0002-8098-9888; De Siena, Martina/0000-0003-4913-7254; Heinrich, Michael/0000-0003-3790-0478	National Institutes of Health (NIH) [P30CA023100]; NIH [R01 CA226803, RO1 CA155620]; Food and Drug Administration [R01 FD006334]; Jonathan David Foundation; GIST Research Fund; GIST Cancer Research Fund; SDH Research Fund; VA Merit Review Grant [2l01BX000338-05]; Kristen Ann Carr Fund	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food and Drug Administration(United States Department of Health & Human Services); Jonathan David Foundation; GIST Research Fund; GIST Cancer Research Fund; SDH Research Fund; VA Merit Review Grant(US Department of Veterans Affairs); Kristen Ann Carr Fund	We thank T. Reya for her critical review of the manuscript. This work was supported in part by National Institutes of Health (NIH) grant nos. P30CA023100 (JKS, AM), as well as NIH grant (R01 CA226803) (RO1 CA155620) (AML), Food and Drug Administration (R01 FD006334, JKS), Jonathan David Foundation (JKS, MCH), GIST Research Fund (JKS), GIST Cancer Research Fund (MCH), SDH Research Fund (JKS), VA Merit Review Grant 2l01BX000338-05 (MCH), and Kristen Ann Carr Fund (JKS).	Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; [Anonymous], 2020, CANCER DISCOV, V10, P1438, DOI 10.1158/2159-8290.cd-rw2020-124; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Boikos SA, 2016, JAMA ONCOL, V2, P922, DOI 10.1001/jamaoncol.2016.0256; Brabletz T, 2018, NAT REV CANCER, V18, P128, DOI 10.1038/nrc.2017.118; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Corless CL, 2008, ANNU REV PATHOL-MECH, V3, P557, DOI 10.1146/annurev.pathmechdis.3.121806.151538; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Dhillon S, 2020, DRUGS, V80, P1133, DOI 10.1007/s40265-020-01348-2; Dhillon S, 2020, DRUGS, V80, P433, DOI 10.1007/s40265-020-01275-2; Dolgin E, 2020, CANCER DISCOV, V10, P334, DOI 10.1158/2159-8290.CD-NB2020-002; Duensing A, 2004, ONCOGENE, V23, P3999, DOI 10.1038/sj.onc.1207525; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Edris B, 2013, P NATL ACAD SCI USA, V110, P3501, DOI 10.1073/pnas.1222893110; Ekpe-Adewuyi E, 2016, ONCOTARGET, V7, P83684, DOI 10.18632/oncotarget.13299; Floris G, 2013, CLIN CANCER RES, V19, P620, DOI 10.1158/1078-0432.CCR-12-2853; Goehrig D, 2019, GUT, V68, P693, DOI 10.1136/gutjnl-2018-317570; Grunewald S, 2021, CANCER DISCOV, V11, P108, DOI 10.1158/2159-8290.CD-20-0487; Hayashi Y, 2015, GASTROENTEROLOGY, V149, P420, DOI 10.1053/j.gastro.2015.04.006; Heinrich MC, 2020, LANCET ONCOL, V21, P935, DOI 10.1016/S1470-2045(20)30269-2; Hessmann E, 2018, GUT, V67, P497, DOI 10.1136/gutjnl-2016-311954; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Janku Filip, 2020, J Clin Oncol, V38, P3294, DOI 10.1200/JCO.20.00522; Joensuu H, 2015, J CLIN ONCOL, V33, P634, DOI 10.1200/JCO.2014.57.4970; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; McDermott U, 2009, CANCER RES, V69, P3937, DOI 10.1158/0008-5472.CAN-08-4327; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Pulkka OP, 2017, BRIT J CANCER, V116, P1195, DOI 10.1038/bjc.2017.82; Ray Katrina, 2020, Nat Rev Gastroenterol Hepatol, V17, P452, DOI 10.1038/s41575-020-0336-2; Ruffini F, 2017, ONCOTARGET, V8, P66833, DOI 10.18632/oncotarget.18706; Schoffski P, 2010, ANN ONCOL, V21, P1990, DOI 10.1093/annonc/mdq076; Shi E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1075-6; Sicklick JK, 2013, J GASTROINTEST SURG, V17, P1997, DOI 10.1007/s11605-013-2243-0; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Van Looy T, 2014, CLIN CANCER RES, V20, P6071, DOI 10.1158/1078-0432.CCR-14-1823; Vitiello GA, 2019, J CLIN INVEST, V129, P1863, DOI 10.1172/JCI124108; Wang LX, 2017, MED SCI MONITOR, V23, P3808, DOI 10.12659/MSM.906038; Wiley SZ, 2018, FASEB J, V32, P1170, DOI 10.1096/fj.201700834R; Zook P, 2017, CLIN CANCER RES, V23, P171, DOI 10.1158/1078-0432.CCR-16-0529	45	13	13	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2021	40	11					1957	1973		10.1038/s41388-021-01685-w	http://dx.doi.org/10.1038/s41388-021-01685-w		FEB 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QZ5PE	33603171	hybrid, Green Published			2022-12-26	WOS:000619405600003
J	Freidel, MR; Armen, RS				Freidel, Matthew R.; Armen, Roger S.			Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase	PLOS ONE			English	Article							COPY SIMULTANEOUS SEARCH; PROTEIN-INTERACTION NETWORKS; LIGAND-BINDING; IN-VITRO; STRUCTURAL BASIS; SCORING FUNCTIONS; ANTIVIRAL DRUGS; VIRUS DRUG; CORONAVIRUS; INHIBITORS	The 2019 emergence of, SARS-CoV-2 has tragically taken an immense toll on human life and far reaching impacts on society. There is a need to identify effective antivirals with diverse mechanisms of action in order to accelerate preclinical development. This study focused on five of the most established drug target proteins for direct acting small molecule antivirals: Nsp5 Main Protease, Nsp12 RNA-dependent RNA polymerase, Nsp13 Helicase, Nsp16 2'-O methyltransferase and the S2 subunit of the Spike protein. A workflow of solvent mapping and free energy calculations was used to identify and characterize favorable small-molecule binding sites for an aromatic pharmacophore (benzene). After identifying the most favorable sites, calculated ligand efficiencies were compared utilizing computational fragment screening. The most favorable sites overall were located on Nsp12 and Nsp16, whereas the most favorable sites for Nsp13 and S2 Spike had comparatively lower ligand efficiencies relative to Nsp12 and Nsp16. Utilizing fragment screening on numerous possible sites on Nsp13 helicase, we identified a favorable allosteric site on the N-terminal zinc binding domain (ZBD) that may be amenable to virtual or biophysical fragment screening efforts. Recent structural studies of the Nsp12:Nsp13 replication-transcription complex experimentally corroborates ligand binding at this site, which is revealed to be a functional Nsp8:Nsp13 protein-protein interaction site in the complex. Detailed structural analysis of Nsp13 ZBD conformations show the role of induced-fit flexibility in this ligand binding site and identify which conformational states are associated with efficient ligand binding. We hope that this map of over 200 possible small-molecule binding sites for these drug targets may be of use for ongoing discovery, design, and drug repurposing efforts. This information may be used to prioritize screening efforts or aid in the process of deciphering how a screening hit may bind to a specific target protein.	[Freidel, Matthew R.; Armen, Roger S.] Thomas Jefferson Univ, Dept Pharmaceut Sci, Coll Pharm, Philadelphia, PA 19107 USA	Jefferson University	Armen, RS (corresponding author), Thomas Jefferson Univ, Dept Pharmaceut Sci, Coll Pharm, Philadelphia, PA 19107 USA.	Roger.Armen@Jefferson.edu			National Institutes of Health [1P01HL114471-06, R01 AR077666]; Dr. Ralph and Marian Falk Medical Research Trust	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Ralph and Marian Falk Medical Research Trust	Roger Armen was partially supported by grants 1P01HL114471-06 and R01 AR077666 from the National Institutes of Health and an award from the Dr. Ralph and Marian Falk Medical Research Trust (to J. Benovic, A. Aplin, P. Wedegaertner, T. Sato, and J. Aguirre-Ghiso). There was no additional external funding received for this study.	Abd El-Aziz TM, 2020, INFECT GENET EVOL, V83, DOI 10.1016/j.meegid.2020.104327; Adedeji AO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036521; Agoni C, 2020, J MOL MODEL, V26, DOI 10.1007/s00894-020-04385-6; Armen RS., 2009, DRUG DISCOVERY CHEM; Battles MB, 2016, NAT CHEM BIOL, V12, P87, DOI [10.1038/nchembio.1982, 10.1038/NCHEMBIO.1982]; Beck DAC, 2008, PROTEIN ENG DES SEL, V21, P353, DOI 10.1093/protein/gzn011; Bongini P, 2020, BIOCHEM BIOPH RES CO, V528, P35, DOI 10.1016/j.bbrc.2020.04.007; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CAFLISCH A, 1993, J MED CHEM, V36, P2142, DOI 10.1021/jm00067a013; Cao LX, 2020, SCIENCE, V370, P426, DOI 10.1126/science.abd9909; Cappel D, 2017, CURR TOP MED CHEM, V17, P2586, DOI 10.2174/1568026617666170414141452; Chakrabarti S, 2011, MOL CELL, V41, P693, DOI 10.1016/j.molcel.2011.02.010; Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14; Chen IJ, 2009, J COMPUT AID MOL DES, V23, P603, DOI 10.1007/s10822-009-9280-5; Chen J, 2020, CELL, V182, P1560, DOI 10.1016/j.cell.2020.07.033; Cournia Z, 2017, J CHEM INF MODEL, V57, P2911, DOI 10.1021/acs.jcim.7b00564; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Decroly E, 2008, J VIROL, V82, P8071, DOI 10.1128/JVI.00407-08; Dong SW, 2018, METHODS MOL BIOL, V1794, P97, DOI 10.1007/978-1-4939-7871-7_7; Dong XL, 2011, CURR COMPUT-AID DRUG, V7, P181, DOI 10.2174/157340911796504332; Drew ED, 2020, BMC MOL CELL BIOL, V21, DOI 10.1186/s12860-020-00294-x; El-Haj BM, 2018, MOLECULES, V23, DOI 10.3390/molecules23092119; Ellis DA, 2008, BIOORG MED CHEM LETT, V18, P4628, DOI 10.1016/j.bmcl.2008.07.014; Ferrara P, 2004, J MED CHEM, V47, P3032, DOI 10.1021/jm030489h; Fornace ME, 2015, J CHEM THEORY COMPUT, V11, P568, DOI 10.1021/ct5011032; Frick DN, 2006, CURR PHARM DESIGN, V12, P1315, DOI 10.2174/138161206776361147; Ghosh AK, 2020, CHEMMEDCHEM, V15, P907, DOI 10.1002/cmdc.202000223; Gil C, 2020, J MED CHEM, V63, P12359, DOI 10.1021/acs.jmedchem.0c00606; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Hajduk PJ, 2005, DRUG DISCOV TODAY, V10, P1675, DOI 10.1016/S1359-6446(05)03624-X; Hall DR, 2015, TRENDS PHARMACOL SCI, V36, P724, DOI 10.1016/j.tips.2015.08.003; Hayden FG, 2019, CURR OPIN INFECT DIS, V32, P176, DOI 10.1097/QCO.0000000000000532; Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x; Hooda Y, 2012, PROTEOMICS, V12, P1697, DOI 10.1002/pmic.201100597; Hubbard RE, 2011, METHOD ENZYMOL, V493, P509, DOI 10.1016/B978-0-12-381274-2.00020-0; Hussein HA, 2017, DRUG DISCOV TODAY, V22, P404, DOI 10.1016/j.drudis.2016.11.021; Jia ZH, 2019, NUCLEIC ACIDS RES, V47, P6538, DOI 10.1093/nar/gkz409; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2017, J COMPUT CHEM, V38, P1114, DOI 10.1002/jcc.24660; Kadam RU, 2017, P NATL ACAD SCI USA, V114, P206, DOI 10.1073/pnas.1617020114; Kalimouttou S, 2009, J NANOSCI NANOTECHNO, V9, P150, DOI 10.1166/jnn.2009.J018; Kazmirski SL, 1999, J MOL BIOL, V290, P283, DOI 10.1006/jmbi.1999.2843; Keum YS, 2012, BIOCHEM PHARMACOL, V84, P1351, DOI 10.1016/j.bcp.2012.08.012; Khan A, 2020, INTERDISCIP SCI, V12, P335, DOI 10.1007/s12539-020-00381-9; Khan MA, 2020, J INEQUAL APPL, V2020, DOI 10.1186/s13660-020-02343-7; Kim S, 2019, NUCLEIC ACIDS RES, V47, pD1102, DOI 10.1093/nar/gky1033; Krafcikova P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17495-9; Lakkaraju SK, 2015, J CHEM INF MODEL, V55, P700, DOI 10.1021/ci500729k; Li DK, 2019, METHODS MOL BIOL, V1911, P3, DOI 10.1007/978-1-4939-8976-8_1; Liu WB, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00461-20; Lu X, 2018, CURR PHARM DESIGN, V24, P3424, DOI 10.2174/1381612824666180810162944; Ludlow RF, 2015, P NATL ACAD SCI USA, V112, P15910, DOI 10.1073/pnas.1518946112; Luo CM, 2018, J VIROL, V92, DOI 10.1128/JVI.00116-18; Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286; Mifsud EJ, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104545; MIRANKER A, 1991, PROTEINS, V11, P29, DOI 10.1002/prot.340110104; Miryala SK, 2018, GENE, V642, P84, DOI 10.1016/j.gene.2017.11.028; Mirza MU, 2020, J PHARM ANAL, V10, P320, DOI 10.1016/j.jpha.2020.04.008; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; Murray CW, 2014, ACS MED CHEM LETT, V5, P616, DOI 10.1021/ml500146d; Nguyen CN, 2016, J CHEM THEORY COMPUT, V12, P414, DOI 10.1021/acs.jctc.5b00939; Nguyen CN, 2014, J CHEM THEORY COMPUT, V10, P2769, DOI 10.1021/ct401110x; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Noble CG, 2016, J BIOL CHEM, V291, P8541, DOI 10.1074/jbc.M115.710731; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pizzorno A, 2020, ANTIVIR RES, V181, DOI 10.1016/j.antiviral.2020.104878; Prajapat M, 2020, INDIAN J PHARMACOL, V52, P142, DOI 10.4103/ijp.IJP_338_20; PUGH CSG, 1978, J BIOL CHEM, V253, P4075; Rahaman O, 2011, J CHEM INF MODEL, V51, P2047, DOI 10.1021/ci1003009; Rehman SU, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030240; Reynolds CH, 2008, J MED CHEM, V51, P2432, DOI 10.1021/jm701255b; Reynolds CH, 2017, J CHEM INF MODEL, V57, P3086, DOI 10.1021/acs.jcim.7b00381; Roche O, 2001, J MED CHEM, V44, P3592, DOI 10.1021/jm000467k; Rosas-Lemus M, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.abe1202; Rut Wioletta, 2020, bioRxiv, DOI 10.1101/2020.04.29.068890; Saalau-Bethell SM, 2012, NAT CHEM BIOL, V8, P920, DOI [10.1038/NCHEMBIO.1081, 10.1038/nchembio.1081]; Sakkal LA, 2017, J COMPUT CHEM, V38, P1209, DOI 10.1002/jcc.24728; Sardiu ME, 2011, J BIOL CHEM, V286, P23645, DOI 10.1074/jbc.R110.174052; Schubert CR, 2009, J COMPUT AID MOL DES, V23, P475, DOI 10.1007/s10822-009-9287-y; Seidel T, 2019, PROG CHEM ORG NAT PR, V110, P99, DOI 10.1007/978-3-030-14632-0_4; Seybert A, 2000, J VIROL, V74, P9586, DOI 10.1128/JVI.74.20.9586-9593.2000; Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893; Shanmugaraj B, 2020, ASIAN PAC J ALLERGY, V38, P10, DOI 10.12932/AP-200220-0773; Shi TL, 2005, CURR PROTEIN PEPT SC, V6, P443, DOI 10.2174/138920305774329313; Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336; Smietanski M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4004; Snider J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156351; Snijder EJ, 2016, ADV VIRUS RES, V96, P59, DOI 10.1016/bs.aivir.2016.08.008; Srinivasan S, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040360; Sun JM, 2020, TRENDS MOL MED, V26, P483, DOI 10.1016/j.molmed.2020.02.008; Tanaka D, 2011, J MED CHEM, V54, P851, DOI 10.1021/jm101273e; Tao ZY, 2018, EUR J MED CHEM, V157, P994, DOI 10.1016/j.ejmech.2018.08.057; Trigueiro-Louro J, 2020, COMPUT STRUCT BIOTEC, V18, P2117, DOI 10.1016/j.csbj.2020.07.017; Vankadari N, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105998; Villemagne B, 2014, J MED CHEM, V57, P4876, DOI 10.1021/jm500422b; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang C, 2020, GASTROENTEROLOGY, V159, P1145, DOI 10.1053/j.gastro.2020.05.015; Wang X, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0169-8; Wang Y, 2015, J VIROL, V89, P8416, DOI 10.1128/JVI.00948-15; Woo Hyeonuk, 2020, bioRxiv, DOI [10.1021/acs.jpcb.0c04553, 10.1101/2020.05.20.103325]; Wrobel AG, 2020, NAT STRUCT MOL BIOL, V27, P763, DOI 10.1038/s41594-020-0468-7; Yadav MK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/156987; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang Y, 2013, EXPERT OPIN DRUG DIS, V8, P277, DOI 10.1517/17460441.2013.749853; Yin WC, 2020, SCIENCE, V368, P1499, DOI 10.1126/science.abc1560; Young RJ, 2018, J MED CHEM, V61, P6421, DOI 10.1021/acs.jmedchem.8b00180; Yu WB, 2014, J COMPUT AID MOL DES, V28, P491, DOI 10.1007/s10822-014-9728-0; Zhang CX, 2020, J PROTEOME RES, V19, P1351, DOI 10.1021/acs.jproteome.0c00129; Zhao YG, 2016, NATURE, V535, P169, DOI 10.1038/nature18615; Zhao Z, 2020, J PROTEOME RES, V19, P4698, DOI 10.1021/acs.jproteome.0c00623; Zhong H, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104872; Zhou Yu, 2015, Methods Mol Biol, V1289, P13, DOI 10.1007/978-1-4939-2486-8_2; Zhu Guoliang, 2020, Curr Res Microb Sci, V1, P53, DOI 10.1016/j.crmicr.2020.06.003; Zhu T, 2013, J MED CHEM, V56, P6560, DOI 10.1021/jm301916b; Zhu Z, 2020, J INFECTION, V81, pE21, DOI 10.1016/j.jinf.2020.03.060	115	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246181	10.1371/journal.pone.0246181	http://dx.doi.org/10.1371/journal.pone.0246181			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596235	gold, Green Published			2022-12-26	WOS:000620633200029
J	Linacre, L; Sanchez-Robles, C; Mirabal-Gomez, U; Lara-Lara, JR; Bazan-Guzman, C				Linacre, Lorena; Sanchez-Robles, Citlalli; Mirabal-Gomez, Uriel; Ruben Lara-Lara, J.; Bazan-Guzman, Carmen			Cell carbon content and biomass assessments of dinoflagellates and diatoms in the oceanic ecosystem of the Southern Gulf of Mexico	PLOS ONE			English	Article								This study assessed the cell carbon content and biomass for genera of dinoflagellates and diatoms in the oceanic ecosystem of the Southern Gulf of Mexico. Carbon content estimates were based on biovolume calculations derived from linear dimension measurements of individual cells and the approximate geometric body shape of each genus. Then, biomass assessments were performed for both groups in two gulf regions (Perdido and Coatzacoalcos) using these carbon content factors and cell abundances. After four seasonal cruises, 11,817 cells of dinoflagellates and 3,412 cells of diatoms were analyzed. Diverse body shapes and cell sizes were observed among 46 dinoflagellate genera and 37 diatom genera. Nano-cells of dinoflagellates (68% <20 mu m) and micro-cells of diatoms (77% 20-200 mu m, mostly 50-75 mu m) were predominant. According to this cell-size structure, on average, diatoms contained 40% more carbon per cell than dinoflagellates. Contrasting carbon content estimates were observed within the genera of both microalgae. Large carbon averages (>10,000 pg C cell(-1)) were attributed to Gonyaulacal and some occasional genera of dinoflagellates (e.g., Pyrocystis and Noctiluca) and centric diatoms. In contrast, values up to 3 orders of magnitude lower were found for Peridinial and Gymnodinial dinoflagellates and pennate diatoms. Based on these carbon content estimates, which can be considered representative for most of this oceanic ecosystem, seasonal and regional differences were found in the biomass assessments conducted for these functional groups. Overall, dinoflagellates (mostly low-carbon Gymnodinales) had larger depth-integrated biomass than diatoms (mainly rich-carbon centric forms) within the euphotic zone. An exception to it was the late-summer cruise at the Coatzacoalcos region when a surface bloom of centric diatoms was observed in stations influenced by river runoff. This work contributes useful reference information for future ecological studies and models for understanding the biogeochemical functioning of this open-ocean ecosystem.	[Linacre, Lorena; Sanchez-Robles, Citlalli; Mirabal-Gomez, Uriel; Ruben Lara-Lara, J.; Bazan-Guzman, Carmen] Baja California CICESE, Ctr Invest Cient & Educ Super Ensenada, Dept Oceanog Biol, Div Oceanol, Ensenada, Baja California, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Linacre, L (corresponding author), Baja California CICESE, Ctr Invest Cient & Educ Super Ensenada, Dept Oceanog Biol, Div Oceanol, Ensenada, Baja California, Mexico.	llinacre@cicese.mx	Linacre, Lorena/B-7815-2016	Linacre, Lorena/0000-0003-2650-6643	Mexican National Council for Science and Technology -Mexican Ministry of Energy Hydrocarbon Fund [201441]	Mexican National Council for Science and Technology -Mexican Ministry of Energy Hydrocarbon Fund	This research has been funded by the Mexican National Council for Science and Technology -Mexican Ministry of Energy Hydrocarbon Fund, project 201441. This is a contribution of the Gulf of Mexico Research Consortium (CIGoM). We acknowledge PEMEX's specific request to the Hydrocarbon Fund to address the environmental effects of oil spills in the Gulf of Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso Rodriguez Rosalba, 2005, Revista Latinoamericana de Microbiologia, V47, P6; Barton AD, 2013, LIMNOL OCEANOGR, V58, P254, DOI 10.4319/lo.2013.58.1.0254; Bland JM, 1996, BRIT MED J, V312, P770; Brokaw RJ, 2019, GEOPHYS RES LETT, V46, P5978, DOI 10.1029/2019GL082931; Buitenhuis ET, 2013, EARTH SYST SCI DATA, V5, P227, DOI 10.5194/essd-5-227-2013; Cupp Easter E., 1943, BULL SCRIPPS INST OCEANOGR, V5, P1; Damien P, 2018, J GEOPHYS RES-OCEANS, V123, P2592, DOI 10.1002/2017JC013456; Edler L., 2010, MICROSCOPIC MOL METH, V55, P13; Escobar-Morales S, 2015, BOT MAR, V58, P9, DOI 10.1515/bot-2014-0049; Ghinaglia LT, 2004, HYDROBIOLOGIA, V519, P85; Gomez F, 2012, SYST BIODIVERS, V10, P267, DOI 10.1080/14772000.2012.721021; Guerrero L, 2020, CONT SHELF RES, V209, DOI 10.1016/j.csr.2020.104243; Guiry M.D., 2020, WORLD WIDE ELECT PUB; Hasle G., 1978, PHYTOPLANKTON MANUAL, V6, P136; Heileman S., 2009, 15 50 GULF MEXICO LM, V182, P673; Hernandez-Becerril DU, 2008, CIENC MAR, V34, P77, DOI 10.7773/cm.v34i1.1263; Hernandez-Becerril DU, 2007, J ENVIRON SCI HEAL A, V42, P1349, DOI 10.1080/10934520701480219; Hernandez-Becerril DU, 1998, BOT MAR, V41, P505, DOI 10.1515/botm.1998.41.1-6.505; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Irwin AJ, 2006, J PLANKTON RES, V28, P459, DOI 10.1093/plankt/fbi148; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; Krayesky D.M., 2009, GULF MEXICO ORIGIN W, P155; Le Quere C, 2005, GLOBAL CHANGE BIOL, V11, P2016, DOI 10.1111/j.1365-2468.2005.01004.x; LEAKEY RJG, 1994, J PLANKTON RES, V16, P375, DOI 10.1093/plankt/16.4.375; Leblanc K, 2012, EARTH SYST SCI DATA, V4, P149, DOI 10.5194/essd-4-149-2012; Lessard EJ, 1996, DEEP-SEA RES PT I, V43, P1045, DOI 10.1016/0967-0637(96)00052-0; Licea S, 2004, PHYCOL RES, V52, P419, DOI 10.1111/j.1440-1835.2004.tb00351.x; Licea S, 2013, MICROPALEAEONTOLOGIC, P155; Licea S., 2016, J BIODIVERSITY ENDAN, V4, P1, DOI [10.4172/2332-2543.1000174, DOI 10.4172/2332-2543.1000174]; Licea S, 2017, NOVOSTI SIST NIZSH R, V51, P121, DOI [DOI 10.31111/NSNR/2017.51.121, 10.31111/nsnr/2017.51.121.]; Licea Sergio, 1991, Anales del Instituto de Ciencias del Mar y Limnologia Universidad Nacional Autonoma de Mexico, V18, P157; Licea S, 2011, J ENVIRON BIOL, V32, P443; Licea-Duran S., 1999, REV SOC MEX HIST NAT, V49, P83; Linacre L, 2019, J GEOPHYS RES-OCEANS, V124, P8342, DOI 10.1029/2019JC015103; Linacre L, 2015, DEEP-SEA RES PT I, V106, P55, DOI 10.1016/j.dsr.2015.09.009; Magana HA, 2003, HARMFUL ALGAE, V2, P163, DOI 10.1016/S1568-9883(03)00026-X; Martinez-Lopez B, 2009, J MARINE SYST, V77, P1, DOI 10.1016/j.jmarsys.2008.10.002; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Menden-Deuer S, 2001, MAR ECOL PROG SER, V222, P41, DOI 10.3354/meps222041; Merino-Virgilio F. del C., 2013, CHECK LIST, V9, P771; Meunier T, 2018, J GEOPHYS RES-OCEANS, V123, P6070, DOI 10.1029/2018JC013801; Monreal-Gomez MA., 1992, CIENC MAR, V18, P115, DOI [10.7773/cm.v18i4.908, DOI 10.7773/CM.V18I4.908]; Moreno Ruiz J. L., 1993, Diatom Research, V8, P419; Moreno-Ruiz JL., 1994, CALIF ACAD SCI, V17, P113; Morey SL, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001674; Okolodkov Yuri B., 2003, Hidrobiológica, V13, P207; Olenina I, 2006, BALT SEA ENV P, V106, P1; Pasulka AL, 2013, DEEP-SEA RES PT II, V93, P44, DOI 10.1016/j.dsr2.2013.01.007; Perez-Brunius P, 2013, DEEP-SEA RES PT II, V85, P182, DOI 10.1016/j.dsr2.2012.07.020; RIEGMAN R, 1993, NETH J SEA RES, V31, P255, DOI 10.1016/0077-7579(93)90026-O; Ryabov A., 2020, BIORXIV PREPRINT, DOI [10.1101/2020.02.06.937219v3, DOI 10.1101/2020.02.06.937219V3]; Schneider LK, 2020, BIODIVERS DATA J, V8, DOI 10.3897/BDJ.8.e56648; Sherr EB, 2007, MAR ECOL PROG SER, V352, P187, DOI 10.3354/meps07161; Smayda TJ, 1978, MONOGRAPHS OCEANOGRA, V6, P273; Stanca E, 2013, HYDROBIOLOGIA, V701, P99, DOI 10.1007/s10750-012-1262-2; Steidinger K A, 1973, CRC Crit Rev Microbiol, V3, P49, DOI 10.3109/10408417309108745; Steidinger Karen A., 2009, P131; STOECKER DK, 1994, MAR ECOL PROG SER, V110, P293, DOI 10.3354/meps110293; Strom SL, 1996, MAR ECOL PROG SER, V130, P229, DOI 10.3354/meps130229; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; Thomas C. R., 1997, IDENTIFYING MARINE P; Throndsen J., 1978, PHYTOPLANKTON MANUAL, P69; Vadrucci M.R., 2013, Transitional Waters Bulletin, V7, P100; Vadrucci M.R., 2007, TRANSITIONAL WATERS, V2, P83, DOI [10.1285/i1825229Xv1n2p83, DOI 10.1285/I1825229XV1N2P83]; VERITY PG, 1993, DEEP-SEA RES PT II, V40, P227, DOI 10.1016/0967-0645(93)90015-F; Vidal V.M.V., 1994, J OCEANOGR, V50, P559, DOI [DOI 10.1007/BF02235424, 10.1007/bf02235424]; Zamudio ME, 2013, MICROPALEAEONTOLOGIC, P233; Zavala-Hidalgo J, 2014, ATMOSFERA, V27, P317, DOI 10.1016/S0187-6236(14)71119-1	68	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247071	10.1371/journal.pone.0247071	http://dx.doi.org/10.1371/journal.pone.0247071			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596253	gold, Green Published			2022-12-26	WOS:000620633200025
J	Statz, M; Ware, D; Perry, N; Huebner, D; Cox, C; Brown, A; Meanley, S; Haberlen, S; Egan, J; Brennan, M; Teplin, LA; Bolan, R; Friedman, MR; Plankey, M				Statz, Matthew; Ware, Deanna; Perry, Nicholas; Huebner, David; Cox, Christopher; Brown, Andre; Meanley, Steven; Haberlen, Sabina; Egan, James; Brennan, Mark; Teplin, Linda A.; Bolan, Robert; Friedman, M. Reuel; Plankey, Michael			Primary and secondary supportive partnerships among HIV-positive and HIV-negative middle-aged and older gay men	PLOS ONE			English	Article								This study describes the primary and secondary partnerships of aging gay men participating in the Understanding Patterns of Healthy Aging Among Men Who Have Sex with Men substudy of the Multicenter AIDS Cohort Study and examines differences in the prevalence of these relationship structures by HIV status while adjusting for age, education, and race/ethnicity. Relationships were compared within the following structural categories: "only a primary partnership", "only a secondary partnership", "both a primary and secondary relationship", or "neither a primary nor secondary relationship". There were 1,054 participants (51.9% HIV negative/48.1% HIV positive) included in the study. Participants had a median age of 62.0 years (interquartile range: 56.0-67.0) and most reported being non-Hispanic white (74.6%) and college educated (88.0%). Of the 1,004 participants with available partnership status data, 384 (38.2%) reported no primary or secondary partnerships, 108 (10.8%) reported secondary-only partnership, 385 (38.3%) reported primary-only partnership, and 127 (12.6%) reported both primary and secondary partnerships. Of participants who reported primary partnerships only, the prevalence rates (PRs) were lower among those 62 years and older, HIV positive, black non-Hispanic and Hispanics. Of participants who reported only having a secondary partnership, the PRs were higher among those 62 years and older and HIV positive. Of participants who did not report having either a primary or secondary partnership, the PRs were higher among those 62 years and older, HIV positive, and black non-Hispanic compared with their respective referent groups. There was no significant difference in PRs of having both primary and secondary partnerships by age category, HIV status, race/ethnicity, and education. This study aimed to fill a knowledge gap in the literature regarding both primary and secondary supportive partnerships among aging HIV-positive and HIV-negative gay men.	[Statz, Matthew] Georgetown Univ, Sch Med, Washington, DC USA; [Ware, Deanna; Plankey, Michael] Georgetown Univ, Med Ctr, Dept Med, Div Infect Dis, Washington, DC 20007 USA; [Perry, Nicholas; Haberlen, Sabina] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Perry, Nicholas] Rhode Isl Hosp, Providence, RI USA; [Huebner, David] George Washington Univ, Milken Inst Publ Hlth, Dept Prevent & Community Hlth, Washington, DC USA; [Cox, Christopher] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Brown, Andre; Egan, James] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA; [Meanley, Steven] Univ Penn, Sch Nursing, Dept Family & Community Hlth, Philadelphia, PA 19104 USA; [Brennan, Mark] CUNY Hunter Coll, Brookdale Ctr Hlth Aging, New York, NY 10021 USA; [Teplin, Linda A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Bolan, Robert] Los Angeles LGBT Ctr, Los Angeles, CA USA; [Friedman, M. Reuel] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA	Georgetown University; Georgetown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; George Washington University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; City University of New York (CUNY) System; Hunter College (CUNY); Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ware, D (corresponding author), Georgetown Univ, Med Ctr, Dept Med, Div Infect Dis, Washington, DC 20007 USA.	dpf38@georgetown.edu	Huebner, David/ABA-2547-2021	Brown, Andre/0000-0003-2022-8283	National Institute for Minority Health Disparities [R01 MD010680]; Atlanta CRS [U01-HL146241]; Baltimore CRS [U01-HL146201]; Bronx CRS [U01-HL146204]; Brooklyn CRS [U01-HL146202]; Data Analysis and Coordination Center [U01-HL146193]; Chicago-Cook County CRS [U01-HL146245]; Chicago-Northwestern CRS [U01-HL146240]; Connie Wofsy Women's HIV Study, Northern California CRS [U01-HL146242]; Los Angeles CRS [U01-HL146333]; Metropolitan Washington CRS [U01-HL146205]; Miami CRS [U01-HL146203]; Pittsburgh CRS [U01-HL146208]; UAB-MS CRS [U01HL146192]; UNC CRS [U01HL146194]; National Heart, Lung, and Blood Institute (NHLBI); Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD); National Institute On Aging (NIA); National Institute Of Dental & Craniofacial Research (NIDCR); National Institute Of Allergy And Infectious Diseases (NIAID); National Institute Of Neurological Disorders And Stroke (NINDS); National Institute Of Mental Health (NIMH); National Institute On Drug Abuse (NIDA); National Institute Of Nursing Research (NINR); National Cancer Institute (NCI); National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Deafness and Other Communication Disorders (NIDCD); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute on Minority Health and Health Disparities (NIMHD); UCSF CTSA [UL1-TR000004]; Atlanta CFAR [P30-AI-050409]; UNC CFAR [P30-AI-050410]; UAB CFAR [P30-AI-027767]	National Institute for Minority Health Disparities; Atlanta CRS; Baltimore CRS; Bronx CRS; Brooklyn CRS; Data Analysis and Coordination Center; Chicago-Cook County CRS; Chicago-Northwestern CRS; Connie Wofsy Women's HIV Study, Northern California CRS; Los Angeles CRS; Metropolitan Washington CRS; Miami CRS; Pittsburgh CRS; UAB-MS CRS; UNC CRS; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute On Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute Of Dental & Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute Of Allergy And Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute Of Neurological Disorders And Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute Of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute On Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute Of Nursing Research (NINR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); UCSF CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Atlanta CFAR; UNC CFAR; UAB CFAR	This study is funded by the National Institute for Minority Health Disparities [grant R01 MD010680 Plankey & Friedman]. The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). MWCCS (Principal Investigators): Atlanta CRS (Ighovwerha Ofotokun, Anandi Sheth, and Gina Wingood), U01-HL146241; Baltimore CRS (Todd Brown and Joseph Margolick), U01-HL146201; Bronx CRS (Kathryn Anastos and Anjali Sharma), U01-HL146204; Brooklyn CRS (Deborah Gustafson and Tracey Wilson), U01-HL146202; Data Analysis and Coordination Center (Gypsyamber D'Souza, Stephen Gange and Elizabeth Golub), U01-HL146193; Chicago-Cook County CRS (Mardge Cohen and Audrey French), U01-HL146245; Chicago-Northwestern CRS (Steven Wolinsky), U01-HL146240; Connie Wofsy Women's HIV Study, Northern California CRS (Bradley Aouizerat, Phyllis Tien, and Jennifer Price), U01-HL146242; Los Angeles CRS (Roger Detels), U01-HL146333; Metropolitan Washington CRS (Seble Kassaye and Daniel Merenstein), U01-HL146205; Miami CRS (Maria Alcaide, Margaret Fischl, and Deborah Jones), U01-HL146203; Pittsburgh CRS (Jeremy Martinson and Charles Rinaldo), U01-HL146208; UAB-MS CRS (Mirjam-Colette Kempf, Jodie Dionne-Odom, and Deborah Konkle-Parker), U01HL146192; UNC CRS (Adaora Adimora), U01HL146194. The MWCCS is funded primarily by the National Heart, Lung, and Blood Institute (NHLBI), with additional co-funding from the Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD), National Institute On Aging (NIA), National Institute Of Dental & Craniofacial Research (NIDCR), National Institute Of Allergy And Infectious Diseases (NIAID), National Institute Of Neurological Disorders And Stroke (NINDS), National Institute Of Mental Health (NIMH), National Institute On Drug Abuse (NIDA), National Institute Of Nursing Research (NINR), National Cancer Institute (NCI), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute on Minority Health and Health Disparities (NIMHD), and in coordination and alignment with the research priorities of the National Institutes of Health, Office of AIDS Research (OAR). MWCCS data collection is also supported by UL1-TR000004 (UCSF CTSA), P30-AI-050409 (Atlanta CFAR), P30-AI-050410 (UNC CFAR), and P30-AI-027767 (UAB CFAR).	Adelman M., 2006, COMMUNITY BUILDING R; Applewhite S., 2016, J BLACK SEXUALITY RE, V2, P1, DOI [10.1353/bsr.2016.0005, DOI 10.1353/BSR.2016.0005]; Awosan C. I., 2016, J BLACK SEXUALITY RE, V3, P25, DOI [10.1353/bsr.2016.0027, DOI 10.1353/BSR.2016.0027]; Beeler JA., 1999, J GAY LESBIAN SOC SE, V9, P31; Bowleg L, 2013, SEX ROLES, V68, P754, DOI 10.1007/s11199-012-0152-4; Brennan-Ing M, 2017, SOC AGING, P54; Cantor M., 2000, SOCIAL CARE ELDERLY; Centers for Disease Control and Prevention, 2017, DIAGN HIV INF US DE, P28; Centers for Disease Control and Prevention, 2019, HIV OLDER AM; Centers for Disease Control and Prevention, 2019, DIAGN HIV INF US DEP, P30; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; de Vries B., 2006, SEXUALITY RES SOCIAL, V3, P1, DOI [DOI 10.1525/SRSP.2006.3.2.1, 10.1525/srsp.2006.3.2.1]; de Vries B, 2007, SEXUAL INEQUALITIES AND SOCIAL JUSTICE, P213; Dewaele A, 2011, J APPL SOC PSYCHOL, V41, P312, DOI 10.1111/j.1559-1816.2010.00715.x; DUDLEY J, 1995, AM J EPIDEMIOL, V142, P323, DOI 10.1093/oxfordjournals.aje.a117638; Dumpson JR., 1993, GROWING OLDER NEW YO; Emlet CA, 2006, HEALTH SOC WORK, V31, P299, DOI 10.1093/hsw/31.4.299; Emlet CA, 2017, GERONTOLOGIST, V57, pS40, DOI 10.1093/geront/gnw171; Gates G. J., 2012, NATL COUNCIL FAMILY, V51, P1; Grossman AH, 2000, J GERONTOL B-PSYCHOL, V55, pP171, DOI 10.1093/geronb/55.3.P171; Grov C, 2010, AIDS CARE, V22, P630, DOI 10.1080/09540120903280901; Hareven T.K, 1978, TRANSITIONS FAMILY L; Haupert ML., 2017, CURRENT SEXUAL HLTH, V9, P155, DOI [10.1007/s11930-017-0121-6, DOI 10.1007/S11930-017-0121-6]; Icard LD., 1996, J GAY LESBIAN SOCIAL, V5, P25; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kim HJ, 2016, GERONTOLOGIST, V56, P548, DOI 10.1093/geront/gnu083; Lyons A, 2016, RES AGING, V38, P234, DOI 10.1177/0164027515588996; Meanley, 2019, AGING MENT HEALTH, P1; Moore MR, 2013, ANNU REV SOCIOL, V39, P491, DOI 10.1146/annurev-soc-071312-145643; NARDI PM, 1982, J ALCOHOL DRUG EDUC, V27, P83; Newsome Valerie, 2015, J Black Sex Relatsh, V1, P113; Nobre NR, 2016, AIDS CARE, V28, P186, DOI 10.1080/09540121.2015.1071774; Peplau LA, 2007, ANNU REV PSYCHOL, V58, P405, DOI 10.1146/annurev.psych.58.110405.085701; Robinson RK, 2008, FORDHAM LAW REV, V76, P2787; Shippy R., 2004, J MENS STUD, V13, P107, DOI [10.3149/jms.1301.107, DOI 10.3149/JMS.1301.107]; Shippy RA, 2005, AGING MENT HEALTH, V9, P246, DOI 10.1080/13607860412331336850; Shippy RA, 2005, RES AGING, V27, P290, DOI 10.1177/0164027504273780; Slomka J, 2013, J ASSOC NURSE AIDS C, V24, P449, DOI 10.1016/j.jana.2012.09.004; Soler JH, 2018, SEX RES SOC POLICY, V15, P123, DOI 10.1007/s13178-017-0288-7; Tsilika E., 2018, INT J HUMANITIES SOC, V8; Vaschel Tessa, 2017, HAPPY PROBLEMS PERFO; Weston Kath, 1991, FAMILIES WE CHOOSE L; Wolfers J., 2015, NEW YORK TIMES, V20; Worth H, 2002, J SOCIOL, V38, P237, DOI 10.1177/144078302128756642	44	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0245863	10.1371/journal.pone.0245863	http://dx.doi.org/10.1371/journal.pone.0245863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8ME	33596240	Green Published, gold			2022-12-26	WOS:000620633200032
J	Son, JP; Sung, JH; Kim, DH; Cho, YH; Kim, SJ; Chung, JW; Chang, WH; Kim, YH; Kim, EH; Moon, GJ; Bang, OY				Son, Jeong Pyo; Sung, Ji Hee; Kim, Dong Hee; Cho, Yeon Hee; Kim, Suk Jae; Chung, Jong-Won; Chang, Won Hyuk; Kim, Yun-Hee; Kim, Eun Hee; Moon, Gyeong Joon; Bang, Oh Young			Brain morphological and connectivity changes on MRI after stem cell therapy in a rat stroke model	PLOS ONE			English	Article								In animal models of stroke, behavioral assessments could be complemented by a variety of neuroimaging studies to correlate them with recovery and better understand mechanisms of improvement after stem cell therapy. We evaluated morphological and connectivity changes after treatment with human mesenchymal stem cells (hMSCs) in a rat stroke model, through quantitative measurement of T-2-weighted images and diffusion tensor imaging (DTI). Transient middle cerebral artery occlusion rats randomly received PBS (PBS-only), FBS cultured hMSCs (FBS-hMSCs), or stroke patients' serum cultured hMSCs (SS-hMSCs). Functional improvement was assessed using a modified neurological severity score (mNSS). Quantitative analyses of T-2-weighted ischemic lesion and ventricular volume changes were performed. Brain microstructure/connectivity changes were evaluated in the ischemic recovery area by DTI-derived microstructural indices such as relative fractional anisotropy (rFA), relative axial diffusivity (rAD), and relative radial diffusivity (rRD), and relative fiber density (rFD) analyses. According to mNSS results, the SS-hMSCs group showed the most prominent functional improvement. Infarct lesion volume of the SS-hMSCs group was significantly decreased at 2 weeks when compared to the PBS-only groups, but there were no differences between the FBS-hMSCs and SS-hMSCs groups. Brain atrophy was significantly decreased in the SS-hMSCs group compared to the other groups. In DTI, rFA and rFD values were significantly higher and rRD value was significant lower in the SS-hMSCs group and these microstructure/connectivity changes were correlated with T-2-weighted morphological changes. T-2-weighted volume alterations (ischemic lesion and brain atrophy), and DTI microstructural indices and rFD changes, were well matched with the results of behavioral assessment. These quantitative MRI measurements could be potential outcome predictors of functional recovery after treatment with stem cells for stroke.	[Son, Jeong Pyo; Kim, Dong Hee; Bang, Oh Young] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Son, Jeong Pyo; Sung, Ji Hee; Kim, Dong Hee; Cho, Yeon Hee; Kim, Eun Hee; Moon, Gyeong Joon; Bang, Oh Young] Samsung Med Ctr, Translat & Stem Cell Res Lab Stroke, Seoul, South Korea; [Son, Jeong Pyo] Osong Med Innovat Fdn, Lab Anim Ctr, Osong, South Korea; [Sung, Ji Hee; Kim, Eun Hee; Bang, Oh Young] S&E Bion Inc, Seoul, South Korea; [Kim, Suk Jae; Chung, Jong-Won; Bang, Oh Young] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Neurol, Seoul, South Korea; [Chang, Won Hyuk; Kim, Yun-Hee] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Phys & Rehabil Med, Seoul, South Korea; [Kim, Eun Hee] Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea; [Moon, Gyeong Joon] Asan Med Ctr, AMC Stem Cell Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Osong Medical Innovation Foundation; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan; Asan Medical Center	Bang, OY (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.; Bang, OY (corresponding author), Samsung Med Ctr, Translat & Stem Cell Res Lab Stroke, Seoul, South Korea.; Bang, OY (corresponding author), S&E Bion Inc, Seoul, South Korea.; Bang, OY (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Neurol, Seoul, South Korea.	ohyoung.bang@samsung.com	Kim, Yun-Hee/GVS-6426-2022; Kim, Yun Hee/F-4600-2014	Son, Jeong Pyo/0000-0002-8655-3495; Moon, Gyeong Joon/0000-0002-2851-9563	Korea Health Technology R&D Project, the Ministry of Health Welfare [HI14C16240000, HI14C3484]	Korea Health Technology R&D Project, the Ministry of Health Welfare	This study was supported by a grant from the Korea Health Technology R&D Project, the Ministry of Health & Welfare (HI14C16240000 and HI14C3484). S&E bio, Inc. provided support for this study in the form of salaries for JHS, EHK, and OYB. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajwa NM, 2019, J NEUROSCI RES, V97, P332, DOI 10.1002/jnr.24343; Bang OY, 2017, TRANSL STROKE RES, V8, P449, DOI 10.1007/s12975-017-0538-2; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Boltze J, 2019, STROKE, V50, P3299, DOI 10.1161/STROKEAHA.119.025436; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chen DC, 2014, CELL TRANSPLANT, V23, P1599, DOI 10.3727/096368914X678562; Chung JW, 2019, STROKE, V50; Cochrane CJ, 2013, NEUROLOGY, V80, P857, DOI 10.1212/WNL.0b013e318284070c; Cui LL, 2019, ANN NEUROL, V86, P5, DOI 10.1002/ana.25493; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Ding GL, 2011, STROKE, V42, P3537, DOI 10.1161/STROKEAHA.111.622092; George P., 2007, QINGCHUAN ZHUGE TRAN, V32; Ghali AA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00228; Green HAL, 2002, STROKE, V33, P1517, DOI 10.1161/01.STR.0000016973.80180.7B; Gutierrez-Fernandez M, 2011, NEUROSCIENCE, V175, P394, DOI 10.1016/j.neuroscience.2010.11.054; Hess DC, 2017, LANCET NEUROL, V16, P360, DOI 10.1016/S1474-4422(17)30046-7; Jang SH, 2011, NEUROREHABILITATION, V28, P345, DOI 10.3233/NRE-2011-0662; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042845; Jung WB, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3704; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim EH, 2016, CELL TRANSPLANT, V25, P1489, DOI 10.3727/096368916X690430; Kim SJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-317; Koh SH, 2017, TRANSL STROKE RES, V8, P3, DOI 10.1007/s12975-016-0460-z; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Lees JS, 2012, INT J STROKE, V7, P582, DOI 10.1111/j.1747-4949.2012.00797.x; Liao WB, 2009, TRANSPLANTATION, V87, P350, DOI 10.1097/TP.0b013e318195742e; Moon GJ, 2018, CELL TRANSPLANT, V27, P485, DOI 10.1177/0963689718755404; Prasad K, 2014, STROKE, V45, P3618, DOI 10.1161/STROKEAHA.114.007028; Roberts TPL, 2005, AM J NEURORADIOL, V26, P2183; Rudrapatna SU, 2014, NEUROIMAGE, V97, P363, DOI 10.1016/j.neuroimage.2014.04.013; Savitz SI, 2019, CIRCULATION, V139, P192, DOI 10.1161/CIRCULATIONAHA.117.030659; Shang JW, 2011, J NEUROSCI RES, V89, P86, DOI 10.1002/jnr.22524; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; Steinberg GK, 2016, STROKE, V47, P1817, DOI 10.1161/STROKEAHA.116.012995; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Stolp HB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22295-9; Sztriha LK, 2012, STROKE, V43, P3124, DOI 10.1161/STROKEAHA.111.649244; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; Vahidy FS, 2016, STROKE, V47, P1632, DOI 10.1161/STROKEAHA.116.012701; van Velthoven CTJ, 2012, ANN NEUROL, V71, P785, DOI 10.1002/ana.23543; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Zacharek A, 2010, STROKE, V41, P524, DOI 10.1161/STROKEAHA.109.568881; Zhang GZ, 2019, STEM CELL TRANSL MED, V8, P999, DOI 10.1002/sctm.18-0220	51	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246817	10.1371/journal.pone.0246817	http://dx.doi.org/10.1371/journal.pone.0246817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592008	Green Published, gold			2022-12-26	WOS:000620632800024
J	Bolanos, CG; Pham, NM; Mair, RD; Meyer, TW; Sirich, TL				Bolanos, Christian G.; Pham, Nhat M.; Mair, Robert D.; Meyer, Timothy W.; Sirich, Tammy L.			Metabolomic analysis of uremic pruritus in patients on hemodialysis	PLOS ONE			English	Article								Pruritus is a common debilitating symptom experienced by hemodialysis patients. Treatment is difficult because the cause of uremic pruritus is not known. This study addressed the hypothesis that pruritus is caused by solutes that accumulate in the plasma when the kidneys fail. We sought to identify solutes responsible for uremic pruritus using metabolomic analysis to compare the plasma of hemodialysis patients with severe pruritus versus mild/no pruritus. Pruritus severity in hemodialysis patients was assessed using a 100-mm visual analogue scale (VAS), with severe pruritus defined as >70 mm and mild/no pruritus defined as <10 mm. Twelve patients with severe pruritus (Itch) and 24 patients with mild/no pruritus (No Itch) were included. Pre-treatment plasma and plasma ultrafiltrate were analyzed using an established metabolomic platform (Metabolon, Inc.). To identify solutes associated with pruritus, we compared the average peak area of each solute in the Itch patients to that of the No Itch patients using the false discovery rate (q value) and principal component analysis. Dialysis vintage, Kt/V-urea, and serum levels of calcium, phosphorus, PTH, albumin, ferritin, and hemoglobin were similar in the Itch and No Itch patients. Metabolomic analysis identified 1,548 solutes of which 609 were classified as uremic. No difference in the plasma or plasma ultrafiltrate levels of any solute or group of solutes was found between the Itch and No Itch patients. Metabolomic analysis of hemodialysis patients did not reveal any solutes associated with pruritus. A limitation of metabolomic analysis is that the solute of interest may not be included in the metabolomic platform's chemical library. A role for uremic solutes in pruritus remains to be established.	[Bolanos, Christian G.; Pham, Nhat M.; Mair, Robert D.; Meyer, Timothy W.; Sirich, Tammy L.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Bolanos, Christian G.; Mair, Robert D.; Meyer, Timothy W.; Sirich, Tammy L.] VA Palo Alto Healthcare Syst, Dept Med, Palo Alto, CA 94304 USA; [Pham, Nhat M.] Santa Clara Valley Med Ctr, Dept Med, San Jose, CA 95128 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Santa Clara Valley Medical Center	Sirich, TL (corresponding author), Stanford Univ, Dept Med, Palo Alto, CA 94304 USA.; Sirich, TL (corresponding author), VA Palo Alto Healthcare Syst, Dept Med, Palo Alto, CA 94304 USA.	tsirich@stanford.edu			Ruth L. Kirschstein National Research Service Award, National Institutes of Health [F32 DK111166]; NIH, National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK101674]; Veterans Affairs Career Development Award, U.S. Department of Veterans Affairs [CX00103601A1]	Ruth L. Kirschstein National Research Service Award, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs Career Development Award, U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	RDM - F32 DK111166 (Ruth L. Kirschstein National Research Service Award, National Institutes of Health) TWM -R01 DK101674 (NIH, National Institute of Diabetes and Digestive and Kidney Diseases) TLS -CX00103601A1 (Veterans Affairs Career Development Award, U.S. Department of Veterans Affairs) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshinnia F, 2018, J AM SOC NEPHROL, V29, P295, DOI 10.1681/ASN.2017030350; Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; ALTMEYER P, 1986, HAUTARZT, V37, P217; Cevikbas F, 2020, PHYSIOL REV, V100, P945, DOI 10.1152/physrev.00017.2019; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Chu L, 2015, INT UROL NEPHROL, V47, P345, DOI 10.1007/s11255-014-0901-0; Dong XT, 2018, NEURON, V98, P482, DOI 10.1016/j.neuron.2018.03.023; Evans A, 2014, METABOLOMICS, V4, pS24; Fishbane S, 2020, NEW ENGL J MED, V382, P222, DOI 10.1056/NEJMoa1912770; Guo LN, 2015, P NATL ACAD SCI USA, V112, pE4901, DOI 10.1073/pnas.1508425112; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imam MH, 2012, J GASTROEN HEPATOL, V27, P1150, DOI 10.1111/j.1440-1746.2012.07109.x; Jimenez F, 2002, DIGEST DIS SCI, V47, P2398, DOI 10.1023/A:1020575001944; Leong SC, 2018, J AM SOC NEPHROL, V29, P1992, DOI 10.1681/ASN.2018010081; Li R, 2019, PEERJ, V7, DOI 10.7717/peerj.7145; Mamianetti A, 2000, CLIN NEPHROL, V53, P194; Mathur VS, 2010, CLIN J AM SOC NEPHRO, V5, P1410, DOI 10.2215/CJN.00100110; Meixiong J, 2019, P NATL ACAD SCI USA, V116, P10525, DOI 10.1073/pnas.1903316116; Meixiong J, 2017, ANNU REV GENET, V51, P103, DOI 10.1146/annurev-genet-120116-024723; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pisoni RL, 2006, NEPHROL DIAL TRANSPL, V21, P3495, DOI 10.1093/ndt/gfl461; Rayner HC, 2017, CLIN J AM SOC NEPHRO, V12, P2000, DOI 10.2215/CJN.03280317; Rhee EP, 2019, CLIN J AM SOC NEPHRO, V14, P40, DOI 10.2215/CJN.07070618; Rhee EP, 2018, AM J KIDNEY DIS, V72, P129, DOI 10.1053/j.ajkd.2017.12.008; Stander S, 2013, ACTA DERM-VENEREOL, V93, P509, DOI 10.2340/00015555-1620; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Weisbord SD, 2004, J PAIN SYMPTOM MANAG, V27, P226, DOI 10.1016/j.jpainsymman.2003.07.004; Wu Q, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4351674	28	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246765	10.1371/journal.pone.0246765	http://dx.doi.org/10.1371/journal.pone.0246765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577623	Green Published, gold			2022-12-26	WOS:000620071700044
J	Chitayat, AB; Wich, SA; Lewis, M; Stewart, FA; Piel, AK				Chitayat, Adrienne B.; Wich, Serge A.; Lewis, Matthew; Stewart, Fiona A.; Piel, Alex K.			Ecological correlates of chimpanzee (Pan troglodytes schweinfurthii) density in Mahale Mountains National Park, Tanzania	PLOS ONE			English	Article								Understanding the ecological factors that drive animal density patterns in time and space is key to devising effective conservation strategies. In Tanzania, most chimpanzees (similar to 75%) live outside national parks where human activities threaten their habitat's integrity and connectivity. Mahale Mountains National Park (MMNP), therefore, is a critical area for chimpanzees (Pan troglodytes schweinfurthii) in the region due to its location and protective status. Yet, despite its importance and long history of chimpanzee research (>50 years), a park-wide census of the species has never been conducted. The park is categorized as a savanna-woodland mosaic, interspersed with riparian forest, wooded grassland, and bamboo thicket. This heterogeneous landscape offers an excellent opportunity to assess the ecological characteristics associated with chimpanzee density, a topic still disputed, which could improve conservation plans that protect crucial chimpanzee habitat outside the park. We examined the influence of fine-scale vegetative characteristics and topographical features on chimpanzee nest density, modeling nest counts using hierarchical distance sampling. We counted 335 nests in forest and woodland habitats across 102 transects in 13 survey sites. Nests were disproportionately found more in or near evergreen forests, on steep slopes, and in feeding tree species. We calculated chimpanzee density in MMNP to be 0.23 ind/km(2), although density varied substantially among sites (0.09-3.43 ind/km(2)). Density was associated with factors related to the availability of food and nesting trees, with topographic heterogeneity and the total basal area of feeding tree species identified as significant positive predictors. Species-rich habitats and floristic diversity likely play a principal role in shaping chimpanzee density within a predominately open landscape with low food abundance. Our results provide valuable baseline data for future monitoring efforts in MMNP and enhance our understanding of this endangered species' density and distribution across Tanzania.	[Chitayat, Adrienne B.; Wich, Serge A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Wich, Serge A.; Stewart, Fiona A.] Liverpool John Moores Univ, Sch Biol & Environm Sci, Liverpool, Merseyside, England; [Lewis, Matthew] Max Planck Inst Evolutionary Anthropol, Loango Gorilla Project Gabon, Leipzig, Germany; [Stewart, Fiona A.; Piel, Alex K.] UCL, Dept Anthropol, London, England	University of Amsterdam; Liverpool John Moores University; Max Planck Society; University of London; University College London	Chitayat, AB (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.; Piel, AK (corresponding author), UCL, Dept Anthropol, London, England.	chitayata@gmail.com; a.piel@ucl.ac.uk		Wich, Serge/0000-0003-3954-5174; Piel, Alexander/0000-0002-4674-537X	Arcus Foundation; UCSD/Salk Institute Centre for Academic Research and Training in Anthropogeny (CARTA)	Arcus Foundation; UCSD/Salk Institute Centre for Academic Research and Training in Anthropogeny (CARTA)	AKP and FAS received funding from the Arcus Foundation and the UCSD/Salk Institute Centre for Academic Research and Training in Anthropogeny (CARTA).	Abwe EE, 2019, ECOL EVOL, V9, P1489, DOI 10.1002/ece3.4871; Amatulli G, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.40; [Anonymous], 2015, APPL HIERARCHICAL MO, DOI DOI 10.1016/C2013-0-19160-X; Balcomb SR, 2000, AM J PRIMATOL, V51, P197, DOI 10.1002/1098-2345(200007)51:3&lt;197::AID-AJP4&gt;3.0.CO;2-C; Baranga D, 2012, TROP CONSERV SCI, V5, P104, DOI 10.1177/194008291200500109; Barelli C, 2015, INT J PRIMATOL, V36, P209, DOI 10.1007/s10764-015-9815-7; Basabose AK, 2002, INT J PRIMATOL, V23, P263, DOI 10.1023/A:1013879427335; Bonnin N, 2020, BIOL CONSERV, V252, DOI 10.1016/j.biocon.2020.108816; Bortolamiol S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102177; Brownlow AR, 2001, AM J PRIMATOL, V55, P49, DOI 10.1002/ajp.1038; Bryson-Morrison N, 2016, AM J PRIMATOL, V78, P1237, DOI 10.1002/ajp.22578; Buckland S.T., 2001, pi; Burnham KP., 1998, MODEL SELECTION MULT, V67, P655; Cade BS, 2015, ECOLOGY, V96, P2370, DOI 10.1890/14-1639.1; Caro T, 2015, TROP CONSERV SCI, V8, P1009, DOI 10.1177/194008291500800411; Carvalho JS, 2015, AM J PRIMATOL, V77, P186, DOI 10.1002/ajp.22321; Chapman CA, 1999, PRIMATES, V40, P215, DOI 10.1007/BF02557712; Clee PRS, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-014-0275-z; Devos C, 2008, AM J PRIMATOL, V70, P439, DOI 10.1002/ajp.20514; Dufour A, 2006, ECOGRAPHY, V29, P573, DOI 10.1111/j.0906-7590.2006.04605.x; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fleury-Brugiere MC, 2010, INT J PRIMATOL, V31, P383, DOI 10.1007/s10764-010-9391-9; Foerster S, 2016, BEHAV ECOL, V27, P1004, DOI 10.1093/beheco/arw004; Ghiglieri M.P., 1984, P1; Goodall JM, 1986, CHIMPANZEES GOMBE PA, V89, P673; Green SJ, 2020, CURR BIOL, V30, DOI 10.1016/j.cub.2020.08.076; Hakizimana D., 2013, PAN AFR NEWS, V20, P16; HASHIMOTO C, 1995, PRIMATES, V36, P477, DOI 10.1007/BF02382870; Hernandez-Aguilar RA, 2013, AM J PRIMATOL, V75, P979, DOI 10.1002/ajp.22163; Hernandez-Aguilar RA, 2009, J HUM EVOL, V57, P350, DOI 10.1016/j.jhevol.2009.03.007; Humle T., 2016, IUCN RED LIST THREAT, V2016, DOI DOI 10.2305/IUCN.UK.2016-2.RLTS.T15933A17964454.EN; Hunt KD, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P35, DOI 10.1017/CBO9780511606397.005; Ihobe H., 2005, PAN AFRICA NEWS, V12, P10, DOI [10.5134/143448, DOI 10.5134/143448]; Itoh N., 2012, ECOLOGICAL IMPACT LO, P249; IVES AR, 1995, ECOL MONOGR, V65, P217, DOI 10.2307/2937138; Jantz SM, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8050427; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; Kamgang SA, 2018, BMC ECOL, V18, DOI 10.1186/s12898-018-0199-3; Kano T, 1971, KYOTO U AFRICAN STUD, V12; Kohi E., 2018, TANZANIA CHIMPANZEE; KORTLANDT A, 1983, J HUM EVOL, V12, P231, DOI 10.1016/S0047-2484(83)80149-3; Kouakou CY, 2009, AM J PRIMATOL, V71, P447, DOI 10.1002/ajp.20673; LEIGHTON M, 1983, P181; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Lindsey P, 2020, NAT ECOL EVOL, V4, P1300, DOI 10.1038/s41559-020-1275-6; Marsden SJ, 2003, IBIS, V145, P45, DOI 10.1046/j.1474-919X.2003.00107.x; Mathewson PD, 2008, ECOL APPL, V18, P208, DOI 10.1890/07-0385.1; McCallum ML, 2015, BIODIVERS CONSERV, V24, P2497, DOI 10.1007/s10531-015-0940-6; Moore JF, 2018, AM J PRIMATOL, V80, DOI 10.1002/ajp.22897; Nakamura M., 2015, MAHALE CHIMPANZEES 5, P1; Nakamura M, 2013, PRIMATES, V54, P171, DOI 10.1007/s10329-012-0337-z; Nakazawa N, 2020, AFR J ECOL, V58, P399, DOI 10.1111/aje.12714; Nishida, 1981, AFR STUDY MONOGR, V1, P109; Nishida T., 1983, AFR STUD MONOGR, V3, P109, DOI DOI 10.14989/67987; Oedekoven CS., 2013, J APPL ECOL; Ogawa Hideshi, 2013, Pan Africa News, V20, P1; Ogawa H, 2014, PRIMATES, V55, P269, DOI 10.1007/s10329-013-0400-4; Owen-Smith N, 2004, LANDSCAPE ECOL, V19, P761, DOI 10.1007/s10980-005-0247-2; Patterson LD, 2020, CAN J ZOOL, V98, P105, DOI 10.1139/cjz-2019-0166; Piel AK, 2007, AM J PHYS ANTHROPOL, P189; Piel AK., 2015, NTAKATA KALOBWE WANS, P1; Piel AK, 2019, AFR J ECOL, V57, P31, DOI 10.1111/aje.12570; Piel AK, 2017, J HUM EVOL, V112, P57, DOI 10.1016/j.jhevol.2017.08.016; Piel AK, 2015, GLOB ECOL CONSERV, V3, P188, DOI 10.1016/j.gecco.2014.11.014; Piel AK, 2015, AM J PRIMATOL, V77, P1027, DOI 10.1002/ajp.22438; Pintea L, 2012, LONG TERM CHANGES AF, P194; Pintea L., 2007, APPLYING REMOTE SENS; Plumptre A.J., 2010, E CHIMPANZEE PAN TRO; Plumptre AJ, 1996, INT J PRIMATOL, V17, P85, DOI 10.1007/BF02696160; Plumptre AJ, 1997, INT J PRIMATOL, V18, P475, DOI 10.1023/A:1026302920674; Plumptre AJ, 2007, BIOL CONSERV, V134, P178, DOI 10.1016/j.biocon.2006.08.021; Potts KB, 2011, INT J PRIMATOL, V32, P669, DOI 10.1007/s10764-011-9494-y; Potts KB, 2009, J ANIM ECOL, V78, P1269, DOI 10.1111/j.1365-2656.2009.01578.x; Pruetz JD, 2002, AM J PRIMATOL, V58, P35, DOI 10.1002/ajp.10035; QGIS Development Team. QGIS.org, 2020, QGIS GEOGRAPHIC INFO; Rizzo AA, 2017, AM MIDL NAT, V178, P123, DOI 10.1674/0003-0031-178.1.123; Rovero F, 2007, AM J PRIMATOL, V69, P1242, DOI 10.1002/ajp.20431; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; Schoeninger MJ, 1999, AM J PRIMATOL, V49, P297, DOI 10.1002/(SICI)1098-2345(199912)49:4<297::AID-AJP2>3.0.CO;2-N; Shannon CE., 1949, MATHIMATICAL THEORY; Stein A, 2014, ECOL LETT, V17, P866, DOI 10.1111/ele.12277; Stevenson PR, 2001, BIOL J LINN SOC, V72, P161, DOI 10.1006/bijl.2000.0497; Stewart FA, 2011, J HUM EVOL, V61, P388, DOI 10.1016/j.jhevol.2011.05.005; Stewart FA., 2014, INT PRIM SOC 15 C HA; Tranquilli S, 2012, CONSERV LETT, V5, P48, DOI 10.1111/j.1755-263X.2011.00211.x; TSUKAHARA T, 1993, AM J PRIMATOL, V29, P1, DOI 10.1002/ajp.1350290102; Tweheyo M, 2005, WILDLIFE BIOL, V11, P237, DOI 10.2981/0909-6396(2005)11[237:POCRBP]2.0.CO;2; Wessling EG., 2020, INT J PRIMATOL; Wessling EG, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00060; WHITE LJT, 1994, J TROP ECOL, V10, P289, DOI 10.1017/S0266467400007975; Wilson ML, 2014, NATURE, V513, P414, DOI 10.1038/nature13727; Wolff JO, 1996, J MAMMAL, V77, P850, DOI 10.2307/1382690; Wrangham R. W, 1975, BEHAV ECOLOGY; Yamagiwa Juichi, 1992, African Study Monographs, V13, P217; Young HS, 2016, ANNU REV ECOL EVOL S, V47, P333, DOI 10.1146/annurev-ecolsys-112414-054142; Zamma Koichiro, 2015, P583; Zamma Koichiro, 2015, P33; Zamma Koichiro, 2012, Pan Africa News, V19, P25; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	99	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246628	10.1371/journal.pone.0246628	http://dx.doi.org/10.1371/journal.pone.0246628			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK0KW	33577598	Green Published, gold, Green Accepted			2022-12-26	WOS:000620071700026
J	Sorge, E; Demidov, D; Lermontova, I; Houben, A; Conrad, U				Sorge, Eberhard; Demidov, Dmitri; Lermontova, Inna; Houben, Andreas; Conrad, Udo			Engineered degradation of EYFP-tagged CENH3 via the 26S proteasome pathway in plants	PLOS ONE			English	Article								Determining the function of proteins remains a key task of modern biology. Classical genetic approaches to knocking out protein function in plants still face limitations, such as the time-consuming nature of generating homozygous transgenic lines or the risk of non-viable loss-of-function phenotypes. We aimed to overcome these limitations by acting downstream of the protein level. Chimeric E3 ligases degrade proteins of interest in mammalian cell lines, Drosophila melanogaster embryos, and transgenic tobacco. We successfully recruited the 26S proteasome pathway to directly degrade a protein of interest located in plant nuclei. This success was achieved via replacement of the interaction domain of the E3 ligase adaptor protein SPOP (Speckle-type POZ adapter protein) with a specific anti-GFP nanobody (VHHGFP4). For proof of concept, the target protein CENH3 of A. thaliana fused to EYFP was subjected to nanobody-guided proteasomal degradation in planta. Our results show the potential of the modified E3-ligase adapter protein VHHGFP4-SPOP in this respect. We were able to point out its capability for nucleus-specific protein degradation in plants.	[Sorge, Eberhard; Demidov, Dmitri; Lermontova, Inna; Houben, Andreas; Conrad, Udo] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany; [Lermontova, Inna] Masaryk Univ, CEITEC, Mendel Ctr Plant Genom & Prote, Brno, Czech Republic	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Masaryk University Brno	Sorge, E; Conrad, U (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany.	Sorge.eberhard@gmail.com; conradu@ipk-gatersleben.de	Lermontova, Inna/G-6533-2019	Lermontova, Inna/0000-0003-3386-2590	German Federal Ministry of Education [031B0192A]	German Federal Ministry of Education(Federal Ministry of Education & Research (BMBF))	This research was funded by the German Federal Ministry of Education and Research (Plant 2030, Project 031B0192A, HaploTools). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudisch B, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00130; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Floss DM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/274346; FRANCK A, 1980, CELL, V21, P285, DOI 10.1016/0092-8674(80)90136-1; Gahrtz Manfred, 2009, V483, P289, DOI 10.1007/978-1-59745-407-0_17; Hauptmann V, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0123-2; Heriche JK, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ishii T., 897074 BIORXIV, V2020, DOI [10.1101/2020.01.07.897074, DOI 10.1101/2020.01.07.897074]; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; Lermontova I, 2006, PLANT CELL, V18, P2443, DOI 10.1105/tpc.106.043174; Lermontova I, 2011, PLANT J, V68, P40, DOI 10.1111/j.1365-313X.2011.04664.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shin YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14269; Takahashi I, 2002, BBA-MOL CELL RES, V1591, P63, DOI 10.1016/S0167-4889(02)00249-5; Theodosiou NA, 1998, DEVELOPMENT, V125, P3411; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Vaquero C, 1999, P NATL ACAD SCI USA, V96, P11128, DOI 10.1073/pnas.96.20.11128; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang X, 2020, NAT PLANTS, V6, P766, DOI 10.1038/s41477-020-0695-2; Weber H, 2009, FEBS J, V276, P6624, DOI 10.1111/j.1742-4658.2009.07373.x; Xu F., 2012, BIO PROTOCOL, V2, DOI DOI 10.21769/BioProtoc.306; Zhang YL, 2017, PROG MOL BIOL TRANSL, V149, P133, DOI 10.1016/bs.pmbts.2017.03.008	35	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0247015	10.1371/journal.pone.0247015	http://dx.doi.org/10.1371/journal.pone.0247015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577589	Green Published, gold			2022-12-26	WOS:000620071700055
J	Kanevski, M				Kanevski, Mikhail			Unsupervised learning of Swiss population spatial distribution	PLOS ONE			English	Article							MORISITA ESTIMATOR; FEATURE-SELECTION; CLUSTER	The paper deals with the analysis of spatial distribution of Swiss population using fractal concepts and unsupervised learning algorithms. The research methodology is based on the development of a high dimensional feature space by calculating local growth curves, widely used in fractal dimension estimation and on the application of clustering algorithms in order to reveal the patterns of spatial population distribution. The notion "unsupervised" also means, that only some general criteria-density, dimensionality, homogeneity, are used to construct an input feature space, without adding any supervised/expert knowledge. The approach is very powerful and provides a comprehensive local information about density and homogeneity/fractality of spatially distributed point patterns.	[Kanevski, Mikhail] Univ Lausanne, Inst Earth Surface Dynam, Lausanne, Switzerland	University of Lausanne	Kanevski, M (corresponding author), Univ Lausanne, Inst Earth Surface Dynam, Lausanne, Switzerland.	Mikhail.Kanevski@unil.ch	, Gustavo/ABC-1706-2022; Kanevski, Mikhail/N-5527-2017	Kanevski, Mikhail/0000-0001-6602-6551				Adolfsson A, 2019, PATTERN RECOGN, V88, P13, DOI 10.1016/j.patcog.2018.10.026; Agarwal P, 2008, SELF ORG MAPS APPL G; Aggarwal CC, 2014, CH CRC DATA MIN KNOW, P1; Baddeley A, 2016, CHAP HALL CRC INTERD, P1; Batty M, 2016, FRACTAL CITIES GEOME; Batty M, 2016, NEW SCI CITIES; BLASHFIELD RK, 1991, J CLASSIF, V8, P277; Bouveyron C, 2019, CA ST PR MA, V50, P1, DOI 10.1017/9781108644181; Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Camastra F, 2016, INFORM SCIENCES, V328, P26, DOI 10.1016/j.ins.2015.08.029; Charrad M, 2014, J STAT SOFTW, V61, P1; Contreras P., 2015, HDB CLUSTER ANAL, V1st, P103, DOI [10.1201/b19706-6, DOI 10.1201/B19706-6]; Diggle P.J., 2013, STAT ANAL SPATIAL SP, V0, DOI [10.1201/b15326, DOI 10.1201/B15326]; Falconer K., 2004, FRACTAL GEOMETRY MAT; Feder J, 1988, FRACTALS; Frankhauser P, 2016, FRACTALITE STRUCTURE; Gelfand AE, 2010, CH CRC HANDB MOD STA, P1, DOI 10.1201/9781420072884; Gionis A, 2005, P KDD 05; Golay J, IDMINING INTRINSIC D; Golay J, 2017, KNOWL-BASED SYST, V135, P125, DOI 10.1016/j.knosys.2017.08.009; Golay J, 2017, PATTERN RECOGN, V70, P126, DOI 10.1016/j.patcog.2017.05.008; Golay J, 2015, PATTERN RECOGN, V48, P4070, DOI 10.1016/j.patcog.2015.06.010; Golay J, 2014, PHYSICA A, V406, P191, DOI 10.1016/j.physa.2014.03.063; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Han J, 2011, FINDING GROUPS DATA; Havens TC, 2012, IEEE T KNOWL DATA EN, V24, P813, DOI 10.1109/TKDE.2011.33; Haykin S, 2008, CONF REC ASILOMAR C, P3, DOI 10.1109/ACSSC.2008.5074349; Hennig C, 2015, PATTERN RECOGN LETT, V64, P53, DOI 10.1016/j.patrec.2015.04.009; Houle ME, 2017, LECT NOTES COMPUT SC, V10609, P64, DOI 10.1007/978-3-319-68474-1_5; Huband JM, 2005, PATTERN RECOGN, V38, P1875, DOI 10.1016/j.patcog.2005.03.018; HURLBERT SH, 1990, OIKOS, V58, P257, DOI 10.2307/3545216; Illian J, 2016, STAT ANAL MODELLING; Kanevski M., 2004, ANAL MODELLING SPATI; Kanevski M., 2009, MACHINE LEARNING SPA; Kanevski M., 2008, ADV MAPPING ENV DATA; Kanevski M, 2017, PHYSICA A, V479, P400, DOI 10.1016/j.physa.2017.02.086; Karbauskaite R, 2016, INFORMATICA-LITHUAN, V27, P257, DOI 10.15388/Informatica.2016.84; Kohonen T., 2001, SELF ORG MAPS; Kohonen T, 2013, NEURAL NETWORKS, V37, P52, DOI 10.1016/j.neunet.2012.09.018; LOVEJOY S, 1986, NATURE, V319, P43, DOI 10.1038/319043a0; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Morisita M., 1959, MEMOIRS FS KYUSHU U, V2, P215; RAMSAY J. O., 2007, APPL FUNCTIONAL DATA; Rodriguez MZ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210236; Rozenfeld HD, 2008, P NATL ACAD SCI USA, V105, P18702, DOI 10.1073/pnas.0807435105; Saichev A., 2009, THEORY ZIPFS LAW; Seuront L., 2009, FRACTALS MULTIFRACTA; Tannier C, 2005, CYBERGEO EUROPEAN J, V8504, P1; THEILER J, 1990, J OPT SOC AM A, V7, P1055, DOI 10.1364/JOSAA.7.001055; Thomas I, 2010, ENVIRON PLANN B, V37, P942, DOI 10.1068/b36039; Vega Orozco C. D., 2015, CYBERGEO EUROPEAN J, V714, P1, DOI 10.4000/cybergeo.26829; VICSEK T, 1990, PHYSICA A, V168, P490, DOI 10.1016/0378-4371(90)90401-D; Von Luxburg U., 2012, P ICML WORKSH UNS TR, P65; Wiegand T, 2014, CH HALL CRC APP ENV, P1	55	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246529	10.1371/journal.pone.0246529	http://dx.doi.org/10.1371/journal.pone.0246529			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571272	gold, Green Published			2022-12-26	WOS:000618274000047
J	Jia, R; Bonifacino, JS				Jia, Rui; Bonifacino, Juan S.			The ubiquitin isopeptidase USP10 deubiquitinates LC3B to increase LC3B levels and autophagic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; P62/SQSTM1; MODULATION; BORC	Components of the autophagy machinery are subject to regulation by various posttranslational modifications. Previous studies showed that monoubiquitination of LC3B catalyzed by the ubiquitin-activating enzyme UBA6 and ubiquitin-conjugating enzyme/ubiquitin ligase BIRC6 targets LC3B for proteasomal degradation, thus reducing LC3B levels and autophagic activity under conditions of stress. However, mechanisms capable of counteracting this process are not known. Herein, we report that LC3B ubiquitination is reversed by the action of the deubiquitinating enzyme USP10. We identified USP10 in a CRISPR-Cas9 knockout screen for ubiquitination-related genes that regulate LC3B levels. Biochemical analyses showed that silencing of USP10 reduces the levels of both the LC3B-I and LC3B-II forms of LC3B through increased ubiquitination and proteasomal degradation. In turn, the reduced LC3B levels result in slower degradation of the autophagy receptors SQSTM1 and NBR1 and an increased accumulation of puromycin-induced aggresome-like structures. Taken together, these findings indicate that the levels of LC3B and autophagic activity are controlled through cycles of LC3B ubiquitination and deubiquitination.	[Jia, Rui; Bonifacino, Juan S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Neurosci & Cellular & Struct Biol Div, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Jia, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Neurosci & Cellular & Struct Biol Div, NIH, Bethesda, MD 20892 USA.	rui.jia@hotmail.com		Bonifacino, Juan S./0000-0002-5673-6370; Jia, Rui/0000-0002-1797-4069	Intramural Program of NICHD [ZIA HD001607]	Intramural Program of NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Intramural Program of NICHD (ZIA HD001607) (to J. S. B.).	Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556; Clague MJ, 2019, NAT REV MOL CELL BIO, V20, P338, DOI 10.1038/s41580-019-0099-1; Deng M, 2016, MOL CELL, V61, P614, DOI 10.1016/j.molcel.2016.01.010; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22; Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013; Hung SY, 2015, NEUROPHARMACOLOGY, V93, P243, DOI 10.1016/j.neuropharm.2015.02.003; Jia R, 2019, ELIFE, V8, DOI 10.7554/eLife.50034; Jia R, 2017, AUTOPHAGY, V13, P1648, DOI 10.1080/15548627.2017.1343768; Jiang HB, 2010, BIOCHEM BIOPH RES CO, V395, P471, DOI 10.1016/j.bbrc.2010.04.030; Jiang TX, 2019, P NATL ACAD SCI USA, V116, P13404, DOI 10.1073/pnas.1901039116; Kang HM, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1520-6; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Lee Min Jae, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.R110.003871; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Liu XD, 2012, J BIOL CHEM, V287, P19687, DOI 10.1074/jbc.M112.350934; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Peng WX, 2015, EXP THER MED, V9, P1271, DOI 10.3892/etm.2015.2266; Pu J, 2015, DEV CELL, V33, P176, DOI 10.1016/j.devcel.2015.02.011; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Shrestha BK, 2020, J BIOL CHEM, V295, P1240, DOI 10.1074/jbc.RA119.010068; Shvets E, 2008, J CELL SCI, V121, P2685, DOI 10.1242/jcs.026005; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Wani WY, 2015, LAB INVEST, V95, P14, DOI 10.1038/labinvest.2014.131; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Xie YC, 2015, AUTOPHAGY, V11, P28, DOI 10.4161/15548627.2014.984267	30	11	11	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100405	10.1016/j.jbc.2021.100405	http://dx.doi.org/10.1016/j.jbc.2021.100405			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33577797	Green Published, gold			2022-12-26	WOS:000672866400379
J	Zemljic-Harpf, AE; Hoe, LES; Schilling, JM; Zuniga-Hertz, JP; Nguyen, A; Vaishnav, YJ; Belza, GJ; Budiono, BP; Patel, PM; Head, BP; Dillmann, WH; Mahata, SK; Peart, JN; Roth, DM; Headrick, JP; Patel, HH				Zemljic-Harpf, Alice E.; Hoe, Louise E. See; Schilling, Jan M.; Zuniga-Hertz, Juan P.; Nguyen, Alexander; Vaishnav, Yash J.; Belza, Gianna J.; Budiono, Boris P.; Patel, Piyush M.; Head, Brian P.; Dillmann, Wolfgang H.; Mahata, Sushil K.; Peart, Jason N.; Roth, David M.; Headrick, John P.; Patel, Hemal H.			Morphine induces physiological, structural, and molecular benefits in the diabetic myocardium	FASEB JOURNAL			English	Article						cardioprotection; diabetic cardiomyopathy; ischemia&#8208; reperfusion injury; mitochondria; opioid receptors		The obesity epidemic has increased type II diabetes mellitus (T2DM) across developed countries. Cardiac T2DM risks include ischemic heart disease, heart failure with preserved ejection fraction, intolerance to ischemia-reperfusion (I-R) injury, and refractoriness to cardioprotection. While opioids are cardioprotective, T2DM causes opioid receptor signaling dysfunction. We tested the hypothesis that sustained opioid receptor stimulus may overcome diabetes mellitus-induced cardiac dysfunction via membrane/mitochondrial-dependent protection. In a murine T2DM model, we investigated effects of morphine on cardiac function, I-R tolerance, ultrastructure, subcellular cholesterol expression, mitochondrial protein abundance, and mitochondrial function. T2DM induced 25% weight gain, hyperglycemia, glucose intolerance, cardiac hypertrophy, moderate cardiac depression, exaggerated postischemic myocardial dysfunction, abnormalities in mitochondrial respiration, ultrastructure and Ca2+-induced swelling, and cell death were all evident. Morphine administration for 5 days: (1) improved glucose homeostasis; (2) reversed cardiac depression; (3) enhanced I-R tolerance; (4) restored mitochondrial ultrastructure; (5) improved mitochondrial function; (6) upregulated Stat3 protein; and (7) preserved membrane cholesterol homeostasis. These data show that morphine treatment restores contractile function, ischemic tolerance, mitochondrial structure and function, and membrane dynamics in type II diabetic hearts. These findings suggest potential translational value for short-term, but high-dose morphine administration in diabetic patients undergoing or recovering from acute ischemic cardiovascular events.	[Zemljic-Harpf, Alice E.; Schilling, Jan M.; Zuniga-Hertz, Juan P.; Nguyen, Alexander; Vaishnav, Yash J.; Belza, Gianna J.; Patel, Piyush M.; Head, Brian P.; Dillmann, Wolfgang H.; Mahata, Sushil K.; Roth, David M.; Patel, Hemal H.] VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Zemljic-Harpf, Alice E.; Schilling, Jan M.; Zuniga-Hertz, Juan P.; Nguyen, Alexander; Vaishnav, Yash J.; Belza, Gianna J.; Patel, Piyush M.; Head, Brian P.; Roth, David M.; Patel, Hemal H.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Hoe, Louise E. See] Univ Queensland, Dept Fac Med, Brisbane, Qld, Australia; [Hoe, Louise E. See] Prince Charles Hosp, Crit Care Res Grp, Brisbane, Qld, Australia; [Budiono, Boris P.; Peart, Jason N.; Headrick, John P.] Griffith Univ, Heart Fdn Res Ctr, Griffith Hlth Inst, Southport, Qld, Australia; [Dillmann, Wolfgang H.; Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of Queensland; Prince Charles Hospital; Griffith University; Menzies Health Institute Queensland; University of California System; University of California San Diego	Patel, HH (corresponding author), VA San Diego Healthcare Syst, San Diego, CA 92161 USA.; Headrick, JP (corresponding author), Griffith Univ, Heart Fdn Res Ctr, Southport, Qld 4222, Australia.; Patel, HH (corresponding author), Univ Calif San Diego, San Diego, CA 92161 USA.	j.headrick@griffith.edu.au; hepatel@ucsd.edu	Hertz, Juan Pablo Zúñiga/J-3588-2019; Hoe, Louise E See/C-6650-2017	Hertz, Juan Pablo Zúñiga/0000-0002-8679-3456; Hoe, Louise E See/0000-0003-0553-205X; Zemljic-Harpf, Alice/0000-0002-5604-9343	National Institutes of Health, USA [HL091071, HL107200]; VA Merit grant [BX001963, BX000783]; VA Research Career Scientist Award [BX005229]; National Health and Medical Research Council of Australia [481922]; National Heart Foundation of Australia; Australian Research Council; QLD state government fellowship	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit grant; VA Research Career Scientist Award; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Australian Research Council(Australian Research Council); QLD state government fellowship	This study was supported by grants from the National Institutes of Health, USA (HL091071, HL107200), a VA Merit grant (BX001963 and BX000783), VA Research Career Scientist Award (BX005229), and the National Health and Medical Research Council of Australia (481922). L.S. was supported by a scholarship from the National Heart Foundation of Australia. J.N.P. was supported by a Future Fellowship from the Australian Research Council. J.P.H. was supported by a QLD state government fellowship.	Akita Y, 2007, AM J PHYSIOL-HEART C, V292, pH2051, DOI 10.1152/ajpheart.01102.2006; Ashton KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072278; Balakumar P, 2012, CELL SIGNAL, V24, P53, DOI 10.1016/j.cellsig.2011.09.007; Barnes AS, 2011, TEX HEART I J, V38, P142; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bolling SF, 1997, ANN THORAC SURG, V64, P623, DOI 10.1016/S0003-4975(97)00631-0; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Brainard RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083174; Budiono BP, 2012, AM J PHYSIOL-REG I, V302, pR1091, DOI 10.1152/ajpregu.00406.2011; Bugger H, 2014, DIABETOLOGIA, V57, P660, DOI 10.1007/s00125-014-3171-6; Cheng JT, 2006, DIABETES, V55, P819, DOI 10.2337/diabetes.55.03.06.db05-0934; Dickson EW, 2008, AM J PHYSIOL-HEART C, V294, pH402, DOI 10.1152/ajpheart.00280.2007; Ferdinandy P, 2014, PHARMACOL REV, V66, P1142, DOI 10.1124/pr.113.008300; Ferenczi S, 2010, NEUROCHEM INT, V57, P323, DOI 10.1016/j.neuint.2010.06.011; Fricovsky ES, 2012, AM J PHYSIOL-REG I, V303, pR689, DOI 10.1152/ajpregu.00548.2011; Fridolfsson HN, 2012, FASEB J, V26, P4637, DOI 10.1096/fj.12-215798; Fryer RM, 2000, J PHARMACOL EXP THER, V294, P451; Gateau-Roesch O, 2006, CARDIOVASC RES, V70, P264, DOI 10.1016/j.cardiores.2006.02.024; Ghosh S, 2001, J AM COLL CARDIOL, V37, P711, DOI 10.1016/S0735-1097(00)01161-X; Gilbert ER, 2011, EXP DIAB RES, V2011; Gross ER, 2007, DIABETES, V56, P127, DOI 10.2337/db06-0907; Guo YR, 2013, MOL CELL PROTEOMICS, V12, P3744, DOI 10.1074/mcp.M113.027441; Hafstad AD, 2013, DIABETES, V62, P2287, DOI 10.2337/db12-1580; Harhous Z, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00150; Hoe LES, 2014, AM J PHYSIOL-HEART C, V307, pH895, DOI 10.1152/ajpheart.00081.2014; KATZ RJ, 1982, ANN NY ACAD SCI, V398, P291, DOI 10.1111/j.1749-6632.1982.tb39501.x; Lee TM, 2003, J CLIN ENDOCR METAB, V88, P531, DOI 10.1210/jc.2002-020904; Lei SQ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9836302; LEVINE AS, 1988, PHARMACOL BIOCHEM BE, V29, P495, DOI 10.1016/0091-3057(88)90010-X; Mammucari C, 2011, BIOFACTORS, V37, P219, DOI 10.1002/biof.160; Marso SP, 2007, AM J CARDIOL, V100, P206, DOI 10.1016/j.amjcard.2007.02.080; Medford HM, 2013, AM J PHYSIOL-HEART C, V305, pH114, DOI 10.1152/ajpheart.00135.2013; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Miki T, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-67; Minamiyama Y, 2007, J PHARMACOL EXP THER, V320, P535, DOI 10.1124/jpet.106.110460; Ng M, 2014, LANCET, V384, P746; Nunes JM, 2019, THROMB RES, V178, P91, DOI 10.1016/j.thromres.2019.04.005; Obame FN, 2008, J PHARMACOL EXP THER, V326, P252, DOI 10.1124/jpet.108.138008; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohsawa M, 1998, J PHARMACOL EXP THER, V286, P780; Olianas MC, 2012, MOL PHARMACOL, V81, P154, DOI 10.1124/mol.111.075267; Opie L., 2004, FUELS AEROBIC ANAERO; Oxberry SG, 2013, J PALLIAT MED, V16, P250, DOI 10.1089/jpm.2012.0270; Panneerselvam M, 2013, MOL NUTR FOOD RES, V57, P1007, DOI 10.1002/mnfr.201300026; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Park SY, 2005, ARCH BIOCHEM BIOPHYS, V436, P276, DOI 10.1016/j.abb.2005.01.010; Pasqua T, 2016, CELL TISSUE RES, V363, P693, DOI 10.1007/s00441-015-2316-3; Peart JN, 2007, J MOL CELL CARDIOL, V42, P972, DOI 10.1016/j.yjmcc.2007.02.011; Peart JN, 2006, AM J PHYSIOL-HEART C, V291, pH1746, DOI 10.1152/ajpheart.00233.2006; Peart JN, 2011, J PHARMACOL EXP THER, V336, P274, DOI 10.1124/jpet.110.172593; Peart JN, 2004, EXP GERONTOL, V39, P1021, DOI 10.1016/j.exger.2004.03.038; Qi JS, 2004, DIABETOLOGIA, V47, P214, DOI 10.1007/s00125-003-1288-0; RUSCHHAUPT DG, 1983, J AM COLL CARDIOL, V2, P77, DOI 10.1016/S0735-1097(83)80379-9; Sack MN, 2009, J MOL CELL CARDIOL, V46, P842, DOI 10.1016/j.yjmcc.2009.02.001; Schilling JM, 2015, BRIT J PHARMACOL, V172, P2114, DOI 10.1111/bph.13009; Schultz JE, 1998, CIRCULATION, V97, P1282, DOI 10.1161/01.CIR.97.13.1282; SCHULTZ JEJ, 1995, AM J PHYSIOL-HEART C, V268, pH2157, DOI 10.1152/ajpheart.1995.268.5.H2157; Sharma K, 2015, DIABETES, V64, P663, DOI 10.2337/db14-0874; Smallwood N, 2015, INTERN MED J, V45, P898, DOI 10.1111/imj.12857; Sood A, 2001, ENDOCR RES, V27, P215, DOI 10.1081/ERC-100107182; Su CF, 2004, HORM METAB RES, V36, P571, DOI 10.1055/s-2004-825763; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Tomai F, 1999, CIRCULATION, V100, P559, DOI 10.1161/01.CIR.100.5.559; Van der Mieren G, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-36; Viola R, 2008, SUPPORT CARE CANCER, V16, P329, DOI 10.1007/s00520-007-0389-6; Wang JW, 2020, LIFE SCI, V247, DOI 10.1016/j.lfs.2019.116942; Wen T, 2009, MOL ENDOCRINOL, V23, P671, DOI 10.1210/me.2008-0345; Xenopoulos NP, 1998, J AM COLL CARDIOL, V31, p65A, DOI 10.1016/S0735-1097(97)83991-5; Yamagishi T, 2010, HEART VESSELS, V25, P417, DOI 10.1007/s00380-009-1222-6; Zatta AJ, 2008, AM J PHYSIOL-HEART C, V294, pH1444, DOI 10.1152/ajpheart.01279.2006; Zemljic-Harpf AE., 2021, FASEB J, V35; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	73	2	2	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21407	10.1096/fj.201903233R	http://dx.doi.org/10.1096/fj.201903233R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33583084				2022-12-26	WOS:000629576700030
J	Acosta, EJ; Rodriguez-Forero, A; Werding, B; Kunzmann, A				Acosta, Ernesto J.; Rodriguez-Forero, Adriana; Werding, Bernd; Kunzmann, Andreas			Ecological and reproductive characteristics of holothuroids Isostichopus badionotus and Isostichopus sp. in Colombia	PLOS ONE			English	Article							SEA-CUCUMBER ECHINODERMATA; GULF-OF-CALIFORNIA; POPULATION-STRUCTURE; FUSCUS LUDWIG; BIOLOGY; GROWTH; CYCLE	Isostichopus badionotus and Isostichopus sp. are two holothuroids exploited in the Caribbean region of Colombia. Until recently, they were considered a single species. During one year, 222 individuals of Isostichopus sp. and 114 of I. badionotus were collected in two bays of the Santa Marta region to study their reproductive biology and collect information on their size, weight and habitat. Both sea cucumber morphotypes showed an annual reproductive cycle, with a reproductive season from September to November, closely related to the increase in water temperature and rainfall. In both sea cucumbers the population structure exhibited a unimodal distribution composed of mature individuals and a sex ratio of 1:1. Isostichopus sp. had an average size and weight (193 +/- 52 mm and 178 +/- 69 g) and size and weight at first maturity (175 mm and 155 g) that was much lower than I. badionotus (respectively, 324 +/- 70 mm and 628 +/- 179 g; 220 mm and 348 g). While 98% of Isostichopus sp. individuals were collected in the upper 2.5 m, on rocky bottoms between cracks, 73% of I. badionotus individuals were found between 3 and 7.8 m depth, exposed on sandy bottoms. These differences imply that management measures (e.g. minimum catch size) should not be the same for both sea cucumbers morphotypes.	[Acosta, Ernesto J.; Kunzmann, Andreas] Leibniz Ctr Trop Marine Res ZMT GmbH, WG Ecophysiol & Expt Aquaculture, Bremen, Germany; [Acosta, Ernesto J.] Corp Ctr Excellence Marine Sci CEMarin, Bogota, Colombia; [Acosta, Ernesto J.] Inst Invest Marinas & Costeras INVEMAR, Santa Marta, Colombia; [Acosta, Ernesto J.; Werding, Bernd] Justus Liebig Univ Giessen, Dept Anim Ecol, Giessen, Germany; [Rodriguez-Forero, Adriana] Univ Magdalena Santa Marta, Aquaculture Res & Technol Dev Grp, Aquaculture Lab Fisheries Engn Program, Santa Marta, Colombia	Justus Liebig University Giessen; Universidad del Magdalena	Acosta, EJ (corresponding author), Leibniz Ctr Trop Marine Res ZMT GmbH, WG Ecophysiol & Expt Aquaculture, Bremen, Germany.; Acosta, EJ (corresponding author), Corp Ctr Excellence Marine Sci CEMarin, Bogota, Colombia.; Acosta, EJ (corresponding author), Inst Invest Marinas & Costeras INVEMAR, Santa Marta, Colombia.; Acosta, EJ (corresponding author), Justus Liebig Univ Giessen, Dept Anim Ecol, Giessen, Germany.	ernesto77.acosta@gmail.com		Acosta Ortiz, Ernesto Joaquin/0000-0001-7143-9254	corporation center of excellence in marine sciences CEMarin [5]; Universidad del Magdalena; Aquaculture Technology Research and Development Group (GIDTA); Marine and Coastal Research Institute INVEMAR; Leibniz Centre for Tropical Marine Research (ZMT) GmbH; Giessen University; Corporation CEMarin	corporation center of excellence in marine sciences CEMarin; Universidad del Magdalena; Aquaculture Technology Research and Development Group (GIDTA); Marine and Coastal Research Institute INVEMAR; Leibniz Centre for Tropical Marine Research (ZMT) GmbH; Giessen University; Corporation CEMarin	E.A. This study was funded by corporation center of excellence in marine sciences CEMarin Call No 5 of year 2015. https://www.cemarin.org The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank The Universidad del Magdalena, especially the Aquaculture Technology Research and Development Group (GIDTA), the Marine and Coastal Research Institute INVEMAR, the Leibniz Centre for Tropical Marine Research (ZMT) GmbH, the Giessen University and Corporation CEMarin, for the support received and the facilities provided for the preparation of this work.	Agudelo-Martinez Vianys, 2017, Beche-de-mer Information Bulletin, V37, P65; Alfonso I., 2004, ADV SEA CUCUMBER AQU, V463, P151; Benitez-Villalobos F., 2013, SEX EARLY DEV AQUAT, V1, P13, DOI [10.3354/sedao00003, DOI 10.3354/SEDAO00003]; CHAO SM, 1994, MAR BIOL, V119, P565, DOI 10.1007/BF00354319; CONAND C, 1981, B MAR SCI, V31, P523; CONAND C, 1993, MAR BIOL, V116, P439, DOI 10.1007/BF00350061; Conand C, 1990, FISHERY RESOURCES 2; Demeuldre Melanie, 2012, Beche-de-mer Information Bulletin, V32, P15; Mancera-Pineda José Ernesto, 2013, Bol. Invest. Mar. Cost., V42, P329; Foglietta LM, 2004, J EXP MAR BIOL ECOL, V303, P19, DOI 10.1016/j.jembe.2003.10.019; Froese R, 2004, FISH FISH, V5, P86, DOI 10.1111/j.1467-2979.2004.00144.x; Garcia-Arraras JE, 2001, MICROSC RES TECHNIQ, V55, P438, DOI 10.1002/jemt.1189; Guzman HM, 2003, MAR BIOL, V142, P271, DOI 10.1007/s00227-002-0939-x; Guzman HM, 2002, CARIBB J SCI, V38, P230; HAMEL JF, 1993, BIOL BULL-US, V184, P125, DOI 10.2307/1542223; Hernandez O., 2017, SEA CUCUMBER ISOSTIC, V8, P278; Herrero-Perezrul MD, 1998, B MAR SCI, V63, P611; Herrero-Perezrul MD, 1999, MAR BIOL, V135, P521, DOI 10.1007/s002270050653; Hopper DR, 1998, B MAR SCI, V63, P1; Koike Haruko, 2015, Beche-de-mer Information Bulletin, V35, P42; KRISHNASWAMY S, 1967, CURR SCI INDIA, V36, P155; Leite-Castro LV, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2842-x; Lovatelli A., 2004, 463 FAO, V463; Ordas MC, 2001, J SHELLFISH RES, V20, P1019; Ortega M., 2011, REV CUBANA INVESTIGA, V28, P8; Palazon Fernez JL, 2001, SAN ANDRES ISLA, P6; Purcell S.W., 2012, FAO SPECIES CATALOGU; Purcell SW, 2018, REG STUD MAR SCI, V17, P127, DOI 10.1016/j.rsma.2017.12.003; Purcell SW., 2010, 520 FAO, V520; Ramofafia C, 2000, MAR BIOL, V136, P1045, DOI 10.1007/s002270000310; Ramofafia C., 2001, SPC BECHE DEMER INF, V15, P13; Rodriguez Forero Adriana, 2013, Beche-de-mer Information Bulletin, V33, P9; Toral-Gra MV., 2008, SEA CUCUMBERS GLOBAL, V516; Toral-Granda MV, 2007, MAR BIOL, V151, P2091, DOI 10.1007/s00227-007-0640-1; TUWO A, 1992, J MAR BIOL ASSOC UK, V72, P745, DOI 10.1017/S0025315400060021; Vergara W, 2018, BAG, J. basic appl. genet., V29, P33; Vergara W., 2016, NATURE RESOUR, V7, P130, DOI DOI 10.4236/NR.2016.73013; Zacarias-Soto M, 2013, J WORLD AQUACULT SOC, V44, P694, DOI 10.1111/jwas.12061	38	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247158	10.1371/journal.pone.0247158	http://dx.doi.org/10.1371/journal.pone.0247158			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617572	Green Published, gold			2022-12-26	WOS:000623082400031
J	Langenbucher, A; Szentmary, N; Weisensee, J; Wendelstein, J; Cayless, A; Menapace, R; Hoffmann, P				Langenbucher, Achim; Szentmary, Nora; Weisensee, Johannes; Wendelstein, Jascha; Cayless, Alan; Menapace, Rupert; Hoffmann, Peter			Prediction model for best focus, power, and spherical aberration of the cornea: Raytracing on a large dataset of OCT data	PLOS ONE			English	Article								Purpose To analyse corneal power based on a large optical coherence tomography dataset using raytracing, and to evaluate corneal power with respect to the corneal front apex plane for different definitions of best focus. Methods A large OCT dataset (10,218 eyes of 8,430 patients) from the Casia 2 (Tomey, Japan) was post-processed in MATLAB (MathWorks, USA). Using radius of curvature, corneal front and back surface asphericity, central corneal thickness, and pupil size (aperture) a bundle of rays was traced through the cornea. Various best focus definitions were tested: a) minimum wavefront error, b) root mean squared ray scatter, c) mean absolute ray scatter, and d) total spot diameter. All 4 target optimisation criteria were tested with each best focus plane. With the best-fit keratometer index the difference of corneal power and keratometric power was evaluated using a multivariate linear model. Results The mean corneal powers for a/b/c/d were 43.02 +/- 1.61/42.92 +/- 1.58/42.91 +/- 1.58/42.94 +/- 1.59 dpt respectively. The root mean squared deviations of corneal power from keratometric power (n(K) = 1.3317/1.3309/1.3308/1.3311 for a/b/c/d) were 0.308/0.185/0.171/0.209 dpt. With the multivariate linear model the respective RMS error was reduced to 0.110/0.052/0.043/0.065 dpt (R-2 = 0.872/0.921/0.935/0.904). Conclusions Raytracing improves on linear Gaussian optics by considering the asphericity of both refracting surfaces and using Snell's law of refraction in preference to paraxial simplifications. However, there is no unique definition of best focus, and therefore the calculated corneal power varies depending on the definition of best focus. The multivariate linear model enabled more precise estimation of corneal power compared to the simple keratometer equation.	[Langenbucher, Achim; Weisensee, Johannes] Saarland Univ, Dept Expt Ophthalmol, Homburg, Germany; [Szentmary, Nora] Saarland Univ, Dr Rolf M Schwiete Ctr Limbal Stem Cell & Aniridi, Homburg, Germany; [Szentmary, Nora] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary; [Wendelstein, Jascha] Johannes Kepler Univ Linz, Dept Ophthalmol, Linz, Austria; [Cayless, Alan] Open Univ, Sch Phys Sci, Milton Keynes, Bucks, England; [Menapace, Rupert] Univ Vienna, Dept Ophthalmol, Vienna, Austria; [Hoffmann, Peter] Augen & Laserklin Castrop Rauxel, Castrop Rauxel, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Semmelweis University; Johannes Kepler University Linz; Open University - UK; University of Vienna	Langenbucher, A (corresponding author), Saarland Univ, Dept Expt Ophthalmol, Homburg, Germany.	achim.langenbucher@uks.eu	Szentmary, Nora/AAE-7643-2022; Wendelstein, Jascha Armin/F-5389-2018	Wendelstein, Jascha Armin/0000-0003-4145-2559; Weisensee, Johannes/0000-0001-7741-1447				Canovas C, 2012, J CATARACT REFR SURG, V38, P1325, DOI 10.1016/j.jcrs.2012.03.033; Damian A, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.1.016001; de Sanctis U, 2014, OPTOMETRY VISION SCI, V91, P1251, DOI 10.1097/OPX.0000000000000380; Haigis W, 2012, SAUDI J OPHTHALMOL, V26, P7, DOI 10.1016/j.sjopt.2011.11.007; Langenbucher A, 2006, OPHTHAL PHYSL OPT, V26, P180, DOI 10.1111/j.1475-1313.2006.00346.x; Langenbucher A, 2002, CURR EYE RES, V24, P422, DOI 10.1076/ceyr.24.6.422.8597; Langenbucher A, 2021, OPHTHALMOLOGE, V118, P356, DOI 10.1007/s00347-020-01182-7; Langenbucher A, 2011, CURR EYE RES, V36, P637, DOI 10.3109/02713683.2011.577265; Langenbucher Achim, 2004, Curr Opin Ophthalmol, V15, P1, DOI 10.1097/00055735-200402000-00002; Liou HL, 1997, J OPT SOC AM A, V14, P1684, DOI 10.1364/JOSAA.14.001684; Navarro R, 2006, J OPT SOC AM A, V23, P219, DOI 10.1364/JOSAA.23.000219; OLSEN T, 1986, BRIT J OPHTHALMOL, V70, P152, DOI 10.1136/bjo.70.2.152; Olsen T, 2018, J REFRACT SURG, V34, P45, DOI 10.3928/1081597X-20171102-01; Preussner PR, 2005, J CATARACT REFR SURG, V31, P525, DOI 10.1016/j.jcrs.2004.09.016; Schwiegerling J, 1997, OPTOMETRY VISION SCI, V74, P906, DOI 10.1097/00006324-199711000-00024	15	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247048	10.1371/journal.pone.0247048	http://dx.doi.org/10.1371/journal.pone.0247048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617531	Green Published, gold, Green Accepted			2022-12-26	WOS:000623082400043
J	Teixeira, CD; Chiroque-Solano, PM; Ribeiro, FV; Carlos-Junior, LA; Neves, LM; Salomon, PS; Salgado, LT; Falsarella, LN; Cardoso, GO; Villela, LB; Freitas, MO; Moraes, FC; Bastos, AC; Moura, RL				Teixeira, Carolina D.; Chiroque-Solano, Pamela M.; Ribeiro, Felipe V.; Carlos-Junior, Lelis A.; Neves, Leonardo M.; Salomon, Paulo S.; Salgado, Leonardo T.; Falsarella, Ludmilla N.; Cardoso, Gabriel O.; Villela, Livia B.; Freitas, Matheus O.; Moraes, Fernando C.; Bastos, Alex C.; Moura, Rodrigo L.			Decadal (2006-2018) dynamics of Southwestern Atlantic's largest turbid zone reefs	PLOS ONE			English	Article							SOUTH ATLANTIC; PHASE-SHIFTS; PALYTHOA-CARIBAEORUM; COMMUNITY DYNAMICS; ABROLHOS BANK; STABLE STATES; CORAL-REEFS; GROWTH; PATTERNS; DRIVERS	Tropical reefs are declining rapidly due to climate changes and local stressors such as water quality deterioration and overfishing. The so-called marginal reefs sustain significant coral cover and growth but are dominated by fewer species adapted to suboptimal conditions to most coral species. However, the dynamics of marginal systems may diverge from that of the archetypical oligotrophic tropical reefs, and it is unclear whether they are more or less susceptible to anthropogenic stress. Here, we present the largest (100 fixed quadrats at five reefs) and longest time series (13 years) of benthic cover data for Southwestern Atlantic turbid zone reefs, covering sites under contrasting anthropogenic and oceanographic forcing. Specifically, we addressed how benthic cover changed among habitats and sites, and possible dominance-shift trends. We found less temporal variation in offshore pinnacles' tops than on nearshore ones and, conversely, higher temporal fluctuation on offshore pinnacles' walls than on nearshore ones. In general, the Abrolhos reefs sustained a stable coral cover and we did not record regional-level dominance shifts favoring other organisms. However, coral decline was evidenced in one reef near a dredging disposal site. Relative abundances of longer-lived reef builders showed a high level of synchrony, which indicates that their dynamics fluctuate under similar drivers. Therefore, changes on those drivers could threaten the stability of these reefs. With the intensification of thermal anomalies and land-based stressors, it is unclear whether the Abrolhos reefs will keep providing key ecosystem services. It is paramount to restrain local stressors that contributed to coral reef deterioration in the last decades, once reversal and restoration tend to become increasingly difficult as coral reefs degrade further and climate changes escalate.	[Teixeira, Carolina D.; Chiroque-Solano, Pamela M.; Ribeiro, Felipe V.; Carlos-Junior, Lelis A.; Salomon, Paulo S.; Falsarella, Ludmilla N.; Cardoso, Gabriel O.; Villela, Livia B.; Moura, Rodrigo L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil; [Teixeira, Carolina D.; Chiroque-Solano, Pamela M.; Ribeiro, Felipe V.; Carlos-Junior, Lelis A.; Salomon, Paulo S.; Falsarella, Ludmilla N.; Cardoso, Gabriel O.; Villela, Livia B.; Moura, Rodrigo L.] Univ Fed Rio de Janeiro, SAGE COPPE, Rio De Janeiro, RJ, Brazil; [Neves, Leonardo M.] Univ Fed Rural Rio de Janeiro, Lab Ecol Aquat & Educ, Rio De Janeiro, RJ, Brazil; [Salgado, Leonardo T.; Moraes, Fernando C.] Inst Pesquisas Jardim Bot Rio de Janeiro JBRJ, Rio De Janeiro, RJ, Brazil; [Freitas, Matheus O.] Inst Meros Brasil, Curitiba, Parana, Brazil; [Bastos, Alex C.] Univ Fed Espirito Santo, Vitoria, ES, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Jardim Botanico do Rio de Janeiro; Universidade Federal do Espirito Santo	Moura, RL (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil.; Moura, RL (corresponding author), Univ Fed Rio de Janeiro, SAGE COPPE, Rio De Janeiro, RJ, Brazil.	moura.uesc@gmail.com	Neves, Leonardo/AAN-1167-2020; Teixeira, Carolina/GSI-6410-2022; Freitas, Matheus Oliveira/B-7204-2013; Solano, Pamela M. Chiroque/AAO-9594-2021; Carlos Junior, Lelis/H-7950-2012	Neves, Leonardo/0000-0002-0269-6588; Solano, Pamela M. Chiroque/0000-0002-2667-8755; Carlos Junior, Lelis/0000-0001-5152-0645; Cardoso, Gabriel/0000-0002-7102-4726; de Vargas RIBEIRO, Felipe/0000-0002-1764-0261	Conservation International; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through program SISBIOTA (2010-2014); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through program PELD-Long Term Ecological Research (2016-2020); National Petroleum Agency (ANP/Brasoil); Rede Rio Doce Mar (RRDM) through Fundacao RENOVA; CNPq; CAPES/IODP; FAPERJ; FAPESP	Conservation International; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through program SISBIOTA (2010-2014)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through program PELD-Long Term Ecological Research (2016-2020)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); National Petroleum Agency (ANP/Brasoil); Rede Rio Doce Mar (RRDM) through Fundacao RENOVA; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/IODP; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Sampling was initially funded by Conservation International (2006-2010), and thereafter by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through programs SISBIOTA (2010-2014) and PELD-Long Term Ecological Research (2016-2020). Complementary funding was received from the National Petroleum Agency (ANP/Brasoil)between 2011 and 2019. From 2018 on sampling was funded by the Rede Rio Doce Mar (RRDM) through Fundacao RENOVA. Authors RLM, LMN, LTS and PSS acknowledge individual grants from CNPq, CAPES/IODP, FAPERJ and/or FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1984, AM NAT, V123, P44, DOI 10.1086/284185; Acosta A, 2001, HYDROBIOLOGIA, V460, P113, DOI 10.1023/A:1013135702430; Acosta Alberto, 2007, Bol. Invest. Mar. Cost., V36, P151; Alvarez-Filip L, 2011, ECOL APPL, V21, P2223, DOI 10.1890/10-1563.1; Amado GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035171; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1986, MULTIVARIATE STAT ME; Anthony KRN, 2006, MAR ECOL PROG SER, V319, P111, DOI 10.3354/meps319111; Bastos AC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27961-6; Beijbom O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130312; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Browne NK, 2012, EARTH-SCI REV, V115, P1, DOI 10.1016/j.earscirev.2012.06.006; Bruno JF, 2019, ANNU REV MAR SCI, V11, P307, DOI 10.1146/annurev-marine-010318-095300; Bruno JF, 2014, MAR POLLUT BULL, V80, P24, DOI 10.1016/j.marpolbul.2014.01.010; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Ceccarelli DM, 2020, ECOL APPL, V30, DOI 10.1002/eap.2008; Connell SD, 2014, MAR ECOL PROG SER, V495, P299, DOI 10.3354/meps10513; Cote IM, 2005, PHILOS T R SOC B, V360, P385, DOI 10.1098/rstb.2004.1591; Cramer KL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax9395; de Santana EFC, 2015, J MAR BIOL ASSOC UK, V95, P301, DOI 10.1017/S0025315414001726; Cruz ICS, 2018, MAR POLLUT BULL, V135, P551, DOI 10.1016/j.marpolbul.2018.07.043; Cruz ICS, 2015, MAR ECOL-EVOL PERSP, V36, P318, DOI 10.1111/maec.12141; de Moraes FC, 2019, MAR ECOL-EVOL PERSP, V40, DOI 10.1111/maec.12531; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Dechnik B, 2019, QUATERNARY SCI REV, V218, P365, DOI 10.1016/j.quascirev.2019.06.039; Done T, 2007, CORAL REEFS, V26, P789, DOI 10.1007/s00338-007-0265-3; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; dos Reis VM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154417; Duarte GAS, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00179; Dudgeon SR, 2010, MAR ECOL PROG SER, V413, P201, DOI 10.3354/meps08751; Ellison AM, 2019, ISCIENCE, V13, P254, DOI 10.1016/j.isci.2019.02.020; Fernando SC, 2015, MICROB ECOL, V69, P267, DOI 10.1007/s00248-014-0474-6; Fong P, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P241, DOI 10.1007/978-94-007-0114-4_17; Francini RB, 2019, SCI TOTAL ENVIRON, V697, DOI 10.1016/j.scitotenv.2019.134038; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Francini RB, 2008, AQUAT CONSERV, V18, P1166, DOI 10.1002/aqc.966; Francini RB, 2010, J MAR BIOL ASSOC UK, V90, P481, DOI 10.1017/S0025315409991147; Francini RB, 2010, BRAZ J OCEANOGR, V58, P77, DOI 10.1590/S1679-87592010000100008; Freitas MO, 2019, PEERJ, V7, DOI 10.7717/peerj.7459; Guest JR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36260; Guilhem IF, 2020, AQUAT INVASIONS, V15, P98, DOI 10.3391/ai.2020.15.1.07; Haas AF, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.42, 10.1038/nmicrobiol.2016.42]; Hudspith M, 2017, AQUAT TOXICOL, V184, P1, DOI 10.1016/j.aquatox.2016.12.019; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P389, DOI 10.1016/j.tree.2013.05.019; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kelmo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065073; KNOWLTON N, 1992, AM ZOOL, V32, P674; Laborel J., 1969, ANN U ABIDJAN E, V2, P1; Lamy T, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2987; Leao Z, 1997, P 8 INT COR REEF S, V2, P1767; Leao ZMAN, 2001, ECOL STU AN, V144, P83; Lisboa DS, 2018, J GEOPHYS RES-OCEANS, V123, P2554, DOI 10.1002/2017JC012824; Loiola M, 2019, MAR ENVIRON RES, V147, P138, DOI 10.1016/j.marenvres.2019.03.013; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Morgan KM, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00224; Morrow KM, 2011, CORAL REEFS, V30, P309, DOI 10.1007/s00338-011-0747-1; Moura RL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501252; Moura RL, 2013, CONT SHELF RES, V70, P109, DOI 10.1016/j.csr.2013.04.036; Mumby PJ, 2013, OIKOS, V122, P481, DOI 10.1111/j.1600-0706.2012.00262.x; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Perry CT, 2003, CORAL REEFS, V22, P427, DOI 10.1007/s00338-003-0330-5; Pinheiro HT, 2018, DIVERS DISTRIB, V24, P951, DOI 10.1111/ddi.12729; Ribeiro FD, 2017, B MAR SCI, V93, P915, DOI 10.5343/bms.2016.1106; Ribeiro FV, 2018, PEERJ, V6, DOI 10.7717/peerj.5419; Rocha LA, 2000, ENVIRON BIOL FISH, V59, P453, DOI 10.1023/A:1026584708092; Russ GR, 2015, MAR BIOL, V162, P2029, DOI 10.1007/s00227-015-2728-3; Schloder C, 2013, B MAR SCI, V89, P1003, DOI 10.5343/bms.2012.1075; Segal B, 2008, CONT SHELF RES, V28, P533, DOI 10.1016/j.csr.2007.11.003; Segal B, 2011, BRAZ J OCEANOGR, V59, P119, DOI 10.1590/S1679-87592011000200001; Silveira CB, 2015, ENVIRON MICROBIOL, V17, P3832, DOI 10.1111/1462-2920.12851; Soares MD, 2020, OCEAN COAST MANAGE, V185, DOI 10.1016/j.ocecoaman.2019.105063; Suggett DJ, 2012, MAR BIOL, V159, P1461, DOI 10.1007/s00227-012-1925-6; Tanner JE, 2017, CORAL REEFS, V36, P1225, DOI 10.1007/s00338-017-1614-5; Taylor BM, 2020, GLOBAL CHANGE BIOL, V26, P1285, DOI 10.1111/gcb.14909; Teixeira CD, 2019, CORAL REEFS, V38, P801, DOI 10.1007/s00338-019-01789-6; Teixeira JB, 2018, CONSERV BIOL, V32, P1096, DOI 10.1111/cobi.12974; Thibaut LM, 2013, ECOL LETT, V16, P140, DOI 10.1111/ele.12019; Villaca Roberto, 1997, Revista Brasileira de Oceanografia, V45, P35; Vroom PS, 2006, AM SCI, V94, P430, DOI 10.1511/2006.61.1004; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3	86	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247111	10.1371/journal.pone.0247111	http://dx.doi.org/10.1371/journal.pone.0247111			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617570	Green Published, gold			2022-12-26	WOS:000623082400025
J	Cordoba, E; Parcesepe, AM; Gallis, JA; Headley, J; Soffo, C; Tchatchou, B; Hembling, J; Baumgartner, JN				Cordoba, Evette; Parcesepe, Angela M.; Gallis, John A.; Headley, Jennifer; Soffo, Claudian; Tchatchou, Berenger; Hembling, John; Baumgartner, Joy Noel			The syndemic effects of mental ill health, household hunger, and intimate partner violence on adherence to antiretroviral therapy among pregnant women living with HIV in Yaounde, Cameroon	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; SUB-SAHARAN AFRICA; FOOD INSECURITY; POSITIVE WOMEN; PMTCT SERVICES; MIDDLE-INCOME; DEPRESSION; PREVENTION; NONADHERENCE; CARE	Background This research advances understanding of interrelationships among three barriers to adherence to antiretroviral therapy (ART) among pregnant women living with HIV (WLWH) in Cameroon: probable common mental disorders (CMD), intimate partner violence (IPV), and hunger. Methods The sample included 220 pregnant WLWH in Cameroon. Multivariable modified Poisson regression was conducted to assess the relationship between IPV, hunger, and CMD on ART adherence. Results Almost half (44%) of participants recently missed/mistimed an ART dose. Probable CMD was associated with greater risk of missed/mistimed ART dose (aRR 1.5 [95% CI 1.1, 1.9]). Hunger was associated with greater risk of missed/mistimed ART dose among those who reported IPV (aRR 1.9 [95% CI 1.2, 2.8]), but not among those who did not (aRR 0.8 [95% CI 0.2, 2.3]). Conclusion Suboptimal ART adherence, CMD, and IPV were common among pregnant WLWH in Cameroon. Pregnant WLWH experiencing IPV and hunger may be especially vulnerable to suboptimal ART adherence.	[Cordoba, Evette] Univ North Carolina Chapel Hill, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Cordoba, Evette] Columbia Univ, Sch Nursing, New York, NY USA; [Parcesepe, Angela M.] Univ North Carolina Chapel Hill, Dept Maternal & Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Parcesepe, Angela M.] Univ North Carolina Chapel Hill, Carolina Populat Ctr, Chapel Hill, NC 27599 USA; [Gallis, John A.; Headley, Jennifer; Baumgartner, Joy Noel] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Gallis, John A.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Tchatchou, Berenger] Catholic Relief Serv, Ndjamena, Chad; [Hembling, John] Catholic Relief Serv, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Duke University	Parcesepe, AM (corresponding author), Univ North Carolina Chapel Hill, Dept Maternal & Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.; Parcesepe, AM (corresponding author), Univ North Carolina Chapel Hill, Carolina Populat Ctr, Chapel Hill, NC 27599 USA.	angela_parcesepe@unc.edu		Hembling, John/0000-0002-0917-5259; Headley, Jennifer/0000-0002-2058-4467	Catholic Relief Services; NIMH [K01 MH114721]; NICHD [P2C HD050924]; CTSA [UL1TR002553]	Catholic Relief Services; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The parent study on which this research was based was funded by Catholic Relief Services. This research was also supported by NIMH grant K01 MH114721 and NICHD grant P2C HD050924 (Carolina Population Center). JAG was supported in part by CTSA grant UL1TR002553. Two of the authors of this publication (JHembling, BT) were paid employees of Catholic Relief Services, the funder of the parent study, at the time this study was carried out and assisted with study design, data collection, and manuscript preparation. However, no CRS author had access to aggregate study data during data collection, nor was any CRS employee involved with data analysis or data interpretation of study results.	Aberman NL, 2014, AIDS BEHAV, V18, pS554, DOI 10.1007/s10461-014-0822-z; Adeniyi OV, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3087-8; Angeles G., 2004, USE DISCRETE DATA PC; Atanga PN, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2058-9; Ballard T., 2011, HOUSEHOLD HUNGER SCA, P360; Bernstein M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011999; Beusenberg M., 1994, WHOMNHPSF948; Brandt R, 2009, AJAR-AFR J AIDS RES, V8, P123, DOI 10.2989/AJAR.2009.8.2.1.853; Chibanda D, 2014, JAIDS-J ACQ IMM DEF, V67, pS54, DOI 10.1097/QAI.0000000000000258; Danel I, 2014, RES EVALUATION AGEND; Dillon Gina, 2013, Int J Family Med, V2013, P313909, DOI 10.1155/2013/313909; Ekama SO, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/851810; Futterman D, 2010, AIDS CARE, V22, P1093, DOI 10.1080/09540121003600352; Gallis JA, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2581; Gonzalez-Guarda RM, 2013, ANN BEHAV MED, V45, P135, DOI 10.1007/s12160-012-9464-4; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Hampanda KM, 2016, SOC SCI MED, V153, P123, DOI 10.1016/j.socscimed.2016.02.011; Harpham T, 2003, HEALTH POLICY PLANN, V18, P344, DOI 10.1093/heapol/czg041; Hatcher AM, 2015, AIDS, V29, P2183, DOI 10.1097/QAD.0000000000000842; Hatcher AM, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19233; Institut National de la Statistique, 2012, ENQ DEM SANT IND MUL; Jones D, 2016, OPEN FORUM INFECT DI; Kaaya SF, 2013, AIDS CARE, V25, P854, DOI 10.1080/09540121.2013.763891; Kapetanovic S, 2009, AIDS PATIENT CARE ST, V23, P101, DOI 10.1089/apc.2008.0125; Kauermann G, 2001, J AM STAT ASSOC, V96, P1387, DOI 10.1198/016214501753382309; Kieffer MP, 2011, JAIDS-J ACQ IMM DEF, V57, pE85, DOI 10.1097/QAI.0b013e31821acc6e; Knettel BA, 2018, JAIDS-J ACQ IMM DEF, V77, P427, DOI 10.1097/QAI.0000000000001616; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Kuonza LR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-218; Laraia BA, 2006, J NUTR, V136, P177, DOI 10.1093/jn/136.1.177; Laurenzi C, 2020, MATERN CHILD HLTH J, V24, P401, DOI 10.1007/s10995-019-02872-8; Mendenhall E, 2020, CURR OPIN HIV AIDS, V15, P213, DOI 10.1097/COH.0000000000000628; Ministry of Public Health, NAT GUID PREV MAN HI; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Njim Tsi, 2018, BMC Res Notes, V11, P868, DOI 10.1186/s13104-018-3979-0; Okonji JA, 2012, JAIDS-J ACQ IMM DEF, V61, P249, DOI 10.1097/QAI.0b013e318262514f; Omonaiye O, 2018, INT J INFECT DIS, V74, P71, DOI 10.1016/j.ijid.2018.07.004; Omonaiye O, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5651-y; Patel R, 2009, AIDS CARE, V21, P1517, DOI 10.1080/09540120902923055; Pefura-Yone EW, 2013, J INFECT PUBLIC HEAL, V6, P307, DOI 10.1016/j.jiph.2013.02.003; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Richter L, 2014, AIDS BEHAV, V18, P706, DOI 10.1007/s10461-014-0694-2; Sellen DW, 2011, ANN ANTHROPL PRACT, V35, P28, DOI 10.1111/j.2153-9588.2011.01065.x; Sheth SS, 2015, AIDS CARE, V27, P350, DOI 10.1080/09540121.2014.998610; Sin NL, 2014, ANN BEHAV MED, V47, P259, DOI 10.1007/s12160-013-9559-6; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; Singer M., 1996, FREE INQ CREAT SOCIO, V24, P99, DOI [10.1093/jn/nxaa361, DOI 10.1093/jn/nxaa361]; Sowa NA, 2015, J CLIN PSYCHIAT, V76, P1385, DOI 10.4088/JCP.14r09186; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Thiese MS, 2016, J THORAC DIS, V8, pE928, DOI 10.21037/jtd.2016.08.16; Trumbo P, 2002, J AM DIET ASSOC, V102, P1621, DOI 10.1016/S0002-8223(02)90346-9; Turan B, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0400-4; USAID, 2011, FANT 3 FOOD NUTR TEC; van der Westhuizen C, 2016, INT J MENT HEALTH AD, V14, P37, DOI 10.1007/s11469-015-9566-x; WHO Guidelines Approved by the Guidelines Review Committee, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2016, MHGAP INT GUID MENT; World Health Organization, 2019, WHONMHNHD1924; Wykowski J, 2019, AIDS BEHAV, V23, P2059, DOI 10.1007/s10461-018-02390-8; Yotebieng M, 2016, JAIDS-J ACQ IMM DEF, V72, pS124, DOI 10.1097/QAI.0000000000001062; Young S, 2014, AIDS BEHAV, V18, pS505, DOI 10.1007/s10461-013-0547-4	60	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246467	10.1371/journal.pone.0246467	http://dx.doi.org/10.1371/journal.pone.0246467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606692	gold, Green Published			2022-12-26	WOS:000620629200125
J	Gardner, B; Dix, S; Lawrence, R; Morgan, C; Sullivan, A; Kurumada, C				Gardner, Bethany; Dix, Sadie; Lawrence, Rebecca; Morgan, Cameron; Sullivan, Anaclare; Kurumada, Chigusa			Online pragmatic interpretations of scalar adjectives are affected by perceived speaker reliability	PLOS ONE			English	Article							PERSPECTIVE-TAKING; LANGUAGE; PERCEPTION; KNOWLEDGE; DOMAINS; COMPREHENSION; IMPLICATURE; ADAPTATION; CONTRAST; CHILDREN	Linguistic communication requires understanding of words in relation to their context. Among various aspects of context, one that has received relatively little attention until recently is the speakers themselves. We asked whether comprehenders' online language comprehension is affected by the perceived reliability with which a speaker formulates pragmatically well-formed utterances. In two eye-tracking experiments, we conceptually replicated and extended a seminal work by Grodner and Sedivy (2011). A between-participant manipulation was used to control reliability with which a speaker follows implicit pragmatic conventions (e.g., using a scalar adjective in accordance with contextual contrast). Experiment 1 replicated Grodner and Sedivy's finding that contrastive inference in response to scalar adjectives was suspended when both the spoken input and the instructions provided evidence of the speaker's (un)reliability: For speech from the reliable speaker, comprehenders exhibited the early fixations attributable to a contextually-situated, contrastive interpretation of a scalar adjective. In contrast, for speech from the unreliable speaker, comprehenders did not exhibit such early fixations. Experiment 2 provided novel evidence of the reliability effect in the absence of explicit instructions. In both experiments, the effects emerged in the earliest expected time window given the stimuli sentence structure. The results suggest that real-time interpretations of spoken language are optimized in the context of a speaker identity, characteristics of which are extrapolated across utterances.	[Gardner, Bethany] Vanderbilt Univ, Dept Psychol & Human Dev, Nashville, TN 37235 USA; [Dix, Sadie] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Lawrence, Rebecca; Morgan, Cameron; Kurumada, Chigusa] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Sullivan, Anaclare] SUNY Albany, Dept Epidemiol & Biostat, Albany, NY USA	Vanderbilt University; Tufts University; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Kurumada, C (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	ckuruma2@ur.rochester.edu		Kurumada, Chigusa/0000-0001-8624-4214; Lawrence, Rebecca/0000-0002-2963-4897; Gardner, Bethany/0000-0002-5154-2040	Department of Brain and Cognitive Sciences at the University of Rochester	Department of Brain and Cognitive Sciences at the University of Rochester	We would like to declare that the authors received funding from the Department of Brain and Cognitive Sciences at the University of Rochester. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN BP, 1990, DEV PSYCHOL, V26, P234, DOI 10.1037/0012-1649.26.2.234; ALTMANN G, 1988, COGNITION, V30, P191, DOI 10.1016/0010-0277(88)90020-0; [Anonymous], 2019, OXFORD HDB EXPT SEMA; Aparicio H., LANGUAGE COGNITION M, P1; Arnold JE, 2007, J EXP PSYCHOL LEARN, V33, P914, DOI 10.1037/0278-7393.33.5.914; Arnold JE, 2010, LANG LINGUIST COMPAS, V4, P187, DOI 10.1111/j.1749-818x.2010.00193.x; Arnold JE, 2009, COGNITION, V110, P131, DOI 10.1016/j.cognition.2008.10.016; Barr DJ, 2008, J MEM LANG, V59, P457, DOI 10.1016/j.jml.2007.09.002; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergen L, 2012, J EXP PSYCHOL LEARN, V38, P1450, DOI 10.1037/a0027850; Bott L, 2004, J MEM LANG, V51, P437, DOI 10.1016/j.jml.2004.05.006; Bott L, 2012, J MEM LANG, V66, P123, DOI 10.1016/j.jml.2011.09.005; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Brown-Schmidt S, 2008, COGNITIVE SCI, V32, P643, DOI 10.1080/03640210802066816; Brown-Schmidt S, 2015, PSYCHOL LEARN MOTIV, V62, P59, DOI 10.1016/bs.plm.2014.09.003; Brown-Schmidt S, 2011, INFORMATION, V2, P302, DOI 10.3390/info2020302; Brown-Schmidt S, 2009, PSYCHON B REV, V16, P893, DOI 10.3758/PBR.16.5.893; Chambers CG, 2004, J EXP PSYCHOL LEARN, V30, P687, DOI 10.1037/0278-7393.30.3.687; Chambers CG, 2002, J MEM LANG, V47, P30, DOI 10.1006/jmla.2001.2832; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; Clark HerbertH., 1981, ELEMENTS DISCOURSE U, P10; Clarke CM, 2004, J ACOUST SOC AM, V116, P3647, DOI 10.1121/1.1815131; Cutler A., 2005, PERCEPTION, V31, P1; Dahan D, 2008, COGNITION, V108, P710, DOI 10.1016/j.cognition.2008.06.003; Degen J, 2015, COGNITIVE SCI, V39, P667, DOI 10.1111/cogs.12171; Dell GS, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0394; DEUTSCH W, 1982, COGNITION, V11, P159, DOI 10.1016/0010-0277(82)90024-5; Engelhardt PE, 2011, BRAIN COGNITION, V77, P304, DOI 10.1016/j.bandc.2011.07.004; Epley N, 2004, J EXP SOC PSYCHOL, V40, P760, DOI 10.1016/j.jesp.2004.02.002; Farmer TA, 2013, BEHAV BRAIN SCI, V36, P211, DOI 10.1017/S0140525X12002312; Fine AB, 2013, COGNITIVE SCI, V37, P578, DOI 10.1111/cogs.12022; Goodman ND, 2013, TOP COGN SCI, V5, P173, DOI 10.1111/tops.12007; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Grodner D.J., 2011, PROCESSING ACQUISITI, P239, DOI DOI 10.7551/MITPRESS/9780262015127.003.0010; Hallett P. E., 1986, HDB PERCEPTION HUMAN, V1, P78; Hanna JE, 2004, COGNITIVE SCI, V28, P105, DOI 10.1016/j.cogsci.2003.10.002; Hanna JE, 2003, J MEM LANG, V49, P43, DOI 10.1016/S0749-596X(03)00022-6; Hanna JE, 2007, J MEM LANG, V57, P596, DOI 10.1016/j.jml.2007.01.008; Heller D, 2008, COGNITION, V108, P831, DOI 10.1016/j.cognition.2008.04.008; Heller D, 2015, LANG SPEECH, V58, P190, DOI 10.1177/0023830914528107; Hendriks P, 2014, LANG COGN NEUROSCI, V29, P391, DOI 10.1080/01690965.2013.766356; Horton WS, 2007, LANG COGNITIVE PROC, V22, P1114, DOI 10.1080/01690960701402933; Horton WS, 2016, TOP COGN SCI, V8, P780, DOI 10.1111/tops.12216; Horton WS, 2005, COGNITION, V96, P127, DOI 10.1016/j.cognition.2004.07.001; Huang YT, 2018, COGNITIVE PSYCHOL, V102, P105, DOI 10.1016/j.cogpsych.2018.01.004; Huang YT, 2011, LANG COGNITIVE PROC, V26, P1161, DOI 10.1080/01690965.2010.508641; Huang YT, 2009, COGNITIVE PSYCHOL, V58, P376, DOI 10.1016/j.cogpsych.2008.09.001; Kaan E, 2018, PSYCHOL LEARN MOTIV, V68, P85, DOI 10.1016/bs.plm.2018.08.003; Kaiser E, 2004, COGNITION, V94, P113, DOI 10.1016/j.cognition.2004.01.002; Kamide Y, 2012, COGNITION, V124, P66, DOI 10.1016/j.cognition.2012.03.001; Keysar B, 2000, PSYCHOL SCI, V11, P32, DOI 10.1111/1467-9280.00211; Kleinschmidt DF, 2015, PSYCHOL REV, V122, P148, DOI 10.1037/a0038695; Koolen R, 2013, COGNITIVE SCI, V37, P395, DOI 10.1111/cogs.12019; Kraljic T, 2008, COGNITION, V107, P54, DOI 10.1016/j.cognition.2007.07.013; Kraljic T, 2008, PSYCHOL SCI, V19, P332, DOI 10.1111/j.1467-9280.2008.02090.x; Kraljic T, 2011, COGNITION, V121, P459, DOI 10.1016/j.cognition.2011.08.015; Kuhlen AK, 2013, PSYCHON B REV, V20, P54, DOI 10.3758/s13423-012-0341-8; Kurumada C, 2016, 22 AMLAP C ARCH MECH; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Levy R, 2009, P NATL ACAD SCI USA, V106, P21086, DOI 10.1073/pnas.0907664106; Liu LD, 2018, COGNITION, V174, P55, DOI 10.1016/j.cognition.2018.01.003; Nadig AS, 2002, PSYCHOL SCI, V13, P329, DOI 10.1111/1467-9280.00460; Norris D, 2003, COGNITIVE PSYCHOL, V47, P204, DOI 10.1016/S0010-0285(03)00006-9; Norris D, 2016, LANG COGN NEUROSCI, V31, P4, DOI 10.1080/23273798.2015.1081703; Nygaard LC, 1998, PERCEPT PSYCHOPHYS, V60, P355, DOI 10.3758/BF03206860; Orena AJ, 2015, CHILD DEV, V86, P1701, DOI 10.1111/cdev.12421; PECHMANN T, 1989, LINGUISTICS, V27, P89, DOI 10.1515/ling.1989.27.1.89; Pogue A, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02035; Roettger TB., 2018, PSYARXIV, P1; Roettger TB, 2019, COGNITIVE SCI, V43, DOI 10.1111/cogs.12745; Rubio-Fernandez P, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00153; Ryskin R, 2019, COGNITIVE SCI, V43, DOI 10.1111/cogs.12769; Ryskin RA, 2017, J EXP PSYCHOL LEARN, V43, P781, DOI 10.1037/xlm0000341; Salverda AP, 2014, J MEM LANG, V71, P145, DOI 10.1016/j.jml.2013.11.002; Samuel AG, 2009, ATTEN PERCEPT PSYCHO, V71, P1207, DOI 10.3758/APP.71.6.1207; Sedivy JC, 1999, COGNITION, V71, P109, DOI 10.1016/S0010-0277(99)00025-6; Sedivy JC, 2003, J PSYCHOLINGUIST RES, V32, P3, DOI 10.1023/A:1021928914454; Squires L, 2014, LANG COGN NEUROSCI, V29, P856, DOI 10.1080/01690965.2013.804193; Stranahan E, 2018, EFFECTS WORKING MEMO; Theodore RM, 2015, J ACOUST SOC AM, V138, P1068, DOI 10.1121/1.4927489; Wolter L, 2011, J MEM LANG, V65, P299, DOI 10.1016/j.jml.2011.04.010; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Xie X, 2018, J ACOUST SOC AM, V143, P2013, DOI 10.1121/1.5027410	86	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0245130	10.1371/journal.pone.0245130	http://dx.doi.org/10.1371/journal.pone.0245130			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606683	Green Published, gold			2022-12-26	WOS:000620629200116
J	Islam, SM; Hossain, SMM; Ray, S				Islam, Sk Mazharul; Hossain, Sk Md Mosaddek; Ray, Sumanta			DTI-SNNFRA: Drug-target interaction prediction by shared nearest neighbors and fuzzy-rough approximation	PLOS ONE			English	Article								In-silico prediction of repurposable drugs is an effective drug discovery strategy that supplements de-nevo drug discovery from scratch. Reduced development time, less cost and absence of severe side effects are significant advantages of using drug repositioning. Most recent and most advanced artificial intelligence (AI) approaches have boosted drug repurposing in terms of throughput and accuracy enormously. However, with the growing number of drugs, targets and their massive interactions produce imbalanced data which may not be suitable as input to the classification model directly. Here, we have proposed DTI-SNNFRA, a framework for predicting drug-target interaction (DTI), based on shared nearest neighbour (SNN) and fuzzy-rough approximation (FRA). It uses sampling techniques to collectively reduce the vast search space covering the available drugs, targets and millions of interactions between them. DTI-SNNFRA operates in two stages: first, it uses SNN followed by a partitioning clustering for sampling the search space. Next, it computes the degree of fuzzy-rough approximations and proper degree threshold selection for the negative samples' undersampling from all possible interaction pairs between drugs and targets obtained in the first stage. Finally, classification is performed using the positive and selected negative samples. We have evaluated the efficacy of DTI-SNNFRA using AUC (Area under ROC Curve), Geometric Mean, and F1 Score. The model performs exceptionally well with a high prediction score of 0.95 for ROC-AUC. The predicted drug-target interactions are validated through an existing drug-target database (Connectivity Map (Cmap)).	[Islam, Sk Mazharul] RCC Inst Informat Technol, Dept Comp Sci & Engn, Kolkata, W Bengal, India; [Hossain, Sk Md Mosaddek; Ray, Sumanta] Aliah Univ, Dept Comp Sci & Engn, Kolkata, W Bengal, India	RCC Institute of Information Technology (RCCIIT); Aliah University	Hossain, SMM (corresponding author), Aliah Univ, Dept Comp Sci & Engn, Kolkata, W Bengal, India.	mosaddek.hossain@gmail.com	Hossain, Sk Md Mosaddek/C-8948-2017; Hossain, Sk Md Mosaddek/GPS-7230-2022	Hossain, Sk Md Mosaddek/0000-0003-0174-2359; Hossain, Sk Md Mosaddek/0000-0003-0174-2359; Ray, Sumanta/0000-0002-3371-8516				Asano K, 1999, KIDNEY INT, V55, P2289, DOI 10.1046/j.1523-1755.1999.00485.x; Bagherian M., 2020, BRIEF BIOINFORM; Blagus R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-106; Cao DS, 2015, BIOINFORMATICS, V31, P279, DOI 10.1093/bioinformatics/btu624; Chen HM, 2018, DRUG DISCOV TODAY, V23, P1241, DOI 10.1016/j.drudis.2018.01.039; Cui Z, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-018-2575-6; D'Souza S, 2020, DRUG DISCOV TODAY, V25, P748, DOI 10.1016/j.drudis.2020.03.003; Ezzat A, 2017, METHODS, V129, P81, DOI 10.1016/j.ymeth.2017.05.016; Ezzat A, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1377-y; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gao HR, 2010, J NEURAL TRANSM, V117, P585, DOI 10.1007/s00702-010-0398-3; Houle ME, 2010, LECT NOTES COMPUT SC, V6187, P482, DOI 10.1007/978-3-642-13818-8_34; Huang KX, 2020, BIOINFORMATICS, V36, P5545, DOI 10.1093/bioinformatics/btaa1005; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Jensen R, 2009, IEEE T FUZZY SYST, V17, P824, DOI 10.1109/TFUZZ.2008.924209; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Matesanz R, 2008, CHEM BIOL, V15, P573, DOI 10.1016/j.chembiol.2008.05.008; Sachdev K, 2019, J BIOMED INFORM, V93, DOI 10.1016/j.jbi.2019.103159; Seal A, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0089-z; Sharma A, 2018, COMPUT METH PROG BIO, V165, P151, DOI 10.1016/j.cmpb.2018.08.011; Szocs E., 2015, **DATA OBJECT**, DOI [10.5281/zenodo.33823, DOI 10.5281/ZENODO.33823]; Tabei Y, 2012, BIOINFORMATICS, V28, pI487, DOI 10.1093/bioinformatics/bts412; van Laarhoven T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066952; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; Vohora D, 2010, DRUG TODAY, V46, P265, DOI 10.1358/dot.2010.46.4.1445795; Yao EH, 2008, AM J HYPERTENS, V21, P1062, DOI 10.1038/ajh.2008.233	28	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246920	10.1371/journal.pone.0246920	http://dx.doi.org/10.1371/journal.pone.0246920			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606741	gold, Green Published			2022-12-26	WOS:000620629200061
J	de Carvalho, ALM; Gonzalez, MC; de Sousa, IM; das Virgens, IPA; de Medeiros, GOC; Oliveira, MN; Dantas, JCAD; Fayh, APT				Miranda de Carvalho, Ana Lucia; Gonzalez, Maria Cristina; de Sousa, Iasmin Matias; Amorim das Virgens, Isabel Pinto; Cunha de Medeiros, Galtieri Otavio; Oliveira, Marilia Nelo; Alves de Souza Dantas, Jeane Cristina; Trussardi Fayh, Ana Paula			Low skeletal muscle radiodensity is the best predictor for short-term major surgical complications in gastrointestinal surgical cancer: A cohort study	PLOS ONE			English	Article								The aim of this study was to evaluate whether body composition, muscle function, and their association are predictive factors for short-term postoperative complications in patients with gastric and colorectal cancer. A prospective cohort study was conducted with patients undergoing resection of gastric and colorectal tumors. Nutritional status was assessed using Patient-Generated Subjective Global Assessment (PG-SGA) and anthropometric techniques. Low handgrip strength (HGS) was observed when <16kg for women, and <27kg for men. Computed tomography images were used to measure visceral adipose tissue, skeletal muscle index (SMI), and skeletal muscle radiodensity (SMD). Complications of grade II or above (according to Clavien-Dindo's classification) were considered in a follow-up period of up to 30 days after surgery. Major complications were defined when they reached grade III or above. A total of 84 patients were analyzed (57.1% female, 59.7 +/- 12.6 years) and 19% were diagnosed with low HGS + low SMI or SMD. Postoperative complications occurred in 51.2%, and these patients presented significantly longer duration of surgery and hospital stay. Major complications were observed in 16.7% of the total number of patients. Binary logistic regression adjusted by age, sex, and tumor staging showed that low SMD, low HGS + low SMI or SMD, and obesity were independent risk factors for postoperative complications, but only low SMD was an independent risk factor for major postoperative complications. Low SMD is an independent risk factor for short-term major complications following surgery in patients with gastric and colorectal cancer.	[Miranda de Carvalho, Ana Lucia; Trussardi Fayh, Ana Paula] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Postgrad Program Nutr, Natal, State Rio Grand, Brazil; [Gonzalez, Maria Cristina] Univ Catolica Pelotas, Postgrad Program Hlth & Behav, Pelotas, State Rio Grand, Brazil; [de Sousa, Iasmin Matias; Amorim das Virgens, Isabel Pinto; Cunha de Medeiros, Galtieri Otavio; Trussardi Fayh, Ana Paula] Univ Fed Rio Grande do Norte, Postgrad Program, Hlth Sci Ctr, Natal, State Rio Grand, Brazil; [Oliveira, Marilia Nelo; Alves de Souza Dantas, Jeane Cristina] Luiz Antonio Hosp, Nutr Dept, Liga Canc, Natal, State Rio Grand, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Catolica de Pelotas; Universidade Federal de Pelotas; Universidade Federal do Rio Grande do Norte	Fayh, APT (corresponding author), Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Postgrad Program Nutr, Natal, State Rio Grand, Brazil.; Fayh, APT (corresponding author), Univ Fed Rio Grande do Norte, Postgrad Program, Hlth Sci Ctr, Natal, State Rio Grand, Brazil.	apfayh@yahoo.com.br		Sousa, Iasmin/0000-0001-6076-3024; Virgens, Isabel/0000-0001-5563-5837; Medeiros, Galtieri/0000-0002-8672-0126	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors ALMC and IMS received funding by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJCC, 2018, AJCC CANC STAGING MA, P99; Aubrey J, 2014, ACTA PHYSIOL, V210, P489, DOI 10.1111/apha.12224; Aversa Z, 2017, THER ADV MED ONCOL, V9, P369, DOI 10.1177/1758834017698643; Barbosa-Silva TG, 2016, J CACHEXIA SARCOPENI, V7, P136, DOI 10.1002/jcsm.12049; Bauer J, 2002, EUR J CLIN NUTR, V56, P779, DOI 10.1038/sj.ejcn.1601412; Boadella JM, 2005, ARCH PHYS MED REHAB, V86, P328, DOI 10.1016/j.apmr.2004.05.003; Borggreve AS, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010199; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bril SI, 2019, HEAD NECK-J SCI SPEC, V41, P1745, DOI 10.1002/hed.25638; Broughman JR, 2015, J GERIATR ONCOL, V6, P442, DOI 10.1016/j.jgo.2015.08.005; Caan BJ, 2017, CANCER EPIDEM BIOMAR, V26, P1008, DOI [10.1158/1055-9965.epi-17-0200, 10.1158/1055-9965.EPI-17-0200]; Chen WZ, 2018, DIGEST DIS SCI, V63, P1620, DOI 10.1007/s10620-018-5019-2; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Daly LE, 2018, P NUTR SOC, V77, P135, DOI 10.1017/S0029665118000046; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Doyle SL, 2013, NUTR RES, V33, P171, DOI 10.1016/j.nutres.2012.12.007; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Fukuta A, 2019, NUTRITION, V58, P65, DOI 10.1016/j.nut.2018.06.022; Gonzalez MC, 2010, REV BRAS NUTR CLIN, V25, P102; Goodpaster BH, 2000, J APPL PHYSIOL, V89, P104, DOI 10.1152/jappl.2000.89.1.104; Harter J, 2017, SUPPORT CARE CANCER, V25, P2525, DOI 10.1007/s00520-017-3661-4; Hayashi N, 2016, ONCOL REP, V35, P1727, DOI 10.3892/or.2015.4475; Horii N, 2020, WORLD J SURG ONCOL, V18, DOI 10.1186/s12957-020-01836-5; INCA, 2019, EST 2020 CANC INC BR, P1; Kamarajah SK, 2019, GASTRIC CANCER, V22, P10, DOI 10.1007/s10120-018-0882-2; Kroenke CH, 2018, CANCER-AM CANCER SOC, V124, P3008, DOI 10.1002/cncr.31405; Lu J, 2018, ANN SURG ONCOL, V25, P439, DOI 10.1245/s10434-017-6269-5; Malietzis G, 2015, EJSO-EUR J SURG ONC, V41, P186, DOI 10.1016/j.ejso.2014.10.056; Margadant CC, 2016, EJSO-EUR J SURG ONC, V42, P1654, DOI 10.1016/j.ejso.2016.05.040; Martin L, 2020, JPEN-PARENTER ENTER, V44, P227, DOI 10.1002/jpen.1597; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Mauricio SF, 2018, CLIN NUTR, V37, P1505, DOI 10.1016/j.clnu.2017.08.026; McSorley ST, 2018, CLIN NUTR, V37, P1279, DOI 10.1016/j.clnu.2017.05.017; MOREIRA LUIS FERNANDO, 2016, Rev. Col. Bras. Cir., V43, P141, DOI 10.1590/0100-69912016003001; Ni Bhuachalla EB, 2018, J CACHEXIA SARCOPENI, V9, P295, DOI 10.1002/jcsm.12258; Papaconstantinou D, 2020, DIS ESOPHAGUS, V33, DOI 10.1093/dote/doaa002; Porporato PE, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.3; Prado CM, 2016, P NUTR SOC, V75, P188, DOI 10.1017/S0029665115004279; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Rollins KE, 2017, NUTRITION, V41, P37, DOI 10.1016/j.nut.2017.02.011; Simonsen C, 2018, ANN SURG, V268, P58, DOI 10.1097/SLA.0000000000002679; Tamagawa H, 2018, MOL CLIN ONCOL, V8, P779, DOI 10.3892/mco.2018.1607; Tamura T, 2019, ANTICANCER RES, V39, P987, DOI 10.21873/anticanres.13203; Tankel J, 2020, INT J COLORECTAL DIS, V35, P85, DOI 10.1007/s00384-019-03423-x; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P129, DOI 10.1007/s13539-010-0014-2; Xiao JJ, 2020, JAMA SURG, V155, P942, DOI 10.1001/jamasurg.2020.2497; Xiao JJ, 2018, J CACHEXIA SARCOPENI, V9, P654, DOI 10.1002/jcsm.12301; Yang J, 2019, COLORECTAL DIS, V21, P538, DOI 10.1111/codi.14558; Zhang SZ, 2019, CLIN NUTR, V38, P2881, DOI 10.1016/j.clnu.2018.12.025; Zhang Y, 2018, CURR ONCOL, V25, pE411, DOI 10.3747/co.25.4014	54	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247322	10.1371/journal.pone.0247322	http://dx.doi.org/10.1371/journal.pone.0247322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606786	gold, Green Published			2022-12-26	WOS:000620629200054
J	Shibaguchi, H; Yasutaka, Y; Futagami, K				Shibaguchi, Hirotomo; Yasutaka, Yuki; Futagami, Koujiro			Novel method to analyze cell kinetics for the rapid diagnosis and determination of the causative agent in allergy	PLOS ONE			English	Article								Drug-induced allergy (DIA), an unexpectedly triggered side effect of drugs used for therapeutic purposes, is a serious clinical issue that needs to be resolved because it interrupts the treatment of the primary disease. Since conventional allergy testing is insufficient to accurately predict the occurrence of DIA or to determine the drugs causing it, the development of diagnostic and predictive tools for allergic reactions is important. We demonstrated a novel method, termed high-sensitive allergy test (HiSAT), for the rapid diagnosis of allergy (within 1 hr; with true-positive diagnosis rates of 89% and 9% for patients with and without allergy-like symptoms, respectively). HiSAT analyzes the cell kinetics as an index against chemotactic factors in a patient's serum, as different from the diagnosis using conventional methods. Once allergy has occurred, HiSAT can be used to determine the causative medicine using culture supernatants incubated with the subject's lymphocytes and the test allergen. This test is more efficient (60%) than the lymphocyte transformation test (20%). Furthermore, in HiSAT, cell mobility significantly increases in a dose-dependent manner against supernatant incubated with lymphocytes from a subject with pollinosis collected at a time when the subject is without allergic symptoms and the antigen. The result demonstraed that HiSAT might be a promising method to rapidly diagnose DIA or to determine with high accuracy the antigen causing allergy.	[Shibaguchi, Hirotomo] Fukuoka Univ, Fac Med, Dept Biochem, Fukuoka, Japan; [Shibaguchi, Hirotomo; Yasutaka, Yuki; Futagami, Koujiro] Fukuoka Univ Hosp, Dept Hosp Pharm, Fukuoka, Japan; [Yasutaka, Yuki; Futagami, Koujiro] Fukuoka Univ, Fac Pharmaceut Sci, Dept Hlth Care Management, Fukuoka, Japan	Fukuoka University; Fukuoka University; Fukuoka University	Shibaguchi, H (corresponding author), Fukuoka Univ, Fac Med, Dept Biochem, Fukuoka, Japan.; Shibaguchi, H (corresponding author), Fukuoka Univ Hosp, Dept Hosp Pharm, Fukuoka, Japan.	shiba-h@fukuoka-u.ac.jp			Kakihara Science and Technology Research Foundation [27-8-3]; Central Research Institute of Fukuoka University [116005, 146003, 187003];  [17K15534]	Kakihara Science and Technology Research Foundation; Central Research Institute of Fukuoka University; 	This study was supported in part by the fund [grant number 27-8-3] from the Kakihara Science and Technology Research Foundation (https://kakiharazaidan.jimdofree.com/) and by the funds [grant numbers 116005, 146003 and 187003] from the Central Research Institute of Fukuoka University (http://www.suisin.fukuoka-u.ac.jp/home1/sougou/sougou.html) (H.S.). This study was also supported by JSPS KAKENHI (https://www.jsps.go.jp/english/index.html) [grant number 17K15534] (Y.Y.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Demoly P, 2014, ALLERGY, V69, P420, DOI 10.1111/all.12350; Gomez E, 2012, ALLERGY ASTHMA IMMUN, V4, P251, DOI 10.4168/aair.2012.4.5.251; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Illing PT, 2016, CURR OPIN IMMUNOL, V42, P31, DOI 10.1016/j.coi.2016.05.003; Islam SA, 2012, NAT MED, V18, P705, DOI 10.1038/nm.2760; Ito A, 2008, J BIOL CHEM, V283, P35715, DOI 10.1074/jbc.M804220200; Ito W, 2007, ALLERGY, V62, P415, DOI 10.1111/j.1398-9995.2006.01299.x; Jutel M, 2016, J ALLERGY CLIN IMMUN, V137, P358, DOI 10.1016/j.jaci.2015.12.1300; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Mayorga C, 2016, ALLERGY, V71, P1103, DOI 10.1111/all.12886; Narita YM, 2011, J DERMATOL, V38, P236, DOI 10.1111/j.1346-8138.2010.01154.x; Nettis E., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P233; Nitta N, 2007, J IMMUNOL METHODS, V320, P155, DOI 10.1016/j.jim.2006.12.010; Notman MJ, 2005, CONTACT DERMATITIS, V53, P335, DOI 10.1111/j.0105-1873.2005.00716.x; Pichler WJ, 2003, ANN INTERN MED, V139, P683, DOI 10.7326/0003-4819-139-8-200310210-00012; Pirmohamed M, 2015, J ALLERGY CLIN IMMUN, V136, P236, DOI 10.1016/j.jaci.2015.06.022; Posadas SJ, 2007, CLIN EXP ALLERGY, V37, P989, DOI 10.1111/j.1365-2222.2007.02742.x; Romano A, 2010, ALLERGY, V65, P1104, DOI 10.1111/j.1398-9995.2009.02318.x; Saito K, 2008, J IMMUNOL, V181, P6889, DOI 10.4049/jimmunol.181.10.6889; Seitz CS, 2009, INT ARCH ALLERGY IMM, V149, P246, DOI 10.1159/000199720; Soyer OU, 2013, ALLERGY, V68, P161, DOI 10.1111/all.12085; Suzuki Y, 2008, CHEST, V134, P1027, DOI 10.1378/chest.07-3088; Sylvia LM., 2014, PHARMACOTHERAPY PATH; Tang YH, 2012, CLIN EXP ALLERGY, V42, P248, DOI 10.1111/j.1365-2222.2011.03875.x; Teraki Y, 2013, J ALLERGY CLIN IMMUN, V131, P907, DOI 10.1016/j.jaci.2012.08.042; Torres MJ, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0144-0; Warrington Rj, 2006, Allergy Asthma Clin Immunol, V2, P62, DOI 10.1186/1710-1492-2-2-62; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; White KD, 2015, J ALLERGY CLIN IMMUN, V136, P219, DOI 10.1016/j.jaci.2015.05.050; Yasuda T, 2016, J CLIN INVEST, V126, P2064, DOI 10.1172/JCI82887	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246125	10.1371/journal.pone.0246125	http://dx.doi.org/10.1371/journal.pone.0246125			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606707	gold, Green Published			2022-12-26	WOS:000620629200080
J	Tsori, Y; Granek, R				Tsori, Yoav; Granek, Rony			Epidemiological model for the inhomogeneous spatial spreading of COVID-19 and other diseases	PLOS ONE			English	Article								We suggest a novel mathematical framework for the in-homogeneous spatial spreading of an infectious disease in human population, with particular attention to COVID-19. Common epidemiological models, e.g., the well-known susceptible-exposed-infectious-recovered (SEIR) model, implicitly assume uniform (random) encounters between the infectious and susceptible sub-populations, resulting in homogeneous spatial distributions. However, in human population, especially under different levels of mobility restrictions, this assumption is likely to fail. Splitting the geographic region under study into areal nodes, and assuming infection kinetics within nodes and between nearest-neighbor nodes, we arrive into a continuous, "reaction-diffusion", spatial model. To account for COVID-19, the model includes five different sub-populations, in which the infectious sub-population is split into pre-symptomatic and symptomatic. Our model accounts for the spreading evolution of infectious population domains from initial epicenters, leading to different regimes of sub-exponential (e.g., power-law) growth. Importantly, we also account for the variable geographic density of the population, that can strongly enhance or suppress infection spreading. For instance, we show how weakly infected regions surrounding a densely populated area can cause rapid migration of the infection towards the populated area. Predicted infection "heat-maps" show remarkable similarity to publicly available heat-maps, e.g., from South Carolina. We further demonstrate how localized lockdown/quarantine conditions can slow down the spreading of disease from epicenters. Application of our model in different countries can provide a useful predictive tool for the authorities, in particular, for planning strong lockdown measures in localized areas-such as those underway in a few countries.	[Tsori, Yoav] Ben Gurion Univ Negev, Dept Chem Engn, Beer Sheva, Israel; [Granek, Rony] Ben Gurion Univ Negev, Avram & Stella Goldstein Gorren Dept Biotechnol E, Beer Sheva, Israel; [Tsori, Yoav; Granek, Rony] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Tsori, Y (corresponding author), Ben Gurion Univ Negev, Dept Chem Engn, Beer Sheva, Israel.; Tsori, Y (corresponding author), Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, Beer Sheva, Israel.	tsori@bgu.ac.il	GRANEK, RONY/F-1987-2012	GRANEK, RONY/0000-0001-6839-5393	Israel Science Foundation [274/19]	Israel Science Foundation(Israel Science Foundation)	YT acknowledges support by the Israel Science Foundation Grant No. 274/19 (www.isf.org.il). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2019, CHAOS, V29, DOI 10.1063/1.5116807; [Anonymous], DELPHI EPIDEMIC MODE; [Anonymous], STATE FLORIDA OFFICE; [Anonymous], SUMMARY PROVINCIAL C; [Anonymous], 2004, HDB STOCHASTIC METHO; [Anonymous], ISRAEL TRAFFIC LIGHT; [Anonymous], CORONAVIRUS DIS 2019; [Anonymous], 2020, CORONAVIRUS DIS 2019; [Anonymous], POLICE CHECKPOINTS S; [Anonymous], COVID 19 DASHBOARD C; [Anonymous], CUMULATIVE HEATMAPS; [Anonymous], NEW YORK STATE EXECU; [Anonymous], 2020, CONSIDERATIONS QUARA; [Anonymous], 2020, COVID 19 CONTAIN FRA; [Anonymous], 2014, BE CODIS MATH MODEL; [Anonymous], 2020, APPL BE CODIS MATH M; [Anonymous], CORONAVIRUS UPDATES; [Anonymous], MODELING 2019 NCOV; [Anonymous], DOTAN GOBERMAN RAMI; [Anonymous], 2018, GRIDDED POPULATION W, DOI [10.7927/H49C6VHW, DOI 10.7927/H49C6VHW]; [Anonymous], 2020, INFECT SNAPSHOT AREA; [Anonymous], 2017, J ANTIMICROB AGENTS, V50, P88, DOI [10.1016/j.ijantimicag.2017.01.033, DOI 10.1016/J.IJANTIMICAG.2020.105924, DOI 10.1016/J.IJANTIMICAG.2017.01.033]; Atkeson A., 2020, WHAT WILL BE EC IMPA, DOI [10.3386/w26867, DOI 10.3386/W26867]; BACKER J, 2020, ANN EUGENIC, V25, DOI DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Blyuss K.B., 2020, EFFECTS LATENCY AGE, DOI [10.1101/2020.04.25.20079848v1, DOI 10.1101/2020.04.25.20079848]; Buss L. F., 2020, HERD IMMUNITY THRESH, DOI 10.1101/2020.07.23.20 160762; Byambasuren Oyungerel, 2020, J Assoc Med Microbiol Infect Dis Can, V5, P223, DOI 10.3138/jammi-2020-0030; Capone F, 2013, RIC MAT, V62, P161, DOI 10.1007/s11587-013-0151-y; Chang LL, 2020, CHAOS, V30, DOI 10.1063/1.5135069; COLIZZA V, 2007, PHYS BIOL, V3, P276, DOI DOI 10.1038/nphys560; Efimov D, 2020, PREDICTION COVID 19; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Getz WM, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0282; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Gjorgjieva J, 2005, MATH BIOSCI ENG, V2, P753; HE D, 2020, NAT MED, V94, P145, DOI DOI 10.1016/J.IJID.2020.04.034; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Jia L, 2020, PREDICTION ANAL CORO; Karin Omer, 2020, MEDRXIV, DOI [10.1101/2020.04.04.20053579, DOI 10.1101/2020.04.04.20053579]; Keeling, 2008, MODELING INFECT DIS; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; KLAUSNER Z, 2020, MEDRXIV, DOI DOI 10.1016/j.ijid.2020.10.016; Kwok KO, 2020, J INFECTION, V80, pE32, DOI 10.1016/j.jinf.2020.03.027; LI M, 1999, J INFECTION, V160, P191; LIU Y, 2020, EUROSURVEILLANCE, DOI DOI 10.1093/jtm/taaa021; Lloyd AL, 1996, J THEOR BIOL, V179, P1, DOI 10.1006/jtbi.1996.0042; Mammeri Y, 2020, REACTION DIFFUSION S; MANCHEIN C, 2020, STRONG CORRELATIONS, V30, DOI DOI 10.1063/5.0009454; Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033; Piskunov, 1937, B MGU A, V1, P1, DOI DOI 10.1016/B978-0-08-092523-3.50014-9; Rader B, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1104-0; Read J. M., 2020, MEDRXIV, DOI 10.1101/2020.01.23.20018549; SINGER H, 2020, MATH BIOSCI ENG, V17, P55001, DOI DOI 10.1088/1478-3975/ab9bf5; Singer HM, 2020, ARXIV200311997; Verma MK., 2020, COVID 19 EPIDEMIC PO; Wang HW, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0148-0; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; 2020, SCIENCE, V172, P577, DOI DOI 10.7326/M20-0504	58	8	8	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246056	10.1371/journal.pone.0246056	http://dx.doi.org/10.1371/journal.pone.0246056			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606684	gold, Green Published, Green Submitted			2022-12-26	WOS:000620629200096
J	Lee, J; Yoon, Y; Kim, EJ; Lee, D; Baek, Y; Takano, C; Chang, B; Iijima, T; Kilgore, PE; Hayakawa, S; Hoshino, T; Kim, DW; Seki, M				Lee, Jiwon; Yoon, Youngbae; Kim, Eun Jin; Lee, Donghyun; Baek, Yeongjun; Takano, Chika; Chang, Bin; Iijima, Takahiro; Kilgore, Paul E.; Hayakawa, Satoshi; Hoshino, Tomonori; Kim, Dong Wook; Seki, Mitsuko			23-valent polysaccharide vaccine (PPSV23)-targeted serotype-specific identification of Streptococcus pneumoniae using the loop-mediated isothermal amplification (LAMP) method	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; SEQUENTIAL MULTIPLEX PCR; DETERMINING CAPSULAR SEROTYPES; HAEMOPHILUS-INFLUENZAE; ANTIMICROBIAL SUSCEPTIBILITY; NEISSERIA-MENINGITIDIS; JAPAN; SURVEILLANCE; ENGLAND; LOCUS	Reports of invasive disease due to Streptococcus pneumoniae have declined since the introduction of pneumococcal conjugate vaccines (PCV7 and PCV13). The incidence of invasive diseases due to S. pneumoniae that are not addressed by the vaccines, however, has increased in children and adults, creating a global public health problem. Previously, we established the loop-mediated isothermal amplification (LAMP) method for a PCV13 serotype-specific assay. In the current study, we developed a rapid, simple, and cost-effective assay to detect serotypes in the 23-valent pneumococcal polysaccharide vaccine (PPSV23) using the LAMP method. In this study, LAMP primer sets for serotypes 2, 8, 9N, 10A, 11A, 12F, 15B, 17F, 20, 22F, and 33F of S. pneumoniae were developed. The reactivity, specificity, and sensitivity of LAMP assays were determined and compared to those of conventional PCR. The feasibility of LAMP assays in clinical application in patients with invasive pneumococcal diseases was validated by defining the detection limit of the LAMP assay with bacterial genomic DNA-spiked blood specimens. The specificity of each LAMP assay was determined using 44 serotypes of pneumococcal strains. Their sensitivity was 100 copies per reaction versus 10(3) to 10(6) copies per reaction for PCR assays. Using DNA-spiked blood specimens, excluding the LAMP assay that targeted serotype 22F (10(3) copies per reaction), the limit of detection of the LAMP assay was similar to that with purified DNA as the template (10(2) copies per reaction), compared with 10(3) to >10(6) copies per reaction for PCR assays. In conclusion, a rapid and simple LAMP-based PPSV23-targeted serotype detection assay was developed for use in many countries. This study is the first report of a LAMP-based assay for identification of PPSV23 serotypes. Further evaluation of this assay is needed through surveillance and vaccine efficacy studies.	[Lee, Jiwon; Yoon, Youngbae; Kim, Eun Jin; Lee, Donghyun; Baek, Yeongjun; Iijima, Takahiro; Hoshino, Tomonori; Seki, Mitsuko] Meikai Univ, Dept Human Dev & Fostering, Div Pediat Dent, Sch Dent, Saitama, Japan; [Lee, Jiwon; Yoon, Youngbae; Kim, Eun Jin; Lee, Donghyun; Baek, Yeongjun; Kim, Dong Wook] Hanyang Univ, Coll Pharm, Dept Pharm, Ansan, South Korea; [Lee, Jiwon; Yoon, Youngbae; Kim, Eun Jin; Lee, Donghyun; Baek, Yeongjun; Kim, Dong Wook] Hanyang Univ, Inst Pharmacol Res, Ansan, South Korea; [Takano, Chika; Hayakawa, Satoshi; Seki, Mitsuko] Nihon Univ, Dept Pathol & Microbiol, Div Microbiol, Sch Med, Tokyo, Japan; [Chang, Bin] Natl Inst Infect Dis, Bacteriol 1, Tokyo, Japan; [Kilgore, Paul E.] Wayne State Univ, Dept Pharm Practice, Eugene Applebaum Coll Pharm & Hlth Sci, Detroit, MI USA	Meikai University; Hanyang University; Hanyang University; Nihon University; National Institute of Infectious Diseases (NIID); Wayne State University	Seki, M (corresponding author), Meikai Univ, Dept Human Dev & Fostering, Div Pediat Dent, Sch Dent, Saitama, Japan.; Kim, DW (corresponding author), Hanyang Univ, Coll Pharm, Dept Pharm, Ansan, South Korea.; Kim, DW (corresponding author), Hanyang Univ, Inst Pharmacol Res, Ansan, South Korea.; Seki, M (corresponding author), Nihon Univ, Dept Pathol & Microbiol, Div Microbiol, Sch Med, Tokyo, Japan.	dongwook@hanyang.ac.kr; mitsuko.seki@dent.meikai-u.ac.jp	Kilgore, Paul E/L-1462-2013; Kilgore, Paul/AAD-2869-2019	Kilgore, Paul E/0000-0003-3214-4482; Kilgore, Paul/0000-0003-3214-4482	JSPS Bilateral Open Partnership Joint Research Projects; National Research Foundation (NRF) of Korea [NRF-2018R1A2A2A05018341, NRF-2020R1C1C1009992]; Institute of Information & Communications Technology Planning & Evaluation (IITP) - Ministry of Science and ICT (MSIT) of Korea [2020-0-01343]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI19C0748]; JSPS Miyata Research Grant	JSPS Bilateral Open Partnership Joint Research Projects; National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Institute of Information & Communications Technology Planning & Evaluation (IITP) - Ministry of Science and ICT (MSIT) of Korea; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; JSPS Miyata Research Grant	MS has been supported by JSPS Bilateral Open Partnership Joint Research Projects and Miyata Research Grant (A). DWK was supported by the grant NRF-2018R1A2A2A05018341 from National Research Foundation (NRF) of Korea, Institute of Information & Communications Technology Planning & Evaluation (IITP) grant No.2020-0-01343 funded by Ministry of Science and ICT (MSIT) of Korea, and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI19C0748). EJK was supported by the grant NRF-2020R1C1C1009992 from National Research Foundation (NRF) of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, Weekly Epidemiological Record, V94, P85; [Anonymous], 2017, M STRATEGIC ADVISORY; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Brown PD, 1998, LANCET, V352, P1295, DOI 10.1016/S0140-6736(98)02239-9; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; FUJITSU L, PRIMEREXPLORER V5 20; Heo JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177342; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042954; Kim DW, 2011, J CLIN MICROBIOL, V49, P3621, DOI 10.1128/JCM.00515-11; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lee D, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01548; Lee D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122922; Martin NG, 2014, LANCET INFECT DIS, V14, P397, DOI 10.1016/S1473-3099(14)70027-1; McAllister DA, 2019, LANCET GLOB HEALTH, V7, pE47, DOI 10.1016/S2214-109X(18)30408-X; McGill F, 2016, LANCET, V388, P3036, DOI 10.1016/S0140-6736(16)30654-7; Messaoudi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151428; Miyamoto S, 2015, ANAL BIOCHEM, V473, P28, DOI 10.1016/j.ab.2014.12.016; Miyazaki H, 2017, J INFECT CHEMOTHER, V23, P234, DOI 10.1016/j.jiac.2016.12.016; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Mori Y, 2020, J INFECT CHEMOTHER, V26, P13, DOI 10.1016/j.jiac.2019.07.020; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Nakano S, 2018, EMERG INFECT DIS, V24, P275, DOI 10.3201/eid2402.171268; Nakano S, 2016, VACCINE, V34, P67, DOI 10.1016/j.vaccine.2015.11.015; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pimenta FC, 2009, J CLIN MICROBIOL, V47, P2353, DOI 10.1128/JCM.00704-09; Prina E, 2015, LANCET, V386, P1097, DOI 10.1016/S0140-6736(15)60733-4; Rane TD, 2015, LAB CHIP, V15, P776, DOI 10.1039/c4lc01158a; Saha SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003576; SATSANGI J, 1994, LANCET, V343, P1509, DOI 10.1016/S0140-6736(94)92622-0; Satzke C, 2019, VACCINE, V37, P296, DOI 10.1016/j.vaccine.2018.10.077; Seki M, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00057; Takano C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56225-0; Takano C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01877; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Torigoe H, 2007, JPN J INFECT DIS, V60, P55; Ubukata K, 2018, EMERG INFECT DIS, V24, P2010, DOI 10.3201/eid2411.180326; van Selm S, 2002, MICROBIOL-SGM, V148, P1747, DOI 10.1099/00221287-148-6-1747; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; World Health Organization G, 2004, LAB BIOSAFETY MANUAL; Wu CJ, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.557404; Yonekawa T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62109-5	47	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246699	10.1371/journal.pone.0246699	http://dx.doi.org/10.1371/journal.pone.0246699			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33591996	Green Published, gold			2022-12-26	WOS:000620632800048
J	Usher-Smith, JA; Mills, KM; Riedinger, C; Saunders, CL; Helsingen, LM; Lytvyn, L; Buskermolen, M; Lansdorp-Vogelaar, I; Bretthauer, M; Guyatt, G; Griffin, SJ				Usher-Smith, Juliet A.; Mills, Katie M.; Riedinger, Christiane; Saunders, Catherine L.; Helsingen, Lise M.; Lytvyn, Lyubov; Buskermolen, Maaike; Lansdorp-Vogelaar, Iris; Bretthauer, Michael; Guyatt, Gordon; Griffin, Simon J.			The impact of information about different absolute benefits and harms on intention to participate in colorectal cancer screening: A think-aloud study and online randomised experiment	PLOS ONE			English	Article							RISK COMMUNICATION; DECISION-MAKING; INFORMED CHOICE; PREFERENCES; FORMATS	Background There is considerable heterogeneity in individuals' risk of disease and thus the absolute benefits and harms of population-wide screening programmes. Using colorectal cancer (CRC) screening as an exemplar, we explored how people make decisions about screening when presented with information about absolute benefits and harms, and how those preferences vary with baseline risk, between screening tests and between individuals. Method We conducted two linked studies with members of the public: a think-aloud study exploring decision making in-depth and an online randomised experiment quantifying preferences. In both, participants completed a web-based survey including information about three screening tests (colonoscopy, sigmoidoscopy, and faecal immunochemical testing) and then up to nine scenarios comparing screening to no screening for three levels of baseline risk (1%, 3% and 5% over 15 years) and the three screening tests. Participants reported, after each scenario, whether they would opt for screening (yes/no). Results Of the 20 participants in the think-aloud study 13 did not consider absolute benefits or harms when making decisions concerning CRC screening. In the online experiment (n = 978), 60% expressed intention to attend at 1% risk of CRC, 70% at 3% and 77% at 5%, with no differences between screening tests. At an individual level, 535 (54.7%) would attend at all three risk levels and 178 (18.2%) at none. The 27% whose intention varied by baseline risk were more likely to be younger, without a family history of CRC, and without a prior history of screening. Conclusions Most people in our population were not influenced by the range of absolute benefits and harms associated with CRC screening presented. For an appreciable minority, however, magnitude of benefit was important.	[Usher-Smith, Juliet A.; Mills, Katie M.; Riedinger, Christiane; Saunders, Catherine L.; Griffin, Simon J.] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England; [Helsingen, Lise M.; Bretthauer, Michael] Univ Oslo, Oslo Univ Hosp, Clin Effectiveness Res Grp, Dept Transplantat Med, Oslo, Norway; [Helsingen, Lise M.; Bretthauer, Michael] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Lytvyn, Lyubov; Guyatt, Gordon] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Buskermolen, Maaike; Lansdorp-Vogelaar, Iris] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands	University of Cambridge; University of Oslo; University of Oslo; McMaster University; Erasmus University Rotterdam; Erasmus MC	Usher-Smith, JA (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England.	jau20@medschl.cam.ac.uk	Helsingen, Lise/ABD-6025-2021; Helsingen, Lise/AAU-2290-2021	Helsingen, Lise/0000-0002-2055-3978; Saunders, Catherine/0000-0002-3127-3218; Riedinger, Christiane/0000-0002-9310-9894; Usher-Smith, Juliet/0000-0002-8501-2531	National Institute for Health Research (NIHR) School for Primary Care Research (Project 427); Cancer Research UK [C55650/A21464]; NIHR Academic Clinical Fellowship	National Institute for Health Research (NIHR) School for Primary Care Research (Project 427); Cancer Research UK(Cancer Research UK); NIHR Academic Clinical Fellowship	This research was funded by the National Institute for Health Research (NIHR) School for Primary Care Research (Project reference 427) (www.spcr.nihr.ac.uk).JA Usher Smith and K Mills were funded by Cancer Research UK (Grant number C55650/A21464) (www.cancerresearchuk.org).C Riedinger is funded by an NIHR Academic Clinical Fellowship (www.nihr.ac.uk).The University of Cambridge has received salary support in respect of Prof. Griffin from the NHS in the East of England through the Clinical Academic Reserve. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. All researchers were independent of the funding body and the funder had no role in data collection, analysis and interpretation of data; in the writing of the report; or decision to submit the article for publication.	Allen JD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1169; Bayne M., 2019, PATIENT EDUC COUNS, DOI [10.1016/j.pec.2019.08.010 31439435, DOI 10.1016/J.PEC.2019.08.01031439435]; Brenner A, 2014, J GEN INTERN MED, V29, P507, DOI 10.1007/s11606-013-2701-0; Buskermolen M, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5383; Cancer Research UK, BOW CANC STAT; Chrysostomou AC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120729; Covey J, 2007, MED DECIS MAKING, V27, P638, DOI 10.1177/0272989x07306783; Edwards AGK, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001865.pub2; Edwards AGK, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001865.pub3; ERICSSON KA, 1980, PSYCHOL REV, V87, P215, DOI 10.1037/0033-295X.87.3.215; Forbes LJL, 2014, J MED SCREEN, V21, P194, DOI 10.1177/0969141314555350; French DP, 2017, ANN BEHAV MED, V51, P718, DOI 10.1007/s12160-017-9895-z; Glasziou P, 2011, PREV MED, V53, P100, DOI 10.1016/j.ypmed.2011.05.011; Han PKJ, 2009, HEALTH EXPECT, V12, P4, DOI 10.1111/j.1369-7625.2008.00524.x; Helsingen LM, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5515; Hersch JK, 2017, PUBLIC HEALTH RES PR, V27, DOI 10.17061/phrp2731728; Hol L, 2010, BRIT J CANCER, V102, P972, DOI 10.1038/sj.bjc.6605566; Hussein Haitham M, 2008, J Vasc Interv Neurol, V1, P106; Johnson CM, 2013, CANCER CAUSE CONTROL, V24, P1207, DOI 10.1007/s10552-013-0201-5; Kerrison RS., 2018, ANN BEHAV MED, P1, DOI [10.1007/s12160-017-9918-9, DOI 10.1007/S12160-017-9918-9]; Kistler CE, 2015, PATIENT PREFER ADHER, V9, P1005, DOI 10.2147/PPA.S82203; Lacasse K, 2017, NEW IDEAS PSYCHOL, V46, P1, DOI 10.1016/j.newideapsych.2015.09.002; Landy R, 2016, BRIT J CANCER, V115, P1140, DOI 10.1038/bjc.2016.290; LERMAN C, 1991, HEALTH PSYCHOL, V10, P259, DOI 10.1037/0278-6133.10.4.259; Lin JS, 2016, JAMA-J AM MED ASSOC, V315, P2576, DOI 10.1001/jama.2016.3332; Lipkus IM, 2007, MED DECIS MAKING, V27, P696, DOI 10.1177/0272989x07307271; Lo SH, 2015, GUT, V64, P282, DOI 10.1136/gutjnl-2013-306144; Loewenstein G, 2003, SER AFFECTIVE SCI, P619; Michie S, 2002, PATIENT EDUC COUNS, V48, P87, DOI 10.1016/S0738-3991(02)00089-7; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Palan S, 2018, J BEHAV EXP FINANC, V17, P22, DOI 10.1016/j.jbef.2017.12.004; Peer E, 2014, BEHAV RES METHODS, V46, P1023, DOI 10.3758/s13428-013-0434-y; QRS International Pty Ltd, NVIVO QUAL DAT AN SO; Radcliffe NM, 2002, PERS SOC PSYCHOL B, V28, P836, DOI 10.1177/0146167202289012; Rebitschek FG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218188; Reventlow S, 2001, SCAND J PRIM HEALTH, V19, P71; Roberto A, 2020, BRIT J CANCER, V123, P714, DOI 10.1038/s41416-020-0935-2; Ropka ME, 2010, J CLIN ONCOL, V28, P3090, DOI 10.1200/JCO.2009.27.8077; Rosenbaum L., 2014, NEW ENGL J MED, V371, P175, DOI [10.1056/NEJMe1405746 25006724, DOI 10.1056/NEJME140574625006724]; Sasieni P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2968; Schreuders EH, 2015, GUT, V64, P1637, DOI 10.1136/gutjnl-2014-309086; Schroy PC, 2012, AM J PREV MED, V43, P573, DOI 10.1016/j.amepre.2012.08.018; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Shah Tajammal Abbas, 2017, J Microsc Ultrastruct, V5, P59, DOI 10.1016/j.jmau.2016.10.002; Slovic P, 2005, HEALTH PSYCHOL, V24, pS35, DOI 10.1037/0278-6133.24.4.S35; Stanesby O, 2017, EUR J HUM GENET, V25, P832, DOI 10.1038/ejhg.2017.60; StataCorp, STAT STAT SOFTW REL; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Trevena LJ, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S7; Usher-Smith JA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017717; van Dam L, 2010, EUR J CANCER, V46, P150, DOI 10.1016/j.ejca.2009.07.014; Vass C, 2019, PATIENT, V12, P113, DOI 10.1007/s40271-018-0326-4; Waldron CA, 2011, PATIENT EDUC COUNS, V82, P169, DOI 10.1016/j.pec.2010.04.014; Waters EA, 2006, J HEALTH COMMUN, V11, P167, DOI 10.1080/10810730500526695	54	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246991	10.1371/journal.pone.0246991	http://dx.doi.org/10.1371/journal.pone.0246991			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8MA	33592037	Green Published, gold, Green Submitted			2022-12-26	WOS:000620632800028
J	Yun, L; Wang, W; Li, YY; Xie, M; Chen, T; Hu, CQ; Luo, P; Li, DN				Yun, Long; Wang, Wei; Li, Yingying; Xie, Mei; Chen, Ting; Hu, Chaoqun; Luo, Peng; Li, Daning			Potential application values of a marine red yeast, Rhodosporidiums sphaerocarpum YLY01, in aquaculture and tail water treatment assessed by the removal of ammonia nitrogen, the inhibition to Vibrio spp., and nutrient composition	PLOS ONE			English	Article							BACTERIA; REDUCTION; LARVAE	In recent years, marine red yeasts have been increasingly used as feed diets for larviculture of aquatic animals mainly due to their rich nutrition and immunopotentiation, however little attention is given to their other probiotic profits. In this study, a marine red yeast strain YLY01 was isolated and purified from farming water and it was identified as a member of Rhodosporidiums sphaerocarpum by the phylogeny based on 18S rDNA sequence. The strain YLY01 could effectively remove ammonia nitrogen from an initial 9.8 mg/L to 1.3 mg/L in 48 h when supplemented with slight yeast extract and glucose in water samples and the removal rate of ammonia nitrogen was up to 86%. Shrimps (Litopenaeus vannamei) in experimental group incubated with the yeast YLY01 exhibited a higher survival rate than those in blank control group and positive control group challenged by Vibrio harveyi, and it manifested that the strain has high biosecurity to at least shrimps. The strain YLY01 could inhibit the growth of Vibrio cells when a small quantity of carbon source was added into farming water. In addition, a nutrition composition assay showed the contents of protein, fatty acids, and total carotenoids of the yeast YLY01 were 30.3%, 3.2%, and 1.2 mg/g of dry cell weight, respectively. All these results indicated that the marine red yeast YLY01 has a great potential to be used as a versatile probiotic in aquaculture and to be developed as a microbial agent for high-ammonia tail water treatment.	[Yun, Long; Wang, Wei; Li, Yingying; Xie, Mei; Chen, Ting; Hu, Chaoqun; Luo, Peng; Li, Daning] Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol LMB, Guangdong Prov Key Lab Appl Marine Biol LAMB, Guangzhou, Peoples R China; [Yun, Long] Univ Paris Diderot, Inst Jacques Monod, CNRS, UMR 7592, Paris, France; [Wang, Wei] Minjiang Univ, Inst Oceanog, Fuzhou, Fujian, Peoples R China; [Li, Yingying; Xie, Mei; Chen, Ting; Hu, Chaoqun; Luo, Peng] Southern Marine Sci & Engn Guangdong Lab, Guangzhou, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Minjiang University; Southern Marine Science & Engineering Guangdong Laboratory	Luo, P (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol LMB, Guangdong Prov Key Lab Appl Marine Biol LAMB, Guangzhou, Peoples R China.; Luo, P (corresponding author), Southern Marine Sci & Engn Guangdong Lab, Guangzhou, Peoples R China.	luopeng@scsio.ac.cn	Daning, Li/E-7149-2016	Daning, Li/0000-0002-0570-9778; Chen, Ting/0000-0002-5777-909X	Natural Science Foundation of Guangdong Province, China [2019A1515011492]; National key Research and development program: Blue Granary Scientific and Technological Innovation [2020YFD0901104]; Key Special Project for Introduced Talents Team of Southern Marine Science and Engineering Guangdong Laboratory [GML2019ZD0402]	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); National key Research and development program: Blue Granary Scientific and Technological Innovation; Key Special Project for Introduced Talents Team of Southern Marine Science and Engineering Guangdong Laboratory	This work was supported by Natural Science Foundation of Guangdong Province, China (2019A1515011492), National key Research and development program: Blue Granary Scientific and Technological Innovation (2020YFD0901104), and Key Special Project for Introduced Talents Team of Southern Marine Science and Engineering Guangdong Laboratory (GML2019ZD0402).	Aksu Z, 2005, PROCESS BIOCHEM, V40, P2985, DOI 10.1016/j.procbio.2005.01.011; Amirkolaie AK, 2011, REV AQUACULT, V3, P19, DOI 10.1111/j.1753-5131.2010.01040.x; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; BARRY AL, 1979, J CLIN MICROBIOL, V10, P885, DOI 10.1128/JCM.10.6.885-889.1979; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown MR, 1996, AQUACULTURE, V143, P341, DOI 10.1016/0044-8486(96)01286-0; Chi Zhenming, 2006, Journal of Ocean University of China, V5, P251; CHOUDARY PV, 1984, ARCH MICROBIOL, V138, P183, DOI 10.1007/BF00402116; Coyle SD, 2000, J WORLD AQUACULT SOC, V31, P89, DOI 10.1111/j.1749-7345.2000.tb00702.x; De Schryver P, 2014, ISME J, V8, P2360, DOI 10.1038/ismej.2014.84; De Silva SS., 1994, SPRINGER SCI BUSINES; Feldmann H., 2012, YEAST MOL CELL BIOL, V2nd ed.; Gatesoupe FJ, 2007, AQUACULTURE, V267, P20, DOI 10.1016/j.aquaculture.2007.01.005; Gethins L, 2015, YEAST, V32, P67, DOI 10.1002/yea.3047; Gong GP, 2016, BIOCATAL BIOTRANSFOR, V34, P18, DOI 10.1080/10242422.2016.1201077; Hai NV, 2015, J APPL MICROBIOL, V119, P917, DOI 10.1111/jam.12886; HASEGAWA J, 1990, AGR BIOL CHEM TOKYO, V54, P1819, DOI 10.1080/00021369.1990.10870226; Jia BJ, 2012, PHYSCS PROC, V24, P425, DOI 10.1016/j.phpro.2012.02.062; Kader MA, 2012, AQUACULTURE, V350, P109, DOI 10.1016/j.aquaculture.2012.04.009; Kuebutornye FKA, 2019, FISH SHELLFISH IMMUN, V87, P820, DOI 10.1016/j.fsi.2019.02.010; Kutty SN, 2008, YEAST, V25, P465, DOI 10.1002/yea.1599; Lee CT, 2015, P NATL ACAD SCI USA, V112, P10798, DOI 10.1073/pnas.1503129112; LEE TH, 1981, AGR BIOL CHEM TOKYO, V45, P1301, DOI 10.1080/00021369.1981.10864726; Li JQ, 2006, AQUACULTURE, V253, P140, DOI 10.1016/j.aquaculture.2005.07.040; Lyman M., 2019, YEASTS BIOTECHNOLOGY; Magasanik B, 2003, EUKARYOT CELL, V2, P827, DOI 10.1128/EC.2.5.827-829.2003; Martinez-Porchas M, 2012, SCI WORLD J, DOI 10.1100/2012/389623; Mota C, 2005, FEMS MICROBIOL ECOL, V54, P391, DOI 10.1016/j.femsec.2005.05.001; Nasrabadi MRN, 2011, FOOD SCI BIOTECHNOL, V20, P445, DOI 10.1007/s10068-011-0062-1; Navarrete P., 2014, SUSTAINABLE AQUACULT, P136; OLIVER JD, 1983, APPL ENVIRON MICROB, V45, P985, DOI 10.1128/AEM.45.3.985-998.1983; Pham KD, 2020, BIOSCI BIOTECH BIOCH, V84, P1501, DOI 10.1080/09168451.2020.1740581; Saenge C, 2011, PROCESS BIOCHEM, V46, P210, DOI 10.1016/j.procbio.2010.08.009; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarlin P.J., 2016, INT J CURR MICROBIOL, V5, P55, DOI [10.20546/ijcmas.2016.501.005, DOI 10.20546/IJCMAS.2016.501.005]; Sepehri A, 2019, APPL WATER SCI, V9, DOI 10.1007/s13201-019-1017-6; Skjermo J, 1999, AQUACULTURE, V177, P333, DOI 10.1016/S0044-8486(99)00096-4; Smit E, 1999, APPL ENVIRON MICROB, V65, P2614; SPEERS RA, 1992, J I BREWING, V98, P293, DOI 10.1002/j.2050-0416.1992.tb01111.x; TALBOT C, 1994, J APPL ICHTHYOL, V10, P258, DOI 10.1111/j.1439-0426.1994.tb00165.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang KFJ, 2016, J INVERTEBR PATHOL, V140, P1, DOI 10.1016/j.jip.2016.08.004; TESHIMA S, 1986, AQUACULTURE, V51, P225, DOI 10.1016/0044-8486(86)90314-5; Vieco-Saiz N, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00057; Wang JH, 2015, FISH SHELLFISH IMMUN, V43, P330, DOI 10.1016/j.fsi.2014.12.028; WASSERMAN A, 1961, J DAIRY SCI, V44, P379, DOI 10.3168/jds.S0022-0302(61)89753-1; Xu JY, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2225-6; Yang SP, 2010, AQUACULTURE, V309, P62, DOI 10.1016/j.aquaculture.2010.09.032; Yang SP., 2011, FEED IND IN CHINESE, V10; Yun L, 2019, AQUACULTURE, V500, P477, DOI 10.1016/j.aquaculture.2018.10.054; Zhan Wen-bin, 2000, Journal of Fishery Sciences of China, V7, P51	51	7	7	10	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246841	10.1371/journal.pone.0246841	http://dx.doi.org/10.1371/journal.pone.0246841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592044	Green Published, gold			2022-12-26	WOS:000620632800085
J	Asiimwe, N; Tabong, PTN; Iro, SA; Noora, CL; Opoku-Mensah, K; Asampong, E				Asiimwe, Nashira; Tabong, Philip Teg-Nefaah; Iro, Stanley Amogu; Noora, Charles Lwanga; Opoku-Mensah, Kwabena; Asampong, Emmanuel			Stakeholders perspective of, and experience with contact tracing for COVID-19 in Ghana: A qualitative study among contact tracers, supervisors, and contacts	PLOS ONE			English	Article							DISEASE; FEAR	Background Ghana confirmed the first two cases of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) infection on 12(th) March 2020. Following this, the government introduced routine and enhanced contact tracing to identify, quarantine, and test contacts for COVID-19. This study, therefore, intends to document the experiences of contact tracers, their supervisors, during COVID-19 containment in Ghana. Methods Purposive sampling was used to select twenty-seven (27) participants; sixteen contact tracers, six supervisors, and five contacts of COVID-19 cases for an in-depth interview using a topic guide. These interviews were conducted on a phone or face-to-face basis whilst maintaining physical distancing protocol. All these were recorded and transcribed verbatim. Then, QSR NVivo 12 was used to analyse the data thematically. Results Contact tracers were selected based on their professional background and surveillance experience with other infectious diseases. They were trained before the first confirmed cases of COVID-19 in the country and before deployment. Deployment of contact tracers was in pairs to monitor contacts daily through physical visits or over the phone. Their activities included educating contacts about the condition, filling the symptoms diary, and providing psychological support. Contacts for COVID-19 were identified through case investigation, and their monitoring is done once a day despite the twice-daily requirement. Wherever a case was confirmed, enhanced contact tracing within a 2km radius was done. Furthermore, it was reported that some contacts were not adhering to the self-quarantine. In addition to this, other challenges included; unstable provision of PPEs and remuneration, refusal of some contact to test, delays in receiving test results, and poor coordination of the whole process. Conclusions The study concludes that contact tracing was generally perceived to be helpful in COVID-19 containment in Ghana. However, adhering to self-quarantine protocol had many challenges for both contact tracers and the contacts. Improving coordination and quick release of test results to contacts is necessary for COVID-19 containment. Lastly, the supply of Personal Protection Equipment and motivation needs to be addressed to help position the country well for effective contact tracing.	[Asiimwe, Nashira] Pharmaceaut Soc Uganda, Kampala, Uganda; [Asiimwe, Nashira; Noora, Charles Lwanga] Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol, Legon, Accra, Ghana; [Tabong, Philip Teg-Nefaah; Opoku-Mensah, Kwabena; Asampong, Emmanuel] Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Social & Behav Sci, Legon, Accra, Ghana; [Iro, Stanley Amogu] Univ Ghana, West African Ctr Cell Biol Infect Pathogens WACCB, Legon, Accra, Ghana	University of Ghana; University of Ghana; University of Ghana	Tabong, PTN (corresponding author), Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Social & Behav Sci, Legon, Accra, Ghana.	philgh2001@yahoo.com	Opoku-Mensah, Kwabena/EYQ-5177-2022	Tabong, Philip/0000-0001-9445-1643; Iro, Stanley Amogu/0000-0002-1398-9570				Adongo PB, 2017, BMC HEALTH SERV RES, DOI 10.1186/s12913-017-2225-0; Adongo PB, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-16; Alden S., 2015, SOCIAL POLICY SOC, DOI [10.1017/S1474746414000426, DOI 10.1017/S1474746414000426]; [Anonymous], 2020, NOVEL CORONAVIRUS DI; [Anonymous], 2017, CONT TRAC; Asampong E, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006219; Assessment RR, 2019, NOV COR DIS 2019 COV; Awoonor-Williams JK, 2016, INT J HLTH PLANN MAN; Birt L, 2016, QUAL HEALTH RES, V26, P1802, DOI 10.1177/1049732316654870; Bowling A., 2014, RES METHODS HLTH INV, Vfourth; Creswell J.W., 2009, RES DESIGN QUALITATI, V3rd, P260, DOI DOI 10.1016/J.MATH.2010.09.003; Elo S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014522633; Evans T, 2004, BRIT J SOC WORK, V34, P871, DOI 10.1093/bjsw/bch106; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Green J., 2018, QUALITATIVE METHODS, VFourth; Guttman N, 2004, BIOETHICS, V18, P531, DOI 10.1111/j.1467-8519.2004.00415.x; Hageman JR, 2020, PEDIATR ANN, V49, pE99, DOI 10.3928/19382359-20200219-01; Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X; Jaiswal J, 2020, AIDS BEHAV, V24, P2776, DOI 10.1007/s10461-020-02925-y; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Leshner G, 2010, J BROADCAST ELECTRON, V54, P485, DOI 10.1080/08838151.2010.498850; Lipsky M, 2010, STREET-LEVEL BUREAUCRACY: DILEMMAS OF THE INDIVIDUAL IN PUBLIC SERVICES, 30TH EDITION, P1; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Miller JC, 2009, J R SOC INTERFACE, V6, P1121, DOI 10.1098/rsif.2008.0524; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Tabong PTN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198915; The Constitution of Ghana, 1992, CONST REP GHAN; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wang KW, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101654; Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748; WHO-AFRO, 2020, AFR COUNTR MOV COVID; World Health Organization, 2020, ARCH WHO TIM COVID 1; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0247038	10.1371/journal.pone.0247038	http://dx.doi.org/10.1371/journal.pone.0247038			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571296	Green Published, gold			2022-12-26	WOS:000618274000079
J	Radbill, AE; Lei, LY; Paranjape, SY; Blackwell, DJ; Abraham, RL; Chew, DS; Raj, SR; Knollmann, BC				Radbill, Andrew E.; Lei, Lucy Y.; Paranjape, Sachin Y.; Blackwell, Daniel J.; Abraham, Robert L.; Chew, Derek S.; Raj, Satish R.; Knollmann, Bjorn C.			Assessment of dynamic cardiac repolarization and contractility in patients with hypertrophic cardiomyopathy	PLOS ONE			English	Article							SUDDEN-DEATH; DEFIBRILLATORS; ARRHYTHMIA	Aims Arrhythmia mechanisms in hypertrophic cardiomyopathy remain uncertain. Preclinical models suggest hypertrophic cardiomyopathy-linked mutations perturb sarcomere length-dependent activation, alter cardiac repolarization in rate-dependent fashion and potentiate triggered electrical activity. This study was designed to assess rate-dependence of clinical surrogates of contractility and repolarization in humans with hypertrophic cardiomyopathy. Methods All participants had a cardiac implantable device capable of atrial pacing. Cases had clinical diagnosis of hypertrophic cardiomyopathy, controls were age-matched. Continuous electrocardiogram and blood pressure were recorded during and immediately after 30 second pacing trains delivered at increasing rates. Results Nine hypertrophic cardiomyopathy patients and 10 controls were enrolled (47% female, median 55 years), with similar baseline QRS duration, QT interval and blood pressure. Median septal thickness in hypertrophic cardiomyopathy patients was 18mm; 33% of hypertrophic cardiomyopathy patients had peak sub-aortic velocity >50mmHg. Ventricular ectopy occurred during or immediately after pacing trains in 4/9 hypertrophic cardiomyopathy patients and 0/10 controls (P = 0.03). During delivery of steady rate pacing across a range of cycle lengths, the QT-RR relationship was not statistically different between HCM and control groups; no differences were seen in subgroup analysis of patients with or without intact AV node conduction. Similarly, there was no difference between groups in the QT interval of the first post-pause recovery beat after pacing trains. No statistically significant differences were seen in surrogate measures for cardiac contractility. Conclusion Rapid pacing trains triggered ventricular ectopy in hypertrophic cardiomyopathy patients, but not controls. This finding aligns with pre-clinical descriptions of excessive cardiomyocyte calcium loading during rapid pacing, increased post-pause sarcoplasmic reticulum calcium release, and subsequent calcium-triggered activity. Normal contractility at all diastolic intervals argues against clinical significance of altered length-dependent myofilament activation.	[Radbill, Andrew E.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Cardiol,Monroe Carell Jr Childrens Hosp, Nashville, TN 37232 USA; [Lei, Lucy Y.; Chew, Derek S.; Raj, Satish R.] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Cardiac Sci, Calgary, AB, Canada; [Paranjape, Sachin Y.; Blackwell, Daniel J.; Raj, Satish R.; Knollmann, Bjorn C.] Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN USA; [Abraham, Robert L.] Vanderbilt Univ, Med Ctr, Arrhythmia Sect, Div Cardiovasc Med, Nashville, TN USA; [Chew, Derek S.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA	Vanderbilt University; Libin Cardiovascular Institute Of Alberta; University of Calgary; Vanderbilt University; Vanderbilt University; Duke University	Radbill, AE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Div Cardiol,Monroe Carell Jr Childrens Hosp, Nashville, TN 37232 USA.	andrew.radbill@vumc.org		Radbill, Andrew/0000-0003-2360-3552	Vanderbilt Clinical and Translational Science Award grant (AER) from the National Center for Advancing Translational Sciences/National Institutes of Health [UL1 TR000445]	Vanderbilt Clinical and Translational Science Award grant (AER) from the National Center for Advancing Translational Sciences/National Institutes of Health	This work was supported in part by the Vanderbilt Clinical and Translational Science Award grant (AER) from the National Center for Advancing Translational Sciences/National Institutes of Health [UL1 TR000445]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external or internal funding received for this study.	Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642; de Tombe PP, 2010, J MOL CELL CARDIOL, V48, P851, DOI 10.1016/j.yjmcc.2009.12.017; Huke S, 2010, J MOL CELL CARDIOL, V48, P824, DOI 10.1016/j.yjmcc.2010.01.011; Link MS, 2017, J CARDIOVASC ELECTR, V28, P531, DOI 10.1111/jce.13194; Maron BJ, 2018, NEW ENGL J MED, V379, P655, DOI 10.1056/NEJMra1710575; Moolman JC, 1997, J AM COLL CARDIOL, V29, P549, DOI 10.1016/S0735-1097(96)00530-X; O'Mahony C, 2013, CIRC-ARRHYTHMIA ELEC, V6, P443, DOI 10.1161/CIRCEP.111.962043; Schober T, 2012, CIRC RES, V111, P170, DOI 10.1161/CIRCRESAHA.112.270041; Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436; van der Velden J, 2015, CARDIOVASC RES, V105, P449, DOI 10.1093/cvr/cvv019; Varnava AM, 2001, CIRCULATION, V104, P1380, DOI 10.1161/hc3701.095952; Wang LL, 2018, J MOL CELL CARDIOL, V114, P320, DOI 10.1016/j.yjmcc.2017.12.002; Weissler-Snir A, 2021, HEART RHYTHM, V18, P63, DOI 10.1016/j.hrthm.2020.08.009; Wolf CM, 2005, P NATL ACAD SCI USA, V102, P18123, DOI 10.1073/pnas.0509145102	14	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246768	10.1371/journal.pone.0246768	http://dx.doi.org/10.1371/journal.pone.0246768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571287	Green Published, gold			2022-12-26	WOS:000618274000040
J	Darling, NJ; Arthur, JSC; Cohen, P				Darling, Nicola J.; Arthur, J. Simon C.; Cohen, Philip			Salt-inducible kinases are required for the IL-33-dependent secretion of cytokines and chemokines in mast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY SMOOTH-MUSCLE; IL-13 PRODUCTION; IKK-BETA; IL-33; PHOSPHORYLATION; PROTEIN; INTERLEUKIN-13; INFLAMMATION; INHIBITION; EXPRESSION	Cytokines and chemokines are important regulators of airway hyper-responsiveness, immune cell infiltration, and inflammation and are produced when mast cells are stimulated with interleukin-33 (IL-33). Here, we establish that the salt-inducible kinases (SIKs) are required for the IL-33-stimulated transcription of il13, gm-csf and tnf and hence the production of these cytokines. The IL-33-stimulated secretion of IL-13, granulocyte-macrophage colony stimulating factor, and tumor necrosis factor was strongly reduced in fetal liver-derived mast cells from mice expressing a kinase-inactive mutant of SIK3 and abolished in cells expressing kinase-inactive mutants of SIK2 and SIK3. The IL-33-dependent secretion of these cytokines and several chemokines was also abolished in SIK2/3 double knock-out bone marrow-derived mast cells (BMMC), reduced in SIK3 KO cells but little affected in BMMC expressing kinase-inactive mutants of SIK1 and SIK2 or lacking SIK2 expression. In SIK2 knock-out BMMC, the expression of SIK3 was greatly increased. Our studies identify essential roles for SIK2 and SIK3 in producing inflammatory mediators that trigger airway inflammation. The effects of SIKs were independent of I kappa B kinase beta, I kappa B kinase beta-mediated NF-kappa B-dependent gene transcription, and activation of the mitogen-activated protein kinase family members p38 alpha and c-jun N-terminal kinases. Our results suggest that dual inhibitors of SIK2 and SIK3 may have therapeutic potential for the treatment of mast cell-driven diseases.	[Darling, Nicola J.; Cohen, Philip] Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Angus, Scotland; [Arthur, J. Simon C.] Univ Dundee, Div Cell Signalling & Immunol, Dundee, Angus, Scotland	University of Dundee; University of Dundee	Cohen, P (corresponding author), Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Angus, Scotland.	p.cohen@dundee.ac.uk		Darling, Nicola/0000-0001-7278-6012; Arthur, Simon/0000-0002-8135-1958	U.K. Medical Research Council [MR/R021406/1]	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by a Programme Grant (MR/R021406/1) from the U.K. Medical Research Council (to P. C.).	Aoki M, 2015, BLOOD CELL MOL DIS, V54, P353, DOI 10.1016/j.bcmd.2015.01.007; Balzar S, 2005, AM J RESP CRIT CARE, V171, P431, DOI 10.1164/rccm.200407-949OC; BRADDING P, 1994, AM J RESP CELL MOL, V10, P471, DOI 10.1165/ajrcmb.10.5.8179909; Bradding Peter, 2008, Allergy Asthma Clin Immunol, V4, P84, DOI 10.1186/1710-1492-4-2-84; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Carroll NG, 2002, THORAX, V57, P677, DOI 10.1136/thorax.57.8.677; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cieslewicz G, 1999, J CLIN INVEST, V104, P301, DOI 10.1172/JCI7010; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Darling NJ, 2017, BIOCHEM J, V474, P521, DOI 10.1042/BCJ20160646; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Drube S, 2016, J IMMUNOL, V197, P3662, DOI 10.4049/jimmunol.1600658; Durham AL, 2016, TRANSL RES, V167, P192, DOI 10.1016/j.trsl.2015.08.004; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fukuishi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060837; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Gopfert C, 2018, J IMMUNOL, V200, P1198, DOI 10.4049/jimmunol.1700727; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hamzaoui A, 2013, J ASTHMA, V50, P803, DOI 10.3109/02770903.2013.816317; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Howarth PH, 2005, THORAX, V60, P1012, DOI 10.1136/thx.2005.045260; Howden AJM, 2019, NAT IMMUNOL, V20, P1542, DOI 10.1038/s41590-019-0495-x; Jensen B. M., 2006, CURR PROTOC IMMUNOL; Junttila IS, 2013, J ALLERGY CLIN IMMUN, V132, P704, DOI 10.1016/j.jaci.2013.03.033; Lang V, 2003, MOL CELL BIOL, V23, P402, DOI 10.1128/MCB.23.1.402-413.2003; Lipworth B, 2018, LANCET RESP MED, V6, pE46, DOI 10.1016/S2213-2600(18)30275-3; Llop-Guevara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088714; Lombardi MS, 2016, J LEUKOCYTE BIOL, V99, P711, DOI 10.1189/jlb.2A0715-307R; Lopez-Pelaez M, 2014, P NATL ACAD SCI USA, V111, P17432, DOI 10.1073/pnas.1418399111; Luan B, 2014, CELL METAB, V19, P1058, DOI 10.1016/j.cmet.2014.03.024; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; Matera MG, 2010, PULM PHARMACOL THER, V23, P121, DOI 10.1016/j.pupt.2009.10.007; McCarthy PC, 2019, IMMUNOL CELL BIOL, V97, P54, DOI 10.1111/imcb.12200; Molfino NA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-007709; Naqvi S, 2014, BIOCHEM J, V458, P469, DOI 10.1042/BJ20131115; Ozanne J, 2015, BIOCHEM J, V465, P271, DOI 10.1042/BJ20141165; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Ren JY, 2014, P NATL ACAD SCI USA, V111, P17438, DOI 10.1073/pnas.1418516111; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shiomi A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/568543; Sundberg TB, 2014, P NATL ACAD SCI USA, V111, P12468, DOI 10.1073/pnas.1412308111; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018; Yahara Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10959; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	49	4	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100428	10.1016/j.jbc.2021.100428	http://dx.doi.org/10.1016/j.jbc.2021.100428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33600797	Green Published, gold			2022-12-26	WOS:000672866400402
J	Muha, V; Authier, F; Szoke-Kovacs, Z; Johnson, S; Gallagher, J; McNeilly, A; McCrimmon, RJ; Teboul, L; van Aalten, DMF				Muha, Villo; Authier, Florence; Szoke-Kovacs, Zsombor; Johnson, Sara; Gallagher, Jennifer; McNeilly, Alison; McCrimmon, Rory J.; Teboul, Lydia; van Aalten, Daan M. F.			Loss of O-GlcNAcase catalytic activity leads to defects in mouse embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINE; PROTEIN MODIFICATION; DYNAMIC GLYCOSYLATION; IN-VITRO; GLCNACYLATION; TRANSFERASE; GENE; IDENTIFICATION; MECHANISM; NEURONS	O-GlcNAcylation is an essential post-translational modification that has been implicated in neurodevelopmental and neurodegenerative disorders. O-GlcNAcase (OGA), the sole enzyme catalyzing the removal of O-GlcNAc from proteins, has emerged as a potential drug target. OGA consists of an N-terminal OGA catalytic domain and a C-terminal pseudo histone acetyltransferase (HAT) domain with unknown function. To investigate phenotypes specific to loss of OGA catalytic activity and dissect the role of the HAT domain, we generated a constitutive knock-in mouse line, carrying a mutation of a catalytic aspartic acid to alanine. These mice showed perinatal lethality and abnormal embryonic growth with skewed Mendelian ratios after day E18.5. We observed tissue-specific changes in O-GlcNAc homeostasis regulation to compensate for loss of OGA activity. Using X-ray microcomputed tomography on late gestation embryos, we identified defects in the kidney, brain, liver, and stomach. Taken together, our data suggest that developmental defects during gestation may arise upon prolonged OGA inhibition specifically because of loss of OGA catalytic activity and independent of the function of the HAT domain.	[Muha, Villo; Authier, Florence; van Aalten, Daan M. F.] Univ Dundee, Sch Life Sci, Div Gene Regulat & Express, Dundee, Scotland; [Szoke-Kovacs, Zsombor; Johnson, Sara; Teboul, Lydia] MRC Harwell Inst, Mary Lyon Ctr, Didcot, Oxon, England; [Gallagher, Jennifer; McCrimmon, Rory J.] Univ Dundee, Div Mol & Clin Med, Dundee, Scotland; [McNeilly, Alison] Univ Dundee, Sch Med, Syst Med, Dundee, Scotland	University of Dundee; MRC Harwell; University of Dundee; University of Dundee	van Aalten, DMF (corresponding author), Univ Dundee, Sch Life Sci, Div Gene Regulat & Express, Dundee, Scotland.	dmfvanaalten@dundee.ac.uk		van Aalten, Daan/0000-0002-1499-6908; McCrimmon, Rory/0000-0002-3957-1981; McNeilly, Alison/0000-0003-4869-178X; Muha, Villo/0000-0003-4156-8463; Johnson, Sara/0000-0001-6308-6401	Wellcome Trust Investigator Award [110061]; MRC [MC_UP_1502/1] Funding Source: UKRI	Wellcome Trust Investigator Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Wellcome Trust Investigator Award (110061) to D. M. F. v. A.	Andres LM, 2017, ACS CHEM BIOL, V12, P2030, DOI 10.1021/acschembio.7b00232; Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241; Bergmann C, 2003, BRAIN, V126, P1537, DOI 10.1093/brain/awg173; Butkinaree C, 2008, J BIOL CHEM, V283, P23557, DOI 10.1074/jbc.M804116200; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; Constable S, 2017, GLYCOBIOLOGY, V27, P927, DOI 10.1093/glycob/cwx055; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Francisco H, 2009, DEV NEUROBIOL, V69, P162, DOI 10.1002/dneu.20695; Fujita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052272; Gambetta MC, 2014, DEV CELL, V31, P629, DOI 10.1016/j.devcel.2014.10.020; Gorelik A, 2019, NAT STRUCT MOL BIOL, V26, P1071, DOI 10.1038/s41594-019-0325-8; Hastings NB, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0181-0; He Y, 2014, ACTA CRYSTALLOGR D, V70, P186, DOI 10.1107/S1399004713029155; Hsieh YL, 2019, CELL REP, V29, P2134, DOI 10.1016/j.celrep.2019.10.053; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; Ishihara K, 2010, BIOCHEM BIOPH RES CO, V398, P489, DOI 10.1016/j.bbrc.2010.06.105; Ishihara K, 2010, CEREB CORTEX, V20, P1131, DOI 10.1093/cercor/bhp176; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Keembiyehetty C, 2015, GENOM DATA, V5, P30, DOI 10.1016/j.gdata.2015.04.026; Keembiyehetty C, 2015, J BIOL CHEM, V290, P7097, DOI 10.1074/jbc.M114.617779; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Kim EJ, 2006, CARBOHYD RES, V341, P971, DOI 10.1016/j.carres.2006.03.004; Kim G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11655-6; Kim HS, 2009, FEBS LETT, V583, P2474, DOI 10.1016/j.febslet.2009.06.052; Koschutzke L, 2015, CELL TISSUE RES, V361, P645, DOI 10.1007/s00441-015-2224-6; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lagerlof O, 2017, P NATL ACAD SCI USA, V114, P1684, DOI 10.1073/pnas.1621367114; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; Li J, 2016, ACS CHEM BIOL, V11, P3002, DOI 10.1021/acschembio.6b00678; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu K, 2004, J NEUROCHEM, V89, P1044, DOI 10.1111/j.1471-4159.2004.02389.x; Ma JF, 2013, EXPERT REV PROTEOMIC, V10, P365, DOI 10.1586/14789450.2013.820536; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Mariappa D, 2015, BIOCHEM J, V470, P255, DOI 10.1042/BJ20150610; Marotta NP, 2015, NAT CHEM, V7, P913, DOI [10.1038/NCHEM.2361, 10.1038/nchem.2361]; Mills JL, 2010, BIRTH DEFECTS RES A, V88, P769, DOI 10.1002/bdra.20757; Muha V, 2020, J BIOL CHEM, V295, P8636, DOI 10.1074/jbc.RA119.010312; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Olivier-Van Stichelen S, 2017, J BIOL CHEM, V292, P6076, DOI 10.1074/jbc.M116.774042; Pantaleon M, 2010, BIOL REPROD, V82, P751, DOI 10.1095/biolreprod.109.076661; Park SK, 2017, CELL REP, V20, P1088, DOI 10.1016/j.celrep.2017.07.017; Parween S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00415; Peng CM, 2017, MOL CELL, V68, P591, DOI 10.1016/j.molcel.2017.10.010; Peterson SB, 2016, CRIT REV BIOCHEM MOL, V51, P150, DOI 10.3109/10409238.2015.1135102; Pravata VM, 2020, EUR J HUM GENET, V28, P706, DOI 10.1038/s41431-020-0589-9; Pravata VM, 2020, FEBS LETT, V594, P717, DOI 10.1002/1873-3468.13640; Pravata VM, 2019, P NATL ACAD SCI USA, V116, P14961, DOI 10.1073/pnas.1900065116; Qian KV, 2018, J BIOL CHEM, V293, P13989, DOI 10.1074/jbc.RA118.004709; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Rao FV, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130021; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; RORABACHER DB, 1991, ANAL CHEM, V63, P139, DOI 10.1021/ac00002a010; Ryan P, 2019, ACS CHEM NEUROSCI, V10, P2209, DOI 10.1021/acschemneuro.9b00143; Sanchez RG, 2019, NEUROBIOL DIS, V124, P531, DOI 10.1016/j.nbd.2019.01.001; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Schimpl M, 2012, CHEM BIOL, V19, P173, DOI 10.1016/j.chembiol.2012.01.011; Schimpl M, 2010, BIOCHEM J, V432, P1, DOI 10.1042/BJ20101338; Schultz J, 2002, FEBS LETT, V529, P179, DOI 10.1016/S0014-5793(02)03322-7; Schwartz R, 2000, SEMIN PERINATOL, V24, P120, DOI 10.1053/sp.2000.6363; Shaffer LG, 2005, GENET MED, V7, P650, DOI 10.1097/01.gim.0000186545.83160.1e; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Skorobogatko Y, 2014, J BIOL CHEM, V289, P3602, DOI 10.1074/jbc.M113.512814; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Swamy M, 2016, NAT IMMUNOL, V17, P712, DOI 10.1038/ni.3439; Tan ZW, 2020, NUCLEIC ACIDS RES, V48, P5656, DOI 10.1093/nar/gkaa263; Tardio L, 2014, OSTEOARTHR CARTILAGE, V22, P259, DOI 10.1016/j.joca.2013.12.001; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Vaidyanathan K, 2017, J BIOL CHEM, V292, P8948, DOI 10.1074/jbc.M116.771030; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Wang AC, 2016, P NATL ACAD SCI USA, V113, P15120, DOI 10.1073/pnas.1606899113; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024763; Wani WY, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0311-1; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Willems AP, 2017, J BIOL CHEM, V292, P12621, DOI 10.1074/jbc.M117.790097; Yanagisawa M, 2009, J NEUROSCI RES, V87, P3535, DOI 10.1002/jnr.22170; Yang YR, 2017, SCI REP-UK, V7, DOI 10.1038/srep44921; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Yuzwa SA, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-42; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]; Zachara NE, 2012, AM J PHYSIOL-HEART C, V302, pH1905, DOI 10.1152/ajpheart.00445.2011; Zhang Z, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00206; Zhu YP, 2018, ACS CHEM NEUROSCI, V9, P1366, DOI 10.1021/acschemneuro.8b00015; Zhu YP, 2015, NAT CHEM BIOL, V11, P319, DOI [10.1038/NCHEMBIO.1774, 10.1038/nchembio.1774]; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	93	16	16	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100439	10.1016/j.jbc.2021.100439	http://dx.doi.org/10.1016/j.jbc.2021.100439			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610549	Green Published, gold			2022-12-26	WOS:000672866400413
J	Belete, YA; Kassa, TY; Baye, MF				Belete, Yohannes Alemu; Kassa, Tilahun Yemane; Baye, Minale Fekadie			Prevalence of intestinal parasite infections and associated risk factors among patients of Jimma health center requested for stool examination, Jimma, Ethiopia	PLOS ONE			English	Article								Background Intestinal parasitic infections are still a serious public health problem in poor and developing countries like Ethiopia. Local epidemiological data is crucial to design and monitor prevention and control strategies. This study aimed to determine the prevalence of intestinal parasite infections and associated risk factors among patients requested for stool examination at Jimma health center, Southwest, Ethiopia. Methods A cross-sectional study was conducted among a total of 384 patients in Jimma health center, Southwest, Ethiopia. Stool samples were collected and examined using direct wet-mount and formal-ether concentration techniques. Data were analyzed using the Chi-Square (X-2) test and SPPS Version 24 and P ValueResults The overall prevalence of intestinal parasite infections was found to be 79(20.6%). The infection rate was slightly higher in females 261(68%) than in males 123(32%). Eight types of intestinal parasites were identified and the highest prevalence was Giardia lamblia 25(6.5%) followed by A. lumbricoides 22(5.7%). Single parasitic infection was found among 67(17.4%) of the patients and double infection was 12(3.1%). Shoe wearing habits, Status of fingernail, Handwashing before a meal and after defecation, Source of water for bathing and drinking were significant factors(p<0.05) for intestinal parasitic infection. Conclusion A relatively low prevalence of intestinal parasite infections was observed among patients of Jimma health center requested for the stool examination.	[Belete, Yohannes Alemu] Jimma Univ, Inst Hlth, Sch Med Lab Sci, Fac Hlth Sci, Jimma, Ethiopia; [Kassa, Tilahun Yemane] Jimma Univ, Sch Med Lab Sci, Dept Clin Lab, Inst Hlth,Hlth Sci, Jimma, Ethiopia; [Baye, Minale Fekadie] Jimma Univ, Sch Biomed Sci, Dept Biochem, Jimma, Ethiopia	Jimma University; Jimma University; Jimma University	Baye, MF (corresponding author), Jimma Univ, Sch Biomed Sci, Dept Biochem, Jimma, Ethiopia.	minale.fekadie@ju.edu.et		Baye, Minale Fekadie/0000-0002-9338-9953				Abossie A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-166; Afrisham, 2017, INT J INFECT, V4; Agency CS, 2014, CSA ADDIS ABABA; Alemu A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-189; Alemu G, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3330-3; Amare Mengistu, 2007, Ethiopian Journal of Health Development, V21, P12; Andualem MA., 2014, J PUBL HLTH RES, V2, P248, DOI DOI 10.12691/AJPHR-2-6-6; Ayalew A., 2011, PREVALENCE RISK FACT, V3, P75; Bahmani P, 2017, IRAN J PARASITOL, V12, P108; Bekele F, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0226-6; Beyene G, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-10; Chala B., 2013, EPIDEMIOL OPEN ACCES, V3, P2161, DOI DOI 10.4172/2161-1165.1000119; Daniel WW, 1999, BIOSTATISTICS FDN AN, V7th; Dejene TJEJoHS, 2008, N ETHIOPIA, V18; Derso A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1859-6; Endris M., 2010, PREVALENCE INTESTINA, V3, P25; Faria CP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005445; Gelaw A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-304; Ghiwot Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109793; Girum Tadesse, 2005, Ethiopian Journal of Health Development, V19, P140; Hailegebriel T, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2466-x; Jejaw Ayalew, 2014, BMC Res Notes, V7, P502, DOI 10.1186/1756-0500-7-502; Kang G, 1998, TROP MED INT HEALTH, V3, P70, DOI 10.1046/j.1365-3156.1998.00175.x; Khanal L K, 2011, Nepal Med Coll J, V13, P272; Lakew A., 2015, ASIAN PAC J TROP DIS, V5, pS85; Mengistu A., 2007, PREVALENCE INTESTIAN, V21, P12; Merid Y., 2001, S ETHIOPIA, V15; Mirisho R, 2015, INTESTINAL HELMINTHS; Mulatu G, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0081-x; Nyantekyi Liza, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS152, DOI 10.12980/APJTB.4.2014C764; Omrani VF, 2015, INFECTION, V43, DOI 10.1007/s15010-015-0778-6; Organization WH, 1997, WORLD HLTH REPORT CO; Organization WH, 1992, BAS LAB METH MED PAR; Quihui L, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-225; Reji P., 2011, ETHIOPIA, V3; Sitotaw B, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3971-x; STEPHENSON LS, 1990, T ROY SOC TROP MED H, V84, P277, DOI 10.1016/0035-9203(90)90286-N; Tadesse G., 2013, J TROP DIS, V1, P2; Wegayehu T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-151; Yimam YT, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.334.4206	40	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247063	10.1371/journal.pone.0247063	http://dx.doi.org/10.1371/journal.pone.0247063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617545	Green Published, gold			2022-12-26	WOS:000623082400014
J	Zahran, AM; El-Badawy, O; Ali, WA; Mahran, ZG; Mahran, EEMO; Rayan, A				Zahran, Asmaa M.; El-Badawy, Omnia; Ali, Wageeh A.; Mahran, Zainab Gaber; Mahran, Essam Eldeen M. O.; Rayan, Amal			Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer	PLOS ONE			English	Article							MICROVESICLES	Background and aim The study aimed to determine whether the MPs levels and platelet activation are affected by the COVID-19 infection in both malignant and non-malignant patients compared to healthy individuals and define their contribution to the COVID-19 associated coagulopathy and the relation of these MPs to other hematologic parameters. Patients and methods We recruited 23 malignant patients with reverse transcription polymerase chain reaction (RT-PCR) positive COVID-19, also, 19 COVID-19 non-malignant patients, and 20 healthy volunteers were also enrolled for comparison. Blood samples were collected from patients and healthy donors into 5 mL vacutainer tube containing 3.5% buffered sodium citrate solution for measurement of total microparticles (TMPs), platelet microparticles (PMPs), endothelial microparticles (EMPs), CD62 activated platelets, and CD41 platelet marker. Results COVID-19 malignant patients had significantly lower hemoglobin and platelets compared to COVID non-malignant ones, while they had significantly higher C-reactive protein, LDH, AST, Albunim, creatinine, and prognostic index (PI) compared to COVID-19 non-malignant patients. significant accumulations of TMPs, PMPs, EMPs, and activated platelets in COVID-19 affected patients compared to healthy controls. TMPs, and EMPs were significantly accumulated in COVID-19 malignant compared to COVID-19 non-malignant patients with no significant difference in PMPs between both. Conclusion Circulating MPs and activated platelets may be promising novel prognostic biomarkers capable of identifying potentially severe COVID-19 patients who require immediate care especially in cancer patients.	[Zahran, Asmaa M.] Assiut Univ, South Egypt Canc Inst, Dept Clin Pathol, Assiut, Egypt; [El-Badawy, Omnia] Assiut Univ, Dept Med Microbiol & Immunol, Fac Med, Assiut, Egypt; [Ali, Wageeh A.] Assiut Univ, Diagnost & Intervent Radiol Dept, Fac Med, Assiut, Egypt; [Mahran, Zainab Gaber; Mahran, Essam Eldeen M. O.] Assiut Univ, Dept Trop Med & Gastroenterol, Fac Med, Assiut, Egypt; [Rayan, Amal] Assiut Univ, Clin Oncol Dept, Fac Med, Assiut, Egypt	Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University	Rayan, A (corresponding author), Assiut Univ, Clin Oncol Dept, Fac Med, Assiut, Egypt.	amal3774rayan@gmail.com		Rayan, Amal/0000-0001-5995-9177				Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; [Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; Ardoin SP, 2007, SCAND J IMMUNOL, V66, P159, DOI 10.1111/j.1365-3083.2007.01984.x; Bernheim Adam, 2020, Radiology, V295, P200463, DOI 10.1148/radiol.2020200463; Brodsky SV, 2008, J GASTROINTEST LIVER, V17, P261; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Falanga A, 2012, THROMB RES, V129, pS132, DOI 10.1016/S0049-3848(12)70033-6; Horstman LL, 1999, CRIT REV ONCOL HEMAT, V30, P111, DOI 10.1016/S1040-8428(98)00044-4; Hussein MNA, 2003, J THROMB HAEMOST, V1, P2434; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Janowska-Wieczorek A, 2006, TRANSFUSION, V46, P1199, DOI 10.1111/j.1537-2995.2006.00871.x; Jenne CN, 2013, INT J LAB HEMATOL, V35, P254, DOI 10.1111/ijlh.12084; Mackman N, 2012, J CLIN INVEST, V122, P2331, DOI 10.1172/JCI60229; Mitra A, 2020, AM J HEMATOL, V95, P999, DOI 10.1002/ajh.25793; National Cancer I, 2010, COMMON TERMINOLOGY C; Nomura S, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-014-0066-z; Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Reynes G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069034; Salem S, 2020, GLOB MID EAST, P1, DOI [10.2214/AJR.20.23034, 10.1017/9781108868969, 10.2214/AJR.20.23034S.]; Sultan OM, 2020, EGYPT J RADIOL NUC M, V51, DOI 10.1186/s43055-020-00223-0; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Tang NLS, 2005, CLIN CHEM, V51, P2333, DOI 10.1373/clinchem.2005.054460; Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841; Thomas MR, 2015, THROMB HAEMOSTASIS, V114, P449, DOI 10.1160/TH14-12-1067; Toyokawa Takahiro, 2018, Oncotarget, V9, P29351, DOI 10.18632/oncotarget.25486; Wang CC, 2017, ONCOTARGET, V8, P75952, DOI 10.18632/oncotarget.18372; Wang CC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/173401; Wong JEL, 2020, JAMA-J AM MED ASSOC, V323, P1243, DOI 10.1001/jama.2020.2467; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Ye Z, 2020, EUR RADIOL, V30, P4381, DOI 10.1007/s00330-020-06801-0; Yuan M., 2020, PLOS ONE, V15, pE0230548, DOI [10.1371/journal.pone.0230548, DOI 10.1371/JOURNAL.PONE.0230548]; Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575; Zubairova LD, 2015, SCI REP-UK, V5, DOI 10.1038/srep17611; Zwicker JI, 2009, CLIN CANCER RES, V15, P6830, DOI 10.1158/1078-0432.CCR-09-0371	38	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0246806	10.1371/journal.pone.0246806	http://dx.doi.org/10.1371/journal.pone.0246806			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617530	gold, Green Published			2022-12-26	WOS:000623082400016
J	Jalal, SD				Jalal, Sana Dlawar			The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories	PLOS ONE			English	Article								Flow cytometry immunophenotyping has an essential role in distinguishing chronic lymphocytic leukemia from other B-chronic lymphoproliferative disorders. Recently, CD200 is considered as a relatively consistent marker in chronic lymphocytic leukemia. We retrospectively assessed CD200 expression in 252 patients with B chronic lymphoproliferative disorders with four-color flow cytometry. CD200 expression estimation included the proportion of positive cells (>= 30%) and the mean fluorescence intensity ratio. Additionally, we have incorporated CD200 into Matutes score, also replaced FMC7 and CD79b in an attempt to improve the score discriminative power. Of 252 patients enrolled, 199(79%) patients were classified as chronic lymphocytic leukemia and 53 (21%) as other B-chronic lymphoproliferative disorders. All chronic lymphocytic leukemia cases and 20 of 53 (37.7%) of other B-chronic lymphoproliferative disorders demonstrated high CD200 expression (>= 30%). Further, CD200 (>= 30%) revealed a higher accuracy in comparison to other markers in Matutes score (range: 51%-92.5%). Also, CD200 addition to the Matutes score has correctly recognized all 199 chronic lymphocytic leukemia cases including 10 atypical chronic lymphocytic leukemia cases. As for non-CLL cases, 20 of 53 attained a higher score, yet keeping the original diagnosis. Moreover, CD200 enhanced the diagnostic accuracy of Matutes score to 100%, and when included in a simplified 4-markers score, showed an accuracy of 99.8% compared to 99.4% of Matutes score. In conclusion, CD200 is an accurate diagnostic marker for chronic lymphocytic leukemia, and can refine the modified Matutes score accuracy when added with other markers.	[Jalal, Sana Dlawar] Univ Sulaimani, Coll Med, Dept Pathol, Sulaimani, Iraq	University of Sulimanyah	Jalal, SD (corresponding author), Univ Sulaimani, Coll Med, Dept Pathol, Sulaimani, Iraq.	dr.sanajalal612@gmail.com		Jalal, Sana/0000-0002-6025-9802				Afacan-Ozturk HB, 2019, CLIN LAB, V65, P313, DOI 10.7754/Clin.Lab.2018.180802; ANDERSON KC, 1984, BLOOD, V63, P1424, DOI 10.1182/blood.V63.6.1424.1424; Autore F, 2018, HAEMATOLOGICA, V103, P931, DOI 10.3324/haematol.2017.186684; Burger JA, 2020, NEW ENGL J MED, V383, P460, DOI 10.1056/NEJMra1908213; Challagundla P, 2014, AM J CLIN PATHOL, V142, P837, DOI 10.1309/AJCPBV9ELXC0ECVL; D'Arena G, 2018, HEMATOL ONCOL, V36, P543, DOI 10.1002/hon.2510; De Propris MS, 2020, BRIT J HAEMATOL, V190, pe346, DOI 10.1111/bjh.16910; Debord C, 2018, HEMATOL ONCOL, V36, P607, DOI 10.1002/hon.2511; Dorfman DM, 2010, AM J CLIN PATHOL, V134, P726, DOI 10.1309/AJCP38XRRUGSQOVC; Elsaid AF, 2019, WORLD ACAD SCI J, V1, P136; Fan L, 2015, LEUKEMIA LYMPHOMA, V56, P3329, DOI 10.3109/10428194.2015.1030642; Gill KZ, 2020, J HEMATOP, V13, P25, DOI 10.1007/s12308-020-00384-x; Hallek M, 2018, BLOOD, V131, P2745, DOI 10.1182/blood-2017-09-806398; Hoffmann J, 2020, CYTOM PART B-CLIN CY, V98, P476, DOI 10.1002/cyto.b.21936; Lesesve JF, 2015, INT J LAB HEMATOL, V37, P486, DOI 10.1111/ijlh.12315; MATUTES E, 1994, LEUKEMIA, V8, P1640; Mongeau-Marceau Z, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.5572.5572; Mora A, 2019, CYTOM PART B-CLIN CY, V96, P143, DOI 10.1002/cyto.b.21722; Moreau EJ, 1997, AM J CLIN PATHOL, V108, P378; Palumbo GA, 2009, LEUKEMIA RES, V33, P1212, DOI 10.1016/j.leukres.2009.01.017; Rahman K, 2017, INT J LAB HEMATOL, V39, P384, DOI 10.1111/ijlh.12637; Sandes AF, 2014, CYTOM PART B-CLIN CY, V86, P98, DOI 10.1002/cyto.b.21128; Sorigue M, 2020, CYTOM PART B-CLIN CY, V98, P441, DOI 10.1002/cyto.b.21849; Sorigue M, 2018, CYTOM PART B-CLIN CY, V94, P136, DOI 10.1002/cyto.b.21509; Spacek M, 2014, BLOOD, V124; Starostka D, 2018, CYTOM PART B-CLIN CY, V94, P576, DOI 10.1002/cyto.b.21607; Sun Y, 2018, CYTOM PART B-CLIN CY, V94, P148, DOI 10.1002/cyto.b.21512; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Ting YS, 2018, INT J LAB HEMATOL, V40, P533, DOI 10.1111/ijlh.12857; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; Wright GJ, 2001, IMMUNOLOGY, V102, P173, DOI 10.1046/j.1365-2567.2001.01163.x	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247491	10.1371/journal.pone.0247491	http://dx.doi.org/10.1371/journal.pone.0247491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606850	gold, Green Published			2022-12-26	WOS:000620629200174
J	Khosla, R; Rain, M; Sharma, S; Anand, A				Khosla, Radhika; Rain, Manjari; Sharma, Suresh; Anand, Akshay			Amyotrophic Lateral Sclerosis (ALS) prediction model derived from plasma and CSF biomarkers	PLOS ONE			English	Article								Amyotrophic Lateral Sclerosis (ALS) is a degenerative disorder of motor neurons which leads to complete loss of movement in patients. The only FDA approved drug Riluzole provides only symptomatic relief to patients. Early Diagnosis of the disease warrants the importance of diagnostic and prognostic models for predicting disease and disease progression respectively. In the present study we represent the predictive statistical model for ALS using plasma and CSF biomarkers. Forward stepwise (Binary likelihood) Logistic regression model is developed for prediction of ALS. The model has been shown to have excellent validity (94%) with good sensitivity (98%) and specificity (93%). The area under the ROC curve is 99.3%. Along with age and BMI, VEGF (Vascular Endothelial Growth Factor), VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) and TDP43 (TAR DNA Binding Protein 43) in CSF and VEGFR2 and OPTN (Optineurin) in plasma are good predictors of ALS.	[Khosla, Radhika; Rain, Manjari; Anand, Akshay] Post Grad Inst Med Educ & Res, Dept Neurol, Neurosci Res Lab, Chandigarh, India; [Sharma, Suresh] Panjab Univ, Dept Stat, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Panjab University	Anand, A (corresponding author), Post Grad Inst Med Educ & Res, Dept Neurol, Neurosci Res Lab, Chandigarh, India.	akshay1anand@rediffmail.com		Anand, Akshay/0000-0001-9003-3532	Indian Council of Medical Research (ICMR) [5/4-5/122Neuro/2013-NCD-I]	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	The funding for the study was provided to AA with grant number (sanction letter no. No.5/4-5/122Neuro/2013-NCD-I by Indian Council of Medical Research (ICMR). https://main.icmr.nic.in/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2015, AMYOTROPH LAT SCL FR, V16, P1, DOI 10.3109/21678421.2014.964258; Akizuki M, 2013, J NEUROCHEM, V126, P699, DOI 10.1111/jnc.12326; Anand A, 2012, EUR J NEUROL, V19, P788, DOI 10.1111/j.1468-1331.2011.03548.x; Anand A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/635831; Anand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049905; Borras-Blasco J, 1998, REV NEUROLOGIA, V27, P1021, DOI 10.33588/rn.27160.98127; Brockington A, 2006, J NEUROPATH EXP NEUR, V65, P26, DOI 10.1097/01.jnen.0000196134.51217.74; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Corcia P, 2008, AMYOTROPH LATERAL SC, V9, P59, DOI 10.1080/17482960701656940; Crivello M, 2018, NEUROPHARMACOLOGY, V133, P503, DOI 10.1016/j.neuropharm.2018.02.022; Gupta PK, 2012, J NEUROL SCI, V312, P68, DOI 10.1016/j.jns.2011.08.021; Gupta PK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-114; Henkel JS, 2006, MOL CELL NEUROSCI, V31, P427, DOI 10.1016/j.mcn.2005.10.016; Khosla R, 2020, MUSCLE NERVE, V62, P528, DOI 10.1002/mus.27026; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Magnus T, 2002, MUSCLE NERVE, V25, P709, DOI 10.1002/mus.10090; Manjaly ZR, 2010, AMYOTROPH LATERAL SC, V11, P439, DOI 10.3109/17482961003610853; Modgil S, 2020, J NEUROSCI RURAL PRA, V11, P573, DOI 10.1055/s-0040-1714314; Nagata T, 2007, NEUROL RES, V29, P772, DOI 10.1179/016164107X229795; Ong ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174925; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Pollari E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00131; Povysheva T, 2017, J NEUROSURG-SPINE, V27, P105, DOI 10.3171/2016.9.SPINE15959; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Sharma NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070193; Sharma NK, 2013, GENE, V523, P106, DOI 10.1016/j.gene.2013.03.052; Sharma NK, 2012, CURR NEUROVASC RES, V9, P256; Sharma NK, 2012, DNA CELL BIOL, V31, P1618, DOI 10.1089/dna.2012.1786; Su XWW, 2013, JAMA NEUROL, V70, P1505, DOI 10.1001/jamaneurol.2013.4646; Talbott EO, 2016, HAND CLINIC, V138, P225, DOI 10.1016/B978-0-12-802973-2.00013-6; Taylor AA, 2016, ANN CLIN TRANSL NEUR, V3, P866, DOI 10.1002/acn3.348; Vijayalakshmi K, 2015, MOL NEUROBIOL, V51, P995, DOI 10.1007/s12035-014-8757-y; Westeneng HJ, 2018, LANCET NEUROL, V17, P423, DOI 10.1016/S1474-4422(18)30089-9; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247025	10.1371/journal.pone.0247025	http://dx.doi.org/10.1371/journal.pone.0247025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606761	gold, Green Published			2022-12-26	WOS:000620629200103
J	Wan, YF; Wang, Y; Shi, ZQ; Rentsch, D; Ward, JL; Hassall, K; Sparks, CA; Huttly, AK; Buchner, P; Powers, S; Shewry, PR; Hawkesford, MJ				Wan, Yongfang; Wang, Yan; Shi, Zhiqiang; Rentsch, Doris; Ward, Jane L.; Hassall, Kirsty; Sparks, Caroline A.; Huttly, Alison K.; Buchner, Peter; Powers, Stephen; Shewry, Peter R.; Hawkesford, Malcolm J.			Wheat amino acid transporters highly expressed in grain cells regulate amino acid accumulation in grain	PLOS ONE			English	Article							GENOME-WIDE SURVEY; PHOTOSYNTHATE TRANSFER; CELLULAR PATHWAY; STRUCTURAL-ANALYSIS; ENDOSPERM; STORAGE; PHLOEM; DEPOSITION; ALEURONE; PERMEASE	Amino acids are delivered into developing wheat grains to support the accumulation of storage proteins in the starchy endosperm, and transporters play important roles in regulating this process. RNA-seq, RT-qPCR, and promoter-GUS assays showed that three amino acid transporters are differentially expressed in the endosperm transfer cells (TaAAP2), starchy endosperm cells (TaAAP13), and aleurone cells and embryo of the developing grain (TaAAP21), respectively. Yeast complementation revealed that all three transporters can transport a broad spectrum of amino acids. RNAi-mediated suppression of TaAAP13 expression in the starchy endosperm did not reduce the total nitrogen content of the whole grain, but significantly altered the composition and distribution of metabolites in the starchy endosperm, with increasing concentrations of some amino acids (notably glutamine and glycine) from the outer to inner starchy endosperm cells compared with wild type. Overexpression of TaAAP13 under the endosperm-specific HMW-GS (high molecular weight glutenin subunit) promoter significantly increased grain size, grain nitrogen concentration, and thousand grain weight, indicating that the sink strength for nitrogen transport was increased by manipulation of amino acid transporters. However, the total grain number was reduced, suggesting that source nitrogen remobilized from leaves is a limiting factor for productivity. Therefore, simultaneously increasing loading of amino acids into the phloem and delivery to the spike would be required to increase protein content while maintaining grain yield.	[Wan, Yongfang; Wang, Yan; Shi, Zhiqiang; Ward, Jane L.; Sparks, Caroline A.; Huttly, Alison K.; Buchner, Peter; Shewry, Peter R.; Hawkesford, Malcolm J.] Rothamsted Res, Plant Sci Dept, Harpenden, Herts, England; [Wang, Yan] Sichuan Agr Univ, Triticeae Inst, Yaan, Sichuan, Peoples R China; [Shi, Zhiqiang] Nanjing Agr Univ, Natl Technol Innovat Ctr Reg Wheat Prod, Key Lab Crop Physiol & Ecol & Prod Southern China, Minist Agr,Natl Engn & Technol Ctr Informat Agr, Nanjing, Peoples R China; [Rentsch, Doris] Univ Bern, Mol Plant Physiol, Bern, Switzerland; [Hassall, Kirsty; Powers, Stephen] Rothamsted Res, Computat & Analyt Sci Dept, Harpenden, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Sichuan Agricultural University; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; University of Bern; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Hawkesford, MJ (corresponding author), Rothamsted Res, Plant Sci Dept, Harpenden, Herts, England.	malcolm.hawkesford@rothamsted.ac.uk	Buchner, Peter/AAS-9377-2021; Hassall, Kirsty/AAD-3222-2019; Hawkesford, Malcolm/AAE-1522-2022	Buchner, Peter/0000-0002-3567-5572; Hassall, Kirsty/0000-0003-0033-1136; wan, Yongfang/0000-0002-9374-5014; Rentsch, Doris/0000-0003-4313-7683; Hawkesford, Malcolm/0000-0001-8759-3969	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/P016855/1]; BBSRC [BBS/E/C/000I0220] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives grantaided support from the Biotechnology and Biological Sciences Research Council (BBSRC) for the Designing Future Wheat strategic program (BB/P016855/1). Funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JM, 2006, PLANT BIOTECHNOL J, V4, P381, DOI 10.1111/j.1467-7652.2006.00197.x; Barron C, 2007, J CEREAL SCI, V45, P88, DOI 10.1016/j.jcs.2006.07.004; Besnard J, 2018, J EXP BOT, V69, P5221, DOI 10.1093/jxb/ery302; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Curtis TY, 2018, FOOD CHEM, V239, P304, DOI 10.1016/j.foodchem.2017.06.113; de Jong A, 2000, J EXP BOT, V51, P1663, DOI 10.1093/jexbot/51.351.1663; Denance N, 2010, PLANT SIGNAL BEHAV, V5, P1302, DOI 10.4161/psb.5.10.13103; Dinkeloo K, 2018, SEMIN CELL DEV BIOL, V74, P105, DOI 10.1016/j.semcdb.2017.07.010; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Fischer WN, 2002, PLANT J, V29, P717, DOI 10.1046/j.1365-313X.2002.01248.x; FISCHER WN, 1995, J BIOL CHEM, V270, P16315, DOI 10.1074/jbc.270.27.16315; FISHER DB, 1986, PLANT PHYSIOL, V82, P1019, DOI 10.1104/pp.82.4.1019; Geisler-Lee J, 2005, PLANT PHYSIOL, V139, P204, DOI 10.1104/pp.105.064295; Gillies SA, 2012, PLANT BIOTECHNOL J, V10, P668, DOI 10.1111/j.1467-7652.2012.00705.x; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; Howarth JR, 2008, J EXP BOT, V59, P3675, DOI 10.1093/jxb/ern218; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; JAUNIAUX JC, 1987, EUR J BIOCHEM, V164, P601, DOI 10.1111/j.1432-1033.1987.tb11169.x; Ji YY, 2020, J EXP BOT, V71, P4763, DOI 10.1093/jxb/eraa256; Koch W, 2003, PLANT J, V33, P211, DOI 10.1046/j.1365-313X.2003.01618.x; Ladwig F, 2012, PLANT PHYSIOL, V158, P1643, DOI 10.1104/pp.111.192583; Lee YH, 2004, PLANT J, V40, P60, DOI 10.1111/j.1365-313X.2004.02186.x; Lohaus G, 2002, ADV PHOTO RESPIRAT, V12, P239; Lu K, 2018, PLANT BIOTECHNOL J, V16, P1710, DOI 10.1111/pbi.12907; Ma HL, 2016, PLANT PHYSIOL BIOCH, V107, P164, DOI 10.1016/j.plaphy.2016.06.007; Muller B, 2015, CURR BIOL, V25, P3126, DOI 10.1016/j.cub.2015.10.038; NEGBI M, 1984, BOT J LINN SOC, V88, P205, DOI 10.1111/j.1095-8339.1984.tb01571.x; Okumoto S, 2004, J EXP BOT, V55, P2155, DOI 10.1093/jxb/erh233; Okumoto S, 2002, J BIOL CHEM, V277, P45338, DOI 10.1074/jbc.M207730200; Palmer LJ, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-27; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Peng B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5847; Perchlik M, 2017, PLANT PHYSIOL, V175, P235, DOI 10.1104/pp.17.00608; Pfeifer M, 2014, SCIENCE, V345, DOI 10.1126/science.1250091; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rentsch D, 2007, FEBS LETT, V581, P2281, DOI 10.1016/j.febslet.2007.04.013; RIENS B, 1991, PLANT PHYSIOL, V97, P227, DOI 10.1104/pp.97.1.227; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Rolletschek H, 2005, PLANT PHYSIOL, V137, P1236, DOI 10.1104/pp.104.056523; Sanders A, 2009, PLANT J, V59, P540, DOI 10.1111/j.1365-313X.2009.03890.x; Santiago JP, 2016, PLANT PHYSIOL, V171, P508, DOI 10.1104/pp.16.00244; Schmidt R, 2007, PLANTA, V226, P805, DOI 10.1007/s00425-007-0527-x; Shewry PR, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600807; Shewry PR, 2012, J CEREAL SCI, V56, P21, DOI 10.1016/j.jcs.2011.11.007; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Shi ZQ, 2019, J AGR FOOD CHEM, V67, P8706, DOI 10.1021/acs.jafc.9b02728; Snowden CJ, 2015, PLANT J, V81, P651, DOI 10.1111/tpj.12766; Sparks CA, 2014, METHODS MOL BIOL, V1099, P201, DOI 10.1007/978-1-62703-715-0_17; Tegeder M, 2012, CURR OPIN PLANT BIOL, V15, P315, DOI 10.1016/j.pbi.2012.02.001; Tegeder M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00021; Tosi P, 2011, ANN BOT-LONDON, V108, P23, DOI 10.1093/aob/mcr098; UGALDE TD, 1990, AUST J PLANT PHYSIOL, V17, P377, DOI 10.1071/PP9900377; Van Herpen TWJM, 2008, ANN BOT-LONDON, V102, P331, DOI 10.1093/aob/mcn114; Wan YF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04473-3; Wan YF, 2014, ANN BOT-LONDON, V113, P607, DOI 10.1093/aob/mct291; Wan YF, 2013, J EXP BOT, V64, P161, DOI 10.1093/jxb/ers318; Wan YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-121; WANG HL, 1995, PLANT CELL ENVIRON, V18, P373, DOI 10.1111/j.1365-3040.1995.tb00373.x; WANG HL, 1995, PLANT CELL ENVIRON, V18, P389, DOI 10.1111/j.1365-3040.1995.tb00374.x; WANG HL, 1994, PROTOPLASMA, V182, P39, DOI 10.1007/BF01403687; WANG HL, 1994, PLANT CELL ENVIRON, V17, P257, DOI 10.1111/j.1365-3040.1994.tb00291.x; Wang J, 2019, PLANT PHYSIOL, V180, P1031, DOI 10.1104/pp.19.00034; WANG L, 2015, PLANT PHYSIOL, DOI DOI 10.1104/PP.15.01170; Weichert N, 2010, PLANT PHYSIOL, V152, P698, DOI 10.1104/pp.109.150854; Wu M, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0908-4; Xiong F, 2013, MOL BIOL REP, V40, P6785, DOI 10.1007/s11033-013-2795-9; Zhang LZ, 2015, PLANT J, V81, P134, DOI 10.1111/tpj.12716; Zhang LZ, 2010, PLANT CELL, V22, P3603, DOI 10.1105/tpc.110.073833; Zhao HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049210; Zheng YK, 2011, PLANT CELL REP, V30, P1281, DOI 10.1007/s00299-011-1039-5	71	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246763	10.1371/journal.pone.0246763	http://dx.doi.org/10.1371/journal.pone.0246763			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606697	Green Submitted, gold, Green Published			2022-12-26	WOS:000620629200079
J	Chen, L; Zhang, YA; Shu, X; Chen, Q; Wei, TT; Wang, HM; Wang, XR; Wu, QR; Zhang, XM; Liu, XY; Zheng, SY; Huang, L; Xiao, JY; Jiang, C; Yang, B; Wang, ZP; Guo, X				Chen, Lu; Zhang, Yanan; Shu, Xin; Chen, Qiong; Wei, Tiantian; Wang, Heman; Wang, Xiaorong; Wu, Qirou; Zhang, Xiaomei; Liu, Xiaoyan; Zheng, Suya; Huang, Lan; Xiao, Junyu; Jiang, Chao; Yang, Bing; Wang, Zhiping; Guo, Xing			Proteasome regulation by reversible tyrosine phosphorylation at the membrane	ONCOGENE			English	Article								Reversible phosphorylation has emerged as an important mechanism for regulating 26S proteasome function in health and disease. Over 100 phospho-tyrosine sites of the human proteasome have been detected, and yet their function and regulation remain poorly understood. Here we show that the 19S subunit Rpt2 is phosphorylated at Tyr439, a strictly conserved residue within the C-terminal HbYX motif of Rpt2 that is essential for 26S proteasome assembly. Unexpectedly, we found that Y439 phosphorylation depends on Rpt2 membrane localization mediated by its N-myristoylation. Multiple receptors tyrosine kinases can trigger Rpt2-Y439 phosphorylation by activating Src, a N-myristoylated tyrosine kinase. Src directly phosphorylates Rpt2-Y439 in vitro and negatively regulates 26S proteasome activity at cellular membranes, which can be reversed by the membrane-associated isoform of protein tyrosine phosphatase nonreceptor type 2 (PTPN2). In H1975 lung cancer cells with activated Src, blocking Rpt2-Y439 phosphorylation by the Y439F mutation conferred partial resistance to the Src inhibitor saracatinib both in vitro and in a mouse xenograft tumor model, and caused significant changes of cellular responses to saracatinib at the proteome level. Our study has defined a novel mechanism involved in the spatial regulation of proteasome function and provided new insights into tyrosine kinase inhibitor-based anticancer therapies.	[Chen, Lu; Zhang, Yanan; Shu, Xin; Chen, Qiong; Wang, Heman; Wu, Qirou; Zhang, Xiaomei; Liu, Xiaoyan; Zheng, Suya; Jiang, Chao; Yang, Bing; Guo, Xing] Zhejiang Univ, Inst Life Sci, Zhejiang Prov Key Lab Canc Mol Cell Biol, Hangzhou, Peoples R China; [Wei, Tiantian; Xiao, Junyu] Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Wang, Xiaorong; Huang, Lan] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Wang, Xiaorong; Huang, Lan] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Wang, Zhiping] Zhejiang Univ, Sch Med, Ctr Neurosci, Hangzhou, Peoples R China; [Wang, Zhiping] Zhejiang Univ, Sch Med, Dept Neurol, NHC & CAMS Key Lab Med Neurobiol,Affiliated Hosp, Hangzhou, Peoples R China	Zhejiang University; Peking University; University of California System; University of California Irvine; University of California System; University of California Irvine; Zhejiang University; Zhejiang University	Guo, X (corresponding author), Zhejiang Univ, Inst Life Sci, Zhejiang Prov Key Lab Canc Mol Cell Biol, Hangzhou, Peoples R China.; Wang, ZP (corresponding author), Zhejiang Univ, Sch Med, Ctr Neurosci, Hangzhou, Peoples R China.; Wang, ZP (corresponding author), Zhejiang Univ, Sch Med, Dept Neurol, NHC & CAMS Key Lab Med Neurobiol,Affiliated Hosp, Hangzhou, Peoples R China.	z4wang@zju.edu.cn; xguo@zju.edu.cn	Liu, XiaoYan/GQA-7216-2022	Xiao, Junyu/0000-0003-1822-1701	Natural Science Foundation of China [31671391, 31870762, 91953103, 31671039]; Zhejiang Natural Science Foundation [LR18C050001]; Fundamental Research Funds for the Central Universities [2016QN81011]; Zhejiang University; National Key Research and Development Plan of the Ministry of Science and Technology of China [2016YF0501000]; NIH [R01GM074830]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang University; National Key Research and Development Plan of the Ministry of Science and Technology of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Xin-Hua Feng, Hai Song, Bin Zhao (Life Sciences Institute, Zhejiang University, LSI-ZJU), Zhong-Yin Zhang (Purdue University), Shigeo Murata (The University of Tokyo), and Susan Lindquist (Massachusetts Institute of Technology) for crucial constructs, cell lines, and reagents. We are grateful for the critical and encouraging comments from Drs. Kun-Liang Guan, Anne-Claude Gingras, Benjamin Neel, Tony Hunter, and Tony Tiganis. We appreciate the technical assistance from Xiaorui Jiang, Fei Zhang, and the Core Facilities of LSI-ZJU. XG was supported by Natural Science Foundation of China (31671391, 31870762), Zhejiang Natural Science Foundation (LR18C050001), Fundamental Research Funds for the Central Universities (2016QN81011), and the startup funding from Zhejiang University. BY was funded by Natural Science Foundation of China (91953103). ZW was supported by Natural Science Foundation of China (31671039) and National Key Research and Development Plan of the Ministry of Science and Technology of China (2016YF0501000). LH was funded by NIH (R01GM074830).	Albert S, 2017, P NATL ACAD SCI USA, V114, P13726, DOI 10.1073/pnas.1716305114; Alevizopoulos K, 2014, CURR DRUG TARGETS, V15, P988, DOI 10.2174/1389450115666140908125025; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Barr AJ, 2010, FUTURE MED CHEM, V2, P1563, DOI [10.4155/fmc.10.241, 10.4155/FMC.10.241]; Bose S, 2001, BIOCHEM J, V353, P291, DOI 10.1042/0264-6021:3530291; Budenholzer L, 2017, J MOL BIOL, V429, P3500, DOI 10.1016/j.jmb.2017.05.027; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Eisele MR, 2018, CELL REP, V24, P1301, DOI 10.1016/j.celrep.2018.07.004; Feng Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00850-0; Finley D, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a033985; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Formisano L, 2015, ONCOTARGET, V6, P26090, DOI 10.18632/oncotarget.4636; Frankson R, 2017, CANCER RES, V77, P5701, DOI 10.1158/0008-5472.CAN-17-1510; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Guo X, 2017, PROTEIN CELL, V8, P255, DOI 10.1007/s13238-017-0382-x; Guo X, 2016, NAT CELL BIOL, V18, P202, DOI 10.1038/ncb3289; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hemmis CW, 2019, J BIOL CHEM, V294, P9659, DOI 10.1074/jbc.AC119.008881; Heun Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184404; Huang XL, 2016, NAT STRUCT MOL BIOL, V23, P778, DOI 10.1038/nsmb.3273; Hunter T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020644; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; Kikuchi J, 2010, PROTEOMICS, V10, P2769, DOI 10.1002/pmic.200900283; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; Kimura A, 2016, J PROTEOMICS, V130, P33, DOI 10.1016/j.jprot.2015.08.021; Kimura A, 2012, BIOCHEMISTRY-US, V51, P8856, DOI 10.1021/bi3007862; Kimura Y, 2003, ARCH BIOCHEM BIOPHYS, V409, P341, DOI 10.1016/S0003-9861(02)00639-2; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; Kumar B, 2010, J BIOL CHEM, V285, P39523, DOI 10.1074/jbc.M110.153627; Kumar P, 2017, J PROTEOME RES, V16, P2789, DOI 10.1021/acs.jproteome.7b00065; Li DP, 2015, CELL REP, V10, P484, DOI 10.1016/j.celrep.2014.12.044; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Liu XY, 2020, P NATL ACAD SCI USA, V117, P328, DOI 10.1073/pnas.1912531117; Liu X, 2006, MOL CELL, V22, P317, DOI 10.1016/j.molcel.2006.04.007; Lokireddy S, 2015, P NATL ACAD SCI USA, V112, pE7176, DOI 10.1073/pnas.1522332112; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Muppirala M, 2013, BBA-MOL CELL RES, V1833, P1125, DOI 10.1016/j.bbamcr.2013.01.004; Murata S, 2018, NAT IMMUNOL, V19, P923, DOI 10.1038/s41590-018-0186-z; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Park S, 2013, NATURE, V497, P512, DOI 10.1038/nature12123; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Ramachandran KV, 2017, NAT STRUCT MOL BIOL, V24, P419, DOI 10.1038/nsmb.3389; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; Satoh K, 2001, BIOCHEMISTRY-US, V40, P314, DOI 10.1021/bi001815n; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Shibahara T, 2002, EUR J BIOCHEM, V269, P1474, DOI 10.1046/j.1432-1033.2002.02792.x; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; St-Denis N, 2016, CELL REP, V17, P2488, DOI 10.1016/j.celrep.2016.10.078; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; TANAKA K, 1990, BIOCHEMISTRY-US, V29, P3777, DOI 10.1021/bi00467a026; Tang M, 2017, THERANOSTICS, V7, P1346, DOI 10.7150/thno.18804; Thinon E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5919; Tibes R, 2005, ANNU REV PHARMACOL, V45, P357, DOI 10.1146/annurev.pharmtox.45.120403.100124; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; VerPlank JJS, 2017, BIOCHEM J, V474, P3355, DOI 10.1042/BCJ20160809; Wang JH, 2015, MOL CELL, V58, P710, DOI 10.1016/j.molcel.2015.05.002; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Wiede F, 2020, EMBO J, V39, DOI 10.15252/embj.2019103637; Ye Diana Zi, 2012, Cell Logist, V2, P105; Ye Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep16599; Zhang S, 2009, J AM CHEM SOC, V131, P13072, DOI 10.1021/ja903733z; Zhang ZY, 2017, ACCOUNTS CHEM RES, V50, P122, DOI 10.1021/acs.accounts.6b00537; Zong C, 2006, CIRC RES, V99, P372, DOI 10.1161/01.RES.0000237389.40000.02	74	3	3	1	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2021	40	11					1942	1956		10.1038/s41388-021-01674-z	http://dx.doi.org/10.1038/s41388-021-01674-z		FEB 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QZ5PE	33603165	Green Submitted, Green Accepted			2022-12-26	WOS:000619433100003
J	Karki, K; Singh, DR; Maharjan, D; Sushmita, KC; Shrestha, S; Thapa, DK				Karki, Kshitij; Singh, Devendra Raj; Maharjan, Dikshya; Sushmita, K. C.; Shrestha, Shreesha; Thapa, Deependra Kaji			Internet addiction and sleep quality among adolescents in a peri-urban setting in Nepal: A cross-sectional school-based survey	PLOS ONE			English	Article							MEDIA USE; ASSOCIATION; DEPRESSION; DURATION; INSOMNIA; STUDENTS; HEALTH; INDEX	Background Excessive use of the internet among adolescents often led to later bedtimes and poor sleep quality. This study assessed the relationship between internet addiction and sleep quality among adolescents in a peri-urban setting in Nepal. Method This cross-sectional study employed a questionnaire survey among 390 adolescent students recruited from two schools in Kirtipur Municipality in Nepal. The Internet Addiction Test and the Pittsburgh Sleep Quality Index were used to assess internet addiction and poor sleep quality respectively. The association between internet addiction and sleep quality was analysed by logistic regression. Results One-fifth (21.5%) of the participants were identified with borderline internet addiction and 13.3% with possible internet addiction. Poor sleep quality was found among 31% of the participants. Internet addiction was significantly associated with poor sleep quality (OR = 1.85, p = 0.022 for borderline, and OR = 3.98, p = <0.001 for possible internet addiction compared to no internet addiction). Conclusion Adolescents with internet addiction were more vulnerable to suffer from poor sleep quality. It is recommended that municipalities and schools should aware the adolescent students on the adverse effects of excessive internet use including poor sleep quality. The findings have implications for adolescents, parents, school authorities and researchers.	[Karki, Kshitij; Singh, Devendra Raj; Maharjan, Dikshya; Shrestha, Shreesha] Purbanchal Univ, Asian Coll Adv Studies, Dept Publ Hlth, Lalitpur, Nepal; [Karki, Kshitij] Grp Tech Assistance Program & Res, Lalitpur, Nepal; [Singh, Devendra Raj] Southeast Asia Dev Act Network SADAN, Innovat Res & Program, Lalitpur, Nepal; [Sushmita, K. C.] Tribhuvan Univ, Fac Humanities & Social Sci, Kathmandu, Nepal; [Thapa, Deependra Kaji] Univ Tasmania, Coll Hlth & Med, Sch Hlth Sci, Sydney, NSW, Australia	Tribhuvan University; University of Tasmania	Karki, K (corresponding author), Purbanchal Univ, Asian Coll Adv Studies, Dept Publ Hlth, Lalitpur, Nepal.; Karki, K (corresponding author), Grp Tech Assistance Program & Res, Lalitpur, Nepal.	kshitijkarki@yahoo.com	Karki, Kshitij/ABE-7737-2020; Singh, Devendra Raj/R-2197-2019	Singh, Devendra Raj/0000-0003-1450-9476; Karki, Khem/0000-0002-4318-1126; Maharjan, Dikshya/0000-0002-5877-7483; Karki, Kshitij/0000-0002-6039-8909				Abdulrhman Khayat M., 2018, EGYPT J HOSP MED; Arora T, 2013, INT J OBESITY, V37, P1254, DOI 10.1038/ijo.2012.209; Arora T, 2014, SLEEP MED, V15, P240, DOI 10.1016/j.sleep.2013.08.799; Bhandari PM, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1275-5; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Celebioglu A, 2020, J CHILD ADOL PS NURS, V33, P221, DOI 10.1111/jcap.12287; Central Bureau of Statistics, 2020, MULT IND CLUST SURV; Chahal H, 2013, PEDIATR OBES, V8, P42, DOI 10.1111/j.2047-6310.2012.00085.x; Cheung LM, 2011, J SLEEP RES, V20, P311, DOI 10.1111/j.1365-2869.2010.00883.x; Cuschieri S, 2019, SAUDI J ANAESTH, V13, P31, DOI 10.4103/sja.SJA_543_18; Eliacik K, 2016, EAT WEIGHT DISORD-ST, V21, P709, DOI 10.1007/s40519-016-0327-z; Evren C, 2014, PSYCHIAT DANUB; Grohol JM, 2019, QUIZ PSYCH CENTRAL; Hale L, 2015, SLEEP MED REV, V21, P50, DOI 10.1016/j.smrv.2014.07.007; Hysing M, 2013, J SLEEP RES, V22, P549, DOI 10.1111/jsr.12055; ITU, 2019, MEASURING DIGITAL DE; Kim SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191713; Kocas F, 2018, TURK J PUBLIC HLTH; Kuss DJ, 2016, WORLD J PSYCHIATR, V6, P143, DOI 10.5498/wjp.v6.i1.143; Lam LT, 2009, INJURY PREV, V15, P403, DOI 10.1136/ip.2009.021949; Lam LT, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0444-1; Lin PH, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00599; Mohamed G, 2020, INT J ADOLESC YOUTH, V25, P479, DOI 10.1080/02673843.2019.1674165; Nagori N, 2019, INT J RES MED SCI, V7, P2703, DOI 10.18203/2320-6012.ijrms20192903; Nepal Telecommunication Authority, 2019, 12 ANN REPORT 2019; Ostovar S, 2016, INT J MENT HEALTH AD, V14, P257, DOI 10.1007/s11469-015-9628-0; Pan PY, 2018, J PEDIATR-US, V197, P262, DOI 10.1016/j.jpeds.2018.01.046; Prabhakaran M C Anusha, 2016, J Family Med Prim Care, V5, P765, DOI 10.4103/2249-4863.201149; Prashanthi B., 2017, IOSR J HUMANIT SOC S, V22, P1; Regmi N, 2017, ELECTR J INF SYS DEV, V82; Sami H, 2018, PSYCHIAT RES, V267, P327, DOI 10.1016/j.psychres.2018.03.067; Shin M-K., 2015, SCI ENG RES SUPPORT, P248, DOI [10.14257/astl.2015.103.53, DOI 10.14257/ASTL.2015.103.53]; Singh A, 2018, INT J ED MANAG STUD, V8; Tateno M, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00455; Tavernier R, 2014, J SLEEP RES, V23, P389, DOI 10.1111/jsr.12132; Tokiya M, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02275-7; Ustinaviciene R, 2016, MEDICINA-LITHUANIA, V52, P199, DOI 10.1016/j.medici.2016.04.002; Wang YQ, 2020, PSYCHIAT INVEST, V17, P237, DOI 10.30773/pi.2019.0131; Wolniczak I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059087; Woods HC, 2016, J ADOLESCENCE, V51, P41, DOI 10.1016/j.adolescence.2016.05.008; Younes F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161126	41	3	3	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0246940	10.1371/journal.pone.0246940	http://dx.doi.org/10.1371/journal.pone.0246940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8JB	33600410	Green Published, Green Accepted, gold			2022-12-26	WOS:000620625100028
J	Lounis, C; Peysakhovich, V; Causse, M				Lounis, Christophe; Peysakhovich, Vsevolod; Causse, Mickael			Visual scanning strategies in the cockpit are modulated by pilots' expertise: A flight simulator study	PLOS ONE			English	Article							SITUATION AWARENESS; GAZE BEHAVIOR; EYE-TRACKING; ATTENTION DISTRIBUTION; PERFORMANCE; COMPLEXITY; PATTERNS; TASK; CLASSIFICATION; MOVEMENTS	During a flight, pilots must rigorously monitor their flight instruments since it is one of the critical activities that contribute to update their situation awareness. The monitoring is cognitively demanding, but is necessary for timely intervention in the event of a parameter deviation. Many studies have shown that a large part of commercial aviation accidents involved poor cockpit monitoring from the crew. Research in eye-tracking has developed numerous metrics to examine visual strategies in fields such as art viewing, sports, chess, reading, aviation, and space. In this article, we propose to use both basic and advanced eye metrics to study visual information acquisition, gaze dispersion, and gaze patterning among novices and pilots. The experiment involved a group of sixteen certified professional pilots and a group of sixteen novice during a manual landing task scenario performed in a flight simulator. The two groups landed three times with different levels of difficulty (manipulated via a double task paradigm). Compared to novices, professional pilots had a higher perceptual efficiency (more numerous and shorter dwells), a better distribution of attention, an ambient mode of visual attention, and more complex and elaborate visual scanning patterns. We classified pilot's profiles (novices-experts) by machine learning based on Cosine KNN (K-Nearest Neighbors) using transition matrices. Several eye metrics were also sensitive to the landing difficulty. Our results can benefit the aviation domain by helping to assess the monitoring performance of the crews, improve initial and recurrent training and ultimately reduce incidents, and accidents due to human error.	[Lounis, Christophe; Peysakhovich, Vsevolod; Causse, Mickael] Univ Toulouse, ISAE SUPAERO, Toulouse, France	Universite de Toulouse; Institut Superieur de l'Aeronautique et de l'Espace (ISAE-SUPAERO)	Lounis, C (corresponding author), Univ Toulouse, ISAE SUPAERO, Toulouse, France.	christophe.lounis@isae-supaero.fr	Peysakhovich, Vsevolod/I-8077-2019	Peysakhovich, Vsevolod/0000-0002-9791-4460; Lounis, Christophe/0000-0002-5804-6170	Dassault Aviation (\CASAC")	Dassault Aviation (\CASAC")	This research was supported by a chair grant from Dassault Aviation (\CASAC", holder: MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboy M, 2006, IEEE T BIO-MED ENG, V53, P2282, DOI 10.1109/TBME.2006.883696; Allsop J, 2014, J APPL RES MEM COGN, V3, P63, DOI 10.1016/j.jarmac.2014.04.010; Bellenkes AH, 1997, AVIAT SPACE ENVIR MD, V68, P569; Brams S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207439; British European Airways (BEA), 2013, STUD AER STAT AW GO; Causse M., 2016, ROLE PILOTS MONITORI; Causse M., 2020, 1 INT WORKSH EYE TRA; Charness N, 2001, MEM COGNITION, V29, P1146, DOI 10.3758/BF03206384; Combrisson E, 2015, J NEUROSCI METH, V250, P126, DOI 10.1016/j.jneumeth.2015.01.010; Curby KM, 2009, J EXP PSYCHOL HUMAN, V35, P94, DOI 10.1037/0096-1523.35.1.94; Di Nocera F, 2007, J COGN ENG DECIS MAK, V1, P271, DOI 10.1518/155534307X255627; Diaz-Piedra C, 2019, APPL ERGON, V77, P92, DOI 10.1016/j.apergo.2019.01.012; Dubois E, 2015, SMART INNOV SYST TEC, V39, P125, DOI 10.1007/978-3-319-19857-6_12; Endsley MR, 1997, IEEE SYS MAN CYBERN, P4177, DOI 10.1109/ICSMC.1997.637352; Ephrath A. R., 1980, Proceedings of the Human Factors Society 24th Annual Meeting, P257; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Federal Aviation Administration (FAA), 2013, 14 CFR 121, V78; Federal Aviation Administration (FAA), 2015, SAF AL OP NO 15011 R; Fitts P. M., 1949, 5837 USAD WRIGHT PAT; Flight Safety Foundation,, 2014, ACT PIL MON WORK GRO; Follet B, 2011, I-PERCEPTION, V2, P592, DOI 10.1068/i0414; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gegenfurtner A, 2011, EDUC PSYCHOL REV, V23, P523, DOI 10.1007/s10648-011-9174-7; Glaholt M. G, 2014, EYE TRACKING COCKPIT; Goldberg J. H., 2002, Proceedings ETRA 2002. Eye Tracking Research and Applications Symposium, P51, DOI 10.1145/507072.507082; Goldberg JH, 1999, INT J IND ERGONOM, V24, P631, DOI 10.1016/S0169-8141(98)00068-7; Haider H, 1999, J EXP PSYCHOL LEARN, V25, P172, DOI 10.1037/0278-7393.25.1.172; Haslbeck A, 2017, APPL ERGON, V63, P62, DOI 10.1016/j.apergo.2017.03.015; Haslbeck A, 2013, ADV HUM FACT ERG SER, P561; Hayashi M, 2005, IEEE SYS MAN CYBERN, P1615; Hayashi M., 2004, THESIS MIT; Heitz RP, 2007, J EXP PSYCHOL GEN, V136, P217, DOI 10.1037/0096-3445.136.2.217; Holmqvist K., 2011, EYE TRACKING COMPREH; Jarvis SR, 2017, AEROSP MED HUM PERF, V88, P1100, DOI 10.3357/AMHP.4882.2017; Jones D. H, 1985, NASA CONTRACTOR REPO; Jones R. E., 1949, 5975 US AIR FORC; Kang ZH, 2014, HUM FACTORS, V56, P1150, DOI 10.1177/0018720814523066; Krejtz K, 2017, J EYE MOVEMENT RES, V10, DOI 10.16910/jemr.10.2.3; Krejtz K, 2016, ACM T APPL PERCEPT, V13, DOI 10.1145/2896452; Krejtz K, 2015, ACM T APPL PERCEPT, V13, DOI 10.1145/2834121; Kundel HL, 2007, RADIOLOGY, V242, P396, DOI 10.1148/radiol.2422051997; Lai ML, 2013, EDUC RES REV-NETH, V10, P90, DOI 10.1016/j.edurev.2013.10.001; Lorenz B., 2006, HUMAN FACTORS AEROSP; Lounis C, 2018, P 2018 ACM S EYE TRA, P1; Lounis C. A, 2020, ACM S EYE TRACK RES, P1; Lounis C, 2020, ADV INTELL SYST COMP, V964, P739, DOI 10.1007/978-3-030-20503-4_66; Melsted P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-333; Milton J. L., 1949, AIR MATERIEL COMMAND; National Transportation Safety Board (NTSB), 1994, REV FLIGHTCR INV MAJ; Nibbeling N, 2012, PSYCHOL SPORT EXERC, V13, P427, DOI 10.1016/j.psychsport.2012.02.002; Norris J. R., 1998, MARKOV CHAINS; Ognjanovic S, 2019, APPL ERGON, V80, P168, DOI 10.1016/j.apergo.2019.05.008; Peissl S, 2018, INT J AEROSP PSYCHOL, V28, P98, DOI 10.1080/24721840.2018.1514978; Peysakhovich V, 2020, 1 INT WORKSH EYE TRA; Peysakhovich V, 2018, SAFETY, V4, DOI 10.3390/safety4010008; Reani M, 2018, 2018 ACM SYMPOSIUM ON EYE TRACKING RESEARCH & APPLICATIONS (ETRA 2018), DOI 10.1145/3204493.3204527; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; Reingold EM, 2011, OXFORD HDB EYE MOVEM, P528, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0029; Robinski M, 2013, J EYE MOVEMENT RES, V6; Schwerd Simon, 2020, Engineering Psychology and Cognitive Ergonomics. Cognition and Design. 17th International Conference, EPCE 2020 Held as Part of the 22nd HCI International Conference, HCII 2020. Proceedings. Lecture Notes in Artificial Intelligence. Subseries of Lecture Notes in Computer Science (LNAI 12187), P412, DOI 10.1007/978-3-030-49183-3_32; SENDERS JW, 1966, IEEE TRANS HUM FACT, VHFE7, P103, DOI 10.1109/THFE.1966.232330; Shannon C. E., 1949, MATH THEORY COMMUNIC; SHAPIRO KL, 1989, ACTA PSYCHOL, V71, P217, DOI 10.1016/0001-6918(89)90010-3; Shiferaw B, 2019, NEUROSCI BIOBEHAV R, V96, P353, DOI 10.1016/j.neubiorev.2018.12.007; Suthaharan S, 2016, INTEGR SER INFORM SY, V36, P1, DOI 10.1007/978-1-4899-7641-3; Svensson E, 1997, ERGONOMICS, V40, P362, DOI 10.1080/001401397188206; Tole J. R., 1983, VISUAL SCANNING BEHA; van de Merwe K, 2012, INT J AVIAT PSYCHOL, V22, P78, DOI 10.1080/10508414.2012.635129; Vickers JN, 2012, HUM MOVEMENT SCI, V31, P101, DOI 10.1016/j.humov.2011.04.004; Wei HY, 2013, CHINESE J AERONAUT, V26, P884, DOI 10.1016/j.cja.2013.04.053; Wen-Chin Li, 2013, Engineering Psychology and Cognitive Ergonomics. Applications and Services. 10th International Conference, EPCE 2013. Held as Part of HCI International 2013. Proceedings: LNCS 8020, P167, DOI 10.1007/978-3-642-39354-9_19; Wickens C., 2001, P 11 INT S AV PSYCH, V6, P325; Wickens CD, 2009, INT J AVIAT PSYCHOL, V19, P182, DOI 10.1080/10508410902766549; Williams AM, 2002, J MOTOR BEHAV, V34, P197, DOI 10.1080/00222890209601941; Xiong W, 2016, LECT NOTES ARTIF INT, V9736, P485, DOI 10.1007/978-3-319-40030-3_47; Yang JH, 2013, AVIAT SPACE ENVIR MD, V84, P116, DOI 10.3357/ASEM.3372.2013; Yu CS, 2016, AEROSP MED HUM PERF, V87, P40, DOI 10.3357/AMHP.4209.2016; Yu CS, 2014, AVIAT SPACE ENVIR MD, V85, P708, DOI 10.3357/ASEM.3847.2014; Ziv G, 2017, INT J AVIAT PSYCHOL, V26, P75, DOI 10.1080/10508414.2017.1313096	79	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247061	10.1371/journal.pone.0247061	http://dx.doi.org/10.1371/journal.pone.0247061			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8JB	33600487	gold, Green Published			2022-12-26	WOS:000620625100015
J	Ohta, Y				Ohta, Yoichi			Effect of bilateral contraction on the ability and accuracy of rapid force production at submaximal force level	PLOS ONE			English	Article							UNILATERAL CONTRACTIONS; LEG PRESS; DEFICIT; DRIVE; HAND	The present study aims to clarify the effects of bilateral contraction on the ability and accuracy of rapid force production at the submaximal force level. Eleven right-handed participants performed rapid gripping as fast and precisely as they could in unilateral (UL) and bilateral (BL) contractions in a standing position. Participants were required to impinge a grip force of 30% and 50% of their maximal voluntary contraction (MVC). Ability and accuracy of rapid force production were evaluated using the rate of force development (RFD) and force error, respectively. The data analysis did not observe a significant difference in the RFD between UL and BL contractions in both 30% (420 +/- 86 vs. 413 +/- 106%MVC/s, p = 0.34) and 50% of MVC (622 +/- 84 vs. 619 +/- 103%MVC/s, p = 0.77). Although the RFD to peak force ratio (RFD/PF) in BL contraction was lower than in UL in 30% of MVC (12.8 +/- 2.8 vs. 13.4 +/- 2.7, p = 0.003), it indicated a small effect size (d = 0.22) of the difference between UL and BL in RFD/PF. The absolute force error of BL contraction was higher than of UL contraction in 30% (4.67 +/- 2.64 vs. 3.64 +/- 1.13%MVC, p = 0.005) and 50% of MVC (5.53 +/- 2.94 vs. 3.53 +/- 0.71%MVC, p = 0.009). In addition, medium and large effect sizes were observed in absolute force error from 30% (d = 0.51) and 50% of MVC (d = 0.94), respectively. In conclusion, results indicated that the bilateral contraction reduced in the ability and accuracy of rapid force production at the submaximal force level. Nevertheless, the present results suggest that the noticeable effect of bilateral contraction is more prominent on the accuracy than in the ability of rapid force production at the submaximal force level.	[Ohta, Yoichi] Shizuoka Univ Welf, Fac Social Welf, Dept Hlth & Welf, Yaizu, Japan	Shizuoka University	Ohta, Y (corresponding author), Shizuoka Univ Welf, Fac Social Welf, Dept Hlth & Welf, Yaizu, Japan.	t_uzura76@live.jp		Ohta, Yoichi/0000-0002-8351-3017	JSPS KAKENHI [17K13161]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported JSPS KAKENHI Grant Number 17K13161. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckthorpe MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057549; Carr JC, 2021, EUR J SPORT SCI, V21, P836, DOI 10.1080/17461391.2020.1800104; Cengiz A, 2015, J PHYS THER SCI, V27, P631, DOI 10.1589/jpts.27.631; Cortina JM., 2000, EFFECT SIZE ANOVA DE; GORDON J, 1987, EXP BRAIN RES, V67, P241, DOI 10.1007/BF00248546; Jakobi JM, 2001, CAN J APPL PHYSIOL, V26, P12, DOI 10.1139/h01-002; Jakobi JM, 1998, J APPL PHYSIOL, V84, P200, DOI 10.1152/jappl.1998.84.1.200; KNUDSON DV, 1989, INT J SPORT BIOMECH, V5, P324, DOI 10.1123/ijsb.5.3.324; Kolev NV., 2015, J BIOMEDICAL CLIN RE, V8, P13; La Monica MB., 2017, J COMBAT SPORTS MART, V2, P101; Levernier G, 2021, SPORT BIOMECH, V20, P495, DOI 10.1080/14763141.2019.1584236; Li F-X., 2002, INTERCEPTIVE ACTIONS, P301; MacDonald M, 2014, APPL PHYSIOL NUTR ME, V39, P1245, DOI 10.1139/apnm-2014-0040; Magnus CRA, 2008, APPL PHYSIOL NUTR ME, V33, P1132, DOI 10.1139/H08-101; Oda S, 1996, EUR J APPL PHYSIOL O, V74, P8, DOI 10.1007/BF00376488; Ohta Y, 2017, J SPORT SCI, V35, P2304, DOI 10.1080/02640414.2016.1266017; OHTSUKI T, 1981, ERGONOMICS, V24, P37, DOI 10.1080/00140138108924828; Sahaly R, 2001, EUR J APPL PHYSIOL, V85, P345, DOI 10.1007/s004210100451; Simoneau-Buessinger E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145077; Skarabot J, 2016, EUR J APPL PHYSIOL, V116, P2057, DOI 10.1007/s00421-016-3458-z; Stretch R., 1995, S AFRICAN J RES SPOR, V18, P83; Takebayashi H., 2004, TOSA REHABILITATION, P1; Taniguchi Y, 1997, EUR J APPL PHYSIOL O, V75, P144, DOI 10.1007/s004210050139; Van Dieen JH, 2003, MED SCI SPORT EXER, V35, P111, DOI 10.1097/00005768-200301000-00018; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Yamaguchi A, 2020, J MOTOR BEHAV, V52, P226, DOI 10.1080/00222895.2019.1609408; Ye X, 2019, HUM MOVEMENT SCI, V64, P329, DOI 10.1016/j.humov.2019.02.017	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247099	10.1371/journal.pone.0247099	http://dx.doi.org/10.1371/journal.pone.0247099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600476	Green Published, gold			2022-12-26	WOS:000620625100050
J	Gemmer, MR; Richter, C; Schmutzer, T; Raorane, ML; Junker, B; Pillen, K; Maurer, A				Gemmer, Mathias Ruben; Richter, Chris; Schmutzer, Thomas; Raorane, Manish L.; Junker, Bjoern; Pillen, Klaus; Maurer, Andreas			Genome-wide association study on metabolite accumulation in a wild barley NAM population reveals natural variation in sugar metabolism	PLOS ONE			English	Article								Metabolites play a key role in plants as they are routing plant developmental processes and are involved in biotic and abiotic stress responses. Their analysis can offer important information on the underlying processes. Regarding plant breeding, metabolite concentrations can be used as biomarkers instead of or in addition to genetic markers to predict important phenotypic traits (metabolic prediction). In this study, we applied a genome-wide association study (GWAS) in a wild barley nested association mapping (NAM) population to identify metabolic quantitative trait loci (mQTL). A set of approximately 130 metabolites, measured at early and late sampling dates, was analysed. For four metabolites from the early and six metabolites from the late sampling date significant mQTL (grouped as 19 mQTL for the early and 25 mQTL for the late sampling date) were found. Interestingly, all of those metabolites could be classified as sugars. Sugars are known to be involved in signalling, plant growth and plant development. Sugar-related genes, encoding mainly sugar transporters, have been identified as candidate genes for most of the mQTL. Moreover, several of them co-localized with known flowering time genes like Ppd-H1, HvELF3, Vrn-H1, Vrn-H2 and Vrn-H3, hinting on the known role of sugars in flowering. Furthermore, numerous disease resistance-related genes were detected, pointing to the signalling function of sugars in plant resistance. An mQTL on chromosome 1H in the region of 13 Mbp to 20 Mbp stood out, that alone explained up to 65% of the phenotypic variation of a single metabolite. Analysis of family-specific effects within the diverse NAM population showed the available natural genetic variation regarding sugar metabolites due to different wild alleles. The study represents a step towards a better understanding of the genetic components of metabolite accumulation, especially sugars, thereby linking them to biological functions in barley.	[Gemmer, Mathias Ruben; Schmutzer, Thomas; Pillen, Klaus; Maurer, Andreas] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Chair Plant Breeding, Halle, Germany; [Richter, Chris; Raorane, Manish L.; Junker, Bjoern] Martin Luther Univ Halle Wittenberg, Inst Pharm, Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Maurer, A (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Chair Plant Breeding, Halle, Germany.	andreas.maurer@landw.uni-halle.de	Pillen, Klaus/I-6511-2012	Pillen, Klaus/0000-0003-4646-6351; Richter, Chris/0000-0001-8615-0322; Schmutzer, Thomas/0000-0003-1073-6719; Maurer, Andreas/0000-0002-2916-7475	European Fund for Regional Development (EFRE) within the research focus "Molecular Biosciences as a Motor of Knowledge-Based Economics"	European Fund for Regional Development (EFRE) within the research focus "Molecular Biosciences as a Motor of Knowledge-Based Economics"	This work was funded by the European Fund for Regional Development (EFRE, https://ec.europa.eu/regional_policy/en/funding/erdf/) within the research focus "Molecular Biosciences as a Motor of Knowledge-Based Economics" (awarded to KP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqudah AM, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00117; Arend D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-214; Bayer MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01792; Bolouri Moghaddam MR, 2012, J EXP BOT, V63, P3989, DOI 10.1093/jxb/ers129; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brilisauer K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08476-8; Cantalapiedra CP, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0253-1; Carrola J, 2011, J PROTEOME RES, V10, P221, DOI 10.1021/pr100899x; Chamarthi SK, 2014, EUR J PLANT PATHOL, V138, P67, DOI 10.1007/s10658-013-0302-8; Chan EKF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001198; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chen W, 2014, NAT GENET, V46, P714, DOI 10.1038/ng.3007; Covarrubias-Pazaran G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156744; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Cui LQ, 2010, J APPL PHYCOL, V22, P563, DOI 10.1007/s10811-009-9494-x; Dan ZW, 2016, SCI REP-UK, V6, DOI 10.1038/srep21732; Dixon RA, 2003, PHYTOCHEMISTRY, V62, P815, DOI 10.1016/S0031-9422(02)00712-4; Eom JS, 2015, CURR OPIN PLANT BIOL, V25, P53, DOI 10.1016/j.pbi.2015.04.005; Evers JB, 2015, PLANT CELL ENVIRON, V38, P1455, DOI 10.1111/pce.12519; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Friendly M, 2002, AM STAT, V56, P316, DOI 10.1198/000313002533; Gemmer MR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234052; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Gomez-Casati DF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/792527; Grauvogel C, 2007, MOL BIOL EVOL, V24, P1611, DOI 10.1093/molbev/msm075; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Herbers K, 1996, PLANT CELL, V8, P793, DOI 10.1105/tpc.8.5.793; Hong J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060767; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; Joseph B, 2013, ELIFE, V2, DOI 10.7554/eLife.00776; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Kondrak M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-74; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Lastdrager J, 2014, J EXP BOT, V65, P799, DOI 10.1093/jxb/ert474; Luo J, 2015, CURR OPIN PLANT BIOL, V24, P31, DOI 10.1016/j.pbi.2015.01.006; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Matros A, 2017, J EXP BOT, V68, P415, DOI 10.1093/jxb/erw441; Maurer A, 2017, HEREDITY, V118, P477, DOI 10.1038/hdy.2016.121; Maurer A., 2019, 50K ILLUMINA INFINIU; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; Per TS, 2017, PLANT PHYSIOL BIOCH, V115, P126, DOI 10.1016/j.plaphy.2017.03.018; Piasecka A, 2017, PLANT J, V89, P898, DOI 10.1111/tpj.13430; R Core Team, 2020, R LANG ENV STAT COMP; Revelle W., 2018, USE PSYCH PACKAGE FA; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; Statista, ANB WICHT GETR WELTW; Steinfath M, 2010, PLANT BIOTECHNOL J, V8, P900, DOI 10.1111/j.1467-7652.2010.00516.x; STONE JM, 1995, PLANT PHYSIOL, V108, P451, DOI 10.1104/pp.108.2.451; Templer SE, 2017, J EXP BOT, V68, P1697, DOI 10.1093/jxb/erx038; Wen WW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4438; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams LE, 2000, TRENDS PLANT SCI, V5, P283, DOI 10.1016/S1360-1385(00)01681-2; Wingler A, 2012, PLANT PHYSIOL, V158, P1241, DOI 10.1104/pp.111.191908; Xu SZ, 2016, PLANT J, V88, P219, DOI 10.1111/tpj.13242; Yang J, 2017, NAT GENET, V49, P1304, DOI 10.1038/ng.3941	61	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246510	10.1371/journal.pone.0246510	http://dx.doi.org/10.1371/journal.pone.0246510			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592061	Green Published, gold			2022-12-26	WOS:000620632800034
J	Lazartigues, L; Mathy, F; Lavigne, F				Lazartigues, Laura; Mathy, Fabien; Lavigne, Frederic			Statistical learning of unbalanced exclusive-or temporal sequences in humans	PLOS ONE			English	Article							TRANSITIONAL PROBABILITY; CONDITIONAL-PROBABILITY; PREFRONTAL CORTEX; SPEECH STREAM; IMPLICIT; FREQUENCY; DYNAMICS; ADJACENT; LANGUAGE; ACCOUNT	A pervasive issue in statistical learning has been to determine the parameters of regularity extraction. Our hypothesis was that the extraction of transitional probabilities can prevail over frequency if the task involves prediction. Participants were exposed to four repeated sequences of three stimuli (XYZ) with each stimulus corresponding to the position of a red dot on a touch screen that participants were required to touch sequentially. The temporal and spatial structure of the positions corresponded to a serial version of the exclusive-or (XOR) that allowed testing of the respective effect of frequency and first- and second-order transitional probabilities. The XOR allowed the first-order transitional probability to vary while being not completely related to frequency and to vary while the second-order transitional probability was fixed (p(Z|X, Y) = 1). The findings show that first-order transitional probability prevails over frequency to predict the second stimulus from the first and that it also influences the prediction of the third item despite the presence of second-order transitional probability that could have offered a certain prediction of the third item. These results are particularly informative in light of statistical learning models.	[Lazartigues, Laura; Mathy, Fabien; Lavigne, Frederic] Univ Cote dAzur, Dept Psychol, BCL, CNRS, Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Lazartigues, L (corresponding author), Univ Cote dAzur, Dept Psychol, BCL, CNRS, Nice, France.	laura.lazartigues@univ-cotedazur.fr		Lazartigues, Laura/0000-0002-5361-647X	French government, through the UCAJEDI Investments in the Future project by the National Research Agency (ANR) [ANR-15-IDEX-01]; National Research Agency (ANR) [ANR-17-CE28-0013-01]	French government, through the UCAJEDI Investments in the Future project by the National Research Agency (ANR)(French National Research Agency (ANR)); National Research Agency (ANR)(French National Research Agency (ANR))	This work has been supported by the French government, through the UCAJEDI Investments in the Future project managed by the National Research Agency (ANR) with the reference number ANR-15-IDEX-01, awarded to Frederic Lavigne, and by a grant from National Research Agency (ANR) with the reference number ANR-17-CE28-0013-01 awarded to Fabien Mathy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Aslin RN, 2017, WIRES COGN SCI, V8, DOI 10.1002/wcs.1373; Aslin RN, 1998, PSYCHOL SCI, V9, P321, DOI 10.1111/1467-9280.00063; Batterink LJ, 2015, J MEM LANG, V83, P62, DOI 10.1016/j.jml.2015.04.004; Bourjaily MA, 2012, J NEUROPHYSIOL, V108, P513, DOI 10.1152/jn.00806.2011; Bourjaily MA, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00037; Bourjaily MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001091; BOWER GH, 1979, COGNITIVE PSYCHOL, V11, P177, DOI 10.1016/0010-0285(79)90009-4; Brunel N, 2009, J COGNITIVE NEUROSCI, V21, P2300, DOI 10.1162/jocn.2008.21156; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Conway CM, 2005, J EXP PSYCHOL LEARN, V31, P24, DOI 10.1037/0278-7393.31.1.24; De Houwer J, 2007, SPAN J PSYCHOL, V10, P230, DOI 10.1017/S1138741600006491; De Houwer J, 2013, PSYCHON B REV, V20, P631, DOI 10.3758/s13423-013-0386-3; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Endress AD, 2017, COGNITIVE PSYCHOL, V92, P37, DOI 10.1016/j.cogpsych.2016.11.004; Endress AD, 2009, J MEM LANG, V60, P351, DOI 10.1016/j.jml.2008.10.003; Ersoz EK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231165; Fiser J, 2005, J EXP PSYCHOL GEN, V134, P521, DOI 10.1037/0096-3445.134.4.521; Fiser J, 2002, J EXP PSYCHOL LEARN, V28, P458, DOI 10.1037//0278-7393.28.3.458; Gaillard V, 2009, EUR J COGN PSYCHOL, V21, P255, DOI 10.1080/09541440802257423; Gebhart AL, 2009, PSYCHON B REV, V16, P486, DOI 10.3758/PBR.16.3.486; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; Hochmann JR, 2010, COGNITION, V115, P444, DOI 10.1016/j.cognition.2010.03.006; Janacsek K, 2012, DEVELOPMENTAL SCI, V15, P496, DOI 10.1111/j.1467-7687.2012.01150.x; Kabdebon C, 2015, BRAIN LANG, V148, P25, DOI 10.1016/j.bandl.2015.03.005; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; Lavigne F, 2016, COGN NEURODYNAMICS, V10, P513, DOI 10.1007/s11571-016-9410-4; Lavigne F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00842; Lavigne F, 2013, ADV COGN PSYCHOL, V9, P1, DOI 10.2478/v10053-008-0126-9; Lavigne F, 2012, COGN NEURODYNAMICS, V6, P467, DOI 10.1007/s11571-012-9206-0; Lavigne F, 2011, J COGNITIVE NEUROSCI, V23, P1447, DOI 10.1162/jocn.2010.21504; Maljkovic V, 2005, VISION RES, V45, P2831, DOI 10.1016/j.visres.2005.05.019; Marcovitch S, 2009, DEVELOPMENTAL SCI, V12, P1020, DOI 10.1111/j.1467-7687.2009.00838.x; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Minier L, 2016, COGNITIVE SCI, V40, P1019, DOI 10.1111/cogs.12279; Mirman D, 2010, INFANCY, V15, P471, DOI 10.1111/j.1532-7078.2009.00023.x; Mongillo G, 2003, EUR J NEUROSCI, V18, P2011, DOI 10.1046/j.1460-9568.2003.02908.x; Muhammad R, 2006, J COGNITIVE NEUROSCI, V18, P974, DOI 10.1162/jocn.2006.18.6.974; Ngon C, 2013, DEVELOPMENTAL SCI, V16, P24, DOI 10.1111/j.1467-7687.2012.01189.x; Ostojic S, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00032; Pacton S, 2008, J EXP PSYCHOL LEARN, V34, P80, DOI 10.1037/0278-7393.34.1.80; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Pelucchi B, 2009, COGNITION, V113, P244, DOI 10.1016/j.cognition.2009.07.011; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; Perruchet P, 2012, J MEM LANG, V66, P807, DOI 10.1016/j.jml.2012.02.010; R Core Team, 2020, R LANG ENV STAT COMP; Remillard G, 2008, Q J EXP PSYCHOL, V61, P400, DOI 10.1080/17470210701210999; Rey A., 2018, TOP COGN SCI; Rigotti M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00024; Rigotti M, 2010, NEUROIMAGE, V52, P833, DOI 10.1016/j.neuroimage.2010.01.047; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 2003, INFANCY, V4, P273, DOI 10.1207/S15327078IN0402_07; Saffran JR, 2003, DEV PSYCHOL, V39, P484, DOI 10.1037/0012-1649.39.3.484; Smith JD, 2011, J EXP PSYCHOL-ANIM B, V37, P20, DOI 10.1037/a0019497; Smith LB, 2018, TRENDS COGN SCI, V22, P325, DOI 10.1016/j.tics.2018.02.004; Soltani A, 2010, NAT NEUROSCI, V13, P112, DOI 10.1038/nn.2450; Thiessen ED, 2013, PSYCHOL BULL, V139, P792, DOI 10.1037/a0030801; Thompson SP, 2007, LANG LEARN DEV, V3, P1, DOI 10.1080/15475440709336999; Toro JM, 2005, PERCEPT PSYCHOPHYS, V67, P867, DOI 10.3758/BF03193539; Toro JM, 2005, J EXP PSYCHOL-ANIM B, V31, P95, DOI 10.1037/0097-7403.31.1.95; Wanrooij K, 2015, FRONT PSYCHOL, V6, DOI [10.3389/fpsyg.2015.01341, 10.3389/fpg.21115.111341]	64	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246826	10.1371/journal.pone.0246826	http://dx.doi.org/10.1371/journal.pone.0246826			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8MA	33592012	gold, Green Published			2022-12-26	WOS:000620632800015
J	Budhiraja, R; Kumar, M; Das, MK; Bafila, AS; Singh, S				Budhiraja, Rajat; Kumar, Manish; Das, Mrinal K.; Bafila, Anil Singh; Singh, Sanjeev			A reservoir computing approach for forecasting and regenerating both dynamical and time-delay controlled financial system behavior	PLOS ONE			English	Article							BIFURCATION TOPOLOGICAL-STRUCTURE; GLOBAL COMPLICATED CHARACTER; CHAOS; KIND	Significant research in reservoir computing over the past two decades has revived interest in recurrent neural networks. Owing to its ingrained capability of performing high-speed and low-cost computations this has become a panacea for multi-variate complex systems having non-linearity within their relationships. Modelling economic and financial trends has always been a challenging task owing to their volatile nature and no linear dependence on associated influencers. Prior studies aimed at effectively forecasting such financial systems, but, always left a visible room for optimization in terms of cost, speed and modelling complexities. Our work employs a reservoir computing approach complying to echo-state network principles, along with varying strengths of time-delayed feedback to model a complex financial system. The derived model is demonstrated to act robustly towards influence of trends and other fluctuating parameters by effectively forecasting long-term system behavior. Moreover, it also re-generates the financial system unknowns with a high degree of accuracy when only limited future data is available, thereby, becoming a reliable feeder for any long-term decision making or policy formulations.	[Budhiraja, Rajat; Das, Mrinal K.; Bafila, Anil Singh; Singh, Sanjeev] Univ Delhi, Inst Informat & Commun, South Campus, New Delhi, India; [Kumar, Manish] Cent Univ Haryana, Sch Engn & Technol, Dept Comp Sci Engn, Mahendergarh, Haryana, India	University of Delhi; Central University of Haryana	Singh, S (corresponding author), Univ Delhi, Inst Informat & Commun, South Campus, New Delhi, India.	sanjeev@south.du.ac.in		BAFILA, ANIL SINGH/0000-0002-3392-2410; Singh, Sanjeev/0000-0002-2416-7011	Department of Science and Technology, India under DU-DST Purse Phase-II [381/382/2209-2015]	Department of Science and Technology, India under DU-DST Purse Phase-II(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	This research was funded by the Department of Science and Technology, India under DU-DST Purse Phase-II (Grant#381/382/2209-2015; https://dst.gov.in/).This grant was received by SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelo E, 2008, IEEE SYS MAN CYBERN, P1842; Barron D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205818; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bozhkov L, 2016, NEURAL NETWORKS, V78, P112, DOI 10.1016/j.neunet.2015.07.005; Chang H, 2019, ARXIV190509419; Chen D, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0122-0; Chen WC, 2008, CHAOS SOLITON FRACT, V37, P1198, DOI 10.1016/j.chaos.2006.10.016; Dan JP, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/137148; Das MK, 2019, 14 ANN C FOR GLOB KN; DOYA K, 1992, 1992 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-6, P2777, DOI 10.1109/ISCAS.1992.230622; Herbert J, 2001, 148 GMD; HERMANN R, 1977, IEEE T AUTOMAT CONTR, V22, P728, DOI 10.1109/TAC.1977.1101601; HSIEH DA, 1991, J FINANC, V46, P1839, DOI 10.2307/2328575; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaeger Herbert, 2013, TUTORIAL TRAINING RE; Jiang J, 2010, COMPUT MED IMAG GRAP, V34, P617, DOI 10.1016/j.compmedimag.2010.07.003; Li DC, 2012, IEEE T NEUR NET LEAR, V23, P787, DOI 10.1109/TNNLS.2012.2188414; Lin XW, 2009, EXPERT SYST APPL, V36, P7313, DOI 10.1016/j.eswa.2008.09.049; Lu ZX, 2017, CHAOS, V27, DOI 10.1063/1.4979665; Lukosevicius M, 2012, LECT NOTES COMPUTER; Lukosevicius M, 2012, KUNSTL INTELL, V26, P365, DOI 10.1007/s13218-012-0204-5; Lukosevicius M, 2009, COMPUT SCI REV, V3, P127, DOI 10.1016/j.cosrev.2009.03.005; Ma JH, 2001, APPL MATH MECH-ENGL, V22, P1240, DOI 10.1023/A:1016313804297; Ma JH, 2001, APPL MATH MECH-ENGL, V22, P1375, DOI 10.1023/A:1022806003937; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Parodi O, 2016, LECT NOTES COMPUTER; Peters E., 1996, CHAOS ORDER CAPITAL; PYRAGAS K, 1995, PHYS LETT A, V206, P323, DOI 10.1016/0375-9601(95)00654-L; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Salmen M, 2005, IEEE INT CONF ROBOT, P1953; Scherer S, 2008, LECT NOTES COMPUTER; Seidens S, 2019, ARXIV190607786V2; Shofer NJ, 2018, RESERVOIR COMPUTING; Skowronski MD, 2007, NEURAL NETWORKS, V20, P414, DOI 10.1016/j.neunet.2007.04.006; Verstraeten D, 2006, IEEE IJCNN, P1050; Xu DM, 2005, IEEE IJCNN, P1483; Yao SC, 2018, COMPUTER, V51, P32, DOI 10.1109/MC.2018.2381131	38	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246737	10.1371/journal.pone.0246737	http://dx.doi.org/10.1371/journal.pone.0246737			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577571	Green Published, gold			2022-12-26	WOS:000620071700004
J	Bugnet, E; Gupta, N; Lorillon, G; Arbabzadeh-Bouchez, S; Lemogne, C; Chevret, S; Tazi, A				Bugnet, Emmanuelle; Gupta, Nishant; Lorillon, Gwenael; Arbabzadeh-Bouchez, Sayena; Lemogne, Cedric; Chevret, Sylvie; Tazi, Abdellatif			Psychological features of adult patients with langerhans cell histiocytosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; HOSPITAL ANXIETY; USE DISORDERS; DEPRESSION; SMOKING; HEALTH; MANAGEMENT; NICOTINE; SCALE; MULTICENTER	Background The prevalence of psychological symptoms and the co-occurrence of substance abuse disorders in adult patients with Langerhans cell histiocytosis (LCH) has not been previously explored. We aimed to use validated scales to evaluate depression and anxiety symptoms experienced by adult LCH patients. Methods In this cross-sectional study, all consecutive adult LCH patients seen at our national reference center between January 2012 and January 2013 were asked to complete the following instruments: the Hospital Anxiety and Depression scale (HADS); Barratt Impulsiveness Scale, Version 10 (BIS-10); and Cannabis Use Disorders Identification Test (CUDIT). Self-reported scores on these scales were used to determine the point prevalence of clinically significant psychological symptoms and substance use disorders in LCH patients. Patient profiles in terms of psychological features were assessed by principal component analysis including the HADS and BIS-10 instruments values, followed by hierarchical clustering. Fisher exact tests and Wilcoxon tests were used to examine the associations between disease-related parameters and high levels of anxiety and impulsivity. Results Seventy-one adult LCH patients, mainly with pulmonary LCH (PLCH), completed the evaluations. Clinically significant anxiety and depression symptoms were reported by 22 (31%) and 4 (6%) subjects, respectively. Impulsivity was detected in 14% (10/71) of the patients. Seventeen percent (12/71) of the patients used cannabis on a regular basis, with 50% of these individuals (6/12) exhibiting scores consistent with cannabis use disorder. Three derived clusters of patients were identified in the principal component analysis; these patient clusters differed in successful weaning from tobacco at the time of evaluation (p = 0.03). In univariate analyses, isolated PLCH and the use of psychotropic treatments were statistically associated with clinically significant anxiety symptoms. Conclusions High levels of anxiety and impulsivity are common in adult patients with LCH. The consequences of these symptoms for the management of LCH patients warrant further evaluation.	[Bugnet, Emmanuelle; Lorillon, Gwenael; Tazi, Abdellatif] Hop St Louis, AP HP, Ctr Natl Reference Histiocytoses, Serv Pneumol, Paris, France; [Gupta, Nishant] Univ Cincinnati, Div Pulm Crit Care & Sleep Med, Cincinnati, OH USA; [Gupta, Nishant] Vet Affairs Med Ctr, Dept Vet Affairs, Cincinnati, OH USA; [Arbabzadeh-Bouchez, Sayena] Hop Fernand Widal, AP HP, Serv Psychiat, Paris, France; [Lemogne, Cedric; Chevret, Sylvie; Tazi, Abdellatif] Univ Paris, F-75006 Paris, France; [Lemogne, Cedric] Hop Europeen Georges Pompidou, AP HP, Serv Psychiat Adulte & Sujet Age, Paris, France; [Chevret, Sylvie] Hop St Louis, AP HP, Serv Biostat & Informat Med, Paris, France; [Chevret, Sylvie; Tazi, Abdellatif] INSERM, Biostat & Clin Epidemiol Res Team ECSTRRA, UMR 1153, CRESS, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Tazi, A (corresponding author), Hop St Louis, AP HP, Ctr Natl Reference Histiocytoses, Serv Pneumol, Paris, France.; Tazi, A (corresponding author), Univ Paris, F-75006 Paris, France.; Tazi, A (corresponding author), INSERM, Biostat & Clin Epidemiol Res Team ECSTRRA, UMR 1153, CRESS, Paris, France.	abdellatif.tazi@aphp.fr						Adamson SJ, 2003, DRUG ALCOHOL REV, V22, P309, DOI 10.1080/0959523031000154454; Allen CE, 2018, NEW ENGL J MED, V379, P856, DOI 10.1056/NEJMra1607548; Anthenelli RM, 2016, LANCET, V387, P2507, DOI 10.1016/S0140-6736(16)30272-0; Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Baker TB, 2016, JAMA-J AM MED ASSOC, V315, P371, DOI 10.1001/jama.2015.19284; Bayle FJ, 2000, CAN J PSYCHIAT, V45, P156, DOI 10.1177/070674370004500206; Bernstrand C, 2001, MED PEDIATR ONCOL, V36, P459, DOI 10.1002/mpo.1110; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Breeman S, 2015, QUAL LIFE RES, V24, P391, DOI 10.1007/s11136-014-0763-z; Buchberger B, 2016, PSYCHONEUROENDOCRINO, V70, P70, DOI 10.1016/j.psyneuen.2016.04.019; Conti AA, 2019, NEUROSCI BIOBEHAV R, V96, P143, DOI 10.1016/j.neubiorev.2018.11.017; Diamond EL, 2019, BLOOD ADV, V3, P934, DOI 10.1182/bloodadvances.2018030502; Elia D, 2015, EUR J INTERN MED, V26, P351, DOI 10.1016/j.ejim.2015.04.001; GAENSLER EA, 1980, ANN THORAC SURG, V30, P411, DOI 10.1016/S0003-4975(10)61291-X; Holas P, 2013, SARCOIDOSIS VASC DIF, V30, P282; Iskrov G, 2016, EUR J HEALTH ECON, V17, P67, DOI 10.1007/s10198-016-0790-5; Jolliffe Ian, 2011, PRINCIPAL COMPONENT; Jouenne F, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01190-2019; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kandel ER, 2014, NEW ENGL J MED, V371, P932, DOI 10.1056/NEJMsa1405092; Kutlu MG, 2015, INT REV NEUROBIOL, V124, P171, DOI 10.1016/bs.irn.2015.08.004; Lau LMS, 2008, PEDIATR BLOOD CANCER, V50, P607, DOI 10.1002/pbc.21322; Le Guen P, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1203-5; Le Pavec J, 2012, CHEST, V142, P1150, DOI 10.1378/chest.11-2490; Liu H, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.132048; Lorillon G, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0070-2017; Luger TM, 2014, ADDICT BEHAV, V39, P1418, DOI 10.1016/j.addbeh.2014.05.011; MARDIA KV, 1970, BIOMETRIKA, V57, P519, DOI 10.1093/biomet/57.3.519; Moeller FG, 2001, J SUBST ABUSE TREAT, V21, P193, DOI 10.1016/S0740-5472(01)00202-1; Mogulkoc N, 1999, CHEST, V115, P1452, DOI 10.1378/chest.115.5.1452; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Nanduri VR, 2006, EUR J CANCER, V42, P2563, DOI 10.1016/j.ejca.2006.05.031; REVELLE W, 1979, MULTIVAR BEHAV RES, V14, P57, DOI 10.1207/s15327906mbr1401_4; Ruglass LM, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0505-5; Schonfeld N, 2012, SARCOIDOSIS VASC DIF, V29, P132; Stead LF, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009670.pub3; Taylor GMJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007078.pub5; Tazi A, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0651-z; Tazi A, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0387-1; Tazi A, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0249-2; Tazi A, 2012, EUR RESPIR J, V40, P905, DOI 10.1183/09031936.00210711; Thomeer M, 2001, ACTA CLIN BELG, V56, P163, DOI 10.1179/acb.2001.026; Vassallo R, 2017, THORAX, V72, P937, DOI 10.1136/thoraxjnl-2017-210125; Vrijmoet-Wiersma CMJ, 2009, PEDIATR BLOOD CANCER, V52, P116, DOI 10.1002/pbc.21740; Weinberger AH, 2012, ADDICTION, V107, P1847, DOI 10.1111/j.1360-0443.2012.03889.x; Whittaker R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006611.pub4; Yohannes AM, 2010, INT J GERIATR PSYCH, V25, P1209, DOI 10.1002/gps.2463; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	49	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246604	10.1371/journal.pone.0246604	http://dx.doi.org/10.1371/journal.pone.0246604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK0KW	33577606	Green Published, gold			2022-12-26	WOS:000620071700049
J	Diress, M; Yeshaw, Y; Bantihun, M; Dagnew, B; Ambelu, A; Seid, MA; Akalu, Y				Diress, Mengistie; Yeshaw, Yigizie; Bantihun, Minychil; Dagnew, Baye; Ambelu, Adugnaw; Seid, Mohammed Abdu; Akalu, Yonas			Refractive error and its associated factors among pregnant women attending antenatal care unit at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; VISUAL IMPAIRMENT; VISION IMPAIRMENT; OCULAR CHANGES; PREVALENCE; BLINDNESS; EYE; POPULATION; MAGNITUDE; ADULTS	Background Refractive error is one of the commonly encountered problems during pregnancy and being the cause of deleterious effects on health. Despite its impacts, there is no evidence on the magnitude and associated factors of refractive error among pregnant women in Ethiopia. This study aimed to determine the prevalence of refractive error and its associated factors among pregnant women attending antenatal care unit at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, 2020. Methods An institution-based cross-sectional study was employed. An ocular examination was performed using Retinoscope and Snellen's illiterate "E" chart. The required data were collected using an interviewer-administered questionnaire which comprised socio-demographic, clinical and pregnancy-related variables. EpiData 3.02 and STATA 14 were used for data entry and analysis respectively. Both bivariable and multivariable binary logistic regression analyses were executed to identify factors associated with refractive error. Variables with a p-value <= 0.05 in the multivariable logistic regression analysis were declared as significantly associated factors with refractive error. Results A total of 401 pregnant women with a median age of 27 (IQR = 24-31) years participated in this study. The overall prevalence of refractive error among the study participants was 35.66% (95% CI: 30.95-40.37). Of the total study participants, ninety-two (22.90%) of them were myopic, forty-five (11.22%) were hyperopic and the rest were antimetropic. Increased maternal age (AOR = 1.31; 95% CI: 1.16-1.48)), increased parity (AOR = 3.17, 95% CI: 1.92-5.25), increased gestational age (AOR = 1.15, 95% CI: 1.08-1.22), and regular use of computers/ watching television (AOR = 6.19, 95% CI: 2.46-15.59) were significantly associated with refractive error. Conclusion The prevalence of refractive error among pregnant women was high where myopia was the most common variety. Advanced maternal age, increased gestational age, increased parity and regular use of computer or watching television were significantly associated with refractive error among pregnant women. Therefore, apart from providing other maternal health services, routine screening and evaluation of pregnant women for refractive error during antenatal care visit is recommended to avoid its negative impacts.	[Diress, Mengistie; Yeshaw, Yigizie; Dagnew, Baye; Ambelu, Adugnaw; Akalu, Yonas] Univ Gondar, Sch Med, Dept Human Physiol, Gondar, Ethiopia; [Yeshaw, Yigizie] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Bantihun, Minychil] Univ Gondar, Sch Med, Dept Optometry, Gondar, Ethiopia; [Seid, Mohammed Abdu] Debre Tabor Univ, Sch Med, Dept Human Physiol, Debre Tabor, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Diress, M (corresponding author), Univ Gondar, Sch Med, Dept Human Physiol, Gondar, Ethiopia.	mengistiediress@gmail.com	Dagnew, Baye/AAL-9572-2020; Dagnew, Baye/AAS-3964-2021; Yeshaw, Yigizie/L-6336-2019	Dagnew, Baye/0000-0002-2397-5930; Dagnew, Baye/0000-0002-2397-5930; Diress, Mengistie/0000-0003-4186-4991; Yeshaw, Yigizie/0000-0003-4587-7925; Abdu Seid, Mohammed/0000-0002-3197-5332				Agrawal N, 2018, NEPAL J OPHTHALMOL, V10, P16, DOI 10.3126/nepjoph.v10i1.21685; Alemayehu AM AM., 2019, WORLD J OPHTHALMOL V, V2, P1; Andualem HB, 2017, CLIN OPTOM, V9, P85, DOI 10.2147/OPTO.S129326; [Anonymous], 2010, World Health Statistics 2010; [Anonymous], 2010, D4318 ASTM; Ari Budi Himawan, 2018, INT C PUBL HLTH, P288; Balasubramanian K, 2017, INT J SCI STUDY, V5, P89, DOI 10.17354/ijss/2017/342; Cappellini MD, 2015, SEMIN HEMATOL, V52, P261, DOI 10.1053/j.seminhematol.2015.07.006; Corbu Catalina., 2013, GINECO EU, V9; Dey A, 2013, KERALA J OPHTHALMOL, V25, P383; DO A., 2017, M J OPHT, V2; Ebeigbe JA, 2012, NIGER J CLIN PRACT, V15, P298, DOI 10.4103/1119-3077.100624; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Gilbert C, 2018, CEYLON MED J, V63, pS33, DOI 10.4038/cmj.v63i5.8740; Gotovac M, 2013, COLLEGIUM ANTROPOL, V37, P189; Guan HY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215827; Hashemi H, 2018, J CURR OPHTHALMOL, V30, P3, DOI 10.1016/j.joco.2017.08.009; Ilhan C., 2018, EC OPHTHALMOLOGY, V9, P308; Irving EL, 2019, J OPTOM, V12, P55, DOI 10.1016/j.optom.2018.02.002; Jee D, 2016, ACTA OPHTHALMOL, V94, pE204, DOI 10.1111/aos.12776; Kaimbo DKW., 2014, SAJ CASE REP, V1, P105; Kalaiselvi B., 2019, INDIAN J CLIN EXPT O, V5, P219; Kalogeropoulos D, 2019, J OBSTET GYNAECOL, V39, P1037, DOI 10.1080/01443615.2019.1584891; Khalaj M., 2010, Journal of Mazandaran University of Medical Sciences, V20, P25; Kim Seung-Hyun, 2015, Korean J Ophthalmol, V29, P53, DOI 10.3341/kjo.2015.29.1.53; Kokab S, 2012, J EVOL MED DENT SCI-, V1, P1223, DOI 10.14260/jemds/199; Krishnaiah S, 2009, CLIN OPHTHALMOL, V3, P17; Kumar KSAB., 2016, INT J MED SCI PUBLIC, V5, P1364; Lee LK, 2007, SEMIN NEUROL, V27, P405, DOI 10.1055/s-2007-991124; Mehdizadehkashi K, 2018, J PREGNANCY, V2018, pCO, DOI 10.1155/2018/5280697; Mountjoy E, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2022; Naidoo K, 2014, BRIT J OPHTHALMOL, V98, P612, DOI 10.1136/bjophthalmol-2013-304081; Nkiru Z Nwachukwu, 2018, J Family Med Prim Care, V7, P1037, DOI 10.4103/jfmpc.jfmpc_335_17; Ofir D, 2015, ARCH GYNECOL OBSTET, V291, P519, DOI 10.1007/s00404-014-3412-4; Parrey MUR, 2019, PAK J MED SCI, V35, P394, DOI 10.12669/pjms.35.2.648; Peltzer K, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070811; Rai BB, 2021, GRAEF ARCH CLIN EXP, V259, P613, DOI 10.1007/s00417-020-04891-6; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Rezai S., 2016, OBSTET GYNECOL INT J, V4; Richdale K, 2016, OPTOMETRY VISION SCI, V93, P3, DOI 10.1097/OPX.0000000000000757; Richdale K, 2013, INVEST OPHTH VIS SCI, V54, P1095, DOI 10.1167/iovs.12-10619; Roos NM, 2012, OBSTET GYNECOL SURV, V67, P242, DOI 10.1097/OGX.0b013e318250a457; Saad A., 2007, Eastern Mediterranean Health Journal, V13, P819; Sabel BA, 2018, EPMA J, V9, P133, DOI 10.1007/s13167-018-0136-8; Samra Khawla Abu, 2013, Oman J Ophthalmol, V6, P87, DOI 10.4103/0974-620X.116626; Sanghavi M, 2014, CIRCULATION, V130, P1003, DOI 10.1161/CIRCULATIONAHA.114.009029; Semanyenzi S., 2015, RWANDA MED J, V72, P8; Sewunet SA, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-95; Shaaban YM, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1263-2; Sharma S, 2006, AUST NZ J OBSTET GYN, V46, P186, DOI 10.1111/j.1479-828X.2006.00569.x; Skalicky SE, 2016, OCULAR VISUAL PHYSL; Stadler Tanja, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.02bc6d927ecee7bbd33532ec8ba6a25f; Stambolian D, 2013, CLIN GENET, V84, P102, DOI 10.1111/cge.12180; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; Tan CSH, 2011, EYE, V25, P1294, DOI 10.1038/eye.2011.144; Toygar O, 2015, TURK J MED SCI, V45, P651, DOI 10.3906/sag-1404-153; Vidusha KSS., 2018, INT J COMMUNITY MED, V5, P1471, DOI 10.18203/2394-6040.ijcmph20181219; Wang M, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1042-0; World Health Organization, 2007, PREV CARD DIS GUID A; Wu FC, 2020, GRAEF ARCH CLIN EXP, V258, P663, DOI 10.1007/s00417-019-04552-3; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Yarbag A, 2015, PAK J MED SCI, V31, P1481, DOI 10.12669/pjms.316.8204; Yemane Berhane, 2007, Ethiopian Journal of Health Development, V21, P204	63	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246174	10.1371/journal.pone.0246174	http://dx.doi.org/10.1371/journal.pone.0246174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577552	Green Published, gold			2022-12-26	WOS:000620071700007
J	Hutajulu, SH; Howdon, D; Taroeno-Hariadi, KW; Hardianti, MS; Purwanto, I; Indrasari, SR; Herdini, C; Hariwiyanto, B; Ghozali, A; Kusumo, H; Dhamiyati, W; Dwidanarti, SR; Tan, IB; Kurnianda, J; Allsop, MJ				Hutajulu, Susanna Hilda; Howdon, Daniel; Taroeno-Hariadi, Kartika Widayati; Hardianti, Mardiah Suci; Purwanto, Ibnu; Indrasari, Sagung Rai; Herdini, Camelia; Hariwiyanto, Bambang; Ghozali, Ahmad; Kusumo, Henry; Dhamiyati, Wigati; Dwidanarti, Sri Retna; Tan, I. Bing; Kurnianda, Johan; Allsop, Matthew John			Survival outcome and prognostic factors of patients with nasopharyngeal cancer in Yogyakarta, Indonesia: A hospital-based retrospective study	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; CARCINOMA PATIENTS; EPIDEMIOLOGY; RADIOTHERAPY	Purpose This study aimed to determine the survival outcome and prognostic factors of patients with nasopharyngeal cancer accessing treatment in Yogyakarta, Indonesia. Methods Data on 759 patients with NPC diagnosed from 2007 to 2016 at Dr Sardjito General Hospital were included. Potential prognostic variables included sociodemographic, clinicopathology and treatment parameters. Multivariable analyses were implemented using semi-parametric Cox proportional hazards modelling and fully parametric survival analysis. Results The median time of observation was 14.39 months. In the whole cohort the median observed survival was 31.08 months. In the univariable analysis, age, education status, insurance type, BMI, ECOG index, stage and treatment strategy had an impact on overall survival (OS) (p values <0.01). Semi-parametric multivariable analyses with stage stratification showed that education status, ECOG index, and treatment modality were independent prognostic factors for OS (p values <0.05). In the fully parametric models age, education status, ECOG index, stage, and treatment modality were independent prognostic factors for OS (p values <0.05). For both multivariable analyses, all treatment strategies were associated with a reduced hazard (semi-parametric models, p values <0.05) and a better OS (parametric models, p values <0.05) compared with no treatment. Furthermore, compared with radiation alone or chemotherapy alone, a combination of chemotherapy and radiation either in a form of concurrent chemoradiotherapy (CCRT), sequential chemotherapy and radiation, or induction chemotherapy followed by CCRT demonstrated a reduced hazard (hazard ratio/HR 0.226, 95% confidence interval/CI 0.089-0.363, and HR 0.390, 95%CI 0.260-0.519) and a better OS (time ratio/TR 3.108, 95%CI 1.274-4.942 and TR 2.531, 95%CI 1.829-3.233) (p values < 0.01). Conclusions Median OS for the cohort was low compared to those reported in both endemic and non-endemic regions. By combining the findings of multivariable analyses, we showed that age, education status, ECOG index, stage and first treatment modality were independent predictors for the OS.	[Hutajulu, Susanna Hilda; Taroeno-Hariadi, Kartika Widayati; Hardianti, Mardiah Suci; Purwanto, Ibnu; Kurnianda, Johan] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Internal Med, Div Hematol & Med Oncol,Dr Sardjito Gen Hosp, Yogyakarta, Indonesia; [Howdon, Daniel; Allsop, Matthew John] Univ Leeds, Fac Med & Hlth, Sch Med, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Indrasari, Sagung Rai; Herdini, Camelia; Hariwiyanto, Bambang; Tan, I. Bing] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Otorhinolaryngol Head & Neck Surg, Dr Sardjito Gen Hosp, Yogyakarta, Indonesia; [Ghozali, Ahmad] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Anat Pathol, Dr Sardjito Gen Hosp, Yogyakarta, Indonesia; [Kusumo, Henry; Dhamiyati, Wigati; Dwidanarti, Sri Retna] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Radiol, Dr Sardjito Gen Hosp, Yogyakarta, Indonesia; [Tan, I. Bing] Maastricht Univ, Dept Otorhinolaryngol Head & Neck Surg, Med Ctr, Maastricht, Netherlands	Gadjah Mada University; University of Leeds; Gadjah Mada University; Gadjah Mada University; Gadjah Mada University; Maastricht University	Hutajulu, SH (corresponding author), Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Internal Med, Div Hematol & Med Oncol,Dr Sardjito Gen Hosp, Yogyakarta, Indonesia.	susanna.hutajulu@ugm.ac.id	Hutajulu, Susanna Hilda/GPP-6026-2022; hardianti, mardiah/GOP-2427-2022; Taroeno-Hariadi, Kartika/AHD-4364-2022; Purwanto, Ibnu/GOV-4298-2022; Kurnianda, Johan/GOV-3648-2022	hardianti, mardiah/0000-0002-5360-6693; Taroeno-Hariadi, Kartika/0000-0002-7791-9010; Allsop, Matthew/0000-0002-7399-0194	Dutch Cancer Society [KWF2012-5423]; Indonesian Society for Hematology and Medical Oncology Yogyakarta Branch; Universitas Gadjah Mada's Publisher and Publication Board [KWF2012-5423]	Dutch Cancer Society(KWF Kankerbestrijding); Indonesian Society for Hematology and Medical Oncology Yogyakarta Branch; Universitas Gadjah Mada's Publisher and Publication Board	IBT received funding from The Dutch Cancer Society (KWF2012-5423). JK received funding from The Indonesian Society for Hematology and Medical Oncology Yogyakarta Branch. SHH received funding from Universitas Gadjah Mada's Publisher and Publication Board. We thank Jaap Middeldorp for having played a crucial role in acquiring the Dutch Cancer Society (KWF2012-5423) fund to enable the work to take place. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102353; Adham M, 2012, CHIN J CANCER, V31, P185, DOI 10.5732/cjc.011.10328; Agustina R, 2019, LANCET, V393, P75, DOI 10.1016/S0140-6736(18)31647-7; Ali H, 2000, ONCOLOGY-NY, V14, P1223; [Anonymous], 2020, WORLD HLTH ORG, DOI DOI 10.1080/09639284.2021.1971095; Bensouda Y, 2011, EUR ANN OTORHINOLARY, V128, P79, DOI 10.1016/j.anorl.2010.10.003; Blanco-Garcia E, 2018, MEDICC REV, V20, P35, DOI 10.37757/MR2018.V20.N4.8; Bozzetti F, 2009, CLIN NUTR, V28, P445, DOI 10.1016/j.clnu.2009.04.011; Braaten T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-178; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Carman J, 2012, REP PRACT ONCOL RADI, V17, P71, DOI 10.1016/j.rpor.2012.01.002; Chan ATC, 2012, ANN ONCOL, V23, P83, DOI 10.1093/annonc/mds266; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073889; Chen J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013483; Chen MY, 2013, CHIN J CANCER, V32, P604, DOI 10.5732/cjc.013.10148; Chen YP, 2019, LANCET, V394, P64, DOI 10.1016/S0140-6736(19)30956-0; Chua MLK, 2016, LANCET, V387, P1012, DOI 10.1016/S0140-6736(15)00055-0; Colevas AD, 2018, J NATL COMPR CANC NE, V16, P479, DOI 10.6004/jnccn.2018.0026; Cooper JS., 2002, AM JOINT COMMITTEE C, V6th ed; Devi BCR, 2004, CANCER EPIDEM BIOMAR, V13, P482; Edge S. B., 2010, AJCC CANC STAGING MA, P7; Fles R, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-81; Gabani P, 2018, CANCER MED-US, V7, P3592, DOI 10.1002/cam4.1626; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kong Moonkyoo, 2018, Asian Pac J Cancer Prev, V19, P1591; Kravdal H, 2014, EUR J PUBLIC HEALTH, V24, P270, DOI 10.1093/eurpub/ckt082; Kwok J, 2010, CANCER-AM CANCER SOC, V116, P476, DOI 10.1002/cncr.24774; Lan XW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160758; Lee AWM, 2014, RADIOTHER ONCOL, V110, P377, DOI 10.1016/j.radonc.2014.02.003; Lee AWM, 2003, INT J CANCER, V103, P680, DOI 10.1002/ijc.10894; Li L, 2019, CANCER MANAG RES, V11, P501, DOI 10.2147/CMAR.S185932; Lin YH, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0443-3; Lin YH, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-0990-5; Liu L, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1092-0; Liu M, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00597; Liu Q, 2013, CHIN J CANCER, V32, P325, DOI 10.5732/cjc.012.10189; Liu WX, 2019, ASIA PAC J CLIN NUTR, V28, P223, DOI 10.6133/apjcn.201906_28(2).0003; Lv JW, 2018, CANCER RES TREAT, V50, P324, DOI 10.4143/crt.2016.544; MOULD RF, 1976, BRIT J CANCER, V34, P180, DOI 10.1038/bjc.1976.141; OuYang PY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002380; Pan XB, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014512; Phua VCE, 2013, ASIAN PAC J CANCER P, V14, P4567, DOI 10.7314/APJCP.2013.14.8.4567; Prasad U, 2000, Med J Malaysia, V55, P230; Prasad U, 2002, INT J RADIAT ONCOL, V53, P648, DOI 10.1016/S0360-3016(02)02765-7; Qiu WZ, 2017, J CANCER RES CLIN, V143, P1563, DOI 10.1007/s00432-017-2401-y; Qiu WZ, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-015-0076-9; Rohlfing ML, 2017, LARYNGOSCOPE, V127, P2784, DOI 10.1002/lary.26713; Ruuskanen M, 2018, ACTA ONCOL, V57, P251, DOI 10.1080/0284186X.2017.1346378; Setakornnukul J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4210-3; SHANMUGARATNAM K, 1993, CANCER-AM CANCER SOC, V71, P2689, DOI 10.1002/1097-0142(19930415)71:8<2689::AID-CNCR2820710843>3.0.CO;2-H; Smailyte G, 2016, ACTA ONCOL, V55, P859, DOI 10.3109/0284186X.2016.1156739; Stoker SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085959; Sun XS, 2019, CANCER RES TREAT, V51, P1449, DOI 10.4143/crt.2018.688; Tai P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-48; Teppo H, 2003, HEAD NECK-J SCI SPEC, V25, P389, DOI 10.1002/hed.10208; Tuan JKL, 2012, RADIOTHER ONCOL, V104, P305, DOI 10.1016/j.radonc.2011.12.028; Wildeman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063706; Wu SG, 2018, J CANCER, V9, P1870, DOI 10.7150/jca.23965; Xu C, 2018, ORAL ONCOL, V78, P37, DOI 10.1016/j.oraloncology.2018.01.008; Xu Zhen-Xi, 2015, Asian Pac J Cancer Prev, V16, P6729; Zeng ZX, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004026; Zhang B, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.13619	63	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246638	10.1371/journal.pone.0246638	http://dx.doi.org/10.1371/journal.pone.0246638			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577563	gold, Green Published			2022-12-26	WOS:000620071700040
J	Apidechkul, T; Yeemard, F; Chomchoei, C; Upala, P; Tamornpark, R				Apidechkul, Tawatchai; Yeemard, Fartima; Chomchoei, Chalitar; Upala, Panupong; Tamornpark, Ratipark			Epidemiology of thalassemia among the hill tribe population in Thailand	PLOS ONE			English	Article							CHIANG-RAI; PREVALENCE; COMPLICATIONS; DISTRICT; ALPHA	Background Thalassemia is a severe disease that occurs due to abnormalities in hemoglobin genes. Various genetic factors in different populations lead to different clinical manifestations of thalassemia disease, particularly among people who have a long history of migration and who have married among tribes, such as the hill tribe people in Thailand. This genetic epidemiological study aimed to estimate the prevalence of various forms of thalassemia among the six main hill tribe populations in Thailand. Methods A cross-sectional study was conducted to obtain information and blood specimens from school children belonging to one of the six main hill tribes in Thailand: Akha, Lau, Hmong, Yao, Karen, and Lisu. Hill tribe children who were attending grades 4-6 in 13 selected schools in Chiang Rai Province, Thailand, were invited to participate in the study. A validated questionnaire and 3 mL blood specimens were collected after obtaining information consent forms from both the children and their parents on a voluntary basis. A complete blood count (CBC) was performed, followed by osmotic fragility (OF) and dichlorophenol indophenol precipitation (DCIP) tests to screen for thalassemia. High-performance liquid chromatography (HPLC) and real-time quantitative polymerase chain reaction (qPCR) were used to identify hemoglobin type and alpha-thalassemia, respectively. A t-test, chi-square and logistic regression were used to detect the associations between variables at the significance level of alpha = 0.05. Results A total of 1,200 participants from 6 different tribes were recruited for the study; 50.0% were males, and 67.3% were aged 11-12 years. The overall prevalence of thalassemia carriers according to the screening tests was 9.8% (117 of 1,200). Among the cases, 83 were A2A (59 cases were alpha-thalassemia 1 carrier or alpha-thalassemia 2 carrier or homozygous alpha-thalassemia 2, and 24 cases were beta-thalassemia trait with or without alpha-thalassemia); 1 case was EE (homozygous Hb E with or without alpha-thalassemia); 31 cases were EA (30 cases were the Hb E trait, and 1 case was Hb E trait with or without alpha-thalassemia); 1 case was A2A Bart's H (Hb H disease alpha-thalassemia 1/alpha-thalassemia 2); and 1 case was A2A with abnormal Hb. The prevalence of the alpha-thalassemia 1 trait among the hill tribe population was 2.5%. The greatest prevalence of the alpha-thalassemia 1 trait was found in the Karen (3.0%) and Hmong (3.0%) tribes. Conclusions The prevalence of some forms of thalassemia in the hill tribe population is higher than that in the Thai and other populations. Effective and available thalassemia screening tests, including essential information to protect the next generation through the specific counseling clinic, are crucial, particularly due to increasing marriages within these populations.	[Apidechkul, Tawatchai; Yeemard, Fartima; Upala, Panupong; Tamornpark, Ratipark] Mae Fah Luang Univ, Ctr Excellence Hill Tribe Hlth Res, Chiang Rai, Thailand; [Apidechkul, Tawatchai] Mae Fah Luang Univ, Sch Hlth Sci, Chiang Rai, Thailand; [Chomchoei, Chalitar] Chulabhorn Royal Acad, Bangkok, Thailand	Mae Fah Luang University; Mae Fah Luang University; Chulabhorn Royal Academy	Apidechkul, T (corresponding author), Mae Fah Luang Univ, Ctr Excellence Hill Tribe Hlth Res, Chiang Rai, Thailand.; Apidechkul, T (corresponding author), Mae Fah Luang Univ, Sch Hlth Sci, Chiang Rai, Thailand.	Tawatchai.api@mfu.ac.th		Apidechkul, Tawatchai/0000-0001-8301-2055	National Research Council of Thailand (NRCT); Mae Fah Luang University [23/2561]	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Mae Fah Luang University	TA was granted from The National Research Council of Thailand (NRCT) and Mae Fah Luang University to support grant(Grant No.23/2561), but they did not involve to the project.	Angastiniotis M, 2019, INT J NEONAT SCREEN, V5, DOI 10.3390/ijns5010016; [Anonymous], 2015, ECONOMIST, P25; [Anonymous], 2008, J AQUAT ANIM HEALTH, V20, P165; Apidechkul T, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7459-9; Apidechkul T, 2016, J HEALTH RES, V30, P67, DOI 10.14456/jhr.2016.10; Apidechkul T, 2015, ASIAN BIOMED, V9, P527, DOI 10.5372/1905-7415.0904.423; Buakhao J, 2017, SE ASIAN J TROP MED, V48, P864; Centers for Disease Control and Prevention (CDC), THAL; Chaibunruang A, 2018, MEDITERR J HEMATOL I, V10, DOI 10.4084/MJHID.2018.054; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Crighton G, 2016, INTERN MED J, V46, P770, DOI 10.1111/imj.13084; Ekwattanakit S, 2018, AM J HEMATOL, V93, P623, DOI 10.1002/ajh.25046; Fucharoen G, 2004, B WORLD HEALTH ORGAN, V82, P364; Hockham C, 2019, ELIFE, V8, DOI 10.7554/eLife.40580; Kadhim KA, 2017, HEMOGLOBIN, V41, P164, DOI 10.1080/03630269.2017.1354877; Kittisares K, 2019, TRANSFUS APHER SCI, V58, P201, DOI 10.1016/j.transci.2019.03.009; KSPJDCEMAA JB, 2015, ANN IND ACAD NEUROL, V18, pS59; Laghmich A, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2080352; Lithanatudom P, 2016, HEMATOLOGY, V21, P480, DOI 10.1080/10245332.2016.1148374; Ministry of Education Thailand, ED MAN INF SYST CHAI; Ministry of Public Health Thailand, 2018, THAL THAIL; Ministry of Public Health Thailand, THAIL NAT GUID THAL; Ministry of Public Health Thailand, THAL THAIL 2018; Muncie HL, 2009, AM FAM PHYSICIAN, V80, P339; Musallam KM, 2013, HAEMATOLOGICA, V98, P833, DOI 10.3324/haematol.2012.066845; National Health Security Office (NHSO), THAL CAR TREATM THAI; Raza S., 2016, INT J MED HEALTH RES, V2, P5; Sangkitporn Siripakorn, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1538; Sayani FA, 2015, ANN MED, V47, P592, DOI 10.3109/07853890.2015.1091942; Taher AT, 2018, LANCET, V391, P155, DOI 10.1016/S0140-6736(17)31822-6; Tantiworawit A, 2016, SE ASIAN J TROP MED, V47, P1335; Tari K., 2018, INT J BIOMED PUBLIC, V1, P48, DOI [10.22631/ijbmph.2018.56102, DOI 10.22631/ijbmph.2018.56102, DOI 10.22631/IJBMPH.2018.56102]; Trisakul N, 2008, J HEMATOL TRANSFUS M, V19, P285; United Nations, COUNTR PROF THAIL 20; Wongprachum K, 2016, SE ASIAN J TROP MED, V47, P1040; World Health Organization (WHO), GLOB EP HEM DIS DER; World Health organization (WHO), MAN HAEM DIS; Yanola J, 2014, SE ASIAN J TROP MED, V45, P920	38	3	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246736	10.1371/journal.pone.0246736	http://dx.doi.org/10.1371/journal.pone.0246736			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571309	gold, Green Published			2022-12-26	WOS:000618274000059
J	de Lima, EEC; Gayawan, E; Baptista, EA; Queiroz, BL				Campos de Lima, Everton Emanuel; Gayawan, Ezra; Baptista, Emerson Augusto; Queiroz, Bernardo Lanza			Spatial pattern of COVID-19 deaths and infections in small areas of Brazil	PLOS ONE			English	Article							POPULATION AGE STRUCTURE	As of mid-August 2020, Brazil was the country with the second-highest number of cases and deaths by the COVID-19 pandemic, but with large regional and social differences. In this study, using data from the Brazilian Ministry of Health, we analyze the spatial patterns of infection and mortality from Covid-19 across small areas of Brazil. We apply spatial autoregressive Bayesian models and estimate the risks of infection and mortality, taking into account age, sex composition of the population and other variables that describe the health situation of the spatial units. We also perform a decomposition analysis to study how age composition impacts the differences in mortality and infection rates across regions. Our results indicate that death and infections are spatially distributed, forming clusters and hotspots, especially in the Northern Amazon, Northeast coast and Southeast of the country. The high mortality risk in the Southeast part of the country, where the major cities are located, can be explained by the high proportion of the elderly in the population. In the less developed areas of the North and Northeast, there are high rates of infection among young adults, people of lower socioeconomic status, and people without access to health care, resulting in more deaths.	[Campos de Lima, Everton Emanuel] Univ Campinas UNICAMP, Coll Philosophy & Human Sci IFCH, Campinas, Brazil; [Gayawan, Ezra] Fed Univ Technol Akure, Dept Stat, Akure, Nigeria; [Baptista, Emerson Augusto] Shanghai Univ, Asian Demog Res Inst ADRI, Shanghai, Peoples R China; [Queiroz, Bernardo Lanza] Univ Fed Minas Gerais UFMG, Dept Demog, Belo Horizonte, MG, Brazil	Universidade Estadual de Campinas; Shanghai University; Universidade Federal de Minas Gerais	Baptista, EA (corresponding author), Shanghai Univ, Asian Demog Res Inst ADRI, Shanghai, Peoples R China.	emersonaug@gmail.com	Baptista, Emerson Augusto/AAY-7362-2021; Baptista, Emerson Augusto/A-2098-2017	Baptista, Emerson Augusto/0000-0001-7582-2736; Lima, Everton/0000-0001-6275-9854	Sao Paulo Research Foundation (FAPESP) [268 2018/18649-7]; University of Campinas Research Fund - 269 FAEPEX	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); University of Campinas Research Fund - 269 FAEPEX	Gayawan contribution was funded by the Sao Paulo Research Foundation (FAPESP) grant 268 2018/18649-7. Lima and Gayawan thank the University of Campinas Research Fund - 269 FAEPEX for support.	[Anonymous], 2020, LANCET, V395, P1461, DOI 10.1016/S0140-6736(20)31095-3; [Anonymous], 2013, DIABETES CARE S1, V36, pS11; Baptista EA, 2020, REGIONAL COVID 19 MO; Baptista EA, 2019, DEMOGR RES, V41, P1437, DOI 10.4054/DemRes.2019.41.51; Barbosa A. L., 2020, MERCADO TRABALHO PAN; Bivand R, 2015, J STAT SOFTW, V63, P1; Borges GM, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00080316, 10.1590/0102-311x00080316]; Candido DS, 2020, SCIENCE, V369, P1255, DOI 10.1126/science.abd2161; Codeco CT., 2020, AN LISE RISCO DISSEM, V3; Dantas RCC, 2022, INFECT CONT HOSP EP, V43, P953, DOI 10.1017/ice.2020.210; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Franca EB, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0156-y; França Elisabeth Barboza, 2020, Rev. bras. epidemiol., V23, pe200053, DOI 10.1590/1980-549720200053; Franch-Pardo I, 2020, SCI TOTAL ENVIRON, V739, DOI 10.1016/j.scitotenv.2020.140033; de Souza CDF, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa145; de Souza CDF, 2020, J BRAS PNEUMOL, V46, DOI 10.36416/1806-3756/e20200208; Goldstein JR, 2020, P NATL ACAD SCI; Jordan RE, 2020, LANCET INFECT DIS, V20, P995, DOI 10.1016/S1473-3099(20)30395-9; Jorge DC, 2020, ASSESSING NATIONWIDE; KITAGAWA EM, 1955, J AM STAT ASSOC, V50, P1168, DOI 10.2307/2281213; LeSage JP, 1997, INT REGIONAL SCI REV, V20, P113, DOI 10.1177/016001769702000107; Lima E, 2020, EXPLORING EXCESS DEA; Martines MR, 2020, DETECTING SPACE TIME; Medford A, 2020, DEMOGR RES, V43, P533, DOI 10.4054/DemRes.2020.43.19; Noronha KVMD, 2020, CAD SAUDE PUBLICA, V36, DOI 10.1590/0102-311X00115320; Ministry of Health, 2020, SIST INF MORT SIM; Mollalo A, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138884; Nepomuceno MR, 2020, P NATL ACAD SCI USA, V117, P13881, DOI 10.1073/pnas.2008760117; Peixoto PS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235732; Pereira RH, 2020, GEOGRAPHIC ACCESS CO; Queiroz BL, 2020, POPULATION CHANGE PU; Queiroz BL, 2020, RISCO MORTALIDADE MI; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Shuchman M, 2020, NAT MED, V26, P986, DOI 10.1038/d41591-020-00020-2; Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000	36	12	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246808	10.1371/journal.pone.0246808	http://dx.doi.org/10.1371/journal.pone.0246808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571268	gold, Green Submitted, Green Published			2022-12-26	WOS:000618274000016
J	Fatur, K; Kreft, S				Fatur, Karsten; Kreft, Samo			Nixing the nightshades: Traditional knowledge of intoxicating members of the Solanaceae among hallucinogenic plant and mushroom users in Slovenia	PLOS ONE			English	Article								Anticholinergic plants of the family Solanaceae have a long history of use as medicines, poisons, and recreational drugs. Though they were the intoxicating substances of choice throughout Europe for centuries, their use for these purposes has declined with the globalisation of other recreational drugs. The present study sought to examine the level of knowledge surrounding these plants among individuals who had used other hallucinogenic plants or mushrooms in Slovenia. Participants were questioned in regards to the anticholinergic Solanaceae that are known to grow wild in Slovenia: Atropa belladonna L., Datura stramonium L., Hyoscyamus niger L., and Scopolia carniolica L. As expected, only a small number of individuals had any substantial knowledge of these plants, and fewer still had used them; some were even unfamiliar with any of these plants. Knowledge of toxicity generally arose from family members, while books and the internet played prominent roles in regards to use knowledge. Knowledge of the plants was vastly varied, with many individuals confusing the plants for others, especially other members of the Solanaceae. Ultimately, a small group of individuals had the largest body of knowledge of these plants, though this was linked with university studies rather than traditional uses. Knowledge of the intoxicating Solanaceae has been largely lost in Slovenia among users of other botanical hallucinogens, likely due to the various dangers their use poses and the undesirable effects they often cause.	[Fatur, Karsten; Kreft, Samo] Univ Ljubljani, Fak Farmacijo, Ljubljana, Slovenia	University of Ljubljana	Fatur, K (corresponding author), Univ Ljubljani, Fak Farmacijo, Ljubljana, Slovenia.	karsten.fatur@gmail.com		Fatur, Karsten/0000-0002-4557-2999				Aikman J, 1827, HIST SCOTLAND TRANSL, VI; Arroo RRJ., 2007, TRANSGENIC CROPS 6, V61, P2; Baraniecka-Olszewska K, 2016, ANTHROPOL J EUR CULT, V25, P118, DOI 10.3167/ajec.2016.250108; Carruthers DMJ, 2015, MOSAIC, V48, P119, DOI 10.1353/mos.2015.0025; Cilensek M, 1892, NA E KODLJIVE RASTLI; Daunay MC, 2007, ACTA HORTIC, P59, DOI 10.17660/ActaHortic.2007.745.3; Dioscorides, 2000, MATERIA MED; Falkowska U., 2018, Polish Journal of Public Health, V128, P19; Fatur K, 2018, POMEGRANATE; Fatur K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245022; Fatur K, 2020, ECON BOT, V74, P140, DOI 10.1007/s12231-020-09498-w; Fatur K, 2019, J ETHNOPHARMACOL, V244, DOI 10.1016/j.jep.2019.112151; Geeta R, 2007, J BIOSCIENCES, V32, P1227, DOI 10.1007/s12038-007-0132-y; Gunda B, 1967, KROEBER ANTHR SOC SP, V1, P1; HOCKING G. M., 1947, Economic Botany, V1, P306, DOI 10.1007/BF02858575; Lenclud G, 1987, TERRAIN, V9, P1; Leonti M, 2011, J ETHNOPHARMACOL, V134, P542, DOI 10.1016/j.jep.2011.01.017; Leporatti ML, 2007, ETHNOBIOLOGICA, V64, P51; Diaz JL, 2010, PHENOMENOL COGN SCI, V9, P159, DOI 10.1007/s11097-010-9157-z; Maheshwari N. O., 2013, Journal of Medicinal Plants Research, V7, P2885; Merlin MD, 2003, ECON BOT, V57, P295, DOI 10.1663/0013-0001(2003)057[0295:AEFTTO]2.0.CO;2; Ostling M, 2016, MAGIC RITUAL WITCHCR, V11, P30, DOI 10.1353/mrw.2016.0008; Penicka S, 2008, DARK SIDE PROC SEVEN, P181; Piccillo GA, 2006, INT J CLIN PRACT, V60, P492, DOI 10.1111/j.1368-5031.2006.00864.x; Pliny the Elder, 1855, NAT HIST; Porta G, 1658, NATURAL MAGICK; Ruck CAP, 2015, HISTORY OF TOXICOLOGY AND ENVIRONMENTAL HEALTH: TOXICOLOGY IN ANTIQUITY, VOL II, P116, DOI 10.1016/B978-0-12-801506-3.00012-1; Sanz C, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00007; Slaughter RJ, 2012, NEW ZEAL MED J, V125, P87; Stevanovic ZD., 2014, ETHNOBOTANY BIOCULTU, P229; Stika HP, 1996, VEG HIST ARCHAEOBOT, V5, P81, DOI 10.1007/BF00189437; Tareau MA, 2017, J ETHNOPHARMACOL, V203, P200, DOI 10.1016/j.jep.2017.03.031; Van Bingen H, 2001, PHYS VARIOUS NATURAL; Waniakowa J., 2007, MANDRAGORA BELLADONN, P124	34	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247688	10.1371/journal.pone.0247688	http://dx.doi.org/10.1371/journal.pone.0247688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617573	Green Published, gold			2022-12-26	WOS:000623082400042
J	Forgacs, D; Abreu, RB; Sautto, GA; Kirchenbaum, GA; Drabek, E; Williamson, KS; Kim, D; Emerling, DE; Ross, TM				Forgacs, David; Abreu, Rodrigo B.; Sautto, Giuseppe A.; Kirchenbaum, Greg A.; Drabek, Elliott; Williamson, Kevin S.; Kim, Dongkyoon; Emerling, Daniel E.; Ross, Ted M.			Convergent antibody evolution and clonotype expansion following influenza virus vaccination	PLOS ONE			English	Article							B-CELLS; MONOCLONAL-ANTIBODIES; NEUTRALIZING EPITOPE; AFFINITY MATURATION; PLASMA-CELLS; HUMAN-BLOOD; REPERTOIRE; RESPONSES; MEMORY; EXPRESSION	Recent advances in high-throughput single cell sequencing have opened up new avenues into the investigation of B cell receptor (BCR) repertoires. In this study, PBMCs were collected from 17 human participants vaccinated with the split-inactivated influenza virus vaccine during the 2016-2017 influenza season. A combination of Immune Repertoire Capture (IRCTM) technology and IgG sequencing was performed on similar to 7,800 plasmablast (PB) cells and preferential IgG heavy-light chain pairings were investigated. In some participants, a single expanded clonotype accounted for similar to 22% of their PB BCR repertoire. Approximately 60% (10/17) of participants experienced convergent evolution, possessing public PBs that were elicited independently in multiple participants. Binding profiles of one private and three public PBs confirmed they were all subtype-specific, cross-reactive hemagglutinin (HA) head-directed antibodies. Collectively, this high-resolution antibody repertoire analysis demonstrated the impact evolution can have on BCRs in response to influenza virus vaccination, which can guide future universal influenza prophylactic approaches.	[Forgacs, David; Abreu, Rodrigo B.; Sautto, Giuseppe A.; Kirchenbaum, Greg A.; Ross, Ted M.] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA; [Drabek, Elliott; Williamson, Kevin S.; Kim, Dongkyoon; Emerling, Daniel E.] Atreca Inc, San Francisco, CA USA; [Ross, Ted M.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Kirchenbaum, Greg A.] Cellular Technol Ltd, Shaker Hts, OH USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ross, TM (corresponding author), Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA.; Ross, TM (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	tedross@uga.edu	; Sautto, Giuseppe Andrea/A-8588-2015	Ross, Ted/0000-0003-1947-7469; Forgacs, David/0000-0002-3553-3320; Sautto, Giuseppe Andrea/0000-0002-0273-2235	NIH [HHSN272201400004C]; University of Georgia (US) [UGA-001]; Georgia Research Alliance [GRA-001]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia (US); Georgia Research Alliance	This study was supported by the NIH contract HHSN272201400004C (NIAID Centers of Excellence for Influenza Research and Surveillance, CEIRS), University of Georgia (US), UGA-001 and the Georgia Research Alliance (GRA-001). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funder provided support in the form of salaries for authors [DF, RBA, GAS, GAK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `Author contributions' section. Some of the authors are affiliated with Atreca, Inc., however, they provided no funding for the study, only assisted with the data collection and the preparation of the manuscript.	Abreu RB, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00902; Abreu RB, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.132155; Adamson PJ, 2017, VACCINE, V35, P5576, DOI 10.1016/j.vaccine.2017.08.053; Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Avnir Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004103; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Cortina-Ceballos B, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0239-y; COX RJ, 1994, VACCINE, V12, P993, DOI 10.1016/0264-410X(94)90334-4; Cyster JG, 2019, CELL, V177, P524, DOI 10.1016/j.cell.2019.03.016; Dunand CJH, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0238; Ecker JW, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030462; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; El-Madhun AS, 1999, J INFECT DIS, V180, P1356, DOI 10.1086/315003; Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533; Fera D, 2014, P NATL ACAD SCI USA, V111, P10275, DOI 10.1073/pnas.1409954111; Frace AM, 1999, VACCINE, V17, P2237, DOI 10.1016/S0264-410X(99)00005-5; Francis ME, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7040133; FRANK A L, 1989, Viral Immunology, V2, P31, DOI 10.1089/vim.1989.2.31; Frasca D, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-14; Galson JD, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.605170; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; HEILMANN C, 1989, SCAND J IMMUNOL, V29, P159, DOI 10.1111/j.1365-3083.1989.tb01112.x; Henry C, 2019, CELL HOST MICROBE, V25, P357, DOI 10.1016/j.chom.2019.01.002; Jackson KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/j.chom.2014.05.013; Joo HM, 2010, VACCINE, V28, P2186, DOI 10.1016/j.vaccine.2009.12.058; Kashyap AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000990; Kirchenbaum GA, 2017, J IMMUNOL, V199, P3798, DOI 10.4049/jimmunol.1701174; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lang SS, 2017, CELL REP, V20, P2935, DOI 10.1016/j.celrep.2017.08.084; Lee J, 2016, NAT MED, V22, P1456, DOI 10.1038/nm.4224; Li S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3333; Manenti A, 2017, VACCINE, V35, P191, DOI 10.1016/j.vaccine.2016.10.024; MANSER T, 1984, SCIENCE, V226, P1283, DOI 10.1126/science.6334361; MATTILA PS, 1986, SCAND J IMMUNOL, V24, P699, DOI 10.1111/j.1365-3083.1986.tb02189.x; MORELL A, 1983, INFECT IMMUN, V39, P565, DOI 10.1128/IAI.39.2.565-568.1983; Nachbagauer R, 2016, MBIO, V7, DOI 10.1128/mBio.01996-15; Neu KE, 2019, J CLIN INVEST, V129, P93, DOI 10.1172/JCI121341; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Paget J, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020421; PENNELL CA, 1989, EUR J IMMUNOL, V19, P1289, DOI 10.1002/eji.1830190721; Powers DC, 1996, CLIN DIAGN LAB IMMUN, V3, P511, DOI 10.1128/CDLI.3.5.511-516.1996; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Roskin KM, 2020, NAT IMMUNOL, V21, P199, DOI 10.1038/s41590-019-0581-0; Roy B, 2017, J IMMUNOL, V199, P782, DOI 10.4049/jimmunol.1700169; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Sautto GA, 2020, J IMMUNOL, V204, P375, DOI 10.4049/jimmunol.1900379; Sautto Giuseppe A, 2018, Immunohorizons, V2, P226, DOI 10.4049/immunohorizons.1800044; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; Setliff I, 2018, CELL HOST MICROBE, V23, P845, DOI 10.1016/j.chom.2018.05.001; Skarlupka AL, 2020, J VIROL, V94, DOI 10.1128/JVI.02061-19; Smith K, 2016, VACCINE, V34, P2813, DOI 10.1016/j.vaccine.2016.04.040; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Strauli NB, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0314-z; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan YC, 2014, ARTHRITIS RHEUMATOL, V66, P2706, DOI 10.1002/art.38754; Tan YC, 2014, CLIN IMMUNOL, V151, P55, DOI 10.1016/j.clim.2013.12.008; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; Wheatley AK, 2015, J IMMUNOL, V195, P602, DOI 10.4049/jimmunol.1402835; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Wong SS, 2013, CLIN MICROBIOL REV, V26, P476, DOI 10.1128/CMR.00097-12; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Wu YCB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00193; Xiao HX, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0086-x; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yang Y, 2015, ELIFE, V4, DOI 10.7554/eLife.09083	75	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247253	10.1371/journal.pone.0247253	http://dx.doi.org/10.1371/journal.pone.0247253			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617543	gold, Green Published			2022-12-26	WOS:000623082400050
J	Germano, ND; Cogo-Moreira, H; Coutinho-Lourenco, F; Bortz, G				Germano, Nayana Di Giuseppe; Cogo-Moreira, Hugo; Coutinho-Lourenco, Fausto; Bortz, Graziela			A new approach to measuring absolute pitch on a psychometric theory of isolated pitch perception: Is it disentangling specific groups or capturing a continuous ability?	PLOS ONE			English	Article							MUSICAL INTERVALS; STANDARD ERRORS; IDENTIFICATION; ANATOMY; MEMORY	Absolute Pitch (AP) is commonly defined as a rare ability that allows an individual to identify any pitch by name. Most researchers use classificatory tests for AP which tracks the number of isolated correct answers. However, each researcher chooses their own procedure for what should be considered correct or incorrect in measuring this ability. Consequently, it is impossible to evaluate comparatively how the stimuli and criteria classify individuals in the same way. We thus adopted a psychometric perspective, approaching AP as a latent trait. Via the Latent Variable Model, we evaluated the consistency and validity for a measure to test for AP ability. A total of 783 undergraduate music students participated in the test. The test battery comprised 10 isolated pitches. All collected data were analyzed with two different rating criteria (perfect and imperfect) under three Latent Variable Model approaches: continuous (Item Response Theory with two and three parameters), categorical (Latent Class Analysis), and the Hybrid model. According to model fit information indices, the perfect approach (only exact pitch responses as correct) measurement model had a better fit under the trait (continuous) specification. This contradicts the usual assumption of a division between AP and non-AP possessors. Alternatively, the categorical solution for the two classes demonstrated the best solution for the imperfect approach (exact pitch responses and semitone deviations considered as correct).	[Germano, Nayana Di Giuseppe] Univ Fed Santa Maria, Dept Mus, Santa Maria, RS, Brazil; [Cogo-Moreira, Hugo] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Peoples R China; [Coutinho-Lourenco, Fausto] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, SP, Brazil; [Bortz, Graziela] Univ Estadual Paulista, Dept Mus, Sao Paulo, SP, Brazil	Universidade Federal de Santa Maria (UFSM); University of Hong Kong; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista	Germano, ND (corresponding author), Univ Fed Santa Maria, Dept Mus, Santa Maria, RS, Brazil.	nayana.germano@ufsm.br	Cogo-Moreira, Hugo/U-6442-2019; Cogo-Moreira, Hugo/E-4602-2011; Cogo-Moreira, Hugo/GSD-6132-2022	Cogo-Moreira, Hugo/0000-0001-9411-9237; Cogo-Moreira, Hugo/0000-0001-9411-9237; Cogo-Moreira, Hugo/0000-0001-9411-9237; Coutinho-Lourenco, Fausto/0000-0002-5656-5137; Di Giuseppe Germano, Nayana/0000-0003-3061-644X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 2016/08377-4, FAPESP 2019/02133-4]; CAPES [0374/2016, 23038.009191/2013-76]; CAPES-Alexander von Humboldt senior research fellowship [88881.145593/2017-01]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES-Alexander von Humboldt senior research fellowship	Germano, N: FAPESP 2016/08377-4 (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) provided funding for the research and publication of this article. Cogo-Moreira, H: CAPES (Thesis award) Grant no. 0374/2016, process no. 23038.009191/2013-76) and CAPES-Alexander von Humboldt senior research fellowship (Grant 88881.145593/2017-01). Bortz, G: FAPESP 2019/02133-4 (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) provided funding for the publication of this article.	Asparouhov T, 2006, COMMUN STAT-THEOR M, V35, P439, DOI 10.1080/03610920500476598; Asparouhov T, 2005, STRUCT EQU MODELING, V12, P411, DOI 10.1207/s15328007sem1203_4; Athos EA, 2007, P NATL ACAD SCI USA, V104, P14795, DOI 10.1073/pnas.0703868104; Baggaley J., 1974, PSYCHOL MUSIC, V2, P11, DOI [10.1177/030573567422002?journalCode=poma, DOI 10.1177/030573567422002]; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Baird JW., 1917, STUDIES PSYCHOL TITC, P43; Baker F., 2001, BASICS ITEM RESPONSE; Bentler PM, 2010, PSYCHOL METHODS, V15, P111, DOI 10.1037/a0019625; Bermudez P, 2009, MUSIC PERCEPT, V27, P89, DOI 10.1525/MP.2009.27.2.89; Bortz G, 2018, INT C MUSIC PERC COG, V15, P164; Deutsch D, 2002, CURR DIR PSYCHOL SCI, V11, P200, DOI 10.1111/1467-8721.00200; Deutsch D, 2013, J ACOUST SOC AM, V133, P1859, DOI 10.1121/1.4792217; Deutsch OE, 1966, MOZART DOCUMENTARY B; Dohn A, 2015, CEREB CORTEX, V25, P1379, DOI 10.1093/cercor/bht334; Germano NG, 2015, THESIS UNESP SAO PAU; Germano NG, 2018, THESIS UNESP SAO PAU; Germano NG., 2011, THESIS UNESP SAO PAU; Hantz EC., 1995, PSYCHOMUSICOLOGY, V14, P53; Hove MJ, 2010, PSYCHON B REV, V17, P310, DOI 10.3758/PBR.17.3.310; Iusca DG., 2019, ED IMPLICATIONS, P353; Keenan JP, 2001, NEUROIMAGE, V14, P1402, DOI 10.1006/nimg.2001.0925; Kim SG, 2016, HUM BRAIN MAPP, V37, P3486, DOI 10.1002/hbm.23254; Levitin DJ, 2005, TRENDS COGN SCI, V9, P26, DOI 10.1016/j.tics.2004.11.007; Levitin DJ., NEW GROVE DICT MUSIC, V2001, P37; Li XN, 2021, PSYCHOL MUSIC, V49, P704, DOI 10.1177/0305735619893437; MIYAZAKI K, 1993, MUSIC PERCEPT, V11, P55; MIYAZAKI KI, 1992, MUSIC PERCEPT, V9, P413; Mull HK, 1925, AM J PSYCHOL, V36, P469, DOI 10.2307/1413906; Muthen B, 2006, TWIN RES HUM GENET, V9, P313, DOI 10.1375/183242706777591317; Muthen B, 2006, ADDICTION, V101, P6, DOI 10.1111/j.1360-0443.2006.01583.x; Muthen B, 2006, ADDICT BEHAV, V31, P1050, DOI 10.1016/j.addbeh.2006.03.026; Muthen LK, 2017, MPLUS VERSION 8 SOFT; Muthen LK., 2017, MPLUS USERS GUIDE, P55; NEU DM, 1947, PSYCHOL BULL, V44, P249, DOI 10.1037/h0054212; Oechslin MS, 2010, CEREB CORTEX, V20, P447, DOI 10.1093/cercor/bhp113; Ogasawara H, 2001, APPL PSYCH MEAS, V25, P53, DOI 10.1177/01466216010251004; Orlando M, 2000, APPL PSYCH MEAS, V24, P48; Petran LA, 1932, PSYCHOL MONOGR, V42, P1; Plantinga J, 2005, COGNITION, V98, P1, DOI 10.1016/j.cognition.2004.09.008; R Core Team, 2020, R LANG ENV STAT COMP; Renninger LB, 2003, MUSIC PERCEPT, V20, P357; RIKER BL, 1946, J EXP PSYCHOL, V36, P331, DOI 10.1037/h0063218; Schulze K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-106; Spender N., 1980, NEW GROVE DICT MUSIC, V6 ed, P27, DOI [10.1016/0022-3999%2880%2990012-4, DOI 10.1016/0022-3999%2880%2990012-4]; Stumpf C, 1890, TONPSYCHOLOGIE S HIR, V206, P365; THISSEN D, 1982, PSYCHOMETRIKA, V47, P397, DOI 10.1007/BF02293705; Vanzella P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015449; Ward W.D., 1999, PSYCHOL MUSIC PP, P265, DOI DOI 10.1016/B978-012213564-4/50009-3; Wengenroth M, 2014, CEREB CORTEX, V24, P1127, DOI 10.1093/cercor/bhs391; Wilson SJ, 2009, CEREB CORTEX, V19, P724, DOI 10.1093/cercor/bhn121; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172	51	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247473	10.1371/journal.pone.0247473	http://dx.doi.org/10.1371/journal.pone.0247473			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QO3ZL	33617560	gold, Green Published			2022-12-26	WOS:000623082400029
J	Devi, TR; Dasgupta, M; Sahoo, MR; Kole, PC; Prakash, N				Devi, Tongbram Roshni; Dasgupta, Madhumita; Sahoo, Manas Ranjan; Kole, Paresh Chandra; Prakash, Narendra			High efficient de novo root-to-shoot organogenesis in Citrus jambhiri Lush.: Gene expression, genetic stability and virus indexing	PLOS ONE			English	Article								A protocol for high-frequency direct organogenesis from root explants of Kachai lemon (Citrus jambhiri Lush.) was developed. Full-length roots (similar to 3 cm) were isolated from the in vitro grown seedlings and cultured on Murashige and Skoog basal medium supplemented with Nitsch vitamin (MSN) with different concentrations of cytokinin [6-benzylaminopurine, (BAP)] and gibberellic acid (GA(3)). The frequency of multiple shoot proliferation was very high, with an average of 34.3 shoots per root explant when inoculated on the MSN medium supplemented with BAP (1.0 mg L-1) and GA(3) (1.0 mg L-1). Optimal rooting was induced in the plantlets under half strength MSN medium supplemented with indole-3-acetic acid (IAA, 0.5-1.0 mg L-1). IAA induced better root structure than 1-naphthaleneacetic acid (NAA), which was evident from the scanning electron microscopy (SEM). The expressions of growth regulating factor genes (GRF1 and GRF5) and GA(3) signaling genes (GA2OX1 and KO1) were elevated in the regenerants obtained from MSN+BAP (1.0 mg L-1)+GA(3) (1.0 mg L-1). The expressions of auxin regulating genes were high in roots obtained in 1/2 MSN+IAA 1.0 mg L-1. Furthermore, indexing of the regenerants confirmed that there was no amplicons detected for Huanglongbing bacterium and Citrus tristeza virus. Random amplified polymorphic DNA (RAPD) and inter simple sequence repeat (ISSR) markers detected no polymorphic bands amongst the regenerated plants. This is the first report that describes direct organogenesis from the root explant of Citrus jambhiri Lush. The high-frequency direct regeneration protocol in the present study provides an enormous significance in Citrus organogenesis, its commercial cultivation and genetic conservation.	[Devi, Tongbram Roshni; Dasgupta, Madhumita; Sahoo, Manas Ranjan; Prakash, Narendra] ICAR Res Complex North Eastern Hill Reg, Imphal, Manipur, India; [Kole, Paresh Chandra] Visva Bharati, Inst Agr, Sriniketan, W Bengal, India	Indian Council of Agricultural Research (ICAR); ICAR - ICAR Research Complex for NEH Region; Visva Bharati University	Sahoo, MR (corresponding author), ICAR Res Complex North Eastern Hill Reg, Imphal, Manipur, India.	manas.sahoo@icar.gov.in	Sahoo, Manas Ranjan/J-6783-2019	Sahoo, Manas Ranjan/0000-0002-1550-8902	Department of Biotechnology (DBT), Govt. of India [BT/PR16132/NER/95/160/2015]	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India)	Department of Biotechnology (DBT), Govt. of India, under the DBT twinning project `In vitro mass-multiplication and conservation of some endangered Citrus species of NEH Region of India' (BT/PR16132/NER/95/160/2015).	Ali Shawkat, 2006, Acta Botanica Croatica, V65, P137; Balwinder Singh, 2011, Journal of Biological Sciences, V11, P374, DOI 10.3923/jbs.2011.374.380; BHAT SR, 1992, PLANT CELL TISS ORG, V29, P19, DOI 10.1007/BF00036141; Carimi F, 2003, FOR SCI, V75, P589; Chaturvedi H. C., 2001, Indian Journal of Experimental Biology, V39, P1080; Cook G, 2012, PLANT DIS, V96, P772, DOI 10.1094/PDIS-11-11-0951-PDN; El-Assal S. E. D., 2012, American Journal of Applied Sciences, V9, P724; Elayaraja D, 2019, BIOCATAL AGR BIOTECH, V21, DOI 10.1016/j.bcab.2019.101320; Fujikawa T, 2012, MOL CELL PROBE, V26, P194, DOI 10.1016/j.mcp.2012.06.001; Gereme Taye M., 2018, ADV CROP SCI TECHNOL, V6, P1, DOI [10.4172/2329-8863.1000329, DOI 10.4172/2329-8863.1000329]; Gorelova V, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00021; Guilfoyle T, 2007, NATURE, V446, P621, DOI 10.1038/446621a; Han FM, 2011, GENE, V473, P23, DOI 10.1016/j.gene.2010.10.010; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Jogam P, 2020, IND CROP PROD, V151, DOI 10.1016/j.indcrop.2020.112476; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Khan MM., 2018, J HORTIC, V5, pe110, DOI [10.4172/2376-0354.1000e110, DOI 10.4172/2376-0354.1000E110]; Kim JH, 2015, J EXP BOT, V66, P6093, DOI 10.1093/jxb/erv349; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Kour K., 2012, IOSR J, V1, P5, DOI [10.9790/2380-0140509, DOI 10.9790/2380-0140509]; Kumar S, 2010, SCI HORTIC-AMSTERDAM, V123, P350, DOI 10.1016/j.scienta.2009.10.008; Li SB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00119; Liu XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169897; Liu X, 2016, MOL BIOL REP, V43, P1059, DOI 10.1007/s11033-016-4048-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Massot B, 2000, PLANT CELL TISS ORG, V62, P11, DOI 10.1023/A:1006430508169; Mesquita GL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00224; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NITSCH JP, 1969, SCIENCE, V163, P85, DOI 10.1126/science.163.3862.85; Nongmaithem S, 2021, J PLANT GROWTH REGUL, V40, P761, DOI 10.1007/s00344-020-10139-8; Rani G., 2004, J IND BOT SOC, V83, P26; Rattanpal HS, 2011, AFR J BIOTECHNOL, V10, P13724; Reinecke DM, 2013, PLANT PHYSIOL, V163, P929, DOI 10.1104/pp.113.225987; Rohini M. R., 2015, Electronic Journal of Plant Breeding, V6, P688; Russell LD., 1998, ELECT MICROSCOPY PRI, P542; Saini HK, 2010, INDIAN J BIOTECHNOL, V9, P419; Savita, 2015, J PLANT GROWTH REGUL, V34, P309, DOI 10.1007/s00344-014-9465-6; Savita, 2012, IN VITRO CELL DEV-PL, V48, P512, DOI 10.1007/s11627-012-9430-7; Sharma S, 2008, PLANT CELL TISS ORG, V92, P85, DOI 10.1007/s11240-007-9307-3; Shenoy VB, 1992, THEOR APPL GENET, V83, P947, DOI 10.1007/BF00232955; Sidhu G. S., 2014, HortFlora Research Spectrum, V3, P386; Sukhjit Kaur, 2016, Journal of Applied and Natural Science, V8, P724; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Tallon CI, 2013, IN VITRO CELL DEV-PL, V49, P145, DOI 10.1007/s11627-012-9476-6; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Velada I, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9020185; Wang JR, 2009, MOL PLANT, V2, P823, DOI 10.1093/mp/ssp023; Zhou JJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092759	49	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246971	10.1371/journal.pone.0246971	http://dx.doi.org/10.1371/journal.pone.0246971			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606806	Green Published, gold			2022-12-26	WOS:000620629200099
J	Kovac, JD; Dakovic, M; Jankovic, A; Mitrovic, M; Dugalic, V; Galun, D; uric-Stefanovic, A; Masulovic, D				Kovac, Jelena Djokic; Dakovic, Marko; Jankovic, Aleksandra; Mitrovic, Milica; Dugalic, Vladimir; Galun, Daniel; uric-Stefanovic, Aleksandra; Masulovic, Dragan			The role of quantitative diffusion-weighted imaging in characterization of hypovascular liver lesions: A prospective comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient	PLOS ONE			English	Article								Background The utility of intravoxel incoherent motion (IVIM) related parameters in differentiation of hypovascular liver lesions is still unknown. Purpose The purpose of this study was to evaluate the value of IVIM related parameters in comparison to apparent diffusion coefficient (ADC) for differentiation among intrahepatic mass-forming cholangiocarcinoma (IMC), and hypovascular liver metastases (HLM). Methods Seventy-four prospectively enrolled patients (21 IMC, and 53 HLM) underwent 1.5T magnetic resonance examination with IVIM diffusion-weighted imaging using seven b values (0-800 s/mm(2)). Two independent readers performed quantitative analysis of IVIM-related parameters and ADC. Interobserver reliability was tested using a intraclass correlation coefficient. ADC, true diffusion coefficient (D), perfusion-related diffusion coefficient (D*), and perfusion fraction (integral) were compared among the lesions using Kruskal-Wallis H test. The diagnostic accuracy of each parameter was assessed by receiver operating characteristic (ROC) curve analysis. Results The interobserver agreement was good for ADC (0.802), and excellent for D, D*, and integral (0.911, 0.927, and 0.942, respectively). ADC, and D values were significantly different among IMC and HLM (both p < 0.05), while there was no significant difference among these lesions for integral and D* (p = 0.101, and p = 0.612, respectively). ROC analysis showed higher diagnostic performance of D in comparison to ADC (AUC = 0.879 vs 0.821). Conclusion IVIM-derived parameters in particular D, in addition to ADC, could help in differentiation between most common hypovascular malignant liver lesions, intrahepatic mass-forming cholangiocarcinoma and hypovascular liver metastases.	[Kovac, Jelena Djokic; Jankovic, Aleksandra; Mitrovic, Milica; uric-Stefanovic, Aleksandra; Masulovic, Dragan] Clin Ctr Serbia, Ctr Radiol & Magnet Resonance Imaging, Belgrade, Serbia; [Kovac, Jelena Djokic; Dugalic, Vladimir; Galun, Daniel; uric-Stefanovic, Aleksandra; Masulovic, Dragan] Univ Belgrade, Sch Med, Belgrade, Serbia; [Dakovic, Marko] Univ Belgrade, Fac Phys Chem, Belgrade, Serbia; [Dugalic, Vladimir; Galun, Daniel] Clin Ctr Serbia, Surg Clin 1, Belgrade, Serbia	Clinical Centre of Serbia; University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Kovac, JD (corresponding author), Clin Ctr Serbia, Ctr Radiol & Magnet Resonance Imaging, Belgrade, Serbia.; Kovac, JD (corresponding author), Univ Belgrade, Sch Med, Belgrade, Serbia.	Jelenadjokickovac@gmail.com		Dakovic, Marko/0000-0001-7455-5584; Kovac, Jelena/0000-0003-4826-0218				Al Ansari N, 2014, ABDOM IMAGING, V39, P1228, DOI 10.1007/s00261-014-0172-3; Andreou A, 2013, EUR RADIOL, V23, P428, DOI 10.1007/s00330-012-2604-1; Braga L, 2003, MAGN RESON IMAGING, V21, P871, DOI 10.1016/S0730-725X(03)00187-5; Bridgewater J, 2014, J HEPATOL, V60, P1268, DOI 10.1016/j.jhep.2014.01.021; Bruegel M, 2008, EUR RADIOL, V18, P477, DOI 10.1007/s00330-007-0785-9; Calistri L, 2016, J COMPUT ASSIST TOMO, V40, P701, DOI 10.1097/RCT.0000000000000458; Choi BI, 2004, ABDOM IMAGING, V29, P548, DOI 10.1007/s00261-004-0188-1; Choi IY, 2017, J MAGN RESON IMAGING, V45, P1589, DOI 10.1002/jmri.25492; Chow AM, 2012, J MAGN RESON IMAGING, V36, P159, DOI 10.1002/jmri.23607; De Robertis R, 2019, ABDOM RADIOL, V44, P131, DOI 10.1007/s00261-018-1684-z; Doblas S, 2013, INVEST RADIOL, V48, P722, DOI 10.1097/RLI.0b013e3182915912; El Fattach H, 2015, EUR J RADIOL, V84, P1444, DOI 10.1016/j.ejrad.2015.05.003; Fritzsche KH, 2012, METHOD INFORM MED, V51, P441, DOI 10.3414/ME11-02-0031; Ichikawa S, 2013, J MAGN RESON IMAGING, V37, P1371, DOI 10.1002/jmri.23930; Iima M, 2016, RADIOLOGY, V278, P13, DOI 10.1148/radiol.2015150244; Kanematsu M, 2013, ABDOM IMAGING, V38, P297, DOI 10.1007/s00261-012-9940-0; Klauss M, 2016, EUR J RADIOL, V85, P1289, DOI 10.1016/j.ejrad.2016.04.011; Kovac JD, 2017, ACTA RADIOL, V58, P1417, DOI 10.1177/0284185117695666; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lemke A, 2010, MAGN RESON MED, V64, P1580, DOI 10.1002/mrm.22565; Lewis S, 2014, MAGN RESON IMAGING C, V22, P373, DOI 10.1016/j.mric.2014.04.009; Lim JH, 2003, AM J ROENTGENOL, V181, P819, DOI 10.2214/ajr.181.3.1810819; Luo M, 2017, TRANSL ONCOL, V10, P831, DOI 10.1016/j.tranon.2017.08.003; Luo M, 2017, DIAGN INTERV RADIOL, V23, P263, DOI 10.5152/dir.2017.16595; Maetani Y, 2001, AM J ROENTGENOL, V176, P1499, DOI 10.2214/ajr.176.6.1761499; Park HJ, 2013, ABDOM IMAGING, V38, P793, DOI 10.1007/s00261-012-9943-x; R Core Team, R LANG ENV STAT COMP; Wang MJ, 2016, MED SCI MONITOR, V22, P702, DOI 10.12659/MSM.895909; Wang YXJ, 2019, QUANT IMAG MED SURG, V9, P1840, DOI 10.21037/qims.2019.09.18; Watanabe H, 2014, ACTA RADIOL, V55, P1166, DOI 10.1177/0284185113514966; Wei Y, 2019, EUR RADIOL, V29, P535, DOI 10.1007/s00330-018-5638-1; Wirestam R, 2001, ACTA RADIOL, V42, P123, DOI 10.1080/028418501127346459; Yoon JH, 2014, J MAGN RESON IMAGING, V39, P276, DOI 10.1002/jmri.24158; Zhu LH, 2015, ACTA RADIOL, V56, P1411, DOI 10.1177/0284185114559426	34	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247301	10.1371/journal.pone.0247301	http://dx.doi.org/10.1371/journal.pone.0247301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606753	Green Published, gold			2022-12-26	WOS:000620629200106
J	Ostendorf, SB; Kampman, CJG; Hoebe, CJPA; van der Velden, J; Hautvast, JLA; van Jaarsveld, CHM				Ostendorf, S. B.; Kampman, C. J. G.; Hoebe, C. J. P. A.; van der Velden, J.; Hautvast, J. L. A.; van Jaarsveld, C. H. M.			Consultation rate and chlamydia positivity among ethnic minority clients at STI clinics in the Netherlands	PLOS ONE			English	Article							TRANSMITTED INFECTION DIAGNOSIS; HEALTH-CARE; LIFE	Objectives Although ethnic minority clients (EMs) from STI endemic countries have a higher risk for STI, little is known about their STI clinic consultation rate proportionality. The aim of this study was to assess consultation and chlamydia positivity rates among different EMs visiting STI clinics in the Netherlands. Methods We calculated consultation rates in EM groups by dividing the number of STI consultations by the total number of inhabitants in the region belonging to an EM, then compared the EM rates to native Dutch rates. Factors associated with chlamydia positivity were analysed using multivariate regression analysis. Results A total of 23,841 clients visiting an eastern Netherlands STI clinic between 2011 and 2013 were included in the analysis, of which 7% were EMs. The consultation rate of native Dutch clients was 22.5 per 1000, compared to 8.5 per 1000 among EMs. Consultation rates in all EMs were lower than in Dutch clients, except for Antillean or Aruban EMs and Latin American EMs. The chlamydia positivity rate among all clients was 15.5%, and Antillean or Aruban ethnicity (27.1%) EMs had the highest rates. Multivariate analysis identified the following factors associated with chlamydia positivity: Eastern or Northern European EM, African EM, Antillean or Aruban EM, STI related symptoms, heterosexual preference, partner in a risk group, receiving a partner notification, and having had three or more partners in the past six months. Conclusion On a population level, most EMs visit STI clinics less often than native Dutch clients, but they have a higher rate of positive chlamydia diagnoses. STI clinics should increase outreach activities for EM clients because they are insufficiently reached by current practices, but contribute substantially to chlamydia incidence rates.	[Ostendorf, S. B.] Publ Hlth Serv Gelderland Midden, Arnhem, Netherlands; [Kampman, C. J. G.] Publ Hlth Serv Twente, Enschede, Netherlands; [Hoebe, C. J. P. A.] Publ Hlth Serv South Limburg, Heerlen, Netherlands; [Hoebe, C. J. P. A.] Maastricht Univ Med Ctr MUMC, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst Maastricht, Dept Social Med & Med Microbiol, Maastricht, Netherlands; [van der Velden, J.; Hautvast, J. L. A.; van Jaarsveld, C. H. M.] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Primary & Community Care, Med Ctr, Nijmegen, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Radboud University Nijmegen	Kampman, CJG (corresponding author), Publ Hlth Serv Twente, Enschede, Netherlands.	k.kampman@ggdtwebte.nl		Kampman, Carolina/0000-0003-0675-6231				Coyle RM, 2018, SEX TRANSM INFECT, V94, P384, DOI 10.1136/sextrans-2017-053308; Dhar J, 2010, SEX TRANSM INFECT, V86, P366, DOI 10.1136/sti.2009.036004; Evans AR, 2011, SEX TRANSM INFECT, V87, P331, DOI 10.1136/sti.2010.046839; Fenton KA, 2005, LANCET, V365, P1246, DOI 10.1016/S0140-6736(05)74813-3; Furegato M, 2016, EPIDEMIOL INFECT, V144, P3253, DOI 10.1017/S0950268816001679; Hoenderboom, 2018, RIVM, DOI 10.21945/RIVM-2018-0012; Hulstein SH, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3533-7; Matser A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067287; Oudhof K., 2011, BEVOLKINGSTRENDS 2E, P97; Pemberton S, 2019, HEALTH PLACE, V55, P128, DOI 10.1016/j.healthplace.2018.12.003; Picavet C., 2012, TIJDSCHRIFT SEKSUOLO, V36, P12; van Oeffelen AAM, 2017, SEX TRANSM INFECT, V93, P46, DOI 10.1136/sextrans-2016-052558; Wasserman J, 2019, AM J PUBLIC HEALTH, V109, pS64, DOI [10.2105/ajph.2018.304922, 10.2105/AJPH.2018.304922]; Wayal S, 2017, LANCET PUBLIC HEALTH, V2, pE458, DOI 10.1016/S2468-2667(17)30159-7; Woestenberg PJ, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0281-2	15	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247130	10.1371/journal.pone.0247130	http://dx.doi.org/10.1371/journal.pone.0247130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606805	Green Published, gold			2022-12-26	WOS:000620629200173
J	Shihab, AH; Eliasy, A; Lopes, BT; Wu, R; White, L; Jones, S; Geraghty, B; Joda, A; Elsheikh, A; Abass, A				Shihab, Ahmad H.; Eliasy, Ashkan; Lopes, Bernardo T.; Wu, Richard; White, Lynn; Jones, Steve; Geraghty, Brendan; Joda, Akram; Elsheikh, Ahmed; Abass, Ahmed			Compressive behaviour of soft contact lenses and its effect on refractive power on the eye and handling off the eye	PLOS ONE			English	Article								Purpose To investigate the stress-strain behaviour of 9 soft contact lens materials, that are commonly used in the market, under uniaxial compression loading. Methods Seven types of hydrogel and two types of silicone-hydrogel soft contact lens materials were hydrated in phosphate-buffered saline (PBS) solution then subjected to uniaxial compression loads. The load rate was set to 16.0 N/min starting with two consecutive initial 5.0 N loading cycles followed by three relaxation periods of 4.0 min within which there were two more 5.0 N loading cycles and eventually, a full loading cycle that stopped at a load of 49.0 N. The load and contraction data obtained experimentally were analysed to derive the stress-strain behaviour. Finite Element (FE) analysis was then utilised to evaluate the performance of soft contact lenses on the human eye and handling lenses off the eye. Results Unlike tensile tests, all tested materials showed nonlinear behaviour when tested under compression. When fitted to first-order Ogden hyperelastic model, parameter mu was found to be varying in the range 0.12 to 0.74 MPa and material parameter alpha was found to be varying in the range 8.2 to 20.326 among the nine tested materials. Compression modulus of elasticity was 2.2 times higher than the tensile modulus of elasticity on average. FE simulation with nonlinear Ogden constitutive model showed a limited change (8%similar to 12%) in the optical performance when compared to other material models, however, it predicted higher stress when the lens was simulated under bending during off-eye handling. Conclusions Compression tests revealed slightly nonlinear behaviour when materials were strained under compression stress down to 15% similar to 30% of their nominal heights. Considering the physiological compression loading range of 8 mmHg, secant moduli of elasticity were 1.5% to 6.9% higher than the tension moduli of elasticity depending on the material. Tensile-based moduli of elasticity could be used in FE analysis as a step towards simulating the optical performance of soft contact lenses on-eye. However, nonlinear compression-based material models are recommended for FE analysis of soft contact lenses when lens-handling is investigated off-eye.	[Shihab, Ahmad H.; Joda, Akram; Elsheikh, Ahmed; Abass, Ahmed] Univ Liverpool, Sch Engn, Dept Mech Mat & Aerosp Engn, Liverpool, Merseyside, England; [Shihab, Ahmad H.] Univ Hertfordshire, Sch Phys Engn & Comp Sci, Dept Engn & Technol, Hatfield, Herts, England; [Eliasy, Ashkan; Lopes, Bernardo T.; Jones, Steve] Univ Liverpool, Sch Engn, Dept Civil Engn & Ind Design, Liverpool, Merseyside, England; [Lopes, Bernardo T.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil; [Wu, Richard] Cent Taiwan Univ Sci & Technol, Dept Optometry, Taichung, Taiwan; [White, Lynn] UltraVis CLPL, R&D Dept, Leighton Buzzard, England; [Geraghty, Brendan] Univ Liverpool, Inst Life Course & Med Sci, Liverpool, Merseyside, England; [Joda, Akram] Higher Coll Technol, Fac Engn, Dubai, U Arab Emirates; [Elsheikh, Ahmed] Beihang Univ, Sch Biol Sci & Biomed Engn, Beijing, Peoples R China; [Elsheikh, Ahmed] Moorfields Eye Hosp NHS Fdn Trust, Natl Inst Hlth Res NIHR, Biomed Res Ctr, London, England; [Elsheikh, Ahmed] UCL Inst Ophthalmol, London, England; [Abass, Ahmed] Port Said Univ, Fac Engn, Dept Prod Engn & Mech Design, Port Said, Egypt	University of Liverpool; University of Hertfordshire; University of Liverpool; Universidade Federal de Sao Paulo (UNIFESP); Central Taiwan University Science & Technology; University of Liverpool; Higher Colleges of Technology - United Arab Emirates; Beihang University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Egyptian Knowledge Bank (EKB); Port Said University	Abass, A (corresponding author), Univ Liverpool, Sch Engn, Dept Mech Mat & Aerosp Engn, Liverpool, Merseyside, England.; Abass, A (corresponding author), Port Said Univ, Fac Engn, Dept Prod Engn & Mech Design, Port Said, Egypt.	A.Abass@liverpool.ac.uk	Abass, Ahmed/S-3107-2019; Eliasy, Ashkan/AAF-4941-2019	Abass, Ahmed/0000-0002-8622-4632; Eliasy, Ashkan/0000-0002-4473-1900; Shihab, Ahmad/0000-0002-6956-2955				Abass A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219789; Abass A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216484; Abass A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207710; Alba-Bueno F, 2009, CONTACT LENS ANTERIO, V32, P88, DOI 10.1016/j.clae.2008.11.002; Ateshian GA, 2007, J BIOMECH ENG-T ASME, V129, P405, DOI 10.1115/1.2720918; Bhamra TS, 2017, CONTACT LENS ANTERIO, V40, P70, DOI 10.1016/j.clae.2016.11.005; Bower A.F., 2009, APPL MECH SOLIDS; Bretz K., 2010, BIOMECHANICA HUNGARI, V3, P61, DOI DOI 10.17489/BIOHUN/2010/1/07; Consejo A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113419; Consejo A, 2019, ACTA OPHTHALMOL, V97, pE266, DOI 10.1111/aos.13901; Consejo A, 2017, J CATARACT REFR SURG, V43, P667, DOI 10.1016/j.jcrs.2017.02.027; Consejo A, 2017, OPHTHAL PHYSL OPT, V37, P263, DOI 10.1111/opo.12377; Davis J.R., 2004, TENSILE TESTING; Dillehay Sally M, 2007, Eye Contact Lens, V33, P148, DOI 10.1097/01.icl.0000245572.66698.b1; DOANE MG, 1980, AM J OPHTHALMOL, V89, P507, DOI 10.1016/0002-9394(80)90058-6; Doll T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242243; Dumbleton K, 2013, EYE CONTACT LENS, V39, P93, DOI 10.1097/ICL.0b013e318271caf4; Dumbleton Kathy, 2002, Cont Lens Anterior Eye, V25, P137, DOI 10.1016/S1367-0484(02)00009-7; Elsheikh A, 2007, CURR EYE RES, V32, P11, DOI 10.1080/02713680601077145; Elsheikh A, 2013, MED ENG PHYS, V35, P211, DOI 10.1016/j.medengphy.2012.09.006; Elsheikh A, 2010, J R SOC INTERFACE, V7, P1475, DOI 10.1098/rsif.2010.0108; FATT I, 1976, AM J OPTOM PHYS OPT, V53, P104; Fonn Desmond, 2005, Eye Contact Lens, V31, P247, DOI 10.1097/01.icl.0000182488.70745.1d; Gabler Stefan, 2009, International Journal of Materials Engineering Innovation, V1, P3, DOI 10.1504/IJMATEI.2009.024024; Geraghty B, 2020, J BIOMECH, V98, DOI 10.1016/j.jbiomech.2019.109438; Graham Andrew D, 2009, Optom Vis Sci, V86, pe324, DOI 10.1097/OPX.0b013e318199d1f7; Guillon M, 2013, EYE CONTACT LENS, V39, P86, DOI 10.1097/ICL.0b013e31827cb99f; Harris MD, 2012, J ORTHOP RES, V30, P1133, DOI 10.1002/jor.22040; Horst CR, 2012, OPTOMETRY VISION SCI, V89, P1468, DOI 10.1097/OPX.0b013e3182691454; Jones LS, 2006, OPTICIAN, V232, P28; Kamath PM., 1969, CONTACTO, V13, P29; KARSON CN, 1983, BRAIN, V106, P643, DOI 10.1093/brain/106.3.643; Kim E, 2018, EYE CONTACT LENS, V44, pS148, DOI 10.1097/ICL.0000000000000442; Kwon KA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0227; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; Lin MC, 2013, EYE CONTACT LENS, V39, P115, DOI 10.1097/ICL.0b013e31827c77fd; Magalhaes R, 2017, ACTA SCI-TECHNOL, V39, P325, DOI 10.4025/actascitechnol.v39i3.29884; Maissa C, 2012, EYE CONTACT LENS, V38, P16, DOI 10.1097/ICL.0b013e31823bad46; Mayah A.A., 2018, BIOMECHANICS SOFT TI; McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520; Mesarovic SD, 1999, P ROY SOC A-MATH PHY, V455, P2707, DOI 10.1098/rspa.1999.0423; Moore J, 2019, BIOENGINEERING-BASEL, V6, DOI 10.3390/bioengineering6040094; MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202; Nakano T, 2013, P NATL ACAD SCI USA, V110, P702, DOI 10.1073/pnas.1214804110; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Rumsey D. J., 2016, STAT DUMMIES, V2nd; Shaw AJ, 2010, INVEST OPHTH VIS SCI, V51, P1911, DOI 10.1167/iovs.09-4090; Snyder C., 2007, CONT LENS SPECTR; Stapleton F, 2017, EYE CONTACT LENS, V43, P32, DOI 10.1097/ICL.0000000000000318; Sulley A, 2017, CONTACT LENS ANTERIO, V40, P248, DOI 10.1016/j.clae.2017.04.001; Sweeney DF, 2013, EYE CONTACT LENS, V39, P53, DOI 10.1097/ICL.0b013e31827c7899; Tranoudis Ioannis, 2004, Cont Lens Anterior Eye, V27, P177, DOI 10.1016/j.clae.2004.08.002; Vidal-Rohr M, 2018, CONTACT LENS ANTERIO, V41, P117, DOI 10.1016/j.clae.2017.09.009; Wang YX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196926; WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0; Young G, 2010, CONTACT LENS ANTERIO, V33, P210, DOI 10.1016/j.clae.2010.06.002; Young G, 2011, EYE CONTACT LENS, V37, P337, DOI 10.1097/ICL.0b013e31822e8c3b; Zhao J, 1998, ACTA OPHTHALMOL SCAN, V76, P438, DOI 10.1034/j.1600-0420.1998.760409.x; Zhou D, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2018.0685	59	0	0	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247194	10.1371/journal.pone.0247194	http://dx.doi.org/10.1371/journal.pone.0247194			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606837	gold, Green Published			2022-12-26	WOS:000620629200036
J	Verma, RR; Srivastava, TK; Singh, P; Manjunath, BL; Kumar, A				Verma, Ram Ratan; Srivastava, Tapendra Kumar; Singh, Pushpa; Manjunath, B. L.; Kumar, Anil			Spatial mapping of soil properties in Konkan region of India experiencing anthropogenic onslaught	PLOS ONE			English	Article							ORGANIC-CARBON; ELECTRICAL-CONDUCTIVITY; MANAGEMENT ZONES; VARIABILITY; FIELD; NITROGEN; GEOSTATISTICS; MODELS; CHINA; PLANTATIONS	Soils of Indian Konkan region, part of ecologically sensitive Western Ghats have been subjected to anthropogenic activities of late. This has endangered the ecological security through conspicuous losses in topsoil quality. The rationale of the present study was to map the soil properties and create management zones for ensuring food and nutritional security. The study was conducted in South Goa district of the state of Goa located in Konkan region. A total of 258 geo-referenced soil samples were collected and analyzed for pH, EC, SOC, available N, P, K and DTPA extractable micronutrients viz., Zn, Cu, Fe and Mn. Soil pH was found to be in acidic range. A wide variability existed in SOC content ranging from 0.12-5.85%. EC was mostly neutral with mean value 0.08 +/- 0.37 dSm(-1), while available nitrogen (AN), available phosphorus (AP) and available potassium (AK) varied in range from 56.4-621.6 kg ha(-1), 0.5-49.7 kg ha(-1) and 31.5-786.2 kg ha(-1) with mean values 211.2 +/- 76.9, 8.4 +/- 8.2 and 202.3 +/- 137.6 kg ha(-1), respectively. A wide range was exhibited by cationic DTPA extractable Zn, Cu, Fe and Mn with mean values, 0.22 +/- 0.30, 0.44 +/- 0.60, 7.78 +/- 5.98 and 7.86 +/- 5.86 mg kg(-1), respectively. Soil pH exhibited significant positive correlation with EC, AP AK and Zn and negative correlation with Fe and Cu. SOC exhibited significantly correlated with AN, AP, AK, Zn and Fe. Geo-statistical analysis revealed J-Bessel as best fit semivariogram model for pH, AP and AK; Rational Quadratic for EC, SOC, Zn and Mn; Hole effect for AN; Stable for Cu and K-Bessel for Fe for their spatial mapping. Four principal components showed eigenvalues more than one and cumulative variability of 59.38%. Three distinct soil management zones showing significant variation in soil properties were identified and delineated for wider scale management of soils. Precision nutrient management based on spatial variation and their mapping would enable refined agricultural and environmental management practices in the region.	[Verma, Ram Ratan; Srivastava, Tapendra Kumar; Singh, Pushpa; Manjunath, B. L.; Kumar, Anil] ICAR Indian Inst Sugarcane Res, Lucknow, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Sugarcane Research	Singh, P (corresponding author), ICAR Indian Inst Sugarcane Res, Lucknow, Uttar Pradesh, India.	parampushpa@gmail.com			ICAR	ICAR(Indian Council of Agricultural Research (ICAR))	The author(s) received no specific funding for this work. However, the work was carried out utilizing the funds provided by ICAR to ICAR-CCARI, Goa for soil sampling and analyses.; The authors are thankful to the Director and Project Coordinator of Soil Test Crop Response, ICAR-Indian Institute of Soil Science, Bhopal and Director of ICAR-Central Coastal Agricultural Research Institute, Goa for providing required facilities and support for the study. Authors also acknowledge the contribution of staff of the Institute's soil testing Laboratory in soil sampling and testing.	Alivelu K, 2003, COMMUN SOIL SCI PLAN, V34, P2633, DOI 10.1081/CSS-120024790; Barros N, 2011, NAT GEOSCI, V4, P593, DOI 10.1038/ngeo1211; Basso B, 2016, ADV AGRON, V136, P27, DOI 10.1016/bs.agron.2015.11.004; Behera SK, 2018, CATENA, V165, P251, DOI 10.1016/j.catena.2018.02.008; Behera SK, 2016, SOLID EARTH, V7, P979, DOI 10.5194/se-7-979-2016; Behera SK, 2015, LAND DEGRAD DEV, V26, P71, DOI 10.1002/ldr.2306; Bhattacharyya R, 2015, SUSTAINABILITY-BASEL, V7, P3528, DOI 10.3390/su7043528; Bhunia Gouri Sankar, 2018, Annals of Agrarian Science, V16, P436, DOI 10.1016/j.aasci.2018.06.003; Birgander J, 2013, SOIL BIOL BIOCHEM, V65, P294, DOI 10.1016/j.soilbio.2013.06.006; Bogunovic I, 2017, SCI TOTAL ENVIRON, V584, P535, DOI 10.1016/j.scitotenv.2017.01.062; Borrelli P, 2015, LAND DEGRAD DEV, V26, P356, DOI 10.1002/ldr.2214; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Brevik EC, 2016, GEODERMA, V264, P256, DOI 10.1016/j.geoderma.2015.05.017; Brown DG, 1998, INT J GEOGR INF SCI, V12, P105, DOI 10.1080/136588198241914; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; Das DC, 2013, INT J BIOASSAYS, V2, P398; Davatgar N, 2012, GEODERMA, V173, P111, DOI 10.1016/j.geoderma.2011.12.005; Egamberdieva D, 2011, BIOL FERT SOILS, V47, P197, DOI 10.1007/s00374-010-0523-3; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Gaonkar CV, 2019, ENVIRON MONIT ASSESS, V191, DOI 10.1007/s10661-019-7506-0; Goenster-Jordan S, 2018, GEODERMA, V330, P99, DOI 10.1016/j.geoderma.2018.05.028; Goovaerts P., 1997, GEOSTATISTICS NATURA, DOI DOI 10.2307/1270969; Haque M. A., 2018, Journal of Bangladesh Academy of Sciences, V42, P11, DOI 10.3329/jbas.v42i1.37829; Islam MS, 2014, ENVIRON MONIT ASSESS, V186, P8727, DOI 10.1007/s10661-014-4040-y; Jackson M. L., 1958, Soil Chemical Analysis.; Jobbagy EG, 2001, BIOGEOCHEMISTRY, V53, P51, DOI 10.1023/A:1010760720215; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kerry R., 2004, International Journal of Applied Earth Observation and Geoinformation, V5, P307, DOI 10.1016/j.jag.2004.07.005; Khaledian Y, 2017, LAND DEGRAD DEV, V28, P128, DOI 10.1002/ldr.2541; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Lei L, 2018, SCI TOTAL ENVIRON, V621, P1360, DOI 10.1016/j.scitotenv.2017.10.092; Li JW, 2008, ECOLOGY, V89, P2911, DOI 10.1890/07-1381.1; Li J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195144; Li QQ, 2016, SCI TOTAL ENVIRON, V547, P173, DOI 10.1016/j.scitotenv.2015.12.094; Li Y, 2007, COMPUT ELECTRON AGR, V56, P174, DOI 10.1016/j.compag.2007.01.013; Lindsay W. L., 1979, Chemical equilibria in soils.; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Liu ZP, 2013, GEODERMA, V197, P67, DOI 10.1016/j.geoderma.2012.12.011; Ma R, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-018-6734-z; Ma WM, 2016, SOIL TILL RES, V155, P69, DOI 10.1016/j.still.2015.07.007; Mahajan GR., 2015, J INDIAN SOC SOIL SC, V63, P232, DOI [10.5958/0974-0228.2015.00031.6, DOI 10.5958/0974-0228.2015.00031.6]; Manerkar GK, 2015, INT J COMM IT SOCIAL, V2, P42; Marshner P., 2012, MINERAL NUTR HIGHER, V3; McKinion JM, 2001, COMPUT ELECTRON AGR, V32, P213, DOI 10.1016/S0168-1699(01)00166-1; Brito WBM, 2018, SOIL TILL RES, V182, P103, DOI 10.1016/j.still.2018.05.008; Mitsch W.J., 2015, WETLANDS, V5th, P456; Mueller TG, 2003, AGRON J, V95, P496, DOI 10.2134/agronj2003.0496; Mulla DJ, 2012, HYDROPEDOLOGY: SYNERGISTIC INTEGRATION OF SOIL SCIENCE AND HYDROLOGY, P637, DOI 10.1016/B978-0-12-386941-8.00020-4; Nang B. D., 2016, Journal of Soil Science and Environmental Management, V7, P53; Nawar S, 2017, ADV AGRON, V143, P175, DOI 10.1016/bs.agron.2017.01.003; Nayak GN., 1998, ENV GEOCHEM, V1, P97; Novara A, 2015, SOLID EARTH, V6, P425, DOI 10.5194/se-6-425-2015; Oliver MA, 2014, CATENA, V113, P56, DOI 10.1016/j.catena.2013.09.006; Patel K. S., 2015, American Journal of Plant Sciences, V6, P3025, DOI 10.4236/ajps.2015.619297; Pereira P, 2013, SOLID EARTH, V4, P153, DOI 10.5194/se-4-153-2013; Peukert S, 2012, RAPID COMMUN MASS SP, V26, P2413, DOI 10.1002/rcm.6336; Rahul T, 2019, ARCH AGRON SOIL SCI, V65, P1775, DOI 10.1080/03650340.2019.1578345; Rajasegar M, 2003, J ENVIRON BIOL, V24, P95; Ranjbar F, 2016, COMPUT ELECTRON AGR, V121, P301, DOI 10.1016/j.compag.2015.12.010; Reddy G. P. O., 2016, Indian Journal of Soil Conservation, V44, P1; Rengel Z, 2015, J SOIL SCI PLANT NUT, V15, P397; Reza S. K., 2018, Journal of the Indian Society of Soil Science, V66, P20, DOI 10.5958/0974-0228.2018.00003.8; Reza SK, 2017, ARCH AGRON SOIL SCI, V63, P1489, DOI 10.1080/03650340.2017.1296134; Saito H, 2005, STOCH ENV RES RISK A, V19, P71, DOI 10.1007/s00477-004-0207-3; Schepers AR, 2004, AGRON J, V96, P195, DOI 10.2134/agronj2004.0195; Sharda VN, 2013, AGR RES, V2, P382, DOI 10.1007/s40003-013-0087-1; Sharmistha Pal, 2010, Indian Journal of Soil Conservation, V38, P178; Simon T, 2005, PLANT SOIL ENVIRON, V51, P276, DOI 10.17221/3586-PSE; Singh AK., 2014, KONKAN REGION ASIAN, V18, P257; Singh KP., 2016, J INDIAN SOC SOIL SC, V64, P427, DOI [10.5958/0974-0228.2016.00055.4, DOI 10.5958/0974-0228.2016.00055.4]; Singh SK, 2016, NBSS PUBL, V173; Sofi JA, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5154-1; SUBBIAH B. V., 1956, CURRENT SCI, V25, P259; Suh J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121463; Talule D.C., 2018, ASIAN J SCI TECHNOL, V8, P5012; Tesfahunegn GB, 2011, SOIL TILL RES, V117, P124, DOI 10.1016/j.still.2011.09.005; Utset A, 2000, GEODERMA, V96, P199, DOI 10.1016/S0016-7061(99)00055-5; Verma RR, 2018, LAND DEGRAD DEV, V29, P4313, DOI 10.1002/ldr.3183; Vieira S. R., 2002, TOPICS SOIL SCI, V2, P1; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22058; Wang XZ, 2009, COMPUT ELECTRON AGR, V65, P168, DOI 10.1016/j.compag.2008.08.008; Wang YQ, 2009, GEODERMA, V150, P141, DOI 10.1016/j.geoderma.2009.01.021; Wang ZM, 2012, AMBIO, V41, P782, DOI 10.1007/s13280-012-0280-7; Wani MA, 2013, J INDIAN SOC REMOTE, V41, P319, DOI 10.1007/s12524-012-0242-3; White JG, 1999, FIELD CROP RES, V60, P11, DOI 10.1016/S0378-4290(98)00130-0; Yang Le, 2014, Acta Ecologica Sinica - International Journal, V34, P204, DOI 10.1016/j.chnaes.2013.05.011; Yang XJ, 2013, ENVIRON DEV, V8, P131, DOI 10.1016/j.envdev.2013.03.006; Yao X, 2019, SCI TOTAL ENVIRON, V683, P98, DOI 10.1016/j.scitotenv.2019.05.221; Zhang HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119175; Zhao DS, 2015, INT J CLIMATOL, V35, P337, DOI 10.1002/joc.3979	93	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247177	10.1371/journal.pone.0247177	http://dx.doi.org/10.1371/journal.pone.0247177			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606778	gold, Green Published			2022-12-26	WOS:000620629200067
J	Fletcher, R; Tong, JS; Risnik, D; Leibowitz, BJ; Wang, YJ; Concha-Benavente, F; DeLiberty, JM; Stolz, DB; Pai, RK; Ferris, RL; Schoen, RE; Yu, J; Zhang, L				Fletcher, Rochelle; Tong, Jingshan; Risnik, Denise; Leibowitz, Brian J.; Wang, Yi-Jun; Concha-Benavente, Fernando; DeLiberty, Jonathan M.; Stolz, Donna B.; Pai, Reet K.; Ferris, Robert L.; Schoen, Robert E.; Yu, Jian; Zhang, Lin			Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN-RESPONSE; APC-DEFICIENT CELLS; INDUCED APOPTOSIS; CANCER CHEMOPREVENTION; SULINDAC; MECHANISMS; PATHWAYS; NSAIDS; COLON	Use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with reduced risk of colorectal cancer (CRC). However, the mechanism by which NSAIDs suppress colorectal tumorigenesis remains unclear. We previously showed that NSAIDs selectively kill emerging tumor cells via death receptor (DR) signaling and a synthetic lethal interaction mediated by the proapoptotic Bcl-2 family protein BID. In this study, we found NSAIDs induce endoplasmic reticulum (ER) stress to activate DR signaling and BID in tumor suppression. Importantly, our results unveiled an ER stress- and BID-dependent immunogenic effect of NSAIDs, which may be critical for tumor suppression. NSAID treatment induced hallmarks of immunogenic cell death (ICD) in CRC cells and colonic epithelial cells upon loss of APC tumor suppressor, and elevated tumor-infiltrating lymphocytes (TILs) in the polyps of APC(Min/+) mice. ER stress inhibition or BID deletion abrogated the antitumor and immunogenic effects of NSAIDs. Furthermore, increased ER stress and TILs were detected in human advanced adenomas from NSAID-treated patients. Together, our results suggest that NSAIDs induce ER stress- and BID-mediated ICD to restore immunosurveillance and suppress colorectal tumor formation.	[Fletcher, Rochelle; Tong, Jingshan; Risnik, Denise; Leibowitz, Brian J.; Wang, Yi-Jun; Concha-Benavente, Fernando; Stolz, Donna B.; Pai, Reet K.; Ferris, Robert L.; Schoen, Robert E.; Yu, Jian; Zhang, Lin] UPMC Hillman Canc Ctr, Pittsburgh, PA 15232 USA; [Fletcher, Rochelle; Tong, Jingshan; Risnik, Denise; Wang, Yi-Jun; DeLiberty, Jonathan M.; Zhang, Lin] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Leibowitz, Brian J.; Pai, Reet K.; Yu, Jian] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Concha-Benavente, Fernando; Ferris, Robert L.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; [Concha-Benavente, Fernando; Ferris, Robert L.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA; [Schoen, Robert E.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Schoen, Robert E.] Univ Pittsburgh, Sch Med, Dept Epidemiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, L (corresponding author), UPMC Hillman Canc Ctr, Pittsburgh, PA 15232 USA.; Zhang, L (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	zhanglx@upmc.edu	Wang, Yixuan/GZK-6559-2022; Wang, Yijun/GXW-1763-2022; Yu, Jian/A-8301-2009; Zhang, Lin/A-7389-2009; wang, yixuan/GXW-2866-2022; Wang, Yin/HCI-9352-2022; Wang, Yu/GZL-9655-2022; wang, yi/GVT-8516-2022	Yu, Jian/0000-0002-4021-1000; Zhang, Lin/0000-0003-0018-3903; Risnik, Denise/0000-0001-8843-7968; DeLiberty, Jonathan/0000-0001-6001-6678; Tong, Jingshan/0000-0003-1640-5769	U.S. National Institute of Health [R01CA172136, R01CA203028, R01CA217141, R01CA236271, R01CA247231, U19AI068021, R01CA215481, U01CA152753, P30CA047904]	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. Michael T. Lotze and our lab members for discussion and critical reading and Ms. Dorothy Coe for technical assistance. This work is supported by U.S. National Institute of Health grants (R01CA172136, R01CA203028, R01CA217141, R01CA236271, and R01CA247231 to LZ; U19AI068021 and R01CA215481 to JY; U01CA152753 to RES). This project used the UPMC Hillman Cancer Center shared facilities that were supported in part by award P30CA047904.	Bank A, 2008, CANCER RES, V68, P276, DOI 10.1158/0008-5472.CAN-07-5242; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Berg AK, 2013, J CLIN PHARMACOL, V53, P403, DOI 10.1002/jcph.26; Bezu L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00187; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cao Y, 2016, GASTROENTEROLOGY, V151, P879, DOI 10.1053/j.gastro.2016.07.030; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Chen DS, 2018, P NATL ACAD SCI USA, V115, P3930, DOI 10.1073/pnas.1717190115; Drew DA, 2016, NAT REV CANCER, V16, P173, DOI 10.1038/nrc.2016.4; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Fletcher R, 2018, BBA-REV CANCER, V1869, P138, DOI 10.1016/j.bbcan.2017.12.002; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Gurpinar E, 2014, CLIN CANCER RES, V20, P1104, DOI 10.1158/1078-0432.CCR-13-1573; He Q, 2003, ONCOGENE, V22, P2674, DOI 10.1038/sj.onc.1206363; Huang Y, 2001, CANCER RES, V61, P6918; Keller JJ, 2003, CANCER BIOL THER, V2, pS140; Kepp O, 2015, SEMIN CANCER BIOL, V33, P86, DOI 10.1016/j.semcancer.2015.02.004; Kim JY, 2016, ANTICANCER RES, V36, P2705; Knickelbein K, 2018, ONCOGENE, V37, P4599, DOI 10.1038/s41388-018-0289-x; Kohli M, 2004, P NATL ACAD SCI USA, V101, P16897, DOI 10.1073/pnas.0403405101; Kratochvilova K, 2016, EUR J CELL BIOL, V95, P115, DOI 10.1016/j.ejcb.2016.02.002; LEE SC, 1995, BIOCHEM PHARMACOL, V49, P1567, DOI 10.1016/0006-2952(95)00093-F; Leibowitz B, 2014, P NATL ACAD SCI USA, V111, P16520, DOI 10.1073/pnas.1415178111; Lonnroth Christina, 2008, Cancer Immun, V8, P5; Lopez-Abaitero A, 2009, J IMMUNOTHER, V32, P465, DOI 10.1097/CJI.0b013e3181a1c24e; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Ma L, 2019, SCIENCE, V365, P162, DOI 10.1126/science.aav8692; Marzbani E, 2013, CANCER PREV RES, V6, P764, DOI 10.1158/1940-6207.CAPR-13-0036; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Pereira Felipe V, 2018, Oncotarget, V9, P25808, DOI 10.18632/oncotarget.25380; Pozzi C, 2016, NAT MED, V22, P624, DOI 10.1038/nm.4078; Qiu W, 2010, P NATL ACAD SCI USA, V107, P20027, DOI 10.1073/pnas.1010430107; Qiu W, 2009, CANCER RES, V69, P4999, DOI 10.1158/0008-5472.CAN-09-0262; Rufo N, 2017, TRENDS CANCER, V3, P643, DOI 10.1016/j.trecan.2017.07.002; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schuler PJ, 2014, CLIN CANCER RES, V20, P2433, DOI 10.1158/1078-0432.CCR-13-2617; Seed MP, 1997, CANCER RES, V57, P1625; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; STRONG HA, 1987, XENOBIOTICA, V17, P685, DOI 10.3109/00498258709043976; STRONG HA, 1985, CLIN PHARMACOL THER, V38, P387, DOI 10.1038/clpt.1985.192; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tan X, 2019, CANCER RES, V79, P1191, DOI 10.1158/0008-5472.CAN-18-3223; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Tong J, 2017, ONCOGENE, V36, P787, DOI 10.1038/onc.2016.247; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Wang Y, 2004, CANCER CELL, V5, P501, DOI 10.1016/S1535-6108(04)00113-8; Wang YJ, 2018, GENES DIS, V5, P194, DOI 10.1016/j.gendis.2018.05.003; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang L, 2010, NATURE, V464, P1058, DOI 10.1038/nature08871; Zhang XB, 2013, CANCER PREV RES, V6, P1337, DOI 10.1158/1940-6207.CAPR-13-0220	55	9	9	1	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2021	40	11					2035	2050		10.1038/s41388-021-01687-8	http://dx.doi.org/10.1038/s41388-021-01687-8		FEB 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QZ5PE	33603166	Green Accepted			2022-12-26	WOS:000619405600002
J	Rey, SF; Franklin, J; Rey, SJ				Rey, Savannah Franklin; Franklin, Janet; Rey, Sergio J.			Microplastic pollution on island beaches, Oahu, Hawai`i	PLOS ONE			English	Article								We report microplastic densities on windward beaches of Oahu, Hawai`i, USA, an island that received about 6 million tourist visits a year. Microplastic densities, surveyed on six Oahu beaches, were highest on the beaches with the coarsest sands, associated with high wave energy. On those beaches, densities were very high (700-1700 particles m(-2)), as high as those recorded on other remote island beaches worldwide. Densities were higher at storm tide lines than high tide lines. Results from our study provide empirical data on the distribution of microplastics on the most populated and visited of the Hawaiian islands.	[Rey, Savannah Franklin] Hawaii Pacific Univ, Dept Nat Sci, Honolulu, HI USA; [Franklin, Janet] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Rey, Sergio J.] Univ Calif Riverside, Sch Publ Policy, Riverside, CA USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Franklin, J (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	jfrankl@ucr.edu	Franklin, Janet/G-6538-2013	Franklin, Janet/0000-0003-0314-4598				Anderson JC, 2016, ENVIRON POLLUT, V218, P269, DOI 10.1016/j.envpol.2016.06.074; Borrelle SB, 2020, SCIENCE, V369, P1515, DOI 10.1126/science.aba3656; Cooper DA, 2010, MAR POLLUT BULL, V60, P650, DOI 10.1016/j.marpolbul.2009.12.026; Corcoran PL, 2009, MAR POLLUT BULL, V58, P80, DOI 10.1016/j.marpolbul.2008.08.022; Costa MF, 2010, ENVIRON MONIT ASSESS, V168, P299, DOI 10.1007/s10661-009-1113-4; de Carvalho DG, 2016, OCEAN COAST MANAGE, V128, P10, DOI 10.1016/j.ocecoaman.2016.04.009; Pinon-Colin TD, 2018, MAR POLLUT BULL, V131, P63, DOI 10.1016/j.marpolbul.2018.03.055; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Diez SM, 2019, MARINE POLLUTION CAR; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Etikan I., 2016, AM J THEORETICAL APP, V5, P1, DOI [10.11648/j.ajtas.20160501.11, DOI 10.11648/J.AJTAS.20160501.11]; Frias JPGL, 2010, MAR POLLUT BULL, V60, P1988, DOI 10.1016/j.marpolbul.2010.07.030; Galloway TS, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0116; Gray AD, 2018, MAR POLLUT BULL, V128, P223, DOI 10.1016/j.marpolbul.2018.01.030; Green DS, 2016, ENVIRON POLLUT, V208, P426, DOI 10.1016/j.envpol.2015.10.010; Hartmann NB, 2019, ENVIRON SCI TECHNOL, V53, P4678, DOI 10.1021/acs.est.9b02238; Hidalgo-Ruz V, 2013, MAR ENVIRON RES, V87-88, P12, DOI 10.1016/j.marenvres.2013.02.015; Hidalgo-Ruz V, 2012, ENVIRON SCI TECHNOL, V46, P3060, DOI 10.1021/es2031505; do Sul JAI, 2014, ENVIRON POLLUT, V185, P352, DOI 10.1016/j.envpol.2013.10.036; do Sul JAI, 2009, MAR POLLUT BULL, V58, P1236, DOI [10.1016/j.marpolbul.2008.05.004, 10.1016/j.marpolbul.2009.05.004]; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Jayasiri HB, 2013, MAR POLLUT BULL, V77, P107, DOI 10.1016/j.marpolbul.2013.10.024; Kappler A, 2016, ANAL BIOANAL CHEM, V408, P8377, DOI 10.1007/s00216-016-9956-3; Laglbauer BJL, 2014, MAR POLLUT BULL, V89, P356, DOI 10.1016/j.marpolbul.2014.09.036; Lamb JB, 2018, SCIENCE, V359, P460, DOI 10.1126/science.aar3320; Lebreton L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22939-w; Liebezeit G, 2012, B ENVIRON CONTAM TOX, V89, P213, DOI 10.1007/s00128-012-0642-7; Lovison S., 2018, TAKING ACTION RISING; Machado AAD, 2018, GLOBAL CHANGE BIOL, V24, P1405, DOI 10.1111/gcb.14020; McDermid KJ, 2004, MAR POLLUT BULL, V48, P790, DOI 10.1016/j.marpolbul.2003.10.017; Pan Z, 2019, SCI TOTAL ENVIRON, V650, P1913, DOI 10.1016/j.scitotenv.2018.09.244; R Core Team, 2020, R LANG ENV STAT COMP; Scopetani C, 2020, ECOTOX ENVIRON SAFE, V189, DOI 10.1016/j.ecoenv.2019.110036; Setala O, 2016, MAR POLLUT BULL, V102, P95, DOI 10.1016/j.marpolbul.2015.11.053; Sharma S, 2017, ENVIRON SCI POLLUT R, V24, P21530, DOI 10.1007/s11356-017-9910-8; Sheavly SB, 2007, J POLYM ENVIRON, V15, P301, DOI 10.1007/s10924-007-0074-3; Song YK, 2015, MAR POLLUT BULL, V93, P202, DOI 10.1016/j.marpolbul.2015.01.015; Song YK, 2014, ENVIRON SCI TECHNOL, V48, P9014, DOI 10.1021/es501757s; Storrier KL, 2007, J COASTAL RES, V23, P813, DOI 10.2112/04-0251.1; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Tosetto L, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2973-0; Turra A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04435; Van A, 2012, CHEMOSPHERE, V86, P258, DOI 10.1016/j.chemosphere.2011.09.039; van Sebille E, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab6d7d; Vedolin MC, 2018, MAR POLLUT BULL, V129, P487, DOI 10.1016/j.marpolbul.2017.10.019; Virsek MK, 2016, JOVE-J VIS EXP, DOI 10.3791/55161; Woodall LC, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140317	47	9	9	8	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247224	10.1371/journal.pone.0247224	http://dx.doi.org/10.1371/journal.pone.0247224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600448	gold, Green Published			2022-12-26	WOS:000620625100013
J	Shiyovich, A; Chodick, G; Azani, L; Tirosh, M; Shuvy, M; Pereg, D; Katz, A; Minha, S				Shiyovich, Arthur; Chodick, Gabriel; Azani, Liat; Tirosh, Matanya; Shuvy, Mony; Pereg, David; Katz, Amos; Minha, Sa'ar			Sex-specific contemporary trends in incidence, prevalence and survival of patients with non-valvular atrial fibrillation: A long-term real-world data analysis	PLOS ONE			English	Article								Introduction Atrial fibrillation (AF) is a major increasing public health problem worldwide, with clinical and epidemiological differences between men and women. However, contemporary population-level data on incidence and survival are scarce. Aim To evaluate sex-specific contemporary trends in the incidence, prevalence, and long-term survival of non-valvular AF in a real-world setting Methods AF patients diagnosed between 2007-2015, insured by a large, state-mandated health organization in Israel (Maccabi Healthcare Services) were included. AF was diagnosed based on registered diagnoses. Patients with valvular disease, active malignancy, cardiac surgery <= 6 months, or recent pregnancy, were excluded. Annual incidence rate, period prevalence, and 5-year survival for each calendar year during the study period, were calculated. Results A total of 15,409 eligible patients (8,288 males, 7,121 females) were identified. Males were more likely to be younger, have higher rates of underlying diseases (ischemic heart disease, heart failure, and chronic obstructive pulmonary disease), but with lower rates of hypertension and chronic kidney diseases as compared to female patients. During the study period, age-adjusted incidence decreased both in men: (-0.020/1,000-person year, p-for trend = 0.033) and, women (-0.025/1,000 person-year p = 0.009). The five-year survival rate was significantly higher among men vs. women (77.1% vs. 71.5%, respectively, p<0.001). Age-adjusted prevalence increased significantly among men (+0.102 per year, p-for trend<0.001) yet decreased among women (-0.082 per year, p-for trend = 0.005). A significant trend toward improved long-term survival was observed in women and not in men. Conclusions The current study shows significant sex-related disparities in the incidence, prevalence, and survival of AF patients between 2007-2015; while the adjusted incidence of both has decreased over-time, prevalence and mortality decreased significantly only in women.	[Shiyovich, Arthur] Rabin Med Ctr, Petah Tiqwa, Israel; [Shiyovich, Arthur; Chodick, Gabriel; Pereg, David; Minha, Sa'ar] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Chodick, Gabriel; Azani, Liat] Kahn Sagol Maccabi Res & Innovat Inst, Maccabi Healthcare Serv, Tel Aviv, Israel; [Tirosh, Matanya] Med Affairs Pfizer Israel, Herzliyya, Israel; [Shuvy, Mony] Hadassah Hebrew Univ, Heart Inst, Med Ctr, Jerusalem, Israel; [Pereg, David] Meir Med Ctr, Dept Cardiol, Kefar Sava, Israel; [Katz, Amos] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Minha, Sa'ar] Shamir Med Ctr, Dept Cardiol, Zerifin, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Pfizer; Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University; Shamir Medical Center (Assaf Harofeh)	Shiyovich, A (corresponding author), Rabin Med Ctr, Petah Tiqwa, Israel.; Shiyovich, A (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.	arthur.shiyovich@gmail.com		/0000-0002-5189-8995; Shiyovich, Arthur/0000-0001-7316-1882	Pfizer Pharmaceuticals Israel ltd. [B0661099]	Pfizer Pharmaceuticals Israel ltd.	The study was sponsored by Pfizer Pharmaceuticals Israel ltd. grant number B0661099 Conflict of interest statement: A. Shiyovich received a honorarium from Pfizer Pharmaceuticals Israel ltd. M. Tirosh is an employee of Pfizer Israel. The remaining authors declare no conflict of interest. The funder approved the study protocol and approved the publication of the study and the manuscript.	Andrade JG, 2018, CAN J CARDIOL, V34, P429, DOI 10.1016/j.cjca.2017.11.022; Anselmino M, 2015, J CARDIOVASC MED, V16, P795, DOI 10.2459/JCM.0000000000000239; Ball J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065795; Bansal N, 2016, CLIN J AM SOC NEPHRO, V11, P1189, DOI 10.2215/CJN.10921015; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Buitrago C, 2000, CELL SIGNAL, V12, P47, DOI 10.1016/S0898-6568(99)00066-2; Chamberlain AM, 2015, AM J MED, V128, P260, DOI 10.1016/j.amjmed.2014.10.030; Chien KL, 2010, INT J CARDIOL, V139, P173, DOI 10.1016/j.ijcard.2008.10.045; Chodick G, 2003, EUR J EPIDEMIOL, V18, P1143, DOI 10.1023/B:EJEP.0000006635.36802.c8; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Cochet H, 2015, J CARDIOVASC ELECTR, V26, P484, DOI 10.1111/jce.12651; DeWilde S, 2006, HEART, V92, P1064, DOI 10.1136/hrt.2005.069492; Drici MD, 1996, CIRCULATION, V94, P1471, DOI 10.1161/01.CIR.94.6.1471; Emdin CA, 2016, AM J CARDIOL, V118, P511, DOI 10.1016/j.amjcard.2016.05.041; Friberg J, 2003, AM J CARDIOL, V92, P1419, DOI 10.1016/j.amjcard.2003.08.050; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hsu JC, 2016, J AM COLL CARDIOL, V67, P2913, DOI 10.1016/j.jacc.2016.03.581; Kamalvand K, 1999, EUR HEART J, V20, P888, DOI 10.1053/euhj.1998.1404; Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051; Kim MH, 2011, CIRC-CARDIOVASC QUAL, V4, P313, DOI 10.1161/CIRCOUTCOMES.110.958165; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Ko D, 2017, NAT REV CARDIOL, V14, P113, DOI 10.1038/nrcardio.2016.171; Ko D, 2016, NAT REV CARDIOL, V13, P321, DOI 10.1038/nrcardio.2016.45; Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280; Kwok CS, 2011, NEUROLOGY, V76, P914, DOI 10.1212/WNL.0b013e31820f2e38; Lane DA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005155; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Majeed A, 2001, HEART, V86, P284, DOI 10.1136/heart.86.3.284; Mathew JS, 2014, CIRCULATION, V130, P298, DOI 10.1161/CIRCULATIONAHA.113.005499; McManus DD, 2010, CIRCULATION, V121, P667, DOI 10.1161/CIRCULATIONAHA.109.885806; Miyasaka Y, 2006, EUR HEART J, V27, P936, DOI 10.1093/eurheartj/ehi694; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Peters SAE, 2019, CIRCULATION, V139, P1025, DOI 10.1161/CIRCULATIONAHA.118.035550; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Potpara TS, 2017, HEART, V103, P979, DOI 10.1136/heartjnl-2016-311085; Potpara TS, 2012, INT J CARDIOL, V161, P39, DOI 10.1016/j.ijcard.2011.04.022; Rahman F, 2014, NAT REV CARDIOL, V11, P639, DOI 10.1038/nrcardio.2014.118; Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8; Scowcroft ACE, 2014, INT J CARDIOL, V171, P169, DOI 10.1016/j.ijcard.2013.11.086; Shalev V, 2011, INT J CARDIOL, V152, P345, DOI 10.1016/j.ijcard.2010.08.002; Soliman EZ, 2014, JAMA INTERN MED, V174, pE107, DOI 10.1001/jamainternmed.2013.11912; Stefansdottir H, 2011, EUROPACE, V13, P1110, DOI 10.1093/europace/eur132; Wilke T, 2013, EUROPACE, V15, P486, DOI 10.1093/europace/eus333; Williams BA, 2017, AM J CARDIOL, V120, P1961, DOI 10.1016/j.amjcard.2017.08.014; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Zulkifly H, 2018, INT J CLIN PRACT, V72, DOI 10.1111/ijcp.13070; Zylla MM, 2016, HEART RHYTHM, V13, P1837, DOI 10.1016/j.hrthm.2016.06.005	50	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247097	10.1371/journal.pone.0247097	http://dx.doi.org/10.1371/journal.pone.0247097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600504	gold, Green Published			2022-12-26	WOS:000620625100056
J	Wang, L; Liang, D; Xiong, X; Lin, YS; Zhu, JL; Yao, ZM; Wang, SH; Guo, Y; Chen, YP; Geary, K; Pan, YL; Zhou, FY; Gao, SG; Zhang, DZ; Yeung, SCJ; Zhang, H				Wang, Lu; Liang, Du; Xiong, Xiao; Lin, Yusheng; Zhu, Jianlin; Yao, Zhimeng; Wang, Shuhong; Guo, Yi; Chen, Yuping; Geary, Kyla; Pan, Yunlong; Zhou, Fuyou; Gao, Shegan; Zhang, Dianzheng; Yeung, Sai-Ching Jim; Zhang, Hao			Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling	ONCOGENE			English	Article								Smoking is one of the most impactful lifestyle-related risk factors in many cancer types including esophageal squamous cell carcinoma (ESCC). As the major component of tobacco and e-cigarettes, nicotine is not only responsible for addiction to smoking but also a carcinogen. Here we report that nicotine enhances ESCC cancer malignancy and tumor-initiating capacity by interacting with cholinergic receptor nicotinic alpha 7 subunit (CHRNA7) and subsequently activating the JAK2/STAT3 signaling pathway. We found that aberrant CHRNA7 expression can serve as an independent prognostic factor for ESCC patients. In multiple ESCC mouse models, dextromethorphan and metformin synergistically repressed nicotine-enhanced cancer-initiating cells (CIC) properties and inhibited ESCC progression. Mechanistically, dextromethorphan non-competitively inhibited nicotine binding to CHRNA7 while metformin downregulated CHRNA7 expression by antagonizing nicotine-induced promoter DNA hypomethylation of CHRNA7. Since dextromethorphan and metformin are two safe FDA-approved drugs with minimal undesirable side-effects, the combination of these drugs has a high potential as either a preventive and/or a therapeutic strategy against nicotine-promoted ESCC and perhaps other nicotine-sensitive cancer types as well.	[Wang, Lu; Liang, Du; Xiong, Xiao; Lin, Yusheng; Zhu, Jianlin; Yao, Zhimeng; Wang, Shuhong; Pan, Yunlong; Zhang, Hao] Jinan Univ, Dept Gen Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Wang, Lu; Liang, Du; Xiong, Xiao; Lin, Yusheng; Zhu, Jianlin; Yao, Zhimeng; Wang, Shuhong; Pan, Yunlong; Zhang, Hao] Jinan Univ, Inst Precis Canc Med & Pathol, Sch Med, Guangzhou, Guangdong, Peoples R China; [Liang, Du] Univ Groningen, Dept Biomed Sci Cells & Syst, Sect Mol Cell Biol & Radiat Oncol, Univ Med Ctr Groningen, Groningen, Netherlands; [Lin, Yusheng] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands; [Guo, Yi] Shantou Univ, Endoscopy Ctr, Coll Med, Affiliated Canc Hosp, Shantou, Guangdong, Peoples R China; [Chen, Yuping] Shantou Univ, Dept Thorac Surg, Affiliated Canc Hosp, Coll Med, Shantou, Guangdong, Peoples R China; [Geary, Kyla; Zhang, Dianzheng] Philadelphia Coll Osteopath Med, Dept Biomed Sci, 4170 City Ave, Philadelphia, PA 19131 USA; [Zhou, Fuyou] Henan Univ Sci & Technol, Affiliated Hosp 4, Anyang 455001, Henan, Peoples R China; [Zhou, Fuyou] Anyang Tumor Hosp, Dept Thorac Surg, Anyang 455001, Henan, Peoples R China; [Gao, Shegan] Henan Univ Sci & Technol, Coll Clin Med, Henan Key Lab Canc Epigenet, Affiliated Hosp 1, Luoyang 471003, Peoples R China; [Yeung, Sai-Ching Jim] Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX 77030 USA; [Yeung, Sai-Ching Jim] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA	Jinan University; Jinan University; University of Groningen; University of Groningen; Shantou University; Shantou University; Henan University of Science & Technology; Henan University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Zhang, H (corresponding author), Jinan Univ, Dept Gen Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.; Zhang, H (corresponding author), Jinan Univ, Inst Precis Canc Med & Pathol, Sch Med, Guangzhou, Guangdong, Peoples R China.	haolabcancercenter@163.com	Yeung, Sai-Ching/AAI-6178-2021	Yeung, Sai-Ching/0000-0001-5170-0822; Du, Liang/0000-0002-1191-2465; Lin, Yusheng/0000-0002-3693-3377; Wang, Lu/0000-0003-2617-655X	National Natural Science Foundation of China [82072683, 81773087, 81071736, 81572876, 30973508, 82002491]; Natural Science Foundation of Guangdong Province of China [9151018004000000, 2020A1515110049]; Special Project on the Integration of Industry, Education and Research of Guangdong Province [2011A090100024]; China Postdoctoral Science Foundation [2020M673078]; Flagship specialty construction project-General surgery [711003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Special Project on the Integration of Industry, Education and Research of Guangdong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Flagship specialty construction project-General surgery	The work was supported by a grant in part by the National Natural Science Foundation of China (82072683, 81773087, 81071736, 81572876, and 30973508 to HZ; 82002491 to LW); the Natural Science Foundation of Guangdong Province of China (9151018004000000 to HZ; 2020A1515110049 to LW); the Science and Technology Planning Project of Guangdong Province of China (2019A030317024 to HZ); Special Project on the Integration of Industry, Education and Research of Guangdong Province (2011A090100024 to HZ); China Postdoctoral Science Foundation (2020M673078 to LW); Flagship specialty construction project-General surgery (Funding no.: 711003).	Al-Wadei MH, 2016, EUR J CANCER, V52, P188, DOI 10.1016/j.ejca.2015.10.003; Bridgeman SC, 2018, DIABETES OBES METAB, V20, P1553, DOI 10.1111/dom.13262; Chen XT, 2013, J CLIN INVEST, V123, P2576, DOI 10.1172/JCI68143; Cummings JL, 2015, JAMA-J AM MED ASSOC, V314, P1242, DOI 10.1001/jama.2015.10214; Cuyas E, 2018, ONCOGENE, V37, P963, DOI 10.1038/onc.2017.367; Damaj MI, 2005, J PHARMACOL EXP THER, V312, P780, DOI 10.1124/jpet.104.075093; Dennis Phillip A, 2005, Cancer Epidemiol Biomarkers Prev, V14, P764, DOI 10.1158/1055-9965.EPI-04-0652; Dong HM, 2017, J PATHOL, V241, P448, DOI 10.1002/path.4839; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; El-Toukhy S, 2018, TOB CONTROL, V27, pS62, DOI 10.1136/tobaccocontrol-2018-054315; Feng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.59; Fillon M, 2019, CA-CANCER J CLIN, V69, P83, DOI 10.3322/caac.21468; Guha P, 2014, BREAST CANCER RES TR, V145, P5, DOI 10.1007/s10549-014-2912-z; Hallden S, 2016, J INTERN MED, V279, P388, DOI 10.1111/joim.12454; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Improgo MRD, 2010, PROG NEUROBIOL, V92, P212, DOI 10.1016/j.pneurobio.2010.05.003; Karam-Hage M, 2014, CA-CANCER J CLIN, V64, P273, DOI 10.3322/caac.21231; Kreslake JM, 2008, AM J PUBLIC HEALTH, V98, P1685, DOI 10.2105/AJPH.2007.125542; Lee HW, 2018, P NATL ACAD SCI USA, V115, pE1560, DOI 10.1073/pnas.1718185115; Li H, 2015, LUNG CANCER, V88, P1, DOI 10.1016/j.lungcan.2015.01.017; Lin YS, 2019, CLIN CANCER RES, V25, P3035, DOI 10.1158/1078-0432.CCR-18-3169; Martin E, 2015, CONTEMP CLIN TRIALS, V41, P146, DOI 10.1016/j.cct.2015.01.012; Mineur YS, 2010, TRENDS PHARMACOL SCI, V31, P580, DOI 10.1016/j.tips.2010.09.004; Moerke MJ, 2020, PHARMACOL REV, V72, P527, DOI 10.1124/pr.119.018028; Momi N, 2013, ONCOGENE, V32, P1384, DOI 10.1038/onc.2012.163; Nelson KA, 1997, NEUROLOGY, V48, P1212, DOI 10.1212/WNL.48.5.1212; Nimmakayala RK, 2018, GASTROENTEROLOGY, V155, P892, DOI 10.1053/j.gastro.2018.05.041; Paleari L, 2009, AM J RESP CRIT CARE, V179, P1141, DOI 10.1164/rccm.200806-908OC; Parada E, 2010, FREE RADICAL BIO MED, V49, P1815, DOI 10.1016/j.freeradbiomed.2010.09.017; Sang CN, 2002, ANESTHESIOLOGY, V96, P1053, DOI 10.1097/00000542-200205000-00005; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Wang L, 2019, CANCER LETT, V450, P22, DOI 10.1016/j.canlet.2019.02.014; Wang SH, 2020, CLIN CANCER RES, V26, P4921, DOI 10.1158/1078-0432.CCR-20-0113; Wright MJ, 2006, PHARMACOL BIOCHEM BE, V85, P507, DOI 10.1016/j.pbb.2006.09.020; Xiong X, 2020, P NATL ACAD SCI USA, V117, P6726, DOI 10.1073/pnas.1913433117; Yan L, 2015, ONCOGENE, V34, P3076, DOI 10.1038/onc.2014.236; Zhang Q, 2020, BRIT J CANCER, V122, P904, DOI 10.1038/s41416-020-0730-0; Zhong T, 2017, ONCOGENE, V36, P2345, DOI 10.1038/onc.2016.391	38	10	10	5	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2021	40	11					1974	1987		10.1038/s41388-021-01682-z	http://dx.doi.org/10.1038/s41388-021-01682-z		FEB 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QZ5PE	33603170	Green Published, hybrid			2022-12-26	WOS:000619433100002
J	Orgueira, AM; Raindo, AP; Lopez, MC; Rodriguez, BA; Arias, JAD; Ferro, RF; Vence, NA; Lopez, AB; Blanco, AA; Perez, LB; Valentin, PM; Perez, MSG; Cerchione, C; Martinelli, G; Fernandez, PM; Encinas, MMP; Lopez, JLB				Mosquera Orgueira, Adrian; Peleteiro Raindo, Andres; Cid Lopez, Miguel; Antelo Rodriguez, Beatriz; Diaz Arias, Jose Angel; Ferreiro Ferro, Roi; Alonso Vence, Natalia; Bendana Lopez, Angeles; Abuin Blanco, Aitor; Bao Perez, Laura; Melero Valentin, Paula; Gonzalez Perez, Marta Sonia; Cerchione, Claudio; Martinelli, Giovanni; Montesinos Fernandez, Pau; Perez Encinas, Manuel Mateo; Bello Lopez, Jose Luis			Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia	PLOS ONE			English	Article								Background FLT3 mutation is present in 25-30% of all acute myeloid leukemias (AML), and it is associated with adverse outcome. FLT3 inhibitors have shown improved survival results in AML both as upfront treatment and in relapsed/refractory disease. Curiously, a variable proportion of wild-type FLT3 patients also responded to these drugs. Methods We analyzed 6 different transcriptomic datasets of AML cases. Differential expression between mutated and wild-type FLT3 AMLs was performed with the Wilcoxon-rank sum test. Hierarchical clustering was used to identify FLT3-mutation like AMLs. Finally, enrichment in recurrent mutations was performed with the Fisher's test. Results A FLT3 mutation-like gene expression pattern was identified among wild-type FLT3 AMLs. This pattern was highly enriched in NPM1 and DNMT3A mutants, and particularly in combined NPM1/DNMT3A mutants. Conclusions We identified a FLT3 mutation-like gene expression pattern in AML which was highly enriched in NPM1 and DNMT3A mutations. Future analysis about the predictive role of this biomarker among wild-type FLT3 patients treated with FLT3 inhibitors is envisaged.	[Mosquera Orgueira, Adrian; Peleteiro Raindo, Andres; Cid Lopez, Miguel; Antelo Rodriguez, Beatriz; Diaz Arias, Jose Angel; Ferreiro Ferro, Roi; Alonso Vence, Natalia; Bendana Lopez, Angeles; Abuin Blanco, Aitor; Bao Perez, Laura; Melero Valentin, Paula; Gonzalez Perez, Marta Sonia; Perez Encinas, Manuel Mateo; Bello Lopez, Jose Luis] Hlth Res Inst Santiago de Compostela IDIS, Santiago, Spain; [Mosquera Orgueira, Adrian; Peleteiro Raindo, Andres; Cid Lopez, Miguel; Antelo Rodriguez, Beatriz; Diaz Arias, Jose Angel; Ferreiro Ferro, Roi; Alonso Vence, Natalia; Bendana Lopez, Angeles; Abuin Blanco, Aitor; Bao Perez, Laura; Gonzalez Perez, Marta Sonia; Perez Encinas, Manuel Mateo; Bello Lopez, Jose Luis] Complexo Hosp Univ Santiago de Compostela CHUS, Div Hematol, SERGAS, Santiago, Spain; [Mosquera Orgueira, Adrian; Peleteiro Raindo, Andres; Cid Lopez, Miguel; Antelo Rodriguez, Beatriz; Perez Encinas, Manuel Mateo; Bello Lopez, Jose Luis] Univ Santiago de Compostela, Santiago, Spain; [Cerchione, Claudio] Univ Bologna, Bologna, Italy; [Martinelli, Giovanni] Ist Sci Romagnolo Studio & Cura Tumori, Meldola, Italy; [Montesinos Fernandez, Pau] Univ Hosp La Fe Valencia, Valencia, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; University of Bologna; IRCCS Meldola (IRST)	Orgueira, AM (corresponding author), Hlth Res Inst Santiago de Compostela IDIS, Santiago, Spain.; Orgueira, AM (corresponding author), Complexo Hosp Univ Santiago de Compostela CHUS, Div Hematol, SERGAS, Santiago, Spain.; Orgueira, AM (corresponding author), Univ Santiago de Compostela, Santiago, Spain.	adrian.mosquera@live.com		Cerchione, Claudio/0000-0002-9104-5436; Montesinos, Pau/0000-0002-3275-5593; Cid Lopez, Miguel/0000-0002-7074-2363; Gonzalez, Marta Sonia/0000-0001-5494-9009; Mosquera Orgueira, Adrian/0000-0003-4838-6750				Bamopoulos SA, 2020, LEUKEMIA, V34, P2621, DOI 10.1038/s41375-020-0839-4; Bezerra MF, 2020, BLOOD, V135, P870, DOI 10.1182/blood.2019003339; ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), 2000, **DROPPED REF**; ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), 2000, **DROPPED REF**; Cortes J, 2018, LANCET ONCOL, V19, P889, DOI 10.1016/S1470-2045(18)30240-7; Cortes JE, 2019, LANCET ONCOL, V20, P984, DOI 10.1016/S1470-2045(19)30150-0; Daver N, 2019, LEUKEMIA, V33, P299, DOI 10.1038/s41375-018-0357-9; DiNardo CD, 2018, NEW ENGL J MED, V378, P2386, DOI 10.1056/NEJMoa1716984; Falini B, 2019, LEUKEMIA, V33, P1043, DOI 10.1038/s41375-018-0299-2; Fischer T, 2010, J CLIN ONCOL, V28, P4339, DOI 10.1200/JCO.2010.28.9678; Goldberg AD, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-117016; Grafone T, 2012, ONCOL REV, V6, P64, DOI 10.4081/oncol.2012.e8; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Levis MJ, 2019, J CLIN ONCOL, V37; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mullighan CG, 2007, LEUKEMIA, V21, P2000, DOI 10.1038/sj.leu.2404808; Nybakken GE, 2016, LEUKEMIA, V30, P1422, DOI 10.1038/leu.2015.320; O'Donnell MR, 2017, J NATL COMPR CANC NE, V15, P926, DOI 10.6004/jnccn.2017.0116; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Perl AE, 2019, NEW ENGL J MED, V381, P1728, DOI 10.1056/NEJMoa1902688; Perl AE, 2017, LANCET ONCOL, V18, P1061, DOI 10.1016/S1470-2045(17)30416-3; Randhawa JK, 2014, BLOOD, V124, P389, DOI [10.1182/blood.V124.21.389.389, DOI 10.1182/BLOOD.V124.21.389.389]; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Stone RM, 2017, NEW ENGL J MED, V377, P454, DOI 10.1056/NEJMoa1614359; Stone RM, 2017, BLOOD, V130; Wang MN, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6962379; Zhao SL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/986048	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247093	10.1371/journal.pone.0247093	http://dx.doi.org/10.1371/journal.pone.0247093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592069	gold, Green Published			2022-12-26	WOS:000620632800087
J	Sander, L; Hass, HC; Michaelis, R; Gross, C; Hausen, T; Pogoda, B				Sander, Lasse; Hass, H. Christian; Michaelis, Rune; Gross, Christopher; Hausen, Tanja; Pogoda, Bernadette			The late Holocene demise of a sublittoral oyster bed in the North Sea	PLOS ONE			English	Article								A fossil oyster bed (Ostrea edulis) was recently encountered offshore Helgoland (German Bight). Oysters are important filter feeders in marine environments and their habitat structure supports a large associated biodiversity. The European flat oyster Ostrea edulis has historically occurred in vast populations in the North Sea, but declined massively in the early 20th century. The ecological restoration of Ostrea habitats is a current focal point in the North Sea. To better understand the mechanisms that caused the local collapse of the oyster population, this study investigated the size structure, weight, and age of the shells, along with the spatial dimensions, seafloor properties, and environmental context of the oyster bed. The results show that the demise of the population occurred around 700 CE, ruling out excessive harvest as a driver of decline. Synchronicity of increased geomorphological activity of rivers and concurrent major land use changes in early medieval Europe suggest that increased sedimentation was a viable stressor that reduced the performance of the oysters. The shells provided no indication of a demographically poor state of the oyster bed prior to its demise, but manifested evidence of the wide-spread occurrence of the boring sponge Cliona sp. Our study challenges the assumption of a stable preindustrial state of the European flat oyster in the North Sea, and we conclude that the long-term variability of environmental conditions needs to be addressed to benchmark success criteria for the restoration of O. edulis.	[Sander, Lasse; Hass, H. Christian; Michaelis, Rune; Pogoda, Bernadette] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Wadden Sea Res Stn, List Auf Sylt, Germany; [Michaelis, Rune] Lower Saxon Wadden Sea Natl Pk Author, Wilhelmshaven, Germany; [Gross, Christopher; Hausen, Tanja; Pogoda, Bernadette] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Shelf Sea Syst Ecol, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Sander, L (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Wadden Sea Res Stn, List Auf Sylt, Germany.	lasse.sander@awi.de	Sander, Lasse/U-5539-2018	Sander, Lasse/0000-0003-1066-7952	Federal Agency for Nature Conservation (BfN); AWI Section "Coastal Ecology"; project RESTORE [FKZ 3516892001]; Alfred-Wegener-Institut Helmholtz-Zentrum fur Polar- und Meeresforschung	Federal Agency for Nature Conservation (BfN); AWI Section "Coastal Ecology"; project RESTORE; Alfred-Wegener-Institut Helmholtz-Zentrum fur Polar- und Meeresforschung	This study received funding from the Federal Agency for Nature Conservation (BfN; www.bfn.de), the AWI Section "Coastal Ecology", and the project RESTORE, in the form of a grant (FKZ 3516892001) awarded to BP. We acknowledge support by the Open Access Publication Funds of Alfred-Wegener-Institut Helmholtz-Zentrum fur Polar- und Meeresforschung.	Andersen S.H., 2007, SHELL MIDDENS ATLANT, P31; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; BECKER GA, 1992, MAR ECOL PROG SER, V91, P9, DOI 10.3354/meps091009; Bennike O, 2019, B GEOL SOC DENMARK, V67, P53; Boos K, 2004, BERICHT ZUSAMMENSETZ, P94; Bromley C, 2016, OCEAN COAST MANAGE, V122, P103, DOI 10.1016/j.ocecoaman.2015.12.012; Carbotte SM, 2004, GEO-MAR LETT, V24, P212, DOI 10.1007/s00367-004-0179-9; Carroll JM, 2015, DIS AQUAT ORGAN, V117, P31, DOI 10.3354/dao02928; Caspers H., 1950, HELGOLANDER WISS MEE, V3, P119, DOI [10.1007/BF02252090, DOI 10.1007/BF02252090]; Colden AM, 2015, MAR ECOL PROG SER, V527, P105, DOI 10.3354/meps11244; Dankers N., 1999, Wadden Sea Ecosystem, V9, P141; Dick S., 2001, 292001 BSH, V29, P1; Farinas-Franco JM, 2018, BIOL CONSERV, V221, P293, DOI 10.1016/j.biocon.2018.03.010; Gercken J, 2014, BFN-SKR, p107P; HANSEN J C, 1970, Veliger, V13, P90; Harding JM, 2008, J SHELLFISH RES, V27, P1109, DOI 10.2983/0730-8000-27.5.1109; Hargis William J. Jr, 1999, P5; HARTMAN WILLARD D., 1958, PEADBODY MUS NAT HIST BULL, V12, P155; Hass HC, 2017, GEO-MAR LETT, V37, P125, DOI 10.1007/s00367-016-0483-1; Hasselmann ZW, 1792, SCHLESWIG HOLSTEINIS, P1; Hayer S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224249; Hebbeln D, 2003, GEO-MAR LETT, V23, P81, DOI 10.1007/s00367-003-0127-0; HeierNielsen S, 1995, RADIOCARBON, V37, P875, DOI 10.1017/S0033822200014958; Helmer L, 2019, PEERJ, V7, DOI 10.7717/peerj.6431; HOEKSEMA B W, 1983, Senckenbergiana Maritima, V15, P55; Hoffmann T, 2008, QUATERNARY SCI REV, V27, P2031, DOI 10.1016/j.quascirev.2008.06.014; IRION G, 1987, J GEOL SOC LONDON, V144, P153, DOI 10.1144/gsjgs.144.1.0153; Janssen F, 1999, GERMAN J HYDROGRAPHY, VS9; Jordan-Cooley WC, 2011, J THEOR BIOL, V289, P1, DOI 10.1016/j.jtbi.2011.08.013; Kamermans P, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10113942; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; Kerckhof F, 2018, BELG J ZOOL, V148, P13, DOI 10.26496/bjz.2018.16; KORRINGA P., 1946, BASTERIA, V10-11, P36; Laing I, 2006, AQUAT LIVING RESOUR, V19, P283, DOI 10.1051/alr:2006029; Lang A, 2003, HYDROL PROCESS, V17, P3321, DOI 10.1002/hyp.1389; LEE A, 1968, HELGOLAND WISS MEER, V17, P44, DOI 10.1007/BF01611211; Lenihan HS, 1999, ECOL MONOGR, V69, P251, DOI 10.1890/0012-9615(1999)069[0251:PBCOOR]2.0.CO;2; Lewis JP, 2016, QUATERNARY SCI REV, V151, P315, DOI 10.1016/j.quascirev.2016.09.004; Lipcius RN, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00065; Lotze HK, 2005, HELGOLAND MAR RES, V59, P71, DOI 10.1007/s10152-004-0208-0; Mann R, 2009, ESTUAR COAST SHELF S, V85, P217, DOI 10.1016/j.ecss.2009.08.004; MCCAVE IN, 1970, J GEOPHYS RES, V75, P4151, DOI 10.1029/JC075i021p04151; Merk V, 2020, AQUAT CONSERV; Michaelis R, 2019, J SEA RES, V144, P78, DOI 10.1016/j.seares.2018.11.009; Mobius KarlA., 1877, AUSTERN AUSTERNWIRTS; Nio S.- D., 1981, SPEC, P415, DOI 10.1002/9781444303759.ch29; Olsen O.T., 1883, PISCATORIAL ATLAS N; Orme LC, 2015, J QUATERNARY SCI, V30, P478, DOI 10.1002/jqs.2792; OTTO L, 1990, NETH J SEA RES, V26, P161, DOI 10.1016/0077-7579(90)90091-T; Perry F., 2017, MARLIN MARINE LIFE I; Pogoda B, 2020, AQUAT CONSERV; Pogoda B, 2019, HUMANITIES-BASEL, V8, DOI 10.3390/h8010009; Pogoda B, 2019, AQUAT LIVING RESOUR, V32, DOI 10.1051/alr/2019012; Pollack JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040839; Quante M, 2016, REG CLIM STUD, P1, DOI 10.1007/978-3-319-39745-0_1; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; REINECK H-E, 1967, Senckenbergiana Lethaea, V48, P219; Rodriguez-Perez A, 2019, MAR POLLUT BULL, V138, P312, DOI 10.1016/j.marpolbul.2018.11.032; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schnakenbeck W, 1928, HDB SEEFISCHEREI NOR, V5; Schneeweiss J, 2014, QUATERN INT, V324, P20, DOI 10.1016/j.quaint.2013.12.059; Schulte DM, 2009, SCIENCE, V325, P1124, DOI 10.1126/science.1176516; Seaman M. N. L., 1997, US DEP COMMERCE NOAA, V129, P57; Siegismund F, 2001, CLIMATE RES, V18, P39, DOI 10.3354/cr018039; Smaal AC, 2015, C02815 I MAR RES EC; Smyth D, 2010, HYDROBIOLOGIA, V655, P25, DOI 10.1007/s10750-010-0401-x; Spaeth C., 1990, KUSTE, V49, P1; Staneva J, 2009, CONT SHELF RES, V29, P302, DOI 10.1016/j.csr.2008.01.006; Theuerkauf SJ, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00064; Thorngren L, 2019, ECOL EVOL, V9, P13877, DOI 10.1002/ece3.5824; Thurstan RH, 2013, J NAT CONSERV, V21, P253, DOI 10.1016/j.jnc.2013.01.004; Valerius J., 2015, KUSTE, V83, P39; Vink A, 2007, QUATERNARY SCI REV, V26, P3249, DOI 10.1016/j.quascirev.2007.07.014; WARBURTON F. E., 1958, FISH RES BD CANADA ATLANTIC PROGR REPTS, V68, P3; zu Ermgassen P., 2006, SETTING OBJECTIVES O, P76	76	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0242208	10.1371/journal.pone.0242208	http://dx.doi.org/10.1371/journal.pone.0242208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33591987	gold, Green Published			2022-12-26	WOS:000620632800010
J	Shin, WY; Kim, JH				Shin, Woo-Young; Kim, Jung-Ha			Poor diet quality is associated with self-reported knee pain in community-dwelling women aged 50 years and older	PLOS ONE			English	Article								In the current study, we aimed to examine the association between knee pain and diet quality in women aged >= 50 years using data from the Korea National Health and Nutrition Examination Survey. This was a population-based, cross-sectional study. Diet quality was assessed using the Diet Quality Index-International (DQI-I), and knee pain and osteoarthritis were self-reported. A multivariate logistic regression model was used to adjust for age, body mass index, household income, marital status, education, occupation, smoking status, hazardous alcohol use, regular physical activity, menopause, and chronic diseases, including hypertension, diabetes, dyslipidemia, osteoarthritis, and depression. A total of 3,881 women were included in this study, and the prevalence of knee pain was 25.4%. The intakes of total energy, protein, and fat were lower in women with knee pain than in those without (all P < 0.01), while the carbohydrate intake was higher (P = 0.01). No significant differences were noted in the scores for variety, overall balance, and moderation components, except for the item of total fat intake, between the DQI-I scores for women with and without knee pain, after adjusting for age. Women without knee pain showed higher scores in several items of the adequacy component (P < 0.05) than did women with knee pain. The total DQI-I scores were lower in women with knee pain than in women without knee pain, after adjusting for covariates, including osteoarthritis (OR = 0.985, 95% CI = 0.973-0.997, P = 0.01). Knee pain independent of osteoarthritis was associated with poor diet quality in community-dwelling women aged >= 50 years.	[Shin, Woo-Young; Kim, Jung-Ha] Chung Ang Univ, Med Ctr, Dept Family Med, Coll Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital	Kim, JH (corresponding author), Chung Ang Univ, Med Ctr, Dept Family Med, Coll Med, Seoul, South Korea.	girlpower219@cau.ac.kr		, Jung-Ha/0000-0002-7630-9501				Ahluwalia N, 2016, ADV NUTR, V7, P121, DOI 10.3945/an.115.009258; Ahmed T, 2010, CLIN INTERV AGING, V5, P207; Bartley EJ, 2016, ARTHRIT CARE RES, V68, P472, DOI 10.1002/acr.22712; Bollwein J, 2013, J GERONTOL A-BIOL, V68, P483, DOI 10.1093/gerona/gls204; Brenn D, 2007, ARTHRITIS RHEUM, V56, P351, DOI 10.1002/art.22282; Chiuve SE, 2011, AM J PREV MED, V40, P505, DOI 10.1016/j.amepre.2010.11.022; Dai ZL, 2017, ANN RHEUM DIS, V76, P1411, DOI 10.1136/annrheumdis-2016-210810; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Eglseer D, 2016, J GERONTOL NURS, V42, P33, DOI 10.3928/00989134-20160613-03; Emery CF, 2017, PAIN, V158, P273, DOI 10.1097/j.pain.0000000000000754; Gerber M, 2001, J NUTR, V131, p3051S, DOI 10.1093/jn/131.11.3051S; Goldberg RJ, 2007, PAIN, V129, P210, DOI 10.1016/j.pain.2007.01.020; Gopinath B, 2014, J ACAD NUTR DIET, V114, P220, DOI 10.1016/j.jand.2013.09.001; Green JA, 2014, P NUTR SOC, V73, P278, DOI 10.1017/S0029665113003935; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Hiza HAB, 2013, J ACAD NUTR DIET, V113, P297, DOI 10.1016/j.jand.2012.08.011; IAEA (International Atomic Energy Agency), DIET QUALITY; Ishihara J, 2015, J NUTR SCI VITAMINOL, V61, pS33, DOI 10.3177/jnsv.61.S33; Jhun HJ, 2013, J KOREAN MED SCI, V28, P1807, DOI 10.3346/jkms.2013.28.12.1807; Jinks C, 2004, RHEUMATOLOGY, V43, P55, DOI 10.1093/rheumatology/keg438; Kiadaliri AA, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0525-4; Kim JS, 1999, J KOREAN ACAD FAM ME, V20, P1152; Kim S, 2003, J NUTR, V133, P3476, DOI 10.1093/jn/133.11.3476; Korea National Health and Nutrition Examination Survey (KNHANES), DESIGN METHODS; Kronschlager MT, 2016, SCIENCE, V354, P1144, DOI 10.1126/science.aah5715; Masino SA, 2013, J CHILD NEUROL, V28, P993, DOI 10.1177/0883073813487595; Mattei J, 2018, CLIN NUTR, V37, P1332, DOI 10.1016/j.clnu.2017.06.003; Ministry of Health Welfare The Korean Nutrition Society, 2015, DIETARY REFERENCE IN; Miranda H, 2002, OSTEOARTHR CARTILAGE, V10, P623, DOI 10.1053/joca.2002.0796; Montalcini T, 2013, ENDOCRINE, V43, P59, DOI 10.1007/s12020-012-9813-x; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; Phyomaung PP, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-10; Raina Sunil Kumar, 2013, N Am J Med Sci, V5, P498, DOI 10.4103/1947-2714.117329; Reedy J, 2014, J NUTR, V144, P881, DOI 10.3945/jn.113.189407; Richter F, 2010, ARTHRITIS RHEUM-US, V62, P3806, DOI 10.1002/art.27715; Rural Development Administration, 2012, NAT I AGR SCI KR STA, V8th; Castell GS, 2015, NUTR HOSP, V31, P46, DOI 10.3305/nh.2015.31.sup3.8750; Sanghi D, 2015, J AM COLL NUTR, V34, P15, DOI 10.1080/07315724.2013.875439; Sato Shinichiro, 2017, Nihon Koshu Eisei Zasshi, V64, P322, DOI 10.11236/jph.64.6_322; Schell J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090949; Stannus OP, 2013, ANN RHEUM DIS, V72, P535, DOI 10.1136/annrheumdis-2011-201047; Strath LJ, 2020, PAIN MED, V21, P150, DOI 10.1093/pm/pnz022; Totsch SK, 2017, SCAND J PAIN, V17, P316, DOI 10.1016/j.sjpain.2017.08.009; Totsch SK, 2016, J PAIN, V17, P119, DOI 10.1016/j.jpain.2015.10.006; United Nations' Department of Economic and Social Affairs, WORLD POP PROSP 2012; Urquhart DM, 2015, SEMIN ARTHRITIS RHEU, V44, P445, DOI 10.1016/j.semarthrit.2014.07.005; van Bokhorst-de van der Schueren MAE, 2013, CLIN NUTR, V32, P1007, DOI 10.1016/j.clnu.2013.05.007; Yun S, 2017, NUTR RES PRACT, V11, P147, DOI 10.4162/nrp.2017.11.2.147	48	1	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0245630	10.1371/journal.pone.0245630	http://dx.doi.org/10.1371/journal.pone.0245630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33591989	Green Published, gold			2022-12-26	WOS:000620632800086
J	Jia, XS; Li, MQ; Wang, JW; Ning, JQ; Zhao, K				Jia Xiaoshi; Li Maoquan; Wang Jiwei; Ning Jinqiu; Zhao Ke			SETD7 mediates the vascular invasion in articular cartilage and chondrocytes apoptosis in osteoarthriis	FASEB JOURNAL			English	Article						angiogenesis; chondrocyte apoptosis; osteoarthritis; oxygen tension; SETD7	RHEUMATOID-ARTHRITIS; NERVE GROWTH; IN-VITRO; HYPOXIA; ANGIOGENESIS; EXPRESSION; INFLAMMATION; MECHANISMS; REPRESSION; BONE	The pathological characteristics of osteoarthritis are cartilage matrix degradation, chondrocytes apoptosis, and low-grade inflammation of the joint. Recent studies have shown that blood vessels grow from the subchondral bone to the articular cartilage. However, the relationship among inflammation, angiogenesis, and chondrocyte apoptosis is still unclear. We found that chondrocytes could secrete chemokines and VEGF to promote the migration of vascular endothelial cells in response to TNF-alpha stimulation. The invasion of blood vessels leads to increased oxygen tension in the local environment, which increased the expression of SETD7 in chondrocytes by activating the JAK-STAT5 pathway. The bond of phosphorylated STAT5 and the specific locus in the promoter of SETD7 directly increased the transcription of SETD7. On the one hand, SETD7-regulated chemokine expression by forming a positive loop; on the other hand, SETD7-mediated chondrocyte apoptosis by inhibiting the nuclear localization of HIF-1 alpha. In this study, we discovered a novel function of chondrocytes as mediators of inflammation and angiogenesis. Our study demonstrates that SETD7 is a potential molecular target to prevent OA development and progression.	[Jia Xiaoshi; Li Maoquan; Ning Jinqiu; Zhao Ke] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Guangzhou 510055, Guangdong, Peoples R China; [Jia Xiaoshi; Li Maoquan; Ning Jinqiu; Zhao Ke] Guangdong Prov Key Lab Stomatol, Guangzhou, Peoples R China; [Jia Xiaoshi; Li Maoquan; Ning Jinqiu; Zhao Ke] Guangdong Engn Res Ctr Technol & Mat Oral Reconst, Guangzhou, Peoples R China; [Wang Jiwei] Guangzhou Med Univ, Guangzhou Inst Oral Dis, Key Lab Oral Med, Stomatol Hosp, Guangzhou, Peoples R China	Sun Yat Sen University; Guangzhou Medical University	Zhao, K (corresponding author), Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Guangzhou 510055, Guangdong, Peoples R China.	zhaoke@mail.sysu.edu.cn			National Natural Science Foundation of China [81901025, 81771110]; China Postdoctoral Science Foundation [2019M653232]; Guangdong Basic and Applied Basic Research Foundation [2019A1515011326]; Fundamental Research Funds for the Central Universities [19ykpy82]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Basic and Applied Basic Research Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China, Grant/Award Number: 81901025 and 81771110; China Postdoctoral Science Foundation, Grant/Award Number: 2019M653232; Guangdong Basic and Applied Basic Research Foundation, Grant/Award Number: 2019A1515011326; Fundamental Research Funds for the Central Universities, Grant/Award Number: 19ykpy82	Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1; Ashraf S, 2011, ANN RHEUM DIS, V70, P523, DOI 10.1136/ard.2010.137844; Barbero G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091060; Bonnet CS, 2005, RHEUMATOLOGY, V44, P7, DOI 10.1093/rheumatology/keh344; Bu HL, 2019, NEUROSCIENCE, V406, P62, DOI 10.1016/j.neuroscience.2019.02.025; Chang SH, 2019, NAT COMMUN, V10; Charlier E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122146; Domm C, 2000, ORTHOPADE, V29, P91; Fenwick SA, 1999, OSTEOARTHR CARTILAGE, V7, P441, DOI 10.1053/joca.1998.0238; Fernandez-Torres J, 2017, EUR REV MED PHARMACO, V21, P2800; Glyn-Jones S, 2015, LANCET, V386, P376, DOI 10.1016/S0140-6736(14)60802-3; Greene MA, 2015, OSTEOARTHR CARTILAGE, V23, P1966, DOI 10.1016/j.joca.2015.01.008; Grimshaw MJ, 2000, OSTEOARTHR CARTILAGE, V8, P386, DOI 10.1053/joca.1999.0314; Han LX, 2018, BONE, V117, P15, DOI 10.1016/j.bone.2018.08.017; Hayami T, 2003, J RHEUMATOL, V30, P2207; Hemker SL, 2016, PEDIATR NEPHROL, V31, P1571, DOI 10.1007/s00467-016-3333-5; Hu HY, 2013, ACTA PHARMACOL SIN, V34, P157, DOI 10.1038/aps.2012.161; Huang XB, 2019, J ORTHOP RES, V37, P84, DOI 10.1002/jor.24142; Jia XS, 2017, ACTA BIOMATER, V53, P495, DOI 10.1016/j.actbio.2017.02.025; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kean TJ, 2016, CONNECT TISSUE RES, V57, P319, DOI 10.1080/03008207.2016.1182996; Kim Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10347; Liu QB, 2019, BIOCHEM BIOPH RES CO, V516, P22, DOI 10.1016/j.bbrc.2019.05.168; Liu Q, 2015, BBA-MOL CELL RES, V1853, P881, DOI 10.1016/j.bbamcr.2015.01.011; Liu X, 2015, NUCLEIC ACIDS RES, V43, P5081, DOI 10.1093/nar/gkv379; Liu-Bryan R, 2015, NAT REV RHEUMATOL, V11, P35, DOI 10.1038/nrrheum.2014.162; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P971, DOI 10.1016/j.joca.2009.03.002; Malemud CJ, 2018, THER ADV MUSCULOSKEL, V10, P117, DOI 10.1177/1759720X18776224; Mapp PI, 2012, NAT REV RHEUMATOL, V8, P390, DOI 10.1038/nrrheum.2012.80; Oppenheimer H, 2014, J BONE MINER RES, V29, P348, DOI 10.1002/jbmr.2052; Paleolog EM, 2009, INT J EXP PATHOL, V90, P249, DOI 10.1111/j.1365-2613.2009.00640.x; Pfander D, 2007, CURR OPIN RHEUMATOL, V19, P457, DOI 10.1097/BOR.0b013e3282ba5693; Pufe T, 2005, ANN ANAT, V187, P461, DOI 10.1016/j.aanat.2005.06.008; Reuther MS, 2012, LARYNGOSCOPE, V122, P2407, DOI 10.1002/lary.23478; Robinson WH, 2016, NAT REV RHEUMATOL, V12, P580, DOI 10.1038/nrrheum.2016.136; Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085; Song H., 2020, INT J MOL SCI, V21; Stegen S, 2019, NATURE, V565, P511, DOI 10.1038/s41586-019-0874-3; Walsh DA, 2010, RHEUMATOLOGY, V49, P1852, DOI 10.1093/rheumatology/keq188; Wu YY, 2019, INT IMMUNOPHARMACOL, V72, P459, DOI 10.1016/j.intimp.2019.04.043; Zhang CT, 2019, J BONE MINER RES, V34, P547, DOI 10.1002/jbmr.3610; Zhang FJ, 2015, JOINT BONE SPINE, V82, P144, DOI 10.1016/j.jbspin.2014.10.003; Zhang X, 2015, CELL MOL LIFE SCI, V72, P4257, DOI 10.1007/s00018-015-2001-4; Zhu SP, 2019, CELL MOL LIFE SCI, V76, P4493, DOI 10.1007/s00018-019-03225-y	45	6	6	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21283	10.1096/fj.202000373RRRR	http://dx.doi.org/10.1096/fj.202000373RRRR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33617050	Bronze			2022-12-26	WOS:000629576700033
J	Lv, X; Chen, SF; Gao, F; Hu, BW; Wang, YK; Ni, SF; Kou, HW; Song, ZM; Qing, XC; Wang, SY; Liu, HJ; Shao, ZW				Lv, Xiao; Chen, Songfeng; Gao, Feng; Hu, Binwu; Wang, Yongkui; Ni, Shuangfei; Kou, Hongwei; Song, Zongmian; Qing, Xiangcheng; Wang, Shangyu; Liu, Hongjian; Shao, Zengwu			Resveratrol-enhanced SIRT1-mediated osteogenesis in porous endplates attenuates low back pain and anxiety behaviors	FASEB JOURNAL			English	Article						anxiety; low back pain; osteogenesis; porous endplates; resveratrol; SIRT1		Low back pain (LBP) is a major clinical problem that lacks effective treatments. The sensory innervation in porous vertebral endplates and anxiety contributes to spinal hyperalgesia. We hypothesized that SIRT1 activator resveratrol alleviates LBP and anxiety via promotion of osteogenesis in the porous endplates. The hyperalgesia and anxiety-related behaviors; sensory innervation, inflammation and porosity of endplates; and osteogenic/osteoclastic factors expression were measured following resveratrol treatment after lumbar spine instability (LSI) surgery. To explore whether resveratrol promotes endplates osteogenesis and thus alleviates LBP through activation of SIRT1 in the osteoprogenitor cells of endplates, SIRT1(OSX)(-/-) mice were employed. Additionally, the levels of inflammation markers, phosphorylation of cAMP response element-binding protein (pCREB), and brain-derived neurotrophic factor (BDNF) in hippocampus were evaluated. After 4 or 8 weeks LSI surgery, the mice suffered from hyperalgesia and anxiety, which were efficiently attenuated by resveratrol at 8 weeks. Resveratrol treatment-enhanced osteogenesis and decreased endplates porosities accompanied with the reduction of TNF alpha, IL-1 beta, and COX2 levels and CGRP+ nerve fibers innervation in porous endplates. Resveratrol-mediated endplates osteogenesis, decreased endplates porosities, and analgesic and antianxiety effects were abrogated in SIRT1(OSX)(-/-) mice. Furthermore, resveratrol relieved inflammation and increased pCREB and BDNF expression in the hippocampus after 8 weeks, which alleviate anxiety-related behaviors. This study provides that resveratrol-mediated porous endplates osteogenesis via the activation of SIRT1 markedly blocked sensory innervation and inflammation in endplates, therefore, alleviating LSI surgery-induced LBP and hippocampus-related anxiety.	[Lv, Xiao; Gao, Feng; Hu, Binwu; Qing, Xiangcheng; Wang, Shangyu; Shao, Zengwu] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthopaed, Wuhan 430022, Peoples R China; [Chen, Songfeng; Wang, Yongkui; Ni, Shuangfei; Kou, Hongwei; Song, Zongmian; Liu, Hongjian] Zhengzhou Univ, Affiliated Hosp 1, Dept Orthopaed, Zhengzhou 450052, Peoples R China	Huazhong University of Science & Technology; Zhengzhou University	Shao, ZW (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthopaed, Wuhan 430022, Peoples R China.; Liu, HJ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Orthopaed, Zhengzhou 450052, Peoples R China.	fccliuhj@zzu.edu.cn; szwpro@163.com			NSFC \ Major Research Plan [91649204]; National Natural Science Foundation of China (NSFC) [81974352, 81902253]; Science and Technology Department of Henan Province (Henan Provincial Science and Technology Department) [192102310111, 192102310118]	NSFC \ Major Research Plan(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Henan Province (Henan Provincial Science and Technology Department)	NSFC vertical bar Major Research Plan, Grant/Award Number: 91649204; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81974352 and 81902253; Science and Technology Department of Henan Province (Henan Provincial Science and Technology Department), Grant/Award Number: 192102310111 and 192102310118	Abe-Higuchi N, 2016, BIOL PSYCHIAT, V80, P815, DOI 10.1016/j.biopsych.2016.01.009; Almeida M, 2018, MED J AUSTRALIA, V208, P272, DOI 10.5694/mja17.01152; Antunes C, 2021, MOL PSYCHIATR, V26, P1445, DOI 10.1038/s41380-020-0695-7; Bailey JF, 2019, SPINE, V44, P1010, DOI 10.1097/BRS.0000000000003035; Beith ID, 2011, PAIN, V152, P1511, DOI 10.1016/j.pain.2011.02.033; Bekhbat M, 2019, BRAIN BEHAV IMMUN, V76, P248, DOI 10.1016/j.bbi.2018.12.005; Bertin E, 2021, MOL PSYCHIATR, V26, P629, DOI 10.1038/s41380-019-0641-8; Bian Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep27093; Brayda-Bruno M, 2018, EUR SPINE J, V27, P2854, DOI 10.1007/s00586-018-5787-6; Butowicz CM, 2020, PAIN MED, V21, P1068, DOI 10.1093/pm/pnz293; Calvo-Munoz I, 2018, CLIN J PAIN, V34, P468, DOI 10.1097/AJP.0000000000000558; Cao DF, 2015, GENE DEV, V29, P1316, DOI 10.1101/gad.265462.115; Chen SF, 2017, APOPTOSIS, V22, P626, DOI 10.1007/s10495-017-1358-2; Chen WK, 2020, FREE RADICAL BIO MED, V146, P92, DOI 10.1016/j.freeradbiomed.2019.10.412; Chen X, 2018, FREE RADICAL BIO MED, V126, P187, DOI 10.1016/j.freeradbiomed.2018.08.001; Chesnokova V, 2016, BRAIN BEHAV IMMUN, V58, P1, DOI 10.1016/j.bbi.2016.01.017; Clouet J, 2019, ADV DRUG DELIVER REV, V146, P306, DOI 10.1016/j.addr.2018.04.017; Belache FTC, 2018, J PHYSIOTHER, V64, P192, DOI 10.1016/j.jphys.2018.02.018; de Cossio LF, 2017, BRAIN BEHAV IMMUN, V64, P33, DOI 10.1016/j.bbi.2016.12.022; Dudli S, 2017, EUR SPINE J, V26, P1362, DOI 10.1007/s00586-017-4955-4; Dudli S, 2016, EUR SPINE J, V25, P3723, DOI 10.1007/s00586-016-4459-7; Fields AJ, 2014, SPINE J, V14, P513, DOI 10.1016/j.spinee.2013.06.075; Foster NE, 2018, LANCET, V391, P2368, DOI 10.1016/S0140-6736(18)30489-6; Frapin L, 2019, ADV DRUG DELIVER REV, V149, P49, DOI 10.1016/j.addr.2019.08.007; Garcia-Cosamalon J, 2010, J ANAT, V217, P1, DOI 10.1111/j.1469-7580.2010.01227.x; Hallegraeff JM, 2020, J PHYSIOTHER, V66, P39, DOI 10.1016/j.jphys.2019.11.011; Karth MM, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00298; Lee S, 2020, J ORTHOP RES, V38, P1238, DOI 10.1002/jor.24560; Li GW, 2018, NEUROPHARMACOLOGY, V133, P181, DOI 10.1016/j.neuropharm.2017.12.035; Liao ZW, 2019, THERANOSTICS, V9, P4084, DOI 10.7150/thno.33638; Libert S, 2011, CELL, V147, P1459, DOI 10.1016/j.cell.2011.10.054; Liu DX, 2014, BEHAV BRAIN RES, V264, P9, DOI 10.1016/j.bbr.2014.01.039; Liu L, 2020, FASEB J, V34, P3743, DOI 10.1096/fj.201900393RR; Lotz JC, 2013, GLOB SPINE J, V3, P153, DOI 10.1055/s-0033-1347298; Louvet L, 2020, BONE, V136, DOI 10.1016/j.bone.2020.115361; Lv X., 2021, FASEB J, V35, pE21414; Maher C, 2017, LANCET, V389, P736, DOI 10.1016/S0140-6736(16)30970-9; Ni SF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13476-9; Noormohammadpour P, 2019, SPINE, V44, pE357, DOI 10.1097/BRS.0000000000002837; Pearson-Leary J, 2020, MOL PSYCHIATR, V25, P1068, DOI 10.1038/s41380-019-0380-x; Price RB, 2020, MOL PSYCHIATR, V25, P530, DOI 10.1038/s41380-019-0615-x; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Rodriguez AG, 2012, J ORTHOP RES, V30, P280, DOI 10.1002/jor.21513; Simula AS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57105-3; Sun W, 2018, METABOLISM, V88, P61, DOI 10.1016/j.metabol.2018.06.006; Tellegen AR, 2018, J CONTROL RELEASE, V286, P439, DOI 10.1016/j.jconrel.2018.08.019; Traeger AC, 2015, JAMA INTERN MED, V175, P733, DOI 10.1001/jamainternmed.2015.0217; Turk DC, 2015, J PAIN, V16, P1012, DOI 10.1016/j.jpain.2015.07.001; Wang H, 2019, J BONE MINER RES, V34, P1169, DOI 10.1002/jbmr.3677; Wang YL, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1054-3; Wang Y, 2011, BONE, V48, P804, DOI 10.1016/j.bone.2010.12.005; Watanabe S, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0062-1; Williams CM, 2014, LANCET, V384, P1586, DOI 10.1016/S0140-6736(14)60805-9; Wuertz K, 2011, SPINE, V36, pE1373, DOI 10.1097/BRS.0b013e318221e655; Yuan YR, 2020, J PSYCHOPHARMACOL, V34, P726, DOI 10.1177/0269881120914221; Zanchi F, 2020, EUR RADIOL, V30, P2583, DOI 10.1007/s00330-019-06626-6; Zehra U, 2019, J ORTHOP RES, V37, P1080, DOI 10.1002/jor.24195; Zhang L, 2018, BIOMED PHARMACOTHER, V104, P300, DOI 10.1016/j.biopha.2018.05.030; Zhu LJ, 2020, BRIT J PHARMACOL, V177, P3674, DOI 10.1111/bph.15084; Zhu SA, 2019, J CLIN INVEST, V129, P1076, DOI 10.1172/JCI121561	61	1	1	3	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21414	10.1096/fj.202002524R	http://dx.doi.org/10.1096/fj.202002524R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33583095	hybrid			2022-12-26	WOS:000629576700014
J	van Bodegraven, EJ; Sluijs, JA; Tan, AK; Robe, PAJT; Hol, EM				van Bodegraven, Emma J.; Sluijs, Jacqueline A.; Tan, A. Katherine; Robe, Pierre A. J. T.; Hol, Elly M.			New GFAP splice isoform (GFAP mu) differentially expressed in glioma translates into 21 kDa N-terminal GFAP protein	FASEB JOURNAL			English	Article						GFAP; glioma; alternative splicing; GFAP isoforms; intermediate filaments	FIBRILLARY ACIDIC PROTEIN; ALTERNATIVE CLEAVAGE; CELLS; POLYADENYLATION; TRANSCRIPTION; ASTROCYTES; FILAMENTS; IDENTIFICATION; INTERACTS; MOTILITY	The glial fibrillary acidic protein (GFAP) is a type III intermediate filament (IF) protein that is highly expressed in astrocytes, neural stem cells, and in gliomas. Gliomas are a heterogeneous group of primary brain tumors that arise from glia cells or neural stem cells and rely on accurate diagnosis for prognosis and treatment strategies. GFAP is differentially expressed between glioma subtypes and, therefore, often used as a diagnostic marker. However, GFAP is highly regulated by the process of alternative splicing; many different isoforms have been identified. Differential expression of GFAP isoforms between glioma subtypes suggests that GFAP isoform-specific analyses could benefit diagnostics. In this study we report on the differential expression of a new GFAP isoform between glioma subtypes, GFAP mu. A short GFAP transcript resulting from GFAP exon 2 skipping was detected by RNA sequencing of human glioma. We show that GFAP mu mRNA is expressed in healthy brain tissue, glioma cell lines, and primary glioma cells and that it translates into a similar to 21 kDa GFAP protein. 21 kDa GFAP protein was detected in the IF protein fraction isolated from human spinal cord as well. We further show that induced GFAFP mu expression disrupts the GFAP IF network. The characterization of this new GFAP isoform adds on to the numerous previously identified GFAP splice isoforms. It emphasizes the importance of studying the contribution of IF splice variants to specialized functions of the IF network and to glioma research.	[van Bodegraven, Emma J.; Sluijs, Jacqueline A.; Tan, A. Katherine; Hol, Elly M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr, Utrecht, Netherlands; [Tan, A. Katherine; Robe, Pierre A. J. T.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Bodegraven, EJ; Hol, EM (corresponding author), Univ Med Ctr Utrecht, Translat Neurosci, Brain Ctr Rudolf Magnus, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	e.m.hol-2@umcutrecht.nl	Hol, Elly M/F-1891-2013	Hol, Elly M/0000-0001-5604-2603; van Bodegraven, Emma J./0000-0002-3796-2516	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [865.09.003]; KWF Kankerbestrijding (Dutch Cancer Society) [KWF 10123]; TP Bohnenn fund	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); KWF Kankerbestrijding (Dutch Cancer Society); TP Bohnenn fund	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Grant/Award Number: 865.09.003; KWF Kankerbestrijding (Dutch Cancer Society), Grant/Award Number: KWF 10123; T&P Bohnenn fund	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Apcher S, 2013, P NATL ACAD SCI USA, V110, P17951, DOI 10.1073/pnas.1309956110; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Blechingberg J, 2007, NUCLEIC ACIDS RES, V35, P7636, DOI 10.1093/nar/gkm931; Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Chen L, 2011, HUM MOL GENET, V20, P4422, DOI 10.1093/hmg/ddr370; CHEN WJ, 1994, J CELL SCI, V107, P2299; Chou YH, 2007, EXP CELL RES, V313, P2236, DOI 10.1016/j.yexcr.2007.04.008; De Filippis L, 2007, STEM CELLS, V25, P2312, DOI 10.1634/stemcells.2007-0040; Dunbar E, 2010, ADV ANAT PATHOL, V17, P187, DOI 10.1097/PAP.0b013e3181d98cd9; Dvinge H, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0168-9; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Gudikote JP, 2005, NAT STRUCT MOL BIOL, V12, P801, DOI 10.1038/nsmb980; Helman G, 2020, HUM MUTAT, V41, P1131, DOI 10.1002/humu.24008; Herzel L, 2017, NAT REV MOL CELL BIO, V18, P637, DOI 10.1038/nrm.2017.63; Hol EM, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a021642; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Hug N, 2016, NUCLEIC ACIDS RES, V44, P1483, DOI 10.1093/nar/gkw010; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Jorgens DM, 2017, J CELL SCI, V130, P177, DOI 10.1242/jcs.190967; Kanski R, 2014, J CELL SCI, V127, P4368, DOI 10.1242/jcs.145912; Lee SCW, 2016, NAT MED, V22, P976, DOI 10.1038/nm.4165; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Moeton M, 2016, CELL MOL LIFE SCI, V73, P4101, DOI 10.1007/s00018-016-2239-5; Moeton M, 2014, FASEB J, V28, P2942, DOI 10.1096/fj.13-245837; Morris AR, 2012, CLIN CANCER RES, V18, P5256, DOI 10.1158/1078-0432.CCR-12-0543; Nielsen AL, 2004, J BIOL CHEM, V279, P41537, DOI 10.1074/jbc.M406601200; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Perry Arie, 2016, Handb Clin Neurol, V134, P71, DOI 10.1016/B978-0-12-802997-8.00005-0; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Stassen OMJA, 2017, ONCOTARGET, V8, P88104, DOI 10.18632/oncotarget.21540; van Bodegraven EJ, 2019, FASEB J, V33, P12941, DOI 10.1096/fj.201900916R; van Bodegraven EJ, 2019, GLIA, V67, P1417, DOI 10.1002/glia.23594; van Strien ME, 2014, STEM CELL TRANSL MED, V3, P470, DOI 10.5966/sctm.2013-0038; VELASCO ME, 1980, CANCER, V45, P484, DOI 10.1002/1097-0142(19800201)45:3<484::AID-CNCR2820450312>3.0.CO;2-9; ZELENIKA D, 1995, MOL BRAIN RES, V30, P251, DOI 10.1016/0169-328X(95)00010-P	41	3	3	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21389	10.1096/fj.202001767R	http://dx.doi.org/10.1096/fj.202001767R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33583081	hybrid			2022-12-26	WOS:000629576700010
J	Chen, YW; Chi, LY; Lee, OKS				Chen, Ya-Wei; Chi, Lin-Yang; Lee, Oscar Kuang-Sheng			Revisit incidence of complications after impacted mandibular third molar extraction: A nationwide population-based cohort study	PLOS ONE			English	Article							RISK-FACTORS; TEMPOROMANDIBULAR DISORDERS; ORTHODONTIC TREATMENT; 3RD-MOLAR REMOVAL; SURGICAL REMOVAL; JAW INJURY; SYMPTOMS; MORBIDITY; SURGERY; TEETH	Most of complications after impacted mandibular third molar (iLM3) extraction surgeries are transient and resolved spontaneously within one or two weeks, but some of them are more complicated and required further treatments to alleviate the symptoms. The aim of study is to revisit incidence and predictors of complications after iLM3 surgery by reviewing previous literature and investigating a population-based data. From Taiwan National Health Insurance Research Database, records of 16,609 patients who had received iLM3 extraction under ambulatory settings were retrieved for analysis. Outcomes of interest included dry socket (DS), prolonged temporomandibular joint symptoms (TMD), and surgical site infection (SSI), which necessitated additional appointments to manage. Odds ratios of having those complications between different variables were analyzed. The incidence rates of DS, TMD, and SSI were 3.6%, 0.41%, 0.17%, respectively; while they ranged from 0.33-19.14% (DS), 0-4.17% (TMD), and 0.2-5.17% (SSI) in previous studies. Logistic regression revealed DS significantly correlated with complexity of odontectomy (2.5-fold of risk) and history of gingivitis or pericoronitis (1.3-fold of risk). More TMD was found in female than male patients (0.5% versus 0.3%). However, no factors associated with SSI was found; neither did we find aging as a risk in association with any of above complications. Compared to previous studies, our data supports that surgical intervention should be considered in iLM3 with risk of gingivitis or pericoronitis to reduce the occurrence of DS. The original information in this article, which provides a "real-world" evidence, along with the organizing data we summarized from previous article, can serve as a reference for clinicians in assessing the complication risks before treatment of iLM3.	[Chen, Ya-Wei] Univ Penn, Sch Dent Med, Philadelphia, PA 19104 USA; [Chen, Ya-Wei; Lee, Oscar Kuang-Sheng] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Chi, Lin-Yang] Taipei City Hosp, Taipei, Taiwan; [Lee, Oscar Kuang-Sheng] Natl Yang Ming Univ, Stem Cell Res Ctr, Taipei, Taiwan; [Lee, Oscar Kuang-Sheng] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Lee, Oscar Kuang-Sheng] Taipei Vet Gen Hosp, Dept Orthoped & Traumatol, Taipei, Taiwan; [Lee, Oscar Kuang-Sheng] China Med Univ Hosp, Dept Orthoped, Taichung, Taiwan	University of Pennsylvania; National Yang Ming Chiao Tung University; Taipei City Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lee, OKS (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Lee, OKS (corresponding author), Natl Yang Ming Univ, Stem Cell Res Ctr, Taipei, Taiwan.; Lee, OKS (corresponding author), Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan.; Lee, OKS (corresponding author), Taipei Vet Gen Hosp, Dept Orthoped & Traumatol, Taipei, Taiwan.; Lee, OKS (corresponding author), China Med Univ Hosp, Dept Orthoped, Taichung, Taiwan.	oscarlee9203@gmail.com		Lee, Oscar/0000-0001-5232-5374				Akhter R, 2008, J OROFAC PAIN, V22, P50; American Association of Oral and Maxillofacial Surgeons, 2017, SUPPORTING INFORM MA; American Association of Oral and Maxillofacial Surgeons, 2017, WHITE PAPER MANAGEME; Baqain ZH, 2008, J ORAL MAXIL SURG, V66, P2276, DOI 10.1016/j.joms.2008.06.047; Barbosa C, 2016, J ORAL FACIAL PAIN H, V30, P221, DOI 10.11607/ofph.1587; Benediktsdottir IS, 2004, ORAL SURG ORAL MED O, V97, P438, DOI 10.1016/j.tripleo.2003.10.018; Berge TI, 2002, ACTA ODONTOL SCAND, V60, P108, DOI 10.1080/000163502753509518; BIRN H, 1970, ACTA ODONTOL SCAND, V28, P773, DOI 10.3109/00016357009028246; BIRN H, 1972, International Journal of Oral Surgery, V1, P34, DOI 10.1016/S0300-9785(72)80034-6; Blakey GH, 2006, J ORAL MAXIL SURG, V64, P189, DOI 10.1016/j.joms.2005.10.014; Blondeau F, 2007, J CAN DENT ASSOC, V73, P325; Blum IR, 2002, INT J ORAL MAX SURG, V31, P309, DOI 10.1054/ijom.2002.0263; Bouloux Gary F, 2007, Oral Maxillofac Surg Clin North Am, V19, P117, DOI 10.1016/j.coms.2006.11.013; BRUCE RA, 1980, J AM DENT ASSOC, V101, P240; Bui CH, 2003, J ORAL MAXIL SURG, V61, P1379, DOI 10.1016/j.joms.2003.04.001; Cardoso CL, 2010, J ORAL MAXIL SURG, V68, P1922, DOI 10.1016/j.joms.2009.09.085; Carter K, 2015, J DENT RES, V94, P886, DOI 10.1177/0022034515581644; Chen YW, 2021, J FORMOS MED ASSOC, V120, P380, DOI 10.1016/j.jfma.2020.06.003; Chuang SK, 2007, J ORAL MAXIL SURG, V65, P1685, DOI 10.1016/j.joms.2007.04.019; FIELD EA, 1985, BRIT J ORAL MAX SURG, V23, P419, DOI 10.1016/0266-4356(85)90026-9; Fisher EL, 2012, J ORAL MAXIL SURG, V70, P1016, DOI 10.1016/j.joms.2011.10.016; Ghaeminia H, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003879.pub5; Haug RH, 2005, J ORAL MAXIL SURG, V63, P1106, DOI 10.1016/j.joms.2005.04.022; Huang GJ, 2008, J DENT RES, V87, P283, DOI 10.1177/154405910808700313; Huang GJ, 2002, J DENT RES, V81, P284, DOI 10.1177/154405910208100412; Huang GJ, 2006, J AM DENT ASSOC, V137, P1547, DOI 10.14219/jada.archive.2006.0090; Huang GJ, 2014, AM J PUBLIC HEALTH, V104, P728, DOI 10.2105/AJPH.2013.301649; Jerjes W, 2010, BRIT DENT J, V209, DOI 10.1038/sj.bdj.2010.581; Juhl GI, 2009, J ORAL REHABIL, V36, P199, DOI 10.1111/j.1365-2842.2008.01925.x; Lee Crystal Ty, 2015, Patient Prefer Adherence, V9, P257, DOI 10.2147/PPA.S76236; Mettes TG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003879.pub3; National Health Insurance Administration Ministry of Health and Welfare Taiwan R.O.C, 2014, NATL HLTH ANN REPORT; Nemcovsky CE, 1996, J CLIN PERIODONTOL, V23, P810, DOI 10.1111/j.1600-051X.1996.tb00616.x; Nunn ME, 2013, J DENT RES, V92, P1095, DOI 10.1177/0022034513509281; OSBORN TP, 1985, J ORAL MAXIL SURG, V43, P767, DOI 10.1016/0278-2391(85)90331-3; RAUSTIA AM, 1991, CRANIO, V9, P356, DOI 10.1080/08869634.1991.11678383; Sweet J B, 1978, Quintessence Int Dent Dig, V9, P9; SWEET JB, 1979, J ORAL SURG, V37, P732; Threlfall AG, 2005, BRIT J ORAL MAX SURG, V43, P13, DOI 10.1016/j.bjoms.2004.10.001; Torres-Lagares Daniel, 2005, Med Oral Patol Oral Cir Bucal, V10, P81; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120	41	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0246625	10.1371/journal.pone.0246625	http://dx.doi.org/10.1371/journal.pone.0246625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617575	Green Published, gold			2022-12-26	WOS:000623082400021
J	Abe, MS; Otake-Matsuura, M				Abe, Masato S.; Otake-Matsuura, Mihoko			Scaling laws in natural conversations among elderly people	PLOS ONE			English	Article							BRIEF SCREENING TOOL; ALZHEIMERS-DISEASE; DYNAMICS; LANGUAGE; SPEECH; TEXT	Language is a result of brain function; thus, impairment in cognitive function can result in language disorders. Understanding the aging of brain functions in terms of language processing is crucial for modern aging societies. Previous studies have shown that language characteristics, such as verbal fluency, are associated with cognitive functions. However, the scaling laws in language in elderly people remain poorly understood. In the current study, we recorded large-scale data of one million words from group conversations among healthy elderly people and analyzed the relationship between spoken language and cognitive functions in terms of scaling laws, namely, Zipf's law and Heaps' law. We found that word patterns followed these scaling laws irrespective of cognitive function, and that the variations in Heaps' exponents were associated with cognitive function. Moreover, variations in Heaps' exponents were associated with the ratio of new words taken from the other participants' speech. These results indicate that the exponents of scaling laws in language are related to cognitive processes.	[Abe, Masato S.; Otake-Matsuura, Mihoko] RIKEN, Ctr Adv Intelligence Project, Chuo Ku, Tokyo, Japan	RIKEN	Abe, MS (corresponding author), RIKEN, Ctr Adv Intelligence Project, Chuo Ku, Tokyo, Japan.	masato.abe@riken.jp	Otake-Matsuura, Mihoko/N-4686-2017	Otake-Matsuura, Mihoko/0000-0003-3644-276X; Abe, Masato/0000-0002-0468-1179	JSPS KAKENHI [JP18K18140, JP17H05920, JP18KT0035, JP19H01138, JP20H05022, JP20H05574]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP18K18140 (MSA), JP17H05920 (MO), JP18KT0035 (MO), JP19H01138 (MO), JP20H05022 (MO), JP20H05574 (MO).	Abe M., 2020, **DATA OBJECT**; Aramaki E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155195; Asgari Meysam, 2017, Alzheimers Dement (N Y), V3, P219, DOI 10.1016/j.trci.2017.01.006; Baixeries J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053227; Bak P., 1999, COPERNICUS; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Bernhardsson S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123015; Bian CH, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/18002; Cancho RFI, 2005, EUR PHYS J B, V44, P249, DOI 10.1140/epjb/e2005-00121-8; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Cancho RFI., 2001, J QUANT LINGUIST, V8, P165, DOI [10.1076/jqul.8.3.165.4101, DOI 10.1076/JQUL.8.3.165.4101]; Cattuto C, 2007, P NATL ACAD SCI USA, V104, P1461, DOI 10.1073/pnas.0610487104; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Corral A, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.022318; Font-Clos F, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.238701; Fraser KC, 2019, COMPUT SPEECH LANG, V53, P121, DOI 10.1016/j.csl.2018.07.005; Fraser KC, 2016, J ALZHEIMERS DIS, V49, P407, DOI 10.3233/JAD-150520; Fujiwara Y, 2010, GERIATR GERONTOL INT, V10, P225, DOI 10.1111/j.1447-0594.2010.00585.x; Gerlach M, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021006; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Heaps Harold Stanley, 1978, INFORM RETRIEVAL COM; Hernandez-Dominguez Laura, 2018, Alzheimers Dement (Amst), V10, P260, DOI 10.1016/j.dadm.2018.02.004; Hoffmann I, 2010, INT J SPEECH-LANG PA, V12, P29, DOI 10.3109/17549500903137256; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Izawa Y, 2009, YONAGO ACTA MED, V52, P11; Jin C, 2019, NAT HUM BEHAV, V3, P837, DOI 10.1038/s41562-019-0638-y; Karsai M, 2018, SPRINGERBR COMPLEX, P1, DOI 10.1007/978-3-319-68540-3; Kello CT, 2010, TRENDS COGN SCI, V14, P223, DOI 10.1016/j.tics.2010.02.005; Kudo T, 2004, P 2004 C EMP METH NA, P230; Laws KR, 2010, CORTEX, V46, P595, DOI 10.1016/j.cortex.2009.04.009; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014139; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; MONSCH AU, 1992, ARCH NEUROL-CHICAGO, V49, P1253, DOI 10.1001/archneur.1992.00530360051017; Mora T, 2011, J STAT PHYS, V144, P268, DOI 10.1007/s10955-011-0229-4; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Otake-Matsuura M., 2019, MEDRXIV, P19004796; Piantadosi ST, 2014, PSYCHON B REV, V21, P1112, DOI 10.3758/s13423-014-0585-6; Piotrowskii RH, 2007, AUTOM DOC MATH LINGU, V41, P159, DOI 10.3103/S000510550704005X; Proekt A, 2012, P NATL ACAD SCI USA, V109, P10564, DOI 10.1073/pnas.1206894109; Sano Y, 2012, PROG THEOR PHYS SUPP, P202; Smith RD, 2008, ARXIV PREPRINT ARXIV; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Sugishita M., 2018, JPN J COGNITIVE NEUR, V20, P91, DOI [10.11253/ninchishinkeikagaku.20.91, DOI 10.11253/NINCHISHINKEIKAGAKU.20.91]; Szatloczki G, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00195; Troyer AK, 1998, J INT NEUROPSYCH SOC, V4, P137, DOI 10.1017/S1355617798001374; van Leijenhorst DC, 2005, INFORM SCIENCES, V170, P263, DOI 10.1016/j.ins.2004.03.006; Viswanathan G. M., 2011, PHYS FORAGING; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wimo A, 2017, ALZHEIMERS DEMENT, V13, P1, DOI 10.1016/j.jalz.2016.07.150; Wulff DU, 2019, TRENDS COGN SCI, V23, P686, DOI 10.1016/j.tics.2019.05.003; Zipf GK, 1950, J CLIN PSYCHOL, V6, P306	52	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246884	10.1371/journal.pone.0246884	http://dx.doi.org/10.1371/journal.pone.0246884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606774	gold, Green Published			2022-12-26	WOS:000620629200078
J	Hermassi, S; Chelly, MS; Michalsik, LB; Sanal, NEM; Hayes, LD; Cadenas-Sanchez, C				Hermassi, Souhail; Chelly, Mohamed Souhaiel; Michalsik, Lars Bojsen; Sanal, Nilihan E. M.; Hayes, Lawrence D.; Cadenas-Sanchez, Cristina			Relationship between fatness, physical fitness, and academic performance in normal weight and overweight schoolchild handball players in Qatar State	PLOS ONE			English	Article								The aim of this study was to examine the correlation between physiological parameters (namely fatness and physical fitness) with academic performance (namely mathematics and science grade point average [GPA]) in normal weight and overweight schoolchild handball players. Thirty-six young male team handball players (age: 9 +/- 1 years; body mass: 45.5 +/- 14.2 kg; height: 1.38 +/- 9.1 m; body fat: 19.7 +/- 5.6%) at the highest national league for their age group participated. Anthropometry was examined by measuring body mass, body fat percentage (%BF), and body mass index (BMI). Fitness testing included the Yo-Yo Intermittent Recovery Test (level 1), squat jumps (SJ) and counter-movement jumps (CMJ), and upper-limb throwing performance (2 kg medicine ball seated front throw), a 15 m sprint test, and a T-half test for change-of-direction (COD) ability. Academic performance was evaluated through school records of grade point average (GPA) of mathematics and science. BMI was negatively correlated with science GPA (r = -0.57, p<0.001) and mathematics GPA (r = -0.39, p<0.001). Significant correlations between Yo-Yo test performance and science GPA (r = 0.73, p<0.001) and mathematics GPA (r = 0.66, p<0.001) existed. T-half test score (less time taken meant a superior performance) was negatively correlated with science GPA (r = 0.48, p = 0.003) and mathematics GPA (r = 0.63, p<0.01). In conclusion, fatness and physical fitness (except for the upper-muscular strength) were significantly related to academic performance in in schoolchild handball players. Based on results of this study, it seems pragmatic and appropriate to engage young schoolchild in physical activity as it associates with superior academic performance.	[Hermassi, Souhail] Qatar Univ, Coll Educ, Phys Educ Dept, Doha, Qatar; [Chelly, Mohamed Souhaiel] Univ La Manouba, Res Unit UR17JS01 Sport Performance Hlth & Soc, Higher Inst Sport & Phys Educ Ksar Said, Tunis, Tunisia; [Michalsik, Lars Bojsen] Univ Southern Denmark, Dept Sport Sci & Clin Biomech, Muscle Physiol & Biomech Res Unit, Odense, Denmark; [Sanal, Nilihan E. M.] Univ Lancaster, Dept Psychol, Lancaster, England; [Hayes, Lawrence D.] Univ West Scotland, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Cadenas-Sanchez, Cristina] Univ Publ Navarra, Inst Innovat & Sustainable Dev Food Chain IS FOOD, Pamplona, Spain	Qatar University; Universite de la Manouba; University of Southern Denmark; Lancaster University; Universidad Publica de Navarra	Hermassi, S (corresponding author), Qatar Univ, Coll Educ, Phys Educ Dept, Doha, Qatar.	shermassi@qu.edu.qa	Hayes, Lawrence D/I-9694-2019; Cadenas-Sanchez, Cristina/J-5635-2019; Hermassi, Souhail/AAF-1987-2019; Hayes, Lawrence/AAI-1315-2020	Hayes, Lawrence D/0000-0002-6654-0072; Cadenas-Sanchez, Cristina/0000-0002-4513-9108; Hermassi, Souhail/0000-0001-9389-8937; Chelly, Mohamed Souhaiel/0000-0002-0713-1308; Sanal Hayes, Nilihan/0000-0003-4979-9653	Qatar National Library; Qatar University Student Grant [QUST-1-CAS-2020-33]	Qatar National Library(Qatar National Research Fund (QNRF)); Qatar University Student Grant(Qatar National Research Fund (QNRF))	Open Access funding was provided by the Qatar National Library. This publication was supported by Qatar University Student Grant QUST-1-CAS-2020-33. The findings achieved herein are solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesi M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01627; Alswat KA, 2017, SAUDI MED J, V38, P186, DOI 10.15537/smj.2017.2.16320; Anderson Angela S, 2017, Prev Med Rep, V5, P220, DOI 10.1016/j.pmedr.2016.12.020; Baxter SD, 2013, J ACAD NUTR DIET, V113, P551, DOI 10.1016/j.jand.2013.01.004; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Bisset S, 2013, INT J OBESITY, V37, P154, DOI 10.1038/ijo.2012.106; Bortz J., 1999, STAT SOCIAL SCI, P237; Burkhalter TM, 2011, ADV NUTR, V2, p201S, DOI 10.3945/an.111.000331; Cadenas-Sanchez C, 2020, J SPORT SCI, V38, P731, DOI 10.1080/02640414.2020.1729516; Castelli DM, 2007, J SPORT EXERCISE PSY, V29, P239, DOI 10.1123/jsep.29.2.239; Chaddock L, 2012, BIOL PSYCHOL, V89, P260, DOI 10.1016/j.biopsycho.2011.10.017; Chelly MS, 2009, J STRENGTH COND RES, V23, P2241, DOI 10.1519/JSC.0b013e3181b86c40; Chen LJ, 2013, J SCHOOL HEALTH, V83, P631, DOI 10.1111/josh.12075; Coe DP, 2013, J SCHOOL HEALTH, V83, P500, DOI 10.1111/josh.12058; Datar A, 2004, OBES RES, V12, P58, DOI 10.1038/oby.2004.9; Davis CL, 2011, PREV MED, V52, pS65, DOI 10.1016/j.ypmed.2011.01.020; Donnelly JE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-307; Esteban-Cornejo I, 2017, NEUROIMAGE, V159, P346, DOI 10.1016/j.neuroimage.2017.08.011; Eveland-Sayers BM, 2009, J PHYS ACT HEALTH, V6, P99, DOI 10.1123/jpah.6.1.99; Fan YO, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-314; Fowler-Brown AG, 2010, OBESITY, V18, P1235, DOI 10.1038/oby.2009.463; Glatthorn JF, 2011, J STRENGTH COND RES, V25, P556, DOI 10.1519/JSC.0b013e3181ccb18d; Goldfield GS, 2010, J SCHOOL HEALTH, V80, P186, DOI 10.1111/j.1746-1561.2009.00485.x; Gunnarsdottir T, 2012, INT J OBESITY, V36, P35, DOI 10.1038/ijo.2011.181; Haapala EA, 2013, J HUM KINET, V36, P55, DOI 10.2478/hukin-2013-0006; Hayes LD, 2010, EUR J APPL PHYSIOL, V108, P701, DOI 10.1007/s00421-009-1288-y; He JB, 2019, PUBLIC HEALTH, V167, P111, DOI 10.1016/j.puhe.2018.11.002; Hermassi S, 2020, J HUM KINET, V71, P191, DOI 10.2478/hukin-2019-0083; Hillman CH, 2005, MED SCI SPORT EXER, V37, P1967, DOI 10.1249/01.mss.0000176680.79702.ce; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hopker J, 2010, INT J SPORTS MED, V31, P731, DOI 10.1055/s-0030-1261968; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hraste M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196024; Kao SC, 2017, MED SCI SPORT EXER, V49, P500, DOI 10.1249/MSS.0000000000001132; Krukowski RA, 2009, INT J PEDIATR OBES, V4, P274, DOI 10.3109/17477160902846203; Krustrup P, 2003, MED SCI SPORT EXER, V35, P697, DOI 10.1249/01.MSS.0000058441.94520.32; Martin A, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009728.pub2, 10.1002/14651858.CD010971.pub2]; Michalsik LB., 2018, HANDBALL SPORTS MED, P15; Moore RD, 2013, BRAIN COGNITION, V82, P43, DOI 10.1016/j.bandc.2013.02.006; Padulo J, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00202; Pan LP, 2013, J ADOLESCENT HEALTH, V52, P64, DOI 10.1016/j.jadohealth.2012.04.003; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Raghuveer G, 2020, CIRCULATION, V142, pE101, DOI 10.1161/CIR.0000000000000866; Raine LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072666; Rauner RR, 2013, J PEDIATR-US, V163, P344, DOI 10.1016/j.jpeds.2013.01.006; Roberts SJ, 2012, PEDIATR EXERC SCI, V24, P72, DOI 10.1123/pes.24.1.72; Ruiz JR, 2010, J PEDIATR-US, V157, P917, DOI 10.1016/j.jpeds.2010.06.026; Sardinha LB, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-176; Sassi RH, 2009, J STRENGTH COND RES, V23, P1644, DOI 10.1519/JSC.0b013e3181b425d2; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Torrijos-Nino C, 2014, J PEDIATR-US, V165, P104, DOI 10.1016/j.jpeds.2014.02.041; Trajkovic N, 2020, BIOL SPORT, V37, P185, DOI 10.5114/biolsport.2020.94240; Van Dusen DP, 2011, J SCHOOL HEALTH, V81, P733, DOI 10.1111/j.1746-1561.2011.00652.x; Wagner H, 2018, J SPORT MED PHYS FIT, V58, P73, DOI 10.23736/S0022-4707.16.06758-X; WOMERSLEY J, 1973, HUM BIOL, V45, P281	55	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246476	10.1371/journal.pone.0246476	http://dx.doi.org/10.1371/journal.pone.0246476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606780	gold, Green Published			2022-12-26	WOS:000620629200049
J	Nurge, B; Schulz, AL; Kaemmerer, D; Sanger, J; Evert, K; Schulz, S; Lupp, A				Nuerge, Benjamin; Schulz, Alan Lennart; Kaemmerer, Daniel; Saenger, Joerg; Evert, Katja; Schulz, Stefan; Lupp, Amelie			Immunohistochemical identification of complement peptide C5a receptor 1 (C5aR1) in non-neoplastic and neoplastic human tissues	PLOS ONE			English	Article								The complement component C5a and its receptor C5aR1 are involved in the development of numerous inflammatory diseases. In addition to immune cells, C5aR1 is expressed in neoplastic cells of multiple tumour entities, where C5aR1 is associated with a higher proliferation rate, advanced tumour stage, and poor patient outcomes. The aim of the present study was to obtain a broad expression profile of C5aR1 in human non-neoplastic and neoplastic tissues, especially in tumour entities not investigated in this respect so far. For this purpose, we generated a novel polyclonal rabbit antibody, {5227}, against the carboxy-terminal tail of C5aR1. The antibody was initially characterised in Western blot analyses and immunocytochemistry using transfected human embryonic kidney (HEK) 293 cells. It was then applied to a large series of formalin-fixed, paraffin-embedded non-neoplastic and neoplastic human tissue samples. C5aR1 was strongly expressed by different types of immune cells in the majority of tissue samples investigated. C5aR1 was also present in alveolar macrophages, bronchial, gut, and bile duct epithelia, Kupffer cells, occasionally in hepatocytes, proximal renal tubule cells, placental syncytiotrophoblasts, and distinct stem cell populations of bone marrow. C5aR1 was also highly expressed in the vast majority of the 32 tumour entities investigated, where a hitherto unappreciated high prevalence of the receptor was detected in thyroid carcinomas, small-cell lung cancer, gastrointestinal stromal tumours, and endometrial carcinomas. In addition to confirming published findings, we found noticeable C5aR1 expression in many tumour entities for the first time. Here, it may serve as an interesting target for future therapies.	[Nuerge, Benjamin; Schulz, Alan Lennart; Schulz, Stefan; Lupp, Amelie] Jena Univ Hosp, Inst Pharmacol & Toxicol, Jena, Germany; [Kaemmerer, Daniel] Zentralklin Bad Berka, Dept Gen & Visceral Surg, Bad Berka, Germany; [Saenger, Joerg] Lab Pathol & Cytol Bad Berka, Bad Berka, Germany; [Evert, Katja] Univ Regensburg, Dept Pathol, Regensburg, Germany; [Evert, Katja] Univ Med Greifswald, Inst Pathol, Greifswald, Germany	Friedrich Schiller University of Jena; Zentralklinik Bad Berka; University of Regensburg; Greifswald Medical School	Lupp, A (corresponding author), Jena Univ Hosp, Inst Pharmacol & Toxicol, Jena, Germany.	Amelie.Lupp@med.uni-jena.de						Ajona D, 2018, AM J RESP CRIT CARE, V197, P1164, DOI 10.1164/rccm.201703-0660OC; Atanes P, 2018, CELL MOL LIFE SCI, V75, P715, DOI 10.1007/s00018-017-2655-1; Baelder R, 2005, J IMMUNOL, V174, P783, DOI 10.4049/jimmunol.174.2.783; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Banadakoppa M, 2014, CLIN EXP IMMUNOL, V177, P743, DOI 10.1111/cei.12371; Bujko K, 2017, STEM CELL REV REP, V13, P793, DOI 10.1007/s12015-017-9769-6; Chen J, 2018, CANCER LETT, V412, P30, DOI 10.1016/j.canlet.2017.10.003; Cho MS, 2014, CELL REP, V6, P1085, DOI 10.1016/j.celrep.2014.02.014; Daveau M, 2004, J IMMUNOL, V173, P3418, DOI 10.4049/jimmunol.173.5.3418; Dunkelberger J, 2012, J IMMUNOL, V188, P4032, DOI 10.4049/jimmunol.1103141; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Ender F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172446; Fayyazi A, 1999, AM J PATHOL, V154, P495, DOI 10.1016/S0002-9440(10)65295-9; Fayyazi A, 2000, IMMUNOLOGY, V99, P38, DOI 10.1046/j.1365-2567.2000.00911.x; Floreani AA, 1998, J IMMUNOL, V160, P5073; Girardi G, 2006, J EXP MED, V203, P2165, DOI 10.1084/jem.20061022; Gu J, 2013, LUNG CANCER, V81, P259, DOI 10.1016/j.lungcan.2013.04.020; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; HAVILAND DL, 1995, J IMMUNOL, V154, P1861; Hu WH, 2016, EXP MOL PATHOL, V100, P101, DOI 10.1016/j.yexmp.2015.10.001; Imamura T, 2016, BREAST CANCER-TOKYO, V23, P876, DOI 10.1007/s12282-015-0654-3; Kaemmerer D, 2017, ONCOTARGET, V8, P89958, DOI 10.18632/oncotarget.21194; Kaida T, 2016, ONCOTARGET, V7, P84798, DOI 10.18632/oncotarget.12656; Karsten CM, 2015, J IMMUNOL, V194, P1841, DOI 10.4049/jimmunol.1401401; Khan MA, 2014, RESP MED, V108, P543, DOI 10.1016/j.rmed.2014.01.005; Klos A, 2013, PHARMACOL REV, V65, P500, DOI 10.1124/pr.111.005223; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Krug N, 2001, AM J RESP CRIT CARE, V164, P1841, DOI 10.1164/ajrccm.164.10.2010096; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Ma Y, 2018, J CELL MOL MED, V22, P1034, DOI 10.1111/jcmm.13466; Maeda Y, 2015, ONCOL REP, V33, P1844, DOI 10.3892/or.2015.3800; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Nitta H, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0834-9; Nitta H, 2013, CLIN CANCER RES, V19, P2004, DOI 10.1158/1078-0432.CCR-12-1204; Nunez-Cruz S, 2012, NEOPLASIA, V14, P994, DOI 10.1593/neo.121262; Oskeritzian CA, 2005, J ALLERGY CLIN IMMUN, V115, P1162, DOI 10.1016/j.jaci.2005.02.022; Ottonello L, 1999, J IMMUNOL, V162, P6510; Phieler J, 2013, J IMMUNOL, V191, P4367, DOI 10.4049/jimmunol.1300038; REMMELE W, 1987, PATHOLOGE, V8, P138; ROLLINS TE, 1991, P NATL ACAD SCI USA, V88, P971, DOI 10.1073/pnas.88.3.971; Schieferdecker HL, 2001, INT IMMUNOPHARMACOL, V1, P469, DOI 10.1016/S1567-5769(00)00038-2; Schlaf G, 2003, HISTOL HISTOPATHOL, V18, P299, DOI 10.14670/HH-18.299; Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; Soruri A, 2003, IMMUNOL LETT, V88, P47, DOI 10.1016/S0165-2478(03)00052-X; Wang Y., 2019, E3S WEB C, V136; WERFEL T, 1992, BLOOD, V79, P152, DOI 10.1182/blood.V79.1.152.bloodjournal791152; Yoneda M, 2019, ONCOL LETT, V17, P913, DOI 10.3892/ol.2018.9715; Zahedi R, 2000, CLIN EXP IMMUNOL, V121, P226, DOI 10.1046/j.1365-2249.2000.01249.x; Zhao CH, 2018, ONCOGENE, V37, P4821, DOI 10.1038/s41388-018-0298-9; Zwirner J, 1999, MOL IMMUNOL, V36, P877, DOI 10.1016/S0161-5890(99)00109-1	54	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246939	10.1371/journal.pone.0246939	http://dx.doi.org/10.1371/journal.pone.0246939			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606748	gold, Green Published			2022-12-26	WOS:000620629200037
J	Yang, BR; Um, HY; Lee, MT; Kim, MS; Jung, SY				Yang, Bo Ram; Um, Hye-Yeon; Lee, Min Taek; Kim, Myo Song; Jung, Sun-Young			Characterizing tramadol users with potentially inappropriate co-medications: A latent class analysis among older adults	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; SEROTONIN SYNDROME; PHARMACOLOGY; ALGORITHM; CRITERIA; TRENDS; SEX; AGE	Background Although tramadol is an effective weak opioid analgesic, careful monitoring of potential central nervous system adverse reactions in older adults is needed, especially when used with concomitant medications which may trigger the adverse effects. We aimed to characterize tramadol users with potentially inappropriate co-medications in older adults using a latent class analysis (LCA). Method Patients aged 65 years or older using tramadol and receiving potentially inappropriate co-medications were included from a nationwide healthcare claims database. We defined antidepressants, first-generation antihistamines, and anxiolytics as potentially inappropriate co-medications. We applied an LCA for grouping tramadol users based on the common characteristics of medication use and healthcare utilization, and each patient was probabilistically assigned to a class. Patients' characteristics in different latent classes were compared. Potential adverse drug reactions (ADRs) was defined as the any visits for emergency department after the occurrence of potentially inappropriate co-medications. Logistic regression analysis was used to examine the association between latent classes and potential ADRs. Results We identified four distinct latent classes of tramadol users representing different patterns of co-medications: multiple potential drug-drug interaction (pDDI) combination users, antihistamines-tramadol users, antidepressants-tramadol users, and anxiolytics-tramadol users. Multiple pDDI combination users showed high proportion of regular tramadol use, tended to visit more medical institutions, and had a high Charlson comorbidity score. The duration of use of potentially inappropriate co-medications with tramadol was the longest in multiple pDDI combination users and the shortest in antihistamines-tramadol users. When compared with antihistamines-tramadol users, increased potential ADR risk was observed in multiple pDDI combination users (adjusted odds ratio (OR), 1.81; 95% confidence interval (CI), 1.75-1.88), antidepressants-tramadol users (1.24; 1.19-1.29), and anxiolytics-tramadol users (1.04; 1.00-1.08). Conclusions Four distinct classes were identified among older adults using tramadol and potentially inappropriate co-medications. Differences in potential ADR risk were observed between these classes. These findings may help to identify patients at a high risk for ADRs owing to potentially inappropriate co-medications with tramadol.	[Yang, Bo Ram] Chungnam Natl Univ, Coll Pharm, Daejeon, South Korea; [Um, Hye-Yeon] Ewha Womans Univ, Dept Stat, Seoul, South Korea; [Lee, Min Taek; Kim, Myo Song; Jung, Sun-Young] Chung Ang Univ, Coll Pharm, Seoul, South Korea; [Lee, Min Taek; Kim, Myo Song; Jung, Sun-Young] Chung Ang Univ, Dept Global Innovat Drugs, Grad Sch, Seoul, South Korea	Chungnam National University; Ewha Womans University; Chung Ang University; Chung Ang University	Jung, SY (corresponding author), Chung Ang Univ, Coll Pharm, Seoul, South Korea.; Jung, SY (corresponding author), Chung Ang Univ, Dept Global Innovat Drugs, Grad Sch, Seoul, South Korea.	jsyoung@cau.ac.kr		Jung, Sun-Young/0000-0003-2032-112X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1D1A1B03032231]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of Korea)	This study was supported in the form of a grant by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education [Grant Number NRF-2017R1D1A1B03032231] awarded to SYJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beakley BD, 2015, PAIN PHYSICIAN, V18, P395; Byrne CJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022500; Cahir C, 2014, BRIT J CLIN PHARMACO, V77, P201, DOI 10.1111/bcp.12161; Calderon-Larranaga A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659295; Cepeda MS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005522.pub2; Clarot F, 2003, FORENSIC SCI INT, V134, P57, DOI 10.1016/S0379-0738(03)00100-2; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Feinstein JA, 2015, PHARMACOEPIDEM DR S, V24, P1049, DOI 10.1002/pds.3843; Gualano MR, 2014, PSYCHIAT SERV, V65, P1226, DOI 10.1176/appi.ps.201300510; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Hider-Mlynarz K, 2018, BRIT J CLIN PHARMACO, V84, P1324, DOI 10.1111/bcp.13564; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kesavan S, 1999, J ROY SOC MED, V92, P474, DOI 10.1177/014107689909200915; Khan S, 2018, CUREUS, V10, DOI 10.7759/cureus.2421; Kim HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098043; Kim S, 2020, KOREAN J FAM MED, V41, P146, DOI 10.4082/kjfm.20.0062; Lantz MS, 1998, INT J GERIATR PSYCH, V13, P343, DOI 10.1002/(SICI)1099-1166(199805)13:5<343::AID-GPS771>3.0.CO;2-5; Marcum ZA, 2012, J AM GERIATR SOC, V60, P34, DOI 10.1111/j.1532-5415.2011.03772.x; Martin RM, 1998, BRIT J CLIN PHARMACO, V46, P505, DOI 10.1046/j.1365-2125.1998.00817.x; McCutcheon AL, 1987, LATENT CLASS ANAL; Miotto K, 2017, ANESTH ANALG, V124, P44, DOI 10.1213/ANE.0000000000001683; Mori M, 2020, JAMA-J AM MED ASSOC, V324, P700, DOI 10.1001/jama.2020.2278; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; Onder G, 2003, ARCH INTERN MED, V163, P301, DOI 10.1001/archinte.163.3.301; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Schwartz JB, 2007, CLIN PHARMACOL THER, V82, P87, DOI 10.1038/sj.clpt.6100226; Seo JS, 2018, CLIN PSYCHOPHARM NEU, V16, P67, DOI 10.9758/cpn.2018.16.1.67; Shin JY, 2014, PHARMACOEPIDEM DR S, V23, P1115, DOI 10.1002/pds.3715; Siebenhuener K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168987; Topinkova E, 2012, DRUG AGING, V29, P477, DOI 10.2165/11632400-000000000-00000; Wagemaakers FN, 2017, INT J CLIN PHARM-NET, V39, P874, DOI 10.1007/s11096-017-0492-9; Wang HR, 2017, CLIN PSYCHOPHARM NEU, V15, P199, DOI 10.9758/cpn.2017.15.3.199; Wang YJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00120	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246426	10.1371/journal.pone.0246426	http://dx.doi.org/10.1371/journal.pone.0246426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606722	gold, Green Published			2022-12-26	WOS:000620629200019
J	Toriyama, J; Hashimoto, S; Osone, Y; Yamashita, N; Tsurita, T; Shimizu, T; Saitoh, TM; Sawano, S; Lehtonen, A; Ishizuka, S				Toriyama, Jumpei; Hashimoto, Shoji; Osone, Yoko; Yamashita, Naoyuki; Tsurita, Tatsuya; Shimizu, Takanori; Saitoh, Taku M.; Sawano, Shinji; Lehtonen, Aleksi; Ishizuka, Shigehiro			Estimating spatial variation in the effects of climate change on the net primary production of Japanese cedar plantations based on modeled carbon dynamics	PLOS ONE			English	Article							BIOME-BGC MODEL; TERRESTRIAL ECOSYSTEM MODEL; CRYPTOMERIA-JAPONICA; BAYESIAN CALIBRATION; STOMATAL CONDUCTANCE; CANOPY CONDUCTANCE; NITROGEN-FIXATION; EAST-ASIA; FOREST; TRANSPIRATION	Spatiotemporal prediction of the response of planted forests to a changing climate is increasingly important for the sustainable management of forest ecosystems. In this study, we present a methodology for estimating spatially varying productivity in a planted forest and changes in productivity with a changing climate in Japan, with a focus on Japanese cedar (Cryptomeria japonica D. Don) as a representative tree species of this region. The process-based model Biome-BGC was parameterized using a plant trait database for Japanese cedar and a Bayesian optimization scheme. To compare productivity under historical (1996-2000) and future (2096-2100) climatic conditions, the climate scenarios of two representative concentration pathways (i.e., RCP2.6 and RCP8.5) were used in five global climate models (GCMs) with approximately 1-km resolution. The seasonality of modeled fluxes, namely gross primary production, ecosystem respiration, net ecosystem exchange, and soil respiration, improved after two steps of parameterization. The estimated net primary production (NPP) of stands aged 36-40 years under the historical climatic conditions of the five GCMs was 0.77 +/- 0.10 kgC m(-2) year(-1) (mean +/- standard deviation), in accordance with the geographical distribution of forest NPP estimated in previous studies. Under the RCP2.6 and RCP8.5 scenarios, the mean NPP of the five GCMs increased by 0.04 +/- 0.07 and 0.14 +/- 0.11 kgC m(-2) year(-1), respectively. The increases in annual NPP were small in the southwestern region because of the decreases in summer NPP and the small increases in winter NPP under the RCP2.6 and RCP8.5 scenarios, respectively. Under the RCP2.6 scenario, Japanese cedar was at risk in the southwestern region, in accordance with previous studies, and monitoring and silvicultural practices should be modified accordingly.	[Toriyama, Jumpei] Forestry & Forest Prod Res Inst FFPRI, Kyushu Res Ctr, Kumamoto, Japan; [Hashimoto, Shoji; Osone, Yoko; Yamashita, Naoyuki; Tsurita, Tatsuya; Ishizuka, Shigehiro] FFPRI, Dept Forest Soils, Tsukuba, Ibaraki, Japan; [Hashimoto, Shoji] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Shimizu, Takanori] FFPRI, Dept Disaster Prevent Meteorol & Hydrol, Tsukuba, Ibaraki, Japan; [Saitoh, Taku M.] Gifu Univ, River Basin Res Ctr, Gifu, Japan; [Sawano, Shinji] FFPRI, Hokkaido Res Ctr, Sapporo, Hokkaido, Japan; [Lehtonen, Aleksi] Nat Resources Inst Finland, Helsinki, Finland	Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; University of Tokyo; Forestry & Forest Products Research Institute - Japan; Gifu University; Forestry & Forest Products Research Institute - Japan; Natural Resources Institute Finland (Luke)	Toriyama, J (corresponding author), Forestry & Forest Prod Res Inst FFPRI, Kyushu Res Ctr, Kumamoto, Japan.	jtori@affrc.go.jp	Ishizuka, Shigehiro/A-9975-2011; Hashimoto, Shoji/C-5785-2011	Ishizuka, Shigehiro/0000-0002-9906-9571; TORIYAMA, JUMPEI/0000-0001-8061-6398; Hashimoto, Shoji/0000-0003-3022-7495; Lehtonen, Aleksi/0000-0003-1388-0388; Yamashita, Naoyuki/0000-0003-3398-6825	Agriculture, Forestry and Fisheries Research Council; JSPS KAKENHI [17K00532, 17K07865]; JSPS; Academy of Finland [325306]	Agriculture, Forestry and Fisheries Research Council(Ministry of Agriculture Forestry & Fisheries - Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Academy of Finland(Academy of Finland)	This study was funded by the Agriculture, Forestry and Fisheries Research Council, under the project "Research on adaptation to climate change for agriculture, forestry and fisheries" (S.H. and T. M.S.) as well as JSPS KAKENHI Grants 17K00532 (J.T.) and 17K07865 (N.Y.). Initial stages of the research were conducted at the Natural Resources Institute Finland under the OECD's Co-operative Research Programme in 2016 (J.T.). We would also like to thank JSPS and the Academy of Finland for funding a joint seminar in Kagoshima in 2019 (AF grant: 325306) (A.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency Forestry, 1947, TREND NUMB FOR JAP 1; Anderegg WRL, 2018, NATURE, V561, P538, DOI 10.1038/s41586-018-0539-7; Anderegg WRL, 2015, NEW PHYTOL, V208, P674, DOI 10.1111/nph.13477; Ando T., 1968, Bulletin of the Government Forest Experiment Station = Ringyo Shikenjo kenkyu hokoku, P1; [Anonymous], 2000, EARTH INTERACT, DOI DOI 10.1175/1087-3562(2000)004%3C0003:PASAOT%3E2.0.CO;2; Bellassen V, 2010, ECOL MODEL, V221, P2458, DOI 10.1016/j.ecolmodel.2010.07.008; Cienciala E, 2006, FOREST ECOL MANAG, V237, P252, DOI 10.1016/j.foreco.2006.09.086; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Ding YX, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11102856; Fang JY, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002253; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Food and Agriculture Organization, 2020, Global Forest Resources Assessment (FRA) 2020: main report, DOI 10.4060/ca9825en; Forest Soil Division P.A, 1976, B GOV FOR EXP STN, V280, P1; Forestry Agency, 2019, STAT HDB FOR FOR; Forestry and Forest Products Research Institute, 2014, FFPRI FLUXNET DAT; Franks PJ, 2013, NEW PHYTOL, V197, P1077, DOI 10.1111/nph.12104; Greenhouse Gas Inventory Office of Japan, 2008, NATL GREENHOUSE GAS; HARLEY PC, 1992, PLANT CELL ENVIRON, V15, P271, DOI 10.1111/j.1365-3040.1992.tb00974.x; Hashimoto S, 2011, J FOREST RES-JPN, V16, P16, DOI 10.1007/s10310-010-0209-6; Hickler T, 2012, GLOBAL ECOL BIOGEOGR, V21, P50, DOI 10.1111/j.1466-8238.2010.00613.x; Hidy D, 2016, GEOSCI MODEL DEV, V9, P4405, DOI 10.5194/gmd-9-4405-2016; Hiraoka Y, 2017, TREE PHYSIOL, V37, P733, DOI 10.1093/treephys/tpx028; Iida S, 2009, AGR FOREST METEOROL, V149, P1129, DOI 10.1016/j.agrformet.2009.02.003; Ishizuka S, 2006, ANN FOREST SCI, V63, P537, DOI 10.1051/forest:2006036; Ito A, 2008, AGR FOREST METEOROL, V148, P738, DOI 10.1016/j.agrformet.2007.12.007; JARVIS PG, 1976, PHILOS T ROY SOC B, V273, P593, DOI 10.1098/rstb.1976.0035; Jonsson AM, 2015, MITIG ADAPT STRAT GL, V20, P201, DOI 10.1007/s11027-013-9487-6; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kattge J, 2020, GLOBAL CHANGE BIOL, V26, P119, DOI 10.1111/gcb.14904; Kimball JS, 1997, AGR FOREST METEOROL, V85, P87, DOI 10.1016/S0168-1923(96)02366-0; Komatsu H, 2014, FOREST ECOL MANAG, V334, P301, DOI 10.1016/j.foreco.2014.08.041; Kumagai T, 2008, AGR FOREST METEOROL, V148, P1444, DOI 10.1016/j.agrformet.2008.04.010; Lei XD, 2016, FOREST ECOL MANAG, V376, P265, DOI 10.1016/j.foreco.2016.06.024; Maruyama Y, 1992, JPN J FOR ENV, V34, P2; Matsumoto M., 2006, FORMATH, V6, P141; Matsumoto Y., 2006, GLOB ENV CHANG, V10, P181; Menge DNL, 2009, ECOLOGY, V90, P2190, DOI 10.1890/08-0877.1; Minunno F, 2019, FOREST ECOL MANAG, V440, P208, DOI 10.1016/j.foreco.2019.02.041; Mitsuda Y., 2018, J FOR PLAN, V22, P47; Morino Y, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015205; Morisada K, 2004, GEODERMA, V119, P21, DOI 10.1016/S0016-7061(03)00220-9; Nagakura J, 2004, TREE PHYSIOL, V24, P1203, DOI 10.1093/treephys/24.11.1203; National Land Agency, 1967, DIG NAT LAND INF LAN; NIOH I, 1980, SOIL SCI PLANT NUTR, V26, P117, DOI 10.1080/00380768.1980.10433218; Nishimori M., 2019, J JAPAN SOC SIMULATI, V38, P150; Nishina K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08111-w; Nishizono T, 2014, J FOREST RES-JPN, V19, P305, DOI 10.1007/s10310-013-0416-z; Noguchi K, 2007, J FOREST RES-JPN, V12, P83, DOI 10.1007/s10310-006-0262-3; Osone Y, 2020, ECOL RES, V35, P274, DOI 10.1111/1440-1703.12062; Pietsch SA, 2005, FOREST ECOL MANAG, V211, P264, DOI 10.1016/j.foreco.2005.02.046; Reeves MC, 2014, CLIMATIC CHANGE, V126, P429, DOI 10.1007/s10584-014-1235-8; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Saito T, 2017, HYDROL PROCESS, V31, P1952, DOI 10.1002/hyp.11162; Saitoh TM, 2013, HYDROL PROCESS, V27, P3341, DOI 10.1002/hyp.9834; Saitoh TM, 2010, J PLANT RES, V123, P473, DOI 10.1007/s10265-009-0308-7; Shigenaga H., 2005, J AGRIC METEOROL, V60, P451, DOI [DOI 10.2480/AGRMET.451, 10.2480/agrmet.451]; Shimizu T, 2015, J HYDROL, V522, P250, DOI 10.1016/j.jhydrol.2014.12.021; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Sun XY, 2017, J MT SCI-ENGL, V14, P142, DOI 10.1007/s11629-016-3867-9; Tatarinov FA, 2006, FOREST ECOL MANAG, V237, P267, DOI 10.1016/j.foreco.2006.09.085; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Thornton PE, 1999, AGR FOREST METEOROL, V93, P211, DOI 10.1016/S0168-1923(98)00126-9; Ueyama M, 2010, BIOGEOSCIENCES, V7, P959, DOI 10.5194/bg-7-959-2010; Ueyama M, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab79e5; Ueyama M, 2011, ECOL MODEL, V222, P3216, DOI 10.1016/j.ecolmodel.2011.05.006; Ugawa Shin, 2012, Bulletin of the Forestry and Forest Products Research Institute, V11, P207; Van Oijen M, 2005, TREE PHYSIOL, V25, P915, DOI 10.1093/treephys/25.7.915; Van Oijen M, 2014, BIOGEOSCIENCES, V11, P6357, DOI 10.5194/bg-11-6357-2014; van Oijen M, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015032; van Vuuren DP, 2007, CLIMATIC CHANGE, V81, P119, DOI 10.1007/s10584-006-9172-9; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Wang W, 2009, ECOL MODEL, V220, P2009, DOI 10.1016/j.ecolmodel.2009.04.051; Yamanaka T, 2011, J FOREST RES-JPN, V16, P1, DOI 10.1007/s10310-010-0201-1; Yashiro Y, 2010, J PLANT RES, V123, P463, DOI 10.1007/s10265-010-0323-8; Yin YH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18798-6; Zhu JT, 2002, VADOSE ZONE J, V1, P261	76	4	4	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247165	10.1371/journal.pone.0247165	http://dx.doi.org/10.1371/journal.pone.0247165			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596265	gold, Green Published			2022-12-26	WOS:000620633200039
J	Delzer, ME; Kkonde, A; McAdams, RM				Delzer, Mackenzie E.; Kkonde, Anthony; McAdams, Ryan M.			Viewpoints of pregnant mothers and community health workers on antenatal care in Lweza village, Uganda	PLOS ONE			English	Article								Background Uganda is a low-income country with high fertility, adolescent birth, and maternal mortality rates. How Ugandan Ministry of Health antenatal education guidelines have been implemented into standardized health education and how pregnant women utilize health facilities remains unclear. Objective We aimed to determine how women obtain education during pregnancy, what guidelines health educators follow, and what barriers exist to receiving antenatal care in Lweza Village, Uganda. Methods Household surveys were conducted with women in Lweza who were or had previously been pregnant. Focus group discussions were conducted with community members and Lweza Primary School teachers. Interviews were conducted with key informants, including midwives, a traditional birth attendant, a community leader, and a Village Health Team member. Data collection was done in English along with a Luganda translator. Results Of the 100 household surveys conducted, 86% of women did not meet the WHO recommendation of 8 antenatal appointments during their pregnancies. Reasons cited for inadequate visits included facing long wait times (>7 h) at health facilities, getting education from family or traditional healers, or being told to delay antenatal care until 6 months pregnant. Informant interviews revealed that no standardized antenatal education program exists. Respondents felt least educated on family planning and postpartum depression, despite 37% of them reporting symptoms consistent with postpartum depression. Education was also lacking on the use of traditional herbs, although most women (60%) reported using them during pregnancy. Conclusions Most women in Lweza do not receive 8 antenatal appointments during their pregnancies or any standardized antenatal education. Educational opportunities on family planning, postpartum depression, and the safety of traditional herbs during pregnancy exist. Future studies should focus on ways to overcome barriers to antenatal care, which could include implementing community-based education programs to improve health outcomes for women in Lweza Village.	[Delzer, Mackenzie E.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Kkonde, Anthony] Mukono Dist Municipal, Mukono, Uganda; [McAdams, Ryan M.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Delzer, ME (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.	mecarlson3@wisc.edu		Delzer, Mackenzie/0000-0002-8237-0122; McAdams, Ryan/0000-0002-9579-1698	University of Wisconsin School of Medicine and Public Health; Herman and Gwendolyn Shapiro Foundation	University of Wisconsin School of Medicine and Public Health; Herman and Gwendolyn Shapiro Foundation	Research support was provided by an award from the University of Wisconsin School of Medicine and Public Health and the Herman and Gwendolyn Shapiro Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, HUMAN DEV INDICATORS; [Anonymous], 2019, MUKONO MUNICIPALITY; Bank TW., FERTILITY RATE TOTAL; Banke-Thomas OE, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1246-3; Bariagaber H., 2016, Studies on Ethno-Medicine, V10, P411; Benova L, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3546-3; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brummelte S, 2016, HORM BEHAV, V77, P153, DOI 10.1016/j.yhbeh.2015.08.008; Committee GR.  Maternal N. Organization TWH, 2016, HUMAN REPROD PROGRAM; Gajaria A, 2018, ASIAN J PSYCHIATR, V37, P112, DOI 10.1016/j.ajp.2018.08.014; Huebl L, 2016, AM J TROP MED HYG, V95, P1440, DOI 10.4269/ajtmh.15-0579; Kyaddondo D, 2017, INT J GYNECOL OBSTET, V139, P38, DOI 10.1002/ijgo.12405; Mbonye MK, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-165; Mengist Hylemariam Mihiretie, 2017, BMC Res Notes, V10, P440, DOI 10.1186/s13104-017-2770-y; Munabi-Babigumira S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213511; Organization TWH (RHR) RHaR (NHD) NfHaD Maternal N Child and Adolescent Health (MCA)., WHO GUIDANCE ANTENAT; Seward N, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002467; Unicef, 2018, LEV TRENDS INESTIMAT; United Nations Population Fund (UNFPA), 2019, TRENDS MAT MORT 2000; Viguera MDA., 2018, POSTPARTUM UNIPOLAR; Waiswa Peter, 2008, BMC Pregnancy Childbirth, V8, P21, DOI 10.1186/1471-2393-8-21; World Health Organization, 2014, WHO REC COMM MOB FAC; Young SL., PICA PREGNANCY	23	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246926	10.1371/journal.pone.0246926	http://dx.doi.org/10.1371/journal.pone.0246926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592036	Green Published, gold			2022-12-26	WOS:000620632800044
J	Marcato, F; van den Brand, H; Jansen, CA; Rutten, VPMG; Kemp, B; Engel, B; Wolthuis-Fillerup, M; van Reenen, K				Marcato, Francesca; van den Brand, Henry; Jansen, Christine A.; Rutten, Victor P. M. G.; Kemp, Bas; Engel, Bas; Wolthuis-Fillerup, Maaike; van Reenen, Kees			Effects of pre-transport diet, transport duration and transport condition on immune cell subsets, haptoglobin, cortisol and bilirubin in young veal calves	PLOS ONE			English	Article								The aim of this study was to investigate effects of pre-transport diets, transport durations and transport conditions on immune cell subsets, haptoglobin, cortisol and bilirubin of young calves upon arrival at the veal farm. An experiment was conducted with a 2 x 2 x 2 factorial arrangement with 3 factors: 1) provision of rearing milk or electrolytes at the collection center (CC); 2) transport duration (6 or 18 hours) and 3) transport condition (open truck or conditioned truck). Holstein-Friesian and cross-bred calves were used (N = 368; 18 +/- 4 days; 45.3 +/- 3.3 kg). Blood samples were collected from calves (N = 128) at the collection center, immediately post-transport (T0) and 4, 24, 48 hours, week 1, 3 and 5 post-transport. Blood was analyzed for cortisol, bilirubin, haptoglobin, IgG and IgM. Moreover, cell counts of neutrophils, lymphocytes, monocytes, basophils and eosinophils were measured in blood samples taken at the collection center and T0. In these same blood samples, different lymphocyte populations were characterized by flow cytometry, including CD14+ cells, NK cells, delta gamma+ T cells, CD8+ cells, CD4+ cells and CD21+ cells. Calves transported in the conditioned truck had higher amounts of white blood cell count (WBC) (Delta = 1.39 x 10(9)/l; P = 0.01), monocytes (Delta = 0.21 x 10(9)/l; P = 0.04), neutrophils (Delta = 0.93 x 10(9)/l; P = 0.003), than calves transported in the open truck regardless, of pre-transport diet or transport duration. The study showed that transport condition and duration influenced parts of the innate immune system of young veal calves. Cortisol, bilirubin and WBC seemed to be connected by similar underlying mechanisms in relation to transport conditions. However, it is unclear which specific pathways in the immune system of young calves are affected by different transport conditions (e.g. temperature, humidity, draught).	[Marcato, Francesca; van den Brand, Henry; Kemp, Bas] Wageningen Univ & Res, Adaptat Physiol Grp, Wageningen, Netherlands; [Marcato, Francesca; Wolthuis-Fillerup, Maaike; van Reenen, Kees] Wageningen Univ & Res, Wageningen Livestock Res, Wageningen, Netherlands; [Jansen, Christine A.; Rutten, Victor P. M. G.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Rutten, Victor P. M. G.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Pretoria, South Africa; [Engel, Bas] Wageningen Univ & Res, Biometris, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Utrecht University; University of Pretoria; Wageningen University & Research	Marcato, F (corresponding author), Wageningen Univ & Res, Adaptat Physiol Grp, Wageningen, Netherlands.; Marcato, F (corresponding author), Wageningen Univ & Res, Wageningen Livestock Res, Wageningen, Netherlands.	francesca.marcato@wur.nl	Rutten, Victor PMG/AAB-6833-2022	Rutten, Victor PMG/0000-0002-6171-1805; Marcato, Francesca/0000-0002-7063-5955	Stichting Brancheorganisatie Kalversector (SBK); Dutch Ministry of Agriculture, Nature and Food Quality	Stichting Brancheorganisatie Kalversector (SBK); Dutch Ministry of Agriculture, Nature and Food Quality	This study was financially supported by Stichting Brancheorganisatie Kalversector (SBK) (www.kalversector.nl) and the Dutch Ministry of Agriculture, Nature and Food Quality (www.minlnv.nl).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2004, PHARMACOLOGY, V72, P196, DOI 10.1159/000080105; Anane LH, 2010, BRAIN BEHAV IMMUN, V24, P608, DOI 10.1016/j.bbi.2010.01.002; Arthington JD, 2008, J ANIM SCI, V86, P2016, DOI 10.2527/jas.2008-0968; Assenat E, 2004, HEPATOLOGY, V40, P951, DOI 10.1002/hep.20387; Autio T, 2007, VET MICROBIOL, V119, P256, DOI 10.1016/j.vetmic.2006.10.001; Averos X, 2008, LIVEST SCI, V119, P174, DOI 10.1016/j.livsci.2008.04.002; Baldwin CL, 2000, RES VET SCI, V69, P175, DOI 10.1053/rvsc.2000.0410; Ballou MA, 2015, J DAIRY SCI, V98, P1972, DOI 10.3168/jds.2014-8783; Bauer ML, 2001, J ANIM SCI, V79, P1917; Bertoni G, 2008, J DAIRY SCI, V91, P3300, DOI 10.3168/jds.2008-0995; Bionaz M, 2007, J DAIRY SCI, V90, P1740, DOI 10.3168/jds.2006-445; Brscic M, 2012, J DAIRY SCI, V95, P2753, DOI 10.3168/jds.2011-4699; Brun-Hansen HC, 2006, VET CLIN PATH, V35, P182, DOI 10.1111/j.1939-165X.2006.tb00111.x; Ceciliani F, 2012, J PROTEOMICS, V75, P4207, DOI 10.1016/j.jprot.2012.04.004; COLE NA, 1988, AM J VET RES, V49, P178; Earley B, 2017, ANIMAL, V11, P486, DOI 10.1017/S1751731116001622; Ganheim C, 2007, VET J, V173, P645, DOI 10.1016/j.tvjl.2006.01.011; GARDYGODILLOT M, 1989, J DAIRY SCI, V72, P1842, DOI 10.3168/jds.S0022-0302(89)79301-2; Grandin T, 2014, LIVESTOCK HANDLING AND TRANSPORT, 4TH EDITION, P1, DOI 10.1079/9781780643212.0000; Honkavaar M, 2003, DEUT TIERARZTL WOCH, V110, P125; Hulbert LE, 2016, J DAIRY SCI, V99, P3199, DOI 10.3168/jds.2015-10198; Ishizaki H, 2010, J VET MED SCI, V72, P747, DOI 10.1292/jvms.09-0441; Joshi V, 2018, MICROB PATHOGENESIS, V116, P33, DOI 10.1016/j.micpath.2018.01.001; Kanematsu N, 2017, JARQ-JPN AGR RES Q, V51, P165, DOI 10.6090/jarq.51.165; Karasuyama H, 2018, J ALLERGY CLIN IMMUN, V142, P370, DOI 10.1016/j.jaci.2017.10.042; KENT JE, 1986, BRIT VET J, V142, P326, DOI 10.1016/0007-1935(86)90028-X; KENT JE, 1983, BRIT VET J, V139, P228, DOI 10.1016/S0007-1935(17)30489-X; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Knowles TG, 1999, VET REC, V145, P575; Lekeux P., 1995, Bovine Practitioner, P71; Lomborg SR, 2008, VET RES COMMUN, V32, P575, DOI 10.1007/s11259-008-9057-7; MacKenzie AM, 1997, RES VET SCI, V63, P227, DOI 10.1016/S0034-5288(97)90025-4; Marcato F, 2020, J DAIRY SCI, V103, P3505, DOI 10.3168/jds.2019-17445; Marcato F, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00133; Masmeijer C, 2019, J VET INTERN MED, V33, P1514, DOI 10.1111/jvim.15482; MITCHELL G, 1988, VET REC, V123, P201, DOI 10.1136/vr.123.8.201; MORMEDE P, 1982, ANN RECH VET, V13, P369; MURATA H, 1993, BRIT VET J, V149, P277, DOI 10.1016/S0007-1935(05)80173-3; MURATA H, 1987, BRIT VET J, V143, P166, DOI 10.1016/0007-1935(87)90008-X; MURATA H, 1991, BRIT VET J, V147, P455, DOI 10.1016/0007-1935(91)90088-5; Nonnecke BJ, 2003, J DAIRY SCI, V86, P3592, DOI 10.3168/jds.S0022-0302(03)73965-4; Odore R, 2004, VET J, V168, P297, DOI 10.1016/j.tvjl.2003.09.008; Odore R, 2011, RES VET SCI, V90, P341, DOI 10.1016/j.rvsc.2010.05.026; Preisler MT, 2000, J DAIRY SCI, V83, P38, DOI 10.3168/jds.S0022-0302(00)74852-1; Renaud DL, 2018, J DAIRY SCI, V101, P2659, DOI [10.3168/jds.2017-13581, 10.3168/jds.2017-13578]; RICHET E, 1985, REPROD NUTR DEV, V25, P427, DOI 10.1051/rnd:19850308; Riondato F, 2008, VET J, V175, P364, DOI 10.1016/j.tvjl.2007.02.001; Salak-Johnson JL, 2007, J ANIM SCI, V85, pE81, DOI 10.2527/jas.2006-538; Sporer KRB, 2008, J ANIM SCI, V86, P1325, DOI 10.2527/jas.2007-0762; Swanson J.C., 2001, J ANIM SCI, V79, pE102, DOI [10.2527/jas2001.79e-supple102x, DOI 10.2527/JAS2001.79E-SUPPLE102X]; TARRANT PV, 1992, LIVEST PROD SCI, V30, P223, DOI 10.1016/0301-6226(92)90071-B; Tothova C, 2014, VET MED-CZECH, V59, P163, DOI 10.17221/7478-VETMED; WARRISS PD, 1995, VET REC, V136, P319, DOI 10.1136/vr.136.13.319; Wessely-Szponder J., 2004, Polish Journal of Veterinary Sciences, V7, P157; WEST HJ, 1990, RES VET SCI, V48, P221, DOI 10.1016/S0034-5288(18)30994-9; Woodward B, 1998, NUTR REV, V56, pS84	56	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246959	10.1371/journal.pone.0246959	http://dx.doi.org/10.1371/journal.pone.0246959			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592073	Green Published, gold			2022-12-26	WOS:000620632800070
J	Valentin, JB; Moller, H; Johnsen, SP				Valentin, Jan Brink; Moller, Henrik; Johnsen, Soren Paaske			The basic reproduction number can be accurately estimated within 14 days after societal lockdown: The early stage of the COVID-19 epidemic in Denmark	PLOS ONE			English	Article								Objective Early identification of the basic reproduction number (BRN) is imperative to political decision making during an epidemic. In this study, we estimated the BRN 7, 14, 21 and 28 days after societal lockdown of Denmark during the early stage of the COVID-19 epidemic. Method We implemented the SEIR dynamical system for disease spread without vital dynamics. The BRN was modulated using a sigmoid function. Model parameters were estimated on number of admitted patients, number of patients in intensive care and cumulative number of deaths using the simulated annealing Monte Carlo algorithm. Results are presented with 95% prediction intervals (PI). Results We were unable to determine any reliable estimate of the BRN at 7 days following lockdown. The BRN had stabilised at day 14 throughout day 28, with the estimate ranging from 0.95 (95% PI: 0.92-0.98) at day 7 to 0.92 (95% PI: 0.92-0.93) at day 28. We estimated the BRN prior to lockdown to be 3.32 (95% PI: 3.31-3.33). The effect of the lockdown was occurring over a period of a few days centred at March 18th (95% PI: 17th-18th) 2020. Conclusion We believe our model provides a valuable tool for decision makers to reliably estimate the effect of a politically determined lockdown during an epidemic.	[Valentin, Jan Brink; Moller, Henrik; Johnsen, Soren Paaske] Aalborg Univ, Danish Ctr Clin Hlth Serv Res DACS, Dept Clin Med, Aalborg, Denmark; [Valentin, Jan Brink; Moller, Henrik; Johnsen, Soren Paaske] Aalborg Univ Hosp, Aalborg, Denmark; [Moller, Henrik] Danish Clin Qual Program & Clin Registries RKKP, Aarhus, Denmark	Aalborg University; Aalborg University; Aalborg University Hospital	Valentin, JB (corresponding author), Aalborg Univ, Danish Ctr Clin Hlth Serv Res DACS, Dept Clin Med, Aalborg, Denmark.; Valentin, JB (corresponding author), Aalborg Univ Hosp, Aalborg, Denmark.	jyalentin@dcm.aau.dk		Valentin, Jan Brink/0000-0002-8205-7179				ALLEN LJS, 1994, MATH BIOSCI, V124, P83, DOI 10.1016/0025-5564(94)90025-6; ARON JL, 1984, J THEOR BIOL, V110, P665, DOI 10.1016/S0022-5193(84)80150-2; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Cao YC, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101647; Dropkin G, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00256; Dureau J, 2013, BIOSTATISTICS, V14, P541, DOI 10.1093/biostatistics/kxs052; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Hyafil A, 2021, GAC SANIT, V35, P453, DOI 10.1016/j.gaceta.2020.05.003; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li W., 2010, NEW ENGL J MED, V18, P121, DOI [10.1101/2020.01.31.929042, DOI 10.1101/2020.01.31.929042]; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Liu Y., 2020, LANCET, DOI [10.1016/S0140-6736%2820%2930462-1, DOI 10.1016/S0140-6736%2820%2930462-1]; Ma JL, 2020, INFECT DIS MODEL, V5, P129, DOI 10.1016/j.idm.2019.12.009; Mason RJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00607-2020; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Pung R, 2020, LANCET, V395, P1039, DOI 10.1016/S0140-6736(20)30528-6; Stehle J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-87; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7	22	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247021	10.1371/journal.pone.0247021	http://dx.doi.org/10.1371/journal.pone.0247021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592029	gold, Green Published, Green Submitted			2022-12-26	WOS:000620632800053
J	da Costa, RB; Costa, MB; Longo, L; Miotto, DE; Dellavia, GH; Michalczuk, MT; Alvares-da-Silva, MR				da Costa, Raquel Boff; Costa, Marisa Boff; Longo, Larisse; Miotto, Daniela Elisa; Dellavia, Gustavo Hirata; Michalczuk, Matheus Trucollo; Alvares-da-Silva, Mario Reis			Direct antiviral agents for hepatitis C and drug interaction risk: A retrospective cohort study with real and simulated data on medication interaction, prevalence of comorbidities and comedications	PLOS ONE			English	Article								Introduction and aim Comorbidities and comedication are common in patients with hepatitis C, which could result in a risk of drug-drug interaction. The objective of this study was to evaluate the prevalence of comorbidities, comedication and drug-drug interactions involving direct-acting antivirals in this population. Methods Comorbidities and comedications were evaluated in a retrospective cohort of hepatitis C patients. Drug-drug interactions were estimated in real life and with simulated data on comedications following drug regimens: telaprevir; elbasvir/grazoprevir, ombitasvir/paritaprevir/r/ritonavir (2D regimen), and sofosbuvir/simeprevir, sofosbuvir/daclatasvir, sofosbuvir/ledipasvir; 2D/dasabuvir (3D regimen); glecaprevir/pibrentasvir and sofosbuvir/velpatasvir/voxilaprevir. The interactions were evaluated according to the University of Liverpool database. Statistical analysis was performed by SPSS(R) 18.0. Results Data from 1433 patients with hepatitis C were evaluated. The mean patient age was 51.7 years (SD +/- 10.7), and 50.6% were female. Direct-acting antivirals were prescribed for 345 (24.1%) patients, and a sustained virological response occurred in 264 (76.5%). The main comorbidities were systemic arterial hypertension [436 (30.4%)], diabetes mellitus [352 (24.6%)] and depression [130 (9.1%)]. The mean number of comorbidities was 1.52 (median [IQR] of 1.00 [1.00-2.00]). The mean number of comedications was 3.16 (median [IQR] of 3.00 [1.00-5.00]). A total of 12916 drug-drug interactions were found, of which 1.859 (14.4%) were high risk, with a mean of 1.29 +/- 3.13 per patient. The 3D regimen, as well as glecaprevir/pibrentasvir and sofosbuvir/velpatasvir/voxilaprevir, presented the highest drug-drug interaction indexes. Conclusion Comorbidities and comedications are common in patients with hepatitis C, as are drug-drug interactions. Even when second generation drugs are used, the occurrence of drug-drug interactions still presents a significant risk.	[da Costa, Raquel Boff; Costa, Marisa Boff; Longo, Larisse; Michalczuk, Matheus Trucollo; Alvares-da-Silva, Mario Reis] Univ Fed Rio Grande do Sul UFRGS, Sch Med, Grad Program Sci Gastroenterol & Hepatol, Porto Alegre, RS, Brazil; [Longo, Larisse; Alvares-da-Silva, Mario Reis] HCPA, Expt Gastroenterol & Hepatol Lab, Ctr Expt Res, Porto Alegre, RS, Brazil; [Miotto, Daniela Elisa; Dellavia, Gustavo Hirata; Michalczuk, Matheus Trucollo; Alvares-da-Silva, Mario Reis] Hosp Clin Porto Alegre HCPA, Gastroenterol Div, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	da Costa, RB (corresponding author), Univ Fed Rio Grande do Sul UFRGS, Sch Med, Grad Program Sci Gastroenterol & Hepatol, Porto Alegre, RS, Brazil.	rbdacosta@hcpa.edu.br	Alvares-da-Silva, Mario Reis/L-3910-2014	Alvares-da-Silva, Mario Reis/0000-0002-5001-246X; Boff da Costa, Raquel/0000-0002-1665-8208; Longo, Larisse/0000-0002-4453-7227	Research Incentive Fund - Hospital de Clinicas de Porto Alegre (FIPE - HCPA); CNPq (National Council for Technological and Scientific Development); CAPES (Coordination for the Improvement of Higher Education Personnel)	Research Incentive Fund - Hospital de Clinicas de Porto Alegre (FIPE - HCPA); CNPq (National Council for Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Research Incentive Fund - Hospital de Clinicas de Porto Alegre (FIPE - HCPA), CNPq (National Council for Technological and Scientific Development) and CAPES (Coordination for the Improvement of Higher Education Personnel) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahmed M, 2018, WORLD J HEPATOL, V10, P670, DOI 10.4254/wjh.v10.i10.670; [Anonymous], 2016, WHOHIV201606; Campiotto S, 2005, BRAZ J MED BIOL RES, V38, P41, DOI 10.1590/S0100-879X2005000100007; CONITEC, 2018, PROT CLIN DIR TER HE; Costa M., 2020, CLIN EPIDEMIOLOGICAL, P7; Fabrizi F, 2018, EXPERT REV CLIN PHAR, V11, P1135, DOI 10.1080/17512433.2018.1534202; Flamm S, 2019, CLIN GASTROENTEROL H, V17, P527, DOI 10.1016/j.cgh.2018.07.003; Hahn D, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.13024; Hudson B, 2017, J MED VIROL, V89, P2158, DOI 10.1002/jmv.24848; Kondili LA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190803; Lanini S, 2016, CLIN MICROBIOL INFEC, V22, P833, DOI 10.1016/j.cmi.2016.07.035; Lauffenburger JC, 2014, EUR J GASTROEN HEPAT, V26, P1073, DOI 10.1097/MEG.0000000000000152; Louie KS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-86; Mansour M, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12972; Mazzarelli C, 2018, J AM GERIATR SOC, V66, P1339, DOI 10.1111/jgs.15392; Ottman AA, 2018, ANN PHARMACOTHER, V52, P763, DOI 10.1177/1060028018766507; Pawlotsky JM, 2015, J HEPATOL, V62, pS87, DOI 10.1016/j.jhep.2015.02.006; Rehman GU, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2416281; Roncero C, 2018, EXPERT REV CLIN PHAR, V11, P999, DOI 10.1080/17512433.2018.1519392; Siederdissen CHZ, 2016, CLIN INFECT DIS, V62, P561, DOI 10.1093/cid/civ973; Soriano V, 2017, EXPERT OPIN DRUG MET, V13, P807, DOI 10.1080/17425255.2017.1351942	21	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0245767	10.1371/journal.pone.0245767	http://dx.doi.org/10.1371/journal.pone.0245767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577593	gold, Green Published			2022-12-26	WOS:000620071700003
J	Hsu, MH; Lin, JW; Liao, CP; Hsu, JY; Huang, WS				Hsu, Min-Hao; Lin, Jhan-Wei; Liao, Chen-Pan; Hsu, Jung-Ya; Huang, Wen-San			Trans-marine dispersal inferred from the saltwater tolerance of lizards from Taiwan	PLOS ONE			English	Article								Dehydration and hypersalinity challenge non-marine organisms crossing the ocean. The rate of water loss and saltwater tolerance thus determine the ability to disperse over sea and further influence species distribution. Surprisingly, this association between physiology and ecology is rarely investigated in terrestrial vertebrates. Here we conducted immersion experiments to individuals and eggs of six lizard species differently distributed across Taiwan and the adjacent islands to understand if the physiological responses reflect the geographical distribution. We found that Plestiodon elegans had the highest rate of water loss and the lowest saltwater tolerance, whereas Eutropis longicaudata and E. multifasciata showed the lowest rate of water loss and the highest saltwater tolerance. Diploderma swinhonis, Hemidactylus frenatus, and Anolis sagrei had medium measurements. For the eggs, only the rigid-shelled eggs of H. frenatus were incubated successfully after treatments. While, the parchment-shelled eggs of E. longicaudata and D. swinhonis lost or gained water dramatically in the immersions without any successful incubation. Combined with the historical geology of the islands and the origin areas of each species, the inferences of the results largely explain the current distribution of these lizards across Taiwan and the adjacent islands, pioneerly showing the association between physiological capability and species distribution.	[Hsu, Min-Hao; Lin, Jhan-Wei; Liao, Chen-Pan; Hsu, Jung-Ya; Huang, Wen-San] Natl Museum Nat Sci, Dept Biol, Taichung, Taiwan; [Hsu, Min-Hao; Huang, Wen-San] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Liao, Chen-Pan; Huang, Wen-San] Tunghai Univ, Dept Life Sci, Taichung, Taiwan	National Chung Hsing University; Tunghai University	Huang, WS (corresponding author), Natl Museum Nat Sci, Dept Biol, Taichung, Taiwan.; Huang, WS (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan.; Huang, WS (corresponding author), Tunghai Univ, Dept Life Sci, Taichung, Taiwan.	wshuang.380@gmail.com		Huang, Wen-San/0000-0003-0073-3557	Ministry of Science and Technology, Taiwan MOST [109-2621-B-178-001-MY3]	Ministry of Science and Technology, Taiwan MOST	Ministry of Science and Technology, Taiwan MOST 109-2621-B-178-001-MY3 to corresponding author Wen-san Huang. he funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres M, 2015, OCEANOGRAPHY, V28, P84, DOI 10.5670/oceanog.2015.84; BAEYENS DA, 1983, COMP BIOCHEM PHYS A, V76, P301, DOI 10.1016/0300-9629(83)90331-6; Bansal R, 2010, MOL PHYLOGENET EVOL, V57, P459, DOI 10.1016/j.ympev.2010.06.008; Betancur-R R, 2011, J BIOGEOGR, V38, P1281, DOI 10.1111/j.1365-2699.2011.02496.x; Borden Ross, 2007, Biawak, V1, P84; Brandley MC, 2012, ZOOL J LINN SOC-LOND, V165, P163, DOI 10.1111/j.1096-3642.2011.00801.x; BROWN SG, 1992, J HERPETOL, V26, P510, DOI 10.2307/1565135; Brown W. C., 1957, Copeia, V1957, P39, DOI 10.2307/1440508; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Calsbeek R, 2003, NATURE, V426, P552, DOI 10.1038/nature02143; Carranza S, 2006, MOL PHYLOGENET EVOL, V38, P531, DOI 10.1016/j.ympev.2005.07.012; Censky EJ, 1998, NATURE, V395, P556, DOI 10.1038/26886; Chen YG, 2001, QUATERNARY SCI REV, V20, P869, DOI 10.1016/S0277-3791(00)00047-0; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Clark PU, 2002, QUATERNARY SCI REV, V21, P1, DOI 10.1016/S0277-3791(01)00118-4; Cox CL, 2015, EVOLUTION, V69, P2507, DOI 10.1111/evo.12742; DAVENPORT J, 1990, J ZOOL, V220, P487, DOI 10.1111/j.1469-7998.1990.tb04320.x; DAWSON WR, 1966, ECOLOGY, V47, P589, DOI 10.2307/1933936; Dmiel R, 1997, BIOTROPICA, V29, P111; DMIEL R, 1985, J THERM BIOL, V10, P145, DOI 10.1016/0306-4565(85)90018-X; ELLIS TM, 1981, J HERPETOL, V15, P187, DOI 10.2307/1563379; Esser LJ, 2011, RAFFLES B ZOOL, V59, P259; Fisher RN, 1997, EVOLUTION, V51, P906, DOI 10.1111/j.1558-5646.1997.tb03672.x; GARDNER AS, 1985, BRIT J HERPETOL, V6, P435; Gerlach J, 2006, J NAT HIST, V40, P2403, DOI 10.1080/00222930601058290; Glor RE, 2005, MOL ECOL, V14, P2419, DOI 10.1111/j.1365-294X.2005.02550.x; Guillon M, 2014, CAN J ZOOL, V92, P81, DOI 10.1139/cjz-2013-0189; Guja LK, 2010, FUNCT PLANT BIOL, V37, P1175, DOI 10.1071/FP10166; Hart KM, 2012, J EXP MAR BIOL ECOL, V413, P56, DOI 10.1016/j.jembe.2011.11.021; HEATWOLE H, 1977, Journal of Herpetology, V11, P341, DOI 10.2307/1563247; HEGER NA, 1992, J HERPETOL, V26, P338, DOI 10.2307/1564892; HILLMAN SS, 1977, OECOLOGIA, V29, P105, DOI 10.1007/BF00345791; Holden Magaly, 2014, Herpetology Notes, V7, P509; Hopkins GR, 2015, HERPETOL MONOGR, V29, P1; Jan S, 2003, DEEP-SEA RES PT II, V50, P1117, DOI 10.1016/S0967-0645(03)00013-4; Josefson AB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168908; Jud ZR, 2015, ENVIRON BIOL FISH, V98, P135, DOI 10.1007/s10641-014-0242-y; Karin BR, 2016, MOL PHYLOGENET EVOL, V102, P220, DOI 10.1016/j.ympev.2016.05.033; KATTAN GH, 1989, PHYSIOL ZOOL, V62, P593, DOI 10.1086/physzool.62.2.30156187; Kobayashi S, 2014, ECOL RES, V29, P1025, DOI 10.1007/s11284-014-1188-4; Koleva V, 2017, WEB ECOL, V17, P1, DOI 10.5194/we-17-1-2017; Kurita K, 2014, ZOOL SCI, V31, P187, DOI 10.2108/zs130179; Lillywhite HB, 2009, J EXP BIOL, V212, P1921, DOI 10.1242/jeb.028704; Losos JB, 2003, OECOLOGIA, V137, P360, DOI 10.1007/s00442-003-1363-8; NEILL WILFRED T., 1958, BULL MARINE SCI GULF AND CARIBBEAN, V8, P1; Nikula R, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0821; Norval G, 2002, ZOOL STUD, V41, P332; Osozawa S, 2012, INT GEOL REV, V54, P1369, DOI 10.1080/00206814.2011.639954; OTA H, 1994, ZOOL STUD, V33, P86; PACKARD GC, 1979, RESP PHYSIOL, V38, P1, DOI 10.1016/0034-5687(79)90002-1; Packard M.J., 1991, P53, DOI 10.1017/CBO9780511585739.006; PACKARD MJ, 1982, HERPETOLOGICA, V38, P136; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; PRANGE HD, 1969, COMP BIOCHEM PHYSIOL, V28, P973, DOI 10.1016/0010-406X(69)92133-1; Qiu Y, 2011, J OCEANOGR, V67, P395, DOI 10.1007/s10872-011-0033-4; ROBERTS JB, 1983, J EXP ZOOL, V228, P1, DOI 10.1002/jez.1402280102; Russell JC, 2010, BIOL INVASIONS, V12, P1747, DOI 10.1007/s10530-009-9586-1; SCHOENER A, 1984, OECOLOGIA, V63, P289, DOI 10.1007/BF00390655; SNYDER JO, 1917, P US NAT MUS, V54, P19; Tabak MA, 2015, CONSERV GENET, V16, P125, DOI 10.1007/s10592-014-0646-4; TEMPLETON JR, 1972, Z VERGL PHYSIOL, V76, P255, DOI 10.1007/BF00303232; Torres-Carvajal O, 2015, NEOBIOTA, V27, P69, DOI 10.3897/neobiota.27.5437; Vidal N, 2008, BIOL LETTERS, V4, P115, DOI 10.1098/rsbl.2007.0531; Wang K, 2019, ZOOL J LINN SOC-LOND, V185, P246, DOI 10.1093/zoolinnean/zly034; Wegener JE, 2014, BIOL J LINN SOC, V113, P570, DOI 10.1111/bij.12380; Yang SF, 2018, J BIOGEOGR, V45, P37, DOI 10.1111/jbi.13111; Yeh HY, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.190488	67	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0247009	10.1371/journal.pone.0247009	http://dx.doi.org/10.1371/journal.pone.0247009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577597	gold, Green Published			2022-12-26	WOS:000620071700038
J	Saliba-Gustafsson, EA; Nyberg, A; Borg, MA; Rosales-Klintz, S; Lundborg, CS				Saliba-Gustafsson, Erika A.; Nyberg, Anna; Borg, Michael A.; Rosales-Klintz, Senia; Lundborg, Cecilia Stalsby			Barriers and facilitators to prudent antibiotic prescribing for acute respiratory tract infections: A qualitative study with general practitioners in Malta	PLOS ONE			English	Article							RANDOMIZED CONTROLLED TRIAL; CROSS-SECTIONAL ANALYSIS; PRIMARY-CARE PHYSICIANS; PATIENTS EXPECTATIONS; COST-EFFECTIVENESS; PRESCRIPTION; PERCEPTIONS; BEHAVIOR; GPS; STRATEGIES	Background Antibiotic resistance is a leading global public health concern and antibiotic use is a key driver. Effective interventions are needed to target key stakeholders, including general practitioners (GPs). In Malta, little is known about factors that influence GPs' antibiotic prescribing, making it challenging to implement targeted interventions. We therefore aimed to explore GPs' understanding of antibiotic use and resistance, and describe their perceived barriers and facilitators to prudent antibiotic prescribing for acute respiratory tract infections in Malta. Methods Face-to-face individual semi-structured interviews were held with a quota sample of 20 GPs in 2014. Interviews were audio recorded and transcribed verbatim, and later analysed iteratively using manifest and latent content analysis. Findings were collated in a socioecological model to depict how GPs as individuals are embedded within larger social systems and contexts, and how each component within this system impacts their prescribing behaviour. Findings We found that GPs' antibiotic prescribing decisions are complex and impacted by numerous barriers and facilitators at the individual, interpersonal, organisational, community, and public policy level. Predominant factors found to impact GPs' antibiotic prescribing included not only intrinsic GP factors such as knowledge, awareness, experience, and misconceptions, but also several external factors. At the interpersonal level, GPs' perceived patient demand and behaviour to be a persistent issue that impacts their prescribing decisions. Similarly, some GPs found pressure from drug reps to be concerning despite being considered an important source of information. Organisational and public policy-level issues such as lack of access to relevant antibiotic prescribing guidelines and current antibiotic resistance data from the community, were also considered major barriers to appropriate antibiotic prescribing. Utilisation of diagnostic testing was found to be low and GPs' perceptions on the introduction of rapid point-of-care tests to support antibiotic prescription decisions, were mixed. Conclusion This study revealed the complexity of the antibiotic prescribing decision and the numerous barriers and facilitators that impact it, visualised through a socioecological model. Addressing GPs' antibiotic prescribing practices will require targeted and coordinated implementation activities at all levels to change behaviour and address misconceptions, whilst also improving the physical and social environment.	[Saliba-Gustafsson, Erika A.; Rosales-Klintz, Senia; Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Global Publ Hlth Hlth Syst & Policy HSP Impr, Stockholm, Sweden; [Saliba-Gustafsson, Erika A.] Stanford Univ, Div Primary Care & Populat Hlth, Sch Med, Stanford, CA 94305 USA; [Nyberg, Anna] Stockholm Univ, Fac Social Sci, Stockholm, Sweden; [Borg, Michael A.] Mater Dei Hosp, Dept Infect Prevent & Control, Msida, Malta; [Borg, Michael A.] Univ Malta, Fac Med & Surg, Msida, Malta; [Rosales-Klintz, Senia] European Ctr Dis Prevent & Control, Unit Surveillance & Response Support SRS, Solna, Sweden	Karolinska Institutet; Stanford University; Stockholm University; University of Malta; European Centre for Disease Prevention & Control	Saliba-Gustafsson, EA (corresponding author), Karolinska Inst, Dept Global Publ Hlth Hlth Syst & Policy HSP Impr, Stockholm, Sweden.; Saliba-Gustafsson, EA (corresponding author), Stanford Univ, Div Primary Care & Populat Hlth, Sch Med, Stanford, CA 94305 USA.	erika.saliba@gmail.com	Gustafsson, Erika Saliba/AAR-7256-2021	Saliba-Gustafsson, Erika A/0000-0003-1587-9591; Stalsby Lundborg, Cecilia/0000-0001-6525-1861; Rosales Klintz, Senia/0000-0002-2897-6123	Karolinska Institutet [3-1233/2013]	Karolinska Institutet(Karolinska Institutet)	This work was supported by Karolinska Institutet funding for doctoral education (KIDfunding 3-1233/2013). It was also supported by funding available to CSL at Karolinska Institutet. This study received no other specific grant from any public, commercial or not-for-profit funding agencies. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkerman AE, 2005, J ANTIMICROB CHEMOTH, V56, P930, DOI 10.1093/jac/dki283; Akkerman AE, 2004, J ANTIMICROB CHEMOTH, V54, P1116, DOI 10.1093/jac/dkh480; Anthierens S, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-101; Arroll B, 2002, J FAM PRACTICE, V51, P954; Ashworth M, 2016, BRIT J GEN PRACT, V66, pE40, DOI 10.3399/bjgp15X688105; Azzopardi-Muscat N., 2017, HLTH SYSTEMS TRANSIT, V19, P1; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Bernier A, 2014, ANTIMICROB AGENTS CH, V58, P71, DOI 10.1128/AAC.01813-13; Biezen R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028329; Bjorkman I, 2013, SCAND J PRIM HEALTH, V31, P50, DOI 10.3109/02813432.2012.751695; Borg MA, 2002, INT J ANTIMICROB AG, V20, P253, DOI 10.1016/S0924-8579(02)00194-2; Borg MA, 2019, J ANTIMICROB CHEMOTH, V74, P3379, DOI 10.1093/jac/dkz312; Borg MA, 2012, J ANTIMICROB CHEMOTH, V67, P763, DOI 10.1093/jac/dkr541; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Butler CC, 2008, SCAND J PRIM HEALTH, V26, P17, DOI 10.1080/02813430701726285; Carlsen B, 2007, BRIT J GEN PRACT, V57, P971, DOI 10.3399/096016407782604820; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Cates C, 1999, BRIT MED J, V318, P715, DOI 10.1136/bmj.318.7185.715; Chahwakilian P, 2011, J ANTIMICROB CHEMOTH, V66, P2872, DOI 10.1093/jac/dkr387; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; Coenen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076691; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Dallas A, 2015, FAM PRACT, V32, P49, DOI 10.1093/fampra/cmu069; Abad MD, 2016, JAMA INTERN MED, V176, P21, DOI 10.1001/jamainternmed.2015.7088; Dekker ARJ, 2015, FAM PRACT, V32, P401, DOI 10.1093/fampra/cmv019; Dempsey PP, 2014, BMC FAM PRACT, V15, DOI 10.1186/s12875-014-0194-5; Deschepper R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-123; Dowell J, 2001, BRIT J GEN PRACT, V51, P200; Dyrkorn R, 2016, SCAND J PRIM HEALTH, V34, P180, DOI 10.3109/02813432.2016.1163035; ECDC, 2018, SURV ANT CONS EUR 20; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Fernandez-Alvarez I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221326; Fickweiler F, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016408; Formoso G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5391; Francis NA, 2012, BRIT J GEN PRACT, V62, DOI [10.3399/bjgp12X654614, 10.3399/bjgp12X653561]; Frich JC, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-12; Gaygisiz U, 2017, J INFECT PUBLIC HEAL, V10, P755, DOI 10.1016/j.jiph.2016.11.011; Germeni E, 2018, BRIT J GEN PRACT, V68, pE633, DOI 10.3399/bjgp18X697889; Golden SD, 2012, HEALTH EDUC BEHAV, V39, P364, DOI 10.1177/1090198111418634; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gulliford MC, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l236; Gulliford MC, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3410; Haeseker MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051860; Hendaus MA, 2015, THER CLIN RISK MANAG, V11, P1265, DOI 10.2147/TCRM.S87789; Hofstede G, 2010, CULTURES ORG SOFTWAR, V3rd; Howick J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005611; Hoye S, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-34; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Ilett KF, 2000, BRIT J CLIN PHARMACO, V49, P168, DOI 10.1046/j.1365-2125.2000.00123.x; Klepser DG, 2012, AM J MANAG CARE, V18, pE145; Kumar S, 2003, BMJ-BRIT MED J, V326, P138, DOI 10.1136/bmj.326.7381.138; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 2004, BMJ-BRIT MED J, V328, P444, DOI 10.1136/bmj.38013.644086.7C; Little P, 2002, BRIT J GEN PRACT, V52, P187; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1606; Llor C, 2014, RESP CARE, V59, P1918, DOI 10.4187/respcare.03275; Mangione-Smith R, 1999, PEDIATRICS, V103, P711, DOI 10.1542/peds.103.4.711; Manne M, 2018, SOUTH MED J, V111, P235, DOI 10.14423/SMJ.0000000000000795; McDermott L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016903; McDonagh MS, 2018, J INT MED RES, V46, P3337, DOI 10.1177/0300060518782519; McKay R, 2016, ANTIMICROB AGENTS CH, V60, P4106, DOI 10.1128/AAC.00209-16; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Meropol SB, 2013, ANN FAM MED, V11, P165, DOI 10.1370/afm.1449; Muijrers PEM, 2005, FAM PRACT, V22, P624, DOI 10.1093/fampra/cmi074; Murphy M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X593820; Namey E, 2005, QUALITATIVE RES METH; National Institute for Health and Care Excellence, 2008, RESP TRACT INF SELF; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; O'Connor R, 2018, IRISH J MED SCI, V187, P969, DOI 10.1007/s11845-018-1774-5; O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations; Oppong R, 2013, BRIT J GEN PRACT, V63, pE465, DOI 10.3399/bjgp13X669185; Peters S, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X593866; PricewaterhouseCoopers, 2012, HEALTHC DEL MALT; Prosser H, 2003, FAM PRACT, V20, P61, DOI 10.1093/fampra/20.1.61; Raft CF, 2017, EUR J GEN PRACT, V23, P191, DOI 10.1080/13814788.2017.1347628; Rosman S, 2008, EUR J PUBLIC HEALTH, V18, P312, DOI 10.1093/eurpub/ckm118; Saliba-Gustafsson EA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032704; Saliba-Gustafsson EA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225506; Saliba-Gustafsson EA, 2019, J ANTIMICROB CHEMOTH, V74, P1116, DOI 10.1093/jac/dky544; Saliba-Gustafsson EA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017992; Shallcross L, 2017, J ANTIMICROB CHEMOTH, V72, P1818, DOI 10.1093/jac/dkx048; Simpson SA, 2007, J ANTIMICROB CHEMOTH, V59, P292, DOI [10.1093/jac/dk1467, 10.1093/jac/dkl467]; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Stanton N, 2010, EUR RESPIR J, V35, P761, DOI 10.1183/09031936.00168409; Thoolen B, 2012, HEALTH PSYCHOL REV, V6, P92, DOI 10.1080/17437199.2011.552061; TNS Opinion & Social, 2016, SPEC EUR 445 ANT RES; TNS Opinion & Social, 2013, SPEC EUR 407 ANT RES; TNS Opinion & Social, 2018, SPEC EUR 478 ANT RES; Tonkin-Crine Sarah Kg, 2017, Cochrane Database Syst Rev, V9, pCD012252, DOI 10.1002/14651858.CD012252.pub2; van Duijn HJ, 2007, BRIT J GEN PRACT, V57, P561; Wald ER, 2013, PEDIATRICS, V132, pE262, DOI 10.1542/peds.2013-1071; Watkins C, 2003, QUAL SAF HEALTH CARE, V12, P29, DOI 10.1136/qhc.12.1.29; Welschen I, 2004, FAM PRACT, V21, P234, DOI 10.1093/fampra/cmh303; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; Zarb P., 2011, Malta Medical Journal, V23, P13; Zoorob R, 2012, AM FAM PHYSICIAN, V86, P817	101	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246782	10.1371/journal.pone.0246782	http://dx.doi.org/10.1371/journal.pone.0246782			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571265	Green Published, gold			2022-12-26	WOS:000618274000023
J	Schonfeld, D; Arias, S; Bossio, JC; Fernandez, H; Gozal, D; Perez-Chada, D				Schonfeld, Daniel; Arias, Sergio; Bossio, Juan Carlos; Fernandez, Hugo; Gozal, David; Perez-Chada, Daniel			Clinical presentation and outcomes of the first patients with COVID-19 in Argentina: Results of 207079 cases from a national database	PLOS ONE			English	Article								Background There is limited evidence on the clinical characteristics of SARS-CoV-2 infection in Latin America. We present findings from a nationwide study in Argentina. Research question What is disease severity measures and risk factors are associated with admission to an intensive care unit and mortality? Study design and methods Data were extracted from the COVID-19 database of the Integrated Argentina Health Information System, encompassing the period of March 3rd to October 2nd, 2020, using a standardized case report form that included information on contact history, clinical signs and symptoms, and clinical diagnosis. Information was collected at the initial site of care and follow-up conducted through calls by the regional healthcare authorities. A confirmed case of COVID-19 was defined as having a positive result through sequencing or real-time reverse-transcriptase polymerase chain reaction (RT-PCR) assay of nasal and pharyngeal swab specimens. Results RT-PCR testing was positive in 738,776 cases. Complete datasets were available for analysis in 207,079 cases. Mean age was 42.9 +/- 18.8 years, 50.0% were males. Frequent co-existing conditions included hypertension (19.2%), diabetes (9.7%), asthma (6.1%) and obesity (5.2%). Most common symptoms included fever (58.5%), cough (58.0%), headache (45.4%), and sore throat (42.1%). Death or ICU admission were independently associated with older age, male, coma, dyspnea or tachypnea, and seizures, with underlying co-morbidities such as immunodeficiency, chronic renal failure, and liver disease showing the strongest effects. Interpretation Most cases of COVID-19 diagnosed in Argentina were mild and had a favorable outcome, but fatality rates were relatively elevated. Risk factors for adverse outcome included older age, male sex, coma and seizures, and the concurrent presence of several morbidities. These data may be useful for healthcare providers and healthcare policy makers of low-middle income and Latin American countries to guide decisions toward optimized care during the pandemic.	[Schonfeld, Daniel] Ctr Diagnost San Jorge, Puerto Madryn, Chubut, Argentina; [Arias, Sergio; Bossio, Juan Carlos; Fernandez, Hugo] Adm Nacl Labs & Inst Salud Dr Carlos G Malbran, Inst Nacl Enfermedades Resp Dr Emilio Coni, Santa Fe, Argentina; [Gozal, David] Univ Missouri, Women & Childrens Hosp, Dept Child Hlth, Columbia, MO USA; [Perez-Chada, Daniel] Hosp Univ Austral, Serv Neumonol, Buenos Aires, DF, Argentina	University of Missouri System; University of Missouri Columbia; Austral University; Hospital Universitario Austral	Arias, S (corresponding author), Adm Nacl Labs & Inst Salud Dr Carlos G Malbran, Inst Nacl Enfermedades Resp Dr Emilio Coni, Santa Fe, Argentina.	sergioariassfe@gmail.com		Fernandez, Hugo/0000-0003-1847-096X; Gozal, David/0000-0001-8195-6036	Centro Diagnostico San Jorge. Puerto Madryn; Centro Diagnostico San Jorge; Instituto Nacional de Enfermedades Respiratorias; Administracion Nacional de Laboratorios e Institutos de Salud; Hospital Universitario Austral; Department of Child Health, Women and Children's Hospital, University of Missouri	Centro Diagnostico San Jorge. Puerto Madryn; Centro Diagnostico San Jorge; Instituto Nacional de Enfermedades Respiratorias; Administracion Nacional de Laboratorios e Institutos de Salud; Hospital Universitario Austral; Department of Child Health, Women and Children's Hospital, University of Missouri	"Centro Diagnostico San Jorge. Puerto Madryn" did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of one of authors' salaries. The author contributions roles were reviewed and accurately indicated. The funder provided support in the form of salaries for authors: a. Centro Diagnostico San Jorge pay salary to Daniel Schonfeld. b. Instituto Nacional de Enfermedades Respiratorias "Dr. Emilio Coni", Administracion Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbran" pay salaries to Sergio Arias, Juan Carlos Bossio and Hugo Fernandez. c. Hospital Universitario Austral pay salaries to Daniel Perez-Chada. d. Department of Child Health, Women and Children's Hospital, University of Missouri, pay salary to David Gozal. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abate SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235653; Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Alqahtani JS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233147; [Anonymous], 2020, CENTRAL S AM NOW INT; Baqui P, 2020, LANCET GLOB HEALTH, V8, P1018, DOI 10.1016/S2214-109X(20)30285-0; Barron E, 2020, LANCET DIABETES ENDO, V8, P813, DOI 10.1016/S2213-8587(20)30272-2; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Bong CL, 2020, ANESTH ANALG, V131, P86, DOI 10.1213/ANE.0000000000004846; Burki T, 2020, LANCET INFECT DIS, V20, P547, DOI 10.1016/S1473-3099(20)30303-0; Canals M, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.99; CDC, 2020, CAS US; Chen XY, 2021, J ADHESION, V97, P873, DOI 10.1080/00218464.2019.1710830; Chou R, 2020, ANN INTERN MED, V173, P120, DOI 10.7326/M20-1632; Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2; Cleverley J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2426; Di Castelnuovo A, 2020, NUTR METAB CARDIOVAS, V30, P1899, DOI 10.1016/j.numecd.2020.07.031; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Figar S, 2020, COMMUNITY LEVEL SARS, DOI [10.1101/2020.07.14.20153858v2.abstract, DOI 10.1101/2020.07.14.20153858V2.ABSTRACT]; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Grasselli G, 2020, JAMA INTERN MED, V180, P1345, DOI 10.1001/jamainternmed.2020.3539; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Izcovich A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241955; Lazzerini M, 2020, LANCET GLOB HEALTH, V8, pE641, DOI 10.1016/S2214-109X(20)30110-8; Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757; Mao R, 2020, LANCET GASTROENTEROL, V5, P426, DOI 10.1016/S2468-1253(20)30076-5; Marin-Sanchez A, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.87; Ministerio da Saude, B EP ESP 22 SE 28 20; Ministerio de Salud de la Nacion, CUART ENC NAC FACT R; Olivares F, 2020, PRELIMINARY REPORT, DOI DOI 10.1101/2020.06.14.20130898V1.ABSTRACT; Patanavanich R, 2020, NICOTINE TOB RES, DOI [10.1093/ntr/ntaa082/33216866/ntaa082.pdf, DOI 10.1093/NTR/NTAA082/33216866/NTAA082.PDF]; Perone G, 2020, DETERMINANTS COVID 1; Rearte Analía, 2020, Rev. argent. salud pública, V12, P5; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000; Wang X, 2020, CLIN MICROBIOL INFEC, V26, P1063, DOI 10.1016/j.cmi.2020.03.032; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; World Health Organization, 2020, REV CAS REP CONF NOV; World Health Organization, 2020, DIR GEN OP REM MED B; Wu Z, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI [10.1001/jama.2020.2648, DOI 10.1001/JAMA.2020.2648]; Yannouchos T, 2020, CHARACTERISTICS RISK, DOI DOI 10.1101/2020.06.04.20122481V1.ABSTRACT; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	44	25	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246793	10.1371/journal.pone.0246793	http://dx.doi.org/10.1371/journal.pone.0246793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571300	gold, Green Published			2022-12-26	WOS:000618274000094
J	Suzuki, K; Sunaga, H; Yamakawa, K; Suga, Y; Kondo, I; Tsubokawa, T; Uezono, S				Suzuki, Kaoru; Sunaga, Hiroshi; Yamakawa, Kentaro; Suga, Yoshifumi; Kondo, Ichiro; Tsubokawa, Tsunehisa; Uezono, Shoichi			Intravenous infusion of rocuronium bromide prolongs emergence from propofol anesthesia in rats	PLOS ONE			English	Article							NEUROMUSCULAR BLOCKING-AGENTS; BISPECTRAL INDEX; MUSCLE; REVERSAL; ELECTROENCEPHALOGRAM; SEVOFLURANE; INHIBITION; ISOFLURANE; SUGAMMADEX; RECEPTORS	Background Neuromuscular blocking agents induce muscle paralysis via the prevention of synaptic transmission at the neuromuscular junction and may have additional effects at other sites of action. With regard to potential effects of neuromuscular blocking agents on the central nervous system, a definitive view has not been established. We investigated whether intravenous infusion of rocuronium bromide affects the emergence from propofol anesthesia. Methods Using an in vivo rat model, we performed propofol infusion for 60 minutes, along with rocuronium bromide at various infusion rates or normal saline. Sugammadex or normal saline was injected at the end of the infusion period, and we evaluated the time to emergence from propofol anesthesia. We also examined the neuromuscular blocking, circulatory, and respiratory properties of propofol infusion along with rocuronium bromide infusion to ascertain possible factors affecting emergence. Results Intravenous infusion of rocuronium bromide dose-dependently increased the time to emergence from propofol anesthesia. Sugammadex administered after propofol infusion not containing rocuronium bromide did not affect the time to emergence. Mean arterial pressure, heart rate, partial pressures of oxygen and carbon dioxide, and pH were not affected by rocuronium bromide infusion. Neuromuscular blockade induced by rocuronium bromide, even at the greatest infusion rate in the emergence experiment, was rapidly antagonized by sugammadex. Conclusions These results suggest that intravenous infusion of rocuronium bromide dose-dependently delays the emergence from propofol anesthesia in rats. Future studies, such as detection of rocuronium in the cerebrospinal fluid or central nervous system, electrophysiologic studies, microinjection of sugammadex into the brain, etc., are necessary to determine the mechanism of this effect.	[Suzuki, Kaoru; Sunaga, Hiroshi; Yamakawa, Kentaro; Suga, Yoshifumi; Kondo, Ichiro; Tsubokawa, Tsunehisa; Uezono, Shoichi] Jikei Univ, Dept Anesthesiol, Sch Med, Tokyo, Japan; [Suga, Yoshifumi] Juntendo Univ, Dept Anesthesiol & Pain Med, Sch Med, Tokyo, Japan	Jikei University; Juntendo University	Sunaga, H (corresponding author), Jikei Univ, Dept Anesthesiol, Sch Med, Tokyo, Japan.	hs-031@jikei.ac.jp			Jikei University Research Fund; JSPS KAKENHI [JP18K08832]	Jikei University Research Fund(Jikei University); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	HS:The Jikei University Research Fund and JSPS KAKENHI grant number JP18K08832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldasoro M, 2017, INT J MED SCI, V14, P224, DOI 10.7150/ijms.17545; Bock M, 2000, BRIT J ANAESTH, V84, P43, DOI 10.1093/oxfordjournals.bja.a013380; CARDONE C, 1994, ANESTHESIOLOGY, V80, P1155, DOI 10.1097/00000542-199405000-00025; Chemali JJ, 2012, ANESTHESIOLOGY, V116, P998, DOI 10.1097/ALN.0b013e3182518bfc; Chiodini FC, 1998, ANESTHESIOLOGY, V88, P1003, DOI 10.1097/00000542-199804000-00021; Ekman A, 2007, NEUROREPORT, V18, P1817, DOI 10.1097/WNR.0b013e3282f13e11; Greif R, 2002, ANESTH ANALG, V94, P604, DOI 10.1097/00000539-200203000-00023; He HW, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021819; Hoshi Y, 2013, J PHARM SCI-US, V102, P3343, DOI 10.1002/jps.23575; Illman H, 2010, J CLIN MONIT COMPUT, V24, P371, DOI 10.1007/s10877-010-9257-x; Inoue S, 2006, INTENS CARE MED, V32, P391, DOI 10.1007/s00134-005-0031-3; Itoh H, 2004, ACTA ANAESTH SCAND, V48, P903, DOI 10.1111/j.0001-5172.2004.00439.x; Jooste E, 2007, ANESTHESIOLOGY, V106, P763, DOI 10.1097/01.anes.0000264763.48920.c9; Joyce C, 2016, A A CASE REP, V6, P286, DOI 10.1213/XAA.0000000000000306; Kurita T, 2002, ANESTHESIOLOGY, V96, P1498, DOI 10.1097/00000542-200206000-00033; Langley RJ, 2016, PEDIATR ANESTH, V26, P109, DOI 10.1111/pan.12789; LANIER WL, 1994, ANESTHESIOLOGY, V80, P392, DOI 10.1097/00000542-199402000-00019; Le Guen M, 2020, ANAESTHESIA, V75, P583, DOI 10.1111/anae.14897; Mansouri MT, 2019, BEHAV BRAIN RES, V367, P59, DOI 10.1016/j.bbr.2019.03.029; Miyazaki Y, 2016, J ANESTH, V30, P671, DOI 10.1007/s00540-016-2178-1; Moeser A, 2015, SMALL ANIMAL CRITICA, P872; OGLESBY MW, 1973, PSYCHOPHARMACOLOGIA, V32, P85, DOI 10.1007/BF00421710; Osawa T, 2008, J ANESTH, V22, P236, DOI 10.1007/s00540-008-0613-7; Palanca JM, 2013, INT J MED SCI, V10, P1278, DOI 10.7150/ijms.6254; Parks CL, 2016, ANESTHESIOLOGY, V124, P1328, DOI 10.1097/ALN.0000000000001080; Schmidt JE, 2000, ANESTHESIOLOGY, V92, P1476, DOI 10.1097/00000542-200005000-00039; SCHWARTZ AE, 1992, ANESTHESIOLOGY, V77, P686, DOI 10.1097/00000542-199210000-00012; Stevens JB, 1997, ACTA ANAESTH SCAND, V41, P502, DOI 10.1111/j.1399-6576.1997.tb04731.x; SZENOHRADSZKY J, 1993, ANESTH ANALG, V76, P1304, DOI 10.1213/00000539-199376060-00020; Weber F, 2010, PEDIATR ANESTH, V20, P697, DOI 10.1111/j.1460-9592.2010.03327.x	30	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246858	10.1371/journal.pone.0246858	http://dx.doi.org/10.1371/journal.pone.0246858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571289	Green Published, gold			2022-12-26	WOS:000618274000058
J	Sorkina, T; Cheng, MH; Bagalkot, TR; Wallace, C; Watkins, SC; Bahar, I; Sorkin, A				Sorkina, Tatiana; Cheng, Mary Hongying; Bagalkot, Tarique R.; Wallace, Callen; Watkins, Simon C.; Bahar, Ivet; Sorkin, Alexander			Direct coupling of oligomerization and oligomerization-driven endocytosis of the dopamine transporter to its conformational mechanics and activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER TRANSPORTERS; MONOAMINE TRANSPORTERS; PLASMA-MEMBRANE; CROSS-LINKING; DYNAMICS; PROTEINS; TRAFFICKING; RECEPTOR; REWARD; DIMER	Dopamine transporter (DAT) mediates the reuptake of synaptically released dopamine, and thus controls the duration and intensity of dopamine neurotransmission. Mammalian DAT has been observed to form oligomers, although the mechanisms of oligomerization and its role in DAT activity and trafficking remain largely unknown. We discovered a series of small molecule compounds that stabilize trimers and induce high-order oligomers of DAT and concomitantly promote its clathrin-independent endocytosis. Using a combination of chemical cross-linking, fluorescence resonance energy transfer microscopy, antibody-uptake endocytosis assay, live-cell lattice light sheet microscopy, ligand binding and substrate transport kinetics analyses, and molecular modeling and simulations, we investigated molecular basis of DAT oligomerization and endocytosis induced by these compounds. Our study showed that small molecule-induced DAT oligomerization and endocytosis are favored by the inward-facing DAT conformation and involve interactions of four hydrophobic residues at the interface between transmembrane (TM) helices TM4 and TM9. Surprisingly, a corresponding quadruple DAT mutant displays altered dopamine transport kinetics and increased cocaine-analog binding. The latter is shown to originate from an increased preference for outward-facing conformation and inward-to-outward transition. Taken together, our results demonstrate a direct coupling between conformational dynamics of DAT, functional activity of the transporter, and its oligomerization leading to endocytosis. The high specificity of such coupling for DAT makes the TM4-9 hub a new target for pharmacological modulation of DAT activity and subcellular localization.	[Sorkina, Tatiana; Bagalkot, Tarique R.; Wallace, Callen; Watkins, Simon C.; Sorkin, Alexander] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Cheng, Mary Hongying; Bahar, Ivet] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sorkin, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	sorkin@pitt.edu	Cheng, Mary Hongying/AAU-3768-2021; Bagalkot, Tarique/N-1189-2019	Cheng, Mary Hongying/0000-0001-5833-8221; Bagalkot, Tarique/0000-0002-2827-0040; bahar, ivet/0000-0001-9959-4176; Sorkin, Alexander/0000-0002-4446-1920	National Institutes of Health [DA014204, P30DA035778, P41GM103712]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants DA014204 (A. S.), P30DA035778 (I. B.) and P41GM103712 (I. B.) from National Institutes of Health.	Aimon S, 2014, DEV CELL, V28, P212, DOI 10.1016/j.devcel.2013.12.012; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Apaja PM, 2010, J CELL BIOL, V191, P553, DOI 10.1083/jcb.201006012; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bellam R, 2016, TRANSIT METAL CHEM, V41, P271, DOI 10.1007/s11243-015-0018-z; Callenberg KM, 2012, J GEN PHYSIOL, V140, P55, DOI 10.1085/jgp.201110766; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Chen NH, 2008, J NEUROCHEM, V105, P910, DOI 10.1111/j.1471-4159.2007.05195.x; Cheng MH, 2019, NAT STRUCT MOL BIOL, V26, P545, DOI 10.1038/s41594-019-0253-7; Cheng MH, 2019, NEUROPHARMACOLOGY, V161, DOI 10.1016/j.neuropharm.2019.107676; Cheng MH, 2018, J PHYS CHEM B, V122, P5336, DOI 10.1021/acs.jpcb.7b10340; Cheng MHY, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00134; Cheng MH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003879; Coleman JA, 2019, NATURE, V569, P141, DOI 10.1038/s41586-019-1135-1; Das AK, 2019, J BIOL CHEM, V294, P5632, DOI 10.1074/jbc.RA118.006178; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Fleckenstein AE, 1997, J PHARMACOL EXP THER, V282, P834; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; Gowrishankar R, 2014, NEUROCHEM INT, V73, P42, DOI 10.1016/j.neuint.2013.10.016; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hilgemann DW, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2019.06.006; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Jaber M, 1997, MOVEMENT DISORD, V12, P629, DOI 10.1002/mds.870120502; Jayaraman K, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006229; Johannes L, 2018, TRENDS CELL BIOL, V28, P405, DOI 10.1016/j.tcb.2018.01.009; Johannes L, 2010, CELL, V142, P507, DOI 10.1016/j.cell.2010.08.007; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Li Y, 2010, J NEUROCHEM, V114, P873, DOI 10.1111/j.1471-4159.2010.06818.x; Ma S., 2018, BIO-PROTOCOL, V8, pE2996; Ma SQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05637-x; Mayor S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016758; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Mortensen OV, 2003, EUR J PHARMACOL, V479, P159, DOI 10.1016/j.ejphar.2003.08.066; Navratna V, 2019, CURR OPIN STRUC BIOL, V54, P161, DOI 10.1016/j.sbi.2019.03.011; Navratna V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200085; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ponzoni L, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0177; Rahbek-Clemmensen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00790-3; Rao A, 2012, FASEB J, V26, P1921, DOI 10.1096/fj.11-196113; Rosholm KR, 2017, NAT CHEM BIOL, V13, P724, DOI 10.1038/nchembio.2372; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sorkina T, 2018, ELIFE, V7, DOI 10.7554/eLife.32293; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Spoden G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003313; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vivian D, 2014, EUR J PHARM SCI, V64, P44, DOI 10.1016/j.ejps.2014.08.007; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; WESTERMARK B, 1990, P NATL ACAD SCI USA, V87, P128, DOI 10.1073/pnas.87.1.128; Wise RA, 2008, NEUROTOX RES, V14, P169, DOI 10.1007/BF03033808; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Wu SJ, 2017, J NEUROSCI, V37, P9438, DOI 10.1523/JNEUROSCI.3885-16.2017; Wu S, 2015, P NATL ACAD SCI USA, V112, P15480, DOI 10.1073/pnas.1512957112; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459; Zhen J, 2018, J NEUROCHEM, V144, P162, DOI 10.1111/jnc.14259; Zhen J, 2015, J NEUROCHEM, V133, P167, DOI 10.1111/jnc.13025	69	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100430	10.1016/j.jbc.2021.100430	http://dx.doi.org/10.1016/j.jbc.2021.100430			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610553	Green Published, gold			2022-12-26	WOS:000672866400404
J	Zeng, HL; Yang, Q; Yuan, PH; Wang, X; Cheng, LM				Zeng, Hao-Long; Yang, Qing; Yuan, Peihong; Wang, Xu; Cheng, Liming			Associations of essential and toxic metals/metalloids in whole blood with both disease severity and mortality in patients with COVID-19	FASEB JOURNAL			English	Article						COVID-19; metals; metalloids; mortality; severity; whole blood	HEAVY-METALS; EXPOSURE; INFECTION; CHROMIUM; SYSTEM; HEALTH; COPPER; ZINC; DNA	The variations and dynamics of essential and toxic metal(loid)s in patients with COVID-19 may associate with the progression and fatal outcome of the disease, which still remains to investigate. In the present study, a retrospective analysis was performed in a cohort of 306 confirmed COVID-19 patients admitted to Tongji hospital (Wuhan, China) from February 10 to March 15, 2020. Whole blood levels of essential and/or toxic metal(loid)s were analyzed, including magnesium, calcium, chromium, manganese, iron, copper, zinc, arsenic, cadmium, mercury, thallium, and lead according to the disease severity and outcome. Compared to the non-severe COVID-19 patients, severe cases showed significant higher levels of whole blood calcium, chromium, and copper, but lower levels of magnesium, manganese, iron, zinc, arsenic, thallium, and lead. These differences were further found consistently across the clinical course since the disease onset by longitudinal analysis. Among the severe patients, chromium and cadmium were higher in the deceased group compared to the recovered group, while arsenic was lower. Whole blood iron, age, and sex were determined to be independent factors associated with the disease severity, while chromium, cadmium, and the comorbidity of cardiovascular disease were determined to be independent factors associated with the mortality. These results suggest that variations of whole blood metal(loid)s may be associated with the severe illness and fatal outcome of COVID-19, which could be persistently monitored and would be helpful in the evaluation of the dynamic changes in patients with COVID-19.	[Zeng, Hao-Long; Yuan, Peihong; Wang, Xu; Cheng, Liming] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lab Med, Wuhan 430030, Peoples R China; [Yang, Qing] Wuhan Polytech Univ, Inst Food Sci & Engn, Wuhan, Peoples R China	Huazhong University of Science & Technology; Wuhan Polytechnic University	Cheng, LM (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lab Med, Wuhan 430030, Peoples R China.		Xiao, Hu/GMX-0258-2022		National Natural Science Foundation of China [31600666]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Foundation of China (31600666).	Besold AN, 2016, J BIOL INORG CHEM, V21, P137, DOI 10.1007/s00775-016-1335-1; Bolondi G, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00323-2; Bortey-Sam N, 2018, ENVIRON POLLUT, V235, P163, DOI 10.1016/j.envpol.2017.12.005; Briffa J, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04691; Calder PC, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041181; Cannas D, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072074; Cappellini F, 2020, CLIN CHEM LAB MED, V58, pE171, DOI 10.1515/cclm-2020-0611; Cernat RI, 2011, INT J TUBERC LUNG D, V15, P1239, DOI 10.5588/ijtld.10.0445; Doboszewska U, 2020, BRIT J PHARMACOL, V177, P4887, DOI 10.1111/bph.15199; Edeas M, 2020, INT J INFECT DIS, V97, P303, DOI 10.1016/j.ijid.2020.05.110; Flem B, 2015, APPL GEOCHEM, V59, P211, DOI 10.1016/j.apgeochem.2015.01.016; Gombart AF, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010236; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Iddir M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061562; Ilback NG, 2008, J TRACE ELEM MED BIO, V22, P120, DOI 10.1016/j.jtemb.2007.12.001; Iotti S, 2020, MAGNESIUM RES, V33, P21, DOI 10.1684/mrh.2020.0465; Lewicki S, 2014, ANN AGR ENV MED, V21, P331, DOI 10.5604/1232-1966.1108599; Li CX, 2015, P NATL ACAD SCI USA, V112, pE5336, DOI 10.1073/pnas.1513447112; Maier JA, 2021, SEMIN CELL DEV BIOL, V115, P37, DOI 10.1016/j.semcdb.2020.11.002; Malavolta M, 2015, MECH AGEING DEV, V151, P93, DOI 10.1016/j.mad.2015.01.004; Marazuela M, 2020, REV ENDOCR METAB DIS, V21, P495, DOI 10.1007/s11154-020-09569-2; Monti MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163313; Moon SS, 2013, DIABETIC MED, V30, pe143, DOI 10.1111/dme.12103; National Health Commission of the People's Republic of China and National Administration of Traditional Chinese Medicine, 2020, DIAGN TREATM SCHEM N; Rahman MT, 2021, BIOL TRACE ELEM RES, V199, P550, DOI 10.1007/s12011-020-02194-9; Razzaque MS, 2020, TOHOKU J EXP MED, V251, P175, DOI 10.1620/tjem.251.175; Rehman K, 2018, J CELL BIOCHEM, V119, P157, DOI 10.1002/jcb.26234; Rhee SY, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-9; Sanna A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010068; Sarzi-Puttini P, 2020, CLIN EXP RHEUMATOL, V38, P337, DOI 10.55563/clinexprheumatol/xcdary; Shrivastava R, 2002, FEMS IMMUNOL MED MIC, V34, P1, DOI 10.1111/j.1574-695X.2002.tb00596.x; Singh AK, 2020, DIABETES OBES METAB, V22, P1915, DOI 10.1111/dom.14124; Sun KY, 2020, LANCET DIGIT HEALTH, V2, pE201, DOI 10.1016/S2589-7500(20)30026-1; Sun SY, 2020, CLIN CHIM ACTA, V507, P174, DOI 10.1016/j.cca.2020.04.024; Tellez-Plaza M, 2013, EPIDEMIOLOGY, V24, P421, DOI 10.1097/EDE.0b013e31828b0631; Tsatsakis A, 2020, FOOD CHEM TOXICOL, V141, DOI 10.1016/j.fct.2020.111418; Valera P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141262; Valera P, 2014, ENVIRON GEOCHEM HLTH, V36, P79, DOI 10.1007/s10653-013-9520-4; Wallace TC, 2020, J AM COLL NUTR, V39, P685, DOI 10.1080/07315724.2020.1785971; Wang CG, 2018, IMMUNITY, V48, P675, DOI 10.1016/j.immuni.2018.03.017; Wessels I, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121286; Xu XH, 2017, ENVIRON POLLUT, V220, P1121, DOI 10.1016/j.envpol.2016.11.023; Xu XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074288; Zeng HL, 2021, FASEB J, V35, DOI 10.1096/fj.202002346RR; Zeng HL, 2019, BIOL TRACE ELEM RES, V189, P344, DOI 10.1007/s12011-018-1486-8; Zhao K, 2020, OPEN FORUM INFECT DI, V7, DOI [10.1093/ofid/ofaa250, 10.1093/ofid/ofaa750]; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhou Q, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3801639; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	50	32	32	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21392	10.1096/fj.202002346RR	http://dx.doi.org/10.1096/fj.202002346RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33577131	Green Published			2022-12-26	WOS:000629576700041
J	Juarez, SP; Urquia, ML; Mussino, E; Liu, C; Qiao, Y; Hjern, A				Juarez, Sol P.; Urquia, Marcelo L.; Mussino, Eleonora; Liu, Can; Qiao, Yao; Hjern, Anders			Preterm disparities between foreign and Swedish born mothers depend on the method used to estimate gestational age. A Swedish population-based register study	PLOS ONE			English	Article								This study aims to examine whether disparities in gestational age outcomes between foreign and Swedish-born mothers are contingent on the measure used to estimate gestational age and, if so, to identify which maternal factors are associated with the discrepancy. Using population register data, we studied all singleton live births in Sweden from 1992-2012 (n = 1,317,265). Multinomial logistic regression was performed to compare gestational age outcomes classified into very (<32 weeks) and late preterm (32-36 weeks), term and post-term derived from the last menstrual period (LMP) and ultrasound estimates in foreign- and Swedish-born women. Compared to Swedish-born women, foreign-born women had similar odds of very preterm birth (OR: 0.98 [95% CI: 0.98, 1.01]) and lower odds of moderately preterm birth (OR: 0.95 [95% CI: 0.92, 0.98]) based on ultrasound, while higher risks based on LMP (respectively, OR: 1.10 [95% CI: 1.07, 1.14] and 1.09 [95% CI: 1.06, 1.13]). Conclusions on disparities in gestational age-related outcomes by mother's country of origin depend on the method used to estimate gestational age. Except for very preterm, foreign-born women had a health advantage when gestational age is based on ultrasound, but a health disadvantage when based on LMP. Studies assessing disparities in very preterm birth by migration status are not affected by the estimation method but caution should be taken when interpreting disparities in moderately preterm and preterm birth rates.	[Juarez, Sol P.; Liu, Can; Hjern, Anders] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies CHESS, Stockholm, Sweden; [Juarez, Sol P.; Liu, Can; Hjern, Anders] Stockholm Univ, Dept Publ Hlth Sci, Stockholm, Sweden; [Urquia, Marcelo L.] Univ Manitoba, Rady Fac Hlth Sci, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Urquia, Marcelo L.; Qiao, Yao] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mussino, Eleonora] Stockholm Univ, Stockholm Univ Demog Unit SUDA, Stockholm, Sweden; [Liu, Can; Hjern, Anders] Karolinska Inst, Clin Epidemiol Div, Dept Med, Stockholm, Sweden; [Qiao, Yao] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Karolinska Institutet; Stockholm University; Stockholm University; University of Manitoba; University of Toronto; Stockholm University; Karolinska Institutet; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Juarez, SP (corresponding author), Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies CHESS, Stockholm, Sweden.; Juarez, SP (corresponding author), Stockholm Univ, Dept Publ Hlth Sci, Stockholm, Sweden.	sol.juarez@su.se		Mussino, Eleonora/0000-0002-5311-4277; Urquia, Marcelo/0000-0002-8289-8090	Strategic Research Council of the Academy of Finland (TITA) [293103]; Swedish Research Council (VR) [2018-01825]; Swedish Research Council for Health, Working Life and Welfare (FORTE) [2012-01190, 2016-07128]	Strategic Research Council of the Academy of Finland (TITA); Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council for Health, Working Life and Welfare (FORTE)	Sol P. Juarez and Eleonora Mussino were supported by the Strategic Research Council of the Academy of Finland (TITA, Grant #293103) and the Swedish Research Council (VR##2018-01825); Sol P. Juarez and Anders Hjern were supported by the Swedish Research Council for Health, Working Life and Welfare (FORTE grant #2012-01190 and #2016-07128). Marcelo L. Urquia holds a Canada Research Chair in Applied Population Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; [Anonymous], 2009, Obstet Gynecol, V114, P386, DOI 10.1097/AOG.0b013e3181b48ef5; [Anonymous], 2017, METH EST DUE DAT, V129, P4; Bensley JG, 2016, ACTA OBSTET GYN SCAN, V95, P652, DOI 10.1111/aogs.12880; Bertagnolli M, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0637-6; Blondel A, 2002, BJOG-INT J OBSTET GY, V109, P718; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; De la Fuente P., 2005, TRATADO OBSTET GINEC, V1, P153; Dietz PM, 2007, PAEDIATR PERINAT EP, V21, P62, DOI 10.1111/j.1365-3016.2007.00862.x; Ekbom A, 2011, METHODS MOL BIOL, V675, P215, DOI 10.1007/978-1-59745-423-0_10; Gagnon AJ, 2009, SOC SCI MED, V69, P934, DOI 10.1016/j.socscimed.2009.06.027; GOURBIN C, 1995, B WORLD HEALTH ORGAN, V73, P449; HADLOCK FP, 1982, AM J ROENTGENOL, V139, P367, DOI 10.2214/ajr.139.2.367; HADLOCK FP, 1982, AM J ROENTGENOL, V138, P649, DOI 10.2214/ajr.138.4.649; HADLOCK FP, 1982, AM J ROENTGENOL, V138, P871, DOI 10.2214/ajr.138.5.871; HENRIKSEN TB, 1995, EPIDEMIOLOGY, V6, P533, DOI 10.1097/00001648-199509000-00012; Juarez S, 2019, SCAND J PUBLIC HEALT, V47, P730, DOI 10.1177/1403494818777432; Juarez S, 2012, PAEDIATR PERINAT EP, V26, P310, DOI 10.1111/j.1365-3016.2012.01287.x; Juarez SP, 2017, SOC SCI MED, V175, P81, DOI 10.1016/j.socscimed.2016.12.045; Juarez SP, 2014, J EPIDEMIOL COMMUN H, V68, P863, DOI 10.1136/jech-2013-202917; Jukic AM, 2015, BJOG-INT J OBSTET GY, V122, P842, DOI 10.1111/1471-0528.13169; KALLEN B, 1995, EUR J EPIDEMIOL, V11, P601, DOI 10.1007/BF01719316; Kullinger M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24894-y; Kullinger M, 2017, ACTA OBSTET GYN SCAN, V96, P86, DOI 10.1111/aogs.13034; Lack N., 2003, EUR J OBSTET GYNECOL, V111, P33, DOI [10.1016/s0301-2115%2803%2900164-7, DOI 10.1016/S0301-2115%2803%2900164-7]; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Ludvigsson JF, 2019, EUR J EPIDEMIOL, V34, P423, DOI 10.1007/s10654-019-00511-8; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Lynch CD, 2007, PAEDIATR PERINAT EP, V21, P86, DOI 10.1111/j.1365-3016.2007.00865.x; Speciale AM, 2011, J IMMIGR MINOR HEALT, V13, P518, DOI 10.1007/s10903-010-9365-1; Martin JA., 2015, 5 CDCP; Morken NH, 2016, PAEDIATR PERINAT EP, V30, P541, DOI 10.1111/ppe.12311; Ny P, 2007, ACTA OBSTET GYN SCAN, V86, P805, DOI 10.1080/00016340701415095; Sorbye IK, 2016, BEST PRACT RES CL OB, V32, P60, DOI 10.1016/j.bpobgyn.2015.08.017; Urquia ML, 2011, J EPIDEMIOL COMMUN H, V65, P467, DOI 10.1136/jech.2010.109405; Wanigaratne S, 2016, J EPIDEMIOL COMMUN H, V70, P622, DOI 10.1136/jech-2015-206529; Wilcox AJ, 2000, BRIT MED J, V321, P1259, DOI 10.1136/bmj.321.7271.1259; Yang H, 2002, AM J OBSTET GYNECOL, V186, P433, DOI 10.1067/mob.2002.120487; Zeitlin J, 2013, BJOG-INT J OBSTET GY, V120, P1356, DOI 10.1111/1471-0528.12281	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247138	10.1371/journal.pone.0247138	http://dx.doi.org/10.1371/journal.pone.0247138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QO3ZL	33617565	Green Published, gold			2022-12-26	WOS:000623082400054
J	Xu, BY; Su, H; Wang, RY; Wang, YX; Zhang, WD				Xu, Bingyong; Su, Hong; Wang, Ruya; Wang, Yixiao; Zhang, Weidong			Metabolic networks of plasma and joint fluid base on differential correlation	PLOS ONE			English	Article								Whether osteoarthritis (OA) is a systemic metabolic disorder remains controversial. The aim of this study was to investigate the metabolic characteristics between plasma and knee joint fluid (JF) of patients with advanced OA using a differential correlation metabolic (DCM) networks approach. Plasma and JF were collected during the joint replacement surgery of patients with knee OA. The biological samples were pretreated with standard procedures for metabolite analysis. The metabolic profiling was conducted by means of liquid mass spectrometry coupled with a AbsoluteIDQ kit. A DCM network approach was adopted for analyzing the metabolomics data between the plasma and JF. The variation in the correlation of the pairwise metabolites was quantified across the plasma and JF samples, and networks analysis was used to characterize the difference in the correlations of the metabolites from the two sample types. Core metabolites that played an important role in the DCM networks were identified via topological analysis. One hundred advanced OA patients (50 men and 50 women) were included in this study, with an average age of 65.0 +/- 7.6 years (65.6 +/- 7.1 years for females and 64.4 +/- 8.1 years for males) and a mean BMI of 32.6 +/- 5.8 kg/m(2) (33.4 +/- 6.3 kg/m(2) for females and 31.7 +/- 5.3 kg/m(2) for males). Age and BMI matched between the male and female groups. One hundred and forty-five nodes, 567 edges, and 131 nodes, 407 edges were found in the DCM networks (p < 0.05) of the female and male groups, respectively. Six metabolites in the female group and 5 metabolites in the male group were identified as key nodes in the network. There was a significant difference in the differential correlation metabolism networks of plasma and JF that may be related to local joint metabolism. Focusing on these key metabolites may help uncover the pathogenesis of knee OA. In addition, the differential metabolic correlation between plasma and JF mostly overlapped, indicating that these common correlations of pairwise metabolites may be a reflection of systemic characteristics of JF and that most significant correlation variations were just a result of "housekeeping" biological reactions.	[Xu, Bingyong; Su, Hong; Wang, Ruya; Wang, Yixiao; Zhang, Weidong] Jilin Univ, Sch Pharmaceut Sci, Changchun, Jilin, Peoples R China; [Xu, Bingyong] Hangzhou Heze Pharmaceut Technol CO LTD, Hangzhou, Zhejiang, Peoples R China; [Su, Hong] Daqing Med Coll, Dept Pharm & Examinat, Daqing, Heilongjiang, Peoples R China	Jilin University	Zhang, WD (corresponding author), Jilin Univ, Sch Pharmaceut Sci, Changchun, Jilin, Peoples R China.	weidongzhang@jlu.edu.cn			Science and Technology Development Plan of Jilin Province [20180101302JC]; Bethune Project Project of Jilin University [2018A08]; Youth technology backbone training program of Health department of Jilin Province [2017Q020]; Hangzhou Heze Pharmaceutical Technology CO., LTD.	Science and Technology Development Plan of Jilin Province; Bethune Project Project of Jilin University; Youth technology backbone training program of Health department of Jilin Province; Hangzhou Heze Pharmaceutical Technology CO., LTD.	This work was supported by the Science and Technology Development Plan of Jilin Province (20180101302JC to WZ); Bethune Project Project of Jilin University (2018A08 to WZ); Youth technology backbone training program of Health department of Jilin Province (2017Q020 to WZ), China; Hangzhou Heze Pharmaceutical Technology CO., LTD. provided support in the form of salary for author BYX. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassuk SS, 2015, ANN EPIDEMIOL, V25, P193, DOI 10.1016/j.annepidem.2014.11.004; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Chen Y, 2005, ANZ J SURG, V75, P1111, DOI 10.1111/j.1445-2197.2005.03619.x; Chen Yi, 2007, J Orthop Surg Res, V2, P14, DOI 10.1186/1749-799X-2-14; Costello CA, 2020, METABOLOMICS, V16, DOI 10.1007/s11306-020-01683-1; Cui XJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222353; DAVIS MA, 1988, AM J EPIDEMIOL, V127, P1019, DOI 10.1093/oxfordjournals.aje.a114878; Edvinsson M, 2019, J INT MED RES, V47, P635, DOI 10.1177/0300060518807062; Emery RL, 2017, PSYCHOL BULL, V143, P868, DOI 10.1037/bul0000105; Farooqui AA, 2000, CHEM PHYS LIPIDS, V106, P1, DOI 10.1016/S0009-3084(00)00128-6; HILLS BA, 1990, J RHEUMATOL, V17, P349; Hu T, 2016, BIOCOMPUT-PAC SYM, P120; Katz JD, 2010, CURR OPIN RHEUMATOL, V22, P512, DOI 10.1097/BOR.0b013e32833bfb4b; Kosinska M, 2018, OSTEOARTHR CARTILAGE, V26, pS169, DOI 10.1016/j.joca.2018.02.368; Kosinska MK, 2016, OSTEOARTHR CARTILAGE, V24, P1470, DOI 10.1016/j.joca.2016.03.017; Kosinska MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091769; Leening MJG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5992; Mabey T, 2014, CLIN BIOCHEM, V47, P547, DOI 10.1016/j.clinbiochem.2014.03.011; Masuko K, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-29; McCarty WJ, 2011, J ORTHOP RES, V29, P240, DOI 10.1002/jor.21209; McCoin CS, 2015, NAT REV ENDOCRINOL, V11, P617, DOI 10.1038/nrendo.2015.129; Oloyede A, 2004, CLIN BIOMECH, V19, P534, DOI 10.1016/j.clinbiomech.2004.01.011; Park JE, 2017, NEURORADIOLOGY, V59, P781, DOI 10.1007/s00234-017-1875-2; Park WJ, 2020, FEBS LETT, V594, P3632, DOI 10.1002/1873-3468.13863; Paterson KL, 2017, CLIN BIOMECH, V49, P72, DOI 10.1016/j.clinbiomech.2017.08.013; Pousinis P, 2020, METABOLOMICS, V16, DOI 10.1007/s11306-020-01652-8; Rinaldo P, 2008, GENET MED, V10, P151, DOI 10.1097/GIM.0b013e3181614289; Rutkowsky JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1378, DOI 10.1152/ajpendo.00656.2013; Sahu SK, 2019, BIOCHIMIE, V158, P257, DOI 10.1016/j.biochi.2019.01.018; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Siska Charlotte, 2017, BMC Res Notes, V10, P54, DOI 10.1186/s13104-016-2331-9; Sukocheva OA, 2020, ADV PROTEIN CHEM STR, V120, P123, DOI 10.1016/bs.apcsb.2019.11.003; Surowiec I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164196; Tootsi K, 2018, INT J RHEUM DIS, V21, P1211, DOI 10.1111/1756-185X.13251; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zhai GJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46185-w; Zhang Q, 2014, MULTIVAR BEHAV RES, V49, P130, DOI 10.1080/00273171.2013.870877; Zhang W, 2016, OSTEOARTHR CARTILAGE, V24, P827, DOI 10.1016/j.joca.2015.12.004; Zhang WD, 2016, RHEUMATOLOGY, V55, P1566, DOI 10.1093/rheumatology/kew207; Zhang WD, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0937-x; Zhang WD, 2015, J RHEUMATOL, V42, P859, DOI 10.3899/jrheum.141252; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135	45	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247191	10.1371/journal.pone.0247191	http://dx.doi.org/10.1371/journal.pone.0247191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617578	gold, Green Published			2022-12-26	WOS:000623082400033
J	Kim, EY; Kim, YJ; Choi, WJ; Lee, GP; Choi, YR; Jin, KN; Cho, YJ				Kim, Eun Young; Kim, Young Jae; Choi, Won-Jun; Lee, Gi Pyo; Choi, Ye Ra; Jin, Kwang Nam; Cho, Young Jun			Performance of a deep-learning algorithm for referable thoracic abnormalities on chest radiographs: A multicenter study of a health screening cohort	PLOS ONE			English	Article							LUNG REGION-SEGMENTATION	Purpose This study evaluated the performance of a commercially available deep-learning algorithm (DLA) (Insight CXR, Lunit, Seoul, South Korea) for referable thoracic abnormalities on chest X-ray (CXR) using a consecutively collected multicenter health screening cohort. Methods and materials A consecutive health screening cohort of participants who underwent both CXR and chest computed tomography (CT) within 1 month was retrospectively collected from three institutions' health care clinics (n = 5,887). Referable thoracic abnormalities were defined as any radiologic findings requiring further diagnostic evaluation or management, including DLA-target lesions of nodule/mass, consolidation, or pneumothorax. We evaluated the diagnostic performance of the DLA for referable thoracic abnormalities using the area under the receiver operating characteristic (ROC) curve (AUC), sensitivity, and specificity using ground truth based on chest CT (CT-GT). In addition, for CT-GT-positive cases, three independent radiologist readings were performed on CXR and clear visible (when more than two radiologists called) and visible (at least one radiologist called) abnormalities were defined as CXR-GTs (clear visible CXR-GT and visible CXR-GT, respectively) to evaluate the performance of the DLA. Results Among 5,887 subjects (4,329 males; mean age 54 +/- 11 years), referable thoracic abnormalities were found in 618 (10.5%) based on CT-GT. DLA-target lesions were observed in 223 (4.0%), nodule/mass in 202 (3.4%), consolidation in 31 (0.5%), pneumothorax in one 1 (<0.1%), and DLA-non-target lesions in 409 (6.9%). For referable thoracic abnormalities based on CT-GT, the DLA showed an AUC of 0.771 (95% confidence interval [CI], 0.751-0.791), a sensitivity of 69.6%, and a specificity of 74.0%. Based on CXR-GT, the prevalence of referable thoracic abnormalities decreased, with visible and clear visible abnormalities found in 405 (6.9%) and 227 (3.9%) cases, respectively. The performance of the DLA increased significantly when using CXR-GTs, with an AUC of 0.839 (95% CI, 0.829-0.848), a sensitivity of 82.7%, and s specificity of 73.2% based on visible CXR-GT and an AUC of 0.872 (95% CI, 0.863-0.880, P <0.001 for the AUC comparison of GT-CT vs. clear visible CXR-GT), a sensitivity of 83.3%, and a specificity of 78.8% based on clear visible CXR-GT. Conclusion The DLA provided fair-to-good stand-alone performance for the detection of referable thoracic abnormalities in a multicenter consecutive health screening cohort. The DLA showed varied performance according to the different methods of ground truth.	[Kim, Eun Young] Gachon Univ, Gil Med Ctr, Dept Radiol, Coll Med, Incheon, South Korea; [Kim, Young Jae; Lee, Gi Pyo] Gachon Univ, Dept Biomed Engn, Coll Med, Incheon, South Korea; [Choi, Won-Jun] Gachon Univ, Dept Occupat & Environm Med, Coll Med, Incheon, South Korea; [Choi, Ye Ra; Jin, Kwang Nam] Boramae Med Ctr, Dept Radiol, Seoul, South Korea; [Choi, Ye Ra; Jin, Kwang Nam] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Cho, Young Jun] Konyang Univ Hosp, Dept Radiol, Daejeon, South Korea; [Cho, Young Jun] Konyang Univ, Sch Med, Daejeon, South Korea	Gachon University; Gachon University; Gachon University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Konyang University; Konyang University Hospital; Konyang University	Jin, KN (corresponding author), Boramae Med Ctr, Dept Radiol, Seoul, South Korea.; Jin, KN (corresponding author), Seoul Natl Univ, Coll Med, Seoul, South Korea.; Cho, YJ (corresponding author), Konyang Univ Hosp, Dept Radiol, Daejeon, South Korea.; Cho, YJ (corresponding author), Konyang Univ, Sch Med, Daejeon, South Korea.	wlsrhkdska@gmail.com; cyi126@kyuh.ac.kr		Jin, Kwang Nam/0000-0001-5494-9113; Lee, Gi Pyo/0000-0002-9785-3776; Choi, Won-Jun/0000-0001-8096-7542	Korea Health Industry Development Institute [HI19C0847]	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	This work was supported by a grant from the Korea Health Industry Development Institute to YJC (Grant number: HI19C0847). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cubuk ED, 2019, PROC CVPR IEEE, P113, DOI 10.1109/CVPR.2019.00020; Donald JJ, 2012, J MED IMAG RADIAT ON, V56, P173, DOI 10.1111/j.1754-9485.2012.02348.x; Oliveira LLG, 2008, INT J MED INFORM, V77, P555, DOI 10.1016/j.ijmedinf.2007.10.010; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hwang EJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.1095; Hwang EJ, 2019, CLIN INFECT DIS, V69, P739, DOI 10.1093/cid/ciy967; Johnson AEW, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0322-0; Kim M., 2020, ARXIV PREPRINT ARXIV; Malhotra P., 2019, J COMPUTATIONAL THE, V16, P4202, DOI [DOI 10.1166/JCTN.2019.8501, 10.1166/jctn.2019.8501]; Nam JG, 2019, RADIOLOGY, V290, P218, DOI 10.1148/radiol.2018180237; Nitta J, 2020, IEEE ENG MED BIO, P1278, DOI 10.1109/EMBC44109.2020.9176214; Omar H, 2019, P BOOK, V183; Portela RDS, 2020, IEEE ENG MED BIO, P1246, DOI 10.1109/EMBC44109.2020.9175478; Rajpurkar P, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002686; Shin DW, 2016, JAMA INTERN MED, V176, P138, DOI 10.1001/jamainternmed.2015.7110; Tigges S, 2004, RADIOLOGY, V233, P575, DOI 10.1148/radiol.2332031796; World Health Organization, 1990, WORLD HLTH STAT Q, V43, P204	18	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246472	10.1371/journal.pone.0246472	http://dx.doi.org/10.1371/journal.pone.0246472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606779	gold, Green Published			2022-12-26	WOS:000620629200045
J	Leis, ML; Madruga, GM; Costa, MO				Leis, Marina L.; Madruga, Gabriela M.; Costa, Matheus O.			The porcine corneal surface bacterial microbiome: A distinctive niche within the ocular surface	PLOS ONE			English	Article							PARACOCCUS-YEEI; SP NOV.; BREVUNDIMONAS; GENE; IDENTIFICATION; PATHOGEN; MUCINS; MODEL; LENS; EYE	Purpose The ocular surface microbiome has been described as paucibacterial. Until now, studies investigating the bacterial community associated with the ocular surface through high-throughput sequencing have focused on the conjunctiva. Conjunctival samples are thought to reflect and be representative of the microbiome residing on the ocular surface, including the cornea. Here, we hypothesized that the bacterial community associated with the corneal surface was different from those of the inferonasal and superotemporal conjunctival fornices, and from the tear film. Methods Both eyes from 15 healthy piglets were sampled using swabs (inferonasal fornix, superotemporal fornix, and corneal surface, n = 30 each) and Schirmer tear test strips (STT, n = 30). Negative sampling controls (swabs and STT, n = 2 each) and extraction controls (n = 4) were included. Total DNA was extracted and high-throughput sequencing targeting the 16S rRNA gene was performed. Bioinformatic analyses included multiple contamination-controlling steps. Results Corneal surface samples had a significantly lower number of taxa detected (P<0.01) and were compositionally different from all other sample types (Bray-Curtis dissimilarity, P<0.04). It also harbored higher levels of Proteobacteria (P<0.05), specifically Brevundimonas spp. (4.1-fold) and Paracoccus spp. (3.4-fold) than other sample types. Negative control STT strip samples yielded the highest amount of 16S rRNA gene copies across all sample types (P<0.05). Conclusions Our data suggests that the corneal surface provides a distinct environmental niche within the ocular surface, leading to a bacterial community compositionally different from all other sample types.	[Leis, Marina L.; Madruga, Gabriela M.] Univ Minnesota, Coll Vet Med, Vet Clin Sci, Minneapolis, MN 55455 USA; [Leis, Marina L.] Univ Saskatchewan, Western Coll Vet Med, Small Anim Clin Sci, Saskatoon, SK, Canada; [Madruga, Gabriela M.] State Univ Sao Paulo, Sao Paulo, Brazil; [Costa, Matheus O.] Univ Saskatchewan, Western Coll Vet Med, Large Anim Clin Sci, Saskatoon, SK, Canada; [Costa, Matheus O.] Univ Utrecht, Fac Vet Med, Dept Populat Hlth, Utrecht, Netherlands	University of Minnesota System; University of Minnesota Twin Cities; University of Saskatchewan; Universidade Estadual Paulista; University of Saskatchewan; Utrecht University	Leis, ML (corresponding author), Univ Minnesota, Coll Vet Med, Vet Clin Sci, Minneapolis, MN 55455 USA.; Leis, ML (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Small Anim Clin Sci, Saskatoon, SK, Canada.	marina.leis@usask.ca			department of Veterinary Clinical Sciences (VCS) at the University of Minnesota (UMN)	department of Veterinary Clinical Sciences (VCS) at the University of Minnesota (UMN)	This study received funding from the department of Veterinary Clinical Sciences (VCS) at the University of Minnesota (UMN).	Abraham WR, 2010, INT J SYST EVOL MICR, V60, P1837, DOI 10.1099/ijs.0.016832-0; Al-Rubeaan KA, 2016, SAUDI MED J, V37, P985, DOI 10.15537/smj.2016.9.14950; Alfano N, 2015, SCI REP-UK, V5, DOI 10.1038/srep10189; Andersson J, 2019, INVEST OPHTH VIS SCI, V60; Baim AD, 2019, EXP BIOL MED, V244, P419, DOI 10.1177/1535370218813616; Banks KC, 2019, VET OPHTHALMOL, V22, P716, DOI 10.1111/vop.12676; Bertschinger DR, 2008, GRAEF ARCH CLIN EXP, V246, P1505, DOI 10.1007/s00417-008-0891-7; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cavuoto KM, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7080259; Cavuoto KM, 2019, CURR OPIN ALLERGY CL, V19, P482, DOI 10.1097/ACI.0000000000000559; Courjaret JC, 2014, EYE CONTACT LENS, V40, pE21, DOI 10.1097/ICL.0b013e31829e8fc7; Dalpke A, 2006, INFECT IMMUN, V74, P940, DOI 10.1128/IAI.74.2.940-946.2006; Dang YL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23861-x; Darden JE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223859; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; DelMonte DW, 2011, J CATARACT REFR SURG, V37, P588, DOI 10.1016/j.jcrs.2010.12.037; Doan T, 2020, OPHTHALMOLOGY, V127, P1127, DOI 10.1016/j.ophtha.2020.02.014; Doan T, 2016, INVEST OPHTH VIS SCI, V57, P5116, DOI 10.1167/iovs.16-19803; Dong QF, 2011, INVEST OPHTH VIS SCI, V52, P5408, DOI 10.1167/iovs.10-6939; Fris M, 2007, CURR EYE RES, V32, P95, DOI 10.1080/02713680601126066; Galletti JG, 2017, IMMUNOLOGY, V150, P397, DOI 10.1111/imm.12716; Gelatt KN, 2014, ESSENTIALS OF VETERINARY OPHTHALMOLOGY, 3RD EDITION, P216; Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5; Gipson IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100393; Graham Joanna E, 2007, Invest Ophthalmol Vis Sci, V48, P5616; Gutierrez K, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00293; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hara H, 2011, CORNEA, V30, P371, DOI 10.1097/ICO.0b013e3181f237ef; Hassan MM, 2019, AM J CLIN PATHOL, V152, pS132; HAYASHI K, 1990, GRAEF ARCH CLIN EXP, V228, P73, DOI 10.1007/BF02764295; Hori Y, 2004, INVEST OPHTH VIS SCI, V45, P114, DOI 10.1167/iovs.03-0903; Kanis MJ, 2010, J CLIN MICROBIOL, V48, P323, DOI 10.1128/JCM.01798-09; Karadag N, 2012, INFECTION, V40, P509, DOI 10.1007/s15010-012-0274-1; Kernaghan Shaun, 2012, Animal Health Research Reviews, V13, P110, DOI 10.1017/S1466252312000102; Khan ST, 2014, EUR J ORAL SCI, V122, P397, DOI 10.1111/eos.12152; Lasek R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02553; Lee SH, 2012, INVEST OPHTH VIS SCI, V53, P5585, DOI 10.1167/iovs.12-9922; Leis ML, 2019, VET OPHTHALMOL, V22, P337, DOI 10.1111/vop.12599; Li Y, 2004, INT J SYST EVOL MICR, V54, P819, DOI 10.1099/ijs.0.02829-0; Lim YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064285; Liu ZP, 2008, INT J SYST EVOL MICR, V58, P257, DOI 10.1099/ijs.0.65237-0; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu Louise J., 2016, Yale Journal of Biology and Medicine, V89, P325; McDermott AM, 2013, EXP EYE RES, V117, P53, DOI 10.1016/j.exer.2013.07.014; Mendes GCC, 2007, AM J INFECT CONTROL, V35, P574, DOI 10.1016/j.ajic.2006.10.014; Menduni F, 2018, CONTACT LENS ANTERIO, V41, P13, DOI 10.1016/j.clae.2017.09.003; Ozkan J, 2019, CURR EYE RES, V44, P685, DOI 10.1080/02713683.2019.1570526; Ozkan J, 2019, OCUL SURF, V17, P111, DOI 10.1016/j.jtos.2018.11.005; Pandit RT, 2012, EYE CONTACT LENS, V38, P63, DOI 10.1097/ICL.0b013e31821c04f7; Pflugfelder SC, 2000, INVEST OPHTH VIS SCI, V41, P1316; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Redfern RL, 2011, EXP EYE RES, V92, P209, DOI 10.1016/j.exer.2010.12.005; Retuerto MA, 2019, EYE CONTACT LENS, V45, P331, DOI 10.1097/ICL.0000000000000578; Ryan MP, 2018, VIRULENCE, V9, P480, DOI 10.1080/21505594.2017.1419116; Scott EM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214877; Shin H, 2016, MBIO, V7, DOI 10.1128/mBio.00198-16; Simmons KT, 2016, INVEST OPHTH VIS SCI, V57, P2443, DOI 10.1167/iovs.15-18396; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Suzuki T, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.2.18; Thomason CA, 2017, ENVIRON MICROBIOL, V19, P1439, DOI 10.1111/1462-2920.13625; Trivedi MN, 2015, J MICROBIOL IMMUNOL, V48, P453, DOI 10.1016/j.jmii.2012.12.001; Vornhagen J, 2013, BIOFOULING, V29, P53, DOI 10.1080/08927014.2012.744395; Watane A, 2019, CURR OPHTHALMOL REP, V7, P196, DOI 10.1007/s40135-019-00217-w; Willis KA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68952-w; Zegans ME, 2014, AM J OPHTHALMOL, V158, P420, DOI 10.1016/j.ajo.2014.06.014	66	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247392	10.1371/journal.pone.0247392	http://dx.doi.org/10.1371/journal.pone.0247392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606829	Green Published, gold			2022-12-26	WOS:000620629200128
J	Mu, YZ; Maharjan, Y; Dutta, RK; Wei, XF; Kim, JH; Son, J; Park, C; Park, R				Mu, Yizhu; Maharjan, Yunash; Dutta, Raghbendra Kumar; Wei, Xiaofan; Kim, Jin Hwi; Son, Jinbae; Park, Channy; Park, Raekil			Pharmacological inhibition of catalase induces peroxisome leakage and suppression of LPS induced inflammatory response in Raw 264.7 cell	PLOS ONE			English	Article								Peroxisomes are metabolically active organelles which are known to exert anti-inflammatory effects especially associated with the synthesis of mediators of inflammation resolution. However, the role of catalase and effects of peroxisome derived reactive oxygen species (ROS) caused by lipid peroxidation through 4-hydroxy-2-nonenal (4-HNE) on lipopolysaccharide (LPS) mediated inflammatory pathway are largely unknown. Here, we show that inhibition of catalase by 3-aminotriazole (3-AT) results in the generation of peroxisomal ROS, which contribute to leaky peroxisomes in RAW264.7 cells. Leaky peroxisomes cause the release of matrix proteins to the cytosol, which are degraded by ubiquitin proteasome system. Furthermore, 3-AT promotes the formation of 4HNE-I kappa B alpha adduct which directly interferes with LPS induced NF-kappa B activation. Even though, a selective degradation of peroxisome matrix proteins and formation of 4HNE- I kappa B alpha adduct are not directly related with each other, both of them are could be the consequences of lipid peroxidation occurring at the peroxisome membrane.	[Mu, Yizhu; Maharjan, Yunash; Dutta, Raghbendra Kumar; Wei, Xiaofan; Kim, Jin Hwi; Son, Jinbae; Park, Channy; Park, Raekil] Gwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST)	Park, R (corresponding author), Gwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea.	rkpark@gist.ac.kr	Dutta, Raghbendra Kumar/GON-9912-2022	Dutta, Raghbendra Kumar/0000-0001-8183-6931	National Research Foundation of Korea (NRF) - Korean government [2019R1A2C208608012]; "GIST Research Institute (GRI) IIBR" grant - Gwangju Institute of Science and Technology (GIST)	National Research Foundation of Korea (NRF) - Korean government(National Research Foundation of Korea); "GIST Research Institute (GRI) IIBR" grant - Gwangju Institute of Science and Technology (GIST)	This work was supported by: center dot National Research Foundation of Korea (NRF) under grants funded by the Korean government No. 2019R1A2C208608012 center dot"GIST Research Institute (GRI) IIBR" grant funded by Gwangju Institute of Science and Technology (GIST) in 2020.	Ahlemeyer B, 2012, DIS MODEL MECH, V5, P125, DOI 10.1242/dmm.007708; Aksam EB, 2008, FREE RADICAL BIO MED, V45, P1115, DOI 10.1016/j.freeradbiomed.2008.07.010; Biswas SK, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5698931; Brautigam C, 1996, ATHEROSCLEROSIS, V119, P77, DOI 10.1016/0021-9150(95)05632-7; Cao C, 2003, BIOCHEMISTRY-US, V42, P10348, DOI 10.1021/bi035023f; Corpas FJ, 2001, TRENDS PLANT SCI, V6, P145, DOI 10.1016/S1360-1385(01)01898-2; CRAWFORD DR, 1988, BIOCHEM BIOPH RES CO, V153, P59, DOI 10.1016/S0006-291X(88)81189-6; DARR D, 1986, BIOCHEM PHARMACOL, V35, P3642, DOI 10.1016/0006-2952(86)90639-8; del Rio LA, 2016, PLANT CELL PHYSIOL, V57, P1364, DOI 10.1093/pcp/pcw076; Di Cara F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20163877; Di Cara F, 2017, IMMUNITY, V47, P93, DOI 10.1016/j.immuni.2017.06.016; Dou XB, 2012, AM J PATHOL, V181, P1702, DOI 10.1016/j.ajpath.2012.08.004; Elsner M, 2011, DIABETES, V60, P200, DOI 10.2337/db09-1401; Francisco T, 2013, J BIOL CHEM, V288, P29151, DOI 10.1074/jbc.M113.487140; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; Islinger M, 2018, HISTOCHEM CELL BIOL, V150, P443, DOI 10.1007/s00418-018-1722-5; Jo DS, 2015, BIOCHEM BIOPH RES CO, V467, P354, DOI 10.1016/j.bbrc.2015.09.153; Koepke JI, 2008, TOXICOL APPL PHARM, V232, P99, DOI 10.1016/j.taap.2008.06.004; Koepke JI, 2007, TRAFFIC, V8, P1590, DOI 10.1111/j.1600-0854.2007.00633.x; Law KB, 2017, AUTOPHAGY, V13, P868, DOI 10.1080/15548627.2017.1291470; Lee JN, 2018, BIOCHEM BIOPH RES CO, V501, P696, DOI 10.1016/j.bbrc.2018.05.050; Lee JN, 2017, MOL CELL TOXICOL, V13, P125, DOI 10.1007/s13273-017-0013-x; Lee JN, 2016, ARCH TOXICOL, V90, P781, DOI 10.1007/s00204-015-1506-9; Manivannan S, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00050; Milton NGN, 2001, NEUROTOXICOLOGY, V22, P767, DOI 10.1016/S0161-813X(01)00064-X; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Nitta Y, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158726; Sargent G, 2016, J CELL BIOL, V214, P677, DOI 10.1083/jcb.201511034; Schwarzer E, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/638416; Shen WJ, 2013, BIOCHEM BIOPH RES CO, V430, P442, DOI 10.1016/j.bbrc.2012.11.037; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Terlecky Stanley R, 2012, World J Biol Chem, V3, P93, DOI 10.4331/wjbc.v3.i5.93; Van der Paal J, 2016, CHEM SCI, V7, P489, DOI 10.1039/c5sc02311d; Vasko R, 2016, ANTIOXID REDOX SIGN, V25, P217, DOI 10.1089/ars.2016.6666; Vijayan V, 2017, J IMMUNOL, V198, P2414, DOI 10.4049/jimmunol.1601596; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329	36	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0245799	10.1371/journal.pone.0245799	http://dx.doi.org/10.1371/journal.pone.0245799			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606716	Green Published, gold			2022-12-26	WOS:000620629200063
J	Treyer, V; Meyer, RS; Buchmann, A; Crameri, GAG; Studer, S; Saake, A; Gruber, E; Unschuld, PG; Nitsch, RM; Hock, C; Gietl, AF				Treyer, Valerie; Meyer, Rafael S.; Buchmann, Andreas; Crameri, Giovanni A. G.; Studer, Sandro; Saake, Antje; Gruber, Esmeralda; Unschuld, Paul G.; Nitsch, Roger M.; Hock, Christoph; Gietl, Anton F.			Physical activity is associated with lower cerebral beta-amyloid and cognitive function benefits from lifetime experience-a study in exceptional aging	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SUBJECTIVE MEMORY COMPLAINTS; ALZHEIMERS-DISEASE; OLDEST-OLD; MOTIVATIONAL RESERVE; PERSONALITY-TRAITS; STYLE ACTIVITIES; MENTAL ACTIVITY; RISK-FACTORS; DEMENTIA	Background Exceptional agers (85+ years) are characterized by preserved cognition presumably due to high cognitive reserve. In the current study, we examined whether personality, risk and protective factors for dementia as well as quality of life are associated with core features of Alzheimer's disease (amyloid-deposition and hippocampal volume) as well as cognition in exceptional aging. Methods We studied 49 exceptional agers (average 87.8 years, range 84-94 years), with preserved activities of daily living and absence of dementia. All participants received a detailed clinical and neuropsychological examination. We used established questionnaires to measure lifetime experience, personality, recent physical and cognitive activity as well as quality of life. Cerebral amyloid-deposition was estimated by 18-[F]-Flutemetamol-PET and manual hippocampal volumetry was performed on 3D T1 MRI images. Results In this sample of exceptional agers with preserved activities of daily living, we found intact cognitive performance in the subjects with the highest amyloid-load in the brain, but a lower quality of life with respect to autonomy as well as higher neuroticism. Higher self-reported physical activity in the last twelve months went with a lower amyloid load. Higher self-reported leisure-time/ not work-related activity went with better executive functioning at older age. Conclusion Even in exceptional aging, high amyloid load may subtly influence personality and quality of life. Our findings support a close relationship between high physical activity and low amyloid-deposition and underscore the importance of extracurricular activities for executive functions. As executive functions are known to be a central resource for everyday functioning in fostering extracurricular activities may be effective in delaying the onset of dementia.	[Treyer, Valerie; Meyer, Rafael S.; Buchmann, Andreas; Crameri, Giovanni A. G.; Studer, Sandro; Saake, Antje; Gruber, Esmeralda; Unschuld, Paul G.; Nitsch, Roger M.; Hock, Christoph; Gietl, Anton F.] Univ Zurich, Inst Regenerat Med IREM, Zurich, Switzerland; [Treyer, Valerie] Univ Zurich, Univ Hosp Zurich, Dept Nucl Med, Zurich, Switzerland; [Unschuld, Paul G.] Psychiat Univ Hosp Zurich, Hosp Psychogeriatr Med, Zurich, Switzerland; [Nitsch, Roger M.; Hock, Christoph] Neurimmune, Schlieren, Switzerland; [Unschuld, Paul G.] Geneva Univ Hosp HUG, Dept Psychiat, Psychogeriatr Med, Geneva, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Geneva	Treyer, V (corresponding author), Univ Zurich, Inst Regenerat Med IREM, Zurich, Switzerland.; Treyer, V (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Nucl Med, Zurich, Switzerland.	Valerie.treyer@usz.ch	Treyer, Valerie/G-6986-2018	Treyer, Valerie/0000-0002-4584-3031; , Andreas/0000-0001-6981-9389; Gietl, Anton/0000-0001-8604-962X; Crameri, Giovanni Andrea Gerardo/0000-0002-4272-1688	ZInEP; Zurich Program for Sustainable Development of Mental Health Services; Maxi Foundation; GE Healthcare (IIS) [270, 114-2014-IIR-0076]	ZInEP; Zurich Program for Sustainable Development of Mental Health Services; Maxi Foundation; GE Healthcare (IIS)(General Electric)	This study was supported by ZInEP, The Zurich Program for Sustainable Development of Mental Health Services, Maxi Foundation, GE Healthcare (IIS ID #270 and 114-2014-IIR-0076) and institutional support from the Institute for Regenerative Medicine (IREM), University of Zurich, Switzerland. Funds were requested by CH, AGF and VT. The funders had no role in study design, data collection ana analysis, decision to publish, or preparation of the manuscript.	Althouse AD, 2016, ANN THORAC SURG, V101, P1644, DOI 10.1016/j.athoracsur.2015.11.024; Anaturk M, 2018, NEUROSCI BIOBEHAV R, V93, P71, DOI 10.1016/j.neubiorev.2018.06.012; Apostolova LG, 2010, NEUROBIOL AGING, V31, P1077, DOI 10.1016/j.neurobiolaging.2008.08.008; Arenaza-Urquijo EM, 2018, NEUROLOGY, V90, P695, DOI 10.1212/WNL.0000000000005303; Balsis S, 2005, J GERONTOL B-PSYCHOL, V60, pP98, DOI 10.1093/geronb/60.2.P98; Bauckneht M, 2015, WORLD J RADIOL, V7, P475, DOI 10.4329/wjr.v7.i12.475; Bennett DA, 2005, NEUROLOGY, V65, P953, DOI 10.1212/01.wnl.0000176286.17192.69; Berlau DJ, 2013, ALZHEIMERS DEMENT, V9, P699, DOI 10.1016/j.jalz.2012.11.011; Bott NT, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092258; Brenowitz WD, 2014, J ALZHEIMERS DIS, V39, P691, DOI 10.3233/JAD-131880; Brown BM, 2013, MOL PSYCHIATR, V18, P875, DOI 10.1038/mp.2012.107; Brown BM, 2019, AGEING RES REV, V50, P9, DOI 10.1016/j.arr.2019.01.003; Burke SN, 2019, NEUROBIOL AGING, V83, P140, DOI 10.1016/j.neurobiolaging.2019.03.023; Carapelle E, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005876; Caselli RJ, 2018, J AM GERIATR SOC, V66, P671, DOI 10.1111/jgs.15182; Chan D, 2018, NEUROBIOL AGING, V70, P180, DOI 10.1016/j.neurobiolaging.2018.06.012; Chantome M, 1999, NEUROIMAGE, V10, P589, DOI 10.1006/nimg.1999.0486; Dawson DV, 2000, ALZ DIS ASSOC DIS, V14, P11, DOI 10.1097/00002093-200001000-00002; De la Rosa A, 2020, J SPORT HEALTH SCI, V9, P394, DOI 10.1016/j.jshs.2020.01.004; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Dubois B, 2016, ALZHEIMERS DEMENT, V12, P292, DOI 10.1016/j.jalz.2016.02.002; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forstmeier S, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0666-8; Forstmeier S, 2012, PSYCHOL AGING, V27, P353, DOI 10.1037/a0025117; Foster JK, 1999, MEMORY, V7, P715, DOI 10.1080/096582199387823; Fotuhi M, 2012, NAT REV NEUROL, V8, P189, DOI 10.1038/nrneurol.2012.27; Fratiglioni L, 2020, LANCET NEUROL, V19, P533, DOI 10.1016/S1474-4422(20)30039-9; Frederiksen KS, 2018, J ALZHEIMERS DIS, V61, P359, DOI 10.3233/JAD-170567; Gallagher M, 2019, NEUROBIOL AGING, V83, P130, DOI 10.1016/j.neurobiolaging.2019.04.016; Gerhard U., 1999, GOTTINGEN HOGREFE, V28, P145, DOI [10.1026//0084-5345.28.2.145, DOI 10.1026//0084-5345.28.2.145]; Gow AJ, 2017, J GERONTOL B-PSYCHOL, V72, P25, DOI 10.1093/geronb/gbw124; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Head D, 2012, ARCH NEUROL-CHICAGO, V69, P636, DOI 10.1001/archneurol.2011.845; Imhof A, 2007, J NEUROL SCI, V257, P72, DOI 10.1016/j.jns.2007.01.025; International AsD, 2019, WORLD ALZHEIMER REPO; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack CR, 2012, RADIOLOGY, V263, P343, DOI 10.1148/radiol.12110433; Jellinger KA, 2005, J NEUROL SCI, V229, P37, DOI 10.1016/j.jns.2004.11.018; Johansson L, 2014, NEUROLOGY, V83, P1538, DOI 10.1212/WNL.0000000000000907; Jung YH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57525-6; Kawas Claudia H., 2006, Current Alzheimer Research, V3, P411, DOI 10.2174/156720506779025233; Kawas CH, 2013, ALZHEIMERS DEMENT, V9, P199, DOI 10.1016/j.jalz.2012.06.005; Kessler J., 2000, WECHSLER GED CHTNIS; Kim MJ, 2013, ARCH GERONTOL GERIAT, V57, P110, DOI 10.1016/j.archger.2013.01.005; Klunk WE, 2015, ALZHEIMERS DEMENT, V11, P1, DOI 10.1016/j.jalz.2014.07.003; Kohler S, 1998, NEUROPSYCHOLOGIA, V36, P901, DOI 10.1016/S0028-3932(98)00017-7; Korner A., 2008, Z FUER MEDIZINISCHE, V17, P133; Lamar M, 2020, NEUROPSYCHOL REV, V30, P546, DOI 10.1007/s11065-020-09460-6; Larson EB, 2013, NEW ENGL J MED, V369, P2275, DOI 10.1056/NEJMp1311405; Lautenschlager NT, 2019, DIALOGUES CLIN NEURO, V21, P61; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Liang KY, 2010, ANN NEUROL, V68, P311, DOI 10.1002/ana.22096; Lista S, 2015, J NUTR HEALTH AGING, V19, P154, DOI 10.1007/s12603-014-0515-3; Low LF, 2013, AM J GERIAT PSYCHIAT, V21, P713, DOI 10.1016/j.jagp.2012.08.004; Lucca U, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-54; Lux S., 2001, BELTZ TEST; Martin SB, 2010, NEUROBIOL AGING, V31, P1099, DOI 10.1016/j.neurobiolaging.2008.08.010; McMaster M, 2020, J AM GERIATR SOC, V68, P2629, DOI 10.1111/jgs.16762; Mikolaenko I, 2005, J NEUROPATH EXP NEUR, V64, P156, DOI 10.1093/jnen/64.2.156; Nelson PT, 2019, BRAIN, V142, P1503, DOI 10.1093/brain/awz099; Norton DJ, 2017, NEUROLOGY, V89, P1464, DOI 10.1212/WNL.0000000000004533; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Olaya B, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1350-5; Ossenkoppele R, 2018, JAMA-J AM MED ASSOC, V320, P1151, DOI 10.1001/jama.2018.12917; Osterrieth P., 1944, ARCH PSYCHOL-GENEVE, V30, P206; Ouanes S, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00063; Pires Carolina, 2012, Int J Alzheimers Dis, V2012, P725329, DOI 10.1155/2012/725329; Pontecorvo MJ, 2019, BRAIN, V142, P1723, DOI 10.1093/brain/awz090; Pugazhenthi S, 2017, BBA-MOL BASIS DIS, V1863, P1037, DOI 10.1016/j.bbadis.2016.04.017; Rabin JS, 2019, JAMA NEUROL, V76, P1203, DOI 10.1001/jamaneurol.2019.1879; Rasmussen IJ, 2020, EUR HEART J, V41, P4024, DOI 10.1093/eurheartj/ehaa695; Rawlings AM, 2019, J ALZHEIMERS DIS, V68, P517, DOI 10.3233/JAD-180785; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Roberts RO, 2018, JAMA NEUROL, V75, P970, DOI 10.1001/jamaneurol.2018.0629; Rodriguez FS, 2021, INT J GERIATR PSYCH, V36, P152, DOI 10.1002/gps.5409; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P1467, DOI 10.1001/archneur.65.11.1467; Rogalski E, 2019, HIPPOCAMPUS, V29, P458, DOI 10.1002/hipo.22828; Rubio MM, 2013, DEMENT GERIATR COGN, V35, P87, DOI 10.1159/000346129; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Schmand B, 1996, NEUROLOGY, V46, P121, DOI 10.1212/WNL.46.1.121; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sink KM, 2015, JAMA-J AM MED ASSOC, V314, P781, DOI 10.1001/jama.2015.9617; Smith-Gamble V, 2002, AM J GERIAT PSYCHIAT, V10, P724, DOI 10.1176/appi.ajgp.10.6.724; Snitz BE, 2015, AM J GERIAT PSYCHIAT, V23, P985, DOI 10.1016/j.jagp.2015.01.008; SOBEL E, 1995, NEUROLOGY, V45, P903, DOI 10.1212/WNL.45.5.903; Soldan A, 2018, PSYCHIAT CLIN N AM, V41, P65, DOI 10.1016/j.psc.2017.10.006; Solomon A, 2013, ADV ALZH DIS, V3, P465, DOI [10.3233/978-1-61499-154-0-465, 10.3233/JAD-2012-129021]; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Sullivan KJ, 2021, BRAIN IMAGING BEHAV, V15, P1355, DOI 10.1007/s11682-020-00334-2; Suo C, 2012, NEUROIMAGE, V63, P1542, DOI 10.1016/j.neuroimage.2012.08.015; Sutin AR, 2018, INT J GERIATR PSYCH, V33, P743, DOI 10.1002/gps.4849; Tabatabaei-Jafari Hossein, 2015, Alzheimers Dement (Amst), V1, P487, DOI 10.1016/j.dadm.2015.11.002; Taylor L B, 1969, Clin Neurosurg, V16, P269; ten Kate M, 2017, NEUROBIOL AGING, V52, P167, DOI 10.1016/j.neurobiolaging.2016.05.024; Terracciano A, 2014, ALZHEIMERS DEMENT, V10, P179, DOI 10.1016/j.jalz.2013.03.002; Thalmann B., 1997, CERAD CONSORTIUM EST; Thoma MV, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0865-5; Valenzuela MJ, 2007, PSYCHOL MED, V37, P1015, DOI 10.1017/S003329170600938X; Valenzuela MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002598; van Bergen JMG, 2018, NEUROBIOL AGING, V64, P68, DOI 10.1016/j.neurobiolaging.2017.12.014; Vemuri P, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0373-z; Vemuri P, 2017, JAMA NEUROL, V74, P718, DOI 10.1001/jamaneurol.2017.0244; Vemuri P, 2016, NEUROLOGY, V86, P1128, DOI 10.1212/WNL.0000000000002490; Vemuri P, 2012, ANN NEUROL, V72, P730, DOI 10.1002/ana.23665; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Vlassenko AG, 2011, ANN NEUROL, V70, P857, DOI 10.1002/ana.22608; Wilson RS, 2019, NEUROLOGY, V92, pE1041, DOI 10.1212/WNL.0000000000007036; Wilson RS, 2011, AM J GERIAT PSYCHIAT, V19, P327, DOI 10.1097/JGP.0b013e31820119da; Winkler I, 2006, PSYCHOTHER PSYCH MED, V56, P63, DOI 10.1055/s-2005-915334; Wirth M, 2014, NEUROBIOL AGING, V35, P1873, DOI 10.1016/j.neurobiolaging.2014.02.015; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053; Yoneda T, 2017, J GERONTOL B-PSYCHOL, V72, P922, DOI 10.1093/geronb/gbw006; Zhao YJ, 2018, JAMA NEUROL, V75, P88, DOI 10.1001/jamaneurol.2017.3029	118	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247225	10.1371/journal.pone.0247225	http://dx.doi.org/10.1371/journal.pone.0247225			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606797	Green Published, Green Accepted, gold			2022-12-26	WOS:000620629200007
J	Li, G; Jung, JJ				Li, Gen; Jung, Jason J.			Dynamic graph embedding for outlier detection on multiple meteorological time series	PLOS ONE			English	Article							ANOMALY DETECTION; NETWORKS	Existing dynamic graph embedding-based outlier detection methods mainly focus on the evolution of graphs and ignore the similarities among them. To overcome this limitation for the effective detection of abnormal climatic events from meteorological time series, we proposed a dynamic graph embedding model based on graph proximity, called DynGPE. Climatic events are represented as a graph where each vertex indicates meteorological data and each edge indicates a spurious relationship between two meteorological time series that are not causally related. The graph proximity is described as the distance between two graphs. DynGPE can cluster similar climatic events in the embedding space. Abnormal climatic events are distant from most of the other events and can be detected using outlier detection methods. We conducted experiments by applying three outlier detection methods (i.e., isolation forest, local outlier factor, and box plot) to real meteorological data. The results showed that DynGPE achieves better results than the baseline by 44.3% on average in terms of the F-measure. Isolation forest provides the best performance and stability. It achieved higher results than the local outlier factor and box plot methods, namely, by 15.4% and 78.9% on average, respectively.	[Li, Gen; Jung, Jason J.] Chung Ang Univ, Dept Comp Engn, Seoul, South Korea	Chung Ang University	Jung, JJ (corresponding author), Chung Ang Univ, Dept Comp Engn, Seoul, South Korea.	j3ung@cau.ac.kr	Jung, Jason J./B-9622-2012	Jung, Jason J./0000-0003-0050-7445	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2020R1A2B5B01002207]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2020R1A2B5B01002207).	Benesty J, 2009, SPRINGER TOP SIGN PR, V2, P37, DOI 10.1007/978-3-642-00296-0_5; Boniol P, 2020, PROC VLDB ENDOW, V13, P1821, DOI 10.14778/3407790.3407792; Breunig MM, 2000, SIGMOD REC, V29, P93, DOI 10.1145/335191.335388; Chen ZZ, 2012, J INTELL INF SYST, V39, P59, DOI 10.1007/s10844-011-0183-2; Cheng ZQ, 2020, AAAI CONF ARTIF INTE, V34, P3617; Croux C, 2010, STAT METHOD APPL-GER, V19, P497, DOI 10.1007/s10260-010-0142-z; Dekking F., 2005, MODERN INTRO PROBABI; Dong Y, 2018, COMPUT INTELL-US, V34, P261, DOI 10.1111/coin.12146; Duan D, 2009, P 1 ACM INT WORKSH C, P11, DOI DOI 10.1145/1651274.1651278; Fan XS, 2020, INFORM SCIENCES, V506, P131, DOI 10.1016/j.ins.2019.08.023; Farag A, 2022, J KING SAUD UNIV-COM, V34, P1446, DOI 10.1016/j.jksuci.2019.09.009; Farah S, 2019, ENERG BUILDINGS, V183, P749, DOI 10.1016/j.enbuild.2018.11.045; Gadiwala MS., 2019, INT J EC ENV GEOL, V4, P10; Giap TK, 2016, ECONOMIES, V4, DOI 10.3390/economies4010003; Gopalakrishnan K, 2019, IEEE DECIS CONTR P, P4769, DOI 10.1109/CDC40024.2019.9029478; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grattarola D, 2020, IEEE T NEUR NET LEAR, V31, P1856, DOI 10.1109/TNNLS.2019.2927301; Gupta M, 2014, IEEE T KNOWL DATA EN, V26, P2250, DOI 10.1109/TKDE.2013.184; Kieu T, 2019, PROCEEDINGS OF THE TWENTY-EIGHTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2725; King DB, 2015, ACS SYM SER, V1214, P1; Lee D., 2019, J SOC E BUSINESS STU, V24; Leichtnam Laetitia, 2020, Detection of Intrusions and Malware, and Vulnerability Assessment. 17th International Conference, DIMVA 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12223), P238, DOI 10.1007/978-3-030-52683-2_12; Li G, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10217677; Liu FT, 2008, IEEE DATA MINING, P413, DOI 10.1109/ICDM.2008.17; Loperfido N, 2020, EUR J FINANC, V26, P142, DOI 10.1080/1351847X.2019.1647864; Lu WN, 2017, IEEE T IMAGE PROCESS, V26, P4321, DOI 10.1109/TIP.2017.2713048; Ma LJ, 2020, INFORM SCIENCES, V519, P22, DOI 10.1016/j.ins.2020.01.027; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Ramos MMP, 2019, LECT NOTES COMPUT SC, V11678, P542, DOI 10.1007/978-3-030-29888-3_44; Pareja A, 2020, AAAI CONF ARTIF INTE, V34, P5363; Pearson K., 1894, Philosophical Transactions, V185a, P71, DOI 10.1098/rsta.1894.0003; Ramachandra B, 2019, STAT ANAL DATA MIN, V12, P88, DOI 10.1002/sam.11398; Ranshous S, 2015, WIRES COMPUT STAT, V7, P223, DOI 10.1002/wics.1347; Reunanen N., 2019, INT J DATA SCI ANAL, P1; Rossi R.A., 2013, P 6 ACM INT C WEB SE, P667, DOI 10.1145/2433396.2433479; Scarselli F, 2009, IEEE T NEURAL NETWOR, V20, P61, DOI 10.1109/TNN.2008.2005605; Schmidt-Hieber J, 2020, ANN STAT, V48, P1875, DOI 10.1214/19-AOS1875; Su Y, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P2828, DOI 10.1145/3292500.3330672; Taheri R, 2020, FUTURE GENER COMP SY, V105, P230, DOI 10.1016/j.future.2019.11.034; Walden AT, 2019, J APPL STAT, V46, P1107, DOI 10.1080/02664763.2018.1536198; Wang DX, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1225, DOI 10.1145/2939672.2939753; Yeung JFKA, 2020, SOFT COMPUT, V24, P1789, DOI 10.1007/s00500-019-04006-2; Yin C, 2020, IEEE T SYST MAN CY-S; Zehua Zhang, 2019, 2019 International Conference on Machine Learning, Big Data and Business Intelligence (MLBDBI), P364, DOI 10.1109/MLBDBI48998.2019.00082	44	5	5	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247119	10.1371/journal.pone.0247119	http://dx.doi.org/10.1371/journal.pone.0247119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600442	gold, Green Published			2022-12-26	WOS:000620625100018
J	Lin, CC; Yang, WH; Lin, YT; Tang, XH; Chen, PH; Ding, CKC; Qu, DC; Alvarez, JV; Chi, JT				Lin, Chao-Chieh; Yang, Wen-Hsuan; Lin, Yi-Tzu; Tang, Xiaohu; Chen, Po-Han; Ding, Chien-Kuang Cornelia; Qu, Dan Chen; Alvarez, James V.; Chi, Jen-Tsan			DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway	ONCOGENE			English	Article								Recurrent breast cancer presents significant challenges with aggressive phenotypes and treatment resistance. Therefore, novel therapeutics are urgently needed. Here, we report that murine recurrent breast tumor cells, when compared with primary tumor cells, are highly sensitive to ferroptosis. Discoidin Domain Receptor Tyrosine Kinase 2 (DDR2), the receptor for collagen I, is highly expressed in ferroptosis-sensitive recurrent tumor cells and human mesenchymal breast cancer cells. EMT regulators, TWIST and SNAIL, significantly induce DDR2 expression and sensitize ferroptosis in a DDR2-dependent manner. Erastin treatment induces DDR2 upregulation and phosphorylation, independent of collagen I. Furthermore, DDR2 knockdown in recurrent tumor cells reduces clonogenic proliferation. Importantly, both the ferroptosis protection and reduced clonogenic growth may be compatible with the compromised YAP/TAZ upon DDR2 inhibition. Collectively, these findings identify the important role of EMT-driven DDR2 upregulation in recurrent tumors in maintaining growth advantage but activating YAP/TAZ-mediated ferroptosis susceptibility, providing potential strategies to eradicate recurrent breast cancer cells with mesenchymal features.	[Lin, Chao-Chieh; Yang, Wen-Hsuan; Lin, Yi-Tzu; Chen, Po-Han; Ding, Chien-Kuang Cornelia; Qu, Dan Chen; Chi, Jen-Tsan] Duke Univ, Dept Mol Genet & Microbiol, Sch Med, Durham, NC 27710 USA; [Lin, Chao-Chieh; Yang, Wen-Hsuan; Lin, Yi-Tzu; Chen, Po-Han; Ding, Chien-Kuang Cornelia; Qu, Dan Chen; Chi, Jen-Tsan] Duke Univ, Ctr Genom & Computat Biol, Sch Med, Durham, NC 27710 USA; [Tang, Xiaohu] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA; [Alvarez, James V.] Duke Univ, Dept Pharmacol & Canc Biol, Sch Med, Durham, NC 27710 USA	Duke University; Duke University; Michigan Technological University; Duke University	Chi, JT (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Sch Med, Durham, NC 27710 USA.; Chi, JT (corresponding author), Duke Univ, Ctr Genom & Computat Biol, Sch Med, Durham, NC 27710 USA.	jentsan.chi@duke.edu	Yang, Wen-Hsuan/GVU-4518-2022; Lin, Chao-Chieh/AAC-9102-2022; Yang, Wen-Hsuan/GVU-6615-2022; Tang, Xiaohu/AAX-4577-2021; Yang, Wen-Hsuan/AAY-9158-2021; CHEN, PO-HAN/ABB-6690-2021	Lin, Chao-Chieh/0000-0001-5890-9004; Yang, Wen-Hsuan/0000-0001-5780-6839; Yang, Wen-Hsuan/0000-0001-5780-6839; CHEN, PO-HAN/0000-0002-9471-4471; Chi, Jen-Tsan/0000-0003-3433-903X; Tang, Mark/0000-0001-6367-4991	DOD [W81XWH-17-1-0143, W81XWH-15-1-0486, W81XWH-19-1-0842, W81XWH-20-1-0907]; NIH [R01GM124062, R01NS111588-01A1, 1R21-AI149205]	DOD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful for technical support from the members of the Chi lab. We also appreciate the generosity of Dr. Everardo Macias for allowing access to the Incucyte S3. We acknowledge the financial support in part by DOD grants (W81XWH-17-1-0143, W81XWH-15-1-0486, W81XWH-19-1-0842, W81XWH-20-1-0907), and NIH grants (R01GM124062, 1R01NS111588-01A1, 1R21-AI149205).	Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Bayer SVH, 2019, ELIFE, V8, DOI 10.7554/eLife.45508; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Burdo J, 2006, J HISTOCHEM CYTOCHEM, V54, P549, DOI 10.1369/jhc.5A6840.2006; Chen PH, 2020, CELL DEATH DIFFER, V27, P1008, DOI 10.1038/s41418-019-0393-7; Chen PH, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1361501; Chen PH, 2017, EMBO J, V36, P2233, DOI 10.15252/embj.201696113; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Corsa CAS, 2016, CELL REP, V15, P2510, DOI 10.1016/j.celrep.2016.05.033; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Ding CKC, 2020, NAT METAB, V2, P270, DOI 10.1038/s42255-020-0181-1; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]; Du K, 2019, INHIBITING XCT SLC7A, DOI [10.1101/2019.12.23.886259, DOI 10.1101/2019.12.23.886259]; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Fan Y, 2016, AM J TRANSL RES, V8, P2845; Fox DB, 2020, NAT METAB, V2, P318, DOI 10.1038/s42255-020-0191-z; Gao MH, 2015, MOL CELL, V59, P298, DOI 10.1016/j.molcel.2015.06.011; Gonzalez ME, 2017, CELL REP, V18, P1215, DOI 10.1016/j.celrep.2016.12.079; Goswami CP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-970; Grither WR, 2018, P NATL ACAD SCI USA, V115, pE7786, DOI 10.1073/pnas.1805020115; Grither WR, 2018, ONCOGENE, V37, P1714, DOI 10.1038/s41388-017-0043-9; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Hayano M, 2016, CELL DEATH DIFFER, V23, P270, DOI 10.1038/cdd.2015.93; Huang CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076421; Hwang PY, 2019, CANCER RES, V79, P1899, DOI 10.1158/0008-5472.CAN-18-2828; Ikeda K, 2002, J BIOL CHEM, V277, P19206, DOI 10.1074/jbc.M201078200; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07126-7; Kimbung S, 2015, SEMIN CANCER BIOL, V35, P85, DOI 10.1016/j.semcancer.2015.08.009; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koo JH, 2020, GENE DEV, V34, P72, DOI 10.1101/gad.331546.119; Lamar JM, 2019, J BIOL CHEM, V294, P2302, DOI 10.1074/jbc.RA118.004364; Li P, 2016, GENE DEV, V30, P798, DOI 10.1101/gad.274951.115; Lin Chao-Chieh, 2020, Oncotarget, V11, P3562, DOI 10.18632/oncotarget.27749; Lin CC, 2020, CELL DEATH DIFFER, V27, P2234, DOI 10.1038/s41418-020-0499-y; Lin CC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03422-6; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Mabe NW, 2018, J CLIN INVEST, V128, P4413, DOI 10.1172/JCI99481; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Sasaki S, 2017, ANTICANCER RES, V37, P2587, DOI 10.21873/anticanres.11603; Si Y, 2017, CANCER RES, V77, P4868, DOI 10.1158/0008-5472.CAN-17-0391; Skouta R, 2014, J AM CHEM SOC, V136, P4551, DOI 10.1021/ja411006a; Slocum E, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1142-z; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Tang X, 2017, ONCOGENE, V36, P4235, DOI 10.1038/onc.2016.394; Tang XH, 2016, CANCER RES, V76, P1892, DOI 10.1158/0008-5472.CAN-15-2328; Tang XH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005158; Terai H, 2015, ACS CHEM BIOL, V10, P2687, DOI 10.1021/acschembio.5b00655; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Toy KA, 2015, BREAST CANCER RES TR, V150, P9, DOI 10.1007/s10549-015-3285-7; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Tsai MC, 2016, ONCOTARGET, V7, P78918, DOI 10.18632/oncotarget.12912; Tu MM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav2437; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Walsh LA, 2011, MATRIX BIOL, V30, P243, DOI 10.1016/j.matbio.2011.03.007; Wu J, 2019, NATURE, V572, P402, DOI 10.1038/s41586-019-1426-6; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Yang K, 2005, J BIOL CHEM, V280, P39058, DOI 10.1074/jbc.M506921200; Yang WH, 2020, MOL CELL ONCOL, V7, DOI 10.1080/23723556.2019.1699375; Yang WH, 2020, MOL CANCER RES, V18, P79, DOI 10.1158/1541-7786.MCR-19-0691; Yang WH, 2019, CELL REP, V28, P2501, DOI 10.1016/j.celrep.2019.07.107; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743	72	24	25	4	19	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2021	40	11					2018	2034		10.1038/s41388-021-01676-x	http://dx.doi.org/10.1038/s41388-021-01676-x		FEB 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QZ5PE	33603168	Green Accepted			2022-12-26	WOS:000619433100005
J	Winston, JA; Rivera, A; Cai, JW; Patterson, AD; Theriot, CM				Winston, Jenessa A.; Rivera, Alissa; Cai, Jingwei; Patterson, Andrew D.; Theriot, Casey M.			Secondary bile acid ursodeoxycholic acid alters weight, the gut microbiota, and the bile acid pool in conventional mice	PLOS ONE			English	Article								Ursodeoxycholic acid (commercially available as ursodiol) is a naturally occurring bile acid that is used to treat a variety of hepatic and gastrointestinal diseases. Ursodiol can modulate bile acid pools, which have the potential to alter the gut microbiota community structure. In turn, the gut microbial community can modulate bile acid pools, thus highlighting the interconnectedness of the gut microbiota-bile acid-host axis. Despite these interactions, it remains unclear if and how exogenously administered ursodiol shapes the gut microbial community structure and bile acid pool in conventional mice. This study aims to characterize how ursodiol alters the gastrointestinal ecosystem in conventional mice. C57BL/6J wildtype mice were given one of three doses of ursodiol (50, 150, or 450 mg/kg/day) by oral gavage for 21 days. Alterations in the gut microbiota and bile acids were examined including stool, ileal, and cecal content. Bile acids were also measured in serum. Significant weight loss was seen in mice treated with the low and high dose of ursodiol. Alterations in the microbial community structure and bile acid pool were seen in ileal and cecal content compared to pretreatment, and longitudinally in feces following the 21-day ursodiol treatment. In both ileal and cecal content, members of the Lachnospiraceae Family significantly contributed to the changes observed. This study is the first to provide a comprehensive view of how exogenously administered ursodiol shapes the healthy gastrointestinal ecosystem in conventional mice. Further studies to investigate how these changes in turn modify the host physiologic response are important.	[Winston, Jenessa A.; Rivera, Alissa; Theriot, Casey M.] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA; [Cai, Jingwei; Patterson, Andrew D.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Winston, Jenessa A.] Ohio State Univ, Dept Vet Clin Sci, Coll Vet Med, Columbus, OH 43210 USA; [Cai, Jingwei] Genentech Inc, Dept Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA	University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Ohio; Ohio State University; Roche Holding; Genentech	Winston, JA (corresponding author), North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.; Winston, JA (corresponding author), Ohio State Univ, Dept Vet Clin Sci, Coll Vet Med, Columbus, OH 43210 USA.	winston.210@osu.edu		Cai, Jingwei/0000-0002-3626-3350	Ruth L. Kirschstein National Research Service Award Research Training grant by NIH [T32OD011130]; National Institute of General Medical Sciences of the National Institutes of Health [R35GM119438]; North Carolina State University College of Veterinary Medicine	Ruth L. Kirschstein National Research Service Award Research Training grant by NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); North Carolina State University College of Veterinary Medicine	JAW was funded by the Ruth L. Kirschstein National Research Service Award Research Training grant T32OD011130 by NIH. CMT is funded by the National Institute of General Medical Sciences of the National Institutes of Health under award number R35GM119438. This project was also funded by an intramural grant from the North Carolina State University College of Veterinary Medicine.	Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Carey EJ, 2015, LANCET, V386, P1565, DOI 10.1016/S0140-6736(15)00154-3; Carino A, 2019, BBA-MOL CELL BIOL L, P1422, DOI 10.1016/j.bbalip.2019.07.006; Chen XS, 2011, EXP DIABETES RES, DOI 10.1155/2011/853501; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Copaci Ionel, 2005, Rom J Gastroenterol, V14, P259; DALESSIO DA, 1994, J CLIN INVEST, V93, P2263, DOI 10.1172/JCI117225; Dilger K, 2012, J HEPATOL, V57, P133, DOI 10.1016/j.jhep.2012.02.014; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Duncan SH, 2007, LETT APPL MICROBIOL, V44, P343, DOI 10.1111/j.1472-765X.2007.02129.x; Duncan SH, 2002, APPL ENVIRON MICROB, V68, P5186, DOI 10.1128/AEM.68.10.5186-5190.2002; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EXCOFFIER L, 1992, GENETICS, V131, P479; Fiorucci S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01853; Fiorucci S, 2015, TRENDS MOL MED, V21, P702, DOI 10.1016/j.molmed.2015.09.001; Fischer S, 2004, EUR J GASTROEN HEPAT, V16, P305; Gu YY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01682-2; HAGEY LR, 1993, J LIPID RES, V34, P1911; Hague A, 1996, P NUTR SOC, V55, P937, DOI 10.1079/PNS19960090; Ibrahim E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25569-4; Ikegami T, 2008, HEPATOL RES, V38, P123, DOI 10.1111/j.1872-034X.2007.00297.x; Kim BT, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051410; Kohli R, 2013, J CLIN ENDOCR METAB, V98, pE708, DOI 10.1210/jc.2012-3736; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kuipers F, 2014, NAT REV ENDOCRINOL, V10, P488, DOI 10.1038/nrendo.2014.60; Lee YY, 2010, BIOCHEM BIOPH RES CO, V397, P735, DOI 10.1016/j.bbrc.2010.06.022; Mandal M, 2001, GASTROENTEROLOGY, V120, P71, DOI 10.1053/gast.2001.20897; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; Mueller M, 2015, J HEPATOL, V62, P1398, DOI 10.1016/j.jhep.2014.12.034; Nie YF, 2015, J ZHEJIANG UNIV-SC B, V16, P436, DOI 10.1631/jzus.B1400327; Pearson T, 2019, CANCER MED-US, V8, P617, DOI 10.1002/cam4.1965; Poupon RE, 2000, SCAND J GASTROENTERO, V35, P642, DOI 10.1080/003655200750023624; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Ridlon JM, 2015, ACTA PHARM SIN B, V5, P99, DOI 10.1016/j.apsb.2015.01.006; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sarafian MH, 2015, ANAL CHEM, V87, P9662, DOI 10.1021/acs.analchem.5b01556; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Serfaty L, 2003, HEPATOLOGY, V38, P203, DOI 10.1053/jhep.2003.50311; SETCHELL KDR, 1983, J LIPID RES, V24, P1085; Shen AM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005157; Sinakos E, 2010, HEPATOLOGY, V52, P197, DOI 10.1002/hep.23631; Staley C, 2017, APPL MICROBIOL BIOT, V101, P47, DOI 10.1007/s00253-016-8006-6; Sun LL, 2018, NAT MED, V24, P1919, DOI 10.1038/s41591-018-0222-4; Tang RQ, 2018, GUT, V67, P534, DOI 10.1136/gutjnl-2016-313332; Theriot CM, 2015, ANNU REV MICROBIOL, V69, P445, DOI 10.1146/annurev-micro-091014-104115; Tsubakio K, 2002, INTERNAL MED, V41, P1142, DOI 10.2169/internalmedicine.41.1142; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wahlstrom A, 2017, DIGEST DIS, V35, P246, DOI 10.1159/000450982; Wang DQH, 2014, WORLD J GASTROENTERO, V20, P9952, DOI 10.3748/wjg.v20.i29.9952; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Winston JA, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00045-20; Wu TZ, 2013, J CLIN ENDOCR METAB, V98, pE718, DOI 10.1210/jc.2012-3961; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Yanguas-Casas N, 2017, J CELL PHYSIOL, V232, P2231, DOI 10.1002/jcp.25742; Zhang L, 2015, EUR REV MED PHARMACO, V19, P3770; Zhang YC, 2014, TOXICOL APPL PHARM, V277, P138, DOI 10.1016/j.taap.2014.03.009	62	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0246161	10.1371/journal.pone.0246161	http://dx.doi.org/10.1371/journal.pone.0246161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600468	Green Published, gold			2022-12-26	WOS:000620625100057
J	Li, JG; Wang, YL; Wang, LQ; Zhu, JY; Deng, J; Tang, R; Chen, GH				Li, Jiguang; Wang, Yanlan; Wang, Liqun; Zhu, Jianyu; Deng, Jing; Tang, Rui; Chen, Guanghui			Integration of transcriptomic and proteomic analyses for finger millet [Eleusine coracana (L.) Gaertn.] in response to drought stress	PLOS ONE			English	Article								Drought is one of the most significant abiotic stresses that affects the growth and productivity of crops worldwide. Finger millet [Eleusine coracana (L.) Gaertn.] is a C-4 crop with high nutritional value and drought tolerance. However, the drought stress tolerance genetic mechanism of finger millet is largely unknown. In this study, transcriptomic (RNA-seq) and proteomic (iTRAQ) technologies were combined to investigate the finger millet samples treated with drought at different stages to determine drought response mechanism. A total of 80,602 differentially expressed genes (DEGs) and 3,009 differentially expressed proteins (DEPs) were identified in the transcriptomic and proteomic levels, respectively. An integrated analysis, which combined transcriptome and proteome data, revealed the presence of 1,305 DEPs were matched with the corresponding DEGs (named associated DEGs-DEPs) when comparing the control to samples which were treated with 19 days of drought (N1-N2 comparison group), 1,093 DEGs-DEPs between control and samples which underwent rehydration treatment for 36 hours (N1-N3 comparison group) and 607 DEGs-DEPs between samples which were treated with drought for 19 days and samples which underwent rehydration treatment for 36 hours (N2-N3 comparison group). Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis identified 80 DEGs-DEPs in the N1-N2 comparison group, 49 DEGs-DEPs in the N1-N3 comparison group, and 59 DEGs-DEPs in the N2-N3 comparison group, which were associated with drought stress. The DEGs-DEPs which were drought tolerance-related were enriched in hydrolase activity, glycosyl bond formation, oxidoreductase activity, carbohydrate binding and biosynthesis of unsaturated fatty acids. Co-expression network analysis revealed two candidate DEGs-DEPs which were found to be centrally involved in drought stress response. These results suggested that the coordination of the DEGs-DEPs was essential to the enhanced drought tolerance response in the finger millet.	[Li, Jiguang; Wang, Liqun; Deng, Jing; Chen, Guanghui] Hunan Agr Univ, Agr Coll, Changsha, Hunan, Peoples R China; [Li, Jiguang; Wang, Yanlan; Zhu, Jianyu; Tang, Rui] Hunan Acad Agr Sci, Crop Res Inst, Changsha, Hunan, Peoples R China	Hunan Agricultural University; Hunan Academy of Agricultural Sciences	Chen, GH (corresponding author), Hunan Agr Univ, Agr Coll, Changsha, Hunan, Peoples R China.; Tang, R (corresponding author), Hunan Acad Agr Sci, Crop Res Inst, Changsha, Hunan, Peoples R China.	195424399@qq.com; ghchen1968@163.com			Natural Science Foundation of Hunan Province [2020JJ4422, NCGRC-2020-056]; Key R&D Program of Xiangxi Autonomous Prefecture [2019NC2003]	Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Key R&D Program of Xiangxi Autonomous Prefecture	Natural Science Foundation of Hunan Province (2020JJ4422), National crop germplasm repository (NCGRC-2020-056), Key R&D Program of Xiangxi Autonomous Prefecture (2019NC2003).	Anjum SA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00069; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown J, 2017, BIOINFORMATICS, V33, P3137, DOI 10.1093/bioinformatics/btx373; Chen J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12516; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Devi PB, 2014, J FOOD SCI TECH MYS, V51, P1021, DOI 10.1007/s13197-011-0584-9; Doxey AC, 2007, MOL BIOL EVOL, V24, P1045, DOI 10.1093/molbev/msm024; Fierens E, 2007, BIOCHEM J, V403, P583, DOI 10.1042/BJ20061291; Gaudioso-Pedraza R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00212; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Ignacimuthu S, 2012, J BIOSCIENCES, V37, P135, DOI 10.1007/s12038-011-9178-y; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; Krishna KR., 2010, ECOLOGY; Kristensen M, 1999, BBA-PROTEIN STRUCT M, V1431, P538, DOI 10.1016/S0167-4838(99)00077-1; Kumar A, 2014, APPL BIOCHEM BIOTECH, V172, P2955, DOI 10.1007/s12010-013-0714-0; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin QH, 2013, NEW PHYTOL, V200, P1009, DOI 10.1111/nph.12446; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; Mukami A, 2019, PHYSIOL MOL BIOL PLA, V25, P837, DOI 10.1007/s12298-019-00679-z; Park HY, 2011, BIOCHEM BIOPH RES CO, V414, P135, DOI 10.1016/j.bbrc.2011.09.039; Parvathi MS, 2019, J GENET, V98, DOI 10.1007/s12041-019-1087-0; Parvathi MS, 2017, J PLANT BIOL, V60, P335, DOI 10.1007/s12374-016-0574-6; Patil Savita Veeranagouda, 2020, Biotechnology Reports, V27, pe00484, DOI 10.1016/j.btre.2020.e00484; Peng RH, 2021, TRENDS PLANT SCI, V26, P199, DOI 10.1016/j.tplants.2020.12.003; Peng ZY, 2009, MOL CELL PROTEOMICS, V8, P2676, DOI 10.1074/mcp.M900052-MCP200; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Salekdeh GH, 2002, PROTEOMICS, V2, P1131, DOI 10.1002/1615-9861(200209)2:9<1131::AID-PROT1131>3.0.CO;2-1; Shailaja HB, 2007, INDIAN J AGR SCI, V77, P672; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma S, 2011, PLANT PHYSIOL, V157, P292, DOI 10.1104/pp.111.183210; Talwar HS, 2020, FUNCT PLANT BIOL, V47, P659, DOI 10.1071/FP19274; Teng MX, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0940-1; Tian T, 2017, NUCLEIC ACIDS RES, V45, pW122, DOI 10.1093/nar/gkx382; Tiwari A, 2020, J CEREAL SCI, V91, DOI 10.1016/j.jcs.2019.102888; Zougmore RB., 2018, PROMOTING CLIMATE SM, DOI [10.1007/978-3-319-58792-9%5F15, DOI 10.1007/978-3-319-58792-9%5F15]	38	2	2	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247181	10.1371/journal.pone.0247181	http://dx.doi.org/10.1371/journal.pone.0247181			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596255	Green Published, gold			2022-12-26	WOS:000620633200005
J	Naravane, AV; Mundae, R; Zhou, YJ; Santilli, C; van Kuijk, FJGM; Nazari, H; Yamanuha, J; Emerson, GG; Koozekanani, DD; Montezuma, SR				Naravane, Ameay, V; Mundae, Rusdeep; Zhou, Yujia; Santilli, Christopher; van Kuijk, Frederik J. G. M.; Nazari, Hossein; Yamanuha, Justin; Emerson, Geoffrey G.; Koozekanani, Dara D.; Montezuma, Sandra R.			Short term visual and structural outcomes of anti-vascular endothelial growth factor (anti-VEGF) treatment delay during the first COVID-19 wave: A pilot study	PLOS ONE			English	Article								Regularly scheduled intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections are essential to maintaining and/or improving many ocular conditions including: neovascular age-related macular degeneration (nAMD), diabetic retinopathy, and retinal vein occlusions with macular edema (RVO). This study aims to assess the effect of unintended delays in anti-VEGF treatment during the first wave of the COVID-19 pandemic. This retrospective case series identified patients receiving regularly scheduled anti-VEGF intravitreal injections based on current procedural terminology (CPT) code at two practices in Minnesota. Diagnoses were limited to nAMD, diabetic macular edema (DME), proliferative diabetic retinopathy, and RVO. Patients were divided into two groups based on whether they maintained or delayed their follow-up visit by more than two weeks beyond the recommended treatment interval during the COVID-19 lockdown. The 'COVID-19 lockdown' was defined as the period after March, 28(th), 2020, when a lockdown was declared in Minnesota. We then compared the visual acuity and structural changes to the retina using ocular coherence tomography (OCT) to assess whether delayed treatment resulted in worse visual outcomes. A total of 167 eyes from 117 patients met criteria for inclusion in this study. In the delayed group, the average BCVA at the pre- and post-lockdown visits were 0.614 and 0.715 (logMAR) respectively (p = 0.007). Central subfield thickness (CST) increased from 341 to 447 in the DME delayed group (p = 0.03) while the CST increased from 301 to 314 (p = 0.4) in the nAMD delayed group. The results of this pilot study suggests that treatment delays may have a negative impact on the visual and anatomic outcomes of patients with nAMD and DME. Future studies with larger sample sizes are required for further investigation.	[Naravane, Ameay, V; Mundae, Rusdeep; Zhou, Yujia; van Kuijk, Frederik J. G. M.; Nazari, Hossein; Yamanuha, Justin; Koozekanani, Dara D.; Montezuma, Sandra R.] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA; [Santilli, Christopher] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Emerson, Geoffrey G.] Retina Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Montezuma, SR (corresponding author), Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA.	smontezu@umn.edu	Nazari, Hossein/GOK-8161-2022	Nazari, Hossein/0000-0002-8945-9680; Naravane, Ameay/0000-0003-2570-7857	Minnesota Lions Foundation; Knobloch Chair Professorship; VitreoRetinal Surgery 2020 Research Award	Minnesota Lions Foundation; Knobloch Chair Professorship; VitreoRetinal Surgery 2020 Research Award	Funding was provided by the Minnesota Lions Foundation, the Knobloch Chair Professorship (SRM), and VitreoRetinal Surgery 2020 Research Award (AN). The funding organizations had no role in the design or conduct of this research.	Agarwal D, 2020, INDIAN J OPHTHALMOL, V68, P1216, DOI 10.4103/ijo.IJO_1391_20; American Academy of Ophthalmology, LIST URG EM OPHTH PR; American Society of Retina Specialists, 2020, MEMB SURV PREF TREND; [Anonymous], COVID 19 HOSP DEATH; Baek SK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49749-y; Bierschbach Briana, 2020, STAR TRIBUNE; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Centers for Disease Control and Prevention, COVID DAT TRACK; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Greenlee TE, 2021, RETINA-J RET VIT DIS, V41, P581, DOI 10.1097/IAE.0000000000002888; Heier JS, 2016, OPHTHALMOLOGY, V123, P2376, DOI 10.1016/j.ophtha.2016.07.032; Huemer J, 2020, BMJ OPEN OPHTHALMOL, V5, DOI 10.1136/bmjophth-2020-000560; Korobelnik JF, 2020, GRAEF ARCH CLIN EXP, V258, P1149, DOI 10.1007/s00417-020-04703-x; Krzystolik MG, 2007, OPHTHALMOLOGY, V114, P1520, DOI 10.1016/j.ophtha.2006.10.055; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Minnesota Department of Public Health, SIT UPD COVID 19; Payne JF, 2017, OPHTHALMOLOGY, V124, P74, DOI 10.1016/j.ophtha.2016.09.021; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Rahimzadeh M, 2020, PHYS, V6, P1; Ramakrishnan MS, 2020, JAMA OPHTHALMOL, V138, P237, DOI 10.1001/jamaophthalmol.2019.4577; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Shmeuli O., 2020, EYE, V4, P1; Wasser Lauren M, 2020, SN Compr Clin Med, V2, P2546, DOI 10.1007/s42399-020-00614-4; Williams G., 2014, REV OPHTHALMOL; Yalamanchili SP, 2020, AM J OPHTHALMOL, V219, P215, DOI 10.1016/j.ajo.2020.06.040; Ziemssen F, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0401-y	26	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247161	10.1371/journal.pone.0247161	http://dx.doi.org/10.1371/journal.pone.0247161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596257	Green Published, gold			2022-12-26	WOS:000620633200052
J	Baker, SA; Kwok, S; Berry, GJ; Montine, TJ				Baker, Steven Andrew; Kwok, Shirley; Berry, Gerald J.; Montine, Thomas J.			Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation	PLOS ONE			English	Article								Mortality due to Covid-19 is highly associated with advanced age, owing in large part to severe lower respiratory tract infection. SARS-CoV-2 utilizes the host ACE2 receptor for infection. Whether ACE2 abundance in the lung contributes to age-associated vulnerability is currently unknown. We set out to characterize the RNA and protein expression profiles of ACE2 in aging human lung in the context of phenotypic parameters likely to affect lung physiology. Examining publicly available RNA sequencing data, we discovered that mechanical ventilation is a critical variable affecting lung ACE2 levels. Therefore, we investigated ACE2 protein abundance in patients either requiring mechanical ventilation or spontaneously breathing. ACE2 distribution and expression were determined in archival lung samples by immunohistochemistry (IHC). Tissues were selected from the specimen inventory at a large teaching hospital collected between 2010-2020. Twelve samples were chosen from patients receiving mechanical ventilation for acute hypoxic respiratory failure (AHRF). Twenty samples were selected from patients not requiring ventilation. We compared samples across age, ranging from 40-83 years old in the ventilated cohort and 14-80 years old in the non-ventilated cohort. Within the alveolated parenchyma, ACE2 expression is predominantly observed in type II pneumocytes (or alveolar type II / AT2 cells) and alveolar macrophages. All 12 samples from our ventilated cohort showed histologic features of diffuse alveolar damage including reactive, proliferating AT2 cells. In these cases, ACE2 was strongly upregulated with age when normalized to lung area (p = 0.004) or cellularity (p = 0.003), associated with prominent expression in AT2 cells. In non-ventilated individuals, AT2 cell reactive changes were not observed and ACE2 expression did not change with age when normalized to lung area (p = 0.231) or cellularity (p = 0.349). In summary, ACE2 expression increases with age in the setting of alveolar damage observed in patients on mechanical ventilation, providing a potential mechanism for higher Covid-19 mortality in the elderly.	[Baker, Steven Andrew; Kwok, Shirley; Berry, Gerald J.; Montine, Thomas J.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	Baker, SA (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	sab73@stanford.edu		Berry, Gerald/0000-0002-6176-2629				Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; AlGhatrif M, 2020, JAMA CARDIOL, V5, P747, DOI 10.1001/jamacardio.2020.1329; Andrade PV, 2014, INFLAMMATION, V37, P486, DOI 10.1007/s10753-013-9762-4; Baker SA., 2020, ANGIOTENSIN CONVERTI, DOI [10.1101/2020.07.05.20140467, DOI 10.1101/2020.07.05.20140467]; Bestle D, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000786; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Braun E, 2019, CLIN TRANSL IMMUNOL, V8, DOI 10.1002/cti2.1073; Bunyavanich S, 2020, JAMA-J AM MED ASSOC, V323, P2427, DOI 10.1001/jama.2020.8707; Cantini F, 2020, DRUGS, V80, P1929, DOI 10.1007/s40265-020-01421-w; Corley M.J., 2020, DNA METHYLATION ANAL, DOI [10.20944/ PREPRINTS202003.0295.V1, DOI 10.20944/PREPRINTS202003.0295.V1, 10.20944/preprints202003.0295.v1]; De Cecco M, 2019, NATURE, V566, P73, DOI 10.1038/s41586-018-0784-9; Dhama K, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101755; Edfors F, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167144; EVANS MJ, 1978, AM REV RESPIR DIS, V118, P787, DOI 10.1164/arrd.1978.118.4.787; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Ferreira PG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02772-x; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Gembardt F, 2005, PEPTIDES, V26, P1270, DOI 10.1016/j.peptides.2005.01.009; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; GTEx Consortium, HARD SCAL DESCR; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Haga S, 2008, P NATL ACAD SCI USA, V105, P7809, DOI 10.1073/pnas.0711241105; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hao SR, 2020, AM J GASTROENTEROL, V115, P1075, DOI 10.14309/ajg.0000000000000717; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuderer NM, 2020, LANCET, V395, P1907, DOI 10.1016/S0140-6736(20)31187-9; Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669; Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x; Li XP, 2008, AM J PHYSIOL-LUNG C, V295, pL178, DOI 10.1152/ajplung.00009.2008; Li YY, 2016, EPIGENOMICS-UK, V8, P1637, DOI 10.2217/epi-2016-0078; Lilly Eli., 2020, BARICITINIB COMBINAT; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lopes RD, 2020, AM HEART J, V226, P49, DOI 10.1016/j.ahj.2020.05.002; Madahar Purnema, 2020, F1000Res, V9, DOI 10.12688/f1000research.20576.1; Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286; Mahmoudi S, 2019, NATURE, V574, P553, DOI 10.1038/s41586-019-1658-5; Mehta N., 2020, JAMA CARDIOL, V5, P1020, DOI [DOI 10.1001/jamacardio.2020.1855, 10.1001/jamacardio.2020.1855]; Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134; MILLER BE, 1990, ENVIRON HEALTH PERSP, V85, P15, DOI 10.2307/3430661; Mueller AL, 2020, AGING-US, V12, P9959, DOI 10.18632/aging.103344; Niazkar HR, 2020, NEUROL SCI, V41, P1667, DOI 10.1007/s10072-020-04486-3; Nin N, 2008, INTENS CARE MED, V34, P923, DOI 10.1007/s00134-007-0960-0; Palaiodimos L, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154262; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; Pinto BGG, 2020, J INFECT DIS, V222, P556, DOI 10.1093/infdis/jiaa332; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Schaller T, 2020, JAMA-J AM MED ASSOC, V323, P2518, DOI 10.1001/jama.2020.8907; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Selby NM, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1963; Sinha IP, 2020, LANCET RESP MED, V8, P446, DOI 10.1016/S2213-2600(20)30152-1; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Smith JC, 2020, DEV CELL, V53, P514, DOI 10.1016/j.devcel.2020.05.012; Spieth PM, 2007, INTENS CARE MED, V33, P308, DOI 10.1007/s00134-006-0428-7; STANLEY MW, 1992, AM J CLIN PATHOL, V97, P669, DOI 10.1093/ajcp/97.5.669; Sultan S, 2020, GASTROENTEROLOGY, V159, P320, DOI 10.1053/j.gastro.2020.05.001; TAKEMURA T, 1981, ACTA PATHOL JAPON, V31, P199; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Touyz Rhian M., 2018, HYPERTENSION, V71, P68, DOI [10.1161/HYPERTENSIONAHA.117.10406, DOI 10.1161/HYPERTENSIONAHA.117.10406]; Uhal BD, 2013, EUR RESPIR J, V42, P198, DOI 10.1183/09031936.00015612; Vuille-Dit-Bille RN, 2015, AMINO ACIDS, V47, P693, DOI 10.1007/s00726-014-1889-6; Wrobel AG, 2020, NAT STRUCT MOL BIOL, V27, P763, DOI 10.1038/s41594-020-0468-7; Xie XD, 2006, LIFE SCI, V78, P2166, DOI 10.1016/j.lfs.2005.09.038; Yu Y., 2020, LANCET RESP MED, V8, P481; Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9; Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134; Zhao QW, 2020, J MED VIROL, V92, P1915, DOI 10.1002/jmv.25889; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou YY, 2020, OPHTHALMOLOGY, V127, P982, DOI 10.1016/j.ophtha.2020.04.028; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035	78	41	42	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247060	10.1371/journal.pone.0247060	http://dx.doi.org/10.1371/journal.pone.0247060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592054	Green Published, Green Submitted, gold			2022-12-26	WOS:000620632800008
J	Seo, N; Park, MS; Choi, JY; Yeom, JS; Kim, MJ; Chung, YE; Ku, NS				Seo, Nieun; Park, Mi-Suk; Choi, Jun Yong; Yeom, Joon-Sup; Kim, Myeong-Jin; Chung, Yong Eun; Ku, Nam Su			A prospective study on the use of ultralow-dose computed tomography with iterative reconstruction for the follow-up of patients liver and renal abscess	PLOS ONE			English	Article								Background Radiation dose reduction is a major concern in patients who undergo computed tomography (CT) to follow liver and renal abscess. Objectives The purpose of this study is to investigate the feasibility of ultralow-dose CT with iterative reconstruction (IR) to follow patients with liver and renal abscess. Methods This prospective study included 18 patients who underwent ultralow-dose CT with IR to follow abscesses (liver abscesses in 10 patients and renal abscesses in 8 patients; ULD group). The control group consisted of 14 patients who underwent follow-up standard-dose CT for liver abscesses during the same period. The objective image noise was evaluated by measuring standard deviation (SD) in the liver and subcutaneous fat to select a specific IR for qualitative analysis. Two radiologists independently evaluated subjective image quality, noise, and diagnostic confidence to evaluate abscess using a five-point Likert scale. Qualitative parameters were compared between the ULD and control groups with the Mann-Whitney U test. Results The mean CT dose index volume and dose length product of standard-dose CT were 8.7 +/- 1.8 mGy and 555.8 +/- 142.8 mGy center dot cm, respectively. Mean dose reduction of ultralow-dose CT was 71.8% compared to standard-dose CT. After measuring SDs, iDose level 5, which showed similar SD to standard-dose CT in both the subcutaneous fat and liver (P = 0.076, and P = 0.124), was selected for qualitative analysis. Ultralow-dose CT showed slightly worse subjective image quality (P < 0.001 for reader 1, and P = 0.005 for reader 2) and noise (P = 0.004 for reader 1, and P = 0.001 for reader 2) than standard-dose CT. However, the diagnostic confidence of ultralow-dose CT for evaluating abscess was comparably excellent to standard-dose CT (P = 0.808 for reader 1, and P = 0.301 for reader 2). Conclusions Ultralow-dose CT with IR can be used in the follow-up of liver and renal abscess with comparable diagnostic confidence.	[Seo, Nieun; Park, Mi-Suk; Kim, Myeong-Jin; Chung, Yong Eun] Yonsei Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Choi, Jun Yong; Yeom, Joon-Sup; Ku, Nam Su] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Choi, Jun Yong; Yeom, Joon-Sup; Ku, Nam Su] Yonsei Univ, AIDS Res Inst, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chung, YE (corresponding author), Yonsei Univ, Dept Radiol, Coll Med, Seoul, South Korea.; Ku, NS (corresponding author), Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Ku, NS (corresponding author), Yonsei Univ, AIDS Res Inst, Coll Med, Seoul, South Korea.	yelv@yuhs.ac; smileboy9@yuhs.ac	Yeom, Joon Sup/Q-5559-2019; Kim, Myeong-Jin/E-1623-2011	Yeom, Joon Sup/0000-0001-8940-7170; Choi, Jun Yong/0000-0002-2775-3315; Ku, Nam Su/0000-0002-9717-4327; Chung, Yong Eun/0000-0003-0811-9578; Kim, Myeong-Jin/0000-0001-7949-5402; Park, Mi-Suk/0000-0001-5817-2444; Seo, Nieun/0000-0001-8745-6454	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Korean Government [NRF-2018R1D1A1B07044998]	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Korean Government	This research was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) which is funded by the Korean Government (NRF-2018R1D1A1B07044998), and the recipient of the funding was Professor Yong Eun Chung. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM EJ, 1991, BAILLIERE CLIN GASTR, V5, P587, DOI 10.1016/0950-3528(91)90044-2; Akinci D, 2005, CARDIOVASC INTER RAD, V28, P744, DOI 10.1007/s00270-004-0281-4; An TJ, 2021, ABDOM RADIOL, V46, P2195, DOI 10.1007/s00261-020-02864-1; BOVA JG, 1985, J UROLOGY, V133, P375, DOI 10.1016/S0022-5347(17)48982-8; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Craig O, 2012, CLIN GASTROENTEROL H, V10, P886, DOI 10.1016/j.cgh.2012.03.014; FRY DE, 1994, SURG CLIN N AM, V74, P693, DOI 10.1016/S0039-6109(16)46337-1; GAZELLE GS, 1994, RADIOL CLIN N AM, V32, P913; Gervais DA, 2004, AM J ROENTGENOL, V182, P463, DOI 10.2214/ajr.182.2.1820463; GERZOF SG, 1981, NEW ENGL J MED, V305, P653, DOI 10.1056/NEJM198109173051201; HALVORSEN RA, 1984, AM J ROENTGENOL, V142, P941, DOI 10.2214/ajr.142.5.941; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Herin E, 2015, EUR RADIOL, V25, P2362, DOI 10.1007/s00330-015-3656-9; Hur J, 2015, ABDOM IMAGING, V40, P2432, DOI 10.1007/s00261-015-0411-2; JOHNSON WC, 1981, ANN SURG, V194, P510, DOI 10.1097/00000658-198110000-00014; Lambert L, 2015, ACTA RADIOL, V56, P517, DOI 10.1177/0284185114533683; LAMBIASE RE, 1992, RADIOLOGY, V184, P167, DOI 10.1148/radiology.184.1.1376932; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laqmani A, 2016, EUR J RADIOL, V85, P1971, DOI 10.1016/j.ejrad.2016.09.001; Larbi A, 2018, DIAGN INTERV IMAG, V99, P311, DOI 10.1016/j.diii.2017.11.003; Lardiere-Deguelte S, 2015, J VISC SURG, V152, P231, DOI 10.1016/j.jviscsurg.2015.01.013; Mehta D., 2013, MED PHYS INT, V1, P147; Mileto A, 2019, RADIOLOGY, V293, P491, DOI 10.1148/radiol.2019191422; Montgomery RS, 1996, CLIN INFECT DIS, V23, P28, DOI 10.1093/clinids/23.1.28; Nelson RC, 2011, J CARDIOVASC COMPUT, V5, P286, DOI 10.1016/j.jcct.2011.07.001; Park M, 2014, INVEST RADIOL, V49, P195, DOI 10.1097/RLI.0000000000000014; PORTER JA, 1985, AM J SURG, V150, P257, DOI 10.1016/0002-9610(85)90132-1; Prasad KN, 2004, BRIT J RADIOL, V77, P97, DOI 10.1259/bjr/88081058; Saini S, 2000, Radiology, V215 Suppl, P173; Scibelli A., 2011, IDOSE4 ITERATIVE REC; Seo N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209754; Song JS, 2015, RADIOL MED, V120, P259, DOI 10.1007/s11547-014-0441-9; Sucha D, 2014, INT J CARDIOVAS IMAG, V30, P785, DOI 10.1007/s10554-014-0379-y; Willemink MJ, 2013, EUR RADIOL, V23, P1632, DOI 10.1007/s00330-012-2764-z; Yoon JH, 2014, J COMPUT ASSIST TOMO, V38, P859, DOI 10.1097/RCT.0000000000000145; Yuki H, 2016, ACTA RADIOL, V57, P295, DOI 10.1177/0284185115575537	36	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246532	10.1371/journal.pone.0246532	http://dx.doi.org/10.1371/journal.pone.0246532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577561	Green Published, gold			2022-12-26	WOS:000620071700015
J	Stratmann, TSM; Dejid, N; Calabrese, JM; Fagan, WF; Fleming, CH; Olson, KA; Mueller, T				Stratmann, Theresa S. M.; Dejid, Nandintsetseg; Calabrese, Justin M.; Fagan, William F.; Fleming, Christen H.; Olson, Kirk A.; Mueller, Thomas			Resource selection of a nomadic ungulate in a dynamic landscape	PLOS ONE			English	Article							DIFFERENCE VEGETATION INDEX; MONGOLIAN GAZELLES; HABITAT SELECTION; MOVEMENT BEHAVIOR; FORAGE QUALITY; WINTER HABITAT; GRAZING LAWNS; SNOW DEPTH; NDVI; MODELS	Nomadic movements are often a consequence of unpredictable resource dynamics. However, how nomadic ungulates select dynamic resources is still understudied. Here we examined resource selection of nomadic Mongolian gazelles (Procapra gutturosa) in the Eastern Steppe of Mongolia. We used daily GPS locations of 33 gazelles tracked up to 3.5 years. We examined selection for forage during the growing season using the Normalized Difference Vegetation Index (NDVI). In winter we examined selection for snow cover which mediates access to forage and drinking water. We studied selection at the population level using resource selection functions (RSFs) as well as on the individual level using step-selection functions (SSFs) at varying spatio-temporal scales from 1 to 10 days. Results from the population and the individual level analyses differed. At the population level we found selection for higher than average NDVI during the growing season. This may indicate selection for areas with more forage cover within the arid steppe landscape. In winter, gazelles selected for intermediate snow cover, which may indicate preference for areas which offer some snow for hydration but not so much as to hinder movement. At the individual level, in both seasons and across scales, we were not able to detect selection in the majority of individuals, but selection was similar to that seen in the RSFs for those individuals showing selection. Difficulty in finding selection with SSFs may indicate that Mongolian gazelles are using a random search strategy to find forage in a landscape with large, homogeneous areas of vegetation. The combination of random searches and landscape characteristics could therefore obscure results at the fine scale of SSFs. The significant results on the broader scale used for the population level RSF highlight that, although individuals show uncoordinated movement trajectories, they ultimately select for similar vegetation and snow cover.	[Stratmann, Theresa S. M.; Mueller, Thomas] Goethe Univ, Dept Biol Sci, Frankfurt, Germany; [Stratmann, Theresa S. M.; Dejid, Nandintsetseg; Mueller, Thomas] Senckenberg Gesell Nat Forsch, Senckenberg Biodivers & Climate Res Ctr, Frankfurt, Germany; [Calabrese, Justin M.] Ctr Adv Syst Understanding, Gorlitz, Germany; [Fagan, William F.; Fleming, Christen H.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Fleming, Christen H.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Olson, Kirk A.] Wildlife Conservat Soc, Mongolia Program, Ulaanbaatar, Mongolia	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University System of Maryland; University of Maryland College Park; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Stratmann, TSM (corresponding author), Goethe Univ, Dept Biol Sci, Frankfurt, Germany.; Stratmann, TSM (corresponding author), Senckenberg Gesell Nat Forsch, Senckenberg Biodivers & Climate Res Ctr, Frankfurt, Germany.	theresastrat@gmail.com	Stratmann, Theresa S. M./AAT-6210-2021	Stratmann, Theresa S. M./0000-0002-7979-6739	MainCampus Stipendium der Stiftung Polytechnischen Gesellschaft Frankfurt am Main; Robert Bosch Foundation; German Federal Ministry of Education and Research (BMBF [01LC1710A, 01LC1820A]; Center of Advanced Systems Understanding (CASUS) - Germany's Federal Ministry of Education and Research (BMBF); Saxon Ministry for Science, Culture and Tourism (SMWK); NSF [IIBR 1915347]	MainCampus Stipendium der Stiftung Polytechnischen Gesellschaft Frankfurt am Main; Robert Bosch Foundation; German Federal Ministry of Education and Research (BMBF(Federal Ministry of Education & Research (BMBF)); Center of Advanced Systems Understanding (CASUS) - Germany's Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Saxon Ministry for Science, Culture and Tourism (SMWK); NSF(National Science Foundation (NSF))	TSMS was funded by the MainCampus Stipendium der Stiftung Polytechnischen Gesellschaft Frankfurt am Main. TSMS, TM, and ND were funded by the Robert Bosch Foundation. TSMS, TM, and ND were funded by the German Federal Ministry of Education and Research (BMBF, 01LC1710A and 01LC1820A). JMC was partially funded by the Center of Advanced Systems Understanding (CASUS) which is financed by Germany's Federal Ministry of Education and Research (BMBF) and by the Saxon Ministry for Science, Culture and Tourism (SMWK) with tax funds on the basis of the budget approved by the Saxon State Parliament. JMC, CHF, and WFF were supported by NSF Grant IIBR 1915347. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikens EO, 2020, CURR BIOL, V30, P3444, DOI 10.1016/j.cub.2020.06.032; Aikens EO, 2017, ECOL LETT, V20, P741, DOI 10.1111/ele.12772; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Armstrong JB, 2016, ECOLOGY, V97, P1099, DOI 10.1890/15-0554.1; Avgar T, 2017, ECOL EVOL, V7, P5322, DOI 10.1002/ece3.3122; Avgar T, 2016, METHODS ECOL EVOL, V7, P619, DOI 10.1111/2041-210X.12528; Avgar T, 2013, J ANIM ECOL, V82, P96, DOI 10.1111/j.1365-2656.2012.02035.x; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berger J, 2010, ORYX, V44, P512, DOI 10.1017/S003060531000058X; Bergman CM, 2001, J ANIM ECOL, V70, P289, DOI 10.1046/j.1365-2656.2001.00496.x; Bischof R, 2012, AM NAT, V180, P407, DOI 10.1086/667590; Bivand R., 2020, **DATA OBJECT**; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Courbin N, 2017, BEHAV ECOL, V28, P1037, DOI 10.1093/beheco/arx062; Couzin ID, 2009, CURR BIOL, V19, pR633, DOI 10.1016/j.cub.2009.05.034; Detsch F., 2019, **DATA OBJECT**; Drent R., 1981, Verhandlungen der Ornithologischen Gesellschaft in Bayern, V23, P239; Dye DG, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016384; Fernandez-Gimenez ME, 1999, J APPL ECOL, V36, P871, DOI 10.1046/j.1365-2664.1999.00447.x; Fernandez-Gimenez ME, 1999, GEOGR REV, V89, P315, DOI 10.2307/216154; Fithian W, 2013, ANN APPL STAT, V7, P1917, DOI 10.1214/13-AOAS667; Fleming CH, 2014, AM NAT, V183, pE154, DOI 10.1086/675504; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Fryxell JM, 2004, ECOLOGY, V85, P2429, DOI 10.1890/04-0147; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; Garroutte EL, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8050404; Gilbert SL, 2017, J MAMMAL, V98, P246, DOI 10.1093/jmammal/gyw167; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hamel S, 2009, J APPL ECOL, V46, P582, DOI 10.1111/j.1365-2664.2009.01643.x; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; HOBBS NT, 1988, AM NAT, V131, P760, DOI 10.1086/284818; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; Ito TY, 2018, MAMM BIOL, V93, P13, DOI 10.1016/j.mambio.2018.07.006; Ito TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056995; IUCN SSC Antelope Specialist Group, 2016, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-3.RLTS.T18232A50193126.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T18232A50193126.EN]; Jiang Zhaowen, 1998, Mammal Study, V23, P63, DOI 10.3106/mammalstudy.23.63; Jiang ZW, 2002, J WILDLIFE MANAGE, V66, P40, DOI 10.2307/3802869; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Johnson HE, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2461; Jones PF, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2782; Kaczensky P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028057; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kawamura K, 2005, INT J REMOTE SENS, V26, P1423, DOI 10.1080/01431160512331326783; Kawamura Kensuke, 2005, Grassland Science, V51, P33, DOI 10.1111/j.1744-697X.2005.00006.x; Leclerc M, 2016, OECOLOGIA, V180, P697, DOI 10.1007/s00442-015-3500-6; Lesmerises R, 2017, OECOLOGIA, V185, P415, DOI 10.1007/s00442-017-3939-8; Lin H, 2002, MODELING SURVIVAL DA, V44, P85; Lukacs PM, 2018, J WILDLIFE MANAGE, V82, P698, DOI 10.1002/jwmg.21438; Luo ZH, 2014, ZOOL SCI, V31, P20, DOI 10.2108/zsj.31.20; Manly B.F.J., 2002, RESOURCE SELECTION A; Martinez-Garcia R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.248106; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; MCNAUGHTON SJ, 1986, AM NAT, V128, P937, DOI 10.1086/284615; Merkle JA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0456; Montgomery RA, 2018, ECOL EVOL, V8, P10893, DOI 10.1002/ece3.4554; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Mueller T, 2008, OIKOS, V117, P654, DOI 10.1111/j.0030-1299.2008.16291.x; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; Mueller T, 2011, GLOBAL ECOL BIOGEOGR, V20, P683, DOI 10.1111/j.1466-8238.2010.00638.x; Muff S, 2020, J ANIM ECOL, V89, P80, DOI 10.1111/1365-2656.13087; Mumma MA, 2017, ECOL EVOL, V7, P10266, DOI 10.1002/ece3.3563; Muntifering JR, 2019, ENDANGER SPECIES RES, V38, P159, DOI 10.3354/esr00941; Mysterud A, 1999, WILDLIFE SOC B, V27, P385; Mysterud A, 1997, WILDLIFE BIOL, V3, P27, DOI 10.2981/wlb.1997.004; Nandintsetseg D, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2924; Nandintsetseg D, 2019, J APPL ECOL, V56, P1916, DOI 10.1111/1365-2664.13380; Nanzad L, 2019, J ARID ENVIRON, V164, P69, DOI 10.1016/j.jaridenv.2019.01.019; Olson KA, 2005, ORYX, V39, P164, DOI 10.1017/S0030605305000402; Olson KA, 2011, CONSERV LETT, V4, P304, DOI 10.1111/j.1755-263X.2011.00180.x; Olson KA, 2010, RANGELAND ECOL MANAG, V63, P593, DOI 10.2111/REM-D-09-00122.1; Olson KA, 2010, J ARID ENVIRON, V74, P1435, DOI 10.1016/j.jaridenv.2010.05.022; Owen M, 1980, WILD GEESE WORLD THE; PARKER KL, 1984, J WILDLIFE MANAGE, V48, P474, DOI 10.2307/3801180; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; R Core Team, 2020, R LANG ENV STAT COMP; Rao MP, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/7/074012; Reinking AK, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2722; Robinson BG, 2012, OIKOS, V121, P28, DOI 10.1111/j.1600-0706.2011.19408.x; Ryan SJ, 2012, J WILDLIFE MANAGE, V76, P1499, DOI 10.1002/jwmg.407; Sawyer H, 2011, J ANIM ECOL, V80, P1078, DOI 10.1111/j.1365-2656.2011.01845.x; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Squires JR, 2013, BIOL CONSERV, V157, P187, DOI 10.1016/j.biocon.2012.07.018; Talbot LM., 1963, E AFRICA, P3; Teitelbaum CS, 2019, TRENDS ECOL EVOL, V34, P569, DOI 10.1016/j.tree.2019.02.005; Therneau T., 2020, **DATA OBJECT**; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; Tsalyuk M, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1348; van Beest FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065972; Van Soest PJ, 1982, NUTR ECOLOGY RUMINAN; Vandandorj S, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-016-6380-0; Wilmshurst JF, 1999, CAN J ZOOL, V77, P1223, DOI 10.1139/cjz-77-8-1223; WILMSHURST JF, 1995, BEHAV ECOL, V6, P209, DOI 10.1093/beheco/6.2.209; Zeller KA, 2019, MOV ECOL, V7, DOI 10.1186/s40462-019-0166-4	97	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246809	10.1371/journal.pone.0246809	http://dx.doi.org/10.1371/journal.pone.0246809			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577613	Green Published, gold			2022-12-26	WOS:000620071700019
J	Gan, SF; Rozhon, W; Varga, E; Halder, J; Berthiller, F; Poppenberger, B				Gan, Sufu; Rozhon, Wilfried; Varga, Elisabeth; Halder, Jyotirmoy; Berthiller, Franz; Poppenberger, Brigitte			The acyltransferase PMAT1 malonylates brassinolide glucoside	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRASSINOSTEROID LEVELS; GENE-EXPRESSION; ARABIDOPSIS; IDENTIFICATION; DETOXIFICATION; HOMEOSTASIS; XENOBIOTICS; METABOLISM; PROTEIN; GROWTH	Brassinosteroids (BRs) are steroid hormones of plants that coordinate fundamental growth and development processes. Their homeostasis is controlled by diverse means, including glucosylation of the bioactive BR brassinolide (BL), which is catalyzed by the UDP-glycosyltransferases (UGTs) UGT73C5 and UGT73C6 and occurs mainly at the C-23 position. Additional evidence had suggested that the resultant BL-23-O-glucoside (BL-23-O-Glc) can be malonylated, but the physiological significance of and enzyme required for this reaction had remained unknown. Here, we show that in Arabidopsis thaliana malonylation of BL-23-O-Glc is catalyzed by the acyltransferase phenolic glucoside malonyl-transferase 1 (PMAT1), which is also known to malonylate phenolic glucosides and lipid amides. Loss of PMAT1 abolished BL-23-O-malonylglucoside formation and enriched BL-23-O-Glc, showing that the enzyme acts on the glucoside. An over-expression of PMAT1 in plants where UGT73C6 was also overexpressed, and thus, BL-23-O-Glc formation was promoted, enhanced the symptoms of BR-deficiency of UGT73-C6oe plants, providing evidence that PMAT1 contributes to BL inactivation. Based on these results, a model is proposed in which PMAT1 acts in the conversion of both endogenous and xenobiotic glucosides to adjust metabolic homeostasis in spatial and temporal modes.	[Gan, Sufu; Rozhon, Wilfried; Halder, Jyotirmoy; Poppenberger, Brigitte] Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Biotechnol Hort Crops, Freising Weihenstephan, Germany; [Varga, Elisabeth; Berthiller, Franz] Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Inst Bioanalyt & Agrometabol, Vienna, Tulln, Austria	Technical University of Munich; University of Natural Resources & Life Sciences, Vienna	Poppenberger, B (corresponding author), Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Biotechnol Hort Crops, Freising Weihenstephan, Germany.	brigitte.poppenberger@wzw.tum.de	Rozhon, Wilfried/AAG-3162-2022; Rozhon, Wilfried/AFK-4445-2022	Rozhon, Wilfried/0000-0003-0659-0593; Rozhon, Wilfried/0000-0003-0659-0593; Poppenberger, Brigitte/0000-0003-1020-0500; Berthiller, Franz/0000-0001-5883-2879; Varga, Elisabeth/0000-0001-6046-3259	China Scholarship Council (CSC fellowship)	China Scholarship Council (CSC fellowship)(China Scholarship Council)	We thank Yanhai Yin for the BES1 antibody, Shozo Fujioka for the BL-O-glucosides used as analytical references and the Nottingham Arabidopsis stock center for the T-DNA insertion lines. Annette Beck, Maria Obermaier, Shafikur Rhaman, and Irene Ziegler are thanked for technical assistance and Tobias Sieberer for valuable discussions. This work was supported by the China Scholarship Council (CSC fellowship to S. G.). S. G. was a member of the TUM graduate school.	Bancos S, 2002, PLANT PHYSIOL, V130, P504, DOI 10.1104/pp.005439; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse Steven D, 2011, Arabidopsis Book, V9, pe0151, DOI 10.1199/tab.0151; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; D'Auria JC, 2007, FEBS LETT, V581, P872, DOI 10.1016/j.febslet.2007.01.060; Ervin SM, 2019, J BIOL CHEM, V294, P18586, DOI 10.1074/jbc.RA119.010950; Gan SF, 2020, PLANT PHYSIOL, V184, P23, DOI 10.1104/pp.20.00338; Goda H, 2002, PLANT PHYSIOL, V130, P1319, DOI 10.1104/pp.011254; Hoyerova K, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00741; Husar S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-51; Khan BR, 2016, J BIOL CHEM, V291, P27112, DOI 10.1074/jbc.M116.751065; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Luo J, 2007, PLANT J, V50, P678, DOI 10.1111/j.1365-313X.2007.03079.x; Ma YL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113643; Marsolais F, 2007, PLANTA, V225, P1233, DOI 10.1007/s00425-006-0413-y; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Raftogianis R, 2000, J Natl Cancer Inst Monogr, P113; Regan SL, 2010, BIOPHARM DRUG DISPOS, V31, P367, DOI 10.1002/bdd.720; Roh H, 2012, PLANT PHYSIOL, V159, P696, DOI 10.1104/pp.112.197202; Rozhon W, 2010, PLANT J, V62, P215, DOI 10.1111/j.1365-313X.2010.04145.x; SANDERMANN H, 1994, PHARMACOGENETICS, V4, P225, DOI 10.1097/00008571-199410000-00001; Schiffer L, 2019, J STEROID BIOCHEM, V194, DOI 10.1016/j.jsbmb.2019.105439; Schneider K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046805; Singh AP, 2015, J EXP BOT, V66, P1123, DOI 10.1093/jxb/erv026; Suzuki H, 2002, PLANT PHYSIOL, V130, P2142, DOI 10.1104/pp.010447; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Taguchi G, 2010, PLANT J, V63, P1031, DOI 10.1111/j.1365-313X.2010.04298.x; Tanaka K, 2005, PLANT PHYSIOL, V138, P1117, DOI 10.1104/pp.104.058040; Tuominen LK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-236; Unterholzner SJ, 2017, METHODS MOL BIOL, V1564, P133, DOI 10.1007/978-1-4939-6813-8_11; Van de Poel B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00640; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Yu XH, 2009, PLANT MOL BIOL, V70, P421, DOI 10.1007/s11103-009-9482-1	40	0	0	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100424	10.1016/j.jbc.2021.100424	http://dx.doi.org/10.1016/j.jbc.2021.100424			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33600798	gold, Green Published			2022-12-26	WOS:000672866400398
J	Shen, H; He, YC; Wang, N; Fritch, MR; Li, XY; Lin, H; Tuan, RS				Shen, He; He, Yuchen; Wang, Ning; Fritch, Madalyn R.; Li, Xinyu; Lin, Hang; Tuan, Rocky S.			Enhancing the potential of aged human articular chondrocytes for high-quality cartilage regeneration	FASEB JOURNAL			English	Article						cell shape; cellular rejuvenation; chondrocytes; ERK1; 2; RhoA; suspension cell culture	SENESCENT CELLS; ACTIN CYTOSKELETON; PROTEIN-KINASE; N-CADHERIN; OSTEOARTHRITIS; DIFFERENTIATION; CHONDROGENESIS; IMPLANTATION; MORPHOLOGY; PHENOTYPE	Autologous chondrocyte implantation (ACI) is a regenerative procedure used to treat focal articular cartilage defects in knee joints. However, age has been considered as a limiting factor and ACI is not recommended for patients older than 40-50 years of age. One reason for this may be due to the reduced capacity of aged chondrocytes in generating new cartilage. Currently, the underlying mechanism contributing to aging-associated functional decline in chondrocytes is not clear and no proven approach exists to reverse chondrocyte aging. Given that chondrocytes in healthy hyaline cartilage typically display a spherical shape, believed to be essential for chondrocyte phenotype stability, we hypothesize that maintaining aged chondrocytes in a suspension culture that forces the cells to adopt a round morphology may help to "rejuvenate" them to a younger state, thus, leading to enhanced cartilage regeneration. Chondrocytes isolated from aged donors displayed reduced proliferation potential and impaired capacity in generating hyaline cartilage, compared to cells isolated from young donors, indicated by increased hypertrophy and cellular senescence. To test our hypothesis, the "old" chondrocytes were seeded as a suspension onto an agarose-based substratum, where they maintained a round morphology. After the 3-day suspension culture, aged chondrocytes displayed enhanced replicative capacity, compared to those grown adherent to tissue culture plastic. Moreover, chondrocytes subjected to suspension culture formed new cartilage in vitro with higher quality and quantity, with enhanced cartilage matrix deposition, concomitant with lower levels of hypertrophy and cellular senescence markers. Mechanistic analysis suggested the involvement of the RhoA and ERK1/2 signaling pathways in the "rejuvenation" process. In summary, our study presents a robust and straightforward method to enhance the function of aged human chondrocytes, which can be conveniently used to generate a large number of high-quality chondrocytes for ACI application in the elderly.	[Shen, He; He, Yuchen; Wang, Ning; Fritch, Madalyn R.; Li, Xinyu; Lin, Hang; Tuan, Rocky S.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, Pittsburgh, PA 15261 USA; [Lin, Hang; Tuan, Rocky S.] Univ Pittsburgh, McGowan Inst Regenerat Med, Sch Med, Pittsburgh, PA USA; [Lin, Hang; Tuan, Rocky S.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA; [Tuan, Rocky S.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese University of Hong Kong	Lin, H (corresponding author), Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, Pittsburgh, PA 15261 USA.; Tuan, RS (corresponding author), Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China.	hal46@pitt.edu; tuanr@cuhk.edu.hk	Lin, Hang/AFO-8482-2022; Lin, Hang/D-3003-2012	Lin, Hang/0000-0002-0781-6630; Tuan, Rocky/0000-0001-6067-6705	National Institutes of Health [R21AG056819, P30AG024827, UL1TR001857]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: R21AG056819, P30AG024827 and UL1TR001857	Appleton CTG, 2010, LAB INVEST, V90, P20, DOI 10.1038/labinvest.2009.111; ARCHER CW, 1982, CELL DIFFER DEV, V11, P245, DOI 10.1016/0045-6039(82)90072-0; Ashraf S, 2016, OSTEOARTHR CARTILAGE, V24, P196, DOI 10.1016/j.joca.2015.07.008; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110; Binette F, 1998, J ORTHOP RES, V16, P207, DOI 10.1002/jor.1100160208; Blain EJ, 2009, INT J EXP PATHOL, V90, P1, DOI 10.1111/j.1365-2613.2008.00625.x; Bobacz K, 2004, ANN RHEUM DIS, V63, P1618, DOI 10.1136/ard.2002.002162; Bobick BE, 2010, J CELL PHYSIOL, V224, P178, DOI 10.1002/jcp.22120; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Chen ZJ, 2015, J BONE MINER RES, V30, P765, DOI 10.1002/jbmr.2409; Coricor G, 2016, SCI REP-UK, V6, DOI 10.1038/srep38616; Davidson ENB, 2005, ARTHRITIS RES THER, V7, pR1338, DOI 10.1186/ar1833; Djouad F, 2009, TISSUE ENG PT A, V15, P2825, DOI [10.1089/ten.tea.2008.0663, 10.1089/ten.TEA.2008.0663]; DOMINICE J, 1987, MECH AGEING DEV, V37, P231, DOI 10.1016/0047-6374(86)90040-0; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Gegg C, 2020, TISSUE ENG PT A, V26, P130, DOI [10.1089/ten.TEA.2019.0068, 10.1089/ten.tea.2019.0068]; Giannoni P, 2005, OSTEOARTHR CARTILAGE, V13, P589, DOI 10.1016/j.joca.2005.02.015; Hall AC, 2019, CURR RHEUMATOL REP, V21, DOI 10.1007/s11926-019-0837-6; Haudenschild Dominik R., 2009, Molecular & Cellular Biomechanics, V6, P135; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; JACENKO O, 1995, DEV DYNAM, V202, P27, DOI 10.1002/aja.1002020104; Jeon OH, 2018, J CLIN INVEST, V128, P1229, DOI 10.1172/JCI95147; Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324; Jha SK, 2017, BBA-MOL BASIS DIS, V1863, P1132, DOI 10.1016/j.bbadis.2016.06.015; Jones Deryk G, 2007, Instr Course Lect, V56, P429; Karim A, 2018, J ANAT, V232, P686, DOI 10.1111/joa.12768; Kim MJ, 2012, BIOCHEM BIOPH RES CO, V418, P500, DOI 10.1016/j.bbrc.2012.01.053; Kon E, 2011, AM J SPORT MED, V39, P1668, DOI 10.1177/0363546511404675; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Liu YW, 2019, BIOMATERIALS, V218, DOI 10.1016/j.biomaterials.2019.119336; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P971, DOI 10.1016/j.joca.2009.03.002; Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157; Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parreno J, 2018, J ORTHOP RES, V36, P2392, DOI 10.1002/jor.23896; Rosenberger RE, 2008, AM J SPORT MED, V36, P2336, DOI 10.1177/0363546508322888; Rottmar M, 2014, EXP CELL RES, V320, P175, DOI 10.1016/j.yexcr.2013.11.004; Sasazaki Y, 2008, RHEUMATOLOGY, V47, P1641, DOI 10.1093/rheumatology/ken341; Sessa A, 2019, JBJS ESSENT SURG TEC, V9, DOI 10.2106/JBJS.ST.18.00089; Shen H, 2018, J MATER CHEM B, V6, P908, DOI 10.1039/c7tb02172k; Shortkroff S, 1996, BIOMATERIALS, V17, P147, DOI 10.1016/0142-9612(96)85759-0; Singh P, 2019, ANN NY ACAD SCI, V1442, P17, DOI 10.1111/nyas.13930; Smeriglio P, 2015, JOVE-J VIS EXP, DOI 10.3791/53085; Solursh M., 1984, CARTILAGE DEV DIFFER, V2, P121; Stokes DG, 2002, ARTHRITIS RHEUM, V46, P404, DOI 10.1002/art.10106; Tran-Khanh N, 2010, CONNECT TISSUE RES, V51, P216, DOI 10.3109/03008200903281683; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; van der Kraan PA, 2008, AGEING RES REV, V7, P106, DOI 10.1016/j.arr.2007.10.001; Vavken P, 2010, OSTEOARTHR CARTILAGE, V18, P857, DOI 10.1016/j.joca.2010.03.005; Verbruggen G, 2000, OSTEOARTHR CARTILAGE, V8, P170, DOI 10.1053/joca.1999.0287; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110; Xu M, 2017, J GERONTOL A-BIOL, V72, P780, DOI 10.1093/gerona/glw154; Yoon YM, 2002, J BIOL CHEM, V277, P8412, DOI 10.1074/jbc.M110608200; ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115; Zhou HW, 2004, RHEUMATOLOGY, V43, P555, DOI 10.1093/rheumatology/keh127	57	3	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21410	10.1096/fj.202002386R	http://dx.doi.org/10.1096/fj.202002386R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33617078	Green Accepted			2022-12-26	WOS:000629576700023
J	Barnes, JD; Guerrero, MD				Barnes, Joel D.; Guerrero, Michelle D.			An R Package for Computing Canadian Assessment of Physical Literacy (CAPL) scores and interpretations from raw data	PLOS ONE			English	Article								The Canadian Assessment of Physical Literacy (CAPL) is the first comprehensive protocol designed to assess a child's level of physical literacy. Current approaches to analyzing CAPL-2 raw data are tedious, inefficient, and/or can lead to computation errors. In this paper we introduce the capl R package (open source), designed to compute and visualize CAPL-2 scores and interpretations from raw data. The capl package takes advantage of the R environment to provide users with a fast, efficient, and reliable approach to analyzing their CAPL-2 raw data and a "quiet" user experience, whereby "noisy" error messages are suppressed via validation. We begin by discussing several preparatory steps that are required prior to using the capl package. These steps include preparing, formatting, and importing CAPL-2 raw data. We then use demo data to show that computing the CAPL-2 scores and interpretations is as simple as executing one line of code. This one line of code uses the main function in the capl package (get_capl()) to compute 40 variables within a matter of seconds. Next, we showcase the helper functions that are called within the main function to compute individual variables and scores for each test element within the four domains as well as an overall physical literacy score. Finally, we show how to visualize CAPL-2 results using the ggplot2 R package.	[Guerrero, Michelle D.] Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario	Guerrero, MD (corresponding author), Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada.	mguerrero@cheo.on.ca						Corbin CB, 2016, RES Q EXERCISE SPORT, V87, P14, DOI 10.1080/02701367.2016.1124722; Edwards LC, 2017, SPORTS MED, V47, P113, DOI 10.1007/s40279-016-0560-7; Li MH, 2020, J SPORT SCI, V38, P2850, DOI 10.1080/02640414.2020.1803016; Longmuir PE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5902-y; Longmuir PE, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2106-6; Robinson DB, 2017, MEAS PHYS EDUC EXERC, V21, P40, DOI [10.1080/1091367x.2016.1249793, 10.1080/1091367X.2016.1249793]; Tremblay M., 2010, PHYS HLTH ED J, V76, P26; Tremblay MS, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5903-x; Tremblay MS, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5891-x	9	1	1	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0243841	10.1371/journal.pone.0243841	http://dx.doi.org/10.1371/journal.pone.0243841			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617576	gold, Green Published			2022-12-26	WOS:000623082400035
J	Buluba, SE; Mawi, NE; Tarimo, EAM				Buluba, Salome E.; Mawi, Neema E.; Tarimo, Edith A. M.			Clients' satisfaction with HIV care and treatment centres in Dar es Salaam, Tanzania: A cross-sectional study	PLOS ONE			English	Article								Background HIV is a major global public health challenge, claiming the lives of over 32 million people so far. The satisfaction of HIV-affected clients with the quality of their HIV services at treatment centres is crucial for quality improvement. This article assesses clients' satisfaction with different aspects of the overall care experience and seeks to determine if the type of health facility ownership is a predictor of satisfaction. Methods A cross-sectional study involving 430 respondents was conducted between September and October 2019. Purposeful and convenient sampling techniques were used to select health facilities and potential respondents, respectively. A pre-tested, interviewer-administered questionnaire was used to collect data. Binary logistic regression was used to assess the association between type of health facility and clients' satisfaction based on the six assessed aspects of care, and p<0.05 was considered statistically significant. Results The general clients' satisfaction with HIV/AIDS services at care and treatment centres was 92.3%. Respondents from public health facilities were most satisfied with privacy and confidentiality (100%), physical environment (100%), counseling (99.5%) and drug availability (99.5%); respondents from private health facilities were most satisfied with the time spent in the facility (95.9%); while respondents from faith-based health facilities were most satisfied with staff-patient communication (99.2%). However, after adjusting for confounders, only one aspect of care, that of "time spent in the facility," showed significant association with the type of health facility. Conclusion Generally, clients' satisfaction with HIV/AIDS services at care and treatment centres in the Ubungo District, Dar es Salaam was high. This finding should encourage health care providers to maintain high-quality services to sustain clients' satisfaction.	[Buluba, Salome E.] Muhimbili Univ Hlth & Allied Sci, Sch Nursing, Dept Clin Nursing, Dar Es Salaam, Tanzania; [Mawi, Neema E.; Tarimo, Edith A. M.] Muhimbili Univ Hlth & Allied Sci, Sch Nursing, Dept Nursing Management, Dar Es Salaam, Tanzania; [Buluba, Salome E.; Mawi, Neema E.; Tarimo, Edith A. M.] Muhimbili Univ Hlth & Allied Sci, Sch Nursing, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences	Buluba, SE (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Nursing, Dept Clin Nursing, Dar Es Salaam, Tanzania.; Buluba, SE (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Nursing, Dar Es Salaam, Tanzania.	bulubasalome.sb@gmail.com			Swedish International Development Agency (SIDA) under Directorate of Research and Publications at Muhimbili University of Health and Allied Sciences [DE.14/298/01]	Swedish International Development Agency (SIDA) under Directorate of Research and Publications at Muhimbili University of Health and Allied Sciences	The study was supported by a small grant from Swedish International Development Agency (SIDA) under Directorate of Research and Publications at Muhimbili University of Health and Allied Sciences 2019/2020 (Ref. No. DE.14/298/01) and the recipient was SEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe TB, 2016, PATIENT PREFER ADHER, V10, P2073, DOI 10.2147/PPA.S114720; Adekanye A O, 2013, Niger J Med, V22, P218; Anosike A, 2019, PUBLIC HEALTH, V167, P50, DOI 10.1016/j.puhe.2018.11.012; Avert, HIV AIDS TANZ GLOB I; Azuike E. C., 2017, Epidemiology: Open Access, V7, P289, DOI 10.4172/2161-1165.1000289; Azuike EC., 2017, INT J ADV MED SCI BI, V3; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046680; Bhutto AQ, 2017, E MEDITERR HEALTH J, V23, P13, DOI 10.26719/2017.23.1.13; Center for Disease Control and Prevention, CLIN INFECT DIS; Chimbindi N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-32; Dapaah JM, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0123-3; Devnani M, 2012, AIDS CARE, V24, P100, DOI 10.1080/09540121.2011.592816; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, UNAIDS DAT 2017; Kagashe GAB., 2011, AFR HEALTH SCI, V11, DOI [10.4314/ahs.v11i3.70072, DOI 10.4314/AHS.V11I3.70072]; Kielmann A., 1995, ASSESSING DISTRICT H; Kwesiga D., 2013, J AIDS CLIN RES, V4, DOI [10.4172/2155-6113.1000220, DOI 10.4172/2155-6113.1000220]; Mfinanga S. G., 2008, BMC Health Services Research, V8; Miller JS, 2014, AIDS CARE, V26, P1150, DOI 10.1080/09540121.2014.882487; Ministry of Health and Social Welfare; National AIDS Control Programme, IMPL HIV AIDS CAR TR; Mselle LT, 2017, QUAL HEALTH RES, V27, P1792, DOI 10.1177/1049732317717695; Naing Nyi Nyi, 2003, Malays J Med Sci, V10, P84; *NAT AIDS CONTR PR, NAT GUID MAN HIV AID; National AIDS Control Programme (NACP), 2019, OP MAN COMP DIFF DEL; NBS, TANZ DEM HLTH SURV 2; Ndayongeje J, 2017, INT Q COMMUNITY HEAL, V37, P113, DOI [10.1177/0272684X17701264, 10.1177/0272684x17701264]; Oche MO, 2013, J AIDS HIV RES, V5, P328, DOI [10.5897/JAHR2013.0247, DOI 10.5897/JAHR2013.0247]; Owoaje EE, 2013, PREV MED, V1, P11, DOI [10.12691/jpm-1-3-1, DOI 10.12691/JPM-1-3-1]; PEPFAR, US PRESIDENTS EMERGE; Perez-Salgado D, 2015, REV INVEST CLIN, V67, P80; Sargent J, PRIV SECT INV HIV SE; Shet A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-277; Tanzania Commission for AIDS (TACAIDS), NAT HIV AIDS RESP RE; Tanzania Commission for AIDS (TACAIDS) International; Zanzibar AIDS Commission (ZAC), TANZ HIV IMP SURV PO; Tanzania Commission for AIDS (TACAIDS) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) ICF International ZAC (ZAC), TANZ HIV AIDS MAL IN; Umeokonkwo CD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206499; United Republic of Tanzania: National Bureau of Statistics, 2013, 2012 POP HOUS CENS P; World Health Organization, HIV AIDS; Wung BA, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1512-5	39	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247421	10.1371/journal.pone.0247421	http://dx.doi.org/10.1371/journal.pone.0247421			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617557	gold, Green Published			2022-12-26	WOS:000623082400012
J	Gottschalk, C; Zhang, SW; Schwallier, P; Rogers, S; Bukovac, MJ; van Nocker, S				Gottschalk, Chris; Zhang, Songwen; Schwallier, Phil; Rogers, Sean; Bukovac, Martin J.; van Nocker, Steve			Genetic mechanisms associated with floral initiation and the repressive effect of fruit on flowering in apple (Malus x domestica Borkh)	PLOS ONE			English	Article							RNA-SEQ EXPERIMENTS; EXPRESSION ANALYSIS; BIENNIAL BEARING; OVER-EXPRESSION; QUALITY; GENOME; GROWTH; RECONSTRUCTION; GENERATION; GIBBERELLINS	Many apple cultivars are subject to biennial fluctuations in flowering and fruiting. It is believed that this phenomenon is caused by a repressive effect of developing fruit on the initiation of flowers in the apex of proximal bourse shoots. However, the genetic pathways of floral initiation are incompletely described in apple, and the biological nature of floral repression by fruit is currently unknown. In this study, we characterized the transcriptional landscape of bourse shoot apices in the biennial cultivar, 'Honeycrisp', during the period of floral initiation, in trees bearing a high fruit load and in trees without fruit. Trees with high fruit load produced almost exclusively vegetative growth in the subsequent year, whereas the trees without fruit produced flowers on the majority of the potential flowering nodes. Using RNA-based sequence data, we documented gene expression at high resolution, identifying >11,000 transcripts that had not been previously annotated, and characterized expression profiles associated with vegetative growth and flowering. We also conducted a census of genes related to known flowering genes, organized the phylogenetic and syntenic relationships of these genes, and compared expression among homeologs. Several genes closely related to AP1, FT, FUL, LFY, and SPLs were more strongly expressed in apices from non-bearing, floral-determined trees, consistent with their presumed floral-promotive roles. In contrast, a homolog of TFL1 exhibited strong and persistent up-regulation only in apices from bearing, vegetative-determined trees, suggesting a role in floral repression. Additionally, we identified four GIBBERELLIC ACID (GA) 2 OXIDASE genes that were expressed to relatively high levels in apices from bearing trees. These results define the flowering-related transcriptional landscape in apple, and strongly support previous studies implicating both gibberellins and TFL1 as key components in repression of flowering by fruit.	[Gottschalk, Chris; Zhang, Songwen; Rogers, Sean; Bukovac, Martin J.; van Nocker, Steve] Michigan State Univ, Dept Hort, Plant & Soil Sci Bldg, E Lansing, MI 48824 USA; [Schwallier, Phil] Michigan State Univ Extens, E Lansing, MI USA	Michigan State University; Michigan State University	van Nocker, S (corresponding author), Michigan State Univ, Dept Hort, Plant & Soil Sci Bldg, E Lansing, MI 48824 USA.	vannocke@msu.edu		Gottschalk, Christopher/0000-0003-4584-0014	Michigan Apple Committee [MAC18-014]; Michigan State University AgBioResearch [GR18068]	Michigan Apple Committee; Michigan State University AgBioResearch	This work was supported by grants from the Michigan Apple Committee (https://www.michiganapples.com/) (Grant #: MAC18-014) and Michigan State University AgBioResearch (https://www.canr.msu.edu/research/) (Grant #: GR18068) to S.v.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Aronesty E, EA UTILS COMMAND LIN; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Butler O, 1917, B TORREY BOT CLUB, V44, P85, DOI DOI 10.2307/2479535; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cevik V, 2010, TREE GENET GENOMES, V6, P271, DOI 10.1007/s11295-009-0247-4; Daccord N, 2017, NAT GENET, V49, P1099, DOI 10.1038/ng.3886; Dadpour MR, 2011, BIOL PLANTARUM, V55, P243, DOI 10.1007/s10535-011-0035-5; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dennis F. G. Jr., 1999, HortTechnology, V9, P317; Embree CG, 2007, HORTSCIENCE, V42, P1622, DOI 10.21273/HORTSCI.42.7.1622; Flachowsky H, 2012, TREE PHYSIOL, V32, P1288, DOI 10.1093/treephys/tps080; Foster T, 2003, ANN BOT-LONDON, V92, P199, DOI 10.1093/aob/mcg120; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Goff LA, 2013, CUMMERBUND ANAL EXPL; Goslin K, 2017, PLANT PHYSIOL, V174, P1097, DOI 10.1104/pp.17.00098; Guitton B, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0739-y; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Haberman A, 2016, PLANT J, V87, P161, DOI 10.1111/tpj.13190; Hattasch C, 2008, TREE PHYSIOL, V28, P1459, DOI 10.1093/treephys/28.10.1459; Hoover E, 2004, J HORTIC SCI BIOTECH, V79, P981, DOI 10.1080/14620316.2004.11511877; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Jonkers H., 1979, Scientia Horticulturae, V11, P303, DOI 10.1016/0304-4238(79)90015-3; Kang YJ, 2017, NUCLEIC ACIDS RES, V45, pW12, DOI 10.1093/nar/gkx428; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kinoshita T, 2001, P NATL ACAD SCI USA, V98, P14156, DOI 10.1073/pnas.241507798; Kittikorn M, 2011, PLANT GROWTH REGUL, V64, P75, DOI 10.1007/s10725-010-9538-x; Kotoda N, 2000, J AM SOC HORTIC SCI, V125, P398, DOI 10.21273/JASHS.125.4.398; Kotoda N, 2005, PLANT SCI, V168, P95, DOI 10.1016/j.plantsci.2004.07.024; Kotoda N, 2002, PLANT SCI, V162, P679, DOI 10.1016/S0168-9452(02)00024-9; Kotoda N, 2010, PLANT CELL PHYSIOL, V51, P561, DOI 10.1093/pcp/pcq021; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-311; Li WM, 2010, BIOL PLANTARUM, V54, P639, DOI 10.1007/s10535-010-0114-z; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; LUCKWILL LC, 1969, J HORTIC SCI BIOTECH, V44, P413, DOI 10.1080/00221589.1969.11514325; McArtney SJ, 2001, J HORTIC SCI BIOTECH, V76, P536; Mimida N, 2011, TREE PHYSIOL, V31, P555, DOI 10.1093/treephys/tpr028; Mimida N, 2009, PLANT CELL PHYSIOL, V50, P394, DOI 10.1093/pcp/pcp001; Monselise S. P., 1984, Horticultural Reviews, V4, P128, DOI 10.1002/9781118060773.ch5; Munoz-Fambuena N, 2011, ANN BOT-LONDON, V108, P511, DOI 10.1093/aob/mcr164; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Peace CP, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0141-7; Pertea Geo, 2020, F1000Res, V9, P304, DOI 10.12688/f1000research.23297.1; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Core Team, 2021, R LANGUAGE ENV STAT; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Takeuchi T, 2018, J AM SOC HORTIC SCI, V143, P194, DOI [10.21273/JASHS04345-18, 10.21273/jashs04345-18]; Tamada Y., 2019, TREE PHYSIOL; Tian Y, 2015, GENE, V555, P277, DOI 10.1016/j.gene.2014.11.018; Trankner C, 2010, PLANTA, V232, P1309, DOI 10.1007/s00425-010-1254-2; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wada M, 2002, PLANT MOL BIOL, V49, P567, DOI 10.1023/A:1015544207121; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; WARDLAW IF, 1990, NEW PHYTOL, V116, P341, DOI 10.1111/j.1469-8137.1990.tb00524.x; Xu ML, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006263; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang SW, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6090-6; Ziv D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110613	68	3	3	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0245487	10.1371/journal.pone.0245487	http://dx.doi.org/10.1371/journal.pone.0245487			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606701	gold, Green Published			2022-12-26	WOS:000620629200104
J	Janakiraman, B; Gebreyesus, T; Yihunie, M; Genet, MG				Janakiraman, Balamurugan; Gebreyesus, Tsiwaye; Yihunie, Mulualem; Genet, Moges Gashaw			Knowledge, attitude, and practice of antenatal exercises among pregnant women in Ethiopia: A cross-sectional study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CARE; BELIEFS; LEVEL	Background "Is pregnancy opportunity or a barrier for engaging in exercise". Maternal health still is a top priority in sub-Saharan Africa including Ethiopia. Participation in exercises during pregnancy in low-middle income countries is constrained. The objective of this study was to evaluate the knowledge, attitude, and practice of antenatal exercises among Ethiopian women during pregnancy, and also to examine the barriers to prenatal physical activity. Methods A descriptive hospital-based cross-sectional study was conducted and 349 pregnant women receiving prenatal care at the ante-natal care clinic, University of Gondar comprehensive specialized hospital were recruited. Data were obtained on maternal characteristics, knowledge, attitude, practice, and barriers towards antenatal exercise (ANEx) by interview method. Results Among 349 pregnant women, 138 (39.5%) and 193 (55.3%) had adequate knowledge, a positive attitude, and good practice respectively. Overall, 108 (30.9) of the respondents practiced antenatal exercise, while only 41 (37.9%) of those pregnant women had a good practice. Brisk walking (90.7%), relaxation (38.9%), and breathing exercise (36.1%) were most practice ANEx, while pelvic floor 6 (5.6%) and 3 (2.8%) yoga were the least practiced. Enhancing post-natal recovery (71%) and vaginal bleeding (64.5) were perceived as benefits and contraindication of ANEx. More than half of the pregnant women (53.6) reported that ANEx is not appropriate for Ethiopian culture. Knowledge, attitude, and practice of ANEx among pregnant women are significantly associated with higher education, government employees, pre-pregnancy exercise, and being advised on ANEx before. Women with adequate knowledge are more likely to have a good practice (AOR 4.53, 95%CI: 1.64, 15.3). Conclusion The findings of this study suggest that knowledge concerning antenatal exercise is low and their attitude is reasonably favorable. However, very few Ethiopian pregnant practices ANEx according to recommended guidelines during pregnancy.	[Janakiraman, Balamurugan; Gebreyesus, Tsiwaye] Mekelle Univ, Coll Hlth Sci & Ayder Comprehens Specialized Hosp, Sch Med, Dept Physiotherapy, Mekelle, Ethiopia; [Yihunie, Mulualem; Genet, Moges Gashaw] Univ Gondar Comprehens Specialized Hosp, Coll Med & Hlth Sci, Sch Med, Dept Physiotherapy, Gondar, Ethiopia	Mekelle University	Janakiraman, B (corresponding author), Mekelle Univ, Coll Hlth Sci & Ayder Comprehens Specialized Hosp, Sch Med, Dept Physiotherapy, Mekelle, Ethiopia.	bala77@physio@gmail.com	Janakiraman, Balamurugan/AAG-9563-2020	Janakiraman, Balamurugan/0000-0003-3866-9351; Gashaw, Moges/0000-0002-4532-1786	University of Gondar [SOM112/7/2019]	University of Gondar	This study was fully resourced and partly funded by the University of Gondar (Grant no: SOM112/7/2019). The views presented in the article are the authors and not necessarily express the views of the funding organization. University of Gondar did not involve in the design of the study, data collection, analysis, and interpretation. There was no additional external funding received for this study.	Ababa A., 2014, FEDERAL DEMOCRATIC R; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; American Pregnancy Association, 2016, EX PREGN, V12, P2017; American Pregnancy Association, 2010, KEG EX; [Anonymous], SEXUAL REPROD HLTH; [Anonymous], PHYS ACTIVITY EXERCI; Asefa F, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0225-x; Awusi V. O., 2009, Benin Journal of Postgraduate Medicine, V11, P21; Chuma Bekalu Thomas, 2020, Depress Res Treat, V2020, P6718342, DOI 10.1155/2020/6718342; Coll CVN, 2017, J SCI MED SPORT, V20, P17, DOI 10.1016/j.jsams.2016.06.007; Comm Obstet Practice, 2015, OBSTET GYNECOL, V126, pe135, DOI 10.1097/AOG.0000000000001214; Downs DS, 2004, J MIDWIFERY WOM HEAL, V49, P138, DOI 10.1016/j.jmwh.2003.11.009; Duncombe D, 2009, MIDWIFERY, V25, P430, DOI 10.1016/j.midw.2007.03.002; Ethiopia C., 2016, DEMOGRAPHIC HLTH SUR; Garland M, 2017, JNP-J NURSE PRACT, V13, P54, DOI 10.1016/j.nurpra.2016.07.005; Gashaw M, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03184-4; Gebregziabher D, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4496-5; Gibson JL, 2020, ACTA OBSTET GYN SCAN, V99, P147, DOI 10.1111/aogs.13785; Hailemariam TT, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2777-6; Hayman M, 2020, WOMEN BIRTH, V33, pE357, DOI 10.1016/j.wombi.2019.07.302; Hjorth MF, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-154; Janakiraman B, 2020, DIABETES METAB SYNDR, V13, P343, DOI 10.2147/DMSO.S235981; Mbada Chidozie E, 2014, ISRN Obstet Gynecol, V2014, P260539, DOI 10.1155/2014/260539; Muche AA, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2492-3; NICE antenatal care guideline, GUIDELINES; Nkhata LA., 2014, J SCI RES REPORTS, P1986; Ojukwu CP., 2018, INT J REPROD CONTRAC, V7, P2541; Regassa N, 2011, AFR HEALTH SCI, V11, P390; Ribeiro CP, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-31; Sujindra E., 2015, INT J ED PSYCHOL RES, V1, P234, DOI [10.4103/2395-2296.158347, DOI 10.4103/2395-2296.158347]; Tafere TE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192428; Tuncalp O, 2017, BJOG-INT J OBSTET GY, V124, P860, DOI 10.1111/1471-0528.14599; UNICEF, 2006, STATE WORLDS CHILDRE, V7; Watson ED, 2018, MATERN CHILD HLTH J, V22, P1190, DOI 10.1007/s10995-018-2504-3; Whitford HM, 2007, MIDWIFERY, V23, P204, DOI 10.1016/j.midw.2006.06.006; Wolfe LA, 2003, CLIN OBSTET GYNECOL, V46, P488, DOI 10.1097/00003081-200306000-00027; Yeneneh A, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1874-2	37	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247533	10.1371/journal.pone.0247533	http://dx.doi.org/10.1371/journal.pone.0247533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606844	Green Published, gold			2022-12-26	WOS:000620629200165
J	Takeuchi, M; Takeuchi, K; Takai, T; Yamaguchi, R; Furukawa, T; Akagi, K; Takeuchi, JK				Takeuchi, Masao; Takeuchi, Kikuko; Takai, Tomoyo; Yamaguchi, Ritsuko; Furukawa, Tetsushi; Akagi, Ken-ichi; Takeuchi, Jun K.			Subcellular localization of glypican-5 is associated with dynamic motility of the human mesenchymal stem cell line U3DT	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CLEAVAGE FURROW; EXTRACELLULAR VESICLES; GROWTH; ACTIVATION; RECEPTORS; MIGRATION; MEMBRANE; RAC1; ENDOCYTOSIS	Glypican-5 (GPC5) is a heparan sulfate proteoglycan (HSPG) localized to the plasma membrane. We previously reported that in the human mesenchymal stem cell line UE6E7T-3, GPC5 is overexpressed in association with transformation and promotes cell proliferation by acting as a co-receptor for Sonic hedgehog signaling. In this study, we found using immunofluorescence microscopy that in transformed cells (U3DT), GPC5 localized not only at primary cilia on the cell surface, but also at the leading edge of migrating cells, at the intercellular bridge and blebs during cytokinesis, and in extracellular vesicles. In each subcellular region, GPC5 colocalized with fibroblast growth factor receptor (FGFR) and the small GTPases Rab11 and ARF6, indicating that GPC5 is delivered to these regions by Rab11-associated recycling endosomes. These colocalizations suggest that GPC5 plays an important role in FGF2 stimulation of cell migration, which was abrogated by knockdown of GPC5. Our findings indicate that GPC5 plays a role in regulation of U3DT cell migration and provides several insights into the functions of GPC5 that could be elucidated by future studies.	[Takeuchi, Masao; Takeuchi, Kikuko; Takai, Tomoyo; Yamaguchi, Ritsuko; Akagi, Ken-ichi] Natl Inst Biomed Innovat Hlth & Nutr, Sect Lab Equipment, Ibaraki, Osaka, Japan; [Takeuchi, Masao; Furukawa, Tetsushi; Takeuchi, Jun K.] Tokyo Med & Dent Univ, Med Res Inst, Div Bioinformat Pharmacol, Bunkyo Ku, Tokyo, Japan; [Akagi, Ken-ichi] RIKEN, Riken Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan	Tokyo Medical & Dental University (TMDU); RIKEN	Takeuchi, JK (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Div Bioinformat Pharmacol, Bunkyo Ku, Tokyo, Japan.	juntakeuchi.bip@mri.tmd.ac.jp		AKAGI, Ken-ichi/0000-0002-7051-4598	Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University	Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University	This study was supported by the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Erkang, 2009, Communicative & Integrative Biology, V2, P444; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10; Chen TC, 2009, J PROTEOME RES, V8, P4943, DOI 10.1021/pr900325f; Choi D, 2017, SEMIN CELL DEV BIOL, V67, P11, DOI 10.1016/j.semcdb.2017.01.003; Chua CC, 2004, CIRC RES, V94, P316, DOI 10.1161/01.RES.0000112965.70691.AC; Couchman John R, 2016, F1000Res, V5, DOI 10.12688/f1000research.8543.1; de Lucas B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150004; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Fielding AB, 2005, EMBO J, V24, P3389, DOI 10.1038/sj.emboj.7600803; Goudarzi M, 2017, DEV CELL, V43, P577, DOI 10.1016/j.devcel.2017.10.030; Guo Lixia, 2016, Biochem Biophys Rep, V6, P108; Heneberg P, 2016, CRIT REV ONCOL HEMAT, V97, P303, DOI 10.1016/j.critrevonc.2015.09.008; Horgan CP, 2004, BIOCHEM BIOPH RES CO, V319, P83, DOI 10.1016/j.bbrc.2004.04.157; Horowitz A, 2002, J CELL BIOL, V157, P715, DOI 10.1083/jcb.200112145; Huang G., 2017, NAT COMMUN, V8, P1, DOI DOI 10.1038/NC0MMS14351; Jing J, 2009, EUR J CELL BIOL, V88, P325, DOI 10.1016/j.ejcb.2009.02.186; Kanada M, 2015, P NATL ACAD SCI USA, V112, pE1433, DOI 10.1073/pnas.1418401112; Kanazawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012228; Kleeff J, 1998, J CLIN INVEST, V102, P1662, DOI 10.1172/JCI4105; Lafaurie-Janvore J, 2013, SCIENCE, V339, P1625, DOI 10.1126/science.1233866; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Li N, 2018, TRENDS CANCER, V4, P741, DOI 10.1016/j.trecan.2018.09.004; Li Y, 2013, ONCOL LETT, V6, P1565, DOI 10.3892/ol.2013.1622; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Morita Y, 2016, J MOL CELL CARDIOL, V92, P158, DOI 10.1016/j.yjmcc.2016.02.008; Nikolovska K, 2015, J CELL SCI, V128, P460, DOI 10.1242/jcs.152660; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Rieck PW, 2001, EXP EYE RES, V73, P639, DOI 10.1006/exer.2001.1067; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Sato M, 2008, J CELL SCI, V121, P3177, DOI 10.1242/jcs.034678; Sedzinski J, 2011, NATURE, V476, P462, DOI 10.1038/nature10286; Su G, 2006, AM J PATHOL, V168, P2014, DOI 10.2353/ajpath.2006.050800; Sun Y, 2018, ONCOL RES, V26, P565, DOI 10.3727/096504017X15044461944385; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Takeuchi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126562; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Volk R, 1999, J BIOL CHEM, V274, P24417, DOI 10.1074/jbc.274.34.24417; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Williamson D, 2007, CANCER RES, V67, P57, DOI 10.1158/0008-5472.CAN-06-1650; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Witt RM, 2013, J BIOL CHEM, V288, P26275, DOI 10.1074/jbc.M112.438937; Yang X, 2013, CANCER LETT, V341, P265, DOI 10.1016/j.canlet.2013.08.020; Yoshigaki T, 1997, EXP CELL RES, V236, P463, DOI 10.1006/excr.1997.3740; Yu BY, 2018, TECHNOL CANCER RES T, V17, DOI 10.1177/1533033818785274; Yuan S, 2016, ONCOGENE, V35, P6120, DOI 10.1038/onc.2016.149; Zhang YN, 2014, ARCH ORAL BIOL, V59, P1172, DOI 10.1016/j.archoralbio.2014.07.009	52	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0226538	10.1371/journal.pone.0226538	http://dx.doi.org/10.1371/journal.pone.0226538			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606708	gold, Green Published			2022-12-26	WOS:000620629200066
J	Xiaokereti, J; Guo, YK; Dong, ZY; Ma, M; Lu, YM; Li, YD; Zhou, XH; Zhang, L; Tang, BP				Xiaokereti, Jiasuoer; Guo, Yan-Kai; Dong, Zhen-Yu; Ma, Mei; Lu, Yan-Mei; Li, Yao-Dong; Zhou, Xian-Hui; Zhang, Ling; Tang, Bao-Peng			Enhanced atrial internal-external neural remodeling facilitates atrial fibrillation in the chronic obstructive sleep apnea model	PLOS ONE			English	Article								Objective Autonomic imbalance plays a crucial role in obstructive sleep apnea (OSA) associated atrial fibrillation (AF). Here, we investigated the potential neural mechanism of AF induced by OSA. Methods Ten dogs were divided into control group (n = 5) and OSA group (n = 5). The chronic OSA model was established by repeat apnea-ventilation cycles for 4 hours a day for 12 weeks. During the process of model establishment, arterial blood gases, atrial effective refractory period (AERP), AF inducibility, normalized low-frequency power (LFnu), normalized high-frequency power (HFnu), and LFnu/ HFnu were evaluated at baseline, 4(th) week, 8(th) week, and 12(th) week. Nerve activities of left stellate ganglion (LSG) and left vagal nerve(LVN) were recorded. Tyrosine hydroxylase(TH), choline acetyltransferase(CHAT), PGP9.5, nerve growth factor(NGF), and c-Fos were detected in the left atrium, LSG, and LVN by immunohistochemistry and western blot. Moreover, high-frequency stimulations of LSG and LVN were conducted to observe the AF inducibility. Results Compared with the control group, the OSA group showed significantly enhanced neural activity of the LSG, increased AF inducibility, and shortened AERP. LFnu and LFnu/HFnu were markedly increased in the OSA group, while no significant difference in HFnu was observed. TH-positive and PGP9.5-positive nerve densities were significantly increased in the LSG and left atrium. Additionally, the protein levels of NGF, c-Fos, and PGP9.5 were upregulated both in the LSG and left atrium. AF inducibility was markedly increased under LSG stimulation without a stimulus threshold change in the OSA group. Conclusions OSA significantly enhanced LSG and left atrial neural remodeling, and hyperactivity of LSG may accelerate left atrial neural remodeling to increase AF inducibility.	[Xiaokereti, Jiasuoer; Guo, Yan-Kai; Dong, Zhen-Yu; Lu, Yan-Mei; Li, Yao-Dong; Zhou, Xian-Hui; Tang, Bao-Peng] Xinjiang Med Univ, Cardiac Pacing & Electrophysiol Dept, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China; [Xiaokereti, Jiasuoer; Guo, Yan-Kai; Dong, Zhen-Yu; Lu, Yan-Mei; Li, Yao-Dong; Zhou, Xian-Hui; Zhang, Ling; Tang, Bao-Peng] Xinjiang Med Univ, Xinjiang Key Lab Cardiac Electrophysiol & Cardiac, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China; [Guo, Yan-Kai] Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 5, Urumqi, Xinjiang, Peoples R China; [Ma, Mei] Xinjiang Med Univ, Dept Teaching Management, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Tang, BP (corresponding author), Xinjiang Med Univ, Cardiac Pacing & Electrophysiol Dept, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China.; Zhang, L; Tang, BP (corresponding author), Xinjiang Med Univ, Xinjiang Key Lab Cardiac Electrophysiol & Cardiac, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China.	ydzhangling@126.com; tangbaopeng1111@163.com		Zhang, Ling/0000-0002-1532-680X	National Natural Science Foundation of China [81860067, 81560064]; Department of Education, Xinjiang Uygur Autonomous Region (CN) [2018Q046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education, Xinjiang Uygur Autonomous Region (CN)	This work was supported by the National Natural Science Foundation of China (Project No: 81860067, 81560064). Department of Education, Xinjiang Uygur Autonomous Region (CN) (2018Q046).	Abboud F, 2014, J CLIN INVEST, V124, P1454, DOI 10.1172/JCI70420; Anter E, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005407; Armour JA, 2004, AM J PHYSIOL-REG I, V287, pR262, DOI 10.1152/ajpregu.00183.2004; Ashton JL, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00240; Beauchamp P, 2006, CIRC RES, V99, P1216, DOI 10.1161/01.RES.0000250607.34498.b4; Nguyen BL, 2012, CARDIOVASC PATHOL, V21, P143, DOI 10.1016/j.carpath.2011.08.001; Bisogni V, 2016, J THORAC DIS, V8, P243, DOI 10.3978/j.issn.2072-1439.2015.11.14; DRAGUNOW M, 1987, NATURE, V329, P441, DOI 10.1038/329441a0; Gerst DG, 2011, J APPL PHYSIOL, V110, P15, DOI 10.1152/japplphysiol.00524.2010; Ghias M, 2009, J AM COLL CARDIOL, V54, P2075, DOI 10.1016/j.jacc.2009.09.014; Gorenek B, 2017, EUROPACE, V19, P190, DOI 10.1093/europace/euw242; Hasan W, 2006, BRAIN RES, V1124, P142, DOI 10.1016/j.brainres.2006.09.054; Hou YL, 2007, J AM COLL CARDIOL, V50, P61, DOI 10.1016/j.jacc.2007.02.066; Huizar JF, 2011, CIRC-ARRHYTHMIA ELEC, V4, P543, DOI 10.1161/CIRCEP.111.962381; Khalyfa Abdelnaby, 2018, Curr Sleep Med Rep, V4, P300, DOI 10.1007/s40675-018-0130-7; Kiuchi MG, 2020, EUROPACE, V22, P1443, DOI 10.1093/europace/euaa089; Kovoor P, 2001, J AM COLL CARDIOL, V37, P2136, DOI 10.1016/S0735-1097(01)01304-3; Li ZY, 2015, PACE, V38, P107, DOI 10.1111/pace.12513; Linz D, 2012, HYPERTENSION, V60, P172, DOI 10.1161/HYPERTENSIONAHA.112.191965; Linz D, 2011, HEART RHYTHM, V8, P1436, DOI 10.1016/j.hrthm.2011.03.053; Luo BB, 2018, INT J MOL MED, V42, P1125, DOI 10.3892/ijmm.2018.3648; Miyauchi Y, 2003, CIRCULATION, V108, P360, DOI 10.1161/01.CIR.0000080327.32573.7C; Nagibin V, 2016, PHYSIOL RES, V65, pS91, DOI 10.33549/physiolres.933389; Nguyen BL, 2009, HEART RHYTHM, V6, P454, DOI 10.1016/j.hrthm.2009.01.010; Palma JA, 2015, CLIN AUTON RES, V25, P225, DOI 10.1007/s10286-015-0297-7; Palma JA, 2014, CLIN NEUROPHYSIOL, V125, P1783, DOI 10.1016/j.clinph.2014.01.029; Roche F, 2003, PACE, V26, P669, DOI 10.1046/j.1460-9592.2003.00116.x; Shu CL, 2017, ANATOL J CARDIOL, V18, P3, DOI 10.14744/AnatolJCardiol.2017.7602; Sohinki D, 2020, TRENDS CARDIOVAS MED, V30, P433, DOI 10.1016/j.tcm.2019.10.009; Stevenson IH, 2008, EUR HEART J, V29, P1662, DOI 10.1093/eurheartj/ehn214; Sun L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14960-2; Swissa M, 2008, CARDIOVASC PATHOL, V17, P303, DOI 10.1016/j.carpath.2007.11.003; Tan AY, 2008, CIRCULATION, V118, P916, DOI 10.1161/CIRCULATIONAHA.108.776203; Vizzardi E, 2014, J CARDIOVASC MED, V15, P235, DOI 10.2459/JCM.0b013e328358554b; Wang SY, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1513-5; Wang YC, 2019, LIFE SCI, V237, DOI 10.1016/j.lfs.2019.116949; Xhyheri B, 2012, PROG CARDIOVASC DIS, V55, P321, DOI 10.1016/j.pcad.2012.09.001; Yamada N, 2019, CIRCULATION, V139, P2157, DOI 10.1161/CIRCULATIONAHA.118.036761; Yang XC, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010254; Yu LL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006264; Zhang WH, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009938; Zhao J, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0427-8; Zhao QY, 2015, HYPERTENSION, V66, P1042, DOI 10.1161/HYPERTENSIONAHA.115.05846; Zhou QN, 2016, INT J CARDIOL, V203, P187, DOI 10.1016/j.ijcard.2015.10.120; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3; Zhou XY, 2016, J CARDIOVASC ELECTR, V27, P217, DOI 10.1111/jce.12859	46	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247308	10.1371/journal.pone.0247308	http://dx.doi.org/10.1371/journal.pone.0247308			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606818	Green Published, gold			2022-12-26	WOS:000620629200090
J	He, CY; Xiang, HD; Liu, C; Yu, SY; Yang, J; Ding, XH; Bian, SZ; Zhang, JH; Tan, H; Jin, J; Hu, MD; Zhang, C; Rao, RS; Huang, L				He, Chunyan; Xiang, Hedong; Liu, Chuan; Yu, Shiyong; Yang, Jie; Ding, Xiaohan; Bian, Shizhu; Zhang, Jihang; Tan, Hu; Jin, Jun; Hu, Mingdong; Zhang, Chen; Rao, Rongsheng; Huang, Lan			Assessment of right atrial dyssynchrony by 2D speckle-tracking in healthy young men following high altitude exposure at 4100 m	PLOS ONE			English	Article								Background High altitude exposure induces overload of right-sided heart and may further predispose to supraventricular arrhythmia. It has been reported that atrial mechanical dyssynchrony is associated with atrial arrhythmia. Whether high altitude exposure causes higher right atrial (RA) dyssynchrony is still unknown. The aim of study was to investigate the effect of high altitude exposure on right atrial mechanical synchrony. Methods In this study, 98 healthy young men underwent clinical examination and echocardiography at sea level (400 m) and high altitude (4100 m) after an ascent within 7 days. RA dyssynchrony was defined as inhomogeneous timing to peak strain and strain rate using 2D speckle-tracking echocardiography. Results Following high altitude exposure, standard deviation of the time to peak strain (SD-TPS) [36.2 (24.5, 48.6) ms vs. 21.7 (12.9, 32.1) ms, p<0.001] and SD-TPS as percentage of R-R' interval (4.6 +/- 2.1% vs. 2.5 +/- 1.8%, p<0.001) significantly increased. Additionally, subjects with higher SD-TPS (%) at high altitude presented decreased right ventricular global longitudinal strain and RA active emptying fraction, but increased RA minimal volume index, which were not observed in lower group. Multivariable analysis showed that mean pulmonary arterial pressure and tricuspid E/A were independently associated with SD-TPS (%) at high altitude. Conclusion Our data for the first time demonstrated that high altitude exposure causes RA dyssynchrony in healthy young men, which may be secondary to increased pulmonary arterial pressure. In addition, subjects with higher RA dyssynchrony presented worse RA contractile function and right ventricular performance.	[He, Chunyan; Xiang, Hedong; Liu, Chuan; Yu, Shiyong; Yang, Jie; Bian, Shizhu; Zhang, Jihang; Tan, Hu; Jin, Jun; Zhang, Chen; Huang, Lan] Third Mil Med Univ, Army Med Univ, Affiliated Hosp 2, Inst Cardiovasc Dis PLA, Chongqing, Peoples R China; [He, Chunyan; Xiang, Hedong; Liu, Chuan; Yu, Shiyong; Yang, Jie; Bian, Shizhu; Tan, Hu; Jin, Jun; Zhang, Chen; Huang, Lan] Third Mil Med Univ, Army Med Univ, Affiliated Hosp 2, Dept Cardiol, Chongqing, Peoples R China; [Ding, Xiaohan] 940th Hosp Joint Logist Support Force PLA, Dept Hlth Care & Geriatr, Lanzhou, Peoples R China; [Hu, Mingdong] Third Mil Med Univ, Army Med Univ, Affiliated Hosp 2, Dept Resp Med, Chongqing, Peoples R China; [Rao, Rongsheng] Third Mil Med Univ, Army Med Univ, Affiliated Hosp 2, Dept Med Ultrason, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Huang, L (corresponding author), Third Mil Med Univ, Army Med Univ, Affiliated Hosp 2, Inst Cardiovasc Dis PLA, Chongqing, Peoples R China.; Huang, L (corresponding author), Third Mil Med Univ, Army Med Univ, Affiliated Hosp 2, Dept Cardiol, Chongqing, Peoples R China.	huanglan260@126.com	huang, lei/GQP-8739-2022	Huang, Lan/0000-0001-9594-4722	National Natural Science Foundation of China [81730054]; Military Logistics Research Project, PLA [BLJ18J007]; Special Health Research Project, Ministry of Health of PR China [201002012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Military Logistics Research Project, PLA; Special Health Research Project, Ministry of Health of PR China	This work was supported by grants from the National Natural Science Foundation of China (Grant No: 81730054), Military Logistics Research Project, PLA (Grant No: BLJ18J007), and the Special Health Research Project, Ministry of Health of PR China (No. 201002012). Lan Huang was the recipient of the three grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu Y, 2011, CIRC-CARDIOVASC IMAG, V4, P524, DOI 10.1161/CIRCIMAGING.110.962761; Badagliacca R, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01419-2016; Badagliacca R, 2015, J HEART LUNG TRANSPL, V34, P381, DOI 10.1016/j.healun.2014.06.010; Badano LP, 2018, EUR HEART J-CARD IMG, V19, P591, DOI 10.1093/ehjci/jey042; Bartsch P, 2007, CIRCULATION, V116, P2191, DOI 10.1161/CIRCULATIONAHA.106.650796; Boos CJ, 2017, CIRCULATION, V135, P812, DOI 10.1161/CIRCULATIONAHA.116.026584; Ciuffo L, 2018, EUR HEART J-CARD IMG, V19, P433, DOI 10.1093/ehjci/jex156; Dell'Era G, 2010, EUR J ECHOCARDIOGR, V11, P577, DOI 10.1093/ejechocard/jeq010; Deng Y, 2015, ECHOCARDIOGR-J CARD, V32, P291, DOI 10.1111/echo.12645; Govindan M, 2017, J ECHOCARDIOGR, V15, P166, DOI 10.1007/s12574-017-0341-9; Grapsa J, 2012, EUR HEART J-CARD IMG, V13, P666, DOI 10.1093/ehjci/jes003; Gupta S, 2013, EUR HEART J, V34, P278, DOI 10.1093/eurheartj/ehs188; Haugaa KH, 2013, JACC-CARDIOVASC IMAG, V6, P841, DOI 10.1016/j.jcmg.2013.03.005; Herron TJ, 2002, CIRC RES, V90, P1150, DOI 10.1161/01.RES.0000022879.57270.11; Hoit BD, 2014, J AM COLL CARDIOL, V63, P493, DOI 10.1016/j.jacc.2013.10.055; Kawakami H, 2019, J AM SOC ECHOCARDIOG, V32, P1268, DOI 10.1016/j.echo.2019.06.002; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Liang HY, 2011, JACC-CARDIOVASC IMAG, V4, P691, DOI 10.1016/j.jcmg.2011.02.019; Liu S, 2018, INT J CARDIOL, V257, P177, DOI 10.1016/j.ijcard.2017.12.042; Liu WW, 2018, HEART LUNG CIRC, V27, P350, DOI 10.1016/j.hlc.2017.02.029; Mitchell C, 2019, J AM SOC ECHOCARDIOG, V32, P1, DOI 10.1016/j.echo.2018.06.004; Mitter SS, 2017, J AM COLL CARDIOL, V69, P1451, DOI 10.1016/j.jacc.2016.12.037; Naeije R, 2010, PROG CARDIOVASC DIS, V52, P456, DOI 10.1016/j.pcad.2010.03.004; Parati G, 2018, EUR HEART J, V39, P1546, DOI 10.1093/eurheartj/ehx720; Patel AR, 2011, JACC-CARDIOVASC IMAG, V4, P938, DOI 10.1016/j.jcmg.2011.05.006; Peluso D, 2013, EUR HEART J-CARD IMG, V14, P1106, DOI 10.1093/ehjci/jet024; Pezzuto B, 2018, EXP PHYSIOL, V103, P1338, DOI 10.1113/EP087027; Rai AB, 2015, CLIN CARDIOL, V38, P692, DOI 10.1002/clc.22438; Roach RC, 2018, HIGH ALT MED BIOL, V19, P4, DOI 10.1089/ham.2017.0164; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sarvari SI, 2016, EUR HEART J-CARD IMG, V17, P660, DOI 10.1093/ehjci/jev185; Sarvari SI, 2011, EUR HEART J, V32, P1089, DOI 10.1093/eurheartj/ehr069; Shen T, 2018, ANESTH ANALG, V126, P62, DOI 10.1213/ANE.0000000000002614; Stembridge M, 2014, J APPL PHYSIOL, V117, P334, DOI 10.1152/japplphysiol.00233.2014; Thomas L, 2019, J AM COLL CARDIOL, V73, P1961, DOI 10.1016/j.jacc.2019.01.059; Todaro MC, 2012, EUR HEART J-CARD IMG, V13, P973, DOI 10.1093/ehjci/jes174; TSUCHIMOCHI H, 1984, J CLIN INVEST, V74, P662, DOI 10.1172/JCI111466; Beeumen K, 2007, AM J CARDIOL, V99, P79, DOI 10.1016/j.amjcard.2006.07.066; Vitarelli A, 2018, CLIN CARDIOL, V41, P1341, DOI 10.1002/clc.23051; Vitarelli A, 2018, ULTRASOUND MED BIOL, V44, P1198, DOI 10.1016/j.ultrasmedbio.2018.02.015; Watanabe Y, 2015, HEART RHYTHM, V12, P490, DOI 10.1016/j.hrthm.2014.12.007; Wierzbowska-Drabik K, 2019, EUR HEART J-CARD IMG, V20, P1027, DOI 10.1093/ehjci/jez029; Woods DR, 2008, CARDIOLOGY, V111, P239, DOI 10.1159/000127445; Yang T, 2015, INT J CARDIOL, V181, P382, DOI 10.1016/j.ijcard.2014.12.044; Yang YQ, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00703	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247107	10.1371/journal.pone.0247107	http://dx.doi.org/10.1371/journal.pone.0247107			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600469	gold, Green Published			2022-12-26	WOS:000620625100005
J	Maciejewska-Rutkowska, I; Bocianowski, J; Wronska-Pilarek, D				Maciejewska-Rutkowska, Irmina; Bocianowski, Jan; Wronska-Pilarek, Dorota			Pollen morphology and variability of Polish native species from genus Salix L.	PLOS ONE			English	Article							SALICACEAE; WILLOWS; EUROPE	The pollen morphology was studied of 24 Salix species native to Poland, which represented two subgenera, 17 sections and five subsections occurring in Poland. The aim of this study was to discover the taxonomical usefulness of the pollen features under analysis, and to investigate the ranges of their interspecific variability. In total, 720 pollen grains were studied. They were analysed with respect to seven quantitative features (length of the polar axis - P, equatorial diameter - E, length of the ectoaperture - Le, exine thickness - Ex, and P/E, Ex/P and Le/P ratios) and the following qualitative ones: pollen outline and exine ornamentation. The most important features were exine ornamentation (muri, lumina and margo) characters. The pollen features should be treated as auxiliary because they allowed to distinguish eight individual Salix species, and five groups of species. Statistical analysis of the studied traits indicated a high variability among the tested species. The most variable biometric features were P, E and Le, while lower variability occurred in P/E, Le/P and d/E.	[Maciejewska-Rutkowska, Irmina; Wronska-Pilarek, Dorota] Poznan Univ Life Sci, Dept Forest Bot, Poznan, Poland; [Bocianowski, Jan] Poznan Univ Life Sci, Dept Math & Stat Methods, Poznan, Poland	Poznan University of Life Sciences; Poznan University of Life Sciences	Maciejewska-Rutkowska, I (corresponding author), Poznan Univ Life Sci, Dept Forest Bot, Poznan, Poland.	irmina.maciejewska@up.poznan.pl		Wronska-Pilarek, Dorota/0000-0003-2431-6192; Maciejewska-Rutkowska, Irmina/0000-0003-4757-7272; Bocianowski, Jan/0000-0002-0102-0084				Argus George W., 2007, Harvard Papers in Botany, V12, P335, DOI 10.3100/1043-4534(2007)12[335:SSDMAA]2.0.CO;2; Babayi F., 2012, Iranian Journal of Botany, V18, P118; Celemli Omur Gencay, 2012, Mellifera, V12, P30; Chen JH, 2010, TAXON, V59, P29, DOI 10.1002/tax.591004; Chester PI, 2001, GRANA, V40, P299, DOI 10.1080/00173130152987535; Cronk Q, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e6258; Diethart B., 2016, PALDAT PALYNOLOGICAL; ERDTMAN G., 1960, SVENSK BOT TIDSKR, V54, P561; Erdtman G., 1967, GRANA PALYNOL, V7, P517; Erdtman G., 1952, POLLEN MORPHOLOGY PL, P1; Evarts-Bunders P.E., 2005, G WILLOWS DETERMINE; Halbritter H., 2016, PALDAT PALYNOLOGICAL; Halbritter H, 2018, ILLUSTRATED POLLEN TERMINOLOGY, 2ND EDITION; He L, 2021, J SYST EVOL, V59, P44, DOI 10.1111/jse.12593; Heywood VH., 1993, FLORA EUROPAEA, V2nd, P53; Horandl E, 2012, WEIDEN OSTERREICH AN; Isebrands JG, 2014, POPLARS AND WILLOWS: TREES FOR SOCIETY AND THE ENVIRONMENT, P1, DOI 10.1079/9781780641089.0000; Iversen J, 1989, J BIOGEOGR; Kim K. H., 1984, Journal of Korean Forestry Society, P64; Kim K. H., 1989, Journal of Korean Forestry Society, V78, P132; Kim K. H., 1989, Journal of Korean Forestry Society, V78, P35; KIM KH, 1990, CAN J BOT, V68, P1497, DOI 10.1139/b90-190; Kuzovkina YA, 2015, HORTSCIENCE, V50, P1608, DOI 10.21273/HORTSCI.50.11.1608; Lauron-Moreau A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121965; Mahalanobis PC, 2018, SANKHYA SER A, V80, P1, DOI 10.1007/s13171-019-00164-5; MEIKLE RD, 1992, P ROY SOC EDINB B, V98, P13, DOI 10.1017/S0269727000007429; Mirek Z., 2002, FLOWERING PLANTS PTE; Oberprieler C, 2013, PLANT SYST EVOL, V299, P1107, DOI 10.1007/s00606-013-0782-1; Praglowski J. R., 1962, Grana Palynologica, V3, P45; Punt W, 2007, REV PALAEOBOT PALYNO, V143, P1, DOI 10.1016/j.revpalbo.2006.06.008; Qureshi RA, 2007, PAK J BOT, V39, P2257; RECHINGER KH, 1992, P ROY SOC EDINB B, V98, P1, DOI 10.1017/S0269727000007417; Seidler-Lozykowska K, 2012, IND CROP PROD, V35, P140, DOI 10.1016/j.indcrop.2011.06.026; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Skvortsov A.K., 1999, FACULTY MATH NATURAL; Sohma Kankichi, 1993, Science Reports of the Tohoku University Fourth Series (Biology), V40, P77; STRAKA H., 1952, SVENSK BOT TIDSKR, V46, P204; Trybush S, 2008, BIOENERG RES, V1, P67, DOI 10.1007/s12155-008-9007-9; Wagner ND, 2018, ECOL EVOL, V8, P8243, DOI 10.1002/ece3.4360; Wronska-Pilarek D, 2015, PALYNOLOGY, V39, P56, DOI 10.1080/01916122.2014.933748; Wu J, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0311-7; Zhen-Fu F., 1987, J SYST EVOL, V25, P307	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0243993	10.1371/journal.pone.0243993	http://dx.doi.org/10.1371/journal.pone.0243993			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600499	gold, Green Published			2022-12-26	WOS:000620625100019
J	Piec, I; English, E; Thomas, MA; Dervisevic, S; Fraser, WD; John, WG				Piec, Isabelle; English, Emma; Thomas, Mary Annette; Dervisevic, Samir; Fraser, William D.; John, William Garry			Performance of SARS-CoV-2 serology tests: Are they good enough?	PLOS ONE			English	Article							HUMAN CORONAVIRUSES 229E; CROSS-REACTIVITY	In the emergency of the SARS-CoV-2 pandemic, great efforts were made to quickly provide serology testing to the medical community however, these methods have been introduced into clinical practice without the complete validation usually required by the regulatory organizations. SARS-CoV-2 patient samples (n = 43) were analyzed alongside pre-pandemic control specimen (n = 50), confirmed respiratory infections (n = 50), inflammatory polyarthritis (n = 22) and positive for thyroid stimulating immunoglobulin (n = 30). Imprecision, diagnostic sensitivity and specificity and concordance were evaluated on IgG serologic assays from EuroImmun, Epitope Diagnostics (EDI), Abbott Diagnostics and DiaSorin and a rapid IgG/IgM test from Healgen. EDI and EuroImmun imprecision was 0.02-14.0% CV. Abbott and DiaSorin imprecision (CV) ranged from 5.2%-8.1% and 8.2%-9.6% respectively. Diagnostic sensitivity of the assays was 100% (CI: 80-100%) for Abbott, EDI and EuroImmun and 95% (CI: 73-100%) for DiaSorin at >= 14 days post PCR. Only the Abbott assay had a diagnostic specificity of 100% (CI: 91-100%). EuroImmun cross-reacted in 3 non-SARS-CoV-2 respiratory infections and 2 controls. The DiaSorin displayed more false negative results and cross-reacted in six cases across all conditions tested. EDI had one cross-reactive sample. The Healgen rapid test showed excellent sensitivity and specificity. Overall, concordance of the assays ranged from 76.1% to 97.9%. Serological tests for SARS-CoV-2 showed good analytical performance. The head-to-head analysis of samples revealed differences in results that may be linked to the use of nucleocapsid or spike proteins. The point of care device tested demonstrated adequate performance for antibody detection.	[Piec, Isabelle; Fraser, William D.] Univ East Anglia, Fac Med, BioAnalyt Facil, Norwich, Norfolk, England; [English, Emma; John, William Garry] Univ East Anglia, Fac Med & Hlth, Norwich, Norfolk, England; [Thomas, Mary Annette] Cardiff & Vale Univ Hlth Board, WEQAS, Cardiff, Wales; [Dervisevic, Samir] Norfolk & Norwich Univ Hosp, Virol Dept, Norwich, Norfolk, England; [Fraser, William D.; John, William Garry] Norfolk & Norwich Univ Hosp, Clin Biochem Dept, Norwich, Norfolk, England	University of East Anglia; University of East Anglia; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Piec, I (corresponding author), Univ East Anglia, Fac Med, BioAnalyt Facil, Norwich, Norfolk, England.	i.piec@uea.ac.uk	Piec, Isabelle Danielle/GQA-9932-2022	Piec, Isabelle Danielle/0000-0002-0648-1330	Norfolk Freemasons; Suffolk Freemasons; Essex Freemasons; Bedfordshire Freemasons	Norfolk Freemasons; Suffolk Freemasons; Essex Freemasons; Bedfordshire Freemasons	The authors received no specific financial support for this study. They acknowledge the Norfolk, Suffolk, Essex and Bedfordshire Freemasons for their generous material support in providing funding for some equipment used in this study.	Ahn JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e149; [Anonymous], 2018, FDA GUID IND, P1; Bastos ML, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2516; Beavis KG, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104468; Boukli N, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01352-20; Burbelo PD, 2020, J INFECT DIS, V222, P206, DOI 10.1093/infdis/jiaa273; Chan KH, 2005, CLIN DIAGN LAB IMMUN, V12, P1317, DOI 10.1128/CDLI.12.11.1317-1321.2005; Chang MS, 2004, BIOCHEM BIOPH RES CO, V314, P931, DOI 10.1016/j.bbrc.2003.12.195; Che XY, 2005, J INFECT DIS, V191, P2033, DOI 10.1086/430355; Deeks JJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013652; Duan Kai, 2020, Proc Natl Acad Sci U S A, V117, P9490, DOI 10.1073/pnas.2004168117; Duong YT, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2655; GISAID, 2020, CLAD LIN NOM AIDS GE; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; Hegerova L, 2020, BLOOD, V136, P759, DOI 10.1182/blood.2020006964; Kaza M, 2019, J PHARMACEUT BIOMED, V165, P381, DOI 10.1016/j.jpba.2018.12.030; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Lv HB, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107725; Mueller MA, 2020, CLIN PRESENTATION VI, DOI 10.1101/2020.03.05.20030502; Neil Carey R., 2014, CLIN LAB STAND I, V34, P1; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Osterhaus ADME., 2020, NAT COMMUN; Patrick David M, 2006, Can J Infect Dis Med Microbiol, V17, P330; Public Health England, 2020, EVALUATION SENSITIVI; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Tang MS, 2020, CLIN CHEM, V66, P1055, DOI 10.1093/clinchem/hvaa120; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; UK Medicines and Healthcare products Regulatory Agency (MHRA), TARG PROD PROF ENZ I; Ye MX, 2020, J MED VIROL, V92, P1890, DOI 10.1002/jmv.25882; Zhang B, 2020, CHEST, V158, pE9, DOI 10.1016/j.chest.2020.03.039; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344; Zheng ZQ, 2020, EUROSURVEILLANCE, V25, P19, DOI 10.2807/1560-7917.ES.2020.25.28.2000291; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0245914	10.1371/journal.pone.0245914	http://dx.doi.org/10.1371/journal.pone.0245914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596236	Green Submitted, gold, Green Published			2022-12-26	WOS:000620633200058
J	Edwards, BD; Edwards, J; Cooper, R; Kunimoto, D; Somayaji, R; Fisher, D				Edwards, Brett D.; Edwards, Jenny; Cooper, Ryan; Kunimoto, Dennis; Somayaji, Ranjani; Fisher, Dina			Rifampin-resistant/multidrug-resistant Tuberculosis in Alberta, Canada: Epidemiology and treatment outcomes in a low-incidence setting	PLOS ONE			English	Article							DRUGS; IMPACT	Treatment of rifampin-monoresistant/multidrug-resistant Tuberculosis (RR/MDR-TB) requires long treatment courses, complicated by frequent adverse events and low success rates. Incidence of RR/MDR-TB in Canada is low and treatment practices are variable due to the infrequent experience and challenges with drug access. We undertook a retrospective cohort study of all RR/MDR-TB cases in Alberta, Canada from 2007-2017 to explore the epidemiology and outcomes in our low incidence setting. We performed a descriptive analysis of the epidemiology, treatment regimens and associated outcomes, calculating differences in continuous and discrete variables using Student's t and Chi-squared tests, respectively. We identified 24 patients with RR/MDR-TB. All patients were foreign-born with the median time to presentation after immigration being 3 years. Prior treatment was reported in 46%. Treatment was individualized. All patients achieved sputum culture conversion within two months of treatment initiation. The median treatment duration after culture conversion was 18 months (IQR: 15-19). The mean number of drugs utilized during the intensive phase was 4.3 (SD: 0.8) and during the continuation phase was 3.3 (SD: 0.9) and the mean adherence to medications was 95%. Six patients completed national guideline-concordant therapy, with many patients developing adverse events (79%). Treatment success (defined as completion of prescribed therapy or cure) was achieved in 23/24 patients and no acquired drug resistance or relapse was detected over 1.8 years of median follow-up. Many cases were captured upon immigration assessment, representing important prevention of community spread. Despite high rates of adverse events and short treatment compared to international guidelines, success in our cohort was very high at 96%. This is likely due to individualization of therapy, frequent use of medications with high effectiveness, intensive treatment support, and early sputum conversion seen in our cohort. There should be ongoing exploration of treatment shortening with well-tolerated, efficacious oral agents to help patients achieve treatment completion.	[Edwards, Brett D.; Somayaji, Ranjani; Fisher, Dina] Univ Calgary, Dept Med, Calgary, AB, Canada; [Edwards, Jenny] Alberta Hlth Serv, Pharm Serv, Calgary, AB, Canada; [Cooper, Ryan; Kunimoto, Dennis] Univ Alberta, Dept Med, Div Infect Dis, Edmonton, AB, Canada; [Somayaji, Ranjani] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Somayaji, Ranjani] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada	University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Alberta; University of Calgary; University of Calgary	Edwards, BD (corresponding author), Univ Calgary, Dept Med, Calgary, AB, Canada.	bdedward@ucalgary.ca		Edwards, Brett/0000-0001-9608-2589				Ahmad N, 2018, LANCET, V392, P821, DOI 10.1016/S0140-6736(18)31644-1; Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Alfarisi O, 2017, EXPERT REV CLIN PHAR, V10, P1027, DOI 10.1080/17512433.2017.1366311; [Anonymous], GLOB TUB REP; [Anonymous], 2020, GOVT CANADA; [Anonymous], 2013, ECONOMIST, P9; [Anonymous], 2017, FAMILY VIOLENCE CANA; [Anonymous], 2018, ASTM C33C33M 18, DOI DOI 10.1520/C0033_C0033M-18; Asadi L, 2017, LANCET PUBLIC HEALTH, V2, pE450, DOI 10.1016/S2468-2667(17)30161-5; Bastos ML, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00803-2016; Boritsch EC, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0020-2016; Brode SK, 2015, CAN RESPIR J, V22, P97, DOI 10.1155/2015/359301; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; Cooper R., 2017, POLICY OPTIONS, P1; Dheda K, 2017, LANCET RESP MED, V5, P291, DOI [10.1016/S2213-2600(17)30079-6, 10.1016/s2213-2600(17)30079-6]; Edwards BD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229691; Elwood K, 2014, CANADIAN TUBERCULOSI, P1; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Falzon D, 2013, EUR RESPIR J, V42, P156, DOI 10.1183/09031936.00134712; Field SK, 2012, THER ADV RESPIR DIS, V6, P255, DOI 10.1177/1753465812452193; Fregonese F, 2018, LANCET RESP MED, V6, P265, DOI 10.1016/S2213-2600(18)30078-X; Gallant V., 2017, CAN COMMU DIS REP, V43, P236; Gegia M, 2017, LANCET INFECT DIS, V17, P223, DOI 10.1016/S1473-3099(16)30407-8; Hersi A, 1999, Can Respir J, V6, P155; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kim DH, 2008, AM J RESP CRIT CARE, V178, P1075, DOI 10.1164/rccm.200801-132OC; Kim J, 2008, INT J TUBERC LUNG D, V12, P1128; LaFreniere M, 2019, Can Commun Dis Rep, V45, P67, DOI 10.14745/ccdr.v45i23a04; LaFreniere Marie, 2020, Can Commun Dis Rep, V46, P9, DOI 10.14745/ccdr.v46i01a02; Lan ZY, 2020, LANCET RESP MED, V8, P383, DOI 10.1016/S2213-2600(20)30047-3; Leung ECC, 2011, EUR RESPIR J, V38, P227, DOI 10.1183/09031936.00186310; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032158; Long R, 1999, AM J RESP CRIT CARE, V159, P2014, DOI 10.1164/ajrccm.159.6.9809076; Long R., 2014, CANADIAN TUBERCULOSI, P1; Long R., 2007, CANADIAN TUBERCULOSI, P146; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Minion J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053466; Mitchison DA, 2000, INT J TUBERC LUNG D, V4, P796; Mitnick CD., 2020, EMERG INFECT DIS; Moonan PK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-19; Nahid P, 2019, AM J RESP CRIT CARE, V200, pE93, DOI 10.1164/rccm.201909-1874ST; Nunn AJ, 2019, NEW ENGL J MED, V380, P1201, DOI 10.1056/NEJMoa1811867; Pareek M, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0595-5; Romanowski K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211355; Smith T, 2014, CURR TOP MICROBIOL, V374, P53, DOI 10.1007/82_2012_279; Subramanian P, 2013, EUR RESPIR J, V42, pP2820; Wallis RS, 2016, LANCET INFECT DIS, V16, pE34, DOI 10.1016/S1473-3099(16)00070-0; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2008, COMMISSION SOCIAL DE, P1; World Health Organization, 2006, COMMUNICATION, P1; Wu SS, 2016, AM J THER, V23, pE521, DOI 10.1097/01.mjt.0000433951.09030.5a; Yin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150511	53	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246993	10.1371/journal.pone.0246993	http://dx.doi.org/10.1371/journal.pone.0246993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592031	Green Published, gold			2022-12-26	WOS:000620632800030
J	Latkin, CA; Dayton, L; Yi, G; Colon, B; Kong, XR				Latkin, Carl A.; Dayton, Lauren; Yi, Grace; Colon, Brian; Kong, Xiangrong			Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US	PLOS ONE			English	Article							ATTITUDES; BEHAVIOR; HESITANCY; IMPACT	Vaccine hesitancy could become a significant impediment to addressing the COVID-19 pandemic. The current study examined the prevalence of COVID-19 vaccine hesitancy and factors associated with vaccine intentions. A national panel survey by the National Opinion Research Center (NORC) was designed to be representative of the US household population. Sampled respondents were invited to complete the survey between May 14 and 18, 2020 in English or Spanish. 1,056 respondents completed the survey-942 via the web and 114 via telephone. The dependent variable was assessed by the item "If a vaccine against the coronavirus becomes available, do you plan to get vaccinated, or not?" Approximately half (53.6%) reported intending to be vaccinated, 16.7% did not intend, and 29.7% were unsure. In the adjusted stepwise multinominal logistic regression, Black and Hispanic respondents were significantly less likely to report intending to be vaccinated as were respondents who were females, younger, and those who were more politically conservative. Compared to those who reported positive vaccine intentions, respondents with negative vaccine intentions were significantly less likely to report that they engaged in the COVID-19 prevention behaviors of wearing masks (aOR = 0.53, CI = 0.37-0.76) and social distancing (aOR = 0.22, CI = 0.12-0.42). In a sub-analysis of reasons not to be vaccinated, significant race/ethnic differences were observed. This national survey indicated a modest level of COVID-19 vaccine intention. These data suggest that public health campaigns for vaccine uptake should assess in greater detail the vaccine concerns of Blacks, Hispanics, and women to tailor programs.	[Latkin, Carl A.; Dayton, Lauren; Yi, Grace] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21218 USA; [Colon, Brian] Johns Hopkins Univ, Krieger Sch Arts & Sci, Baltimore, MD USA; [Kong, Xiangrong] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Latkin, CA (corresponding author), Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21218 USA.	clatkin@jhsph.edu			National Institute on Drug Abuse (US) [R01 DA040488]; Johns Hopkins Alliance for a Healthier World	National Institute on Drug Abuse (US); Johns Hopkins Alliance for a Healthier World	This study received support from the following sources: National Institute on Drug Abuse (US), grant R01 DA040488, awarded to CAL; Johns Hopkins Alliance for a Healthier World, awarded to CAL.	Amin AB, 2017, NAT HUM BEHAV, V1, P873, DOI 10.1038/s41562-017-0256-5; Bhala N, 2020, LANCET, V395, P1673, DOI 10.1016/S0140-6736(20)31102-8; Buckman C, 2020, SOC SCI MED, V260, DOI 10.1016/j.socscimed.2020.113187; Cacciatore MA, 2018, RISK ANAL, V38, P2178, DOI 10.1111/risa.13120; Centers for Disease Control and Prevention, FLU VACCINATION COVE; Chaudhry R, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100464; Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y; Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212; Giese H, 2020, VACCINE, V38, P2070, DOI 10.1016/j.vaccine.2019.11.038; Hogg MA, 1995, SOC PSYCHOL QUART, V58, P255, DOI 10.2307/2787127; Hornsey MJ, 2018, HEALTH PSYCHOL, V37, P307, DOI 10.1037/hea0000586; KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Martinie MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180531; Megget K, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2184; Mills EJ, 2005, J CLIN EPIDEMIOL, V58, P1101, DOI 10.1016/j.jclinepi.2005.01.014; National Center for Health Statistics, 2020, PROV DEATH COUNTS CO; Opel DJ, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0802; Peretti-Watel P, 2020, LANCET INFECT DIS, V20, P769, DOI 10.1016/S1473-3099(20)30426-6; Quinn SC, 2017, VACCINE, V35, P7154, DOI 10.1016/j.vaccine.2017.10.083; Quinn SC, 2017, VACCINE, V35, P1167, DOI 10.1016/j.vaccine.2016.12.046; Sheeran P, 2016, HEALTH PSYCHOL, V35, P1178, DOI 10.1037/hea0000387; The Associated Press-NORC Center for Public Affairs Research, MAY 2020 AP NORC CTR; The Associated Press-NORC Center for Public Affairs Research, EXP COVID 19 VACC MA; WHO, DRAFT LANDSC COVID 1; Zuk P, 2020, GLOB PUBLIC HEALTH, V15, P790, DOI 10.1080/17441692.2020.1718733	26	100	101	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246970	10.1371/journal.pone.0246970	http://dx.doi.org/10.1371/journal.pone.0246970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8MA	33592035	Green Published, gold			2022-12-26	WOS:000620632800055
J	Rider, NL; Cahill, G; Motazedi, T; Wei, L; Kurian, A; Noroski, LM; Seeborg, FO; Chinn, IK; Roberts, K				Rider, Nicholas L.; Cahill, Gina; Motazedi, Tina; Wei, Lei; Kurian, Ashok; Noroski, Lenora M.; Seeborg, Filiz O.; Chinn, Ivan K.; Roberts, Kirk			PI Prob: A risk prediction and clinical guidance system for evaluating patients with recurrent infections	PLOS ONE			English	Article								Background Primary immunodeficiency diseases represent an expanding set of heterogeneous conditions which are difficult to recognize clinically. Diagnostic rates outside of the newborn period have not changed appreciably. This concern underscores a need for novel methods of disease detection. Objective We built a Bayesian network to provide real-time risk assessment about primary immunodeficiency and to facilitate prescriptive analytics for initiating the most appropriate diagnostic work up. Our goal is to improve diagnostic rates for primary immunodeficiency and shorten time to diagnosis. We aimed to use readily available health record data and a small training dataset to prove utility in diagnosing patients with relatively rare features. Methods We extracted data from the Texas Children's Hospital electronic health record on a large population of primary immunodeficiency patients (n = 1762) and appropriately-matched set of controls (n = 1698). From the cohorts, clinically relevant prior probabilities were calculated enabling construction of a Bayesian network probabilistic model(PI Prob). Our model was constructed with clinical-immunology domain expertise, trained on a balanced cohort of 100 cases-controls and validated on an unseen balanced cohort of 150 cases-controls. Performance was measured by area under the receiver operator characteristic curve (AUROC). We also compared our network performance to classic machine learning model performance on the same dataset. Results PI Prob was accurate in classifying immunodeficiency patients from controls (AUROC = 0.945; p<0.0001) at a risk threshold of >= 6%. Additionally, the model was 89% accurate for categorizing validation cohort members into appropriate International Union of Immunological Societies diagnostic categories. Our network outperformed 3 other machine learning models and provides superior transparency with a prescriptive output element. Conclusion Artificial intelligence methods can classify risk for primary immunodeficiency and guide management. PI Prob enables accurate, objective decision making about risk and guides the user towards the appropriate diagnostic evaluation for patients with recurrent infections. Probabilistic models can be trained with small datasets underscoring their utility for rare disease detection given appropriate domain expertise for feature selection and network construction.	[Rider, Nicholas L.; Cahill, Gina; Noroski, Lenora M.; Seeborg, Filiz O.; Chinn, Ivan K.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Rider, Nicholas L.; Cahill, Gina; Noroski, Lenora M.; Seeborg, Filiz O.; Chinn, Ivan K.] Texas Childrens Hosp, Sect Immunol Allergy & Retrovirol, Houston, TX 77030 USA; [Rider, Nicholas L.; Wei, Lei; Kurian, Ashok] Texas Childrens Hosp, Dept Informat Serv, Houston, TX 77030 USA; [Motazedi, Tina] Massachusetts Gen Hosp, Div Allergy & Immunol, Boston, MA 02114 USA; [Roberts, Kirk] Univ Texas Houston, Sch Biomed Informat, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Health Science Center Houston	Rider, NL (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Rider, NL (corresponding author), Texas Childrens Hosp, Sect Immunol Allergy & Retrovirol, Houston, TX 77030 USA.; Rider, NL (corresponding author), Texas Childrens Hosp, Dept Informat Serv, Houston, TX 77030 USA.	nlrider@bcm.edu	Roberts, Kirk/AAZ-4169-2021	Roberts, Kirk/0000-0001-6525-5213; Chinn, Ivan/0000-0001-5684-5457	Jeffrey Modell Foundation (JMF Translational Grant) [482 58293-I]	Jeffrey Modell Foundation (JMF Translational Grant)	This study was funded by the Jeffrey Modell Foundation (JMF Translational Grant-482 58293-I).	Amirkhani H, 2017, IEEE T PATTERN ANAL, V39, P2154, DOI 10.1109/TPAMI.2016.2636828; Arora P, 2019, VALUE HEALTH, V22, P439, DOI 10.1016/j.jval.2019.01.006; Bonilla FA, 2015, J ALLERGY CLIN IMMUN, V136, P1186, DOI 10.1016/j.jaci.2015.04.049; cdc, MANAGING RISK MENING; CDC, CLIN INFORM MENINGOC; Constantinou AC, 2016, ARTIF INTELL MED, V67, P75, DOI 10.1016/j.artmed.2016.01.002; Costa-Carvalho BT, 2014, J CLIN IMMUNOL, V34, P10, DOI 10.1007/s10875-013-9954-6; Daly R, 2011, KNOWL ENG REV, V26, P99, DOI 10.1017/S0269888910000251; Esteva A, 2019, NAT MED, V25, P24, DOI 10.1038/s41591-018-0316-z; Heckerman D, 1996, IEEE T SYST MAN CY A, V26, P826, DOI 10.1109/3468.541341; HECKERMAN DE, 1992, METHOD INFORM MED, V31, P106; HECKERMAN DE, 1992, METHOD INFORM MED, V31, P90; Heckerman DE, 1995, CONTRACT NO MSR T 95; Hosny A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002711; Huang SS, 2011, VACCINE, V29, P3398, DOI 10.1016/j.vaccine.2011.02.088; Islam MS, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6020054; Korb K., 2011, BAYSIAN ARTIFICIAL I; Kwan A, 2014, JAMA-J AM MED ASSOC, V312, P729, DOI 10.1001/jama.2014.9132; Li M, 2018, INT J DISAST RISK SC, V9, P237, DOI 10.1007/s13753-018-0171-z; Loghmanpour NA, 2016, JACC-HEART FAIL, V4, P711, DOI 10.1016/j.jchf.2016.04.004; Lucas PJF, 2004, ARTIF INTELL MED, V30, P201, DOI 10.1016/j.artmed.2003.11.001; Modell V, 2011, IMMUNOL RES, V51, P61, DOI 10.1007/s12026-011-8241-y; Odnoletkova I, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0941-0; Onisko A, 2019, DIAGN CYTOPATHOL, V47, P41, DOI 10.1002/dc.23993; Onisko A, 2013, ARTIF INTELL MED, V57, P197, DOI 10.1016/j.artmed.2013.01.004; Rider NL, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00070; Sadeghi B, 2015, EXPERT REV CLIN IMMU, V11, P681, DOI 10.1586/1744666X.2015.1029457; Sanchez-Vega F, 2013, IEEE T PATTERN ANAL, V35, P398, DOI 10.1109/TPAMI.2012.96; Sendak M. P, 2020, EMJ INNOV, V10, P19, DOI [10.33590/emjinnov/19-00172, DOI 10.33590/EMJINNOV/19-00172]; Sesen MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082349; Stojadinovic A, 2013, ANN SURG ONCOL, V20, P161, DOI 10.1245/s10434-012-2555-4; Stray-Pedersen A, 2017, J ALLERGY CLIN IMMUN, V139, P232, DOI 10.1016/j.jaci.2016.05.042; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; Tcheng JE, 2017, OPTIMIZING STRATEGIE; Topol E., 2019, DEEP MED ARTIFICIAL; Wasyluk H, 2001, Med Sci Monit, V7 Suppl 1, P327; Wiens J, 2019, NAT MED, V25, P1627, DOI 10.1038/s41591-019-0609-x; Zhang Q, 2017, CURR OPIN IMMUNOL, V48, P122, DOI 10.1016/j.coi.2017.09.002	38	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0237285	10.1371/journal.pone.0237285	http://dx.doi.org/10.1371/journal.pone.0237285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33591972	gold, Green Submitted, Green Published			2022-12-26	WOS:000620632800067
J	Robinson, DP; Hyland, K; Beukes, G; Vettan, A; Mabadikate, A; Jabado, RW; Rohner, CA; Pierce, SJ; Baverstock, W				Robinson, David P.; Hyland, Kevin; Beukes, Gerhard; Vettan, Abdulkareem; Mabadikate, Aneeshkumar; Jabado, Rima W.; Rohner, Christoph A.; Pierce, Simon J.; Baverstock, Warren			Satellite tracking of rehabilitated sea turtles suggests a high rate of short-term survival following release	PLOS ONE			English	Article								The rehabilitation of wildlife can contribute directly to the conservation of threatened species by helping to maintain wild populations. This study focused on determining the post-rehabilitation survival and spatial ecology of sea turtles and on comparing the movements of individuals with flipper amputations (amputees) to non-amputee animals. Our aims were to assess whether rehabilitated sea turtles survive after release, to compare and contrast the movement characteristics of the different species of sea turtles we tracked, and to examine whether amputees and non-amputees within species behaved similarly post-release. Twenty-six rehabilitated sea turtles from four species, including hawksbill Eretmochelys imbricata (n = 12), loggerhead Caretta caretta (n = 11), green Chelonia mydas (n = 2), and olive ridley Lepidochelys olivacea (n = 1) sea turtles from the United Arab Emirates were fitted with satellite tags before release. Rehabilitation times ranged from 89 to 817 days (mean 353 +/- 237 days). Post-release movements and survival were monitored for 8 to 387 days (mean 155 +/- 95 days) through satellite tracking. Tag data suggested that three tracked sea turtles died within four days of release, one after 27 days, and one after 192 days from what are thought to be anthropogenic factors unrelated to their pre-rehabilitation ailments. We then compared habitat use and movement characteristics among the different sea turtle species. Although half of all turtles crossed one or more international boundaries, dispersal varied among species. Loggerhead turtles had a high dispersal, with 80% crossing an international boundary, while hawksbill turtles displayed higher post-release residency, with 66% remaining within UAE territorial waters. Amputee turtles moved similarly to non-amputee animals of the same species. Loggerhead turtles travelled faster (mean +/- sd = 15.3 +/- 8 km/day) than hawksbill turtles (9 +/- 7 km/day). Both amputee and non-amputee sea turtles within a species moved similarly. Our tracking results highlight that rehabilitated sea turtles, including amputees, can successfully survive in the wild following release for up to our similar to one-year monitoring time therefore supporting the suitability for release of sea turtles that have recovered from major injuries such as amputations. However, more broadly, the high mortality from anthropogenic factors in the Arabian Gulf region is clearly a serious issue and conservation challenge.	[Robinson, David P.; Hyland, Kevin; Beukes, Gerhard; Vettan, Abdulkareem; Mabadikate, Aneeshkumar; Baverstock, Warren] Dubai Turtle Rehabil Project, Dubai, U Arab Emirates; [Robinson, David P.] Sundive Res, Byron Bay, NSW, Australia; [Robinson, David P.; Rohner, Christoph A.; Pierce, Simon J.] Marine Megafauna Fdn, Truckee, CA 96161 USA; [Hyland, Kevin] Wildlife Protect Off, Dubai, U Arab Emirates; [Beukes, Gerhard; Vettan, Abdulkareem; Mabadikate, Aneeshkumar] Jumeirah Grp, Dubai, U Arab Emirates; [Jabado, Rima W.] Elasmo Project, Dubai, U Arab Emirates; [Baverstock, Warren] Amaala, Riyadh, Saudi Arabia		Robinson, DP (corresponding author), Dubai Turtle Rehabil Project, Dubai, U Arab Emirates.; Robinson, DP (corresponding author), Sundive Res, Byron Bay, NSW, Australia.; Robinson, DP (corresponding author), Marine Megafauna Fdn, Truckee, CA 96161 USA.	david@sundive.com.au		Rohner, Christoph/0000-0001-8760-8972; Jabado, Rima/0000-0001-6239-6723				Aitken G, 2018, NEW APPROACH CONSERV; Baker L, 2015, ENDANGER SPECIES RES, V29, P13, DOI 10.3354/esr00696; Bentivegna F., 1993, MAR TURT NEWSL, V61, P6; Bentivegna F, 1996, P 16 ANN S SEA TURTL, P20; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Blumenthal J.M., 2006, ENDANGER SPECIES RES, V2, P51, DOI [DOI 10.3354/ESR00044, 10.3354/esr002051]; Caliendo Valentina, 2010, Journal of Herpetological Medicine and Surgery, V20, P117, DOI 10.5818/1529-9651-20.4.117; Cardona L, 2012, AQUAT CONSERV, V22, P104, DOI 10.1002/aqc.1242; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Gasperetti J, 1993, TURTLES ARABIA FAUNA, V13, P170; Gilbert J, 2011, QUEENSL COAST C AUST; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Hays GC, 2003, MAR ECOL PROG SER, V262, P305, DOI 10.3354/meps262305; Hays GC, 2014, CONSERV BIOL, V28, P1636, DOI 10.1111/cobi.12325; Hochscheid S, 2007, MAR ECOL PROG SER, V340, P287, DOI 10.3354/meps340287; Horikoshi K., 1994, P 14 ANN S SEA TURTL, P1; Jabado R., 2012, MARINE ECOSYSTEMS UN; Jeffers VF, 2016, BIOL CONSERV, V199, P172, DOI 10.1016/j.biocon.2016.04.032; Kami HG, 2013, IRANIAN COASTAL WATE, P37; Kirkwood JK, 2013, ANIM WELFARE, V22, P147, DOI 10.7120/09627286.22.1.147; MacLeod C., 2013, INTRO USING GIS MARI; Mestre F, 2014, MAR BIOL RES, V10, P996, DOI 10.1080/17451000.2013.872801; Natoli A, 2017, J EXP MAR BIOL ECOL, V491, P9, DOI 10.1016/j.jembe.2017.01.009; Pilcher NJ, 2015, ENDANGER SPECIES RES, V28, P163, DOI 10.3354/esr00688; Pilcher NJ, 2014, J EXP MAR BIOL ECOL, V460, P89, DOI 10.1016/j.jembe.2014.06.009; Pilcher NJ, 1999, MAR POLLUT BULL, V38, P966, DOI 10.1016/S0025-326X(99)00110-1; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; Rees AF, 2013, CHELONIAN CONSERV BI, V12, P157; Rees AF, 2012, MAR ECOL PROG SER, V450, P195, DOI 10.3354/meps09527; Rees AF, 2010, MAR ECOL PROG SER, V418, P201, DOI 10.3354/meps08767; Robinson DP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184286; Ross J.P., 1982, BIOL CONSERVATION SE, P373; Schofield G, 2020, ECOLOGY, V101, DOI 10.1002/ecy.3027; Sheppard C, 2010, MAR POLLUT BULL, V60, P13, DOI 10.1016/j.marpolbul.2009.10.017; Thomson JA, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3225-7; Trendler K, 1995, P SASOL S WILDL REH; Wallace BP, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00388.1; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Wilson S., 2002, STATUS CORAL REEFS W, P53; Wimberger K, 2010, ANIM WELFARE, V19, P481; Yaghmour F, 2018, MAR POLLUT BULL, V135, P55, DOI 10.1016/j.marpolbul.2018.07.013	42	4	4	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246241	10.1371/journal.pone.0246241	http://dx.doi.org/10.1371/journal.pone.0246241			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592007	Green Published, gold			2022-12-26	WOS:000620632800045
J	Li, A; Yuen, SL; Stroik, DR; Kleinboehl, E; Cornea, RL; Thomas, DD				Li, Ang; Yuen, Samantha L.; Stroik, Daniel R.; Kleinboehl, Evan; Cornea, Razvan L.; Thomas, David D.			The transmembrane peptide DWORF activates SERCA2a via dual mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLAMBAN; ISOFORMS; DYNAMICS; MUTANTS	The Ca-ATPase isoform 2a (SERCA2a) pumps cytosolic Ca2+ into the sarcoplasmic reticulum (SR) of cardiac myocytes, enabling muscle relaxation during diastole. Abnormally high cytosolic [Ca2+] is a central factor in heart failure, suggesting that augmentation of SERCA2a Ca2+ transport activity could be a promising therapeutic approach. SERCA2a is inhibited by the protein phospholamban (PLB), and a novel transmembrane peptide, dwarf open reading frame (DWORF), is proposed to enhance SR Ca2+ uptake and myocyte contractility by displacing PLB from binding to SERCA2a. However, establishing DWORF's precise physiological role requires further investigation. In the present study, we developed cell-based FRET biosensor systems that can report on protein-protein interactions and structural changes in SERCA2a complexes with PLB and/or DWORF. To test the hypothesis that DWORF competes with PLB to occupy the SERCA2a-binding site, we transiently transfected DWORF into a stable HEK cell line expressing SERCA2a labeled with a FRET donor and PLB labeled with a FRET acceptor. We observed a significant decrease in FRET efficiency, consistent with a decrease in the fraction of SERCA2a bound to PLB. Surprisingly, we also found that DWORF also activates SERCA's enzymatic activity directly in the absence of PLB at subsaturating calcium levels. Using site-directed mutagenesis, we generated DWORF variants that do not activate SERCA, thus identifying residues P15 and W22 as necessary for functional SERCA2a-DWORF interactions. This work advances our mechanistic understanding of the regulation of SERCA2a by small transmembrane proteins and sets the stage for future therapeutic development in heart failure research.	[Li, Ang; Yuen, Samantha L.; Stroik, Daniel R.; Kleinboehl, Evan; Cornea, Razvan L.; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Thomas, DD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	DDT@ddt.umn.edu		Thomas, David D./0000-0002-8822-2040; Cornea, Razvan/0000-0001-5739-0992	NIH [R01HL139065, R37AG026160]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NIH grants R01HL139065 (to D. D. T. and R. L. C.; formerly R01GM027906) and R37AG026160 (to D. D. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Ceholski DK, 2018, J MOL CELL CARDIOL, V119, P147, DOI 10.1016/j.yjmcc.2018.05.007; Cornea RL, 2013, J BIOMOL SCREEN, V18, P97, DOI 10.1177/1087057112456878; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; Dong XQ, 2014, BIOCHEM BIOPH RES CO, V449, P196, DOI 10.1016/j.bbrc.2014.04.166; Gruber SJ, 2012, BIOCHEM BIOPH RES CO, V420, P236, DOI 10.1016/j.bbrc.2012.02.125; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Li J, 2012, J MOL BIOL, V418, P379, DOI 10.1016/j.jmb.2012.02.011; Liu ZH, 2020, HEART FAIL REV, V25, P523, DOI 10.1007/s10741-019-09873-3; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Makarewich CA, 2018, ELIFE, V7, DOI 10.7554/eLife.38319; McCarthy MR, 2020, BIOPHYS J, V118, P1090, DOI 10.1016/j.bpj.2020.01.010; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Muretta JM, 2015, P NATL ACAD SCI USA, V112, P14272, DOI 10.1073/pnas.1514859112; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Schaaf TM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051170; Schaaf TM, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8040099; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Singh DR, 2019, J MOL BIOL, V431, P4429, DOI 10.1016/j.jmb.2019.07.037; Smeazzetto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052744; Smith KA, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00517; Stammers AN, 2015, CAN J PHYSIOL PHARM, V93, P843, DOI 10.1139/cjpp-2014-0463; Stroik DR, 2020, J MOL CELL CARDIOL, V138, P59, DOI 10.1016/j.yjmcc.2019.11.147; Stroik DR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29685-z; THOMAS DD, 1994, PORTL PR P, P1	27	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100412	10.1016/j.jbc.2021.100412	http://dx.doi.org/10.1016/j.jbc.2021.100412			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33581112	gold, Green Published			2022-12-26	WOS:000672866400386
J	Onken, MD; Makepeace, CM; Kaltenbronn, KM; Choi, J; Hernandez-Aya, L; Weilbaecher, KN; Piggott, KD; Rao, PK; Yuede, CM; Dixon, AJ; Osei-Owusu, P; Cooper, JA; Blumer, KJ				Onken, Michael D.; Makepeace, Carol M.; Kaltenbronn, Kevin M.; Choi, Joelle; Hernandez-Aya, Leonel; Weilbaecher, Katherine N.; Piggott, Kisha D.; Rao, P. Kumar; Yuede, Carla M.; Dixon, Alethia J.; Osei-Owusu, Patrick; Cooper, John A.; Blumer, Kendall J.			Targeting primary and metastatic uveal melanoma with a G protein inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TREATMENT OPTIONS; MUTATIONS; GNAQ; DEFECTS; GENE; VALIDATION; YM-254890; OCCUR; G(Q); RB	Uveal melanoma (UM) is the most common intraocular tumor in adults. Nearly half of UM patients develop metastatic disease and often succumb within months because effective therapy is lacking. A novel therapeutic approach has been suggested by the discovery that UM cell lines driven by mutant constitutively active Gq or G11 can be targeted by FR900359 (FR) or YM-254890, which are bioavailable, selective inhibitors of the Gq/11/14 subfamily of heterotrimeric G proteins. Here, we have addressed the therapeutic potential of FR for UM. We found that FR inhibited all oncogenic Gq/11 mutants reported in UM. FR arrested growth of all Gq/11-driven UM cell lines tested, but induced apoptosis only in a few. Similarly, FR inhibited growth of, but did not efficiently kill, UM tumor cells from biopsies of primary or metastatic tumors. FR evoked melanocytic redifferentiation of UM tumor cells with low (class 1), but not high (class 2), metastatic potential. FR administered systemically below its LD50 strongly inhibited growth of PDX-derived class 1 and class 2 UM tumors in mouse xenograft models and reduced blood pressure transiently. FR did not regress xenografted UM tumors or significantly affect heart rate, liver function, hematopoiesis, or behavior. These results indicated the existence of a therapeutic window in which FR can be explored for treating UM and potentially other diseases caused by constitutively active Gq/11.	[Onken, Michael D.; Cooper, John A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Makepeace, Carol M.; Kaltenbronn, Kevin M.; Choi, Joelle; Blumer, Kendall J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Hernandez-Aya, Leonel; Weilbaecher, Katherine N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Piggott, Kisha D.; Rao, P. Kumar] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Yuede, Carla M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Dixon, Alethia J.; Osei-Owusu, Patrick] Drexel Univ, Coll Med, Dept Pharmacol & Physiol, Philadelphia, PA USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Drexel University	Blumer, KJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	kblumer@wustl.edu	Onken, Michael D/H-5620-2013	Onken, Michael D/0000-0003-4082-1105; Dixon, Alethia/0000-0002-4374-0688	NIH [GM124093, CA234533, GM118171, HL139754]; AHA [16SDG2726027]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association)	This work was supported by NIH grants GM124093 and CA234533 to K. J. B. GM118171 to J. A. C., and HL139754 to P. O. and by an AHA grant 16SDG2726027 to P. O.	Amirouchene-Angelozzi N, 2014, MOL ONCOL, V8, P1508, DOI 10.1016/j.molonc.2014.06.004; Annala S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau5948; Bichsel CA, 2019, JAMA OPHTHALMOL, V137, P91, DOI 10.1001/jamaophthalmol.2018.5141; Brantley MA, 2000, AM J PATHOL, V157, P1795, DOI 10.1016/S0002-9440(10)64817-1; Carvajal RD, 2017, BRIT J OPHTHALMOL, V101, P38, DOI 10.1136/bjophthalmol-2016-309034; Chen X, 2017, CANCER CELL, V31, P685, DOI 10.1016/j.ccell.2017.04.002; Chua V, 2017, MOL CANCER RES, V15, P501, DOI 10.1158/1541-7786.MCR-17-0007; Delston RB, 2011, ONCOGENE, V30, P588, DOI 10.1038/onc.2010.442; Dettlaff-Swiercz DA, 2005, DEV BIOL, V282, P174, DOI 10.1016/j.ydbio.2005.03.006; Eschelman DJ, 2013, SEMIN INTERVENT RAD, V30, P39, DOI 10.1055/s-0033-1333652; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Feng XD, 2019, CANCER CELL, V35, P457, DOI 10.1016/j.ccell.2019.01.009; Francis JH, 2019, OPHTHALMOLOGY, V126, P759, DOI 10.1016/j.ophtha.2018.12.011; FUJIOKA M, 1988, J ORG CHEM, V53, P2820, DOI 10.1021/jo00247a030; Gonsalves CF, 2019, RADIOLOGY, V293, P223, DOI 10.1148/radiol.2019190199; Graham DL, 2015, SYNAPSE, V69, P434, DOI 10.1002/syn.21830; Griewank KG, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00971.x; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hitchman T. D., 2020, CLIN CANCER RES; Johnson CP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178189; Joseph NM, 2018, AM J SURG PATHOL, V42, P1201, DOI 10.1097/PAS.0000000000001110; Kawasaki T, 2005, THROMB HAEMOSTASIS, V94, P184, DOI 10.1160/TH04-09-0635; Kawasaki T, 2003, THROMB HAEMOSTASIS, V90, P406, DOI 10.1160/TH03-02-0115; Kostenis E, 2020, J BIOL CHEM, V295, P5206, DOI 10.1074/jbc.REV119.007061; Krantz BA, 2017, CLIN OPHTHALMOL, V11, P279, DOI 10.2147/OPTH.S89591; Kusters-Vandevelde HVN, 2010, ACTA NEUROPATHOL, V119, P317, DOI 10.1007/s00401-009-0611-3; Lapadula D, 2019, MOL CANCER RES, V17, P963, DOI 10.1158/1541-7786.MCR-18-0574; Li D, 2014, J CLIN ENDOCR METAB, V99, pE1774, DOI 10.1210/jc.2014-1029; Matatall KA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-371; Matthey M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2288; Meleka MM, 2019, PHARMACOL RES, V141, P264, DOI 10.1016/j.phrs.2019.01.012; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Onken MD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6852; Onken MD, 2012, OPHTHALMOLOGY, V119, P1596, DOI 10.1016/j.ophtha.2012.02.017; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Owens EA, 2017, KIDNEY INT, V92, P1100, DOI 10.1016/j.kint.2017.04.044; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Sheng XA, 2016, EUR J CANCER, V65, P156, DOI 10.1016/j.ejca.2016.06.019; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Singh AD, 2005, OPHTHALMOLOGY, V112, P1784, DOI 10.1016/j.ophtha.2005.06.011; Sivaraj KK, 2015, CARDIOVASC RES, V108, P171, DOI 10.1093/cvr/cvv216; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Woll E, 1999, MELANOMA RES, V9, P575; Wozniak DF, 2004, NEUROBIOL DIS, V17, P403, DOI 10.1016/j.nbd.2004.08.006	52	11	11	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100403	10.1016/j.jbc.2021.100403	http://dx.doi.org/10.1016/j.jbc.2021.100403			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33577798	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400377
J	Rossi, M; Rana, I; Buonuomo, PS; Battafarano, G; Mariani, E; D'Agostini, M; Porzio, O; De Martino, V; Minisola, S; Macchiaiolo, M; De Vito, R; Vecchio, D; Gonfiantini, MV; Jenkner, A; Bartuli, A; Del Fattore, A				Rossi, Michela; Rana, Ippolita; Buonuomo, Paola Sabrina; Battafarano, Giulia; Mariani, Eda; D'Agostini, Matteo; Porzio, Ottavia; De Martino, Viviana; Minisola, Salvatore; Macchiaiolo, Marina; De Vito, Rita; Vecchio, Davide; Gonfiantini, Michaela Veronika; Jenkner, Alessandro; Bartuli, Andrea; Del Fattore, Andrea			Dysregulated miRNAs in bone cells of patients with Gorham-Stout disease	FASEB JOURNAL			English	Article						Gorham&#8208; Stout disease; miRNA; osteoblast; osteoclast	MASSIVE OSTEOLYSIS; OSTEOGENIC DIFFERENTIATION; DISAPPEARING BONE; MICRORNAS; LYMPHANGIOGENESIS; MECHANISM; REGULATORS; SERUM	Gorham-Stout disease (GSD) is a very rare disease characterized by increased bone erosion with angiomatous proliferation. The mechanisms underlying this disorder have not been deeply investigated. Due to its rarity, no guidelines are currently available for treatment and management of GSD. We recently evaluated the cellular alterations of the bone remodeling in patients showing that osteoclast precursors displayed increased ability to differentiate into osteoclasts and that affected osteoclasts resorb bone more actively than control cells. Moreover, osteoblasts isolated from a patient showed a defective ability to form mineralized nodules. In this paper, we investigated the molecular pathways involved in the cellular defects of GSD bone cells. For this study, we recruited nine patients and performed miRNome analysis of bone cells. Between the 178 miRNAs robustly expressed in GSD osteoclasts, significant modulation of three miRNAs (miR-1246, miR-1-3p, and miR-137-3p) involved in the regulation of osteoclast formation and activity or in the angiomatous proliferation was found in patients' cells. Interestingly, miR-1246 was also up-regulated in serum exosomes from patients. Analysis of miRNAs from patient osteoblasts suggested alteration of miR-204a-5p, miR-615-3p and miR-378a-3p regulating osteoblast function and differentiation. The resulting miRNA pattern may help to understand better the mechanisms involved in GSD and to identify new potential therapeutic targets for this rare disease.	[Rossi, Michela; Battafarano, Giulia; Del Fattore, Andrea] Bambino Gesu Pediat Hosp, IRCCS, Bone Physiopathol Res Unit, Genet & Rare Dis Res Div, Viale San Paolo 15, I-00146 Rome, Italy; [Rana, Ippolita; Buonuomo, Paola Sabrina; Macchiaiolo, Marina; Vecchio, Davide; Gonfiantini, Michaela Veronika; Bartuli, Andrea] Bambino Gesu Pediat Hosp, Rare Dis & Med Genet Unit, IRCCS, Rome, Italy; [Mariani, Eda] Bambino Gesu Pediat Hosp, IRCCS, Res Labs, Rome, Italy; [D'Agostini, Matteo; Porzio, Ottavia] Bambino Gesu Pediat Hosp, IRCCS, Clin Lab, Rome, Italy; [Porzio, Ottavia] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy; [De Martino, Viviana; Minisola, Salvatore] Sapienza Univ, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Rome, Italy; [De Vito, Rita] Bambino Gesu Pediat Hosp, IRCCS, Dept Histopathol, Rome, Italy; [Jenkner, Alessandro] Bambino Gesu Pediat Hosp, IRCCS, Div Immunol & Infect Dis, Rome, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Rome Tor Vergata; Sapienza University Rome; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Del Fattore, A (corresponding author), Bambino Gesu Pediat Hosp, IRCCS, Bone Physiopathol Res Unit, Genet & Rare Dis Res Div, Viale San Paolo 15, I-00146 Rome, Italy.	andrea.delfattore@opbg.net	Rossi, Michela/AAI-1642-2019; Vecchio, Davide/K-8166-2016; MARIANI, EDA/GNH-4218-2022; Battafarano, Giulia/N-8048-2013; macchiaiolo, marina/HGU-2371-2022; De Martino, Viviana/ABA-3813-2021	Vecchio, Davide/0000-0003-2907-3206; MARIANI, EDA/0000-0002-5119-0022; De Martino, Viviana/0000-0002-7034-7718; ROSSI, MICHELA/0000-0002-6844-6469; Battafarano, Giulia/0000-0002-9297-5184	University of Pennsylvania [MDBR-17-116-GLA/GSD59]; Italian Ministry of Health	University of Pennsylvania; Italian Ministry of Health(Ministry of Health, Italy)	University of Pennsylvania, Grant/Award Number: #MDBR-17-116-GLA/GSD59; Italian Ministry of Health	[Anonymous], 1838, BOSTON MED SURG J; Bhagirath D, 2018, CANCER RES, V78, P1833, DOI 10.1158/0008-5472.CAN-17-2069; Brodszki N, 2011, ACTA PAEDIATR, V100, P1448, DOI 10.1111/j.1651-2227.2011.02361.x; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Colucci S, 2006, J BONE MINER RES, V21, P207, DOI 10.1359/JBMR.051019; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; de Vries TJ, 2005, J CELL BIOCHEM, V94, P954, DOI 10.1002/jcb.20326; Del Fattore A, 2006, J MED GENET, V43, P315, DOI 10.1136/jmg.2005.036673; Devlin RD, 1996, J CLIN ENDOCR METAB, V81, P1893, DOI 10.1210/jc.81.5.1893; DICKSON GR, 1990, BONE, V11, P205, DOI 10.1016/8756-3282(90)90215-K; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Eghbali-Fatourechi G, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0109-y; Feng L, 2020, MOL THER-NUCL ACIDS, V21, P1017, DOI 10.1016/j.omtn.2020.07.018; Feng QY, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180453; Garcia V, 2016, COLOMB MEDICA, V47, P213; GORHAM LW, 1955, J BONE JOINT SURG AM, V37, P985, DOI 10.2106/00004623-195537050-00008; GORHAM LW, 1954, AM J MED, V17, P674, DOI 10.1016/0002-9343(54)90027-3; Hagendoorn J, 2006, NAT CLIN PRACT ONCOL, V3, P693, DOI 10.1038/ncponc0660; Hammer F, 2005, J BONE MINER RES, V20, P350, DOI 10.1359/JBMR.041113; Harvey NL, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-15; HEFFEZ L, 1983, ORAL SURG ORAL MED O, V55, P331, DOI 10.1016/0030-4220(83)90185-8; Heyd R, 2011, INT J RADIAT ONCOL, V81, pE179, DOI 10.1016/j.ijrobp.2011.01.006; HEYDEN G, 1977, J BONE JOINT SURG AM, V59, P57, DOI 10.2106/00004623-197759010-00009; Hopman SMJ, 2012, AM J MED GENET A, V158A, P1719, DOI 10.1002/ajmg.a.35406; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Kar UP, 2017, J BIOSCIENCES, V42, P333, DOI 10.1007/s12038-017-9680-y; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Liu Y, 2016, CLIN RHEUMATOL, V35, P813, DOI 10.1007/s10067-014-2780-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00375; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Mahmoudi E, 2017, MOL PSYCHIATR, V22, P44, DOI 10.1038/mp.2016.150; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Mishima Y, 2007, CELL, V129, P247, DOI 10.1016/j.cell.2007.04.008; Mo Andrew Z, 2018, JBJS Case Connect, V8, pe70, DOI 10.2106/JBJS.CC.17.00287; Narayanan A, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116676; Rossi M, 2020, BONE, V130, DOI 10.1016/j.bone.2019.115068; Ruggieri P, 2011, SKELETAL RADIOL, V40, P1391, DOI 10.1007/s00256-010-1051-9; Sakha S, 2016, SCI REP-UK, V6, DOI 10.1038/srep38750; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang Y., 2018, BIOSCIENCE REP, V38; Yang QL, 2008, MATRIX BIOL, V27, P589, DOI 10.1016/j.matbio.2008.06.005; Yin JC, 2017, CELL BIOL INT, V41, P779, DOI 10.1002/cbin.10780; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zhang ZY, 2019, HEMATOL ONCOL, V37, P409, DOI 10.1002/hon.2639; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhu YZ, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07125-4; Zou X, 2020, GENE, V722, DOI 10.1016/j.gene.2019.144104; Zou YW, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017814	49	4	4	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21424	10.1096/fj.202001904RR	http://dx.doi.org/10.1096/fj.202001904RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33609323				2022-12-26	WOS:000629576700013
J	Akhtar, I; Stewart, FA; Harle, A; Droste, A; Beller, M				Akhtar, Irfan; Stewart, Fiona A.; Haerle, Anna; Droste, Andrea; Beller, Mathias			Visualization of endogenous gut bacteria in Drosophila melanogaster using fluorescence in situ hybridization	PLOS ONE			English	Article								All metazoans are colonized by a complex and diverse set of microorganisms. The microbes colonize all parts of the body and are especially abundant in the gastrointestinal tract, where they constitute the gut microbiome. The fruit fly Drosophila melanogaster turned out to be an exquisite model organism to functionally test the importance of an intact gut microbiome. Still, however, fundamental questions remain unanswered. For example, it is unknown whether a fine-tuned regionalization of the gut microbiome exists and how such a spatial organization could be established. In order to pave the way for answering this question, we generated an optimized and adapted fluorescence in situ hybridization (FISH) protocol. We focused on the detection of the two major Drosophila gut microbiome constituting bacteria genera: Acetobacter and Lactobacillus. FISH allows to detect the bacteria in situ and thus to investigate their spatial localization in respect to the host as well as to other microbiome members. We demonstrate the applicability of the protocol using a diverse set of sample types.	[Akhtar, Irfan; Stewart, Fiona A.; Haerle, Anna; Droste, Andrea; Beller, Mathias] Heinrich Heine Univ Dusseldorf, Inst Mathemat Modellierung Biolog Syst, Dusseldorf, Germany; [Akhtar, Irfan; Stewart, Fiona A.; Haerle, Anna; Droste, Andrea; Beller, Mathias] Heinrich Heine Univ Dusseldorf, Systembiol Fettstoffwechsels, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Beller, M (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Mathemat Modellierung Biolog Syst, Dusseldorf, Germany.; Beller, M (corresponding author), Heinrich Heine Univ Dusseldorf, Systembiol Fettstoffwechsels, Dusseldorf, Germany.	mathias.beller@hhu.de	Beller, Mathias/AAF-9153-2020	Akhtar, Irfan/0000-0003-1566-2755; Beller, Mathias/0000-0003-0987-0080	Bundesministerium fur Bildung und Forschung (BMBF) [031A306]; Deutsche Forschungsgemeinschaft (DFG) [INST 208/760-1FUGG]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The project was financed by the Bundesministerium fur Bildung und Forschung (BMBF grant 031A306 to MB) and in part by the Deutsche Forschungsgemeinschaft (DFG grant INST 208/760-1FUGG to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm EW, 1996, APPL ENVIRON MICROB, V62, P3557, DOI 10.1128/AEM.62.10.3557-3559.1996; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Castillo M, 2007, FEMS MICROBIOL ECOL, V59, P138, DOI 10.1111/j.1574-6941.2006.00204.x; Consuegra J, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101232; Earle KA, 2015, CELL HOST MICROBE, V18, P478, DOI 10.1016/j.chom.2015.09.002; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Grunwald S, 2010, SYST APPL MICROBIOL, V33, P25, DOI 10.1016/j.syapm.2009.10.002; Harmsen HJM, 2002, APPL ENVIRON MICROB, V68, P2982, DOI 10.1128/AEM.68.6.2982-2990.2002; Henriques SF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18049-9; Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787; Jarvinen AK, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-161; Johansson MEV, 2012, METHODS MOL BIOL, V842, P229, DOI 10.1007/978-1-61779-513-8_13; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kralik P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00108; LANGERSAFER PR, 1982, P NATL ACAD SCI-BIOL, V79, P4381, DOI 10.1073/pnas.79.14.4381; Lee WJ, 2013, ANNU REV CELL DEV BI, V29, P571, DOI 10.1146/annurev-cellbio-101512-122333; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Marx V, 2015, NAT METHODS, V12, P609, DOI 10.1038/nmeth.3443; Motro Yair, 2017, Biomol Detect Quantif, V14, P1, DOI 10.1016/j.bdq.2017.10.002; Pais IS, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005710; PUCHTLER H, 1968, HISTOCHEMISTRY, V16, P361, DOI 10.1007/BF00306359; Sannino DR, 2018, MBIO, V9, DOI 10.1128/mBio.00155-18; Sela S, 2005, APPL ENVIRON MICROB, V71, P4052, DOI 10.1128/AEM.71.7.4052-4056.2005; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Sghir A, 1998, SYST APPL MICROBIOL, V21, P291, DOI 10.1016/S0723-2020(98)80036-2; Simhadri RK, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00287-17, 10.1128/msphere.00287-17]; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Vacchini V, 2017, ENV MICROBIOL REP, V9, P91, DOI 10.1111/1758-2229.12505; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; Wang BH, 2017, ENGINEERING, V3, P71, DOI 10.1016/J.ENG.2017.01.008; Wang BH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32002; Wayland MT, 2014, J INSECT PHYSIOL, V69, P126, DOI 10.1016/j.jinsphys.2014.05.023	37	0	0	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247376	10.1371/journal.pone.0247376	http://dx.doi.org/10.1371/journal.pone.0247376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606846	Green Published, gold			2022-12-26	WOS:000620629200159
J	Geyer, S; Fleig, K; Norozi, K; Robbel, L; Paul, T; Muller, M; Dellas, C				Geyer, Siegfried; Fleig, Katharina; Norozi, Kambiz; Roebbel, Lena; Paul, Thomas; Mueller, Matthias; Dellas, Claudia			Life chances after surgery of congenital heart disease: A case-control-study of inter- and intragenerational social mobility over 15 years	PLOS ONE			English	Article								Background Patients of congenital heart disease surgery have good prospects for reaching old age. Against the backdrop of increasing life expectancies, the question of how well such patients are mastering daily routines and their working life emerges. In our study, the educational and occupational performance of patients over 15 years was examined. Methods Intergenerational social mobility (changes in social positions from the parental generation to the generation of children) was examined in terms of education, and intragenerational social mobility (changes in positions within the same generation, i.e., in individuals over their life courses) was examined in terms of occupational positions. Comparisons were made between patients and a control group drawn from the German Socio-Economic Panel (SOEP). Controls were drawn from respondents who participated in the 2004 and 2018 SOEP surveys. Results The data were from 244 out of 360 patients (68%) with complete social data from the first survey (2003-2004) and who were included in the follow-up (2017-2019), and 238 controls were drawn from the SOEP. At the time of the second survey, subjects' ages ranged from 28 to 59 years of age (M = 40.1 years). Intergenerational educational mobility did not differ between cases and controls. For intragenerational social mobility, downward changes were more frequent among controls. This latter finding may be explained by patients retiring earlier than the general population. Retirement rates increased over time, particularly among patients with severe congenital malformations. Unemployment rates were also higher among patients. Conclusions Taken together, although a considerable proportion of patients with congenital heart disease retired prematurely or never entered the labour force, their educational and occupational careers proceeded more favourably than expected.	[Geyer, Siegfried; Fleig, Katharina] Hannover Med Sch, Med Sociol Unit, Hannover, Germany; [Norozi, Kambiz] Western Univ, Dept Paediat, London, ON, Canada; [Norozi, Kambiz; Paul, Thomas; Mueller, Matthias; Dellas, Claudia] Univ Med Ctr, Dept Paediat Cardiol Intens Care & Pneumol, Gottingen, Germany; [Norozi, Kambiz] Hannover Med Sch, Dept Paediat Cardiol & Intens Care Med, Hannover, Germany; [Roebbel, Lena] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany	Hannover Medical School; Western University (University of Western Ontario); University of Gottingen; Hannover Medical School; Hannover Medical School	Geyer, S (corresponding author), Hannover Med Sch, Med Sociol Unit, Hannover, Germany.	geyer.siegfried@mh-hannover.de			German Research Foundation (Deutsche Forschungsgemeinschaft-DFG) [WE 2670/1-1, GE1167/2-1]; Stiftung Kinderherzen [WGO-014/2016]	German Research Foundation (Deutsche Forschungsgemeinschaft-DFG)(German Research Foundation (DFG)); Stiftung Kinderherzen	This report is based on two research projects. The first one was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft-DFG) under grant numbers WE 2670/1-1 and GE1167/2-1 to SG (URL: https://www.dfg.de) The follow-up was funded by Stiftung Kinderherzen, grant number WGO-014/2016 (URL: https://www.kinderherzen.de) to TP, KN and SG. The funders had not been involved in the study design, in the collection, analysis and interpretation of data, and in writing the manuscript.	[Anonymous], 2019, ARBEITSLOSE ARBEITSL; Apers S, 2016, J AM COLL CARDIOL, V67, P2237, DOI 10.1016/j.jacc.2016.03.477; Best KE, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002846; Brida M, 2019, ACTA PAEDIATR, V108, P1757, DOI 10.1111/apa.14921; Bygstad E, 2012, CARDIOL YOUNG, V22, P417, DOI 10.1017/S1047951111001934; CLARK VA, 1983, INT J EPIDEMIOL, V12, P193, DOI 10.1093/ije/12.2.193; Cook DA., 2015, CCMATCH PACKAGE DRAW; Enomoto J, 2020, PEDIATR INT, V62, P390, DOI 10.1111/ped.14152; Geis AJ., 2004, ZUMA NACHRICHTEN, V28, P29; Geyer S, 2007, EUR J CARDIOV PREV R, V14, P128, DOI 10.1097/01.hjr.0000238398.27471.39; Geyer S, 2009, CONGENIT HEART DIS, V4, P25, DOI 10.1111/j.1747-0803.2008.00239.x; Geyer Siegfried, 2008, Congenit Heart Dis, V3, P26, DOI 10.1111/j.1747-0803.2007.00159.x; Goebel J, 2019, JAHRB NATL STAT, V239, P345, DOI 10.1515/jbnst-2018-0022; Gramlich T, 2008, 129 DIW BERL; Greutmann M, 2012, FUTUR CARDIOL, V8, P171, DOI [10.2217/FCA.12.6, 10.2217/fca.12.6]; Groves RM, 2006, PUBLIC OPIN QUART, V70, P720, DOI 10.1093/poq/nfl036; Haisken-DeNew J.P., 2005, DTC DESKTOP COMPANIO; Hoffmann W, 2004, GESUNDHEITSWESEN, V66, P482, DOI 10.1055/s-2004-813094; ILO ILO, 2012, INT STANDARD CLASSIF; Karsenty C, 2015, ARCH CARDIOVASC DIS, V108, P589, DOI 10.1016/j.acvd.2015.06.004; Legewie N., 2018, DIW WEEKLY REPORT, V8, P169, DOI [DOI 10.18723/DIW_WB:2018-20-1, 10.18723/diw_wb:2018-20-1]; McCusker CG, 2013, CARDIOL YOUNG, V23, P507, DOI 10.1017/S1047951112001667; Mulkey SB, 2016, J PEDIATR-US, V178, P47, DOI 10.1016/j.jpeds.2016.06.063; Nieminen H, 2003, PEDIATRICS, V112, P1345, DOI 10.1542/peds.112.6.1345; Nieminen HP, 2001, CIRCULATION, V104, P570, DOI 10.1161/hc3101.093968; Norozi K, 2006, AM J CARDIOL, V97, P1238, DOI 10.1016/j.amjcard.2005.10.065; Perloff JK., 1998, CONGENITAL HEART DIS; Pfitzer C, 2018, CARDIOL YOUNG, V28, P32, DOI 10.1017/S104795111700138X; Pirzada A, 2004, AM J EPIDEMIOL, V159, P94, DOI 10.1093/aje/kwh012; Raissadati A, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015354; Sluman MA, 2019, CONGENIT HEART DIS, V14, P362, DOI 10.1111/chd.12747; STATA SC, 2007, STATA STAT SOFTWARE; Sticker EJ, 2013, CHRONISCHE ERKRANKUN, P90; Thorpe C, 2009, FAM PRACT, V26, P65, DOI 10.1093/fampra/cmn097; Zomer AC, 2012, AM J CARDIOL, V109, P1657, DOI 10.1016/j.amjcard.2012.01.397; Zunzunegui MV, 2001, J CLIN EPIDEMIOL, V54, P501, DOI 10.1016/S0895-4356(00)00325-5	36	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246169	10.1371/journal.pone.0246169	http://dx.doi.org/10.1371/journal.pone.0246169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606726	gold, Green Published			2022-12-26	WOS:000620629200168
J	Li, Y; Wei, JQ; Yang, HZ; Dai, J; Ge, XZ				Li, Ying; Wei, Jinqing; Yang, Huizhen; Dai, Jing; Ge, Xizhen			Molecular dynamics investigation of the interaction between Colletotrichum capsici cutinase and berberine suggested a mechanism for reduced enzyme activity	PLOS ONE			English	Article								Berberine is a promising botanical pesticide against fungal plant pathogens. However, whether berberine inhibits the invasion of fungal pathogen across plant surface remains unclear. Here we demonstrated that the enzyme activities of purified cutinase from fungal pathogen Colletotrichum capsici were partially inhibited in presence of berberine toward different substrates. Molecular dynamics simulation results suggested the rigidity of cutinase was decreased with berberine added into the system. Interestingly, aggregations of berberine to the catalytic center of cutinase were observed, and stronger hydrophobic interactions were detected between key residue His 208 and berberine with concentrations of berberine increased. More importantly, this hydrophobic interaction conferred conformational change of the imidazole ring of His 208, which swung out of the catalytic center to an inactive mode. In summary, we provided the molecular mechanism of the effect of berberine on cutinase from C. capsici.	[Li, Ying; Wei, Jinqing; Yang, Huizhen; Ge, Xizhen] Beijing Union Univ, Coll Biochem Engn, Beijing Key Lab Biomass Waste Resource Utilizat, Beijing, Peoples R China; [Dai, Jing] Beijing Aerosp Petrochem EC & EP Technol Co Ltd, Beijing, Peoples R China	Beijing Union University	Ge, XZ (corresponding author), Beijing Union Univ, Coll Biochem Engn, Beijing Key Lab Biomass Waste Resource Utilizat, Beijing, Peoples R China.	shtxizhen@buu.edu.cn		Ge, Xizhen/0000-0001-6495-0361; Li, Ying/0000-0001-8321-022X	Beijing Municipal Commission of Education [KZ201911417049]; Special Project of Major Science and Technology of Hebei Province [19026517Z]; Beijing Municipal Education Commission Technology Plan [KM202011417006]	Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Special Project of Major Science and Technology of Hebei Province; Beijing Municipal Education Commission Technology Plan	Ying Li and Xizhen Ge received funding from Beijing Municipal Commission of Education [KZ201911417049]; Special Project of Major Science and Technology of Hebei Province [19026517Z]; Beijing Municipal Education Commission Technology Plan [KM202011417006]. The funders only provided financial support in the form of research materials while had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mrs Jing Dai is a staff of the commercial company 'Beijing Aerospace Petrochemical EC&EP Technology Co., Ltd'. This company only provided salaries for Mrs Jing Dai.	Carvalho CML, 1999, BIOTECHNOL BIOENG, V66, P17, DOI 10.1002/(SICI)1097-0290(1999)66:1&lt;17::AID-BIT2&gt;3.0.CO;2-F; Chen S, 2013, BIOTECHNOL ADV, V31, P1754, DOI 10.1016/j.biotechadv.2013.09.005; Domadia PN, 2008, BIOCHEMISTRY-US, V47, P3225, DOI 10.1021/bi7018546; Gross C, 2017, J CHEM INF MODEL, V57, P243, DOI 10.1021/acs.jcim.6b00556; Heredia A, 2003, BBA-GEN SUBJECTS, V1620, P1, DOI 10.1016/S0304-4165(02)00510-X; Hou DY, 2010, CROP PROT, V29, P979, DOI 10.1016/j.cropro.2010.05.015; Hu XY, 2016, POLYM DEGRAD STABIL, V134, P211, DOI 10.1016/j.polymdegradstab.2016.10.012; Hu YJ, 2009, BIOMACROMOLECULES, V10, P517, DOI 10.1021/bm801120k; Kannangara R, 2007, PLANT CELL, V19, P1278, DOI 10.1105/tpc.106.047076; Kjolbye LR, 2019, J CHEM INF MODEL, V59, P1977, DOI 10.1021/acs.jcim.8b00857; KOLLER W, 1995, CAN J BOT, V73, pS1109, DOI 10.1139/b95-366; Li Y, 2018, J ASIAN NAT PROD RES, V20, P148, DOI 10.1080/10286020.2017.1329300; Longhi S, 1997, PROTEIN SCI, V6, P275; MAITI IB, 1979, SCIENCE, V205, P507, DOI 10.1126/science.205.4405.507; MANNESSE MLM, 1995, BIOCHEMISTRY-US, V34, P6400, DOI 10.1021/bi00019a020; Matak MY, 2009, BIOCHEM BIOPH RES CO, V390, P201, DOI 10.1016/j.bbrc.2009.09.073; Miyakawa T, 2015, APPL MICROBIOL BIOT, V99, P4297, DOI 10.1007/s00253-014-6272-8; Nyon MP, 2009, J MOL BIOL, V385, P226, DOI 10.1016/j.jmb.2008.10.050; Pei QH, 2019, CROP PROT, V116, P92, DOI 10.1016/j.cropro.2018.10.017; Schue M, 2010, FASEB J, V24, P1893, DOI 10.1096/fj.09-144766; SEBASTIAO MJ, 1993, BIOTECHNOL BIOENG, V42, P326, DOI 10.1002/bit.260420309; Serralha FN, 2001, CATAL LETT, V73, P63, DOI 10.1023/A:1016660913912; STAHL DJ, 1992, PLANT CELL, V4, P621, DOI 10.1105/tpc.4.6.621; TRAIL F, 1990, PHYSIOL MOL PLANT P, V36, P495, DOI 10.1016/0885-5765(90)90022-P; TRAIL F, 1993, PHYSIOL MOL PLANT P, V42, P205, DOI 10.1006/pmpp.1993.1019; Walters DR, 2007, ANN APPL BIOL, V151, P307, DOI 10.1111/j.1744-7348.2007.00176.x; Xing SF, 2014, PLANT J, V79, P270, DOI 10.1111/tpj.12559; Yu JS, 2002, SPECTROCHIM ACTA A, V58, P249, DOI 10.1016/S1386-1425(01)00536-4	28	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247236	10.1371/journal.pone.0247236	http://dx.doi.org/10.1371/journal.pone.0247236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606796	Green Published, gold			2022-12-26	WOS:000620629200026
J	Pascottini, OB; Spricigo, JFW; Van Schyndel, SJ; Mion, B; Rousseau, J; Weese, JS; LeBlanc, SJ				Pascottini, O. Bogado; Spricigo, J. F. W.; Van Schyndel, S. J.; Mion, B.; Rousseau, J.; Weese, J. S.; LeBlanc, S. J.			Effects of parity, blood progesterone, and non-steroidal anti-inflammatory treatment on the dynamics of the uterine microbiota of healthy postpartum dairy cows	PLOS ONE			English	Article							BIRTH-WEIGHT; CALVING EASE; MORTALITY; METRITIS; HOLSTEIN; GENE	This study evaluated the effects of treatment with meloxicam (a non-steroidal anti-inflammatory drug), parity, and blood progesterone concentration on the dynamics of the uterine microbiota of 16 clinically healthy postpartum dairy cows. Seven primiparous and 9 multiparous postpartum Holstein cows either received meloxicam (0.5 mg/kg SC, n = 7 cows) once daily for 4 days (10 to 13 days in milk (DIM)) or were untreated (n = 9 cows). Endometrial cytology samples were collected by cytobrush at 10, 21, and 35 DIM, from which the microbiota analysis was conducted using 16S rRNA gene sequence analysis. A radioimmunoassay was used to measure progesterone concentration in blood serum samples at 35 DIM and cows were classified as > 1 ng/mL (n = 10) or <= 1 ng/mL (n = 6). Alpha diversity for bacterial genera (Chao1, Shannon-Weiner, and Camargo's evenness indices) were not affected by DIM, meloxicam treatment, parity, or progesterone category. For beta diversity (genera level), principal coordinate analysis (Bray-Curtis) showed differences in microbiota between parity groups. At the phylum level, the relative abundance of Actinobacteria was greater in primiparous than multiparous cows. At the genus level, there was lesser relative abundance of Bifidobacterium, Lactobacillus, Neisseriaceae, Paracoccus, Staphylococcus, and Streptococcus and greater relative abundance of Bacillus and Fusobacterium in primiparous than multiparous cows. Bray-Curtis dissimilarity did not differ by DIM at sampling, meloxicam treatment, or progesterone category at 35 DIM. In conclusion, uterine bacterial composition was not different at 10, 21, or 35 DIM, and meloxicam treatment or progesterone category did not affect the uterine microbiota in clinically healthy postpartum dairy cows. Primiparous cows presented a different composition of uterine bacteria than multiparous cows. The differences in microbiota associated with parity might be attributable to changes that occur consequent to the first calving, but this hypothesis should be investigated further.	[Pascottini, O. Bogado; Van Schyndel, S. J.; LeBlanc, S. J.] Univ Guelph, Ontario Vet Coll, Populat Med, Guelph, ON, Canada; [Spricigo, J. F. W.; Mion, B.] Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada; [Rousseau, J.; Weese, J. S.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada	University of Guelph; University of Guelph; University of Guelph	Pascottini, OB (corresponding author), Univ Guelph, Ontario Vet Coll, Populat Med, Guelph, ON, Canada.	osvaldo.bogado@ugent.be	Pascottini, Osvaldo Bogado/AAP-6730-2021; Pascottini, Osvaldo Bogado/Q-9047-2016; Sprícigo, José Felipe Warmling/L-9564-2015; LeBlanc, Stephen/U-3105-2019	Pascottini, Osvaldo Bogado/0000-0002-5305-2133; Pascottini, Osvaldo Bogado/0000-0002-5305-2133; Sprícigo, José Felipe Warmling/0000-0002-5507-3923; LeBlanc, Stephen/0000-0003-2027-7704	Ontario Ministry of Agriculture, Food and Rural Affairs (Guelph, ON, Canada); Boehringer-Ingelheim Vetmedica (Burlington, ON, Canada)	Ontario Ministry of Agriculture, Food and Rural Affairs (Guelph, ON, Canada); Boehringer-Ingelheim Vetmedica (Burlington, ON, Canada)	Ontario Ministry of Agriculture, Food and Rural Affairs (Guelph, ON, Canada). S.J. LeBlanc. Boehringer-Ingelheim Vetmedica (Burlington, ON, Canada). S. J. LeBlanc.	Bah T., 2011, INKSCAPE GUIDE VECTO, V4; Baker JM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00208; Bates D, **DATA OBJECT**; Bicalho MLS, 2017, J DAIRY SCI, V100, P3863, DOI 10.3168/jds.2016-12061; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cunha F, 2018, THERIOGENOLOGY, V114, P25, DOI 10.1016/j.theriogenology.2018.03.016; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; Day A.heatmap.plus:, **DATA OBJECT**; DELVECCHIO RP, 1994, THERIOGENOLOGY, V41, P413, DOI 10.1016/0093-691X(94)90077-V; Dhakal K, 2013, J DAIRY SCI, V96, P690, DOI 10.3168/jds.2012-5817; Diaz-Gonzalez F, 2015, EUR J IMMUNOL, V45, P679, DOI 10.1002/eji.201445222; Dubuc J, 2010, J DAIRY SCI, V93, P5225, DOI 10.3168/jds.2010-3428; Galvao KN, 2019, J DAIRY SCI, V102, P11786, DOI 10.3168/jds.2019-17106; GIER HT, 1968, AM J VET RES, V29, P83; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Jeon SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165740; Jeon SJ, 2015, APPL ENVIRON MICROB, V81, P6324, DOI 10.1128/AEM.01753-15; Johanson JM, 2003, J DAIRY SCI, V86, P3745, DOI 10.3168/jds.S0022-0302(03)73981-2; Kindt R, **DATA OBJECT**; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kuzmycz O, 2020, CANCER BIOL THER, V21, P486, DOI 10.1080/15384047.2020.1736483; LeBlanc SJ, 2014, ANIMAL, V8, P54, DOI 10.1017/S1751731114000524; Lewis Gregory S, 2003, Reprod Biol Endocrinol, V1, P117; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miranda-CasoLuengo R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0200974; Pascottini OB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69317-z; Pascottini OB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62103-x; Pascottini OB, 2020, PREV VET MED, V176, DOI 10.1016/j.prevetmed.2020.104908; Pascottini OB, 2020, THERIOGENOLOGY, V150, P193, DOI 10.1016/j.theriogenology.2020.01.042; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sheldon IM, 2008, VET J, V176, P115, DOI 10.1016/j.tvjl.2007.12.031; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; Umaru T, 2009, AFR J BIOTECHNOL, V8, P7332; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Viniker DA, 1999, HUM REPROD UPDATE, V5, P373, DOI 10.1093/humupd/5.4.373; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Wang ML, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02691	40	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0233943	10.1371/journal.pone.0233943	http://dx.doi.org/10.1371/journal.pone.0233943			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606706	Green Published, gold, Green Submitted			2022-12-26	WOS:000620629200109
J	Montalli, VAM; Garcez, AS; de Oliveira, LVC; Sperandio, M; Napimoga, MH; Motta, RHL				Martins Montalli, Victor Angelo; Garcez, Aguinaldo Silva; Canuto de Oliveira, Lais Viana; Sperandio, Marcelo; Napimoga, Marcelo Henrique; Lopes Motta, Rogerio Heladio			A novel dental biosafety device to control the spread of potentially contaminated dispersion particles from dental ultrasonic tips	PLOS ONE			English	Article								Strategies to return to dental practice in pandemic times is a new challenge due to the generation and spread of potentially contaminated dispersion particles (PCDP) that may contain the SARS-CoV-2, the etiological factor of the COVID-19 disease. Due to the significant dispersion of PCDP in the dental environment, the use of equipment such as ultrasonic tips have been inadvisable during the pandemic. Several clinical procedures, however, benefit from the use of such equipment. Thus, using a microbial dispersion model of PCDP, the aim of this study was to compare the dispersion caused by the dental drill (DD) an ultrasonic tip (UT) alone and the UT coupled with a Spray control (SC) device. The DD, UT (with or without the SC) were activated for one minute having had the water from the reservoir replaced with a suspension of Lactobacillus casei Shirota (1.5 x 10(8) CFU/mL). Petri dishes containing MRS agar were positioned at 50cm, 100cm and 150cm from the headrest of the dental chair at different angles (0 degree and 90 degrees). At 50 cm, the mean CFU (standard deviation) of L. casei Shirota was 13554.60 (4071.03) for the DD, 286.67 (73.99) for the US (97.89% reduction), and 4.5 (0.58) CFU for the UT-SC (p < 0.0001), establishing a further 98.43% reduction between UT and UT with SC. The UT with SC model proved effective in reducing dispersion from the UT, endorsing its use as an additional strategy to reduce PCDP in the dental environment in times of pandemic.	[Martins Montalli, Victor Angelo; Garcez, Aguinaldo Silva; Canuto de Oliveira, Lais Viana] Fac Sao Leopoldo Mandic, Div Microbiol, Sao Paulo, Brazil; [Martins Montalli, Victor Angelo; Sperandio, Marcelo] Fac Sao Leopoldo Mandic, Div Oral Med, Sao Paulo, Brazil; [Napimoga, Marcelo Henrique] Fac Sao Leopoldo Mandic, Div Immunol, Sao Paulo, Brazil; [Lopes Motta, Rogerio Heladio] Fac Sao Leopoldo Mandic, Div Pharmacol, Sao Paulo, Brazil	Faculdade Sao Leopoldo Mandic; Faculdade Sao Leopoldo Mandic; Faculdade Sao Leopoldo Mandic; Faculdade Sao Leopoldo Mandic	Montalli, VAM (corresponding author), Fac Sao Leopoldo Mandic, Div Microbiol, Sao Paulo, Brazil.; Montalli, VAM (corresponding author), Fac Sao Leopoldo Mandic, Div Oral Med, Sao Paulo, Brazil.	victor.montalli@slmandic.edu.br	Montalli, Victor/E-7246-2013; Napimoga, Marcelo/S-2434-2019; Motta, Rogério Heládio Lopes/F-1243-2015; cao, xiaoxiang/AAR-9291-2021	Montalli, Victor/0000-0002-1927-7718; Napimoga, Marcelo/0000-0003-4472-365X; Motta, Rogério Heládio Lopes/0000-0002-6983-7883; 				[Anonymous], [No title captured]; Arabaci T, 2007, Int J Dent Hyg, V5, P2, DOI 10.1111/j.1601-5037.2007.00217.x; BENTLEY CD, 1994, J AM DENT ASSOC, V125, P579, DOI 10.14219/jada.archive.1994.0093; Bin SY, 2016, CLIN INFECT DIS, V62, P755, DOI 10.1093/cid/civ1020; Cabrera-Tasayco FD, 2021, DISASTER MED PUBLIC, V15, pE34, DOI 10.1017/dmp.2020.269; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P477; Clementini M, 2022, ORAL DIS, V28, P852, DOI 10.1111/odi.13649; Drisko C L, 2000, J Periodontol, V71, P1792; European Centre for Disease Prevention and Controle (ECDC), 2020, COR DIS 2019 COVID 1; Harrel SK, 2004, J AM DENT ASSOC, V135, P429, DOI 10.14219/jada.archive.2004.0207; Innes N., SYSTEMATIC REV DROPL, DOI [10.1016/j.jdent.2020.103556, DOI 10.1016/J.JDENT.2020.103556]; Kasper MR, 2020, NEW ENGL J MED, V383, P2417, DOI 10.1056/NEJMoa2019375; Kilian M, 2016, BRIT DENT J, V221, P657, DOI 10.1038/sj.bdj.2016.865; MARTHI B, 1990, APPL ENVIRON MICROB, V56, P3463, DOI 10.1128/AEM.56.11.3463-3467.1990; Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246; MONTALLI Victor Angelo Martins, 2020, RGO, Rev. Gaúch. Odontol., V68, pe20200088, DOI 10.1590/1981-863720200001820200088; Morawska L, 2020, ENVIRON INT, V142, DOI 10.1016/j.envint.2020.105832; Motta RHL, 2005, AM J DENT, V18, P340; Motta RHL, 2007, INFECT CONT HOSP EP, V28, P185, DOI 10.1086/510867; NAPIMOGA Marcelo Henrique, 2020, RGO, Rev. Gaúch. Odontol., V68, pe20200011, DOI 10.1590/1981-863720200001120200034; Ntovas Panagiotis, 2017, Eur J Dent, V11, P268, DOI 10.4103/ejd.ejd_232_16; Pasquarella C, 2000, J HOSP INFECT, V46, P241, DOI 10.1053/jhin.2000.0820; Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9; Putrino A, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01187-3; Freitas ARR, 2020, EPIDEMIOL SERV SAUDE, V29, DOI 10.5123/S1679-49742020000200008; Russell C, 2020, J ENDODONT, V46, P1144, DOI 10.1016/j.joen.2020.05.012; Szymanska J, 2007, ANN AGR ENV MED, V14, P203; Teichert R, 2020, INT ENDOD J, V53, P1588, DOI 10.1111/iej.13373; Timmerman MF, 2004, J CLIN PERIODONTOL, V31, P458, DOI 10.1111/j.1600-051X.2004.00511.x; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Veena HR, 2015, J INFECT PUBLIC HEAL, V8, P260, DOI 10.1016/j.jiph.2014.11.004; Viani Isabella, 2020, Acta Biomed, V91, P92, DOI 10.23750/abm.v91i3-S.9434; Wang TT, 2020, J ORAL MAXIL SURG, V78, P1268, DOI 10.1016/j.joms.2020.05.003; Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247029	10.1371/journal.pone.0247029	http://dx.doi.org/10.1371/journal.pone.0247029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600421	gold, Green Published			2022-12-26	WOS:000620625100002
J	Song, XY; Petrak, J; Jiang, Y; Singh, I; Maynard, D; Bontcheva, K				Song, Xingyi; Petrak, Johann; Jiang, Ye; Singh, Iknoor; Maynard, Diana; Bontcheva, Kalina			Classification aware neural topic model for COVID-19 disinformation categorisation	PLOS ONE			English	Article								The explosion of disinformation accompanying the COVID-19 pandemic has overloaded fact-checkers and media worldwide, and brought a new major challenge to government responses worldwide. Not only is disinformation creating confusion about medical science amongst citizens, but it is also amplifying distrust in policy makers and governments. To help tackle this, we developed computational methods to categorise COVID-19 disinformation. The COVID-19 disinformation categories could be used for a) focusing fact-checking efforts on the most damaging kinds of COVID-19 disinformation; b) guiding policy makers who are trying to deliver effective public health messages and counter effectively COVID-19 disinformation. This paper presents: 1) a corpus containing what is currently the largest available set of manually annotated COVID-19 disinformation categories; 2) a classification-aware neural topic model (CANTM) designed for COVID-19 disinformation category classification and topic discovery; 3) an extensive analysis of COVID-19 disinformation categories with respect to time, volume, false type, media type and origin source.	[Song, Xingyi; Petrak, Johann; Jiang, Ye; Singh, Iknoor; Maynard, Diana; Bontcheva, Kalina] Univ Sheffield, Dept Comp Sci, Sheffield, S Yorkshire, England; [Petrak, Johann] Austrian Res Inst Artificial Intelligence, Vienna, Austria; [Singh, Iknoor] Panjab Univ, Chandigarh, India	University of Sheffield; Panjab University	Song, XY (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield, S Yorkshire, England.	x.song@sheffield.ac.uk	Petrak, Johann/K-9368-2019	Petrak, Johann/0000-0001-8038-3096; Song, Xingyi/0000-0002-4188-6974; Bontcheva, Kalina/0000-0001-6152-9600; Jiang, Ye/0000-0002-6683-0205; Maynard, Diana/0000-0002-1773-7020	European Union [825297, 825091]	European Union(European Commission)	This research has been supported by European Union under grant agreement No.825297 WeVerify (https://weverify.eu/) and No. 825091 RISIS (https://www.risis2.eu/).There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Mageed M., 2020, ARXIV PREPRINT ARXIV; Alam, 2020, ARXIV PREPRINT ARXIV; [Anonymous], 2020, EP UPD MONK MULT OUT; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Brennen J. S., 2020, TYPES SOURCES CLAIMS; Card D, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P2031; Chauhan, 2020, P 6 WORKSH NOIS US G, P440; Chen Emily, 2020, JMIR Public Health Surveill, V6, pe19273, DOI 10.2196/19273; Chen Lan., 2020, ARXIV PREPRINT ARXIV; Chen Xiao, 2014, Reluctance torque evaluation for interior permanent magnet machines using frozen permeability, DOI 10.1049/iet-tv.50.19173; Cinelli Marco, 2021, Environment Systems & Decisions, V41, DOI 10.1007/s10669-020-09784-x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Devlin J., 2019, BERT PRETRAINING DEE, V1, P4171, DOI [10.18653/v1/N19-1423, DOI 10.18653/V1/N19-1423]; Ding R., 2018, EMPIRICAL METHODS NA, P830, DOI DOI 10.18653/V1/D18-1096; Eisenstein J., 2011, P 28 INT C INT C MAC, P1041; Feng F, 2020, ARXIV PREPRINT ARXIV; Feng YL, 2020, PROCEEDINGS OF THE 2020 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING (EMNLP), P1295; Gencoglu O, 2020, MACH LEARN KNOW EXTR, V2, P603, DOI 10.3390/make2040032; Gupta R.K, 2020, ARXIV PREPRINT ARXIV; Gururangan S, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P5880; Hongxu Yin, 2020, 2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR). Proceedings, P8712, DOI 10.1109/CVPR42600.2020.00874; Hossain Tamanna, 2020, P 1 WORKSH NLP COVID, DOI DOI 10.18653/V1/2020.NLPCOVID19-2.11; Hosseini P., 2020, ARXIV PREPRINT ARXIV; IFCN, 2021, IFCN COVID 19 MIS PO; Khan A., 2020, INDORE STONE PELTING; Kingma D.P., 2014, AUTO ENCODING VARIAT, V1050, P10; Kingma D. P., 2013, P INT C LEARN REPR I, P1; Kingma DP., 2014, ADAM METHOD STOCHAST; Korshunova I, 2019, ADV NEUR IN, V32; Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255; Kumar P., 2020, P 6 WORKSH NOIS US G; Kummervold PE., 2020, ARXIV PREPRINT ARXIV; Liakata M, 2020, ARXIV PREPRINT ARXIV; Liu Yinhan, 2019, ROBERTA ROBUSTLY OPT; Maas A.L., 2013, INT C MACHINE LEARNI, V30, P3, DOI DOI 10.1016/0010-0277(84)90022-2; Madria S, 2020, ARXIV PREPRINT ARXIV; McAuliffe J.D., 2008, ADV NEURAL INFORM PR, P121; McCallum A., 2008, P 24 C UNC ART INT U; Medford RJ, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa258; Mehrpour O, 2020, ARCH TOXICOL, P1; Miao Y., 2017, INT C MACH LEARN, P2410; Miao YS, 2016, PR MACH LEARN RES, V48; Mnih Andriy, 2014, P 31 INT C INT C MAC, V32, pII; Moi, ABS191003771 ARXIV; Noel P., 2020, DATA DEFICITS WHY WE; Park S, 2020, J MED INTERNET RES; Posetti J., 2020, POLICY BRIEF 1 DISIN; Qazi Umair, 2020, SIGSPATIAL Special, V12, P6, DOI 10.1145/3404820.3404823; Ramage D., 2009, P C EMP METH NAT LAN, P248, DOI [10.3115/1699510.1699543, DOI 10.5555/1699510.1699543, DOI 10.3115/1699510.1699543]; Rao HR, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102187; Rehurek R., 2010, P LREC 2010 WORKSH N; Rezende DJ, 2014, PR MACH LEARN RES, V32, P1278; Roberts ME, 2014, AM J POLIT SCI, V58, P1064, DOI 10.1111/ajps.12103; Rosen-Zvi M., 2004, AUTHOR TOPIC MODEL A, P487, DOI DOI 10.5555/1036843.1036902; Ruch A, 2020, ARXIV PREPRINT ARXIV; Serrano Juan Carlos Medina, 2020, P 1 WORKSH NLP COVID; Shahi Gautam Kishore, 2020, P CYSOC 2020 INT WOR; Sharma K., 2020, ARXIV PREPRINT ARXIV; Simeone O., 2020, ARXIV PREPRINT ARXIV; Singh Lisa, 2020, ArXiv; Sutton, 2017, P 2017 INT C LEARN R; Vaswani A., 2017, PROC ANN C NEURAL IN, V30, P5998; Vijjali R., 2020, P 3 NLP4IF WORKSH NL; Wang X., 2006, P 12 ACM SIGKDD INT, P424; Wang Xueting, 2020, medRxiv, DOI 10.1101/2020.07.12.20151936; Wicke P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240010; WILLIAMS RJ, 1992, MACH LEARN, V8, P229, DOI 10.1007/BF00992696; World Health Organization, 2021, NOV COR 2019 NCOV SI; Xue J, 2020, J MED INTERNET RES, V22, DOI 10.2196/20550; Yang ZW, 2021, ANIM BIOTECHNOL, V32, P67, DOI 10.1080/10495398.2019.1653901; Zeng J., 2018, P 2018 C EMP METH NA, P3120, DOI [DOI 10.18653/V1/D18-1351, 10.18653/v1/d18-1351]; Zhai C., 2020, ARXIV PREPRINT ARXIV; Zhou XY, 2020, LECT NOTES ARTIF INT, V12085, P354, DOI 10.1007/978-3-030-47436-2_27; Zhu Q., 2018, P 2018 C EMP METH NA, P4663	76	9	9	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247086	10.1371/journal.pone.0247086	http://dx.doi.org/10.1371/journal.pone.0247086			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600477	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000620625100043
J	Suhandynata, RT; Gao, YQ; Zhou, AL; Yang, YS; Wang, PC; Zhou, HL				Suhandynata, Raymond T.; Gao, Yong-Qi; Zhou, Ann L.; Yang, Yusheng; Wang, Pang-Che; Zhou, Huilin			Shared and distinct roles of Esc2 and Mms21 in suppressing genome rearrangements and regulating intracellular sumoylation	PLOS ONE			English	Article								Protein sumoylation, especially when catalyzed by the Mms21 SUMO E3 ligase, plays a major role in suppressing duplication-mediated gross chromosomal rearrangements (dGCRs). How Mms21 targets its substrates in the cell is insufficiently understood. Here, we demonstrate that Esc2, a protein with SUMO-like domains (SLDs), recruits the Ubc9 SUMO conjugating enzyme to specifically facilitate Mms21-dependent sumoylation and suppress dGCRs. The D430R mutation in Esc2 impairs its binding to Ubc9 and causes a synergistic growth defect and accumulation of dGCRs with mutations that delete the Siz1 and Siz2 E3 ligases. By contrast, esc2-D430R does not appreciably affect sensitivity to DNA damage or the dGCRs caused by the catalytically inactive mms21-CH. Moreover, proteome-wide analysis of intracellular sumoylation demonstrates that esc2-D430R specifically down-regulates sumoylation levels of Mms21-preferred targets, including the nucleolar proteins, components of the SMC complexes and the MCM complex that acts as the catalytic core of the replicative DNA helicase. These effects closely resemble those caused by mms21-CH, and are relatively unaffected by deleting Siz1 and Siz2. Thus, by recruiting Ubc9, Esc2 facilitates Mms21-dependent sumoylation to suppress the accumulation of dGCRs independent of Siz1 and Siz2.	[Suhandynata, Raymond T.; Gao, Yong-Qi; Zhou, Ann L.; Yang, Yusheng; Wang, Pang-Che; Zhou, Huilin] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Sch Med, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Zhou, HL (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Zhou, HL (corresponding author), Univ Calif San Diego, Sch Med, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA.	huzhou@health.UCSD.edu		Yang, Yusheng/0000-0002-6023-2677; Zhou, Huilin/0000-0002-1350-4430	NCI [T32 CA009523]; NIH [RO1 GM116897, S10 OD023498]; University of California Faculty seed grant	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Faculty seed grant	RTS was supported by a postdoc fellowship from NCI T32 CA009523. HZ is supported by NIH RO1 GM116897, S10 OD023498 and University of California Faculty seed grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Albuquerque CP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003670; Boddy MN, 2003, MOL CELL BIOL, V23, P5939, DOI 10.1128/MCB.23.16.5939-5946.2003; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Coster G, 2014, MOL CELL, V55, P666, DOI 10.1016/j.molcel.2014.06.034; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; de Albuquerque CP, 2016, J BIOL CHEM, V291, P8825, DOI 10.1074/jbc.M116.716399; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Jorgensen SW, 2019, NUCLEIC ACIDS RES, V47, P4597, DOI 10.1093/nar/gkz158; Labib K, 2001, MOL BIOL CELL, V12, P3658, DOI 10.1091/mbc.12.11.3658; Liang J, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007250; Mankouri HW, 2009, MOL BIOL CELL, V20, P1683, DOI 10.1091/mbc.E08-08-0877; Novatchkova M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-22; Ohya T, 2008, GENETICS, V180, P41, DOI 10.1534/genetics.107.086249; Prudden J, 2011, MOL CELL BIOL, V31, P2299, DOI 10.1128/MCB.05188-11; Prudden J, 2009, NAT STRUCT MOL BIOL, V16, P509, DOI 10.1038/nsmb.1582; Putnam C. D., 2010, COLD SPRING HARB PRO, V2010; Putnam CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11256; Putnam CD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000933; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sebesta M, 2017, NUCLEIC ACIDS RES, V45, P215, DOI 10.1093/nar/gkw882; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Srivatsan A, 2019, P NATL ACAD SCI USA, V116, P17377, DOI 10.1073/pnas.1906921116; Urulangodi M, 2015, GENE DEV, V29, P2067, DOI 10.1101/gad.265629.115; Wei L, 2016, NAT STRUCT MOL BIOL, V23, P209, DOI 10.1038/nsmb.3173; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Yong-Gonzales V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051540; Yu Q, 2010, J BIOL CHEM, V285, P7525, DOI 10.1074/jbc.M109.016360; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	35	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247132	10.1371/journal.pone.0247132	http://dx.doi.org/10.1371/journal.pone.0247132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600463	Green Published, gold			2022-12-26	WOS:000620625100049
J	van den Toren, SJ; van Grieken, A; Raat, H				van den Toren, Suzanne J.; van Grieken, Amy; Raat, Hein			Associations of socio-demographic characteristics, well-being, school absenteeism, and substance use with recreational nitrous oxide use among adolescents: A cross-sectional study	PLOS ONE			English	Article							DRUG-USE; ALCOHOL; DRINKING; ABUSE	Purpose A rapid increase of recreational nitrous oxide use (i.e. laughing gas, N2O) has been reported in several countries, while it has received limited attention in scientific research. We aimed to study the association of socio-demographic characteristics, mental well-being, sickness absence, truancy, and substance use with the frequency of lifetime nitrous oxide use among adolescents. Methods We used self-reported questionnaire data of adolescents (N = 555) attending secondary schools to cross-sectionally assess the frequency of nitrous oxide use and potential factors associated with nitrous oxide use, such as gender, mental well-being, and binge drinking. Ordinal logistic regression models were applied with lifetime nitrous oxide use (never, once, >= two times) as the outcome variable. Results Adolescents were on average 15.6 years old (SD = 0.83, range 14-18), 47.0% were female. In total, 86 (15.6%) adolescents had used nitrous oxide at least once in their life. In the multivariable ordinal regression model, the risk of having a higher category of lifetime nitrous oxide use was associated with a non-Dutch ethnic background (OR = 2.10, 95% CI 1.22; 3.61), attending pre-vocational education (OR = 1.88, 95% CI 1.06; 3.34), a higher score on the scale of externalizing problems (OR = 1.10, 95% CI 1.01; 1.20), binge drinking twice or more in the past four weeks (OR = 2.49, 95% CI 1.25; 4.94), and cannabis use (OR = 1.98, 95% CI 1.03; 3.79). Conclusions Youth Health Care professionals should be aware of nitrous oxide use in adolescents, especially among adolescents with a non-Dutch ethnic background, lower education levels, externalizing problems, frequent binge drinking, and cannabis use.	[van den Toren, Suzanne J.; van Grieken, Amy; Raat, Hein] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Raat, H (corresponding author), Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	h.raat@erasmusmc.nl			ZonMw, the Netherlands Organization for Health Research and Development [736100001]	ZonMw, the Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This study was funded by ZonMw, the Netherlands Organization for Health Research and Development (project number: 736100001). The study sponsor had no role in the study design, collection, analysis and interpretation of the data, the writing and the decision to submit the manuscript for publication.	Bachman JG., 2008, ED DRUG USE CONNECTI; Bennett ME, 2000, J SUBST ABUSE, V12, P227, DOI 10.1016/S0899-3289(00)00052-3; Camchong J, 2017, CEREB CORTEX, V27, P1922, DOI 10.1093/cercor/bhw015; Das JK, 2016, J ADOLESCENT HEALTH, V59, pS61, DOI 10.1016/j.jadohealth.2016.06.021; deVries H, 2003, HEALTH EDUC RES, V18, P611, DOI 10.1093/her/cyg031; Dutch Center for Youth Health (NCJ), LAND PROF KAD; Ehirim EM, 2018, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00312; Garakani A, 2016, AM J ADDICTION, V25, P358, DOI 10.1111/ajad.12372; GGD (Municipal and Regional Health Service) Centraal Bureau voor de Statistiek (CBS) RIVM, 2015, GEZ JEUGD; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Henry Kimberly L, 2007, J Adolesc Health, V40, DOI 10.1016/j.jadohealth.2006.11.138; Henry KL, 2009, J STUD ALCOHOL DRUGS, V70, P5, DOI 10.15288/jsad.2009.70.5; Heradstveit O, 2018, NORD STUD ALCOHOL DR, V35, P357, DOI 10.1177/1455072518789852; Heradstveit O, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01023; Huang R, 2016, DRUG ALCOHOL DEPEN, V164, P47, DOI 10.1016/j.drugalcdep.2016.04.028; Hwang JCF, 1996, BURNS, V22, P152, DOI 10.1016/0305-4179(95)00090-9; Inchley J., 2020, SPOTLIGHT ADOLESCENT, V2; Johannessen EL, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4389-2; Kaar SJ, 2016, J PSYCHOPHARMACOL, V30, P395, DOI 10.1177/0269881116632375; Lan SY, 2019, BRAIN DEV-JPN, V41, P428, DOI 10.1016/j.braindev.2018.12.003; Meader N, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3373-6; Meruelo AD, 2017, BEHAV BRAIN RES, V325, P44, DOI 10.1016/j.bbr.2017.02.025; Miller JW, 2007, PEDIATRICS, V119, P76, DOI 10.1542/peds.2006-1517; Monshouwer K., 2016, GROTE UITGAANSONDERZ; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Muris P, 2003, EUR CHILD ADOLES PSY, V12, P1, DOI 10.1007/s00787-003-0298-2; Myers R., 1990, CLASSICAL MODERN REG; Nabben T., 2017, ROES MET LUCHTJE GEB; Netherlands Enterprise Agency, 2021, COMM ACT NETH ENT AG; Netherlands Institute of Mental Health and Addiction (Trimbos-instituut), 2018, FACTSH NITR OX; Nguyen HT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114164; Oussalah A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040551; Pedersen MU, 2018, EUR CHILD ADOLES PSY, V27, P1551, DOI 10.1007/s00787-018-1148-6; Police department, 2019, POL DAT TRAFF INC; Statistics Netherlands, 2020, DEF STAT NETH; Stevens G.J.W.M., 2017, GEZONDHEID WELZIJN J; Stewart-Brown SL, 2011, J EPIDEMIOL COMMUN H, V65, DOI 10.1136/jech.2011.143586.86; Strandheim Arve, 2009, Child Adolesc Psychiatry Ment Health, V3, P18, DOI 10.1186/1753-2000-3-18; United Nations Educational Scientific and Cultural Organization (UNESCO), 2012, INT STANDARD CLASSIF; van Amsterdam J, 2015, REGUL TOXICOL PHARM, V73, P790, DOI 10.1016/j.yrtph.2015.10.017; van Dorsselaer S, 2016, JEUGD RISKANT GEDRAG; van Laar MW., 2019, NATL DRUG MONITOR JA; WALLACE JM, 1991, SOC PROBL, V38, P333; Wieske RCN, 2012, INT J PUBLIC HEALTH, V57, P637, DOI 10.1007/s00038-011-0305-1; Winstock AR, 2020, J PSYCHOPHARMACOL, V34, P229, DOI 10.1177/0269881119882532; Wu LT, 2005, J ADOLESCENT HEALTH, V37, P52, DOI 10.1016/j.jadohealth.2004.06.007	46	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247230	10.1371/journal.pone.0247230	http://dx.doi.org/10.1371/journal.pone.0247230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8JB	33600449	Green Published, gold			2022-12-26	WOS:000620625100024
J	Funamizu, T; Nagatomo, Y; Saji, M; Iguchi, N; Daida, H; Yoshikawa, T				Funamizu, Takehiro; Nagatomo, Yuji; Saji, Mike; Iguchi, Nobuo; Daida, Hiroyuki; Yoshikawa, Tsutomu			Low muscle mass assessed by psoas muscle area is associated with clinical adverse events in elderly patients with heart failure	PLOS ONE			English	Article								Background Acute decompensated heart failure (ADHF) is a growing healthcare burden with increasing prevalence and comorbidities due to progressive aging society. Accumulating evidence suggest that low skeletal muscle mass has a negative impact on clinical outcome in elderly adult population. We sought to determine the significance of psoas muscle area as a novel index of low skeletal muscle mass in elderly patients with ADHF. Methods In this single-center retrospective observational study, we reviewed consecutive 865 elderly participants (65 years or older) who were hospitalized for ADHF and 392 were available for analysis (79 years [74-85], 56% male). Cross-sectional areas of psoas muscle at the level of fourth lumbar vertebra were measured by computed tomography and normalized by the square of height to calculate psoas muscle index (PMI, cm(2)/m(2)). Results Dividing the patients by the gender-specific quartile value (2.47 cm(2)/m(2) for male and 1.68 cm(2)/m(2) for female), we defined low PMI as the lowest gender-based quartile of PMI. Multiple linear regression analysis revealed female sex, body mass index (BMI), and E/e', but not left ventricular ejection fraction, were independently associated with PMI. Kaplan-Meier analysis showed low PMI was associated with higher rate of composite endpoint of all-cause death and ADHF re-hospitalization (P = 0.033). Cox proportional hazard model analysis identified low PMI, but not BMI, was an independent predictor of the composite endpoint (Hazard ratio: 1.52 [1.06-2.16], P = 0.024). Conclusions PMI predicted future clinical adverse events in elderly patients with ADHF. Further studies are needed to assess whether low skeletal muscle mass can be a potential therapeutic target to improve the outcome of ADHF.	[Funamizu, Takehiro; Nagatomo, Yuji; Saji, Mike; Iguchi, Nobuo; Yoshikawa, Tsutomu] Sakakibara Heart Inst, Dept Cardiol, Tokyo, Japan; [Funamizu, Takehiro; Daida, Hiroyuki] Juntendo Univ, Dept Cardiovasc Biol & Med, Grad Sch Med, Tokyo, Japan; [Nagatomo, Yuji] Natl Def Med Coll, Dept Cardiol, Tokorozawa, Saitama, Japan	Juntendo University; National Defense Medical College - Japan	Nagatomo, Y (corresponding author), Sakakibara Heart Inst, Dept Cardiol, Tokyo, Japan.; Nagatomo, Y (corresponding author), Natl Def Med Coll, Dept Cardiol, Tokorozawa, Saitama, Japan.	con401@ndmc.ac.jp	Nagatomo, Yuji/HDM-4151-2022; Nagatomo, Yuji/AAQ-1590-2020; Saji, Mike/AAF-4407-2019	Nagatomo, Yuji/0000-0002-3430-4614; Saji, Mike/0000-0003-2057-109X	JSPS [23591062, 26461088, 16K09469]; Health Labour Sciences Research Grant [14528506]; Sakakibara Clinical Research Grant for the Promotion of Sciences, 2012-2017	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Sakakibara Clinical Research Grant for the Promotion of Sciences, 2012-2017	This study was supported by a JSPS Grant-in-Aid for Scientific Research (C) (#23591062, #26461088, #16K09469), a Health Labour Sciences Research Grant (#14528506), and the Sakakibara Clinical Research Grant for the Promotion of Sciences, 2012-2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afilalo J, 2014, J AM COLL CARDIOL, V63, P747, DOI 10.1016/j.jacc.2013.09.070; Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Bakal JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106494; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bekfani T, 2016, INT J CARDIOL, V222, P41, DOI 10.1016/j.ijcard.2016.07.135; Belardinelli R, 1999, CIRCULATION, V99, P1173, DOI 10.1161/01.CIR.99.9.1173; Candow DG, 2006, EUR J APPL PHYSIOL, V97, P548, DOI 10.1007/s00421-006-0223-8; Carter ND, 2002, GERONTOLOGY, V48, P360, DOI 10.1159/000065504; Casas-Vara A, 2012, NUTRITION, V28, P616, DOI 10.1016/j.nut.2011.10.006; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; Chien MY, 2008, J AM GERIATR SOC, V56, P1710, DOI 10.1111/j.1532-5415.2008.01854.x; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Fonarow GC, 2007, AM HEART J, V153, P74, DOI 10.1016/j.ahj.2006.09.007; Fulster S, 2013, EUR HEART J, V34, P512, DOI 10.1093/eurheartj/ehs381; Fujimoto K, 2019, SPINE SURG RELAT RES, V3, P335, DOI 10.22603/ssrr.2018-0040; Gillette-Goyonnet S, 2003, MECH AGEING DEV, V124, P311, DOI 10.1016/S0047-6374(02)00198-7; Horwich TB, 2001, J AM COLL CARDIOL, V38, P789, DOI 10.1016/S0735-1097(01)01448-6; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Kim NH, 2011, J AM GERIATR SOC, V59, P2062, DOI 10.1111/j.1532-5415.2011.03664.x; Ko BJ, 2018, INT J CARDIOL, V255, P118, DOI 10.1016/j.ijcard.2017.07.089; Landi F, 2013, AGE AGEING, V42, P203, DOI 10.1093/ageing/afs194; Lopez PD, 2019, CARDIOLOGY, V142, P28, DOI 10.1159/000496460; Malmstrom TK, 2013, J CACHEXIA SARCOPENI, V4, P179, DOI 10.1007/s13539-013-0106-x; Mamane S, 2016, CAN J CARDIOL, V32, P177, DOI 10.1016/j.cjca.2015.12.002; MANCINI DM, 1992, CIRCULATION, V85, P1364, DOI 10.1161/01.CIR.85.4.1364; Melton LJ, 2000, J AM GERIATR SOC, V48, P625; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Narumi T, 2015, EUR J INTERN MED, V26, P118, DOI 10.1016/j.ejim.2015.01.008; Newman AB, 2003, J AM GERIATR SOC, V51, P1602, DOI 10.1046/j.1532-5415.2003.51534.x; Okamura H, 2019, J THORAC CARDIOV SUR, V157, P1071, DOI 10.1016/j.jtcvs.2018.06.098; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Saji M, 2016, AM J CARDIOL, V118, P251, DOI 10.1016/j.amjcard.2016.04.043; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Szulc P, 2005, J BONE MINER RES, V20, P721, DOI 10.1359/JBMR.041230; Tanko LB, 2002, METABOLISM, V51, P69, DOI 10.1053/meta.2002.28960; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Zuckerman J, 2017, ANN THORAC SURG, V103, P1498, DOI 10.1016/j.athoracsur.2016.09.005	44	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247140	10.1371/journal.pone.0247140	http://dx.doi.org/10.1371/journal.pone.0247140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8MA	33592068	Green Published, gold			2022-12-26	WOS:000620632800057
J	Jain, RH; Xu, W				Jain, Rahi; Xu, Wei			HDSI: High dimensional selection with interactions algorithm on feature selection and testing	PLOS ONE			English	Article							RANDOM SUBSPACE METHOD; VARIABLE SELECTION; REGRESSION; LASSO; REGULARIZATION; MODELS; SHRINKAGE	Feature selection on high dimensional data along with the interaction effects is a critical challenge for classical statistical learning techniques. Existing feature selection algorithms such as random LASSO leverages LASSO capability to handle high dimensional data. However, the technique has two main limitations, namely the inability to consider interaction terms and the lack of a statistical test for determining the significance of selected features. This study proposes a High Dimensional Selection with Interactions (HDSI) algorithm, a new feature selection method, which can handle high-dimensional data, incorporate interaction terms, provide the statistical inferences of selected features and leverage the capability of existing classical statistical techniques. The method allows the application of any statistical technique like LASSO and subset selection on multiple bootstrapped samples; each contains randomly selected features. Each bootstrap data incorporates interaction terms for the randomly sampled features. The selected features from each model are pooled and their statistical significance is determined. The selected statistically significant features are used as the final output of the approach, whose final coefficients are estimated using appropriate statistical techniques. The performance of HDSI is evaluated using both simulated data and real studies. In general, HDSI outperforms the commonly used algorithms such as LASSO, subset selection, adaptive LASSO, random LASSO and group LASSO.	[Jain, Rahi; Xu, Wei] Princess Margaret Canc Res Ctr, Biostat Dept, Toronto, ON, Canada; [Xu, Wei] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Xu, W (corresponding author), Princess Margaret Canc Res Ctr, Biostat Dept, Toronto, ON, Canada.; Xu, W (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	wei.xu@uhnresearch.ca	xu, wei/HHD-2891-2022	Xu, Wei/0000-0002-0257-8856	Canadian Network for Research and Innovation in Machining Technology; Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-06672]; Prostate Cancer Canada	Canadian Network for Research and Innovation in Machining Technology; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Prostate Cancer Canada	The authors received the following funding support: Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada, RGPIN-2017-06672, Dr Wei Xu; Prostate Cancer Canada, Dr Wei Xu.	Bach FR., 2008, P 25 INT C MACHINE L, V33, P40, DOI [10.1145/1390156.1390161, DOI 10.1145/1390156.1390161]; Basu S, 2018, P NATL ACAD SCI USA, V115, P1943, DOI 10.1073/pnas.1711236115; Bien J, 2013, ANN STAT, V41, P1111, DOI 10.1214/13-AOS1096; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; BUCKLAND ST, 1993, J APPL ECOL, V30, P478, DOI 10.2307/2404188; Cohen J.E., 1988, STAT POWER ANAL BEHA; Desboulets LDD, 2018, ECONOMETRICS, V6, DOI 10.3390/econometrics6040045; DONOGHUE JR, 1995, MULTIVAR BEHAV RES, V30, P385, DOI 10.1207/s15327906mbr3003_5; Emmert-streib F., 2019, MACH LEARN KNOWL EXT, V1, P359; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hastie T., 2019, GLINTERNET LEARNING; Heinze G, 2018, BIOMETRICAL J, V60, P431, DOI 10.1002/bimj.201700067; Heinze G, 2017, TRANSPL INT, V30, P6, DOI 10.1111/tri.12895; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Ishwaran H, 2007, ELECTRON J STAT, V1, P519, DOI 10.1214/07-EJS039; Kotsiantis S, 2012, INT J INNOV COMPUT I, V8, P3953; LEHR R, 1992, STAT MED, V11, P1099, DOI 10.1002/sim.4780110811; Li R., 2007, P INT C MATH MADR AU, P595; Morozova O, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0066-2; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Tavallali P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187676; Teisseyre P, 2016, COMPUTATION STAT, V31, P943, DOI 10.1007/s00180-016-0658-2; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Walter S, 2009, EUR J EPIDEMIOL, V24, P733, DOI 10.1007/s10654-009-9411-2; Wang SJ, 2011, ANN APPL STAT, V5, P468, DOI 10.1214/10-AOAS377; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735; Zycinski G., 2013, SOURCE CODE BIOL MED, V8, P1, DOI [10.1186/1751-0473-8-1, DOI 10.1186/1751-0473-8-1]	32	3	3	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246159	10.1371/journal.pone.0246159	http://dx.doi.org/10.1371/journal.pone.0246159			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592034	gold, Green Published			2022-12-26	WOS:000620632800074
J	Araujo, AP; Colichio, GBC; Oliveira, MLS; German, E; Nikolaou, E; Chen, T; Adler, H; Ferreira, DM; Miyaji, EN				Araujo, Adriano P.; Colichio, Gabriela B. C.; Oliveira, Maria Leonor S.; German, Esther; Nikolaou, Elissavet; Chen, Tao; Adler, Hugh; Ferreira, Daniela M.; Miyaji, Eliane N.			Serum levels of anti-PspA and anti-PspC IgG decrease with age and do not correlate with susceptibility to experimental human pneumococcal colonization	PLOS ONE			English	Article								Older adults are at increased risk of pneumococcal disease. This work aims to evaluate whether there is any decrease in serum IgG against variants of the antigens Pneumococcal surface protein A (PspA) and Pneumococcal surface protein C (PspC) in healthy adults with increasing age. Levels of IgG against PspA and PspC variants were determined by ELISA in serum samples comparing volunteers 18-30 years of age with volunteers who were 50-70+ before and after an experimental pneumococcal colonization challenge. The serotype 6B strain used in the challenge belongs to a minor group of pneumococcal isolates expressing two PspC variants. There was a decrease in levels of IgG with increasing age for the most common PspA variants and for all PspC variants analyzed. No correlation was found between basal levels of IgG against these antigens and protection against colonization. There was an increase in levels of IgG against PspA variants that are more cross-reactive with the variant expressed by the challenge strain post challenge in younger individuals who became colonized. Since the challenge strain used in our study expresses two different PspC variants, an increase in serum IgG against all PspC variants tested was observed in younger individuals who became colonized. For some of the antigen variants tested, a decrease in serum IgG was observed in young volunteers who were challenged but did not become colonized. Serum IgG antibodies against PspA and PspC variants thus decrease with age in healthy adults, but there is no correlation between levels of IgG against these antigens and protection against human experimental colonization. Though no correlation between naturally induced serum IgG antibodies against PspA and PspC and protection against colonization was observed, these results do not rule out the protective potential of these antigens as vaccines against pneumococcal infections.	[Araujo, Adriano P.; Colichio, Gabriela B. C.; Oliveira, Maria Leonor S.; Miyaji, Eliane N.] Inst Butantan, Lab Bacteriol, Sao Paulo, Brazil; [German, Esther; Nikolaou, Elissavet; Chen, Tao; Adler, Hugh; Ferreira, Daniela M.] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Colichio, Gabriela B. C.] Hosp Israelite Albert Einstein, Sao Paulo, Brazil	Instituto Butantan; Liverpool School of Tropical Medicine; Hospital Israelita Albert Einstein	Miyaji, EN (corresponding author), Inst Butantan, Lab Bacteriol, Sao Paulo, Brazil.	eliane.miyaji@butantan.gov.br	Miyaji, Eliane N/D-7642-2012; Oliveira, Maria Leonor S/F-4988-2012; Ferreira, Daniela M/AAE-9881-2022; Ferreira, Daniela M/AFF-4763-2022	Miyaji, Eliane N/0000-0003-1689-5366; Ferreira, Daniela M/0000-0002-0594-0902; Nikolaou, Elissavet/0000-0003-4797-4710; Oliveira, Maria Leonor/0000-0003-4849-3062	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP] [2018/25165-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq] [303072/2018-0]; Fundacao Butantan; Bill and Melinda Gates Foundation [OPP1117728]; UK Medical Research Council [MR/M011569/1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP](Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq](Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/) [ENM - FAPESP 2018/25165-6], Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) [ENM - CNPq 303072/2018-0] and Fundacao Butantan (http://www.fundacaobutantan.org.br/).APA received a studentship from Fundacao Butantan. The experimental human pneumococcal carriage studies were funded by the Bill and Melinda Gates Foundation (https://www.gatesfoundation.org/) [DMF - Grant number OPP1117728] and the UK Medical Research Council (https://mrc.ukri.org/) [DMF - Grant number MR/M011569/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler H, 2021, AM J RESP CRIT CARE, V203, P604, DOI 10.1164/rccm.202004-1483OC; Azarian T, 2017, J INFECT DIS, V215, P713, DOI 10.1093/infdis/jiw628; Brandileone MCC, 2004, VACCINE, V22, P3890, DOI 10.1016/j.vaccine.2004.04.009; Browall S, 2014, J INFECT DIS, V209, P377, DOI 10.1093/infdis/jit481; Coral MCV, 2001, EMERG INFECT DIS, V7, P832; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Darrieux M, 2008, J MED MICROBIOL, V57, P273, DOI 10.1099/jmm.0.47661-0; Drayss M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212052; Ferreira DM, 2009, CLIN VACCINE IMMUNOL, V16, P636, DOI 10.1128/CVI.00395-08; Ferreira DM, 2013, AM J RESP CRIT CARE, V187, P855, DOI 10.1164/rccm.201212-2277OC; Frazao N, 2005, PEDIATR INFECT DIS J, V24, P243, DOI 10.1097/01.inf.0000154326.77617.3e; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Holmlund E, 2009, CLIN VACCINE IMMUNOL, V16, P916, DOI 10.1128/CVI.00050-09; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Iannelli F, 2002, GENE, V284, P63, DOI 10.1016/S0378-1119(01)00896-4; Jain S, 2015, NEW ENGL J MED, V373, P2382; Krone CL, 2014, LANCET RESP MED, V2, P141, DOI 10.1016/S2213-2600(13)70165-6; McCool TL, 2002, J EXP MED, V195, P359, DOI 10.1084/jem.20011576; Melin MM, 2008, CLIN VACCINE IMMUNOL, V15, P1529, DOI 10.1128/CVI.00181-08; Moreno AT, 2012, CLIN VACCINE IMMUNOL, V19, P499, DOI 10.1128/CVI.05706-11; Moreno AT, 2010, CLIN VACCINE IMMUNOL, V17, P439, DOI 10.1128/CVI.00430-09; Mukerji R, 2018, VACCINE, V36, P6834, DOI 10.1016/j.vaccine.2018.08.045; Pathak A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05494-w; Pennington SH, 2016, AM J RESP CRIT CARE, V194, P1523, DOI 10.1164/rccm.201512-2467OC; Pimenta FC, 2006, J CLIN MICROBIOL, V44, P2838, DOI 10.1128/JCM.00156-06; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Rapola S, 2000, J INFECT DIS, V182, P1146, DOI 10.1086/315822; Ridda I, 2010, VACCINE, V28, P3902, DOI 10.1016/j.vaccine.2010.03.073; Rylance J., 2018, BIORXIV, DOI [10.1101/343319, DOI 10.1101/343319]; Rylance J, 2019, AM J RESP CRIT CARE, V199, P1160, DOI 10.1164/rccm.201811-2081LE; Simell B, 2008, CLIN VACCINE IMMUNOL, V15, P1391, DOI 10.1128/CVI.00110-08; Soininen A, 2001, J INFECT DIS, V184, P569, DOI 10.1086/322794; Wilson R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006137; YOTHER J, 1992, J BACTERIOL, V174, P601, DOI 10.1128/jb.174.2.601-609.1992; YOTHER J, 1994, J BACTERIOL, V176, P2976, DOI 10.1128/JB.176.10.2976-2985.1994	36	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0247056	10.1371/journal.pone.0247056	http://dx.doi.org/10.1371/journal.pone.0247056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577617	gold, Green Published, Green Accepted			2022-12-26	WOS:000620071700050
J	Kadkol, GP; Meza, J; Simpfendorfer, S; Harden, S; Cullis, B				Kadkol, Gururaj Pralhad; Meza, Jess; Simpfendorfer, Steven; Harden, Steve; Cullis, Brian			Genetic variation for fusarium crown rot tolerance in durum wheat	PLOS ONE			English	Article							SEEDLING RESISTANCE; WATER-STRESS; CULMORUM; DISEASE; BARLEY; YIELD; PSEUDOGRAMINEARUM; MARKERS; QTL; DNA	Tolerance to the cereal disease Fusarium crown rot (FCR) was investigated in a set of 34 durum wheat genotypes, with Suntop, (bread wheat) and EGA Bellaroi (durum) as tolerant and intolerant controls, in a series of replicated field trials over four years with inoculated (FCR-i) and non-inoculated (FCR-n) plots of the genotypes. The genotypes included conventional durum lines and lines derived from crossing durum with 2-49, a bread wheat genotype with the highest level of partial resistance to FCR. A split plot trial design was chosen to optimize the efficiency for the prediction of FCR tolerance for each genotype. A multi-environment trial (MET) analysis was undertaken which indicated that there was good repeatability of FCR tolerance across years. Based on an FCR tolerance index, Suntop was the most tolerant genotype and EGA Bellaroi was very intolerant, but some durum wheats had FCR tolerance indices which were comparable to Suntop. These included some conventional durum genotypes, V101030, TD1702, V11TD013*3X-63 and DBA Bindaroi, as well as genotypes from crosses with 2-49 (V114916 and V114942). The correlation between FCR tolerance and FCR-n yield predictions was moderately negative indicating it could be somewhat difficult to develop FCR-tolerant genotypes that are high yielding under low disease pressure. However, FCR tolerance showed a positive correlation with FCR-i yield predictions in seasons of high disease expression indicating it could be possible to screen for FCR tolerance using only FCR-i treatments. These results are the first demonstration of genetic diversity in durum germplasm for FCR tolerance and they provide a basis for breeding for this trait.	[Kadkol, Gururaj Pralhad; Simpfendorfer, Steven; Harden, Steve] NSW DPI, Tamworth Agr Inst, Calala, NSW, Australia; [Meza, Jess; Cullis, Brian] Univ Wollongong, Ctr Bioinformat & Biometr, Natl Inst Appl Stat Res Australia, Wollongong, NSW, Australia	NSW Department of Primary Industries; University of Wollongong	Kadkol, GP (corresponding author), NSW DPI, Tamworth Agr Inst, Calala, NSW, Australia.	Gururaj.Kadkol@dpi.nsw.gov.au	harden, steven/AAB-1796-2019	harden, steven/0000-0002-0632-2452; Meza, Jess/0000-0002-6943-4291; Kadkol, Gururaj Pralhad/0000-0002-7042-498X; Cullis, Brian/0000-0001-6319-8155	GRDC [9175799]; NSW DPI [9175799]; University of Adelaide [9175799]	GRDC; NSW DPI; University of Adelaide	This research was conducted under the Durum Breeding Australia project (GK, No. 9175799) funded by the GRDC (https://access.grdc.com.au/), NSW DPI (http://www.dpi.nsw.gov.au/) and The University of Adelaide (https://www.adelaide.edu.au/).The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Akinsanmi OA, 2004, AUST J AGR RES, V55, P97, DOI 10.1071/AR03090; Alahmad S, 2018, AUSTRALAS PLANT PATH, V47, P285, DOI 10.1007/s13313-018-0554-z; [Anonymous], 2018, ASREML VERSION 4; Backhouse D, 2004, AUSTRALAS PLANT PATH, V33, P255, DOI 10.1071/AP04010; Bailey R. A., 2008, DESIGN COMP EXPT; BEDDIS AL, 1992, PHYTOPATHOLOGY, V82, P78, DOI 10.1094/Phyto-82-78; Bovill WD, 2006, PLANT BREEDING, V125, P538, DOI 10.1111/j.1439-0523.2006.01251.x; Bovill WD, 2010, THEOR APPL GENET, V121, P127, DOI 10.1007/s00122-010-1296-7; Brown JKM, 2013, PLANT PATHOL, V62, P83, DOI 10.1111/ppa.12163; Burgess LW, 2001, FUSARIUM: PAUL E. NELSON MEMORIAL SYMPOSIUM, P271; Chekali S, 2011, CROP PROT, V30, P718, DOI 10.1016/j.cropro.2011.01.007; Collard BCY, 2006, AUST J AGR RES, V57, P967, DOI 10.1071/AR05419; Collard BCY, 2005, PLANT BREEDING, V124, P532, DOI 10.1111/j.1439-0523.2005.01163.x; Davies P., 2016, RESISTANCE TOLERANCE; DODMAN RL, 1987, AUST J AGR RES, V38, P475; Eberhard FS, 2010, CROP PASTURE SCI, V61, P619, DOI 10.1071/CP10131; ELASHOFF JD, 1969, AM EDUC RES J, V6, P383, DOI 10.2307/1161858; Evans ML, 2010, AUSTRALAS PLANT PATH, V39, P376, DOI 10.1071/AP09092; Forknall CR, 2019, PHYTOPATHOLOGY, V109, P932, DOI 10.1094/PHYTO-09-18-0354-R; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; Hollaway GJ, 2013, PLANT DIS, V97, P977, DOI 10.1094/PDIS-09-12-0867-RE; Huerta-Espino J, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00824; Kause Antti, 2012, Frontiers in Genetics, V3, P262, DOI 10.3389/fgene.2012.00262; Kelly A., 2016, 9 AUSTR SOILB DIS S; Kirkegaard JA, 2004, AUST J AGR RES, V55, P321, DOI 10.1071/AR03178; Lemerle D, 2006, EUPHYTICA, V149, P85, DOI 10.1007/s10681-005-9056-5; Li XM, 2008, J PHYTOPATHOL, V156, P751, DOI 10.1111/j.1439-0434.2008.01425.x; Liu CJ, 2015, PLANT BREEDING, V134, P365, DOI 10.1111/pbr.12274; Ma J, 2012, EUPHYTICA, V186, P67, DOI 10.1007/s10681-011-0492-0; Martin A, 2013, EUPHYTICA, V192, P463, DOI 10.1007/s10681-013-0890-6; Mitter V, 2006, PLANT PATHOL, V55, P433, DOI 10.1111/j.1365-3059.2006.01384.x; Neate SM, 2016, DAFF CROWN ROT RESIS; Ophel-Keller K, 2008, AUSTRALAS PLANT PATH, V37, P243, DOI 10.1071/AP08029; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Raman H R, 2013, PLANT BREEDING LAB F; Raman H, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.01184; SALISBURY PA, 1995, AUST J EXP AGR, V35, P665, DOI 10.1071/EA9950665; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Simpfendorfer S., 2019, AUSTR AGR 2020 CONSE, P173; Singh RP, 1997, CROP SCI, V37, P390, DOI 10.2135/cropsci1997.0011183X003700020014x; Smiley RW, 2009, PLANT DIS, V93, P954, DOI 10.1094/PDIS-93-9-0954; Smiley RW, 2005, PLANT DIS, V89, P595, DOI 10.1094/PD-89-0595; Smith AB, 2019, J AGR BIOL ENVIR ST, V24, P573, DOI 10.1007/s13253-019-00362-6; Smith AB, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2220-5; SUMMERELL BA, 1990, PHYTOPATHOLOGY, V80, P877, DOI 10.1094/Phyto-80-877; Thompson JP, 1999, AUSTRALAS PLANT PATH, V28, P45, DOI 10.1071/AP99006; TRUDGILL DL, 1991, ANNU REV PHYTOPATHOL, V29, P167, DOI 10.1146/annurev.py.29.090191.001123; Wallwork H, 2004, AUSTRALAS PLANT PATH, V33, P1, DOI 10.1071/AP03073; WILDERMUTH GB, 1994, PLANT DIS, V78, P949, DOI 10.1094/PD-78-0949; Yang XM, 2010, EUR J PLANT PATHOL, V128, P495, DOI 10.1007/s10658-010-9680-3	51	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0240766	10.1371/journal.pone.0240766	http://dx.doi.org/10.1371/journal.pone.0240766			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577599	Green Submitted, Green Published, gold			2022-12-26	WOS:000620071700027
J	van der Pijl, MSG; Kasperink, M; Hollander, MH; Verhoeven, C; Kingma, E; de Jonge, A				van der Pijl, Marit S. G.; Kasperink, Marlies; Hollander, Martine H.; Verhoeven, Corine; Kingma, Elselijn; de Jonge, Ank			Client-care provider interaction during labour and birth as experienced by women: Respect, communication, confidentiality and autonomy	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CHILDBIRTH EXPERIENCES; MATERNITY CARE; QUALITY; MISTREATMENT; PREVALENCE; POSTPARTUM; DISRESPECT; BEHAVIOR; TRAUMA	Introduction Respectful Maternity Care is important for achieving a positive labour and birth experience. Client-care provider interaction-specifically respect, communication, confidentiality and autonomy-is an important aspect of Respectful Maternity Care. The aim of this study was twofold: (1) to assess Dutch women's experience of respect, communication, confidentiality and autonomy during labour and birth and (2) to identify which client characteristics are associated with experiencing optimal respect, communication, confidentiality and autonomy. Methods Pregnant women and women who recently gave birth in the Netherlands were recruited to fill out a validated web-based questionnaire (ReproQ). Mean scores per domain (scale 1-4) were calculated. Domains were dichotomised in non-optimal (score 1, 2,3) and optimal client-care provider interaction (score 4), and a multivariable logistic regression analysis was performed. Results Of the 1367 recruited women, 804 respondents completed the questionnaire and 767 respondents completed enough questions to be included for analysis. Each domain had a mean score above 3.5. The domain confidentiality had the highest proportion of optimal scores (64.0%), followed by respect (53.3%), communication (45.1%) and autonomy (36.2%). In all four domains, women who gave birth at home with a community midwife had a higher proportion of optimal scores than women who gave birth in the hospital with a (resident) obstetrician or hospital-based midwife. Lower education level, being multiparous and giving birth spontaneously were also significantly associated with a higher proportion of optimal scores in (one of) the domains. Discussion This study shows that on average women scored high on experienced client-care provider interaction in the domains respect, communication, confidentiality and autonomy. At the same time, client-care provider interaction in the Netherlands still fell short of being optimal for a large number of women, in particular regarding women's autonomy. These results show there is still room for improvement in client-care provider interaction during labour and birth.	[van der Pijl, Marit S. G.; Kasperink, Marlies; Verhoeven, Corine; de Jonge, Ank] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Dept Midwifery Sci, AVAG Amsterdam Publ Hlth, Amsterdam, Netherlands; [Hollander, Martine H.] Radboud Univ Nijmegen, Med Ctr, Amalia Childrens Hosp, Dept Obstet, Nijmegen, Netherlands; [Verhoeven, Corine] Univ Nottingham, Sch Hlth Sci, Div Midwifery, Nottingham, England; [Verhoeven, Corine] Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands; [Kingma, Elselijn] Univ Southampton, Dept Philosophy, Southampton, Hants, England; [Kingma, Elselijn] Tech Univ Eindhoven, Dept Ind Engn & Innovat Sci, Philosophy & Eth, Eindhoven, Netherlands	Vrije Universiteit Amsterdam; Radboud University Nijmegen; University of Nottingham; Maxima Medical Center; University of Southampton; Eindhoven University of Technology	van der Pijl, MSG (corresponding author), Vrije Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Dept Midwifery Sci, AVAG Amsterdam Publ Hlth, Amsterdam, Netherlands.	m.vanderpijl@amsterdamumc.nl	de Jonge, Ank/F-6475-2013	van der Pijl, Marit/0000-0002-5291-5988; De Jonge, Ank/0000-0002-5384-3744				Afulani PA, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3183-x; Attanasio LB, 2014, MATERN CHILD HLTH J, V18, P1280, DOI 10.1007/s10995-013-1363-1; AVAG, INCAS22016 AVAG; Baas CI, 2017, BIRTH-ISS PERINAT C, V44, P58, DOI 10.1111/birt.12266; Baranowska B, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2675-y; Beck CT, 2004, NURS RES, V53, P216, DOI 10.1097/00006199-200407000-00004; Bell AF, 2018, SEX REPROD HEALTHC, V16, P67, DOI 10.1016/j.srhc.2018.02.007; Bernhard C, 2014, J MIDWIFERY WOM HEAL, V59, P160, DOI 10.1111/jmwh.12113; Bohren MA, 2019, LANCET, V394, P1750, DOI 10.1016/S0140-6736(19)31992-0; Bolten N, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1130-6; Byrne V, 2017, MIDWIFERY, V51, P1, DOI 10.1016/j.midw.2017.04.017; Centraal Bureau voor de Statistiek , 2016, STAND OND 2006 ED 20, V40; Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; College Perinatale Zorg, 2016, ZORGST INT GEB, P1; Donabedian A, 2005, MILBANK Q, V83, P691, DOI 10.1111/j.1468-0009.2005.00397.x; Dunn JT, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1496-0; Feijen-de Jong EI, 2020, WOMEN BIRTH, V33, pE447, DOI 10.1016/j.wombi.2019.10.008; Franchi M, 2020, ARCH GYNECOL OBSTET, V301, P427, DOI 10.1007/s00404-019-05404-5; Freedman LP, 2014, LANCET, V384, pE42, DOI 10.1016/S0140-6736(14)60859-X; Grekin R, 2014, CLIN PSYCHOL REV, V34, P389, DOI 10.1016/j.cpr.2014.05.003; Hammerly C, 2022, LINGUIST INQ, V53, P823, DOI 10.1162/ling_a_00422; Handelzalts JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169132; Hodnett ED, 2002, AM J OBSTET GYNECOL, V186, pS160, DOI 10.1067/mob.2002.121141; Hollander MH, 2017, ARCH WOMEN MENT HLTH, V20, P515, DOI 10.1007/s00737-017-0729-6; Hyde A, 2004, SOC SCI MED, V58, P2613, DOI 10.1016/j.socscimed.2003.09.014; Jenkins MG, 2014, WOMEN BIRTH, V27, P214, DOI 10.1016/j.wombi.2014.03.002; Jiang H, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000081.pub3; Karlstrom A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0683-0; Khosla R, 2016, HEALTH HUM RIGHTS, V18, P131; Knovel, VERL SYST NED; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Macpherson I, 2016, MIDWIFERY, V41, P68, DOI 10.1016/j.midw.2016.08.003; Mondy T, 2016, MIDWIFERY, V43, P37, DOI 10.1016/j.midw.2016.10.009; Neerland CE, 2019, MIDWIFERY, V77, P110, DOI 10.1016/j.midw.2019.07.004; Newnham E, 2019, NURS ETHICS, V26, P2147, DOI 10.1177/0969733018819119; Perdok H, 2014, BIRTH-ISS PERINAT C, V41, P195, DOI 10.1111/birt.12102; Perined, PER ZORG NED 2016; Ravaldi C, 2018, EUR J OBSTET GYN R B, V224, P208, DOI 10.1016/j.ejogrb.2018.03.055; Reed R, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-016-1197-0; Rijnders M, 2008, BIRTH-ISS PERINAT C, V35, P107, DOI 10.1111/j.1523-536X.2008.00223.x; Rundell S, 1991, INTENSIVE CARE NURS, DOI [10.1016/0266-612X%2891%2990006-D, DOI 10.1016/0266-612X%2891%2990006-D]; Sadler M, 2016, REPROD HEALTH MATTER, V24, P47, DOI 10.1016/j.rhm.2016.04.002; Sandall J., 2015, ENTRE NOUS EUR MAG S, V81, P16; Sawyer A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-108; Scheerhagen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117031; Schrijvers AJP, 2013, PSYCHOMETRISCHE EIGE; Seijmonsbergen-Schermers A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017993; Serbin JW, 2016, J MIDWIFERY WOM HEAL, V61, P694, DOI 10.1111/jmwh.12572; Shakibazadeh E, 2018, BJOG-INT J OBSTET GY, V125, P932, DOI 10.1111/1471-0528.15015; Simpson M, 2016, WOMEN BIRTH, V29, P203, DOI 10.1016/j.wombi.2015.10.009; Soet JE, 2003, BIRTH-ISS PERINAT C, V30, P36, DOI 10.1046/j.1523-536X.2003.00215.x; Valentine N, 2003, HLTH SYSTEMS PERFORM, P573; Valentine NB, 2007, QUAL LIFE RES, V16, P1107, DOI 10.1007/s11136-007-9189-1; van der Pijl MSG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233114; van Stenus CMV, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1369-6; Vedam S, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0729-2; Vedam S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171804; Vogel JP, 2016, BJOG-INT J OBSTET GY, V123, P671, DOI 10.1111/1471-0528.13750; Waldenstrom U, 2004, BIRTH-ISS PERINAT C, V31, P102, DOI 10.1111/j.0730-7659.2004.00287.x; Waldenstrom U, 2003, BIRTH-ISS PERINAT C, V30, P248, DOI 10.1046/j.1523-536X.2003.00254.x; Windau-Melmer, GUIDE ADVOCATING RES; Yang XJ, 2017, ARCH GYNECOL OBSTET, V296, P503, DOI 10.1007/s00404-017-4445-2	62	5	5	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246697	10.1371/journal.pone.0246697	http://dx.doi.org/10.1371/journal.pone.0246697			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK0KW	33577594	Green Published, gold			2022-12-26	WOS:000620071700014
J	Chichizola, GA; Gonzalez, SL; Rovere, AE				Chichizola, Giselle Ailin; Gonzalez, Sofia Laura; Rovere, Adriana Edit			Alien plant species on roadsides of the northwestern Patagonian steppe (Argentina)	PLOS ONE			English	Article							SEMIARID MEDITERRANEAN ENVIRONMENTS; SOIL SEED-BANK; EPILOBIUM-BRACHYCARPUM; RUMEX-ACETOSELLA; VEGETATION; DISPERSAL; INVASIONS; PATTERNS; FOREST; REVEGETATION	The introduction of alien species represents one of the greatest threats to biodiversity worldwide. Highway construction increases the dispersal and invasion of exotic plant species. This study examined the assembly process of the plant communities to determine whether the roadsides of the Patagonian steppe represent a reservoir and dispersal source of invasive exotic species. We analyzed the composition of exotic and native species and functional groups present in the established vegetation and seed banks of roadsides and reference areas nearby. The type of dispersal of exotic and native species at the roadsides was also evaluated. Total cover and that of exotic and native species was lower at the roadsides than in the reference areas; however, at the roadsides the cover and seed abundance of exotic species was higher than that of native species. In the roadsides vegetation, native shrubs such as Acaena splendens predominated, along with exotic perennial herbs and grasses which were mainly represented by Rumex acetosella. In the seed bank the predominant species were exotic perennial herbs, also represented by R. acetosella, annual exotic species such as Epilobium brachycarpum and Verbascum thapsus, and annual native species such as Heliotropium paronychioides. No exotic shrubs were found either at the roadsides or in the reference areas. The species at the roadsides did not present a dominant type of dispersal. The abundance of exotic species at the roadsides, both in the aboveground vegetation and the seed bank, may be due to the stressful environment and the characteristics of the species themselves, such as the ability to form seed banks. This work revealed that the roadsides of the Patagonian steppe constitute reservoirs of invasive exotic species, highlighting the importance of identifying them and controlling their spread, with a view to generating ecosystem management programs.	[Chichizola, Giselle Ailin; Gonzalez, Sofia Laura; Rovere, Adriana Edit] Univ Nacl Comahue, INIBIOMA, CONICET, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Chichizola, GA (corresponding author), Univ Nacl Comahue, INIBIOMA, CONICET, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina.	giyochichi@gmail.com						[Anonymous], 2019, GLOBAL INVASIVE SPEC; Ansong M, 2016, BASIC APPL ECOL, V17, P516, DOI 10.1016/j.baae.2016.03.002; Barthelemy D, 2008, PLANTAS PATAGONIA; Beckman NG, 2018, J ECOL, V106, P1349, DOI 10.1111/1365-2745.12989; Bochet E., 2011, RESTAURACION ECOLOGI; Bochet E, 2007, RESTOR ECOL, V15, P88, DOI 10.1111/j.1526-100X.2006.00193.x; Cadenasso ML, 2001, CONSERV BIOL, V15, P91, DOI 10.1046/j.1523-1739.2001.99309.x; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Corcos D, 2020, APPL VEG SCI, V23, P277, DOI 10.1111/avsc.12481; Correa MN, 1969, FLORA PATAGONICA REP, VVIII; D'Antonio C, 2001, CONSERVATION BIOLOGY: RESEARCH PRIORITIES FOR THE NEXT DECADE, P59; Davies KW, 2011, OECOLOGIA, V167, P481, DOI 10.1007/s00442-011-1992-2; Dekker J., 1999, Journal of Crop Production, V2, P139; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; Espigares T, 2011, RESTOR ECOL, V19, P35, DOI 10.1111/j.1526-100X.2009.00546.x; Ezcurra C., 2005, PLANTAS NAHUEL HUAPI; Flory SL, 2010, BIOL INVASIONS, V12, P1285, DOI 10.1007/s10530-009-9546-9; Fonseca CR, 2013, BIOL INVASIONS, V15, P1751, DOI 10.1007/s10530-013-0406-2; Franzese J, 2014, J ARID ENVIRON, V106, P58, DOI 10.1016/j.jaridenv.2014.03.004; Franzese Jorgelina, 2012, Ecol. austral, V22, P101; Fuentes N, 2014, CONCEPCION; Funes G, 2001, AUSTRAL ECOL, V26, P205, DOI 10.1046/j.1442-9993.2001.01102.x; Gaitan J., 2004, CARACTERISTICAS DIST; Gelbard JL, 2003, ECOL APPL, V13, P404, DOI 10.1890/1051-0761(2003)013[0404:RHARFN]2.0.CO;2; Gelbard JL, 2003, CONSERV BIOL, V17, P420, DOI 10.1046/j.1523-1739.2003.01408.x; Ghermandi L, 2015, J ARID ENVIRON, V122, P154, DOI 10.1016/j.jaridenv.2015.06.020; Ghermandi L, 2004, J VEG SCI, V15, P67, DOI 10.1111/j.1654-1103.2004.tb02238.x; Ghermandi L., 1995, THESIS; Gioria M, 2016, BIOSCIENCE, V66, P40, DOI 10.1093/biosci/biv165; Gioria M, 2009, J PLANT ECOL-UK, V2, P153, DOI 10.1093/jpe/rtp013; Global Register of Introduced and Invasive Species (GRIIS), 2019, GLOB REG INV SPEC GR; Godagnone R, 2009, INVENTARIO INTEGRADO; Gonzalez S, 2008, PLANT ECOL, V199, P175, DOI 10.1007/s11258-008-9422-1; Gonzalez S, 2004, 2 BINACIONAL ECOLOGI; Gonzalez SL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212058; Gregor T, 2013, TUEXENIA, P259; Grime J. P., 2001, PLANT STRATEGIES VEG; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; GROSS KL, 1980, J ECOL, V68, P919, DOI 10.2307/2259465; Guo QF, 2018, INVAS PLANT SCI MANA, V11, P163, DOI 10.1017/inp.2018.29; Hobbs Richard J., 2000, P55; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huber UM, 2003, HOLOCENE, V13, P567, DOI 10.1191/0959683603hl647rp; Humphrey LD, 2001, WEST N AM NATURALIST, V61, P85; LEON R J C, 1985, Phytocoenologia, V13, P181, DOI 10.1127/phyto/13/1985/181; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Margutti L, 1996, INT J ECOL ENV SCI, V22, P159; Matteucci, 1982, METODOLOGIA ESTUDIO, V22; McDougall KL, 2018, BIOL INVASIONS, V20, P3461, DOI 10.1007/s10530-018-1787-z; Mola I, 2011, RESTOR ECOL, V19, P83, DOI 10.1111/j.1526-100X.2009.00547.x; Musso C, 2019, BIOL INVASIONS, V21, P1683, DOI 10.1007/s10530-019-01928-8; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nierbauer KU, 2016, BIOL INVASIONS, V18, P3265, DOI 10.1007/s10530-016-1216-0; Paiaro V, 2011, AUSTRAL ECOL, V36, P176, DOI 10.1111/j.1442-9993.2010.02134.x; Parendes LA, 2000, CONSERV BIOL, V14, P64, DOI 10.1046/j.1523-1739.2000.99089.x; Paruelo J.M., 2007, PHYS GEOGRAPHY S AM, P232, DOI 10.1093/oso/9780195313413.003.0022; Pauchard A, 2006, FOREST ECOL MANAG, V223, P327, DOI 10.1016/j.foreco.2005.11.020; Pauchard A, 2004, CONSERV BIOL, V18, P238, DOI 10.1111/j.1523-1739.2004.00300.x; Pollnac F, 2012, BIOL INVASIONS, V14, P1753, DOI 10.1007/s10530-012-0188-y; Puntieri J, 2011, GUIA BREVE IDENTIFIC, V1st; Pysek P, 2017, PRESLIA, V89, P203, DOI 10.23855/preslia.2017.203; R Core Team, 2020, R LANG ENV STAT COMP; Ramirez-Marcial N, 2005, DIVERSIDAD BIOL CHIA, P251; Rauschert ESJ, 2017, POPUL ECOL, V59, P79, DOI 10.1007/s10144-016-0569-7; Reich PB, 2003, INT J PLANT SCI, V164, pS143, DOI 10.1086/374368; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Rogers G, 2020, DESERT WEEDS, P3; Rovere Adriana E, 2013, Ecol. austral, V23, P165; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; Sera B, 2010, POL J ECOL, V58, P69; Soons MB, 2008, J ECOL, V96, P581, DOI 10.1111/j.1365-2745.2008.01370.x; Speziale KL, 2014, WEED RES, V54, P70, DOI 10.1111/wre.12047; Speziale KL, 2011, J ARID ENVIRON, V75, P890, DOI 10.1016/j.jaridenv.2011.04.014; Speziale KL, 2018, PEERJ, V6, DOI 10.7717/peerj.5529; Stroup WW, 2012, GEN LINEAR MIXED MOD; Sullivan JJ, 2009, NEW ZEAL J ECOL, V33, P190; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; THOMPSON K, 1979, J ECOL, V67, P893, DOI 10.2307/2259220; Thompson K., 1997, SOIL SEED BANKS N W; Tormo J, 2009, ECOSISTEMAS, V18, P79; Ullmann I, 1998, FLORA, V193, P149, DOI 10.1016/S0367-2530(17)30832-0; Vakhlamova T, 2016, PLANT ECOL, V217, P241, DOI 10.1007/s11258-016-0565-1; Valladares F, 2008, J VEG SCI, V19, P381, DOI 10.3170/2008-8-18378; Valladares F, 2011, BASE CIENTIFICA SOLU; Von der Lippe M, 2007, CONSERV BIOL, V21, P986, DOI 10.1111/j.1523-1739.2007.00722.x; von der Lippe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052733; von der Lippe M, 2012, PERSPECT PLANT ECOL, V14, P123, DOI 10.1016/j.ppees.2011.09.006; Wearne LJ, 2006, PLANT ECOL, V183, P361, DOI 10.1007/s11258-005-9046-7; Zida D, 2020, ACTA OECOL, V108, DOI 10.1016/j.actao.2020.103607; Zuloaga FO, 2008, MONOGRAPHS SYSTEMATI, V107; Zuur Alain F., 2009, P1	92	2	2	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246657	10.1371/journal.pone.0246657	http://dx.doi.org/10.1371/journal.pone.0246657			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571278	Green Accepted, Green Published, gold			2022-12-26	WOS:000618274000006
J	Su, GS; Wang, WB; Chen, J; Liu, M; Zheng, J; Guo, DAH; Bi, JF; Zhao, ZF; Shi, JD; Zhang, L; Lu, WG				Su, Guangsong; Wang, Wenbin; Chen, Jun; Liu, Man; Zheng, Jian; Guo, Dianhao; Bi, Jinfang; Zhao, Zhongfang; Shi, Jiandang; Zhang, Lei; Lu, Wange			CTCF-binding element regulates ESC differentiation via orchestrating long-range chromatin interaction between enhancers and HoxA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; TRANSCRIPTION; OCT4; DOMAINS; NANOG; PLURIPOTENCY; CONFORMATION; CLUSTERS; LOCUS	Proper expression of Homeobox A cluster genes (HoxA) is essential for embryonic stem cell (ESC) differentiation and individual development. However, mechanisms controlling precise spatiotemporal expression of HoxA during early ESC differentiation remain poorly understood. Herein, we identified a functional CTCF-binding element (CBE+47) closest to the 3'-end of HoxA within the same topologically associated domain (TAD) in ESC. CRISPR-Cas9-mediated deletion of CBE+47 significantly upregulated HoxA expression and enhanced early ESC differentiation induced by retinoic acid (RA) relative to wild-type cells. Mechanistic analysis by chromosome conformation capture assay (Capture-C) revealed that CBE+47 deletion decreased interactions between adjacent enhancers, enabling formation of a relatively loose enhancer-enhancer interaction complex (EEIC), which overall increased interactions between that EEIC and central regions of HoxA chromatin. These findings indicate that CBE+47 organizes chromatin interactions between its adjacent enhancers and HoxA. Furthermore, deletion of those adjacent enhancers synergistically inhibited HoxA activation, suggesting that these enhancers serve as an EEIC required for RA-induced HoxA activation. Collectively, these results provide new insight into RA-induced HoxA expression during early ESC differentiation, also highlight precise regulatory roles of the CTCF-binding element in orchestrating high-order chromatin structure.	[Su, Guangsong; Wang, Wenbin; Chen, Jun; Liu, Man; Zheng, Jian; Guo, Dianhao; Bi, Jinfang; Zhao, Zhongfang; Shi, Jiandang; Zhang, Lei; Lu, Wange] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China	Nankai University	Zhang, L; Lu, WG (corresponding author), Nankai Univ, Coll Life Sci, Tianjin, Peoples R China.	joyleizhang@nankai.edu.cn; wangelv@gmail.com			National Key R&D Program of China [2017YFA0102600]; Chinese National Natural Science Foundation of China [NSFC31530027]	National Key R&D Program of China; Chinese National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank all members of our laboratory for many helpful discussions. We also thank Dr Elise Lamar for editing our article. This work was supported by the National Key R&D Program of China (NO.2017YFA0102600), Chinese National Natural Science Foundation of China (NSFC31530027).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arzate-Mejia RG, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.137729; Ba ZQ, 2020, NATURE, V586, P305, DOI 10.1038/s41586-020-2578-0; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Beagan JA, 2017, GENOME RES, V27, P1139, DOI 10.1101/gr.215160.116; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buganim Y, 2014, CELL STEM CELL, V15, P295, DOI 10.1016/j.stem.2014.07.003; Cao KX, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap8747; Cao KX, 2017, GENE DEV, V31, P787, DOI 10.1101/gad.294744.116; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davies JOJ, 2016, NAT METHODS, V13, P74, DOI [10.1038/NMETH.3664, 10.1038/nmeth.3664]; De Kumar B, 2017, P NATL ACAD SCI USA, V114, P5838, DOI 10.1073/pnas.1610612114; De Kumar B, 2015, GENOME RES, V25, P1229, DOI 10.1101/gr.184978.114; de Wit E, 2015, MOL CELL, V60, P676, DOI 10.1016/j.molcel.2015.09.023; Denissov S, 2014, DEVELOPMENT, V141, P526, DOI 10.1242/dev.102681; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Ferraiuolo MA, 2010, NUCLEIC ACIDS RES, V38, P7472, DOI 10.1093/nar/gkq644; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Gajovic S, 1997, DIFFERENTIATION, V62, P187; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Ghasemi R, 2021, LEUKEMIA, V35, P404, DOI 10.1038/s41375-020-0856-3; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Jain S, 2018, CELL, V174, P102, DOI 10.1016/j.cell.2018.04.035; Ji X, 2016, CELL STEM CELL, V18, P262, DOI 10.1016/j.stem.2015.11.007; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kashyap V, 2011, J BIOL CHEM, V286, P3250, DOI 10.1074/jbc.M110.157545; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Korkmaz G, 2019, NUCLEIC ACIDS RES, V47, P9557, DOI 10.1093/nar/gkz675; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Li Y, 2020, NUCLEIC ACIDS RES, V48, P3119, DOI 10.1093/nar/gkaa098; Liang YC, 2020, DEV CELL, V53, P561, DOI 10.1016/j.devcel.2020.05.007; Liu GY, 2016, NUCLEIC ACIDS RES, V44, P2613, DOI 10.1093/nar/gkv1315; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo HC, 2019, JOVE-J VIS EXP, DOI 10.3791/59382; Luo HC, 2018, BLOOD, V132, P837, DOI 10.1182/blood-2017-11-814319; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Luppino JM, 2020, NAT GENET, V52, P840, DOI 10.1038/s41588-020-0647-9; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nanni L, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02108-x; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Qian YY, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw6710; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Rousseau M, 2014, NUCLEIC ACIDS RES, V42, P1524, DOI 10.1093/nar/gkt998; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sato T, 2020, ELIFE, V9, DOI 10.7554/eLife.53608; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simandi Z, 2016, MOL CELL, V63, P647, DOI 10.1016/j.molcel.2016.06.039; Su GS, 2019, NUCLEIC ACIDS RES, V47, P6737, DOI 10.1093/nar/gkz482; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tastemel M, 2017, STEM CELL RES, V25, P250, DOI 10.1016/j.scr.2017.11.012; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; VALCARCEL R, 1994, GENE DEV, V8, P3068, DOI 10.1101/gad.8.24.3068; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Wang P, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02030-2; Wang YL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1519-9; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; Weintraub AS, 2017, CELL, V171, P1573, DOI 10.1016/j.cell.2017.11.008; Xiao S, 2012, CELL, V149, P1381, DOI 10.1016/j.cell.2012.04.029; Yin YF, 2015, CELL STEM CELL, V16, P504, DOI 10.1016/j.stem.2015.03.007; Zhang L, 2020, GENOME RES, V30, P155, DOI 10.1101/gr.251058.119; Zhao H, 2020, NUCLEIC ACIDS RES, V48, P9621, DOI 10.1093/nar/gkaa711; Zheng H, 2019, NAT REV MOL CELL BIO, V20, P535, DOI 10.1038/s41580-019-0132-4; Zheng RB, 2019, NUCLEIC ACIDS RES, V47, pD729, DOI 10.1093/nar/gky1094; Zhou X, 2013, NAT METHODS, V10, P375, DOI 10.1038/nmeth.2440; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	83	4	4	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100413	10.1016/j.jbc.2021.100413	http://dx.doi.org/10.1016/j.jbc.2021.100413			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33581110	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400387
J	Nyondo-Mipando, AL; Kapesa, LS; Salimu, S; Kazuma, T; Mwapasa, V				Nyondo-Mipando, Alinane Linda; Kapesa, Leticia Suwedi; Salimu, Sangwani; Kazuma, Thokozani; Mwapasa, Victor			"Dispense antiretrovirals daily!" restructuring the delivery of HIV services to optimize antiretroviral initiation among men in Malawi	PLOS ONE			English	Article							CARE; PEOPLE; PERSPECTIVES; INTERVIEWS; INSIGHTS; OUTCOMES; THERAPY; AFRICA; AIDS	Background Gender disparities exist in the scale-up and uptake of HIV services with men being disproportionately under-represented in the services. In Eastern and Southern Africa, of the people living with HIV infection, more adult women than men were on treatment highlighting the disparities in HIV services. Delayed initiation of antiretroviral treatment creates a missed opportunity to prevent transmission of HIV while increasing HIV and AIDS-associated morbidity and mortality. The main objective of this study was to assess the strategies that men prefer for Antiretroviral Therapy (ART) initiation in Blantyre, Malawi. Methods This was a qualitative study conducted in 7 Health facilities in Blantyre from January to July 2017. We selected participants following purposive sampling. We conducted 20 in-depth interviews (IDIs) with men of different HIV statuses, 17 interviews with health care workers (HCWs), and 14 focus group discussions (FGDs) among men of varying HIV statuses. We digitally recorded all the data, transcribed verbatim, managed using NVivo, and analysed it thematically. Results Restructuring the delivery of antiretroviral (ARVs) treatment and conduct of ART clinics is key to optimizing early initiation of treatment among heterosexual men in Blantyre. The areas requiring restructuring included: Clinic days by offering ARVs daily; Clinic hours to accommodate schedules of men; Clinic layout and flow that preserves privacy and establishment of male-specific clinics; ARV dispensing procedures where clients receive more pills to last them longer than 3 months. Additionally there is need to improve the packaging of ARVs, invent ARVs with less dosing frequency, and dispense ARVs from the main pharmacy. It was further suggested that the test-and-treat strategy be implemented with fidelity and revising the content in counseling sessions with an emphasis on the benefits of ARVs. Conclusion The success in ART initiation among men will require a restructuring of the current ART services to make them accessible and available for men to initiate treatment. The inclusion of people-centered approaches will ensure that individual preferences are incorporated into the initiation of ARVs. The type, frequency, distribution, and packaging of ARVs should be aligned with other medicines readily available within a health facility to minimize stigma.	[Nyondo-Mipando, Alinane Linda; Kapesa, Leticia Suwedi; Salimu, Sangwani; Kazuma, Thokozani] Coll Med, Sch Publ Hlth & Family Med, Dept Hlth Syst & Policy, Blantyre, Malawi; [Mwapasa, Victor] Coll Med, Sch Publ Hlth & Family Med, Dept Publ Hlth, Blantyre, Malawi	University of Malawi; University of Malawi	Nyondo-Mipando, AL (corresponding author), Coll Med, Sch Publ Hlth & Family Med, Dept Hlth Syst & Policy, Blantyre, Malawi.	lmipando@medcol.mw	Nyondo, Alinane/AFN-8844-2022	Nyondo, Alinane/0000-0002-3572-3810	Malawi HIV Implementation Research Scientist Training program [Fogarty: D43 TW010060]	Malawi HIV Implementation Research Scientist Training program	This study was funded by the Malawi HIV Implementation Research Scientist Training program (Fogarty: D43 TW010060).	Adjetey V, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3878-7; Ahmed S, 2018, SOC SCI MED, V213, P72, DOI 10.1016/j.socscimed.2018.05.048; Auld AF, 2015, MMWR-MORBID MORTAL W, V64, P1281, DOI 10.15585/mmwr.mm6446a2; Ayieko J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202990; Barker C, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21648; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Bond V, 2019, HEALTH PLACE, V55, P87, DOI 10.1016/j.healthplace.2018.11.006; Bonnington O, 2017, SEX TRANSM INFECT, V93, DOI 10.1136/sextrans-2016-052975; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burla L, 2008, NURS RES, V57, P113, DOI 10.1097/01.NNR.0000313482.33917.7d; Camlin CS, 2016, AIDS CARE, V28, P67, DOI 10.1080/09540121.2016.1164806; Chimpule T., 2019, TAKING DIFFERENTIATE; Cohen DB, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6015-3; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Colvin CJ, 2019, LANCET HIV, V6, pE191, DOI 10.1016/S2352-3018(19)30032-3; Cornell M, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21902; Cornell M, 2011, TROP MED INT HEALTH, V16, P828, DOI 10.1111/j.1365-3156.2011.02767.x; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; De Allegri M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130216; Dovel K, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25517; Dovel K, 2015, AIDS, V29, P1123, DOI 10.1097/QAD.0000000000000655; Doyal L, 2009, SOC SCI MED, V68, P1901, DOI 10.1016/j.socscimed.2009.02.032; Duncombe C, 2015, TROP MED INT HEALTH, V20, P430, DOI 10.1111/tmi.12460; EGPAF, 2018, ADDRESSING THE BLIND; Eshun-Wilson I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210408; Flamig K, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25235; Fox MP, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20888; Genberg Becky, 2019, J Int Assoc Provid AIDS Care, V18, p2325958218823285, DOI 10.1177/2325958218823285; Government of Malawi M of H and P, 2015, NAT STRAT PLAN HIV A; Grimsrud A, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25526; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Ha JH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029748; Harrison A, 2016, BLACKWELL CRIT BIOGR, P1; Higgins JA, 2010, AM J PUBLIC HEALTH, V100, P435, DOI 10.2105/AJPH.2009.159723; Hlongwa M, 2020, JBI EVID SYNTH, V18, P571, DOI 10.11124/JBISRIR-D-19-00097; Jennings GR, 2012, ELGAR ORIG REF, P309; Kalua T, 2017, JAIDS-J ACQ IMM DEF, V75, pS43, DOI [10.1097/QAI.0000000000001326, 10.1097/qai.0000000000001326]; Kelly N, 2019, CURR HIV-AIDS REP, V16, P292, DOI 10.1007/s11904-019-00451-8; Kibicho J, 2011, J AM PHARM ASSOC, V51, P746, DOI 10.1331/JAPhA.2011.10190; Kumar N, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.107.7010; Kuznetsova AV, 2016, AIDS BEHAV, V20, P2433, DOI 10.1007/s10461-015-1282-9; Lambert VA, 2012, PAC RIM INT J NURS R, V16, P255; Leung Lawrence, 2015, J Family Med Prim Care, V4, P324, DOI 10.4103/2249-4863.161306; Li HC, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2158-7; Loeliger KB, 2016, AIDS PATIENT CARE ST, V30, P385, DOI 10.1089/apc.2016.0096; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mills EJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001167; Miners AH, 2017, SEX TRANSM INFECT, V93, P105, DOI 10.1136/sextrans-2016-052643; Mohlabane N, 2016, HEALTH SA GESONDHEID, V21, DOI 10.1016/j.hsag.2015.11.001; Moser A, 2017, EUR J GEN PRACT, V24, DOI [10.1080/13814788.2017.1375091, 10.1080/13814788.2017.1375092]; Mukumbang FC, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0638-0; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Nyondo AL, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/s12914-014-0030-y; Nyumba TO, 2018, METHODS ECOL EVOL, V9, P20, DOI 10.1111/2041-210X.12860; Oleribe OO, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.329.5138; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Phillippi J, 2018, QUAL HEALTH RES, V28, P381, DOI 10.1177/1049732317697102; Prust ML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196498; Prust ML, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21650; Rosen S, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002015, 10.1371/journal.pmed.1002106]; Rutakumwa R, 2020, QUAL RES, V20, P565, DOI 10.1177/1468794119884806; Shand T, 2014, IDS BULL-I DEV STUD, V45, P53, DOI 10.1111/1759-5436.12068; Sileo KM, 2017, J HEALTH PSYCHOL, V22, P1552, DOI 10.1177/1359105316630297; Skovdal M, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-13; Stillwaggon E, 2003, DEV CHANGE, V34, P809, DOI 10.1111/j.1467-7660.2003.00330.x; Tarimo EAM., 2014, TANZAN J HLTH RES, V16, P1, DOI [10.4314/thrb.v16i2.3, DOI 10.4314/THRB.V16I2.3]; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Topp SM, 2011, B WORLD HEALTH ORGAN, V89, P328, DOI 10.2471/BLT.10.084442; UNAIDS, 2019, UNAIDS DAT 2019; Wilkinson L, 2015, S AFR J HIV MED, V16, P21, DOI [10.4102/sajhivmed.v16i1.367, 10.4102/SAJHIVMED.V16I1.367]; Wirtz AL, 2015, JAIDS-J ACQ IMM DEF, V70, P155, DOI 10.1097/QAI.0000000000000693; Zaba B., 2016, ORIGINAL ARTICLE SUS, P1; Zakumumpa H, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0578-8; Zakumumpa H, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0160-5	75	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247409	10.1371/journal.pone.0247409	http://dx.doi.org/10.1371/journal.pone.0247409			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QO3ZL	33617561	Green Published, gold			2022-12-26	WOS:000623082400036
J	Godara, P; Herminghaus, S; Heidemann, KM				Godara, Prakhar; Herminghaus, Stephan; Heidemann, Knut M.			A control theory approach to optimal pandemic mitigation	PLOS ONE			English	Article							DEATH	In the framework of homogeneous susceptible-infected-recovered (SIR) models, we use a control theory approach to identify optimal pandemic mitigation strategies. We derive rather general conditions for reaching herd immunity while minimizing the costs incurred by the introduction of societal control measures (such as closing schools, social distancing, lockdowns, etc.), under the constraint that the infected fraction of the population does never exceed a certain maximum corresponding to public health system capacity. Optimality is derived and verified by variational and numerical methods for a number of model cost functions. The effects of immune response decay after recovery are taken into account and discussed in terms of the feasibility of strategies based on herd immunity.	[Godara, Prakhar; Herminghaus, Stephan; Heidemann, Knut M.] Max Planck Inst Dynam & Self Org, Gottingen, Germany	Max Planck Society	Heidemann, KM (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.	knut.heidemann@ds.mpg.de		Heidemann, Knut/0000-0002-3535-2773; Godara, Prakhar/0000-0003-4867-8542	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	P. G., S. H., and K. M. H. gratefully acknowledge support from the Max Planck Society.	Becerra V. M., 2010, 2010 IEEE International Symposium on Computer-Aided Control System Design (CACSD) part of the IEEE Multi-Conference on Systems & Control (MSC 2010), P1391, DOI 10.1109/CACSD.2010.5612676; Contreras S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20699-8; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; Djidjou-Demasse R., 2020, OPTIMAL COVID 19 EPI, DOI [10.1101/2020.04.02.20049189, DOI 10.1101/2020.04.02.20049189]; Enserink M, 2020, SCIENCE, V367, P1414, DOI 10.1126/science.367.6485.1414-b; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Gros D., 2021, CONTAINMENT EFFICIEN; Harko T, 2014, APPL MATH COMPUT, V236, P184, DOI 10.1016/j.amc.2014.03.030; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Kuhn H. W., 1951, P 2 BERK S MATH STAT, P481, DOI DOI 10.1007/BF01582292; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Parshani R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.258701; Perkins T Alex, 2020, Bull Math Biol, V82, P118, DOI 10.1007/s11538-020-00795-y; Priesemann V, 2020, ARXIV200905732QBIO; Sondhi SL, 2020, DIGITAL HERD IMMUNIT; WHO, 2020, REPORT WHO CHINA JOI; Wu LP, 2007, EMERG INFECT DIS, V13, P1562, DOI 10.3201/eid1310.070576; Zlatic V, 2020, NONLINEAR DYNAM, V101, P1635, DOI 10.1007/s11071-020-05888-w	21	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247445	10.1371/journal.pone.0247445	http://dx.doi.org/10.1371/journal.pone.0247445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606802	Green Submitted, gold, Green Published			2022-12-26	WOS:000620629200047
J	Grubyte, S; Urboniene, J; Nedzinskiene, L; Jelinskaite, A; Zagminas, K; Ambrozaitis, A; Jancoriene, L				Grubyte, Samanta; Urboniene, Jurgita; Nedzinskiene, Laura; Jelinskaite, Auguste; Zagminas, Kestutis; Ambrozaitis, Arvydas; Jancoriene, Ligita			Prevalence, incidence and residual risk of transfusion transmitted viruses (HBV, HCV and HIV infections) in Lithuanian blood donors from 2004 to 2018: The incidence/window-period model study	PLOS ONE			English	Article								Introduction Estimation of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) transfusion risk in blood donors is essential for monitoring the safety of the blood supply and the impact of new screening tests. Due to improvements in donor selection and continuing progress in screening assays, residual risk of virus transmission has significantly decreased over the past years. It is not practical and sometimes even not possible to measure residual risk in blood donors directly and mathematical models are used. The aim of this study was to calculate the prevalence, incidence rates of HBV, HCV and HIV infections and analyse evolution of their transmission residual risk from 2004 to 2018 at the National Blood Center of Lithuania. Materials and methods Data from the archives of the National Blood Center of Lithuania from 2004 to 2018 was retrospectively analysed. The residual risk was calculated for each virus and year by applying the incidence/window-period model suggested by World Health Organization. For the analysis of the residual risk yearly trends a linear regression was used. Results A total of 754,755 blood donors and 1,245,568 donations were included in the analysis and represented a 2.06 donations per donor over 15 years. Average residual risk for HBV, HCV and HIV respectively was 570.04, 807.14 and 35.72 per 1,00,000 donations. During the study period, there was statistically significant downward trend in the residual risk for every analysed virus. Discussion Residual risk of virus transmission has been steadily decreasing over past 15 years in Lithuanian donors, but the current risk remains quite high. It is difficult to establish how much the risk is affected by statistical assumptions or virus prevalence in general population. However, results of this study indicate the need of the population screening program of transfusion transmitted viruses.	[Grubyte, Samanta; Zagminas, Kestutis] Vilnius Univ, Fac Med, Inst Hlth Sci, Dept Publ Hlth, Vilnius, Lithuania; [Grubyte, Samanta; Ambrozaitis, Arvydas; Jancoriene, Ligita] Vilnius Univ, Fac Med, Inst Clin Med, Clin Infect Dis & Dermatovenerol, Vilnius, Lithuania; [Urboniene, Jurgita; Jelinskaite, Auguste] Vilnius Univ Hosp Santaros Klin, Ctr Infect Dis, Vilnius, Lithuania; [Nedzinskiene, Laura] Vilnius Univ, Fac Med, Inst Biomed Sci, Dept Anat Histol & Anthropol, Vilnius, Lithuania	Vilnius University; Vilnius University; Vilnius University	Grubyte, S (corresponding author), Vilnius Univ, Fac Med, Inst Hlth Sci, Dept Publ Hlth, Vilnius, Lithuania.; Grubyte, S (corresponding author), Vilnius Univ, Fac Med, Inst Clin Med, Clin Infect Dis & Dermatovenerol, Vilnius, Lithuania.	samanta.grubyte@mf.vu.lt			National Blood Center of Lithuania	National Blood Center of Lithuania	We would like to acknowledge the National Blood Center of Lithuania for supporting the authors and providing retrospective surveillance data from their archives.	[Anonymous], 2007, LANCET, V370, P361; Aronsohn Andrew, 2018, Gastroenterol Hepatol (N Y), V14, P240; BASTIAANS MJS, 1982, VOX SANG, V42, P203, DOI 10.1111/j.1423-0410.1982.tb01096.x; Chudy M, 2012, TRANSFUSION, V52, P431, DOI 10.1111/j.1537-2995.2011.03281.x; Durro V, 2010, CLIN LAB, V56, P591; European Centre for Disease Prevention and Control, ECDC ANN EPIDEMIOLOG; European Centre for Disease Prevention and Control, 2019, WEEKLY EPIDEMIOLOGIC; Hofstraat SHI, 2017, EPIDEMIOL INFECT, V145, P2873, DOI [10.1017/S0950268817001947, 10.1017/s0950268817001947]; Humpe A, 2000, THROMB HAEMOSTASIS, V84, P784; Lithuanian Institute of Hygiene, 2019, DATA YEAR 2018 NATL; Lopez-Menchero C, 2019, BLOOD TRANSFUS-ITALY, V17, P418, DOI 10.2450/2019.0058-19; Luban NLC, 2005, ANN NY ACAD SCI, V1054, P325, DOI 10.1196/annals.1345.040; Nat Acad Sci Engn Med, 2016, ELIMINATING THE PUBLIC HEALTH PROBLEM OF HEPATITIS B AND C IN THE UNITED STATES: PHASE ONE REPORT, P1, DOI 10.17226/23407; PETERMAN TA, 1987, TRANSFUSION, V27, P371, DOI 10.1046/j.1537-2995.1987.27587320525.x; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Schmidt M, 2009, TRANSFUSION, V49, P1836, DOI 10.1111/j.1537-2995.2009.02203.x; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Seed CR, 2017, VOX SANG, V112, P3, DOI 10.1111/vox.12446; Soldan K, 2003, VOX SANG, V84, P274, DOI 10.1046/j.1423-0410.2003.00296.x; van der Poel CL, 2002, VOX SANG, V83, P285, DOI 10.1046/j.1423-0410.2002.00239.x; Velati C, 2019, BLOOD TRANSFUS-ITALY, V17, P409, DOI 10.2450/2019.0245-19; Velati C, 2018, BLOOD TRANSFUS-ITALY, V16, P422, DOI 10.2450/2018.0069-18; WHO, 2016, COMBATING HEPATITIS; World Health Organization Regional Office for the Eastern Mediterranean, 2017, STRATEGIC FRAMEWORK, P5	24	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246704	10.1371/journal.pone.0246704	http://dx.doi.org/10.1371/journal.pone.0246704			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606700	gold, Green Published			2022-12-26	WOS:000620629200021
J	Lee, J; Shin, Y; Choi, E; Choi, S; Son, J; Jung, YK; Hong, SB				Lee, Jinmi; Shin, Yujung; Choi, Eunjoo; Choi, Sunhui; Son, Jeongsuk; Jung, Youn Kyung; Hong, Sang-Bum			Impact of hospitalization duration before medical emergency team activation: A retrospective cohort study	PLOS ONE			English	Article								Background The rapid response system has been implemented in many hospitals worldwide and, reportedly, the timing of medical emergency team (MET) attendance in relation to the duration of hospitalization is associated with the mortality of MET patients. We evaluated the relationship between duration of hospitalization before MET activation and patient mortality. We compared cases of MET activation for early, intermediate, and late deterioration to patient characteristics, activation characteristics, and patient outcomes. We also aimed to determine the relationship, after adjusting for confounders, between the duration of hospitalization before MET activation and patient mortality. Materials and methods We retrospectively evaluated patients who triggered MET activation in general wards from March 2009 to February 2015 at the Asan Medical Center in Seoul. Patients were categorized as those with early deterioration (less than 2 days after admission), intermediate deterioration (2-7 days after admission), and late deterioration (more than 7 days after admission) and compared them to patient characteristics, activation characteristics, and patient outcomes. Results Overall, 7114 patients were included. Of these, 1793 (25.2%) showed early deterioration, 2113 (29.7%) showed intermediate deterioration, and 3208 (45.1%) showed late deterioration. Etiologies of MET activation were similar among these groups. The clinical outcomes significantly differed among the groups (intensive care unit transfer: 34.1%, 35.6%, and 40.4%; p < 0.001 and mortality: 26.3%, 31.5%, and 41.2%; p < 0.001 for early, intermediate, and late deterioration, respectively). Compared with early deterioration and adjusted for confounders, the odds ratio of mortality for late deterioration was 1.68 (1.46-1.93). Conclusions Nearly 50% of the acute clinically-deteriorating patients who activated the MET had been hospitalized for more than 7 days. Furthermore, they presented with higher rates of mortality and ICU transfer than patients admitted for less than 7 days before MET activation and had mortality as an independent risk factor.	[Lee, Jinmi; Shin, Yujung; Choi, Eunjoo; Choi, Sunhui; Son, Jeongsuk; Jung, Youn Kyung] Asan Med Ctr, Med Emergency Team, Seoul, South Korea; [Hong, Sang-Bum] Univ Ulsan, Asan Med Ctr, Dept Pulm & Crit Care Med, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Hong, SB (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Pulm & Crit Care Med, Coll Med, Seoul, South Korea.	sbhong@amc.seoul.kr		Hong, Sang-Bum/0000-0003-2737-7695	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea [HI18C0599]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute and was funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI18C0599). The funders had no role in the study design, data collection and analysis, manuscript preparation, or decision to publish.	Ahn JH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233078; Alp E, 2018, AUST CRIT CARE, V31, P363, DOI 10.1016/j.aucc.2017.10.005; Boniatti MM, 2010, RESUSCITATION, V81, P667, DOI 10.1016/j.resuscitation.2010.01.025; Calzavacca P, 2010, RESUSCITATION, V81, P1509, DOI 10.1016/j.resuscitation.2010.06.017; Casamento Andrew J, 2008, Crit Care Resusc, V10, P29; DeVita MA, 2006, CRIT CARE MED, V34, P2463, DOI 10.1097/01.CCM.0000235743.38172.6E; Downar J, 2013, RESUSCITATION, V84, P1339, DOI 10.1016/j.resuscitation.2013.03.003; Echevarria C, 2019, THORAX, V74, P941, DOI 10.1136/thoraxjnl-2019-213470; Hodgson LE, 2017, THORAX, V72, P23, DOI 10.1136/thoraxjnl-2016-208436; Huh JW, 2014, CRIT CARE MED, V42, P801, DOI 10.1097/CCM.0000000000000031; Jaderling G, 2011, INTENS CARE MED, V37, P1000, DOI 10.1007/s00134-011-2156-x; Jones D, 2013, CRIT CARE RESUSC, V15, P15; Jones D, 2013, CURR OPIN CRIT CARE, V19, P616, DOI 10.1097/MCC.0b013e3283636be2; Jones Daryl A, 2007, Crit Care Resusc, V9, P151; Jones DA, 2011, NEW ENGL J MED, V365, P139, DOI 10.1056/NEJMra0910926; Jones DA, 2012, CRIT CARE MED, V40, P98, DOI 10.1097/CCM.0b013e31822e9d50; Kim WY, 2017, J CRIT CARE, V40, P213, DOI 10.1016/j.jcrc.2017.04.024; Lee BY, 2019, ACUTE CRIT CARE, V34, P108, DOI 10.4266/acc.2019.00535; Lyons Patrick G, 2019, J Oncol Pract, V15, pe652, DOI 10.1200/JOP.18.00765; Micallef S, 2011, RESUSCITATION, V82, P815, DOI 10.1016/j.resuscitation.2011.02.048; Smith RJ, 2015, J CRIT CARE, V30, P692, DOI 10.1016/j.jcrc.2015.04.004; Stelfox HT, 2014, CRIT CARE MED, V42, P1601, DOI 10.1097/CCM.0000000000000315	22	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247066	10.1371/journal.pone.0247066	http://dx.doi.org/10.1371/journal.pone.0247066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606743	Green Published, gold			2022-12-26	WOS:000620629200006
J	Saunders, AS; Bender, DE; Ray, AL; Wu, XY; Morris, KT				Saunders, Apryl S.; Bender, Dawn E.; Ray, Anita L.; Wu, Xiangyan; Morris, Katherine T.			Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data	PLOS ONE			English	Article								Colorectal cancer is the 2nd leading cause of cancer-related deaths in the world. The mechanisms underlying CRC development, progression, and resistance to treatment are complex and not fully understood. The immune response in the tumor microenvironment has been shown to play a significant role in many cancers, including colorectal cancer. Colony-stimulating factor 3 (CSF3) has been associated with changes to the immune environment in colorectal cancer animal models. We hypothesized that CSF3 signaling would correlate with pro-tumor tumor microenvironment changes associated with immune infiltrate and response. We utilized publicly available datasets to guide future mechanistic studies of the role CSF3 and its receptor (CSF3R) play in colorectal cancer development and progression. Here, we use bioinformatics data and mRNA from patients with colon (n = 242) or rectal (n = 92) cancers, obtained from The Cancer Genome Atlas Firehose Legacy dataset. We examined correlations of CSF3 and CSF3R expression with patient demographics, tumor stage and consensus molecular subtype classification. Gene expression correlations, cell type enrichment, Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data scores and Gene Ontology were used to analyze expression of receptor and ligand, tumor microenvironment infiltration of immune cells, and alterations in biological pathways. We found that CSF3 and CSF3R expression is highest in consensus molecular subtype 1 and consensus molecular subtype 4. Ligand and receptor expression are also correlated with changes in T cell and macrophage signatures. CSF3R significantly correlates with a large number of genes that are associated with poor colorectal cancer prognosis.	[Saunders, Apryl S.; Bender, Dawn E.; Ray, Anita L.; Morris, Katherine T.] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK 73106 USA; [Wu, Xiangyan] Fujian Univ Tradit Chinese Med, Acad Integrat Med, Fuzhou, Fujian, Peoples R China; [Wu, Xiangyan] Fujian Univ Tradit Chinese Med, Fujian Key Lab Integrat Med Geriatr, Fuzhou, Fujian, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; Fujian University of Traditional Chinese Medicine; Fujian University of Traditional Chinese Medicine	Morris, KT (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK 73106 USA.	katherine-morris@ouhsc.edu		Saunders, Apryl/0000-0003-1185-4258	American Cancer Society [MRSG-15-136-01-CCE]	American Cancer Society(American Cancer Society)	This work was funded by the American Cancer Society under Grant MRSG-15-136-01-CCE (KTM) https://urldefense.proofpoint.com/v2/url?u=http-3A__www.cancer.org&d=DwIGaQ&c=VjzId-SM5S6aVB_cCGQ0d3uo9UfKByQ3sI6Audoy6dY &r=47E30vBjgUhCUgf1o9ZUiNABBuJGlF2-pQOCqm470bM&m=	Baker KJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01197; Becht E, 2016, CLIN CANCER RES, V22, P4057, DOI 10.1158/1078-0432.CCR-15-2879; Bednarczyk M, 2017, INT J IMMUNOPATH PH, V30, P322, DOI 10.1177/0394632017716048; Bhagwat SV, 2020, MOL CANCER THER, V19, P325, DOI 10.1158/1535-7163.MCT-19-0183; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Braster R, 2017, IMMUNOBIOLOGY, V222, P21, DOI 10.1016/j.imbio.2015.08.011; Cabrero-de las Heras S, 2018, WORLD J GASTROENTERO, V24, P4738, DOI 10.3748/wjg.v24.i42.4738; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen WH, 2009, IMMUNOPHARM IMMUNOT, V31, P267, DOI 10.1080/08923970802530510; Chen YB, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0568-z; Cortese N, 2019, CANCERS, V11, DOI 10.3390/cancers11050633; De Rosa M, 2015, ONCOL REP, V34, P1087, DOI 10.3892/or.2015.4108; Deraz EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025438; DiBlasio B, 1996, CARBOHYD RES, V282, P41, DOI 10.1016/0008-6215(95)00357-6; Eide PW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16747-x; Emmanouil G, 2018, ANAL CELL PATHOL, V2018, DOI 10.1155/2018/1616973; Eng C, 2019, LANCET ONCOL, V20, P849, DOI 10.1016/S1470-2045(19)30027-0; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Franzke A, 2003, BLOOD, V102, P734, DOI 10.1182/blood-2002-04-1200; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goldman MJ, 2020, NAT BIOTECHNOL, V38, P675, DOI 10.1038/s41587-020-0546-8; Grothey A., 2018, ANN ONCOL, V29; Hollmen M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1115177; Hu BW, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0562-7; Huang TC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181034; Idos GE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60255-4; Ji YY, 2018, GENET TEST MOL BIOMA, V22, P5, DOI 10.1089/gtmb.2017.0113; Johnston SRD, 2001, LANCET ONCOL, V2, P18, DOI 10.1016/S1470-2045(00)00191-1; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; Kamezaki K, 2005, STEM CELLS, V23, P252, DOI 10.1634/stemcells.2004-0173a; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Lai CF, 1996, BLOOD, V87, P4143, DOI 10.1182/blood.V87.10.4143.bloodjournal87104143; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Li JJ, 2020, INT J BIOL SCI, V16, P2323, DOI 10.7150/ijbs.46651; Li TW, 2020, NUCLEIC ACIDS RES, V48, pW509, DOI 10.1093/nar/gkaa407; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Li TT, 2014, WORLD J GASTROENTERO, V20, P17699, DOI 10.3748/wjg.v20.i47.17699; Li YJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-87; Liu GC, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00307; Liu W, 2018, ONCOL LETT, V15, P4351, DOI 10.3892/ol.2018.7855; Malashchenko VV, 2018, CELL IMMUNOL, V325, P23, DOI 10.1016/j.cellimm.2018.01.007; Menter David G, 2019, Curr Gastroenterol Rep, V21, P5, DOI 10.1007/s11894-019-0674-9; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Morris KT, 2014, BRIT J CANCER, V110, P1211, DOI 10.1038/bjc.2013.822; Morris KT, 2015, ONCOTARGET, V6, P22338, DOI 10.18632/oncotarget.4169; Okita Akira, 2018, Oncotarget, V9, P18698, DOI 10.18632/oncotarget.24617; Pan JH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00006; Peranzoni E, 2018, P NATL ACAD SCI USA, V115, pE4041, DOI 10.1073/pnas.1720948115; Pinto ML, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01875; Prenen H, 2019, CELL MOL LIFE SCI, V76, P1447, DOI 10.1007/s00018-018-2997-3; Qiu WZ, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0722-6; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Reissfelder C, 2015, J CLIN INVEST, V125, P739, DOI 10.1172/JCI74894; Romero-Moreno R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12108-6; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Strasser K, 2019, EUR J CANCER, V110, pS8; Sturm G, 2019, BIOINFORMATICS, V35, pI436, DOI 10.1093/bioinformatics/btz363; Sugarbaker PH., 1985, COLORECTAL CANCER; Thanikachalam K, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010164; Thompson ED, 2010, J EXP MED, V207, P1791, DOI 10.1084/jem.20092454; Toh HC, 2009, CLIN IMMUNOL, V132, P83, DOI 10.1016/j.clim.2009.03.509; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trumpi K, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.48; Tsareva SA, 2007, NEOPLASIA, V9, P279, DOI 10.1593/neo.06820; Voloshin T, 2011, BLOOD, V118, P3426, DOI 10.1182/blood-2010-11-320812; Wang Y, 2020, MOL THER-NUCL ACIDS, V22, P236, DOI 10.1016/j.omtn.2020.08.029; Wei C, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0976-4; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; WEINBERG RA, 1989, CANCER RES, V49, P3713; White A, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4786-7; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; World Health Organization (WHO), WORLD CANC REPORT 20; Wu XY, 2020, CANCERS, V12, DOI 10.3390/cancers12020274; Xia AL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01719; Xu HY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-330; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang HJ, 2018, J BIOL CHEM, V293, P7387, DOI 10.1074/jbc.RA118.002417; Zhou G, 2019, ONCOL LETT, V17, P2266, DOI 10.3892/ol.2018.9857; Zhou JW, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00188	81	3	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247233	10.1371/journal.pone.0247233	http://dx.doi.org/10.1371/journal.pone.0247233			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606788	gold, Green Published			2022-12-26	WOS:000620629200024
J	Allison, A; Fouladkhah, AC				Allison, Abimbola; Fouladkhah, Aliyar Cyrus			Sensitivity of wild-type and rifampicin-resistant O157 and non-O157 Shiga toxin-producing Escherichia coli to elevated hydrostatic pressure and lactic acid in ground meat and meat homogenate	PLOS ONE			English	Article								Various serogroups of Shiga toxin-producing Escherichia coli have been epidemiologically associated with foodborne disease episodes in the United States and around the globe, with E. coli O157: H7 as the dominant serogroup of public health concern. Serogroups other than O157 are currently associated with about 60% of Shiga toxin-producing E. coli related foodborne illness episodes. Current study evaluated sensitivity of the O157 and epidemiologically important non-O157 serogroups of the pathogen to elevated hydrostatic pressure and 1% lactic acid. Pressure intensity of 250 to 650 MPa were applied for 0 to 7 min for inactivation of strain mixtures of wild-type and rifampicin-resistant E. coli O157, as well as O26, O45, O103, O111, O121, and O145 serogroups and ATCC(R) 43895((TM)) strain in ground meat and 10% meat homogenate. E. coli O157 were reduced (p < 0.05) from 6.86 +/- 0.2 to 4.56 +/- 0.1 log CFU/g when exposed to pressure of 650 MPa for 7 min. Corresponding reductions (p < 0.05) for non-O157 E. coli were from 6.98 +/- 0.3 to 4.72 +/- 0.1. The D-values at 650 MPa were 3.71 and 3.47 min for O157 and non-O157 serogroups, respectively. Presence of 1% lactic acid to a great extent augmented (p < 0.05) decontamination efficacy of the treatment in meat homogenate resulting in up to 5.6 and 6.0 log CFU/mL reductions for O157 and non-O157 serogroups, respectively. Among the tested serogroups, the wild-type and rifampicin-resistant phenotypes exhibited (p >= 0.05) comparable pressure sensitivity. Thus, these two phenotypes could be used interchangeably in validation studies. Our results also illustrate that, application of elevated hydrostatic pressure could be utilized for assuring safety of ground and non-intact meat products against various serogroups of Shiga toxin-producing E. coli. Addition of 1% lactic acid additionally provided industrially appreciable augmentation in efficacy of the pressure-based treatments.	[Allison, Abimbola; Fouladkhah, Aliyar Cyrus] Tennessee State Univ, Publ Hlth Microbiol Lab, Nashville, TN 37203 USA	Tennessee State University	Fouladkhah, AC (corresponding author), Tennessee State Univ, Publ Hlth Microbiol Lab, Nashville, TN 37203 USA.	afouladk@tnstate.edu		Fouladkhah, Aliyar/0000-0001-9204-2870	Pressure BioScience Inc.; USDA National Institute of Food and Agriculture [2017-07534, 201707975, 2017-06088]	Pressure BioScience Inc.; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work is funded in part by Pressure BioScience Inc. and USDA National Institute of Food and Agriculture (Projects 2017-07534; 201707975; 2017-06088). Technical assistance of students and staff from Public Health Microbiology program is acknowledged gratefully by the corresponding author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison A, 2018, DATA BRIEF, V21, P480, DOI 10.1016/j.dib.2018.09.071; Allison A, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6040102; Allison A, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6010023; Aras S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020563; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; CDC, 2013, ANTIBIOTIC RESISTANC, DOI [DOI 10.15620/CDC:82532, 10.15620/cdc:82532]; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P258; Centers for Disease Control and Prevention (CDC), 2011, E COL OUTBR GERM; Chien SY, 2019, FOOD BIOPROCESS TECH, V12, P359, DOI 10.1007/s11947-018-2211-5; Chien SY, 2017, FOOD CONTROL, V73, P672, DOI 10.1016/j.foodcont.2016.09.017; European Centre for Disease Prevention and Control (ECDC), 2019, SHIG TOX VER PROD ES; Food and Agriculture Organization of the United Nations (FAO)/ World Health Organization (WHO), 2016, MICR RISK ASS SER; Fouladkhah A, 2013, FOOD MICROBIOL, V36, P260, DOI 10.1016/j.fm.2013.06.005; Fouladkhah A, 2013, J FOOD SCI, V78, pM880, DOI 10.1111/1750-3841.12123; Fouladkhah A, 2012, J FOOD PROTECT, V75, P1751, DOI 10.4315/0362-028X.JFP-12-128; Fouladkhah AC, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8050748; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Kabir MN, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8030408; Kabir MN, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7050145; Kabir N, 2019, IAFP 2019 ANN M JUL; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; KASPAR CW, 1993, APPL ENVIRON MICROB, V59, P2425, DOI 10.1128/AEM.59.8.2425-2429.1993; Kato C, 1998, APPL ENVIRON MICROB, V64, P1510; MARCH SB, 1986, J CLIN MICROBIOL, V23, P869, DOI 10.1128/JCM.23.5.869-872.1986; Mathusa EC, 2010, J FOOD PROTECT, V73, P1721, DOI 10.4315/0362-028X-73.9.1721; Oliver SP, 2009, J ANIM SCI, V87, P419, DOI 10.2527/jas.2008-2008-1151; Porto-Fett ACS, 2020, J FOOD PROTECT, V83, P865, DOI 10.4315/JFP-19-558; Samelis J, 2002, APPL ENVIRON MICROB, V68, P2600, DOI 10.1128/AEM.68.5.2600-2604.2002; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Sofos JN, 2008, MEAT SCI, V78, P3, DOI 10.1016/j.meatsci.2007.07.027; Thomas CL, 2020, LWT-FOOD SCI TECHNOL, V117, DOI 10.1016/j.lwt.2019.108689; U.S. Department of Agriculture F.S. and I.S. (USDA-FSIS), 2011, FED REGISTER, V76, P58157; Wang CY, 2016, CRIT REV FOOD SCI, V56, P527, DOI 10.1080/10408398.2012.745479; Weinstein ZB, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01243-18; Woerner DR, 2018, J FOOD PROTECT, V81, P1068, DOI [10.4315/0362-028X.JFP-17-385, 10.4315/0362-028x.jfp-17-385]; Zhou YJ, 2016, FOOD MICROBIOL, V58, P7, DOI 10.1016/j.fm.2016.02.010	36	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0246735	10.1371/journal.pone.0246735	http://dx.doi.org/10.1371/journal.pone.0246735			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600440	Green Published, gold			2022-12-26	WOS:000620625100003
J	Bhoyar, RC; Jain, A; Sehgal, P; Divakar, MK; Sharma, D; Imran, M; Jolly, B; Ranjan, G; Rophina, M; Sharma, S; Siwach, S; Pandhare, K; Sahoo, S; Sahoo, M; Nayak, A; Mohanty, JN; Das, J; Bhandari, S; Mathur, SK; Kumar, A; Sahlot, R; Rojarani, P; Lakshmi, JV; Surekha, A; Sekhar, PC; Mahajan, S; Masih, S; Singh, P; Kumar, V; Jose, B; Mahajan, V; Gupta, V; Gupta, R; Arumugam, P; Singh, A; Nandy, A; Ragavendran, PV; Jha, RM; Kumari, A; Gandotra, S; Rao, V; Faruq, M; Kumar, S; Reshma, GB; Varma, GN; Roy, SS; Sengupta, A; Chattopadhyay, S; Singhal, K; Pradhan, S; Jha, D; Naushin, S; Wadhwa, S; Tyagi, N; Poojary, M; Scaria, V; Sivasubbu, S				Bhoyar, Rahul C.; Jain, Abhinav; Sehgal, Paras; Divakar, Mohit Kumar; Sharma, Disha; Imran, Mohamed; Jolly, Bani; Ranjan, Gyan; Rophina, Mercy; Sharma, Sumit; Siwach, Sanjay; Pandhare, Kavita; Sahoo, Swayamprabha; Sahoo, Maheswata; Nayak, Ananya; Mohanty, Jatindra Nath; Das, Jayashankar; Bhandari, Sudhir; Mathur, Sandeep K.; Kumar, Anshul; Sahlot, Rahul; Rojarani, Pallavali; Lakshmi, Juturu Vijaya; Surekha, Avileli; Sekhar, Pulala Chandra; Mahajan, Shelly; Masih, Shet; Singh, Pawan; Kumar, Vipin; Jose, Blessy; Mahajan, Vidur; Gupta, Vivek; Gupta, Rakesh; Arumugam, Prabhakar; Singh, Anjali; Nandy, Ananya; Ragavendran, P., V; Jha, Rakesh Mohan; Kumari, Anupama; Gandotra, Sheetal; Rao, Vivek; Faruq, Mohammed; Kumar, Sanjeev; Reshma, Betsy G.; Varma, Narendra G.; Roy, Shuvra Shekhar; Sengupta, Antara; Chattopadhyay, Sabyasachi; Singhal, Khushboo; Pradhan, Shalini; Jha, Diksha; Naushin, Salwa; Wadhwa, Saruchi; Tyagi, Nishu; Poojary, Mukta; Scaria, Vinod; Sivasubbu, Sridhar			High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing	PLOS ONE			English	Article							TREE	The rapid emergence of coronavirus disease 2019 (COVID-19) as a global pandemic affecting millions of individuals globally has necessitated sensitive and high-throughput approaches for the diagnosis, surveillance, and determining the genetic epidemiology of SARS-CoV-2. In the present study, we used the COVIDSeq protocol, which involves multiplex-PCR, barcoding, and sequencing of samples for high-throughput detection and deciphering the genetic epidemiology of SARS-CoV-2. We used the approach on 752 clinical samples in duplicates, amounting to a total of 1536 samples which could be sequenced on a single S4 sequencing flow cell on NovaSeq 6000. Our analysis suggests a high concordance between technical duplicates and a high concordance of detection of SARS-CoV-2 between the COVIDSeq as well as RT-PCR approaches. An in-depth analysis revealed a total of six samples in which COVIDSeq detected SARS-CoV-2 in high confidence which were negative in RT-PCR. Additionally, the assay could detect SARS-CoV-2 in 21 samples and 16 samples which were classified inconclusive and pan-sarbeco positive respectively suggesting that COVIDSeq could be used as a confirmatory test. The sequencing approach also enabled insights into the evolution and genetic epidemiology of the SARS-CoV-2 samples. The samples were classified into a total of 3 clades. This study reports two lineages B.1.112 and B.1.99 for the first time in India. This study also revealed 1,143 unique single nucleotide variants and added a total of 73 novel variants identified for the first time. To the best of our knowledge, this is the first report of the COVIDSeq approach for detection and genetic epidemiology of SARS-CoV-2. Our analysis suggests that COVIDSeq could be a potential high sensitivity assay for the detection of SARS-CoV-2, with an additional advantage of enabling the genetic epidemiology of SARS-CoV-2.	[Bhoyar, Rahul C.; Jain, Abhinav; Sehgal, Paras; Divakar, Mohit Kumar; Sharma, Disha; Imran, Mohamed; Jolly, Bani; Ranjan, Gyan; Rophina, Mercy; Sharma, Sumit; Siwach, Sanjay; Pandhare, Kavita; Arumugam, Prabhakar; Singh, Anjali; Nandy, Ananya; Ragavendran, P., V; Jha, Rakesh Mohan; Kumari, Anupama; Gandotra, Sheetal; Rao, Vivek; Faruq, Mohammed; Kumar, Sanjeev; Reshma, Betsy G.; Varma, Narendra G.; Roy, Shuvra Shekhar; Sengupta, Antara; Chattopadhyay, Sabyasachi; Singhal, Khushboo; Pradhan, Shalini; Jha, Diksha; Naushin, Salwa; Wadhwa, Saruchi; Tyagi, Nishu; Poojary, Mukta; Scaria, Vinod; Sivasubbu, Sridhar] CSIR Inst Genom & Integrat Biol CSIR IGIB, New Delhi, India; [Jain, Abhinav; Sehgal, Paras; Divakar, Mohit Kumar; Imran, Mohamed; Jolly, Bani; Ranjan, Gyan; Rophina, Mercy; Arumugam, Prabhakar; Singh, Anjali; Nandy, Ananya; Ragavendran, P., V; Jha, Rakesh Mohan; Kumari, Anupama; Gandotra, Sheetal; Rao, Vivek; Faruq, Mohammed; Kumar, Sanjeev; Reshma, Betsy G.; Roy, Shuvra Shekhar; Sengupta, Antara; Chattopadhyay, Sabyasachi; Singhal, Khushboo; Jha, Diksha; Naushin, Salwa; Wadhwa, Saruchi; Tyagi, Nishu; Poojary, Mukta; Scaria, Vinod; Sivasubbu, Sridhar] Acad Sci & Innovat Res, Human Resource Dev Ctr Campus, Ghaziabad, Uttar Pradesh, India; [Sahoo, Swayamprabha; Sahoo, Maheswata; Nayak, Ananya; Mohanty, Jatindra Nath; Das, Jayashankar] Siksha O Anusandhan Deemed Univ, Inst Med Sci & SUM Hosp, Bhubaneswar, Odisha, India; [Bhandari, Sudhir; Mathur, Sandeep K.; Kumar, Anshul; Sahlot, Rahul] Sawai Man Singh Med Coll, Jaipur, Rajasthan, India; [Rojarani, Pallavali; Lakshmi, Juturu Vijaya; Surekha, Avileli; Sekhar, Pulala Chandra] Kurnool Med Coll, Kurnool, Andhra Pradesh, India; [Mahajan, Shelly; Masih, Shet; Singh, Pawan; Kumar, Vipin; Jose, Blessy; Mahajan, Vidur] Ctr Adv Res Imaging Neurosci & Genom, Delhi, India; [Gupta, Vivek; Gupta, Rakesh] Govt Inst Med Sci, Noida, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR); Siksha 'O' Anusandhan University; SMS Medical College & Hospital; Kurnool Medical College	Scaria, V; Sivasubbu, S (corresponding author), CSIR Inst Genom & Integrat Biol CSIR IGIB, New Delhi, India.; Scaria, V; Sivasubbu, S (corresponding author), Acad Sci & Innovat Res, Human Resource Dev Ctr Campus, Ghaziabad, Uttar Pradesh, India.	vinods@igib.res.in; s.sivasubbu@igib.res.in	Imran, Mohamed/ABB-2040-2021; Sharma, Disha/AAX-8702-2021; Jain, Abhinav/AAY-1166-2021; Rophina, Mercy/CAF-6359-2022; Scaria, Vinod/AAS-3151-2021	Jain, Abhinav/0000-0001-6017-5492; Reshma, Betsy/0000-0002-7844-7932; Tyagi, Nishu/0000-0002-3455-068X; WADHWA, SARUCHI/0000-0001-7271-0421; , PRABHAKAR/0000-0002-9446-9285; Singhal, Dr. Khushboo/0000-0003-1251-7683; Gottumukkala, Narendra Varma/0000-0001-5394-0520; Kumari, Anupama/0000-0001-5896-5807; Pallavali, Roja Rani/0000-0001-8729-3528; PALLAVALI, ROJARANI/0000-0001-5865-2974; Roy, Shuvra Shekhar/0000-0001-6005-2767	Council of Scientific and Industrial Research (CSIR), India through grant CODEST; Council of Scientific and Industrial Research (CSIR), India through grant MLP2005	Council of Scientific and Industrial Research (CSIR), India through grant CODEST; Council of Scientific and Industrial Research (CSIR), India through grant MLP2005	Authors acknowledge funding for the work from the Council of Scientific and Industrial Research (CSIR), India through grants CODEST and MLP2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, NAT BIOTECHNOL, V38, P777, DOI 10.1038/s41587-020-0608-y; Baker DJ., 2020, CORONAHIT LARGE SCAL, DOI [10.1101/2020.06.24.162156, DOI 10.1101/2020.06.24.162156]; Banu S, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa434; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; de Lusignan S, 2020, JMIR PUBLIC HLTH SUR, V6, P126, DOI 10.2196/18606; Dohla M, 2020, PUBLIC HEALTH, V182, P170, DOI 10.1016/j.puhe.2020.04.009; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Harilal D, 2020, CLIN CHEM, V66, P1450, DOI 10.1093/clinchem/hvaa187; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kryazhimskiy S, 2008, J VIROL, V82, P4938, DOI 10.1128/JVI.02415-07; Kucirka L, 2020, VARIATION FALSE NEGA, DOI [10.1101/2020.04.07.20051474, DOI 10.1101/2020.04.07.20051474, 10.7326/M20-1495]; Langat Pinky, 2017, PLoS Pathog, V13, pe1006749, DOI 10.1371/journal.ppat.1006749; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lu J, 2020, CELL, V181, P997, DOI 10.1016/j.cell.2020.04.023; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Michie A, 2020, J VIROL, V94, DOI 10.1128/JVI.01234-19; Ng YX, 2020, MMWR-MORBID MORTAL W, V69, P307, DOI 10.15585/mmwr.mm6911e1; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Palmieri D., 2020, MOL BIOL+, P78; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Rockett RJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-1000-7., 10.1038/s41591-020-1000-7]; Rophina, FAVICOV COMPREHENSIV; Scaria V, 2019, COMPUTATIONAL PROTOC; Scaria V., COMPUTATIONAL ANAL P; Schmid-Burgk JL., 2020, MOL BIOL+, P2431; Shakya M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58356-1; Shen W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163962; Shu Y., 2017, NUCLEIC ACIDS RES, V22, DOI [10.2807/1560-7917.ES.2017.22.13.30494, DOI 10.2807/1560-7917.ES.2017.22.13.30494]; Stoecklin SB, 2020, EUROSURVEILLANCE, V25, P20, DOI 10.2807/1560-7917.ES.2020.25.6.2000094; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang YS, 2020, J MED VIROL, V92, P538, DOI 10.1002/jmv.25721; Warne B., 2020, LANCET INFECT DIS, DOI DOI 10.1016/S1473-3099%2820%2930562-4; Wen SQ, 2020, J MED VIROL, V92, P2221, DOI 10.1002/jmv.26116; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xiao MF, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00751-4; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	40	52	53	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0247115	10.1371/journal.pone.0247115	http://dx.doi.org/10.1371/journal.pone.0247115			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596239	Green Submitted, Green Published, gold			2022-12-26	WOS:000620633200022
J	Malagoli, LR; Pezzuti, TL; Bang, DL; Faivovich, J; Lyra, ML; Giovanelli, JGR; Garcia, PCD; Sawaya, RJ; Haddad, CFB				Malagoli, Leo Ramos; Pezzuti, Tiago Leite; Bang, Davi Lee; Faivovich, Julian; Lyra, Mariana Lucio; Ribeiro Giovanelli, Joao Gabriel; de Anchietta Garcia, Paulo Christiano; Sawaya, Ricardo Jannini; Baptista Haddad, Celio Fernando			A new reproductive mode in anurans: Natural history of Bokermannohyla astartea (Anura: Hylidae) with the description of its tadpole and vocal repertoire	PLOS ONE			English	Article							ATLANTIC RAIN-FOREST; ADVERTISEMENT CALL; SOUTHEASTERN BRAZIL; CENTRAL BAHIA; SAO-PAULO; BEHAVIOR; EVOLUTION; TREEFROG; AMPHIBIA; PATTERNS	Anurans have the greatest diversity of reproductive modes among tetrapod vertebrates, with at least 41 being currently recognized. We describe a new reproductive mode for anurans, as exhibited by the Paranapiacaba Treefrog, Bokermannohyla astartea, an endemic and poorly known species of the Brazilian Atlantic Forest belonging to the B. circumdata group. We also describe other aspects of its reproductive biology, that are relevant to understanding the new reproductive mode, such as courtship behavior, spawning, and tadpoles. Additionally, we redescribe its advertisement call and extend its vocal repertoire by describing three additional call types: courtship, amplectant, and presumed territorial. The new reproductive mode exhibited by B. astartea consists of: (1) deposition of aquatic eggs in leaf-tanks of terrestrial or epiphytic bromeliads located on or over the banks of temporary or permanent streams; (2) exotrophic tadpoles remain in the leaf-tanks during initial stages of development (until Gosner stage 26), after which they presumably jump or are transported to streams after heavy rains that flood their bromeliad tanks; and (3) tadpole development completes in streams. The tadpoles of B. astartea are similar to those of other species of the B. circumdata group, although with differences in the spiracle, eyes, and oral disc. The vocal repertoire of B. astartea exhibits previously unreported acoustic complexity for the genus. Bokermannohyla astartea is the only bromeligenous species known to date among the 187 known species within the tribe Cophomantini. We further discuss evolutionary hypotheses for the origin of this novel reproductive mode.	[Malagoli, Leo Ramos] Fundacao Conservacao & Prod Florestal Estado Sao, Nucleo Sao Sebastiao, Parque Estadual Serra Mar, Sao Sebastiao, SP, Brazil; [Malagoli, Leo Ramos; Lyra, Mariana Lucio; Ribeiro Giovanelli, Joao Gabriel; Baptista Haddad, Celio Fernando] Univ Estadual Paulista, Dept Biodiversidade, Inst Biociencias, Rio Claro, SP, Brazil; [Malagoli, Leo Ramos; Lyra, Mariana Lucio; Ribeiro Giovanelli, Joao Gabriel; Baptista Haddad, Celio Fernando] Univ Estadual Paulista, Ctr Aquicultura CAUNESP, Inst Biociencias, Rio Claro, SP, Brazil; [Pezzuti, Tiago Leite; de Anchietta Garcia, Paulo Christiano] Univ Fed Minas Gerais, Inst Ciencias Biol, Programa Posgrad Zool, Belo Horizonte, MG, Brazil; [Bang, Davi Lee] Univ Sao Paulo, Dept Biol, Programa Posgrad Biol Comparada, FFCLRP, Ribeirao Preto, SP, Brazil; [Faivovich, Julian] Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Nat, Div Herpetol, Buenos Aires, DF, Argentina; [Faivovich, Julian] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina; [Sawaya, Ricardo Jannini] Univ Fed ABC UFABC, Ctr Ciencias Nat & Humanas, Sao Bernardo Do Campo, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); University of Buenos Aires	Malagoli, LR (corresponding author), Fundacao Conservacao & Prod Florestal Estado Sao, Nucleo Sao Sebastiao, Parque Estadual Serra Mar, Sao Sebastiao, SP, Brazil.; Malagoli, LR (corresponding author), Univ Estadual Paulista, Dept Biodiversidade, Inst Biociencias, Rio Claro, SP, Brazil.; Malagoli, LR (corresponding author), Univ Estadual Paulista, Ctr Aquicultura CAUNESP, Inst Biociencias, Rio Claro, SP, Brazil.	lrmalagoli@gmail.com	Lyra, Mariana Lucio/O-6405-2014; Garcia, Paulo/A-9983-2010; Ribeiro Giovanelli, Joao Gabriel/C-1657-2019	Lyra, Mariana Lucio/0000-0002-7863-4965; Garcia, Paulo/0000-0002-4789-7033; Ribeiro Giovanelli, Joao Gabriel/0000-0002-7314-9442	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [141259/2014-0]; Sao Paulo Research Foundation (FAPESP) [2008/54472-2, 2008/50928-1, 2013/50741-7, 2014/50342-8, 2014/23677-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [440665/2015-9]; CNPq [202081/2015-0, 306623/2018-8, 312795/2018-1, 310301/2018-1]; FAPESP [2017/27137-7, 2018/15425-0, 2017/26162-8]; Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT PICT 2015-820]; CAPES [001]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was part of L. R. M.'s PhD degree. L. R. M. thanks Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for doctoral fellowship (grant #141259/2014-0). For financial support, we thank Sao Paulo Research Foundation (FAPESP) (grants #2008/54472-2, #2008/50928-1, #2013/50741-7, #2014/50342-8, and #2014/23677-9). T. L. P. thanks Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for PROTAX fellowship (grant #440665/2015-9) and CNPq for "Ciencia Sem Fronteiras" fellowship (grant #202081/2015-0). D. L. B. thanks FAPESP for doctoral fellowship (grant #2017/27137-7). J. F. thanks Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT 2015-820), and FAPESP (grant #2018/15425-0). M. L. L. thanks FAPESP for fellowship (grant #2017/26162-8). J. G. R. G. thanks CAPES for doctoral fellowship (Financing Code 001). C. F. B. H., R. J. S and P. C. A. G. thanks CNPq for research productivity fellowship (grants #306623/2018-8, #312795/2018-1, #310301/2018-1, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; Albecker MA, 2017, FRONT ZOOL, V14, DOI 10.1186/s12983-017-0222-0; Altig R, 1999, TADPOLES, P24; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Alves-Silva R, 2009, J NAT HIST, V43, P205, DOI 10.1080/00222930802568808; Baldo D, 2014, BIOL J LINN SOC, V112, P417, DOI 10.1111/bij.12296; Bertoluci J, 2002, AMPHIBIA-REPTILIA, V23, P161, DOI 10.1163/156853802760061804; Bertoluci J, 2003, AMPHIBIA-REPTILIA, V24, P509, DOI 10.1163/156853803322763963; BOKERMANN W C A, 1967, Revista Brasileira de Biologia, V27, P157; BOKERMANN W C A, 1973, Revista Brasileira de Biologia, V33, P329; Bradfield KS, 2004, DOC SCI INT SER, V191; Buxton VL, 2017, BIOSCIENCE, V67, P25, DOI 10.1093/biosci/biw149; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CARDOSO A J, 1982, Revista Brasileira de Biologia, V42, P589; Centeno Fernanda C., 2015, Herpetological Review, V46, P166; Center for Conservation Bioacoustics, 2014, RAV PROINT SOUND AN; Chen Z, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14356-3; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Costa PN, 2010, ZOOTAXA, P61; Crump ML, 2015, J HERPETOL, V49, P1, DOI 10.1670/14-097; da Silva FR, 2012, J BIOGEOGR, V39, P1720, DOI 10.1111/j.1365-2699.2012.02726.x; Lima NGD, 2014, J NAT HIST, V48, P1439, DOI 10.1080/00222933.2013.840940; De Carvalho TR, 2012, ZOOTAXA, P37; de Magalhaes RF, 2018, S AM J HERPETOL, V13, P202, DOI 10.2994/SAJH-D-17-00039.1; de Moura MR, 2011, ZOOLOGIA-CURITIBA, V28, P142, DOI 10.1590/S1984-46702011000100021; de Sa FP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145444; Donnelly M. A., 1994, MEASURING MONITORING, P277; Dudley N., 2008, GUIDELINES APPL PROT, DOI [10.2305/IUCN.CH.2008.PAPS.2.en, DOI 10.2305/IUCN.CH.2008.PAPS.2.EN]; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Faivovich J, 2018, S AM J HERPETOL, V13, P1, DOI 10.2994/SAJH-D-17-00115.1; Faivovich J, 2013, AM MUS NOVIT, P1; Faraulo MD, 2019, SALAMANDRA, V55, P242; FELLERS GM, 1979, ANIM BEHAV, V27, P107, DOI 10.1016/0003-3472(79)90131-3; Finn RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113686; Frost D.R., 2020, AMPHIBIAN SPECIES WO, DOI [10.5531/db.vz.0001, DOI 10.5531/DB.VZ.0001]; Gaiga R, 2013, S AM J HERPETOL, V8, P127, DOI 10.2994/SAJH-D-12-00023.1; Garcia Ricardo Jose Francischetti, 2005, Hoehnea, V32, P1; Garcia Ricardo Jose Francischetti, 2003, Hoehnea, V30, P217; Garey MV, 2020, S AM J HERPETOL, V17, P1, DOI 10.2994/SAJH-D-18-00006.1; Gomez-Mestre I, 2012, EVOLUTION, V66, P3687, DOI 10.1111/j.1558-5646.2012.01715.x; Grosjean S, 2005, CONTRIB ZOOL, V74, P61, DOI 10.1163/18759866-0740102005; Haad B, 2011, STUD NEOTROP FAUNA E, V46, P91, DOI 10.1080/01650521.2011.593124; Haddad C.F.B., 2013, GUIA ANFIBIOS MATA A; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; HADDAD CFB, 1991, J HERPETOL, V25, P226, DOI 10.2307/1564657; Haddad CFB, 2000, BIOTROPICA, V32, P862; Hartmann MT, 2004, AMPHIBIA-REPTILIA, V25, P395, DOI 10.1163/1568538042788933; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; Quinzio SI, 2019, AMPHIBIA-REPTILIA, V40, P543, DOI 10.1163/15685381-20191226; Iskandar DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115884; Kardong K., 2008, VERTEBRATES COMP ANA, V2nd ed.; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kessing B, 1989, SIMPLE FOOLS GUIDE P; Kohler J, 2017, ZOOTAXA, V4251, P1, DOI 10.11646/zootaxa.4251.1.1; Kusrini MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116154; Lannoo J.M., 1987, FIELDIANA ZOOL, V38, P1, DOI DOI 10.5962/BHL.TITLE.2932; LANNOO MJ, 1987, J MORPHOL, V191, P115, DOI 10.1002/jmor.1051910203; LAVILLA E O, 1986, Physis Seccion B las Aguas Continentales y sus Organismos, V44, P39; Lehner PN, 1996, HDB ETHOLOGICAL METH; Ligges U, 2018, **DATA OBJECT**; Lugli L, 2006, HERPETOLOGICA, V62, P453, DOI 10.1655/0018-0831(2006)62[453:ANSOTB]2.0.CO;2; Lutz B., 1973, BRAZILIAN SPECIES HY; Lyra ML, 2020, ZOOL J LINN SOC-LOND, V190, P1235, DOI 10.1093/zoolinnean/zlaa033; Lyra ML, 2017, MOL ECOL RESOUR, V17, P966, DOI 10.1111/1755-0998.12648; Magalhaes FD, 2015, S AM J HERPETOL, V10, P211, DOI 10.2994/SAJH-D-15-00017.1; Magalhaes FDM, 2012, ZOOTAXA, P58; MAGNUSSON WE, 1991, OECOLOGIA, V86, P310, DOI 10.1007/BF00317595; Malagoli L.R, 2013, THESIS U ESTADUAL PA; Maniatis T., 1982, MOL CLONING; MARTINS M, 1988, Amphibia-Reptilia, V9, P49, DOI 10.1163/156853888X00206; Merces ED, 2015, ZOOTAXA, V3904, P298; Merces ED, 2012, ZOOTAXA, P66; Miranda Daniele Bazzo, 2008, Pap. Avulsos Zool. (São Paulo), V48, P335, DOI 10.1590/S0031-10492008002900001; Murphy CG, 2002, BEHAV ECOL, V13, P472, DOI 10.1093/beheco/13.4.472; Nali RC, 2014, AM NAT, V184, P727, DOI 10.1086/678455; Nali RC, 2014, SALAMANDRA, V50, P181; Nali RC, 2012, AMPHIBIA-REPTILIA, V33, P337, DOI 10.1163/15685381-00002836; Napoli MF, 2005, HERPETOLOGICA, V61, P63, DOI 10.1655/03-41; Napoli MF, 2000, THESIS U FEDERAL RIO; Orrico VGD, 2006, REV BRAS ZOOL, V23, P994, DOI 10.1590/S0101-81752006000400003; PEIXOTO O L, 1981, Revista Brasileira de Biologia, V41, P515; Peixoto Oswaldo Luiz, 1995, Revista Universidade Rural Serie Ciencias da Vida, V17, P75; Pezzuti TL, 2016, ZOOL ANZ, V261, P22, DOI 10.1016/j.jcz.2016.02.002; Pezzuti TL, 2015, ZOOTAXA, V4048, P151, DOI 10.11646/zootaxa.4048.2.1; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; POMBAL JP, 1993, HERPETOLOGICA, V49, P16; Portik DM, 2016, EVOLUTION, V70, P2017, DOI 10.1111/evo.12997; Pupin NC, 2010, HERPETOL J, V20, P147; R Core Team, 2020, R LANG ENV STAT COMP; Lins ACR, 2018, ZOOTAXA, V4527, P501, DOI 10.11646/zootaxa.4527.4.3; Rojas-Runjaic FJM, 2018, ZOOTAXA, V4382, P121, DOI 10.11646/zootaxa.4382.1.4; Ryan MJ, 2003, EVOLUTION, V57, P2608, DOI 10.1111/j.0014-3820.2003.tb01503.x; Salthe S.N., 1973, P229; SALTHE SN, 1969, AM MIDL NAT, V81, P467, DOI 10.2307/2423983; SAZIMA I, 1988, Memorias do Instituto Butantan (Sao Paulo), V50, P83; Schacht Mathew C., 2009, Herpetological Review, V40, P303; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHINE R, 1979, COPEIA, P297, DOI 10.2307/1443418; Silva Nelson R., 2019, Herpetology Notes, V12, P319; Silva NR, 2020, BIOL J LINN SOC, V131, P600, DOI 10.1093/biolinnean/blaa126; Silva-Soares T, 2010, BIOTA NEOTROP, V10, P225, DOI [10.1590/S1676-06032010000200025, 10.1590/S1676-06032010000300028]; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Taucce PPG, 2015, ZOOTAXA, V3915, P99, DOI 10.11646/zootaxa.3915.1.4; Tonini JFR, 2020, EVOLUTION, V74, P1815, DOI 10.1111/evo.14037; Touchon JC, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0376; Vagi B, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2737; Verdade VK., 2009, RESERVA BIOL PARANAP, P579; Vieites DR, 2004, NATURE, V431, P305, DOI 10.1038/nature02879; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WELLS KD, 1977, ECOLOGY, V58, P750, DOI 10.2307/1936211; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Zamudio KR, 2016, AM NAT, V188, pS41, DOI 10.1086/687547; Zar JH., 2010, BIOSTAT ANAL, V5th; Zina Juliana, 2007, Herpetological Review, V38, P282; Zornosa-Torres C, 2019, S AM J HERPETOL, V14, P71, DOI 10.2994/SAJH-D-16-00057.1	116	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246401	10.1371/journal.pone.0246401	http://dx.doi.org/10.1371/journal.pone.0246401			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596209	Green Published, gold			2022-12-26	WOS:000620633200065
J	Amaro, E; Moore-Lotridge, SN; Wessinger, B; Benvenuti, MA; An, TJ; Oelsner, WK; Polkowski, GG; Schoenecker, JG				Amaro, Emilie; Moore-Lotridge, Stephanie N.; Wessinger, Bronson; Benvenuti, Michael A.; An, Thomas J.; Oelsner, William K.; Polkowski, Gregory G.; Schoenecker, Jonathan G.			Albumin and the fibrinogen-to-albumin ratio: Biomarkers for the acute phase response following total knee arthroplasty	PLOS ONE			English	Article								Purpose Complications following total knee arthroplasty (TKA) lead to patient morbidity and cost. While acute phase reactants, such as c-reactive protein (CRP) and fibrinogen, have been used to predict complications following TKA, the extent and duration of changes in albumin levels following TKA are unknown. It is hypothesized that like CRP and fibrinogen, albumin, and the fibrinogen/albumin ratio (FAR) represent useful measures of the acute phase response (APR) following TKA. The purpose of this study was to describe the longitudinal course of albumin and FAR in healthy patients following TKA, relative to established biomarkers, and examine if the variance in albumin or FAR correlates with patient comorbidities. Methods This retrospective cohort study of patients undergoing TKA at a tertiary medical center. CRP, fibrinogen, and albumin values were collected pre- and post-operatively. An age-adjusted Charlson comorbidity index (CCI) was utilized as a measure of patient comorbidity status. Results The median preoperative albumin value was 4.3 g/dL, which dropped to 3.6 g/dL on postoperative day 1 following TKA. The albumin value returned to 93% of the baseline by postoperative week 2. The course of albumin inversely mirrored the course of CRP (r = -0.41). Median preoperative FAR was 0.087 g/L, which rose to 0.130 g/L by postoperative week 2 and returned to baseline by postoperative week 6. While preoperative FAR strongly correlated with postoperative week 2 values (r = 0.74), there was a weak positive correlation between age-adjusted CCI and pre-operative FAR (r = 0.24) in patients undergoing primary TKA. Conclusion Albumin levels follow a predictable postoperative decline that inversely correlates with CRP in healthy patients following TKA. Given the low cost and abundance of laboratories offering albumin levels, direct albumin levels and/or albumin ratios such as FAR may be underutilized biomarkers for monitoring the APR following TKA.	[Amaro, Emilie; Moore-Lotridge, Stephanie N.; Benvenuti, Michael A.; Oelsner, William K.; Polkowski, Gregory G.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Orthoped, Nashville, TN 37235 USA; [Moore-Lotridge, Stephanie N.; Schoenecker, Jonathan G.] Vanderbilt Univ, Vanderbilt Ctr Bone Biol, Med Ctr, Nashville, TN 37235 USA; [Wessinger, Bronson; An, Thomas J.] Vanderbilt Univ, Med Ctr, Sch Med, Nashville, TN 37232 USA; [Schoenecker, Jonathan G.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN 37235 USA; [Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Orthoped, Nashville, TN 37235 USA.; Schoenecker, JG (corresponding author), Vanderbilt Univ, Vanderbilt Ctr Bone Biol, Med Ctr, Nashville, TN 37235 USA.; Schoenecker, JG (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN 37235 USA.; Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.; Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	Jon.schoenecker@vumc.org		Schoenecker, Jonathan/0000-0002-3097-5496; Moore-Lotridge, Stephanie/0000-0002-3045-4199; An, Thomas/0000-0002-3782-4500; Wessinger, Bronson/0000-0002-4195-6346	Caitlin Lovejoy Fund; Vanderbilt University Medical Center Department of Orthopaedics; Schoenecker Research Fund	Caitlin Lovejoy Fund; Vanderbilt University Medical Center Department of Orthopaedics; Schoenecker Research Fund	This work was supported by the Caitlin Lovejoy Fund in the form of funds awarded to JGS, the Vanderbilt University Medical Center Department of Orthopaedics in the form of funds awarded to JGS, and the Schoenecker Research Fund in the form of funds awarded to JGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal VK, 2013, INDIAN J ORTHOP, V47, P10, DOI 10.4103/0019-5413.106884; Aguayo-Becerra OA, 2013, CLINICS, V68, P940, DOI 10.6061/clinics/2013(07)09; Baker CE, 2018, CLIN REV BONE MINER, V16, P142, DOI 10.1007/s12018-018-9256-x; Benvenuti M, 2017, ORTHOP CLIN N AM, V48, P181, DOI 10.1016/j.ocl.2016.12.009; Birim O, 2005, EUR J CARDIO-THORAC, V28, P759, DOI 10.1016/j.ejcts.2005.06.046; Bouillanne O, 2011, NUTRITION, V27, P165, DOI 10.1016/j.nut.2009.12.007; Celebi S, 2020, CORONARY ARTERY DIS, V31, P512, DOI 10.1097/MCA.0000000000000868; Chapman G, 2016, CLIN BIOCHEM, V49, P219, DOI 10.1016/j.clinbiochem.2015.10.018; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen T, 2020, CORONARY ARTERY DIS, V31, P586, DOI 10.1097/MCA.0000000000000890; de Mutsert R, 2009, J RENAL NUTR, V19, P127, DOI 10.1053/j.jrn.2008.08.003; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Fried L, 2001, AM J KIDNEY DIS, V37, P337, DOI 10.1053/ajkd.2001.21300; Fryhofer GW, 2019, J ORTHOP, V16, P552, DOI 10.1016/j.jor.2019.04.019; Gabbe BJ, 2005, ACAD EMERG MED, V12, P318, DOI 10.1197/j.aem.2004.12.002; Gronbeck Christian, 2019, Arthroplast Today, V5, P126, DOI 10.1016/j.artd.2018.10.002; Haller C, 2005, KIDNEY BLOOD PRESS R, V28, P307, DOI 10.1159/000090185; Hebert CK, 1996, CLIN ORTHOP RELAT R, P140; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Huang R, 2013, J ARTHROPLASTY, V28, P21, DOI 10.1016/j.arth.2013.05.038; Hubner M, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/8743187; Hwang KT, 2017, J BREAST CANCER, V20, P254, DOI 10.4048/jbc.2017.20.3.254; Jin Y, 2013, CLINICS, V68, P686, DOI 10.6061/clinics/2013(05)17; Kamath AF, 2017, J KNEE SURG, V30, P269, DOI 10.1055/s-0036-1584575; KIMBALL SR, 1995, AM J PHYSIOL-ENDOC M, V268, pE6, DOI 10.1152/ajpendo.1995.268.1.E6; Kirkland LL, 2011, AM J MED QUAL, V26, P461, DOI 10.1177/1062860611402188; Kishawi D, 2020, J BONE JOINT SURG AM, V102, P889, DOI 10.2106/JBJS.19.00511; Kuzuya M, 2007, CLIN NUTR, V26, P84, DOI 10.1016/j.clnu.2006.07.009; Lakomkin N, 2017, J ARTHROPLASTY, V32, P1121, DOI 10.1016/j.arth.2016.11.014; LEBOUTON AV, 1984, ANAT RECORD, V209, P67, DOI 10.1002/ar.1092090109; Lee JI, 2015, ORAL DIS, V21, P178, DOI 10.1111/odi.12232; Lee JS, 2012, KOREAN J INTERN MED, V27, P13, DOI 10.3904/kjim.2012.27.1.13; Lee KJ, 2015, J ORTHOP TRANSL, V3, P21, DOI 10.1016/j.jot.2014.10.001; Liu M, 2020, CLIN CHIM ACTA, V505, P136, DOI 10.1016/j.cca.2020.02.029; Mahomed NN, 2003, J BONE JOINT SURG AM, V85A, P27, DOI 10.2106/00004623-200301000-00005; Margarson MP, 1998, ANAESTHESIA, V53, P789, DOI 10.1046/j.1365-2044.1998.00438.x; Mehrotra R, 2011, AM J KIDNEY DIS, V58, P418, DOI 10.1053/j.ajkd.2011.03.018; Nakamura T, 2013, EUR J CANCER, V49, P377, DOI 10.1016/j.ejca.2012.09.004; Nicholson JP, 2000, BRIT J ANAESTH, V85, P599, DOI 10.1093/bja/85.4.599; Oelsner WK, 2017, J ARTHROPLASTY, V32, P309, DOI 10.1016/j.arth.2016.06.027; Park JE, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100333; Povoa P, 2002, INTENS CARE MED, V28, P235, DOI 10.1007/s00134-002-1209-6; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Ravi B, 2014, ARTHRITIS RHEUMATOL, V66, P254, DOI 10.1002/art.38231; Ravi B, 2012, ARTHRITIS RHEUM-US, V64, P3839, DOI 10.1002/art.37690; ROTHSCHILD MA, 1968, J CLIN INVEST, V47, P2591, DOI 10.1172/JCI105941; Ryan AM, 2007, J GASTROINTEST SURG, V11, P1355, DOI 10.1007/s11605-007-0223-y; Santonocito C, 2014, ANESTH ANALG, V119, P624, DOI 10.1213/ANE.0000000000000263; Sinvani L, 2019, J HEALTHC QUAL, V41, P146, DOI 10.1097/JHQ.0000000000000153; SMALE BF, 1982, JPEN-PARENTER ENTER, V6, P395, DOI 10.1177/0148607182006005395; SMEETS HJ, 1994, INT SURG, V79, P152; Testa G, 2009, AGE AGEING, V38, P734, DOI 10.1093/ageing/afp165; Tominaga T, 2018, INDIAN J SURG, V80, P54, DOI 10.1007/s12262-016-1544-4; VIGUSHIN DM, 1993, J CLIN INVEST, V91, P1351, DOI 10.1172/JCI116336; Xu QD, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/4925498; YAP SH, 1981, ANN NUTR METAB, V25, P158, DOI 10.1159/000176490; Zhang J, 2017, ONCOTARGET, V8, P75195, DOI 10.18632/oncotarget.20661; Zhang JB, 2020, GASTROENT RES PRACT, V2020, DOI 10.1155/2020/3207345	59	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247070	10.1371/journal.pone.0247070	http://dx.doi.org/10.1371/journal.pone.0247070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592030	gold, Green Published			2022-12-26	WOS:000620632800022
J	Gebabo, TF; Zewdie, TH; Shagaro, SS; Haile, F				Gebabo, Teshale Fikadu; Zewdie, Tadiwos Hailu; Shagaro, Sewunet Sako; Haile, Firehiwot			Determinants of peripheral neuropathy among diabetic patients under follow-up in chronic care clinics of public hospitals at Gamo and Gofa zones, southern Ethiopia	PLOS ONE			English	Article								Background Peripheral neuropathy is a leading cause of morbidity and increased mortality among diabetic patients. It is characterized by significant deficits in vibration and tactile sensation. With an annual incidence of 2%, it affects as many as 110 million people worldwide. The aim of this study was to assess factors associated with peripheral neuropathy among diabetic patients in chronic care clinic in Gamo and Gofa zone, South Ethiopia. Methods An institution- based unmatched case control study was employed among 528 randomly selected participants using a pre-tested, interviewer-administered, and structured questionnaire. Bivariate and multivariable logistic regression analysis was conducted to identifiy determinants of peripheral neuropathy using IBM SPSS version 25. Result The odds of being an urban dweller was 2.67 times higher among cases than controls [AOR = 2.67 (1.27, 5.63)]. The likelihood of fasting blood glucose level between 203 and 282 and 282 and above was 2.55 and 3.88 times higher among cases than controls [AOR = 2.55 (1.91, 7.16)] and [AOR = 3.88 (1.42, 10.60)] respectively. The probability of living with diabetes mellitus for 10 and more years was 3.88 times higher among cases than controls [AOR = 3.88 (1.42, 10.60)]. The odds of controlling glucose level after developing symptom was 5.33 times higher among cases than controls [AOR = 5.33 (1.28, 12.24)]. The probability of having high blood pressure was 2.36 times higher among cases than controls [AOR = 2.36 (1.26, 4.43)]. The likelihood of having a family history of complication from diabetes mellitus was 5.60 times higher among cases than controls [AOR = 5.60 (2.03, 15.43)]. The odds of exercising 3 times per week for 15 to 30 minutes and for less than 15 minutes were 2.96 and 4.92 times higher among cases than controls respectively [AOR = 2.96 (1.32, 6.61)] and AOR = 4.92, 95% CI (1.85, 13.04) respectively. The likelihood of having a waist circumference greater than or equal to 40 inch was 2.72 times higher among cases than controls [AOR = 2.72 (1.07, 6.94)]. Conclusion This study showed that residence, duration of diabetic mellitus, family history of complication from diabetic mellitus, level of fasting blood glucose, method of glycemic control, having a high blood pressure/hypertension/, frequency and duration of physical activity and waist circumference were found to be determinants of peripheral neuropathy. Thus, the concerned health authorities and health professionals should target on these factors in their efforts to prevent peripheral neuropathy among diabetics in the study area.	[Gebabo, Teshale Fikadu; Shagaro, Sewunet Sako; Haile, Firehiwot] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Arba Minch, Ethiopia; [Zewdie, Tadiwos Hailu] Arba Minch Univ, Coll Med & Hlth Sci, Sch Med, Arba Minch, Ethiopia	Arba Minch University; Arba Minch University	Gebabo, TF (corresponding author), Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Arba Minch, Ethiopia.	fikaduteshale1@gmail.com	Shagaro, Sewunet Sako/AFS-0391-2022	Shagaro, Sewunet/0000-0003-0126-0165; Fikadu, Teshale/0000-0002-4177-9159	Arba Minch University [GOV/AMU/TH12/CMHS/PH/03/11]	Arba Minch University	This project was funded by Arba Minch University with project Code: GOV/AMU/TH12/CMHS/PH/03/11. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdissa D, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/9562920; Al-Kaabi JM, 2014, J DIABETES METAB, V5, DOI 10.4172/2155-6156.1000346; Al-Taweel YA, 2016, EGYPT J NEUROL PSYCH, V53, P232, DOI 10.4103/1110-1083.202383; Alleman CJM, 2015, DIABETES RES CLIN PR, V109, P215, DOI 10.1016/j.diabres.2015.04.031; Almobarak AO, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.07.01; Amour AA, 2019, INT J ENDOCRINOL, V2019, DOI 10.1155/2019/5404781; Beagley J, 2014, DIABETES RES CLIN PR, V103, P150, DOI 10.1016/j.diabres.2013.11.001; Booya F, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-24; Brinati LM, 2017, REV PESQUI-CUID FUND, V9, P347, DOI 10.9789/2175-5361.2017.v9i2.347-355; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; D'Souza Monisha, 2015, J Public Health Res, V4, P450, DOI 10.4081/jphr.2015.450; Deli G, 2013, NEUROENDOCRINOLOGY, V98, P267, DOI 10.1159/000358728; Emdin CA, 2015, J AM COLL CARDIOL, V66, P1552, DOI 10.1016/j.jacc.2015.07.059; Feteh VF, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0247-1; Gizaw M, 2015, PUBLIC HEALTH ACTION, V5, P74, DOI 10.5588/pha.14.0107; Gudina EK, 2011, BMC ENDOCR DISORD, V11, DOI 10.1186/1472-6823-11-19; Herman WH, 2012, DIABETIC MED, V29, P937, DOI 10.1111/j.1464-5491.2012.03644.x; International Diabetes Federation, 2020, IDF DIABETES ATLAS; Jember G, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0295-5; Kasim K., 2010, INT J DIABETES MELLI, V2, P20, DOI [10.1016/j.ijdm.2009.10.002, DOI 10.1016/J.IJDM.2009.10.002]; Katulanda P, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-21; Khawaja N, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0309-6; Kisozi T, 2017, AFR HEALTH SCI, V17, P463, DOI 10.4314/ahs.v17i2.21; Kuate-Tegueu C, 2015, J NEUROL SCI, V355, P108, DOI 10.1016/j.jns.2015.05.035; Laiteerapong N, 2019, DIABETES CARE, V42, P416, DOI 10.2337/dc17-1144; Liu XX, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212574; Moghtaderi A, 2006, CLIN NEUROL NEUROSUR, V108, P477, DOI 10.1016/j.clineuro.2005.08.003; Nisar MU, 2015, CUREUS, V7, DOI 10.7759/cureus.302; Non-Communicable O, 2016, NAT STRAT ACT PLAN N; Nshisso LD, 2012, DIABETES METAB SYND, V6, P36, DOI 10.1016/j.dsx.2012.05.005; Oh TJ, 2019, J OBES METAB SYNDR, V28, P112, DOI 10.7570/jomes.2019.28.2.112; Pan Q, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00617; Peer N, 2014, DIABETES RES CLIN PR, V103, P197, DOI 10.1016/j.diabres.2013.11.006; Pfannkuche A., 2020, ENDOCR METABOL SCI, V1, DOI [10.1016/j.endmts.2020.100053, DOI 10.1016/J.ENDMTS.2020.100053]; Samu AM, 2017, J TAIBAH UNIV MED SC, V12, P164, DOI 10.1016/j.jtumed.2016.12.006; Selvarajah D, 2019, LANCET DIABETES ENDO, V7, P938, DOI 10.1016/S2213-8587(19)30081-6; Sheshah E, 2017, J DIABETES, V4, DOI [10.15406/jdmdc.2017.04.00108, DOI 10.15406/JDMDC.2017.04.00108]; Shiferaw WS, 2020, BMC ENDOCR DISORD, V20, DOI 10.1186/s12902-020-0534-5; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Worku D, 2010, ETHIOP J HEALTH SCI, V20, P33; Yagihashi S, 2011, J DIABETES INVEST, V2, P18, DOI 10.1111/j.2040-1124.2010.00070.x; Yeboah K, 2016, J CLIN TRANSL ENDOCR, V5, P26, DOI 10.1016/j.jcte.2016.07.001	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246722	10.1371/journal.pone.0246722	http://dx.doi.org/10.1371/journal.pone.0246722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592011	gold, Green Published			2022-12-26	WOS:000620632800077
J	Morrison-Lanjouw, SM; Coutinho, RA; Boahene, K; Pool, R				Morrison-Lanjouw, Sandrella M.; Coutinho, Roel A.; Boahene, Kwasi; Pool, Robert			Exploring the characteristics of a local demand for African wild meat: A focus group study of long-term Ghanaian residents in the Netherlands	PLOS ONE			English	Article								While there is a growing body of research documenting unregulated African wild meat imports into Europe from the Africa continent, the drivers of this demand are virtually unknown. This study employs focus group discussions and a survey questionnaire to examine the attitudes and practices related to African wild meat consumption in the city of Amsterdam, Netherlands. The Ghanaian community was selected as the object of this study, as it is the largest West African population in the Netherlands and represents an important part of Dutch society. We model our report on a recent US study of the Liberian community of Minneapolis, Minnesota, which allows for the comparison of results between two Western countries. The overall perceived health risk of consuming African wild meat in The Netherlands is low and unlikely to deter consumption. However, local prices for the meat may be prohibitive in some cases. Incentives include health benefits, cultural drivers and a strong preference for the taste of African wild meat over all local meat alternatives. The study calls for further research into the nature of the drivers of demand for African wild meat as well as its public health consequences, in the Netherlands and beyond.	[Morrison-Lanjouw, Sandrella M.; Coutinho, Roel A.] Univ Med Ctr Utrecht UMCU, Julius Ctr, Utrecht, Netherlands; [Coutinho, Roel A.; Boahene, Kwasi] PharmAccess Fdn, Amsterdam, Netherlands; [Boahene, Kwasi] Univ Utrecht, Utrecht, Netherlands; [Pool, Robert] Univ Amsterdam, Dept Anthropol, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; University of Amsterdam	Morrison-Lanjouw, SM (corresponding author), Univ Med Ctr Utrecht UMCU, Julius Ctr, Utrecht, Netherlands.	S.m.morrison@umcutrecht.nl		Morrison-Lanjouw, Sandrella/0000-0001-7467-1198				Apetrei C, 2004, LANCET, V364, P137, DOI 10.1016/S0140-6736(04)16620-8; Asokan GV, 2016, J EPIDEMIOL GLOB HEA, V6, P125, DOI 10.1016/j.jegh.2015.10.002; Bowen-Jones E, 2003, AREA, V35, P390, DOI 10.1111/j.0004-0894.2003.00189.x; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Brown H, 2014, MED ANTHROPOL Q, V28, P280, DOI 10.1111/maq.12092; Calattini S, 2007, EMERG INFECT DIS, V13, P1314, DOI 10.3201/eid1309.061162; Chaber AL, 2010, CONSERV LETT, V3, P317, DOI 10.1111/j.1755-263X.2010.00121.x; Cowlishaw G, 2005, CONSERV BIOL, V19, P139; Elton S, 2013, MONKEYS MENU; Fa JE, 2009, ANIM CONSERV, V12, P599, DOI 10.1111/j.1469-1795.2009.00289.x; Falk H, 2013, REV SCI TECH OIE, V32, P727; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; Hunting B, 2005, EMERG INFECT DIS, V11, P1822, DOI [10.3201/eid1112.040789, DOI 10.3201/EID1112.040789]; Jansen W, 2019, VET J, V244, P75, DOI 10.1016/j.tvjl.2018.12.009; Karesh WB, 2009, MT SINAI J MED, V76, P429, DOI 10.1002/msj.20139; Li V, 2014, J GLOB HEALTH; McNamara J, 2020, ENVIRON RESOUR ECON, V76, P1045, DOI 10.1007/s10640-020-00474-5; Nasi R, 2011, INT FOREST REV, V13, P355, DOI 10.1505/146554811798293872; Ordaz-Nemeth I, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005450; Radder L, 2009, J FOOD PROD MARK, V15, P164, DOI 10.1080/10454440802317022; Schoder D, 2015, INT J FOOD MICROBIOL, V209, P3, DOI 10.1016/j.ijfoodmicro.2014.08.010; Siren A, 2008, INTERCIENCIA, V33, P186; Smith KM, 2012, PLOS ONE, V7, P71, DOI 10.1371/journal.pone.0029505; Temmam S, 2017, TRANSBOUND EMERG DIS, V64, P1159, DOI 10.1111/tbed.12481; Van Vliet N., 2017, BUSHMEAT HUMAN HLTH; van Vliet N, 2011, NON-TIMBER FOREST PRODUCTS IN THE GLOBAL CONTEXT, P129, DOI 10.1007/978-3-642-17983-9_6; Walelign SZ, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00162; Walz E, 2017, EMERG INFECT DIS, V23, P2095, DOI 10.3201/eid2312.170563; Wilkie DS, 2005, CONSERV BIOL, V19, P268, DOI 10.1111/j.1523-1739.2005.00372.x; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; World Health Organization, 2020, NEGL ZOON DIS	31	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246868	10.1371/journal.pone.0246868	http://dx.doi.org/10.1371/journal.pone.0246868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592000	Green Published, gold			2022-12-26	WOS:000620632800060
J	Muratore, P; Capone, C; Paolucci, PS				Muratore, Paolo; Capone, Cristiano; Paolucci, Pier Stanislao			Target spike patterns enable efficient and biologically plausible learning for complex temporal tasks	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; NETWORKS; MODEL	Recurrent spiking neural networks (RSNN) in the brain learn to perform a wide range of perceptual, cognitive and motor tasks very efficiently in terms of energy consumption and their training requires very few examples. This motivates the search for biologically inspired learning rules for RSNNs, aiming to improve our understanding of brain computation and the efficiency of artificial intelligence. Several spiking models and learning rules have been proposed, but it remains a challenge to design RSNNs whose learning relies on biologically plausible mechanisms and are capable of solving complex temporal tasks. In this paper, we derive a learning rule, local to the synapse, from a simple mathematical principle, the maximization of the likelihood for the network to solve a specific task. We propose a novel target-based learning scheme in which the learning rule derived from likelihood maximization is used to mimic a specific spatio-temporal spike pattern that encodes the solution to complex temporal tasks. This method makes the learning extremely rapid and precise, outperforming state of the art algorithms for RSNNs. While error-based approaches, (e.g. e-prop) trial after trial optimize the internal sequence of spikes in order to progressively minimize the MSE we assume that a signal randomly projected from an external origin (e.g. from other brain areas) directly defines the target sequence. This facilitates the learning procedure since the network is trained from the beginning to reproduce the desired internal sequence. We propose two versions of our learning rule: spike-dependent and voltage-dependent. We find that the latter provides remarkable benefits in terms of learning speed and robustness to noise. We demonstrate the capacity of our model to tackle several problems like learning multidimensional trajectories and solving the classical temporal XOR benchmark. Finally, we show that an online approximation of the gradient ascent, in addition to guaranteeing complete locality in time and space, allows learning after very few presentations of the target output. Our model can be applied to different types of biological neurons. The analytically derived plasticity learning rule is specific to each neuron model and can produce a theoretical prediction for experimental validation.	[Muratore, Paolo] SISSA Int Sch Adv Studies, Trieste, Italy; [Capone, Cristiano; Paolucci, Pier Stanislao] Ist Nazl Fis Nucl, Sez Roma, Rome, Italy	International School for Advanced Studies (SISSA); Istituto Nazionale di Fisica Nucleare (INFN)	Muratore, P (corresponding author), SISSA Int Sch Adv Studies, Trieste, Italy.	pmurator@sissa.it	Capone, Cristiano/AFS-4717-2022; Paolucci, Pier Stanislao/J-3457-2012	Paolucci, Pier Stanislao/0000-0003-1937-6086; Muratore, Paolo/0000-0003-4520-5950; Capone, Cristiano/0000-0002-9958-2551	European Union Horizon 2020 Research and Innovation program under the FET Flagship Human Brain Project [945539, 785907]; INFN APE Parallel/Distributed Computing laboratory	European Union Horizon 2020 Research and Innovation program under the FET Flagship Human Brain Project; INFN APE Parallel/Distributed Computing laboratory	This work has been supported by the European Union Horizon 2020 Research and Innovation program under the FET Flagship Human Brain Project (grant agreement SGA3 n. 945539 and grant agreement SGA2 n. 785907) and by the INFN APE Parallel/Distributed Computing laboratory. Fundings were received by P.S. Paolucci. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemi A, 2018, AAAI CONF ARTIF INTE, P588; Balazia M, 2016, LECT NOTES COMPUT SC, V10029, P310, DOI 10.1007/978-3-319-49055-7_28; Bellec G, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17236-y; Brea J, 2013, J NEUROSCI, V33, P9565, DOI 10.1523/JNEUROSCI.4098-12.2013; Capone C, 2019, PHYS REV E, V100, DOI 10.1103/PhysRevE.100.062413; Capone C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45525-0; Capone C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35433-0; Capone C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118412; CARR CE, 1990, J NEUROSCI, V10, P3227; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Cone I., 2020, LEARNING PRECISE SPA; DePasquale B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191527; di Volo M, 2019, NEURAL COMPUT, V31, P653, DOI 10.1162/neco_a_01173; Diehl PU, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00099; Gardner B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161335; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Ingrosso A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220547; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Kim CM, 2018, ELIFE, V7, DOI 10.7554/eLife.37124; King DB, 2015, ACS SYM SER, V1214, P1; Klos C, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.088103; KNUDSEN EI, 1994, J NEUROSCI, V14, P3985; Laje R, 2013, NAT NEUROSCI, V16, P925, DOI 10.1038/nn.3405; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; LeCun Y., 2015, NATURE, V521, P436, DOI [10.1038/nature14539, DOI 10.1038/nmeth.3707, DOI 10.1038/nature14539, DOI 10.1038/NATURE14539]; Lee DH, 2015, LECT NOTES ARTIF INT, V9284, P498, DOI 10.1007/978-3-319-23528-8_31; Lillicrap TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13276; Maes A, 2020, PLOS COMPUT BIOL, V16, DOI [10.1371/journal.pcbi.1007606, 10.1371/journal.pcbi.1007606.r001, 10.1371/journal.pcbi.1007606.r002, 10.1371/journal.pcbi.1007606.r003, 10.1371/journal.pcbi.1007606.r004, 10.1371/journal.pcbi.1007606.r005, 10.1371/journal.pcbi.1007606.r006]; McKenna MC., 2011, BASIC NEUROCHEMISTRY, P557; Memmesheimer RM, 2014, NEURON, V82, P925, DOI 10.1016/j.neuron.2014.03.026; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mozafari M, 2019, PATTERN RECOGN, V94, P87, DOI 10.1016/j.patcog.2019.05.015; Murray JM, 2019, ELIFE, V8, DOI 10.7554/eLife.43299; Murray JM, 2017, ELIFE, V6, DOI 10.7554/eLife.26084; Nicola W, 2019, NAT NEUROSCI, V22, P1168, DOI 10.1038/s41593-019-0415-2; Nicola W, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01827-3; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Pfister JP, 2006, NEURAL COMPUT, V18, P1318, DOI 10.1162/neco.2006.18.6.1318; Rezende DJ, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00038; Sacramento J, 2018, ADV NEUR IN, V31; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Urbanczik R, 2014, NEURON, V81, P521, DOI 10.1016/j.neuron.2013.11.030; Zenke F, 2018, NEURAL COMPUT, V30, P1514, DOI 10.1162/neco_a_01086	43	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247014	10.1371/journal.pone.0247014	http://dx.doi.org/10.1371/journal.pone.0247014			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592040	Green Submitted, Green Published, gold			2022-12-26	WOS:000620632800084
J	Hsu, HP; Chen, YT; Chen, YY; Lin, CY; Chen, PY; Liao, SY; Lim, CCY; Yamaguchi, Y; Hsu, CL; Dzhagalov, IL				Hsu, Hsuan-Po; Chen, Yun-Tzu; Chen, Yu-Ying; Lin, Chih-Yu; Chen, Po-Yu; Liao, Shio-Yi; Lim, Ciara Christianne Y.; Yamaguchi, Yu; Hsu, Chia-Lin; Dzhagalov, Ivan L.			Heparan sulfate is essential for thymus growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITORS; CHEMOKINE PRESENTATION; NEGATIVE SELECTION; DENDRITIC CELLS; THYMOCYTE MIGRATION; SKELETAL DYSPLASIA; MEDULLA MIGRATION; MESENCHYME; MICE; DISRUPTION	Thymus organogenesis and T cell development are coordinated by various soluble and cell-bound molecules. Heparan sulfate (HS) proteoglycans can interact with and immobilize many soluble mediators, creating fields or gradients of secreted ligands. While the role of HS in the development of many organs has been studied extensively, little is known about its function in the thymus. Here, we examined the distribution of HS in the thymus and the effect of its absence on thymus organogenesis and T cell development. We found that HS was expressed most abundantly on the thymic fibroblasts and at lower levels on endothelial, epithelial, and hematopoietic cells. To study the function of HS in the thymus, we eliminated most of HS in this organ by genetically disrupting the glycosyl-transferase Ext1 that is essential for its synthesis. The absence of HS greatly reduced the size of the thymus in fetal thymic organ cultures and in vivo, in mice, and decreased the production of T cells. However, no specific blocks in T cell development were observed. Wild-type thymic fibroblasts were able to physically bind the homeostatic chemokines CCL19, CCL21, and CXCL12 ex vivo. However, this binding was abolished upon HS degradation, disrupting the CCL19/CCL21 chemokine gradients and causing impaired migration of dendritic cells in thymic slices. Thus, our results show that HS plays an essential role in the development and growth of the thymus and in regulating interstitial cell migration.	[Hsu, Hsuan-Po; Chen, Yun-Tzu; Chen, Yu-Ying; Lin, Chih-Yu; Chen, Po-Yu; Liao, Shio-Yi; Lim, Ciara Christianne Y.; Hsu, Chia-Lin; Dzhagalov, Ivan L.] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan; [Yamaguchi, Yu] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA	National Yang Ming Chiao Tung University; Sanford Burnham Prebys Medical Discovery Institute	Dzhagalov, IL (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan.	ivan.dzhagalov@ym.edu.tw		Hsu, Chia-Lin/0000-0001-9383-6330; Lin, Chih-Yu/0000-0002-5315-3786; Chen, Yu-Ying/0000-0003-3580-9961; Dzhagalov, Ivan/0000-0001-9209-4582	MOST [103-2321-B-010-028, 104-2321-B-010-025-, 105-2321-B-010-015-, 106-2320-B-010-026-MY3, 107-2320-B-010-016-MY3, 104-2628-B-010-002-MY4, 107-2320-B-010-020]; Yen Tjing Ling Medical Foundation [CI-107-6, CI-108-5]	MOST; Yen Tjing Ling Medical Foundation	This work was supported by grants from MOST, 103-2321-B-010-028-, 104-2321-B-010-025-, 105-2321-B-010-015-, 106-2320-B-010-026-MY3, 107-2320-B-010-016-MY3 (I. L. D.), 104-2628-B-010-002-MY4 (C. L. H.), and 107-2320-B-010-020 (C. L. H.), and grants from the Yen Tjing Ling Medical Foundation, CI-107-6, and CI-108-5 (I. L. D.).	Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Anderson G, 1997, EUR J IMMUNOL, V27, P1200, DOI 10.1002/eji.1830270522; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Banwell CM, 2000, EUR J IMMUNOL, V30, P2125, DOI 10.1002/1521-4141(2000)30:8<2125::AID-IMMU2125>3.0.CO;2-H; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Bellomo A, 2020, IMMUNITY, V53, P127, DOI 10.1016/j.immuni.2020.06.008; Benz C, 2004, EUR J IMMUNOL, V34, P3652, DOI 10.1002/eji.200425248; Breed ER, 2018, SEMIN CELL DEV BIOL, V84, P2, DOI 10.1016/j.semcdb.2017.07.045; Buechler MB, 2019, IMMUNITY, V51, P119, DOI 10.1016/j.immuni.2019.05.010; Calderon L, 2011, P NATL ACAD SCI USA, V108, P7517, DOI 10.1073/pnas.1016428108; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; de Paz LL, 2007, ACS CHEM BIOL, V2, P735, DOI 10.1021/cb700159m; Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183; Gallagher J, 2015, INT J EXP PATHOL, V96, P203, DOI 10.1111/iep.12135; Garner OB, 2008, IMMUNOLOGY, V125, P420, DOI 10.1111/j.1365-2567.2008.02856.x; Gordts PLSM, 2014, CELL METAB, V20, P813, DOI 10.1016/j.cmet.2014.09.016; Graham GJ, 2019, TRENDS IMMUNOL, V40, P472, DOI 10.1016/j.it.2019.03.009; Halkias J, 2013, J CLIN INVEST, V123, P2131, DOI 10.1172/JCI67175; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; Hu ZC, 2015, J EXP MED, V212, P1947, DOI 10.1084/jem.20150178; Hu ZC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00398; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jenkinson WE, 2003, J EXP MED, V198, P325, DOI 10.1084/jem.20022135; Jenkinson WE, 2007, BLOOD, V109, P954, DOI 10.1182/blood-2006-05-023143; Kadakia T, 2019, J EXP MED, V216, P1749, DOI 10.1084/jem.20182285; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lund J, 2014, J MOL ENDOCRINOL, V52, P345, DOI 10.1530/JME-13-0184; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Muller SM, 2008, J IMMUNOL, V180, P5344, DOI 10.4049/jimmunol.180.8.5344; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Nitta T, 2020, NAT IMMUNOL, V21, P1172, DOI 10.1038/s41590-020-0756-8; Odaka C, 2009, J HISTOCHEM CYTOCHEM, V57, P373, DOI 10.1369/jhc.2008.952895; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Oud MM, 2017, AM J HUM GENET, V100, P281, DOI 10.1016/j.ajhg.2017.01.013; Peske JD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8114; Porritt HE, 2003, J EXP MED, V198, P957, DOI 10.1084/jem.20030837; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reijmers RM, 2011, BLOOD, V117, P6162, DOI 10.1182/blood-2010-12-325522; Reijmers RM, 2010, J IMMUNOL, V184, P3656, DOI 10.4049/jimmunol.0902200; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Sitnik KM, 2016, CELL REP, V14, P2375, DOI 10.1016/j.celrep.2016.02.033; Sitnik KM, 2012, J IMMUNOL, V188, P4801, DOI 10.4049/jimmunol.1200358; Sun LN, 2015, SCI REP-UK, V5, DOI 10.1038/srep14871; Tsuboi K, 2013, J IMMUNOL, V191, P448, DOI 10.4049/jimmunol.1203061; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Volpi S, 2017, J EXP MED, V214, P623, DOI 10.1084/jem.20161525; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Weist BM, 2015, NAT IMMUNOL, V16, P635, DOI 10.1038/ni.3171; Wrenshall LE, 1999, J IMMUNOL, V163, P3793; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yin X, 2014, J IMMUNOL, V192, P2133, DOI 10.4049/jimmunol.1301286; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222; Zhang FM, 2019, MOLECULES, V24, DOI 10.3390/molecules24183360; Zhou TA, 2020, METHODS MOL BIOL, V2111, P205, DOI 10.1007/978-1-0716-0266-9_17; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	70	3	3	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100419	10.1016/j.jbc.2021.100419	http://dx.doi.org/10.1016/j.jbc.2021.100419			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33600795	gold, Green Published			2022-12-26	WOS:000672866400393
J	Okuyama, M; Serizawa, R; Tanuma, M; Kikuchi, A; Sadahiro, J; Tagami, T; Lang, W; Kimura, A				Okuyama, Masayuki; Serizawa, Ryo; Tanuma, Masanari; Kikuchi, Asako; Sadahiro, Juri; Tagami, Takayoshi; Lang, Weeranuch; Kimura, Atsuo			Molecular insight into regioselectivity of transfructosylation catalyzed by GH68 levansucrase and beta-fructofuranosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR LEVANSUCRASE; ERWINIA-AMYLOVORA; CRYSTAL-STRUCTURE; FRUCTAN; PURIFICATION; CDNA; CRYSTALLIZATION; MUTAGENESIS; EXPRESSION; SEQUENCE	Glycoside hydrolase family 68 (GH68) enzymes catalyze beta-fructosyltransfer from sucrose to another sucrose, the so-called transfructosylation. Although regioselectivity of transfructosylation is divergent in GH68 enzymes, there is insufficient information available on the structural factor(s) involved in the selectivity. Here, we found two GH68 enzymes, beta-fructofuranosidase (FFZm) and levansucrase (LSZm), encoded tandemly in the genome of Zymomonas mobilis, displayed different selectivity: FFZm catalyzed the beta-(2 -> 1)-trans-fructosylation (1-TF), whereas LSZm did both of 1-TF and beta-(2 -> 6)-trans-fructosylation (6-TF). We identified His79(FFZm) and Ala343(FFZm) and their corresponding Asn84(LSZm) and Ser345(LSZm) respectively as the structural factors for those regioselectivities. LSZm with the respective substitution of FFZm-type His and Ala for its Asn84(LSZm) and Ser345(LSZm) (N84H/S345A-LSZm) lost 6-TF and enhanced 1-TF. Conversely, the LSZm-type replacement of His79(FFZm) and Ala343(FFZm) in FFZm (H79N/A343S-FFZm) almost lost 1-TF and acquired 6-TF. H79N/A343S-FFZm exhibited the selectivity like LSZm but did not produce the beta-(2 -> 6)-fructoside-linked levan and/or long levanooligo-saccharides that LSZm did. We assumed Phe189(LSZm) to be a responsible residue for the elongation of levan chain in LSZm and mutated the corresponding Leu187(FFZm) in FFZm to Phe. An H79N/L187F/A343S-FFZm produced a higher quantity of long levanooligosaccharides than H79N/A343S-FFZm (or H79N-FFZm), although without levan formation, suggesting that LSZm has another structural factor for levan production. We also found that FFZm generated a sucrose analog, beta-D-fructofuranosyl alpha-D-mannopyranoside, by beta-fructosyltransfer to D-mannose and regarded His79(FFZm) and Ala343(FFZm) as key residues for this acceptor specificity. In summary, this study provides insight into the structural factors of regioselectivity and acceptor specificity in transfructosylation of GH68 enzymes.	[Okuyama, Masayuki; Serizawa, Ryo; Tanuma, Masanari; Kikuchi, Asako; Sadahiro, Juri; Tagami, Takayoshi; Lang, Weeranuch; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan	Hokkaido University	Okuyama, M; Kimura, A (corresponding author), Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan.	okuyama@abs.agr.hokudai.ac.jp; kimura@abs.agr.hokudai.ac.jp		Okuyama, Masayuki/0000-0001-7013-6032	Japan Society for the Promotion of Science KAKENHI [26450114, 17H03801]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the Japan Society for the Promotion of Science KAKENHI Grant Nos. 26450114 and 17H03801.	Alvaro-Benito M, 2012, J BIOL CHEM, V287, P19674, DOI 10.1074/jbc.M112.355503; Belorkar SA, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0253-5; Brumer H, 1999, BIOCHEM J, V339, P43, DOI 10.1042/0264-6021:3390043; Cairns AJ, 1999, NEW PHYTOL, V142, P79, DOI 10.1046/j.1469-8137.1999.00378.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caputi L, 2013, J AGR FOOD CHEM, V61, P12265, DOI 10.1021/jf4023178; de Abreu M, 2013, ADV SYNTH CATAL, V355, P1698, DOI 10.1002/adsc.201200769; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Goldman D, 2008, J BIOL CHEM, V283, P32209, DOI 10.1074/jbc.M805985200; He CJ, 2018, APPL MICROBIOL BIOT, V102, P3217, DOI 10.1007/s00253-018-8854-3; HERNANDEZ L, 1995, BIOCHEM J, V309, P113, DOI 10.1042/bj3090113; Homann A, 2007, BIOCHEM J, V407, P189, DOI 10.1042/BJ20070600; Kawabata T, 2007, PROTEINS, V68, P516, DOI 10.1002/prot.21283; Kawabata T, 2010, PROTEINS, V78, P1195, DOI 10.1002/prot.22639; KYONO K, 1995, BIOSCI BIOTECH BIOCH, V59, P289, DOI 10.1271/bbb.59.289; Lasseur B, 2006, J EXP BOT, V57, P2719, DOI 10.1093/jxb/erl034; Li SY, 2011, MOL BIOL REP, V38, P2437, DOI 10.1007/s11033-010-0379-5; Liao JL, 2016, BIOSCI BIOTECH BIOCH, V80, P1747, DOI 10.1080/09168451.2015.1136884; Linde D, 2012, BIORESOURCE TECHNOL, V109, P123, DOI 10.1016/j.biortech.2012.01.023; LIU JH, 1991, CARBOHYD RES, V217, P43, DOI 10.1016/0008-6215(91)84115-U; Loehlin DW, 2016, P NATL ACAD SCI USA, V113, P5988, DOI 10.1073/pnas.1605886113; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ortiz-Soto ME, 2008, PROTEIN ENG DES SEL, V21, P589, DOI 10.1093/protein/gzn036; Ortiz-Soto ME, 2019, CARBOHYD POLYM, V219, P130, DOI 10.1016/j.carbpol.2019.05.014; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porras-Dominguez JR, 2015, CARBOHYD POLYM, V132, P338, DOI 10.1016/j.carbpol.2015.06.056; Possiel C., 2019, SCI REP-UK, V9, P1; Raga-Carbajal E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32872-7; Rodrigo-Frutos D, 2019, APPL MICROBIOL BIOT, V103, P279, DOI 10.1007/s00253-018-9446-y; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scholz-Ahrens KE, 2007, J NUTR, V137, p2513S, DOI 10.1093/jn/137.11.2513S; Seibel J, 2005, TETRAHEDRON, V61, P7081, DOI 10.1016/j.tet.2005.05.063; Seibel J, 2006, CARBOHYD RES, V341, P2335, DOI 10.1016/j.carres.2006.07.001; Strube CP, 2011, J BIOL CHEM, V286, P17593, DOI 10.1074/jbc.M110.203166; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamura K, 2009, J EXP BOT, V60, P893, DOI 10.1093/jxb/ern337; Tochio T, 2018, FOODS, V7, DOI 10.3390/foods7090140; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ueno K, 2005, NEW PHYTOL, V165, P813, DOI 10.1111/j.1469-8137.2004.01294.x; Versluys M, 2018, PLANT CELL ENVIRON, V41, P16, DOI 10.1111/pce.13070; Win TT, 2004, BIOTECHNOL LETT, V26, P499, DOI 10.1023/B:BILE.0000019557.44196.63; Wu C, 2015, CARBOHYD RES, V401, P122, DOI 10.1016/j.carres.2014.11.001; Wuerges J, 2015, J STRUCT BIOL, V191, P290, DOI 10.1016/j.jsb.2015.07.010; YANASE H, 1992, BIOSCI BIOTECH BIOCH, V56, P1335, DOI 10.1271/bbb.56.1335; YANASE H, 1995, J FERMENT BIOENG, V79, P367, DOI 10.1016/0922-338X(95)93997-X; Yanase H, 2002, J BIOCHEM, V132, P565, DOI 10.1093/oxfordjournals.jbchem.a003258	48	3	3	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100398	10.1016/j.jbc.2021.100398	http://dx.doi.org/10.1016/j.jbc.2021.100398			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33571525	gold, Green Published			2022-12-26	WOS:000672866400372
J	Dingeta, T; Oljira, L; Worku, A; Berhane, Y				Dingeta, Tariku; Oljira, Lemessa; Worku, Alemayehu; Berhane, Yemane			Low contraceptive utilization among young married women is associated with perceived social norms and belief in contraceptive myths in rural Ethiopia	PLOS ONE			English	Article							CHILD MARRIAGE; UNMET NEED; KNOWLEDGE; ATTITUDES; INTERVENTIONS; MULTICOUNTRY; BARRIERS; BEHAVIOR; HEALTH; ADULTS	Introduction Despite the increasingly wider availability of contraceptives and the high levels of unmet need for family planning in rural Ethiopia, contraceptive utilization among young married women is low. Studies on associated factors in Ethiopia so far have been focused on individual factors with little emphasis on socio-cultural factors. This study aimed to assess the association between contraceptive utilization and socio-cultural factors among young married women in Eastern Ethiopia. Methods A community-based survey was conducted among young married women aged 14-24 years. A total of 3039 women were interviewed by trained data collectors using a structured questionnaire. Adjusted Odds Ratio (AOR) with 95% Confidence Intervals (CI) was used to identify factors associated with contraceptive utilization using multivariable logistic regression analysis. Results The current contraceptive prevalence rate was 14.1% (95% CI: 12.8-15.5). Perceived social approval (AOR = 1.90; 95% CI = 1.60-2.30) and perception of friends' contraceptive practice (AOR = 1.34; 95% CI: 1.20-1.54) were significantly and positively associated with contraceptive utilization. On the contrary, increased score of belief in contraceptive myths was significantly and negatively associated with contraceptive use (AOR = 0.60; 95% CI: 0.49-0.73). Moreover, recent exposure to family planning information (AOR = 1.67; 95% CI: 1.22-2.28), ever-mother (AOR = 9.68; 95% CI: 4.47-20.90), and secondary and above education level (AOR = 1.90; 95% CI: 1.38-2.70) were significantly associated with higher odds of contraceptive utilization. Conclusion Only about one-in-seven young married women were using contraceptive methods. Socio-cultural factors significantly influence young married women's contraceptive utilization. Interventions to address social norms and pervasive myths and misconceptions could increase the use of contraceptive methods in young married women.	[Dingeta, Tariku; Oljira, Lemessa] Haramaya Univ, Sch Publ Hlth, Coll Hlth & Med Sci, Harar, Ethiopia; [Worku, Alemayehu] Addis Ababa Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Addis Ababa, Ethiopia; [Berhane, Yemane] Addis Continental Inst Publ Hlth, Dept Epidemiol, Addis Ababa, Ethiopia	Haramaya University; Addis Ababa University; Addis Continental Institute of Public Health	Dingeta, T (corresponding author), Haramaya Univ, Sch Publ Hlth, Coll Hlth & Med Sci, Harar, Ethiopia.	tarikuud@gmail.com		Oljira, Lemessa/0000-0003-4542-2509; Dingeta, Tariku/0000-0003-2078-1740; Dingeta, Tariku/0000-0002-3121-8999	Haramaya University [HURG-2018-02-04]	Haramaya University	TD LO HURG-2018-02-04 Haramaya University www.haramaya.edu.et No-The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, Saudi Med J, V24, P1154; Assefa N, 2016, INT J EPIDEMIOL, V45, P94, DOI 10.1093/ije/dyv284; Babalola S, 2015, DEMOGR RES, V33, P211, DOI 10.4054/DemRes.2015.33.8; Bader VG, 2015, INFLUENCES CONTRACEP; Beyeza-Kashesy Jolly, 2010, Afr J Reprod Health, V14, P71; Chandra-Mouli V, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-1; Cislaghi B, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0398-x; Colleran H, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0398; Cornet A, 2013, CURR OPIN OBSTET GYN, V25, pS1, DOI 10.1097/GCO.0b013e32835e06fd; Costenbader E, 2017, STUD FAMILY PLANN, V48, P377, DOI 10.1111/sifp.12040; CSACE I., 2016, ETHIOPIA DEMOGRAPHIC; Ebrahim NB, 2018, HEALTH CARE WOMEN IN, V39, P208, DOI 10.1080/07399332.2017.1383993; Elmusharaf K, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0273-2; Ethiopian Public Health Institute ICF, 2019, ETH MIN DEM HLTH SUR; Frost JJ, 2012, PERSPECT SEX REPRO H, V44, P107, DOI 10.1363/4410712; Ghule Mohan, 2015, Asian J Res Soc Sci Humanit, V5, P18, DOI 10.5958/2249-7315.2015.00132.X; Godha D, 2013, J ADOLESCENT HEALTH, V52, P552, DOI 10.1016/j.jadohealth.2013.01.021; Gueye A, 2015, INT PERSPECT SEX R H, V41, P191, DOI 10.1363/4119115; Haider TL, 2013, INT Q COMMUNITY HEAL, V33, P403, DOI 10.2190/IQ.33.4.g; Hall KS, 2014, J WOMENS HEALTH, V23, P596, DOI 10.1089/jwh.2013.4574; Hall MG, 2014, GLOB PUBLIC HEALTH, V9, P455, DOI 10.1080/17441692.2014.890238; Hildebr DFN., 2012, BRAZ BUS REV, V9, P120; Institute Guttmacher., 2017, ADDING IT INVESTING; Irani L, 2013, GLOB PUBLIC HEALTH, V8, P1048, DOI 10.1080/17441692.2013.838598; Islam AZ, 2016, EUR J CONTRACEP REPR, V21, P443, DOI 10.1080/13625187.2016.1234034; Kaye K., 2009, FOG ZONE MISPERCEPTI; Kiene SM, 2014, J HEALTH PSYCHOL, V19, P1564, DOI 10.1177/1359105313495906; Last JM, 1988, DICT EPIDEMIOLOGY; Marcus R., 2015, SOCIAL NORMS GENDER; Mardi A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5116-3; Mayaki F, 2015, S AFR J PSYCHOL, V45, P249, DOI 10.1177/0081246315570356; McClendon KA, 2018, CULT HEALTH SEX, V20, P799, DOI 10.1080/13691058.2017.1383513; Mon MM, 2012, ASIA-PAC J PUBLIC HE, V24, P151, DOI 10.1177/1010539510381918; Moneti F., 2014, WHAT ARE SOCIAL NORM; Mutumba M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5331-y; Nicola J., 2020, SOCIAL NORMS STOP ET; Ochako R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1483-1; Oluwasanu MM, 2019, INT Q COMMUNITY HEAL, V39, P233, DOI 10.1177/0272684X18821300; Pankhurst A, 2019, FEMINIST ENCOUNTERS, V3, P1; Radovich E, 2018, J ADOLESCENT HEALTH, V62, P273, DOI 10.1016/j.jadohealth.2017.09.013; Scholmerich VLN, 2016, HEALTH EDUC BEHAV, V43, P246, DOI 10.1177/1090198116629442; Shahabuddin ASM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157664; Sutton JA, 2017, J AM COLL HEALTH, V65, P339, DOI 10.1080/07448481.2017.1312414; Thulaseedharan JV, 2018, OPEN ACCESS J CONTR, V9, P1, DOI 10.2147/OAJC.S152178; Tirivayi N., 2020, WOMEN SUSTAINABLE HU, P125, DOI [10.1016/j.puhe.2020.03.012, DOI 10.1016/J.PUHE.2020.03.012]; Uddin J, 2016, CONTRACEPTION, V94, P18, DOI 10.1016/j.contraception.2016.02.026; Wasti S P, 2017, Kathmandu Univ Med J (KUMJ), V15, P222; Watts MCNC, 2014, J CLIN NURS, V23, P2131, DOI 10.1111/jocn.12335; WHO UNICEF, 2018, ARS PRIM GUID INV MI, V3rd; Williamson Lisa M, 2009, Reprod Health, V6, P3, DOI 10.1186/1742-4755-6-3; Worku AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116525; Yadav D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118584; Yenealem F, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4203-6; Zelalem Desalew, 2015, Fertil Res Pract, V1, P18, DOI 10.1186/s40738-015-0010-5	54	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247484	10.1371/journal.pone.0247484	http://dx.doi.org/10.1371/journal.pone.0247484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QO3ZL	33617550	Green Published, gold			2022-12-26	WOS:000623082400040
J	Sandoval, RL; Leite, ACR; Barbalho, DM; Assad, DX; Barroso, R; Polidorio, N; dos Anjos, CH; de Miranda, AD; Ferreira, ACSD; Fernandes, GD; Achatz, MI				Sandoval, Renata Lazari; Rathsam Leite, Ana Carolina; Barbalho, Daniel Meirelles; Assad, Daniele Xavier; Barroso, Romualdo; Polidorio, Natalia; dos Anjos, Carlos Henrique; de Miranda, Andrea Discaciati; Salles de Mendonca Ferreira, Ana Carolina; Fernandes, Gustavo dos Santos; Achatz, Maria Isabel			Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis	PLOS ONE			English	Article								Brazil is the largest country in South America and the most genetically heterogeneous. The aim of the present study was to determine the prevalence of germline pathogenic variants (PVs) in Brazilian patients with breast cancer (BC) who underwent genetic counseling and genetic testing at a tertiary Oncology Center. We performed a retrospective analysis of the medical records of Brazilian patients with BC referred to genetic counseling and genetic testing between August 2017 and August 2019. A total of 224 unrelated patients were included in this study. Premenopausal women represented 68.7% of the cohort. The median age at BC diagnosis was 45 years. Multigene panel testing was performed in 219 patients, five patients performed single gene analysis or family variant testing. Forty-eight germline PVs distributed among 13 genes were detected in 20.5% of the patients (46/224). Eighty-five percent of the patients (91/224) fulfilled NCCN hereditary BC testing criteria. Among these patients, 23.5% harbored PVs (45/191). In the group of patients that did not meet NCCN criteria, PV detection rate was 3% (1/33). A total of 61% of the patients (28/46) harbored a PV in a high-penetrance BC gene: 19 (8.5%) BRCA1/2, 8 (3.5%) TP53, 1 (0.5%) PALB2. Moderate penetrance genes (ATM, CHEK2) represented 15.2% (7/46) of the positive results. PVs detection was statistically associated (p<0.05) with BC diagnosis before age 45, high-grade tumors, bilateral BC, history of multiple primary cancers, and family history of pancreatic cancer. According to the current hereditary cancer guidelines, 17.4% (39/224) of the patients had actionable variants. Nine percent of the patients (20/224) had actionable variants in non-BRCA genes, it represented 43.5% of the positive results and 51.2% of the actionable variants. Considering the observed prevalence of PVs in actionable genes beyond BRCA1/2 (9%, 20/224), multigene panel testing may offer an effective first-tier diagnostic approach in this population.	[Sandoval, Renata Lazari; Rathsam Leite, Ana Carolina; Barbalho, Daniel Meirelles; Assad, Daniele Xavier; Barroso, Romualdo; Polidorio, Natalia; dos Anjos, Carlos Henrique; Fernandes, Gustavo dos Santos] Hosp Sirio Libanes, Dept Oncol, Brasilia, DF, Brazil; [de Miranda, Andrea Discaciati] Clin Mama, Brasilia, DF, Brazil; [Salles de Mendonca Ferreira, Ana Carolina] Oncoclin, Brasilia, DF, Brazil; [Achatz, Maria Isabel] Hosp Sirio Libanes, Dept Oncol, Sao Paulo, SP, Brazil	Hospital Sirio Libanes	Sandoval, RL (corresponding author), Hosp Sirio Libanes, Dept Oncol, Brasilia, DF, Brazil.	rsandoval.med@gmail.com	Achatz, Maria Isabel/C-5751-2013	Achatz, Maria Isabel/0000-0001-6894-1219; SANDOVAL, RENATA/0000-0001-8446-3675; Leite, Ana Carolina/0000-0001-7192-3425				Abud Jamile, 2012, Arq. Gastroenterol., V49, P273; Achatz MI, 2020, JCO GLOB ONCOL, V6, P439, DOI 10.1200/JGO.19.00170; Afghahi A, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0468-y; [Anonymous], Dados gerais; Bonache S, 2018, J CANCER RES CLIN, V144, P2495, DOI 10.1007/s00432-018-2763-9; Cipriano NM, 2019, BREAST CANCER-TOKYO, V26, P397, DOI 10.1007/s12282-018-00938-z; Cock-Rada AM, 2018, FAM CANCER, V17, P23, DOI 10.1007/s10689-017-0004-z; Copur MS., 2019, ONCOLOGY WILLISTON P, V33; Couch FJ, 2017, JAMA ONCOL, V3, P1190, DOI 10.1001/jamaoncol.2017.0424; Crawford B, 2017, BREAST CANCER RES TR, V163, P383, DOI 10.1007/s10549-017-4181-0; Cruz-Correa M, 2017, J GENET COUNS, V26, P379, DOI 10.1007/s10897-016-0051-x; Carvalho SDES, 2020, BMC MED GENOMICS, V13, DOI 10.1186/s12920-019-0652-y; de Souza AM, 2019, GENET MOL BIOL, V42, P495, DOI [10.1590/1678-4685-GMB-2018-0076, 10.1590/1678-4685-gmb-2018-0076]; Timoteo ARD, 2018, BREAST CANCER RES TR, V172, P637, DOI 10.1007/s10549-018-4938-0; Desai NV., 2020, CANCER, P1, DOI [10.1038/s41568-019-0232-7, DOI 10.1038/S41568-019-0232-7]; Desmond A, 2015, JAMA ONCOL, V1, P943, DOI 10.1001/jamaoncol.2015.2690; Ewald IP, 2016, GENET MOL BIOL, V39, P223, DOI 10.1590/1678-4685-GMB-2014-0350; Fanale D., 2020, CANCERS BASEL, V12, P1; Felix Gabriela Es, 2014, Hum Genome Var, V1, P14012, DOI 10.1038/hgv.2014.12; Foulkes WD, 2016, NAT REV CLIN ONCOL, V13, P41, DOI 10.1038/nrclinonc.2015.173; Fountzilas C, 2018, CANCER TREAT RES, V173, P121, DOI 10.1007/978-3-319-70197-4_8; Fulk K, 2019, FAM CANCER, V18, P197, DOI 10.1007/s10689-018-00114-4; Giacomazzi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099893; Hahn EC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209934; Hoang LN, 2018, ADV ANAT PATHOL, V25, P85, DOI 10.1097/PAP.0000000000000177; Kerkhof J, 2017, J MOL DIAGN, V19, P905, DOI 10.1016/j.jmoldx.2017.07.004; Kuchenbaecker KB, 2017, JAMA-J AM MED ASSOC, V317, P2402, DOI 10.1001/jama.2017.7112; LaDuca H, 2014, GENET MED, V16, P830, DOI 10.1038/gim.2014.40; Manchanda R, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju380; Moller P, 2007, EUR J CANCER, V43, P1713, DOI 10.1016/j.ejca.2007.04.023; National Comprehensive Cancer Network, 2021, NCCN CLIN PRACTICE G; Nelson HD, 2019, RISK ASSESSMENT GENE; Palmer-Young EC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20369-2; Palmero EI, 2009, GENET MOL BIOL, V32, P447, DOI 10.1590/S1415-47572009005000058; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roberts ME, 2018, GENET MED, V20, P1167, DOI 10.1038/gim.2017.254; Solano AR, 2017, ONCOTARGET, V8, P60487, DOI 10.18632/oncotarget.10814; Rowley SM, 2019, GENET MED, V21, P913, DOI 10.1038/s41436-018-0277-0; Shao D, 2020, CANCER SCI, V111, P647, DOI 10.1111/cas.14242; Shimelis H, 2018, JNCI-J NATL CANCER I, V110, P855, DOI 10.1093/jnci/djy106; Shin HC, 2020, CANCER RES TREAT, V52, P697, DOI 10.4143/crt.2019.559; Silva FC, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-55; Sorscher S, 2019, AM J MED, V132, pE765, DOI 10.1016/j.amjmed.2019.03.012; Tung N, 2016, NAT REV CLIN ONCOL, V13, P581, DOI 10.1038/nrclinonc.2016.90; Tung NM, 2020, J CLIN ONCOL, V38, P2080, DOI 10.1200/JCO.20.00299; Achatz MIW, 2007, CANCER LETT, V245, P96, DOI 10.1016/j.canlet.2005.12.039; Weber-Lassalle N, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1137-9; Wetterstrand KA., 2020, DNA SEQUENCING COSTS; Win AK, 2016, INT J CANCER, V139, P1557, DOI 10.1002/ijc.30197; Yamauchi H, 2018, BREAST CANCER-TOKYO, V25, P141, DOI 10.1007/s12282-017-0803-y	50	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247363	10.1371/journal.pone.0247363	http://dx.doi.org/10.1371/journal.pone.0247363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606809	Green Published, gold			2022-12-26	WOS:000620629200142
J	Diana, A; Haszard, JJ; Sari, SYI; Rahmannia, S; Fathonah, A; Sofiah, WN; Rizqi, H; Haekal, R; Gilmartin, A; Harper, M; Petri, W; Houghton, L; Gibson, R				Diana, Aly; Haszard, Jillian J.; Sari, Sri Y. Irda; Rahmannia, Sofa; Fathonah, Annisha; Sofiah, Wina Nur; Rizqi, Haidar; Haekal, Raulia; Gilmartin, Allissia; Harper, Michelle; Petri, William; Houghton, Lisa; Gibson, Rosalind			Determination of modifiable risk factors for length-for-age z-scores among resource-poor Indonesian infants	PLOS ONE			English	Article							ENVIRONMENTAL ENTERIC DYSFUNCTION; RETINOL-BINDING-PROTEIN; VITAMIN-A; CHILD GROWTH; NUTRITIONAL INTERVENTIONS; SELENIUM STATUS; YOUNG-CHILDREN; LINEAR GROWTH; WATER-QUALITY; GUT INTEGRITY	To reduce the burden of early-life linear growth faltering in low- and middle-income countries, interventions have focused on nutrition strategies, sometimes combined with water quality, sanitation, and hygiene (WASH). However, even when combined, their effects on linear growth have been inconsistent. Here, we investigate potential predictors of length-for-age z-scores (LAZ) in a cohort of resource-poor rural Indonesian infants to inform the optimal strategies to reduce linear growth faltering. Apparently healthy rural breastfed Indonesian infants were randomly selected from birth registries at age 6 months (n = 230) and followed up at 9 (n = 202) and 12 (n = 190) months. Using maximum likelihood estimation, we examined longitudinal relationships among socio-demographic status, maternal height, infant sex, age, water source, sanitation facility, energy, protein, micronutrient intakes and biomarkers (serum ferritin, zinc, retinol binding protein (RBP), selenium-adjusted for inflammation), and alpha-1-acid glycoprotein (AGP) and C-reactive protein (CRP) (systemic inflammation biomarkers) at age 6 and 9 months on LAZ at age 9 and 12 months. Stunting (LAZ <-2) at 6, 9, and 12 months was 15.7%, 19.3%, and 22.6%, respectively. In the full model, the predictor variable at age 6 months that was most strongly associated with infant LAZ at 9 months was maternal height (0.18 (95% CI 0.03, 0.32) SD). At age 9 months, the strongest predictors of LAZ at 12 months were improved drinking water source (-0.40 (95% CI -0.65, -0.14) vs. not improved), elevated AGP compared to not elevated (0.26 (95%CI -0.06, 0.58), maternal height (0.16 (95% CI 0.02, 0.31) SD), sex (0.22 (95% CI -0.02,0.45) female vs. male), serum RBP (0.12 (95% CI -0.01, 0.25) SD), and protein intake (0.17 (95% CI -0.01, 0.35) SD). Health promotion that includes exclusive breastfeeding up to the first six months and follows microbial water quality guidelines to ensure water intake is always safe should be considered.	[Diana, Aly; Fathonah, Annisha; Sofiah, Wina Nur; Rizqi, Haidar; Haekal, Raulia] Univ Padjadjaran, Fac Med, Nutr Working Grp, Bandung, Indonesia; [Diana, Aly; Haszard, Jillian J.; Harper, Michelle; Houghton, Lisa; Gibson, Rosalind] Univ Otago, Dept Human Nutr, Dunedin, New Zealand; [Sari, Sri Y. Irda] Univ Padjadjaran, Fac Med, Dept Publ Hlth, Bandung, Indonesia; [Rahmannia, Sofa] Univ Pasundan, Fac Med, Bandung, Indonesia; [Gilmartin, Allissia; Petri, William] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA	Universitas Padjadjaran; University of Otago; Universitas Padjadjaran; Pasundan University; University of Virginia	Diana, A (corresponding author), Univ Padjadjaran, Fac Med, Nutr Working Grp, Bandung, Indonesia.; Diana, A (corresponding author), Univ Otago, Dept Human Nutr, Dunedin, New Zealand.	diana.aly@gmail.com	Rahmannia, Sofa/AAE-2084-2021; Houghton, Lisa/F-5305-2011	Rahmannia, Sofa/0000-0003-2988-1334; Houghton, Lisa/0000-0002-2276-6205; Diana, Aly/0000-0002-9394-5235	Meat and Livestock Australia; University of Otago Research Grant; Universitas Padjadjaran Research Grant	Meat and Livestock Australia(Meat and Livestock Australia); University of Otago Research Grant; Universitas Padjadjaran Research Grant	This work was supported by the Meat and Livestock Australia: (https://www.mla.com.au/), the University of Otago Research Grant, and Universitas Padjadjaran Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo VM, 2016, MATERN CHILD NUTR, V12, P3, DOI 10.1111/mcn.12283; [Anonymous], 1985, WHO TECH REP SER, P1; Arsenault JE, 2011, EUR J CLIN NUTR, V65, P184, DOI 10.1038/ejcn.2010.234; Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; BAPPEDA, 2014, PROFIL DAERAH KABUPA; Beal T, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12617; Bork KA, 2017, J NUTR, V147, P940, DOI 10.3945/jn.116.243246; Chen P, 2003, J HEALTH POPUL NUTR, V21, P309; Cumming O, 2016, MATERN CHILD NUTR, V12, P91, DOI 10.1111/mcn.12258; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Onis M, 2013, MATERN CHILD NUTR, V9, P6, DOI 10.1111/mcn.12075; de Wit CC, 2013, J PEDIATR-US, V162, P415, DOI 10.1016/j.jpeds.2012.10.014; DHS National Population and Family Planning Board (BKKBN) Statistics Indonesia (BPS) Ministry of Health (Kemenkes) and ICF, 2017, INDONESIA DEMOGRAPHI; Diana A, 2019, CURR DEV NUTR, V3, DOI 10.1093/cdn/nzz022; Diana A, 2017, BRIT J NUTR, V118, P830, DOI 10.1017/S0007114517002860; Diana A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175952; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Gibson R, 2005, PRINCIPLES NUTR ASSE; Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239; Hadi H, 2004, EUR J CLIN NUTR, V58, P990, DOI 10.1038/sj.ejcn.1601920; Harttig U, 2011, EUR J CLIN NUTR, V65, pS87, DOI 10.1038/ejcn.2011.92; Haszard JJ., 2020, BRIT J NUTR, P1; Hotz C., 2004, Food and Nutrition Bulletin, V25, pS94; Huang ZY, 2018, J CLIN MED, V7, DOI 10.3390/jcm7090258; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Iqbal NT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21319-8; Jones AD, 2015, AM J TROP MED HYG, V92, P463, DOI 10.4269/ajtmh.14-0448; Kemiskinan TNPP., 2017, 100 KABUPATENKOTA PR; Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549; Lassi ZS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S13; Luby SP, 2018, LANCET GLOB HEALTH, V6, pE302, DOI 10.1016/S2214-109X(17)30490-4; Lunn PG, 2000, P NUTR SOC, V59, P147, DOI 10.1017/S0029665100000173; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Mihrshahi S, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-28; Montresor A., 1998, WORLD HLTH ORG; Ngure FM, 2013, AM J TROP MED HYG, V89, P709, DOI 10.4269/ajtmh.12-0568; Null C, 2018, LANCET GLOB HEALTH, V6, pE316, DOI 10.1016/S2214-109X(18)30005-6; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Prendergast A, 2012, AM J TROP MED HYG, V86, P756, DOI 10.4269/ajtmh.2012.11-0743; Prendergast AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086928; Quadro L, 2000, J INFECT DIS, V182, pS97, DOI 10.1086/315920; Ramli, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-64; Riskesdas Jawa Barat: Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan, 2018, LAPORAN PROVINSI JAW; Riskesdas: National Institute of Health Research and Development, 2018, INDONESIA BASIC HLTH; Sari M., 2018, IOP C SERIES EARTH E, V2018; Shaheed A, 2014, B WORLD HEALTH ORGAN, V92, P283, DOI 10.2471/BLT.13.119594; Shi DX, 2019, EDUC PSYCHOL MEAS, V79, P310, DOI 10.1177/0013164418783530; Statistics Indonesia, 2013, IND DEM HLTH SURV ID; Suchdev PS, 2016, ADV NUTR, V7, P349, DOI 10.3945/an.115.010215; Sudfeld CR, 2015, PEDIATRICS, V135, pE1266, DOI 10.1542/peds.2014-3111; Syed S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091158; Syed S, 2016, J PEDIATR GASTR NUTR, V63, P6, DOI 10.1097/MPG.0000000000001147; Tanumihardjo SA, 2016, J NUTR, V146, P1816, DOI 10.3945/jn.115.229708; Thomson CD, 2004, EUR J CLIN NUTR, V58, P391, DOI 10.1038/sj.ejcn.1601800; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Thurnham DI, 2000, J INFECT DIS, V182, pS23, DOI 10.1086/315912; Torlesse H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3339-8; UNICEF, 2013, UNICEF ANN REPORT 20; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; WHO, 2018, DEV DRINKING WATER Q; WHO, 2011, WHONMHNHDMNM111; WHO UNICEF, 2012, RAPID ASSESSMENT DRI; Williams R, 2018, STATA J, V18, P293, DOI 10.1177/1536867X1801800201; World Health Organization (WHO), 2017, SAFELY MANAGED DRINK	65	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247247	10.1371/journal.pone.0247247	http://dx.doi.org/10.1371/journal.pone.0247247			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600460	Green Published, gold			2022-12-26	WOS:000620625100036
J	De Maria, B; Dalla Vecchia, LA; Maestri, R; Pinna, GD; Parati, M; Perego, F; Bari, V; Cairo, B; Gelpi, F; La Rovere, MT; Porta, A				De Maria, Beatrice; Dalla Vecchia, Laura Adelaide; Maestri, Roberto; Pinna, Gian Domenico; Parati, Monica; Perego, Francesca; Bari, Vlasta; Cairo, Beatrice; Gelpi, Francesca; La Rovere, Maria Teresa; Porta, Alberto			Lack of association between heart period variability asymmetry and respiratory sinus arrhythmia in healthy and chronic heart failure individuals	PLOS ONE			English	Article							NONLINEAR DYNAMICS; SPECTRUM ANALYSIS; COMPLEXITY; IRREVERSIBILITY; HUMANS; RATIO	Temporal asymmetry is a peculiar aspect of heart period (HP) variability (HPV). HPV asymmetry (HPVA) is reduced with aging and pathology, but its origin is not fully elucidated. Given the impact of respiration on HPV resulting in the respiratory sinus arrhythmia (RSA) and the asymmetric shape of the respiratory pattern, a possible link between HPVA and RSA might be expected. In this study we tested the hypothesis that HPVA is significantly associated with RSA and asymmetry of the respiratory rhythm. We studied 42 middle-aged healthy (H) subjects, and 56 chronic heart failure (CHF) patients of whom 26 assigned to the New York Heart Association (NYHA) class II (CHF-II) and 30 to NYHA class III (CHF-III). Electrocardiogram and lung volume were monitored for 8 minutes during spontaneous breathing (SB) and controlled breathing (CB) at 15 breaths/minute. The ratio of inspiratory (INSP) to expiratory (EXP) phases, namely the I/E ratio, and RSA were calculated. HPVA was estimated as the percentage of negative HP variations, traditionally measured via the Porta's index (PI). Departures of PI from 50% indicated HPVA and its significance was tested via surrogate data. We found that RSA increased during CB and I/E ratio was smaller than 1 in all groups and experimental conditions. In H subjects the PI was about 50% during SB and it increased significantly during CB. In both CHF-II and CHF-III groups the PI was about 50% during SB and remained unmodified during CB. The PI was uncorrelated with RSA and I/E ratio regardless of the experimental condition and group. Pooling together data of different experimental conditions did not affect conclusions. Therefore, we conclude that the HPVA cannot be explained by RSA and/or I/E ratio, thus representing a peculiar feature of the cardiac control that can be aroused in middle-aged H individuals via CB.	[De Maria, Beatrice; Dalla Vecchia, Laura Adelaide; Parati, Monica; Perego, Francesca] IRCCS Ist Clin Sci Maugeri, Milan, Italy; [Maestri, Roberto; Pinna, Gian Domenico; La Rovere, Maria Teresa] IRCCS Ist Clin Sci Maugeri, Pavia, Italy; [Parati, Monica] Politecn Milan, Dept Elect Informat & Bioengn, Neuroengn & Med Robot Lab, Milan, Italy; [Bari, Vlasta; Gelpi, Francesca; Porta, Alberto] IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy; [Cairo, Beatrice; Porta, Alberto] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; Polytechnic University of Milan; IRCCS Policlinico San Donato; University of Milan	Porta, A (corresponding author), IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy.; Porta, A (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.	alberto.porta@unimi.it	Maestri, Roberto/J-8168-2016; Vecchia, Laura Dalla/AAA-6676-2020; Gelpi, Francesca/ABG-9613-2020; La Rovere, Maria Teresa/D-6796-2019; Bari, Vlasta/J-8591-2016; De Maria, Beatrice/K-3293-2018; Maestri, Roberto/AAA-7585-2019; Cairo, Beatrice/AAG-7863-2020	Maestri, Roberto/0000-0002-2873-0430; Vecchia, Laura Dalla/0000-0002-6516-0959; Gelpi, Francesca/0000-0002-9221-6153; La Rovere, Maria Teresa/0000-0002-1884-5058; Bari, Vlasta/0000-0002-5346-2677; De Maria, Beatrice/0000-0001-5360-3137; Maestri, Roberto/0000-0002-2873-0430; Cairo, Beatrice/0000-0003-3396-6883; Parati, Monica/0000-0002-7836-7246				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baselli G, 1997, IEEE T BIO-MED ENG, V44, P1092, DOI 10.1109/10.641336; Caiani EG, 2000, PHYSIOL MEAS, V21, P175, DOI 10.1088/0967-3334/21/1/321; Camm AJ, 1996, EUR HEART J, V17, P354; Casali KR, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066204; Chladekova L, 2012, PHYSIOL MEAS, V33, P1747, DOI 10.1088/0967-3334/33/10/1747; Cooke WH, 1999, J PHYSIOL-LONDON, V517, P617, DOI 10.1111/j.1469-7793.1999.0617t.x; Costa M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.198102; De Maria B., 2020, P 11 ANN INT C EUR S; De Maria B, 2019, AM J PHYSIOL-REG I, V317, pR539, DOI 10.1152/ajpregu.00112.2019; Elstad M, 2018, AM J PHYSIOL-HEART C, V315, pH6, DOI 10.1152/ajpheart.00701.2017; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Guzik P, 2006, BIOMED TECH, V51, P272, DOI 10.1515/BMT.2006.054; Guzik P, 2010, CLIN AUTON RES, V20, P255, DOI 10.1007/s10286-010-0057-7; Guzzetti S, 2005, EUR HEART J, V26, P357, DOI 10.1093/eurheartj/ehi067; HIRSCH JA, 1981, AM J PHYSIOL, V241, pH620, DOI 10.1152/ajpheart.1981.241.4.H620; Hou FZ, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012908; KAPLAN DT, 1991, BIOPHYS J, V59, P945, DOI 10.1016/S0006-3495(91)82309-8; Karmakar C, 2015, BIOMED SIGNAL PROCES, V21, P43, DOI 10.1016/j.bspc.2015.05.010; Karmakar C, 2010, COMPUT CARDIOL CONF, V37, P601; KAY SM, 1981, P IEEE, V69, P1380, DOI 10.1109/PROC.1981.12184; Klintworth A, 2012, PHYSIOL MEAS, V33, P1717, DOI 10.1088/0967-3334/33/10/1717; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; MONTANO N, 1994, CIRCULATION, V90, P1826, DOI 10.1161/01.CIR.90.4.1826; Pinna GD, 2006, AM J PHYSIOL-HEART C, V290, pH424, DOI 10.1152/ajpheart.00438.2005; Pinna GD, 2017, J HYPERTENS, V35, P1666, DOI 10.1097/HJH.0000000000001377; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Porta A, 2008, AM J PHYSIOL-REG I, V295, pR550, DOI 10.1152/ajpregu.00129.2008; Porta A, 1998, MED BIOL ENG COMPUT, V36, P35, DOI 10.1007/BF02522855; Porta A., 2006, COMPUTING CARDIOLOGY, V33, P77; Porta A, 2007, IEEE T BIO-MED ENG, V54, P94, DOI 10.1109/TBME.2006.883789; Porta A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00071; Porta A, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0096; Porta A, 2009, PHILOS T R SOC A, V367, P1359, DOI 10.1098/rsta.2008.0265; Porta A, 2009, PHILOS T R SOC A, V367, P1215, DOI 10.1098/rsta.2008.0292; PREISS G, 1974, AM J PHYSIOL, V226, P724, DOI 10.1152/ajplegacy.1974.226.3.724; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Schwartz PJ, 2015, CIRC-HEART FAIL, V8, P619, DOI 10.1161/CIRCHEARTFAILURE.114.001964; SEALS DR, 1990, CIRC RES, V67, P130, DOI 10.1161/01.RES.67.1.130; Smith JC, 2000, RESP PHYSIOL, V122, P131, DOI 10.1016/S0034-5687(00)00155-9; TAHA BH, 1995, J APPL PHYSIOL, V78, P638, DOI 10.1152/jappl.1995.78.2.638; Takahashi ACM, 2012, INTERN EMERG MED, V7, P229, DOI 10.1007/s11739-011-0512-z; Tonhajzerova I, 2014, PHYSIOL RES, V63, pS509, DOI 10.33549/physiolres.932919; TOSKA K, 1993, J PHYSIOL-LONDON, V472, P501, DOI 10.1113/jphysiol.1993.sp019958; Wang YP, 2013, J APPL PHYSIOL, V115, P1648, DOI 10.1152/japplphysiol.00163.2013; WEISS G, 1975, J APPL PROBAB, V12, P831, DOI 10.2307/3212735; Willie CK, 2011, HYPERTENSION, V57, P927, DOI 10.1161/HYPERTENSIONAHA.110.164616	48	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247145	10.1371/journal.pone.0247145	http://dx.doi.org/10.1371/journal.pone.0247145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592077	gold, Green Published			2022-12-26	WOS:000620632800052
J	Kumar, A; Bellayr, IH; Singh, HS; Puri, RK				Kumar, Abhinav; Bellayr, Ian H.; Singh, Hridaya S.; Puri, Raj K.			IL-13R alpha 2 gene expression is a biomarker of adverse outcome in patients with adrenocortical carcinoma	PLOS ONE			English	Article								Adrenocortical carcinoma (ACC) is a rare but aggressive endocrine malignancy that usually results in a fatal outcome. To allow the better clinical management and reduce mortality, we searched for clinical and molecular markers that are reliable predictor of disease severity and clinical outcome in ACC patients. We determined a correlation between the overexpression of IL-13R alpha 2 and the clinical outcome in ACC patients using comprehensive data available in The Cancer Genome Atlas (TCGA) database. The dataset of 79 ACC subjects were divided into groups of low, medium, or high expression of IL-13R alpha 2 as determined by RNA-seq. These patients were also stratified by length of survival, overall survival, incidence of a new tumor event, incidence of metastasis, and production of excess hormones. We report a correlation between IL-13R alpha 2 expression and survival of subjects with ACC. High expression of IL-13R alpha 2 in ACC tumors was significantly associated with a lower patient survival rate and period of survival compared to low expression (p = 0.0084). In addition, high IL-13R alpha 2 expression was significantly associated with a higher incidence of new tumor events and excess hormone production compared to low or medium IL-13R alpha 2 expression. Within the cohort of patients that produced excess hormone, elevated IL-13R alpha 2 expression was significantly associated with a lower survival rate. Additionally, IL-13R alpha 1 had a potential relationship between transcript level and ACC survival. Our results and promising antitumor activity in preclinical models and trials indicate that IL-13R alpha 2 expression is an important prognostic biomarker of ACC disease outcome and a promising target for therapeutic treatment of ACC.	[Kumar, Abhinav; Bellayr, Ian H.; Puri, Raj K.] US FDA, Ctr Biol & Evaluat Res, Tumor Vaccines & Biotechnol Branch, Div Cellular & Gene Therapies, Silver Spring, MD 20993 USA; [Singh, Hridaya S.] Chaudhary Charan Singh Univ, Dept Zool, Meerut, Uttar Pradesh, India; [Bellayr, Ian H.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); Chaudhary Charan Singh University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Puri, RK (corresponding author), US FDA, Ctr Biol & Evaluat Res, Tumor Vaccines & Biotechnol Branch, Div Cellular & Gene Therapies, Silver Spring, MD 20993 USA.	Raj.Puri@fda.hhs.gov		Kumar, Abhinav/0000-0003-3457-0215	Intramural Research Program of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration	Intramural Research Program of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration	This work was supported by the Intramural Research Program of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration.	Arima K, 2005, J BIOL CHEM, V280, P24915, DOI 10.1074/jbc.M502571200; Barderas R, 2012, CANCER RES, V72, P2780, DOI 10.1158/0008-5472.CAN-11-4090; Else T, 2014, ENDOCR REV, V35, P282, DOI 10.1210/er.2013-1029; Fassnacht M, 2009, BEST PRACT RES CL EN, V23, P273, DOI 10.1016/j.beem.2008.10.008; Fay AP, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0047-3; Fernandez-Ranvier GG, 2008, ARCH SURG-CHICAGO, V143, P841, DOI 10.1001/archsurg.143.9.841; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fujisawa T, 2012, INT J CANCER, V131, P344, DOI 10.1002/ijc.26366; Han J, 2018, J NEURO-ONCOL, V136, P463, DOI 10.1007/s11060-017-2680-9; Han J, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-27; Hsi LC, 2011, MOL CANCER THER, V10, P1149, DOI 10.1158/1535-7163.MCT-10-1064; Jain M, 2012, CANCER-AM CANCER SOC, V118, P5698, DOI 10.1002/cncr.27629; Joshi BH, 2009, IMMUNOTHERAPY-UK, V1, P321, DOI 10.2217/IMT.09.8; Kioi M, 2006, CANCER-AM CANCER SOC, V107, P1407, DOI 10.1002/cncr.22134; Kwon M, 2015, EUR J CANCER, V51, P177, DOI 10.1016/j.ejca.2014.11.010; Liu-Chittenden Y, 2015, CANCER MED-US, V4, P1060, DOI 10.1002/cam4.449; Obiri NI, 1997, J IMMUNOL, V158, P756; Park MH, 2017, ANN SURG ONCOL, V24, P3780, DOI 10.1245/s10434-017-5907-2; Rahaman SO, 2002, CANCER RES, V62, P1103; Ronchi CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105855; See L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069958; Shimamura T, 2010, CLIN CANCER RES, V16, P577, DOI 10.1158/1078-0432.CCR-09-2015; Suzuki A, 2015, CYTOKINE, V75, P79, DOI 10.1016/j.cyto.2015.05.026; Thaci B, 2014, NEURO-ONCOLOGY, V16, P1304, DOI 10.1093/neuonc/nou045; Viita H, 2012, IN VIVO, V26, P1; Volante M, 2012, CLIN CANCER RES, V18, P3452, DOI 10.1158/1078-0432.CCR-11-2692; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Zdanov A, 2008, CELL, V132, P179, DOI 10.1016/j.cell.2008.01.006	28	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246632	10.1371/journal.pone.0246632	http://dx.doi.org/10.1371/journal.pone.0246632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33591997	gold, Green Published			2022-12-26	WOS:000620632800033
J	Huang, CY; Wang, SC; Chan, L; Hsieh, TY; Sung, WW; Chen, SL				Huang, Cheng-Yu; Wang, Shao-Chuan; Chan, Lung; Hsieh, Tzuo-Yi; Sung, Wen-Wei; Chen, Sung-Lang			Gender differences in trends of bladder cancer mortality-to-incidence ratios according to health expenditure in 55 countries	PLOS ONE			English	Article								The association between bladder cancer mortality-to-incidence ratios (MIRs) and healthcare disparities has gender differences. However, no evidence supports gender as an issue in the association between changes in the MIR and health expenditures on bladder cancer. Changes in the MIR were defined as the difference in data from the years 2012 and 2018, which was named delta MIR. Current health expenditures (CHE) and the human development index (HDI) were obtained from the World Health Organization and the Human Development Report Office. The association between variables was analyzed by Spearman's rank correlation coefficient. In total, 55 countries were analyzed according to data quality and the exclusion of missing data. Globally, the MIR changed according to the HDI level in both genders. Among the 55 countries studied, a high HDI and CHE were significantly associated with a favorable age-standardized rate-based MIR (ASR-based MIR) in both genders and the subgroups according to gender (for both genders, MIR vs. HDI: rho = -0.720, p < 0.001; MIR vs. CHE per capita: rho = -0.760, p < 0.001; MIR vs. CHE as a percentage of gross domestic product (CHE/GDP): rho = -0.663, p < 0.001). Importantly, in females only, the CHE/GDP but neither the HDI score nor the CHE per capita was significantly associated with a favorable ASR-based delta MIR (ASR-based delta MIR vs. CHE/GDP: rho = 0.414, p = 0.002). In the gender subgroups, the association between the HDI and the CHE was statistically significant for females and less significant for males. In conclusion, favorable bladder ASR-based MIRs were associated with a high CHE; however, improvement of the ASR-based delta MIR data was more correlated with the CHE in females. Further investigation of the gender differences via a cohort survey with detailed information of clinical-pathological characteristics, treatment strategies, and outcomes might clarify these issues and improve therapeutic and/or screening strategies for bladder cancer.	[Huang, Cheng-Yu] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Wang, Shao-Chuan; Hsieh, Tzuo-Yi; Sung, Wen-Wei; Chen, Sung-Lang] Chung Shan Med Univ Hosp, Dept Urol, Taichung, Taiwan; [Wang, Shao-Chuan; Chan, Lung; Hsieh, Tzuo-Yi; Sung, Wen-Wei; Chen, Sung-Lang] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wang, Shao-Chuan; Hsieh, Tzuo-Yi; Sung, Wen-Wei; Chen, Sung-Lang] Chung Shan Med Univ, Inst Med, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University	Sung, WW; Chen, SL (corresponding author), Chung Shan Med Univ Hosp, Dept Urol, Taichung, Taiwan.; Sung, WW; Chen, SL (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Sung, WW; Chen, SL (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	flutewayne@gmail.com; cshy650@csh.org.tw	Chan, Will Lung/AFS-4031-2022; Sung, Wen-Wei/P-5053-2019	Chan, Will Lung/0000-0001-7133-8103; Sung, Wen-Wei/0000-0002-2375-0029	Chung Shan Medical University Hospital research program, Taichung, Taiwan [CSH-2019-C-031]	Chung Shan Medical University Hospital research program, Taichung, Taiwan	This work was jointly supported by grants from Chung Shan Medical University Hospital research program, Taichung, Taiwan (SC Wang, CSH-2019-C-031). URL: https://www.csmu.edu.tw/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen SL, 2017, SCI REP-UK, V7, DOI 10.1038/srep40003; Cumberbatch MG, 2016, EUR UROL, V70, P458, DOI 10.1016/j.eururo.2015.06.042; Cumberbatch MGK, 2018, EUR UROL, V74, P784, DOI 10.1016/j.eururo.2018.09.001; Dobruch J, 2016, EUR UROL, V69, P300, DOI 10.1016/j.eururo.2015.08.037; Donsky H, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.04.010; Huang CY, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122889; Janisch F, 2019, CURR OPIN UROL, V29, P249, DOI 10.1097/MOU.0000000000000602; Letasiova S, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S11; Lucca I, 2014, CURR OPIN UROL, V24, P500, DOI 10.1097/MOU.0000000000000092; Mahdavifar Neda, 2016, Asian Pac J Cancer Prev, V17, P381; Mun DH, 2019, CURR OPIN UROL, V29, P279, DOI 10.1097/MOU.0000000000000606; Shariat SF, 2010, BJU INT, V105, P300, DOI 10.1111/j.1464-410X.2009.09076.x; Sung WW, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4698-6; Sunkara V, 2015, CANCER-AM CANCER SOC, V121, P1563, DOI 10.1002/cncr.29228; Wang SC, 2020, AGING-US, V12, P21308, DOI 10.18632/aging.103865; Wang SC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04083-z; Wong MCS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19199-z; Yee DS, 2011, UROLOGY, V78, P544, DOI 10.1016/j.urology.2011.02.042	19	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0244510	10.1371/journal.pone.0244510	http://dx.doi.org/10.1371/journal.pone.0244510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577604	gold, Green Published			2022-12-26	WOS:000620071700001
J	Marsh, RJ; Dorahy, MJ; Butler, C; Middleton, W; de Jong, PJ; Kemp, S; Huntjens, R				Marsh, Rosemary J.; Dorahy, Martin J.; Butler, Chandele; Middleton, Warwick; de Jong, Peter J.; Kemp, Simon; Huntjens, Rafaele			Inter-identity amnesia for neutral episodic self-referential and autobiographical memory in Dissociative Identity Disorder: An assessment of recall and recognition	PLOS ONE			English	Article							MULTIPLE PERSONALITY-DISORDER; EXPERIENCES; VALIDITY	Amnesia is a core diagnostic criterion for Dissociative Identity Disorder (DID), however previous research has indicated memory transfer. As DID has been conceptualised as being a disorder of distinct identities, in this experiment, behavioral tasks were used to assess the nature of amnesia for episodic 1) self-referential and 2) autobiographical memories across identities. Nineteen DID participants, 16 DID simulators, 21 partial information, and 20 full information comparison participants from the general population were recruited. In the first study, participants were presented with two vignettes (DID and simulator participants received one in each of two identities) and asked to imagine themselves in the situations outlined. The second study used a similar methodology but with tasks assessing autobiographical experience. Subjectively, all DID participants reported amnesia for events that occurred in the other identity. On free recall and recognition tasks they presented a memory profile of amnesia similar to simulators instructed to feign amnesia and partial information comparisons. Yet, on tests of recognition, DID participants recognized significantly more of the event that occurred in another identity than simulator and partial information comparisons. As such, results indicate that the DID performance profile was not accounted for by true or feigned amnesia, lending support to the idea that reported amnesia may be more of a perceived than actual memory impairment.	[Marsh, Rosemary J.; Dorahy, Martin J.; Butler, Chandele; Middleton, Warwick; Kemp, Simon] Univ Canterbury, Sch Psychol Speech & Hearing, Canterbury, New Zealand; [Marsh, Rosemary J.; de Jong, Peter J.; Huntjens, Rafaele] Univ Groningen, Dept Clin Psychol, Groningen, Netherlands; [Dorahy, Martin J.; Middleton, Warwick] Belmt Private Hosp, Cannan Inst, Brisbane, Qld, Australia	University of Canterbury; University of Groningen	Dorahy, MJ (corresponding author), Univ Canterbury, Sch Psychol Speech & Hearing, Canterbury, New Zealand.; Dorahy, MJ (corresponding author), Belmt Private Hosp, Cannan Inst, Brisbane, Qld, Australia.	martin.dorahy@canterbury.ac.nz	de Jong, Peter/ABB-1750-2020	de Jong, Peter/0000-0002-3512-3663; Huntjens, Rafaele/0000-0001-6329-9810; Dorahy, Martin/0000-0003-0171-4913				Allen JJB, 2000, INT J PSYCHOPHYSIOL, V38, P21, DOI 10.1016/S0167-8760(00)00128-8; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Blanca MJ, 2017, PSICOTHEMA, V29, P552, DOI 10.7334/psicothema2016.383; BOON S, 1993, AM J PSYCHIAT, V150, P489; Boysen GA, 2014, CLIN PSYCHOL REV, V34, P14, DOI 10.1016/j.cpr.2013.10.008; BRYANT RA, 1995, J ABNORM PSYCHOL, V104, P625, DOI 10.1037/0021-843X.104.4.625; CARLSON EB, 1993, AM J PSYCHIAT, V150, P1030; Carlson EB, 1993, DISSOCIATION PROGR D, V6, P16, DOI DOI 10.1177/1073191116645904; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Dorahy MJ, 2017, BEHAV RES THER, V89, P75, DOI 10.1016/j.brat.2016.11.007; Dorahy MJ, 2014, AUST NZ J PSYCHIAT, V48, P402, DOI 10.1177/0004867414527523; Eich E, 1997, PSYCHOL SCI, V8, P417, DOI 10.1111/j.1467-9280.1997.tb00454.x; Ellenberger H., 1970, DISCOV UNCONSCIOUS; Elzinga BM, 2003, J ABNORM PSYCHOL, V112, P237, DOI 10.1037/0021-843X.112.2.237; Fink G, 2007, STRESS CONSEQUENCES, P60; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; Huntjens RJC, 2007, BEHAV RES THER, V45, P775, DOI 10.1016/j.brat.2006.07.001; Huntjens RJC, 2006, PSYCHOL MED, V36, P857, DOI 10.1017/S0033291706007100; Huntjens RJC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040580; Huntjens RJC, 2005, CONSCIOUS COGN, V14, P377, DOI 10.1016/j.concog.2004.10.001; Huntjens RJC, 2005, BEHAV RES THER, V43, P243, DOI 10.1016/j.brat.2004.01.007; Huntjens RJC, 2003, J ABNORM PSYCHOL, V112, P290, DOI 10.1037/0021-843X.112.2.290; Huntjens RJC, 2002, MEM COGNITION, V30, P1033, DOI 10.3758/BF03194321; Kong LL, 2008, J ABNORM PSYCHOL, V117, P686, DOI 10.1037/0021-843X.117.3.686; Macmillan NA, 2005, DETECTION THEORY USE; Marsh RJ, 2018, J ABNORM PSYCHOL, V127, P751, DOI 10.1037/abn0000377; Moss J, 1993, MULTIPLE PERSONALITY; Nimon KF, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00322, 10.3389/fpsyg.2012.00102]; NISSEN MJ, 1988, BRAIN COGNITION, V8, P117, DOI 10.1016/0278-2626(88)90043-7; Palmer M., 2010, DEVIL KNOCKS; Perona-Garcelan S, 2012, J TRAUMA STRESS, V25, P323, DOI 10.1002/jts.21693; Peters ML, 1998, CONSCIOUS COGN, V7, P27, DOI 10.1006/ccog.1997.0323; Prebble SC, 2013, PSYCHOL BULL, V139, P815, DOI 10.1037/a0030146; Reinders AATS, 2014, PSYCHIAT RES-NEUROIM, V223, P236, DOI 10.1016/j.pscychresns.2014.05.005; Ross C.A., 1989, DISSOCIATION, V2, P169, DOI [10.1037/e609942012-089, DOI 10.1176/AJP.147.12.1698-B]; Stevens J, 1996, APPL MULTIVARIATE ST, V3rd ed.; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Tulving E., 1972, ORG MEMORY, P423; van der Hart O, 2006, HAUNTED SELF STRUCTU; Vermetten E, 2006, AM J PSYCHIAT, V163, P630, DOI 10.1176/appi.ajp.163.4.630	40	1	1	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0245849	10.1371/journal.pone.0245849	http://dx.doi.org/10.1371/journal.pone.0245849			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK0KW	33577556	Green Published, gold			2022-12-26	WOS:000620071700037
J	de Lucas, B; Perez, LM; Bernal, A; Galvez, BG				de Lucas, Beatriz; Perez, Laura M.; Bernal, Aurora; Galvez, Beatriz G.			Application of low-intensity pulsed therapeutic ultrasound on mesenchymal precursors does not affect their cell properties	PLOS ONE			English	Article							STEM-CELLS; FRACTURE; STIMULATION; APOPTOSIS; MECHANOTRANSDUCTION; ACTIVATION; EXPRESSION; MIGRATION; EXPOSURE; CHANNELS	Ultrasound is considered a safe and non-invasive tool in regenerative medicine and has been used in the clinic for more than twenty years for applications in bone healing after the approval of the Exogen device, also known as low-intensity pulsed ultrasound (LIPUS). Beyond its effects on bone health, LIPUS has also been investigated for wound healing of soft tissues, with positive results for various cell processes including cell proliferation, migration and angiogenesis. As LIPUS has the potential to treat chronic skin wounds, we sought to evaluate the effects produced by a conventional therapeutic ultrasound device at low intensities (also considered LIPUS) on the migration capacity of mouse and human skin mesenchymal precursors (s-MPs). Cells were stimulated for 3 days (20 minutes per day) using a traditional ultrasound device with the following parameters: 100 mW/cm(2) with 20% duty cycle and frequency of 3 MHz. At the parameters used, ultrasound failed to affect s-MP proliferation, with no evident changes in morphology or cell groupings, and no changes at the cytoskeletal level. Further, the migration and invasion ability of s-MPs were unaffected by the ultrasound protocol, and no major changes were detected in the gene/protein expression of ROCK1, integrin beta 1, laminin beta 1, type I collagen and transforming growth factor beta 1. Finally, RNA-seq analysis revealed that only 10 genes were differentially expressed after ultrasound stimulation. Among them, 5 encode for small nuclear RNAs and 2 encode for proteins belonging to the nuclear pore complex. Considering the results overall, while the viability of s-MPs was not affected by ultrasound stimulation and no changes were detected in proliferation/migration, RNA-seq analysis would suggest that s-MPs do respond to ultrasound. The use of 100 mW/cm(2) intensity or conventional therapeutic ultrasound devices might not be optimal for the stimulation the properties of cell populations. Future studies should investigate the potential application of ultrasound using variations of the tested parameters.	[de Lucas, Beatriz; Perez, Laura M.; Galvez, Beatriz G.] Univ Europea Madrid, Fac Biomed & Hlth Sci, Madrid, Spain; [Bernal, Aurora] Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain	European University of Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Galvez, BG (corresponding author), Univ Europea Madrid, Fac Biomed & Hlth Sci, Madrid, Spain.	beatriz.ggalvez@ufv.es	Bernal, Aurora/AAG-1926-2019; de Lucas Moreno, Beatriz/P-1378-2019; Gálvez, Beatriz G./H-1644-2015	Bernal, Aurora/0000-0002-5741-7865; de Lucas Moreno, Beatriz/0000-0002-2852-0118; Gálvez, Beatriz G./0000-0002-8082-9323	Spanish Ministry of Science and Innovation [SAF 2015-67911-R]; FPU fellowship from the Spanish Ministry	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPU fellowship from the Spanish Ministry	This study was supported by grants from the Spanish Ministry of Science and Innovation (SAF 2015-67911-R) to BGG. BdL is supported by FPU fellowship from the Spanish Ministry.	Angle SR, 2011, ULTRASONICS, V51, P281, DOI 10.1016/j.ultras.2010.09.004; Atherton P, 2017, J CELL SCI, V130, P2277, DOI 10.1242/jcs.192781; Bernal A, 2012, CELL DEATH DIFFER, V19, P345, DOI 10.1038/cdd.2011.110; Bernal A, 2015, STEM CELL REV REP, V11, P852, DOI 10.1007/s12015-015-9608-6; Bernal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053215; Bohari SPM, 2015, J TISSUE ENG, V6, DOI 10.1177/2041731415615777; Boyle Sarah T, 2016, Small GTPases, V7, P139, DOI 10.1080/21541248.2016.1173771; Carovac Aladin, 2011, Acta Inform Med, V19, P168, DOI 10.5455/aim.2011.19.168-171; Chan CW, 2006, J ORTHOP RES, V24, P2072, DOI 10.1002/jor.20258; Chen Y, 2010, J CELL MOL MED, V14, P1494, DOI 10.1111/j.1582-4934.2009.00912.x; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; de Lucas B, 2020, GENES-BASEL, V11, DOI 10.3390/genes11091086; de Lucas B, 2018, J CELL MOL MED, V22, P746, DOI 10.1111/jcmm.13422; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; European Food Safety Authority (EFSA), 2015, EFSA J, V13, pe4138, DOI 10.2903/j.efsa.2015.4138; Feril LB, 2005, CANCER LETT, V221, P145, DOI 10.1016/j.canlet.2004.08.034; Fung CH, 2012, ULTRASOUND MED BIOL, V38, P745, DOI 10.1016/j.ultrasmedbio.2012.01.022; Gallo M, 2018, FOODS, V7, DOI 10.3390/foods7100164; Gao QH, 2017, J ENDODONT, V43, P1130, DOI 10.1016/j.joen.2017.02.022; Harrison A, 2016, ULTRASONICS, V70, P45, DOI 10.1016/j.ultras.2016.03.016; Hebert MD, 2013, INT J BIOCHEM CELL B, V45, P1314, DOI 10.1016/j.biocel.2013.03.019; HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26, DOI 10.2106/00004623-199401000-00004; Huang JJ, 2015, AM J TRANSL RES, V7, P1106; Ikeda T, 2016, ADV EXP MED BIOL, V880, P113, DOI 10.1007/978-3-319-22536-4_7; Iwanabe Y, 2016, J PROSTHODONT RES, V60, P308, DOI 10.1016/j.jpor.2016.03.002; Karijolich J, 2010, RNA BIOL, V7, P192, DOI 10.4161/rna.7.2.11207; KC A., 2017, J TOUR HOSP ED, V7, P25, DOI [10.3126/jthe.v7i0.17688, DOI 10.3126/JTHE.V7I0.17688]; Kosters A, 2017, INT ORTHOP, V41, P2067, DOI 10.1007/s00264-017-3574-3; Kristiansen TK, 1997, J BONE JOINT SURG AM, V79A, P961, DOI 10.2106/00004623-199707000-00002; Lafarga M, 2017, RNA BIOL, V14, P712, DOI 10.1080/15476286.2016.1231360; Lagneaux L, 2002, EXP HEMATOL, V30, P1293, DOI 10.1016/S0301-472X(02)00920-7; Lemaster JE, 2018, ACS APPL NANO MATER, V1, P1321, DOI 10.1021/acsanm.8b00063; Leskinen JJ, 2012, ULTRASOUND MED BIOL, V38, P777, DOI 10.1016/j.ultrasmedbio.2012.01.019; Lv YG, 2013, BIOTECHNOL LETT, V35, P2201, DOI 10.1007/s10529-013-1313-4; Man J, 2012, J BONE MINER METAB, V30, P602, DOI 10.1007/s00774-012-0368-y; Monden K, 2015, J HARD TISSUE BIOL, V24, P189, DOI 10.2485/jhtb.24.189; Nagao M, 2017, J CELL PHYSIOL, V232, P3337, DOI 10.1002/jcp.25777; Padilla F, 2014, ULTRASONICS, V54, P1125, DOI 10.1016/j.ultras.2014.01.004; Poh YC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1873; Prieto ML, 2018, ULTRASOUND MED BIOL, V44, P1217, DOI 10.1016/j.ultrasmedbio.2017.12.020; Qiu ZH, 2019, ISCIENCE, V21, P448, DOI 10.1016/j.isci.2019.10.037; Robey Pamela, 2017, F1000Res, V6, DOI 10.12688/f1000research.10955.1; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roper JA, 2015, J INVEST DERMATOL, V135, P2842, DOI 10.1038/jid.2015.224; Rubin C, 2001, J BONE JOINT SURG AM, V83A, P259, DOI 10.2106/00004623-200102000-00015; Saito M, 2004, BONE, V35, P644, DOI 10.1016/j.bone.2004.04.024; Samandari M, 2017, J BIOMECH, V60, P39, DOI 10.1016/j.jbiomech.2017.06.003; Santana LD, 2013, ULTRASONICS, V53, P870, DOI 10.1016/j.ultras.2012.12.009; Shi MF, 2016, ULTRASONICS, V64, P43, DOI 10.1016/j.ultras.2015.07.011; Tsai WC, 2006, J ORTHOP RES, V24, P1310, DOI 10.1002/jor.20130; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Warden SJ, 2006, PHYS THER, V86, P1118, DOI 10.1093/ptj/86.8.1118; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yilmaz V, 2017, EUR J RHEUMATOL, V4, P104, DOI 10.5152/eurjrheum.2017.160089; Zhang L, 2015, INT J HYPERTHER, V31, P280, DOI 10.3109/02656736.2014.996790; Zhao L, 2017, ULTRASOUND MED BIOL, V43, P1986, DOI 10.1016/j.ultrasmedbio.2017.04.020; Zhao XY, 2017, SCI REP-UK, V7, DOI 10.1038/srep40512; Zhou SX, 2004, J BIOL CHEM, V279, P54463, DOI 10.1074/jbc.M404786200; Zura R, 2017, J ORTHOP TRAUMA, V31, P248, DOI 10.1097/BOT.0000000000000778; Zura R, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0498-1; 2019, J CROHNS COLITIS S1, V13	62	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246261	10.1371/journal.pone.0246261	http://dx.doi.org/10.1371/journal.pone.0246261			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571276	Green Published, gold			2022-12-26	WOS:000618274000028
J	Hetherington, E; Adhikari, K; Tomfohr-Madsen, L; Patten, S; Metcalfe, A				Hetherington, Erin; Adhikari, Kamala; Tomfohr-Madsen, Lianne; Patten, Scott; Metcalfe, Amy			Birth outcomes, pregnancy complications, and postpartum mental health after the 2013 Calgary flood: A difference in difference analysis	PLOS ONE			English	Article							PRENATAL MATERNAL STRESS; NATURAL DISASTERS; IMPACT; EXPOSURE; VALIDATION; EARTHQUAKE; LOUISIANA; CANADA	Background In June 2013, the city of Calgary, Alberta and surrounding areas sustained significant flooding which resulted in large scale evacuations and closure of businesses and schools. Floods can increase stress which may negatively impact perinatal outcomes and mental health, but previous research is inconsistent. The objectives of this study are to examine the impact of the flood on pregnancy health, birth outcomes and postpartum mental health. Methods Linked administrative data from the province of Alberta were used. Outcomes included preterm birth, small for gestational age, a new diagnoses of preeclampsia or gestational hypertension, and a diagnosis of, or drug prescription for, depression or anxiety. Data were analyzed using a quasi-experimental difference in difference design, comparing flooded and non-flooded areas and in affected and unaffected time periods. Multivariable log binomial regression models were used to estimate risk ratios, adjusted for maternal age. Marginal probabilities for the difference in difference term were used to show the potential effect of the flood. Results Participants included 18,266 nulliparous women for the pregnancy outcomes, and 26,956 women with infants for the mental health analysis. There were no effects for preterm birth (DID 0.00, CI: -0.02, 0.02), small for gestational age (DID 0.00, CI: -0.02, 0.02), or new cases of preeclampsia (DID 0.00, CI: -0.01, 0.01). There was a small increase in new cases of gestational hypertension (DID 0.02, CI: 0.01, 0.03) in flood affected areas. There were no differences in postpartum anxiety or depression prescriptions or diagnoses. Conclusion The Calgary 2013 flood was associated with a minor increase in gestational hypertension and not other health outcomes. Universal prenatal care and magnitude of the disaster may have minimized impacts of the flood on pregnant women.	[Hetherington, Erin; Metcalfe, Amy] Univ Calgary, Cumming Sch Med, Dept Obstet & Gynaecol, Calgary, AB, Canada; [Adhikari, Kamala; Patten, Scott] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Adhikari, Kamala] Alberta Hlth Serv, Alberta Canc Prevent Legacy Fund, Calgary, AB, Canada; [Tomfohr-Madsen, Lianne] Univ Calgary, Fac Arts, Dept Psychol, Calgary, AB, Canada; [Patten, Scott] Univ Calgary, Cumming Sch Med, Dept Psychiat, Calgary, AB, Canada	University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary	Hetherington, E (corresponding author), Univ Calgary, Cumming Sch Med, Dept Obstet & Gynaecol, Calgary, AB, Canada.	elhether@ucalgary.ca	Patten, Scott/B-4434-2011	Patten, Scott/0000-0001-9871-4041	Alberta Children's Hospital Research Institute; Alberta Innovates; Canadian Institutes of Health Research; Canadian Child Health Clinician Scientist Program; Cuthbertson & Fischer Chair in Pediatric Mental Health	Alberta Children's Hospital Research Institute; Alberta Innovates; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Child Health Clinician Scientist Program; Cuthbertson & Fischer Chair in Pediatric Mental Health	Erin Hetherington: Alberta Children's Hospital Research Institute and Alberta Innovates Dr. Lianne Tomfohr-Madsen: Canadian Institutes of Health Research and Canadian Child Health Clinician Scientist Program Dr. Amy Metcalfe: Canadian Institutes of Health Research Dr. Scott Patten: Cuthbertson & Fischer Chair in Pediatric Mental Health All of the sources of funding are for general support of the investigators, and did not specifically relate to this work.	Adhikari K, 2019, CAN J PSYCHIAT, V64, P199, DOI 10.1177/0706743718802809; Ahern M, 2005, EPIDEMIOL REV, V27, P36, DOI 10.1093/epirev/mxi004; Alberta AG-Po, 2015, REP AUD GEN ALB EDM; [Anonymous], 2015, NAT METHODS, V12, P1; Antipova A, 2015, DISASTERS, V39, P665, DOI 10.1111/disa.12125; Center for Research on the Epidemiology of Disasters, 2020, EMDAT OFDA CRED INT; Chalmers B, 2008, J OBSTET GYNAECOL CA, V30, P217, DOI 10.1016/S1701-2163(16)32758-X; Dancause KN, 2011, EARLY HUM DEV, V87, P813, DOI 10.1016/j.earlhumdev.2011.06.007; Debessai Y, 2016, J PERINATOL, V36, P420, DOI 10.1038/jp.2015.218; Dennis CL, 2006, BIRTH-ISS PERINAT C, V33, P323, DOI 10.1111/j.1523-536X.2006.00130.x; Dunkel Schetter C, 2012, PREGNANCY BIRTH OUTC; Eiriksdottir VH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138534; Fernandez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119929; Fiest KM, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0289-5; Gionet L, 2013, BREASTFEEDING TRENDS; Glynn LM, 2001, AM J OBSTET GYNECOL, V184, P637, DOI 10.1067/mob.2001.111066; Goldmann E, 2014, ANNU REV PUBL HEALTH, V35, P169, DOI 10.1146/annurev-publhealth-032013-182435; Government of Alberta, 2013, SO ALB 2013 FLOODS P; Grabich SC, 2017, DISASTER MED PUBLIC, V11, P407, DOI 10.1017/dmp.2016.158; Harville E, 2010, OBSTET GYNECOL SURV, V65, P713, DOI 10.1097/OGX.0b013e31820eddbe; Harville EW, 2010, DISASTER MED PUBLIC, V4, pS39, DOI 10.1001/dmp.2010.15; Harville EW, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-21; Hetherington E, 2018, J DEV BEHAV PEDIATR, V39, P547, DOI 10.1097/DBP.0000000000000586; Hinds A, 2016, CAN J PUBLIC HEALTH, V107, pE56, DOI [10.17269/cjph.107.5244, 10.17269/CJPH.107.5244]; HOROWITZ MJ, 1991, PSYCHIAT ANN, V21, P556, DOI 10.3928/0048-5713-19910901-14; Intergovernmental Panel on Climate Change, 2015, CLIMATE CHANGE 2014; Joseph KS, 2009, CHRONIC DIS CAN, V29, P96; King S, 2012, BIRTH DEFECTS RES C, V96, P273, DOI 10.1002/bdrc.21026; Kramer MS, 2009, AM J EPIDEMIOL, V169, P1319, DOI 10.1093/aje/kwp061; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Kyozuka H, 2020, J MATERN-FETAL NEO M, V33, P4043, DOI 10.1080/14767058.2019.1594763; Lanes A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-302; Leeners B, 2007, HYPERTENS PREGNANCY, V26, P211, DOI 10.1080/10641950701274870; Lowe SR, 2019, CURR ENV HLTH REP, V6, P344, DOI 10.1007/s40572-019-00245-5; Mallett LH, 2018, DISASTERS, V42, P432, DOI 10.1111/disa.12256; Marrie RA, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-16; Mendez-Figueroa H, 2019, OBSTET GYNECOL, V134, P1005, DOI 10.1097/AOG.0000000000003522; Metcalfe A, 2015, BJOG-INT J OBSTET GY, V122, P1748, DOI 10.1111/1471-0528.13254; Norris FH, 2002, PSYCHIATRY, V65, P240, DOI 10.1521/psyc.65.3.240.20169; Norris FH, 2009, SOC SCI MED, V68, P2190, DOI 10.1016/j.socscimed.2009.03.043; Noy I, 2016, NAT HAZARDS, V84, pS7, DOI 10.1007/s11069-015-1957-6; O'Donnell S, 2016, EPIDEMIOL PSYCH SCI, V25, P360, DOI 10.1017/S2045796015000463; Oyarzo C, 2012, J MATERN-FETAL NEO M, V25, P1868, DOI 10.3109/14767058.2012.678437; Qu ZY, 2012, J AFFECT DISORDERS, V136, P117, DOI 10.1016/j.jad.2011.08.021; Sahni V, 2016, CAN J PUBLIC HEALTH, V107, pE142, DOI [10.17269/cjph.107.5188, 10.17269/CJPH.107.5188]; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Sekizuka Naomi, 2010, Environmental Health and Preventive Medicine, V15, P292, DOI 10.1007/s12199-010-0142-5; Sugawara J, 2018, PREHOSP DISASTER MED, V33, P215, DOI 10.1017/S1049023X18000183; Tan CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008200; Tong V, 2011, MATERN CHILD HLTH J, V15, P281, DOI 10.1007/s10995-010-0576-9; Torche F, 2012, HUM REPROD, V27, P558, DOI 10.1093/humrep/der390; Tremblay MA, 2006, J APPL SOC PSYCHOL, V36, P1502, DOI 10.1111/j.0021-9029.2006.00069.x; Wing C, 2018, ANNU REV PUBL HEALTH, V39, P453, DOI 10.1146/annurev-publhealth-040617-013507; Xiao JP, 2019, SCI TOTAL ENVIRON, V678, P755, DOI 10.1016/j.scitotenv.2019.04.436; Xiong X, 2008, AM J MED SCI, V336, P111, DOI 10.1097/MAJ.0b013e318180f21c; Zhang SC, 2013, OBSTET GYNECOL SURV, V68, P825, DOI 10.1097/OGX.0000000000000001	56	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246670	10.1371/journal.pone.0246670	http://dx.doi.org/10.1371/journal.pone.0246670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	33571314	gold, Green Published			2022-12-26	WOS:000618274000093
J	Jungo, S; Moreau, N; Mazevet, ME; Ejeil, AL; Duplan, MB; Salmon, B; Smail-Faugeron, V				Jungo, Sebastien; Moreau, Nathan; Mazevet, Marco E.; Ejeil, Anne-Laure; Duplan, Martin Biosse; Salmon, Benjamin; Smail-Faugeron, Violaine			Prevalence and risk indicators of first-wave COVID-19 among oral health-care workers: A French epidemiological survey	PLOS ONE			English	Article							H1N1 INFLUENZA; INFECTIONS; OUTBREAK	Background Previous studies have highlighted the increased risk of contracting the COVID-19 for health-care workers and suggest that oral health-care workers may carry the greatest risk. Considering the transmission route of the SARS-CoV-2 infection, a similar increased risk can be hypothesized for other respiratory infections. However, no study has specifically assessed the risk of contracting COVID-19 within the dental profession. Methods An online survey was conducted within a population of French dental professionals between April 1 and April 29, 2020. Univariable and multivariable logistic regression analyses were performed to explore risk indicators associated with laboratory-confirmed COVID-19 and COVID-19-related clinical phenotypes (i.e. phenotypes present in 15% or more of SARS-CoV-2-positive cases). Results 4172 dentists and 1868 dental assistants responded to the survey, representing approximately 10% of French oral health-care workers. The prevalence of laboratory-confirmed COVID-19 was 1.9% for dentists and 0.8% for dental assistants. Higher prevalence was found for COVID-19-related clinical phenotypes both in dentists (15.0%) and dental assistants (11.8%). Chronic kidney disease and obesity were associated with increased odds of laboratory-confirmed COVID-19, whereas working in a practice limited to endodontics was associated with decreased odds. Chronic obstructive pulmonary disease, use of public transportation and having a practice limited to periodontology were associated with increased odds of presenting a COVID-19-related clinical phenotype. Moreover, changes in work rhythm or clinical practice were associated with decreased odds of both outcomes. Conclusions Although oral health-care professionals were surprisingly not at higher risk of COVID-19 than the general population, specific risk indicators could exist, notably among high aerosol-generating dental subspecialties such as periodontology. Considering the similarities between COVID-19-related clinical phenotypes other viral respiratory infections, lessons can be learned from the COVID-19 pandemic regarding the usefulness of equipping and protecting oral health-care workers, notably during seasonal viral outbreaks, to limit infection spread. Impact Results from this study may provide important insights for relevant health authorities regarding the overall infection status of oral health-care workers in the current pandemic and draw attention to particular at-risk groups, as illustrated in the present study. Protecting oral health-care workers could be an interesting public health strategy to prevent the resurgence of COVID-19 and/or the emergence of new pandemics.	[Jungo, Sebastien; Moreau, Nathan; Ejeil, Anne-Laure; Duplan, Martin Biosse; Salmon, Benjamin; Smail-Faugeron, Violaine] Univ Paris, UFR Odontol, Bretonneau Hosp, AP HP,Dent Med Dept, Paris, France; [Moreau, Nathan] Univ Paris, Lab Orofacial Neurobiol, EA7543, Paris, France; [Mazevet, Marco E.] Guys Hosp, Kings Coll London, Fac Dent Oral & Craniofacial Sci, Dent Innovat & Translat Hub, Tower Wing, London, England; [Ejeil, Anne-Laure; Salmon, Benjamin] Univ Paris, Lab Orofacial Pathol Imaging & Biotherapies, UR2496, Montrouge, France; [Duplan, Martin Biosse] INSERM, Imagine Inst, U1163, Paris, France; [Smail-Faugeron, Violaine] Univ Paris, Dent Mat Res Unit, URB2I, Montrouge, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bretonneau - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Smail-Faugeron, V (corresponding author), Univ Paris, UFR Odontol, Bretonneau Hosp, AP HP,Dent Med Dept, Paris, France.; Smail-Faugeron, V (corresponding author), Univ Paris, Dent Mat Res Unit, URB2I, Montrouge, France.	violaine.smail-faugeron@u-paris.fr	SALMON, Benjamin/X-4286-2019; Anne-Laure, Ejeil/AGP-6185-2022	SALMON, Benjamin/0000-0001-8739-2753; Smail-Faugeron, Violaine/0000-0002-3197-6650; Jungo, Sebastien/0000-0001-7747-7286				[Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; Beeching NJ, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1403; Cai QX, 2020, DIABETES CARE, V43, P1392, DOI 10.2337/dc20-0576; Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X; CNAM-TS, 2020, ACT QUELQ CHIFFR 202; COCHRAN MA, 1989, J AM DENT ASSOC, V119, P141, DOI 10.14219/jada.archive.1989.0131; DAVIES KJ, 1994, BRIT DENT J, V176, P262, DOI 10.1038/sj.bdj.4808430; Edelson PJ, 2011, TRAVEL MED INFECT DI, V9, P27, DOI 10.1016/j.tmaid.2010.11.001; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Heald-Sargent T, 2020, JAMA PEDIATR, V174, P902, DOI 10.1001/jamapediatrics.2020.3651; Iacobucci G, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1316; Jiang C, 2020, MICROBES INFECT, V22, P236, DOI 10.1016/j.micinf.2020.05.005; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Kutter JS, 2018, CURR OPIN VIROL, V28, P142, DOI 10.1016/j.coviro.2018.01.001; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Larson HJ, 2018, NATURE, V562, P309, DOI 10.1038/d41586-018-07034-4; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lesage FX, 2012, OCCUP MED-OXFORD, V62, P600, DOI 10.1093/occmed/kqs140; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3; Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246; NEYMAN J, 1955, SCIENCE, V122, P401, DOI 10.1126/science.122.3166.401; Ng K, 2020, ANN INTERN MED, V172, P766, DOI 10.7326/L20-0175; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9; Peto J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1163; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Sabino-Silva R, 2020, CLIN ORAL INVEST, V24, P1619, DOI 10.1007/s00784-020-03248-x; Saglanmak N, 2011, VACCINE, V29, pB42, DOI 10.1016/j.vaccine.2011.02.065; Seron Marcelo Augusto, 2020, Braz. Dent. J., V31, P567, DOI 10.1590/0103-6440202003760; Sharma G., 2017, INT J APPL RES, V3, P749, DOI DOI 10.22271/ALLRESEARCH.2017.V3.I3I; Sim MR, 2020, OCCUP ENVIRON MED, V77, P281, DOI 10.1136/oemed-2020-106567; Smith David S, 2020, SN Compr Clin Med, V2, P1947, DOI 10.1007/s42399-020-00603-7; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Varia M, 2003, CAN MED ASSOC J, V169, P285; Virlogeux V, 2016, SCI REP-UK, V6, DOI 10.1038/srep35839; Vujicic M, 2012, J AM DENT ASSOC, V143, P452, DOI 10.14219/jada.archive.2012.0204; Wang XH, 2020, RESEARCH-CHINA, V2020, DOI 10.34133/2020/2402961; Wu D, 2020, INT J INFECT DIS, V94, P44, DOI 10.1016/j.ijid.2020.03.004; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhang JS, 2020, AM J CLIN NUTR, V111, P1297, DOI 10.1093/ajcn/nqaa095; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; 2011, MOD HEALTHC, V41	46	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246586	10.1371/journal.pone.0246586	http://dx.doi.org/10.1371/journal.pone.0246586			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571264	Green Published, gold			2022-12-26	WOS:000618274000078
J	Mapanga, W; Norris, SA; Chen, WLC; Blanchard, C; Graham, A; Baldwin-Ragaven, L; Boyles, T; Donde, B; Greef, L; Huddle, K; Khumalo, B; Leepile, E; Lubuzo, B; Makhutle, R; Mayet, Y; Tsitsi, M; Mistri, P; Mmoledi, K; Ratshikana-Moloko, M; Morer, R; Pretorius, L; Punwasi, J; Richards, GA; Ruff, P; Shabalala, D; Sibadela, M; Soma, N; Wong, M; Joffe, M				Mapanga, Witness; Norris, Shane A.; Chen, Wenlong C.; Blanchard, Charmaine; Graham, Anita; Baldwin-Ragaven, Laurel; Boyles, Tom; Donde, Bernard; Greef, Linda; Huddle, Ken; Khumalo, Busisiwe; Leepile, Elizabeth; Lubuzo, Buhle; Makhutle, Raynolda; Mayet, Yusuf; Tsitsi, Merika; Mistri, Preethi; Mmoledi, Keletso; Ratshikana-Moloko, Mpho; Morer, Rajen; Pretorius, Lauren; Punwasi, Jayshina; Richards, Guy A.; Ruff, Paul; Shabalala, Dineo; Sibadela, Maureen; Soma, Nita; Wong, Michelle; Joffe, Maureen			Consensus study on the health system and patient-related barriers for lung cancer management in South Africa	PLOS ONE			English	Article							TUBERCULOSIS; STIGMA; RISK	Background Lung cancer is the highest incident cancer globally and is associated with significant morbidity and mortality particularly if identified at a late stage. Poor patient outcomes in low- and middle-income countries (LMIC's) might reflect contextual patient and health system constraints at multiple levels, that act as barriers to prevention, disease recognition, diagnosis, and treatment. Lung cancer screening, even for high-risk patients, is not available in the public health sector in South Africa (SA), where the current HIV and tuberculosis (TB) epidemics often take precedence. Yet, there has been no formal assessment of the individual and health-system related barriers that may delay patients with lung cancer from seeking and accessing help within the public health care system and receiving the appropriate and effective diagnosis and treatment. This study aimed to derive consensus from health-system stakeholders in the urban Gauteng Province of SA on the most important challenges faced by the health services and patients in achieving optimum lung cancer management and to identify potential solutions. Methods The study was undertaken among 27 participant stakeholders representing clinical managers, clinicians, opinion leaders from the public health sector and non-governmental organisation (NGO) representatives. The study compromised two components: consensus and engagement. For the consensus component, the Delphi Technique was employed with open-ended questions and item ranking from five rounds of consensus-seeking, to achieve collective agreement on the most important challenges faced by patients and the health services in achieving optimal lung cancer management. For the engagement component, the Nominal Group Technique was used to articulate ideas and reach an agreement on the group's recommendations for solution strategies and approaches. Results Public health sector stakeholders suggested that a lack of knowledge and awareness of lung cancer, and the apparent stigma associated with the disease and its risk factors, as well as symptoms and signs, are critical to treatment delay. Furthermore, delays in up-referral of patients with suspected lung cancer from district health care level were attributed to inadequate knowledge arising from a lack of in-service training of nurses and doctors regarding oncologic symptoms, risk factors, need for further investigation, interpretation of x-rays and available treatments. At a tertiary level, participants suggested that insufficient availability of specialised diagnostic resources (imaging, cytological and pathological services including biomolecular assessment of lung cancer), theatres, cardiothoracic surgeons, and appropriate therapeutic modalities (chemotherapeutic agents and radiation oncology) are the main barriers to the provision of optimal care. It was suggested that a primary prevention programme initiated by the government that involves private-public partnerships may improve lung cancer management nationally. Conclusions Considerable barriers to the early identification and treatment of lung cancer exist. Finding solutions to overcome both individual and health-system level obstacles to lung cancer screening and management are vital to facilitate early identification and treatment, and to improve survival. Furthermore, research on inexpensive biomarkers for asymptomatic disease detection, the introduction of diagnostic imaging tools that utilise artificial intelligence to compensate for inadequate human resources and improving clinical integration across all levels of the healthcare system are essential.	[Mapanga, Witness; Norris, Shane A.; Blanchard, Charmaine; Makhutle, Raynolda; Mmoledi, Keletso; Ratshikana-Moloko, Mpho; Joffe, Maureen] Univ Witwatersrand, Fac Hlth Sci, Div Wits Hlth Consortium, Noncommunicable Dis Res NCDR, Johannesburg, South Africa; [Mapanga, Witness; Mayet, Yusuf; Ruff, Paul; Shabalala, Dineo] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Div Med Oncol, Johannesburg, South Africa; [Norris, Shane A.; Joffe, Maureen] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat, SAMRC Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Chen, Wenlong C.] Natl Canc Registry, Natl Hlth Lab Serv, Johannesburg, South Africa; [Chen, Wenlong C.] Univ Witwatersrand, Fac Hlth Sci, Sydney Brenner Inst Mol Biosci, Johannesburg, South Africa; [Blanchard, Charmaine; Ratshikana-Moloko, Mpho] Univ Witwatersrand, Fac Hlth Sci, Ctr Palliat Care, Johannesburg, South Africa; [Graham, Anita; Huddle, Ken; Khumalo, Busisiwe; Tsitsi, Merika; Morer, Rajen; Richards, Guy A.; Wong, Michelle] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Div Pulmonol, Johannesburg, South Africa; [Baldwin-Ragaven, Laurel; Punwasi, Jayshina] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Family Med & Primary Care, Johannesburg, South Africa; [Boyles, Tom] Helen Joseph Hosp, Johannesburg, Gauteng, South Africa; [Boyles, Tom] ANOVA Hlth Inst, Johannesburg, South Africa; [Boyles, Tom] London Sch Hyg & Trop Med, London, England; [Donde, Bernard] Univ Witwatersrand, Fac Hlth Sci, Dept Radiat Sci, Div Radiat Oncol, Johannesburg, South Africa; [Greef, Linda] Canc Alliance, Johannesburg, South Africa; [Leepile, Elizabeth] Tladi Prov Clin, Gauteng Dept Hlth, Johannesburg, South Africa; [Lubuzo, Buhle] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa; [Tsitsi, Merika; Soma, Nita] Chris Hani Baragwanath Acad Hosp, Johannesburg, South Africa; [Mistri, Preethi] CANSA Assoc South Africa, Johannesburg, South Africa; [Pretorius, Lauren] Campaigning Canc, Johannesburg, South Africa; [Sibadela, Maureen] Alpha World Minist Social Care Ctr, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; University of Kwazulu Natal	Mapanga, W (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Div Wits Hlth Consortium, Noncommunicable Dis Res NCDR, Johannesburg, South Africa.; Mapanga, W (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Div Med Oncol, Johannesburg, South Africa.	wittymapanga@gmail.com	Chen, Wenlong/ABA-6218-2020; Mapanga, Witness/J-1617-2019; Norris, Shane/C-4664-2014; Baldwin-Ragaven, Laurel/GZA-8069-2022	Chen, Wenlong/0000-0002-3248-4906; Mapanga, Witness/0000-0001-8719-3084; Norris, Shane/0000-0001-7124-3788; Blanchard, Charmaine/0000-0002-9302-1454; Joffe, Maureen/0000-0001-8616-9672	Bristol Myers Squibb Foundation [1004]	Bristol Myers Squibb Foundation(Bristol-Myers Squibb)	This study has been supported by a Bristol Myers Squibb Foundation Secure the Future grant, 1004 entitled "Centre of Respiratory Excellence, Gauteng". The Principal Invistigator is Dr. Anita Graham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Institute of Health and Welfare, 2012, CANC SURV REV AUSTR; Baker SR, 2013, J THORAC IMAG, V28, P388, DOI 10.1097/RTI.0b013e3182a21be2; Barrett J, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-31; Birt L, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000067; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Conlon A, 2010, J PSYCHOSOC ONCOL, V28, P98, DOI 10.1080/07347330903438982; de Groot PM, 2018, TRANSL LUNG CANCER R, V7, P220, DOI 10.21037/tlcr.2018.05.06; del Ciello A, 2017, DIAGN INTERV RADIOL, V23, P118, DOI 10.5152/dir.2016.16187; Denton E, 2016, J MULTIDISCIP HEALTH, V9, DOI 10.2147/JMDH.S76762; Else-Quest NM, 2009, PSYCHOL HEALTH, V24, P949, DOI 10.1080/08870440802074664; Engels EA, 2009, INT J CANCER, V124, P1183, DOI 10.1002/ijc.24042; Hamra GB, 2014, ENVIRON HEALTH PERSP, V122, P906, DOI [10.1289/ehp.1408092, 10.1289/ehp/1408092]; Holsapple CW, 2002, INFORM MANAGE-AMSTER, V39, P477, DOI 10.1016/S0378-7206(01)00109-4; Kingham TP, 2013, LANCET ONCOL, V14, pE158, DOI 10.1016/S1470-2045(12)70472-2; Lei F, 2019, ONCOL NURS FORUM, V46, pE60, DOI [10.1188/19.ONF.E60-E71, 10.1188/19.ONF.E60-71]; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Molto J, 2015, TRANSL LUNG CANCER R, V4, P678, DOI 10.3978/j.issn.2218-6751.2015.08.10; Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Parkin DM, 2014, CANCER EPIDEM BIOMAR, V23, P953, DOI 10.1158/1055-9965.EPI-14-0281; Quaife SL, 2014, BRIT J CANCER, V110, P12, DOI 10.1038/bjc.2013.684; Ramachandran K, 2016, J CLIN DIAGN RES, V10, pOC5, DOI 10.7860/JCDR/2016/22737.8823; Reddy P, 2015, SAMJ S AFR MED J, V105, P648, DOI [10.7196/SAMJnew.7932, 10.7196/SAMJNEW.7932]; Rodgers M., 2016, HEALTH SERV DELIVERY, V4; Ruhstaller T, 2006, EUR J CANCER, V42, P2459, DOI 10.1016/j.ejca.2006.03.034; Spitz MR, 2006, CANC EPIDEMIOLOGY PR, P638; Straif K, 2013, IARC SCI PUB, V161; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Thomas S., 2012, ATASCOCITA OBSERVER; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vento S, 2013, LANCET ONCOL, V14, P277, DOI 10.1016/S1470-2045(13)70022-6; WHO INT AGCY RES CANC, 1994, IARC MONOG EVAL CARC, V60, P389; Woldeamanuel YW, 2013, LANCET ONCOL, V14, P289, DOI 10.1016/S1470-2045(12)70399-6; World Health Organization, EARL DET SCREEN VAR; Wright FC, 2007, EUR J CANCER, V43, P1002, DOI 10.1016/j.ejca.2007.01.025; Wu MH, 2008, CLIN RADIOL, V63, P518, DOI 10.1016/j.crad.2007.09.011; Yu YH, 2011, J THORAC ONCOL, V6, P32, DOI 10.1097/JTO.0b013e3181fb4fcc; ZHENG W, 1987, BRIT J CANCER, V56, P501, DOI 10.1038/bjc.1987.233	37	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246716	10.1371/journal.pone.0246716	http://dx.doi.org/10.1371/journal.pone.0246716			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571312	Green Published, gold			2022-12-26	WOS:000618274000092
J	St-Martin, G; Viborg, PH; Andersen, ABT; Andersen, B; Christensen, J; Ejersbo, D; Heje, HN; Jochumsen, KM; Johansen, T; Larsen, LG; Lynge, E; Serizawa, RR; Waldstrom, M				St-Martin, Gry; Viborg, Petra Hall; Andersen, Ane Birgitte Telen; Andersen, Berit; Christensen, Jette; Ejersbo, Dorthe; Heje, Hanne Norgaard; Jochumsen, Kirsten Marie; Johansen, Tonje; Larsen, Lise Grupe; Lynge, Elsebeth; Serizawa, Reza Rafiolsadat; Waldstrom, Marianne			Histological outcomes in HPV-screened elderly women in Denmark	PLOS ONE			English	Article							CERVICAL-CANCER	Introduction Danish women exit cervical cancer screening at age 65 years, but 23% of cervical cancer cases occur beyond this age. In addition, due to gradual implementation of cervical cancer screening, older women are underscreened by today ' s standards. A one-time screening with HPV test was therefore offered to Danish women born before 1948. Methods Register based study reporting histology diagnoses and conizations in women found HPV positive in the one-time screening. Number and proportion of women with severe or non-severe histology results were calculated for screened and HPV-positive women by age group or region of residence. Number of women with biopsy and/or conization per case of cervical intraepithelial neoplasia (CIN) grade 2 or worse (CIN2+) or CIN3+ were also calculated by age groups and region. Results 4,479 (4.1% of screened women) had positive HPV test. 94% of these had one or more additional tests. 2,785 (62%) of HPV-positive women had histology results, and conization was performed in 1,076 (24% of HPV-positive and 1% of all screened women). HPV positivity and CIN3+ detection varied little between regions, but the proportions of HPV positive women undergoing histology varied between regions from 40% to 86% and the proportion with conization from 13% to 36%. Correspondingly, the number of histologies and conizations per CIN3+ detected varied from 5.9 to 11.2 and 1.8 to 4.7, respectively. In total, 514 CIN2+ (0.47% of screened women, 11% of HPV-positive) and 337 CIN3+ (0.31% of screened women, 7.5% of HPV-positive) were diagnosed, including 37 cervical cancer cases. Discussion HPV screening of insufficiently screened birth cohorts can potentially prevent morbidity and mortality from cervical cancer but longer follow-up is needed to see if cancer incidence declines in the screened women in the coming years. Management strategies differed among regions which influenced the proportions undergoing biopsy/conization.	[St-Martin, Gry; Lynge, Elsebeth] Nykobing Falster Hosp, Ctr Epidemiol Res, Nykobing, Denmark; [Viborg, Petra Hall; Andersen, Ane Birgitte Telen] Danish Clin Registries RKKP, Frederiksberg N, Denmark; [Andersen, Berit] Randers Reg Hosp, Dept Publ Hlth Programmes, Randers, Denmark; [Andersen, Berit] Aarhus Univ Hosp, Dept Clin Med, Aarhus, Denmark; [Christensen, Jette] Aalborg Univ Hosp, Dept Pathol, Aalborg, Denmark; [Ejersbo, Dorthe; Waldstrom, Marianne] Lillebaelt Hosp, Dept Pathol, Vejle, Denmark; [Heje, Hanne Norgaard] Gen Practice, Aarhus C, Denmark; [Jochumsen, Kirsten Marie] Odense Univ Hosp, Dept Gynecol & Obstet, Odense C, Denmark; [Johansen, Tonje] Randers Reg Hosp, Dept Pathol, Randers NO, Denmark; [Larsen, Lise Grupe] Zealand Univ Hosp, Dept Pathol, Naestved, Denmark; [Lynge, Elsebeth] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Serizawa, Reza Rafiolsadat] Hvidovre Univ Hosp, Dept Pathol, Hvidovre, Denmark; [Waldstrom, Marianne] Univ Southern Denmark, Inst Reg Hlth Sci, Odense, Denmark	Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital; Aarhus University; University of Copenhagen; University of Copenhagen; University of Southern Denmark	St-Martin, G (corresponding author), Nykobing Falster Hosp, Ctr Epidemiol Res, Nykobing, Denmark.	grys@regionsjaelland.dk	Andersen, Berit/J-3402-2017	Andersen, Berit/0000-0003-4074-6504; waldstroem, marianne/0000-0001-6272-7297	Region Zealand; Southern Denmark Region; Danish Cancer Society; Fabrikant Einar Willumsens Mindelegat	Region Zealand; Southern Denmark Region; Danish Cancer Society(Danish Cancer Society); Fabrikant Einar Willumsens Mindelegat	This study was financially supported by Region Zealand, Southern Denmark Region, The Danish Cancer Society, and Fabrikant Einar Willumsens Mindelegat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen B, 2019, GYNECOL ONCOL, V154, P118, DOI 10.1016/j.ygyno.2019.04.680; [Anonymous], 2019, EUROPE HUMAN PAPILLO; Bjerregaard B, 2011, SCAND J PUBLIC HEALT, V39, P72, DOI 10.1177/1403494810393563; Castanon A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001585; Curry SJ, 2018, OBSTET GYNECOL SURV, V73, P689, DOI [10.1001/jama.2018.10897, 10.1097/01.ogx.0000549540.69362.81]; Danish Health Authority, 2018, SCREEN LIVM ANB; Danish Health Authority, 2012, SCREEN LIVM ANB; Elit L, 2016, GYNECOL ONCOL, V142, P381, DOI 10.1016/j.ygyno.2016.08.230; Government of Denmark, 2016, KRAEFTPL 4 SUNDH IDR; Hammer A, 2019, CANCER MED-US, V8, P418, DOI 10.1002/cam4.1926; Hammer A, 2018, J LOW GENIT TRACT DI, V22, P1, DOI 10.1097/LGT.0000000000000351; Hermansson RS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189300; Knudsen AO, 2016, ACTA ONCOL, V55, P65, DOI 10.3109/0284186X.2015.1115119; Lanner L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229758; Lindstrom AK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207714; Lynge E, 2018, ACTA ONCOL, V57, P354, DOI 10.1080/0284186X.2017.1355110; Lynge E, 2017, EUR J CANCER, V74, P82, DOI 10.1016/j.ejca.2016.12.021; Petersen LK, 2019, UDREDNING BEHANDLING; Rebolj M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147326; Sawaya GF, 2016, GYNECOL ONCOL, V142, P383, DOI 10.1016/j.ygyno.2016.08.229; Soung MC, 2015, MED CLIN N AM, V99, P249, DOI 10.1016/j.mcna.2014.11.002; Statistics Denmark, STAT; von Karsa L, 2015, PAPILLOMAVIRUS RES, V1, P22, DOI 10.1016/j.pvr.2015.06.006; Wang JR, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002414	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246902	10.1371/journal.pone.0246902	http://dx.doi.org/10.1371/journal.pone.0246902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571319	Green Published, gold			2022-12-26	WOS:000618274000074
J	Tessua, KK; Munseri, P; Matuja, SS				Tessua, Kezia Kodawa; Munseri, Patricia; Matuja, Sarah Shali			Outcomes within a year following first ever stroke in Tanzania	PLOS ONE			English	Article							1ST-EVER STROKE; ISCHEMIC-STROKE; PREVENTION; SURVIVAL; HEALTH; RELIABILITY; PREDICTORS; DISABILITY; VALIDITY; AFRICA	Background Stroke contributes to a significant proportion of deaths and disability worldwide, with a high fatality rate within 30 days following a first ever stroke. We describe the outcomes within one year among patients who succumbed a first ever stroke and survived the first 30 days. Methods Participants were patients who survived after 30 days from succumbing a first ever stroke admitted at the Muhimbili University of Health and Allied Sciences Academic Medical Center. Stroke survivors or their next of kin were contacted at one year after succumbing a first stroke to determine the outcomes. We assessed participants' vital status and level of disability using the modified Rankin scale. Assessment on utilization of stroke secondary preventive measures among survivors was done by an interviewer-based questionnaire that assessed the number of times participants attended follow up clinics, medication refill and adherence. Participants were examined for waist-hip ratio, body mass index and blood pressure. Cholesterol levels were assessed at one year post first stroke for survivors. Outcomes were summarized as proportions, survival at one year was estimated by using the Kaplan Meier analysis and Cox regression analysis was performed to determine for predictors of mortality. Results We recruited 130 first stroke survivors. Mortality within one year was 53/130 (40.8%) and disability rate measured by Modified Rankin Scale with scores of 3-5 was 29/77 (37.7%) among survivors. Factors associated with mortality were residual disability HR = 8.60, {95% CI (1.16-63.96)}, severe stroke, HR = 2.67 {95% CI (1.44-4.95)} and residing in Dar-es-Salaam HR = 2.15 {95% (CI 1.06-4.36)}. Non-adherence rates to antihypertensives, antiplatelets and statins was 11/73 (15.1%), 9/23 (39.1%) and 18/22 (81.8%) respectively. Attendance rates of follow-up clinics among all survivors and physiotherapy among survivors with disability are 45/77 (58.4%) and 16/29 (55.2%) respectively. Conclusions The mortality and disability rates within a year following a first ever stroke among 30 days stroke survivors is high. Secondary stroke preventive measures should be enhanced to mitigate stroke adverse outcomes. Community outreach programs could be useful interventions in preventing the adverse outcomes of stroke.	[Tessua, Kezia Kodawa; Munseri, Patricia] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Matuja, Sarah Shali] Catholic Univ Hlth & Allied Sci, Dept Internal Med, Mwanza, Tanzania	Muhimbili University of Health & Allied Sciences	Tessua, KK (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania.	ktessua@gmail.com						[Anonymous], 2019, LANCET NEUROL; Appelros P, 2003, STROKE, V34, P122, DOI 10.1161/01.STR.0000047852.05842.3C; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Eriksson M, 2008, CEREBROVASC DIS, V25, P423, DOI 10.1159/000121343; Esenwa C, 2015, VASC HEALTH RISK MAN, V11, P437, DOI 10.2147/VHRM.S63791; Ganesh A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005788; Gebremariam Sennay A, 2016, eNeurologicalSci, V3, P41, DOI 10.1016/j.ensci.2016.02.010; Gong WW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165647; Hankey GJ, 2007, NEUROLOGY, V68, P1583, DOI 10.1212/01.wnl.0000260967.77422.97; Hankey GJ, 2014, LANCET NEUROL, V13, P178, DOI 10.1016/S1474-4422(13)70255-2; Hertz JT, 2019, AFR J EMERG MED, V9, P180, DOI 10.1016/j.afjem.2019.07.001; Hinkle JL, 2014, STROKE, V45, pE32, DOI 10.1161/STROKEAHA.113.004243; Howitt SC, 2011, J NEUROL, V258, P1422, DOI 10.1007/s00415-011-5948-6; Hussmanns R, 2003, INT C LAB STAT BUR S, P1; Johnston KC, 1998, STROKE, V29, P447, DOI 10.1161/01.STR.29.2.447; Levira F, 2017, J URBAN HEALTH, V94, P437, DOI 10.1007/s11524-017-0137-2; Liu XF, 2006, CEREBROVASC DIS, V22, P130, DOI 10.1159/000093241; Magdon-Ismail Z, 2019, TOP STROKE REHABIL, V25, P576, DOI 10.1080/10749357.2018.1499303; Matuja SS, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01793-2; Ramos-Lima MJM, 2018, CLINICS, V73, DOI 10.6061/clinics/2017/e418; Olindo S, 2017, INT J STROKE, V12, P844, DOI 10.1177/1747493016685720; Owolabi M, 2018, J CLIN HYPERTENS, V20, P47, DOI 10.1111/jch.13152; Pandian JD, 2018, LANCET, V392, P1269, DOI 10.1016/S0140-6736(18)31269-8; Regenhardt RW, 2019, INT J QUAL HEALTH C, V31, P385, DOI 10.1093/intqhc/mzy188; Rejno A, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1300; Romain G, 2020, NEUROEPIDEMIOLOGY, V54, P498, DOI 10.1159/000505160; Sennfalt S, 2019, STROKE, V50, P53, DOI 10.1161/STROKEAHA.118.022913; Shin J, 2017, J EPIDEMIOL, V27, P381, DOI 10.1016/j.je.2016.08.020; Swarowska M, 2016, ARCH MED SCI, V12, P552, DOI 10.5114/aoms.2016.59928; Thorogood M, 2004, B WORLD HEALTH ORGAN, V82, P503; Walker R, 2010, LANCET NEUROL, V9, P786, DOI 10.1016/S1474-4422(10)70144-7; Wasserman S, 2009, SAMJ S AFR MED J, V99, P579; Williums G, 2018, ESCESH GUIDELINES MA, P1953; World Health Organization (WHO), 2011, WAIST CIRCUMFERENCE	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246492	10.1371/journal.pone.0246492	http://dx.doi.org/10.1371/journal.pone.0246492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571298	Green Published, gold			2022-12-26	WOS:000618274000015
J	Fill, JM; Zamora, C; Baruzzi, C; Salazar-Castro, J; Crandall, RM				Fill, Jennifer M.; Zamora, Cesar; Baruzzi, Carolina; Salazar-Castro, Javier; Crandall, Raelene M.			Wiregrass (Aristida beyrichiana) survival and reproduction after fire in a long-unburned pine savanna	PLOS ONE			English	Article							FLORIDA; FOREST; MORTALITY; WILDFIRES; PATTERNS; SANDHILL	Restoring fire regimes is a major goal of biodiversity conservation efforts in fire-prone ecosystems from which fire has been excluded. In the southeastern U.S.A., nearly a century of fire exclusion in pine savannas has led to significant biodiversity declines in one of the most species-rich ecosystems of North America. In these savannas, frequent fires that support biodiversity are driven by vegetation-fire feedbacks. Understory grasses are key components of these feedbacks, fueling the spread of fires that keep tree density low and maintain a high-light environment. When fire is reintroduced to long-unburned sites, however, remnant populations of bunchgrasses might experience high mortality from fuel accumulation during periods of fire exclusion. Our objective was to quantify fire effects on wiregrass (Aristida beyrichiana), a key component of vegetation-fire feedbacks, following 16 years without fire in a dry pine savanna typically considered to burn every 1-3 years. We examined how wiregrass size and fuel (duff depth and presence of pinecones) affected post-fire survival, inflorescence and seed production, and seed germination. Wiregrass exhibited high survival regardless of size or fuels. Probability of flowering and inflorescence number per plant were unaffected by fuel treatments but increased significantly with plant size (p = 0.016). Germination of filled seeds was consistent (29-43%) regardless of fuels, although plants in low duff produced the greatest proportion of filled seeds. The ability of bunchgrasses to persist and reproduce following fire exclusion could jumpstart efforts to reinstate frequent-fire regimes and facilitate biodiversity restoration where remnant bunchgrass populations remain.	[Fill, Jennifer M.; Zamora, Cesar; Baruzzi, Carolina; Salazar-Castro, Javier; Crandall, Raelene M.] Univ Florida, Sch Nat Resources & Conservat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Fill, JM (corresponding author), Univ Florida, Sch Nat Resources & Conservat, Gainesville, FL 32611 USA.	jfill@ufl.edu		Baruzzi, Carolina/0000-0003-1796-9355	USDA National Institute of Food and Agriculture, Agriculture and Food Research Initiative, Foundational and Applied Science Program Award [2018-07356]; USDA AFRI Education and Workforce Development Award [2018-08049]; McIntire-Stennis Project [FLA-FOR-005759]; University of Florida, Institute of Food and Agricultural Sciences Ordway Swisher Biological Station Jumpstart Award	USDA National Institute of Food and Agriculture, Agriculture and Food Research Initiative, Foundational and Applied Science Program Award; USDA AFRI Education and Workforce Development Award; McIntire-Stennis Project; University of Florida, Institute of Food and Agricultural Sciences Ordway Swisher Biological Station Jumpstart Award	This research was supported by USDA National Institute of Food and Agriculture, Agriculture and Food Research Initiative, Foundational and Applied Science Program Award #2018-07356 (to RMC), USDA AFRI Education and Workforce Development Award #2018-08049 (to JMF), McIntire-Stennis Project #FLA-FOR-005759 (to RMC), and University of Florida, Institute of Food and Agricultural Sciences Ordway Swisher Biological Station Jumpstart Award (to RMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson WG, 1996, J VEG SCI, V7, P565, DOI 10.2307/3236306; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckage B, 2011, ECOL MODEL, V222, P2227, DOI 10.1016/j.ecolmodel.2011.01.015; Blasco-Moreno A, 2019, METHODS ECOL EVOL, V10, P949, DOI 10.1111/2041-210X.13185; Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x; CLEWELL A F, 1989, Natural Areas Journal, V9, P223; Dell JE, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1964; Fill JM, 2016, PLANT ECOL, V217, P331, DOI 10.1007/s11258-016-0574-0; Fill JM, 2015, FOREST ECOL MANAG, V356, P54, DOI 10.1016/j.foreco.2015.07.021; Fill JM, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00044.1; Fonda RW, 2004, NORTHWEST SCI, V78, P322; Franklin J, 2001, ECOL MODEL, V142, P261, DOI 10.1016/S0304-3800(01)00286-1; Frost C. C., 1993, P 18 TALL TIMB FIR E, P17; Gagnon PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029674; Groover JC, 2018, THESIS MURRAY STATE; He TH, 2019, BIOL REV, V94, P1983, DOI 10.1111/brv.12544; Hiers JK, 2007, ECOL APPL, V17, P806, DOI 10.1890/06-1015; Hoffmann WA, 2009, ECOLOGY, V90, P1326, DOI 10.1890/08-0741.1; Kirkman LK, 2007, J APPL ECOL, V44, P604, DOI 10.1111/j.1365-2664.2007.01310.x; Le Page Y, 2010, GLOBAL ECOL BIOGEOGR, V19, P575, DOI 10.1111/j.1466-8238.2010.00525.x; LEMON PC, 1949, ECOLOGY, V30, P135, DOI 10.2307/1931182; Maliakal SK, 2000, J TORREY BOT SOC, V127, P125, DOI 10.2307/3088690; Means DB., 1997, RESTORATION MANAGEME, V15, P52; Miller HM, 2019, AM MIDL NAT, V182, P276, DOI 10.1674/0003-0031-182.2.276; Mitchell RJ, 2009, J FOREST, V107, P391; Mulligan MK, 2002, PLANT ECOL, V163, P39, DOI 10.1023/A:1020312408663; Nagy RC, 2018, FIRE-BASEL, V1, DOI 10.3390/fire1010004; NOSS R F, 1989, Natural Areas Journal, V9, P211; Noss RF, 2015, DIVERS DISTRIB, V21, P236, DOI 10.1111/ddi.12278; O'Brien JJ, 2016, CAN J REMOTE SENS, V42, P489, DOI 10.1080/07038992.2016.1199271; Outcalt KW., 1996, USDA FOREST SERVICE; Parrott RT, 1967, THESIS DUKE U; Perez HE, 2010, NAT AREA J, V30, P387, DOI 10.3375/043.030.0403; R Core Team, 2020, R LANG ENV STAT COMP; Readle EL., 1990, SOIL SURVEY PUTNAM C; Reinhart KO, 2004, APPL VEG SCI, V7, P141, DOI 10.1111/j.1654-109X.2004.tb00604.x; Reside AE, 2012, DIVERS DISTRIB, V18, P213, DOI 10.1111/j.1472-4642.2011.00818.x; Rodriguez E., 2011, THESIS U FLORIDA; Shearman TM, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2541; Shlisky A., 2007, FIRE ECOSYSTEMS PEOP; Thaxton JM, 2006, ECOLOGY, V87, P1331, DOI 10.1890/0012-9658(2006)87[1331:SFVAFI]2.0.CO;2; Van Eerden BP., 1997, THESIS U GEORGIA; van Mantgem P, 2001, NAT AREA J, V21, P266; Varner JM, 2005, RESTOR ECOL, V13, P536, DOI 10.1111/j.1526-100X.2005.00067.x; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; WALKER J, 1984, VEGETATIO, V55, P163, DOI 10.1007/BF00045019; White DL., 1989, NAT AREA J, V9, P234; Wiggers MS, 2013, FOREST ECOL MANAG, V310, P54, DOI 10.1016/j.foreco.2013.07.030	48	2	2	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	2							e0247159	10.1371/journal.pone.0247159	http://dx.doi.org/10.1371/journal.pone.0247159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QI3KL	33596591	Green Published, gold			2022-12-26	WOS:000618877600001
J	Davison, RJ; Gurven, MD				Davison, Raziel J.; Gurven, Michael D.			Human uniqueness? Life history diversity among small-scale societies and chimpanzees	PLOS ONE			English	Article							TRADE-OFF; ELASTICITY ANALYSIS; WILD CHIMPANZEES; MORTALITY-RATES; FERTILITY; EVOLUTION; GROWTH; LONGEVITY; PATTERNS; EXPECTANCY	Background Humans life histories have been described as "slow", patterned by slow growth, delayed maturity, and long life span. While it is known that human life history diverged from that of a recent common chimpanzee-human ancestor some similar to 4-8 mya, it is unclear how selection pressures led to these distinct traits. To provide insight, we compare wild chimpanzees and human subsistence societies in order to identify the age-specific vital rates that best explain fitness variation, selection pressures and species divergence. Methods We employ Life Table Response Experiments to quantify vital rate contributions to population growth rate differences. Although widespread in ecology, these methods have not been applied to human populations or to inform differences between humans and chimpanzees. We also estimate correlations between vital rate elasticities and life history traits to investigate differences in selection pressures and test several predictions based on life history theory. Results Chimpanzees' earlier maturity and higher adult mortality drive species differences in population growth, whereas infant mortality and fertility variation explain differences between human populations. Human fitness is decoupled from longevity by postreproductive survival, while chimpanzees forfeit higher potential lifetime fertility due to adult mortality attrition. Infant survival is often lower among humans, but lost fitness is recouped via short birth spacing and high peak fertility, thereby reducing selection on infant survival. Lastly, longevity and delayed maturity reduce selection on child survival, but among humans, recruitment selection is unexpectedly highest in longer-lived populations, which are also faster-growing due to high fertility. Conclusion Humans differ from chimpanzees more because of delayed maturity and lower adult mortality than from differences in juvenile mortality or fertility. In both species, high child mortality reflects bet-hedging costs of quality/quantity tradeoffs borne by offspring, with high and variable child mortality likely regulating human population growth over evolutionary history. Positive correlations between survival and fertility among human subsistence populations leads to selection pressures in human subsistence societies that differ from those in modern populations undergoing demographic transition.	[Davison, Raziel J.; Gurven, Michael D.] Univ Calif Santa Barbara, Dept Anthropol, Integrat Anthropol Sci, Santa Barbara, CA 93106 USA; [Davison, Raziel J.; Gurven, Michael D.] Univ Calif Santa Barbara, Broom Ctr Demog, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Davison, RJ (corresponding author), Univ Calif Santa Barbara, Dept Anthropol, Integrat Anthropol Sci, Santa Barbara, CA 93106 USA.; Davison, RJ (corresponding author), Univ Calif Santa Barbara, Broom Ctr Demog, Santa Barbara, CA 93106 USA.	razieldavison@gmail.com						Benton TG, 1999, TRENDS ECOL EVOL, V14, P467, DOI 10.1016/S0169-5347(99)01724-3; Bronikowski AM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.6; Burger O, 2012, P NATL ACAD SCI USA, V109, P18210, DOI 10.1073/pnas.1215627109; Caswell H, 2000, ECOLOGY, V81, P619, DOI 10.2307/177364; CASWELL H, 1989, ECOL MODEL, V46, P221, DOI 10.1016/0304-3800(89)90019-7; Caswell H., 2001, CONSTRUCTION ANAL IN, V585, P258; Cervellati M, 2011, J ECON GROWTH, V16, P99, DOI 10.1007/s10887-011-9065-2; CHARLESWORTH B, 1990, EVOLUTION, V44, P520, DOI 10.1111/j.1558-5646.1990.tb05936.x; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; Coale AJ, 1989, SOCIAL ECONOMICS, P16; Crone EE, 2001, EVOLUTION, V55, P2611; Duda P, 2013, J HUM EVOL, V65, P424, DOI 10.1016/j.jhevol.2013.07.009; DYKE B, 1995, AM J PRIMATOL, V37, P25, DOI 10.1002/ajp.1350370104; Ellis S, 2018, ECOL EVOL, V8, P2482, DOI 10.1002/ece3.3856; GAGE TB, 1989, YEARB PHYS ANTHROPOL, V32, P185; Gagnon A, 2009, AM J HUM BIOL, V21, P533, DOI 10.1002/ajhb.20893; Gillespie DOS, 2008, P ROY SOC B-BIOL SCI, V275, P713, DOI 10.1098/rspb.2007.1000; Gurven MD., 2017, CHIMPANZEES HUMAN EV, P181, DOI 10.4159/9780674982642-005; Gurven M, 2007, POPUL DEV REV, V33, P321, DOI 10.1111/j.1728-4457.2007.00171.x; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Gurven MD, 2019, P NATL ACAD SCI USA, V116, P12758, DOI 10.1073/pnas.1902406116; HARPENDING H, 1994, AM J PHYS ANTHROPOL, V93, P385, DOI 10.1002/ajpa.1330930310; Hawkes Kristen, 2003, P204; Hawkes K, 2009, AM J HUM BIOL, V21, P578, DOI 10.1002/ajhb.20890; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Horvitz C., 1997, STRUCTURED POPULATIO, P247, DOI DOI 10.1007/978-1-4615-5973-3; Jakalaniemi A, 2013, EVOL ECOL, V27, P533, DOI 10.1007/s10682-012-9606-y; Johnson HE, 2010, ECOL APPL, V20, P1753, DOI 10.1890/09-1107.1; Jones JH, 2015, P NATL ACAD SCI USA, V112, P8982, DOI 10.1073/pnas.1422037112; Jones JH, 2011, CURR BIOL, V21, pR708, DOI 10.1016/j.cub.2011.08.025; Jones JH, 2009, EVOL HUM BEHAV, V30, P305, DOI 10.1016/j.evolhumbehav.2009.01.005; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kaplan H., 2015, POPULATION HUMAN SCI, P361; Kaplan H, 2010, ANN NY ACAD SCI, V1204, P30, DOI [10.1111/J.1749-6632.2010.05528.x, 10.1111/j.1749-6632.2010.05528.x]; Kelly RL., 2013, LIFEWAYS HUNTERGATHE; Keyfitz N., 1990, WORLD POPULATION GRO, DOI [10.1080/08898489009525297, DOI 10.1080/08898489009525297]; Knott C, 2001, FOUND HUM B, P429; Kramer KL, 2010, ANNU REV ANTHROPOL, V39, P417, DOI 10.1146/annurev.anthro.012809.105054; LANDE R, 1982, ECOLOGY, V63, P607, DOI 10.2307/1936778; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Lawson DW, 2012, P ROY SOC B-BIOL SCI, V279, P4755, DOI 10.1098/rspb.2012.1635; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Littleton J, 2005, AM J PRIMATOL, V67, P281, DOI 10.1002/ajp.20185; Marsden SB, 2006, INT J PRIMATOL, V27, P391, DOI 10.1007/s10764-006-9029-0; Miller IF, 2019, J HUM EVOL, V130, P36, DOI 10.1016/j.jhevol.2018.12.007; Mills LS, 1999, CONSERV BIOL, V13, P815, DOI 10.1046/j.1523-1739.1999.98232.x; Mitani JC, 2010, CURR BIOL, V20, pR507, DOI 10.1016/j.cub.2010.04.021; Morris WF, 2011, AM NAT, V177, pE14, DOI 10.1086/657443; Muller MN, 2014, J HUM EVOL, V66, P107, DOI 10.1016/j.jhevol.2013.10.004; Pavard S, 2007, EVOLUTION, V61, P2801, DOI 10.1111/j.1558-5646.2007.00236.x; Pavard S, 2012, THEOR POPUL BIOL, V82, P364, DOI 10.1016/j.tpb.2012.01.007; Pereira PM., 2003, PRIMATE LIFE HIST SO; Pfister CA, 1998, P NATL ACAD SCI USA, V95, P213, DOI 10.1073/pnas.95.1.213; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Ross C, 1998, EVOL ANTHROPOL, V6, P54, DOI 10.1002/(SICI)1520-6505(1998)6:2<54::AID-EVAN3>3.3.CO;2-D; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; SILER W, 1979, ECOLOGY, V60, P750, DOI 10.2307/1936612; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; SLATKIN M, 1974, NATURE, V250, P704, DOI 10.1038/250704b0; SOLWAY JS, 1992, CURR ANTHROPOL, V33, P187, DOI 10.1086/204024; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Strier KB, 2017, AM J PHYS ANTHROPOL, V162, P4, DOI 10.1002/ajpa.23143; Tabatabaie V, 2011, AGING-US, V3, P1202, DOI 10.18632/aging.100415; Thompson ME, 2007, CURR BIOL, V17, P2150, DOI 10.1016/j.cub.2007.11.033; Thompson ME, 2016, P NATL ACAD SCI USA, V113, P7780, DOI 10.1073/pnas.1522168113; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; VANGROENENDAEL J, 1994, ECOLOGY, V75, P2410, DOI 10.2307/1940894; Walker KK, 2018, J HUM EVOL, V114, P131, DOI 10.1016/j.jhevol.2017.10.010; Wisdom MJ, 1997, J WILDLIFE MANAGE, V61, P302, DOI 10.2307/3802585; Wood BM, 2017, J HUM EVOL, V105, P41, DOI 10.1016/j.jhevol.2017.01.003; Wrangham R. W., 2001, TREE ORIGIN WHAT PRI, P121; Zuidema PA, 2007, ECOL APPL, V17, P118, DOI 10.1890/1051-0761(2007)017[0118:TSBPAR]2.0.CO;2	76	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0239170	10.1371/journal.pone.0239170	http://dx.doi.org/10.1371/journal.pone.0239170			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QO3ZL	33617556	Green Published, Green Submitted, gold			2022-12-26	WOS:000623082400023
J	Kolter, JF; Hildenbrand, MF; Popp, S; Nauroth, S; Bankmann, J; Rother, L; Waider, J; Deckert, J; Asan, E; Jakob, PM; Lesch, KP; Schmitt-Bohrer, A				Kolter, Jann F.; Hildenbrand, Markus F.; Popp, Sandy; Nauroth, Stephan; Bankmann, Julian; Rother, Lisa; Waider, Jonas; Deckert, Juergen; Asan, Esther; Jakob, Peter M.; Lesch, Klaus-Peter; Schmitt-Boehrer, Angelika			Serotonin transporter genotype modulates resting state and predator stress-induced amygdala perfusion in mice in a sex-dependent manner	PLOS ONE			English	Article								The serotonin transporter (5-HTT) is a key molecule of serotoninergic neurotransmission and target of many anxiolytics and antidepressants. In humans, 5-HTT gene variants resulting in lower expression levels are associated with behavioral traits of anxiety. Furthermore, functional magnetic resonance imaging (fMRI) studies reported increased cerebral blood flow (CBF) during resting state (RS) and amygdala hyperreactivity. 5-HTT deficient mice as an established animal model for anxiety disorders seem to be well suited for investigating amygdala (re-)activity in an fMRI study. We investigated wildtype (5-HTT+/+), heterozygous (5-HTT+/-), and homozygous 5-HTT-knockout mice (5-HTT-/-) of both sexes in an ultra-high-field 17.6 Tesla magnetic resonance scanner. CBF was measured with continuous arterial spin labeling during RS, stimulation state (SS; with odor of rats as aversive stimulus), and post-stimulation state (PS). Subsequently, post mortem c-Fos immunohistochemistry elucidated neural activation on cellular level. The results showed that in reaction to the aversive odor CBF in total brain and amygdala of all mice significantly increased. In male 5-HTT+/+ mice amygdala RS CBF levels were found to be significantly lower than in 5-HTT+/- mice. From RS to SS 5-HTT+/+ amygdala perfusion significantly increased compared to both 5-HTT+/- and 5-HTT-/- mice. Perfusion level changes of male mice correlated with the density of c-Fos-immunoreactive cells in the amygdaloid nuclei. In female mice the perfusion was not modulated by the 5-Htt-genotype, but by estrous cycle stages. We conclude that amygdala reactivity is modulated by the 5-Htt genotype in males. In females, gonadal hormones have an impact which might have obscured genotype effects. Furthermore, our results demonstrate experimental support for the tonic model of 5-HTTLPR function.	[Kolter, Jann F.; Bankmann, Julian; Rother, Lisa; Deckert, Juergen; Schmitt-Boehrer, Angelika] Univ Wurzburg, Ctr Mental Hlth, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Kolter, Jann F.; Popp, Sandy; Nauroth, Stephan; Waider, Jonas; Lesch, Klaus-Peter] Univ Wurzburg, Ctr Mental Hlth, Div Mol Psychiat, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Hildenbrand, Markus F.] Fraunhofer Dev Ctr Xray Technol, Dept Magnet Resonance & Xray Imaging, Wurzburg, Germany; [Asan, Esther] Univ Wurzburg, Inst Anat & Cell Biol, Wurzburg, Germany; [Jakob, Peter M.] Univ Wurzburg, Dept Expt Phys 5, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Schmitt-Bohrer, A (corresponding author), Univ Wurzburg, Ctr Mental Hlth, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany.	Schmitt_A3@ukw.de	Lesch, Klaus-Peter/J-4906-2013	Lesch, Klaus-Peter/0000-0001-8348-153X	German Research Foundation (DFG) [44541416]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by the German Research Foundation (DFG; https://www.dfg.de/), grant number 44541416: Collaborative Research Centre/Transregio 58 (CRC-TRR58), subproject A1 to KPL and subproject A5 to KPL and ASB. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrams JK, 2004, ANN NY ACAD SCI, V1018, P46, DOI 10.1196/annals.1296.005; Adamec R, 2006, BEHAV BRAIN RES, V170, P126, DOI 10.1016/j.bbr.2006.02.012; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Asan E, 2013, HISTOCHEM CELL BIOL, V139, P785, DOI 10.1007/s00418-013-1081-1; Asok A, 2013, BEHAV BRAIN RES, V248, P85, DOI 10.1016/j.bbr.2013.03.047; Banik A, 2011, BEHAV BRAIN RES, V216, P466, DOI 10.1016/j.bbr.2010.07.035; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Bergan JF, 2014, ELIFE, V3, DOI 10.7554/eLife.02743; Bodden C, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00047; Boll S, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00255; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Brockmann H, 2011, J PSYCHIATR RES, V45, P442, DOI 10.1016/j.jpsychires.2010.08.016; Campos KFC, 2013, BEHAV BRAIN RES, V240, P160, DOI 10.1016/j.bbr.2012.11.023; Calvo-Torrent A, 1999, PHYSIOL BEHAV, V67, P189, DOI 10.1016/S0031-9384(99)00051-7; Canli T, 2005, P NATL ACAD SCI USA, V102, P12224, DOI 10.1073/pnas.0503880102; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Canli T, 2006, P NATL ACAD SCI USA, V103, P16033, DOI 10.1073/pnas.0601674103; Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9; Chen W, 2009, BEHAV BRAIN RES, V201, P8, DOI 10.1016/j.bbr.2009.01.019; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Detre JA, 1999, EUR J RADIOL, V30, P115, DOI 10.1016/S0720-048X(99)00050-9; Dewan A, 2013, NATURE, V497, P486, DOI 10.1038/nature12114; Dogra N., 2017, PSYCHIAT 10 TEACHERS, VSecond, DOI [10.1201/9781315380612, DOI 10.1201/9781315380612]; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Duchesne A, 2009, PROG NEURO-PSYCHOPH, V33, P251, DOI 10.1016/j.pnpbp.2008.11.012; Fabre V, 2000, EUR J NEUROSCI, V12, P2299, DOI 10.1046/j.1460-9568.2000.00126.x; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; Gobbi G, 2001, J PHARMACOL EXP THER, V296, P987; Halberstadt AL, 2006, NEUROSCIENCE, V140, P1067, DOI 10.1016/j.neuroscience.2006.02.053; Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Heiming RS, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00187; Heinz A, 2007, BIOL PSYCHIAT, V61, P1011, DOI 10.1016/j.biopsych.2006.08.019; Hennig J, 2003, J MAGN RESON IMAGING, V18, P1, DOI 10.1002/jmri.10330; Hildebrandt A, 2016, GENES BRAIN BEHAV, V15, P453, DOI 10.1111/gbb.12295; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P2077, DOI 10.1038/sj.npp.1300266; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; Homberg JR, 2016, NEUROSCI BIOBEHAV R, V71, P472, DOI 10.1016/j.neubiorev.2016.09.029; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Huo Y, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00116; JACOBS BL, 1978, BRAIN RES, V147, P149, DOI 10.1016/0006-8993(78)90779-5; Johansen JP, 2010, NAT NEUROSCI, V13, P979, DOI 10.1038/nn.2594; Karabeg MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078238; Kass MD, 2013, SCIENCE, V342, P1389, DOI 10.1126/science.1244916; Keshavarzi S, 2015, J NEUROSCI, V35, P13020, DOI 10.1523/JNEUROSCI.0627-15.2015; Koizumi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059074; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Kugaya A, 2003, NEUROPSYCHOPHARMACOL, V28, P413, DOI 10.1038/sj.npp.1300036; Lesch KP, 2005, PROG NEURO-PSYCHOPH, V29, P1062, DOI 10.1016/j.pnpbp.2005.03.012; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li Q, 2003, J NEUROCHEM, V84, P1256, DOI 10.1046/j.1471-4159.2003.01607.x; Li Y, 2018, CURR OPIN NEUROBIOL, V53, P120, DOI 10.1016/j.conb.2018.07.005; Liu YJ, 2017, CHEM SENSES, V42, P247, DOI 10.1093/chemse/bjw164; Maeng LY, 2015, JOVE-J VIS EXP, DOI 10.3791/52202; Mathews TA, 2004, J NEUROSCI METH, V140, P169, DOI 10.1016/j.jneumeth.2004.05.017; MCDONALD AJ, 1982, J COMP NEUROL, V212, P293, DOI 10.1002/cne.902120307; McLean AC, 2012, JOVE-J VIS EXP, DOI 10.3791/4389; Milad MR, 2009, NEUROSCIENCE, V164, P887, DOI 10.1016/j.neuroscience.2009.09.011; Mitsushima D, 2006, EUR J NEUROSCI, V24, P3245, DOI 10.1111/j.1460-9568.2006.05214.x; MOLINA V, 1987, PHARMACOL BIOCHEM BE, V27, P123, DOI 10.1016/0091-3057(87)90486-2; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Muzerelle A, 2016, BRAIN STRUCT FUNCT, V221, P535, DOI 10.1007/s00429-014-0924-4; Nietzer SL, 2011, BEHAV BRAIN RES, V220, P42, DOI 10.1016/j.bbr.2011.01.011; Olivier JDA, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00074; Periaswamy S, 2006, MED IMAGE ANAL, V10, P452, DOI 10.1016/j.media.2005.03.006; Periaswamy S, 2003, LECT NOTES COMPUT SC, V2717, P102; Pham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018386; Pham Mirko, 2010, Exp Transl Stroke Med, V2, P6, DOI 10.1186/2040-7378-2-6; Rao HY, 2007, BIOL PSYCHIAT, V62, P600, DOI 10.1016/j.biopsych.2006.11.028; Robins MT, 2020, NEUROSCIENCE, V431, P143, DOI 10.1016/j.neuroscience.2020.02.006; Root CM, 2014, NATURE, V515, P269, DOI 10.1038/nature13897; Ross JM., 2017, OLFACTORY FEAR CONDI, DOI [10.1101/194415, DOI 10.1101/194415]; SCHWARTZ WJ, 1979, SCIENCE, V205, P723, DOI 10.1126/science.462184; Shen HW, 2004, NEUROPSYCHOPHARMACOL, V29, P1790, DOI 10.1038/sj.npp.1300476; Sotnikov SV, 2014, EUR J NEUROSCI, V40, P2691, DOI 10.1111/ejn.12624; Staiger JF, 2002, NEUROSCIENCE, V109, P687, DOI 10.1016/S0306-4522(01)00501-2; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P274, DOI 10.1016/j.conb.2010.02.013; Thompson JA, 2012, J COMP NEUROL, V520, P1819, DOI 10.1002/cne.23015; Tovote P, 2016, NATURE, V534, P206, DOI 10.1038/nature17996; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Velasquez F, 2017, DEV COGN NEUROS-NETH, V24, P12, DOI 10.1016/j.dcn.2016.12.002; Vertes RP, 1999, J COMP NEUROL, V407, P555; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; Viviani R, 2010, BIOL PSYCHIAT, V67, P317, DOI 10.1016/j.biopsych.2009.08.035; von dem Hagen EAH, 2011, NEUROPSYCHOLOGIA, V49, P674, DOI 10.1016/j.neuropsychologia.2010.12.013; Walf AA, 2009, BEHAV BRAIN RES, V196, P254, DOI 10.1016/j.bbr.2008.09.016; Watson C., 2012, PAXINOS FRANKLINS MO; Weera MM, 2020, NEUROPHARMACOLOGY, V166, DOI 10.1016/j.neuropharm.2020.107979; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wong EC, 1998, MAGNET RESON MED, V40, P348, DOI 10.1002/mrm.1910400303; Yang M, 2004, PHYSIOL BEHAV, V81, P465, DOI 10.1016/j.physbeh.2004.02.010; Yokoyama M, 2005, NEUROSCI LETT, V379, P37, DOI 10.1016/j.neulet.2004.12.047; Zanoveli JM, 2009, BRAIN RES, V1294, P106, DOI 10.1016/j.brainres.2009.07.074; Zhang L, 1999, NEUROSCIENCE, V94, P251, DOI 10.1016/S0306-4522(99)00234-1	99	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247311	10.1371/journal.pone.0247311	http://dx.doi.org/10.1371/journal.pone.0247311			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606835	Green Published, gold			2022-12-26	WOS:000620629200123
J	Rehman, N; Varghese, J				Rehman, Niyas; Varghese, Jishy			Larval nutrition influences adult fat stores and starvation resistance in Drosophila	PLOS ONE			English	Article								Insulin plays a major role in connecting nutrient availability to energy homeostasis by regulating metabolic pathways. Defects in insulin signalling is the primary cause for diabetes, obesity and various metabolic disorders. Nutritional status during growth and developmental stages play a crucial role in determining adult size, fecundity and ageing. However, the association between developmental nutrition and adult metabolic disorders has not been fully explored. Here, we address the effects of nutrient status during the larval growth phase on adult metabolism in Drosophila. We report that restricted food supply in larvae led to higher fat reserves and starvation resistance in mature adult flies, which we attribute to low insulin signalling. A lesser amount of stored fat was mobilised during early adult stages and during acute starvation, which accounts for the metabolic effects. Furthermore, larval diet influenced the expression of fat mobilisation genes brummer and lipid storage droplet-2 in adult flies, which led to the metabolic phenotypes reported here. Thus, the restricted nutrient environment in developing larvae led to adaptive changes that entrain the adult flies for scarce food availability.	[Rehman, Niyas; Varghese, Jishy] Indian Inst Sci Educ & Res IISER TVM, Sch Biol, Thiruvananthapuram, Kerala, India	Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram	Varghese, J (corresponding author), Indian Inst Sci Educ & Res IISER TVM, Sch Biol, Thiruvananthapuram, Kerala, India.	jishy@iisertvm.ac.in			Science and Engineering Research Board, Department of Science and Technology, Ministry of Science and Technology, India [EMR/2016/004978]; Department of Science and Technology, Ministry of Science and Technology, India [SR/S2/RJN-140/2011]	Science and Engineering Research Board, Department of Science and Technology, Ministry of Science and Technology, India; Department of Science and Technology, Ministry of Science and Technology, India(Department of Science & Technology (India))	This work was supported by a grant from the Science and Engineering Research Board, Department of Science and Technology, Ministry of Science and Technology, India (EMR/2016/004978) awarded to JV and a grant from the Department of Science and Technology, Ministry of Science and Technology, India (SR/S2/RJN-140/2011 Ramanujan Fellowship) awarded to JV. http://www.serb.gov.in/http://www.serb.gov.in/rnf.php.	Aguila JR, 2007, J EXP BIOL, V210, P956, DOI 10.1242/jeb.001586; Aguila JR, 2013, J EXP BIOL, V216, P399, DOI 10.1242/jeb.078311; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bi JF, 2012, J CELL SCI, V125, P3568, DOI 10.1242/jcs.101329; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Botchlett R, 2017, J ENDOCRINOL, V233, pR145, DOI 10.1530/JOE-16-0580; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Chapman T, 1996, NATURE, V381, P189, DOI 10.1038/381189a0; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Fauny JD, 2005, DEV DYNAM, V232, P725, DOI 10.1002/dvdy.20277; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Haselton A, 2010, CELL CYCLE, V9, P3063, DOI 10.4161/cc.9.15.12458; HAYWOOD S, 1992, P ROY SOC B-BIOL SCI, V249, P195, DOI 10.1098/rspb.1992.0103; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Hodin J, 2000, DEV GENES EVOL, V210, P358, DOI 10.1007/s004270000079; Hong SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002857; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Kannan K, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00288; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kuhnlein RP, 2012, J LIPID RES, V53, P1430, DOI 10.1194/jlr.R024299; LEPESANT J-A, 1982, Journal of Molecular and Applied Genetics, V1, P371; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loeb J, 1917, J BIOL CHEM, V32, P103; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Lumey L H, 1993, Paediatr Perinat Epidemiol, V7, P354, DOI 10.1111/j.1365-3016.1993.tb00415.x; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063; May CM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3968-z; May CM, 2015, ECOL EVOL, V5, P1156, DOI 10.1002/ece3.1389; Merila J, 1997, J AVIAN BIOL, V28, P279, DOI 10.2307/3676940; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Moustafa JSES, 2013, NAT REV ENDOCRINOL, V9, P402, DOI 10.1038/nrendo.2013.57; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Nassel DR, 2015, GEN COMP ENDOCR, V221, P255, DOI 10.1016/j.ygcen.2014.11.021; Nassel DR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00252; Nelliot A, 2006, GENESIS, V44, P396, DOI 10.1002/dvg.20229; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Park S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004555; Pletcher SD, 2005, AGEING RES REV, V4, P451, DOI 10.1016/j.arr.2005.06.007; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Richard D, 2015, NAT REV ENDOCRINOL, V11, P489, DOI 10.1038/nrendo.2015.103; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Stein AD, 2000, HUM BIOL, V72, P641; Sudhakar SR, 2020, DEV BIOL, V459, P87, DOI 10.1016/j.ydbio.2019.11.013; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Teixeira L, 2003, MECH DEVELOP, V120, P1071, DOI 10.1016/S0925-4773(03)00158-8; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Tu MP, 2003, AGING CELL, V2, P327, DOI 10.1046/j.1474-9728.2003.00064.x; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Varghese J, 2010, GENE DEV, V24, P2748, DOI 10.1101/gad.1995910; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Wilcox Gisela, 2005, Clin Biochem Rev, V26, P19; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wong RHF, 2010, CURR OPIN PHARMACOL, V10, P684, DOI 10.1016/j.coph.2010.08.004; Woods SC, 2009, CELL METAB, V9, P489, DOI 10.1016/j.cmet.2009.04.007; Xu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002478; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106	84	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247175	10.1371/journal.pone.0247175	http://dx.doi.org/10.1371/journal.pone.0247175			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606785	gold, Green Published			2022-12-26	WOS:000620629200070
J	Blanco, JF; da Casa, C; Pablos-Hernandez, C; Gonzalez-Ramirez, A; Julian-Enriquez, JM; Diaz-Alvarez, A				Blanco, Juan F.; da Casa, Carmen; Pablos-Hernandez, Carmen; Gonzalez-Ramirez, Alfonso; Miguel Julian-Enriquez, Jose; Diaz-Alvarez, Agustin			30-day mortality after hip fracture surgery: Influence of postoperative factors	PLOS ONE			English	Article								Purpose The 30-day mortality rate after hip fracture surgery has been considered as an indirect indicator of the quality of care. The aim of this work is to analyse preoperative and postoperative factors potentially related to early 30-day mortality in patients over 65 undergoing hip fracture surgery. Methods Prospective cohort study including all consecutive primary hip fracture patients over 65 admitted to Trauma and Orthopaedics department from January 1, 2018 to December 31, 2019. Bed-ridden, non- surgically treated patients, and high energy trauma or tumoral aetiology fractures were excluded. A total of 943 patients were eligible (attrition rate: 2.1%). Follow-up included 30-days after discharge. We noted the 30-day mortality after hip fracture surgery, analysing 130 potentially related variables including biodemographic, fracture-related, preoperative, and postoperative clinical factors. Qualitative variables were assessed by chi(2), and quantitative variables by non-parametric tests. Odds ratio determined by binary logistic regression. We selected preventable candidate variables for multivariate risk assessment by logistic regression. Results A total of 923 patients were enrolled (mean age 86.22 +/- 6.8, 72.9% women). The 30-day mortality rate was 6.0%. We noted significant increased mortality on men (OR = 2.381[1.371-4.136], p = 0.002), ageing patients (ORyear = 1.073[1.025-1.122], p = 0.002), and longer time to surgery (ORday = 1.183[1.039-1146], p<0.001), on other 20 preoperative clinical variables, like lymphopenia (lymphocyte count <10(3)/mu l, OR = 1.842[1.063-3.191], p = 0.029), hypoalbuminemia (<= 3.5g/dl, OR = 2.474[1.316-4.643], p = 0.005), and oral anticoagulant intake (OR = 2.499[1.415-4.415], p = 0.002), and on 25 postoperative clinical variables, like arrhythmia (OR = 13.937[6.263-31.017], p<0.001), respiratory insufficiency (OR = 7.002[3.947-12.419], p<0.001), hyperkalaemia (OR = 10.378[3.909-27.555], p<0.001), nutritional supply requirement (OR = 3.576[1.894-6.752], p = 0.021), or early arthroplasty dislocation (OR = 6.557[1.206-35.640], p = 0.029). We developed a predictive model for early mortality after hip fracture surgery based on postoperative factors with 96.0% sensitivity and 60.7% specificity (AUC = 0.863). Conclusion We revealed that not only preoperative, but also postoperative factors have a great impact after hip fracture surgery. The influence of post-operative factors on 30-day mortality has a logical basis, albeit so far they have not been identified or quantified before. Our results provide an advantageous picture of the 30-day mortality after hip fracture surgery.	[Blanco, Juan F.; Miguel Julian-Enriquez, Jose] Univ Hosp Salamanca, Trauma & Orthopaed Dept, Salamanca, Spain; [Blanco, Juan F.; da Casa, Carmen; Pablos-Hernandez, Carmen; Gonzalez-Ramirez, Alfonso; Miguel Julian-Enriquez, Jose; Diaz-Alvarez, Agustin] Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain; [Pablos-Hernandez, Carmen; Gonzalez-Ramirez, Alfonso] Univ Hosp Salamanca, Orthogeriatr Unit, Salamanca, Spain; [Diaz-Alvarez, Agustin] Univ Hosp Salamanca, Anaesthesiol Dept, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	da Casa, C (corresponding author), Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain.	cdacasap@saludcastillayleon.es	Diaz-Alvarez, Agustin/L-9999-2019; Blanco, Juan F/AAI-5787-2021	Diaz-Alvarez, Agustin/0000-0002-6229-8311; Blanco, Juan F/0000-0001-7803-9149; Pablos Hernandez, Maria del Carmen/0000-0001-5083-6971				Beaupre LA, 2019, INJURY, V50, P950, DOI 10.1016/j.injury.2019.03.031; Bohl DD, 2017, J BONE JOINT SURG AM, V99, P2110, DOI 10.2106/JBJS.16.01620; Durand WM, 2018, INJURY, V49, P1141, DOI 10.1016/j.injury.2018.03.019; Empana JP, 2004, J AM GERIATR SOC, V52, P685, DOI 10.1111/j.1532-5415.2004.52203.x; Farahmand BY, 2005, OSTEOPOROSIS INT, V16, P1583, DOI 10.1007/s00198-005-2024-z; Forni C, 2019, INT ORTHOP, V43, P275, DOI 10.1007/s00264-018-4057-x; Giannoudis V, 2016, INJURY, V47, P2385, DOI 10.1016/j.injury.2016.10.007; Gill JR, 2018, BONE JOINT J, V100B, P1618, DOI 10.1302/0301-620X.100B12.BJJ-2018-0281.R1; Gronskag AB, 2012, OSTEOPOROSIS INT, V23, P1807, DOI 10.1007/s00198-011-1811-y; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hansson S, 2020, ACTA ORTHOP, V91, P133, DOI 10.1080/17453674.2019.1690339; Hu FK, 2012, INJURY, V43, P676, DOI 10.1016/j.injury.2011.05.017; Iosifidis M, 2016, J ORTHOP SCI, V21, P48, DOI 10.1016/j.jos.2015.09.009; Jones Carl, 2017, Open Orthop J, V11, P1200, DOI 10.2174/1874325001711011200; Kanis JA, 2003, BONE, V32, P468, DOI 10.1016/S8756-3282(03)00061-9; Karres J, 2015, INJURY, V46, P371, DOI 10.1016/j.injury.2014.11.004; Katsoulis M, 2017, J INTERN MED, V281, P300, DOI 10.1111/joim.12586; Khan MA, 2013, INT ORTHOP, V37, P2119, DOI 10.1007/s00264-013-2068-1; Khan SK, 2009, INJURY, V40, P692, DOI 10.1016/j.injury.2009.01.010; Kishimoto Y, 2020, J ARTHROPLASTY, V35, P3237, DOI 10.1016/j.arth.2020.05.064; Kristensen PK, 2016, AGE AGEING, V45, P66, DOI 10.1093/ageing/afv155; Lawrence JE, 2017, CLIN ORTHOP RELAT R, V475, P273, DOI 10.1007/s11999-016-5056-0; Lee R, 2019, EUR J ORTHOP SURG TR, V29, P1253, DOI 10.1007/s00590-019-02438-y; Lewis PM, 2016, BONE JOINT J, V98B, P1573, DOI 10.1302/0301-620X.98B12.BJJ-2016-0362.R2; Liu Y, 2018, AGING CLIN EXP RES, V30, P323, DOI 10.1007/s40520-017-0789-5; Lopez S, 2020, EUR GERIATR MED, V11, P555, DOI 10.1007/s41999-020-00293-3; Maxwell BG, 2020, JAMA SURG, V155, P167, DOI 10.1001/jamasurg.2019.4471; Menendez-Colino R, 2018, INJURY, V49, P656, DOI 10.1016/j.injury.2018.01.003; Mosk Christina A, 2017, Clin Interv Aging, V12, P421, DOI 10.2147/CIA.S115945; Nijmeijer WS, 2016, INJURY, V47, P2138, DOI 10.1016/j.injury.2016.07.022; Nikkel LE, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6246; Novoa-Parra C D, 2019, Rev Esp Cir Ortop Traumatol (Engl Ed), V63, P202, DOI 10.1016/j.recot.2018.10.007; Ojeda-Thies C, 2019, OSTEOPOROSIS INT, V30, P1243, DOI 10.1007/s00198-019-04939-2; Pincus D, 2017, JAMA-J AM MED ASSOC, V318, P1994, DOI 10.1001/jama.2017.17606; Richmond J, 2003, J ORTHOP TRAUMA, V17, P53, DOI 10.1097/00005131-200301000-00008; Rutenberg TF, 2018, THROMB RES, V166, P106, DOI 10.1016/j.thromres.2018.04.022; Salem KMI, 2014, ANN ROY COLL SURG, V96, P446, DOI 10.1308/003588414X13946184903045; Sheikh HQ, 2017, CLIN ORTHOP SURG, V9, P10, DOI 10.4055/cios.2017.9.1.10; Smith T, 2014, AGE AGEING, V43, P464, DOI 10.1093/ageing/afu065; van de Ree CLP, 2020, HIP INT, V30, P354, DOI 10.1177/1120700019836962; Wilson JM, 2019, J ORTHOP TRAUMA, V33, P284, DOI 10.1097/BOT.0000000000001448; Yong EL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19706	42	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246963	10.1371/journal.pone.0246963	http://dx.doi.org/10.1371/journal.pone.0246963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592047	gold, Green Published			2022-12-26	WOS:000620632800078
J	Enria, L; Waterlow, N; Rogers, NT; Brindle, H; Lal, S; Eggo, RM; Lees, S; Roberts, CH				Enria, Luisa; Waterlow, Naomi; Rogers, Nina Trivedy; Brindle, Hannah; Lal, Sham; Eggo, Rosalind M.; Lees, Shelley; Roberts, Chrissy h			Trust and transparency in times of crisis: Results from an online survey during the first wave (April 2020) of the COVID-19 epidemic in the UK	PLOS ONE			English	Article								Background The success of a government's COVID-19 control strategy relies on public trust and broad acceptance of response measures. We investigated public perceptions of the UK government's COVID-19 response, focusing on the relationship between trust and perceived transparency, during the first wave (April 2020) of the COVID-19 pandemic in the United Kingdom. Methods Anonymous survey data were collected (2020-04-06 to 2020-04-22) from 9,322 respondents, aged 20+ using an online questionnaire shared primarily through Facebook. We took an embedded-mixed-methods approach to data analysis. Missing data were imputed via multiple imputation. Binomial & multinomial logistic regression were used to detect associations between demographic characteristics and perceptions or opinions of the UK government's response to COVID-19. Structural topic modelling (STM), qualitative thematic coding of sub-sets of responses were then used to perform a thematic analysis of topics that were of interest to key demographic groups. Results Most respondents (95.1%) supported government enforcement of behaviour change. While 52.1% of respondents thought the government was making good decisions, differences were apparent across demographic groups, for example respondents from Scotland had lower odds of responding positively than respondents in London. Higher educational levels saw decreasing odds of having a positive opinion of the government response and decreasing household income associated with decreasing positive opinion. Of respondents who thought the government was not making good decisions 60% believed the economy was being prioritised over people and their health. Positive views on government decision-making were associated with positive views on government transparency about the COVID-19 response. Qualitative analysis about perceptions of government transparency highlighted five key themes: (1) the justification of opacity due to the condition of crisis, (2) generalised mistrust of politics, (3) concerns about the role of scientific evidence, (4) quality of government communication and (5) questions about political decision-making processes. Conclusion Our study suggests that trust is not homogenous across communities, and that generalised mistrust, concerns about the transparent use and communication of evidence and insights into decision-making processes can affect perceptions of the government's pandemic response. We recommend targeted community engagement, tailored to the experiences of different groups and a new focus on accountability and openness around how decisions are made in the response to the UK COVID-19 pandemic.	[Enria, Luisa; Lees, Shelley] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London, England; [Waterlow, Naomi; Eggo, Rosalind M.] London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, Dept Infect Dis Epidemiol, London, England; [Rogers, Nina Trivedy] UCL, Fac Med Sci, UCL Res Dept Epidemiol & Publ Hlth, London, England; [Brindle, Hannah; Lal, Sham; Roberts, Chrissy h] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Roberts, CH (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London, England.	chrissy.roberts@LSHTM.ac.uk		Rogers, Nina/0000-0003-1857-2122; Roberts, Chrissy h./0000-0003-1064-5980; Brindle, Hannah/0000-0003-1684-5801; Eggo, Rosalind M/0000-0002-0362-6717; Waterlow, Naomi R/0000-0002-9210-9657				Abramowitz S, 2017, ANNU REV ANTHROPOL, V46, P421, DOI 10.1146/annurev-anthro-102116-041616; Abrams D, 2018, BRIT J SOC PSYCHOL, V57, P310, DOI 10.1111/bjso.12233; Boland S, COVID 19 HAS FORCED; Cremers L., 2019, PEOPLE CTR EPIDEMIC, P1, DOI 10.1093/inthealth/ihw029 27620922; Creswell J.W., 2003, HDB MIXED METHODS SO, V209, P209, DOI DOI 10.4135/9781506335193; Depoux A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa031; Dhillon RS, 2015, NEW ENGL J MED, V373, P787, DOI 10.1056/NEJMp1508413; Dodd V., 2020, GUARDIAN 0603; Ellinas AA, 2014, COMP POLIT, V46, P231, DOI 10.5129/001041514809387342; Enria L, 2019, DEV CHANGE, V50, P1602, DOI 10.1111/dech.12538; Enria L, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3799-x; Ignatieff M, 2013, LESSER EVIL POLITICA; Kanwar V, 2006, ICON-INT J CONST LAW, V4, P567, DOI 10.1093/icon/mol023; Kirby T, 2020, LANCET RESP MED, V8, P547, DOI 10.1016/S2213-2600(20)30228-9; Lammy D., LAMMY REV INDEPENDEN; Larson HJ, 2010, JAMA-J AM MED ASSOC, V303, P271, DOI 10.1001/jama.2009.2023; Lau LS, 2020, NAT MED, V26, P647, DOI 10.1038/s41591-020-0851-2; Marcis F.L., 2019, J HUMANIT AFF, V1, P23, DOI 10.7227/JHA.014; Murtin Fabrice., 2018, TRUST ITS DETERMINAN, DOI [10.1016/j.compbiomed.2017.10.027, DOI 10.1016/J.COMPBIOMED.2017.10.027]; Phillips T., 2020, BSGWP2020032 U OXF B; Roberts ME, 2019, J STAT SOFTW, V91, P1, DOI 10.18637/jss.v091.i02; Roberts ME, 2014, AM J POLIT SCI, V58, P1064, DOI 10.1111/ajps.12103; Ryan MJ, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001272; Sanders D, 2014, ETHNIC RACIAL STUD, V37, P120, DOI 10.1080/01419870.2013.827795; Nguyen VK, 2019, NEW ENGL J MED, V380, P1298, DOI 10.1056/NEJMp1902682; Wilkinson A, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0305; Williamson E, 2020, MEDRXIV, V7, P1, DOI [10.1101/2020.05.06.20092999v1, 10.1101/2020.05.06.20092999]	27	28	28	17	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0239247	10.1371/journal.pone.0239247	http://dx.doi.org/10.1371/journal.pone.0239247			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8MA	33591985	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000620632800059
J	Shukla, R; Ganeshani, M; Agarwal, M; Jangir, R; Kandel, G; Sankanagoudar, S; Srivastava, S				Shukla, Ravindra; Ganeshani, Mayank; Agarwal, Monica; Jangir, Rakesh; Kandel, Gaurav; Sankanagoudar, Shrimanjunath; Srivastava, Shival			Dehydroepiandrostenedione sulphate (DHEAS) levels predict high risk of rheumatoid arthritis (RA) in subclinical hypothyroidism	PLOS ONE			English	Article								Introduction The presence of rheumatism is well recognized in primary hypothyroidism. Dehydroepiandrstenedione sulphate (DHEAS) is associated with rheumatological diseases like rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). This study aims to explore relationship between joint pains and DHEAS levels in primary hypothyroidism. Methods Retrospective study of 78 subjects with subclinical hypothyroidism, with TSH within reference range. The joint pains were evaluated by European Union League against rheumatism (EULAR-CSA) score and compared with serum DHEAS, RA factor, Anti-TPO antibody, highly sensitive C-recative protein (hsCRP), vitamin D levels. Result DHEAS levels <43.6 mcg/dl significantly predicted clinical features of pre RA as assessed by EULAR CSA criteria with acceptable specificity (82%). EULAR CSA score is fairly valid in assessing imminent RA in primary hypothyroidism. Conclusion Lower DHEAS predicts clinical features of imminent RA in subjects with primary hypothyroidism. This is akin to low DHEAS seen in many rheumatological disease with possibly similar mechanism. Another possibility is low DHEAS alters hepato-hypothalamo pituitary adrenal axis in presense of cytokines and induces a hitherto unrecognized state of pre rheumatoid arthritis like syndrome. Future studies on primary hypothyroidism should focus on role of lower DHEAS levels in inducing symptoms of fatigue and joint pains.	[Shukla, Ravindra; Ganeshani, Mayank; Agarwal, Monica; Jangir, Rakesh; Kandel, Gaurav] AIIMS, Dept Endocrinol, Jodhpur, Rajasthan, India; [Ganeshani, Mayank] SMS, Dept Orthopaed, Jaipur, Rajasthan, India; [Jangir, Rakesh] BKMC, Dept Paediat, Bikaner, India; [Sankanagoudar, Shrimanjunath] AIIMS, Dept Biochem, Jodhpur, Rajasthan, India; [Srivastava, Shival] AIIMS, Dept Physiol, Jodhpur, Rajasthan, India	All India Institute of Medical Sciences (AIIMS) Jodhpur; SMS Medical College & Hospital; All India Institute of Medical Sciences (AIIMS) Jodhpur; All India Institute of Medical Sciences (AIIMS) Jodhpur	Shukla, R (corresponding author), AIIMS, Dept Endocrinol, Jodhpur, Rajasthan, India.	ravindrashukla2@rediffmail.com	Srivastav, Shival/AAG-4142-2020	Srivastav, Shival/0000-0002-5509-0635; shukla, ravindra/0000-0002-5742-4096; Sankanagoudar, Shrimanjunath/0000-0002-9497-9242				Chaigne B, 2017, QUAL LIFE RES, V26, P1767, DOI 10.1007/s11136-017-1534-4; Cicatiello AG, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00474; Cleare AJ, 1995, CLIN ENDOCRINOL, V43, P713, DOI 10.1111/j.1365-2265.1995.tb00540.x; Ding X, 2017, ONCOTARGET, V8, P16158, DOI 10.18632/oncotarget.15300; DiSilvestro D, 2014, HORM MOL BIOL CLIN I, V19, P39, DOI 10.1515/hmbci-2014-0019; Durcan L, 2016, J AUTOIMMUN, V74, P73, DOI 10.1016/j.jaut.2016.06.010; Emamifar A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008357; Ernestam S, 2007, J RHEUMATOL, V34, P1451; Hashizume M, 2011, ARTHRITIS, DOI 10.1155/2011/765624; Hennessey JV, 2018, INT J CLIN PRACT, V72, DOI 10.1111/ijcp.13062; Jonklaas J, 2014, THYROID, V24, P1670, DOI 10.1089/thy.2014.0028; Kadam Prashant, 2010, Int J Ayurveda Res, V1, P55, DOI 10.4103/0974-7788.59946; Kelderman-Bolk N, 2015, EUR J ENDOCRINOL, V173, P507, DOI 10.1530/EJE-15-0395; Lashkari Mahin, 2018, Electron Physician, V10, P6500, DOI 10.19082/6500; Lizcano F, 2011, ENDOCR J, V58, P137, DOI 10.1507/endocrj.K10E-369; ORENTREICH N, 1984, J CLIN ENDOCR METAB, V59, P551, DOI 10.1210/jcem-59-3-551; Porings AS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49743-4; Reddy VS, 2013, HORM METAB RES, V45, P754, DOI 10.1055/s-0033-1348262; Rutkowski K, 2014, DRUGS, V74, P1195, DOI 10.1007/s40265-014-0259-8; Sawalha Amr H, 2008, Curr Rheumatol Rep, V10, P286, DOI 10.1007/s11926-008-0046-1; Spies CM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4687; Stathatos N, 2012, CURR OPIN RHEUMATOL, V24, P70, DOI 10.1097/BOR.0b013e32834ddb27; Sternberg EM, 2007, J RHEUMATOL, V34, P1443; Tagawa N, 2000, CLIN CHEM, V46, P523; Tayde Parimal S, 2017, Indian J Endocrinol Metab, V21, P886, DOI 10.4103/ijem.IJEM_265_17; van Steenbergen HW, 2017, ANN RHEUM DIS, V76, P491, DOI 10.1136/annrheumdis-2016-209846; Vernerova L, 2018, CELL MOL NEUROBIOL, V38, P379, DOI 10.1007/s10571-017-0522-0; Weidler C, 2005, ARTHRITIS RHEUM-US, V52, P1721, DOI 10.1002/art.21112	28	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246195	10.1371/journal.pone.0246195	http://dx.doi.org/10.1371/journal.pone.0246195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592022	gold, Green Published			2022-12-26	WOS:000620632800039
J	Liu, CH; Chang, JTC; Lee, TH; Chang, PY; Chang, CH; Wu, HC; Chang, TY; Huang, KL; Lin, CY; Fan, KH; Chu, CL; Chang, YJ				Liu, Chi-Hung; Chang, Joseph Tung-Chieh; Lee, Tsong-Hai; Chang, Pi-Yueh; Chang, Chien-Hung; Wu, Hsiu-Chuan; Chang, Ting-Yu; Huang, Kuo-Lun; Lin, Chien-Yu; Fan, Kang-Hsing; Chu, Chan-Lin; Chang, Yeu-Jhy			Total plaque score helps to determine follow-up strategy for carotid artery stenosis progression in head and neck cancer patients after radiation therapy	PLOS ONE			English	Article								Background To identify predictors of carotid artery stenosis (CAS) progression in head and neck cancer (HNC) patients after radiation therapy (RT). Methods We included 217 stroke-naive HNC patients with mild carotid artery stenosis after RT in our hospital. These patients underwent annual carotid duplex ultrasound (CDU) studies to monitor CAS progression. CAS progression was defined as the presence of >= 50% stenosis of the internal/common carotid artery on follow-up CDU. We recorded total plaque score (TPS) and determined the cut-off TPS to predict CAS progression. We categorized patients into high (HP) and low plaque (LP) score groups based on their TPS at enrolment. We analyzed the cumulative events of CAS progression in the two groups. Results The TPS of the CDU study at enrolment was a significant predictor for CAS progression (adjusted odds ratio [aOR] = 1.69, p = 0.002). The cut-off TPS was 7 (area under the curve: 0.800), and a TPS >= 7 strongly predicted upcoming CAS progression (aOR = 41.106, p = 0.002). The HP group had a higher risk of CAS progression during follow-up (adjusted hazard ratio = 6.15; 95% confident interval: 2.29-16.53) in multivariable Cox analysis, and also a higher trend of upcoming ischemic stroke (HP vs. LP: 8.3% vs. 2.2%, p = 0.09). Conclusions HNC patients with a TPS >= 7 in any CDU study after RT are susceptible to CAS progression and should receive close monitoring within the following 2 years.	[Liu, Chi-Hung; Lee, Tsong-Hai; Chang, Chien-Hung; Wu, Hsiu-Chuan; Chang, Ting-Yu; Huang, Kuo-Lun; Chu, Chan-Lin; Chang, Yeu-Jhy] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Stroke Ctr, Taoyuan, Taiwan; [Liu, Chi-Hung; Lee, Tsong-Hai; Chang, Chien-Hung; Wu, Hsiu-Chuan; Chang, Ting-Yu; Huang, Kuo-Lun; Chu, Chan-Lin; Chang, Yeu-Jhy] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taoyuan, Taiwan; [Liu, Chi-Hung; Lee, Tsong-Hai; Chang, Chien-Hung; Wu, Hsiu-Chuan; Chang, Ting-Yu; Huang, Kuo-Lun; Chu, Chan-Lin; Chang, Yeu-Jhy] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chang, Joseph Tung-Chieh; Lin, Chien-Yu; Fan, Kang-Hsing] Chang Gung Med Fdn, Linkou Chang Gung Mem Hosp, Proton & Radiat Therapy Ctr, Dept Radiat Oncol, Taoyuan, Taiwan; [Chang, Joseph Tung-Chieh; Lin, Chien-Yu; Fan, Kang-Hsing] Chang Gung Mem Hosp, Taipei Chang Gung Head & Neck Oncol Grp, Linkou Med Ctr, Taoyuan, Taiwan; [Chang, Joseph Tung-Chieh; Lin, Chien-Yu; Fan, Kang-Hsing] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Chang, Pi-Yueh] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Lab Med, Taoyuan, Taiwan; [Chang, Pi-Yueh] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Lin, Chien-Yu] Chang Gung Univ, Particle Phys & Beam Delivery Core Lab, Inst Radiol Res, Chang Gung Mem Hosp, Taoyuan, Taiwan; [Chang, Yeu-Jhy] Chang Gung Med Educ Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chang, YJ (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Stroke Ctr, Taoyuan, Taiwan.; Chang, YJ (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taoyuan, Taiwan.; Chang, YJ (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Chang, YJ (corresponding author), Chang Gung Med Educ Res Ctr, Taoyuan, Taiwan.	yjc0601@cgmh.org.tw	Fan, K/GXH-3734-2022	Chang, Ting-Yu/0000-0003-4642-7352	Chang Gung Memorial Hospital [CMRPG381503, CMRPG3C0763, CMRPG3G0261, BMRPF99]; Ministry of Science and Technology [106-2511-S-182A-002 -MY2, 108-2314-B-182A-050-MY3, NMRPG3G6411-2, NMRPG3J6131-3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	Funding was provided by Chang Gung Memorial Hospital (grant number: CMRPG381503, CMRPG3C0763, CMRPG3G0261, BMRPF99) and the Ministry of Science and Technology (grant numbers: 106-2511-S-182A-002 -MY2, 108-2314-B-182A-050-MY3, NMRPG3G6411-2, and NMRPG3J6131-3).	Abayomi OK, 2004, ORAL ONCOL, V40, P872, DOI 10.1016/j.oraloncology.2003.12.005; Arthurs E, 2016, INT J RADIAT ONCOL, V96, P589, DOI 10.1016/j.ijrobp.2016.07.007; Borrego-Soto G, 2015, GENET MOL BIOL, V38, P420, DOI 10.1590/S1415-475738420150019; Cainzos-Achirica M, 2018, ATHEROSCLEROSIS, V278, P217, DOI 10.1016/j.atherosclerosis.2018.09.034; Carpenter DJ, 2018, ORAL ONCOL, V80, P9, DOI 10.1016/j.oraloncology.2018.02.021; Chang YJ, 2009, J VASC SURG, V50, P280, DOI 10.1016/j.jvs.2009.01.033; Cheng SWK, 1999, AM J SURG, V178, P323, DOI 10.1016/S0002-9610(99)00184-1; Chua MLK, 2016, LANCET, V387, P1012, DOI 10.1016/S0140-6736(15)00055-0; Du XJ, 2017, HEAD NECK-J SCI SPEC, V39, P492, DOI 10.1002/hed.24631; Gujral DM, 2014, CLIN ONCOL-UK, V26, P94, DOI 10.1016/j.clon.2013.10.002; Gujral DM, 2014, RADIOTHER ONCOL, V110, P31, DOI 10.1016/j.radonc.2013.08.009; Hedin U, 2019, J VASC SURG, V69, P944, DOI 10.1016/j.jvs.2018.10.051; Hoving S, 2011, RADIOTHER ONCOL, V101, P100, DOI 10.1016/j.radonc.2011.09.019; Hoving S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012874; Hsu CW, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6205158; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Liu CH, 2018, CURR NEUROVASC RES, V15, P18, DOI 10.2174/1567202615666180319150021; Liu CH, 2015, ANGIOLOGY, V66, P180, DOI 10.1177/0003319714522854; Maruhashi T, 2018, ATHEROSCLEROSIS, V278, P226, DOI 10.1016/j.atherosclerosis.2018.10.007; Murphy ES, 2015, J NEURO-ONCOL, V122, P421, DOI 10.1007/s11060-015-1732-2; Pereira EB, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-134; Plummer C, 2011, STROKE, V42, P2410, DOI 10.1161/STROKEAHA.111.615203; Rettig EM, 2015, SURG ONCOL CLIN N AM, V24, P379, DOI 10.1016/j.soc.2015.03.001; Song CF, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20170939; Tanaka A, 2018, INT J CARDIOL, V272, P308, DOI 10.1016/j.ijcard.2018.06.017; Trojanowski P, 2019, TRANSL ONCOL, V12, P1026, DOI 10.1016/j.tranon.2019.05.001; Tseng K Y, 1992, Zhonghua Yi Xue Za Zhi (Taipei), V50, P302; Wang HM, 2017, J FORMOS MED ASSOC, V116, P185, DOI 10.1016/j.jfma.2016.03.005; Wilbers J, 2014, RADIOTHER ONCOL, V113, P359, DOI 10.1016/j.radonc.2014.10.012; Wu L, 2018, EXP THER MED, V15, P3687, DOI 10.3892/etm.2018.5878; Yu SCH, 2014, STROKE, V45, P1402, DOI 10.1161/STROKEAHA.113.003995; Zou WNXY, 2013, STROKE, V44, P401, DOI 10.1161/STROKEAHA.112.674036	32	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246684	10.1371/journal.pone.0246684	http://dx.doi.org/10.1371/journal.pone.0246684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577590	gold, Green Published			2022-12-26	WOS:000620071700053
J	Ohira, H; Tsuruya, A; Oikawa, D; Nakagawa, W; Mamoto, R; Hattori, M; Waki, T; Takahashi, S; Fujioka, Y; Nakayama, T				Ohira, Hideo; Tsuruya, Atsuki; Oikawa, Daiki; Nakagawa, Wao; Mamoto, Rie; Hattori, Masahira; Waki, Toshiyuki; Takahashi, Seiji; Fujioka, Yoshio; Nakayama, Toru			Alteration of oxidative-stress and related marker levels in mouse colonic tissues and fecal microbiota structures with chronic ethanol administration: Implications for the pathogenesis of ethanol-related colorectal cancer	PLOS ONE			English	Article								Chronic ethanol consumption is a risk factor for colorectal cancer, and ethanol-induced reactive oxygen species have been suggested to play important roles in the pathogenesis of ethanol-related colorectal cancer (ER-CRC). In this study, the effects of 10-week chronic administration of ethanol on the colonic levels of oxidative stress and advance glycation end product (AGE) levels, as well as fecal microbiota structures, were examined in a mouse model. Chronic oral administration of ethanol in mice (1.0 mL of 1.5% or 5.0% ethanol (v/v) per day per mouse, up to 10 weeks) resulted in the elevation of colonic levels of oxidative stress markers (such as 8-hydroxy-2'-deoxyguanosine and 4-hydroxynonenal) compared to control mice, and this was consistently accompanied by elevated levels of inflammation-associated cytokines and immune cells (Th17 and macrophages) and a decreased level of regulatory T (Treg) cells to produce colonic lesions. It also resulted in an alteration of mouse fecal microbiota structures, reminiscent of the alterations observed in human inflammatory bowel disease, and this appeared to be consistent with the proposed sustained generation of oxidative stress in the colonic environment during chronic ethanol consumption. Moreover, the first experimental evidence that chronic ethanol administration results in elevated levels of advanced glycation end products (AGEs) and their receptors (RAGE) in the colonic tissues in mice is also shown, implying enhanced RAGE-mediated signaling with chronic ethanol administration. The RAGE-mediated signaling pathway has thus far been implicated as a link between the accumulation of AGEs and the development of many types of chronic colitis and cancers. Thus, enhancement of this pathway likely exacerbates the ethanol-induced inflammatory states of colonic tissues and might at least partly contribute to the pathogenesis of ER-CRC.	[Ohira, Hideo; Nakagawa, Wao; Mamoto, Rie; Fujioka, Yoshio] Kobe Gakuin Univ, Fac Nutr, Div Clin Nutr, Kobe, Hyogo, Japan; [Tsuruya, Atsuki; Oikawa, Daiki; Waki, Toshiyuki; Takahashi, Seiji; Nakayama, Toru] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi, Japan; [Hattori, Masahira] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan	Kobe Gakuin University; Tohoku University; Waseda University	Ohira, H (corresponding author), Kobe Gakuin Univ, Fac Nutr, Div Clin Nutr, Kobe, Hyogo, Japan.	oohira@nutr.kobegakuin.ac.jp	Ohira, Hideo/ABD-3068-2021	Ohira, Hideo/0000-0002-1723-7173	JSPS KAKENHI from Kobe Gakuin University, Tohoku University, Japan [18K11087, 15K14682, 18K19721]	JSPS KAKENHI from Kobe Gakuin University, Tohoku University, Japan	This study was supported in part by JSPS KAKENHI grants 18K11087(HO), 15K14682 (TN1) and 18K19721(TN2) for research from Kobe Gakuin University, Tohoku University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy M, 2006, AM J PATHOL, V169, P1223, DOI 10.2353/ajpath.2006.050713; APPLEYARD CB, 1995, AM J PHYSIOL-GASTR L, V269, pG119, DOI 10.1152/ajpgi.1995.269.1.G119; Barbi J, 2014, IMMUNOL REV, V259, P115, DOI 10.1111/imr.12172; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; BUCALA R, 1993, P NATL ACAD SCI USA, V90, P6434, DOI 10.1073/pnas.90.14.6434; Bull-Otterson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053028; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005; HALSTED CH, 1973, AM J CLIN NUTR, V26, P831, DOI 10.1093/ajcn/26.8.831; Hayashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070034; Lin L, 2009, FRONT BIOSCI-LANDMRK, V14, P1403, DOI 10.2741/3315; Linhart K, 2014, REDOX BIOL, V3, P56, DOI 10.1016/j.redox.2014.08.009; Lord R, 2018, WORLD J GASTROENTERO, V24, P1167, DOI 10.3748/wjg.v24.i10.1167; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Mizoue T, 2008, AM J EPIDEMIOL, V167, P1397, DOI 10.1093/aje/kwn073; Mizukami T, 2017, ALCOHOL ALCOHOLISM, V52, P131, DOI 10.1093/alcalc/agw071; Moura FA, 2020, CURR MED CHEM, V27, P2059, DOI 10.2174/0929867325666180904115633; Na HK, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061116; Namiki M, 1988, Adv Food Res, V32, P115, DOI 10.1016/S0065-2628(08)60287-6; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Piperi C, 2017, CANCER LETT, V390, P153, DOI 10.1016/j.canlet.2017.01.020; Purohit V, 2009, ALCOHOL CLIN EXP RES, V33, P191, DOI 10.1111/j.1530-0277.2008.00827.x; Rossi M, 2018, CANCERS, V10, DOI 10.3390/cancers10020038; Sakellariou S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2213-5; Schroter D, 2018, CURR PHARM DESIGN, V24, P5245, DOI 10.2174/1381612825666190130145549; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Shih MF, 1997, BRIT J PHARMACOL, V120, P721, DOI 10.1038/sj.bjp.0700973; SIMANOWSKI UA, 1994, GUT, V35, P1102, DOI 10.1136/gut.35.8.1102; Tahan G, 2011, DIGEST DIS SCI, V56, P715, DOI 10.1007/s10620-010-1364-5; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Tsuruya A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27923; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685; WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243; Wu DF, 2003, ALCOHOL RES HEALTH, V27, P277; YAN SD, 1994, J BIOL CHEM, V269, P9889	35	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246580	10.1371/journal.pone.0246580	http://dx.doi.org/10.1371/journal.pone.0246580			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577585	gold, Green Published			2022-12-26	WOS:000620071700035
J	Rasedee, AFN; Sathar, MHA; Othman, KI; Hamzah, SR; Ishak, N				Rasedee, Ahmad Fadly Nurullah; Sathar, Mohammad Hasan Abdul; Othman, Khairil Iskandar; Hamzah, Siti Raihana; Ishak, Norizarina			Approximating non linear higher order ODEs by a three point block algorithm	PLOS ONE			English	Article								Differential equations are commonly used to model various types of real life applications. The complexity of these models may often hinder the ability to acquire an analytical solution. To overcome this drawback, numerical methods were introduced to approximate the solutions. Initially when developing a numerical algorithm, researchers focused on the key aspect which is accuracy of the method. As numerical methods becomes more and more robust, accuracy alone is not sufficient hence begins the pursuit of efficiency which warrants the need for reducing computational cost. The current research proposes a numerical algorithm for solving initial value higher order ordinary differential equations (ODEs). The proposed algorithm is derived as a three point block multistep method, developed in an Adams type formulae (3PBCS) and will be used to solve various types of ODEs and systems of ODEs. Type of ODEs that are selected varies from linear to nonlinear, artificial and real life problems. Results will illustrate the accuracy and efficiency of the proposed three point block method. Order, stability and convergence of the method are also presented in the study.	[Rasedee, Ahmad Fadly Nurullah] Univ Sains Islam Malaysia, Fak Ekon & Muamalat, Nilai, Negeri Sembilan, Malaysia; [Sathar, Mohammad Hasan Abdul] Putra Univ Malaysia, Ctr Fdn Studies Agr Sci, Serdang, Selangor, Malaysia; [Othman, Khairil Iskandar] Univ Teknol MARA, Fac Comp & Math Sci, Shah Alam, Selangor, Malaysia; [Hamzah, Siti Raihana; Ishak, Norizarina] Univ Sains Islam Malaysia, Fak Sains & Teknol, Nilai, Negeri Sembilan, Malaysia	Universiti Sains Islam Malaysia; Universiti Putra Malaysia; Universiti Teknologi MARA; Universiti Sains Islam Malaysia	Rasedee, AFN (corresponding author), Univ Sains Islam Malaysia, Fak Ekon & Muamalat, Nilai, Negeri Sembilan, Malaysia.	fadlynurullah@usim.edu.my	Rasedee, Ahmad Fadly Nurullah/R-5676-2018	Rasedee, Ahmad Fadly Nurullah/0000-0002-4425-9087; ISHAK, NORIZARINA/0000-0002-2477-1489	Univeristi Sains Islam Malaysia; Ministry of Education (MoE), Malaysia under the Fundamental Research Grant Scheme (FRGS) [USIM/FRGS/FST/055002/51819]; Universiti Putra Malaysia under the Putra Grant Scheme [GP-IPM95859600]	Univeristi Sains Islam Malaysia; Ministry of Education (MoE), Malaysia under the Fundamental Research Grant Scheme (FRGS); Universiti Putra Malaysia under the Putra Grant Scheme	Hamzah SR, Univeristi Sains Islam Malaysia together with the Ministry of Education (MoE), Malaysia under the Fundamental Research Grant Scheme (FRGS), project number USIM/FRGS/FST/055002/51819 Addul Sathar, MH. Universiti Putra Malaysia under the Putra Grant Scheme, project number GP-IPM95859600. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J. C., 1883, ATTEMPT TEST THEORIE; Asnor AI, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11101289; Bin Suleiman M, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/810324; BINSULEIMAN M, 1993, MATH COMPUT, V60, P635, DOI 10.1090/S0025-5718-1993-1176717-5; Duffy BR, 1997, APPL MATH LETT, V10, P63, DOI 10.1016/S0893-9659(97)00036-0; FATUNLA SO, 1991, INT J COMPUT MATH, V41, P55, DOI 10.1080/00207169108804026; Fawzi F.A., 2018, INT J PURE APPL MATH, V120, P27; GEAR CW, 1967, MATH COMPUT, V21, P146, DOI 10.2307/2004155; Hall G., 1976, MODERN NUMERICAL MET; Henrici P, 1962, COMPUTATIONAL METHOD; Ibrahim ZB, 2019, SAINS MALAYS, V48, P1761, DOI 10.17576/jsm-2019-4808-23; Ijam HM, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11111342; Ijam HM, 2018, AIP C P, V1974; Iqbal MK, 2020, PUNJAB UNIV J MATH, V52, P47; Iqbal MK, 2020, INT J ADV APPL SCI, V7, P48, DOI 10.21833/ijaas.2020.06.007; Iqbal MK, 2019, PUNJAB UNIV J MATH, V51, P43; Iqbal MK, 2018, COMMUN MATH APPL, V9, P377, DOI 10.26713/cma.v9i3.802; Iqbal MK, 2018, APPL MATH COMPUT, V331, P319, DOI 10.1016/j.amc.2018.03.025; Ismail F, 2016, SAINS MALAYS, V45, P1747; Krogh FT, 1968, IFIP C, V68, P194; Lambert J.D., 1973, COMPUTATIONAL METHOD; Majid ZA, 2007, LECT NOTES ENG COMP, P812; Meia MD., 2019, AM J CIRCUITS SYSTEM, V5, P1; Milne W.E., 1926, AM MATH MON, V33, P455; MILNE WE, 1953, NUMERICAL SOLUTION D; Mohd Ijam H., 2014, ABSTR APPL ANAL, V2014, DOI [10.1155/2014/867095, DOI 10.1155/2014/867095]; Mukhtar Nur Zahidah, 2012, International Journal of Modern Physics: Conference Series, V9, P560, DOI 10.1142/S2010194512005661; Omar Z, 2005, MATEMATIKA, V21, P15; Phan HT., 2002, NEW NUMERICAL APPROA; Rasedee AFN, 2020, 2 POINT BLOCK UNPUB; Rasedee AFN., 2021, ADV MATH SCI J, V10, P19; Rasedee AFN., 2009, DIRECT METHOD USING; Rasedee AFNB, 2016, AIP C P, V1775; Rasedee AFN, 2017, AIP CONF PROC, V1905, DOI 10.1063/1.5012174; Rasedee AFN, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/565137; Shampine LF., 1975, COMPUTER SOLUTION OR; Suleiman MB., 1979, GEN MULTISTEP ADAMS; TUCK EO, 1990, SIAM REV, V32, P453, DOI 10.1137/1032079; Vigo-Aguiar J, 2006, J COMPUT APPL MATH, V192, P114, DOI 10.1016/j.cam.2005.04.043; Waeleh N., 2016, INT J MATH MATH SCI, V2016, DOI [10.1155/2016/9823147, DOI 10.1155/2016/9823147]; Wasim I, 2019, J MATH COMPUT SCI-JM, V19, P258, DOI 10.22436/jmcs.019.04.06; Watts H. A., 1972, BIT (Nordisk Tidskrift for Informationsbehandling), V12, P252, DOI 10.1007/BF01932819	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246904	10.1371/journal.pone.0246904	http://dx.doi.org/10.1371/journal.pone.0246904			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577619	Green Published, gold			2022-12-26	WOS:000620071700025
J	da Silva, CB; Volpato, MC; Muniz, BV; dos Santos, CP; Serpe, L; Ferreira, LEN; de Melo, NFS; Fraceto, LF; Groppo, FC; Franz-Montan, M				da Silva, Camila Batista; Volpato, Maria Cristina; Muniz, Bruno Vilela; dos Santos, Cleiton Pita; Serpe, Luciano; Nunes Ferreira, Luiz Eduardo; Silva de Melo, Nathalie Ferreira; Fraceto, Leonardo Fernandes; Groppo, Francisco Carlos; Franz-Montan, Michelle			Promising potential of articaine-loaded poly(epsilon-caprolactone) nanocapules for intraoral topical anesthesia	PLOS ONE			English	Article							IN-VITRO ASSAYS; INFILTRATION ANESTHESIA; HUMAN KERATINOCYTES; LOCAL-ANESTHETICS; LIDOCAINE; EFFICACY; CYTOTOXICITY; HYDROCHLORIDE; NANOCAPSULES; ROPIVACAINE	To determine whether the permeation capacity and analgesic efficacy of articaine (ATC) could be increased and cytotoxicity decreased by encapsulation in poly(e-caprolactone) nanocapsules (ATC(nano)), aiming at local or topical anesthesia in dentistry. Cellular viability was evaluated (using the MTT test and fluorescence microscopy) after 1 h and 24 h exposure of HaCaT cells to ATC, ATC(nano), ATC with epinephrine (ATC(epi)), and ATC in nanocapsules with epinephrine (ATC(nanoepi)). The profiles of permeation of 2% ATC and 2% ATC(nano) across swine esophageal epithelium were determined using Franz-type vertical diffusion cells. Analgesic efficacy was evaluated with a von Frey anesthesiometer in a postoperative pain model in rats, comparing the 2% ATC, 2% ATC(nano), 2% ATC(epi), and 2% ATC(nanoepi) formulations to 4% ATC(epi) (a commercially available formulation). We show that use of the nanocapsules decreased the toxicity of articaine (P<0.0001) and increased its flux (P = 0.0007). The 2% ATC(epi) and 4% ATC(epi) formulations provided higher analgesia success and duration (P<0.05), compared to 2% ATC, 2% ATC(nano), and 2% ATC(nanoepi). Articaine-loaded poly(e-caprolactone) nanocapsules constitute a promising formulation for intraoral topical anesthesia (prior to local anesthetic injection), although it is not effective when injected in inflamed tissues for pain control, such as irreversible pulpitis.	[da Silva, Camila Batista; Volpato, Maria Cristina; Muniz, Bruno Vilela; dos Santos, Cleiton Pita; Serpe, Luciano; Nunes Ferreira, Luiz Eduardo; Groppo, Francisco Carlos; Franz-Montan, Michelle] Univ Estadual Campinas, UNICAMP, Piracicaba Dent Sch, Dept Biosci, Piracicaba, SP, Brazil; [da Silva, Camila Batista] Univ Mogi das Cruzes UMC, Hlth Sci, Mogi Das Cruzes, SP, Brazil; [Muniz, Bruno Vilela] Itapeva Fac Social & Agr Sci FAIT, Itapeva, SP, Brazil; [Serpe, Luciano] Univ Estadual Ponta Grossa, Dept Dent, Ponta Grossa, Parana, Brazil; [Nunes Ferreira, Luiz Eduardo] Guarulhos Univ UNG, Lab Inflammat & Immunol, Guarulhos, SP, Brazil; [Silva de Melo, Nathalie Ferreira; Fraceto, Leonardo Fernandes] Sao Paulo State Univ, Dept Environm Engn, Sorocaba, SP, Brazil; [Silva de Melo, Nathalie Ferreira] Sao Leopoldo Mandic Res Inst, Dept Immunol & Mol Biol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade de Mogi das Cruzes; Universidade Estadual de Ponta Grossa; Universidade Guarulhos; Universidade Estadual Paulista; Faculdade Sao Leopoldo Mandic	Franz-Montan, M (corresponding author), Univ Estadual Campinas, UNICAMP, Piracicaba Dent Sch, Dept Biosci, Piracicaba, SP, Brazil.	mfranz@unicamp.br	groppo, francisco carlos/HIK-2053-2022; Ferreira, Luiz Eduardo Nunes/E-5334-2016; Franz-Montan, Michelle/AAN-1071-2021; Fraceto, Leonardo Fernandes/ABF-2797-2021; Fraceto, Leonardo/C-4468-2012	groppo, francisco carlos/0000-0002-8513-773X; Ferreira, Luiz Eduardo Nunes/0000-0002-4882-5402; Franz-Montan, Michelle/0000-0003-0760-1389; Fraceto, Leonardo Fernandes/0000-0002-2827-2038; 	Sao Paulo Research Foundation (FAPESP) [2012/06974-4, 2012/07310-2]; FAPESP [2012/02539-1]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support for this study was provided by the Sao Paulo Research Foundation (FAPESP, grants #2012/06974-4 and #2012/07310-2). Camila Batista da Silva acknowledges a scholarship provided by FAPESP (grant #2012/02539-1).	Abdel-Mottaleb MMA, 2011, EUR J PHARM BIOPHARM, V79, P36, DOI 10.1016/j.ejpb.2011.04.009; Albalawi Farraj, 2018, Anesth Prog, V65, P82, DOI 10.2344/anpr-65-02-02; Ashraf H, 2013, J ENDODONT, V39, P6, DOI 10.1016/j.joen.2012.10.012; Boonkaew B, 2014, BURNS, V40, P1562, DOI 10.1016/j.burns.2014.02.009; Cevc G, 2004, ADV DRUG DELIVER REV, V56, P675, DOI 10.1016/j.addr.2003.10.028; Corhett IP, 2008, J ENDODONT, V34, P514, DOI 10.1016/j.joen.2008.02.042; Cubayachi C, 2015, COLLOID SURFACE B, V136, P1193, DOI 10.1016/j.colsurfb.2015.11.005; da Silva CB, 2016, BRIT J ORAL MAX SURG, V54, P295, DOI 10.1016/j.bjoms.2016.01.005; Ribeiro LND, 2018, INT J NANOMED, V13, P6453, DOI 10.2147/IJN.S180080; de Paula E, 2012, EXPERT OPIN DRUG DEL, V9, P1505, DOI 10.1517/17425247.2012.738664; Del Consuelo ID, 2005, J PHARM SCI-US, V94, P2777, DOI 10.1002/jps.20409; Franz-Montan M, 2017, EXPERT OPIN DRUG DEL, V14, P673, DOI 10.1080/17425247.2016.1227784; Franz-Montan M, 2015, J LIPOSOME RES, V25, P11, DOI 10.3109/08982104.2014.911315; Franz-Montan M, 2013, J LIPOSOME RES, V23, P54, DOI 10.3109/08982104.2012.742536; Grillo R, 2010, J DRUG TARGET, V18, P688, DOI 10.3109/10611861003649738; Hillerup S, 2011, J AM DENT ASSOC, V142, P531, DOI 10.14219/jada.archive.2011.0223; Hintze A, 2006, CLIN ORAL INVEST, V10, P145, DOI 10.1007/s00784-005-0025-0; Jacobs TF, 2011, KNEE SURG SPORT TR A, V19, P1206, DOI 10.1007/s00167-011-1420-5; Jakobs W, 1995, Anesth Prog, V42, P113; Jiao QQ, 2013, ARCH DERMATOL RES, V305, P629, DOI 10.1007/s00403-013-1339-4; Kanaa MD, 2009, INT ENDOD J, V42, P238, DOI 10.1111/j.1365-2591.2008.01507.x; Kanaa MD, 2006, J ENDODONT, V32, P296, DOI 10.1016/j.joen.2005.09.016; Kirke DM., 2009, METHODOL INNOV ONLIN, V4, P23, DOI [DOI 10.1177/205979910900400103, 10.1177/205979910900400103]; Lygre H, 2009, ACTA ODONTOL SCAND, V67, P1, DOI 10.1080/00016350802443466; Malamed SF, 2001, J AM DENT ASSOC, V132, P177, DOI 10.14219/jada.archive.2001.0152; Mishra B, 2010, NANOMED-NANOTECHNOL, V6, P9, DOI 10.1016/j.nano.2009.04.008; Ferreira LEN, 2017, J PHARM PHARMACOL, V69, P161, DOI 10.1111/jphp.12680; Ferreira LEN, 2016, J PHARM PHARMACOL, V68, P791, DOI 10.1111/jphp.12552; Nydeggen B, 2014, J ENDODONT, V40, P1912, DOI 10.1016/j.joen.2014.08.001; Paxton Kellie, 2010, Dent Clin North Am, V54, P643, DOI 10.1016/j.cden.2010.06.005; Portugal-Cohen M, 2010, J DERMATOL SCI, V58, P105, DOI 10.1016/j.jdermsci.2010.03.010; Prado AR, 2017, J PHARM PHARMACOL, V69, P652, DOI 10.1111/jphp.12703; Preetz C, 2008, NANOMED-NANOTECHNOL, V4, P106, DOI 10.1016/j.nano.2008.03.003; Rahnama R, 2013, J BONE JOINT SURG AM, V95A, P132, DOI 10.2106/JBJS.K.01291; Campos EVR, 2013, J COLLOID SCI BIOTEC, V2, P106, DOI 10.1166/jcsb.2013.1040; Campos EVR, 2013, J PHARM SCI-US, V102, P215, DOI 10.1002/jps.23350; Schaffazick SR, 2003, QUIM NOVA, V26, P726, DOI 10.1590/S0100-40422003000500017; Senes AM, 2015, J DENT RES, V94, p166S, DOI 10.1177/0022034515596313; de Melo NFS, 2018, J NANOSCI NANOTECHNO, V18, P4428, DOI 10.1166/jnn.2018.15235; de Melo NFS, 2014, COLLOID SURFACE B, V121, P66, DOI 10.1016/j.colsurfb.2014.05.035; Tofoli Giovana Radomille, 2003, Anesth Prog, V50, P164; Yang SF, 2011, REGION ANESTH PAIN M, V36, P444, DOI 10.1097/AAP.0b013e318228c835; Zhou ZF, 2010, YAKUGAKU ZASSHI, V130, P1061, DOI 10.1248/yakushi.130.1061; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	44	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246760	10.1371/journal.pone.0246760	http://dx.doi.org/10.1371/journal.pone.0246760			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571275	gold, Green Published			2022-12-26	WOS:000618274000050
J	Kamble, P; Hall, K; Chandak, M; Tang, Q; Caglayan, M				Kamble, Pradnya; Hall, Kalen; Chandak, Mahesh; Tang, Qun; Caglayan, Melike			DNA ligase I fidelity mediates the mutagenic ligation of pol beta oxidized and mismatch nucleotide insertion products in base excision repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; POLYMERASE-BETA; APRATAXIN DEFICIENCY; STRUCTURAL INSIGHTS; INDUCED-FIT; REPLICATION; MECHANISM; ERROR; MISINCORPORATION; COMPLEMENTATION	DNA ligase I (LIG1) completes the base excision repair (BER) pathway at the last nick-sealing step after DNA polymerase (pol) beta gap-filling DNA synthesis. However, the mechanism by which LIG1 fidelity mediates the faithful substrate-product channeling and ligation of repair intermediates at the final steps of the BER pathway remains unclear. We previously reported that pol beta 8-oxo-2'-deoxyribonucleoside 5'-triphosphate insertion confounds LIG1, leading to the formation of ligation failure products with a 5'-adenylate block. Here, using reconstituted BER assays in vitro, we report the mutagenic ligation of pol beta 8-oxo-2'-deoxyribonucleoside 5'-triphosphate insertion products and an inefficient ligation of pol beta Watson-Crick-like dG:T mismatch insertion by the LIG1 mutant with a perturbed fidelity (E346A/E592A). Moreover, our results reveal that the substrate discrimination of LIG1 for the nicked repair intermediates with preinserted 3'-8-oxodG or mismatches is governed by mutations at both E346 and E592 residues. Finally, we found that aprataxin and flap endonuclease 1, as compensatory DNA-end processing enzymes, can remove the 5'-adenylate block from the abortive ligation products harboring 3'-8-oxodG or the 12 possible non-canonical base pairs. These findings contribute to the understanding of the role of LIG1 as an important determinant in faithful BER and how a multiprotein complex (LIG1, pol beta, aprataxin, and flap endonuclease 1) can coordinate to prevent the formation of mutagenic repair intermediates with damaged or mismatched ends at the downstream steps of the BER pathway.	[Kamble, Pradnya; Hall, Kalen; Chandak, Mahesh; Tang, Qun; Caglayan, Melike] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Caglayan, M (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	caglayanm@ufl.edu	Tang, Qun/AHC-5915-2022	Tang, Qun/0000-0001-8943-0012; CAGLAYAN, MELIKE/0000-0003-1107-1042	National Institutes of Health/National Institute of Environmental Health Sciences [4R00ES026191]; University of Florida Thomas H. Maren Junior Investigator Fund [P0158597]	National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of Florida Thomas H. Maren Junior Investigator Fund	This work was supported by the National Institutes of Health/National Institute of Environmental Health Sciences Grant 4R00ES026191 and the University of Florida Thomas H. Maren Junior Investigator Fund P0158597 to M. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Ahn JW, 1998, BIOCHEM J, V331, P79, DOI 10.1042/bj3310079; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2010, NAT STRUCT MOL BIOL, V17, P889, DOI 10.1038/nsmb.1852; Beard WA, 2019, ANNU REV BIOCHEM, V88, P137, DOI 10.1146/annurev-biochem-013118-111315; Bebenek K, 2011, P NATL ACAD SCI USA, V108, P1862, DOI 10.1073/pnas.1012825108; Bentley DJ, 2002, J CELL SCI, V115, P1551; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Caglayan M, 2020, DNA REPAIR, V95, DOI 10.1016/j.dnarep.2020.102945; Caglayan M, 2020, NUCLEIC ACIDS RES, V48, P3708, DOI 10.1093/nar/gkaa151; Caglayan M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57886-y; Caglayan M, 2019, J MOL BIOL, V431, P2068, DOI 10.1016/j.jmb.2019.04.028; Caglayan M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06700-5; Caglayan M, 2017, J RADIAT RES, V58, P603, DOI 10.1093/jrr/rrx027; Caglayan M, 2017, NUCLEIC ACIDS RES, V45, P10079, DOI 10.1093/nar/gkx654; Caglayan M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14045; Caglayan M, 2015, DNA REPAIR, V35, P85, DOI 10.1016/j.dnarep.2015.09.010; Caglayan M, 2015, NUCLEIC ACIDS RES, V43, P2271, DOI 10.1093/nar/gkv079; Caglayan M, 2014, NAT STRUCT MOL BIOL, V21, P497, DOI 10.1038/nsmb.2818; Carpio RVD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005766; Cherepanov AV, 2002, EUR J BIOCHEM, V269, P5993, DOI 10.1046/j.1432-1033.2002.03309.x; Conlin MP, 2017, CELL REP, V20, P2810, DOI 10.1016/j.celrep.2017.08.091; Cooley N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/152909; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Dickson KS, 2000, J BIOL CHEM, V275, P15828, DOI 10.1074/jbc.M910044199; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; El-Khamisy SF, 2009, DNA REPAIR, V8, P760, DOI 10.1016/j.dnarep.2009.02.002; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freudenthal BD, 2015, NATURE, V517, P635, DOI 10.1038/nature13886; Harrison C, 2002, CANCER RES, V62, P4065; Howes Timothy R L, 2012, Subcell Biochem, V62, P327, DOI 10.1007/978-94-007-4572-8_17; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Jurkiw TJ, 2021, NUCLEIC ACIDS RES, V49, P1619, DOI 10.1093/nar/gkaa1297; Kaminski AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05024-8; Katafuchi A, 2010, MUTAT RES-GEN TOX EN, V703, P24, DOI 10.1016/j.mrgentox.2010.06.004; Kimsey IJ, 2018, NATURE, V554, P195, DOI 10.1038/nature25487; Kimsey IJ, 2015, NATURE, V519, P315, DOI 10.1038/nature14227; Kirouac KN, 2011, P NATL ACAD SCI USA, V108, P3210, DOI 10.1073/pnas.1013909108; Koag MC, 2014, NUCLEIC ACIDS RES, V42, P11233, DOI 10.1093/nar/gku789; Krahn JM, 2004, STRUCTURE, V12, P1823, DOI 10.1016/j.str.2004.08.001; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Lindahl T, 2001, PROG NUCLEIC ACID RE, V68, pXVII; Liu PF, 2004, NUCLEIC ACIDS RES, V32, P4503, DOI 10.1093/nar/gkh781; Nakabeppu Y, 2006, BIOL CHEM, V387, P373, DOI 10.1515/BC.2006.050; Ochi T, 2013, STRUCTURE, V21, P672, DOI 10.1016/j.str.2013.02.014; Ochi T, 2012, STRUCTURE, V20, P1212, DOI 10.1016/j.str.2012.04.012; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Prasad R, 2011, MOL BIOL+, V45, P536, DOI 10.1134/S0026893311040091; Prasad R, 2010, J BIOL CHEM, V285, P40479, DOI 10.1074/jbc.M110.155267; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; Reynolds JJ, 2009, MOL CELL BIOL, V29, P1354, DOI 10.1128/MCB.01471-08; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Showalter AK, 2006, CHEM REV, V106, P340, DOI 10.1021/cr040487k; Simonelli V, 2017, ONCOTARGET, V8, P84827, DOI 10.18632/oncotarget.10185; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Tang Q, 2020, MUTAGENESIS, V35, P391, DOI 10.1093/mutage/geaa023; Taylor MR, 2011, J BIOL CHEM, V286, P23054, DOI 10.1074/jbc.M111.248831; Timson DJ, 2000, MUTAT RES-DNA REPAIR, V460, P301, DOI 10.1016/S0921-8777(00)00033-1; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Tomkinson AE, 1998, MUTAT RES-DNA REPAIR, V407, P1, DOI 10.1016/S0921-8777(97)00050-5; Tumbale P, 2018, EMBO J, V37, DOI 10.15252/embj.201798875; Tumbale PP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13478-7; Ventura I, 2010, MUTAT RES-GEN TOX EN, V703, P59, DOI 10.1016/j.mrgentox.2010.06.008; Wang WN, 2011, P NATL ACAD SCI USA, V108, P17644, DOI 10.1073/pnas.1114496108; WEBSTER ADB, 1992, LANCET, V339, P1508, DOI 10.1016/0140-6736(92)91266-B; Whitaker AM, 2018, DNA REPAIR, V71, P93, DOI 10.1016/j.dnarep.2018.08.012; Williams JS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20800-1; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; YANG SW, 1992, J BIOL CHEM, V267, P8117	73	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100427	10.1016/j.jbc.2021.100427	http://dx.doi.org/10.1016/j.jbc.2021.100427			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33600799	gold, Green Published, Green Submitted			2022-12-26	WOS:000672866400401
J	de Souza, GHD; Radai, JAD; Vaz, MSM; da Silva, KE; Fraga, TL; Barbosa, LS; Simionatto, S				de Souza, Gleyce Hellen de Almeida; dos Santos Radai, Joyce Alencar; Mattos Vaz, Marcia Soares; Esther da Silva, Kesia; Fraga, Thiago Leite; Barbosa, Leticia Spanivello; Simionatto, Simone			In vitro and in vivo antibacterial activity assays of carvacrol: A candidate for development of innovative treatments against KPC-producing Klebsiella pneumoniae	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIVITY; CARBAPENEM-RESISTANT; ESCHERICHIA-COLI; ESSENTIAL OILS; MODEL	Dissemination of carbapenem-resistant Klebsiella pneumoniae poses a threat to the successful treatment of bacterial diseases and increases the need for new antibacterial agents development. The objective of this study was to determine the antimicrobial activity of carvacrol against multidrug-resistant K. pneumoniae. Carbapenemase production was detected by MALDI-TOF. The PCR and sequencing showed that the bla(KPC-2,) bla(OXA-48), bla(NDM-1), bla(CTX-M-8) genes were present in carbapenem-resistant K. pneumoniae strains. The polymyxin-resistant K. pneumoniae strain exhibited alterations in mgrB gene. The antimicrobial activity of carvacrol was evaluated in vitro using broth microdilution and time-kill methods. For this, carbapenem-resistant K. pneumoniae and polymyxin-resistant strains, were evaluated. The in vitro results showed that carvacrol had antimicrobial activity against all isolates evaluated. The survival curves showed that carvacrol eradicated all of the bacterial cells within 4 h. The antimicrobial effect of carvacrol in vivo was determined using a mouse model of infection with Klebsiella pneumoniae carbapenemase (KPC). The treatment with carvacrol was associated with increased survival, and significantly reduced bacterial load in peritoneal lavage. In addition, groups treated with carvacrol, had a significant reduction in the total numbers of white cell and significantly increased of platelets when compared to the untreated group. In vivo and in vitro studies showed that carvacrol regimens exhibited significant antimicrobial activity against KPC-producing K. pneumoniae, making it an interesting candidate for development of alternative treatments.	[de Souza, Gleyce Hellen de Almeida; dos Santos Radai, Joyce Alencar; Mattos Vaz, Marcia Soares; Esther da Silva, Kesia; Barbosa, Leticia Spanivello; Simionatto, Simone] Univ Fed Grande Dourados UFGD, Lab Pesquisa Ciencias Saude, Dourados, MS, Brazil; [Fraga, Thiago Leite] Ctr Univ Grande Dourados UNIGRAN, Dourados, MS, Brazil	Universidade Federal da Grande Dourados	Simionatto, S (corresponding author), Univ Fed Grande Dourados UFGD, Lab Pesquisa Ciencias Saude, Dourados, MS, Brazil.	simonesimionatto@ufgd.edu.br		Simionatto, Simone/0000-0003-2367-0915	Federal University of Grande Dourados (UFGD); University Center of Grande Dourados (UNIGRAN); Coordination for the Improvement of Higher Education Personnel (CAPES)	Federal University of Grande Dourados (UFGD); University Center of Grande Dourados (UNIGRAN); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors would like to thank the Federal University of Grande Dourados (UFGD) and the University Center of Grande Dourados (UNIGRAN). K.E.S., M.S.M.V. and G.H.A.S. received a scholarship from the Coordination for the Improvement of Higher Education Personnel (CAPES). The development agencies had no role in the study design, data collection and analysis, decision to publish or prepare the manuscript. There was no additional external funding received for this study.	Alagawany M., 2015, ADV ANIMAL VET SCI B, V3, P73, DOI DOI 10.14737/JOURNAL.AAVS/2015/3.2S.73.84; Alatoom A, 2017, INT J INFECT DIS, V62, P39, DOI 10.1016/j.ijid.2017.06.007; Andre WPP, 2016, VET PARASITOL, V218, P52, DOI 10.1016/j.vetpar.2016.01.001; Assinger A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00649; Burt SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093414; Campana EH, 2017, BRAZ J INFECT DIS, V21, P57, DOI 10.1016/j.bjid.2016.10.008; Chueca B, 2014, INT J FOOD MICROBIOL, V189, P126, DOI 10.1016/j.ijfoodmicro.2014.08.008; CLSI, C28A3 CLSI, V29th; da Silva KE, 2016, J MED MICROBIOL, V65, P547, DOI 10.1099/jmm.0.000254; Dati LM, 2017, NEUROSCIENCE, V356, P176, DOI 10.1016/j.neuroscience.2017.05.013; Deng ZQ, 2012, ENVIRON SCI TECHNOL, V46, P7746, DOI 10.1021/es203490f; Enomoto S, 2001, BIOL PHARM BULL, V24, P307, DOI 10.1248/bpb.24.307; Fachini-Queiroz FC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/657026; Fukuda T, 2017, J VET MED SCI, V79, P1707, DOI 10.1292/jvms.17-0387; Guclu E, 2013, AFR HEALTH SCI, V13, P333, DOI 10.4314/ahs.v13i2.19; Gyawali R, 2020, FOOD CONTROL, V111, DOI 10.1016/j.foodcont.2019.107062; Hyldgaard M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00012; Iredell J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6420; Karkabounas S., 2006, Experimental Oncology, V28, P121; Lee GC, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-32; Lima MD, 2013, EUR J PHARMACOL, V699, P112, DOI 10.1016/j.ejphar.2012.11.040; Liu SQ, 2017, BIOMATERIALS, V127, P36, DOI 10.1016/j.biomaterials.2017.02.027; Lomonaco S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198526; Maciel WG, 2017, REV SOC BRAS MED TRO, V50, P135, DOI 10.1590/0037-8682-0284-2016; Magi G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00165; Man A, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8010015; Marsh JW, 2019, MBIO, V10, DOI 10.1128/mBio.01945-19; Memar MY, 2017, REV MED MICROBIOL, V28, P63, DOI 10.1097/MRM.0000000000000100; Toledo PVM, 2015, ANTIMICROB AGENTS CH, V59, P4301, DOI 10.1128/AAC.00323-15; Morales-Fernandez L, 2014, EUR J CLIN MICROBIOL, V33, P103, DOI 10.1007/s10096-013-1934-5; Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451; Nishikawa M., 1988, BLOOD VESSELS, V19, P632, DOI [10.2491/jjsth1970.19.632, DOI 10.2491/JJSTH1970.19.632]; Nostro Antonia, 2012, Recent Pat Antiinfect Drug Discov, V7, P28; O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations; ONeill J., 2015, ANTIMICROBIALS AGR E; Qu MM, 2018, ANN HEMATOL, V97, P1701, DOI 10.1007/s00277-018-3367-9; Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007; Sanchez C, 2015, INT J FOOD MICROBIOL, V192, P72, DOI 10.1016/j.ijfoodmicro.2014.09.028; Silva FV, 2012, J MED FOOD, V15, P984, DOI 10.1089/jmf.2012.0102; Silva KE, 2015, J CLIN MICROBIOL, V53, P2324, DOI 10.1128/JCM.00727-15; Suntres ZE, 2015, CRIT REV FOOD SCI, V55, P304, DOI 10.1080/10408398.2011.653458; Tackenberg MW, 2015, INT J PHARMACEUT, V478, P597, DOI 10.1016/j.ijpharm.2014.12.012; Vasconcelos NG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236505; Vivas R, 2019, MICROB DRUG RESIST, V25, P890, DOI 10.1089/mdr.2018.0319; WHO, 2017, WORLD HLTH ORG, P7, DOI DOI 10.1016/S1473-3099(09)70222-1; Ye HQ, 2013, FOOD CONTROL, V34, P619, DOI 10.1016/j.foodcont.2013.05.032; Zhu CY, 2017, J CONTROL RELEASE, V259, P83, DOI 10.1016/j.jconrel.2017.02.005	47	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0246003	10.1371/journal.pone.0246003	http://dx.doi.org/10.1371/journal.pone.0246003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617571	Green Published, gold			2022-12-26	WOS:000623082400053
J	Chen, B; Chu, TW; Chiu, K; Hong, MC; Wu, TM; Ma, JW; Liang, CM; Wang, WK				Chen, Bonien; Chu, Tah-Wei; Chiu, Kuohsun; Hong, Ming-Chang; Wu, Tsung-Meng; Ma, Jui-Wen; Liang, Chih-Ming; Wang, Wei-Kuang			Transcriptomic analysis elucidates the molecular processes associated with hydrogen peroxide-induced diapause termination in Artemia-encysted embryos	PLOS ONE			English	Article								Treatment with hydrogen peroxide (H2O2) raises the hatching rate through the development and diapause termination of Artemia cysts. To comprehend the upstream genetic regulation of diapause termination activated by exterior H2O2 elements, an Illumina RNA-seq analysis was performed to recognize and assess comparative transcript amounts to explore the genetic regulation of H2O2 in starting the diapause termination of cysts in Artemia salina. We examined three groupings treated with no H2O2 (control), 180 mu M H2O2 (low) and 1800 mu M H2O2 (high). The results showed a total of 114,057 unigenes were identified, 41.22% of which were functionally annotated in at least one particular database. When compared to control group, 34 and 98 differentially expressed genes (DEGs) were upregulated in 180 mu M and 1800 mu M H2O2 treatments, respectively. On the other hand, 162 and 30 DEGs were downregulated in the 180 mu M and 1800 mu M H2O2 treatments, respectively. Cluster analysis of DEGs demonstrated significant patterns among these types of 3 groups. GO and KEGG enrichment analysis showed the DEGs involved in the regulation of blood coagulation (GO: 0030193; GO: 0050818), regulation of wound healing (GO:0061041), regulation of hemostasis (GO: 1900046), antigen processing and presentation (KO04612), the Hippo signaling pathway (KO04391), as well as the MAPK signaling pathway (KO04010). This research helped to define the diapause-related transcriptomes of Artemia cysts using RNA-seq technology, which might fill up a gap in the prevailing body of knowledge.	[Chen, Bonien; Chu, Tah-Wei; Chiu, Kuohsun; Hong, Ming-Chang; Ma, Jui-Wen] Natl Kaohsiung Univ Sci & Technol, Dept & Grad Inst Aquaculture, Kaohsiung, Taiwan; [Chiu, Kuohsun] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan; [Wu, Tsung-Meng] Natl Pingtung Univ Sci & Technol, Dept Aquaculture, Pingtung, Taiwan; [Liang, Chih-Ming; Wang, Wei-Kuang] Feng Chia Univ, Dept Environm Engn & Sci, Taichung, Taiwan	National Kaohsiung University of Science & Technology; National Sun Yat Sen University; National Pingtung University Science & Technology; Feng Chia University	Wang, WK (corresponding author), Feng Chia Univ, Dept Environm Engn & Sci, Taichung, Taiwan.	wkwang@fcu.edu.tw		Wang, Weikuang/0000-0003-4068-0429	Ministry of Science and Technology, Taiwan [MOST 1082221-E-035-057, MOST 109-2221-E-035-034]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work partially supported by Ministry of Science and Technology, Taiwan (MOST 1082221-E-035-057 and MOST 109-2221-E-035-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Boswell LC, 2014, CELL STRESS CHAPERON, V19, P329, DOI 10.1007/s12192-013-0458-3; Chen WH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-52; Clegg JS, 2011, J INSECT PHYSIOL, V57, P660, DOI 10.1016/j.jinsphys.2010.11.023; CLEGG JS, 1992, FEBS LETT, V303, P45, DOI 10.1016/0014-5793(92)80474-U; Clegg JS, 1997, J EXP BIOL, V200, P467; Davidson NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0410-6; De Vos S, 2019, AQUACULTURE, V500, P305, DOI 10.1016/j.aquaculture.2018.09.067; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han XK, 2019, CRUSTACEANA, V92, P841, DOI 10.1163/15685403-00003916; Hong MC, 2017, COMP BIOCHEM PHYS D, V24, P118, DOI 10.1016/j.cbd.2017.09.001; Iryani MTM, 2020, CELL STRESS CHAPERON, V25, P1099, DOI 10.1007/s12192-020-01113-0; Jiang GJ, 2016, CELL STRESS CHAPERON, V21, P1077, DOI 10.1007/s12192-016-0732-2; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; King AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043723; LeBlanc BM, 2020, TISSUE CELL, V67, DOI 10.1016/j.tice.2020.101410; LeBlanc BM, 2019, CELL STRESS CHAPERON, V24, P979, DOI 10.1007/s12192-019-01025-8; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; MacRae TH, 2016, CELL STRESS CHAPERON, V21, P9, DOI 10.1007/s12192-015-0635-7; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Malitan HS, 2019, BIOCHEM CELL BIOL, V97, P471, DOI 10.1139/bcb-2018-0231; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Qiu ZJ, 2008, FEBS J, V275, P3556, DOI 10.1111/j.1742-4658.2008.06501.x; Qu ZJ, 2008, BIOCHEM J, V411, P605, DOI 10.1042/BJ20071472; Robbins HM, 2010, J EXP BIOL, V213, P1464, DOI 10.1242/jeb.041772; Rowarth NM, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.189001; Rowarth NM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201477; Tan J, 2019, CELL STRESS CHAPERON, V24, P385, DOI 10.1007/s12192-019-00971-7; Tan JB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200153; Tarrant AM, 2016, INTEGR COMP BIOL, V56, P1157, DOI 10.1093/icb/icw060; Tarrant AM, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0091-8; Toxopeus J, 2014, CELL STRESS CHAPERON, V19, P939, DOI 10.1007/s12192-014-0518-3; Tu XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11402; Valenzuela-Miranda D, 2014, MAR GENOM, V18, P151, DOI 10.1016/j.margen.2014.10.007; Warner AH, 2016, CELL STRESS CHAPERON, V21, P139, DOI 10.1007/s12192-015-0647-3; Warner AH, 2012, COMP BIOCHEM PHYS D, V7, P260, DOI 10.1016/j.cbd.2012.04.002; Wu G, 2011, COMP BIOCHEM PHYS B, V160, P32, DOI 10.1016/j.cbpb.2011.05.005; Yi XL, 2020, CHEMOSPHERE, V238, DOI 10.1016/j.chemosphere.2019.124661; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang YL, 2018, FISH SHELLFISH IMMUN, V81, P92, DOI 10.1016/j.fsi.2018.06.033; Zhao W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162272; Zhu XJ, 2007, STRESS, V10, P53, DOI 10.1080/10253890601130773	43	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247160	10.1371/journal.pone.0247160	http://dx.doi.org/10.1371/journal.pone.0247160			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606769	Green Published, gold			2022-12-26	WOS:000620629200058
J	Higgins, AY; Arbune, A; Soufer, A; Ragheb, E; Kwan, JM; Lamy, J; Henry, M; Cuomo, JR; Charifa, A; Gallegos, C; Hull, S; Coviello, JS; Bader, AS; Peters, DC; Huber, S; Mojibian, HR; Sinusas, AJ; Kluger, H; Baldassarre, LA				Higgins, Angela Y.; Arbune, Amit; Soufer, Aaron; Ragheb, Elio; Kwan, Jennifer M.; Lamy, Jerome; Henry, Mariana; Cuomo, Jason R.; Charifa, Ahmad; Gallegos, Cesia; Hull, Sarah; Coviello, Jessica Shank; Bader, Anna S.; Peters, Dana C.; Huber, Steffen; Mojibian, Hamid R.; Sinusas, Albert J.; Kluger, Harriet; Baldassarre, Lauren A.			Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity	PLOS ONE			English	Article								Background Immune checkpoint inhibitors (ICIs) are highly effective in treating cancer; however, cardiotoxicity can occur, including myocarditis. Cardiac magnetic resonance (CMR) imaging is useful for evaluation of myocarditis, although it has not been well studied in ICI cardiotoxicity. Methods We identified patients referred for CMR evaluation of ICI cardiotoxicity from September 2015 through September 2019. We assessed structural and functional parameters, feature tracking (FT) left ventricular and atrial strain, T2- weighted ratios and quantitative late gadolinium enhancement (LGE). We also applied the Updated Lake Louise Criteria for diagnosis of myocarditis. Results Of the 20 patients referred, the median left ventricular ejection fraction (LVEF) was 52.5% +/- 19.1 and 50% had a normal LVEF (>= 53%). FT strain analysis revealed an average abnormal global longitudinal strain (GLS) of -9.8%+/- 4.2%. In patients with a normal LVEF, the average GLS remained depressed at -12.3%+/- 2.4%. In all patients, GLS demonstrated a significant negative correlation with LVEF (r(s) = -0.64, p 0.002). Sixteen patients (80%) had presence of LGE (14 non-ischemic pattern and 2 ischemic). Percent LGE did not correlate with any CMR parameters and notably did not correlate with LVEF (r(s) = -0.29, p = 0.22) or GLS (r(s) = 0.10, p = 0.67), highlighting the value of tissue characterization beyond functional assessment. Nine patients (45%) met full Updated Lake Louise Criteria and 85% met at least one criterion, suggestive of myocarditis in the correct clinical context. Thirteen patients (65%) were treated for ICI-associated myocarditis and, of these, 54% (n = 7) had recovery of LVEF to normal. There was no correlation between LVEF (p = 0.47), GLS (0.89), or % LGE (0.15) and recovery of LVEF with treatment. Conclusion In patients with suspected ICI cardiotoxicity, CMR is an important diagnostic tool, even in the absence of overt left ventricular dysfunction, as abnormalities in left ventricular strain, T2 signal and LGE can identifying disease.	[Higgins, Angela Y.; Arbune, Amit; Soufer, Aaron; Ragheb, Elio; Kwan, Jennifer M.; Henry, Mariana; Cuomo, Jason R.; Gallegos, Cesia; Hull, Sarah; Sinusas, Albert J.; Baldassarre, Lauren A.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Lamy, Jerome; Peters, Dana C.; Huber, Steffen; Mojibian, Hamid R.; Sinusas, Albert J.; Baldassarre, Lauren A.] Yale Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT 06510 USA; [Charifa, Ahmad] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Coviello, Jessica Shank; Bader, Anna S.] Yale Sch Nursing, New Haven, CT USA; [Coviello, Jessica Shank; Bader, Anna S.] Smilow Canc Hosp, New Haven, CT USA; [Sinusas, Albert J.] Yale Univ, Sch Engn & Appl Sci, Dept Biomed Engn, New Haven, CT USA; [Kluger, Harriet] Yale Univ, Sch Med, Dept Internal Med, Sect Med Oncol, New Haven, CT 06510 USA	Yale University; Yale University; Oregon Health & Science University; Yale University; Yale University; Yale University	Baldassarre, LA (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.; Baldassarre, LA (corresponding author), Yale Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT 06510 USA.	lauren.baldassarre@yale.edu	Charifa, Ahmad/AAY-9186-2021	Charifa, Ahmad/0000-0002-8476-1610; Peters, Dana/0000-0001-7556-4642; LAMY, Jerome/0000-0003-1931-2971	American Heart Association [18CDA34110361]; National Cancer Institute [R01 CA227473]	American Heart Association(American Heart Association); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	1) LB, grant #18CDA34110361, American Heart Association. https://www.heart.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2) HK, grant #R01 CA227473, National Cancer Institute. https://www.cancer.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammirati E, 2017, INT J CARDIOL, V231, P216, DOI 10.1016/j.ijcard.2016.11.282; Amzulescu MS, 2019, EUR HEART J-CARD IMG, V20, P605, DOI 10.1093/ehjci/jez041; [Anonymous], 2018, NAT REV DRUG DISCOV, V17, P854, DOI 10.1038/nrd.2018.210; Atallah-Yunes SA, 2019, J CANCER RES CLIN, V145, P1527, DOI 10.1007/s00432-019-02927-x; Awadalla M, 2020, J AM COLL CARDIOL, V75, P467, DOI 10.1016/j.jacc.2019.11.049; Bonaca MP, 2019, CIRCULATION, V140, P80, DOI 10.1161/CIRCULATIONAHA.118.034497; Brahmer JR, 2018, J ONCOL PRACT, V14, P247, DOI 10.1200/JOP.18.00005; Cao JJ, 2018, J CARDIOVASC MAGN R, V20, DOI 10.1186/s12968-018-0448-9; Chan RH, 2015, AM J CARDIOL, V116, P436, DOI 10.1016/j.amjcard.2015.04.060; De Velasco G, 2017, CANCER IMMUNOL RES, V5, P312, DOI 10.1158/2326-6066.CIR-16-0237; Doerner J, 2018, EUR J RADIOL, V104, P120, DOI 10.1016/j.ejrad.2018.05.012; Drobni ZD, 2020, CIRCULATION, V142, P2299, DOI 10.1161/CIRCULATIONAHA.120.049981; Evin M, 2016, AM J PHYSIOL-HEART C, V310, pH542, DOI 10.1152/ajpheart.00504.2015; Fent GJ, 2017, INT J CARDIOVAS IMAG, V33, P1561, DOI 10.1007/s10554-017-1138-7; Ferreira VM, 2018, J AM COLL CARDIOL, V72, P3158, DOI 10.1016/j.jacc.2018.09.072; Foks AC, 2017, BRIT J PHARMACOL, V174, P3940, DOI 10.1111/bph.13802; Friedrich MG, 2020, EUR HEART J, V41, P1744, DOI 10.1093/eurheartj/ehaa136; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; From AM, 2011, MAYO CLIN PROC, V86, P1095, DOI 10.4065/mcp.2011.0296; Gallegos C, 2019, EUR HEART J-CASE REP, V3, DOI 10.1093/ehjcr/yty149; Giri S, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-56; Gruen S, 2012, J AM COLL CARDIOL, V59, P1604, DOI 10.1016/j.jacc.2012.01.007; HAUCK AJ, 1989, MAYO CLIN PROC, V64, P1235, DOI 10.1016/S0025-6196(12)61286-5; Heinzerling L, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0152-y; Hinojar Rocio, 2015, JACC Cardiovasc Imaging, V8, P37, DOI 10.1016/j.jcmg.2014.07.016; Hu JR, 2019, CARDIOVASC RES, V115, P854, DOI 10.1093/cvr/cvz026; Jolly MP, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0373-3; Lamy J, 2018, COMPUT BIOL MED, V92, P197, DOI 10.1016/j.compbiomed.2017.11.015; Luetkens JA, 2016, EUR HEART J-CARD IMG, V17, P154, DOI 10.1093/ehjci/jev246; Mahmood SS, 2018, J AM COLL CARDIOL, V71, P1755, DOI 10.1016/j.jacc.2018.02.037; Pedrizzetti G, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0269-7; Plana JC, 2014, J AM SOC ECHOCARDIOG, V27, P911, DOI [10.1016/j.echo.2014.07.012, 10.1093/ehjci/jeu192]; Porcari A, 2020, CLIN RES CARDIOL, V109, P869, DOI 10.1007/s00392-019-01577-w; Thavendiranathan P, 2014, J AM COLL CARDIOL, V63, P2751, DOI 10.1016/j.jacc.2014.01.073; Tomita Y, 2017, ANN ONCOL, V28, P2893, DOI 10.1093/annonc/mdx326; Tsukamoto J, 2018, CASE REP ONCOL, V11, P648, DOI 10.1159/000492463; Vo HQ, 2018, JACC-CARDIOVASC IMAG, V11, P196, DOI 10.1016/j.jcmg.2016.12.025; von Knobelsdorff-Brenkenhoff F, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005242; Wang YC, 2019, JAMA ONCOL, V5, P1008, DOI 10.1001/jamaoncol.2019.0393; Yi JE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208100; Zhang LL, 2020, EUR HEART J, V41, P1733, DOI 10.1093/eurheartj/ehaa051; Zhou YW, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01350	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246764	10.1371/journal.pone.0246764	http://dx.doi.org/10.1371/journal.pone.0246764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606757	Green Published, gold			2022-12-26	WOS:000620629200077
J	Kim, HK; Chung, HJ; Le, HG; Na, BK; Cho, MC				Kim, Hyun-Ki; Chung, Hye Jin; Le, Huong Giang; Na, Byoung-Kuk; Cho, Min-Chul			Serum 24,25-dihydroxyvitamin D level in general Korean population and its relationship with other vitamin D biomarkers	PLOS ONE			English	Article								Background Vitamin D status is presently assessed by measuring total serum concentration of 25-hydroxyvitamin D [25(OH)D]. However, 25(OH)D concentration alone might not accurately reflect vitamin D status owing to its weak relationship with various clinical indices and inconsistency across races. Recently, 24,25-dihydroxyvitamin D [24,25(OH)(2)D] and vitamin D metabolite ratio [VMR; ratio of 24,25(OH)(2)D to 25(OH)D] have emerged as vitamin D biomarkers. The present study aimed to determine the values of 24,25(OH)(2)D and VMR in healthy Koreans and compare them with other vitamin D biomarkers, including 25(OH)D and bioavailable 25(OH)D. Methods Serum samples and medical information were collected from 200 individuals (100 females and 100 males) who underwent general health checks without self-reported symptoms. We measured 24,25(OH)(2)D concentration using liquid chromatography-tandem mass spectrometry, and concentrations of 25(OH)D and vitamin D binding protein using immunoassays. VMR and bioavailable 25(OH)D concentration were calculated using the above data. Serum parathyroid hormone level, and bone mineral density (BMD) data were collected as clinical outcomes, and the effects of the vitamin D markers on them were tested using multiple linear regression models. Results The mean values of 25(OH)D, 24,25(OH)(2)D, VMR, and bioavailable 25(OH)D were 24.3 +/- 8.5 ng/mL, 1.9 +/- 1.1 ng/mL, 7.6 +/- 2.5, and 3.2 +/- 1.2 ng/mL, respectively. The concentration of 25(OH)D closely correlated with 24,25(OH)(2)D (R = 0.868, P < 0.001) and bioavailable 25(OH)D (R = 0.862, P < 0.001). No significant effects of 24,25(OH)(2)D, VMR, and bioavailable 25(OH)D were observed on the prediction of PTH and BMD in the multiple linear regression models. Conclusion Our study presents the distribution of 24,25(OH)(2)D concentration and VMR in Korean population for the first time. Overall, our data reaffirm that 25(OH)D is the primary marker for determining vitamin D status in the general population.	[Kim, Hyun-Ki] Univ Ulsan, Ulsan Univ Hosp, Dept Lab Med, Coll Med, Ulsan, South Korea; [Chung, Hye Jin] Gyeongsang Natl Univ, Coll Pharm, Jinju, South Korea; [Chung, Hye Jin] Gyeongsang Natl Univ, Res Inst Pharmaceut Sci, Jinju, South Korea; [Le, Huong Giang; Na, Byoung-Kuk] Gyeongsang Natl Univ, Dept Parasitol & Trop Med, Coll Med, Jinju, South Korea; [Le, Huong Giang; Na, Byoung-Kuk] Gyeongsang Natl Univ, Dept Convergence Med Sci, BK21Plus Team Antiaging Biotechnol & Ind, Jinju, South Korea; [Cho, Min-Chul] Gyeongsang Natl Univ Hosp, Gyeongsang Natl Univ, Dept Lab Med, Coll Med, Jinju, South Korea; [Cho, Min-Chul] Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea	University of Ulsan; Ulsan University Hospital; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University	Cho, MC (corresponding author), Gyeongsang Natl Univ Hosp, Gyeongsang Natl Univ, Dept Lab Med, Coll Med, Jinju, South Korea.; Cho, MC (corresponding author), Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea.	mccho@gnu.ac.kr		Chung, Hye Jin/0000-0003-2274-6607; Cho, Min-Chul/0000-0002-0609-7734	Roche Diagnostics Korea [IIS-CPS-19-04]	Roche Diagnostics Korea	This study was funded by Roche Diagnostics Korea (IIS-CPS-19-04 to MCC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia J, 2017, CLIN ENDOCRINOL, V86, P674, DOI 10.1111/cen.13319; ARNAUD J, 1993, HUM GENET, V92, P183; Ashraf AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114689; Bartley J, 2010, EXPERT REV ANTI-INFE, V8, P1359, DOI 10.1586/eri.10.102; Berg AH, 2015, CLIN CHEM, V61, P877, DOI 10.1373/clinchem.2015.240051; Bhan I, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/561214; Bhan I, 2012, KIDNEY INT, V82, P84, DOI 10.1038/ki.2012.19; Bosworth CR, 2012, KIDNEY INT, V82, P693, DOI 10.1038/ki.2012.193; Chun RF, 2012, CELL BIOCHEM FUNCT, V30, P445, DOI 10.1002/cbf.2835; de Boer IH, 2014, AM J KIDNEY DIS, V64, P187, DOI 10.1053/j.ajkd.2014.02.015; Delanaye P, 2012, NEPHROL DIAL TRANSPL, V27, P2664, DOI 10.1093/ndt/gfs265; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Gerdhem P, 2005, OSTEOPOROSIS INT, V16, P1425, DOI 10.1007/s00198-005-1860-1; Hannan MT, 2008, J CLIN ENDOCR METAB, V93, P40, DOI 10.1210/jc.2007-1217; Heijboer AC, 2012, CLIN CHEM, V58, P543, DOI 10.1373/clinchem.2011.176545; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Johnsen MS, 2014, SCAND J CLIN LAB INV, V74, P177, DOI 10.3109/00365513.2013.869701; Jones G, 2014, J LIPID RES, V55, P13, DOI 10.1194/jlr.R031534; Jung JY, 2014, YONSEI MED J, V55, P1318, DOI 10.3349/ymj.2014.55.5.1318; KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950; Kim HJ, 2017, ANN LAB MED, V37, P34, DOI 10.3343/alm.2017.37.1.34; Kim HY, 2019, INT J ENDOCRINOL, V2019, DOI 10.1155/2019/9120467; Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9; Nimitphong H, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.24054; Park JH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011032; Pike JW, 2012, ARCH BIOCHEM BIOPHYS, V523, P2, DOI 10.1016/j.abb.2011.12.003; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Schwartz JB, 2014, J CLIN ENDOCR METAB, V99, P1631, DOI 10.1210/jc.2013-3874; SHERMAN SS, 1992, J BONE MINER RES, V7, P1123; Tang JCY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43462-6; Tang JCY, 2017, J NUTR BIOCHEM, V46, P21, DOI 10.1016/j.jnutbio.2017.04.005; van den Ouweland JMW, 2010, J CHROMATOGR B, V878, P1163, DOI 10.1016/j.jchromb.2010.03.035; Wagner D, 2011, J STEROID BIOCHEM, V126, P72, DOI 10.1016/j.jsbmb.2011.05.003; Yu SL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000585	39	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246541	10.1371/journal.pone.0246541	http://dx.doi.org/10.1371/journal.pone.0246541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606762	gold, Green Published			2022-12-26	WOS:000620629200028
J	Lloyd, NR; Wuttke, DS				Lloyd, Neil R.; Wuttke, Deborah S.			Cyp33 binds AU-rich RNA motifs via an extended interface that competitively disrupts the gene repressive Cyp33-MLL1 interaction in vitro	PLOS ONE			English	Article								Cyp33 is an essential human cyclophilin prolyl isomerase that plays myriad roles in splicing and chromatin remodeling. In addition to a canonical cyclophilin (Cyp) domain, Cyp33 contains an RNA-recognition motif (RRM) domain, and RNA-binding triggers proline isomerase activity. One prominent role for Cyp33 is through a direct interaction with the mixed lineage leukemia protein 1 (MLL1, also known as KMT2A) complex, which is a histone methyltransferase that serves as a global regulator of human transcription. MLL activity is regulated by Cyp33, which isomerizes a key proline in the linker between the PHD3 and Bromo domains of MLL1, acting as a switch between gene activation and repression. The direct interaction between MLL1 and Cyp33 is critical, as deletion of the MLL1-PHD3 domain responsible for this interaction results in oncogenesis. The Cyp33 RRM is central to these activities, as it binds both the PHD3 domain and RNA. To better understand how RNA binding drives the action of Cyp33, we performed RNA-SELEX against full-length Cyp33 accompanied by deep sequencing. We have identified an enriched Cyp33 binding motif (AAUAAUAA) broadly represented in the cellular RNA pool as well as tightly binding RNA aptamers with affinities comparable and competitive with the Cyp33 MLL1-PHD3 interaction. RNA binding extends beyond the canonical RRM domain, but not to the Cyp domain, suggesting an indirect mechanism of interaction. NMR chemical shift mapping confirms an overlapping, but not identical, interface on Cyp33 for RNA and PHD3 binding. This finding suggests RNA can disrupt the gene repressive Cyp33-MLL1 complex providing another layer of regulation for chromatin remodeling by MLL1.	[Lloyd, Neil R.; Wuttke, Deborah S.] Univ Colorado, Dept Biochem, UCB 596, Boulder, CO 80309 USA; [Lloyd, Neil R.] KBI Biopharma, Louisville, CO USA	University of Colorado System; University of Colorado Boulder	Wuttke, DS (corresponding author), Univ Colorado, Dept Biochem, UCB 596, Boulder, CO 80309 USA.	Deborah.wuttke@colorado.edu		WUTTKE, DEBORAH/0000-0002-8158-8795	National Science Foundation [MCB 1716425]; National Institutes of Health, General Medicine Division [T32 GM-065103]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health, General Medicine Division(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	DSW, MCB 1716425, The National Science Foundation, https://www.nsf.gov NL, T32 GM-065103, The National Institutes of Health, General Medicine Division, https://www.nih.gov.	Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bessonov S, 2010, RNA, V16, P2384, DOI 10.1261/rna.2456210; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen J, 2008, CANCER RES, V68, P6199, DOI 10.1158/0008-5472.CAN-07-6514; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Gustafson CL, 2017, MOL CELL, V66, P447, DOI 10.1016/j.molcel.2017.04.011; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hanes SD, 2015, BBA-GEN SUBJECTS, V1850, P2017, DOI 10.1016/j.bbagen.2014.10.028; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hoinka J, 2018, MOL THER-NUCL ACIDS, V11, P515, DOI 10.1016/j.omtn.2018.04.006; Hom RA, 2010, J MOL BIOL, V400, P145, DOI 10.1016/j.jmb.2010.04.067; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Lee JH, 2009, STRUCTURE, V17, P833, DOI 10.1016/j.str.2009.04.010; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; McKercher MA, 2018, PROTEINS, V86, P164, DOI 10.1002/prot.25420; Mi HF, 1996, FEBS LETT, V398, P201, DOI 10.1016/S0014-5793(96)01248-3; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mohr S, 2013, RNA, V19, P958, DOI 10.1261/rna.039743.113; Muto Y, 2012, WIRES RNA, V3, P229, DOI 10.1002/wrna.1107; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; NAKAMURA T, 1993, P NATL ACAD SCI USA, V90, P4631, DOI 10.1073/pnas.90.10.4631; Nath PR, 2015, IMMUNOL LETT, V163, P120, DOI 10.1016/j.imlet.2014.11.002; Park S, 2010, BIOCHEMISTRY-US, V49, P6576, DOI 10.1021/bi1009387; Dao P, 2016, CELL SYST, V3, P62, DOI 10.1016/j.cels.2016.07.003; Rideau AP, 2006, NAT STRUCT MOL BIOL, V13, P839, DOI 10.1038/nsmb1137; Rivas E, 2017, NAT METHODS, V14, P45, DOI [10.1038/NMETH.4066, 10.1038/nmeth.4066]; RUBNITZ JE, 1994, BLOOD, V84, P1747; Song JK, 2008, P NATL ACAD SCI USA, V105, P15317, DOI 10.1073/pnas.0801274105; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang Y, 2008, FEBS LETT, V582, P835, DOI 10.1016/j.febslet.2008.01.055; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100	42	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0237956	10.1371/journal.pone.0237956	http://dx.doi.org/10.1371/journal.pone.0237956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606679	gold, Green Published, Green Submitted			2022-12-26	WOS:000620629200034
J	Qin, MS; Zhang, Y; Wan, SQ; Yue, Y; Cheng, Y; Zhang, B				Qin, Mengsheng; Zhang, Yuan; Wan, Shiquan; Yue, Yuan; Cheng, Yuan; Zhang, Bo			Impact of climate change on "evaporation paradox" in province of Jiangsu in southeastern China	PLOS ONE			English	Article							REFERENCE CROP EVAPOTRANSPIRATION; KEY METEOROLOGICAL VARIABLES; HUAI RIVER-BASIN; PAN EVAPORATION; POTENTIAL EVAPOTRANSPIRATION; TREND ANALYSIS; SPATIAL-DISTRIBUTION; TEMPORAL TRENDS; ABRUPT CHANGES; ARIDITY INDEX	Contrary to the common expectation that the reference evapotranspiration (ETo), which is an indicator of the atmospheric evaporation capability, increases in warming climate, the decline of the ETo has been reported worldwide, and this contradiction between the expected increasing ETo and the observed decreasing one is now termed the "evaporation paradox". Based on the updated meteorological data (1960-2019), we separately detected the spatiotemporal characteristics and the causes of the "evaporation paradox" in three subregions, namely Huaibei, Jianghuai, and Sunan, and throughout the entire province of Jiangsu in southeastern China. Different from the reported continuous unidirectional variations in the ETo, in the province of Jiangsu, it generally showed a decreasing trend before 1990 but followed an increasing trend from 1990 to 2019, which led to the different characteristics of the "evaporation paradox" in the periods from 1960 to 1989, from 1990 to 2019, and from 1960 to 2019. In the first 30 years, the reduction of the wind speed (WS) was the main reason for the decreased ETo, which consequently gave rise to the "evaporation paradox" in spring and winter in the Huaibei region and only in winter in the two other subregions and throughout the entire province. We noticed that the "evaporation paradox" in spring in the Sunan region was expressed by the decreased daily mean air temperature (T-mean) and the increased ETo which was chiefly induced by the decreased relative humidity (RH) and the increased vapor pressure deficit (VPD). After 1990, the decreased WS also dominated the decreased ETo and resulted in the "evaporation paradox" in winter in the Jianghuai region. Furthermore, the decreased sunshine hour (SH) was the main factor influencing the decreased ETo, thereby inducing the "evaporation paradox" in summer and autumn in the Jianghuai region and only in autumn in the Huaibei region and throughout the whole province from 1990 to 2019. In the whole study period from 1960 to 2019, the decreased SH was also found to be responsible for the decreased ETo and for the "evaporation paradox" in summer in all the subregions and throughout the whole province. However, regarding the "evaporation paradox" in autumn, in winter, and in the entire year in the Huaibei region and throughout the whole province, the observed decreased ETo was largely due to the reduced WS from 1960 to 2019. In summary, in addition to the air temperature, the ETo has shifted due to the other meteorological variables (especially the WS, the SH, and the VPD) and shaped the unique spatiotemporal characteristics of the "evaporation paradox" in the province of Jiangsu in southeastern China. Moreover, future studies and simulations addressing the regional climate change and hydrological cycles should take account of the changeable key meteorological variables in different subregions and seasons of the province of Jiangsu.	[Qin, Mengsheng; Zhang, Yuan; Wan, Shiquan; Cheng, Yuan; Zhang, Bo] Yangzhou Meteorol Off, Yangzhou, Jiangsu, Peoples R China; [Yue, Yuan] Meteorol Observ Jilin Prov, Changchun, Peoples R China	Chinese Academy of Sciences; Changchun Observatory, NAOC, CAS	Wan, SQ (corresponding author), Yangzhou Meteorol Off, Yangzhou, Jiangsu, Peoples R China.	wan_sq@qq.com		Qin, mengsheng/0000-0002-7009-7464	Jiangsu Meteorological Bureau Science Foundation for Young Scholars [KQ202015]; National Natural Science Foundation of China [:42075051]	Jiangsu Meteorological Bureau Science Foundation for Young Scholars; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is financially supported by Jiangsu Meteorological Bureau Science Foundation for Young Scholars (NO: KQ202015) and National Natural Science Foundation of China (NO:42075051).	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Bao ZX., 2014, J WATER RESOUR WATER, V25, P1; Burn DH, 2007, J HYDROL, V336, P61, DOI 10.1016/j.jhydrol.2006.12.011; Chen SB, 2006, CLIMATIC CHANGE, V76, P291, DOI 10.1007/s10584-006-9080-z; Chylek P, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038777; Cohen S, 2002, AGR FOREST METEOROL, V111, P83, DOI 10.1016/S0168-1923(02)00016-3; Cong ZT, 2009, HYDROL EARTH SYST SC, V13, P357, DOI 10.5194/hess-13-357-2009; [崔林丽 CUI Linli], 2008, [地理研究, Geographical Research], V27, P775; Dabral PP, 2014, GLOBAL NEST J, V16, P280; Darshana, 2013, STOCH ENV RES RISK A, V27, P1407, DOI 10.1007/s00477-012-0677-7; Dinpashoh Y, 2011, J HYDROL, V399, P422, DOI 10.1016/j.jhydrol.2011.01.021; Fan JL, 2016, J HYDROL, V542, P923, DOI 10.1016/j.jhydrol.2016.09.060; Geng Ting, 2012, Journal of Triticeae Crops, V32, P1183; Gu CL, 2011, HABITAT INT, V35, P544, DOI 10.1016/j.habitatint.2011.03.002; Guerreiro SB, 2014, INT J CLIMATOL, V34, P114, DOI 10.1002/joc.3669; HIRSCH RM, 1982, WATER RESOUR RES, V18, P107, DOI 10.1029/WR018i001p00107; Huo ZL, 2013, J HYDROL, V492, P24, DOI 10.1016/j.jhydrol.2013.04.011; Irmak S, 2012, J HYDROL, V420, P228, DOI 10.1016/j.jhydrol.2011.12.006; Jhajharia D, 2012, HYDROL PROCESS, V26, P421, DOI 10.1002/hyp.8140; [蒋冲 Jiang Chong], 2013, [生态学报, Acta Ecologica Sinica], V33, P844; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kousari MR, 2012, INT J CLIMATOL, V32, P2387, DOI 10.1002/joc.3404; Li M, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12051743; Li M, 2018, SCI TOTAL ENVIRON, V625, P496, DOI 10.1016/j.scitotenv.2017.12.317; Li ZL, 2013, HYDROL RES, V44, P904, DOI 10.2166/nh.2012.125; Li Z, 2013, WATER RESOUR RES, V49, P2205, DOI 10.1002/wrcr.20202; Liu BH, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004511; Liu QA, 2010, HYDROL PROCESS, V24, P2171, DOI 10.1002/hyp.7649; Lu XH, 2016, INT SOIL WATER CONSE, V4, P45, DOI 10.1016/j.iswcr.2016.02.004; [马雪宁 Ma Xuening], 2012, [地理学报, Acta Geographica Sinica], V67, P645; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; McVicar TR, 2012, J HYDROL, V416, P182, DOI 10.1016/j.jhydrol.2011.10.024; Moonen AC, 2002, AGR FOREST METEOROL, V111, P13, DOI 10.1016/S0168-1923(02)00012-6; Novick KA, 2016, NAT CLIM CHANGE, V6, P1023, DOI [10.1038/nclimate3114, 10.1038/NCLIMATE3114]; PETERSON TC, 1995, NATURE, V377, P687, DOI 10.1038/377687b0; Pettitt A. N., 1979, Applied Statistics, V28, P126, DOI 10.2307/2346729; Pielke RA, 2005, SCIENCE, V310, P1625, DOI 10.1126/science.1120529; Qin MS, 2019, J AM WATER RESOUR AS, V55, P189, DOI 10.1111/1752-1688.12714; Roderick ML, 2004, INT J CLIMATOL, V24, P1077, DOI 10.1002/joc.1061; Roderick ML, 2002, SCIENCE, V298, P1410; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Soltani E., 2008, Research Journal of Environmental Sciences, V2, P316; Tabari H, 2011, METEOROL ATMOS PHYS, V111, P121, DOI 10.1007/s00703-011-0125-0; Tabari H, 2011, AGR FOREST METEOROL, V151, P128, DOI 10.1016/j.agrformet.2010.09.009; Tao SL, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8030214; Tebakari T, 2005, J HYDROL ENG, V10, P205, DOI 10.1061/(ASCE)1084-0699(2005)10:3(205); Vicente-Serrano SM, 2014, WATER RESOUR RES, V50, P8458, DOI 10.1002/2014WR015427; [王炳亮 Wang Bingliang], 2014, [地理科学, Scientia Geographica Sinica], V34, P1233; Wang TT, 2017, WIRES WATER, V4, DOI 10.1002/wat2.1207; [王永东 Wang Yongdong], 2013, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V27, P114; Wang ZL, 2017, J HYDROL, V544, P97, DOI 10.1016/j.jhydrol.2016.11.021; [王忠富 Wang Zhongfu], 2015, [冰川冻土, Journal of Glaciology and Geocryology], V37, P1323; Wypych A, 2010, THEOR APPL CLIMATOL, V101, P475, DOI 10.1007/s00704-009-0221-y; [谢平 Xie Ping], 2016, [灌溉排水学报, Journal of Irrigation and Drainage], V35, P81; Xing WQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep39503; Xu CY, 2006, J HYDROL, V327, P81, DOI 10.1016/j.jhydrol.2005.11.029; Xu LH, 2015, HYDROL PROCESS, V29, P4846, DOI 10.1002/hyp.10541; Yang LinShan, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P102; Yue Yuan, 2017, Shengtaixue Zazhi, V36, P1993, DOI 10.13292/j.1000-4890.201707.030; Zha SP., 2011, J ANHUI AGR SCI, V8, P4692; Zhang D, 2013, STOCH ENV RES RISK A, V27, P1871, DOI 10.1007/s00477-013-0723-0; Zhao N, 2015, IAHS-AISH P, V368, P287; [周旗 ZHOU Qi], 2011, [地理学报, Acta Geographica Sinica], V66, P1211; Zuo DP, 2012, HYDROL PROCESS, V26, P1149, DOI 10.1002/hyp.8206	65	6	6	18	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247278	10.1371/journal.pone.0247278	http://dx.doi.org/10.1371/journal.pone.0247278			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606798	gold, Green Published			2022-12-26	WOS:000620629200124
J	Shahidi, RK; Hoffmann, JM; Hedjazifar, S; Bonnet, L; Baboota, RK; Heasman, S; Church, C; Elias, I; Bosch, F; Boucher, J; Hammarstedt, A; Smith, U				Shahidi, Roxana Khatib; Hoffmann, Jenny M.; Hedjazifar, Shahram; Bonnet, Laurianne; Baboota, Ritesh K.; Heasman, Stephanie; Church, Christopher; Elias, Ivet; Bosch, Fatima; Boucher, Jeremie; Hammarstedt, Ann; Smith, Ulf			Adult mice are unresponsive to AAV8-Gremlin1 gene therapy targeting the liver	PLOS ONE			English	Article								Objective Gremlin 1 (GREM1) is a secreted BMP2/4 inhibitor which regulates commitment and differentiation of human adipose precursor cells and prevents the browning effect of BMP4. GREM1 is an insulin antagonist and serum levels are high in type 2 diabetes (T2D). We here examined in vivo effects of AAV8 (Adeno-Associated Viral vectors of serotype eight) GREM 1 targeting the liver in mature mice to increase its systemic secretion and also, in a separate study, injected recombinant GREM 1 intraperitoneally. The objective was to characterize systemic effects of GREM 1 on insulin sensitivity, glucose tolerance, body weight, adipose cell browning and other local tissue effects. Methods Adult mice were injected with AAV8 vectors expressing GREM1 in the liver or receiving regular intra-peritoneal injections of recombinant GREM1 protein. The mice were fed with a low fat or high fat diet (HFD) and followed over time. Results Liver-targeted AAV8-GREM1 did not alter body weight, whole-body glucose and insulin tolerance, or adipose tissue gene expression. Although GREM1 protein accumulated in liver cells, GREM1 serum levels were not increased suggesting that it may not have been normally processed for secretion. Hepatic lipid accumulation, inflammation and fibrosis were also not changed. Repeated intraperitoneal rec-GREM1 injections for 5 weeks were also without effects on body weight and insulin sensitivity. UCP1 was slightly but significantly reduced in both white and brown adipose tissue but this was not of sufficient magnitude to alter body weight. We validated that recombinant GREM1 inhibited BMP4-induced pSMAD1/5/9 in murine cells in vitro, but saw no direct inhibitory effect on insulin signalling and pAkt (ser 473 and thr 308) activation. Conclusion GREM1 accumulates intracellularly when overexpressed in the liver cells of mature mice and is apparently not normally processed/secreted. However, also repeated intraperitoneal injections were without effects on body weight and insulin sensitivity and adipose tissue UCP1 levels were only marginally reduced. These results suggest that mature mice do not readily respond to GREMLIN 1 but treatment of murine cells with GREMLIN 1 protein in vitro validated its inhibitory effect on BMP4 signalling while insulin signalling was not altered.	[Shahidi, Roxana Khatib; Hoffmann, Jenny M.; Hedjazifar, Shahram; Bonnet, Laurianne; Baboota, Ritesh K.; Boucher, Jeremie; Hammarstedt, Ann; Smith, Ulf] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden; [Bonnet, Laurianne; Boucher, Jeremie] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden; [Heasman, Stephanie; Church, Christopher] AstraZeneca, Biosci Metab Res & Early Dev, BioPharmaceut R&D, Cardiovasc Renal & Metab CVRM, Cambridge, England; [Elias, Ivet; Bosch, Fatima] Univ Autonoma Barcelona, Sch Vet Med, Ctr Anim Biotechnol & Gene Therapy, Bellaterra, Spain; [Elias, Ivet; Bosch, Fatima] Univ Autonoma Barcelona, Sch Vet Med, Dept Biochem & Mol Biol, Bellaterra, Spain; [Elias, Ivet; Bosch, Fatima] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Boucher, Jeremie] AstraZeneca, BioPharmaceut R&D, Biosci Metab Res & Early Dev, Cardiovasc Renal & Metab CVRM, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; AstraZeneca; Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; AstraZeneca	Smith, U (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden.	ulf.smith@medic.gu.se		BOSCH, FATIMA/0000-0002-7705-5515	Swedish Research Council; Novo Nordisk Foundation; Torsten Soderberg Foundation; Swedish ALF Funds [718601]; Swedish Diabetes Association	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Torsten Soderberg Foundation; Swedish ALF Funds; Swedish Diabetes Association	Ulf Smith received financial support from the Swedish Research Council, the Novo Nordisk Foundation, the Torsten Soderberg Foundation, the Swedish ALF Funds (no. 718601) and the Swedish Diabetes Association. Co-authors SH, CC and JB are employees of Astra Zeneca. However, the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries. The specific roles of these authors are articulated in the `author contributions' section.	Anguela XM, 2013, DIABETES, V62, P551, DOI 10.2337/db11-1776; Bowers RR, 2007, CELL CYCLE, V6, P385, DOI 10.4161/cc.6.4.3804; Calpe S, 2016, MABS-AUSTIN, V8, P678, DOI 10.1080/19420862.2016.1158380; Chiodelli P, 2011, ARTERIOSCL THROM VAS, V31, pE116, DOI 10.1161/ATVBAHA.111.235184; Christensen GL, 2015, DIABETOLOGIA, V58, P1282, DOI 10.1007/s00125-015-3568-x; Church RH, 2017, AM J PHYSIOL-RENAL, V312, pF1141, DOI 10.1152/ajprenal.00344.2016; Dutton LR, 2019, J BIOL CHEM, V294, P18041, DOI 10.1074/jbc.AC119.010148; Goulley J, 2007, CELL METAB, V5, P207, DOI 10.1016/j.cmet.2007.01.009; Grillo E, 2016, ONCOTARGET, V7, P35353, DOI 10.18632/oncotarget.9286; Gustafson B, 2015, ATHEROSCLEROSIS, V241, P27, DOI 10.1016/j.atherosclerosis.2015.04.812; Gustafson B, 2015, DIABETES, V64, P1670, DOI 10.2337/db14-1127; Hammarstedt A, 2018, PHYSIOL REV, V98, P1911, DOI 10.1152/physrev.00034.2017; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; Hedjazifar S, 2020, DIABETES, V69, P331, DOI 10.2337/db19-0701; Hoffmann JM, 2020, MOL METAB, V32, P15, DOI 10.1016/j.molmet.2019.11.016; Hoffmann JM, 2017, CELL REP, V20, P1038, DOI 10.1016/j.celrep.2017.07.020; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; Modica S, 2016, CELL REP, V16, P2243, DOI 10.1016/j.celrep.2016.07.048; Muller I, 2013, J BIOL CHEM, V288, P31635, DOI 10.1074/jbc.M113.477745; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Roxburgh SA, 2009, DIABETES, V58, P1641, DOI 10.2337/db08-1365; Sanders LN, 2016, CIRC RES, V119, P434, DOI 10.1161/CIRCRESAHA.116.308700; Shi W, 2001, AM J PHYSIOL-LUNG C, V280, pL1030, DOI 10.1152/ajplung.2001.280.5.L1030; Tumelty KE, 2018, J BIOL CHEM, V293, P3039, DOI 10.1074/jbc.M117.804021; Vila L, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.39; Wang YH, 2015, MECH DEVELOP, V138, P256, DOI 10.1016/j.mod.2015.10.003; Wordinger RJ, 2008, EXP EYE RES, V87, P78, DOI 10.1016/j.exer.2007.11.016; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	30	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247300	10.1371/journal.pone.0247300	http://dx.doi.org/10.1371/journal.pone.0247300			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606810	Green Published, gold			2022-12-26	WOS:000620629200101
J	Umar, Z; Gubareva, M; Naeem, M; Akhter, A				Umar, Zaghum; Gubareva, Mariya; Naeem, Muhammad; Akhter, Ayesha			Return and volatility transmission between oil price shocks and agricultural commodities	PLOS ONE			English	Article								This paper studies the connectedness between oil price shocks and agricultural commodities. Our sample period ranges from January 2002 to July 2020, covering the three global crises; Global Financial Crisis, the European sovereign debt crisis and Covid-19 pandemic crisis. We employ Granger causality tests, and the static and dynamic connectedness spillover index methodology. We find that the shocks in oil prices are Granger-caused mainly by price changes of grains, live cattle, and wheat, while supply shock granger causes variations mostly in grain prices. We find that, from the point of view of static connectedness, for both, price and volatility spillovers, the livestock is the largest transmitter, while the lean hogs are the major receiver. Our dynamic analysis evidences that connectedness increases during the financial crisis period. Our results are potentially useful for investors, portfolios managers and policy makers.	[Umar, Zaghum] Zayed Univ, Coll Business, Abu Dhabi, U Arab Emirates; [Umar, Zaghum] South Ural State Univ, Chelyabinsk, Russia; [Gubareva, Mariya] Inst Politecn Lisboa, ISCAL Lisbon Accounting & Business Sch, Lisbon, Portugal; [Gubareva, Mariya] SOCIUS CSG Res Social Sci & Management Rua Miguel, Lisbon, Portugal; [Naeem, Muhammad; Akhter, Ayesha] Univ Cent Punjab, UCP Business Sch, Lahore, Punjab, Pakistan	Zayed University; South Ural State University; Polytechnic Institute of Lisbon; University of Central Punjab	Gubareva, M (corresponding author), Inst Politecn Lisboa, ISCAL Lisbon Accounting & Business Sch, Lisbon, Portugal.; Gubareva, M (corresponding author), SOCIUS CSG Res Social Sci & Management Rua Miguel, Lisbon, Portugal.	mgubareva@iscal.ipl.pt	Naeem, Muhammad Abubakr/HCH-3576-2022; Gubareva, Mariya/Y-8520-2018	Naeem, Muhammad Abubakr/0000-0001-6962-3175; Gubareva, Mariya/0000-0001-6829-7021; Umar, Zaghum/0000-0002-0425-2665	Instituto Politecnico de Lisboa (IPL); FCT, I.P., the Portuguese national funding agency for science, research and technology [UIDB/04521/2020]	Instituto Politecnico de Lisboa (IPL); FCT, I.P., the Portuguese national funding agency for science, research and technology	The second author thankfully acknowledges the financial support by Instituto Politecnico de Lisboa (IPL) and by FCT, I.P., the Portuguese national funding agency for science, research and technology, under the Project UIDB/04521/2020.	Adam P., 2016, AGRIS On-line Papers in Economics and Informatics, V8, P3; Adam P., 2018, INT, V8, P90; Ahmadi M, 2016, ENERG ECON, V59, P11, DOI 10.1016/j.eneco.2016.07.006; Baumeister C, 2014, ECON POLICY, V29, P691, DOI 10.1111/1468-0327.12039; Beckmann J, 2015, N AM J ECON FINANC, V34, P292, DOI 10.1016/j.najef.2015.09.015; Chang TH, 2010, ENERGY, V35, P2807, DOI 10.1016/j.energy.2010.03.006; Chen SS, 2010, ENERG ECON, V32, P490, DOI 10.1016/j.eneco.2009.08.018; Ciaian P, 2011, RESOUR ENERGY ECON, V33, P326, DOI 10.1016/j.reseneeco.2010.07.004; Cooke B., 2009, INT FOOD POLICY RES; Diebold FX, 2014, J ECONOMETRICS, V182, P119, DOI 10.1016/j.jeconom.2014.04.012; Diebold FX, 2012, INT J FORECASTING, V28, P57, DOI 10.1016/j.ijforecast.2011.02.006; Diebold FX, 2009, ECON J, V119, P158, DOI 10.1111/j.1468-0297.2008.02208.x; Esmaeili A, 2011, ENERG POLICY, V39, P1022, DOI 10.1016/j.enpol.2010.11.004; Fowowe B, 2016, ENERGY, V104, P149, DOI 10.1016/j.energy.2016.03.101; Frankel J., 2008, VOXEU; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hochman G, 2012, AGRICULTURE-BASEL, V2, P272, DOI 10.3390/agriculture2030272; Kilian L, 2009, AM ECON REV, V99, P1053, DOI 10.1257/aer.99.3.1053; Koirala KH, 2015, ENERGY, V81, P430, DOI 10.1016/j.energy.2014.12.055; Koop G, 1996, J ECONOMETRICS, V74, P119, DOI 10.1016/0304-4076(95)01753-4; Lu YX, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11020396; Lucotte Y, 2016, ECON LETT, V147, P142, DOI 10.1016/j.econlet.2016.08.032; Malik F, 2019, ENERG ECON, V84, DOI 10.1016/j.eneco.2019.104501; Mikutowski M, 2020, FINANC RES LETT; Naeem M, 2020, PHYSICA A, V557, DOI 10.1016/j.physa.2020.124885; Nazlioglu S, 2012, ENERG ECON, V34, P1098, DOI 10.1016/j.eneco.2011.09.008; Pal D, 2018, PHYSICA A, V492, P1032, DOI 10.1016/j.physa.2017.11.033; Pesaran HH, 1998, ECON LETT, V58, P17, DOI 10.1016/S0165-1765(97)00214-0; Rafiq S, 2009, RESOUR POLICY, V34, P121, DOI 10.1016/j.resourpol.2008.09.001; Ready RC, 2018, REV FINANC, V22, P155, DOI 10.1093/rof/rfw071; Spierdijk L, 2015, J ECON BUS, V79, P1, DOI 10.1016/j.jeconbus.2014.12.004; Sugden C, 2009, ASIAN-PAC ECON LIT, V23, P79, DOI 10.1111/j.1467-8411.2009.01224.x; Umar Z, 2013, NETSPAR DISCUSSION P, DOI [10.2139/ssrn.1964632, DOI 10.2139/SSRN.1964632]; Umar Z, 2020, ECON MODEL, V93, P112, DOI 10.1016/j.econmod.2020.08.007; Umar Z, 2019, RESOUR POLICY, V64, DOI 10.1016/j.resourpol.2019.101516; Umar Z, 2019, RESOUR POLICY, V63, DOI 10.1016/j.resourpol.2019.101472; Vacha L, 2013, ENERG ECON, V40, P233, DOI 10.1016/j.eneco.2013.06.015; Wang YD, 2014, ENERG ECON, V44, P22, DOI 10.1016/j.eneco.2014.03.016; Zaremba A, 2019, ECON LETT, V181, P90, DOI 10.1016/j.econlet.2019.05.002; Zhang CG, 2015, ENERG ECON, V51, P354, DOI 10.1016/j.eneco.2015.07.012	40	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246886	10.1371/journal.pone.0246886	http://dx.doi.org/10.1371/journal.pone.0246886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606770	Green Published, gold			2022-12-26	WOS:000620629200062
J	Gallois, S; Heger, T; Henry, AG; van Andel, T				Gallois, Sandrine; Heger, Thomas; Henry, Amanda Georganna; van Andel, Tinde			The importance of choosing appropriate methods for assessing wild food plant knowledge and use: A case study among the Baka in Cameroon	PLOS ONE			English	Article								In tropical rainforests, access to and availability of natural resources are vital for the dietary diversity and food security of forest-dwelling societies. In the Congo Basin, these are challenged by the increasing exploitation of forests for bushmeat, commercial hardwood, mining, and large-scale agriculture. In this context, a balanced approach is needed between the pressures from forest exploitation, non-timber forest product trade and the livelihood and dietary behavior of rural communities. While there is a general positive association between tree cover and dietary diversity, the complex biocultural interactions between tropical forest food resources and the communities they sustain are still understudied. This research focuses on the knowledge and use of wild food plants by the forest-dwelling Baka people in southeast Cameroon. By using two different sets of methods, namely ex-situ interviews and in-situ surveys, we collected ethnographic and ethnobotanical data in two Baka settlements and explored the diversity of wild edible plants known, the frequency of their consumption, and potential conflicts between local diet and commercial trade in forest resources. Within a single Baka population, we showed that the in-situ walk-in-the-woods method resulted in more detailed information on wild food plant knowledge and use frequency than the ex-situ methods of freelisting and dietary recalls. Our in-situ method yielded 91 wild edible species, much more than the ex-situ freelisting interviews (38 spp.) and dietary recalls (12 spp.). Our results suggest that studies that are based only on ex-situ interviews may underestimate the importance of wild food plants for local communities. We discuss the limitations and strengths of these different methods for investigating the diversity of wild food plant knowledge and uses. Our analysis shows that future studies on wild food plants would profit from a mixed approach that combines in-situ and ex-situ methods.	[Gallois, Sandrine; Henry, Amanda Georganna] Leiden Univ, Fac Archaeol, Leiden, Netherlands; [Heger, Thomas; van Andel, Tinde] Wageningen Univ, Biosystemat Grp, Wageningen, Netherlands; [van Andel, Tinde] Nat Biodivers Ctr, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Wageningen University & Research; Naturalis Biodiversity Center	Gallois, S (corresponding author), Leiden Univ, Fac Archaeol, Leiden, Netherlands.	galloissandrine.ethnoeco@gmail.com	Gallois, Sandrine/AAG-4964-2019; van Andel, Tinde/F-4962-2016	Gallois, Sandrine/0000-0002-4354-7685; van Andel, Tinde/0000-0002-4951-1894; Henry, Amanda/0000-0002-2923-4199	European Research Council under the European Union's Horizon 2020 research and innovation program [STG-677576]; Naturalis Biodiversity Center; TreubMaatschappij; Alberta Mennega Stichting	European Research Council under the European Union's Horizon 2020 research and innovation program; Naturalis Biodiversity Center; TreubMaatschappij; Alberta Mennega Stichting	This research has received funding from the European Research Council under the European Union's Horizon 2020 research and innovation program; grant agreement number STG-677576 ("HARVEST") awarded to AGH. The botanical fieldwork was funded by Naturalis Biodiversity Center (https://www.naturalis.nl/en)to TVA, the TreubMaatschappij and the Alberta Mennega Stichting (https://www.alberta-mennegastichting.nl) to TH. None of the funders has played a role in the research design, data collection, analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2020, PLANTS WORLD ONLINE; Association de Botanique Tropicale, FLORE CAMEROUN, P1963; Awuh HE, 2016, TRANSFERS, V6, P54, DOI 10.3167/TRANS.2016.060205; Bahuchet S., 1992, FORET AFRIQUE CENTRA; Baudron F, 2019, FRONT SUSTAIN FOOD S, V3, DOI 10.3389/fsufs.2019.00097; Beaune D, 2013, FOREST ECOL MANAG, V295, P109, DOI 10.1016/j.foreco.2012.12.041; Betti JL, 2020, ETHNOBOT RES APPL, V19, P1; Bharucha Z, 2010, PHILOS T R SOC B, V365, P2913, DOI 10.1098/rstb.2010.0123; Fils PEB, 2020, J ETHNOBIOL ETHNOMED, V16, DOI 10.1186/s13002-020-00413-0; Brisson R., 2010, PETIT DICT BAKA FRAN; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; CITES, 2019, UNEP WCMC SPECIES DA; Crittenden AN., 2009, AM J PHYS ANTHROPOL, V138, P75, DOI [10.1002/ajpa.21030, DOI 10.1002/AJPA.21030]; Da Cunha LVFC, 2006, ENVIRON MONIT ASSESS, V114, P1, DOI 10.1007/s10661-006-1074-9; de Albuquerque UP, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-30; De Wasseige C., 2012, FORETS BASSIN CONGO; Delang CO, 2006, ECOL ECON, V59, P64, DOI 10.1016/j.ecolecon.2005.10.006; do Nascimento VT, 2013, ECOL FOOD NUTR, V52, P317, DOI 10.1080/03670244.2012.707434; DOUNIAS E, 1993, MAN BIOSPH, V13, P621; Fa JE, 2003, ENVIRON CONSERV, V30, P71, DOI 10.1017/S0376892903000067; Fentahun Mengistu, 2008, Ethnobotany Research and Applications, V6, P487; Fongnzossie EF, 2020, J ETHNOBIOL ETHNOMED, V16, DOI 10.1186/s13002-020-00362-8; Friant S, 2019, FRONT SUSTAIN FOOD S, V3, DOI 10.3389/fsufs.2019.00113; Gallois S, 2020, ECON BOT, V74, P178, DOI 10.1007/s12231-020-09497-x; Gallois S, 2020, ECON BOT, V74, P46, DOI 10.1007/s12231-020-09489-x; Gallois S, 2017, J ETHNOBIOL, V37, P60, DOI 10.2993/0278-0771-37.1.60; Gallois S, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0072-9; Ghorbani A, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-17; Godoy R, 2007, J ANTHROPOL RES, V63, P239, DOI 10.3998/jar.0521004.0063.207; Grandjean AC, 2012, NUTR REV, V70, pS101, DOI 10.1111/j.1753-4887.2012.00545.x; GROSS DR, 1984, ANNU REV ANTHROPOL, V13, P519, DOI 10.1146/annurev.an.13.100184.002511; Harris D. J., 1996, Bulletin du Jardin Botanique National de Belgique, V65, P143, DOI 10.2307/3668184; Hawthorne W.D., 2006, WOODY PLANTS W AFRIC; Hoare A. L, 2007, USE NONTIMBER FOREST; Ickowitz A, 2014, GLOBAL ENVIRON CHANG, V24, P287, DOI 10.1016/j.gloenvcha.2013.12.001; Ingram V, 2010, REV NONTIMBER FOREST; ISE (International Society of Ethnobiology)`, INT SOC ETHN COD ETH; Kennedy G., 2011, GUID MEAS HOUS IND D; Kuhnlein H.V., 2009, INDIGENOUS PEOPLES F; LECLERC C, 2012, ADOPTION AGR CHEZ PY; Letouzey R, 1985, NOTICE CARTE PHYTOGE, V5; Levang P., 2015, Forests, Trees and Livelihoods, V24, P128, DOI 10.1080/14728028.2014.1000980; Lulekal E, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-63; Magwe-Tindo J, 2018, TAXON, V67, P905, DOI 10.12705/675.4; Martin G.J., 2010, ETHNOBOTANY METHODS, DOI [10.4324/9781849775854, DOI 10.4324/9781849775854]; Matig OE, 2006, FRUITIERS FORESTIERS; Miranda TM, 2007, FIELD METHOD, V19, P76, DOI 10.1177/1525822X06295987; MUNGER RG, 1992, AM J EPIDEMIOL, V136, P192, DOI 10.1093/oxfordjournals.aje.a116485; Ndoye O, 2004, SCAND J FOREST RES, V19, P36, DOI 10.1080/14004080410034047; Ngome P. I. T., 2017, Agriculture and Food Security, V6, DOI 10.1186/s40066-017-0097-5; Ogle BM, 2001, THESIS  U UPPSALA; Ong HG, 2017, FOOD SECUR, V9, P11, DOI 10.1007/s12571-016-0630-6; Pandey A., 2017, J MED PLANTS STUD, V5, P123; Zambrana NYP, 2018, NAT PLANTS, V4, P201, DOI 10.1038/s41477-018-0128-7; Pardo-De-Santayana M, 2015, NATURE, V518, P487, DOI 10.1038/518487a; Pennec F, 2012, FLAME 1 1 FREE LIST; Peroni N., 2014, METHODS TECHNIQUES E, P398; PHILLIPS O, 1993, ECON BOT, V47, P33, DOI 10.1007/BF02862204; de Sousa DCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165838; Quinlan M., 2005, FIELD METHOD, V17, P219, DOI [10.1177/1525822X05277460, DOI 10.1177/1525822X05277460]; Quinlan MB., 2017, HDB RES METHODS HLTH, P1, DOI [10.1007/978-981-10-2779-6_12-1, DOI 10.1007/978-981-10-2779-6_12-1]; Quiroz D, 2016, J ETHNOPHARMACOL, V188, P48, DOI 10.1016/j.jep.2016.05.006; Reyes-Garcia V., 2005, Ethnobotany Research and Applications, V3, P201; Reyes-Garcia V, 2019, FOOD SECUR, V11, P109, DOI 10.1007/s12571-018-0882-4; Riddell M, 2013, CONSERV SOC, V11, P199, DOI 10.4103/0972-4923.121002; Rist L, 2012, FOREST ECOL MANAG, V268, P57, DOI 10.1016/j.foreco.2011.04.037; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Robillard Marine, 2012, J AFRICANISTES, V82, P15; Royal Botanical Gardens Kew, FLORA W TROPICAL AFR, P1931; Rozzi FVR, 2018, P NATL ACAD SCI USA, V115, pE6126, DOI 10.1073/pnas.1719637115; Setalaphruk C, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-33; Shapiro A., 2020, FOREST CONDITION CON, DOI [10.1101/2020.03.25.008110, DOI 10.1101/2020.03.25.008110]; Terashima, 2003, AFR STUDY MONOGR, V24, P1, DOI DOI 10.14989/68220; Termote C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030533; Termote C, 2011, GENET RESOUR CROP EV, V58, P585, DOI 10.1007/s10722-010-9602-4; Thomas E, 2007, ECON BOT, V61, P376, DOI 10.1663/0013-0001(2007)61[376:WWITFA]2.0.CO;2; Van Dijk JFW, 1999, NONTIMBER FOREST PRO; Wortley A.H., 2018, SYST BOT MONOGR, V104, P1; Yasuoka H., 2012, AFR STUDY MONOGR SUP, V43, P85	79	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0247108	10.1371/journal.pone.0247108	http://dx.doi.org/10.1371/journal.pone.0247108			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8JB	33600479	Green Published, gold, Green Submitted			2022-12-26	WOS:000620625100001
J	Pal, A; Ogren, JA; Aysola, RS; Kumar, R; Henderson, LA; Harper, RM; Macey, PM				Pal, Amrita; Ogren, Jennifer A.; Aysola, Ravi S.; Kumar, Rajesh; Henderson, Luke A.; Harper, Ronald M.; Macey, Paul M.			Insular functional organization during handgrip in females and males with obstructive sleep apnea	PLOS ONE			English	Article								Study objectives Brain regulation of autonomic function in obstructive sleep apnea (OSA) is disrupted in a sex-specific manner, including in the insula, which may contribute to several comorbidities. The insular gyri have anatomically distinct functions with respect to autonomic nervous system regulation; yet, OSA exerts little effect on the organization of insular gyral responses to sympathetic components of an autonomic challenge, the Valsalva. We further assessed neural responses of insular gyri in people with OSA to a static handgrip task, which principally involves parasympathetic withdrawal. Methods We measured insular function with blood oxygen level dependent functional MRI. We studied 48 newly-diagnosed OSA (age mean +/- std:46.5 +/- 9 years; AHI +/- std:32.6 +/- 21.1 events/hour; 36 male) and 63 healthy (47.2 +/- 8.8 years;40 male) participants. Subjects performed four 16s handgrips (1 min intervals, 80% subjective maximum strength) during scanning. fMRI time trends from five insular gyri-anterior short (ASG); mid short (MSG); posterior short (PSG); anterior long (ALG); and posterior long (PLG)-were assessed for within-group responses and between-group differences with repeated measures ANOVA (p<0.05) in combined and separate female-male models; age and resting heart-rate (HR) influences were also assessed. Results Females showed greater right anterior dominance at the ASG, but no differences emerged between OSA and controls in relation to functional organization of the insula in response to handgrip. Males showed greater left anterior dominance at the ASG, but there were also no differences between OSA and controls. The males showed a group difference between OSA and controls only in the ALG. OSA males had lower left activation at the ALG compared to control males. Responses were mostly influenced by HR and age; however, age did not impact the response for right anterior dominance in females. Conclusions Insular gyri functional responses to handgrip differ in OSA vs controls in a sex-based manner, but only in laterality of one gyrus, suggesting anterior and right-side insular dominance during sympathetic activation but parasympathetic withdrawal is largely intact, despite morphologic injury to the overall structure.	[Pal, Amrita; Macey, Paul M.] Univ Calif Los Angeles, UCLA Sch Nursing, Los Angeles, CA 90095 USA; [Ogren, Jennifer A.; Harper, Ronald M.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Aysola, Ravi S.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA, Div Pulm & Crit Care, Los Angeles, CA 90095 USA; [Kumar, Rajesh] Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90024 USA; [Kumar, Rajesh] Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90024 USA; [Henderson, Luke A.] Univ Sydney, Sydney Med Sch, Dept Anat & Histol, Sydney, NSW, Australia	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Sydney	Macey, PM (corresponding author), Univ Calif Los Angeles, UCLA Sch Nursing, Los Angeles, CA 90095 USA.	pmacey@ucla.edu	Pal, Amrita/AIE-9087-2022; Macey, Paul/B-5037-2008	Macey, Paul/0000-0003-4093-7458; Pal, Amrita/0000-0001-9983-6286	National Institute of Nursing Research [NR-017435]; National Institute of Heart, Lung and Blood Institute [HL135562]	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institute of Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Institute of Nursing Research NR-017435 and National Institute of Heart, Lung and Blood Institute HL135562. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; CECHETTO DF, 1990, AM J PHYSIOL, V258, pR245, DOI 10.1152/ajpregu.1990.258.1.R245; Chen LT, 2018, NEUROPSYCH DIS TREAT, V14, P1059, DOI 10.2147/NDT.S161085; Chouchou F, 2019, HUM BRAIN MAPP, V40, P2611, DOI 10.1002/hbm.24548; Dancey DR, 2001, CHEST, V120, P151, DOI 10.1378/chest.120.1.151; de Morree HM, 2016, J NEUROSURG ANESTH, V28, P153, DOI 10.1097/ANA.0000000000000207; Fatouleh RH, 2014, NEUROIMAGE-CLIN, V6, P275, DOI 10.1016/j.nicl.2014.08.021; Faux MD, 2004, SLEEP, V27, P1113, DOI 10.1093/sleep/27.6.1113; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Fogel RB, 2001, J CLIN ENDOCR METAB, V86, P1175, DOI 10.1210/jc.86.3.1175; GALLO L, 1988, PFLUG ARCH EUR J PHY, V412, P128, DOI 10.1007/BF00583741; GANDEVIA SC, 1993, J PHYSIOL-LONDON, V470, P85, DOI 10.1113/jphysiol.1993.sp019849; GANDEVIA SC, 1990, J PHYSIOL-LONDON, V430, P105, DOI 10.1113/jphysiol.1990.sp018284; GOODWIN GM, 1972, J PHYSIOL-LONDON, V226, P173, DOI 10.1113/jphysiol.1972.sp009979; Guadagni V, 2018, EUR J NEUROSCI, V48, P2288, DOI 10.1111/ejn.14124; Guenot M, 2004, ADV TECH STAND NEUR, V29, P265; Han SH, 2019, SLEEP BREATH, V23, P1255, DOI 10.1007/s11325-019-01869-5; Harper RM, 2003, J APPL PHYSIOL, V94, P1583, DOI 10.1152/japplphysiol.00881.2002; Henderson LA, 2003, J APPL PHYSIOL, V94, P1063, DOI 10.1152/japplphysiol.00702.2002; Henderson LA, 2012, ANAT REC, V295, P1396, DOI 10.1002/ar.22513; HOLLANDER AP, 1975, J APPL PHYSIOL, V38, P272, DOI 10.1152/jappl.1975.38.2.272; Innes CRH, 2015, SLEEP, V38, P699, DOI 10.5665/sleep.4658; IWAMOTO GA, 1987, J APPL PHYSIOL, V62, P149, DOI 10.1152/jappl.1987.62.1.149; Kang J, 2018, NEUROREPORT, V29, P981, DOI 10.1097/WNR.0000000000001065; Kluess HA, 2005, AM J MED SCI, V329, P117, DOI 10.1097/00000441-200503000-00002; Kumar R, 2012, J NEUROSCI RES, V90, P2043, DOI 10.1002/jnr.23083; Labarca G, 2020, SLEEP MED REV, V52, DOI 10.1016/j.smrv.2020.101312; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Macefield VG, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116119; Macefield VG, 2016, J NEUROPHYSIOL, V116, P1199, DOI 10.1152/jn.00783.2015; Macey KE, 2006, RESP PHYSIOL NEUROBI, V151, P44, DOI 10.1016/j.resp.2005.05.024; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193854; Macey PM, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0135-9; Macey PM, 2016, J SLEEP RES, V25, P390, DOI 10.1111/jsr.12392; Macey PM, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00513; Macey PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105261; Macey PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076631; Macey PM, 2012, AUTON NEUROSCI-BASIC, V168, P72, DOI 10.1016/j.autneu.2012.01.009; Macey PM, 2003, RESP PHYSIOL NEUROBI, V138, P275, DOI 10.1016/j.resp.2003.09.002; Macey PM, 2016, DETECTING VARIABLE R; Macey PM, 2020, SUMMARY FMRI DATA HA; MACIEL BC, 1985, BRAZ J MED BIOL RES, V18, P303; Magri C, 2012, J NEUROSCI, V32, P1395, DOI 10.1523/JNEUROSCI.3985-11.2012; Mai J.K., 2015, ATLAS HUMAN BRAIN, Vfourth; Marins FR, 2020, AUTON NEUROSCI-BASIC, V227, DOI 10.1016/j.autneu.2020.102695; Mazzola L, 2019, REV NEUROL-FRANCE, V175, P150, DOI 10.1016/j.neurol.2018.12.003; McCord JL, 2010, TRANSLATIONAL PAIN R; Middlekauff HR, 2012, AM J PHYSIOL-HEART C, V302, pH2560, DOI 10.1152/ajpheart.00579.2011; Mokhlesi B, 2016, EUR RESPIR J, V47, P1162, DOI 10.1183/13993003.01618-2015; Murphy MN, 2011, AM J PHYSIOL-HEART C, V301, pH1191, DOI 10.1152/ajpheart.00208.2011; Nagai M, 2010, J AM SOC HYPERTENS, V4, P174, DOI 10.1016/j.jash.2010.05.001; Nakano K, 1999, ANN NY ACAD SCI, V877, P667, DOI 10.1111/j.1749-6632.1999.tb09297.x; Ongur D, 1998, J COMP NEUROL, V401, P480; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Oppenheimer S, 2016, COMPR PHYSIOL, V6, P1081, DOI 10.1002/cphy.c140076; Pal A, 2021, SLEEP, V44, DOI 10.1093/sleep/zsaa124; Parish JM, 2004, MAYO CLIN PROC, V79, P1036, DOI 10.4065/79.8.1036; Park B, 2016, SLEEP, V39, P989, DOI 10.5665/sleep.5738; Peng DC, 2014, NEUROPSYCH DIS TREAT, V10, P1819, DOI 10.2147/NDT.S67805; Randby A, 2013, CHEST, V144, P915, DOI 10.1378/chest.12-2283; Risold PY, 1997, BRAIN RES REV, V24, P197, DOI 10.1016/S0165-0173(97)00007-6; RUGGIERO DA, 1987, J COMP NEUROL, V257, P189, DOI 10.1002/cne.902570206; Saaresranta T, 2003, EUR RESPIR J, V22, P161, DOI 10.1183/09031936.03.00062403; Saleh TM, 2005, BRAIN RES, V1037, P114, DOI 10.1016/j.brainres.2005.01.010; Sander M, 2010, J APPL PHYSIOL, V108, P1691, DOI 10.1152/japplphysiol.91539.2008; SANDERS JS, 1989, CIRCULATION, V79, P815, DOI 10.1161/01.CIR.79.4.815; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; Siddharth S, 2015, CURR EPIDEMIOL REP, V2, P257, DOI [DOI 10.1007/S40471-015-0058-0, 10.1007/s40471-015-0058-0]; Smith JR, 2019, MED SCI SPORT EXER, V51, P874, DOI 10.1249/MSS.0000000000001877; Tahmasian M, 2016, NEUROSCI BIOBEHAV R, V65, P142, DOI 10.1016/j.neubiorev.2016.03.026; Taylor KS, 2018, SLEEP, V41, DOI 10.1093/sleep/zsx208; Tietjens JR, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010440; Tummala S, 2017, J COMPUT ASSIST TOMO, V41, P181, DOI 10.1097/RCT.0000000000000537; Williamson JW, 2002, J APPL PHYSIOL, V92, P1317, DOI 10.1152/japplphysiol.00939.2001; Williamson JW, 2003, J APPL PHYSIOL, V94, P1726, DOI 10.1152/japplphysiol.01152.2002; Williamson JW, 1997, J PHYSIOL-LONDON, V503, P277, DOI 10.1111/j.1469-7793.1997.277bh.x; Yadav SK, 2014, SLEEP, V37, P951, DOI 10.5665/sleep.3668; Yeung AWK, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12857; Zhang Q, 2015, SLEEP MED, V16, P1062, DOI 10.1016/j.sleep.2015.04.018; Ziemssen T, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00053	82	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2021	16	2							e0246368	10.1371/journal.pone.0246368	http://dx.doi.org/10.1371/journal.pone.0246368			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8JB	33600443	Green Published, gold			2022-12-26	WOS:000620625100055
J	Heck, TG; Frantz, RZ; Frizzo, MN; Francois, CHR; Ludwig, MS; Mesenburg, MA; Buratti, GP; Franz, LBB; Berlezi, EM				Heck, Thiago Gomes; Frantz, Rafael Z.; Frizzo, Matias Nunes; Ramires Francois, Carlos Henrique; Ludwig, Mirna Stela; Mesenburg, Marilia Arndt; Buratti, Giovano Pereira; Bento Franz, Ligia Beatriz; Berlezi, Evelise Moraes			Insufficient social distancing may contribute to COVID-19 outbreak: The case of Ijui city in Brazil	PLOS ONE			English	Article								The coronavirus disease that emerged in 2019 (COVID-19) is highly contagious and has given way to a global pandemic. A present COVID-19 has high transmission rates worldwide, including in small Brazilian cities such as Ijui. Located in the northwest part of the state of Rio Grande do Sul (RS) and with a population of 83,475, Ijui was selected as the site of a population-based survey involving 2,222 subjects, from April to June 2020. Subjects were tested for the presence of antibodies against coronavirus (SARS-CoV-2) and answered questions regarding social distance adherence (SDA), daily preventive routines (DPR), comorbidities, and sociodemographic characteristics. In parallel, the local government registered the official COVID-19 cases in Ijui, as well as the mobile social distancing index (MSDI). In this study, we demonstrate that there was a decrease in the levels of SDA, DPR and MSDI before the beginning of COVID-19 community transmission in Ijui. Furthermore, we provide predictions for the number of COVID-19 cases, hospitalizations, and deaths in the city. We conclude that insufficient social distancing, as evidenced by different methods, may be related to the rapid increase of COVID-19 cases in Ijui. Our study predicts an approaching outbreak of COVID-19 in Ijui through community spread, which could be avoided or attenuated with increased levels of social distancing among the population.	[Heck, Thiago Gomes; Frizzo, Matias Nunes; Ludwig, Mirna Stela] Reg Univ Northwestern Rio Grande do Sul State, Res Grp Physiol, Ijui, RS, Brazil; [Heck, Thiago Gomes; Frizzo, Matias Nunes; Ludwig, Mirna Stela; Buratti, Giovano Pereira; Bento Franz, Ligia Beatriz; Berlezi, Evelise Moraes] Reg Univ Northwestern Rio Grande do Sul State, Postgrad Program Integral Attent Hlth, Ijui, RS, Brazil; [Heck, Thiago Gomes; Frizzo, Matias Nunes; Ramires Francois, Carlos Henrique; Ludwig, Mirna Stela; Berlezi, Evelise Moraes] Reg Univ Northwestern Rio Grande do Sul State, Dept Life Sci, Ijui, RS, Brazil; [Heck, Thiago Gomes; Frantz, Rafael Z.] Postgrad Program Math & Computat Modeling, Ijui, RS, Brazil; [Frantz, Rafael Z.] Reg Univ Northwestern Rio Grande do Sul State, Dept Exact Sci & Engn, Ijui, RS, Brazil; [Mesenburg, Marilia Arndt] Fed Univ Pelotas UFPeI, Pelotas, RS, Brazil; [Mesenburg, Marilia Arndt] Fed Univ Hlth Sci Porto Alegre UFCSPA, Porto Alegre, RS, Brazil; [Bento Franz, Ligia Beatriz; Berlezi, Evelise Moraes] Reg Univ Northwestern Rio Grande do Sul State, Res Grp Human Aging, Ijui, RS, Brazil	Universidade Federal de Ciencias da Saude de Porto Alegre	Heck, TG (corresponding author), Reg Univ Northwestern Rio Grande do Sul State, Res Grp Physiol, Ijui, RS, Brazil.; Heck, TG (corresponding author), Reg Univ Northwestern Rio Grande do Sul State, Postgrad Program Integral Attent Hlth, Ijui, RS, Brazil.; Heck, TG (corresponding author), Reg Univ Northwestern Rio Grande do Sul State, Dept Life Sci, Ijui, RS, Brazil.; Heck, TG (corresponding author), Postgrad Program Math & Computat Modeling, Ijui, RS, Brazil.	thiago.heck@Unijui.edu.br	Mesenburg, Marilia Arndt/GRJ-6044-2022; Heck, Thiago Gomes/D-2251-2011; Frantz, Rafael Z./J-9521-2012	Heck, Thiago Gomes/0000-0002-1242-5423; Frantz, Rafael Z./0000-0003-3740-7560; Pereira Buratti, Giovano/0000-0001-5339-0039; frizzo, matias/0000-0001-5578-4656; Ludwig, Mirna Stela/0000-0003-0300-1511; Arndt Mesenburg, Marilia/0000-0001-9598-4193				Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Ajzenman N., 2020, CEPR DISCUSSION PAPE, DOI 10.2139/ssrn.3582908; Aleta A, 2020, NAT HUM BEHAV, V4, P964, DOI 10.1038/s41562-020-0931-9; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Atalan A, 2020, ANN MED SURG, V56, P38, DOI 10.1016/j.amsu.2020.06.010; Barros AJD, 2020, REV SAUDE PUBL, V54, P29, DOI [10.11606/s1518-8787.2020054002810, 10.11606/s1518-8787.2020054002810.]; Block P, 2020, NAT HUM BEHAV, V4, P588, DOI 10.1038/s41562-020-0898-6; Brazilian Ministery of Health, 2020, BRAZ NAT GOV COVID 1; Canabarro A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236310; Caramelo F, 2020, ESTIMATION RISK FACT, DOI [10.1101/2020.02.24.20027268, DOI 10.1101/2020.02.24.20027268]; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Chakraborty R, 2020, BIOCHEM PHARMACOL, V180, DOI 10.1016/j.bcp.2020.114184; de Oliveira SB., 2020, MONITORING SOCIAL DI, DOI [10.2139/ssrn.3640544, DOI 10.1101/2020.04.30.20082172]; Dellagostin OA, 2020, SENSITIVITY SPECIFIC, P1, DOI 10.1101/2020.05.06.20093476; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Ganem F., 2020, MEDRXIV, DOI [10.1101/2020.04.06.20055103, DOI 10.1101/2020.04.06.20055103]; Grad S., 2020, SOCIAL DISTANCING ST, V2020, DOI [10.11392/jsao.49.40, DOI 10.1101/2020.03.22.20041079]; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Hallal PC, 2020, CIENC SAUDE COLETIVA, V25, P3573, DOI 10.1590/1413-81232020259.25532020; Heck TG, 2020, CLIN SCI, V134, P1991, DOI 10.1042/CS20200596; Hou J., 2020, MEDRXIV, DOI 10.1101/2020.03.27.20045757; IBGE, 2019, NATL I GEOGRAPHY STA; Jefferies S, 2020, LANCET PUBLIC HEALTH, V5, pE612, DOI 10.1016/S2468-2667(20)30225-5; Johns Hopkins University, 2020, COVID 19 MAP JOHNS H; Li RR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8297; Li Y, 2021, LANCET INFECT DIS, V21, P193, DOI 10.1016/S1473-3099(20)30785-4; Li ZY, 2020, J DESTIN MARK MANAGE, V18, DOI 10.1016/j.jdmm.2020.100502; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Maglio SJ, 2020, SOC PERSONAL PSYCHOL, V14, DOI 10.1111/spc3.12552; Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Ng OT, 2021, LANCET INFECT DIS, V21, P333, DOI 10.1016/S1473-3099(20)30833-1; Nussbaumer-Streit B, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013574.pub2, 10.1002/14651858.CD013574]; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Peixoto PS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235732; Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2025, DOI 10.1001/jama.2020.6775; Rio Grande do Sul State Governament, 2020, RIO GRANDE CORONAV R; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; da Silva LLS, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311X00185020, 10.1590/0102-311x00185020]; Silveira MF, 2020, NAT MED, V26, P1196, DOI 10.1038/s41591-020-0992-3; Slovic P, 2010, SAUDE SOC, V19, P731, DOI 10.1590/S0104-12902010000400002; Souza WMd, 2020, EPIDEMIOLOGICAL CLIN; Struchiner C., 2020, REMARKABLE VARIABILI, DOI 10.1101/2020.05.30.20117531; Taylor S, 2020, FEM PSYCHOL, V30, P63, DOI 10.1177/0959353519864390; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; USP, EPIDEMIC SIMULATOR F; Vaninov Natalie, 2020, Nat Rev Immunol, V20, P277, DOI 10.1038/s41577-020-0305-6; WHO, 2020, WHO EUR DISC DEAL PA; World Health Organization, 2021, NOV COR 2019 NCOV SI; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Yang QH, 2020, INFECT DIS MODEL, V5, P563, DOI 10.1016/j.idm.2020.08.001; Yang X., 2020, ARXIV PREPRINT ARXIV, V2003, P13865; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	53	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246520	10.1371/journal.pone.0246520	http://dx.doi.org/10.1371/journal.pone.0246520			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596229	Green Published, gold			2022-12-26	WOS:000620633200061
J	Kamsa-ard, S; Santong, C; Kamsa-ard, S; Luvira, V; Luvira, V; Suwanrungruang, K; Bhudhisawasdi, V				Kamsa-ard, Supot; Santong, Chalongpon; Kamsa-ard, Siriporn; Luvira, Vor; Luvira, Varisara; Suwanrungruang, Krittika; Bhudhisawasdi, Vajarabhongsa			Decreasing trends in cholangiocarcinoma incidence and relative survival in Khon Kaen, Thailand: An updated, inclusive, population-based cancer registry analysis for 1989-2018	PLOS ONE			English	Article							OPISTHORCHIS-VIVERRINI INFECTION; SURGICAL-TREATMENT; NORTHEAST; PERIOD; AGE; EPIDEMIOLOGY; PREVALENCE; COMMUNITY; DISEASES	Background Cholangiocarcinoma (CCA) is a leading cause of cancer death in northeastern Thailand. We reported on the incidence of CCA using only one method. In the current study, we used three different statistical methods to forecast future trends and estimate relative survival. Methods We reviewed the CCA cases diagnosed between 1989 and 2018 recorded in the population-based Khon Kaen Cancer Registry (KKCR). Annual percent change (APC) was calculated to quantify the incidence rate trends using Joinpoint regression. Age-period-cohort models (APC model) were used to examine the temporal trends of CCA by age, calendar year, and birth cohort. We projected the incidence of CCA up to 2028 using three independent approaches: the Joinpoint, Age-period-cohort, and Nordpred models. Survival assessments were based on relative survival (RS). Results The respective APC in males and females decreased significantly (-3.1%; 95%CI: -4.0 to -2.1 and -2.4%; 95%CI: -3.6 to -1.2). The APC model-AC-P for male CCA-decreased according to a birth-cohort. The CCA incidence for males born in 1998 was 0.09 times higher than for those born in 1966 (Incidence rate ratios, IRR = 0.09; 95%CI: 0.07 to 0.12). The relative incidence for female CCA similarly decreased according to a birth-cohort (IRR = 0.11; 95%CI: 0.07 to 0.17). The respective projection for the age-standardized rate for males and females for 2028 will be 7.6 per 100,000 (102 patients) and 3.6 per 100,000 (140 patients). The five-year RS for CCA was 10.9% (95%CI: 10.3 to 11.6). Conclusion The incidence rate of CCA has decreased. The projection for 2028 is that the incidence will continue to decline. Nevertheless, the survival of patients with CCA remains poor.	[Kamsa-ard, Supot; Kamsa-ard, Siriporn] Khon Kaen Univ, Fac Publ Hlth, Dept Epidemiol & Biostat, Khon Kaen, Thailand; [Kamsa-ard, Supot; Kamsa-ard, Siriporn; Luvira, Vor; Suwanrungruang, Krittika] Khon Kaen Univ, ASEAN Canc Epidemiol & Prevent Res Grp, Khon Kaen, Thailand; [Santong, Chalongpon; Suwanrungruang, Krittika] Khon Kaen Univ, Srinagarind Hosp, Fac Med, Canc Unit, Khon Kaen, Thailand; [Luvira, Vor; Bhudhisawasdi, Vajarabhongsa] Khon Kaen Univ, Fac Med, Dept Surg, Khon Kaen, Thailand; [Luvira, Varisara] Khon Kaen Univ, Fac Med, Dept Community Med, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Kamsa-ard, S (corresponding author), Khon Kaen Univ, Fac Publ Hlth, Dept Epidemiol & Biostat, Khon Kaen, Thailand.; Kamsa-ard, S (corresponding author), Khon Kaen Univ, ASEAN Canc Epidemiol & Prevent Res Grp, Khon Kaen, Thailand.	supot@kku.ac.th		Luvira, Vor/0000-0001-7333-2936; Kamsa-ard, Supot/0000-0002-1554-7696; Santong, Chalongpon/0000-0003-2958-7688	Faculty of Publich Health, Khon Kaen University, Khon Kaen, Thailand [PH/2563]	Faculty of Publich Health, Khon Kaen University, Khon Kaen, Thailand	This work was supported by Faculty of Publich Health, Khon Kaen University, Khon Kaen, Thailand (Grant No. PH/2563) to S.K.	Andrews RH, 2008, TRENDS PARASITOL, V24, P497, DOI 10.1016/j.pt.2008.08.011; [Anonymous], 1995, World Health Organ Tech Rep Ser, V849, P1; [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1; [Anonymous], 2018, ASTM C33C33M 18, DOI DOI 10.1520/C0033_C0033M-18; BHAMARAPRAVATI N, 1966, AM J GASTROENTEROL, V45, P267; Bhudhisawasdi V, 2012, SRINAGARIND MED J, V27, P331; Bray F, 2006, NAT REV CANCER, V6, P63, DOI 10.1038/nrc1781; Bray F, 2002, CANCER CAUSE CONTROL, V13, P175, DOI 10.1023/A:1014344519276; Bureau of Health Promotion, 1987, DEV PRIM HLTH CAR 6; Duangsong R, 2013, ASIAN PAC J CANCER P, V14, P7039, DOI 10.7314/APJCP.2013.14.11.7039; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; GREEN A, 1991, TROP GEOGR MED, V43, P193; Grundy-Warr C, 2012, PARASITOL INT, V61, P65, DOI 10.1016/j.parint.2011.06.015; HOLFORD TR, 1994, STAT MED, V13, P23, DOI 10.1002/sim.4780130105; HOLFORD TR, 1983, BIOMETRICS, V39, P311, DOI 10.2307/2531004; International Association of Cancer Registries, IACR CANREG5; Jongsuksuntigul P., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P327; Jongsuksuntigul P, 2003, ACTA TROP, V88, P229, DOI 10.1016/j.actatropica.2003.01.002; Kachroo S, 2013, E-HEALTH BIOENG CONF, DOI 10.1109/EHB.2013.6707388; Kaewpitoon N, 2008, WORLD J GASTROENTERO, V14, P2297, DOI 10.3748/wjg.14.2297; Kamsa-Ard S., 2019, J EPIDEMIOL, V29, P197, DOI [10.2188/jea.JE20180007, DOI 10.2188/JEA.JE20180007]; Kamsa-ard Siriporn, 2018, Asian Pac J Cancer Prev, V19, P605; Kamsa-ard S, 2011, ASIAN PAC J CANCER P, V12, P2209; Kleinbaum David G, SURVIVAL ANAL A SELF; KUPPER LL, 1985, J CHRON DIS, V38, P811, DOI 10.1016/0021-9681(85)90105-5; London WT., 2006, CANC EPIDEMIOLOGY PR, V3rd ed; Luvira Vor, 2016, Asian Pac J Cancer Prev, V17, P401; Mairiang Eimorn, 2006, Asian Pac J Cancer Prev, V7, P431; Mistry M, 2011, BRIT J CANCER, V105, P1795, DOI 10.1038/bjc.2011.430; Moller B, 2003, STAT MED, V22, P2751, DOI 10.1002/sim.1481; National Statistical Office, 2012, 3 INT HOUS SURV IHS3; Pattanathien P., 2013, ASIAN PAC J CANCER P, V14, P321, DOI [10.7314/apjcp.2013.14.1.321, DOI 10.7314/APJCP.2013.14.1.321]; Prevention C-C for DC and. CDC, 2014, OPISTHORCHIS FREQUEN; Promthet Paitoon, 2015, Asian Pac J Cancer Prev, V16, P7789; R Development Core Team, R LANG ENV STAT COMP; Sarfati D, 2010, INT J EPIDEMIOL, V39, P598, DOI 10.1093/ije/dyp392; Sasieni PD, 2012, STATA J, V12, P45, DOI 10.1177/1536867X1201200104; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Sithithaworn P, 2003, ACTA TROP, V88, P187, DOI 10.1016/j.actatropica.2003.02.001; Sithithaworn P., 2005, SRINAGARIND MED J, V20, P135; Sithithaworn P, 2014, J HEPATO-BIL-PAN SCI, V21, P301, DOI 10.1002/jhbp.62; Songserm Nopparat, 2015, Asian Pac J Cancer Prev, V16, P7375; Sriamporn S, 2004, TROP MED INT HEALTH, V9, P588, DOI 10.1111/j.1365-3156.2004.01234.x; Sripa B., 2005, SRINAGARIND MED J, V20, P122; Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Sriputtha S, 2013, ASIAN PAC J CANCER P, V14, P1107, DOI 10.7314/APJCP.2013.14.2.1107; Srisawangwong T, 1997, Southeast Asian J Trop Med Public Health, V28 Suppl 1, P224; StataCorp LLC, STAT DAT AN STAT SOF; Sungkasubun P, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2390-2; Suwanrungruang K, 2011, ASIAN PAC J CANCER P, V12, P173; THAMAVIT W, 1992, CARCINOGENESIS, V13, P309, DOI 10.1093/carcin/13.2.309; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; UPATHAM ES, 1984, B WORLD HEALTH ORGAN, V62, P451; VATANASAPT V, 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P489; WHO, 2011, EUR CTR ENV HLTH BUR; Wongba N, 2011, ASIAN PAC J CANCER P, V12, P1367; Woradet S., 2013, ASIAN PAC J CANCER P, V14, P1623, DOI [10.7314/apjcp.2013.14.3.1623, DOI 10.7314/APJCP.2013.14.3.1623]; Yeesoonsang S., 2016, BMC CANCER, V16, P1, DOI [10.1186/s12885-016-2441-8, DOI 10.1186/S12885-016-2441-8]	59	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0246490	10.1371/journal.pone.0246490	http://dx.doi.org/10.1371/journal.pone.0246490			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592053	gold, Green Published			2022-12-26	WOS:000620632800009
J	Moon, SJ; Jhun, J; Ryu, J; Kwon, JY; Kim, SY; Jung, K; Cho, ML; Min, JK				Moon, Su-Jin; Jhun, Jooyeon; Ryu, Jaeyoon; Kwon, Ji Ye; Kim, Se-Young; Jung, KyoungAh; Cho, Mi-La; Min, Jun-Ki			The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines	PLOS ONE			English	Article								Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is an important transcription factor that plays a pivotal role in cellular defense against oxidative injury. Nrf2 signaling is involved in attenuating autoimmune disorders such as rheumatoid arthritis (RA). B cells play several roles in the pathogenesis of RA, such as in autoantibody production, antigen presentation, and T-cell activation. We investigated the anti-arthritic mechanisms of sulforaphane, an activator of Nrf2, in terms of its effect on B cells. To investigate the effect of sulforaphane on collagen-induced arthritis (CIA), sulforaphane was administered intraperitoneally after CIA induction. Hematoxylin and eosin-stained sections were scored for inflammation, pannus invasion, and bone and cartilage damage. We assessed the expression levels of inflammation-related factors by real-time PCR and the levels of various IgG subclasses by enzyme-linked immunosorbent assay. Sulforaphane treatment reduced the arthritis score and the severity of histologic inflammation in CIA mice. The joints from sulforaphane-treated CIA mice showed decreased expression of interleukin (IL)-6, IL-17, tumor necrosis factor (TNF)-alpha, receptor activator of NF-kappa B ligand, and tartrate-resistant acid phosphatase. Sulforaphane-treated mice showed lower circulating levels of type-II-collagen-specific IgG, IgG1, and IgG2a. In vitro, sulforaphane treatment significantly reduced the differentiation of lipopolysaccharide-stimulated murine splenocytes into plasma B cells and germinal-center B cells. Finally, sulforaphane significantly inhibited the production of IL-6, TNF-alpha, and IL-17 by human peripheral blood mononuclear cells stimulated with an anti-CD3 monoclonal antibody in a dose-dependent manner. Inhibition of differentiation into plasma B and Germinal Center B cells may be the mechanism underlying the anti-arthritic effect of sulforaphane.	[Moon, Su-Jin] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Rheumatol,Uijeongbu St Marys Hosp, Uijongbu, South Korea; [Jhun, Jooyeon; Ryu, Jaeyoon; Kwon, Ji Ye; Kim, Se-Young; Cho, Mi-La] Catholic Univ Korea, Rheumatism Res Ctr, Catholic Res Inst Med Sci, Seoul, South Korea; [Jung, KyoungAh; Cho, Mi-La] Impact Biotech, Seoul, South Korea; [Cho, Mi-La] Catholic Univ Korea, Coll Med, Lab Immune Network, Converst Res Consortium Immunol Dis, Seoul, South Korea; [Min, Jun-Ki] Dept Internal Med, Bucheon St Marys Hosp, Bucheon Si, South Korea; [Min, Jun-Ki] Dept Internal Med, Clin Med Res Inst, Bucheon Si, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Cho, ML (corresponding author), Catholic Univ Korea, Rheumatism Res Ctr, Catholic Res Inst Med Sci, Seoul, South Korea.; Cho, ML (corresponding author), Impact Biotech, Seoul, South Korea.; Cho, ML (corresponding author), Catholic Univ Korea, Coll Med, Lab Immune Network, Converst Res Consortium Immunol Dis, Seoul, South Korea.; Min, JK (corresponding author), Dept Internal Med, Bucheon St Marys Hosp, Bucheon Si, South Korea.; Min, JK (corresponding author), Dept Internal Med, Clin Med Res Inst, Bucheon Si, South Korea.	iammila@catholic.ac.kr; rmin6403@hanmail.net	Kim, SeYoung/GSE-5296-2022	Kim, SeYoung/0000-0001-9188-868X	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [HI14C1851]; National Research Foundation of Korea(NRF) - Korea government(MSIT) [NRF-2018R1C1B6005854]; National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF-2018R1A2B6007648]	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea; National Research Foundation of Korea(NRF) - Korea government(MSIT); National Research Foundation of Korea (NRF) - Korea government (MSIT)	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI14C1851). This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT) (No. NRF-2018R1C1B6005854). This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2018R1A2B6007648).	Boackle SA, 2003, BIOMED PHARMACOTHER, V57, P269, DOI 10.1016/S0753-3322(03)00084-2; Burkhardt H, 2002, ARTHRITIS RHEUM, V46, P2339, DOI 10.1002/art.10472; Burmester GR, 2014, NAT REV RHEUMATOL, V10, P77, DOI 10.1038/nrrheum.2013.168; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Cordova EJ, 2010, LUPUS, V19, P1237, DOI 10.1177/0961203310367917; Dahdah A, 2018, ARTHRITIS RHEUMATOL, V70, P193, DOI 10.1002/art.40354; DECLERCK LS, 1995, CLIN RHEUMATOL, V14, P14, DOI 10.1007/BF02215852; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Fragoulis A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4059; Javaheri B, 2017, BONE, V103, P308, DOI 10.1016/j.bone.2017.07.028; Kong JS, 2010, ARTHRITIS RHEUM-US, V62, P159, DOI 10.1002/art.25017; Leandro MJ, 2002, ANN RHEUM DIS, V61, P883, DOI 10.1136/ard.61.10.883; Li B, 2019, J CELL PHYSIOL, V234, P561, DOI 10.1002/jcp.26769; Liang J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02584; Lugade AA, 2011, AM J RESP CELL MOL, V45, P557, DOI 10.1165/rcmb.2010-0321OC; Martinez-Gamboa L, 2006, AUTOIMMUN REV, V5, P437, DOI 10.1016/j.autrev.2006.02.004; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Nandakumar KS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2089; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Pistoia V, 1997, IMMUNOL TODAY, V18, P343, DOI 10.1016/S0167-5699(97)01080-3; Schultze JL, 1999, J EXP MED, V189, P1, DOI 10.1084/jem.189.1.1; Serreze David V, 2003, Curr Dir Autoimmun, V6, P212; Silva Rodrigues JF, 2018, MOLECULES, V23, DOI 10.3390/molecules23050988; Steiner Gunter, 2002, Arthritis Res, V4 Suppl 2, pS1, DOI 10.1186/ar551; Syversen SW, 2008, ANN RHEUM DIS, V67, P212, DOI 10.1136/ard.2006.068247; Tak PP, 2017, ANN RHEUM DIS, V76, P1924, DOI 10.1136/annrheumdis-2017-211351; Tran Chinh N, 2005, Pathophysiology, V12, P183, DOI 10.1016/j.pathophys.2005.07.005; Veldhoen M, 2017, NAT IMMUNOL, V18, P612, DOI 10.1038/ni.3742; Verheul MK, 2015, CLIN IMMUNOL, V161, P2, DOI 10.1016/j.clim.2015.04.005; Wang H, 2001, NAT IMMUNOL, V2, P632, DOI 10.1038/89782; Wu WJ, 2016, REDOX BIOL, V10, P157, DOI 10.1016/j.redox.2016.08.011; Yang G, 2018, RHEUMATOLOGY, V57, P727, DOI 10.1093/rheumatology/kex499	32	10	10	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0245986	10.1371/journal.pone.0245986	http://dx.doi.org/10.1371/journal.pone.0245986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592002	Green Published, gold			2022-12-26	WOS:000620632800065
J	Fiordelli, M; Fadda, M; Amati, R; Albanese, E				Fiordelli, Maddalena; Fadda, Marta; Amati, Rebecca; Albanese, Emiliano			Older adults' motivations to participate or not in epidemiological research. Qualitative inquiry on a study into dementia in Switzerland	PLOS ONE			English	Article								Introduction High participation in epidemiological studies is crucial for both external and internal validity. Because response rates have declined in recent years, there is an increasing need to understand the drivers and the barriers to research participation. This study aims to uncover the motivations in favour and against participation of older adults to an epidemiological study on health and dementia. Methods Twenty-two older adults, who already took part to the preliminary phase of an epidemiological study in Switzerland, agreed to participate to semi-structured, face-to- face interviews. An experienced researcher carried out all interviews in a quiet place of choice of the interviewee either at their domicile or the university, between November 2019 and January 2020. The interviews were audio and video taped, transcribed verbatim, and thematically analysed by two independent researchers. Results We identified three main themes for the motivations in favour of participation (i.e. personal, related to the outcomes of research, and altruistic motivations), and we highlighted subthemes for each theme (e.g. personal motivations: curiosity; civic engagement; interest in the topic; trust in science; everyone counts; openness; play the game). Motivations against participation reflected the first two themes, while there was no counterpart for altruistic motivations. Conclusions Our thematic analysis revealed that older adults hold specular motivations in favour and against participation to research. Studying jointly motivations in favour and against provides information for recruitment strategies and to overcome barriers to participation, respectively. Participatory action research can inform the design and conduction of and should precede epidemiological studies in older adults, and can potentially contribute to attain high response rates.	[Fiordelli, Maddalena; Fadda, Marta; Amati, Rebecca; Albanese, Emiliano] Univ Svizzera Italiana, Fac Biomed Sci, Inst Publ Hlth, Lugano, Switzerland	Universita della Svizzera Italiana	Fiordelli, M (corresponding author), Univ Svizzera Italiana, Fac Biomed Sci, Inst Publ Hlth, Lugano, Switzerland.	maddalena.fiordelli@usi.ch	Amati, Rebecca/HHM-4485-2022	Amati, Rebecca/0000-0001-5698-9071; Fiordelli, Maddalena/0000-0001-9775-0219; Fadda, Marta/0000-0003-3537-0346	Institute of Public Health	Institute of Public Health	This work has been self-supported by the Institute of Public Health.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Akmatov MK, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0302-z; Baczynska AM, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0439-9; Bardach SH., J APPL GERONTOL, V8; Birks M., 2014, QUALITATIVE METHODOL; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cai JW, 2004, BIOMETRICS, V60, P1015, DOI 10.1111/j.0006-341X.2004.00257.x; Crome P, 2011, DRUG AGING, V28, P667, DOI 10.2165/11591990-000000000-00000; Dahlin-Ivanoff S, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1238-4; Dong XQ, 2014, J AGING HEALTH, V26, P1085, DOI 10.1177/0898264314526620; Doyle S, 2013, QUAL HEALTH RES, V23, P248, DOI 10.1177/1049732312467854; Fishbein M, 1980, Nebr Symp Motiv, V27, P65; Gao L, 2015, AGE AGEING, V44, P867, DOI 10.1093/ageing/afv101; Goldberg L. R., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; Hart AR, 2017, EDUC GERONTOL, V43, P440, DOI 10.1080/03601277.2017.1321449; Hunsaker A, 2011, AM J ALZHEIMERS DIS, V26, P227, DOI 10.1177/1533317511399569; Jefferson AL, 2011, J ALZHEIMERS DIS, V23, P443, DOI 10.3233/JAD-2010-101536; Kim MY, 2006, BIOMETRICS, V62, P929, DOI 10.1111/j.1541-0420.2006.00639_1.x; Limkakeng A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051328; Mahlmann L, 2017, PUBLIC HEALTH GENOM, V20, P293, DOI 10.1159/000486588; Mancini J, 2014, J AM GERIATR SOC, V62, P1191, DOI 10.1111/jgs.12820; McMurdo MET, 2011, AGE AGEING, V40, P659, DOI 10.1093/ageing/afr115; Nohr EA, 2018, ACTA OBSTET GYN SCAN, V97, P407, DOI 10.1111/aogs.13319; Patton M. Q., 1990, QUALITATIVE EVALUATI; Puts MTE, 2017, J NATL COMPR CANC NE, V15, P1208, DOI 10.6004/jnccn.2017.0159; Ries NM, 2017, J BIOETHIC INQ, V14, P359, DOI 10.1007/s11673-017-9794-9; Sano M, 2018, ALZHEIMERS DEMENT, V14, P1397, DOI 10.1016/j.jalz.2018.05.016; Schlenk EA, 2009, CLIN NURS RES, V18, P348, DOI 10.1177/1054773809341732; Toledano MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131521; Treloar SA, 2007, COMMUNITY GENET, V10, P61, DOI 10.1159/000099083; van der Graaf R, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2402-9	31	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0247141	10.1371/journal.pone.0247141	http://dx.doi.org/10.1371/journal.pone.0247141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK0KW	33577607	Green Published, gold			2022-12-26	WOS:000620071700017
J	Habib, G; Steinberg, D; Jabbour, A				Habib, George; Steinberg, Doron; Jabbour, Adel			The impact of medical cannabis consumption on the oral flora and saliva	PLOS ONE			English	Article								Objective To evaluate the effect of medical cannabis consumption on oral flora and saliva. Design A clinical prospective study, at the rheumatology clinic of the Nazareth Hospital in Nazareth, recruiting consecutively patients approved for medical cannabis, evaluating their saliva flow, pH and microbial load of Streptococcus mutans and Lactobacillus, prior to and under medical cannabis treatment. Methods Patients recently licensed for medical cannabis treatment, were recruited just prior to starting medical cannabis consumption (week 0), 1 and 4 weeks later, patients provided 5-minute time saliva samples, which were measured for their volume and pH, and cultured on a special microbial kit, evaluating the growth of Streptococcus mutans and Lactobacillus. Results Out of 16 patients enrolled, 14 were female and had fibromyalgia. The mean age of the patients was 52.8 +/- 12.9 years. The mean saliva flow at week 0, week 1 and week 4 were 5.38 +/- 3.36 ml/5-minutes, 6 (p = 0.769) and 5.45 (p = 0.391), respectively, and for saliva pH were 6.28, 5.94 (p = 0.51) and 5.5 (p = 0.07) respectively also. The mean Streptococcus mutans growth score at weeks 0, 1 and 4 was1.8 +/- 0.75, 1.6 +/- 0.83 (p = 0.234), and 2.4 +/- 0.84 (p = 0.058), respectively. The mean Lactobacilli growth score at weeks 0, 1 and 4 was 2.59 +/- 0.88, 3.1 +/- 0.69 (p = 0.033) and 3.3 +/- 0.67 (p = 0.025), respectively. Conclusions The results of this study show that medical cannabis consumption has no significant effect on saliva volume or pH, but it may be associated with changes in salivary levels of oral microbes such as Streptococcus mutans and Lactobacilli.	[Habib, George] Laniado Hosp, Dept Med C, Azrieli Fac Med, Netanya, Israel; [Habib, George] Laniado Hosp, Rheumatol Unit, Netanya, Israel; [Habib, George] Bar Ilan Univ, Rheumatol Clin Nazareth Hosp, Safed, Israel; [Steinberg, Doron] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Fac Dent Med, Biofilm Res Lab, Jerusalem, Israel; [Jabbour, Adel] Bar Ilan Univ, Nazareth Hosp EMMS, Azrieli Fac Med, Med Lab, Safed, Israel	Bar Ilan University; Hebrew University of Jerusalem; Hadassah University Medical Center; Bar Ilan University	Habib, G (corresponding author), Laniado Hosp, Dept Med C, Azrieli Fac Med, Netanya, Israel.; Habib, G (corresponding author), Laniado Hosp, Rheumatol Unit, Netanya, Israel.; Habib, G (corresponding author), Bar Ilan Univ, Rheumatol Clin Nazareth Hosp, Safed, Israel.	gshabib@gmail.com						Atalay S, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9010021; Balash Y, 2017, CLIN NEUROPHARMACOL, V40, P268, DOI 10.1097/WNF.0000000000000246; Baron EP, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0862-2; Chakraborty S, 2018, J INTEGR MED-JIM, V16, P350, DOI 10.1016/j.joim.2018.07.005; Christensen LB, 2001, ACTA ODONTOL SCAND, V59, P116; DICUGNO F, 1981, ARCH ORAL BIOL, V26, P363, DOI 10.1016/0003-9969(81)90031-5; DIGREGORIO GJ, 1976, DRUG ALCOHOL DEPEN, V1, P377, DOI 10.1016/0376-8716(76)90002-8; Felder CC, 1998, ANNU REV PHARMACOL, V38, P179, DOI 10.1146/annurev.pharmtox.38.1.179; Gu Z, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02288; Habib G, 2018, JCR-J CLIN RHEUMATOL, V24, P255, DOI 10.1097/RHU.0000000000000702; Hua T, 2020, CELL, V180, P655, DOI 10.1016/j.cell.2020.01.008; Iseppi R, 2019, MOLECULES, V24, DOI 10.3390/molecules24122302; Prospero-Garcia O, 2019, ARCH MED RES, V50, P518, DOI 10.1016/j.arcmed.2019.09.005; Sanchez-Garcia S, 2008, GERODONTOLOGY, V25, P26, DOI 10.1111/j.1741-2358.2007.00184.x; Soni D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0499-0; Tyree GA, 2019, CANNABIS CANNABINOID, V4, P62, DOI 10.1089/can.2018.0027; Wang GS, 2020, CLIN PHARMACOKINET, V59, P1005, DOI 10.1007/s40262-020-00869-z; Zeyl V, 2020, SUBST USE MISUSE, V55, P1223, DOI 10.1080/10826084.2020.1731547; Zhao SS, 2019, BEST PRACT RES CL RH, V33, DOI 10.1016/j.berh.2019.06.005	19	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0247044	10.1371/journal.pone.0247044	http://dx.doi.org/10.1371/journal.pone.0247044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577600	Green Published, gold			2022-12-26	WOS:000620071700042
J	Chundawat, SPS; Nemmaru, B; Hackl, M; Brady, SK; Hilton, MA; Johnson, MM; Chang, S; Lang, MJ; Huh, H; Lee, SH; Yarbrough, JM; Lopez, CA; Gnanakaran, S				Chundawat, Shishir P. S.; Nemmaru, Bhargava; Hackl, Markus; Brady, Sonia K.; Hilton, Mark A.; Johnson, Madeline M.; Chang, Sungrok; Lang, Matthew J.; Huh, Hyun; Lee, Sang-Hyuk; Yarbrough, John M.; Lopez, Cesar A.; Gnanakaran, Sandrasegaram			Molecular origins of reduced activity and binding commitment of processive cellulases and associated carbohydrate-binding proteins to cellulose III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNCHROTRON X-RAY; HYDROGEN-BONDING SYSTEM; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; CELLOBIOHYDROLASE-I; BIOMASS RECALCITRANCE; FUNGAL CELLULASES; IMAGING ANALYSIS; AMINO-ACIDS; MODULE	Efficient enzymatic saccharification of cellulosic biomass into fermentable sugars can enable production of bioproducts like ethanol. Native crystalline cellulose, or cellulose I, is inefficiently processed via enzymatic hydrolysis but can be converted into the structurally distinct cellulose III allomorph that is processed via cellulase cocktails derived from Trichoderma reesei up to 20-fold faster. However, characterization of individual cellulases from T. reesei, like the processive exocellulase Cel7A, shows reduced binding and activity at low enzyme loadings toward cellulose III. To clarify this discrepancy, we monitored the single-molecule initial binding commitment and subsequent processive motility of Cel7A enzymes and associated carbohydrate-binding modules (CBMs) on cellulose using optical tweezers force spectroscopy. We confirmed a 48% lower initial binding commitment and 32% slower processive motility of Cel7A on cellulose III, which we hypothesized derives from reduced binding affinity of the Cel7A binding domain CBM1. Classical CBM-cellulose pull-down assays, depending on the adsorption model fitted, predicted between 1.2- and 7-fold reduction in CBM1 binding affinity for cellulose III. Force spectroscopy measurements of CBM1-cellulose interactions, along with molecular dynamics simulations, indicated that previous interpretations of classical binding assay results using multisite adsorption models may have complicated analysis, and instead suggest simpler single-site models should be used. These findings were corroborated by binding analysis of other type-A CBMs (CBM2a, CBM3a, CBM5, CBM10, and CBM64) on both cellulose allomorphs. Finally, we discuss how complementary analytical tools are critical to gain insight into the complex mechanisms of insoluble polysaccharides hydrolysis by cellulolytic enzymes and associated carbohydrate-binding proteins.	[Chundawat, Shishir P. S.; Nemmaru, Bhargava; Hackl, Markus] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA; [Brady, Sonia K.; Hilton, Mark A.; Johnson, Madeline M.; Chang, Sungrok; Lang, Matthew J.] Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Lang, Matthew J.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Huh, Hyun; Lee, Sang-Hyuk] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ USA; [Yarbrough, John M.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO USA; [Lopez, Cesar A.; Gnanakaran, Sandrasegaram] Los Alamos Natl Lab, Theoret Div, Los Alamos, NM USA	Rutgers State University New Brunswick; Vanderbilt University; Vanderbilt University; Rutgers State University New Brunswick; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); Los Alamos National Laboratory	Chundawat, SPS (corresponding author), Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.	shishir.chundawat@rutgers.edu	Nemmaru, Bhargava/GPP-5485-2022	Nemmaru, Bhargava/0000-0002-5005-4678; Chundawat, Shishir/0000-0003-3677-6735	NSF CBET awards [1604421, 1846797]; ORAU Ralph E. Powe Award; NSF MCB award [1330792]; NIH [R01GM101001]; Rutgers Global Grant, Rutgers Division of Continuing Studies, Rutgers School of Engineering, DOE Bioimaging Award (Office of Science) [DE-SC0019313]; Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; Department of Energy, Office of Energy Efficiency and Renewable Energy (EERE) [28598]	NSF CBET awards(National Science Foundation (NSF)); ORAU Ralph E. Powe Award; NSF MCB award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Global Grant, Rutgers Division of Continuing Studies, Rutgers School of Engineering, DOE Bioimaging Award (Office of Science); Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); Department of Energy, Office of Energy Efficiency and Renewable Energy (EERE)(United States Department of Energy (DOE))	The authors acknowledge support from the NSF CBET awards (1604421 and 1846797), ORAU Ralph E. Powe Award, NSF MCB award (1330792), NIH Grant (R01GM101001), Rutgers Global Grant, Rutgers Division of Continuing Studies, Rutgers School of Engineering, DOE Bioimaging Award (Office of Science DE-SC0019313), and the Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494). C. A. L. and S. G. acknowledge support from LANL LDRD ER (XWX2) and LANL institutional program for computational resources. J. M. Y. acknowledges support from the Department of Energy, Office of Energy Efficiency and Renewable Energy (EERE) under agreement no. 28598. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott DW, 2012, METHOD ENZYMOL, V510, P211, DOI 10.1016/B978-0-12-415931-0.00011-2; Alekozai EM, 2014, CELLULOSE, V21, P951, DOI 10.1007/s10570-013-0026-0; Atalla R. J., 1987, IPC TECHNICAL PAPER, V217; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Brady SK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10149; Brunecky R, 2020, GREEN CHEM, V22, P478, DOI 10.1039/c9gc03062j; Buffon G, 1777, HIST NAT G N RALE ER, P46; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Dale BE, 2010, ENVIRON SCI TECHNOL, V44, P8385, DOI [10.1021/es101864b, 10.1021/es1031618]; Das DK, 2016, J BIOL CHEM, V291, P25292, DOI 10.1074/jbc.M116.752865; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Fox JM, 2013, NAT CHEM BIOL, V9, P356, DOI 10.1038/nchembio.1227; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gao DH, 2013, P NATL ACAD SCI USA, V110, P10922, DOI 10.1073/pnas.1213426110; Gao DH, 2011, BIOTECHNOL BIOENG, V108, P1788, DOI 10.1002/bit.23140; Garvey CJ, 2005, MACROMOL CHEM PHYS, V206, P1568, DOI 10.1002/macp.200500008; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hu FH, 2018, CELLULOSE, V25, P1185, DOI 10.1007/s10570-017-1629-7; Igarashi K, 2012, METHOD ENZYMOL, V510, P169, DOI 10.1016/B978-0-12-415931-0.00009-4; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jana S, 2016, J PHYS CHEM B, V120, P1236, DOI 10.1021/acs.jpcb.5b12610; Jobst MA, 2015, ELIFE, V4, DOI 10.7554/eLife.10319; Kari J, 2018, ACS CATAL, V8, P11966, DOI 10.1021/acscatal.8b03547; King JR, 2015, LANGMUIR, V31, P3431, DOI 10.1021/la504836u; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Kont R, 2016, J BIOL CHEM, V291, P26013, DOI 10.1074/jbc.M116.756007; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Latour RA, 2015, J BIOMED MATER RES A, V103, P949, DOI 10.1002/jbm.a.35235; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Lim S, 2014, PROTEIN EXPRES PURIF, V98, P1, DOI 10.1016/j.pep.2014.02.013; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251; Liu YX, 2020, ACS SUSTAIN CHEM ENG, V8, P5028, DOI 10.1021/acssuschemeng.9b06792; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Moran-Mirabal JM, 2011, BIOPHYS CHEM, V155, P20, DOI 10.1016/j.bpc.2011.02.003; Mudinoor AR, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-1649-7; Nakamura A, 2016, J BIOL CHEM, V291, P22404, DOI 10.1074/jbc.M116.752048; Nemmaru B, 2021, BIOTECHNOL BIOENG, V118, P1141, DOI 10.1002/bit.27637; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Novy V, 2019, P NATL ACAD SCI USA, V116, P22545, DOI 10.1073/pnas.1912354116; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; Rakshit S, 2012, P NATL ACAD SCI USA, V109, P18815, DOI 10.1073/pnas.1208349109; REINIKAINEN T, 1992, PROTEINS, V14, P475, DOI 10.1002/prot.340140408; Rico F, 2019, P NATL ACAD SCI USA, V116, P6594, DOI 10.1073/pnas.1816909116; Santoro N, 2010, BIOENERG RES, V3, P93, DOI 10.1007/s12155-009-9074-6; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; Sousa LD, 2019, ACS SUSTAIN CHEM ENG, V7, P14411, DOI 10.1021/acssuschemeng.9b00606; Sousa LD, 2016, ENERG ENVIRON SCI, V9, P1215, DOI [10.1039/c5ee03051j, 10.1039/C5EE03051J]; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Varnai A, 2014, ADV APPL MICROBIOL, V88, P103, DOI 10.1016/B978-0-12-800260-5.00004-8; Vermaas JV, 2019, P NATL ACAD SCI USA, V116, P23061, DOI 10.1073/pnas.1913398116; Wada M, 2004, MACROMOLECULES, V37, P8548, DOI 10.1021/ma0485585; Walker JA, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0402-0; WILEY JH, 1987, CARBOHYD RES, V160, P113, DOI 10.1016/0008-6215(87)80306-3; Wu M, 2013, J BIOL CHEM, V288, P33107, DOI 10.1074/jbc.M113.502765	72	3	3	5	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100431	10.1016/j.jbc.2021.100431	http://dx.doi.org/10.1016/j.jbc.2021.100431			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610545	gold, Green Published			2022-12-26	WOS:000672866400405
J	Roberts, JP; Stokoe, SA; Sathler, MF; Nichols, RA; Kim, S				Roberts, Jessica P.; Stokoe, Sarah A.; Sathler, Matheus F.; Nichols, Robert A.; Kim, Seonil			Selective coactivation of alpha 7-and alpha 4 beta 2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACH RECEPTORS; LIGAND-BINDING DOMAIN; ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; COGNITIVE FUNCTION; INTERNEURONS; PEPTIDE; SUBTYPES; ACTIVATION; LONG	Beta-amyloid (A beta) has been recognized as an early trigger in the pathogenesis of Alzheimer's disease (AD) leading to synaptic and cognitive impairments. A beta can alter neuronal signaling through interactions with nicotinic acetylcholine receptors (nAChRs), contributing to synaptic dysfunction in AD. The three major nAChR subtypes in the hippocampus are composed of alpha 7-, alpha 4 beta 2-, and alpha 3 beta 4-nAChRs. A beta selectively affects alpha 7- and alpha 4 beta 2-nAChRs, but not alpha 3 beta 4-nAChRs in hippocampal neurons, resulting in neuronal hyperexcitation. However, how nAChR subtype selectivity for A beta affects synaptic function in AD is not completely understood. Here, we showed that A beta associated with alpha 7- and alpha 4 beta 2-nAChRs but not alpha 3 beta 4-nAChRs. Computational modeling suggested that two amino acids in alpha 7-nAChRs, arginine 208 and glutamate 211, were important for the interaction between A beta and alpha 7-containing nAChRs. These residues are conserved only in the alpha 7 and alpha 4 subunits. We therefore mutated these amino acids in alpha 7-containing nAChRs to mimic the alpha 3 subunit and found that mutant alpha 7-containing receptors were unable to interact with A beta. In addition, mutant alpha 3-containing nAChRs mimicking the alpha 7 subunit interact with A beta. This provides direct molecular evidence for how A beta selectively interacted with alpha 7- and alpha 4 beta 2-nAChRs, but not alpha 3 beta 4-nAChRs. Selective coactivation of alpha 7- and alpha 4 beta 2-nAChRs also sufficiently reversed A beta-induced AMPA receptor dysfunction, including A beta-induced reduction of AMPA receptor phosphorylation and surface expression in hippocampal neurons. Moreover, costimulation of alpha 7- and alpha 4 beta 2-nAChRs reversed the A beta-induced disruption of long-term potentiation. These findings support a novel mechanism for A beta's impact on synaptic function in AD, namely, the differential regulation of nAChR subtypes.	[Roberts, Jessica P.; Stokoe, Sarah A.; Kim, Seonil] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA; [Roberts, Jessica P.; Stokoe, Sarah A.; Sathler, Matheus F.; Kim, Seonil] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Nichols, Robert A.] Univ Hawaii Manoa, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	Colorado State University; Colorado State University; University of Hawaii System; University of Hawaii Manoa	Kim, S (corresponding author), Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA.; Kim, S (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	soenil.kim@colostate.edu			University of Hawai'i Foundation Preclinical Alzheimer's Research Fund; Colorado Clinical and Translational Sciences Institute; College Research Council Shared Research Program from Colorado State University; Boettcher Foundation's Webb-Waring Biomedical Research Program; The Barry Goldwater Scholarship and Excellence in Education Foundation; Astronaut Scholarship Foundation; Student Experiential Learning Grant from Colorado State University	University of Hawai'i Foundation Preclinical Alzheimer's Research Fund; Colorado Clinical and Translational Sciences Institute; College Research Council Shared Research Program from Colorado State University; Boettcher Foundation's Webb-Waring Biomedical Research Program; The Barry Goldwater Scholarship and Excellence in Education Foundation; Astronaut Scholarship Foundation; Student Experiential Learning Grant from Colorado State University	This work is supported by the University of Hawai'i Foundation Preclinical Alzheimer's Research Fund (R. A. N.), the pilot program from the Colorado Clinical and Translational Sciences Institute (S. K.), College Research Council Shared Research Program from Colorado State University (S. K.), the Boettcher Foundation's Webb-Waring Biomedical Research Program (S. K.), The Barry Goldwater Scholarship and Excellence in Education Foundation (J. P. R.), Astronaut Scholarship Foundation (J. P. R.), and Student Experiential Learning Grant from Colorado State University (J. P. R. and S. A. S.).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alkondon M, 2001, J NEUROPHYSIOL, V86, P3043, DOI 10.1152/jn.2001.86.6.3043; Alkondon M, 1998, BRAIN RES, V810, P257, DOI 10.1016/S0006-8993(98)00880-4; Alkondon M, 2003, J NEUROPHYSIOL, V90, P1613, DOI 10.1152/jn.00214.2003; Auld DS, 1998, TRENDS NEUROSCI, V21, P43, DOI 10.1016/S0166-2236(97)01144-2; Barykin EP, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176272; Benson DL, 1996, J NEUROSCI, V16, P6424; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Blaszczyk M, 2016, METHODS, V93, P72, DOI 10.1016/j.ymeth.2015.07.004; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Buccafusco J, 2004, MOL INTERV, V4, P285, DOI 10.1124/mi.4.5.8; Buhler AV, 2002, J NEUROPHYSIOL, V87, P548, DOI 10.1152/jn.00316.2001; Buhler AV, 2001, NEUROSCIENCE, V106, P55, DOI 10.1016/S0306-4522(01)00257-3; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cincotta SL, 2008, CURR OPIN INVEST DR, V9, P47; Clementi F, 2000, EUR J PHARMACOL, V393, P3, DOI 10.1016/S0014-2999(00)00066-2; DAVIES P, 1976, LANCET, V2, P1403; Diering GH, 2014, NEURON, V84, P790, DOI 10.1016/j.neuron.2014.09.024; Dimidschstein J, 2016, NAT NEUROSCI, V19, P1743, DOI 10.1038/nn.4430; Dineley KT, 2007, FRONT BIOSCI-LANDMRK, V12, P5030, DOI 10.2741/2445; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Espinoza-Fonseca LM, 2004, BIOCHEM BIOPH RES CO, V320, P587, DOI 10.1016/j.bbrc.2004.05.207; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Ferreira-Vieira TH, 2016, CURR NEUROPHARMACOL, V14, P101, DOI 10.2174/1570159X13666150716165726; Forest KH, 2018, J NEUROCHEM, V144, P201, DOI 10.1111/jnc.14257; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Frazier CJ, 1998, J NEUROSCI, V18, P1187; Ge SY, 2005, J NEUROSCI, V25, P6084, DOI 10.1523/JNEUROSCI.0542-05.2005; Gharpure A, 2019, NEURON, V104, P501, DOI 10.1016/j.neuron.2019.07.030; Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Grassi F, 2003, J PHYSIOL-LONDON, V547, P147, DOI 10.1113/jphysiol.2002.035436; Guan ZZ, 2000, J NEUROCHEM, V74, P237, DOI 10.1046/j.1471-4159.2000.0740237.x; Guntupalli S, 2017, J BIOL CHEM, V292, P8186, DOI 10.1074/jbc.M116.774554; Haider Syed R, 2012, Methods Mol Biol, V869, P81, DOI 10.1007/978-1-61779-821-4_8; Hefft S, 1999, J PHYSIOL-LONDON, V515, P769, DOI 10.1111/j.1469-7793.1999.769ab.x; Heinitz K, 2006, J NEUROCHEM, V98, P1930, DOI 10.1111/j.1471-4159.2006.04015.x; Hoskin JL, 2019, NICOTINE TOB RES, V21, P370, DOI 10.1093/ntr/nty116; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jahn Holger, 2013, Dialogues Clin Neurosci, V15, P445; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Ji DY, 2000, J NEUROPHYSIOL, V83, P2682, DOI 10.1152/jn.2000.83.5.2682; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; Jurgensen S, 2010, J MOL NEUROSCI, V40, P221, DOI 10.1007/s12031-009-9237-0; Kabbani N, 2018, TRENDS PHARMACOL SCI, V39, P354, DOI 10.1016/j.tips.2018.01.002; Kadir A, 2006, PSYCHOPHARMACOLOGY, V188, P509, DOI 10.1007/s00213-006-0447-7; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim S, 2016, MOL PSYCHIATR, V21, P707, DOI 10.1038/mp.2015.97; Kim S, 2015, NEUROBIOL AGING, V36, P3239, DOI 10.1016/j.neurobiolaging.2015.09.007; Kim S, 2015, P NATL ACAD SCI USA, V112, P3122, DOI 10.1073/pnas.1417498112; Kim S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001900; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lawrence JLM, 2014, J NEUROSCI, V34, P14210, DOI 10.1523/JNEUROSCI.0326-14.2014; Levin ED, 1998, PSYCHOPHARMACOLOGY, V138, P217, DOI 10.1007/s002130050667; Levin ED, 2002, DRUG DEVELOP RES, V55, P97, DOI 10.1002/ddr.10024; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; Lindstrom JM, 2003, ANN NY ACAD SCI, V998, P41, DOI 10.1196/annals.1254.007; Liu Q, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-155; Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598; Lombardo S, 2015, NEUROPHARMACOLOGY, V96, P255, DOI 10.1016/j.neuropharm.2014.11.018; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Ma T, 2012, J NEUROCHEM, V120, P140, DOI 10.1111/j.1471-4159.2011.07506.x; Maatuk N, 2013, NEUROTOXICOLOGY, V34, P236, DOI 10.1016/j.neuro.2012.09.007; Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; McClure-Begley TD, 2009, MOL PHARMACOL, V75, P918, DOI 10.1124/mol.108.052274; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; McQuiston AR, 1999, J NEUROSCI, V19, P2887; Minano-Molina AJ, 2011, J BIOL CHEM, V286, P27311, DOI 10.1074/jbc.M111.227504; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mulugeta E, 2003, BRAIN RES, V960, P259, DOI 10.1016/S0006-8993(02)03542-4; Nashmi R, 2003, J NEUROSCI, V23, P11554; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; Olivero G, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00166; Oloris SCS, 2010, TOXICOL APPL PHARM, V242, P299, DOI 10.1016/j.taap.2009.10.020; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Parri HR, 2010, CURR ALZHEIMER RES, V7, P27, DOI 10.2174/156720510790274464; Parri HR, 2011, BIOCHEM PHARMACOL, V82, P931, DOI 10.1016/j.bcp.2011.06.039; Pettit DL, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-01-j0003.2001; Pym L, 2005, BRIT J PHARMACOL, V146, P964, DOI 10.1038/sj.bjp.0706403; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Redrobe JR, 2009, EUR J PHARMACOL, V602, P58, DOI 10.1016/j.ejphar.2008.09.035; Rui YF, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-10; Sathler M. F., PHOSPHORYLATION AMPA; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Son JH, 2008, J COMP NEUROL, V511, P286, DOI 10.1002/cne.21828; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sudweeks SN, 2000, J PHYSIOL-LONDON, V527, P515, DOI 10.1111/j.1469-7793.2000.00515.x; Sun JL, 2019, NEUROBIOL AGING, V84, P166, DOI 10.1016/j.neurobiolaging.2019.09.005; Sun Y, 2008, EUR J NEUROL, V15, P278, DOI 10.1111/j.1468-1331.2007.02049.x; SVENSSON AL, 1992, BRAIN RES, V596, P142, DOI 10.1016/0006-8993(92)91541-L; Sztukowski K, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005315; Thompson Sarah, 2004, Expert Opin Drug Saf, V3, P425, DOI 10.1517/14740338.3.5.425; Tong M, 2011, J BIOL CHEM, V286, P34373, DOI 10.1074/jbc.M111.241299; Tozaki H, 2002, BIOCHEM BIOPH RES CO, V294, P42, DOI 10.1016/S0006-291X(02)00429-1; Vicens Paloma, 2003, Neural Plasticity, V10, P303, DOI 10.1155/NP.2003.303; Vicens P, 2011, BEHAV BRAIN RES, V216, P341, DOI 10.1016/j.bbr.2010.08.015; Wang HY, 2009, J NEUROSCI, V29, P10961, DOI 10.1523/JNEUROSCI.6088-08.2009; Wang HY, 2003, J BIOL CHEM, V278, P31547, DOI 10.1074/jbc.M212532200; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858; Wu J, 2004, J BIOL CHEM, V279, P37842, DOI 10.1074/jbc.M400335200; Wu Jin, 2010, Int J Alzheimers Dis, V2010, P548913, DOI 10.4061/2010/548913; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	114	12	12	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100402	10.1016/j.jbc.2021.100402	http://dx.doi.org/10.1016/j.jbc.2021.100402			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33571523	Green Submitted, Green Published, gold			2022-12-26	WOS:000672866400376
J	Valent, AM; Choi, H; Kolahi, KS; Thornburg, KL				Valent, Amy M.; Choi, Haeri; Kolahi, Kevin S.; Thornburg, Kent L.			Hyperglycemia and gestational diabetes suppress placental glycolysis and mitochondrial function and alter lipid processing	FASEB JOURNAL			English	Article						BODIPY; cytotrophoblast; gestational diabetes; hyperglycemia; lipids; metabolism; mitochondria; mitochondrial respiration; placenta; syncytiotrophoblast	GLUCOSE-TRANSPORT; IN-VITRO; OXYGEN-CONSUMPTION; FATTY-ACIDS; WOMEN; EXPRESSION; OBESITY; CYTOTROPHOBLASTS; DIFFERENTIATION; ACCUMULATION	The degree that maternal glycemia affects placental metabolism of trophoblast cell types [cytotrophoblast (CTB) and syncytiotrophoblast (SCT)] in pregnant persons with gestational diabetes mellitus (GDM) is unknown. We tested the hypotheses that (a) hyperglycemia suppresses the metabolic rates of CTB and SCT; and (b) low placental metabolic activity from GDM placentas is due to decreased oxygen consumption of CTB. Trophoblast cells isolated from GDM and non-GDM term placentas were cultured for 8-hour (CTB) and following syncytialization at 72-hour (SCT) in 5 mM of glucose or 25 mM of glucose. Oxygen consumption rates, glycolysis, ATP levels, and lipid droplet morphometries were determined in CTB and SCT. In CTB from GDM placentas compared to control CTB: (a) oxidative phosphorylation was decreased by 44% (41.8 vs 74.2 pmol O-2/min/100 ng DNA, P = .002); (b) ATP content was 39% lower (1.1 x 10(-7) vs 1.8 x 10(-7) nM/ng DNA, P = .046); and (c) lipid droplets were two times larger (31.0 vs 14.4 mu m(2)/cell, P < .001) and 1.7 times more numerous (13.5 vs 7.9 lipid droplets/cell, P < .001). Hyperglycemia suppressed CTB glycolysis by 55%-60% (mean difference 20.4 [GDM, P = .008] and 15.4 [non-GDM, P = .029] mpH/min/100 ng DNA). GDM SCT was not metabolically different from non-GDM SCT. However, GDM SCT had significantly decreased expression of genes associated with differentiation including hCG, GCM1, and syncytin-1. We conclude that suppressed metabolic activity by the GDM placenta is attributable to metabolic dysfunction of CTB, not SCT. Critical placental hormone expression and secretion are decreased in GDM trophoblasts.	[Valent, Amy M.; Choi, Haeri] Oregon Hlth & Sci Univ, Div Maternal Fetal Med, Dept Obstet & Gynecol, 3181 Sw Sam Jackson Pk Rd,Mail Locat L-458, Portland, OR 97239 USA; [Choi, Haeri; Thornburg, Kent L.] Oregon Hlth & Sci Univ, Ctr Dev Hlth, Knight Cardiovasc Inst, Portland, OR 97239 USA; [Kolahi, Kevin S.; Thornburg, Kent L.] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Valent, AM (corresponding author), Oregon Hlth & Sci Univ, Div Maternal Fetal Med, Dept Obstet & Gynecol, 3181 Sw Sam Jackson Pk Rd,Mail Locat L-458, Portland, OR 97239 USA.	valent@ohsu.edu		Valent, Amy/0000-0003-3832-2024	NIH [5 K12 HD085809-03, 1 R21 HD090529-01, 5 F30 HD084095-04]; M. Lowell Edwards Endowment	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. Lowell Edwards Endowment	Amy M. Valent: NIH 5 K12 HD085809-03. Haeri Choi: NIH 1 R21 HD090529-01. Kevin Kolahi: NIH 5 F30 HD084095-04. Kent L. Thornburg: NIH 1 R21 HD090529-01; M. Lowell Edwards Endowment	Aas V, 2004, DIABETOLOGIA, V47, P1452, DOI 10.1007/s00125-004-1465-9; Aas V, 2011, BBA-MOL BASIS DIS, V1812, P94, DOI 10.1016/j.bbadis.2010.09.014; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; Araujo JR, 2013, J NUTR BIOCHEM, V24, P1741, DOI 10.1016/j.jnutbio.2013.03.003; Barbour LA, 2018, OBESITY, V26, P1347, DOI 10.1002/oby.22246; BOIME I, 1982, BIOL REPROD, V26, P73, DOI 10.1095/biolreprod26.1.73; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2469, DOI 10.1001/jama.2011.1798; Calabuig-Navarro V, 2017, ENDOCRINOLOGY, V158, P2543, DOI 10.1210/en.2017-00152; Carter AM, 2000, PLACENTA, V21, pS31, DOI 10.1053/plac.1999.0513; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Couch SC, 1998, J DIABETES COMPLICAT, V12, P1, DOI 10.1016/S1056-8727(97)00007-X; Cunningham P, 2009, J NUTR, V139, P636, DOI 10.3945/jn.108.098608; Debieve F, 2000, MOL HUM REPROD, V6, P743, DOI 10.1093/molehr/6.8.743; Deputy NP, 2018, MMWR-MORBID MORTAL W, V67, P1201, DOI 10.15585/mmwr.mm6743a2; DeSisto CL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130415; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; DOUGLAS GC, 1990, J CELL SCI, V96, P131; Ertunc ME, 2016, J LIPID RES, V57, P2099, DOI 10.1194/jlr.R066514; Farabi SS., 2017, AM DIAB ASS 77 SCI S; Friedman JE, 2015, DIABETES CARE, V38, P1402, DOI 10.2337/dc15-0628; Guilbert LJ, 2002, PLACENTA, V23, P175, DOI 10.1053/plac.2001.0756; Hahn T, 1998, FASEB J, V12, P1221, DOI 10.1096/fasebj.12.12.1221; Hammoud NM, 2018, DIABETOLOGIA, V61, P1037, DOI 10.1007/s00125-018-4584-4; Harmon KA, 2011, DIABETES CARE, V34, P2198, DOI 10.2337/dc11-0723; Hauguel-de Mouzon S, 2001, PLACENTA, V22, P619, DOI 10.1053/plac.2001.0698; HAY WW, 1995, PLACENTA, V16, P19, DOI 10.1016/0143-4004(95)90078-0; Haythorne E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10189-x; Hulme CH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50626-x; Illsley NP, 2000, CLIN OBSTET GYNECOL, V43, P116, DOI 10.1097/00003081-200003000-00012; Jansson T, 1999, AM J OBSTET GYNECOL, V180, P163, DOI 10.1016/S0002-9378(99)70169-9; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Kolahi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153522; Kolahi KS, 2018, PLACENTA, V72-73, P1, DOI 10.1016/j.placenta.2018.07.014; Kolahi KS, 2017, SCI REP-UK, V7, DOI 10.1038/srep42941; Lee IK, 2014, DIABETES METAB J, V38, P181, DOI 10.4093/dmj.2014.38.3.181; Lee SJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/327167; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Meyer B, 1996, AUST NZ J OBSTET GYN, V36, P255, DOI 10.1111/j.1479-828X.1996.tb02705.x; Muralimanoharan S, 2016, CLIN SCI, V130, P931, DOI 10.1042/CS20160076; Napso T, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01091; Nguyen TB, 2017, DEV CELL, V42, P9, DOI 10.1016/j.devcel.2017.06.003; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Ryckman KK, 2015, BJOG-INT J OBSTET GY, V122, P643, DOI 10.1111/1471-0528.13261; Schaefer-Graf UM, 2008, DIABETES CARE, V31, P1858, DOI 10.2337/dc08-0039; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Segura MT, 2017, PLACENTA, V57, P144, DOI 10.1016/j.placenta.2017.07.001; SILVERMAN BL, 1991, DIABETES, V40, P121, DOI 10.2337/diab.40.2.S121; Stirm L, 2018, J CLIN ENDOCR METAB, V103, P3299, DOI 10.1210/jc.2018-00397; Visiedo F, 2015, REPROD SCI, V22, P798, DOI 10.1177/1933719114561558; Visiedo F, 2013, AM J PHYSIOL-ENDOC M, V305, pE205, DOI 10.1152/ajpendo.00032.2013; Wang Y, 2019, J CLIN ENDOCR METAB, V104, P4178, DOI 10.1210/jc.2019-00166	51	8	9	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21423	10.1096/fj.202000326RR	http://dx.doi.org/10.1096/fj.202000326RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33605480	Green Accepted			2022-12-26	WOS:000629576700012
J	Bhatti, FA; Hamedani, GG; Korkmaz, MC; Sheng, WH; Ali, A				Bhatti, Fiaz Ahmad; Hamedani, G. G.; Korkmaz, Mustafa C.; Sheng, Wenhui; Ali, Azeem			On the Burr XII-moment exponential distribution	PLOS ONE			English	Article								In this study, a new flexible lifetime model called Burr XII moment exponential (BXII-ME) distribution is introduced. We derive some of its mathematical properties including the ordinary moments, conditional moments, reliability measures and characterizations. We employ different estimation methods such as the maximum likelihood, maximum product spacings, least squares, weighted least squares, Cramer-von Mises and Anderson-Darling methods for estimating the model parameters. We perform simulation studies on the basis of the graphical results to see the performance of the above estimators of the BXII-ME distribution. We verify the potentiality of the BXII-ME model via monthly actual taxes revenue and fatigue life applications.	[Bhatti, Fiaz Ahmad] Natl Coll Business Adm & Econ, Lahore, Pakistan; [Hamedani, G. G.; Sheng, Wenhui] Marquette Univ, Milwaukee, WI 53233 USA; [Korkmaz, Mustafa C.] Artvin Coruh Univ, Dept Measurement & Evaluat, Artvin, Turkey; [Ali, Azeem] Univ Vet & Anim Sci, Lahore, Pakistan	Marquette University; Artvin Coruh University; University of Veterinary & Animal Science - Pakistan	Bhatti, FA (corresponding author), Natl Coll Business Adm & Econ, Lahore, Pakistan.	fiazahmad72@gmail.com	Korkmaz, Mustafa Ç./AAK-1910-2021; Sheng, Wenhui/AAI-7283-2021	Korkmaz, Mustafa Ç./0000-0003-3302-0705; 				Abbas S, 2020, J NATL SCI FOUND SRI, V48, P265, DOI 10.4038/jnsfsr.v48i3.8836; Alzaatreh A, 2016, HACET J MATH STAT, V45, P1143; ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; BHATTACHARYYA GK, 1974, J AM STAT ASSOC, V69, P966, DOI 10.2307/2286173; BIRNBAUM ZW, 1969, J APPL PROBAB, V6, P328, DOI 10.2307/3212004; Burr IW, 1942, ANN MATH STAT, V13, P215, DOI 10.1214/aoms/1177731607; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; CHEN GM, 1995, J QUAL TECHNOL, V27, P154, DOI 10.1080/00224065.1995.11979578; Cheng R.C.H., 1979, MATH REPORT, V791; CHENG RCH, 1983, J ROY STAT SOC B MET, V45, P394; Cordeiro GM, 2018, J STAT COMPUT SIM, V88, P432, DOI 10.1080/00949655.2017.1392524; Dara S. T., 2012, THESIS NATL COLL BUS; Dong BW, 2018, J ADV TRANSPORT, DOI 10.1155/2018/2702360; El-Morshedy M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241970; Gad A.M, 2019, PAK J STAT; Glanzel W., 1990, STATISTICS-ABINGDON, V210, P0613, DOI [10.1080/02331889008802273, DOI 10.1080/02331889008802273]; Goual H, 2020, J APPL STAT, V47, P393, DOI 10.1080/02664763.2019.1639642; Hashmi S, 2019, J RELIAB STAT STUD, V12, P1; Hasnain S. A., 2015, PAK J STAT, V31, P267; Iqbal Z, 2014, PAK J STAT; Jodra P, 2010, MATH COMPUT SIMULAT, V81, P851, DOI 10.1016/j.matcom.2010.09.006; Kotz S, 2003, IIE TRANS, V35, P1103, DOI 10.1080/07408170390237225; KYURKCHIEV V, 2018, INT J PURE APPL MATH, V119, P639, DOI DOI 10.12732/IJPAM.V119I4.6; Ma XX, 2016, J TRANSP ENG, V142, DOI 10.1061/(ASCE)TE.1943-5436.0000882; Mdlongwa P, 2017, ELECTRON J APPL STAT, V10, P118, DOI 10.1285/i20705948v10n1p118; Nasir MA, 2018, J RELIAB STAT STUD, V11, P143; Nassar MM., 2011, J STAT ADV THEORY AP, V6, P1; Oluyede B. O., 2018, STATS, V1, P77; RANNEBY B, 1984, SCAND J STAT, V11, P93; Silva RB, 2015, BRAZ J PROBAB STAT, V29, P565, DOI 10.1214/13-BJPS234; Yari G, 2018, APPL APPL MATH, V13; Yousof HM, 2019, COMMUN STAT-SIMUL C, V48, P264, DOI 10.1080/03610918.2017.1377241; Zeng Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082768; Zeng Q, 2019, TRANSPORTMETRICA A, V15, P1867, DOI 10.1080/23249935.2019.1652867; Zeng Q, 2020, J TRANSP SAF SECUR, V12, P566, DOI 10.1080/19439962.2018.1516259	35	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0246935	10.1371/journal.pone.0246935	http://dx.doi.org/10.1371/journal.pone.0246935			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617564	Green Published, gold			2022-12-26	WOS:000623082400005
J	Hepp, M; Palsson, E; Thomsen, SK; Green, DJ				Hepp, Mathew; Palsson, Eirikur; Thomsen, Sarah K.; Green, David J.			Predicting the effects of reservoir water level management on the reproductive output of a riparian songbird	PLOS ONE			English	Article							ECOLOGICAL TRAP; RIVER; HABITAT; SURVIVAL; SUCCESS; POPULATION; PARASITISM; BIRDS; DAMS; AGE	Dams and reservoirs alter natural water flow regimes with adverse effects on natural ecosystems. Quantifying and reducing these effects are important as global demands for energy and water, and the number of dams and reservoir, increase. However, costs and logistic constraints typically preclude experimental assessment of reservoir effects on the environment. We developed a stochastic individual-based model (IBM), parameterized using empirical data, to estimate the annual productivity of yellow warblers that breed in riparian habitat within the footprint of the Arrow Lakes Reservoir in British Columbia, Canada. The IBM incorporated information on breeding phenology, nest site selection, brood parasitism, daily nest survival, re-nesting probabilities and post-fledging survival. We used the IBM to estimate the effect of four different water management scenarios on annual productivity. We found that the IBM accurately estimated average nest success (0.39 +/- 0.10 SD), the proportion of females that produced at least one fledgling during a breeding season (0.56 +/- 0.11), and annual fledging success (2.06 +/- 0.43) under current conditions. The IBM estimated that reservoir operations currently reduce the annual productivity of this population by 37%, from an average of 1.62 to 1.06 independent young/female. Delaying when reservoir water levels reach 435m asl (the minimum elevation occupied by yellow warblers) by approximately 2 weeks was predicted to increase annual productivity to 1.44 independent young/female. The standardized effect on annual productivity of reducing the maximum elevation of the reservoir so that yellow warbler habitat is not inundated (Cohen's d = 1.52) or delaying when water is stored (Cohen's d = 0.83) was primarily driven by inundation effects on post-fledging survival. Reservoir operation effects on breeding birds will be species specific, but this IBM can easily be modified to allow the environmental impacts on the entire breeding bird community to be incorporated into water management decisions.	[Hepp, Mathew; Thomsen, Sarah K.; Green, David J.] Simon Fraser Univ, Dept Biol Sci, Ctr Wildlife Ecol, Burnaby, BC, Canada; [Palsson, Eirikur] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada; [Thomsen, Sarah K.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA	Simon Fraser University; Simon Fraser University; Oregon State University	Green, DJ (corresponding author), Simon Fraser Univ, Dept Biol Sci, Ctr Wildlife Ecol, Burnaby, BC, Canada.	djgreen@sfu.ca		Green, David/0000-0001-7284-1819	National Science and Research Council [RGPIN 2009-261899, 2014-05798, 201905513, RGPIN-2016-04625]; Columbia Basic Fish and Wildlife Compensation Program [SPI 4639]; Environment and Climate Change grant; BC Hydro Water License Requirements contract [CLBMON-36];  [GCXE19SO59]	National Science and Research Council; Columbia Basic Fish and Wildlife Compensation Program; Environment and Climate Change grant; BC Hydro Water License Requirements contract; 	Funding for this work came from National Science and Research Council Discovery grants to DJG (RGPIN 2009-261899, 2014-05798, 201905513) and EP (RGPIN-2016-04625) and a Columbia Basic Fish and Wildlife Compensation Program (http://fwcp.ca) grant to DJG (SPI 4639). Fieldwork was supported by an Environment and Climate Change grant and contribution to the Centre for Wildlife Ecology, Simon Fraser University (GCXE19SO59). Fieldwork was also indirectly supported through a BC Hydro Water License Requirements contract to Cooper Beauchesne and Associates Ltd (CLBMON-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammon EM, 1997, CONDOR, V99, P7, DOI 10.2307/1370219; [Anonymous], 2017, R LANG ENV STAT COMP, V55, P275; Anteau MJ, 2012, OECOLOGIA, V170, P1167, DOI 10.1007/s00442-012-2384-y; Baril LM, 2011, ECOL APPL, V21, P2283, DOI 10.1890/10-0169.1; Buckingham DL, 2015, AGR ECOSYST ENVIRON, V208, P21, DOI 10.1016/j.agee.2015.04.018; Capon SJ, 2018, ECOL MANAG RESTOR, V19, P44, DOI 10.1111/emr.12326; Cox WA, 2014, J WILDLIFE MANAGE, V78, P183, DOI 10.1002/jwmg.670; Cox WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047591; Drake A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097152; Drake A, 2013, J AVIAN BIOL, V44, P321, DOI 10.1111/j.1600-048X.2013.05828.x; Ellis LA, 2009, J WILDLIFE MANAGE, V73, P946, DOI 10.2193/2008-297; Figarski T, 2015, HYDROBIOLOGIA, V744, P287, DOI 10.1007/s10750-014-2084-1; Grill G, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/1/015001; Hanowski J, 2005, J WILDLIFE MANAGE, V69, P689, DOI 10.2193/0022-541X(2005)069[0689:BBRTVA]2.0.CO;2; Hepp M., 2018, AVIAN CONSERV ECOL, V13; Hunter EA, 2017, CONDOR, V119, P459, DOI 10.1650/CONDOR-17-11.1; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lowther PE, 1999, BIRDS N AM ONLINE PO; Martin M., 2019, IBIS, DOI [10.1016/j.jtherbio.2019.01.004, DOI 10.1016/J.JTHERBIO.2019.01.004]; Moran EF, 2018, P NATL ACAD SCI USA, V115, P11891, DOI 10.1073/pnas.1809426115; New T, 2008, BIODIVERS CONSERV, V17, P3149, DOI 10.1007/s10531-008-9416-2; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; NILSSON C, 1994, REGUL RIVER, V9, P45, DOI 10.1002/rrr.3450090105; Nilsson C, 2000, BIOSCIENCE, V50, P783, DOI 10.1641/0006-3568(2000)050[0783:AORECB]2.0.CO;2; O'Neil HCL, 2017, HYDROL RES, V48, P915, DOI 10.2166/nh.2016.057; Payne RB, 1998, BEHAV ECOL, V9, P64, DOI 10.1093/beheco/9.1.64; Quinlan SP, 2012, CAN J ZOOL, V90, P320, DOI [10.1139/Z11-138, 10.1139/z11-138]; Ratcliffe N, 2005, J APPL ECOL, V42, P834, DOI 10.1111/j.1365-2664.2005.01076.x; Rock CA, 2013, CAN J ZOOL, V91, P505, DOI 10.1139/cjz-2013-0014; Rotella JJ., 2006, PROGRAM MARK GENTLE; Smith CM, 2006, BIOL CONSERV, V128, P431, DOI 10.1016/j.biocon.2005.10.008; Stillman RA, 2015, ECOSPHERE, V6, DOI 10.1890/ES1400455.1; Swan DC, 2015, ANIM BEHAV, V105, P29, DOI 10.1016/j.anbehav.2015.03.012; van Oort H, 2015, CONDOR, V117, P376, DOI 10.1650/CONDOR-14-154.1; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440	36	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0247318	10.1371/journal.pone.0247318	http://dx.doi.org/10.1371/journal.pone.0247318			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617585	Green Submitted, Green Published, gold			2022-12-26	WOS:000623082400019
J	Kim, B; Kim, S; Jang, W; Jung, S; Lim, J				Kim, Byungwon; Kim, Seonghong; Jang, Woncheol; Jung, Sungkyu; Lim, Johan			Estimation of the case fatality rate based on stratification for the COVID-19 outbreak	PLOS ONE			English	Article								This work is motivated by the recent worldwide pandemic of the novel coronavirus disease (COVID-19). When an epidemiological disease is prevalent, estimating the case fatality rate, the proportion of deaths out of the total cases, accurately and quickly is important as the case fatality rate is one of the crucial indicators of the risk of a disease. In this work, we propose an alternative estimator of the case fatality rate that provides more accurate estimate during an outbreak by reducing the downward bias (underestimation) of the naive CFR, the proportion of deaths out of confirmed cases at each time point, which is the most commonly used estimator due to the simplicity. The proposed estimator is designed to achieve the availability of real-time update by using the commonly reported quantities, the numbers of confirmed, cured, deceased cases, in the computation. To enhance the accuracy, the proposed estimator adapts a stratification, which allows the estimator to use information from heterogeneous strata separately. By the COVID-19 cases of China, South Korea and the United States, we numerically show the proposed stratification-based estimator plays a role of providing an early warning about the severity of a epidemiological disease that estimates the final case fatality rate accurately and shows faster convergence to the final case fatality rate.	[Kim, Byungwon; Kim, Seonghong; Jang, Woncheol; Jung, Sungkyu; Lim, Johan] Seoul Natl Univ, Dept Stat, Seoul, South Korea	Seoul National University (SNU)	Jang, W (corresponding author), Seoul Natl Univ, Dept Stat, Seoul, South Korea.	wcjang@snu.ac.kr	Jung, Sungkyu/AFA-8963-2022	Jung, Sungkyu/0000-0002-6023-8956	National Research Foundation of Korea (NRF); Korea Health Industry Development Institute (KHIDI) - Korea government(MSIT); Ministry of Health & Welfare, Republic of Korea [2017R1A2B2012816, HI19C0378]; National Research Foundation of Korea (NRF) - Korea government (MSIT) [2019R1A2C2002256]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Health Industry Development Institute (KHIDI) - Korea government(MSIT); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	W.J. and B.K. were supported by the National Research Foundation of Korea (NRF) grant and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Korea government(MSIT) and the Ministry of Health & Welfare, Republic of Korea (No. 2017R1A2B2012816, HI19C0378). S.J. and B.K. were supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2019R1A2C2002256).	[Anonymous], NEW YORK TIMES; Chen Z, 2009, LIFETIME DATA ANAL, V15, P316, DOI 10.1007/s10985-009-9119-3; DS4C project, DS4C DATA SCI COVID; Ejima K, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/978901; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Johns Hopkins CSSE, 2019 NOVEL CORONAVIR; Kucharski AJ, 2014, LANCET, V384, P1260, DOI 10.1016/S0140-6736(14)61706-2; Lee S, 2019, STAT MED, V38, P2664, DOI 10.1002/sim.8125; Leung GM, 2004, INFECT CONT HOSP EP, V25, P1033, DOI 10.1086/502340; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; Michigan Health Watch, MICHIGAN HAS HIGHEST; Ministry of Health and Welfare Republic of Korea, COR DIS 19 COVID 19; Nishiura H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006852; World Health Organization, 2013, CORONAVIRUS DIS COVI; World Health Organization, CORONAVIRUS DIS 2019; Xinhuanet, FULL TEXT WUHANS NOT; Yip PSF, 2005, AM J EPIDEMIOL, V161, P700, DOI 10.1093/aje/kwi088; Yoshikura H, 2009, JPN J INFECT DIS, V62, P411; Yu PLH, 2006, AM STAT, V60, P81, DOI 10.1198/000313006X91421; Zhang B, 2020, ARXIV200402944	21	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2021	16	2							e0246921	10.1371/journal.pone.0246921	http://dx.doi.org/10.1371/journal.pone.0246921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QO3ZL	33617534	gold, Green Submitted, Green Published			2022-12-26	WOS:000623082400046
J	Barros, JBD; Santos, KD; Azevedo, RM; de Oliveira, RPD; Leobas, ACD; Bento, DDP; Santos, RD; Reis, AAD				de Sousa Barros, Jessica Barletto; Santos, Kamilla de Faria; Azevedo, Romulo Morais; Dantas de Oliveira, Rayana Pereira; Dourado Leobas, Ana Carolina; Pereira Bento, Dhiogo da Cruz; Santos, Rodrigo da Silva; da Silva Reis, Angela Adamski			No association of GSTP1 rs1695 polymorphism with amyotrophic lateral sclerosis: A case-control study in the Brazilian population	PLOS ONE			English	Article							RISK; EXPOSURE; GENDER; GENES; ALS	Amyotrophic Lateral Sclerosis (ALS) is a rare neurodegenerative disease that affects motor neurons and promotes progressive muscle atrophy. It has a multifactorial etiology, where environmental conditions playing a remarkable role through the increase of oxidative stress. Genetic polymorphisms in cell detoxification genes, such as Glutathione S-Transferase Pi 1 (GSTP1) can contribute to excessive oxidative stress, and therefore may be a risk factor to ALS. Thus, this study aimed to investigate the role of the GSTP1 rs1695 polymorphism in ALS susceptibility in different genetic inheritance models and evaluate the association of the genotypes with risk factors, clinical and demographic characteristics of ALS patients from the Brazilian central population. This case-control study was conducted with 101 patients with ALS and 101 healthy controls. GSTP1 rs1695 polymorphism genotyping was performed with Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). The statistical analysis was carried out using the SPSS statistical package and SNPStats software. Analysis of genetic inheritance models was performed by logistic regression, which was used to determine the Odds Ratio. The results of this first study in the Brazilian population demonstrated that there was no risk association between the development of ALS and the GSTP1 rs1695 polymorphism in any genetic inheritance model (codominant, dominant, recessive, overdominant, and logarithmic); and that the polymorphic variants were not associated with the clinical and demographic characteristics of ALS patients. No association of the GSTP1 rs1695 polymorphism and ALS development in the Brazilian central population was found. These findings may be justified by the multifactorial character of the disease.	[de Sousa Barros, Jessica Barletto; Santos, Kamilla de Faria; Azevedo, Romulo Morais; Dantas de Oliveira, Rayana Pereira; Dourado Leobas, Ana Carolina; Santos, Rodrigo da Silva; da Silva Reis, Angela Adamski] Fed Univ Goias UFG, Inst Biol Sci, Dept Biochem & Mol Biol, Lab Mol Pathol, Goiania, Go, Brazil; [Pereira Bento, Dhiogo da Cruz] Rehabil & Readaptat Med Ctr Dr Henrique Santillo, Goiania, Go, Brazil	Universidade Federal de Goias	Santos, RD; Reis, AAD (corresponding author), Fed Univ Goias UFG, Inst Biol Sci, Dept Biochem & Mol Biol, Lab Mol Pathol, Goiania, Go, Brazil.	rdssantos@ufg.br; angela@ufg.br	DA SILVA, ANGELA ADAMSKI/AAJ-1403-2021	DA SILVA, ANGELA ADAMSKI/0000-0002-8281-7334; da Silva Santos, Rodrigo/0000-0002-9480-4362; CP Bento, Dhiogo/0000-0001-8895-2628; PEREIRA DANTAS DE OLIVEIRA, RAYANA/0000-0003-3750-4942; Barros, Jessica/0000-0002-0377-3004; de Faria Santos, Kamilla/0000-0002-0555-3072; Morais Azevedo, Romulo/0000-0001-9058-5126				Agundez JAG, 2015, CELL MOL IMMUNOL, V12, P777, DOI 10.1038/cmi.2014.121; Baronica KB, 2014, ACTA NEUROBIOL EXP, V74, P257; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Blasco H, 2012, AMYOTROPH LATERAL SC, V13, P585, DOI 10.3109/17482968.2012.706303; Calvo A, 2016, J NEUROL NEUROSUR PS, V87, P1229, DOI 10.1136/jnnp-2016-313793; Carrera-Julia S, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00063; Werneck LC, 2007, ARQ NEURO-PSIQUIAT, V65, P189, DOI 10.1590/S0004-282X2007000200001; Chen L, 2015, J NEUROL NEUROSUR PS, V86, P1075, DOI 10.1136/jnnp-2015-310471; Chen S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-28; Chia R, 2018, LANCET NEUROL, V17, P94, DOI 10.1016/S1474-4422(17)30401-5; Chio A, 2013, NEUROEPIDEMIOLOGY, V41, P118, DOI 10.1159/000351153; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; D'Amico E., 2013, FREE RADICAL BIO MED, V29, P997; de Jong SW, 2012, AM J EPIDEMIOL, V176, P233, DOI 10.1093/aje/kws015; de Lima RM, 2018, MOL CELL ENDOCRINOL, V478, P10, DOI 10.1016/j.mce.2018.07.001; Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145; de Souza AM, 2019, GENET MOL BIOL, V42, P495, DOI [10.1590/1678-4685-GMB-2018-0076, 10.1590/1678-4685-gmb-2018-0076]; de Souza IM, 2021, J RACIAL ETHN HEALTH, V8, P350, DOI 10.1007/s40615-020-00789-5; de Vasconcelos K, 2019, REV ASSOC MED BRAS, V65, P576, DOI 10.1590/1806-9282.65.5.576; Ercegovac M, 2015, SEIZURE-EUR J EPILEP, V32, P30, DOI 10.1016/j.seizure.2015.08.010; Eum KD, 2015, AMYOTROPH LAT SCL FR, V16, P72, DOI 10.3109/21678421.2014.964259; Filippini T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17030857; Gajewska B, 2015, CNS NEUROL DISORD-DR, V14, P1328, DOI 10.2174/1871527314666150821104019; Gladman M, 2015, EXPERT REV PHARM OUT, V15, P439, DOI 10.1586/14737167.2015.1039941; Hardiman O., 2017, NAT REV DIS PRIMERS, V3, P3; Harries LW, 1997, CARCINOGENESIS, V18, P641, DOI 10.1093/carcin/18.4.641; Holmes A, 2013, PSYCHOPHARMACOLOGY, V229, P539, DOI 10.1007/s00213-013-3226-2; Huisman MHB, 2015, JAMA NEUROL, V72, P1155, DOI 10.1001/jamaneurol.2015.1584; Jafarian Z, 2018, NEUROL RES, V40, P41, DOI 10.1080/01616412.2017.1390902; Kazmierczak B, 2011, ACTA BIOCHIM POL, V58, P621; Kuzma M, 2006, CLIN CHIM ACTA, V364, P217, DOI 10.1016/j.cccn.2005.07.008; Lian L, 2019, J CLIN NEUROSCI, V66, P12, DOI 10.1016/j.jocn.2019.05.036; Little J, 2009, GENET EPIDEMIOL, V33, P581, DOI 10.1002/gepi.20410; Longo GS, 2013, ARQ NEURO-PSIQUIAT, V71, P446, DOI 10.1590/0004-282X20130060; Loureiro MPS, 2012, J NEUROL SCI, V316, P61, DOI 10.1016/j.jns.2012.01.029; McCombe PA, 2010, GENDER MED, V7, P557, DOI 10.1016/j.genm.2010.11.010; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Peng B, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072316; Riancho J, 2018, INT J BIOMETEOROL, V62, P1361, DOI 10.1007/s00484-018-1550-2; Roosli M, 2018, REV ENVIRON HEALTH, V33, P295, DOI 10.1515/reveh-2018-0019; Rooney JPK, 2017, NEUROLOGY, V89, P1283, DOI 10.1212/WNL.0000000000004390; Prado LDR, 2016, AMYOTROPH LAT SCL FR, V17, P282, DOI 10.3109/21678421.2016.1143011; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Soriguer F., 2007, ENDOCRINOL NUTR, V54, P169; van Rheenen W, 2016, NAT GENET, V48, P1043, DOI 10.1038/ng.3622; Wang H, 2011, ARCH NEUROL-CHICAGO, V68, P207, DOI 10.1001/archneurol.2010.367; Yu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101186; Zeng P, 2019, HUM MOL GENET, V28, P688, DOI 10.1093/hmg/ddy384; Zhan YQ, 2019, ANN NEUROL, V85, P482, DOI 10.1002/ana.25443; Zherebtsova AL, 2004, RUSS J GENET+, V40, P691, DOI 10.1023/B:RUGE.0000033319.46071.84; Zufiria M, 2016, PROG NEUROBIOL, V142, P104, DOI 10.1016/j.pneurobio.2016.05.004	51	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247024	10.1371/journal.pone.0247024	http://dx.doi.org/10.1371/journal.pone.0247024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606765	gold, Green Published			2022-12-26	WOS:000620629200094
J	Parikh, RB; Linn, KA; Yan, JL; Maciejewski, ML; Rosland, AM; Volpp, KG; Groeneveld, PW; Navathe, AS				Parikh, Ravi B.; Linn, Kristin A.; Yan, Jiali; Maciejewski, Matthew L.; Rosland, Ann-Marie; Volpp, Kevin G.; Groeneveld, Peter W.; Navathe, Amol S.			A machine learning approach to identify distinct subgroups of veterans at risk for hospitalization or death using administrative and electronic health record data	PLOS ONE			English	Article								Background Identifying individuals at risk for future hospitalization or death has been a major priority of population health management strategies. High-risk individuals are a heterogeneous group, and existing studies describing heterogeneity in high-risk individuals have been limited by data focused on clinical comorbidities and not socioeconomic or behavioral factors. We used machine learning clustering methods and linked comorbidity-based, sociodemographic, and psychobehavioral data to identify subgroups of high-risk Veterans and study long-term outcomes, hypothesizing that factors other than comorbidities would characterize several subgroups. Methods and findings In this cross-sectional study, we used data from the VA Corporate Data Warehouse, a national repository of VA administrative claims and electronic health data. To identify high-risk Veterans, we used the Care Assessment Needs (CAN) score, a routinely-used VA model that predicts a patient's percentile risk of hospitalization or death at one year. Our study population consisted of 110,000 Veterans who were randomly sampled from 1,920,436 Veterans with a CAN score >= 75(th) percentile in 2014. We categorized patient-level data into 119 independent variables based on demographics, comorbidities, pharmacy, vital signs, laboratories, and prior utilization. We used a previously validated density-based clustering algorithm to identify 30 subgroups of high-risk Veterans ranging in size from 50 to 2,446 patients. Mean CAN score ranged from 72.4 to 90.3 among subgroups. Two-year mortality ranged from 0.9% to 45.6% and was highest in the home-based care and metastatic cancer subgroups. Mean inpatient days ranged from 1.4 to 30.5 and were highest in the post-surgery and blood loss anemia subgroups. Mean emergency room visits ranged from 1.0 to 4.3 and were highest in the chronic sedative use and polysubstance use with amphetamine predominance subgroups. Five subgroups were distinguished by psychobehavioral factors and four subgroups were distinguished by sociodemographic factors. Conclusions High-risk Veterans are a heterogeneous population consisting of multiple distinct subgroups-many of which are not defined by clinical comorbidities-with distinct utilization and outcome patterns. To our knowledge, this represents the largest application of ML clustering methods to subgroup a high-risk population. Further study is needed to determine whether distinct subgroups may benefit from individualized interventions.	[Parikh, Ravi B.; Volpp, Kevin G.; Navathe, Amol S.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Parikh, Ravi B.; Rosland, Ann-Marie; Volpp, Kevin G.; Groeneveld, Peter W.; Navathe, Amol S.] VA Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15240 USA; [Parikh, Ravi B.; Yan, Jiali; Volpp, Kevin G.; Navathe, Amol S.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Parikh, Ravi B.; Yan, Jiali; Volpp, Kevin G.; Groeneveld, Peter W.; Navathe, Amol S.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Linn, Kristin A.] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Maciejewski, Matthew L.] Durham Vet Affairs Hlth Care Syst, Durham Ctr Innovat Accelerate Discovery & Practic, Durham, NC USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Navathe, AS (corresponding author), Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.; Navathe, AS (corresponding author), VA Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15240 USA.; Navathe, AS (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA.; Navathe, AS (corresponding author), Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA.	amol@pennmedicine.upenn.edu		Parikh, Ravi/0000-0003-2692-6306; Rosland, Ann-Marie/0000-0002-5809-5861; Groeneveld, Peter/0000-0002-7374-4292; Navathe, Amol/0000-0001-7182-4988	VA HSRD Pilot [PPO 17-272-2]	VA HSRD Pilot	This study was funded a VA HSR&D Pilot PPO 17-272-2 to ASN (https://www.hsrd.research.va.gov/). The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; Backus LI, 2013, JAMA INTERN MED, V173, P1549, DOI 10.1001/jamainternmed.2013.8133; Blumenthal D, 2016, JAMA-J AM MED ASSOC, V316, P1657, DOI 10.1001/jama.2016.12388; Byrne CM, 2010, HEALTH AFFAIR, V29, P629, DOI 10.1377/hlthaff.2010.0119; Center for Substance Abuse Treatment, 1998, SUBSTANCE ABUSE AND; Choudhry NK, 2009, AM J MANAG CARE, V15, P457; Clough JD, 2016, HEALTHCARE-J DEL SCI, V4, P160, DOI 10.1016/j.hjdsi.2015.09.005; Cohen SB, 2015, 481 AG HLTH RES QUAL; Eick CF, 2004, PROC INT C TOOLS ART, P774; Fihn S, 2016, UPDATE CARE ASSESSME; Fihn S, 2016, PREDICTING RISK HOSP; Fihn SD, 2014, HEALTH AFFAIR, V33, P1203, DOI 10.1377/hlthaff.2014.0054; Fraze T, 2016, HEALTH AFFAIR, V35, P2109, DOI 10.1377/hlthaff.2016.0727; Frisch NB, 2020, J AM ACAD ORTHOP SUR, V28, P923, DOI 10.5435/JAAOS-D-19-00775; Hayes Susan L, 2016, Issue Brief (Commonw Fund), V26, P1; Hong Clemens S, 2014, Issue Brief (Commonw Fund), V19, P1; Joynt KE, 2017, HEALTHCARE-J DEL SCI, V5, P62, DOI 10.1016/j.hjdsi.2016.11.002; Long P., 2018, EFFECTIVE CARE HIGH; Maynard C., 2019, VIREC DAT METH SEM F; McWilliams JM, 2016, NEW ENGL J MED, V375, P2218, DOI 10.1056/NEJMp1610821; Noel PH, 2010, J REHABIL RES DEV, V47, P739, DOI 10.1682/JRRD.2009.08.0110; O'Malley Ann S, 2019, Issue Brief (Commonw Fund), V2019, P1; Parikh RB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18318; Parikh RB, 2017, NEW ENGL J MED, V376, P1609, DOI 10.1056/NEJMp1613224; Parikh RB, 2016, JAMA-J AM MED ASSOC, V315, P651, DOI 10.1001/jama.2015.19417; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Powers BW, 2019, J GEN INTERN MED, V34, P218, DOI 10.1007/s11606-018-4759-1; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang L, 2013, MED CARE, V51, P368, DOI 10.1097/MLR.0b013e31827da95a; Wong ES, 2020, AM J MANAG CARE, V26, P40, DOI 10.37765/ajmc.2020.42144; Wong ES, 2018, J GEN INTERN MED, V33, P2120, DOI 10.1007/s11606-018-4653-x; Yan JL, 2019, J GEN INTERN MED, V34, P211, DOI 10.1007/s11606-018-4760-8; Yoon J, 2014, MED CARE, V52, pS31, DOI 10.1097/MLR.0000000000000061; Zulman DM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007771	35	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247203	10.1371/journal.pone.0247203	http://dx.doi.org/10.1371/journal.pone.0247203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK8KQ	33606819	gold, Green Published			2022-12-26	WOS:000620629200048
J	Rahman, MM				Rahman, Mohammed M.			Rapid and sensitive detection of selective 1,2-diaminobenzene based on facile hydrothermally prepared doped Co3O4/Yb2O3 nanoparticles	PLOS ONE			English	Article								In this approach, the performance of a newly developed sensor probe coated with low-dimensional Co3O4/Yb2O3 nanoparticles (NPs) in rapidly detecting 1,2-diaminobenzene was evaluated by an electrochemical technique. The sensor probe was fabricated by depositing a very thin layer consisting of synthesized Co3O4/Yb2O3 NPs using a 5% Nafion conducting binder onto a glassy carbon electrode (GCE). The facile hydrothermally prepared Co3O4/Yb2O3 NPs were totally characterized by conventional methods such as FTIR, UV-vis, TEM, XPS, EDS, and XRD analyses. The fabricated chemical sensor probe was found to exhibit long-term activity, stability in electrochemical response, good sensitivity (5.6962 mu A mu M(-1)cm(-2)), lowest detection limit (0.02 +/- 0.001 pM), and broad linear dynamic range (0.1 pM to 0.01 mM). The observed performances suggest that the newly introduced sensor could play an efficient role in detecting 1,2-diaminobenzene especially in healthcare and environmental applications on a broad scale.	[Rahman, Mohammed M.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia	King Abdulaziz University	Rahman, MM (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia.	mmrahman@kau.edu.sa	Rahman, Mohammed M./H-5823-2012	Rahman, Mohammed M./0000-0003-2773-1244	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [130-019-D1433]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. 130-019-D1433. The authors, therefore, acknowledge with thanks DSR technical and financial support.	Alam MK, 2017, ELECTROCHIM ACTA, V241, P353, DOI 10.1016/j.electacta.2017.04.135; Alevli M, 2011, J CRYST GROWTH, V335, P51, DOI 10.1016/j.jcrysgro.2011.09.003; Altun O, 2007, SPECTROCHIM ACTA A, V66, P499, DOI 10.1016/j.saa.2006.02.065; Bilal S, 2007, ELECTROCHIM ACTA, V52, P5346, DOI 10.1016/j.electacta.2007.02.034; Celebioglu A, 2014, RSC ADV, V4, P61698, DOI 10.1039/c4ra12073f; Chang YY, 2015, CHEM COMMUN, V51, P7657, DOI 10.1039/c5cc00684h; Cherginets VL, 2017, J CHEM THERMODYN, V113, P1, DOI 10.1016/j.jct.2017.05.034; Cui JW, 2015, J MATER CHEM A, V3, P10425, DOI 10.1039/c5ta00860c; Dang LF, 2014, J MATER CHEM A, V2, P4558, DOI 10.1039/c3ta15019d; Dong SQ, 2008, ANAL BIOANAL CHEM, V391, P653, DOI 10.1007/s00216-008-2053-5; Edla R, 2016, APPL CATAL A-GEN, V515, P1, DOI 10.1016/j.apcata.2016.01.031; Gichner T, 2001, MUTAT RES-GEN TOX EN, V495, P117, DOI 10.1016/S1383-5718(01)00204-2; He K, 2015, MATER RES BULL, V69, P98, DOI 10.1016/j.materresbull.2014.11.054; Hou JT, 2014, ACS APPL MATER INTER, V6, P14981, DOI 10.1021/am5027743; Huang XN, 2013, ENERGY TECHNOL-GER, V1, P751, DOI 10.1002/ente.201300129; Hussain MM, 2017, J ENVIRON SCI, V53, P27, DOI 10.1016/j.jes.2016.03.028; Hussain MM, 2016, RSC ADV, V6, P80511, DOI 10.1039/c6ra12256f; Jeong S, 2011, ADV ENERGY MATER, V1, P368, DOI 10.1002/aenm.201100029; Kang M, 2015, AIMS MATER SCI, V2, P16, DOI 10.3934/matersci.2015.1.16; Kumar S, 2016, RSC ADV, V6, P8651, DOI 10.1039/c5ra14184b; Lee JS, 2016, J MATER CHEM B, V4, P4447, DOI 10.1039/c6tb00726k; Leng XN, 2015, SCI REP-UK, V5, DOI 10.1038/srep16629; Li JH, 2011, CHINESE J ANAL CHEM, V39, P1864, DOI 10.3724/SP.J.1096.2011.01864; Li N, 2015, SPECTROCHIM ACTA A, V140, P328, DOI 10.1016/j.saa.2014.12.053; Li N, 2014, BIOSENS BIOELECTRON, V54, P521, DOI 10.1016/j.bios.2013.11.040; Li YJ, 2003, CHEMOSPHERE, V53, P1229, DOI 10.1016/S0045-6535(03)00590-3; Liu JB, 2012, SENSOR ACTUAT B-CHEM, V166, P708, DOI 10.1016/j.snb.2012.03.045; Liu SD, 2017, J MATER CHEM A, V5, P1043, DOI 10.1039/c6ta07842g; Liu YJ, 2012, CRYSTENGCOMM, V14, P6264, DOI 10.1039/c2ce25788b; Luo X, 2014, NANOSCALE RES LETT, V9, P1, DOI 10.1186/1556-276X-9-625; Matsumoto M, 2012, ARCH TOXICOL, V86, P791, DOI 10.1007/s00204-012-0800-z; Nidhin M, 2012, CHEM ENG J, V185, P352, DOI 10.1016/j.cej.2011.11.104; Patel VK, 2015, RSC ADV, V5, P21471, DOI 10.1039/c4ra14751k; Qian C, 2013, ADV COND MATTER PHYS, V2013, DOI 10.1155/2013/519869; Rahman MM, 2018, TALANTA, V176, P17, DOI 10.1016/j.talanta.2017.07.093; Rahman MM, 2017, MATER EXPRESS, V7, P169, DOI 10.1166/mex.2017.1367; Rahman MM, 2017, TALANTA, V170, P215, DOI 10.1016/j.talanta.2017.04.017; Rahman MM, 2017, RSC ADV, V7, P22627, DOI 10.1039/c7ra01852e; Rahman MM, 2013, ELECTROCHIM ACTA, V103, P143, DOI 10.1016/j.electacta.2013.04.067; Rahman MM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-60; Rahman MM, 2012, TALANTA, V99, P924, DOI 10.1016/j.talanta.2012.07.060; Rahman MM, 2011, J PHYS CHEM C, V115, P9503, DOI 10.1021/jp202252j; Ramasamy R, 2015, RSC ADV, V5, P76538, DOI 10.1039/c5ra11739a; Rastogi SC, 2001, J SEP SCI, V24, P173, DOI 10.1002/1615-9314(20010301)24:3<173::AID-JSSC173>3.3.CO;2-C; Rivera-Lopez F, 2012, SURF INTERFACE ANAL, V44, P927, DOI 10.1002/sia.4921; Sasikumar R, 2017, J COLLOID INTERF SCI, V504, P149, DOI 10.1016/j.jcis.2017.05.043; Shang CQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08335; Shestakov MV, 2011, OPT EXPRESS, V19, P15955, DOI 10.1364/OE.19.015955; Solf V., 1979, J ELECTROANAL CHEM, V105, P169, DOI [10.1016/S0022-0728%2879%2980348-4, DOI 10.1016/S0022-0728%2879%2980348-4]; Tan YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep12382; Wang S, 2014, J MATER CHEM C, V2, P4406, DOI 10.1039/c3tc32576h; Wang SP, 2005, ANAL CHIM ACTA, V534, P207, DOI 10.1016/j.aca.2004.11.038; Wu ZS, 2010, ACS NANO, V4, P3187, DOI 10.1021/nn100740x; Xia H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02978; Xu HY, 2015, J NANOMATER, V2015, DOI 10.1155/2015/845983; Yang XL, 2012, J MATER CHEM, V22, P17278, DOI 10.1039/c2jm32571c; Ye W, 2015, NANOSCALE, V7, P9558, DOI 10.1039/c4nr06917j; Ye YX, 2012, J MATER CHEM, V22, P19132, DOI 10.1039/c2jm33893a; Yuan CZ, 2011, J MATER CHEM, V21, P18183, DOI 10.1039/c1jm14173b; Zhao C, 2016, TALANTA, V159, P365, DOI 10.1016/j.talanta.2016.06.043; Zhao J, 2014, CRYSTENGCOMM, V16, P2001, DOI 10.1039/c3ce41535j; Zhou H, 2004, TALANTA, V64, P467, DOI 10.1016/j.talanta.2004.03.015	62	0	0	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0246756	10.1371/journal.pone.0246756	http://dx.doi.org/10.1371/journal.pone.0246756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606736	gold, Green Published			2022-12-26	WOS:000620629200044
J	Singh, K; Kwong, AC; Madarati, H; Kunasekaran, S; Sparring, T; Fox-Robichaud, AE; Liaw, PC; Kretz, CA				Singh, Kanwal; Kwong, Andrew C.; Madarati, Hasam; Kunasekaran, Sharumathy; Sparring, Taylor; Fox-Robichaud, Alison E.; Liaw, Patricia C.; Kretz, Colin A.			Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients	PLOS ONE			English	Article								Sepsis is a life-threatening disease characterized by excessive host response to infection that can lead to activation of the coagulation system. Von Willebrand Factor (VWF) and ADAMTS13 are important regulators of hemostasis and their dysregulation during sepsis progression is not well understood. Herein we characterize ADAMTS13 and VWF in septic and non-septic patients. ADAMTS13 activity, ADAMTS13 antigen, VWF antigen, myeloperoxidase, and protein C, were measured in plasma collected from 40 septic patients (20 non-survivors and 20 survivors) and 40 non-septic patients on the first and last day of their ICU stay. ADAMTS13 activity and ADAMTS13 antigen were reduced, whereas VWF antigen was elevated among septic patients compared to non-septic patients and healthy controls. Non-septic patients also exhibited elevated VWF antigen and reduced ADAMTS13 activity, but to a lesser extent than septic patients. Non-survivor septic patients exhibited the lowest levels of ADAMTS13 activity. ADAMTS13 activity:antigen ratio was similar across all patient cohorts suggesting that the specific activity of ADAMTS13 remains unchanged. Therefore, reduced ADAMTS13 function in circulation is likely due to a reduction in circulating levels. We suggest that massive release of VWF in response to inflammation consumes limited circulating ADAMTS13, resulting in the imbalance observed between VWF and ADAMTS13 among septic and to a lesser extent in non-septic ICU patients. Changes to ADAMTS13 did not correlate with myeloperoxidase or protein C levels. Reduced ADAMTS13 activity and antigen, and elevated VWF antigen observed among all patient cohorts on admission remained unchanged in survivors at ICU discharge. Prolonged reduction in ADAMTS13 activity and antigen in septic patients coincides with elevated levels of VWF. The persistent abnormalities in ADAMTS13 and VWF in sepsis patients discharged from the ICU may contribute to a sustained prothrombotic state.	[Singh, Kanwal; Kwong, Andrew C.; Madarati, Hasam; Kunasekaran, Sharumathy; Sparring, Taylor; Fox-Robichaud, Alison E.; Liaw, Patricia C.; Kretz, Colin A.] McMaster Univ, Thrombosis & Atherosclerosis Res Inst TaARI, Dept Hlth Sci, Hamilton, ON, Canada; [Fox-Robichaud, Alison E.; Liaw, Patricia C.; Kretz, Colin A.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University	Kretz, CA (corresponding author), McMaster Univ, Thrombosis & Atherosclerosis Res Inst TaARI, Dept Hlth Sci, Hamilton, ON, Canada.; Kretz, CA (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	colin.kretz@taari.ca		Singh, Kanwal/0000-0003-3303-5966	Canadian Institutes of Health Research [PJT-168987, PJT-159658]; Hamilton Health Sciences New Investigator Fund; McMaster University Department of Medicine; Ontario Graduate Scholarship; CanVECTOR student scholarships	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Hamilton Health Sciences New Investigator Fund; McMaster University Department of Medicine; Ontario Graduate Scholarship(Ontario Graduate Scholarship); CanVECTOR student scholarships	This work was supported by the Canadian Institutes of Health Research PJT-168987 (CAK), PJT-159658 (PCL), and Hamilton Health Sciences New Investigator Fund (CAK). CAK was the recipient of the McMaster University Department of Medicine Internal Career Award. KS was the recipient of the Ontario Graduate Scholarship. KS and HM were supported by CanVECTOR student scholarships. URL of website not available. NO - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, CURR INFECT DIS REP, DOI [10.1007/s11908-016-0526-9, DOI 10.1007/S11908-016-0526-9]; Azfar MF, 2017, CLIN INVEST MED, V40, pE49, DOI 10.25011/cim.v40i2.28195; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; Dempfle CE, 2004, THROMB HAEMOSTASIS, V91, P213, DOI 10.1160/TH03-03-0182; Dwivedi DJ, 2012, CRIT CARE, V16, DOI 10.1186/cc11466; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Furlan M, 1999, THROMB HAEMOSTASIS, V81, P8; Garland KS, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00232; Hovinga JAK, 2007, J THROMB HAEMOST, V5, P2284; Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x; Lerolle N, 2009, J THROMB HAEMOST, V7, P843, DOI 10.1111/j.1538-7836.2009.03313.x; Levi M, 2018, J THROMB HAEMOST, V16, P646, DOI 10.1111/jth.13953; Liaw Patricia C, 2019, Crit Care Explor, V1, pe0032, DOI 10.1097/CCE.0000000000000032; Mackie I, 2020, INT J LAB HEMATOL, V42, P685, DOI 10.1111/ijlh.13295; Nguyen TC, 2007, HAEMATOL-HEMATOL J, V92, P121, DOI 10.3324/haematol.10262; Ono T, 2006, BLOOD, V107, P528, DOI 10.1182/blood-2005-03-1087; Pillai VG, 2016, BLOOD, V128, P110, DOI 10.1182/blood-2015-12-688747; Pipe SW, 2016, BLOOD, V128, P2007, DOI 10.1182/blood-2016-04-713289; Plautz WE, 2018, TRANSFUSION, V58, P2453, DOI 10.1111/trf.14804; Reiter RA, 2005, THROMB HAEMOSTASIS, V93, P554, DOI 10.1160/TH04-08-0467; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; Semeraro N., 2010, MEDITERR J HEMATOL I, P2; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Springer TA, 2014, BLOOD, V124, P1412, DOI 10.1182/blood-2014-05-378638; Uemura M, 2010, INT J HEMATOL, V91, P20, DOI 10.1007/s12185-009-0481-4	26	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2021	16	2							e0247017	10.1371/journal.pone.0247017	http://dx.doi.org/10.1371/journal.pone.0247017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8KQ	33606732	gold, Green Published			2022-12-26	WOS:000620629200166
J	Meng, X; Chen, WW; Wang, YY; Huang, ZR; Ye, X; Chen, LS; Yang, LT				Meng, Xin; Chen, Wei-Wei; Wang, Yan-Yu; Huang, Zeng-Rong; Ye, Xin; Chen, Li-Song; Yang, Lin-Tong			Effects of phosphorus deficiency on the absorption of mineral nutrients, photosynthetic system performance and antioxidant metabolism in Citrus grandis	PLOS ONE			English	Article							CHLOROPHYLL-A FLUORESCENCE; ELECTRON-TRANSPORT; PHOSPHATE DEFICIENCY; PHOTOSYSTEM-II; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; MAGNESIUM-DEFICIENCY; ALUMINUM-TOXICITY; CO2 ASSIMILATION; TIBETAN WILD; PLANTS	Phosphorus (P) is an essential macronutrient for plant growth, development and production. However, little is known about the effects of P deficiency on nutrient absorption, photosynthetic apparatus performance and antioxidant metabolism in citrus. Seedlings of 'sour pummelo' (Citrus grandis) were irrigated with a nutrient solution containing 0.2 mM (Control) or 0 mM (P deficiency) KH2PO4 until saturated every other day for 16 weeks. P deficiency significantly decreased the dry weight (DW) of leaves and stems, and increased the root/shoot ratio in C. grandis but did not affect the DW of roots. The decreased DW of leaves and stems might be induced by the decreased chlorophyll (Chl) contents and CO2 assimilation in P deficient seedlings. P deficiency heterogeneously affected the nutrient contents of leaves, stems and roots. The analysis of Chl a fluorescence transients showed that P deficiency impaired electron transport from the donor side of photosystem II (PSII) to the end acceptor side of PSI, which showed a greater impact on the performance of the donor side of PSII than that of the acceptor side of PSII and photosystem I (PSI). P deficiency increased the contents of ascorbate (ASC), H2O2 and malondialdehyde (MDA) as well as the activities of superoxide dismutase (SOD), catalase (CAT), ascorbate peroxidase (APX), dehydroascorbate reductase (DHAR) and glutathione reductase (GR) in leaves. In contrast, P deficiency increased the ASC content, reduced the glutathione (GSH) content and the activities of SOD, CAT, APX and monodehydroascorbate reductase (MDHAR), but did not increase H2O2 production, anthocyanins and MDA content in roots. Taking these results together, we conclude that P deficiency affects nutrient absorption and lowers photosynthetic performance, leading to ROS production, which might be a crucial cause of the inhibited growth of C. grandis.	[Meng, Xin; Chen, Wei-Wei; Wang, Yan-Yu; Huang, Zeng-Rong; Ye, Xin; Chen, Li-Song; Yang, Lin-Tong] Fujian Agr & Forestry Univ, Coll Resources & Environm, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University	Yang, LT (corresponding author), Fujian Agr & Forestry Univ, Coll Resources & Environm, Fuzhou, Fujian, Peoples R China.	talstoy@163.com	Chen, Li-Song/W-3896-2017; Yang, Lintong/HHD-2975-2022	Chen, Li-Song/0000-0001-8425-1306; Yang, Lin-Tong/0000-0002-1876-4127	National Key R&D Program of China [2017YFD0202000]	National Key R&D Program of China	This study was financially supported by the National Key R&D Program of China (2017YFD0202000) to Lin-Tong Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; [Anonymous], 1978, CHLOROPLAST DEV; AULAKH MS, 1977, PLANT SOIL, V47, P341, DOI 10.1007/BF00011493; Bukhov NG, 1999, PHOTOSYNTH RES, V59, P81, DOI 10.1023/A:1006149317411; CAKMAK I, 1994, J EXP BOT, V45, P1251, DOI 10.1093/jxb/45.9.1251; Carstensen A, 2018, PLANT PHYSIOL, V177, P271, DOI 10.1104/pp.17.01624; Chen LS, 2008, PLANTA, V228, P745, DOI 10.1007/s00425-008-0776-3; Chen LS, 2005, ANN BOT-LONDON, V96, P35, DOI 10.1093/aob/mci145; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Cornic G, 2000, PLANTA, V210, P468, DOI 10.1007/PL00008154; de Groot CC, 2003, J EXP BOT, V54, P1957, DOI 10.1093/jxb/erg193; Dong DF, 2004, PHYSIOL PLANTARUM, V122, P190, DOI 10.1111/j.1399-3054.2004.00373.x; FREDEEN AL, 1990, PLANTA, V181, P399, DOI 10.1007/BF00195894; Fu YQ, 2014, ACTA PHYSIOL PLANT, V36, P179, DOI 10.1007/s11738-013-1398-3; Fujita M, 2003, PLANT CELL PHYSIOL, V44, P481, DOI 10.1093/pcp/pcg060; Gallardo K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00580; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; GRAHAM JH, 1985, NEW PHYTOL, V101, P667, DOI 10.1111/j.1469-8137.1985.tb02872.x; Graham JH, 1997, NEW PHYTOL, V135, P335, DOI 10.1046/j.1469-8137.1997.00636.x; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Guo P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122570; Hasanuzzaman M, 2011, PLANT BIOTECHNOL REP, V5, P353, DOI 10.1007/s11816-011-0189-9; Heber U, 2002, PHOTOSYNTH RES, V73, P223, DOI 10.1023/A:1020459416987; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hirsch J, 2006, BIOCHIMIE, V88, P1767, DOI 10.1016/j.biochi.2006.05.007; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; JACOB J, 1993, J EXP BOT, V44, P1635, DOI 10.1093/jxb/44.11.1635; Juszczuk I, 2001, J PLANT PHYSIOL, V158, P1299, DOI 10.1078/0176-1617-00541; Kalaji HM, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2113-y; Kato Y, 2009, PLANT CELL PHYSIOL, V50, P58, DOI 10.1093/pcp/pcn168; Kaya C, 2009, SCI HORTIC-AMSTERDAM, V121, P284, DOI 10.1016/j.scienta.2009.02.011; KOWALENKO CG, 1976, CAN J SOIL SCI, V56, P537, DOI 10.4141/cjss76-068; Lazar D, 2006, FUNCT PLANT BIOL, V33, P9, DOI 10.1071/FP05095; Lee J, 2005, J AOAC INT, V88, P1269; Li LY, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00170; Li Q, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-42; Li Y, 2015, J SOIL SCI PLANT NUT, V15, P615, DOI 10.4067/S0718-95162015005000029; Li ZX, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-89; Li ZY, 2018, PLANT MOL BIOL, V96, P473, DOI 10.1007/s11103-018-0711-3; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lin ZH, 2012, ACTA PHYSIOL PLANT, V34, P2443, DOI 10.1007/s11738-012-1034-7; Lin ZH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-43; Lopez-Arredondo DL, 2014, ANNU REV PLANT BIOL, V65, P95, DOI 10.1146/annurev-arplant-050213-035949; Long LZ, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1949-x; Lu R.K, 1999, SOIL AGROCHEMISTRY A; Lu YB, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0642-y; Luo JJ, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-2283-z; Lynch Jonathan P., 2008, V7, P83; Martinez-Andujar C, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00533; Mathur S, 2018, PHOTOSYNTHETICA, V56, P354, DOI 10.1007/s11099-018-0767-y; Matnur S, 2020, IND CROP PROD, V143, DOI 10.1016/j.indcrop.2019.111934; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Muneer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134103; Nadira UA, 2014, SOIL SCI PLANT NUTR, V60, P832, DOI 10.1080/00380768.2014.949853; Pan XiangWen, 2008, Agricultural Sciences in China, V7, P958, DOI 10.1016/S1671-2927(08)60135-2; Parra-Almuna L, 2018, PLANT PHYSIOL BIOCH, V130, P445, DOI 10.1016/j.plaphy.2018.07.031; Pieters AJ, 2001, J EXP BOT, V52, P1083, DOI 10.1093/jexbot/52.358.1083; Pyo YJ, 2010, PLANT PHYSIOL, V153, P863, DOI 10.1104/pp.110.154369; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; RAO IM, 1995, PLANT PHYSIOL, V107, P1313, DOI 10.1104/pp.107.4.1313; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser BJ, 1997, PHOTOSYNTH RES, V52, P147, DOI 10.1023/A:1005896029778; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; Tyburski J, 2009, PLANT GROWTH REGUL, V59, P27, DOI 10.1007/s10725-009-9385-9; Valentinuzzi F, 2015, J EXP BOT, V66, P6483, DOI 10.1093/jxb/erv364; Veronica N, 2017, PHOTOSYNTHETICA, V55, P285, DOI 10.1007/s11099-016-0640-4; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Weng XY, 2008, BIOL PLANTARUM, V52, P307, DOI 10.1007/s10535-008-0064-x; Xu HX, 2007, RUSS J PLANT PHYSL+, V54, P741, DOI 10.1134/S1021443707060040; Xu WF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14891-z; Yamane Y, 1997, PHOTOSYNTH RES, V52, P57, DOI 10.1023/A:1005884717655; YAMANOUCHI M., 1980, NIPPON DOJO HIRYOGAK, V51, P126; Yan N, 2015, PHOTOSYNTHETICA, V53, P630, DOI 10.1007/s11099-015-0149-7; Yang GH, 2012, TREES-STRUCT FUNCT, V26, P1237, DOI 10.1007/s00468-012-0699-2; Yang LT, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133129; Yang LT, 2012, ENVIRON EXP BOT, V82, P1, DOI 10.1016/j.envexpbot.2012.03.004; Yoneyama K, 2012, PLANTA, V235, P1197, DOI 10.1007/s00425-011-1568-8; Zhang KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098215; Zhang W, 2018, FIELD CROP RES, V219, P113, DOI 10.1016/j.fcr.2018.01.031; Zou XH, 2018, TREES-STRUCT FUNCT, V32, P897, DOI 10.1007/s00468-018-1683-2	81	23	23	15	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0246944	10.1371/journal.pone.0246944	http://dx.doi.org/10.1371/journal.pone.0246944			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596244	Green Published, gold			2022-12-26	WOS:000620633200010
J	Morokutti-Kurz, M; Froba, M; Graf, P; Grosse, M; Grassauer, A; Auth, J; Schubert, U; Prieschl-Grassauer, E				Morokutti-Kurz, Martina; Froeba, Maria; Graf, Philipp; Grosse, Maximilian; Grassauer, Andreas; Auth, Janina; Schubert, Ulrich; Prieschl-Grassauer, Eva			Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro	PLOS ONE			English	Article							NASAL SPRAY; COMMON COLD; DOUBLE-BLIND; EFFICACY; PLACEBO; SYMPTOMS; SAFETY	In the absence of a vaccine and other effective prophylactic or therapeutic countermeasures the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) remains a significant public health threat. Attachment and entry of coronaviruses including SARS-CoV-2 is mainly mediated by the spike glycoprotein. Here, we show that iota-carrageenan can inhibit the cell entry of the SARS-CoV-2 spike pseudotyped lentivirus in a dose dependent manner. SARS-CoV-2 spike pseudotyped lentivirus particles were efficiently neutralized with an IC50 value of 2.6 mu g/ml iota-carrageenan. Experiments with patient isolated wild type SARS-CoV-2 virus showed an inhibition of replication in a similar range. In vitro data on iota-carrageenan against various Rhino- and endemic Coronaviruses showed similar IC50 values and translated readily into clinical effectiveness when a nasal spray containing iota-carrageenan demonstrated a reduction of severity and duration of symptoms of common cold caused by various respiratory viruses. Accordingly, our in vitro data on SARS-CoV-2 spike pseudotyped lentivirus and replication competent SARS-CoV-2 suggest that administration of iota-carrageenan may be an effective and safe prophylaxis or treatment for SARS-CoV-2 infections.	[Morokutti-Kurz, Martina; Graf, Philipp; Grassauer, Andreas; Prieschl-Grassauer, Eva] Marinomed Biotech AG, Korneuburg, Austria; [Froeba, Maria; Grosse, Maximilian; Auth, Janina; Schubert, Ulrich] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Virol, Erlangen, Germany	University of Erlangen Nuremberg	Prieschl-Grassauer, E (corresponding author), Marinomed Biotech AG, Korneuburg, Austria.	eva.prieschl@marinomed.com			Austrian Science Promotion Agency (FFG) [880687]; German Research Council [GRK 2504]; Interdisciplinary Center for Clinical Research (IZKF) at the University hospital of the University of Erlangen-Nurnberg; Marinomed Biotech AG	Austrian Science Promotion Agency (FFG); German Research Council(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) at the University hospital of the University of Erlangen-Nurnberg; Marinomed Biotech AG	This work was co-funded by the Austrian Science Promotion Agency (FFG) project number 880687 (https://www.ffg.at).Marinomed Biotech AG (www.marinomed.com) provided support in form of salaries for all authors employed by Marinomed Biotech AG. Marinomed Biotech AG had a role in study design, data collection and analysis, decision to publish, preparation of the manuscript and financing the processing charge of the manuscript. This work was supported by graduate program GRK 2504 from the German Research Council to U.S., and it was performed in partial fulfillment of the requirements for obtaining Dr. med. Degree at the Friedrich-Alexander University Erlangen-Nurnberg for J.A. and M.F.. We would like to thank C. Steininger for helpful suggestions and Pia Rauch for superior technical assistance. For providing antiserum against SARS-CoV-2 we thank T. Hahn. This work was supported by Interdisciplinary Center for Clinical Research (IZKF) at the University hospital of the University of Erlangen-Nurnberg and further by graduate program GRK 2504 from the German Research Council to U.S, and it was performed in partial fulfillment of the requirements for obtaining Dr. med. Degree at the Friedrich-Alexander University Erlangen-Nurnberg for J.A. and M.F.	Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Dogan Mikail, 2020, medRxiv, DOI 10.1101/2020.07.07.20148106; Eccles R., 2020, The Open Virology Journal, V14, P9, DOI 10.2174/1874357902014010009; Eccles R, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0281-8; Eccles R, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-108; Fazekas T, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-147; Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762; Grassauer A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-107; Gro&beta;e M., 2020, EVIDENCE QUININE EXH; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Koenighofer M, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-57; Leibbrandt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014320; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Ludwig M, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-124; MCINTOSH K, 1967, P NATL ACAD SCI USA, V57, P933, DOI 10.1073/pnas.57.4.933; Morokutti-Kurz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128794; Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126; REED L. J., 1938, AMER JOUR HYG, V27, P493; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	20	39	40	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2021	16	2							e0237480	10.1371/journal.pone.0237480	http://dx.doi.org/10.1371/journal.pone.0237480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8ME	33596218	Green Published, gold			2022-12-26	WOS:000620633200031
J	Liu, XL; Jia, YC; Shi, CY; Kong, DC; Wu, YM; Zhang, TT; Wei, AJ; Wang, D				Liu, Xiaoling; Jia, Yichen; Shi, Changyuan; Kong, Dechen; Wu, Yuanming; Zhang, Tiantian; Wei, Anjie; Wang, Dan			CYP4B1 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma	PLOS ONE			English	Article							SURFACTANT PROTEIN D; CYTOCHROME-P450 4B1; BLADDER-CANCER; GENE; RISK; EXPRESSION; POLYMORPHISMS; ASSOCIATION; ACTIVATION	CYP4B1 belongs to the mammalian CYP4 enzyme family and is predominantly expressed in the lungs of humans. It is responsible for the oxidative metabolism of a wide range of endogenous compounds and xenobiotics. In this study, using data from The Cancer Genome Atlas (TCGA) project and the Gene Expression Omnibus (GEO) database, a secondary analysis was performed to explore the expression profile of CYP4B1, as well as its prognostic value in patients with lung adenocarcinoma (LUAD). Based on the obtained results, a significantly decreased CYP4B1 expression was discovered in patients with LUAD when compared with their normal counterparts (p<0.05), and was linked to age younger than 65 years (p = 0.0041), history of pharmaceutical (p = 0.0127) and radiation (p = 0.0340) therapy, mutations in KRAS/EGFR/ALK (p = 0.0239), and living status of dead (p = 0.0026). Survival analysis indicated that the low CYP4B1 expression was an independent prognostic indicator of shorter survival in terms of overall survival (OS) and recurrence-free survival (RFS) in patients with LUAD. The copy number alterations (CNAs) and sites of cg23440155 and cg23414387 hypermethylation might contribute to the decreased CYP4B1 expression. Gene set enrichment analysis (GSEA) suggested that CYP4B1 might act as an oncogene in LUAD by preventing biological metabolism pathways of exogenous and endogenous compounds and enhancing DNA replication and cell cycle activities. In conclusion, CYP4B1 expression may serve as a valuable independent prognostic biomarker and a potential therapeutic target in patients with LUAD.	[Liu, Xiaoling; Kong, Dechen; Zhang, Tiantian] Jining Med Univ, Coll Basic Med, Jining City, Peoples R China; [Jia, Yichen] Qiqihar Med Univ, Inst Med Technol, Qiqihar City, Peoples R China; [Shi, Changyuan; Wu, Yuanming; Wei, Anjie; Wang, Dan] Jining Med Univ, Inst Forens Med & Lab Med, Jining City, Peoples R China	Jining Medical University; Qiqihar Medical University; Jining Medical University	Wang, D (corresponding author), Jining Med Univ, Inst Forens Med & Lab Med, Jining City, Peoples R China.	wangdanchn@163.com	Liu, Xiaoling/HGD-3566-2022	Wang, Dan/0000-0002-6032-5638	NSFC cultivation project of Jining Medical University [JYP2019KJ10]; Medical and Health Science and Technology Development Project of Shandong Province [2019WS357]; Shanxi Provincial Key Laboratory of Forensic Science, China [SFM2019002]; Student Innovation Training Program Project of Shandong Province [S202010443043]	NSFC cultivation project of Jining Medical University; Medical and Health Science and Technology Development Project of Shandong Province; Shanxi Provincial Key Laboratory of Forensic Science, China; Student Innovation Training Program Project of Shandong Province	This study was supported by the NSFC cultivation project of Jining Medical University (JYP2019KJ10), the Medical and Health Science and Technology Development Project of Shandong Province (2019WS357), the open project of Shanxi Provincial Key Laboratory of Forensic Science, China (SFM2019002) and the Student Innovation Training Program Project of Shandong Province (S202010443043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2015, IMEDPUB, V1, DOI DOI 10.21767/2393-8862.100031; Amin MB, 2018, AJCC CANC STAGING MA, V8th, DOI DOI 10.1007/978-3-319-40618-3; Ashkar S, 2004, J OCUL PHARMACOL TH, V20, P65, DOI 10.1089/108076804772745473; Baer BR, 2006, DRUG METAB REV, V38, P451, DOI 10.1080/03602530600688503; Chalela R, 2017, J THORAC DIS, V9, P2142, DOI 10.21037/jtd.2017.06.20; CZERWINSKI M, 1994, CANCER RES, V54, P1085; Denisenko TV, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0063-y; Devita Jr VT, 2015, DEVITA HELLMAN ROSEN; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Hiratsuka Masahiro, 2004, Drug Metab Pharmacokinet, V19, P114, DOI 10.2133/dmpk.19.114; Imaoka S, 2000, BIOCHEM BIOPH RES CO, V277, P776, DOI 10.1006/bbrc.2000.3740; Iscan M, 2001, BREAST CANCER RES TR, V70, P47, DOI 10.1023/A:1012526406741; Ishii T, 2012, COPD, V9, P409, DOI 10.3109/15412555.2012.676110; Jian W, 2019, J CELL BIOCHEM, V120, P5386, DOI 10.1002/jcb.27817; Lin JT, 2019, APMIS, V127, P170, DOI 10.1111/apm.12939; Lo-Guidice JM, 2002, PHARMACOGENETICS, V12, P367, DOI 10.1097/00008571-200207000-00004; Mastyugin V, 2004, J CELL BIOCHEM, V91, P1218, DOI 10.1002/jcb.20018; Murtha TD, 2017, SURGERY, V161, P257, DOI 10.1016/j.surg.2016.04.056; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Rainov NG, 1998, HUM GENE THER, V9, P1261, DOI 10.1089/hum.1998.9.9-1261; Sasaki T, 2008, JPN J CLIN ONCOL, V38, P634, DOI 10.1093/jjco/hyn081; Seta F, 2007, PROSTAG OTH LIPID M, V84, P116, DOI 10.1016/j.prostaglandins.2007.05.001; Tamaki Y, 2011, DRUG METAB PHARMACOK, V26, P516, DOI 10.2133/dmpk.DMPK-11-RG-046; Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Umeda Y, 2017, ONCOGENE, V36, P6432, DOI 10.1038/onc.2017.253; Vasaikar SV, 2018, NUCLEIC ACIDS RES, V46, pD956, DOI 10.1093/nar/gkx1090; Wei XP, 2020, INT IMMUNOPHARMACOL, V79, DOI 10.1016/j.intimp.2019.106155; Wiek C, 2015, BIOCHEM J, V465, P103, DOI 10.1042/BJ20140813; Yu GP, 2012, TUMOR BIOL, V33, P223, DOI 10.1007/s13277-011-0265-3; Yu GP, 2015, J THORAC DIS, V7, P1806, DOI 10.3978/j.issn.2072-1439.2015.10.17; Yu GP, 2014, TUMOR BIOL, V35, P10341, DOI 10.1007/s13277-014-2284-3	33	5	5	6	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0247020	10.1371/journal.pone.0247020	http://dx.doi.org/10.1371/journal.pone.0247020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33592039	gold, Green Published			2022-12-26	WOS:000620632800058
J	Wang, YL; Grooms, NWF; Civale, SC; Chung, SH				Wang, Yao L.; Grooms, Noa W. F.; Civale, Sabrina C.; Chung, Samuel H.			Confocal imaging capacity on a widefield microscope using a spatial light modulator	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; STRUCTURED ILLUMINATION; LIVE-CELL; RESOLUTION; ELEGANS	Confocal microscopes can reject out-of-focus and scattered light; however, widefield microscopes are far more common in biological laboratories due to their accessibility and lower cost. We report confocal imaging capacity on a widefield microscope by adding a spatial light modulator (SLM) and utilizing custom illumination and acquisition methods. We discuss our illumination strategy and compare several procedures for postprocessing the acquired image data. We assessed the performance of this system for rejecting out-of-focus light by comparing images taken at 1.4 NA using our widefield microscope, our SLM-enhanced setup, and a commercial confocal microscope. The optical sectioning capability, assessed on thin fluorescent film, was 0.85 +/- 0.04 mu m for our SLM-enhanced setup and 0.68 +/- 0.04 mu m for a confocal microscope, while a widefield microscope exhibited no sectioning capability. We demonstrate our setup by imaging the same set of neurons in C. elegans on widefield, SLM, and confocal microscopes. SLM enhancement greatly reduces background from the cell body, allowing visualization of dim fibers nearby. Our SLM-enhanced setup identified 96% of the dim neuronal fibers seen in confocal images while a widefield microscope only identified 50% of the same fibers. Our microscope add-on represents a very simple (2-component) and inexpensive (<$600) approach to enable widefield microscopes to optically section thick samples.	[Wang, Yao L.; Grooms, Noa W. F.; Civale, Sabrina C.; Chung, Samuel H.] Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA	Northeastern University	Chung, SH (corresponding author), Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA.	schung@northeastern.edu		Wang, Yao/0000-0001-9915-4015; Grooms, Noa/0000-0001-7999-2687; Chung, Samuel/0000-0003-2553-1396	NIH National Center for Research Resources (NCRR)	NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	SHC received award no grant #Northeastern University TIER 1 grant https://resdev.northeastern.edu/resources/internal-grants/tier-1-seed-grantproof-of-concept-program/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center (CGC), which is funded by the NIH National Center for Research Resources (NCRR). NG3146 and CHB1226 are gifts from Gian Garriga and Maxwell Heiman, respectively. We thank the Institute for Chemical Imaging of Living Systems at Northeastern University for consultation and imaging support. We acknowledge Kai Zhang from Bryan Spring's laboratory (Northeastern Physics Dept.) for helpful discussion in resolving SLM aliasing. We acknowledge Noah Joseph (Northeastern Bioengineering Dept.) for 3D printing the SLM mount.	BRENNER S, 1974, GENETICS, V77, P71; Cai HN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53581-9; Chung SH, 2009, APPL PHYS A-MATER, V96, P335, DOI 10.1007/s00339-009-5201-7; Chung SH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-30; DAVIDOVITS P, 1969, NATURE, V223, P831, DOI 10.1038/223831a0; De Luca GMR, 2013, BIOMED OPT EXPRESS, V4, P2644, DOI 10.1364/BOE.4.002644; Fiolka R, 2008, OPT LETT, V33, P1629, DOI 10.1364/OL.33.001629; Hanley QS, 1999, J MICROSC-OXFORD, V196, P317, DOI 10.1046/j.1365-2818.1999.00602.x; Heintzmann R, 2006, APPL OPTICS, V45, P5037, DOI 10.1364/AO.45.005037; Hoebe RA, 2007, NAT BIOTECHNOL, V25, P249, DOI 10.1038/nbt1278; Huang D, 2012, AM J PHYS, V80, P211, DOI 10.1119/1.3666834; Krishnaswami V, 2016, Q REV BIOPHYS, V49, DOI 10.1017/S0033583516000135; Muller CB, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.198101; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Nikolenko V, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/045001; Pawley J, 2013, HDB BIOL CONFOCAL MI; PETRAN M, 1968, J OPT SOC AM, V58, P661, DOI 10.1364/JOSA.58.000661; Rector DM, 2003, METHODS, V30, P16, DOI 10.1016/S1046-2023(03)00004-5; Roth S., 2013, OPT NANOSC, V2, P5, DOI 10.1186/2192-2853-2-5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SHEPPARD CJR, 1988, OPTIK, V80, P53; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Theer P, 2014, NAT METHODS, V11, P981, DOI 10.1038/nmeth.3102; Wilhelm S., 2003, MICROSCOPY CARL ZEIS; Yang RH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06065-7; Yang WJ, 2016, NEURON, V89, P269, DOI 10.1016/j.neuron.2015.12.012; York AG, 2012, NAT METHODS, V9, P749, DOI [10.1038/nmeth.2025, 10.1038/NMETH.2025]	27	1	1	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2021	16	2							e0244034	10.1371/journal.pone.0244034	http://dx.doi.org/10.1371/journal.pone.0244034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK8MA	33591984	Green Published, gold, Green Submitted			2022-12-26	WOS:000620632800056
J	Al-Rifai, RH; Acuna, J; Al Hossany, FI; Aden, B; Al Memari, SA; Al Mazrouei, SK; Ahmed, LA				Al-Rifai, Rami H.; Acuna, Juan; Al Hossany, Farida Ismail; Aden, Bashir; Al Memari, Shamma Abdullah; Al Mazrouei, Shereena Khamis; Ahmed, Luai A.			Epidemiological characterization of symptomatic and asymptomatic COVID-19 cases and positivity in subsequent RT-PCR tests in the United Arab Emirates	PLOS ONE			English	Article							TUBERCULOSIS; PREVALENCE	The coronavirus disease 2019 (COVID-19) cases could be symptomatic or asymptomatic. We (1) characterized and analyzed data collected from the first cohort of reverse transcriptase polymerase chain reaction (RT-PCR)-confirmed COVID-19 cases reported in the Emirate of Abu Dhabi, United Arab Emirates, according to the symptomatic state, and (2) identified factors associated with the symptomatic state. The association between the symptomatic state and testing positive in three subsequent RT-PCR testing rounds was also quantified. Between February 28 and April 8, 2020, 1,249 cases were reported. Sociodemographic characteristics, working status, travel history, and chronic comorbidities of 791 cases were analyzed according to the symptomatic state (symptomatic or asymptomatic). After the first confirmatory test, the results of three subsequent tests were analyzed. The mean age of the 791 cases was 35.6 +/- 12.7 years (range: 1-81). Nearly 57.0% of cases were symptomatic. The two most frequent symptoms were fever (58.0%) and cough (41.0%). Symptomatic cases (mean age 36.3 +/- 12.6 years) were significantly older than asymptomatic cases (mean age 34.5 +/- 12.7 years). Compared with nonworking populations, working in public places (adjusted odds ratio (aOR), 1.76, 95% confidence interval (95% CI): 1.11-2.80), healthcare settings (aOR, 2.09, 95% CI: 1.01-4.31), or in the aviation and tourism sectors (aOR, 2.24, 95% CI: 1.14-4.40) was independently associated with the symptomatic state. Reporting at least one chronic comorbidity was also associated with symptomatic cases (aOR, 1.76, 95% CI: 1.03-3.01). Compared with asymptomatic cases, symptomatic cases had a prolonged duration of viral shedding and consistent odds of >= 2 positive COVID-19 tests result out of the three subsequent testing rounds. A substantial proportion of the diagnosed COVID-19 cases in the Emirate of Abu Dhabi were asymptomatic. Quarantining asymptomatic cases, implementing prevention measures, and raising awareness among populations working in high-risk settings are warranted.	[Al-Rifai, Rami H.; Ahmed, Luai A.] United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates; [Acuna, Juan] Khalifa Univ, Coll Med & Hlth Sci, Dept Epidemiol & Publ Hlth, Abu Dhabi, U Arab Emirates; [Al Hossany, Farida Ismail; Aden, Bashir; Al Memari, Shamma Abdullah; Al Mazrouei, Shereena Khamis] Abu Dhabi Publ Hlth Ctr, Abu Dhabi, U Arab Emirates	United Arab Emirates University; Khalifa University of Science & Technology	Al-Rifai, RH (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates.	rrifai@uaeu.ac.ae	Ahmed, Luai A./J-7225-2013	Ahmed, Luai A./0000-0001-5292-8212; Al-Rifai, Rami H./0000-0001-6102-0353				A. A.Teheran, 2020, medRxiv, DOI 10.1101/2020.06.18.20134734; A. W.Boots, 2020, bioRxiv, DOI 10.1101/2020.03.13.991455; Al-Rifai RH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187967; B.Zhang, 2020, medRxiv, DOI 10.1101/2020.02.28.20029181; Baggett TP, 2020, JAMA-J AM MED ASSOC, V323, P2191, DOI 10.1001/jama.2020.6887; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; Chang D, 2020, LANCET RESP MED, V8, pE13, DOI 10.1016/S2213-2600(20)30066-7; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503; Jiang Q., 2020, HYPERTENSION DIABETE, DOI [10.1101/2020.03.22.20040774, DOI 10.1101/2020.03.22.20040774]; Kim Hyungjin, 2020, Radiology, V296, pE145, DOI 10.1148/radiol.2020201343; Krastinova E, 2021, OCCUP ENVIRON MED, V78, P479, DOI 10.1136/oemed-2020-106866; Latest United Arab Emirates, COVID 19 DAT; Lechien JR, 2020, J INTERN MED, V288, P335, DOI 10.1111/joim.13089; Lee S, 2020, JAMA INTERN MED, V180, P1447, DOI 10.1001/jamainternmed.2020.3862; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Muniyappa R, 2020, AM J PHYSIOL-ENDOC M, V318, pE736, DOI 10.1152/ajpendo.00124.2020; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Sulaiman N, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0287-0; WHO. World Health Organization, COR DIS COVID 19 IS; World Health Organizatio, B WHO WEIG AFFL; World Health Organization, 46 WHO; Worldometer, COVID 19 COR PAND; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Yang RR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10182; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhang HY, 2020, EMERG MICROBES INFEC, V9, P2509, DOI 10.1080/22221751.2020.1837015; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zhu Y, 2020, CLIN INFECT DIS, DOI [DOI 10.1093/CID/CIAA1825, 10.1093/cid/ciaa1825]; Zhuang G H, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P485, DOI 10.3760/cma.j.cn112338-20200221-00144; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737; Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0	39	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246903	10.1371/journal.pone.0246903	http://dx.doi.org/10.1371/journal.pone.0246903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QI7IP	33577582	Green Submitted, Green Published, gold			2022-12-26	WOS:000619155900002
J	Holme, P				Holme, Petter			Fast and principled simulations of the SIR model on temporal networks	PLOS ONE			English	Article							CONTACT; REACHABILITY; SPREAD	The Susceptible-Infectious-Recovered (SIR) model is the canonical model of epidemics of infections that make people immune upon recovery. Many of the open questions in computational epidemiology concern the underlying contact structure's impact on models like the SIR model. Temporal networks constitute a theoretical framework capable of encoding structures both in the networks of who could infect whom and when these contacts happen. In this article, we discuss the detailed assumptions behind such simulations-how to make them comparable with analytically tractable formulations of the SIR model, and at the same time, as realistic as possible. We also present a highly optimized, open-source code for this purpose and discuss all steps needed to make the program as fast as possible.	[Holme, Petter] Tokyo Inst Technol, Inst Innovat Res, Tokyo Tech World Res Hub Initiat WRHI, Yokohama, Kanagawa, Japan	Tokyo Institute of Technology	Holme, P (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Tokyo Tech World Res Hub Initiat WRHI, Yokohama, Kanagawa, Japan.	holme@cns.pi.titech.ac.jp	Holme, Petter/A-7646-2008	Holme, Petter/0000-0003-2156-1096	JSPS KAKENHI [JP 18H01655]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	P.H. was supported by JSPS KAKENHI Grant Number JP 18H01655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H., 2012, STOCHASTIC EPIDEMIC; Badie-Modiri A, 2020, PHYS REV E, V101, DOI 10.1103/PhysRevE.101.052303; Barrat A, 2020, EFFECT MANUAL DIGITA; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Bottcher L, 2020, PHYS REV RES, V2, DOI 10.1103/PhysRevResearch.2.033121; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Colman E, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3117-6; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Himmel AS, 2020, STUD COMPUT INTELL, V882, P494, DOI 10.1007/978-3-030-36683-4_40; Holme P, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.062305; Holme P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14462; Holme P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120567; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hu┬vel, 2017, TEMPORAL NETWORK EPI, P215, DOI DOI 10.1007/978-981-10-5287-3_10; Jankowski J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32081-2; Janson S, 2014, RANDOM STRUCT ALGOR, V45, P724, DOI 10.1002/rsa.20575; Kiss I. Z., 2017, MATH EPIDEMICS NETWO, DOI DOI 10.1007/978-3-319-50806-1; Krylova O, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0098; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036439; Masuda N., 2017, TEMPORAL NETWORK EPI, DOI DOI 10.1007/978-981-10-5287-3; Masuda N, 2018, SIAM REV, V60, P95, DOI 10.1137/16M1055876; Masuda Naoki, 2013, F1000Prime Rep, V5, P6, DOI 10.12703/P5-6; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; ONeill ME, 2014, ACM T MATH SOFTWARE; Petrovic LV., 2019, COUNTING CAUSAL PATH; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Sapiezynski P, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0325-x; St-Onge G, 2019, COMPUT PHYS COMMUN, V240, P30, DOI 10.1016/j.cpc.2019.02.008; Starnini M, 2013, J THEOR BIOL, V337, P89, DOI 10.1016/j.jtbi.2013.07.004; Takaguchi T, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/9/093003; Van den Broeck W, 2012, LEONARDO, V45, P285, DOI 10.1162/LEON_a_00377; VanderWaal KL, 2016, FUNCT ECOL, V30, P1606, DOI 10.1111/1365-2435.12645; Vergu E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009371	34	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246961	10.1371/journal.pone.0246961	http://dx.doi.org/10.1371/journal.pone.0246961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577564	gold, Green Published, Green Submitted			2022-12-26	WOS:000620071700056
J	Lima, VD; Wang, L; Sereda, P; McLinden, T; Barrios, R; Montaner, JSG				Lima, Viviane D.; Wang, Lu; Sereda, Paul; McLinden, Taylor; Barrios, Rolando; Montaner, Julio S. G.			Estimation of time of HIV seroconversion using a modified CD4 depletion model	PLOS ONE			English	Article								Introduction Several methods have been proposed to estimate the time of HIV seroconversion, including those based on CD4 cell depletion models. However, previous models have failed to consider the heterogeneity that exists in CD4 trajectories among different sub-populations. Our objective was to estimate the time from HIV seroconversion relative to the HIV diagnosis date in a population-based cohort of people living with HIV (PLWH) in the province of British Columbia, Canada. Methods We used linked administrative and clinical data from the British Columbia Seek and Treat for Optimal Prevention of HIV/AIDS (STOP HIV/AIDS) cohort, which contains longitudinal individual-level data on all PLWH ever diagnosed in the province. Eligible participants were aged >= 18 years and diagnosed with HIV between 1989 and 2013. The outcome was pre-antiretroviral treatment CD4 cell count measurements assessed every six months. Models were stratified by age and stage of HIV infection at diagnosis. Several explanatory variables were considered including longitudinal viral load measurements. Longitudinal CD4, square root transformed, was modeled via a non-linear mixed effects model; time was modeled using an exponential decay function. We assumed a Gaussian distribution (identity link), an AR(1) correlation structure, and a random intercept and slope for the longitudinal viral load measurements. Due to the population variation in CD4 count among uninfected individuals, we assumed 500 to 1500 cells/mm(3) as the normal range when estimating the time of HIV seroconversion. Results Longitudinal data on 1,253 individuals were analysed: 80% male, 33% White, and the median age at diagnosis was 38 years (25(th)-75(th) percentile [Q(1)-Q(3)], 31 to 45). CD4 decay differed by stage of infection at diagnosis and age, with those >= 50 years in Stages 1 and 2 experiencing a faster decline in CD4 over time. The median duration of infection from seroconversion until HIV diagnosis was 6.9 (Q(1)-Q(3), 3.9 to 10.1) years. Conclusions Considering the heterogeneity that exists in individual CD4 cell trajectories in a population, we presented a methodology that only relies on routinely collected HIV-related data, which can be further extended to estimate other epidemic measures.	[Lima, Viviane D.; Wang, Lu; Sereda, Paul; McLinden, Taylor; Barrios, Rolando; Montaner, Julio S. G.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lima, Viviane D.; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Dept Med, Div Infect Dis, Vancouver, BC, Canada; [Barrios, Rolando] Vancouver Coastal Hlth, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Vancouver Coastal Health Research Institute	Lima, VD (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.; Lima, VD (corresponding author), Univ British Columbia, Fac Med, Dept Med, Div Infect Dis, Vancouver, BC, Canada.	vlima@bccfe.ca		Sereda, Paul/0000-0002-6411-8089	British Columbia government; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; Public Health Agency of Canada; Vancouver Coastal Health Authority; Canadian Trials Network	British Columbia government; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Public Health Agency of Canada; Vancouver Coastal Health Authority; Canadian Trials Network	The programmatic funding for the Drug Treatment Program, Treatment as Prevention and STOP HIV/AIDS initiatives was provided by the British Columbia government. Additional research funding was provided by the Canadian Institutes of Health Research (VDL), the Michael Smith Foundation for Health Research (VDL), the Public Health Agency of Canada (JSGM), Vancouver Coastal Health Authority (JSGM), and the Canadian Trials Network (JSGM). The sponsors had no role in the design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all data in the study and had final responsibility to submit for publication.	[Anonymous], 2018, HEALTHLINK BC HEALTH; British Columbia Centre for Disease Control, HIV AIDS REP; British Columbia Centre for Disease Control, REP DIS DAT DASHB; British Columbia Centre for Disease Control: Communicable Disease Control Manual, 2016, SEX TRANSM INF GUID; British Columbia Centre for Excellence in HIV/AIDS (BC-CfE), 2020, STOP HIV AIDS Q MON; British Columbia Centre for Excellence in HIV/AIDS (BC-CfE):, 2020, THER GUID ANT ARV TR; British Columbia Centre for Excellence in HIV/AIDS (BCCfE), 2019, DRUG TREATM PROGR; British Columbia Centre for Excellence in HIV/AIDS (BCCfE):, 2019, SEEK TREAT OPT PREV; British Columbia Ministry of Health, 2016, MED SERV PLAN MSP PA; British Columbia Vital Statistics Agency [creator], 2016, VIT STAT DEATHS BRIT; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Brumme CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043882; Canadian AIDS Society, 2020, HIST CAN AIDS SOC; Canadian Institute of Health Information, 2016, DISCH ABSTR DAT HOSP; CATIE, 2019, HIST HIV AIDS; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Daar ES, 2008, CURR OPIN HIV AIDS, V3, P10, DOI 10.1097/COH.0b013e3282f2e295; De Bel A, 2010, J CLIN MICROBIOL, V48, P1337, DOI 10.1128/JCM.01226-09; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Eisinger RW, 2019, JAMA-J AM MED ASSOC, V321, P451, DOI 10.1001/jama.2018.21167; European Centre for Disease Prevention and Control, 2017, ECDC HIV MOD TOOL US; Farahani M, 2016, AIDS RES HUM RETROV, V32, P573, DOI [10.1089/AID.2015.0348, 10.1089/aid.2015.0348]; Government of Canada Department of Justice, 2017, AGE CONS SEX ACT; Hallett TB, 2011, CURR OPIN HIV AIDS, V6, P102, DOI 10.1097/COH.0b013e328343bfdb; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Heath K, 2014, INT J EPIDEMIOL, V43, P1073, DOI 10.1093/ije/dyu070; Hogg RS, 2017, LANCET HIV, V4, pE270, DOI 10.1016/S2352-3018(17)30029-2; Jacobson SA, 2011, HEALTH SOC WORK, V36, P149, DOI 10.1093/hsw/36.2.149; Johnson AS, 2017, JAIDS-J ACQ IMM DEF, V76, P116, DOI 10.1097/QAI.0000000000001495; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014, 90 90 90 AMB TARG HE; Klein Marina B, 2014, CMAJ Open, V2, pE318, DOI 10.9778/cmajo.20140017; Langford Simone E, 2007, AIDS Res Ther, V4, P11, DOI 10.1186/1742-6405-4-11; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lima VD, 2020, CURR HIV-AIDS REP, V17, P77, DOI 10.1007/s11904-020-00482-6; Lima VD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047859; Liu ML, 2007, BIOMETRICS, V63, P363, DOI 10.1111/j.1541-0420.2007.00708.x; McCullagh P., 1989, GEN LINEAR MODELS; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Nacher M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199267; Pinheiro JCB., 2000, STAT COMPUT; Presanis AM, 2010, AIDS, V24, P2849, DOI 10.1097/QAD.0b013e32834021ed; Rocheleau G, 2018, CLIN MICROBIOL INFEC, V24, P185, DOI 10.1016/j.cmi.2017.06.014; Schumacher W, 2007, J CLIN VIROL, V38, P304, DOI 10.1016/j.jcv.2006.12.022; Song RG, 2017, JAIDS-J ACQ IMM DEF, V74, P3, DOI 10.1097/QAI.0000000000001151; Stover J, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010157; Stover J, 2019, AIDS, V33, pS227, DOI 10.1097/QAD.0000000000002357; Sun R, 1998, J CLIN MICROBIOL, V36, P2964, DOI 10.1128/JCM.36.10.2964-2969.1998; Touloumi G, 2013, CLIN INFECT DIS, V56, P888, DOI 10.1093/cid/cis1000; U.S. Department of Veterans Affairs, CD4 COUNT T CELL COU; UN, 2015, MILLENNIUM DEV GOALS; van Sighem A, 2015, EPIDEMIOLOGY, V26, P653, DOI 10.1097/EDE.0000000000000324; Womack JA, 2020, CURR OPIN HIV AIDS, V15, P218, DOI 10.1097/COH.0000000000000635; Wong NS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159021; Yan P., 2011, STAT COMMUNICATIONS; Yu TT, 2018, BIOSTATISTICS, V19, P374, DOI 10.1093/biostatistics/kxx047	56	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2021	16	2							e0246135	10.1371/journal.pone.0246135	http://dx.doi.org/10.1371/journal.pone.0246135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QK0KW	33577551	Green Published, gold			2022-12-26	WOS:000620071700010
J	Montoya-Martinez, J; Vanthornhout, J; Bertrand, A; Francart, T				Montoya-Martinez, Jair; Vanthornhout, Jonas; Bertrand, Alexander; Francart, Tom			Effect of number and placement of EEG electrodes on measurement of neural tracking of speech	PLOS ONE			English	Article							RESPONSES; SELECTION	Measurement of neural tracking of natural running speech from the electroencephalogram (EEG) is an increasingly popular method in auditory neuroscience and has applications in audiology. The method involves decoding the envelope of the speech signal from the EEG signal, and calculating the correlation with the envelope of the audio stream that was presented to the subject. Typically EEG systems with 64 or more electrodes are used. However, in practical applications, set-ups with fewer electrodes are required. Here, we determine the optimal number of electrodes, and the best position to place a limited number of electrodes on the scalp. We propose a channel selection strategy based on an utility metric, which allows a quick quantitative assessment of the influence of a channel (or a group of channels) on the reconstruction error. We consider two use cases: a subject-specific case, where the optimal number and position of the electrodes is determined for each subject individually, and a subject-independent case, where the electrodes are placed at the same positions (in the 10-20 system) for all the subjects. We evaluated our approach using 64-channel EEG data from 90 subjects. In the subject-specific case we found that the correlation between actual and reconstructed envelope first increased with decreasing number of electrodes, with an optimum at around 20 electrodes, yielding 29% higher correlations using the optimal number of electrodes compared to all electrodes. This means that our strategy of removing electrodes can be used to improve the correlation metric in high-density EEG recordings. In the subject-independent case, we obtained a stable decoding performance when decreasing from 64 to 22 channels. When the number of channels was further decreased, the correlation decreased. For a maximal decrease in correlation of 10%, 32 well-placed electrodes were sufficient in 91% of the subjects.	[Montoya-Martinez, Jair; Vanthornhout, Jonas; Francart, Tom] Katholieke Univ Leuven, Dept Neurosci, Res Grp Expt Otorhinolaryngol, Leuven, Belgium; [Montoya-Martinez, Jair] VITO NV, Waste Recycling Technol Sustainable Mat Managemen, Mol, Belgium; [Bertrand, Alexander] Katholieke Univ Leuven, Dept Elect Engn ESAT, Stadius Ctr Dynam Syst Signal Proc & Data Analyt, Leuven, Belgium	KU Leuven; VITO; KU Leuven	Francart, T (corresponding author), Katholieke Univ Leuven, Dept Neurosci, Res Grp Expt Otorhinolaryngol, Leuven, Belgium.	tom.francart@kuleuven.be	Bertrand, Alexander/B-2990-2015	Bertrand, Alexander/0000-0002-4827-8568; Montoya Martinez, Jair/0000-0003-1778-6620	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [637424]; ERC	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission)	This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No 637424, ERC starting Grant to Tom Francart).	Aiken SJ, 2008, EAR HEARING, V29, P139, DOI 10.1097/AUD.0b013e31816453dc; [Anonymous], 2018, CONF REC ASILOMAR C; Bertrand A, 2018, IEEE SIGNAL PROC MAG, V35, P93, DOI 10.1109/MSP.2018.2856632; Biesmans W, 2017, IEEE T NEUR SYS REH, V25, P402, DOI 10.1109/TNSRE.2016.2571900; Boutsidis C, 2009, PROCEEDINGS OF THE TWENTIETH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P968; Braiman C, 2018, CURR BIOL, V28, P3833, DOI 10.1016/j.cub.2018.10.057; Brodbeck C, 2018, NEUROIMAGE, V172, P162, DOI 10.1016/j.neuroimage.2018.01.042; Crosse MJ, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00604; de Cheveigne A, 2018, NEUROIMAGE, V172, P206, DOI 10.1016/j.neuroimage.2018.01.033; de Cheveigne A, 2016, J NEUROSCI METH, V262, P14, DOI 10.1016/j.jneumeth.2016.01.005; Ding N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00311; Ding N, 2012, P NATL ACAD SCI USA, V109, P11854, DOI 10.1073/pnas.1205381109; Ding N, 2012, J NEUROPHYSIOL, V107, P78, DOI 10.1152/jn.00297.2011; Francart T, 2008, J NEUROSCI METH, V172, P283, DOI 10.1016/j.jneumeth.2008.04.020; Fuglsang SA, 2017, NEUROIMAGE, V156, P435, DOI 10.1016/j.neuroimage.2017.04.026; Goossens T, 2019, NEUROBIOL AGING, V74, P202, DOI 10.1016/j.neurobiolaging.2018.10.008; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Lalor EC, 2010, EUR J NEUROSCI, V31, P189, DOI 10.1111/j.1460-9568.2009.07055.x; Lesenfants D, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab3c92; Mirkovic B, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00349; Mirkovic B, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046007; Narayanan A. M., 2019, IEEE T BIOMEDICAL EN; O'Sullivan JA, 2015, CEREB CORTEX, V25, P1697, DOI 10.1093/cercor/bht355; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; Poelmans H, 2012, JARO-J ASSOC RES OTO, V13, P867, DOI 10.1007/s10162-012-0348-x; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Somers B, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aaac92; Sondergaard P., 2013, TECHNOLOGY BINAURAL, P33, DOI 10.1007/978-3-642-37762-4_2; Sondergaard PL, 2012, INT J WAVELETS MULTI, V10, DOI 10.1142/S0219691312500324; Van Eeckhoutte M., 2018, TRENDS HEAR, V22; Vanthornhout J, 2018, JARO-J ASSOC RES OTO, V19, P181, DOI 10.1007/s10162-018-0654-z; Vanvooren S, 2015, HEARING RES, V327, P153, DOI 10.1016/j.heares.2015.06.011; Verschueren E, 2019, HEARING RES, V373, P23, DOI 10.1016/j.heares.2018.12.004	33	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246769	10.1371/journal.pone.0246769	http://dx.doi.org/10.1371/journal.pone.0246769			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QH4VJ	33571299	Green Published, Green Accepted, gold			2022-12-26	WOS:000618274000046
